Citrus Sinensis ID: 004642

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740
Protein Sequence
MACAFSNTCRAVTVFIWAALTLLIVHVASATKISIHVAASEIERQALLNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISELRN
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHccccccccccccccccccccccEEcccccccccEEEccccccEEEcccccccccccccEEEcccccccccccccccccccccEEEccccEEcccccHHHcccccccEEEccccEEEEcccccccccccccEEEcccccccccccHHHHcccccccccccccccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccEEccccccccccccHHHHccccccEEccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccHHHHHHHHcccccccEEEEccccEEEEEEcccccEEEEEEEccccccccccHHHHHHHHHHHccccccccccEEEEEEcccccEEEEcccccccccHHcccccccccccHHHHHHHHHHHHHHHHccccccccccEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHcccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHcccHHHcccccccccccccccccccccccEcccccccEEEEEEccccccccccHHHHccccccEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHccccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccHHHccccccccccEEccccHHccccccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHHcccccEEEccccccEEEccHHHccEEEEEccccccccccHHHccccccHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccHccccccccEEEcccccccHHHHHHHHHccccccEEEcccccEEEEEEcccccEEEEEEcccccccccccccHHHHHHHHHHHccHHHHHHHHEEEccccccEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEEcccccEEEccccccHHHHccHEEEEccccccEEEEEEccccccccHcEEEEEcccccHHHHHHHHHHHHccccccccHHHHHHHHHHccccHHHccccccccccHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccccccccccHHHccc
Coil and Loop (DISEMBL)
macafsntcRAVTVFIWAALTLLIVHVASATKISIHVAASEIERQALLnsgwwkdriphnssdhcnwvgitcdyegritdidllnsnikgelgrlnfscfpnlksldlwnnslsgsippqigslsKLKCLYLhgnnltgiipkeigslrnlrglflysnklsgvlpqeignlKSLTELYVTnnalgglipstlfrltnissnqfhssipleignfsaldtldlsdnkihgiipdeltklsqlknlnlssnllsgqipyAIGKLFNLMYLdlsknklsgsipteigncsalknltlnhnsldgtipleMGKILLLQNLdlshnnlsgtipktlrpmyvdlsfnnlegeiptylrgnppksfvgnkglsgnvegfpsssqrqkltpsiSLFAKIFLPLNLVLAFIIFGFTLLFkcqnknprlnsraakngdvfsvwnydgkiLYEDLINATEDFHIKycigtggygsvykaelpegKVVALKKLhhsetedsaFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHrdissnnilldsnleasvadfgtarllhvdssyrtlragtygyiapeLAYTIVVTGKCDVYSFGVVALEVLmgthpggllsslssssgpkiMLIDVlnqrlsppvnqkiVQDIILVSTIAFAclssqpksrptMQRISQELLAGKTPMQKALKEISISELRN
Flexible Loop (DISEMBL)
MACAFSNTCRAVTVFIWAALTLLIVHVASATKISIHVAASEIERQALLNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRlnsraakngdvfSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLssqpksrptMQRISQellagktpmqkalkeisiselrn
Low Complexity Region (SEG)
MACAFSNTCRAVTVFIWAALTLLIVHVASATKISIHVAASEIERQALLNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEltklsqlknlnlssnllsGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPggllsslssssgPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISELRN
Disordered region (IsUnstruct)
**CAFSNTCRAVTVFIWAALTLLIVHVASATKISIHVAASEIERQALLNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLR*******************************SISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLL*********KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACL**************************************
Disordered Region (DISOPRED)
**********AVTVFIWAALTLLIVHVASATKISI************LNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSG**********************KIFLPLNLVLAFIIFGFTLLFK*********************WNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHH**********SFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL**************SIS****
Disordered Region (DISEMBL)
MACAFSNTCRAVTVFIWAALTLLIVHVASATKISIHVAASEIERQALLNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVE**********LTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSS********QRISQELLAGKTPMQKALKEISISELRN
Disordered Region (DISPRO)
*ACAFSNTCRAVTVFIWAALTLLIVHVASATKISIHVAASEIERQALLNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVEGFPSSS****LTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNK***********GDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK*****************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MACAFSNTCRAVTVFIWAALTLLIVHVASATKISIHVAASEIERQALLNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISELRN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	740	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.833	0.590	0.402	1e-131
Q9LP24	1120	Probable leucine-rich rep	no	no	0.858	0.566	0.382	1e-123
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.822	0.553	0.392	1e-106
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.825	0.554	0.362	1e-101
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.822	0.487	0.362	3e-97
Q6XAT2	967	LRR receptor-like serine/	no	no	0.821	0.628	0.366	5e-96
Q42371	976	LRR receptor-like serine/	no	no	0.814	0.617	0.358	1e-95
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.858	0.532	0.349	3e-94
O49318	1124	Probable leucine-rich rep	no	no	0.870	0.572	0.326	9e-93
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.801	0.591	0.350	2e-92

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  469 bits (1206), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 278/691 (40%), Positives = 393/691 (56%), Gaps = 74/691 (10%)

Query: 97   FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
            F     L+ L L +N LSG IPP I + ++L  L L  NN TG +P  I     L  L L
Sbjct: 354  FGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTL 413

Query: 157  YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTL-----FRLTNISSNQFHS----- 206
              N   G +P+ + + KSL  +    N+  G I             ++S+N FH      
Sbjct: 414  DDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSAN 473

Query: 207  -------------------SIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNL 247
                               +IP EI N + L  LDLS N+I G +P+ ++ ++++  L L
Sbjct: 474  WEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQL 533

Query: 248  SSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLE 307
            + N LSG+IP  I  L NL YLDLS N+ S  IP  + N   L  + L+ N LD TIP  
Sbjct: 534  NGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEG 593

Query: 308  MGKILLLQ------------------------NLDLSHNNLSGTIPKTLRPM----YVDL 339
            + K+  LQ                         LDLSHNNLSG IP + + M    +VD+
Sbjct: 594  LTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDV 653

Query: 340  SFNNLEGEIP--TYLRGNPPKSFVGNKGLSGNV---EGFP--SSSQRQKLTPSISLFAKI 392
            S NNL+G IP     R  PP +F GNK L G+V   +G    S +  +K     +L   I
Sbjct: 654  SHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYI 713

Query: 393  FLPL--NLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATE 450
             +P+   +++  +  G  + F+ + K    ++ +   G+  S++++DGK+ Y+++I AT 
Sbjct: 714  LVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATG 773

Query: 451  DFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFV-----KSFQNEAHVLST 505
            +F  KY IGTGG+G VYKA+LP   ++A+KKL+  ET DS+       + F NE   L+ 
Sbjct: 774  EFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLN--ETTDSSISNPSTKQEFLNEIRALTE 830

Query: 506  VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
            +RHRN+VKL+GFC H++  FL+YEYMERGSL  VL +DDEA +L+W KR+N+VK VAHAL
Sbjct: 831  IRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHAL 890

Query: 566  SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
            SY+HHD + +I+HRDISS NILL  + EA ++DFGTA+LL  DSS  +  AGTYGY+APE
Sbjct: 891  SYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPE 950

Query: 626  LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ 685
            LAY + VT KCDVYSFGV+ LEV+ G HPG L+S+LSSS     + +  ++    P    
Sbjct: 951  LAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTP 1010

Query: 686  KIVQDIILVSTIAFACLSSQPKSRPTMQRIS 716
            +I ++++ +  +A  CL S P++RPTM  IS
Sbjct: 1011 EIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  441 bits (1135), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 270/705 (38%), Positives = 389/705 (55%), Gaps = 70/705 (9%)

Query: 78   ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
            + ++DL  + + G +   +F  F  L+SL L  N LSG+IPP + + S L  L L  NN 
Sbjct: 416  MINLDLSQNKLTGSVPD-SFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNF 474

Query: 138  TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTE-------------------- 177
            TG  P+ +   R L+ + L  N L G +P+ + + KSL                      
Sbjct: 475  TGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYP 534

Query: 178  ----------------------------LYVTNNALGGLIPSTLFRLT-----NISSNQF 204
                                        L ++NN + G IP+ ++ +T     ++S+N  
Sbjct: 535  DLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNL 594

Query: 205  HSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLF 264
               +P  IGN + L  L L+ N++ G +P  L+ L+ L++L+LSSN  S +IP       
Sbjct: 595  FGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFL 654

Query: 265  NLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNL 324
             L  ++LS+NK  GSIP  +   + L  L L+HN LDG IP ++  +  L  LDLSHNNL
Sbjct: 655  KLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNL 713

Query: 325  SGTIPKTLRPMY----VDLSFNNLEGEIPTY--LRGNPPKSFVGNKGLSGNV--EGFPSS 376
            SG IP T   M     VD+S N LEG +P     R     +   N GL  N+  +     
Sbjct: 714  SGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPC 773

Query: 377  SQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAA--KNGDVFSVW 434
             + +K   + +L   I +P+  VL  +         C  K    N R    + G+  S++
Sbjct: 774  RELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIF 833

Query: 435  NYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHS---ETEDSA 491
            + DGK  Y+D+I +T +F   + IGTGGY  VY+A L +  ++A+K+LH +   E     
Sbjct: 834  SVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANL-QDTIIAVKRLHDTIDEEISKPV 892

Query: 492  FVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNW 551
              + F NE   L+ +RHRN+VKL+GFC H++  FLIYEYME+GSL  +L +D+EA  L W
Sbjct: 893  VKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTW 952

Query: 552  TKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY 611
            TKR+N+VK VAHALSY+HHD    I+HRDISS NILLD++  A ++DFGTA+LL  DSS 
Sbjct: 953  TKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSN 1012

Query: 612  RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIML 671
             +  AGTYGY+APE AYT+ VT KCDVYSFGV+ LE+++G HPG L+SSLSSS G  + L
Sbjct: 1013 WSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSL 1072

Query: 672  IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRIS 716
              + ++R+  P  Q   + ++ +  +A  CL + P+SRPTM  IS
Sbjct: 1073 RSISDERVLEPRGQN-REKLLKMVEMALLCLQANPESRPTMLSIS 1116

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  385 bits (990), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 258/658 (39%), Positives = 362/658 (55%), Gaps = 49/658 (7%)

Query: 96   NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
            +F  F  L  L L +N LSG+IP  + +   L  L L  N LTG +P E+ +L+NL  L 
Sbjct: 422  HFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALE 481

Query: 156  LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT-----NISSNQFHSSIPL 210
            L+ N LSG +  ++G LK+L  L + NN   G IP  +  LT     NISSNQ    IP 
Sbjct: 482  LHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPK 541

Query: 211  EIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLD 270
            E+G+   +  LDLS NK  G I  EL +L  L+ L LS N L+G+IP++ G L  LM L 
Sbjct: 542  ELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQ 601

Query: 271  LSKNKLSGSIPTEIGNCSALK-NLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIP 329
            L  N LS +IP E+G  ++L+ +L ++HN+L GTIP  +G + +L+ L L+ N LSG IP
Sbjct: 602  LGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIP 661

Query: 330  KT----LRPMYVDLSFNNLEGEIP--TYLRGNPPKSFVGNKGLSGNVEG-----FPSS-- 376
             +    +  +  ++S NNL G +P     +     +F GN GL  +         P S  
Sbjct: 662  ASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDS 721

Query: 377  --------SQRQK-LTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKN 427
                    SQRQK LT +  +   +FL   L L + I         + + P   +   + 
Sbjct: 722  KLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTI---------KRREPAFVALEDQT 772

Query: 428  G-DVFSVWNYDGK-ILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHS 485
              DV   + +  K   Y+ L++AT +F     +G G  G+VYKAE+  G+V+A+KKL+ S
Sbjct: 773  KPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLN-S 831

Query: 486  ETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDE 545
              E ++   SF+ E   L  +RHRNIVKLYGFC H+    L+YEYM +GSL   L   ++
Sbjct: 832  RGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEK 891

Query: 546  AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL 605
               L+W  R  I    A  L YLHHDC   I+HRDI SNNILLD   +A V DFG A+L+
Sbjct: 892  NCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLI 951

Query: 606  HVD-SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP-------GGL 657
             +  S   +  AG+YGYIAPE AYT+ VT KCD+YSFGVV LE++ G  P       G L
Sbjct: 952  DLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDL 1011

Query: 658  LSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
            ++ +  S    I  I++ + RL    +++ V ++ LV  IA  C S+ P SRPTM+ +
Sbjct: 1012 VNWVRRSIRNMIPTIEMFDARLDTN-DKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  370 bits (951), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 256/706 (36%), Positives = 369/706 (52%), Gaps = 95/706 (13%)

Query: 95   LNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGL 154
            L F     L  L L+ NSLSG+IPP++G  S L  L +  N+L+G IP  +    N+  L
Sbjct: 379  LGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIIL 438

Query: 155  FLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISS-----NQFHSSIP 209
             L +N LSG +P  I   K+L +L +  N L G  PS L +  N+++     N+F  SIP
Sbjct: 439  NLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIP 498

Query: 210  LEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI--------- 260
             E+GN SAL  L L+DN   G +P E+  LSQL  LN+SSN L+G++P  I         
Sbjct: 499  REVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRL 558

Query: 261  ---------------GKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIP 305
                           G L+ L  L LS N LSG+IP  +GN S L  L +  N  +G+IP
Sbjct: 559  DMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIP 618

Query: 306  LEMGKILLLQ-NLDLSHNNLSGTIPKTLRPMYV--------------------------- 337
             E+G +  LQ  L+LS+N L+G IP  L  + +                           
Sbjct: 619  RELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLG 678

Query: 338  -DLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGN-----VEGFPSSSQRQKLTPSISLFAK 391
             + S+N+L G IP  LR     SF+GN+GL G      ++  P +  +    P     +K
Sbjct: 679  YNFSYNSLTGPIP-LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSK 737

Query: 392  IFLPLNLVLAFIIFGFTLLFKC-----QNKNPRLNSRAAKNG-------DVFSVWNYDGK 439
            I      + A +I G +L+          +  R  + +A++G       D++  +     
Sbjct: 738  IIA----ITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIY--FPPKEG 791

Query: 440  ILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKL--HHSETEDSAFVKSFQ 497
              ++DL+ AT++F   + +G G  G+VYKA LP G  +A+KKL  +H    ++    SF+
Sbjct: 792  FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFR 851

Query: 498  NEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI 557
             E   L  +RHRNIVKL+GFC H+    L+YEYM +GSL  +LHD   +  L+W+KR  I
Sbjct: 852  AEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDP--SCNLDWSKRFKI 909

Query: 558  VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-SSYRTLRA 616
                A  L+YLHHDC   I HRDI SNNILLD   EA V DFG A+++ +  S   +  A
Sbjct: 910  ALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIA 969

Query: 617  GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP-------GGLLSSLSSSSGPKI 669
            G+YGYIAPE AYT+ VT K D+YS+GVV LE+L G  P       G +++ + S      
Sbjct: 970  GSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDA 1029

Query: 670  MLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
            +   VL+ RL+   +++IV  ++ V  IA  C S  P +RP+M+++
Sbjct: 1030 LSSGVLDARLTLE-DERIVSHMLTVLKIALLCTSVSPVARPSMRQV 1074

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  356 bits (914), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 241/665 (36%), Positives = 348/665 (52%), Gaps = 56/665 (8%)

Query: 105  SLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGV 164
            S D+ NN     IP ++G+   L  L L  N LTG IP  +G +R L  L + SN L+G 
Sbjct: 579  SFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGT 638

Query: 165  LPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNI-----SSNQFHSSIPLEIGNFSALD 219
            +P ++   K LT + + NN L G IP  L +L+ +     SSNQF  S+P E+ N + L 
Sbjct: 639  IPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLL 698

Query: 220  TLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGS 279
             L L  N ++G IP E+  L  L  LNL  N  SG +P A+GKL  L  L LS+N L+G 
Sbjct: 699  VLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGE 758

Query: 280  IPTEIGNCSALKN-LTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM--- 335
            IP EIG    L++ L L++N+  G IP  +G +  L+ LDLSHN L+G +P ++  M   
Sbjct: 759  IPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSL 818

Query: 336  -YVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGN----VEGFPSSSQRQKLTPSISLFA 390
             Y+++SFNNL G++       P  SF+GN GL G+         S++++Q L+    +  
Sbjct: 819  GYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVII 878

Query: 391  KIFLPLNLVLAFIIFGFTLLFKCQN---KNPRLNSRA---------AKNGDVFSVWNYDG 438
                 L   +  +I    L FK ++   K     S A         A +  +F       
Sbjct: 879  SAISALT-AIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKS 937

Query: 439  KILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQN 498
             I +ED++ AT +   ++ IG+GG G VYKAEL  G+ VA+KK+   +  D    KSF  
Sbjct: 938  DIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKD--DLMSNKSFSR 995

Query: 499  EAHVLSTVRHRNIVKLYGFCLHKK--CMFLIYEYMERGSLFCVLHDDDEAIE-----LNW 551
            E   L  +RHR++VKL G+C  K      LIYEYM+ GS++  LH+D   +E     L+W
Sbjct: 996  EVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDW 1055

Query: 552  TKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL----HV 607
              R+ I   +A  + YLHHDC   I+HRDI S+N+LLDSN+EA + DFG A++L      
Sbjct: 1056 EARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDT 1115

Query: 608  DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGG----------- 656
            ++   T  A +YGYIAPE AY++  T K DVYS G+V +E++ G  P             
Sbjct: 1116 NTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVR 1175

Query: 657  -LLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
             + + L  +   +  LID   + L P       Q    V  IA  C  + P+ RP+ ++ 
Sbjct: 1176 WVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQ----VLEIALQCTKTSPQERPSSRQA 1231

Query: 716  SQELL 720
               LL
Sbjct: 1232 CDSLL 1236

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1

 Score =  352 bits (904), Expect = 5e-96,   Method: Compositional matrix adjust.
 Identities = 235/641 (36%), Positives = 349/641 (54%), Gaps = 33/641 (5%)

Query: 103 LKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLS 162
           L  LDL +N L+G IPP +G+LS    LYLHGN LTG IP E+G++  L  L L  N+L 
Sbjct: 290 LAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNMSRLSYLQLNDNELV 349

Query: 163 GVLPQEIGNLKSLTELYVTNNALGGLIPSTL-----FRLTNISSNQFHSSIPLEIGNFSA 217
           G +P E+G L+ L EL + NN L GLIPS +         N+  N    ++PLE  N  +
Sbjct: 350 GKIPPELGKLEQLFELNLANNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGS 409

Query: 218 LDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLS 277
           L  L+LS N   G IP EL  +  L  L+LS N  SG IP  +G L +L+ L+LS+N L+
Sbjct: 410 LTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLN 469

Query: 278 GSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMY- 336
           G++P E GN  +++ + ++ N L G IP E+G++  + +L L++N + G IP  L   + 
Sbjct: 470 GTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFS 529

Query: 337 ---VDLSFNNLEGEIP---TYLRGNPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISLFA 390
              +++SFNNL G IP    + R +P  SF GN  L GN  G    S      P   +F 
Sbjct: 530 LANLNISFNNLSGIIPPMKNFTRFSP-ASFFGNPFLCGNWVG----SICGPSLPKSQVFT 584

Query: 391 KIFLPLNLVLAFIIFG---FTLLFKCQNKNPRL--NSRAAKNGDVFSVWNYDGKI-LYED 444
           ++ + + +VL FI      F  ++K + + P L  +S+  +      + + D  I  ++D
Sbjct: 585 RVAV-ICMVLGFITLICMIFIAVYKSKQQKPVLKGSSKQPEGSTKLVILHMDMAIHTFDD 643

Query: 445 LINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           ++  TE+   KY IG G   +VYK      + +A+K++++    +    + F+ E   + 
Sbjct: 644 IMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSN---FREFETELETIG 700

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           ++RHRNIV L+G+ L      L Y+YME GSL+ +LH   + ++L+W  R+ I    A  
Sbjct: 701 SIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLKIAVGAAQG 760

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY-RTLRAGTYGYIA 623
           L+YLHHDCT  IIHRDI S+NILLD N EA ++DFG A+ +    +Y  T   GT GYI 
Sbjct: 761 LAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAKSIPATKTYASTYVLGTIGYID 820

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP---GGLLSSLSSSSGPKIMLIDVLNQRLS 680
           PE A T  +  K D+YSFG+V LE+L G         L  +  S      +++ ++  +S
Sbjct: 821 PEYARTSRLNEKSDIYSFGIVLLELLTGKKAVDNEANLHQMILSKADDNTVMEAVDAEVS 880

Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA 721
             V       I     +A  C    P  RPTMQ +S+ LL+
Sbjct: 881 --VTCMDSGHIKKTFQLALLCTKRNPLERPTMQEVSRVLLS 919

Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1

 Score =  351 bits (901), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 231/644 (35%), Positives = 354/644 (54%), Gaps = 41/644 (6%)

Query: 103 LKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLS 162
           L  LDL  N LSGSIPP +G+L+  + LYLH N LTG IP E+G++  L  L L  N L+
Sbjct: 285 LAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLT 344

Query: 163 GVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISS-----NQFHSSIPLEIGNFSA 217
           G +P E+G L  L +L V NN L G IP  L   TN++S     N+F  +IP       +
Sbjct: 345 GHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLES 404

Query: 218 LDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLS 277
           +  L+LS N I G IP EL+++  L  L+LS+N ++G IP ++G L +L+ ++LS+N ++
Sbjct: 405 MTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHIT 464

Query: 278 GSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSG---TIPKTLRP 334
           G +P + GN  ++  + L++N + G IP E+ ++  +  L L +NNL+G   ++   L  
Sbjct: 465 GVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSL 524

Query: 335 MYVDLSFNNLEGEIP---TYLRGNPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISLFAK 391
             +++S NNL G+IP    + R +P  SF+GN GL G+    P    R+ +  SIS  A 
Sbjct: 525 TVLNVSHNNLVGDIPKNNNFSRFSP-DSFIGNPGLCGSWLNSPCHDSRRTVRVSISRAAI 583

Query: 392 IFLPLNLVLAFIIFGFTLLFKCQNKNP------RLNSRAAKNGDVFSVWNYDGKI-LYED 444
           + + +      +I    L+  C+  NP       L+     +     + + +  + +YED
Sbjct: 584 LGIAIG---GLVILLMVLIAACRPHNPPPFLDGSLDKPVTYSTPKLVILHMNMALHVYED 640

Query: 445 LINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           ++  TE+   KY IG G   +VYK  L   K VA+K+L+   + +   +K F+ E  +LS
Sbjct: 641 IMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLY---SHNPQSMKQFETELEMLS 697

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           +++HRN+V L  + L      L Y+Y+E GSL+ +LH   +   L+W  R+ I    A  
Sbjct: 698 SIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKTLDWDTRLKIAYGAAQG 757

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY-RTLRAGTYGYIA 623
           L+YLHHDC+  IIHRD+ S+NILLD +LEA + DFG A+ L V  S+  T   GT GYI 
Sbjct: 758 LAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCVSKSHTSTYVMGTIGYID 817

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSL-----SSSSGPKIMLIDVLNQR 678
           PE A T  +T K DVYS+G+V LE+L         S+L     S +   ++M        
Sbjct: 818 PEYARTSRLTEKSDVYSYGIVLLELLTRRKAVDDESNLHHLIMSKTGNNEVM-------E 870

Query: 679 LSPPVNQKIVQDIILVSTI---AFACLSSQPKSRPTMQRISQEL 719
           ++ P      +D+ +V  +   A  C   QP  RPTM ++++ L
Sbjct: 871 MADPDITSTCKDLGVVKKVFQLALLCTKRQPNDRPTMHQVTRVL 914

Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  346 bits (888), Expect = 3e-94,   Method: Compositional matrix adjust.
 Identities = 253/723 (34%), Positives = 373/723 (51%), Gaps = 88/723 (12%)

Query: 76   GRITDIDLLNSNIKGELGRL--NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLH 133
            G++T + +LN N     G++        +L +LDL +N+L G IP +I +L++L+CL L 
Sbjct: 493  GKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLS 552

Query: 134  GNNLTGIIPK---------EIGSLRNLR--GLF-LYSNKLSGVLPQEIGNLKSLTELYVT 181
             NNL+G IP          E+  L  L+  G+F L  N+LSG +P+E+G    L E+ ++
Sbjct: 553  YNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLS 612

Query: 182  NNALGGLIPSTLFRLTNI-----SSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEL 236
            NN L G IP++L RLTN+     S N    SIP E+GN   L  L+L++N+++G IP+  
Sbjct: 613  NNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESF 672

Query: 237  TKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLN 296
              L  L  LNL+ N L G +P ++G L  L ++DLS N LSG + +E+     L  L + 
Sbjct: 673  GLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIE 732

Query: 297  HNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPT-Y 351
             N   G IP E+G +  L+ LD+S N LSG IP  +  +    +++L+ NNL GE+P+  
Sbjct: 733  QNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDG 792

Query: 352  LRGNPPKSFV-GNKGLSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLL 410
            +  +P K+ + GNK L G V G     +  KL  +  +         L+L F I  F  +
Sbjct: 793  VCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGIAG-------LMLGFTIIVFVFV 845

Query: 411  FKC----------QNKNPRLNSRAAKNGDV-----------------FSVWNYDG---KI 440
            F            Q  +P     +   G V                  ++  ++    K+
Sbjct: 846  FSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKV 905

Query: 441  LYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
               D++ AT+ F  K  IG GG+G+VYKA LP  K VA+KKL  ++T+ +   + F  E 
Sbjct: 906  RLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGN---REFMAEM 962

Query: 501  HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE-LNWTKRVNIVK 559
              L  V+H N+V L G+C   +   L+YEYM  GSL   L +    +E L+W+KR+ I  
Sbjct: 963  ETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAV 1022

Query: 560  SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV-DSSYRTLRAGT 618
              A  L++LHH     IIHRDI ++NILLD + E  VADFG ARL+   +S   T+ AGT
Sbjct: 1023 GAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGT 1082

Query: 619  YGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIM--LIDVLN 676
            +GYI PE   +   T K DVYSFGV+ LE++ G  P G       S G  ++   I  +N
Sbjct: 1083 FGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTG--PDFKESEGGNLVGWAIQKIN 1140

Query: 677  QRLSPPVNQKIVQDIILVST------IAFACLSSQPKSRPTMQRISQELLAGKTPMQKAL 730
            Q  +  V   ++  + L ++      IA  CL+  P  RP M  +            KAL
Sbjct: 1141 QGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDV-----------LKAL 1189

Query: 731  KEI 733
            KEI
Sbjct: 1190 KEI 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  342 bits (876), Expect = 9e-93,   Method: Compositional matrix adjust.
 Identities = 267/817 (32%), Positives = 378/817 (46%), Gaps = 173/817 (21%)

Query: 84   LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPK 143
            LN  I  ELG+L+      +  +D   N LSG IP ++  +S+L+ LYL  N LTGIIP 
Sbjct: 313  LNGTIPKELGKLS-----KVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPN 367

Query: 144  EIGSLRNL------------------------RGLFLYSNKLSGVLPQEIG--------- 170
            E+  LRNL                        R L L+ N LSGV+PQ +G         
Sbjct: 368  ELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVD 427

Query: 171  ---------------------------------------NLKSLTELYVTNNALGGLIPS 191
                                                     KSL +L V  N L G  P+
Sbjct: 428  FSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPT 487

Query: 192  TLFRLTNISS-----------------------------NQFHSSIPLEIGNFSALDTLD 222
             L +L N+S+                             NQF S++P EI   S L T +
Sbjct: 488  ELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFN 547

Query: 223  LSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPT 282
            +S N + G IP E+     L+ L+LS N   G +P  +G L  L  L LS+N+ SG+IP 
Sbjct: 548  VSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPF 607

Query: 283  EIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQ-NLDLSHNNLSGTIPKTLRP----MYV 337
             IGN + L  L +  N   G+IP ++G +  LQ  ++LS+N+ SG IP  +      MY+
Sbjct: 608  TIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYL 667

Query: 338  DLSFNNLEGEIPTY----------------LRGNPP----------KSFVGNKGLSG--- 368
             L+ N+L GEIPT                 L G  P           SF+GNKGL G   
Sbjct: 668  SLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHL 727

Query: 369  -----------NVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKN 417
                       ++    + S R+     I       + L L+   + F   L    +   
Sbjct: 728  RSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHF---LRNPVEPTA 784

Query: 418  PRLNSRAA--KNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGK 475
            P ++ +    +  D++ V     +   +D++ AT+ FH  Y +G G  G+VYKA +P GK
Sbjct: 785  PYVHDKEPFFQESDIYFV--PKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGK 842

Query: 476  VVALKKLH----HSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCMFLIYE 529
             +A+KKL      +    +    SF+ E   L  +RHRNIV+LY FC H+      L+YE
Sbjct: 843  TIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYE 902

Query: 530  YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD 589
            YM RGSL  +LH   ++  ++W  R  I    A  L+YLHHDC   IIHRDI SNNIL+D
Sbjct: 903  YMSRGSLGELLH-GGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILID 961

Query: 590  SNLEASVADFGTARLLHVD-SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
             N EA V DFG A+++ +  S   +  AG+YGYIAPE AYT+ VT KCD+YSFGVV LE+
Sbjct: 962  ENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLEL 1021

Query: 649  LMGTHP------GGLLSSLSSSSGPKIMLI-DVLNQRLSPPVNQKIVQDIILVSTIAFAC 701
            L G  P      GG L++ + +      L  ++L+  L+   +  I+  +I V+ IA  C
Sbjct: 1022 LTGKAPVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLC 1081

Query: 702  LSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
              S P  RPTM+ +   L+       K +   + S+L
Sbjct: 1082 TKSSPSDRPTMREVVLMLIESGERAGKVIVSTTCSDL 1118

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  340 bits (873), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 236/674 (35%), Positives = 330/674 (48%), Gaps = 81/674 (12%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSN 159
            P L+ L LW N+ +GSIP ++G   +L  L L  N LTG +P  + S   L  L    N
Sbjct: 334 MPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGN 393

Query: 160 KLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRL----------------------- 196
            L G +P  +G  +SLT + +  N L G IP  LF L                       
Sbjct: 394 FLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGG 453

Query: 197 -------TNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSS 249
                   ++S+NQ   S+P  IGN S +  L L  NK  G IP E+ +L QL  L+ S 
Sbjct: 454 VSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSH 513

Query: 250 NLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMG 309
           NL SG+I   I +   L ++DLS+N+LSG IP E+     L  L L+ N L G+IP+ + 
Sbjct: 514 NLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIA 573

Query: 310 KILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGN 369
            +  L ++D S+NNLSG +P T +  Y + +                  SFVGN  L G 
Sbjct: 574 SMQSLTSVDFSYNNLSGLVPSTGQFSYFNYT------------------SFVGNSHLCGP 615

Query: 370 VEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGD 429
             G       Q     +S   K+ L L L+   ++F    + K         +R+ +N  
Sbjct: 616 YLGPCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIK---------ARSLRNAS 666

Query: 430 VFSVWNYDG----KILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHS 485
               W            +D++++ ++ +I   IG GG G VYK  +P+G +VA+K+L  +
Sbjct: 667 EAKAWRLTAFQRLDFTCDDVLDSLKEDNI---IGKGGAGIVYKGTMPKGDLVAVKRL-AT 722

Query: 486 ETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDE 545
            +  S+    F  E   L  +RHR+IV+L GFC + +   L+YEYM  GSL  VLH    
Sbjct: 723 MSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG 782

Query: 546 AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL 605
              L+W  R  I    A  L YLHHDC+  I+HRD+ SNNILLDSN EA VADFG A+ L
Sbjct: 783 G-HLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL 841

Query: 606 HVDSSYRTLR--AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSS--- 660
               +   +   AG+YGYIAPE AYT+ V  K DVYSFGVV LE++ G  P G       
Sbjct: 842 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVD 901

Query: 661 -----LSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
                 S +   K  ++ V++ RLS       V ++  V  +A  C+  Q   RPTM+ +
Sbjct: 902 IVQWVRSMTDSNKDCVLKVIDLRLS----SVPVHEVTHVFYVALLCVEEQAVERPTMREV 957

Query: 716 SQELLA-GKTPMQK 728
            Q L    K P+ K
Sbjct: 958 VQILTEIPKIPLSK 971

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	740
225452698	727	PREDICTED: probable LRR receptor-like se	0.920	0.936	0.521	0.0
359488983	758	PREDICTED: probable LRR receptor-like se	0.962	0.939	0.473	0.0
359488981	757	PREDICTED: probable LRR receptor-like se	0.962	0.940	0.471	0.0
225466223	736	PREDICTED: probable leucine-rich repeat	0.962	0.967	0.477	0.0
225452749	783	PREDICTED: probable LRR receptor-like se	0.975	0.922	0.459	0.0
359484066	843	PREDICTED: probable LRR receptor-like se	0.851	0.747	0.529	1e-180
296085303	789	unnamed protein product [Vitis vinifera]	0.851	0.798	0.529	1e-180
225465647	820	PREDICTED: probable LRR receptor-like se	0.820	0.740	0.524	1e-176
359484068	868	PREDICTED: probable leucine-rich repeat	0.910	0.776	0.491	1e-176
296085307	874	unnamed protein product [Vitis vinifera]	0.910	0.771	0.491	1e-176

>gi|225452698|ref|XP_002276923.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/702 (52%), Positives = 486/702 (69%), Gaps = 21/702 (2%)

Query: 40  SEIERQALLNSGWWK-DRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFS 98
           S++E++ALL SGWW  +    + SDHC+W GITC+ EG +  +    S   GEL +L FS
Sbjct: 16  SQVEKEALLESGWWSGETDHDHDSDHCDWSGITCNEEGHVIAVYYRAS---GELSKLKFS 72

Query: 99  CFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
            FP+L+++DL +  LSG IP QIGSL+K+  L L  N L+G IP +I +L  L  L L  
Sbjct: 73  SFPSLRTIDLHDGRLSGRIPHQIGSLTKVIYLDLSRNELSGSIPDQIATLTKLTYLDLSR 132

Query: 159 NKLSGVLPQEIGNLKSLTELYVTNNALGGLIPS---TLFRLTNIS--SNQFHSSIPLEIG 213
           N+LSG +P +I  L SL  L +++N L G IP    TL RLT++   SN+   SIP EI 
Sbjct: 133 NELSGSIPPQINTLTSLNYLDLSHNELNGRIPQQIGTLIRLTHLDLYSNELSGSIPDEID 192

Query: 214 NFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSK 273
             + L  LDLS+N ++G IP +L  L++L   +LS N LSG IP + G L NL+ L L+ 
Sbjct: 193 TLTELAYLDLSNNVLNGSIPHQLGALAKLTYFDLSWNELSGDIPSSFGHLSNLISLCLNN 252

Query: 274 NKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLR 333
           N+++G IP +IGN   L +L L+ NS+ G IP ++  +  L+NL+LS N LSG IP +L 
Sbjct: 253 NQINGPIPEDIGNLEDLVDLDLSSNSISGKIPSQIQNLKRLENLNLSRNKLSGAIPPSLT 312

Query: 334 PMY----VDLSFNNLEGEIPTYLR-GNPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISL 388
             Y    +DLS+N+LEG IP  L+  +PP  F  NK L G +  +P   + QK+T    L
Sbjct: 313 YDYKWTSIDLSYNDLEGHIPFELQFESPPGVFEHNKHLCGEIRHWPHCKKGQKIT----L 368

Query: 389 FAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAA--KNGDVFSVWNYDGKILYEDLI 446
              I L   L +AF    F LL +   K   +++ AA  + GD+FSVW+YDG I Y+D+I
Sbjct: 369 ILVISLLATLCIAFAFLKFLLLPRKMRKMRHMSASAAETRRGDLFSVWDYDGTIAYQDII 428

Query: 447 NATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            +TE+F IKYC+G GGYGSVY+A+LP GKVVALKKLH  E E+  ++KSF+NEA +LS +
Sbjct: 429 QSTENFDIKYCVGVGGYGSVYRAQLPCGKVVALKKLHGWEREEPTYLKSFENEAQILSKI 488

Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RHRNIVKL+GFCLH++ MFL+Y++MERGSLFC+L  + EA+EL+WTKR+N+VKS+AHALS
Sbjct: 489 RHRNIVKLHGFCLHRRSMFLVYQFMERGSLFCMLSHEVEALELDWTKRLNVVKSIAHALS 548

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y+HHDC+  IIHRDISSNN+LL+S LEA V+DFGTARLL  DSS +TL  GTYGYIAPEL
Sbjct: 549 YMHHDCSPPIIHRDISSNNVLLNSQLEAFVSDFGTARLLDPDSSIQTLLVGTYGYIAPEL 608

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK 686
           AYT+ VT KCDVYSFGVVALE +MG HP  +++SLSSSSG  I+L DVL+ RL+ P N +
Sbjct: 609 AYTMTVTKKCDVYSFGVVALETMMGKHPREVITSLSSSSGQDILLRDVLDPRLALPENPQ 668

Query: 687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQK 728
           + +DI+ V  +A  C+ S P+SRPTMQ+IS +LL G  P  K
Sbjct: 669 VAKDIVFVVLLALKCIHSNPQSRPTMQQISYKLL-GDIPFPK 709

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488983|ref|XP_002277433.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  664 bits (1713), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/763 (47%), Positives = 496/763 (65%), Gaps = 51/763 (6%)

Query: 13  TVFIWAALTLLIVHVASATKISIHVAASEIERQALLNSGWWKDRIPHNSSDHCNWVGITC 72
           T  +    T++++  + A  IS   ++++ E +AL ++GWW     +++S HC+W G+ C
Sbjct: 9   TAVVIVTSTMMMMLFSLAKAISSPSSSTD-EAEALRSTGWW-----NSTSAHCHWDGVYC 62

Query: 73  DYEGRITDIDLLNSNIK-GELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLY 131
           +  GR+T I L  S  + GEL +L FS FP+L  L+L    L+GSIP QIG+L++L  L 
Sbjct: 63  NNAGRVTGIALNGSGKELGELSKLEFSSFPSLVELNLCACGLNGSIPHQIGTLTQLTVLS 122

Query: 132 LHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLT--ELYVTN------- 182
           LH NNLTG IP  + +L  L  L L SN L G +P EIG +K+L   +L  +N       
Sbjct: 123 LHDNNLTGEIPLSLANLTQLLYLTLCSNPLHGSIPPEIGKMKNLIFLDLGYSNLIGVIPS 182

Query: 183 ---------------NALGGLIPSTLFRLTNISS-----NQFHSSIPLEIGNFSALDTLD 222
                          N + GLIP  + ++ N+ S     N  H  IP EIG    L+ L+
Sbjct: 183 SFGNLTTLTTLYLDGNQISGLIPPQIGKMKNLKSLLLSHNGLHGPIPPEIGGMKNLNKLN 242

Query: 223 LSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPT 282
           L  N + G+IP     L+ + +L+   N +SG IP  I  L NL YLDLS+N++SG IP 
Sbjct: 243 LGYNNLTGVIPSSFGNLTNMNSLSFRGNQISGFIPLEIWYLLNLSYLDLSENQISGFIPE 302

Query: 283 EIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMY-----V 337
           EI N   L +L +++N + G IP ++G +  ++  +LSHNNLSGTIP ++   Y     +
Sbjct: 303 EIVNLKKLSHLDMSNNLISGKIPSQLGNLKEVKYFNLSHNNLSGTIPYSISSNYNKWTLI 362

Query: 338 DLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISLFAKIFLPLN 397
           DLS N LEG+        P ++F  NKGL G ++G P   +R ++T    L   + L   
Sbjct: 363 DLSNNRLEGQTRA-----PVEAFGHNKGLCGEIKGRPRCKKRHQIT----LIIVVSLSTT 413

Query: 398 LVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYC 457
           L+L+  I GF    +   KN  L +   KNGD+FS+W+YDG I Y+D+I ATEDF IKYC
Sbjct: 414 LLLSIAILGFLFHKRRIRKNQLLETTKVKNGDLFSIWDYDGVIAYQDIIQATEDFDIKYC 473

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IGTGGYGSVY+A+LP GKVVALKKLH  E  D  ++KSF+NE  +L+ +RHRNIVKL+GF
Sbjct: 474 IGTGGYGSVYRAQLPSGKVVALKKLHGWERGDPTYLKSFENEVQMLTRIRHRNIVKLHGF 533

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           CLHK+CMFL+Y+YME+GSL+C+L D+ EA+EL+W KRVN+VKS+A+ALSY+HHDC L II
Sbjct: 534 CLHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHHDCDLPII 593

Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCD 637
           HRDISSNNILLDS LEA V+DFGTARLL  DSS RTL  GTYGYIAPELAYT+VVT KCD
Sbjct: 594 HRDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLVGTYGYIAPELAYTMVVTEKCD 653

Query: 638 VYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTI 697
           +YSFG+VALE +MG HPG  ++SLSSSS     L DVL+ RLS P + ++  +I L+ ++
Sbjct: 654 IYSFGMVALETMMGMHPGEFVTSLSSSSTQNTTLKDVLDSRLSSPKSTQVANNIALIVSL 713

Query: 698 AFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISELRN 740
           A  CL S P+ RP+MQ +S +L++ ++   + +  IS+ +L++
Sbjct: 714 ALKCLHSNPQFRPSMQEVSSKLVSTRS-FPQPISTISLLQLKD 755

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488981|ref|XP_002275364.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  663 bits (1710), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 359/762 (47%), Positives = 496/762 (65%), Gaps = 50/762 (6%)

Query: 13  TVFIWAALTLLIVHVASATKISIHVAASEIERQALLNSGWWKDRIPHNSSDHCNWVGITC 72
           T  +    T++++  + A  IS   ++++ E +AL ++GWW     +++S HC+W G+ C
Sbjct: 9   TAVVIVTSTMMMMLFSLAKAISSPSSSTD-EAEALRSTGWW-----NSTSAHCHWDGVYC 62

Query: 73  DYEGRITDIDLLNSNIK-GELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLY 131
           +  GR+T I L  S  + GEL +L FS FP+L  L+L    L+GSIP QIG+L++L  L 
Sbjct: 63  NNAGRVTGIALYGSGKELGELSKLEFSSFPSLVELNLSACGLNGSIPHQIGTLTQLTVLS 122

Query: 132 LHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLT--ELYVTN------- 182
           LH NNLTG IP  + +L  L  L L SN L G +P EIG +K+L   +L  +N       
Sbjct: 123 LHDNNLTGEIPLSLANLTQLLYLTLCSNPLHGSIPPEIGKMKNLIFLDLGYSNLIGVIPS 182

Query: 183 ---------------NALGGLIPSTLFRLTNISS-----NQFHSSIPLEIGNFSALDTLD 222
                          N + G IP  + ++ N+ S     N  H  IP EIG    L+ L+
Sbjct: 183 SFGNLTTLTTLYLDGNQISGFIPPQIGKMKNLKSLLLSYNGLHGPIPPEIGKMKNLNKLN 242

Query: 223 LSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPT 282
           L  N + G+IP     L+ + +L+   N +SG IP  IG L NL YLDLS+N++SG IP 
Sbjct: 243 LGYNNLTGVIPSSFGNLTNMNSLSFRGNQISGFIPPEIGHLLNLSYLDLSENQISGFIPE 302

Query: 283 EIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMY----VD 338
           E+ N   L +L +++N + G IP ++G +  ++  +LSHNNLSGTIP ++   Y    +D
Sbjct: 303 EMVNLKKLSHLDMSNNLISGKIPSQLGNLKEVKYFNLSHNNLSGTIPYSISSNYRWTLID 362

Query: 339 LSFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNL 398
           LS N LEG+        P ++F  NKGL G ++G+    +R ++T    L   + L   L
Sbjct: 363 LSNNRLEGQARA-----PVEAFGHNKGLCGEIKGWARCKKRHQIT----LIIVVSLSTTL 413

Query: 399 VLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCI 458
           +L+  I GF    +   KN  L +   KNGD+FS+W++DG I Y+D+I ATEDF IKYCI
Sbjct: 414 LLSVAILGFLFHKRRIRKNQLLETTKVKNGDLFSIWDFDGVIAYQDIIQATEDFDIKYCI 473

Query: 459 GTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFC 518
           GTGGYGSVY+A+LP GKVVALKKLH  E ED  ++KSF+NE  +L+ +RHRNIVKL+GFC
Sbjct: 474 GTGGYGSVYRAQLPSGKVVALKKLHGWEREDPTYLKSFENEVQMLTRIRHRNIVKLHGFC 533

Query: 519 LHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIH 578
           LHK+CMFL+Y+YME+GSL+C+L D+ EA+EL+W KRVN+VKS+A+ALSY+HHDC L IIH
Sbjct: 534 LHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHHDCDLPIIH 593

Query: 579 RDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDV 638
           RDISSNNILLDS LEA V+DFGTARLL  DSS RTL AGTYGYIAPELAYT+VVT KCDV
Sbjct: 594 RDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLAGTYGYIAPELAYTMVVTEKCDV 653

Query: 639 YSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIA 698
           YSFG+VALE +MG HPG  ++SLSSSS     L DVL+ RLS P + ++  +I L+ ++A
Sbjct: 654 YSFGMVALETMMGMHPGEFITSLSSSSTQNTTLKDVLDSRLSSPKSTRVANNIALIVSLA 713

Query: 699 FACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISELRN 740
             CL   P+  P+MQ +S +L++ ++   + +  IS+ +L++
Sbjct: 714 LKCLHFNPQFCPSMQEVSSKLVSTRS-FPQPISAISLLQLKD 754

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225466223|ref|XP_002267065.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710 [Vitis vinifera] gi|147859823|emb|CAN79273.1| hypothetical protein VITISV_014885 [Vitis vinifera]

 Score =  644 bits (1661), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/733 (47%), Positives = 490/733 (66%), Gaps = 21/733 (2%)

Query: 22  LLIVHVASATKISIHVAASEIERQALLNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDI 81
           ++++ V +    +   + + IE +AL  S WW+    + ++ HCNW GI+C+  G +T+I
Sbjct: 8   VIVMWVVAMAAAAAASSQTWIEGEALRRSTWWRSY--NTTTGHCNWPGISCNAGGSVTEI 65

Query: 82  DLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGII 141
             + +   G L + NFS FPNL  L+  +  L+G IP QIG+L+KL  L L  N L+G +
Sbjct: 66  WAVPTQENGLLTQFNFSSFPNLVRLNFSSLGLNGDIPHQIGTLTKLTHLDLSHNFLSGEL 125

Query: 142 PKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISS 201
           P  + +L  L  L L  N +SG +P EIGNL++L  L +  N L G+IPS+L +LT ++S
Sbjct: 126 PLSLTNLTKLVELNLGYNHISGQIPSEIGNLRNLVGLVLDCNYLNGVIPSSLGQLTRLTS 185

Query: 202 -----NQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQI 256
                NQ   SIP EI +  +L  +    N + G+IP  +  L+ L +L+L+SN ++G I
Sbjct: 186 LYIGWNQMEGSIPPEIWSLKSLVDIYFDHNILTGVIPSSVGNLTNLTSLHLASNQITGSI 245

Query: 257 PYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQN 316
           P  IG L  L+ L L  NKL G IP E+GNC +L+ L++  N L+G+IP E+G ++ L+ 
Sbjct: 246 PSEIGSLKKLVDLALDNNKLVGVIPKELGNCHSLRYLSMKFNRLNGSIPSEIGGLVALRK 305

Query: 317 LDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPTYLR-GNPPKSFVGNKGLSGNVE 371
           LDLS NN+SGTIP   +      Y+DLS+N LEG +P  L   +  ++F  NKGL G+ +
Sbjct: 306 LDLSVNNISGTIPLQFQNFNSLEYLDLSYNYLEGYVPFELHLPSLFRAFEHNKGLCGDTK 365

Query: 372 -GFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAA---KN 427
            G P   +R ++T  I     I L   L+++ IIFG  L+++   K  +L    A   +N
Sbjct: 366 FGIPPCRKRNRITIIII--VVICLCSALLISSIIFGVLLIWR--RKTRKLQPEEATTTQN 421

Query: 428 GDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSET 487
           GD+FS+W+YDGKI YED+I ATEDF IKYCIGTGGYGSVY+A+L  GK VALKKLH  E+
Sbjct: 422 GDIFSIWDYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYRAKLTNGKEVALKKLHTLES 481

Query: 488 EDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAI 547
           ++  ++KSF NE  VLS +RHRNIVKLYGFCLHK+CMFL+YEYMERGSL CVL D+ EA+
Sbjct: 482 QNPTYMKSFTNEVRVLSKIRHRNIVKLYGFCLHKRCMFLVYEYMERGSLHCVLSDEIEAL 541

Query: 548 ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
           E +W KRVN+VKS+A+ALSY+H+DC   ++HRDISS NILLDS   A V+DFGTARLL  
Sbjct: 542 EFDWIKRVNVVKSIANALSYMHNDCIPPLLHRDISSGNILLDSEFRAVVSDFGTARLLDP 601

Query: 608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGP 667
           DSS +TL AGTYGY+APELAYT+VVT KCDVYSFGV+ LE++MG HP  L++ LS+SS  
Sbjct: 602 DSSNQTLLAGTYGYVAPELAYTMVVTEKCDVYSFGVLTLEIMMGKHPRELVTILSTSSSQ 661

Query: 668 KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQ 727
            IML+D+L+ RL+P ++ +++ +++L+  +A  C++  P SRPTMQ + +E     TP  
Sbjct: 662 NIMLVDILDPRLAPHIDPEVIDNVVLIIRLALKCINLNPTSRPTMQHVCKE-FETCTPFP 720

Query: 728 KALKEISISELRN 740
                IS+ + ++
Sbjct: 721 IPFHAISLGQSKD 733

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452749|ref|XP_002277477.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  642 bits (1656), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/798 (45%), Positives = 500/798 (62%), Gaps = 76/798 (9%)

Query: 1   MACAFSNTCRAVTVFIWAALTLLIVHVASATKISIHVAASEIERQALLNSGWWKDRIPHN 60
           MA +       V V I + + +++  +A+A       ++S  E +AL ++GWW     ++
Sbjct: 1   MASSIIIFTAVVVVTITSTMMIMLFPLANAIS---SPSSSTDEAEALRSTGWW-----NS 52

Query: 61  SSDHCNWVGITCDYEGRITDIDLLNSNIK-GELGRLNFSCFPNLKSLDLWNNSLSGSIPP 119
           +S HC+W G+ C+  GR+T I L  S  + GEL +L+FS FP+L  L L +  L+GSIP 
Sbjct: 53  TSAHCHWDGVFCNNAGRVTGIALYGSGKELGELSKLDFSSFPSLVELSLSDCGLNGSIPH 112

Query: 120 QIGSLSKLKCL-----------------------------YLHG---------------- 134
           QIG+L++L  L                              LHG                
Sbjct: 113 QIGTLTQLTYLSLGLNNLTGELPLSLANLTQLEVLSFYSNRLHGSILPEIGKMKNLTVLD 172

Query: 135 ---NNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPS 191
              NNLTG+IP   G+L NL  L+L  NK+SG +P +IG LK+L  LY+++N L G IP 
Sbjct: 173 LGNNNLTGVIPSSFGNLTNLTFLYLDGNKISGFIPPQIGKLKNLRFLYLSSNGLHGPIPP 232

Query: 192 TLFRLTNIS-----SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLN 246
            + +L N+       N+ H  IP EIGN   L  L+L  N + G+IP     L+ L +L 
Sbjct: 233 EIGKLKNLEVLYLFYNKLHGLIPPEIGNMKKLIFLNLRSNNLTGVIPSSFGNLTNLNSLT 292

Query: 247 LSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPL 306
           L  N +SG IP  IG L NL YLDLS+N++SG IP EI N   L +L +++N + G IP 
Sbjct: 293 LRGNQISGFIPPEIGYLLNLSYLDLSENQISGFIPEEIVNLKKLGHLDMSNNLIRGKIPS 352

Query: 307 EMGKILLLQNLDLSHNNLSGTIPKTLRPMY----VDLSFNNLEGEIPTYLRGNPPKSFVG 362
           ++G +  ++  +LSHNNLSGTIP ++   Y    +DLS N LE +  T     P ++F  
Sbjct: 353 QLGYLKEVEYFNLSHNNLSGTIPHSISNNYMWTSIDLSHNQLESQSTT-----PHEAFGH 407

Query: 363 NKGLSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNS 422
           +KGL G + G     +R +    I L   I L   L+L+    GF    +   KN    +
Sbjct: 408 DKGLCGGINGLSHCKKRHQ----IVLIVVISLSATLLLSVTALGFLFHKQKIRKNQLSKT 463

Query: 423 RAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKL 482
             AKNGD+FS+W+YDG I Y+D+I ATEDF IKYCIGTGGYGSVY+A+LP GKVVALKKL
Sbjct: 464 TKAKNGDLFSIWDYDGTIAYDDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKL 523

Query: 483 HHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
           H  E ED  ++KSF+NE  +LST++HRNIVKL+GFCLH +CMFL+Y+YME+GSL+C+L D
Sbjct: 524 HSWEREDPTYLKSFENEVQMLSTIQHRNIVKLHGFCLHNRCMFLVYKYMEKGSLYCMLRD 583

Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA 602
           + E +EL+W KRVN+VKS+A ALSY+HHD  + IIHRDISSNNILLDS LEA V+DFGTA
Sbjct: 584 EVEVVELDWIKRVNVVKSIASALSYMHHDYVMPIIHRDISSNNILLDSKLEACVSDFGTA 643

Query: 603 RLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS 662
           RLL   SS +TL  GTYGYIAPELAYT+VVT KCDVYSFG+VALE +MG HPG L++SLS
Sbjct: 644 RLLDPYSSNQTLLVGTYGYIAPELAYTMVVTEKCDVYSFGMVALETMMGMHPGELVTSLS 703

Query: 663 SSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG 722
           SSS     L DVL+ RLS P + ++  ++ L+ ++A  CL S P+ RP+MQ +S +L++ 
Sbjct: 704 SSSTQNTTLKDVLDSRLSSPKSTRVANNVALIVSLALKCLHSNPRFRPSMQEVSLKLVST 763

Query: 723 KTPMQKALKEISISELRN 740
           K+   + +  IS+ +L++
Sbjct: 764 KS-FPQPISAISLLQLKD 780

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  639 bits (1649), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 343/648 (52%), Positives = 449/648 (69%), Gaps = 18/648 (2%)

Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
           NLK LDL  N ++GSIP QIG+L  L  LYL  N+L+G+IP  + +L NL  LFL  N++
Sbjct: 198 NLKYLDLSINEINGSIPYQIGNLKNLTHLYLVSNSLSGVIPSSLANLSNLEYLFLNFNRI 257

Query: 162 SGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNIS-----SNQFHSSIPLEIGNFS 216
           +G +P EIGNLK+L +L  ++N+L G IP +L  LTN++     +NQ    IPL  G+ +
Sbjct: 258 NGSIPSEIGNLKNLVQLCFSHNSLIGTIPPSLGHLTNLTYLHLFNNQIQGGIPLSFGHLT 317

Query: 217 ALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKL 276
            L  L+L DN+I+G IP  +  L  L +L L  N L+G IP ++G L +L   ++S N++
Sbjct: 318 KLTDLNLCDNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLNEFNISGNRI 377

Query: 277 SGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTL---- 332
           +G IP+ IGN + L  L L+ N + G IP ++  +  L  L+LSHN LSG+IP  L    
Sbjct: 378 NGHIPSTIGNLNNLTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDH 437

Query: 333 -RPMYVDLSFNNLEGEIPTYLRGNPPK-SFVGNKGLSGNVEGFPSSSQRQKLTPSISLFA 390
            +P  +DLS N+LEG IP  L+    + SF  NKGL G+++G P   +  K T  I    
Sbjct: 438 IKPS-LDLSHNDLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIV--- 493

Query: 391 KIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATE 450
            I L   L L F++ GF LL + + +  +      KNGD+FSVWNYDGKI YED+I ATE
Sbjct: 494 -ISLSTTLFLFFVVLGFLLLSR-KTRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATE 551

Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           DF IKYCIGTGGYGSVYKA+LP G VVALKKLH  E +++ ++KSFQNE  +LS +RHRN
Sbjct: 552 DFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRN 611

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           IVKL G+CLHK+CMFLIY YM RGSL+CVL ++ EA+EL+W KRVN+VKS+ HA+ Y+HH
Sbjct: 612 IVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHH 671

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI 630
           DCT  IIHRDISSNNILLDS L+A ++DFGTARLLH DSS +TL AGTYGYIAPELAYT+
Sbjct: 672 DCTPPIIHRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTM 731

Query: 631 VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQD 690
           VVT KCDVYSFGVVALE +MG HPG L + LSSSS   IML ++L+ RL  P +Q++ +D
Sbjct: 732 VVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQVARD 791

Query: 691 IILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
           ++LV  +A  C+ S P+SRPTMQ I  +LL  ++P       IS+ +L
Sbjct: 792 VVLVVWLALKCIHSNPRSRPTMQHILSKLLT-QSPFLGPFNWISLCQL 838

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera]

 Score =  638 bits (1645), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 343/648 (52%), Positives = 449/648 (69%), Gaps = 18/648 (2%)

Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
           NLK LDL  N ++GSIP QIG+L  L  LYL  N+L+G+IP  + +L NL  LFL  N++
Sbjct: 144 NLKYLDLSINEINGSIPYQIGNLKNLTHLYLVSNSLSGVIPSSLANLSNLEYLFLNFNRI 203

Query: 162 SGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNIS-----SNQFHSSIPLEIGNFS 216
           +G +P EIGNLK+L +L  ++N+L G IP +L  LTN++     +NQ    IPL  G+ +
Sbjct: 204 NGSIPSEIGNLKNLVQLCFSHNSLIGTIPPSLGHLTNLTYLHLFNNQIQGGIPLSFGHLT 263

Query: 217 ALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKL 276
            L  L+L DN+I+G IP  +  L  L +L L  N L+G IP ++G L +L   ++S N++
Sbjct: 264 KLTDLNLCDNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLNEFNISGNRI 323

Query: 277 SGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTL---- 332
           +G IP+ IGN + L  L L+ N + G IP ++  +  L  L+LSHN LSG+IP  L    
Sbjct: 324 NGHIPSTIGNLNNLTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDH 383

Query: 333 -RPMYVDLSFNNLEGEIPTYLRGNPPK-SFVGNKGLSGNVEGFPSSSQRQKLTPSISLFA 390
            +P  +DLS N+LEG IP  L+    + SF  NKGL G+++G P   +  K T  I    
Sbjct: 384 IKPS-LDLSHNDLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIV--- 439

Query: 391 KIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATE 450
            I L   L L F++ GF LL + + +  +      KNGD+FSVWNYDGKI YED+I ATE
Sbjct: 440 -ISLSTTLFLFFVVLGFLLLSR-KTRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATE 497

Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           DF IKYCIGTGGYGSVYKA+LP G VVALKKLH  E +++ ++KSFQNE  +LS +RHRN
Sbjct: 498 DFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRN 557

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           IVKL G+CLHK+CMFLIY YM RGSL+CVL ++ EA+EL+W KRVN+VKS+ HA+ Y+HH
Sbjct: 558 IVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHH 617

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI 630
           DCT  IIHRDISSNNILLDS L+A ++DFGTARLLH DSS +TL AGTYGYIAPELAYT+
Sbjct: 618 DCTPPIIHRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTM 677

Query: 631 VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQD 690
           VVT KCDVYSFGVVALE +MG HPG L + LSSSS   IML ++L+ RL  P +Q++ +D
Sbjct: 678 VVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQVARD 737

Query: 691 IILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
           ++LV  +A  C+ S P+SRPTMQ I  +LL  ++P       IS+ +L
Sbjct: 738 VVLVVWLALKCIHSNPRSRPTMQHILSKLLT-QSPFLGPFNWISLCQL 784

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225465647|ref|XP_002270862.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  626 bits (1614), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 340/648 (52%), Positives = 441/648 (68%), Gaps = 41/648 (6%)

Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
           NLK LDL  N ++GSIP QIG+L  L  LYL  N+L+G+IP  + +L NL  LFL  N++
Sbjct: 198 NLKYLDLSINEINGSIPSQIGNLKNLTHLYLVSNSLSGVIPSPLANLSNLEYLFLNFNRI 257

Query: 162 SGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNIS-----SNQFHSSIPLEIGNFS 216
           +G +P EIGNLK+L +L +++N+L G IPS+L  LTN++     +NQ    IPL  G+ +
Sbjct: 258 NGSIPSEIGNLKNLVQLCLSHNSLIGAIPSSLGHLTNLTYLHLFNNQIQGGIPLSFGHLT 317

Query: 217 ALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKL 276
            L  L L  N+I+G IP  +  L  L +L L  N L+G IP ++G L +L   ++S N++
Sbjct: 318 NLTDLYLCYNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLHEFNISGNQI 377

Query: 277 SGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTL---- 332
           SG IP+ IGN + L  L L+ N + G IP ++  +  L  L+LSHN LSG+IP  L    
Sbjct: 378 SGQIPSSIGNLNNLTRLDLSDNLIHGKIPSQVQNLKRLVYLNLSHNKLSGSIPTLLIYDH 437

Query: 333 -RPMYVDLSFNNLEGEIPTYLRGNPPK-SFVGNKGLSGNVEGFPSSSQRQKLTPSISLFA 390
            RP  +DLS+N+LEG IP  L+    + SF  NKGL G+++G P   +  K T  I+   
Sbjct: 438 IRPS-LDLSYNDLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIITR-- 494

Query: 391 KIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATE 450
                                K Q K         KNGD+FSVWNYDGKI YED+I ATE
Sbjct: 495 ---------------------KIQTK-----EIPTKNGDIFSVWNYDGKIAYEDIIKATE 528

Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           DF IKYCIGTGGYGSVYKA+LP G VVALKKLH  ET+++ ++KSFQNE  +LS +RHRN
Sbjct: 529 DFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWETDEATYLKSFQNEVQILSKIRHRN 588

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           IVKL G+CLHK+CMFLIY YM RGSL+CVL ++ EA+EL+W KRVN+VKS+ HA+ Y+HH
Sbjct: 589 IVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHH 648

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI 630
           DCT  IIHRDISSNNILLDS L+A ++DFGT+RLLH DSS +TL +GTYGYIAPELAYT+
Sbjct: 649 DCTPPIIHRDISSNNILLDSKLDAFLSDFGTSRLLHPDSSNQTLLSGTYGYIAPELAYTM 708

Query: 631 VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQD 690
           VVT KCDVYSFGVVALE +MG HPG L + LSSSS   IML D+L+ RL  P +Q++ +D
Sbjct: 709 VVTEKCDVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTDMLDSRLPSPQDQQVARD 768

Query: 691 IILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
           ++LV  +A  C+ S P+SRPTMQ IS +LL  ++P       IS+ +L
Sbjct: 769 VVLVVWLALKCIHSNPRSRPTMQHISSKLLT-QSPFLGPFHGISLWQL 815

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484068|ref|XP_002271708.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera]

 Score =  625 bits (1611), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 347/706 (49%), Positives = 470/706 (66%), Gaps = 32/706 (4%)

Query: 51  GWWKDRIPHNSSDHCNWVGITCDYEGRITDI-------DLLNSNIKGELGRLNFSCFPNL 103
           G+ K+ I  + S + +  G+     G +T++       + +N +I  E+G L      NL
Sbjct: 172 GYLKNLIHLDLSHNSDLYGVIPSSLGNLTNLVYLSLNFNRINGSIPSEIGNLK-----NL 226

Query: 104 KSLDL-WNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLS 162
             LDL +N  LSG+IP  IG L  L  L L  N+L+ +IP  +GSL NL  L+L  N+++
Sbjct: 227 IHLDLSYNYYLSGAIPSSIGYLKNLIHLDLGSNSLSSVIPSSLGSLTNLEYLYLNFNRIN 286

Query: 163 GVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNIS-----SNQFHSSIPLEIGNFSA 217
           G +P EIGNLK+L +L +++NAL G IPS+L  L N++      NQ    IPL  GN + 
Sbjct: 287 GSIPSEIGNLKNLVQLSLSHNALLGTIPSSLGNLINLTYFHLIDNQIQGLIPLSFGNLTN 346

Query: 218 LDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLS 277
           L  L L  N+I+G IP  +  L  L +L L  N L+G IP ++G L +L   ++ +N++ 
Sbjct: 347 LTHLYLRYNQINGSIPPVIWNLKNLIHLRLDHNNLTGVIP-SLGYLIHLNVFNIRRNRIR 405

Query: 278 GSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMY- 336
           G IP++IGN + L +L L+ N +DG IP ++  +  L++L+LSHN LSG IP     ++ 
Sbjct: 406 GHIPSKIGNLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPLSIYIHK 465

Query: 337 ---VDLSFNNLEGEIPTYLRG-NPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISLFAKI 392
              +D S N+ EG IP  L+   PP+ F  NKGL G  EG P   +  K    ISL   +
Sbjct: 466 GSSIDFSHNDFEGHIPHELQFVYPPRVFGHNKGLCGEREGLPHCKRGHKTILIISLSTIL 525

Query: 393 FLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDF 452
           FL      +F+  G  LL +   +N +  + + KNGD+FSVWNYDGKI YED+I ATEDF
Sbjct: 526 FL------SFVALGILLLSRKTRRN-QTKATSTKNGDIFSVWNYDGKIAYEDIIEATEDF 578

Query: 453 HIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV 512
            IKYCIGTGGYGSVYKA+LP G VVALKKLH  E +++ ++KSFQNE  VLS ++HRNI+
Sbjct: 579 DIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNII 638

Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
           KL+G+CLHK+CMFLIY+YMERGSL+CVL ++ EA+EL+W KRVN++KS+ HAL Y+HHD 
Sbjct: 639 KLHGYCLHKRCMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDS 698

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
           T  IIHRD+SSNNILLD  L+A ++DFGTARLLH DSS +TL AGTYGYIAPELAYT+ V
Sbjct: 699 TPPIIHRDVSSNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMAV 758

Query: 633 TGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDII 692
           T KCDVYSFGVVALE +MG HP  L + LSSSS   IML D+L+ RL  P ++++ +D++
Sbjct: 759 TEKCDVYSFGVVALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVARDVV 818

Query: 693 LVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
           LV  +A  C+ S P+SRPTMQ IS +LL  ++P  +    IS+ +L
Sbjct: 819 LVVWLALKCIHSNPRSRPTMQHISSKLLI-QSPFLEPFHGISLWQL 863

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera]

 Score =  624 bits (1608), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 347/706 (49%), Positives = 470/706 (66%), Gaps = 32/706 (4%)

Query: 51  GWWKDRIPHNSSDHCNWVGITCDYEGRITDI-------DLLNSNIKGELGRLNFSCFPNL 103
           G+ K+ I  + S + +  G+     G +T++       + +N +I  E+G L      NL
Sbjct: 178 GYLKNLIHLDLSHNSDLYGVIPSSLGNLTNLVYLSLNFNRINGSIPSEIGNLK-----NL 232

Query: 104 KSLDL-WNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLS 162
             LDL +N  LSG+IP  IG L  L  L L  N+L+ +IP  +GSL NL  L+L  N+++
Sbjct: 233 IHLDLSYNYYLSGAIPSSIGYLKNLIHLDLGSNSLSSVIPSSLGSLTNLEYLYLNFNRIN 292

Query: 163 GVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNIS-----SNQFHSSIPLEIGNFSA 217
           G +P EIGNLK+L +L +++NAL G IPS+L  L N++      NQ    IPL  GN + 
Sbjct: 293 GSIPSEIGNLKNLVQLSLSHNALLGTIPSSLGNLINLTYFHLIDNQIQGLIPLSFGNLTN 352

Query: 218 LDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLS 277
           L  L L  N+I+G IP  +  L  L +L L  N L+G IP ++G L +L   ++ +N++ 
Sbjct: 353 LTHLYLRYNQINGSIPPVIWNLKNLIHLRLDHNNLTGVIP-SLGYLIHLNVFNIRRNRIR 411

Query: 278 GSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMY- 336
           G IP++IGN + L +L L+ N +DG IP ++  +  L++L+LSHN LSG IP     ++ 
Sbjct: 412 GHIPSKIGNLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPLSIYIHK 471

Query: 337 ---VDLSFNNLEGEIPTYLRG-NPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISLFAKI 392
              +D S N+ EG IP  L+   PP+ F  NKGL G  EG P   +  K    ISL   +
Sbjct: 472 GSSIDFSHNDFEGHIPHELQFVYPPRVFGHNKGLCGEREGLPHCKRGHKTILIISLSTIL 531

Query: 393 FLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDF 452
           FL      +F+  G  LL +   +N +  + + KNGD+FSVWNYDGKI YED+I ATEDF
Sbjct: 532 FL------SFVALGILLLSRKTRRN-QTKATSTKNGDIFSVWNYDGKIAYEDIIEATEDF 584

Query: 453 HIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV 512
            IKYCIGTGGYGSVYKA+LP G VVALKKLH  E +++ ++KSFQNE  VLS ++HRNI+
Sbjct: 585 DIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNII 644

Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
           KL+G+CLHK+CMFLIY+YMERGSL+CVL ++ EA+EL+W KRVN++KS+ HAL Y+HHD 
Sbjct: 645 KLHGYCLHKRCMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDS 704

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
           T  IIHRD+SSNNILLD  L+A ++DFGTARLLH DSS +TL AGTYGYIAPELAYT+ V
Sbjct: 705 TPPIIHRDVSSNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMAV 764

Query: 633 TGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDII 692
           T KCDVYSFGVVALE +MG HP  L + LSSSS   IML D+L+ RL  P ++++ +D++
Sbjct: 765 TEKCDVYSFGVVALETMMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVARDVV 824

Query: 693 LVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
           LV  +A  C+ S P+SRPTMQ IS +LL  ++P  +    IS+ +L
Sbjct: 825 LVVWLALKCIHSNPRSRPTMQHISSKLLI-QSPFLEPFHGISLWQL 869

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	740
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.835	0.591	0.374	2.6e-109
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.824	0.544	0.377	5.3e-104
TAIR|locus:2182855	967	ERL2 "ERECTA-like 2" [Arabidop	0.856	0.655	0.348	1.5e-92
TAIR|locus:2167948	966	ERL1 "ERECTA-like 1" [Arabidop	0.874	0.669	0.348	3.9e-92
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.845	0.568	0.361	1.7e-91
TAIR|locus:2005507	976	ER "ERECTA" [Arabidopsis thali	0.855	0.648	0.341	3.6e-89
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.858	0.633	0.349	1.6e-88
TAIR|locus:2005540	999	HAE "HAESA" [Arabidopsis thali	0.847	0.627	0.355	2.9e-87
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.877	0.518	0.333	6.4e-86
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.868	0.572	0.347	6.9e-86

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 1080 (385.2 bits), Expect = 2.6e-109, P = 2.6e-109
 Identities = 247/659 (37%), Positives = 370/659 (56%)

Query:    76 GRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGN 135
             G++ ++ L +++ +G + +    C  +L  +    NS SG I    G    L  + L  N
Sbjct:   406 GKLENLTLDDNHFEGPVPKSLRDC-KSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNN 464

Query:   136 NLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFR 195
             N  G +       + L    L +N ++G +P EI N+  L++L                 
Sbjct:   465 NFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQL----------------- 507

Query:   196 LTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXXXXGQ 255
               ++SSN+    +P  I N + +  L L+ N++ G IP                     +
Sbjct:   508 --DLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSE 565

Query:   256 IPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQ 315
             IP  +  L  L Y++LS+N L  +IP  +   S L+ L L++N LDG I  +   +  L+
Sbjct:   566 IPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLE 625

Query:   316 NLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIP--TYLRGNPPKSFVGNKGLSGN 369
              LDLSHNNLSG IP + + M    +VD+S NNL+G IP     R  PP +F GNK L G+
Sbjct:   626 RLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGS 685

Query:   370 V---EGF-PSS-SQRQKLTPSISLFAKIFLPL--NLVLAFIIFGFTLLFKCQNKNPRLNS 422
             V   +G  P S +  +K     +L   I +P+   +++  +  G  + F+ + K    ++
Sbjct:   686 VNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHT 745

Query:   423 RAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKL 482
              +   G+  S++++DGK+ Y+++I AT +F  KY IGTGG+G VYKA+LP   ++A+KKL
Sbjct:   746 DSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKL 804

Query:   483 HHSETEDSAFV-----KSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLF 537
             +  ET DS+       + F NE   L+ +RHRN+VKL+GFC H++  FL+YEYMERGSL 
Sbjct:   805 N--ETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLR 862

Query:   538 CVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVA 597
              VL +DDEA +L+W KR+N+VK VAHALSY+HHD + +I+HRDISS NILL  + EA ++
Sbjct:   863 KVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKIS 922

Query:   598 DFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXX 657
             DFGTA+LL  DSS  +  AGTYGY+APELAY + VT KCDVYSFGV+ LEV+ G HP   
Sbjct:   923 DFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDL 982

Query:   658 XXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRIS 716
                         + +  ++    P    +I ++++ +  +A  CL S P++RPTM  IS
Sbjct:   983 VSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 1030 (367.6 bits), Expect = 5.3e-104, P = 5.3e-104
 Identities = 239/633 (37%), Positives = 344/633 (54%)

Query:   103 LKSLDLWNNSLSGSIPPQIGSLSKL-KCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
             L+++ L  N L G IP  +     L +  +L GN  TG I +  G   +L  +    NK 
Sbjct:   488 LQNISLDYNHLEGPIPKSLRDCKSLIRARFL-GNKFTGDIFEAFGIYPDLNFIDFSHNKF 546

Query:   162 SGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT-----NISSNQFHSSIPLEIGNFS 216
              G +         L  L ++NN + G IP+ ++ +T     ++S+N     +P  IGN +
Sbjct:   547 HGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLT 606

Query:   217 ALDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXXXXGQIPYAIGKLFNLMYLDLSKNKL 276
              L  L L+ N++ G +P                     +IP        L  ++LS+NK 
Sbjct:   607 NLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKF 666

Query:   277 SGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMY 336
              GSIP  +   + L  L L+HN LDG IP ++  +  L  LDLSHNNLSG IP T   M 
Sbjct:   667 DGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMI 725

Query:   337 ----VDLSFNNLEGEIPTY--LRGNPPKSFVGNKGLSGNV--EGFPSSSQRQKLTPSISL 388
                 VD+S N LEG +P     R     +   N GL  N+  +      + +K   + +L
Sbjct:   726 ALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNL 785

Query:   389 FAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAA--KNGDVFSVWNYDGKILYEDLI 446
                I +P+  VL  +         C  K    N R    + G+  S+++ DGK  Y+D+I
Sbjct:   786 VVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDII 845

Query:   447 NATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSA--FVKS-FQNEAHVL 503
              +T +F   + IGTGGY  VY+A L +  ++A+K+LH +  E+ +   VK  F NE   L
Sbjct:   846 ESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKAL 904

Query:   504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
             + +RHRN+VKL+GFC H++  FLIYEYME+GSL  +L +D+EA  L WTKR+N+VK VAH
Sbjct:   905 TEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAH 964

Query:   564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
             ALSY+HHD    I+HRDISS NILLD++  A ++DFGTA+LL  DSS  +  AGTYGY+A
Sbjct:   965 ALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVA 1024

Query:   624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPV 683
             PE AYT+ VT KCDVYSFGV+ LE+++G HP              + L  + ++R+  P 
Sbjct:  1025 PEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLRSISDERVLEPR 1084

Query:   684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRIS 716
              Q   + ++ +  +A  CL + P+SRPTM  IS
Sbjct:  1085 GQNR-EKLLKMVEMALLCLQANPESRPTMLSIS 1116

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 922 (329.6 bits), Expect = 1.5e-92, P = 1.5e-92
 Identities = 232/666 (34%), Positives = 349/666 (52%)

Query:    77 RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN 136
             ++  + L  + + G +  +       L  LDL +N L+G IPP +G+LS    LYLHGN 
Sbjct:   265 QVATLSLQGNKLTGRIPEV-IGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNK 323

Query:   137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRL 196
             LTG IP E+G++  L  L L  N+L G +P E+G L+ L EL + NN L GLIPS +   
Sbjct:   324 LTGQIPPELGNMSRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSC 383

Query:   197 T-----NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXX 251
                   N+  N    ++PLE  N  +L  L+LS N   G IP E                
Sbjct:   384 AALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNN 443

Query:   252 XXGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKI 311
               G IP  +G L +L+ L+LS+N L+G++P E GN  +++ + ++ N L G IP E+G++
Sbjct:   444 FSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQL 503

Query:   312 LLLQNLDLSHNNLSGTIPKTLRPMY----VDLSFNNLEGEIP---TYLRGNPPKSFVGNK 364
               + +L L++N + G IP  L   +    +++SFNNL G IP    + R +P  SF GN 
Sbjct:   504 QNINSLILNNNKIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSPA-SFFGNP 562

Query:   365 GLSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFG---FTLLFKCQNKNPRL- 420
              L GN  G   S     L P   +F ++ + + +VL FI      F  ++K + + P L 
Sbjct:   563 FLCGNWVG---SICGPSL-PKSQVFTRVAV-ICMVLGFITLICMIFIAVYKSKQQKPVLK 617

Query:   421 -NSRAAKNGDVFSVWNYDGKI-LYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVA 478
              +S+  +      + + D  I  ++D++  TE+   KY IG G   +VYK      + +A
Sbjct:   618 GSSKQPEGSTKLVILHMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIA 677

Query:   479 LKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFC 538
             +K++++     S F + F+ E   + ++RHRNIV L+G+ L      L Y+YME GSL+ 
Sbjct:   678 IKRIYNQYP--SNF-REFETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWD 734

Query:   539 VLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVAD 598
             +LH   + ++L+W  R+ I    A  L+YLHHDCT  IIHRDI S+NILLD N EA ++D
Sbjct:   735 LLHGPGKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSD 794

Query:   599 FGTARLLHVDSSYR-TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXX 657
             FG A+ +    +Y  T   GT GYI PE A T  +  K D+YSFG+V LE+L G      
Sbjct:   795 FGIAKSIPATKTYASTYVLGTIGYIDPEYARTSRLNEKSDIYSFGIVLLELLTGKKAVDN 854

Query:   658 XXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVST--IAFACLSSQPKSRPTMQRI 715
                       K     V+ + +   V+   +    +  T  +A  C    P  RPTMQ +
Sbjct:   855 EANLHQMILSKADDNTVM-EAVDAEVSVTCMDSGHIKKTFQLALLCTKRNPLERPTMQEV 913

Query:   716 SQELLA 721
             S+ LL+
Sbjct:   914 SRVLLS 919

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IGI;RCA

GO:0009553 "embryo sac development" evidence=IGI

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009686 "gibberellin biosynthetic process" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009845 "seed germination" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

GO:0048608 "reproductive structure development" evidence=RCA

TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 918 (328.2 bits), Expect = 3.9e-92, P = 3.9e-92
 Identities = 234/672 (34%), Positives = 343/672 (51%)

Query:    77 RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN 136
             ++  + L  + + G +  +       L  LDL +N L G IPP +G+LS    LYLHGN 
Sbjct:   263 QVATLSLQGNRLTGRIPEV-IGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNM 321

Query:   137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRL 196
             LTG IP E+G++  L  L L  NKL G +P E+G L+ L EL + NN L G IPS +   
Sbjct:   322 LTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSC 381

Query:   197 T-----NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXX 251
                   N+  N    SIPL   N  +L  L+LS N   G IP E                
Sbjct:   382 AALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNN 441

Query:   252 XXGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKI 311
               G IP  +G L +L+ L+LS+N LSG +P E GN  +++ + ++ N L G IP E+G++
Sbjct:   442 FSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQL 501

Query:   312 LLLQNLDLSHNNLSGTIPKTLRPMY----VDLSFNNLEGEIPTYLRGN--PPKSFVGNKG 365
               L +L L++N L G IP  L   +    +++SFNNL G +P     +   P SFVGN  
Sbjct:   502 QNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPY 561

Query:   366 LSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRL--NSR 423
             L GN  G  S       +   S  A I + L  V+  +   F  ++K   +   L  +S+
Sbjct:   562 LCGNWVG--SICGPLPKSRVFSRGALICIVLG-VITLLCMIFLAVYKSMQQKKILQGSSK 618

Query:   424 AAKNGDVFSVWNYDGKI-LYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKL 482
              A+      + + D  I  ++D++  TE+ + K+ IG G   +VYK  L   + +A+K+L
Sbjct:   619 QAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRL 678

Query:   483 HHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
             ++    +   ++ F+ E   + ++RHRNIV L+G+ L      L Y+YME GSL+ +LH 
Sbjct:   679 YNQYPHN---LREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHG 735

Query:   543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA 602
               + ++L+W  R+ I    A  L+YLHHDCT  IIHRDI S+NILLD N EA ++DFG A
Sbjct:   736 SLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIA 795

Query:   603 RLLHVDSSYR-TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXX 661
             + +    ++  T   GT GYI PE A T  +  K D+YSFG+V LE+L G          
Sbjct:   796 KSIPASKTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKAVDNEANL 855

Query:   662 XXXXXPKIMLIDVLNQRLSPPVNQKIVQ--DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                   K     V+ + + P V    +    I     +A  C    P  RPTM  +S+ L
Sbjct:   856 HQLILSKADDNTVM-EAVDPEVTVTCMDLGHIRKTFQLALLCTKRNPLERPTMLEVSRVL 914

Query:   720 LAGKTPMQKALK 731
             L+    +Q A K
Sbjct:   915 LSLVPSLQVAKK 926

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IGI;RCA

GO:0009553 "embryo sac development" evidence=IGI

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0016020 "membrane" evidence=IDA

GO:0001708 "cell fate specification" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0048441 "petal development" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 912 (326.1 bits), Expect = 1.7e-91, P = 1.7e-91
 Identities = 240/663 (36%), Positives = 349/663 (52%)

Query:    72 CDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLY 131
             C ++  I  + L ++ + G + R   +C  +L  L L +N L+GS+P ++ +L  L  L 
Sbjct:   424 CRFQTLIL-LSLGSNKLSGNIPRDLKTC-KSLTKLMLGDNQLTGSLPIELFNLQNLTALE 481

Query:   132 LHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPS 191
             LH N L+G I  ++G L+NL  L L +N  +G +P EIGNL  +    +++N L G IP 
Sbjct:   482 LHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPK 541

Query:   192 ------TLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEXXXXXXXXXX 245
                   T+ RL ++S N+F   I  E+G    L+ L LSDN++ G IP            
Sbjct:   542 ELGSCVTIQRL-DLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMEL 600

Query:   246 XXXXXXXXGQIPYAIGKLFNLMY-LDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTI 304
                       IP  +GKL +L   L++S N LSG+IP  +GN   L+ L LN N L G I
Sbjct:   601 QLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEI 660

Query:   305 PLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLS-FNNLEGEIPTYLRGNPPKSFVGN 363
             P  +G ++ L   ++S+NNL GT+P T     +D S F    G   +      P     +
Sbjct:   661 PASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSD 720

Query:   364 KGLSGNVEGFPSSSQRQK-LTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNS 422
               L+  + G    SQRQK LT +  +   +FL     + F+   +T+    + + P   +
Sbjct:   721 SKLNWLING----SQRQKILTITCIVIGSVFL-----ITFLGLCWTI----KRREPAFVA 767

Query:   423 RAAKNG-DVFSVWNYDGK-ILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALK 480
                +   DV   + +  K   Y+ L++AT +F     +G G  G+VYKAE+  G+V+A+K
Sbjct:   768 LEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVK 827

Query:   481 KLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL 540
             KL+ S  E ++   SF+ E   L  +RHRNIVKLYGFC H+    L+YEYM +GSL   L
Sbjct:   828 KLN-SRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQL 886

Query:   541 HDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG 600
                ++   L+W  R  I    A  L YLHHDC   I+HRDI SNNILLD   +A V DFG
Sbjct:   887 QRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFG 946

Query:   601 TARLLHVD-SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXX 659
              A+L+ +  S   +  AG+YGYIAPE AYT+ VT KCD+YSFGVV LE++ G  P     
Sbjct:   947 LAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLE 1006

Query:   660 XXXX-------XXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTM 712
                             I  I++ + RL    +++ V ++ LV  IA  C S+ P SRPTM
Sbjct:  1007 QGGDLVNWVRRSIRNMIPTIEMFDARLDTN-DKRTVHEMSLVLKIALFCTSNSPASRPTM 1065

Query:   713 QRI 715
             + +
Sbjct:  1066 REV 1068

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)]

 Score = 890 (318.4 bits), Expect = 3.6e-89, P = 3.6e-89
 Identities = 227/665 (34%), Positives = 346/665 (52%)

Query:    77 RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN 136
             ++  + L  + + G++  +       L  LDL  N LSGSIPP +G+L+  + LYLH N 
Sbjct:   260 QVATLSLQGNQLSGKIPSV-IGLMQALAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSNK 318

Query:   137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRL 196
             LTG IP E+G++  L  L L  N L+G +P E+G L  L +L V NN L G IP  L   
Sbjct:   319 LTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSC 378

Query:   197 TNISS-----NQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXX 251
             TN++S     N+F  +IP       ++  L+LS N I G IP E                
Sbjct:   379 TNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNK 438

Query:   252 XXGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKI 311
               G IP ++G L +L+ ++LS+N ++G +P + GN  ++  + L++N + G IP E+ ++
Sbjct:   439 INGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQL 498

Query:   312 LLLQNLDLSHNNLSGTI---PKTLRPMYVDLSFNNLEGEIP---TYLRGNPPKSFVGNKG 365
               +  L L +NNL+G +      L    +++S NNL G+IP    + R +P  SF+GN G
Sbjct:   499 QNIILLRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPD-SFIGNPG 557

Query:   366 LSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNP------R 419
             L G+    P    R+ +  SIS  A + + +      +I    L+  C+  NP       
Sbjct:   558 LCGSWLNSPCHDSRRTVRVSISRAAILGIAIG---GLVILLMVLIAACRPHNPPPFLDGS 614

Query:   420 LNSRAAKNGDVFSVWNYDGKI-LYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVA 478
             L+     +     + + +  + +YED++  TE+   KY IG G   +VYK  L   K VA
Sbjct:   615 LDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVA 674

Query:   479 LKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFC 538
             +K+L+ S    S  +K F+ E  +LS+++HRN+V L  + L      L Y+Y+E GSL+ 
Sbjct:   675 IKRLY-SHNPQS--MKQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWD 731

Query:   539 VLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVAD 598
             +LH   +   L+W  R+ I    A  L+YLHHDC+  IIHRD+ S+NILLD +LEA + D
Sbjct:   732 LLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTD 791

Query:   599 FGTARLLHVDSSYR-TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXX 657
             FG A+ L V  S+  T   GT GYI PE A T  +T K DVYS+G+V LE+L        
Sbjct:   792 FGIAKSLCVSKSHTSTYVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRRKAVDD 851

Query:   658 XXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTI---AFACLSSQPKSRPTMQR 714
                       K    +V+   ++ P      +D+ +V  +   A  C   QP  RPTM +
Sbjct:   852 ESNLHHLIMSKTGNNEVME--MADPDITSTCKDLGVVKKVFQLALLCTKRQPNDRPTMHQ 909

Query:   715 ISQEL 719
             +++ L
Sbjct:   910 VTRVL 914

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048281 "inflorescence morphogenesis" evidence=IMP

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005739 "mitochondrion" evidence=IDA

GO:0050832 "defense response to fungus" evidence=IMP

GO:0010103 "stomatal complex morphogenesis" evidence=RCA;IMP

GO:0001558 "regulation of cell growth" evidence=IGI;IMP

GO:0009965 "leaf morphogenesis" evidence=RCA;IMP

GO:0010148 "transpiration" evidence=IMP

GO:0030155 "regulation of cell adhesion" evidence=IMP

GO:0051302 "regulation of cell division" evidence=IGI;IMP

GO:0009664 "plant-type cell wall organization" evidence=IMP

GO:0008356 "asymmetric cell division" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0031540 "regulation of anthocyanin biosynthetic process" evidence=RCA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:2000027 "regulation of organ morphogenesis" evidence=IMP

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 884 (316.2 bits), Expect = 1.6e-88, P = 1.6e-88
 Identities = 236/675 (34%), Positives = 334/675 (49%)

Query:    78 ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
             +T ++L  + + G +        P L+ L LW N+ +GSIP ++G   +L  L L  N L
Sbjct:   313 LTLLNLFRNKLYGAIPEF-IGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKL 371

Query:   138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT 197
             TG +P  + S   L  L    N L G +P  +G  +SLT + +  N L G IP  LF L 
Sbjct:   372 TGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLP 431

Query:   198 NISS-----NQFHSSIPLEIGNFSA-LDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXX 251
              +S      N     +P+  G  S  L  + LS+N++ G +P                  
Sbjct:   432 KLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNK 491

Query:   252 XXGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKI 311
               G IP  IG+L  L  LD S N  SG I  EI  C  L  + L+ N L G IP E+  +
Sbjct:   492 FSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGM 551

Query:   312 LLLQNLDLSHNNLSGTIPKTLRPMY----VDLSFNNLEGEIPTYLRGN--PPKSFVGNKG 365
              +L  L+LS N+L G+IP T+  M     VD S+NNL G +P+  + +     SFVGN  
Sbjct:   552 KILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSH 611

Query:   366 LSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAA 425
             L G   G       Q     +S   K+ L L L+   ++F    + K ++     N+  A
Sbjct:   612 LCGPYLGPCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLR---NASEA 668

Query:   426 KNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHS 485
             K   + +    D     +D++++ ++ +I   IG GG G VYK  +P+G +VA+K+L  +
Sbjct:   669 KAWRLTAFQRLD--FTCDDVLDSLKEDNI---IGKGGAGIVYKGTMPKGDLVAVKRLA-T 722

Query:   486 ETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDE 545
              +  S+    F  E   L  +RHR+IV+L GFC + +   L+YEYM  GSL  VLH    
Sbjct:   723 MSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG 782

Query:   546 AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL 605
                L+W  R  I    A  L YLHHDC+  I+HRD+ SNNILLDSN EA VADFG A+ L
Sbjct:   783 G-HLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL 841

Query:   606 HVDSSYRTLRA--GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXX-- 661
                 +   + A  G+YGYIAPE AYT+ V  K DVYSFGVV LE++ G  P         
Sbjct:   842 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVD 901

Query:   662 ------XXXXXPKIMLIDVLNQRLSP-PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQR 714
                         K  ++ V++ RLS  PV++     +  V  +A  C+  Q   RPTM+ 
Sbjct:   902 IVQWVRSMTDSNKDCVLKVIDLRLSSVPVHE-----VTHVFYVALLCVEEQAVERPTMRE 956

Query:   715 ISQELLA-GKTPMQK 728
             + Q L    K P+ K
Sbjct:   957 VVQILTEIPKIPLSK 971

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)]

 Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
 Identities = 236/663 (35%), Positives = 335/663 (50%)

Query:    78 ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
             +  ++L  + ++G L   + +    L  L L+NN L+G +P Q+G+ S L+ + L  N  
Sbjct:   309 LESLNLFENMLEGPLPE-SITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRF 367

Query:   138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLF--- 194
             +G IP  +     L  L L  N  SG +   +G  KSLT + ++NN L G IP   +   
Sbjct:   368 SGEIPANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLP 427

Query:   195 RLT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXXX 252
             RL+   +S N F  SIP  I     L  L +S N+  G IP+E                 
Sbjct:   428 RLSLLELSDNSFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDF 487

Query:   253 XGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKIL 312
              G+IP ++ KL  L  LDLSKN+LSG IP E+     L  L L +N L G IP E+G + 
Sbjct:   488 SGEIPESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILP 547

Query:   313 LLQNLDLSHNNLSGTIPKTLRPM---YVDLSFNNLEGEIPT-YLRGNPPKSFVGNKGLSG 368
             +L  LDLS N  SG IP  L+ +    ++LS+N+L G+IP  Y        F+GN GL  
Sbjct:   548 VLNYLDLSSNQFSGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLCV 607

Query:   369 NVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNG 428
             +++G      R K    + +   IFL   LV  F++     + KC+    +L  RA K+ 
Sbjct:   608 DLDGLCRKITRSKNIGYVWILLTIFLLAGLV--FVVGIVMFIAKCR----KL--RALKSS 659

Query:   429 DVF-SVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSE- 486
              +  S W    K+ + +     +    K  IG G  G VYK EL  G+VVA+KKL+ S  
Sbjct:   660 TLAASKWRSFHKLHFSEH-EIADCLDEKNVIGFGSSGKVYKVELRGGEVVAVKKLNKSVK 718

Query:   487 ------TEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL 540
                   + DS     F  E   L T+RH++IV+L+  C    C  L+YEYM  GSL  VL
Sbjct:   719 GGDDEYSSDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVL 778

Query:   541 HDDDEA-IELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF 599
             H D +  + L W +R+ I    A  LSYLHHDC   I+HRD+ S+NILLDS+  A VADF
Sbjct:   779 HGDRKGGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADF 838

Query:   600 GTARLLHVDSSYRTLRA-----GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
             G A++  +  S +T  A     G+ GYIAPE  YT+ V  K D+YSFGVV LE++ G  P
Sbjct:   839 GIAKVGQMSGS-KTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQP 897

Query:   655 XXXXXXXXXXXXPKIMLIDV--LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTM 712
                              +D   L   + P ++ K  ++I  V  I   C S  P +RP+M
Sbjct:   898 TDSELGDKDMAKWVCTALDKCGLEPVIDPKLDLKFKEEISKVIHIGLLCTSPLPLNRPSM 957

Query:   713 QRI 715
             +++
Sbjct:   958 RKV 960

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 863 (308.9 bits), Expect = 6.4e-86, P = 6.4e-86
 Identities = 231/693 (33%), Positives = 351/693 (50%)

Query:    56 RIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSG 115
             RI  +S+     +   C     ++  D+  +  +G++  L      NL  L L  N  +G
Sbjct:   557 RINFSSNKFNGSISPLCGSSSYLS-FDVTENGFEGDIP-LELGKSTNLDRLRLGKNQFTG 614

Query:   116 SIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSL 175
              IP   G +S+L  L +  N+L+GIIP E+G  + L  + L +N LSGV+P  +G L  L
Sbjct:   615 RIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLL 674

Query:   176 TELYVTNNALGGLIPSTLFRLTNI-----SSNQFHSSIPLEIGNFSALDTLDLSDNKIHG 230
              EL +++N   G +P+ +F LTNI       N  + SIP EIGN  AL+ L+L +N++ G
Sbjct:   675 GELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSG 734

Query:   231 IIPDEXXXXXXXXXXXXXXXXXXGQIPYAIGKLFNLMY-LDLSKNKLSGSIPTEIGNCSA 289
              +P                    G+IP  IG+L +L   LDLS N  +G IP+ I     
Sbjct:   735 PLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPK 794

Query:   290 LKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIP 349
             L++L L+HN L G +P ++G +  L  L+LS+NNL G + K       D    N  G   
Sbjct:   795 LESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNA-G--- 850

Query:   350 TYLRGNPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTL 409
               L G+P      N+  S N      S +   +  +IS  A I L + +++ F      L
Sbjct:   851 --LCGSPLSHC--NRAGSKNQRSL--SPKTVVIISAISSLAAIALMVLVIILFFKQNHDL 904

Query:   410 LFKCQNKNPRLNSRAAKN-GDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYK 468
               K +  N   +S ++ +   +FS       I ++D++ AT   + ++ IG+GG G VYK
Sbjct:   905 FKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYK 964

Query:   469 AELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK--CMFL 526
             AEL  G+ +A+KK+   +  D    KSF  E   L T+RHR++VKL G+C  K      L
Sbjct:   965 AELKNGETIAVKKILWKD--DLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLL 1022

Query:   527 IYEYMERGSLFCVLHDDDEAIE---LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISS 583
             IYEYM  GS++  LH ++   +   L W  R+ I   +A  + YLH+DC   I+HRDI S
Sbjct:  1023 IYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKS 1082

Query:   584 NNILLDSNLEASVADFGTARLL--HVDSSYR--TLRAGTYGYIAPELAYTIVVTGKCDVY 639
             +N+LLDSN+EA + DFG A++L  + D++    T+ AG+YGYIAPE AY++  T K DVY
Sbjct:  1083 SNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVY 1142

Query:   640 SFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIIL------ 693
             S G+V +E++ G  P              +    VL+        +K++   +       
Sbjct:  1143 SMGIVLMEIVTGKMPTEAMFDEETDMVRWVET--VLDTPPGSEAREKLIDSELKSLLPCE 1200

Query:   694 ------VSTIAFACLSSQPKSRPTMQRISQELL 720
                   V  IA  C  S P+ RP+ ++ S+ LL
Sbjct:  1201 EEAAYQVLEIALQCTKSYPQERPSSRQASEYLL 1233

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 859 (307.4 bits), Expect = 6.9e-86, P = 6.9e-86
 Identities = 236/679 (34%), Positives = 341/679 (50%)

Query:    84 LNSN-IKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIP 142
             L SN I G +      C  +L  L +  N L+G  P ++  L  L  + L  N  +G +P
Sbjct:   452 LGSNRIFGNIPPGVLRC-KSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLP 510

Query:   143 KEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTL-----FRLT 197
              EIG+ + L+ L L +N+ S  LP EI  L +L    V++N+L G IPS +      +  
Sbjct:   511 PEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRL 570

Query:   198 NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXXXXGQIP 257
             ++S N F  S+P E+G+   L+ L LS+N+  G IP                    G IP
Sbjct:   571 DLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIP 630

Query:   258 YAIGKLFNLMY-LDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQN 316
               +G L +L   ++LS N  SG IP EIGN   L  L+LN+N L G IP     +  L  
Sbjct:   631 PQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLG 690

Query:   317 LDLSHNNLSGTIPKTLRPMYVDL-SFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVEGFPS 375
              + S+NNL+G +P T     + L SF   +G    +LR   P S      +S    G   
Sbjct:   691 CNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDP-SHSSWPHISSLKAG--- 746

Query:   376 SSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAA--KNGDVFSV 433
             S++R ++   I + + +   ++L+L  I+  F L    +   P ++ +    +  D++ V
Sbjct:   747 SARRGRI---IIIVSSVIGGISLLLIAIVVHF-LRNPVEPTAPYVHDKEPFFQESDIYFV 802

Query:   434 WNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSE----TED 489
                  +   +D++ AT+ FH  Y +G G  G+VYKA +P GK +A+KKL  +        
Sbjct:   803 PKE--RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNS 860

Query:   490 SAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCMFLIYEYMERGSLFCVLHDDDEAI 547
             +    SF+ E   L  +RHRNIV+LY FC H+      L+YEYM RGSL  +LH   ++ 
Sbjct:   861 NNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGG-KSH 919

Query:   548 ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
              ++W  R  I    A  L+YLHHDC   IIHRDI SNNIL+D N EA V DFG A+++ +
Sbjct:   920 SMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDM 979

Query:   608 DSSYRTLR-AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXX 666
               S      AG+YGYIAPE AYT+ VT KCD+YSFGVV LE+L G  P            
Sbjct:   980 PLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLAT 1039

Query:   667 -PKIMLID-VLNQRLSPPVNQKIVQDIIL-----VSTIAFACLSSQPKSRPTMQRISQEL 719
               +  + D  L   +  P   K+  D+IL     V+ IA  C  S P  RPTM+ +   L
Sbjct:  1040 WTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099

Query:   720 LAGKTPMQKALKEISISEL 738
             +       K +   + S+L
Sbjct:  1100 IESGERAGKVIVSTTCSDL 1118

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	740
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-65
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-48
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-46
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-43
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-43
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-33
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-29
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-27
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-27
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-27
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-26
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-26
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-26
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-26
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-24
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-21
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-21
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-21
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-19
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-19
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-18
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-18
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-18
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-18
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-18
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-17
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-16
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	9e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-15
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-15
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-14
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-14
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-14
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-06
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	3e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	7e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	1e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	5e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	7e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  233 bits (596), Expect = 3e-65
 Identities = 204/704 (28%), Positives = 325/704 (46%), Gaps = 101/704 (14%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN 136
           ++  +DL ++++ GE+  L      NL+ L L++N+ +G IP  + SL +L+ L L  N 
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQ-LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTL--- 193
            +G IPK +G   NL  L L +N L+G +P+ + +  +L +L + +N+L G IP +L   
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403

Query: 194 --FRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNL 251
              R   +  N F   +P E      +  LD+S+N + G I      +  L+ L+L+ N 
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463

Query: 252 LSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKI 311
             G +P + G    L  LDLS+N+ SG++P ++G+ S L  L L+ N L G IP E+   
Sbjct: 464 FFGGLPDSFGSK-RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC 522

Query: 312 LLLQNLDLSHNNLSGTIPKTLRPMYV----DLSFNNLEGEIPT----------------Y 351
             L +LDLSHN LSG IP +   M V    DLS N L GEIP                 +
Sbjct: 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582

Query: 352 LRGNPP----------KSFVGNKGLSG--NVEGFPSSSQRQKLTPSISLFAKIFLPLNLV 399
           L G+ P           +  GN  L G     G P   + +K TPS   +    L   LV
Sbjct: 583 LHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK-TPSWWFYITCTLGAFLV 641

Query: 400 LAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDG-------------KILYEDLI 446
           LA + FGF  +            R   N ++  V N DG              I   D++
Sbjct: 642 LALVAFGFVFI------------RGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL 689

Query: 447 NATEDFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLST 505
           ++ ++ ++   I  G  G+ YK +  +  +   +K+++   +  S+ +            
Sbjct: 690 SSLKEENV---ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK------- 739

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           ++H NIVKL G C  +K  +LI+EY+E  +L  VL +      L+W +R  I   +A AL
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKAL 793

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
            +LH  C+ +++  ++S   I++D   E  +       LL  D+      A    Y+APE
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----YVAPE 848

Query: 626 LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS---------SGPKI-MLIDVL 675
              T  +T K D+Y FG++ +E+L G  P      +  S         S   + M ID  
Sbjct: 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908

Query: 676 NQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             R    VNQ    +I+ V  +A  C ++ P +RP    + + L
Sbjct: 909 -IRGDVSVNQN---EIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  186 bits (475), Expect = 2e-49
 Identities = 124/326 (38%), Positives = 162/326 (49%), Gaps = 37/326 (11%)

Query: 61  SSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFP------------------- 101
           S+D C W GITC+   R+  IDL   NI G++    F   P                   
Sbjct: 54  SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDD 112

Query: 102 ------NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
                 +L+ L+L NN+ +GSIP   GS+  L+ L L  N L+G IP +IGS  +L+ L 
Sbjct: 113 IFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNIS-----SNQFHSSIPL 210
           L  N L G +P  + NL SL  L + +N L G IP  L ++ ++       N     IP 
Sbjct: 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY 230

Query: 211 EIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLD 270
           EIG  ++L+ LDL  N + G IP  L  L  L+ L L  N LSG IP +I  L  L+ LD
Sbjct: 231 EIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLD 290

Query: 271 LSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPK 330
           LS N LSG IP  +     L+ L L  N+  G IP+ +  +  LQ L L  N  SG IPK
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350

Query: 331 TLRP----MYVDLSFNNLEGEIPTYL 352
            L        +DLS NNL GEIP  L
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGL 376

Length = 968

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  171 bits (436), Expect = 1e-48
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 10/204 (4%)

Query: 452 FHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           + I   +G G +G VY A +   GK+VA+K +   + +     +    E  +L  ++H N
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPN 58

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           IV+LY     +  ++L+ EY E G LF +L      +  +  +    ++ +  AL YLH 
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARF--YLRQILSALEYLH- 114

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI 630
             +  I+HRD+   NILLD +    +ADFG AR L       T   GT  Y+APE+    
Sbjct: 115 --SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF-VGTPEYMAPEVLLGK 171

Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D++S GV+  E+L G  P
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  166 bits (422), Expect = 1e-46
 Identities = 86/271 (31%), Positives = 123/271 (45%), Gaps = 20/271 (7%)

Query: 452 FHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           + +   +G+G +G+VYKA     GK+VA+K L     E S   ++ + E  +L  + H N
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           IV+L      K  ++L+ EY E G LF  L        L+  +   I   +   L YLH 
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHS 116

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-LAYT 629
                IIHRD+   NILLD N    +ADFG A+ L   SS  T   GT  Y+APE L   
Sbjct: 117 ---NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 630 IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ 689
                K DV+S GV+  E+L G  P         S    +  + ++ + L PP+     +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP--------FSGENILDQLQLIRRILGPPLEFDEPK 225

Query: 690 DIILVST---IAFACLSSQPKSRPTMQRISQ 717
                     +   CL+  P  RPT + I Q
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  162 bits (413), Expect = 5e-46
 Identities = 69/193 (35%), Positives = 104/193 (53%), Gaps = 10/193 (5%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG+G+VY A     GK VA+K +   ++     ++    E  +L  + H NIVKLYG
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYG 58

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
               +  ++L+ EY E GSL  +L +++   +L+  + + I+  +   L YLH      I
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHS---NGI 113

Query: 577 IHRDISSNNILLDS-NLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-LAYTIVVTG 634
           IHRD+   NILLDS N +  +ADFG ++LL  D S      GT  Y+APE L      + 
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 635 KCDVYSFGVVALE 647
           K D++S GV+  E
Sbjct: 174 KSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  168 bits (428), Expect = 2e-43
 Identities = 102/257 (39%), Positives = 140/257 (54%), Gaps = 9/257 (3%)

Query: 103 LKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLS 162
           L+ L L +N L G IP ++G +  LK +YL  NNL+G IP EIG L +L  L L  N L+
Sbjct: 190 LEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT 249

Query: 163 GVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNI-----SSNQFHSSIPLEIGNFSA 217
           G +P  +GNLK+L  L++  N L G IP ++F L  +     S N     IP  +     
Sbjct: 250 GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQN 309

Query: 218 LDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLS 277
           L+ L L  N   G IP  LT L +L+ L L SN  SG+IP  +GK  NL  LDLS N L+
Sbjct: 310 LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369

Query: 278 GSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM-- 335
           G IP  + +   L  L L  NSL+G IP  +G    L+ + L  N+ SG +P     +  
Sbjct: 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429

Query: 336 --YVDLSFNNLEGEIPT 350
             ++D+S NNL+G I +
Sbjct: 430 VYFLDISNNNLQGRINS 446

Length = 968

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  156 bits (398), Expect = 3e-43
 Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 42/278 (15%)

Query: 458 IGTGGYGSVYKAEL----PEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV 512
           +G G +G VYK  L       +V VA+K L    +E    ++ F  EA ++  + H NIV
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIV 64

Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
           KL G C  ++ + ++ EYM  G L   L  +    EL+ +  ++    +A  + YL    
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLES-- 121

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GTYGYIAPE----LA 627
             + IHRD+++ N L+  NL   ++DFG +R L+ D  Y+         ++APE      
Sbjct: 122 -KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLSPP 682
           +T     K DV+SFGV+  E+           +L     P +   +VL       RL  P
Sbjct: 181 FTS----KSDVWSFGVLLWEIF----------TLGEEPYPGMSNAEVLEYLKKGYRLPKP 226

Query: 683 VN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            N    +  ++L       C +  P+ RPT   + + L
Sbjct: 227 PNCPPELYKLML------QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  155 bits (395), Expect = 6e-43
 Identities = 76/277 (27%), Positives = 126/277 (45%), Gaps = 40/277 (14%)

Query: 458 IGTGGYGSVYKAEL-----PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV 512
           +G G +G VYK  L          VA+K L    +E+    + F  EA ++  + H NIV
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE--REEFLEEASIMKKLSHPNIV 64

Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
           +L G C   + ++++ EYM  G L   L    E + L     + +   +A  + YL    
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE--- 119

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG---YIAPELAYT 629
           + + +HRD+++ N L+  NL   ++DFG +R ++ D  YR  R G      ++APE    
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRK-RGGGKLPIKWMAPESLKD 178

Query: 630 IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLSPPVN 684
              T K DV+SFGV+  E+           +L     P +   +VL       RL  P N
Sbjct: 179 GKFTSKSDVWSFGVLLWEIF----------TLGEQPYPGMSNEEVLELLEDGYRLPRPEN 228

Query: 685 --QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
              ++  +++L       C +  P+ RPT   + ++L
Sbjct: 229 CPDEL-YELML------QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  155 bits (395), Expect = 7e-43
 Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 43/278 (15%)

Query: 458 IGTGGYGSVYKAEL--PEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV 512
           +G G +G VYK +L    GK    VA+K L    +E    ++ F  EA ++  + H N+V
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64

Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
           KL G C  ++ ++++ EYME G L   L  +   +  + +  ++    +A  + YL    
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL--SLSDLLSFALQIARGMEYLES-- 120

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GTYGYIAPE----LA 627
             + IHRD+++ N L+  NL   ++DFG +R L+ D  YR         ++APE      
Sbjct: 121 -KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLSPP 682
           +T     K DV+SFGV+  E+           +L     P +   +VL       RL  P
Sbjct: 180 FTS----KSDVWSFGVLLWEIF----------TLGEQPYPGMSNEEVLEYLKNGYRLPQP 225

Query: 683 VN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            N    + D++L       C +  P+ RPT   + + L
Sbjct: 226 PNCPPELYDLML------QCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  144 bits (367), Expect = 5e-39
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 41/281 (14%)

Query: 458 IGTGGYGSVYKAEL---PEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G G +G VYK +L         VA+K L    +E+    K F  EA V+  + H N+V+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNVVR 60

Query: 514 LYGFCLHKKCMFLIYEYMERGSL------FCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           L G C  ++ ++L+ EYME G L         +    E   L+    ++    +A  + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT--YGYIAPE 625
           L        +HRD+++ N L+  +L   ++DFG +R ++ D  YR    G     ++APE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 626 LAYTIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RL 679
                + T K DV+SFGV+  E+  +G  P      LS+         +VL       RL
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP---YPGLSNE--------EVLEYLRKGYRL 226

Query: 680 SPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             P      + +++L      +C    P+ RPT   + + L
Sbjct: 227 PKPEYCPDELYELML------SCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  141 bits (359), Expect = 4e-38
 Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 22/211 (10%)

Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
            F I   IG GG+G VYKA     GK VA+K +     E     +   NE  +L   +H 
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN------IVKSVAH 563
           NIVK YG  L K  ++++ E+   GSL        + ++ +  + +       + K +  
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSL-------KDLLK-STNQTLTESQIAYVCKELLK 109

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
            L YLH   +  IIHRDI + NILL S+ E  + DFG +  L  D+  R    GT  ++A
Sbjct: 110 GLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMA 165

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+        K D++S G+ A+E+  G  P
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (342), Expect = 1e-35
 Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 39/276 (14%)

Query: 457 CIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
            +G G +GSVY A   + G+++A+K +     +    +++ + E  +LS+++H NIV+ Y
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVE-LSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 516 GFCLHK-KCMFLIY-EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           G    + K    I+ EY+  GSL  +L      +     ++    + +   L+YLH   +
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKY--TRQILEGLAYLH---S 119

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLH--VDSSYRTLRAGTYGYIAPELAYTIV 631
             I+HRDI   NIL+DS+    +ADFG A+ L             GT  ++APE+     
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 632 VTGKCDVYSFGVVALEVLMGTHP----GGLLSSLSSSSGPKIM---LIDVLNQRLSPPVN 684
                D++S G   +E+  G  P    G  +++L      KI        + + LS    
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY-----KIGSSGEPPEIPEHLSE--- 231

Query: 685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
               +D +        CL   PK RPT    + ELL
Sbjct: 232 --EAKDFLR------KCLRRDPKKRPT----ADELL 255

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  132 bits (333), Expect = 1e-33
 Identities = 86/282 (30%), Positives = 130/282 (46%), Gaps = 17/282 (6%)

Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH-R 509
            + I   +G G +G VY A     K+VALK L       S  V+ F  E  +L+++ H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKLY F   +  ++L+ EY++ GSL  +L        L+ ++ + I+  +  AL YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 570 HDCTLSIIHRDISSNNILLDSNL-EASVADFGTARLLHVDSSYRTLRA------GTYGYI 622
              +  IIHRDI   NILLD +     + DFG A+LL    S  ++ A      GT GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 623 APELAYTIV---VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG-PKIMLIDVLNQR 678
           APE+   +     +   D++S G+   E+L G  P     + S++S   KI+L       
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
            SP             S +    L+  PK+R +        L
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  128 bits (325), Expect = 2e-33
 Identities = 79/285 (27%), Positives = 117/285 (41%), Gaps = 45/285 (15%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
            D      +G G  G VYK    P GK+ ALKK+H     D  F K    E   L +   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCES 58

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV--NIVKSVAHALS 566
             +VK YG    +  + ++ EYM+ GSL      D         + V   I + +   L 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSL-----ADLLKKVGKIPEPVLAYIARQILKGLD 113

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH----VDSSYRTLRAGTYGYI 622
           YLH      IIHRDI  +N+L++S  E  +ADFG +++L       +++     GT  Y+
Sbjct: 114 YLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF----VGTVTYM 167

Query: 623 APEL----AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIM-LIDVLNQ 677
           +PE     +Y+       D++S G+  LE  +G  P            P    L+  +  
Sbjct: 168 SPERIQGESYSY----AADIWSLGLTLLECALGKFP------FLPPGQPSFFELMQAICD 217

Query: 678 RLSPPVNQKIVQDIILVSTIAF--ACLSSQPKSRPTMQRISQELL 720
              P +  +            F  ACL   PK RP+    + ELL
Sbjct: 218 GPPPSLPAEEFSP----EFRDFISACLQKDPKKRPS----AAELL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  121 bits (305), Expect = 1e-30
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 41/281 (14%)

Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKK--LHHSETEDSAFVKSFQNEAHVLSTVR 507
            + I   IG G +G VY      +GK+  LK+  L +   ++        NE  +L  + 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA---LNEVKILKKLN 57

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE-------LNWTKRVNIVKS 560
           H NI+K Y     K  + ++ EY + G L   +    +  +       L+W   V +   
Sbjct: 58  HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCL- 114

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
              AL YLH      I+HRDI   NI L SN    + DFG +++L           GT  
Sbjct: 115 ---ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPY 168

Query: 621 YIAPEL----AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLN 676
           Y++PEL     Y      K D++S G V  E+    HP          +  ++ L  +L 
Sbjct: 169 YLSPELCQNKPYNY----KSDIWSLGCVLYELCTLKHP------FEGENLLELAL-KILK 217

Query: 677 QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
            +  PP+  +   ++     +  + L   P+ RP++ +I Q
Sbjct: 218 GQY-PPIPSQYSSEL---RNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 1e-29
 Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 8/205 (3%)

Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ +   IG G +G VYK   L  G  VA+K++   E      +KS   E  +L  ++H 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQIS-LEKIKEEALKSIMQEIDLLKNLKHP 59

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVK  G       +++I EY E GSL  ++           +     V  V   L+YLH
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLH 116

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 +IHRDI + NIL   +    +ADFG A  L+  S       GT  ++APE+   
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173

Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
              +   D++S G   +E+L G  P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  118 bits (299), Expect = 1e-29
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 20/203 (9%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G VYKA +   GK VA+KK+   +      +    NE  ++   +H NIV  Y 
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII----NEILIMKDCKHPNIVDYYD 82

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    ++++ EYM+ GSL  ++      + +N  +   + + V   L YLH   + ++
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDII--TQNFVRMNEPQIAYVCREVLQGLEYLH---SQNV 137

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG-- 634
           IHRDI S+NILL  +    +ADFG A  L  + S R    GT  ++APE     V+    
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE-----VIKRKD 192

Query: 635 ---KCDVYSFGVVALEVLMGTHP 654
              K D++S G++ +E+  G  P
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 2e-28
 Identities = 84/276 (30%), Positives = 129/276 (46%), Gaps = 39/276 (14%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           ED+ +   IG+G YG VYKA ++  G++VA+K +     +D    +  Q E  +L   RH
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD---FEIIQQEISMLKECRH 59

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIV  +G  L +  ++++ EY   GSL  +         L+  +   + +     L+YL
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKGLAYL 117

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA- 627
           H       IHRDI   NILL  + +  +ADFG +  L    + R    GT  ++APE+A 
Sbjct: 118 HE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174

Query: 628 ------YTIVVTGKCDVYSFGVVALEV------LMGTHPGGLLSSLSSSSGPKIMLIDVL 675
                 Y     GKCD+++ G+ A+E+      +   HP   L  +S S+ P   L D  
Sbjct: 175 VERKGGY----DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD-- 228

Query: 676 NQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPT 711
            ++ SP     +  D I        CL+  PK RPT
Sbjct: 229 KEKWSP-----VFHDFIKK------CLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 2e-28
 Identities = 74/283 (26%), Positives = 129/283 (45%), Gaps = 48/283 (16%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++  +   IG G +G V   +   G+ VA+K L     +DS   ++F  EA V++T+RH 
Sbjct: 6   KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLK----DDSTAAQAFLAEASVMTTLRHP 60

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G  L    ++++ EYM +GSL   L     A+ +   +++     V   + YL 
Sbjct: 61  NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE 119

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
                + +HRD+++ N+L+  +L A V+DFG A+    ++S     +G     + APE  
Sbjct: 120 EK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQ-GQDSGKLPVKWTAPEAL 171

Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLSPP 682
                + K DV+SFG++  E+           S      P+I L DV+       R+  P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIY----------SFGRVPYPRIPLKDVVPHVEKGYRMEAP 221

Query: 683 ------VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                 V + +             C    P  RPT +++ ++L
Sbjct: 222 EGCPPEVYKVMKD-----------CWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  113 bits (284), Expect = 8e-28
 Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 30/265 (11%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G  G V K    P GK++A+K +      + A  K    E  +L       IV  YG
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
              +   + +  EYM+ GSL  +L +    I      ++ +  +V   L+YLH      I
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEK--HKI 122

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE----LAYTIVV 632
           IHRD+  +NIL++S  +  + DFG +  L V+S  +T   GT  Y+APE      Y++  
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTF-VGTSSYMAPERIQGNDYSV-- 178

Query: 633 TGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS--PPVNQKIVQD 690
             K D++S G+  +E+  G  P          + P   + ++L   ++  PP   ++   
Sbjct: 179 --KSDIWSLGLSLIELATGRFP------YPPENDPPDGIFELLQYIVNEPPP---RLPSG 227

Query: 691 IILVSTIAF--ACLSSQPKSRPTMQ 713
                   F   CL   P+ RP+ +
Sbjct: 228 KFSPDFQDFVNLCLIKDPRERPSYK 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 4e-27
 Identities = 80/274 (29%), Positives = 129/274 (47%), Gaps = 43/274 (15%)

Query: 458 IGTGGYGSVYKA--ELPEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           IG G +G V +   +LP  K   VA+K L    ++       F  EA ++    H NI++
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPNIIR 69

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L G     + + +I EYME GSL   L ++D   +    + V +++ +A  + YL     
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLL-HVDSSYRTLRAGTYG--YIAPE-LAYT 629
              +HRD+++ NIL++SNL   V+DFG +R L   +++Y T + G     + APE +AY 
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT-KGGKIPIRWTAPEAIAYR 183

Query: 630 IVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQ--RLSPPVN-- 684
              T   DV+SFG+V  EV+  G  P   +S+          +I  +    RL PP++  
Sbjct: 184 K-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYRLPPPMDCP 234

Query: 685 ---QKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
               +++ D          C       RPT  +I
Sbjct: 235 SALYQLMLD----------CWQKDRNERPTFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 6e-27
 Identities = 91/296 (30%), Positives = 144/296 (48%), Gaps = 48/296 (16%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH---RNIVK 513
           IG G YG+VY+   +P G+VVALK ++    +D   V   Q E  +LS +R     NI K
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD--VSDIQREVALLSQLRQSQPPNITK 66

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHALSYLHH 570
            YG  L    +++I EY E GS+  ++      ++ I +       I++ V  AL Y+H 
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHK 119

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI 630
                +IHRDI + NIL+ +     + DFG A LL+ +SS R+   GT  ++APE     
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE----- 171

Query: 631 VVTG------KCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLI-DVLNQRLSPPV 683
           V+T       K D++S G+   E+  G  P   + +  +     +MLI      RL    
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MMLIPKSKPPRLEDNG 226

Query: 684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISELR 739
             K++++ +       ACL  +PK R +    ++ELL  K+   KA  +  +S L+
Sbjct: 227 YSKLLREFVA------ACLDEEPKERLS----AEELL--KSKWIKAHSKTPVSILK 270

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  110 bits (277), Expect = 7e-27
 Identities = 83/295 (28%), Positives = 130/295 (44%), Gaps = 46/295 (15%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL----PEGK--VVALKKLHHSETEDSAFVKSFQNEAHVL 503
           +   +K  +G G +G V+  E     PE    +VA+K L  + + D+   K F+ EA +L
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELL 62

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL--HDDDEAI---------ELNWT 552
           +  +H NIVK YG C       +++EYME G L   L  H  D A          EL  +
Sbjct: 63  TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR 612
           + + I   +A  + YL    +   +HRD+++ N L+  +L   + DFG +R ++    YR
Sbjct: 123 QLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179

Query: 613 TLRAGT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGP 667
               G       ++ PE       T + DV+SFGVV  E+   G  P   LS+       
Sbjct: 180 V--GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----- 232

Query: 668 KIMLIDVLNQR--LSPP-VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
              +I+ + Q   L  P      V DI+L       C    P+ R  ++ I + L
Sbjct: 233 ---VIECITQGRLLQRPRTCPSEVYDIML------GCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  109 bits (273), Expect = 1e-26
 Identities = 82/277 (29%), Positives = 130/277 (46%), Gaps = 32/277 (11%)

Query: 451 DFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +    VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 62

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 63  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 121

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 122 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 176

Query: 626 LAYTIVVTGKCDVYSFGVVALEVL---MGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP 682
           LAY      K DV++FGV+  E+    M  +PG  LS +         L++   +   P 
Sbjct: 177 LAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------LLEKGYRMERPE 228

Query: 683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                V +++       AC    P  RP+   I Q  
Sbjct: 229 GCPPKVYELMR------ACWQWNPSDRPSFAEIHQAF 259

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 1e-26
 Identities = 93/295 (31%), Positives = 132/295 (44%), Gaps = 39/295 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKK--LHHSETEDSAFVKSFQNEAHVLSTV 506
           E F +  CIG G +G VYKA +    +VVA+K   L  +E E    ++  Q E   LS  
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE----IEDIQQEIQFLSQC 56

Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           R   I K YG  L    +++I EY   GS   +L    +  +L+ T    I++ V   L 
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLE 112

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           YLH +     IHRDI + NILL    +  +ADFG +  L    S R    GT  ++APE+
Sbjct: 113 YLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEV 169

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK 686
                   K D++S G+ A+E+  G  P   LS L        M +  L  + +PP    
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP---LSDLHP------MRVLFLIPKNNPP---S 217

Query: 687 IVQDIILVSTIAF--ACLSSQPKSRPTMQRISQELL-------AGKTPMQKALKE 732
           +  +        F   CL+  PK RP+    ++ELL       A KT     L E
Sbjct: 218 LEGNKFSKPFKDFVSLCLNKDPKERPS----AKELLKHKFIKKAKKTSYLTLLIE 268

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 2e-26
 Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 13/202 (6%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA ++  +RH 
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ----EAQIMKKLRHD 61

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY  C  ++ ++++ EYM +GSL   L    E  +L   + V++   +A  ++YL 
Sbjct: 62  KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI---APEL 626
              + + IHRD+++ NIL+  NL   +ADFG ARL+  D  Y T R G    I   APE 
Sbjct: 121 ---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE-DDEY-TAREGAKFPIKWTAPEA 175

Query: 627 AYTIVVTGKCDVYSFGVVALEV 648
           A     T K DV+SFG++  E+
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  108 bits (271), Expect = 3e-26
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 21/208 (10%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G VY A  L  G+++A+K++   +  D   +K   +E  VL  ++H N+VK YG
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIR-IQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLH---DDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
             +H++ +++  EY   G+L  +L      DE +     +       +   L+YLH   +
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV----IRV--YTLQLLEGLAYLH---S 117

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS-SYRTL---RAGTYGYIAPELAYT 629
             I+HRDI   NI LD N    + DFG A  L  ++ +        AGT  Y+APE+   
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 630 IVVTGK---CDVYSFGVVALEVLMGTHP 654
               G     D++S G V LE+  G  P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  108 bits (271), Expect = 4e-26
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 21/217 (9%)

Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHH---SETEDSAFVKSFQNEAHVLSTV 506
           D+ +   IG G +G+V K     +GK++  K++ +   +E E    V    +E ++L  +
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV----SEVNILREL 56

Query: 507 RHRNIVKLYGFCLHK--KCMFLIYEYMERGSLFCVL---HDDDEAIELN--WTKRVNIVK 559
           +H NIV+ Y   + +  + ++++ EY E G L  ++     + + IE    W     I+ 
Sbjct: 57  KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILT 112

Query: 560 SVAHALSYLHH--DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
            +  AL   H+  D   +++HRD+   NI LD+N    + DFG A++L  DSS+     G
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172

Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           T  Y++PE    +    K D++S G +  E+   + P
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 6e-26
 Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 25/207 (12%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL-Y 515
           +G G +G V    +   GK+ A+K L   +      V+    E ++LS + H  IVKL Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDD---DEAIELNWTKRVNIVKSVAHALSYLHHDC 572
            F   +K ++L+ EY   G LF  L  +    E       +       +  AL YLH   
Sbjct: 61  AFQTEEK-LYLVLEYAPGGELFSHLSKEGRFSEE----RARF--YAAEIVLALEYLH--- 110

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
           +L II+RD+   NILLD++    + DFG A+ L  + S      GT  Y+APE     V+
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPE-----VL 165

Query: 633 TGK-----CDVYSFGVVALEVLMGTHP 654
            GK      D +S GV+  E+L G  P
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  107 bits (268), Expect = 8e-26
 Identities = 79/293 (26%), Positives = 126/293 (43%), Gaps = 53/293 (18%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +D+ +   IG G    VY A  LP  + VA+K++   +      V   + E   +S   H
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD------DEAIELNWTKRVNIVKSVA 562
            N+VK Y   +    ++L+  Y+  GSL  ++         DEAI         ++K V 
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI------IATVLKEVL 112

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH--VDSSYRTLR--AGT 618
             L YLH +     IHRDI + NILL  +    +ADFG +  L    D + +  +   GT
Sbjct: 113 KGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169

Query: 619 YGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLID 673
             ++APE+      Y      K D++SFG+ A+E+  G  P      +      K++++ 
Sbjct: 170 PCWMAPEVMEQVHGYDF----KADIWSFGITAIELATGAAPYSKYPPM------KVLMLT 219

Query: 674 VLNQRLSPPVNQ------KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
           + N   S           K  + +I +      CL   P  RPT    ++ELL
Sbjct: 220 LQNDPPSLETGADYKKYSKSFRKMISL------CLQKDPSKRPT----AEELL 262

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  106 bits (267), Expect = 8e-26
 Identities = 73/264 (27%), Positives = 120/264 (45%), Gaps = 23/264 (8%)

Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF I   IG G +G V+K     + +V A+K++  S+  +    +   +EA VL+ +   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSS 59

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAI---ELNWTKRVNIVKSVAHALS 566
            I++ Y   L K  + ++ EY E G L  +L          +  W   + I+      L+
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLA 115

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           +LH      I+HRDI S N+ LD+     + D G A+LL  ++++     GT  Y++PEL
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK 686
                   K DV++ GVV  E   G HP          +  +  LI  + + + PPV+Q 
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHP--------FDANNQGALILKIIRGVFPPVSQM 224

Query: 687 IVQDIILVSTIAFACLSSQPKSRP 710
             Q +  +      CL+   + RP
Sbjct: 225 YSQQLAQLID---QCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 8e-26
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)

Query: 452 FHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           +     +G G YG VYKA +   G++VALKK+     E+     + + E  +L  ++H N
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPN 59

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           IVKL      ++ ++L++EY +   L   L      +  N  K   I+  +   L+Y H 
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCHS 116

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL---- 626
                I+HRD+   NIL++ +    +ADFG AR   +     T    T  Y APE+    
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 627 -AYTIVVTGKCDVYSFGVVALEVLMGT 652
             Y+  V    D++S G +  E++ G 
Sbjct: 174 KHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  104 bits (260), Expect = 1e-24
 Identities = 87/288 (30%), Positives = 133/288 (46%), Gaps = 37/288 (12%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+K  +    KVVA+K +   E ED   ++  Q E  VLS      + K YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    +++I EY+  GS   +L    E   L+ T+   I++ +   L YLH +     
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KK 122

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI + N+LL  + E  +ADFG A  L      R    GT  ++APE+        K 
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182

Query: 637 DVYSFGVVALEVLMGT------HPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQD 690
           D++S G+ A+E+  G       HP  +L  +  ++ P       L    S P+ + +   
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP------TLEGNYSKPLKEFVE-- 234

Query: 691 IILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
                    ACL+ +P  RPT    ++ELL  K  ++ A K   ++EL
Sbjct: 235 ---------ACLNKEPSFRPT----AKELLKHKFIVRFAKKTSYLTEL 269

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 2e-24
 Identities = 70/260 (26%), Positives = 121/260 (46%), Gaps = 25/260 (9%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V++        VA+K L       +   K F  EA ++  +RH  +++LY  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTL----KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           C  ++ ++++ E M+ GSL   L        L   + +++   VA  ++YL      + I
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLE---AQNYI 125

Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+++ N+L+  N    VADFG AR++  +  Y   R G      + APE A     + 
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVI-KEDIY-EAREGAKFPIKWTAPEAALYNRFSI 183

Query: 635 KCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN-QKIVQDIIL 693
           K DV+SFG++  E++  T+  G +     ++   +  +D    R+  P    K + DI+L
Sbjct: 184 KSDVWSFGILLTEIV--TY--GRMPYPGMTNAEVLQQVDQ-GYRMPCPPGCPKELYDIML 238

Query: 694 VSTIAFACLSSQPKSRPTMQ 713
                  C    P  RPT +
Sbjct: 239 ------DCWKEDPDDRPTFE 252

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  103 bits (259), Expect = 2e-24
 Identities = 81/296 (27%), Positives = 134/296 (45%), Gaps = 43/296 (14%)

Query: 450 EDFHIKYC--IGTGGYGSVYKAEL-PE----GKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E  H+K+   +G G +G V      P     G+ VA+K L+HS  E       F+ E  +
Sbjct: 2   EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH--RSDFEREIEI 59

Query: 503 LSTVRHRNIVKLYGFC--LHKKCMFLIYEYMERGSL--FCVLHDDDEAIELNWTKRVNIV 558
           L T+ H NIVK  G C     + + LI EY+  GSL  +   H D    ++N  + +   
Sbjct: 60  LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFS 115

Query: 559 KSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY---RTLR 615
             +   + YL    +   IHRD+++ NIL++S     ++DFG A++L  D  Y   +   
Sbjct: 116 SQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172

Query: 616 AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTH-------PGGLLSSLSSSSGPK 668
                + APE   T   +   DV+SFGV   E  + T+       P   L  +  + G  
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYE--LFTYGDPSQSPPAEFLRMIGIAQGQM 230

Query: 669 IM--LIDVL--NQRLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           I+  L+++L   +RL  P +    V D++ +      C  ++P+ RP+   +   +
Sbjct: 231 IVTRLLELLKEGERLPRPPSCPDEVYDLMKL------CWEAEPQDRPSFADLILIV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 3e-24
 Identities = 66/208 (31%), Positives = 100/208 (48%), Gaps = 30/208 (14%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG VYKA     G++VALKK+   E E   F  +   E  +L  +RH NIV+L  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 517 FCLHKKC--MFLIYEYMERGSLFCVLHD-----DDEAIELNWTKRVNIVKSVAHALSYLH 569
               K    +++++EYM+        HD     D   ++   ++    +K +   L YLH
Sbjct: 66  IVTSKGKGSIYMVFEYMD--------HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGTYGYIAPEL-- 626
            +    I+HRDI  +NIL++++    +ADFG AR     +S   T R  T  Y  PEL  
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174

Query: 627 ---AYTIVVTGKCDVYSFGVVALEVLMG 651
               Y      + D++S G +  E+ +G
Sbjct: 175 GATRY----GPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  102 bits (255), Expect = 4e-24
 Identities = 71/211 (33%), Positives = 106/211 (50%), Gaps = 27/211 (12%)

Query: 458 IGTGGYGSVYKAELP-EGK---VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           IG G +G V++  L   G+    VA+K L    TE     + F +EA ++    H NI++
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHHNIIR 70

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L G     K   +I EYME G+L   L D D   E +  + V +++ +A  + YL     
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSD--- 125

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG---------YIAP 624
           ++ +HRD+++ NIL++SNLE  V+DFG +R+L  D        GTY          + AP
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE------GTYTTSGGKIPIRWTAP 179

Query: 625 ELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
           E       T   DV+SFG+V  EV+  G  P
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  101 bits (255), Expect = 6e-24
 Identities = 75/299 (25%), Positives = 115/299 (38%), Gaps = 50/299 (16%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-R 507
           +DF     IG G + +V  A E    K  A+K L   +      VK  + E  VL+ +  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAH 563
           H  I+KLY     ++ ++ + EY   G L   +      D++               +  
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT-------RFYAAEILL 113

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH--------------VDS 609
           AL YLH   +  IIHRD+   NILLD ++   + DFGTA++L               +DS
Sbjct: 114 ALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 610 SYRTLRA------GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS 663
                R       GT  Y++PEL          D+++ G +  ++L G  P         
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP------FRG 224

Query: 664 SSGPKIMLIDVLNQRLS-PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA 721
           S+        +L    S PP      +D+I         L   P+ R  +     EL A
Sbjct: 225 SNEYLTFQ-KILKLEYSFPPNFPPDAKDLIE------KLLVLDPQDRLGVNEGYDELKA 276

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  101 bits (253), Expect = 9e-24
 Identities = 84/305 (27%), Positives = 136/305 (44%), Gaps = 62/305 (20%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE----LPEGK--VVALKKLHHSETEDSAFVKSFQNEAHVL 503
            D  +K+ +G G +G V+ AE    LPE    +VA+K L   E  +SA  + FQ EA +L
Sbjct: 5   RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESA-RQDFQREAELL 61

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL--FCVLHDDDEAI----------ELNW 551
           + ++H++IV+ YG C   + + +++EYM  G L  F   H  D  I          +L  
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 552 TKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY 611
            + + I   +A  + YL    +L  +HRD+++ N L+   L   + DFG +R ++    Y
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 178

Query: 612 RT-------LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSS 663
           R        +R     ++ PE       T + D++SFGVV  E+   G  P   LS+  +
Sbjct: 179 RVGGRTMLPIR-----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233

Query: 664 SSGPKIMLIDVLNQ-------RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRIS 716
                   I+ + Q       R  PP    I+Q           C   +P+ R  ++ I 
Sbjct: 234 --------IECITQGRELERPRTCPPEVYAIMQ----------GCWQREPQQRMVIKDIH 275

Query: 717 QELLA 721
             L A
Sbjct: 276 SRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  100 bits (252), Expect = 9e-24
 Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 15/208 (7%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E F I   +G G YGSVYKA     G+VVA+K +     ED    +    E  +L     
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDL---QEIIKEISILKQCDS 57

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE--LNWTKRVNIVKSVAHALS 566
             IVK YG       ++++ EY   GS+     D  +     L   +   I+      L 
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSV----SDIMKITNKTLTEEEIAAILYQTLKGLE 113

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           YLH   +   IHRDI + NILL+   +A +ADFG +  L    + R    GT  ++APE+
Sbjct: 114 YLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
              I    K D++S G+ A+E+  G  P
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 1e-23
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 27/205 (13%)

Query: 458 IGTGGYGSVYKAE-LPEG---KV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV 512
           +G+G +G+VYK   +PEG   K+ VA+K L   E       K   +EA+V+++V H ++V
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYVMASVDHPHVV 72

Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRVNIVKSVAHALSYL 568
           +L G CL  +   LI + M  G L   + +  + I     LNW  ++      A  +SYL
Sbjct: 73  RLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125

Query: 569 --HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAP 624
                    ++HRD+++ N+L+ +     + DFG A+LL VD        G     ++A 
Sbjct: 126 EEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 625 ELAYTIVVTGKCDVYSFGVVALEVL 649
           E     + T K DV+S+GV   E++
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  100 bits (251), Expect = 1e-23
 Identities = 73/289 (25%), Positives = 133/289 (46%), Gaps = 60/289 (20%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKL---HHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +GTG + S Y+A ++  G ++A+K++    ++ +E    V++ + E  +++ + H +I++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDD---DEAIELNWTKRVNIVKSVAHALSYLHH 570
           + G         L  E+M  GS+  +L       EA+ +N+T++      +   LSYLH 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ------LLRGLSYLHE 121

Query: 571 DCTLSIIHRDISSNNILLDSN-LEASVADFGTARLLHVDSS----YRTLRAGTYGYIAPE 625
           +    IIHRD+   N+L+DS      +ADFG A  L    +    ++    GT  ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 626 LAYTIVVTGK-----CDVYSFGVVALEVLMGTHPGG---------LLSSLSSSSGPKIML 671
                V+ G+     CDV+S G V +E+     P           L+  ++S++      
Sbjct: 179 -----VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA---- 229

Query: 672 IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                    P + + +      +  +   CL  QP+ RP     S+ELL
Sbjct: 230 ---------PSIPEHLSPG---LRDVTLRCLELQPEDRPP----SRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  100 bits (251), Expect = 1e-23
 Identities = 74/272 (27%), Positives = 136/272 (50%), Gaps = 21/272 (7%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E+F ++  +G+G +G V++        VA+K L   +++D    + FQ E   L  +RH+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKIL---KSDDLLKQQDFQKEVQALKRLRHK 62

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           +++ L+  C   + +++I E ME+GSL   L   +  + L     +++   VA  ++YL 
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLE 121

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-YGYIAPELAY 628
                + IHRD+++ NIL+  +L   VADFG ARL+  +  Y +      Y + APE A 
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAAS 177

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRL-SPPVNQKI 687
               + K DV+SFG++  E+   T+  G +     ++      I     R+  P    + 
Sbjct: 178 HGTFSTKSDVWSFGILLYEMF--TY--GQVPYPGMNNHEVYDQITA-GYRMPCPAKCPQE 232

Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +  I+L       C +++P+ RP+ + + +EL
Sbjct: 233 IYKIML------ECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 67/202 (33%), Positives = 96/202 (47%), Gaps = 20/202 (9%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G YG V K      G++VA+KK   SE +D    K+   E  VL  +RH NIV L  
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEA----IELNWTKRVNIVKSVAHALSYLH-HD 571
               K  ++L++EY+ER      L +  EA    +  +  +    +  +  A++Y H H+
Sbjct: 68  AFRRKGRLYLVFEYVERT-----LLELLEASPGGLPPDAVRS--YIWQLLQAIAYCHSHN 120

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGTYGYIAPELAYTI 630
               IIHRDI   NIL+  +    + DFG AR L    +   T    T  Y APEL    
Sbjct: 121 ----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176

Query: 631 VVTGK-CDVYSFGVVALEVLMG 651
              GK  DV++ G +  E+L G
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 98.8 bits (246), Expect = 6e-23
 Identities = 76/246 (30%), Positives = 119/246 (48%), Gaps = 33/246 (13%)

Query: 454 IKYCIGTGGYGSVYKAEL-PEGK---VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           I+  IG G +G V +  L   GK    VA+K L    TE     + F +EA ++    H 
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHP 65

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI+ L G     + + +I E+ME G+L   L  +D   +    + V +++ +A  + YL 
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLS 123

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI-----AP 624
               ++ +HRD+++ NIL++SNL   V+DFG +R L  D+S  T  +   G I     AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 625 ELAYTIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQ-----R 678
           E       T   DV+S+G+V  EV+  G  P   +S+            DV+N      R
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----------DVINAIEQDYR 229

Query: 679 LSPPVN 684
           L PP++
Sbjct: 230 LPPPMD 235

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)

Query: 452 FHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           F +   IG G +G V   +  +  K+ A+K ++  +  +   V++  NE  +L  + H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 511 IVKL-YGFCLHKKCMFLIYEYMERGSL-FCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
           +V L Y F   +  M+L+ + +  G L + +       +E ++         +  +  AL
Sbjct: 62  LVNLWYSFQDEEN-MYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVLAL 113

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
            YLH   +  IIHRDI  +NILLD      + DF  A  +    +  T  +GT GY+APE
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTSGTPGYMAPE 169

Query: 626 LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           +      +   D +S GV A E L G  P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 40/276 (14%)

Query: 458 IGTGGYGSVYKA--ELPEGKV--VALKKLH--HSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +GSV K    +  GK   VA+K L   H       F++    EA V++ + H  I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR----EASVMAQLDHPCI 58

Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           V+L G C  +  M L+ E    G L   L    E    +      +   VA  ++YL   
Sbjct: 59  VRLIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLE-- 112

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPEL 626
            +   +HRD+++ N+LL +  +A ++DFG +R L   S Y   RA T G     + APE 
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--YRATTAGRWPLKWYAPEC 169

Query: 627 AYTIVVTGKCDVYSFGVVALEVL-MGTHP-GGLLSSLSSSSGPKIMLIDVLNQRLSPPVN 684
                 + K DV+S+GV   E    G  P G +        G +++ +    +RL  P  
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-------KGAEVIAMLESGERLPRPEE 222

Query: 685 QKI-VQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
               +  I+L      +C   +P+ RPT   +    
Sbjct: 223 CPQEIYSIML------SCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 97.8 bits (243), Expect = 2e-22
 Identities = 86/305 (28%), Positives = 139/305 (45%), Gaps = 51/305 (16%)

Query: 451 DFHIKYCIGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           D  +K  +G G +G V+ AE        +  +VA+K L   +    A  K FQ EA +L+
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLT 62

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL--FCVLHDDDEAI-----------ELNW 551
            ++H +IVK YG C     + +++EYM+ G L  F   H  D  I           EL  
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 552 TKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY 611
           ++ ++I   +A  + YL    +   +HRD+++ N L+ +NL   + DFG +R ++    Y
Sbjct: 123 SQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179

Query: 612 RTLRAGTYG-----YIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSS 665
           R    G +      ++ PE       T + DV+SFGV+  E+   G  P   L       
Sbjct: 180 RV---GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL------- 229

Query: 666 GPKIMLIDVLNQRL--SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA-G 722
               ++  +   R+   P V  K V DI+L       C   +P+ R  ++ I + L A G
Sbjct: 230 SNTEVIECITQGRVLERPRVCPKEVYDIML------GCWQREPQQRLNIKEIYKILHALG 283

Query: 723 K-TPM 726
           K TP+
Sbjct: 284 KATPI 288

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 97.0 bits (241), Expect = 2e-22
 Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 36/273 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 61

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 62  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 119

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPEL 626
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y T R G      + APE 
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEY-TARQGAKFPIKWTAPEA 174

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLS- 680
           A     T K DV+SFG++  E          L++      P ++  +VL+Q     R+  
Sbjct: 175 ALYGRFTIKSDVWSFGILLTE----------LTTKGRVPYPGMVNREVLDQVERGYRMPC 224

Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C   +P+ RPT +
Sbjct: 225 PPECPESLHDLMC------QCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 82/281 (29%), Positives = 112/281 (39%), Gaps = 49/281 (17%)

Query: 458 IGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G  GSV K  L     + ALK +  +   +    K    E  +  + +   IVK YG
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTI--TTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 517 FCLHKK-CMFLI-YEYMERGSLFCVLHDDDEAIELNWTKRVN---------IVKSVAHAL 565
             L +      I  EY E GSL        ++I     KR           I +SV   L
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSL--------DSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
           SYLH   +  IIHRDI  +NILL    +  + DFG +  L V+S   T   GT  Y+APE
Sbjct: 119 SYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTF-TGTSFYMAPE 173

Query: 626 ----LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ--RL 679
                 Y+I      DV+S G+  LEV     P            P +  I++L+    +
Sbjct: 174 RIQGKPYSI----TSDVWSLGLTLLEVAQNRFP------FPPEGEPPLGPIELLSYIVNM 223

Query: 680 SPPVNQKIVQDIILVSTIAF-----ACLSSQPKSRPTMQRI 715
             P  +    + I  S   F      CL   P  RPT   +
Sbjct: 224 PNPELKDEPGNGIKWSE-EFKDFIKQCLEKDPTRRPTPWDM 263

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 18/201 (8%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+KA +   G+ VALKK+     E          E   L   +H  +VKL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLD 66

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
              H     L+ EYM    L  VL D++  +     K    ++ +   ++Y+H      I
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMH---ANGI 120

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGTYGYIAPEL-----AYTI 630
           +HRD+   N+L+ ++    +ADFG ARL   +     + +  T  Y APEL      Y  
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180

Query: 631 VVTGKCDVYSFGVVALEVLMG 651
            V    D+++ G +  E+L G
Sbjct: 181 GV----DLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 95.6 bits (238), Expect = 6e-22
 Identities = 70/265 (26%), Positives = 116/265 (43%), Gaps = 21/265 (7%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG G +G VYK  L     VA+K    +   D    + F  EA +L    H NIVKL G 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIGV 60

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           C+ K+ ++++ E +  GSL   L      + +   K + +    A  + YL        I
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKNC---I 115

Query: 578 HRDISSNNILLDSNLEASVADFGTARLLH--VDSSYRTLRAGTYGYIAPELAYTIVVTGK 635
           HRD+++ N L+  N    ++DFG +R     + +    L+     + APE       T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175

Query: 636 CDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILV 694
            DV+S+G++  E   +G  P      +S+    +   I+    R+  P  Q   ++I   
Sbjct: 176 SDVWSYGILLWETFSLGDTP---YPGMSNQQTRE--RIES-GYRMPAP--QLCPEEI--- 224

Query: 695 STIAFACLSSQPKSRPTMQRISQEL 719
             +   C +  P++RP+   I  EL
Sbjct: 225 YRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 95.1 bits (237), Expect = 8e-22
 Identities = 80/277 (28%), Positives = 116/277 (41%), Gaps = 35/277 (12%)

Query: 458 IGTGGYGSVYKAEL--PEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G G +G V + E     GKV  VA+K L     + S  +  F  EA ++ ++ H N+++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCL--KSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEA---IELNWTKRVNIVKSVAHALSYLHH 570
           LYG  L    M ++ E    GSL   L  D      I       V I       + YL  
Sbjct: 61  LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIAN----GMRYLES 115

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTAR-LLHVDSSYRTL--RAGTYGYIAPELA 627
                 IHRD+++ NILL S+ +  + DFG  R L   +  Y         + + APE  
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172

Query: 628 YTIVVTGKCDVYSFGVVALEVL-MGTHP-GGLLSSLSSSSGPKIM-LIDVLNQRLSPPVN 684
            T   +   DV+ FGV   E+   G  P  GL       SG +I+  ID   +RL  P  
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-------SGSQILKKIDKEGERLERP-- 223

Query: 685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA 721
           +   QDI     +   C +  P  RPT   + + L  
Sbjct: 224 EACPQDIY---NVMLQCWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 95.9 bits (239), Expect = 8e-22
 Identities = 78/289 (26%), Positives = 128/289 (44%), Gaps = 47/289 (16%)

Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRN 510
           +G G +G V KAE        E   VA+K L    TE    +    +E  ++  + +H+N
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKN 77

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-----------DDDEAIELNWTKR--VNI 557
           I+ L G C  +  ++++ EY   G+L   L            DD    E   T++  V+ 
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
              VA  + +L    +   IHRD+++ N+L+  +    +ADFG AR +H    YR    G
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194

Query: 618 --TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKI---MLI 672
                ++APE  +  V T + DV+SFGV+  E+           +L  S  P I    L 
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF----------TLGGSPYPGIPVEELF 244

Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N    Q+   +  +   C    P  RPT +++ ++L
Sbjct: 245 KLLKEGYRMEKPQN--CTQE---LYHLMRDCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 36/272 (13%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHH-SETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G +G V+  +      VA+K +   + +ED      F  EA V+  + H N+V+LYG
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD-----FIEEAKVMMKLSHPNLVQLYG 66

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
            C  ++ +F++ EYM  G L   L +    +   W   +++   V  A+ YL  +     
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---F 121

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVT 633
           IHRD+++ N L+  +    V+DFG AR + +D  Y T   GT     +  PE+      +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQY-TSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 634 GKCDVYSFGVVALEVL-MGTHPGGLLSSL----SSSSGPKIMLIDVLNQRLSPPVNQKIV 688
            K DV+SFGV+  EV   G  P    S+     S S+G       +   +L+P       
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-----YRLYRPKLAPTE----- 229

Query: 689 QDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                V TI ++C   +P+ RP  +++  +L 
Sbjct: 230 -----VYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 87/288 (30%), Positives = 125/288 (43%), Gaps = 49/288 (17%)

Query: 458 IGTGGYGSVYKAELP------EGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           +G+G +G VY+           G + VA+K L    T D    + F  EAH++S   H N
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKE-FLKEAHLMSNFNHPN 60

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRVNIVKSVAHALS 566
           IVKL G CL  +  ++I E ME G L   L D          L   + ++I   VA    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 567 YLHHDCTLSIIHRDISSNNILL-----DSNLEASVADFGTARLLHVDSSYRTLRAGTYG- 620
           YL     +  IHRD+++ N L+     D++    + DFG AR ++    YR    G    
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 621 -YIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQ- 677
            ++APE       T + DV+SFGV+  E+L +G  P   L++            +VL   
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----------QEVLQHV 226

Query: 678 ----RLSPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
               RL  P N   KI Q +         C +  P  RPT  RI + L
Sbjct: 227 TAGGRLQKPENCPDKIYQLMTN-------CWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 85/286 (29%), Positives = 127/286 (44%), Gaps = 33/286 (11%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G VYK  +    +VVA+K +   E ED   ++  Q E  VLS      I + YG
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYITRYYG 69

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    +++I EY+  GS   +L        L  T    I++ +   L YLH +     
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RK 122

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI + N+LL    +  +ADFG A  L      R    GT  ++APE+        K 
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 637 DVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ----KIVQDII 692
           D++S G+ A+E+  G  P   L           M +  L  + SPP  +    K  ++ +
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHP---------MRVLFLIPKNSPPTLEGQYSKPFKEFV 233

Query: 693 LVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
                  ACL+  P+ RPT    ++ELL  K   +   K   ++EL
Sbjct: 234 E------ACLNKDPRFRPT----AKELLKHKFITRYTKKTSFLTEL 269

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG+G V   ++  + +  ALK +      ++   +   +E  +L    H  IVKLY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
               KK ++++ EY   G L+ +L D    +   +T R   +  V  A  YLH+     I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLHN---RGI 114

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK- 635
           I+RD+   N+LLDSN    + DFG A+ L       T   GT  Y+APE     ++  K 
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF-CGTPEYVAPE-----IILNKG 168

Query: 636 ----CDVYSFGVVALEVLMGTHP 654
                D +S G++  E+L G  P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 94.2 bits (234), Expect = 2e-21
 Identities = 70/207 (33%), Positives = 104/207 (50%), Gaps = 22/207 (10%)

Query: 454 IKYCIGTGGYGSVYKAELP-EGK---VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           I+  IG G +G V    L   GK    VA+K L    TE     + F +EA ++    H 
Sbjct: 8   IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHP 65

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDD---EAIELNWTKRVNIVKSVAHALS 566
           NI+ L G     K + ++ EYME GSL   L   D     I+L     V +++ +A  + 
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMK 120

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD--SSYRTLRAGTYG--YI 622
           YL     +  +HRD+++ NIL++SNL   V+DFG +R+L  D  ++Y T R G     + 
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIRWT 176

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL 649
           APE       T   DV+S+G+V  EV+
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 94.1 bits (234), Expect = 4e-21
 Identities = 84/293 (28%), Positives = 135/293 (46%), Gaps = 53/293 (18%)

Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 2   EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH---LRDFEREIEI 58

Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + L+ EY+  GSL   L    E ++    +++ +  S
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD---HRKLLLYAS 115

Query: 561 -VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + YL    +   +HRD+++ NIL++S     + DFG  ++L  D  Y  +R    
Sbjct: 116 QICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172

Query: 620 GYI---APELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS------------ 664
             I   APE       +   DV+SFGVV  E+   T+     S  S S            
Sbjct: 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELF--TY-----SDKSCSPPAEFMRMMGND 225

Query: 665 -SGPKIM--LIDVL--NQRL-SPPVNQKIVQDIILVSTIAFACLSSQPKSRPT 711
             G  I+  LI++L  N RL +PP     +  I+        C ++ P  RP+
Sbjct: 226 KQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMK------ECWNNDPSQRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 81/296 (27%), Positives = 120/296 (40%), Gaps = 48/296 (16%)

Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           L + T  F +   IG G YG VYKA     G++VA+K +   E E+    +  + E ++L
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNIL 56

Query: 504 STV-RHRNIVKLYGFCLHKKC------MFLIYEYMERGS---LFCVLHDDDEAIELNWTK 553
                H NI   YG  + K        ++L+ E    GS   L   L    + ++  W  
Sbjct: 57  RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116

Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
              I++     L+YLH +    +IHRDI   NILL  N E  + DFG +  L      R 
Sbjct: 117 Y--ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171

Query: 614 LRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEV------LMGTHPGGLLSSLS 662
              GT  ++APE+             + DV+S G+ A+E+      L   HP   L  + 
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP 231

Query: 663 SSSGPKIMLIDVLNQRLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
            +  P           L  P N  K   D I        CL    + RP M+ + +
Sbjct: 232 RNPPPT----------LKSPENWSKKFNDFISE------CLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 93.6 bits (232), Expect = 5e-21
 Identities = 83/283 (29%), Positives = 128/283 (45%), Gaps = 27/283 (9%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+K  +    +VVA+K +   E ED   ++  Q E  VLS      + K YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    +++I EY+  GS   +L     A   +  +   ++K +   L YLH +     
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHSE---KK 122

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI + N+LL    +  +ADFG A  L      R    GT  ++APE+        K 
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182

Query: 637 DVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL-VS 695
           D++S G+ A+E+  G  P       +S   P  M +  L  + +PP    +  +      
Sbjct: 183 DIWSLGITAIELAKGEPP-------NSDMHP--MRVLFLIPKNNPPT---LTGEFSKPFK 230

Query: 696 TIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
               ACL+  P  RPT    ++ELL  K  ++ A K   ++EL
Sbjct: 231 EFIDACLNKDPSFRPT----AKELLKHKFIVKNAKKTSYLTEL 269

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 93.3 bits (232), Expect = 6e-21
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 36/217 (16%)

Query: 458 IGTGGYGSVYKAEL--PEGK-------VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +G G +G VYK EL  P  +       +  LK+    + +       F+ EA ++S ++H
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-----FRQEAELMSDLQH 67

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSL--FCVLH-----------DDDEAIELNWTKRV 555
            NIV L G C  ++   +++EY+  G L  F V +           D+     L+ +  +
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 556 NIVKSVAHALSYL--HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
           +I   +A  + YL  HH      +HRD+++ N L+   L   ++DFG +R ++    YR 
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182

Query: 614 L--RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
                    ++ PE       T + D++SFGVV  E+
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 92.7 bits (230), Expect = 6e-21
 Identities = 73/269 (27%), Positives = 132/269 (49%), Gaps = 38/269 (14%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG G +G+V + E   G+ VA+K +    T      ++F  E  V++ + H+N+V+L G 
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            LH   ++++ E M +G+L   L     A+ ++  + +     VA  + YL    +  ++
Sbjct: 68  ILHNG-LYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLE---SKKLV 122

Query: 578 HRDISSNNILLDSNLEASVADFGTARL--LHVDSSYRTLRAGTYGYIAPELAYTIVVTGK 635
           HRD+++ NIL+  +  A V+DFG AR+  + VD+S   ++     + APE       + K
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-----WTAPEALKHKKFSSK 177

Query: 636 CDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLSPPVNQKIVQD 690
            DV+S+GV+  EV           S   +  PK+ L +V        R+ PP        
Sbjct: 178 SDVWSYGVLLWEVF----------SYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227

Query: 691 IILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +++ S     C  ++PK RP+  ++ ++L
Sbjct: 228 VLMTS-----CWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 92.6 bits (230), Expect = 7e-21
 Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 14/195 (7%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA----EANLMKQLQHPRLVRLYA- 68

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L    E I+L   K +++   +A  ++++      + I
Sbjct: 69  VVTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYI 124

Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL+  D+ Y T R G      + APE       T 
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI-EDNEY-TAREGAKFPIKWTAPEAINYGTFTI 182

Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 183 KSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 92.8 bits (230), Expect = 7e-21
 Identities = 77/281 (27%), Positives = 122/281 (43%), Gaps = 32/281 (11%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           N  EDF +   IG+G YG VYKA  +  G++ A+K +     ED A V   Q E  ++  
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVV---QQEIIMMKD 62

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
            +H NIV  +G  L +  +++  E+   GSL  + H      E    +   + +     L
Sbjct: 63  CKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES---QIAYVSRETLQGL 119

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
            YLH       +HRDI   NILL  N    +ADFG +  +    + R    GT  ++APE
Sbjct: 120 YYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176

Query: 626 LAYTIVVTGK---CDVYSFGVVALEV------LMGTHPGGLLSSLSSSSGPKIMLIDVLN 676
           +A      G    CD+++ G+ A+E+      +   HP   L  ++ S+           
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN----------- 225

Query: 677 QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
               PP  +  ++            L+  PK RPT +++ Q
Sbjct: 226 --FQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 92.7 bits (231), Expect = 7e-21
 Identities = 64/216 (29%), Positives = 95/216 (43%), Gaps = 35/216 (16%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           I  G YG V+ A+    G + A+K +  ++      V     E  +LS  +   +VKLY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLH-----DDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
               KK ++L+ EY+  G L  +L      D+D A           +  +  AL YLH  
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA--------RIYIAEIVLALEYLH-- 110

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--------GTYGYIA 623
            +  IIHRD+  +NIL+DSN    + DFG +++  V                 GT  YIA
Sbjct: 111 -SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 624 PELAYTIVVTGK-----CDVYSFGVVALEVLMGTHP 654
           PE     V+ G+      D +S G +  E L+G  P
Sbjct: 170 PE-----VILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 92.4 bits (229), Expect = 8e-21
 Identities = 62/195 (31%), Positives = 101/195 (51%), Gaps = 14/195 (7%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        +F++    EA ++  +RH  +V+LY  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKLRHDKLVQLYA- 68

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ ++++ EYM +GSL   L D +    L     V++   VA  ++Y+     ++ I
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIER---MNYI 124

Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ S NIL+   L   +ADFG ARL+  D+ Y T R G      + APE A     T 
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIE-DNEY-TARQGAKFPIKWTAPEAALYGRFTI 182

Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 183 KSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 32/279 (11%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           N   D+ +   +G+G YG VYKA  L  G++ A+K +     +D + +   Q E  ++  
Sbjct: 6   NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLI---QQEIFMVKE 62

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
            +H NIV  +G  L ++ +++  EY   GSL  + H      EL   +   + +     L
Sbjct: 63  CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGL 119

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
           +YLH   +   +HRDI   NILL  N +  +ADFG A  +    + R    GT  ++APE
Sbjct: 120 AYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176

Query: 626 LAYTIVVTGK---CDVYSFGVVALEV------LMGTHPGGLLSSLSSSSGPKIMLIDVLN 676
           +A      G    CD+++ G+ A+E+      +   HP   L  +S S+           
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN----------- 225

Query: 677 QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
               PP  +   +            L+  PK RPT +R+
Sbjct: 226 --FQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 59/195 (30%), Positives = 103/195 (52%), Gaps = 13/195 (6%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L       +  V++F  EA+++ T++H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              ++ +++I EYM +GSL   L   DE  ++   K ++    +A  ++Y+      + I
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 125

Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + N+L+  +L   +ADFG AR++  D+ Y T R G      + APE       T 
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIE-DNEY-TAREGAKFPIKWTAPEAINFGSFTI 183

Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 184 KSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 15/199 (7%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKL---HHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           IG G YG VYKA +   G++VA+KK+     SE      ++    E  +L  + H NI+K
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L     HK  ++L++E+M+   L+ ++   D    L  +   + +  +   L++ H    
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH-- 117

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVT 633
             I+HRD+   N+L+++     +ADFG AR         T    T  Y APEL       
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 634 G-KCDVYSFGVVALEVLMG 651
               D++S G +  E+L  
Sbjct: 177 STPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 90.9 bits (225), Expect = 3e-20
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 14/203 (6%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF++    EA ++  +RH 
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ----EAQIMKKLRHD 61

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V LY   + ++ ++++ E+M +GSL   L + D    L   + V++   +A  ++Y+ 
Sbjct: 62  KLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE 119

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPEL 626
               ++ IHRD+ + NIL+  NL   +ADFG ARL+  D+ Y T R G      + APE 
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARLIE-DNEY-TARQGAKFPIKWTAPEA 174

Query: 627 AYTIVVTGKCDVYSFGVVALEVL 649
           A     T K DV+SFG++  E++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 91.3 bits (226), Expect = 4e-20
 Identities = 69/229 (30%), Positives = 113/229 (49%), Gaps = 31/229 (13%)

Query: 454 IKYCIGTGGYGSVYKAEL----PEGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           +K  +G G +G V+ AE     PE    +VA+K L   +  D+A  K F  EA +L+ ++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNA-RKDFHREAELLTNLQ 65

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSL--FCVLHDDDEAI--------ELNWTKRVNI 557
           H +IVK YG C+    + +++EYM+ G L  F   H  D  +        EL  ++ ++I
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
            + +A  + YL    +   +HRD+++ N L+  NL   + DFG +R ++    YR    G
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV---G 179

Query: 618 TYG-----YIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSS 660
            +      ++ PE       T + DV+S GVV  E+   G  P   LS+
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 92.2 bits (229), Expect = 4e-20
 Identities = 73/280 (26%), Positives = 122/280 (43%), Gaps = 54/280 (19%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG+G  G+VYK    P G++ ALK ++ +   +    +    E  +L  V H N+VK + 
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
              H   + ++ E+M+ GSL    H  DE          ++ + +   ++YLH      I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGT-HIADEQ------FLADVARQILSGIAYLHRR---HI 189

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLH-----VDSSYRTLRAGTYGYIAPELAYTIV 631
           +HRDI  +N+L++S     +ADFG +R+L       +SS      GT  Y++PE   T +
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-----VGTIAYMSPERINTDL 244

Query: 632 VTGKCD-----VYSFGVVALEVLMGTHPGG---------LLSSLSSSSGPKIMLIDVLNQ 677
             G  D     ++S GV  LE  +G  P G         L+ ++  S  P+         
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE--------- 295

Query: 678 RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             +P    +  +  I        CL  +P  R +  ++ Q
Sbjct: 296 --APATASREFRHFISC------CLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 89.1 bits (221), Expect = 9e-20
 Identities = 70/278 (25%), Positives = 129/278 (46%), Gaps = 27/278 (9%)

Query: 446 INATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           IN +E   +K  +G+G +G V+  +      VA+K ++    E +   + F  EA V+  
Sbjct: 1   INPSELTFMKE-LGSGQFGVVHLGKWRAQIKVAIKAIN----EGAMSEEDFIEEAKVMMK 55

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           + H  +V+LYG C  +K ++++ E+ME G L   L      +  +    +++ + V   +
Sbjct: 56  LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGM 113

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIA 623
            YL  +   S IHRD+++ N L+ S     V+DFG  R + +D  Y +     +   +  
Sbjct: 114 EYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSP 169

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRL-SP 681
           PE+      + K DV+SFGV+  EV   G  P          S  +++ +     RL  P
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP------FEKKSNYEVVEMISRGFRLYRP 223

Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +    V +++      ++C   +P+ RPT   + + +
Sbjct: 224 KLASMTVYEVM------YSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 24/265 (9%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G V+     E + VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE----EAQVMMKLSHPKLVQLYGV 67

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           C  +  + L++E+ME G L   L    +  + +    + +   V   ++YL       +I
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+++ N L+  N    V+DFG  R + +D  Y T   GT     + +PE+      + 
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQY-TSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 635 KCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILV 694
           K DV+SFGV+  EV       G     + S+   +  I+   +   P +  + V +++  
Sbjct: 181 KSDVWSFGVLMWEV----FSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ- 235

Query: 695 STIAFACLSSQPKSRPTMQRISQEL 719
                 C   +P+ RP+   +  +L
Sbjct: 236 -----HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 89.5 bits (223), Expect = 1e-19
 Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 18/210 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF     +GTG +G V        GK  ALK L  ++      V+   NE  +L ++RH
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             +V LYG       ++L+ EY+  G LF               +       V  AL YL
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFS-HLRKSGRFPEPVARFY--AAQVVLALEYL 117

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H    L I++RD+   N+LLDS+    + DFG A+   V     TL  GT  Y+APE+  
Sbjct: 118 HS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--RVKGRTYTL-CGTPEYLAPEIIL 171

Query: 627 --AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
              Y   V    D ++ G++  E+L G  P
Sbjct: 172 SKGYGKAV----DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 65/219 (29%), Positives = 97/219 (44%), Gaps = 50/219 (22%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKL---HHSETED----SAFVKSFQNEAHVLSTVRHR 509
           +G G Y  VYKA   E G++VA+KK+      E +D    +A       E  +L  ++H 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-----REIKLLQELKHP 62

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH------ 563
           NI+ L     HK  + L++E+ME          D E +     K  +IV + A       
Sbjct: 63  NIIGLLDVFGHKSNINLVFEFME---------TDLEKV----IKDKSIVLTPADIKSYML 109

Query: 564 ----ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGT 618
                L YLH      I+HRD+  NN+L+ S+    +ADFG AR      + + T +  T
Sbjct: 110 MTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKMTHQVVT 165

Query: 619 YGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMGT 652
             Y APEL      Y        D++S G +  E+L+  
Sbjct: 166 RWYRAPELLFGARHY----GVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 30/195 (15%)

Query: 452 FHIKYCIGTGGYGSVYKA---ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           + I+ CIG G YG VYKA      +GK  A+KK    + + +   +S   E  +L  ++H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 509 RNIVKLYGFCLHK--KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV--NIVKS---- 560
            N+V L    L    K ++L+++Y E   L+ ++    +A        +  ++VKS    
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAK----RVSIPPSMVKSLLWQ 116

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS----VADFGTARLLHVDSSYRTLRA 616
           + + + YLH +    ++HRD+   NIL+           + D G ARL +  +  + L  
Sbjct: 117 ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN--APLKPLAD 171

Query: 617 G-----TYGYIAPEL 626
                 T  Y APEL
Sbjct: 172 LDPVVVTIWYRAPEL 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 89.0 bits (221), Expect = 3e-19
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 23/204 (11%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG VY+A +   G++VALKK+      D   + S + E  +L  +RH NIV+L  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKE 73

Query: 517 FCL--HKKCMFLIYEYMER--GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
             +  H   +FL+ EY E+   SL      D+     + ++   ++  +   L YLH + 
Sbjct: 74  VVVGKHLDSIFLVMEYCEQDLASLL-----DNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-----A 627
              IIHRD+  +N+LL       +ADFG AR   + +   T +  T  Y APEL      
Sbjct: 129 ---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTT 185

Query: 628 YTIVVTGKCDVYSFGVVALEVLMG 651
           YT  +    D+++ G +  E+L  
Sbjct: 186 YTTAI----DMWAVGCILAELLAH 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 76/268 (28%), Positives = 134/268 (50%), Gaps = 30/268 (11%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+ A   +   VA+K +       S  V++F  EA+V+ T++H  +VKL+  
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLHA- 68

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + K+ +++I E+M +GSL   L   DE  +    K ++    +A  ++++      + I
Sbjct: 69  VVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 124

Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+ ++L   +ADFG AR++  D+ Y T R G      + APE       T 
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIE-DNEY-TAREGAKFPIKWTAPEAINFGSFTI 182

Query: 635 KCDVYSFGVVALEVLM---GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDI 691
           K DV+SFG++ +E++      +PG         S P++  I  L +    P  +   +++
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPG--------MSNPEV--IRALERGYRMPRPENCPEEL 232

Query: 692 ILVSTIAFACLSSQPKSRPTMQRISQEL 719
                I   C  ++P+ RPT + I   L
Sbjct: 233 Y---NIMMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.6 bits (217), Expect = 3e-19
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 26/211 (12%)

Query: 457 CIGTGGYGSVYKA-ELPEGKVVALKKLH--HSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
            +G G +G VY   ++  G+ +A+K++       E    V + + E  +L  ++H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 514 LYGFCLHKKCMFLIY-EYMERGSLFCVLHDDDEAI-ELNWTKRVNIVKSVAHALSYLHHD 571
            YG CL       I+ EYM  GS+     D  +A   L  T      + +   + YLH +
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSV----KDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTA-RLLHVDSSYRTLRA--GTYGYIAPELAY 628
               I+HRDI   NIL DS     + DFG + RL  + SS   +++  GT  +++PE   
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE--- 177

Query: 629 TIVVTG-----KCDVYSFGVVALEVLMGTHP 654
             V++G     K DV+S G   +E+L    P
Sbjct: 178 --VISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 17/200 (8%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G YG V K +  E G++VA+KK   SE +D    K    E  +L  +RH N+V L  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESE-DDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEA----IELNWTKRVNIVKSVAHALSYLHHDC 572
               KK ++L++E+++   L     DD E     ++ +  ++   +  +   + + H   
Sbjct: 68  VFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRK--YLFQILRGIEFCHSH- 119

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
             +IIHRDI   NIL+  +    + DFG AR L       T    T  Y APEL      
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 633 TGK-CDVYSFGVVALEVLMG 651
            G+  D+++ G +  E+L G
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 87.2 bits (216), Expect = 5e-19
 Identities = 69/265 (26%), Positives = 124/265 (46%), Gaps = 32/265 (12%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHH-SETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +GTG +G V   +      VA+K +   S +ED      F  EA V+  + H  +V+LYG
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-----FIEEAKVMMKLSHEKLVQLYG 66

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
            C  ++ ++++ EYM  G L   L +  +  +   ++ + + K V   ++YL    +   
Sbjct: 67  VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLE---SKQF 121

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVT 633
           IHRD+++ N L+D      V+DFG +R + +D  Y T   G+     +  PE+      +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEY-TSSVGSKFPVRWSPPEVLLYSKFS 179

Query: 634 GKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP--VNQKIVQD 690
            K DV++FGV+  EV  +G  P    ++       + +       RL  P   ++K+   
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEKVSQGLRLYRPHLASEKVYA- 232

Query: 691 IILVSTIAFACLSSQPKSRPTMQRI 715
                 I ++C   + + RPT Q++
Sbjct: 233 ------IMYSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 87.2 bits (216), Expect = 5e-19
 Identities = 75/279 (26%), Positives = 140/279 (50%), Gaps = 38/279 (13%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETE----DSA---FVKSFQNEAHVLSTVRHR 509
           IG G YG VY A  +  G+++A+K++    T     DS     VK+ ++E   L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD---DEAIELNWTKRVNIVKSVAHALS 566
           NIV+  GF   ++ + +  EY+  GS+   L      +E +   +T++V         L+
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------LEGLA 122

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGYI 622
           YLH      I+HRD+ ++N+L+D++    ++DFG ++    D  Y   +     G+  ++
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWM 177

Query: 623 APEL--AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS 680
           APE+  +Y+   + K D++S G V LE+  G  P     ++++       +  + N+R +
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-------MFKLGNKRSA 230

Query: 681 PPVNQKIVQDIILVSTIAF--ACLSSQPKSRPTMQRISQ 717
           PP+   +  ++  V+ + F  AC +  P +RPT + + Q
Sbjct: 231 PPIPPDVSMNLSPVA-LDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 86.7 bits (215), Expect = 9e-19
 Identities = 77/281 (27%), Positives = 113/281 (40%), Gaps = 46/281 (16%)

Query: 458 IGTGGYGSVYKAE---LPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+          V   VA+K L  S +E       F  EA ++S   H+NI
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE--SDFLMEALIMSKFNHQNI 71

Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD----DEAIELNWTKRVNIVKSVAHALSY 567
           V+L G    +   F++ E M  G L   L ++    +    L     +   + VA    Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 568 LHHDCTLSIIHRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGT----YG 620
           L        IHRDI++ N LL        A +ADFG AR ++  S YR  + G       
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR--KGGRAMLPIK 186

Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQRL 679
           ++ PE     + T K DV+SFGV+  E+  +G  P          +  ++M       RL
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP------YPGRTNQEVMEFVTGGGRL 240

Query: 680 SPPVN-----QKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
            PP        +I+ D          C    P+ RP    I
Sbjct: 241 DPPKGCPGPVYRIMTD----------CWQHTPEDRPNFATI 271

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 73/299 (24%), Positives = 130/299 (43%), Gaps = 60/299 (20%)

Query: 458 IGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G V KA             VA+K L   E   S+ ++   +E ++L  V H ++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML--KENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------------------HDDDEAIE 548
           +KLYG C     + LI EY + GSL   L                       + D+ A  
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA-- 123

Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           L     ++    ++  + YL     + ++HRD+++ N+L+    +  ++DFG +R ++ +
Sbjct: 124 LTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 609 SSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG 666
            SY  R+       ++A E  +  + T + DV+SFGV+  E++          +L  +  
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV----------TLGGNPY 230

Query: 667 PKIMLIDVLN-----QRLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           P I    + N      R+  P N  + + +++L       C   +P  RPT   IS+EL
Sbjct: 231 PGIAPERLFNLLKTGYRMERPENCSEEMYNLML------TCWKQEPDKRPTFADISKEL 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 32/218 (14%)

Query: 458 IGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           IG G +G V++A  P         +VA+K L    + D      FQ EA +++   H NI
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMAEFDHPNI 70

Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVL------------HDDDEA-------IELNWT 552
           VKL G C   K M L++EYM  G L   L            H    A       + L+ T
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR 612
           +++ I K VA  ++YL        +HRD+++ N L+  N+   +ADFG +R ++    Y+
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 613 TLR--AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
                A    ++ PE  +    T + DV+++GVV  E+
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 19/210 (9%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLH------HSETEDSAFVKSFQNEAHVLSTVRHRN 510
           IG+G +GSVY       G+++A+K++        S+    + + +   E  +L  ++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           IV+  G  L    + +  EY+  GS+  +L ++  A E    +  N V+ +   L+YLH+
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVR--NFVRQILKGLNYLHN 124

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA------GTYGYIAP 624
                IIHRDI   NIL+D+     ++DFG ++ L  +S             G+  ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+      T K D++S G + +E+L G HP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 84/301 (27%), Positives = 129/301 (42%), Gaps = 38/301 (12%)

Query: 444 DLINATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           DL N  ED      +G G  GSV K + +P G V+A K +H      S+  K    E  +
Sbjct: 1   DLRN--EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQI 56

Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           +   R   IV  YG  L++  + +  E+M+ GSL  +     +   +       I  +V 
Sbjct: 57  MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVV 113

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L+YL++     I+HRDI  +NIL++S  +  + DFG +  L ++S   T   GT  Y+
Sbjct: 114 EGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTF-VGTSTYM 169

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ----- 677
           +PE       T K DV+S G+  +E+ +G  P    +         + ++D+L Q     
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229

Query: 678 --RLS----PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALK 731
             RL     P   +  V           ACL   P  RPT Q      L    P  +AL+
Sbjct: 230 PPRLPSSDFPEDLRDFVD----------ACLLKDPTERPTPQ-----QLCAMPPFIQALR 274

Query: 732 E 732
            
Sbjct: 275 A 275

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 70/276 (25%), Positives = 124/276 (44%), Gaps = 34/276 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++  +   IG G +G V   +   G  VA+K + +  T      ++F  EA V++ +RH 
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHS 59

Query: 510 NIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           N+V+L G  + +K  ++++ EYM +GSL   L     ++ L     +     V  A+ YL
Sbjct: 60  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 118

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
             +   + +HRD+++ N+L+  +  A V+DFG   L    SS +        + APE   
Sbjct: 119 EAN---NFVHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALR 172

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV 688
               + K DV+SFG++  E+           S      P+I L DV+     P V +   
Sbjct: 173 EKKFSTKSDVWSFGILLWEIY----------SFGRVPYPRIPLKDVV-----PRVEKGYK 217

Query: 689 QDII-----LVSTIAFACLSSQPKSRPTMQRISQEL 719
            D       +V  +   C      +RP+  ++ ++L
Sbjct: 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 68/292 (23%), Positives = 115/292 (39%), Gaps = 61/292 (20%)

Query: 458 IGTGGYGSVYKAELPEG------KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G V+ A+           +V +K L   +T+D      F+ E  +   + H+N+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE------LNWTKRVNIVKSVAHAL 565
           V+L G C   +  ++I EY + G L   L       E      L+  ++V +   +A  +
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR------TLRAGTY 619
            +L        +HRD+++ N L+ S  E  V+    ++ ++    Y+       LR    
Sbjct: 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR---- 183

Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQ- 677
            ++APE       + K DV+SFGV+  EV   G  P   LS              VLN+ 
Sbjct: 184 -WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-----------VLNRL 231

Query: 678 -----RLSPPVN-----QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                 L  P        K++            C +  PK RP+   +   L
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMT----------RCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 86.4 bits (214), Expect = 3e-18
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 15/214 (7%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF +K  +G G +G V    E   G + A+K +  S       V  F+ E  +LS    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 509 RNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
             I +L Y F   K  ++L+ EY   G L  +L+  ++  + +  +    +  +  A+  
Sbjct: 61  PWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--LAELVLAIHS 117

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS-YRTLRAGTYGYIAPEL 626
           +H    +  +HRDI   N+L+D      +ADFG+A  L  +      L  GT  YIAPE+
Sbjct: 118 VH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174

Query: 627 AYTIVVTGK------CDVYSFGVVALEVLMGTHP 654
             T+   GK      CD +S GV+A E++ G  P
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.0 bits (210), Expect = 3e-18
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLH-HSETEDSA--FVKSFQNEAHVLSTVRHRNIVKL 514
           +G G YG+VY     +G+++A+K++   +    +A    +  Q E  +L +++H NIV+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
            G CL    + +  E++  GS+  +L+      E  + K     K +   ++YLH++C  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLL-----HVDSS--YRTLRAGTYGYIAPELA 627
            ++HRDI  NN++L  N    + DFG AR L     H   S   +++  GT  ++APE+ 
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMAPEVI 180

Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
                  K D++S G    E+  G  P
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 88.7 bits (220), Expect = 3e-18
 Identities = 40/96 (41%), Positives = 62/96 (64%)

Query: 218 LDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLS 277
           +D L L +  + G IP++++KL  L+++NLS N + G IP ++G + +L  LDLS N  +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 278 GSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILL 313
           GSIP  +G  ++L+ L LN NSL G +P  +G  LL
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515

Length = 623

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 70/294 (23%), Positives = 125/294 (42%), Gaps = 47/294 (15%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G VYKA+  E  + A  K+   + E    ++ F  E  +LS  +H NIV LY  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKI--IQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIE--LNWTKRVNIVKSVAHALSYLHHDCTLS 575
             ++  ++++ E+ + G+L  ++      +E  L   +   + + +  AL++LH      
Sbjct: 71  YFYENKLWILIEFCDGGALDSIM----LELERGLTEPQIRYVCRQMLEALNFLHSH---K 123

Query: 576 IIHRDISSNNILLDSNLEASVADFG-TARLLHVDSSYRTLRAGTYGYIAPEL-------- 626
           +IHRD+ + NILL  + +  +ADFG +A+         T   GT  ++APE+        
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAPEVVACETFKD 182

Query: 627 -AYTIVVTGKCDVYSFGVVALEVLMG------THPGGLLSSLSSSSGPKIMLIDVLNQRL 679
             Y      K D++S G+  +E+          +P  +L  +  S  P +          
Sbjct: 183 NPYDY----KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL---------D 229

Query: 680 SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEI 733
            P        D +       +CL   P  RPT   + +          KA+K++
Sbjct: 230 QPSKWSSSFNDFLK------SCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDL 277

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 32/282 (11%)

Query: 450 EDFHIKYCIGTGGYGSVYK---AELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVL 503
           E   +   +G G +G VY+     + +G+    VA+K ++  E         F NEA V+
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN--ENASMRERIEFLNEASVM 63

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH----DDDEA---IELNWTKRVN 556
                 ++V+L G     +   ++ E M +G L   L     + +           K + 
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
           +   +A  ++YL        +HRD+++ N ++  +L   + DFG  R ++    YR    
Sbjct: 124 MAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 617 GTYG--YIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLID 673
           G     ++APE     V T K DV+SFGVV  E+  +   P   LS  +      ++   
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--NEEVLKFVIDGG 238

Query: 674 VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
            L+   + P     + +++        C    PK RPT   I
Sbjct: 239 HLDLPENCPD---KLLELMR------MCWQYNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 84.2 bits (208), Expect = 8e-18
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 17/201 (8%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+K+++  +      +    NE  V+   +H NIV    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII---NEILVMRENKHPNIVNYLD 83

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
             L    ++++ EY+  GSL  V+ +   D+  I         + +    AL +LH +  
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-------AAVCRECLQALEFLHSN-- 134

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVT 633
             +IHRDI S+NILL  +    + DFG    +  + S R+   GT  ++APE+       
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 634 GKCDVYSFGVVALEVLMGTHP 654
            K D++S G++A+E++ G  P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 13/198 (6%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V+K    E G++VA+KK   SE +D    K    E  +L  ++H N+V L  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESE-DDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE-LNWTKRVNIVKSVAHALSYLH-HDCTL 574
               K+ + L++EY +      VL++ ++    +       I+     A+++ H H+C  
Sbjct: 68  VFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC-- 121

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
             IHRD+   NIL+    +  + DFG AR+L       T    T  Y APEL       G
Sbjct: 122 --IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179

Query: 635 K-CDVYSFGVVALEVLMG 651
              DV++ G V  E+L G
Sbjct: 180 PPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 16/209 (7%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +D      +GTG +G V+   +       ALK +   E       +   NE  VL  V H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             I++L+     ++ ++++ EY+  G LF  L +   +   + +  +     +  AL YL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYL 117

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  I++RD+   NILLD      + DFG A+ L  D ++ TL  GT  Y+APE+  
Sbjct: 118 H---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTW-TL-CGTPEYLAPEV-- 169

Query: 629 TIVVTGK---CDVYSFGVVALEVLMGTHP 654
            I   G     D ++ G++  E+L+G  P
Sbjct: 170 -IQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 15/200 (7%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALK--KLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           IG G  G V  A E   G+ VA+K   L   +  +  F     NE  ++   +H+N+V++
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-----NEVVIMRDYQHQNVVEM 83

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
           Y   L  + ++++ E+++ G+L  ++        LN  +   + +SV  AL YLH   + 
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLH---SQ 136

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            +IHRDI S++ILL  +    ++DFG    +  D   R    GT  ++APE+        
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196

Query: 635 KCDVYSFGVVALEVLMGTHP 654
           + D++S G++ +E++ G  P
Sbjct: 197 EVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 71/230 (30%), Positives = 106/230 (46%), Gaps = 21/230 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSET---EDSAFVKSFQNEAHVLST 505
           EDF +   IG G +G V         +V A+K L   E     DSAF   F  E  +++ 
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF---FWEERDIMAH 99

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
                IV+L+      K ++++ EYM  G L  ++ + D  I   W +       V  AL
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFY--TAEVVLAL 155

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GTYGYIAP 624
             +H   ++  IHRD+  +N+LLD +    +ADFGT   +  +   R   A GT  YI+P
Sbjct: 156 DAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212

Query: 625 ELAYTIVVTG----KCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIM 670
           E+  +    G    +CD +S GV   E+L+G  P     SL  +   KIM
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP-FYADSLVGTYS-KIM 260

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 67/273 (24%), Positives = 125/273 (45%), Gaps = 30/273 (10%)

Query: 458 IGTGGYGSVYKAELPEG--KVVALKK--LHHSE-----TEDSAFVKSFQNEAHVL-STVR 507
           +G+G +G VYK         ++ALK+  +H+        E    +    +E  ++   +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSL---FCVLHDDDEAIELNWTKRV-NIVKSVAH 563
           H NIV+ Y   L    ++++ + +E   L   F  L +  +       +R+ NI   +  
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWNIFVQMVL 124

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
           AL YLH +    I+HRD++ NNI+L  + + ++ DFG A+      S  T   GT  Y  
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVVGTILYSC 181

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV 683
           PE+        K DV++FG +  ++     P    S+   S   KI+      + +  P+
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLSLATKIV------EAVYEPL 233

Query: 684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRIS 716
            + +  +   V+ +  +CL+   ++RP + ++S
Sbjct: 234 PEGMYSE--DVTDVITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKK--LHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           IG G  G V  A +   G+ VA+KK  L   +  +  F     NE  ++   +H NIV++
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHPNIVEM 81

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
           Y   L    ++++ E++E G+L     D      +N  +   +  +V  ALS+LH     
Sbjct: 82  YSSYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIATVCLAVLKALSFLH---AQ 134

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            +IHRDI S++ILL S+    ++DFG    +  +   R    GT  ++APE+   +    
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194

Query: 635 KCDVYSFGVVALEVLMGTHP 654
           + D++S G++ +E++ G  P
Sbjct: 195 EVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 52/189 (27%), Positives = 79/189 (41%), Gaps = 25/189 (13%)

Query: 477 VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL 536
           VA+K L           + F  E  +LS +   NI +L G C     + +I EYME G L
Sbjct: 49  VAVKVL--RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 537 -----FCVLHDDDEAIELNWTKR---VNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL 588
                  V      A           + +   +A  + YL    +L+ +HRD+++ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV 163

Query: 589 DSNLEASVADFGTARLLHVDSSYRT-------LRAGTYGYIAPELAYTIVVTGKCDVYSF 641
             N    +ADFG +R L+    YR        +R     ++A E       T K DV++F
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR-----WMAWESVLLGKFTTKSDVWAF 218

Query: 642 GVVALEVLM 650
           GV   E+L 
Sbjct: 219 GVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 81.2 bits (200), Expect = 5e-17
 Identities = 69/270 (25%), Positives = 113/270 (41%), Gaps = 26/270 (9%)

Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+   L  +   VA+K     ET        F  EA +L    H NIV+L G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
            C  K+ ++++ E ++ G     L    E   L   + + +V++ A  + YL        
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLR--TEGPRLKVKELIQMVENAAAGMEYLESKHC--- 115

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLH--VDSSYRTLRAGTYGYIAPELAYTIVVTG 634
           IHRD+++ N L+       ++DFG +R     V +S   ++     + APE       + 
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 635 KCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQ--RLSPPVNQKIVQDI 691
           + DV+SFG++  E   +G  P   LS+  +         + + Q  RL  P         
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTR--------EAIEQGVRLPCPELCPDA--- 224

Query: 692 ILVSTIAFACLSSQPKSRPTMQRISQELLA 721
             V  +   C    P  RP+   + QEL +
Sbjct: 225 --VYRLMERCWEYDPGQRPSFSTVHQELQS 252

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 71/276 (25%), Positives = 117/276 (42%), Gaps = 33/276 (11%)

Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKK-----LHHSETEDSAFVKSFQNEAHVLS 504
           DF +   +G G YGSVYK + L + +  ALK+     +   E ED+       NE  +L+
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV------NEIRILA 54

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV-NIVKSVAH 563
           +V H NI+      L    + ++ EY   G L   +    +  +L   + +  I   +  
Sbjct: 55  SVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
            L  LH      I+HRD+ S NILL +N    + D G +++L  + +   +  GT  Y+A
Sbjct: 115 GLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--GTPHYMA 169

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP--GGLLSSLSSSSGPKIMLIDVLNQRLSP 681
           PE+      + K D++S G +  E+     P     +  L      K+       +   P
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY----KVQ------RGKYP 219

Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
           P+     QD+        + L  +PK RP   +I  
Sbjct: 220 PIPPIYSQDL---QNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 82.0 bits (202), Expect = 5e-17
 Identities = 73/273 (26%), Positives = 127/273 (46%), Gaps = 33/273 (12%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALK---KLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +G+VYK   +PEG+ V +    K+ +  T   A V+ F +EA +++++ H ++V+
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVR 73

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRVNIVKSVAHALSYLH 569
           L G CL    + L+ + M  G L   +H+  + I     LNW  ++      A  + YL 
Sbjct: 74  LLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
                 ++HRD+++ N+L+ S     + DFG ARLL  D        G     ++A E  
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRL-SPPVNQK 686
           +    T + DV+S+GV   E++  T  G     + +   P ++      +RL  PP+   
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELM--TFGGKPYDGIPTREIPDLL---EKGERLPQPPICT- 237

Query: 687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                I V  +   C      SRP  + ++ E 
Sbjct: 238 -----IDVYMVMVKCWMIDADSRPKFKELAAEF 265

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 81.8 bits (202), Expect = 5e-17
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G YGSVYK    P G  +A+K++   E ++S F      E  +L       IV  YG
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKF-NQIIMELDILHKAVSPYIVDFYG 66

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
               +  +++  EYM+ GSL  +         +       I  +V   L +L  +   +I
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNI 124

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE----------L 626
           IHRD+   N+L++ N +  + DFG +  L V S  +T   G   Y+APE           
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKT-NIGCQSYMAPERIKSGGPNQNP 182

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            YT+    + DV+S G+  LE+ +G +P
Sbjct: 183 TYTV----QSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 82.0 bits (202), Expect = 6e-17
 Identities = 72/293 (24%), Positives = 127/293 (43%), Gaps = 53/293 (18%)

Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 80

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSL---------------FCVLHDDDEAIELNWTK 553
           +NI+ L G C     +++I EY  +G+L               + +    DE  ++ +  
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE--QMTFKD 138

Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            V+    VA  + YL    +   IHRD+++ N+L+  N    +ADFG AR ++    Y+ 
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 614 LRAGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIML 671
              G     ++APE  +  V T + DV+SFGV+  E+           +L  S  P I +
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF----------TLGGSPYPGIPV 245

Query: 672 IDVLN-----QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            ++        R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 246 EELFKLLKEGHRMDKPAN--CTNELYMMMR---DCWHAIPSHRPTFKQLVEDL 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 75/278 (26%), Positives = 124/278 (44%), Gaps = 45/278 (16%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALK--KLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G+G +GSVY+   L +G   A+K   L          VK  + E  +LS ++H NIV+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDD---EAIELNWTKRVNIVKSVAHALSYLHHD 571
            G    +  +++  E +  GSL  +L       E +   +T++  I+      L YLH  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ--ILL----GLEYLHDR 121

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL----- 626
              + +HRDI   NIL+D+N    +ADFG A+ +   S  ++ +   Y ++APE+     
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY-WMAPEVIAQQG 177

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK 686
            Y +      D++S G   LE+  G  P   L  +++       +  +   +  PP+   
Sbjct: 178 GYGLAA----DIWSLGCTVLEMATGKPPWSQLEGVAA-------VFKIGRSKELPPIPDH 226

Query: 687 I---VQDIILVSTIAFACLSSQPKSRPTMQRISQELLA 721
           +    +D IL       CL   P  RPT    + ELL 
Sbjct: 227 LSDEAKDFILK------CLQRDPSLRPT----AAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.4 bits (198), Expect = 9e-17
 Identities = 69/268 (25%), Positives = 119/268 (44%), Gaps = 24/268 (8%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+K  L +   VA+K       ++      F +EA +L    H NIVKL G 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIGV 60

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           C  ++ ++++ E +  G     L    +  EL   + V      A  ++YL    + + I
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLE---SKNCI 115

Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT--LRAGTYGYIAPELAYTIVVTGK 635
           HRD+++ N L+  N    ++DFG +R    D  Y +  L+     + APE       + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174

Query: 636 CDVYSFGVVALEVL-MGTHP-GGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL 693
            DV+S+G++  E   +G  P  G+ +  +     K         R+S P  QK   D+  
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-------GYRMSCP--QKCPDDV-- 223

Query: 694 VSTIAFACLSSQPKSRPTMQRISQELLA 721
              +   C   +P++RP    + +EL A
Sbjct: 224 -YKVMQRCWDYKPENRPKFSELQKELAA 250

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 83.7 bits (207), Expect = 1e-16
 Identities = 52/162 (32%), Positives = 85/162 (52%), Gaps = 27/162 (16%)

Query: 245 LNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTI 304
           L L +  L G IP  I KL +L  ++LS N + G+IP  +G+ ++L+ L L++NS +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 305 PLEMGKILLLQNLDLSHNNLSGTIPKTL--RPMYVDLSFNNLEGEIPTYLRGNPPKSFVG 362
           P  +G++  L+ L+L+ N+LSG +P  L  R ++   SFN                 F  
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLH-RASFN-----------------FTD 524

Query: 363 NKGLSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFII 404
           N GL G + G  +        P +S+ AKI +   + +AF+ 
Sbjct: 525 NAGLCG-IPGLRACG------PHLSVGAKIGIAFGVSVAFLF 559

Length = 623

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 24/264 (9%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G V  A E   GK VA+KK+   + +    +    NE  ++    H N+V +Y 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF---NEVVIMRDYHHENVVDMYN 86

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    ++++ E++E G+L     D      +N  +   +  SV  ALSYLH      +
Sbjct: 87  SYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGV 139

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI S++ILL S+    ++DFG    +  +   R    GT  ++APE+   +    + 
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 637 DVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVST 696
           D++S G++ +E++ G  P          + P +  +  +   L P      V+D   VS+
Sbjct: 200 DIWSLGIMVIEMIDGEPP--------YFNEPPLQAMRRIRDNLPPR-----VKDSHKVSS 246

Query: 697 IAFACLSSQPKSRPTMQRISQELL 720
           +    L       P+ +  +QELL
Sbjct: 247 VLRGFLDLMLVREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 37/220 (16%)

Query: 452 FHIKYCIGTGGYGSVYKAELPEGKV---------VALKKLHHSETEDSAFVKSFQNEAHV 502
           + I   IG G +G +Y   L + K          + L K+   E E S      + E  +
Sbjct: 2   YEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEAS------KKEVIL 52

Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLF-------CVLHDDDEAIELNWTKRV 555
           L+ ++H NIV  +        +F++ EY + G L         VL  +D+   L+W  ++
Sbjct: 53  LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI--LSWFVQI 110

Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN-LEASVADFGTARLLHVDSSYRTL 614
           ++       L ++H      I+HRDI S NI L  N + A + DFG AR L+        
Sbjct: 111 SL------GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161

Query: 615 RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
             GT  Y++PE+        K D++S G V  E+    HP
Sbjct: 162 CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 54/213 (25%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR--------- 507
           IG G YG+VYKA +L  G+ VALKK+    +E+             LST+R         
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI----------PLSTLREIALLKQLE 56

Query: 508 ---HRNIVKLYGFCL-----HKKCMFLIYEYMERGSLFCVLHD----------DDEAIEL 549
              H NIV+L   C       +  + L++E+++       L              E I+ 
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIK- 110

Query: 550 NWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS 609
                 ++++ +   + +LH   +  I+HRD+   NIL+ S+ +  +ADFG AR+   + 
Sbjct: 111 ------DLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM 161

Query: 610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFG 642
           +  T    T  Y APE+          D++S G
Sbjct: 162 A-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVG 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 72/268 (26%), Positives = 119/268 (44%), Gaps = 35/268 (13%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLH-HSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G G +G V+      + K+V +K++     T+D     + QNE  VL  + H NI++ Y
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER--LAAQNECQVLKLLSHPNIIEYY 65

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
              L  K + ++ EY   G+L   +     ++    T    I+      L  LHH  T  
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT----ILHFFVQILLALHHVHTKL 121

Query: 576 IIHRDISSNNILLDSN-LEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
           I+HRD+ + NILLD + +   + DFG +++L   S   T+  GT  YI+PEL        
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VGTPCYISPELCEGKPYNQ 180

Query: 635 KCDVYSFGVVALEVLM-------GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI 687
           K D+++ G V  E+            P  +L  +S +  P       ++ R SP + Q I
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP-------ISDRYSPDLRQLI 233

Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRI 715
           +           + L+  P  RP + +I
Sbjct: 234 L-----------SMLNLDPSKRPQLSQI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 80.2 bits (197), Expect = 2e-16
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G+V+ A ++  G+ VA+K+++  +      +    NE  V+  +++ NIV    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII---NEILVMKELKNPNIVNFLD 83

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDD--DEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
             L    +F++ EY+  GSL  V+ +   DEA      +   + +    AL +LH +   
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTETCMDEA------QIAAVCRECLQALEFLHAN--- 134

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            +IHRDI S+N+LL  +    + DFG    +  + S R+   GT  ++APE+        
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 635 KCDVYSFGVVALEVLMGTHP 654
           K D++S G++A+E++ G  P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 50/238 (21%)

Query: 446 INATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKK-LHHSETEDSAFVKSFQNEAHVL 503
            +   D+ I   +G G +G VYKA ++  G+VVALKK L H+E +   F  +   E  +L
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKIL 61

Query: 504 STVRHRNIVKLYGFCLH--------KKCMFLIYEYMERGSLFCVLHD-----DDEAIELN 550
             ++H N+V L    +         +  ++++  YM+        HD     ++ +++L 
Sbjct: 62  KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--------HDLSGLLENPSVKLT 113

Query: 551 WTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS 610
            ++    +  +   ++YLH +    I+HRDI + NIL+D+     +ADFG AR       
Sbjct: 114 ESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD-GPP 169

Query: 611 YRTLRAGTYG------------YIAPELA-----YTIVVTGKCDVYSFGVVALEVLMG 651
                 G  G            Y  PEL      YT  V    D++  G V  E+   
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 80.0 bits (197), Expect = 3e-16
 Identities = 73/272 (26%), Positives = 127/272 (46%), Gaps = 31/272 (11%)

Query: 458 IGTGGYGSVYKA-ELPEGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV 512
           +G+G +G+VYK   +PEG+     VA+K+L  + +  +   K   +EA+V+++V + ++ 
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPHVC 72

Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
           +L G CL      LI + M  G L   + +  + I   +   +N    +A  ++YL    
Sbjct: 73  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAKGMNYLEER- 128

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELAYTI 630
              ++HRD+++ N+L+ +     + DFG A+LL  D        G     ++A E     
Sbjct: 129 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186

Query: 631 VVTGKCDVYSFGVVALEVL-MGTHP-GGLLSSLSSSSGPKIMLIDVLNQRL-SPPVNQKI 687
           + T + DV+S+GV   E++  G+ P  G+ +S  SS   K        +RL  PP+    
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GERLPQPPICT-- 237

Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
               I V  I   C      SRP  + +  E 
Sbjct: 238 ----IDVYMIMVKCWMIDADSRPKFRELIIEF 265

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 58/202 (28%), Positives = 83/202 (41%), Gaps = 18/202 (8%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-NIVKLY 515
           I  G +GSVY A+    G   A+K L  S+      V + + E  ++        + KLY
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 516 GFCLHKKCMFLIYEYMERG---SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
                K  ++L+ EY+  G   SL   L    E    +W K    +  V   +  LH   
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE----DWAK--QYIAEVVLGVEDLHQR- 116

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
              IIHRDI   N+L+D      + DFG +R    +  +     GT  Y+APE    +  
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF----VGTPDYLAPETILGVGD 170

Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
               D +S G V  E L G  P
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 79.7 bits (196), Expect = 4e-16
 Identities = 73/269 (27%), Positives = 124/269 (46%), Gaps = 32/269 (11%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G+VY A ++   +VVA+KK+ +S  + +   +    E   L  ++H N ++  G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 517 FCLHKKCMFLIYEYM--ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
             L +   +L+ EY       L  V     + +E+       I       L+YLH   + 
Sbjct: 93  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYLH---SH 144

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI---V 631
           ++IHRDI + NILL    +  +ADFG+A +    +S+     GT  ++APE+   +    
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF----VGTPYWMAPEVILAMDEGQ 200

Query: 632 VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDI 691
             GK DV+S G+  +E+     P   ++++S+        +  + Q  SP +      D 
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPTLQSNEWSDY 252

Query: 692 ILVSTIAFACLSSQPKSRPTMQRISQELL 720
                   +CL   P+ RPT    S+ELL
Sbjct: 253 F--RNFVDSCLQKIPQDRPT----SEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 79.1 bits (196), Expect = 4e-16
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 33/208 (15%)

Query: 457 CIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQ-----NEAHVLSTV-RHR 509
            +G G +GSVY A   E G++VA+KK+            S++      E   L  +  H 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKK-------FYSWEECMNLREVKSLRKLNEHP 58

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKL         ++ ++EYME G+L+  L  D +    + +   +I+  +   L+++H
Sbjct: 59  NIVKLKEVFRENDELYFVFEYME-GNLY-QLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS--YRTLRAGTYGYIAPEL- 626
                   HRD+   N+L+       +ADFG AR   + S   Y T    T  Y APE+ 
Sbjct: 117 K---HGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPY-TDYVSTRWYRAPEIL 170

Query: 627 ----AYTIVVTGKCDVYSFGVVALEVLM 650
               +Y+  V    D+++ G +  E+  
Sbjct: 171 LRSTSYSSPV----DIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 59/186 (31%), Positives = 88/186 (47%), Gaps = 29/186 (15%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY- 515
           IG G YG VYKA +   G++VALKK+   + E   F  +   E  +L  + HRNIV L  
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVR-LDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 516 ---------GFCLHKKCMFLIYEYMERGSLFCVLHD-----DDEAIELNWTKRVNIVKSV 561
                     F   K   +L++EYM+        HD     +   +  +     + +K +
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMD--------HDLMGLLESGLVHFSEDHIKSFMKQL 125

Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY-RTLRAGTYG 620
              L+Y H     + +HRDI  +NILL++  +  +ADFG ARL + + S   T +  T  
Sbjct: 126 LEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182

Query: 621 YIAPEL 626
           Y  PEL
Sbjct: 183 YRPPEL 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 68/232 (29%), Positives = 98/232 (42%), Gaps = 44/232 (18%)

Query: 442 YEDLINATEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEA 500
            EDL +  E       IG G +G+V K      G ++A+K++    T D    K    + 
Sbjct: 3   AEDLKDLGE-------IGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDL 53

Query: 501 HVLSTVRHRN---IVKLYGFCLHKK----CMFLIYEYMERGSLFCVLHDDDEAIELNWTK 553
            V   +R  +   IVK YG    +     CM L+   +++   +          E     
Sbjct: 54  DV--VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPE----- 106

Query: 554 RVNIVKSVA----HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS 609
              I+  +A     AL+YL     L IIHRD+  +NILLD N    + DFG +  L VDS
Sbjct: 107 --EILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDS 161

Query: 610 SYRTLRAGTYGYIAPEL-------AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
             +T  AG   Y+APE         Y +    + DV+S G+   EV  G  P
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 13/205 (6%)

Query: 451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  IK  IG G  G V  A +   GK+VA+KK+   + +    +    NE  ++   +H 
Sbjct: 23  DNFIK--IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF---NEVVIMRDYQHE 77

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V++Y   L    ++++ E++E G+L     D      +N  +   +  +V  ALS LH
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIAAVCLAVLKALSVLH 133

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 +IHRDI S++ILL  +    ++DFG    +  +   R    GT  ++APEL   
Sbjct: 134 ---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR 190

Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
           +    + D++S G++ +E++ G  P
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 78.6 bits (193), Expect = 6e-16
 Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+K+++  +      +    NE  V+   ++ NIV    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 83

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDD--DEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
             L    ++++ EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALDFLHSN--- 134

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            +IHRDI S+NILL  +    + DFG    +  + S R+   GT  ++APE+        
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 635 KCDVYSFGVVALEVLMGTHP 654
           K D++S G++A+E++ G  P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 75/280 (26%), Positives = 126/280 (45%), Gaps = 35/280 (12%)

Query: 458 IGTGGYGSVYKAELPE----GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G G +GSV +A+L       + VA+K L  ++   S+ ++ F  EA  +    H N++K
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 514 LYGFCLHKKCM------FLIYEYMERGSLFCVL---HDDDEAIELNWTKRVNIVKSVAHA 564
           L G  L  +         +I  +M+ G L   L      +E   L     V  +  +A  
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYI 622
           + YL      + IHRD+++ N +L+ N+   VADFG ++ ++    YR   A      ++
Sbjct: 126 MEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHP-GGLLSSLSSSSGPKIMLIDVLNQRL- 679
           A E     V T   DV++FGV   E++  G  P  G+ +S       +I    +   RL 
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-------EIYNYLIKGNRLK 235

Query: 680 SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            PP   + V +++        C S +PK RP+ Q +  +L
Sbjct: 236 QPPDCLEDVYELM------CQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 78.7 bits (194), Expect = 8e-16
 Identities = 73/275 (26%), Positives = 121/275 (44%), Gaps = 32/275 (11%)

Query: 458 IGTGGYGSVYKAEL----PEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRN 510
           +G G +G V +A          V  VA+K L    T  S+  ++  +E  ++S +  H N
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKML--KPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           IV L G C     + +I EY   G L   L    E+  L     ++    VA  +++L  
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL-- 157

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY---GYIAPELA 627
             + + IHRD+++ N+LL       + DFG AR +  DS+Y  ++        ++APE  
Sbjct: 158 -ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY-VVKGNARLPVKWMAPESI 215

Query: 628 YTIVVTGKCDVYSFGVVALEV--LMGT-HPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN 684
           +  V T + DV+S+G++  E+  L    +PG  + S          LI    +   P   
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK------LIKEGYRMAQPEHA 269

Query: 685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
              + DI+        C  + P  RPT ++I Q +
Sbjct: 270 PAEIYDIMK------TCWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 77.9 bits (192), Expect = 9e-16
 Identities = 69/286 (24%), Positives = 120/286 (41%), Gaps = 47/286 (16%)

Query: 458 IGTGGYGSVYKAEL--PEGKV--VALKKLH---HSETEDSAFVKSFQNEAHVLSTVRHRN 510
           +G G +GSV + +L   +G    VA+K +    H+ +E   F+     EA  +    H N
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLS----EAACMKDFDHPN 62

Query: 511 IVKLYGFCLHKKCM------FLIYEYMERGSLFCVL---HDDDEAIELNWTKRVNIVKSV 561
           ++KL G C     +       +I  +M+ G L   L          +L     +  +  +
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY-- 619
           A  + YL      + IHRD+++ N +L  ++   VADFG ++ ++    YR  R      
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLN-- 676
            +IA E     V T K DV++FGV   E+   G  P            P +   ++ +  
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP-----------YPGVENHEIYDYL 228

Query: 677 ---QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
               RL  P +      +  +  + ++C  + PK RPT  ++ + L
Sbjct: 229 RHGNRLKQPEDC-----LDELYDLMYSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.8 bits (192), Expect = 9e-16
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 20/214 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKA--ELPEGKVVALK-KLHHSETEDSAFVKSFQNEAHVLSTV 506
           ED  +  CIG G +G VY+     PE + +A+  K   + T  S   K F  EA+++   
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQF 64

Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK---SVAH 563
            H +IVKL G       ++++ E    G L   L      +        +++     ++ 
Sbjct: 65  DHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQ-----VNKYSLDLASLILYSYQLST 118

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GY 621
           AL+YL    +   +HRDI++ N+L+ S     + DFG +R L  D SY     G     +
Sbjct: 119 ALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKW 174

Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
           +APE       T   DV+ FGV   E+LM G  P
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 79.6 bits (196), Expect = 9e-16
 Identities = 89/270 (32%), Positives = 130/270 (48%), Gaps = 28/270 (10%)

Query: 77  RITDIDLLNSNIKGEL-GRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGN 135
           R+  +DLL+ +    L G  N      L SLDL  N L  +I   +  L+ L  L L  N
Sbjct: 68  RLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNN 126

Query: 136 NLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFR 195
           N+T I P       NL+ L L  NK+   LP  + NL +L  L ++ N L          
Sbjct: 127 NITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL---------- 175

Query: 196 LTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQ 255
                     S +P  + N S L+ LDLS NKI   +P E+  LS L+ L+LS+N +  +
Sbjct: 176 ----------SDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-E 223

Query: 256 IPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQ 315
           +  ++  L NL  L+LS NKL   +P  IGN S L+ L L++N +  +    +G +  L+
Sbjct: 224 LLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLR 280

Query: 316 NLDLSHNNLSGTIPKTLRPMYVDLSFNNLE 345
            LDLS N+LS  +P     + +     NL 
Sbjct: 281 ELDLSGNSLSNALPLIALLLLLLELLLNLL 310

Length = 394

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 65/291 (22%), Positives = 130/291 (44%), Gaps = 41/291 (14%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G VYKA+  E   +A  K+  +++E+   ++ +  E  +L+T  H  IVKL G 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYMVEIEILATCNHPYIVKLLGA 77

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
                 ++++ E+   G++  ++ + D  +     +   I + +  AL YLH   ++ II
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ--VICRQMLEALQYLH---SMKII 132

Query: 578 HRDISSNNILLDSNLEASVADFGTA----RLLHVDSSYRTLRAGTYGYIAPELAYTIVVT 633
           HRD+ + N+LL  + +  +ADFG +    + L    S+     GT  ++APE+     + 
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF----IGTPYWMAPEVVMCETMK 188

Query: 634 G-----KCDVYSFGVVALEVLM------GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP 682
                 K D++S G+  +E+          +P  +L  ++ S  P +           P 
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL---------SQPS 239

Query: 683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEI 733
                 +D +  +      L   P++RP+  ++ +          + L+E+
Sbjct: 240 KWSMEFRDFLKTA------LDKHPETRPSAAQLLEHPFVSSVTSNRPLREL 284

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 23/209 (11%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHV-LSTVRHRNIVKLY 515
           +G G YG V K   +P G ++A+K++    T +S   K    +  + + +V     V  Y
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 516 GFCLHKKCMFLIYEYMERG--SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           G    +  +++  E M+      +  ++D    I  +   +  I  S+  AL YLH    
Sbjct: 67  GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHS--K 122

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL------- 626
           LS+IHRD+  +N+L++ N +  + DFG +  L VDS  +T+ AG   Y+APE        
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYMAPERINPELNQ 181

Query: 627 -AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
             Y +    K DV+S G+  +E+  G  P
Sbjct: 182 KGYDV----KSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 16/214 (7%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF I   IG G +G V   ++   G+V A+K L+  E    A    F+ E  VL     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 509 RNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           R I  L Y F   +  ++L+ +Y   G L  +L   ++ +  +   R  + + V  A+  
Sbjct: 61  RWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYLAEMVL-AIDS 117

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GTYGYIAPEL 626
           +H    L  +HRDI  +N+LLD N    +ADFG+   L  D + ++  A GT  YI+PE+
Sbjct: 118 VHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174

Query: 627 AYTIVVTGK------CDVYSFGVVALEVLMGTHP 654
               +  GK      CD +S GV   E+L G  P
Sbjct: 175 LQA-MEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 78/286 (27%), Positives = 123/286 (43%), Gaps = 48/286 (16%)

Query: 458 IGTGGYGSVYKAELPEGKV---VALKKLH-----HSETEDSAFVKSFQNEAHVLSTVRHR 509
           +G G +GSV + +L +      VA+K +       SE ED      F +EA  +    H 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED------FLSEAVCMKEFDHP 60

Query: 510 NIVKLYGFCLHKK------CMFLIYEYMERGSLFCVL---HDDDEAIELNWTKRVNIVKS 560
           N+++L G CL            +I  +M+ G L   L      D    L     V  +  
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY- 619
           +A  + YL    + S IHRD+++ N +L+ N+   VADFG ++ ++    YR  R     
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 620 -GYIAPELAYTIVVTGKCDVYSFGVVALEVL---MGTHPGGLLSSLSSSSGPKIMLIDVL 675
             +IA E     V T K DV+SFGV   E+       +PG     + +S      + D L
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-----VENSE-----IYDYL 227

Query: 676 NQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            Q  RL  P +      +  + ++  +C    PK RP+ + +  EL
Sbjct: 228 RQGNRLKQPPDC-----LDGLYSLMSSCWLLNPKDRPSFETLRCEL 268

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 52/237 (21%)

Query: 429 DVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSET 487
           ++FS    D + L+ DL    E       IG G +G+VY A ++   +VVA+KK+ +S  
Sbjct: 6   ELFS--KDDPEKLFTDL---RE-------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGK 53

Query: 488 EDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCV-------- 539
           + +   +    E   L  +RH N ++  G  L +   +L+ EY       C+        
Sbjct: 54  QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY-------CLGSASDILE 106

Query: 540 -----LHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEA 594
                L + + A          I       L+YLH       IHRDI + NILL      
Sbjct: 107 VHKKPLQEVEIAA---------ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTV 154

Query: 595 SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI---VVTGKCDVYSFGVVALEV 648
            +ADFG+A L+   +S+     GT  ++APE+   +      GK DV+S G+  +E+
Sbjct: 155 KLADFGSASLVSPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 18/198 (9%)

Query: 458 IGTGGYGSVYKA---ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G+G +G+V K         K VA+K L  ++  D A       EA+V+  + +  IV++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILK-NDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
            G C  +  M L+ E  E G L   L  +    E N T+   +V  V+  + YL      
Sbjct: 62  IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEET--- 114

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPELAYT 629
           + +HRD+++ N+LL +   A ++DFG ++ L  D +Y   +A T+G     + APE    
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY--YKAKTHGKWPVKWYAPECMNY 172

Query: 630 IVVTGKCDVYSFGVVALE 647
              + K DV+SFGV+  E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 75/291 (25%), Positives = 132/291 (45%), Gaps = 49/291 (16%)

Query: 458 IGTGGYGSVYKAEL-------PEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V +AE        P+  V VA+K L  + T+    +    +E  ++  + +H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD--LADLISEMELMKLIGKH 77

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-----------DDDEAIE--LNWTKRV 555
           +NI+ L G C  +  +++I EY  +G+L   L            D  +  E  L++   V
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR +H    Y+   
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKI---M 670
            G     ++APE  +  V T + DV+SFG++  E+           +L  S  P I    
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF----------TLGGSPYPGIPVEE 244

Query: 671 LIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           L  +L +  R+  P N     ++ ++      C  + P  RPT +++ + L
Sbjct: 245 LFKLLREGHRMDKPSN--CTHELYMLMR---ECWHAVPTQRPTFKQLVEAL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 78.5 bits (193), Expect = 2e-15
 Identities = 71/248 (28%), Positives = 116/248 (46%), Gaps = 37/248 (14%)

Query: 426 KNGDVFSVWNYDGKILYE--DLINATEDFHIKYCIGTGGYGSV----YKAELPEGKVVAL 479
           KN ++ +  N   KI+ +   L    ED+ +   IG G +G V    +K+     KV A+
Sbjct: 17  KNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSS---QKVYAM 73

Query: 480 KKLHHSET---EDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL 536
           K L   E     DSAF   F  E  +++      +V+L+      K ++++ EYM  G L
Sbjct: 74  KLLSKFEMIKRSDSAF---FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL 130

Query: 537 FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASV 596
             ++ + D  +   W K       V  AL  +H   ++ +IHRD+  +N+LLD +    +
Sbjct: 131 VNLMSNYD--VPEKWAKFYT--AEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKL 183

Query: 597 ADFGTAR------LLHVDSSYRTLRAGTYGYIAPELAYTIVVTG----KCDVYSFGVVAL 646
           ADFGT        ++  D++      GT  YI+PE+  +    G    +CD +S GV   
Sbjct: 184 ADFGTCMKMDETGMVRCDTA-----VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238

Query: 647 EVLMGTHP 654
           E+L+G  P
Sbjct: 239 EMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 77.1 bits (189), Expect = 2e-15
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 15/200 (7%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+++++  +      +    NE  V+   ++ NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 84

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDD--DEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
             L    ++++ EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN--- 135

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            +IHRDI S+NILL  +    + DFG    +  + S R+   GT  ++APE+        
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 635 KCDVYSFGVVALEVLMGTHP 654
           K D++S G++A+E++ G  P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 77/285 (27%), Positives = 119/285 (41%), Gaps = 39/285 (13%)

Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTV- 506
           D   +  IG G +G V KA + +  +    A+K++    ++D    + F  E  VL  + 
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 65

Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLF------CVLHDD-------DEAIELNWTK 553
            H NI+ L G C H+  ++L  EY   G+L        VL  D         A  L+  +
Sbjct: 66  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            ++    VA  + YL        IHRD+++ NIL+  N  A +ADFG +R   V      
Sbjct: 126 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182

Query: 614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEV--LMGTHPGGLLSSLSSSSGPKIML 671
            R          L Y++  T   DV+S+GV+  E+  L GT   G+  +      P    
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---- 237

Query: 672 IDVLNQRLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
                 RL  P+N    V D++        C   +P  RP+  +I
Sbjct: 238 ---QGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQI 273

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 70/274 (25%), Positives = 124/274 (45%), Gaps = 35/274 (12%)

Query: 458 IGTGGYGSVYKA-ELPEGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV 512
           +G+G +G+VYK   +P+G+     VA+K L  + +  +   K   +EA+V++ V    + 
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPYVC 72

Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRVNIVKSVAHALSYL 568
           +L G CL      L+ + M  G L   + ++ + I     LNW  ++      A  +SYL
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPEL 626
                + ++HRD+++ N+L+ S     + DFG ARLL +D +      G     ++A E 
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 627 AYTIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ 685
                 T + DV+S+GV   E++  G  P      + +   P ++      +RL  P   
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKP---YDGIPAREIPDLL---EKGERLPQPPIC 236

Query: 686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            I   +I+V      C     + RP  + +  E 
Sbjct: 237 TIDVYMIMVK-----CWMIDSECRPRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 25/203 (12%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG VYKA +    + +ALKK+   E ED     +   E  +L  ++H NIV+L  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS----VAHALSYLHHDC 572
               +K ++L++EY++   L    H D      ++ K   ++K+    +   ++Y H   
Sbjct: 69  VVHSEKRLYLVFEYLD---LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCH--- 119

Query: 573 TLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPEL----- 626
           +  ++HRD+   N+L+D    A  +ADFG AR   +     T    T  Y APE+     
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179

Query: 627 AYTIVVTGKCDVYSFGVVALEVL 649
            Y+  V    D++S G +  E++
Sbjct: 180 HYSTPV----DIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 20/212 (9%)

Query: 446 INATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +N  E + I   +G G +G VYKA+  E  V+A  K+  +++E+   ++ +  E  +L++
Sbjct: 1   LNPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE--LEDYMVEIDILAS 58

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
             H NIVKL     ++  ++++ E+   G++  V+ + +  +     + V   K    AL
Sbjct: 59  CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVV--CKQTLEAL 116

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA----RLLHVDSSYRTLRAGTYGY 621
           +YLH +    IIHRD+ + NIL   + +  +ADFG +    R +    S+     GT  +
Sbjct: 117 NYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF----IGTPYW 169

Query: 622 IAPELAYTIVVTG-----KCDVYSFGVVALEV 648
           +APE+             K DV+S G+  +E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 71/291 (24%), Positives = 128/291 (43%), Gaps = 49/291 (16%)

Query: 458 IGTGGYGSVYKAE---LPEGK-----VVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE   L + K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 83

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCVLHDDDEAIELNWTKRV 555
           +NI+ L G C     +++I EY  +G+L             +C         +L++   V
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR +H    Y+   
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLID 673
            G     ++APE  +  + T + DV+SFGV+  E+           +L  S  P + + +
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF----------TLGGSPYPGVPVEE 250

Query: 674 VLN-----QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +        R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 251 LFKLLKEGHRMDKPSN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 77.4 bits (190), Expect = 4e-15
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 19/220 (8%)

Query: 444 DLINATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSET---EDSAFVKSFQNE 499
           DL    ED+ +   IG G +G V         KV A+K L   E     DSAF   F  E
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF---FWEE 93

Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
             +++      +V+L+      + ++++ EYM  G L  ++ + D  +   W +      
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYT--A 149

Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GT 618
            V  AL  +H   ++  IHRD+  +N+LLD +    +ADFGT   ++ +   R   A GT
Sbjct: 150 EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 206

Query: 619 YGYIAPELAYTIVVTG----KCDVYSFGVVALEVLMGTHP 654
             YI+PE+  +    G    +CD +S GV   E+L+G  P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 16/198 (8%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H NIVKL  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
               +  ++L++E++ +     +       I L   K  + +  +   L++ H   +  +
Sbjct: 67  VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCH---SHRV 121

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA-----YTIV 631
           +HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+      Y+  
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 181

Query: 632 VTGKCDVYSFGVVALEVL 649
           V    D++S G +  E++
Sbjct: 182 V----DIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 75.8 bits (186), Expect = 6e-15
 Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 54/274 (19%)

Query: 476 VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGS 535
           +VA+K L    T+ +     F  E  ++S +++ NI++L G C+    + +I EYME G 
Sbjct: 46  LVAVKMLRADVTKTAR--NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103

Query: 536 LFCVLHDDDEAIELNWTKRVNI-----------VKSVAHALSYLHHDCTLSIIHRDISSN 584
           L   L   +  IE  +T   NI              +A  + YL    +L+ +HRD+++ 
Sbjct: 104 LNQFLSQRE--IESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATR 158

Query: 585 NILLDSNLEASVADFGTARLLHVDSSYRTL-RAGTYGYIAP--ELAYTIVVTGK----CD 637
           N L+ ++    +ADFG +R L+    YR   RA     + P   +A+  ++ GK     D
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRA-----VLPIRWMAWESILLGKFTTASD 213

Query: 638 VYSFGVVALEV--LMGTHPGGLLS---------SLSSSSGPKIMLIDVLNQRLSPPVNQK 686
           V++FGV   E+  L    P  LLS             + G +I L          P+   
Sbjct: 214 VWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLS-------QTPLCPS 266

Query: 687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
            V  +++       C S   K RPT  +I   L 
Sbjct: 267 PVFKLMM------RCWSRDIKDRPTFNKIHHFLR 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 75.3 bits (185), Expect = 7e-15
 Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 42/290 (14%)

Query: 452 FHIKYC-----IGTGGYGSVY-----KAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH 501
           FH +Y      +G G +G V       A    G++VA+K L     + +     ++ E +
Sbjct: 1   FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEIN 58

Query: 502 VLSTVRHRNIVKLYGFCLHK--KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           +L T+ H NIVK  G C  +  K + LI EY+  GSL   L        LN  + +   +
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQ 114

Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   ++YLH   +   IHRD+++ N+LLD++    + DFG A+   V   +   R    
Sbjct: 115 QICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVRED 169

Query: 620 G-----YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTH-------PGGLLSSLSSSSG- 666
           G     + A E       +   DV+SFGV   E+L  TH       P      +    G 
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL--THCDSKQSPPKKFEEMIGPKQGQ 227

Query: 667 -PKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
              + LI++L + +  P  +   Q+   V  +   C  ++ K RPT + +
Sbjct: 228 MTVVRLIELLERGMRLPCPKNCPQE---VYILMKNCWETEAKFRPTFRSL 274

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 76.1 bits (188), Expect = 8e-15
 Identities = 72/235 (30%), Positives = 103/235 (43%), Gaps = 69/235 (29%)

Query: 452 FHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR--- 507
           + I   +G G YG V+KA +    +VVALKK+            +F+N      T R   
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF----------DAFRNATDAQRTFREIM 58

Query: 508 -------HRNIVKLYGFCLHK----KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
                  H NIVKL    + K    K ++L++EYME       LH     I      R N
Sbjct: 59  FLQELGDHPNIVKLLN--VIKAENDKDIYLVFEYMETD-----LH---AVI------RAN 102

Query: 557 IVKSVAH---------ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
           I++ V           AL Y+H   + ++IHRD+  +NILL+S+    +ADFG AR L  
Sbjct: 103 ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159

Query: 608 DSSYRTLRAGTYGYIA------PEL-----AYTIVVTGKCDVYSFGVVALEVLMG 651
                     T  Y+A      PE+      YT  V    D++S G +  E+L+G
Sbjct: 160 LEENPENPVLTD-YVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 75.5 bits (185), Expect = 8e-15
 Identities = 65/260 (25%), Positives = 116/260 (44%), Gaps = 28/260 (10%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G+VY A ++   +VVA+KK+ +S  + +   +    E   L  +RH N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 517 FCLHKKCMFLIYEYM--ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
             L +   +L+ EY       L  V     + +E+       +       L+YLH     
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYLHSH--- 134

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI---V 631
           ++IHRD+ + NILL       + DFG+A ++   + +     GT  ++APE+   +    
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF----VGTPYWMAPEVILAMDEGQ 190

Query: 632 VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDI 691
             GK DV+S G+  +E+     P   ++++S+        +  + Q  SP +      + 
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPALQSGHWSEY 242

Query: 692 ILVSTIAFACLSSQPKSRPT 711
                   +CL   P+ RPT
Sbjct: 243 F--RNFVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 75.0 bits (184), Expect = 9e-15
 Identities = 71/246 (28%), Positives = 110/246 (44%), Gaps = 35/246 (14%)

Query: 430 VFSVWNYDGKIL-YEDLINATEDFHIKYCIGTGGYGSVYK-AELPEGKVVALKKLHHSET 487
           ++ ++ Y+  +L  E L + T+ + I   IG G YG VYK     +G + A+K L     
Sbjct: 1   LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60

Query: 488 EDSAFVKSFQNEAHVLSTV-RHRNIVKLYG-FCLHKKC----MFLIYEYMERGS------ 535
            D    +  + E ++L ++  H N+VK YG F    K     ++L+ E    GS      
Sbjct: 61  VD----EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVK 116

Query: 536 --LFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLE 593
             L C    D+  I         I+      L +LH++    IIHRD+  NNILL +   
Sbjct: 117 GLLICGQRLDEAMISY-------ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166

Query: 594 ASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEV 648
             + DFG +  L      R    GT  ++APE+      Y      +CDV+S G+ A+E+
Sbjct: 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Query: 649 LMGTHP 654
             G  P
Sbjct: 227 GDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.5 bits (191), Expect = 1e-14
 Identities = 34/85 (40%), Positives = 53/85 (62%), Gaps = 5/85 (5%)

Query: 182 NNALGGLIPSTLFRL-----TNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEL 236
           N  L G IP+ + +L      N+S N    +IP  +G+ ++L+ LDLS N  +G IP+ L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 237 TKLSQLKNLNLSSNLLSGQIPYAIG 261
            +L+ L+ LNL+ N LSG++P A+G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 76.2 bits (187), Expect = 1e-14
 Identities = 76/224 (33%), Positives = 116/224 (51%), Gaps = 13/224 (5%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQIGSL-SKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
             NL SLDL NN+++  IPP IG L S LK L L  N +   +P  + +L NL+ L L  
Sbjct: 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172

Query: 159 NKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNIS----SNQFHSSIPLEIGN 214
           N LS  LP+ + NL +L  L ++ N +   +P  +  L+ +     SN     +   + N
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSN 230

Query: 215 FSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKN 274
              L  L+LS+NK+   +P+ +  LS L+ L+LS+N +S     ++G L NL  LDLS N
Sbjct: 231 LKNLSGLELSNNKL-EDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGN 287

Query: 275 KLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLD 318
            LS ++P        L+ L     +L   + L++  ILL  N+ 
Sbjct: 288 SLSNALPLIALLLLLLELLLNLLLTLK-ALELKLNSILLNNNIL 330

Length = 394

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 34/270 (12%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G+VY A      +VVA+KK+ +S  + +   +    E   L  ++H N ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 517 FCLHKKCMFLIYEY-MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
             L +   +L+ EY +   S    +H       L   +   I       L+YLH      
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHN--- 141

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI---VV 632
           +IHRDI + NILL    +  +ADFG+A      +S+     GT  ++APE+   +     
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF----VGTPYWMAPEVILAMDEGQY 197

Query: 633 TGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDII 692
            GK DV+S G+  +E+     P   ++++S+        +  + Q  SP +      D  
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNDSPTLQSNEWTD-- 247

Query: 693 LVSTIAFA--CLSSQPKSRPTMQRISQELL 720
             S   F   CL   P+ RP     S ELL
Sbjct: 248 --SFRGFVDYCLQKIPQERPA----SAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 1e-14
 Identities = 72/259 (27%), Positives = 105/259 (40%), Gaps = 54/259 (20%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF +   IG G +G V+     + G+V A+K L  S+      +   + E  +L+    
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERG---SLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
             IVKLY     ++ ++L+ EYM  G   +L        E        R  I + V  AL
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE----ETA-RFYIAELVL-AL 114

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA----------------------- 602
             +H    L  IHRDI  +NIL+D++    +ADFG                         
Sbjct: 115 DSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 603 --RLLHVDSSYRTLRA----GTYGYIAPELAYTIVVTGK-----CDVYSFGVVALEVLMG 651
              +   D   R +RA    GT  YIAPE     V+ G      CD +S GV+  E+L G
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPE-----VLRGTPYGLECDWWSLGVILYEMLYG 226

Query: 652 THPGGLLSSLSSSSGPKIM 670
             P    S     +  KI+
Sbjct: 227 FPP--FYSDTLQETYNKII 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 458 IGTGGYGSVYKAELPEG----KVVALKKLHHS----ETEDSAFVKSFQNEAHVLSTVRHR 509
           +G GGYG V++     G    K+ A+K L  +      +D+A  K+   E ++L  V+H 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA---ERNILEAVKHP 60

Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            IV L Y F    K ++LI EY+  G LF  +H + E I +  T    + + ++ AL +L
Sbjct: 61  FIVDLIYAFQTGGK-LYLILEYLSGGELF--MHLEREGIFMEDTACFYLSE-ISLALEHL 116

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR-LLHVDSSYRTLRAGTYGYIAPELA 627
           H      II+RD+   NILLD+     + DFG  +  +H  +   T   GT  Y+APE+ 
Sbjct: 117 HQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF-CGTIEYMAPEIL 172

Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
                    D +S G +  ++L G  P
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 34/208 (16%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG VYKA +   G++VALKK+   ETED     +   E  +L  + H NIV+L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIR-LETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDD-----DEAIELNWTKRVNIVKS----VAHALSY 567
               +  ++L++E+         L  D     D +          ++KS    +   ++Y
Sbjct: 66  VVHSENKLYLVFEF---------LDLDLKKYMDSSPLTGLDPP--LIKSYLYQLLQGIAY 114

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL- 626
            H   +  ++HRD+   N+L+D      +ADFG AR   V     T    T  Y APE+ 
Sbjct: 115 CH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 171

Query: 627 ----AYTIVVTGKCDVYSFGVVALEVLM 650
                Y+  V    D++S G +  E++ 
Sbjct: 172 LGSRQYSTPV----DIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.1 bits (184), Expect = 2e-14
 Identities = 74/293 (25%), Positives = 128/293 (43%), Gaps = 53/293 (18%)

Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          +   VA+K L    T+    +    +E  ++  + +H
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD--LSDLVSEMEMMKMIGKH 77

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSL-----------------FCVLHDDDEAIELNW 551
           +NI+ L G C     ++++ EY  +G+L                  C L ++    +L +
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE----QLTF 133

Query: 552 TKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY 611
              V+    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR +H    Y
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190

Query: 612 RTLRAGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG-PK 668
           +    G     ++APE  +  V T + DV+SFGV+  E+      GG     S   G P 
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---LGG-----SPYPGIPV 242

Query: 669 IMLIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             L  +L +  R+  P N     ++ +   I   C  + P  RPT +++ ++L
Sbjct: 243 EELFKLLKEGHRMDKPAN--CTHELYM---IMRECWHAVPSQRPTFKQLVEDL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 75.1 bits (184), Expect = 2e-14
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 14/213 (6%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEG-KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF I   IG G +G V   +L    KV A+K L+  E    A    F+ E  VL    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           + I  L+     +  ++L+ +Y   G L  +L   ++ +  +   R  + + V  A+  +
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYLAEMVI-AIDSV 118

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGTYGYIAPELA 627
           H    L  +HRDI  +NIL+D N    +ADFG+   L  D + + ++  GT  YI+PE+ 
Sbjct: 119 HQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175

Query: 628 YTIVVTGK------CDVYSFGVVALEVLMGTHP 654
             +   GK      CD +S GV   E+L G  P
Sbjct: 176 QAM-EDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 32/216 (14%)

Query: 451 DFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF I   +G GGYG V+ A+  + G++VALK++  S       V+    E  +L+T +  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERG---SLFCVLH--DDDEAIELNWTKRVNIVKSVAH 563
            +VKL Y F    + ++L  EY+  G   +L   L    +D A       R  + +    
Sbjct: 62  WLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA-------RFYMAEMFE- 112

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
           A+  LH    L  IHRD+   N L+D++    + DFG ++ +    +Y     G+  Y+A
Sbjct: 113 AVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVVGSPDYMA 166

Query: 624 PELAYTIVVTGK-----CDVYSFGVVALEVLMGTHP 654
           PE     V+ GK      D +S G +  E L G  P
Sbjct: 167 PE-----VLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 23/217 (10%)

Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHR 509
           F +   +G G YG VYK   +  G++ A+K +  +E E+    +  + E ++L     HR
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYSHHR 73

Query: 510 NIVKLYGFCL------HKKCMFLIYEYMERGSLF-CVLHDDDEAIELNWTKRVNIVKSVA 562
           NI   YG  +      H   ++L+ E+   GS+   V +    A++ +W     I + + 
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREIL 131

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L++LH      +IHRDI   N+LL  N E  + DFG +  L      R    GT  ++
Sbjct: 132 RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188

Query: 623 APELAYT-----IVVTGKCDVYSFGVVALEVLMGTHP 654
           APE+             + D++S G+ A+E+  G  P
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 23/217 (10%)

Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHR 509
           F +   +G G YG VYK   +  G++ A+K +  +  E+    +  + E ++L     HR
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 63

Query: 510 NIVKLYGFCLHKKC------MFLIYEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVA 562
           NI   YG  + K        ++L+ E+   GS+  ++ +     ++  W     I + + 
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 121

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             LS+LH      +IHRDI   N+LL  N E  + DFG +  L      R    GT  ++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178

Query: 623 APELAYT-----IVVTGKCDVYSFGVVALEVLMGTHP 654
           APE+             K D++S G+ A+E+  G  P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 18/214 (8%)

Query: 451 DFHIKYCIGTGGYGSVY---KAELPE-GKVVALKKLHHSE-TEDSAFVKSFQNEAHVLST 505
           +F +   +GTG YG V+   K    + GK+ A+K L  +   + +  V+  + E +VL  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 506 VRHRN-IVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI-VKSVA 562
           VR    +V L Y F    K + LI +Y+  G +F  L+  D   E      V      + 
Sbjct: 61  VRQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSE----DEVRFYSGEII 115

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGY 621
            AL +LH    L I++RDI   NILLDS     + DFG ++    +   RT    GT  Y
Sbjct: 116 LALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 622 IAPELAYTIVVTGKC-DVYSFGVVALEVLMGTHP 654
           +APE+       GK  D +S G++  E+L G  P
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 20/206 (9%)

Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G YG VY A     +V +A+K++      DS +V+    E  + S ++HRNIV+  G
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEI---PERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
                    +  E +  GSL  +L      ++ N    +   K +   L YLH      I
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQI 129

Query: 577 IHRDISSNNILLDS-NLEASVADFGTA-RLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
           +HRDI  +N+L+++ +    ++DFGT+ RL  ++    T   GT  Y+APE    ++  G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-TGTLQYMAPE----VIDKG 184

Query: 635 K------CDVYSFGVVALEVLMGTHP 654
                   D++S G   +E+  G  P
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 72.8 bits (178), Expect = 4e-14
 Identities = 73/278 (26%), Positives = 127/278 (45%), Gaps = 43/278 (15%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHH--SETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G G +G VY   ++  G+ +A K++       E S  V + + E  +L  ++H  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 515 YGFCLH---KKCMFLIYEYMERGSLFCVLHDDDEAI-ELNWTKRVNIVKSVAHALSYLHH 570
           YG CL    +K + +  EYM  GS+     D  +A   L  +      + +   +SYLH 
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSV----KDQLKAYGALTESVTRKYTRQILEGMSYLHS 124

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTA-RLLHVDSSYRTLRA--GTYGYIAPELA 627
           +    I+HRDI   NIL DS     + DFG + RL  +  S   +R+  GT  +++PE  
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE-- 179

Query: 628 YTIVVTG-----KCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP 682
              V++G     K DV+S G   +E+L    P     ++++       +  +  Q  +P 
Sbjct: 180 ---VISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-------IFKIATQPTNPQ 229

Query: 683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
           +   I +     +     C+  + + RP+    ++ELL
Sbjct: 230 LPSHISEH----ARDFLGCIFVEARHRPS----AEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 4e-14
 Identities = 75/263 (28%), Positives = 111/263 (42%), Gaps = 53/263 (20%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHS---ETEDSAFVKSFQNEAHVLST 505
           +DF     IG G +G V   +  + G + A+KKL  S   E E  A V++   E  +L+ 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRA---ERDILAE 57

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
             +  +VKLY     +  ++LI EY+  G +  +L   D   E   T R  I +++  A+
Sbjct: 58  ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTE-EET-RFYIAETIL-AI 114

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTL-------- 614
             +H    L  IHRDI  +N+LLD+     ++DFG    L   H    YR L        
Sbjct: 115 DSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171

Query: 615 ---------------------RA------GTYGYIAPELAYTIVVTGKCDVYSFGVVALE 647
                                RA      GT  YIAPE+        +CD +S GV+  E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231

Query: 648 VLMGTHPGGLLSSLSSSSGPKIM 670
           +L+G  P    S     +  KI+
Sbjct: 232 MLVGYPP--FCSDNPQETYRKII 252

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 73.4 bits (180), Expect = 4e-14
 Identities = 70/274 (25%), Positives = 122/274 (44%), Gaps = 57/274 (20%)

Query: 476 VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGS 535
           +VA+K L     +++     F  E  +LS ++  NI++L G C+ +  + +I EYME G 
Sbjct: 48  LVAVKILRPDANKNAR--NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105

Query: 536 LFCVL---HDDDEAIE-------------LNWTKRVNIVKSVAHALSYLHHDCTLSIIHR 579
           L   L   H DD+                ++++  +++   +A  + YL    +L+ +HR
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHR 162

Query: 580 DISSNNILLDSNLEASVADFGTARLLHVDSSYRTL-RAGTYGYIAP--ELAYTIVVTGK- 635
           D+++ N L+  NL   +ADFG +R L+    YR   RA     + P   +A+  ++ GK 
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRA-----VLPIRWMAWECILMGKF 217

Query: 636 ---CDVYSFGVVALEVLM--GTHPGGLLS---------SLSSSSGPKIMLIDVLNQRLSP 681
               DV++FGV   E+LM     P G L+               G ++ L         P
Sbjct: 218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYL-------FRP 270

Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
           P   + + +++L       C S   + RP+   I
Sbjct: 271 PPCPQGLYELML------QCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 80/301 (26%), Positives = 127/301 (42%), Gaps = 41/301 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           ED   +  IG G +G V +A + +  +    A+K L    +E+    + F  E  VL  +
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH--RDFAGELEVLCKL 59

Query: 507 -RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-------------DDDEAIELNWT 552
             H NI+ L G C ++  +++  EY   G+L   L              +   A  L   
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR 612
           + +     VA  + YL        IHRD+++ N+L+  NL + +ADFG +R   V    +
Sbjct: 120 QLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK-K 175

Query: 613 TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEV--LMGTHPGGLLSSLSSSSGPKIM 670
           T+      ++A E     V T K DV+SFGV+  E+  L GT   G+  +      P+  
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 233

Query: 671 LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKAL 730
                  R+  P N     D   V  +   C   +P  RP   +IS +L    + M +A 
Sbjct: 234 -----GYRMEKPRN---CDD--EVYELMRQCWRDRPYERPPFAQISVQL----SRMLEAR 279

Query: 731 K 731
           K
Sbjct: 280 K 280

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 72.9 bits (180), Expect = 7e-14
 Identities = 64/231 (27%), Positives = 93/231 (40%), Gaps = 62/231 (26%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG+G YG V  A     G+ VA+KK+ +   +D    K    E  +L  +RH NI+ L  
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-VFDDLIDAKRILREIKLLRHLRHENIIGLLD 66

Query: 517 FCLHKKCM-----FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS-----VAH--- 563
                        +++ E ME         D      L+      ++KS       H   
Sbjct: 67  ILRPPSPEDFNDVYIVTELME--------TD------LH-----KVIKSPQPLTDDHIQY 107

Query: 564 -------ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
                   L YLH   + ++IHRD+  +NIL++SN +  + DFG AR   VD        
Sbjct: 108 FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR--GVDPDEDEKGF 162

Query: 617 GTYG-----YIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMGTH--PG 655
            T       Y APEL      YT  +    D++S G +  E+L      PG
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKPLFPG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 72.3 bits (177), Expect = 8e-14
 Identities = 70/219 (31%), Positives = 99/219 (45%), Gaps = 27/219 (12%)

Query: 451 DFHIKYCIGTGGYGSVYKAEL----PEGKVVALKKLHHSE-TEDSAFVKSFQNEAHVLST 505
           +F +   +GTG YG V+          GK+ A+K L  +   + +   +  + E  VL  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 506 VRHRN-IVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI-VKSVA 562
           +R    +V L Y F    K + LI +Y+  G LF  L   +   E    + V I    + 
Sbjct: 61  IRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIV 115

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGY 621
            AL +LH    L II+RDI   NILLDSN    + DFG ++  H D   R     GT  Y
Sbjct: 116 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 622 IAPELAYTIVVTGK------CDVYSFGVVALEVLMGTHP 654
           +AP+    IV  G        D +S GV+  E+L G  P
Sbjct: 173 MAPD----IVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 23/207 (11%)

Query: 458 IGTGGYGSVY---KAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G G +G V+   K   P+ G++ A+K L  +  +    V++ + E  +L+ V H  IVK
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62

Query: 514 L-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK----SVAHALSYL 568
           L Y F    K ++LI +++  G LF  L     + E+ +T+    VK     +A AL +L
Sbjct: 63  LHYAFQTEGK-LYLILDFLRGGDLFTRL-----SKEVMFTE--EDVKFYLAELALALDHL 114

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELA 627
           H   +L II+RD+   NILLD      + DFG ++   +D   +     GT  Y+APE+ 
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
                T   D +SFGV+  E+L G+ P
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 62/232 (26%), Positives = 95/232 (40%), Gaps = 56/232 (24%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR- 507
            D      IG+G  G VYK      G V+A+K++  +  ++            +L  +  
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--------ENKRILMDLDV 66

Query: 508 ----HR--NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN----- 556
               H    IVK YG+ +    +F+  E M   +    L            KR+      
Sbjct: 67  VLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKL-----------LKRIQGPIPE 113

Query: 557 -----IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA-RLLHVDSS 610
                +  ++  AL YL       +IHRD+  +NILLD++    + DFG + RL  VDS 
Sbjct: 114 DILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSK 169

Query: 611 YRTLRAGTYGYIAPEL--------AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            +T  AG   Y+APE          Y I    + DV+S G+  +E+  G  P
Sbjct: 170 AKTRSAGCAAYMAPERIDPPDPNPKYDI----RADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 27/214 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +++     I  G YG VY+A +   G++VALKKL   E E   F  +   E ++L  ++H
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKM-EKEKEGFPITSLREINILLKLQH 63

Query: 509 RNIVKL----YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI--VKSVA 562
            NIV +     G  L K  ++++ EY+E        HD    +E    +      VK + 
Sbjct: 64  PNIVTVKEVVVGSNLDK--IYMVMEYVE--------HDLKSLME-TMKQPFLQSEVKCLM 112

Query: 563 H----ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT 618
                 +++LH +    I+HRD+ ++N+LL++     + DFG AR         T    T
Sbjct: 113 LQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVT 169

Query: 619 YGYIAPELAY-TIVVTGKCDVYSFGVVALEVLMG 651
             Y APEL       +   D++S G +  E+L  
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 60/242 (24%), Positives = 106/242 (43%), Gaps = 23/242 (9%)

Query: 475 KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERG 534
           K V L +L   E  D+       NE  +LS ++H NI+  Y   +    + +  EY   G
Sbjct: 31  KEVNLTRLSEKERRDA------LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84

Query: 535 SLF-CVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLE 593
           +L+  ++    +  E      +  +  +  A+SY+H      I+HRDI + NI L     
Sbjct: 85  TLYDKIVRQKGQLFEEEMV--LWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGL 139

Query: 594 ASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTH 653
             + DFG +++L  + S      GT  Y++PEL   +    K D+++ G V  E+L    
Sbjct: 140 IKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT--- 196

Query: 654 PGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
               L     ++ P  +++ ++    +P V+    + I LV     + L   P+ RPT  
Sbjct: 197 ----LKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH----SLLQQDPEKRPTAD 248

Query: 714 RI 715
            +
Sbjct: 249 EV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.9 bits (179), Expect = 3e-13
 Identities = 42/124 (33%), Positives = 66/124 (53%), Gaps = 7/124 (5%)

Query: 67  WVGITCDYEGR-----ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI 121
           W G  C ++       I  + L N  ++G +   + S   +L+S++L  NS+ G+IPP +
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSL 462

Query: 122 GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGN-LKSLTELYV 180
           GS++ L+ L L  N+  G IP+ +G L +LR L L  N LSG +P  +G  L        
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522

Query: 181 TNNA 184
           T+NA
Sbjct: 523 TDNA 526

Length = 623

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 71/224 (31%), Positives = 100/224 (44%), Gaps = 37/224 (16%)

Query: 451 DFHIKYCIGTGGYGSVYKAEL----PEGKVVALKKLHHSETEDSAFVKSFQN---EAHVL 503
           +F +   +GTG YG V+          GK+ A+K L  +     A  K+ ++   E  VL
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKA--KTAEHTRTERQVL 58

Query: 504 STVRHRN-IVKL-YGFCLHKKCMFLIYEYMERGSLFCVL----HDDDEAIELNWTKRVNI 557
             VR    +V L Y F    K + LI +Y+  G LF  L    H  +  +      RV I
Sbjct: 59  EAVRRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTESEV------RVYI 111

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-A 616
            + V  AL +LH    L II+RDI   NILLDS     + DFG ++    +   R     
Sbjct: 112 AEIVL-ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC 167

Query: 617 GTYGYIAPELAYTIVVTGK------CDVYSFGVVALEVLMGTHP 654
           GT  Y+APE    ++  G        D +S GV+  E+L G  P
Sbjct: 168 GTIEYMAPE----VIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 41/242 (16%)

Query: 458 IGTGGYGSVYKA-ELPEGKV----VALKKLHHSETEDSAFVKSFQN-EAHVLS--TVRHR 509
           +G+G +G+V+K   +PEG      VA+K +     +D +  ++FQ    H+L+  ++ H 
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-----QDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRVNIVKSVAHAL 565
            IV+L G C     + L+ +    GSL   +    ++++    LNW  ++      A  +
Sbjct: 70  YIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGM 122

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS---YRTLRAGTYGYI 622
            YL       ++HR++++ NILL S+    +ADFG A LL+ D     Y   +     ++
Sbjct: 123 YYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT-PIKWM 178

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLM-------GTHPG---GLLSSLSSSSGPKIMLI 672
           A E       T + DV+S+GV   E++        G  P     LL      + P+I  I
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTI 238

Query: 673 DV 674
           DV
Sbjct: 239 DV 240

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 66/279 (23%), Positives = 117/279 (41%), Gaps = 38/279 (13%)

Query: 454 IKYCIGTGGYGSV--------YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           I+  +GTG +G +         K ELP    VA+  L    ++     + F  EA  L  
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELP----VAIHTLRAGCSDKQR--RGFLAEALTLGQ 62

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSL--FCVLHDDDEAIELNWTKRVNIVKSVAH 563
             H NIV+L G       M ++ EYM  G+L  F   H+     +L   + + ++  +A 
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG----QLVAGQLMGMLPGLAS 118

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-YI 622
            + YL     +  +H+ ++++ +L++S+L   ++ F   +    ++ Y T+   +   + 
Sbjct: 119 GMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP 681
           APE       +   DV+SFG+V  EV+  G  P          SG  ++       RL  
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERP------YWDMSGQDVIKAVEDGFRLPA 229

Query: 682 PVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           P N   ++  ++L       C   +   RP   +I   L
Sbjct: 230 PRNCPNLLHQLML------DCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 22/204 (10%)

Query: 458 IGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           IG G +G VY   L   +G+ +  A+K L  +   D   V+ F  E  ++    H N++ 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 514 LYGFCLHKKCMFLI-YEYMERGSLFCVLHDDDEAIELNWTKR--VNIVKSVAHALSYLHH 570
           L G CL  +   L+   YM+ G L   +  +      N T +  +     VA  + YL  
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYL-- 114

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPE 625
             +   +HRD+++ N +LD +    VADFG AR ++ D  Y ++   T       ++A E
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIY-DKEYYSVHNHTGAKLPVKWMALE 172

Query: 626 LAYTIVVTGKCDVYSFGVVALEVL 649
              T   T K DV+SFGV+  E++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.9 bits (171), Expect = 4e-13
 Identities = 73/267 (27%), Positives = 122/267 (45%), Gaps = 26/267 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +D   +  +G G  G+VYKA  L   +++A+K +    T +    K   +E  +L     
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDS 58

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             I+  YG    +  + +  E+M+ GSL     D    I  +   R+ +  +V   L+YL
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSL-----DVYRKIPEHVLGRIAV--AVVKGLTYL 111

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
               +L I+HRD+  +N+L+++  +  + DFG +  L V+S  +T   GT  Y+APE   
Sbjct: 112 ---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTY-VGTNAYMAPERIS 166

Query: 627 --AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN 684
              Y I      DV+S G+  +E+ +G  P   +     S  P  +L  ++++   PPV 
Sbjct: 167 GEQYGI----HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--DPPVL 220

Query: 685 QKIVQDIILVSTIAFACLSSQPKSRPT 711
                    V  I   C+  QPK RP 
Sbjct: 221 PVGQFSEKFVHFIT-QCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 70.8 bits (173), Expect = 4e-13
 Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 26/244 (10%)

Query: 416 KNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGK 475
           KN +L+ +  K+ D         K+ YED       F+    +GTG +G V  A      
Sbjct: 5   KNLQLHKK--KDSDSTKEPKRKNKMKYED-------FNFIRTLGTGSFGRVILATYKNED 55

Query: 476 V--VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMER 533
              VA+K+   S+      V    +E  +L+ + H   V LYG    +  ++L+ E++  
Sbjct: 56  FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIG 115

Query: 534 GSLFCVLHDDDE---AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS 590
           G  F  L  +      +   +  ++ ++        YL    +L+I++RD+   N+LLD 
Sbjct: 116 GEFFTFLRRNKRFPNDVGCFYAAQIVLI------FEYLQ---SLNIVYRDLKPENLLLDK 166

Query: 591 NLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM 650
           +    + DFG A++  VD+   TL  GT  YIAPE+   +      D ++ G+   E+L+
Sbjct: 167 DGFIKMTDFGFAKV--VDTRTYTL-CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILV 223

Query: 651 GTHP 654
           G  P
Sbjct: 224 GCPP 227

Length = 340

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 23/201 (11%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG VYK      G++VA+KK+   E+E+     +   E  +L  ++H NIV L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIR-LESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH----ALSYLHHDC 572
             + +  ++LI+E+     L   L    +++         +VKS  +     + + H   
Sbjct: 67  VLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--- 118

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-----A 627
           +  ++HRD+   N+L+D+     +ADFG AR   +     T    T  Y APE+      
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178

Query: 628 YTIVVTGKCDVYSFGVVALEV 648
           Y+  V    D++S G +  E+
Sbjct: 179 YSTPV----DIWSIGTIFAEM 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 70.4 bits (172), Expect = 6e-13
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 12/212 (5%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEG-KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF I   IG G +G V   ++    ++ A+K L+  E    A    F+ E +VL     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           + I  L+     +  ++L+ +Y   G L  +L   ++ +  +  +    +  +  A+  +
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--IAEMVLAIHSI 118

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GTYGYIAPELA 627
           H    L  +HRDI  +N+LLD N    +ADFG+   ++ D + ++  A GT  YI+PE+ 
Sbjct: 119 HQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175

Query: 628 YTIV-VTGK----CDVYSFGVVALEVLMGTHP 654
             +    GK    CD +S GV   E+L G  P
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 18/210 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF     +G G  G V K    P G ++A +KL H E +  A       E  VL     
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMA-RKLIHLEIK-PAIRNQIIRELKVLHECNS 58

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             IV  YG       + +  E+M+ GSL  VL       E N   +++I  +V   L+YL
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-NILGKISI--AVLRGLTYL 115

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE--- 625
                  I+HRD+  +NIL++S  E  + DFG +  L  DS   +   GT  Y++PE   
Sbjct: 116 REK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSF-VGTRSYMSPERLQ 171

Query: 626 -LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
              YT+    + D++S G+  +E+ +G +P
Sbjct: 172 GTHYTV----QSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 25/214 (11%)

Query: 451 DFHIKYCIGTGGYG-SVYKAELPEGKVVALKKLH----HSETEDSAFVKSFQNEAHVLST 505
            +++   +G G +G ++    +   +  A+K++      S  EDS      + EA +L+ 
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS------RKEAVLLAK 54

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDD-----EAIELNWTKRVNIVKS 560
           ++H NIV           ++++ EY + G L   +         E   L W   V +   
Sbjct: 55  MKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF--VQMCLG 112

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           V H    +H      ++HRDI S NI L  N +  + DFG+ARLL    +Y     GT  
Sbjct: 113 VQH----IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY 165

Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y+ PE+   +    K D++S G +  E+    HP
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 76/281 (27%), Positives = 120/281 (42%), Gaps = 37/281 (13%)

Query: 458 IGTGGYGSVYKAELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVK 513
           IG G +G V KA + +  +    A+K++    ++D    + F  E  VL  +  H NI+ 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 60

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLH-------------DDDEAIELNWTKRVNIVKS 560
           L G C H+  ++L  EY   G+L   L               +  A  L+  + ++    
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           VA  + YL        IHRD+++ NIL+  N  A +ADFG +R   V    +T+      
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPVR 176

Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEV--LMGTHPGGLLSSLSSSSGPKIMLIDVLNQR 678
           ++A E     V T   DV+S+GV+  E+  L GT   G+  +      P+         R
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-------GYR 229

Query: 679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           L  P+N     D   V  +   C   +P  RP+  +I   L
Sbjct: 230 LEKPLN---CDD--EVYDLMRQCWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 39/225 (17%)

Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G   +G VYK  L       + + VA+K L   +  +    + F++EA + S ++H NI
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 512 VKLYGFCLHKKCMFLIYEYMERGSL--FCVLH---------DDDEAIE--LNWTKRVNIV 558
           V L G    ++ + +I+ Y     L  F V+          DDD+ ++  L     V+IV
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 559 KSVAHALSYL--HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
             +A  + +L  HH     ++H+D+++ N+L+   L   ++D G  R ++    Y+ +  
Sbjct: 131 TQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185

Query: 617 GTYG--YIAPELAYTIVVTGKC----DVYSFGVVALEVL-MGTHP 654
                 +++PE     ++ GK     D++S+GVV  EV   G  P
Sbjct: 186 SLLPIRWMSPE----AIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 36/216 (16%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKL--HHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G G +G VY   +   G+ +A+K++       E S  V + + E  +L  +RH  IV+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 515 YGFCLH---KKCMFLIYEYMERGSLFCVLHDDDE-----AIELNWTKRVNIVKSVAHALS 566
           YG CL    +K + +  EYM  GS+       D+     A+  N T+R    + +   +S
Sbjct: 70  YG-CLRDPEEKKLSIFVEYMPGGSI------KDQLKAYGALTENVTRRYT--RQILQGVS 120

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA-RLLHVDSSYRTLRA--GTYGYIA 623
           YLH +    I+HRDI   NIL DS     + DFG + R+  +  S   +++  GT  +++
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177

Query: 624 PELAYTIVVTG-----KCDVYSFGVVALEVLMGTHP 654
           PE     V++G     K DV+S     +E+L    P
Sbjct: 178 PE-----VISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 26/204 (12%)

Query: 458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G Y +VYK +    GK+VALK +   E E + F      EA +L  ++H NIV L+ 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI--REASLLKGLKHANIVLLHD 70

Query: 517 FCLHKKCMFLIYEYMERGSLFCV--------LHDDDEAIELNWTKRVNIVKSVAHALSYL 568
               K+ + L++EY+   +  C         LH ++  + L    R          LSY+
Sbjct: 71  IIHTKETLTLVFEYVH--TDLCQYMDKHPGGLHPENVKLFLFQLLR---------GLSYI 119

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H      I+HRD+   N+L+    E  +ADFG AR   V S   +    T  Y  P++  
Sbjct: 120 HQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 629 TIVVTGKC-DVYSFGVVALEVLMG 651
                  C D++  G + +E++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 67/281 (23%), Positives = 116/281 (41%), Gaps = 33/281 (11%)

Query: 449 TEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
             +F I+  IG G +  VYKA  L +G+VVALKK+   E  D+   +    E  +L  + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL---HDDDEAIELN--WTKRVNIVKSVA 562
           H N++K     +    + ++ E  + G L  ++         I     W   V +     
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
            AL ++H      I+HRDI   N+ + +     + D G  R     ++      GT  Y+
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS-SGPKIMLIDVLN---QR 678
           +PE  +      K D++S G +  E          +++L S   G K+ L  +     + 
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE----------MAALQSPFYGDKMNLYSLCKKIEKC 223

Query: 679 LSPPVNQKIVQDII--LVSTIAFACLSSQPKSRPTMQRISQ 717
             PP+      + +  LVS     C++  P+ RP +  + Q
Sbjct: 224 DYPPLPADHYSEELRDLVS----RCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 26/208 (12%)

Query: 458 IGTGGYGSVYKAELPEGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIV 512
           +G G +G V  AEL        V  LKK    + +D   V+    E  VL+   +H  + 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD---VECTMTEKRVLALAGKHPFLT 59

Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
           +L+     K  +F + EY+  G L   +       E    +       +   L +LH   
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE---PRARFYAAEIVLGLQFLHER- 115

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTAR--LLHVDSSYRTLRAGTYGYIAPEL---- 626
              II+RD+  +N+LLDS     +ADFG  +  +L   ++  T   GT  YIAPE+    
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT-STF-CGTPDYIAPEILSYQ 171

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            Y   V    D ++ GV+  E+L G  P
Sbjct: 172 PYGPAV----DWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 22/183 (12%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+KA      ++VALKK+   E E   F  +   E  +L  ++H N+V L  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLM-ENEKEGFPITALREIKILQLLKHENVVNLIE 78

Query: 517 FCLHKKCMFLIYEYMERGSLFCVL----HD-----DDEAIELNWTKRVNIVKSVAHALSY 567
            C  K   +  Y    +GS + V     HD      ++ ++   ++   ++K + + L Y
Sbjct: 79  ICRTKATPYNRY----KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV----DSSYRTLRAGTYGYIA 623
           +H +    I+HRD+ + NIL+  +    +ADFG AR   +      +  T R  T  Y  
Sbjct: 135 IHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 624 PEL 626
           PEL
Sbjct: 192 PEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 22/207 (10%)

Query: 458 IGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           +G G +G VY+        + PE +V A+K ++ + +        F NEA V+      +
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEASVMKEFNCHH 70

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTKRVNIVKSVAH 563
           +V+L G     +   +I E M RG L   L      +E N         K + +   +A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG--Y 621
            ++YL+ +     +HRD+++ N ++  +    + DFG  R ++    YR    G     +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEV 648
           ++PE     V T   DV+SFGVV  E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 18/152 (11%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG+V+KA+  E  ++VALK++   + +D     S   E  +L  ++H+NIV+LY 
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE-LNWTKRVNIVKS----VAHALSYLHHD 571
                K + L++EY ++        D  +  +  N      IVKS    +   L++ H  
Sbjct: 67  VLHSDKKLTLVFEYCDQ--------DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTAR 603
              +++HRD+   N+L++ N E  +ADFG AR
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 27/219 (12%)

Query: 458 IGTGGYGSVYKAEL-----PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV 512
           +G   +G +YK  L        ++VA+K L   +  +      FQ EA +++ + H NIV
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 513 KLYGFCLHKKCMFLIYEYMERGSL--FCVLH----------DDDEAIE--LNWTKRVNIV 558
            L G    ++ + +++EY+ +G L  F ++           D+D  ++  L+    ++I 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 559 KSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT 618
             +A  + YL    +   +H+D+++ NIL+   L   ++D G +R ++    YR      
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 619 YG--YIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
               ++ PE       +   D++SFGVV  E+   G  P
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 65/264 (24%), Positives = 115/264 (43%), Gaps = 35/264 (13%)

Query: 476 VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGS 535
           +VA+K L     +++     F  E  ++S ++  NI++L   C+    + +I EYME G 
Sbjct: 48  LVAVKMLREDANKNAR--NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105

Query: 536 L--FCVLHD------DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNIL 587
           L  F   H+        + + ++++  + +   +A  + YL    +L+ +HRD+++ N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCL 162

Query: 588 LDSNLEASVADFGTARLLHVDSSYRTL-RAGTYGYIAP--ELAYTIVVTGK----CDVYS 640
           +  N    +ADFG +R L+    YR   RA     + P   +++  ++ GK     DV++
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRA-----VLPIRWMSWESILLGKFTTASDVWA 217

Query: 641 FGVVALEVLM--GTHPGGLLSSLSSSSGPKIMLIDVLNQR--LSPPVNQKIVQDIILVST 696
           FGV   E+L      P   LS             D   Q     P +    +  ++L   
Sbjct: 218 FGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLML--- 274

Query: 697 IAFACLSSQPKSRPTMQRISQELL 720
              +C     K RP+ Q I   LL
Sbjct: 275 ---SCWRRNAKERPSFQEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 14/200 (7%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHV--LSTVRHRNIVKL 514
           IG G YG+VYKA  P  G  VALK +     ED   + + +  A +  L    H NIV+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 515 YGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
              C   +      + L++E++++  L   L D      L      ++++     L +LH
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
            +C   I+HRD+   NIL+ S  +  +ADFG AR+     +   +   T  Y APE+   
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-TLWYRAPEVLLQ 181

Query: 630 IVVTGKCDVYSFGVVALEVL 649
                  D++S G +  E+ 
Sbjct: 182 STYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 71/269 (26%), Positives = 117/269 (43%), Gaps = 28/269 (10%)

Query: 456 YC----IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           YC    +G G YG V       +GK   +KKL+          K+ + EA +LS ++H N
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN-LRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 511 IVKLYGFCLHKKCM-FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           IV        +  + +++  + E G L+  L +    + L   + V     +A AL YLH
Sbjct: 61  IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLH 119

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+ + N+ L       V D G AR+L       +   GT  Y++PEL   
Sbjct: 120 EK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 630 IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIM---LIDVLNQRLSPPVNQK 686
                K DV++ G    E          +++L  +   K M   +  ++  +L PP+ + 
Sbjct: 177 KPYNYKSDVWALGCCVYE----------MATLKHAFNAKDMNSLVYRIIEGKL-PPMPKD 225

Query: 687 IVQDIILVSTIAFACLSSQPKSRPTMQRI 715
              +  L   IA   LS +P+ RP+++ I
Sbjct: 226 YSPE--LGELIA-TMLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 20/210 (9%)

Query: 451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF +   +GTG +G V  A+    G+  A+K L   E      V+    E  +L  + H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA----- 564
            IV +      +  ++ + E++  G LF  L            +  N V    HA     
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--------RFPNDVAKFYHAELVLA 130

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
             YLH   +  II+RD+   N+LLD+     V DFG A+ +  D ++ TL  GT  Y+AP
Sbjct: 131 FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTF-TL-CGTPEYLAP 184

Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+  +       D ++ GV+  E + G  P
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 75/286 (26%), Positives = 115/286 (40%), Gaps = 56/286 (19%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     IG G +G V   +  + G V A+K L  ++  +   V   + E  +L     
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             +VK++     K  ++LI E++  G +  +L   D   E     +  I ++V  A+  +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTE--EETQFYIAETVL-AIDSI 117

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLR---------- 615
           H    L  IHRDI  +N+LLDS     ++DFG    L   H    YR L           
Sbjct: 118 HQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 616 ----------------------AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTH 653
                                  GT  YIAPE+         CD +S GV+  E+L+G  
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 654 PGGLLSSLSSSSGPKIMLIDVLNQR----LSP--PVNQKIVQDIIL 693
           P         S  P+     V+N +      P  P+++K  +D+IL
Sbjct: 235 P-------FCSETPQETYKKVMNWKETLIFPPEVPISEK-AKDLIL 272

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 12/201 (5%)

Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG+G V   ++   GK+ A KKL     +         NE  +L  V  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 517 FCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
               K  + L+   M  G L F + H  +   E    + V     +   L  LH +    
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE--EGRAVFYAAEICCGLEDLHQE---R 122

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL--RAGTYGYIAPELAYTIVVT 633
           I++RD+   NILLD +    ++D G A  +HV    +T+  R GT GY+APE+      T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEG-QTIKGRVGTVGYMAPEVVKNERYT 179

Query: 634 GKCDVYSFGVVALEVLMGTHP 654
              D ++ G +  E++ G  P
Sbjct: 180 FSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 10/200 (5%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL-Y 515
           +G GG+G V   ++   GK+ A KKL     +     +   NE  +L  V  R IV L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
            F   K  + L+   M  G L   +++  E       + +     +   L +LH      
Sbjct: 61  AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQ---RR 115

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHV-DSSYRTLRAGTYGYIAPELAYTIVVTG 634
           I++RD+   N+LLD +    ++D G A  + +        RAGT GY+APE+    V   
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173

Query: 635 KCDVYSFGVVALEVLMGTHP 654
             D ++ G    E++ G  P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 53/186 (28%), Positives = 84/186 (45%), Gaps = 24/186 (12%)

Query: 475 KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERG 534
           K + + K+   E E+S      + E  VLS ++H NIV+          ++++ +Y E G
Sbjct: 31  KEINISKMSPKEREES------RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84

Query: 535 SLFC-------VLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNIL 587
            L+        VL  +D+   L+W   V I  ++ H      HD    I+HRDI S NI 
Sbjct: 85  DLYKKINAQRGVLFPEDQI--LDWF--VQICLALKHV-----HD--RKILHRDIKSQNIF 133

Query: 588 LDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALE 647
           L  +    + DFG AR+L+          GT  Y++PE+        K D+++ G V  E
Sbjct: 134 LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYE 193

Query: 648 VLMGTH 653
           +    H
Sbjct: 194 MCTLKH 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.8 bits (165), Expect = 5e-12
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 8/205 (3%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +DF     +G G  G V K +     ++  +KL H E +  A       E  VL      
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 63

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            IV  YG       + +  E+M+ GSL  VL +     E     +V+I  +V   L+YL 
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSI--AVLRGLAYLR 120

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+  +NIL++S  E  + DFG +  L +DS   +   GT  Y++PE    
Sbjct: 121 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQG 176

Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
              + + D++S G+  +E+ +G +P
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 21/232 (9%)

Query: 458 IGTGGYGSVYKA--ELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G+G +G V K   ++ + ++ VA+K L      + +       EA ++  + +  IV++
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVL--KNENEKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
            G C  +  M L+ E    G L   L    + I +  +  V ++  V+  + YL      
Sbjct: 61  IGVCEAEALM-LVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLEGK--- 114

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG---TYGYIAPELAYTIV 631
           + +HRD+++ N+LL +   A ++DFG ++ L  D SY   R+       + APE      
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 632 VTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP 682
            + + DV+S+G+   E    G  P           GP++M      +RL  P
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKP------YKKMKGPEVMSFIEQGKRLDCP 220

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.1 bits (169), Expect = 6e-12
 Identities = 66/239 (27%), Positives = 97/239 (40%), Gaps = 41/239 (17%)

Query: 474 GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY--GFCLHKKCMFLIYEYM 531
           G  VA+K L     E+      F+ E  + + + H NIV L   G       +F ++EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 532 ERGSLFCVLHDDD--EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL- 588
              +L  VL  D    A E        ++  V  AL+  H+     I+HRD+   NI++ 
Sbjct: 62  PGRTLREVLAADGALPAGE-----TGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVS 113

Query: 589 --DSNLEASVADFGTARLL---HVDSSYRTLRA----GTYGYIAPELAYTIVVTGKCDVY 639
                  A V DFG   LL            R     GT  Y APE      VT   D+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 640 SFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIA 698
           ++G++ LE L G       +S++          ++L Q+LSP        D+ L   IA
Sbjct: 174 AWGLIFLECLTG-QRVVQGASVA----------EILYQQLSP-------VDVSLPPWIA 214

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 26/211 (12%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHS--ETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G G +G VY   +   G+ +A+K++       E S  V + + E  +L  + H  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 515 YGFCLH---KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           YG CL    ++ + +  E+M  GS+   L       E N T++    + +   +SYLH +
Sbjct: 70  YG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTRKYT--RQILEGVSYLHSN 125

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLH---VDSSYRTLRAGTYGYIAPELAY 628
               I+HRDI   NIL DS     + DFG ++ L    +  +      GT  +++PE   
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE--- 179

Query: 629 TIVVTG-----KCDVYSFGVVALEVLMGTHP 654
             V++G     K D++S G   +E+L    P
Sbjct: 180 --VISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.5 bits (165), Expect = 1e-11
 Identities = 31/78 (39%), Positives = 48/78 (61%)

Query: 208 IPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLM 267
           IP +I     L +++LS N I G IP  L  ++ L+ L+LS N  +G IP ++G+L +L 
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 268 YLDLSKNKLSGSIPTEIG 285
            L+L+ N LSG +P  +G
Sbjct: 494 ILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 67.0 bits (163), Expect = 1e-11
 Identities = 62/241 (25%), Positives = 98/241 (40%), Gaps = 42/241 (17%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF     IG G +G V   +  + G + A+K L  ++  +   V   + E  +L     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             +VK++     K+ ++LI E++  G +  +L   D   E     +  I ++V  A+  +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSE--EATQFYIAETVL-AIDAI 117

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTL----------- 614
           H    L  IHRDI  +N+LLD+     ++DFG    L   H    YR L           
Sbjct: 118 HQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 615 ---------------------RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTH 653
                                  GT  YIAPE+         CD +S GV+  E+L+G  
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 654 P 654
           P
Sbjct: 235 P 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 60/226 (26%), Positives = 92/226 (40%), Gaps = 44/226 (19%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQN------------EAHVLS 504
           +G G YG V KA     GK+VA+KK+   E  +    K  Q             E  +++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDV-TKDRQLVGMCGIHFTTLRELKIMN 75

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
            ++H NI+ L    +    + L+ + M    L  V+   D  I L  ++   I+  + + 
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV---DRKIRLTESQVKCILLQILNG 131

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---------- 614
           L+ LH       +HRD+S  NI ++S     +ADFG AR         TL          
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 615 ----RAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMG 651
               +  T  Y APEL      Y        D++S G +  E+L G
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKY----HFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 65.6 bits (161), Expect = 1e-11
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 21/153 (13%)

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           + N +KLY      K   LI +Y++ G LF +L  +    +L+  +   I++ +  AL+ 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALND 124

Query: 568 LH-HDCTLSIIHRDISSNNILLDSNLE-ASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
           LH H    +IIH DI   N+L D   +   + D+G  +++   S Y     GT  Y +PE
Sbjct: 125 LHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD----GTLDYFSPE 176

Query: 626 ----LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                 Y +      D ++ GV+  E+L G HP
Sbjct: 177 KIKGHNYDVSF----DWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 50/197 (25%), Positives = 97/197 (49%), Gaps = 10/197 (5%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G Y +VYK      G++VALK++H    E +    +   E  ++  ++H NIV+L+ 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHENIVRLHD 65

Query: 517 FCLHKKCMFLIYEYMERG-SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
               +  + L++EYM++    +   H    A++ N  K  +    +   +++ H +    
Sbjct: 66  VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVK--SFTYQLLKGIAFCHEN---R 120

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-LAYTIVVTG 634
           ++HRD+   N+L++   E  +ADFG AR   +  +  +    T  Y AP+ L  +   + 
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180

Query: 635 KCDVYSFGVVALEVLMG 651
             D++S G +  E++ G
Sbjct: 181 SIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 34/232 (14%)

Query: 458 IGTGGYGSVYKAEL----PEG----KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +G G +G   K EL    PEG    + VA+K L      +   +   + E  +L  + H 
Sbjct: 12  LGEGHFG---KVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHE 66

Query: 510 NIVKLYGFCLHK--KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           NIVK  G C       + LI E++  GSL   L  +   I L   +++     +   + Y
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGMDY 124

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR----AGTYGYIA 623
           L    +   +HRD+++ N+L++S  +  + DFG  + +  D  Y T++    +  + Y A
Sbjct: 125 LG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-A 180

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVL 675
           PE           DV+SFGV   E         LL+   S S P  + + ++
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYE---------LLTYCDSESSPMTLFLKMI 223

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 32/162 (19%)

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-- 618
           VA  + +L    +   IHRD+++ NILL  N    + DFG AR ++ D  Y  +R G+  
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGSAR 237

Query: 619 --YGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLN 676
               ++APE  +  V T + DV+SFGV+  E+           SL +S  P + + +   
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF----------SLGASPYPGVQINEEFC 287

Query: 677 QRL-------SPPVNQKIVQDIILVSTIAFACLSSQPKSRPT 711
           QRL       +P      +  I+L      AC    PK RPT
Sbjct: 288 QRLKDGTRMRAPENATPEIYRIML------ACWQGDPKERPT 323

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 20/205 (9%)

Query: 458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLY 515
           +G G +G V+ AEL    +  A+K L          V+    E  VLS    H  +  LY
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA------LSYLH 569
                K+ +F + EY+  G L            +    + ++ ++  +A      L +LH
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLM---------FHIQSCHKFDLPRATFYAAEIICGLQFLH 113

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
              +  I++RD+  +NILLD++    +ADFG  +   +  +      GT  YIAPE+   
Sbjct: 114 ---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
                  D +SFGV+  E+L+G  P
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.9 bits (166), Expect = 1e-11
 Identities = 77/290 (26%), Positives = 121/290 (41%), Gaps = 40/290 (13%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG GG G VY A  P   + VALKK+    +E+    K F  EA + + + H  IV +Y 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC---- 572
            C     ++    Y+E  +L  +L    +   L  +K +    SV   LS  H  C    
Sbjct: 70  ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKICATIE 127

Query: 573 ---TLSIIHRDISSNNILLDSNLEASVADFGTAR--------LLHVDSSYRTLR------ 615
              +  ++HRD+  +NILL    E  + D+G A         LL +D   R +       
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187

Query: 616 ----AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIML 671
                GT  Y+APE    +  +   D+Y+ GV+  ++L  + P           G KI  
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP------YRRKKGRKIS- 240

Query: 672 IDVLNQRLSPPVNQKIVQDII-LVSTIAFACLSSQPKSR-PTMQRISQEL 719
                  +  P+     ++I   +S IA   L+  P  R  ++Q + Q+L
Sbjct: 241 ---YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287

Length = 932

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 69/283 (24%), Positives = 119/283 (42%), Gaps = 36/283 (12%)

Query: 440 ILYEDLINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQN 498
           I+++   + ++ + I   IG G YG V+K      G   A+K L      D    +  + 
Sbjct: 8   IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEA 63

Query: 499 EAHVLSTVR-HRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWT 552
           E ++L  +  H N+VK YG    K       ++L+ E    GS+      D     L   
Sbjct: 64  EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----TDLVKGFLKRG 118

Query: 553 KRVN--IVKSVAH----ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH 606
           +R+   I+  + H     L +LH + T   IHRD+  NNILL +     + DFG +  L 
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175

Query: 607 VDSSYRTLRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEV------LMGTHPG 655
                R    GT  ++APE+             +CDV+S G+ A+E+      L   HP 
Sbjct: 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235

Query: 656 GLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIA 698
             L  +  +  P +   ++ +   +  + + + +D     T++
Sbjct: 236 RALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVS 278

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 64/260 (24%), Positives = 105/260 (40%), Gaps = 53/260 (20%)

Query: 451 DFHIKY----CIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           D   +Y     IG+G YG V  A +   GK VA+KK+ H+    +   ++ + E  +L  
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRH 60

Query: 506 VRHRNIVKLYGFCLHK----KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
            +H NI+ +           K ++++ + ME   L  ++H D    E             
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTE------------- 106

Query: 562 AHA----------LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL----HV 607
            H           L Y+H      +IHRD+  +N+L++ + E  + DFG AR L      
Sbjct: 107 EHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163

Query: 608 DSSYRTLRAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVLMGTH--PGGLLSSLSSS 664
              + T    T  Y APEL  ++   T   D++S G +  E+L      PG       + 
Sbjct: 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG------KNY 217

Query: 665 SGPKIMLIDVLNQRLSPPVN 684
                +++ VL    SP   
Sbjct: 218 VHQLKLILSVLG---SPSEE 234

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 65.5 bits (160), Expect = 3e-11
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 62/223 (27%)

Query: 458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQN---------EAHVLSTVR 507
           IG G +G V+    P +GK VALKK+             FQN         E  +L   +
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKM----------PNVFQNLVSCKRVFRELKMLCFFK 57

Query: 508 HRNIVKLYGF-------CLHKKCMFLIYEYMERGSLFCVLHD--------DDEAIELNWT 552
           H N++               +  ++++ E M+       LH           + +++   
Sbjct: 58  HDNVLSALDILQPPHIDPFEE--IYVVTELMQ-----SDLHKIIVSPQPLSSDHVKV--- 107

Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS-Y 611
                +  +   L YLH   +  I+HRDI   N+L++SN    + DFG AR+   D S +
Sbjct: 108 ----FLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH 160

Query: 612 RTLRAGTYGYIAPELA-----YTIVVTGKCDVYSFGVVALEVL 649
            T    T  Y APE+      Y    T   D++S G +  E+L
Sbjct: 161 MTQEVVTQYYRAPEILMGSRHY----TSAVDIWSVGCIFAELL 199

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 10/200 (5%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL-Y 515
           +G GG+G V   ++   GK+ A KKL     +  +  K    E  +L  V    IV L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 516 GFCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
            F   K  + L+   M  G L + + +  +  +E+   + ++    +   + +LH   ++
Sbjct: 61  AF-ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME--RVIHYSAQITCGILHLH---SM 114

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            I++RD+   N+LLD      ++D G A  L  D    T RAGT GY+APE+      + 
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKTITQRAGTNGYMAPEILKEEPYSY 173

Query: 635 KCDVYSFGVVALEVLMGTHP 654
             D ++ G    E++ G  P
Sbjct: 174 PVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 11/200 (5%)

Query: 452 FHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           F +   +G G YG V K    E K +VA+KK   SE E+    ++   E  +L T++  N
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE-ENEEVKETTLRELKMLRTLKQEN 61

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           IV+L      +  ++L++EY+E+  L  +    +        K  + +  +  A+ + H 
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP---EKVRSYIYQLIKAIHWCHK 118

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH--VDSSYRTLRAGTYGYIAPELAY 628
           +    I+HRDI   N+L+  N    + DFG AR L    +++Y T    T  Y +PEL  
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLL 174

Query: 629 TIVVTGKCDVYSFGVVALEV 648
                   D++S G +  E+
Sbjct: 175 GAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 458 IGTGGYGSVY----KAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G G +G+VY    K  + E ++  LK++   E   +  V++ Q EA +LS + H  IVK
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLDHPAIVK 66

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV----NIVKSVAHALSYLH 569
            +   L +    +I EY E   L      D +  EL  T +      + +     L  +H
Sbjct: 67  FHASFLERDAFCIITEYCEGRDL------DCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           +     I+HRD+ + NI L +NL   + DFG +RLL       T   GT  Y++PE    
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179

Query: 630 IVVTGKCDVYSFGVVALEVLMGTH 653
                K D++S G +  E+    H
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAH 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 64.4 bits (157), Expect = 5e-11
 Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 14/202 (6%)

Query: 458 IGTGGYGSVYKAELPEGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIV 512
           +G G +G V  AEL        + ALKK    E +D   V+    E  VL+    H  + 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD---VECTMVERRVLALAWEHPFLT 59

Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
            L+     K+ +F + EY+  G L   +     +   +  +       +   L +LH   
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLH--- 113

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
              II+RD+  +N+LLD +    +ADFG  +         +   GT  YIAPE+      
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173

Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
               D +SFGV+  E+L+G  P
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 65.0 bits (158), Expect = 5e-11
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 15/174 (8%)

Query: 485 SETEDSAFVKSFQ-----NEAHVLSTVRHRNIVKLYG-FCLHKKCMFLIYEYMERGSLFC 538
           ++T +   +K+ Q      EAH+L  + H +I++L G F  +K    ++  Y  +  L+C
Sbjct: 114 NKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYC 171

Query: 539 VLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVAD 598
            L        +     + I +SV  A+ YLH +    IIHRDI + NI ++   +  + D
Sbjct: 172 YLAAKRN---IAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGD 225

Query: 599 FGTARL-LHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
           FG A   + ++++     AGT    APEL          D++S G+V  E+   
Sbjct: 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.2 bits (159), Expect = 7e-11
 Identities = 34/88 (38%), Positives = 49/88 (55%)

Query: 106 LDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVL 165
           L L N  L G IP  I  L  L+ + L GN++ G IP  +GS+ +L  L L  N  +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 166 PQEIGNLKSLTELYVTNNALGGLIPSTL 193
           P+ +G L SL  L +  N+L G +P+ L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.8 bits (155), Expect = 7e-11
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 20/205 (9%)

Query: 458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLY 515
           +G G +G V  AEL  +G+  A+K L          V+    E  VL+    +  +  LY
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA------LSYLH 569
                K+ +F + E++  G L  + H  D+        R ++ ++  +A      L +LH
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDL--MFHIQDKG-------RFDLYRATFYAAEIVCGLQFLH 113

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 II+RD+  +N++LD +    +ADFG  +      +  +   GT  YIAPE+   
Sbjct: 114 SK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
           +  T   D +SFGV+  E+L+G  P
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 63/200 (31%), Positives = 88/200 (44%), Gaps = 10/200 (5%)

Query: 458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVL-STVRHRNIVKL- 514
           IG G +G V  A+   +GK  A+K L           K    E +VL   V+H  +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
           Y F    K  F++ +Y+  G LF  L  +    E    +       +A AL YLH   +L
Sbjct: 63  YSFQTADKLYFVL-DYVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLH---SL 115

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
           +II+RD+   NILLDS     + DFG  +     S   +   GT  Y+APE+        
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175

Query: 635 KCDVYSFGVVALEVLMGTHP 654
             D +  G V  E+L G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 10/200 (5%)

Query: 458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVL-STVRHRNIVKL- 514
           IG G +G V  A+   +GK  A+K L      +    K    E +VL   V+H  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
           Y F   +K ++ + +++  G LF  L  +    E    +       +A AL YLH   ++
Sbjct: 63  YSFQTTEK-LYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLH---SI 115

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
           +I++RD+   NILLDS     + DFG  +     S   T   GT  Y+APE+        
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 635 KCDVYSFGVVALEVLMGTHP 654
             D +  G V  E+L G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 17/202 (8%)

Query: 458 IGTGGYGSVYKA-ELPEG-KVVALKKLHHSETEDSAFVKSFQNEAHVL---STVRHRNIV 512
           IG G YG V+KA +L  G + VALK++   +T +     S   E  VL    T  H N+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 513 KLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           +L+  C   +      + L++E++++     +    +  +     K  +++  +   L +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDF 125

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH   +  ++HRD+   NIL+ S+ +  +ADFG AR+     +  ++   T  Y APE+ 
Sbjct: 126 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVL 181

Query: 628 YTIVVTGKCDVYSFGVVALEVL 649
                    D++S G +  E+ 
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 8e-11
 Identities = 61/245 (24%), Positives = 88/245 (35%), Gaps = 56/245 (22%)

Query: 451 DFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
            F     +G G  G V+   L   GK+ ALK L   E      VK    E  +L+T+ H 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR--VNIVK----SVAH 563
            +  LY     +  + L+ +Y   G LF +L       +    K     + +     V  
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLL-------QRQPGKCLSEEVARFYAAEVLL 114

Query: 564 ALSYLHHDCTLSIIHRDISSNNILL---------DSNLEASVADFGTARLLHVDSSYRTL 614
           AL YLH    L I++RD+   NILL         D +L              +    R  
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 615 RA--------------------GTYGYIAPELAYTIVVTGK-----CDVYSFGVVALEVL 649
                                 GT  YIAPE     V++G       D ++ G++  E+L
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-----VISGDGHGSAVDWWTLGILLYEML 226

Query: 650 MGTHP 654
            GT P
Sbjct: 227 YGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.7 bits (155), Expect = 9e-11
 Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 20/226 (8%)

Query: 499 EAHVLSTVRHRNIVKLYGFCLHKK--CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
           EA +L  V H +++++    +     CM L +       L+  L      + ++  + + 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY---SSDLYTYLTKRSRPLPID--QALI 161

Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
           I K +   L YLH      IIHRD+ + NI ++   +  + D G A+   V  ++  L A
Sbjct: 162 IEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL-A 217

Query: 617 GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIM-----L 671
           GT    APE+        K D++S G+V  E+L   +P  +     S+    +      L
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML--AYPSTIFEDPPSTPEEYVKSCHSHL 275

Query: 672 IDVLNQRLSPPVNQKIVQDIILVST-IAFACLSSQPKSR-PTMQRI 715
           + +++     P          LV   I +A L  QP +R P  QR+
Sbjct: 276 LKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRV 321

Length = 357

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 59/239 (24%), Positives = 89/239 (37%), Gaps = 39/239 (16%)

Query: 458 IGTGGYGSVYKAELPEGKVVA---LKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           IG G +G V   E   G   A   +K+L  S T D      F  E      + H N+++ 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL--LFLQEVQPYRELNHPNVLQC 60

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV--NIVKSVAHALSYLHHDC 572
            G C+      L+ E+   G L   L  +   +     K V   +   VA  L +LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT-------LRAGTYGYIAPE 625
               IH D++  N  L ++L   + D+G A   + +  Y T       LR     ++APE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR-----WLAPE 172

Query: 626 LA-------YTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ 677
           L             T K +++S GV   E          L + +    P +    VL Q
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWE----------LFTAADQPYPDLSDEQVLKQ 221

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 10/206 (4%)

Query: 450 EDFHIKYCIGTGGYGSVYK-AELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF     +G G  G V+K +  P G ++A +KL H E +  A       E  VL     
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLEIK-PAIRNQIIRELQVLHECNS 62

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             IV  YG       + +  E+M+ GSL  VL       E     +V+I  +V   L+YL
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSI--AVIKGLTYL 119

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
                  I+HRD+  +NIL++S  E  + DFG +  L +DS   +   GT  Y++PE   
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQ 175

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
               + + D++S G+  +E+ +G +P
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 13/208 (6%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
            AT   +++  +G G Y +VYK      G++VALK +     E   F      EA +L  
Sbjct: 3   AATSYLNLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI--REASLLKG 59

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERG-SLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           ++H NIV L+     K+ +  ++EYM    + + + H       L+       +  +   
Sbjct: 60  LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG----LHPYNVRLFMFQLLRG 115

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           L+Y+H      I+HRD+   N+L+    E  +ADFG AR   + S   +    T  Y  P
Sbjct: 116 LAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172

Query: 625 E-LAYTIVVTGKCDVYSFGVVALEVLMG 651
           + L      +   D++  G + +E+L G
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 60/200 (30%), Positives = 86/200 (43%), Gaps = 10/200 (5%)

Query: 458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVL-STVRHRNIVKL- 514
           IG G +G V  A+   +G   A+K L                E +VL   ++H  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
           Y F   +K ++ + +Y+  G LF   H   E   L    R      VA A+ YLH   +L
Sbjct: 63  YSFQTAEK-LYFVLDYVNGGELF--FHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
           +II+RD+   NILLDS     + DFG  +         +   GT  Y+APE+        
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 635 KCDVYSFGVVALEVLMGTHP 654
             D +  G V  E+L G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 27/215 (12%)

Query: 452 FHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           + I+  IG G YG V  A +   G+ VA+KK++    E  +       E  +L  +RH +
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-FEHVSDATRILREIKLLRLLRHPD 60

Query: 511 IVKLYGFCLHK-----KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           IV++    L       K +++++E ME   L  V+  +D+   L        +  +  AL
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---LTPEHHQFFLYQLLRAL 116

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS---YRTLRAGTYGYI 622
            Y+H   T ++ HRD+   NIL +++ +  + DFG AR+   D+    + T    T  Y 
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 623 APELA------YTIVVTGKCDVYSFGVVALEVLMG 651
           APEL       YT  +    D++S G +  EVL G
Sbjct: 174 APELCGSFFSKYTPAI----DIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 17/148 (11%)

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT----YGYIAPELAYTIVV 632
           IHRD+++ NILL  N    + DFG AR ++ D  Y  +R G       ++APE  +  V 
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPESIFDKVY 252

Query: 633 TGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDII 692
           T + DV+SFGV+  E+           SL +S  P + + +   +RL      +  +   
Sbjct: 253 TTQSDVWSFGVLLWEIF----------SLGASPYPGVQIDEEFCRRLKEGTRMRAPEYAT 302

Query: 693 L-VSTIAFACLSSQPKSRPTMQRISQEL 719
             + +I   C  + P+ RPT   + + L
Sbjct: 303 PEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 4e-10
 Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 40/226 (17%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +    +     IG G YG V  A   P G  VA+KK+  S  E   F +    E  +L  
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTLREIKILRR 59

Query: 506 VRHRNIVKLY------GFCLHKKCMFLIYEYMERGSLFCV-----LHDDDEAIELNWTKR 554
            +H NI+ +        F      ++++ E ME   L+ +     L +D     L    R
Sbjct: 60  FKHENIIGILDIIRPPSFESFND-VYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR 117

Query: 555 VNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL---LHVDSSY 611
                     L Y+H   + +++HRD+  +N+LL++N +  + DFG AR+    H  + +
Sbjct: 118 ---------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 612 RTLRAGTYGYIAPELAYTIVVTGK-----CDVYSFGVVALEVLMGT 652
            T    T  Y APE    I++  K      D++S G +  E+L   
Sbjct: 166 LTEYVATRWYRAPE----IMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 32/208 (15%)

Query: 458 IGTGGYGSV-YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YG+V    +   G  VA+KKL+     +  F K    E  +L  ++H N++ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMKHENVIGLLD 81

Query: 517 FCLHKKCM------FLIYEYM--ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
                  +      +L+  +M  + G L       ++ I+        +V  +   L Y+
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYI 134

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE--- 625
           H      IIHRD+   N+ ++ + E  + DFG AR    DS   T    T  Y APE   
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEM-TGYVVTRWYRAPEVIL 188

Query: 626 --LAYTIVVTGKCDVYSFGVVALEVLMG 651
             + YT  V    D++S G +  E+L G
Sbjct: 189 NWMHYTQTV----DIWSVGCIMAEMLTG 212

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 25/208 (12%)

Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV---RHRNIVK 513
           +G G +G V  AE    G++ A+K L   +      V+S   E  +  T    RH  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+     +  +  + EY   G L   +H D      +  + V     V   L YLH +  
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN-- 120

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA---GTYGYIAPEL---- 626
             I++RD+  +N+LLD+     +ADFG   L      +    +   GT  ++APE+    
Sbjct: 121 -KIVYRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRTSTFCGTPEFLAPEVLTET 176

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           +YT  V    D +  GV+  E+L+G  P
Sbjct: 177 SYTRAV----DWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 42/219 (19%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN-IVKLY 515
           IG G YG VYKA +   GK+VALKK    E ++     +   E  +L  +     IV+L 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIYIVRL- 66

Query: 516 GFCLH-------KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR-----VNIVKSVAH 563
              +        K  ++L++EY++         D  + ++ N            +KS  +
Sbjct: 67  -LDVEHVEEKNGKPSLYLVFEYLDS--------DLKKFMDSNGRGPGRPLPAKTIKSFMY 117

Query: 564 AL----SYLHHDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGT 618
            L    ++ H      ++HRD+   N+L+D       +AD G  R   +     T    T
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVT 174

Query: 619 YGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMGT 652
             Y APE+      Y+  V    D++S G +  E+    
Sbjct: 175 LWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 10/200 (5%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL-STVRHRNIVKL- 514
           IG G +G V  A    E K  A+K L           K   +E +VL   V+H  +V L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
           + F    K ++ + +Y+  G LF   H   E   L    R      +A AL YLH   +L
Sbjct: 63  FSFQTADK-LYFVLDYINGGELF--YHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
           +I++RD+   NILLDS     + DFG  +     +   +   GT  Y+APE+ +      
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 635 KCDVYSFGVVALEVLMGTHP 654
             D +  G V  E+L G  P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 7/200 (3%)

Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL-Y 515
           +G GG+G V   ++   GK+ A KKL+    +     +    E  +L+ V  R IV L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 516 GFCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
            F   K  + L+   M  G L + + + D+E       +       +   L +LH     
Sbjct: 61  AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            II+RD+   N+LLD++    ++D G A  L    S     AGT G++APEL        
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 635 KCDVYSFGVVALEVLMGTHP 654
             D ++ GV   E++    P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 8/199 (4%)

Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG+G V   ++   GK+ A K+L     +         NE  +L  V  + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 517 FCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
               K  + L+   M  G L F + +  +   E    + +     +   L  LH +   +
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE--RALFYAAEILCGLEDLHRE---N 122

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK 635
            ++RD+   NILLD      ++D G A  +    S R  R GT GY+APE+      T  
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG-RVGTVGYMAPEVLNNQRYTLS 181

Query: 636 CDVYSFGVVALEVLMGTHP 654
            D +  G +  E++ G  P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)

Query: 458 IGTGGYGSVYK--AELPEGKVVALK--KLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G G Y +V+K  ++L E  +VALK  +L H E      ++    E  +L  ++H NIV 
Sbjct: 13  LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVT 67

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK-SVAHALSYLHHDC 572
           L+     ++C+ L++EY++      +    D    L     V I    +   LSY H   
Sbjct: 68  LHDIIHTERCLTLVFEYLDSD----LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR- 122

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-LAYTIV 631
              I+HRD+   N+L++   E  +ADFG AR   V +   +    T  Y  P+ L  +  
Sbjct: 123 --KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 632 VTGKCDVYSFGVVALEVLMG 651
            +   D++  G +  E+  G
Sbjct: 181 YSTPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 3/199 (1%)

Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +F I+  IG G +  VY+A  L +G  VALKK+   +  D+        E  +L  + H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N++K Y   +    + ++ E  + G L  ++    +   L   K V   K      S L 
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV--WKYFVQLCSALE 120

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           H  +  ++HRDI   N+ + +     + D G  R     ++      GT  Y++PE  + 
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 630 IVVTGKCDVYSFGVVALEV 648
                K D++S G +  E+
Sbjct: 181 NGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.8 bits (150), Expect = 7e-10
 Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 27/157 (17%)

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV---DSSYRTLRAGTYGYIAP 624
           +HH  +  +IHRDI S NILL SN    + DFG +++      D   RT   GT  Y+AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-CGTPYYVAP 214

Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS---- 680
           E+      + K D++S GV+  E+L    P           G  +   +V+++ L+    
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRP---------FDGENME--EVMHKTLAGRYD 263

Query: 681 --PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
             PP     +Q+I  V+ +    LSS PK RP+  ++
Sbjct: 264 PLPPSISPEMQEI--VTAL----LSSDPKRRPSSSKL 294

Length = 496

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 21/273 (7%)

Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +F I+  IG G +  VY+A  L + K VALKK+   E  D+   +    E  +L  + H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N++K     +    + ++ E  + G L  ++    +   L       + K      S + 
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL--IPERTVWKYFVQLCSAVE 120

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           H  +  ++HRDI   N+ + +     + D G  R     ++      GT  Y++PE  + 
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 630 IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV-----N 684
                K D++S G +  E+        L S           L   + Q   PP+     +
Sbjct: 181 NGYNFKSDIWSLGCLLYEM------AALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234

Query: 685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
           +K+ +   LVS     C+   P  RP +  + Q
Sbjct: 235 EKLRE---LVSM----CIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 7/198 (3%)

Query: 458 IGTGGYGSVYKAELPEG-KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V +    +  ++ ALK +  +     + V     E  VL+ V    IV L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
                + ++L+  ++  G LF  L  +      + ++       +  AL  LH     ++
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGR---FDLSRARFYTAELLCALENLH---KFNV 114

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           I+RD+   NILLD     ++ DFG  +L   D        GT  Y+APEL      T   
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV 174

Query: 637 DVYSFGVVALEVLMGTHP 654
           D ++ GV+  E+L G  P
Sbjct: 175 DWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 16/199 (8%)

Query: 458 IGTGGYGSVYK--AELPEGKVVALK--KLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G G Y +VYK  ++L +  +VALK  +L H E      ++    E  +L  ++H NIV 
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVT 68

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+     +K + L++EY+++  L   L D   +I ++  K    +  +   L+Y H    
Sbjct: 69  LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKL--FLFQLLRGLNYCHRR-- 123

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-LAYTIVV 632
             ++HRD+   N+L++   E  +ADFG AR   + +   +    T  Y  P+ L  +   
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 633 TGKCDVYSFGVVALEVLMG 651
           + + D++  G +  E+  G
Sbjct: 183 STQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 41/212 (19%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G+ VA+KKL     +   F K    E  +L  ++H N++ L  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 517 FCLHKKCM------FLIYEYME------RGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
                         +L+  YM+       G         ++ ++        +V  +   
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQTDLQKIMG-----HPLSEDKVQY-------LVYQMLCG 129

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           L Y+H   +  IIHRD+   N+ ++ + E  + DFG AR  H D+   T    T  Y AP
Sbjct: 130 LKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM-TGYVVTRWYRAP 183

Query: 625 E-----LAYTIVVTGKCDVYSFGVVALEVLMG 651
           E     + Y   V    D++S G +  E+L G
Sbjct: 184 EVILNWMHYNQTV----DIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 14/208 (6%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLY 515
           IG G Y  V    L +  ++ A+K +      D   +   Q E HV      H  +V L+
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN---WTKRVNIVKSVAHALSYLHHDC 572
                +  +F + EY+  G L   +    +  E +   ++  +++      AL+YLH   
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER- 115

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
              II+RD+  +N+LLDS     + D+G  +         +   GT  YIAPE+      
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 633 TGKCDVYSFGVVALEVLMGTHPGGLLSS 660
               D ++ GV+  E++ G  P  ++ S
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGS 201

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 32/198 (16%)

Query: 530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD 589
           Y+++     +L +D+ A++      ++    VA  +S+L    + + IHRD+++ NILL 
Sbjct: 194 YIDQDVTSEILEEDELALDTE--DLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLT 248

Query: 590 SNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTGKCDVYSFGVVAL 646
                 + DFG AR +  DS+Y  ++        ++APE  +  V T + DV+S+G++  
Sbjct: 249 HGRITKICDFGLARDIRNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLW 307

Query: 647 EVLMGTHPGGLLSSLSSSSGPKI-------MLIDVLNQRLSPPVNQKIVQDIILVSTIAF 699
           E+           SL SS  P +        +I    + LSP      + DI+       
Sbjct: 308 EIF----------SLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMK------ 351

Query: 700 ACLSSQPKSRPTMQRISQ 717
           +C  + P  RPT ++I Q
Sbjct: 352 SCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.7 bits (147), Expect = 2e-09
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 17/161 (10%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F I   I  G +G VY   +    K+ A+K +  ++  +   V   Q E   L+  + 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-----DDDEAIELNWTKRVNIVKSVAH 563
             IV LY        ++L+ EY+  G +  +LH     D++ A        V  +  VA 
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA--------VKYISEVAL 115

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL 604
           AL YLH      IIHRD+  +N+L+ +     + DFG +++
Sbjct: 116 ALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 20/205 (9%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLY 515
           +G G +G V  A L E G++ A+K L          V+    E  +LS  R H  + +LY
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 516 GFCLHK-KCMFLIYEYMERGSLF-----CVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
             C      +F + E++  G L          D+  A              +  AL +LH
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA--------RFYAAEITSALMFLH 113

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 II+RD+  +N+LLD      +ADFG  +    +    +   GT  YIAPE+   
Sbjct: 114 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170

Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
           ++     D ++ GV+  E+L G  P
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 41/217 (18%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK--- 513
           IG G +G VY+    +  ++ A+K L           K    +  V  T+  RNI+    
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK---------KEIVAKKEVAHTIGERNILVRTL 51

Query: 514 ------LYG--FCLHKKC-MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI-VKSVAH 563
                 + G  F       ++L+ +YM  G LF  L  +    E     R    +  +  
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE----DRAKFYIAELVL 107

Query: 564 ALSYLH-HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
           AL +LH +D    I++RD+   NILLD+    ++ DFG ++    D+       GT  Y+
Sbjct: 108 ALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYL 163

Query: 623 APEL-----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           APE+      YT  V    D +S GV+  E+  G  P
Sbjct: 164 APEVLLDEKGYTKHV----DFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 57/199 (28%), Positives = 84/199 (42%), Gaps = 9/199 (4%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL-Y 515
           +G G +G V    E   GK  A+K L          V     E+ VL   RH  +  L Y
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
            F    +  F++ EY+  G LF   H   E +      R    + V+ AL YLH      
Sbjct: 63  SFQTKDRLCFVM-EYVNGGELF--FHLSRERVFSEDRTRFYGAEIVS-ALDYLHSG---K 115

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK 635
           I++RD+   N++LD +    + DFG  +    D++      GT  Y+APE+         
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 636 CDVYSFGVVALEVLMGTHP 654
            D +  GVV  E++ G  P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 42/175 (24%)

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-- 618
           VA  + +L    +   IHRD+++ NILL  N    + DFG AR ++ D  Y  +R G   
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGDAR 242

Query: 619 --YGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLN 676
               ++APE  +  V T + DV+SFGV+  E+           SL +S  P + + +   
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF----------SLGASPYPGVKIDEEFC 292

Query: 677 QRL------------SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +RL            +P + Q ++            C   +P  RPT   + + L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLD-----------CWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.9 bits (143), Expect = 4e-09
 Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 74/234 (31%)

Query: 457 CIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN---------EAHVLSTV 506
            IG G YG V  A+  E  + VA+KK+            +F N         E  +L  +
Sbjct: 12  PIGRGAYGIVCSAKNSETNEKVAIKKIA----------NAFDNRIDAKRTLREIKLLRHL 61

Query: 507 RHRNIVKLYGFCLHKKCM-----------FLIYEYMERGSLFCVLHDDDEAIELNWTKRV 555
            H N++ +      K  M           +++YE M          D D    L+   R 
Sbjct: 62  DHENVIAI------KDIMPPPHREAFNDVYIVYELM----------DTD----LHQIIRS 101

Query: 556 NIVKSVAH----------ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL 605
           +   S  H           L Y+H   + +++HRD+  +N+LL++N +  + DFG AR  
Sbjct: 102 SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158

Query: 606 HVDSSYRTLRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                + T    T  Y APEL      YT  +    DV+S G +  E L+G  P
Sbjct: 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAI----DVWSVGCIFAE-LLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 15/150 (10%)

Query: 458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G Y +VYK      G++VALK++     E + F      EA +L  ++H NIV L+ 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI--REASLLKDLKHANIVTLHD 70

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK---SVAHALSYLHHDCT 573
               KK + L++EY++   L   + D    + ++     N+      +   L+Y H    
Sbjct: 71  IIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH-----NVRLFLFQLLRGLAYCHQR-- 122

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTAR 603
             ++HRD+   N+L+    E  +ADFG AR
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 57/199 (28%), Positives = 84/199 (42%), Gaps = 9/199 (4%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL-Y 515
           +G G +G V    E   G+  A+K L          V     E+ VL   RH  +  L Y
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
            F  H +  F++ EY   G LF   H   E +      R    + V+ AL YLH   +  
Sbjct: 63  AFQTHDRLCFVM-EYANGGELF--FHLSRERVFTEERARFYGAEIVS-ALEYLH---SRD 115

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK 635
           +++RDI   N++LD +    + DFG  +    D +      GT  Y+APE+         
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 636 CDVYSFGVVALEVLMGTHP 654
            D +  GVV  E++ G  P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.2 bits (138), Expect = 6e-09
 Identities = 37/131 (28%), Positives = 65/131 (49%), Gaps = 20/131 (15%)

Query: 461 GGYGSVYKAELPEGKVVALK---KLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           G YG ++K E      V LK   K H + +E      SF   A ++S + H+++V  YG 
Sbjct: 20  GDYGELHKTE------VLLKVLDKSHRNYSE------SFFEAASMMSQLSHKHLVLNYGV 67

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           C+      ++ EY++ GSL   L  +   I ++W  ++ + K +A AL +L       + 
Sbjct: 68  CVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLT 122

Query: 578 HRDISSNNILL 588
           H ++ + N+LL
Sbjct: 123 HGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.7 bits (140), Expect = 6e-09
 Identities = 44/211 (20%), Positives = 84/211 (39%), Gaps = 23/211 (10%)

Query: 457 CIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           C        + K + P   +VA+KK++  ++     +K  Q E      ++H NI+    
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKIN-LDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66

Query: 517 FCLHKKCMFLIYEYMERGSLFC-VLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
             +    ++++   M  GS  C  L        L       I+K V +AL Y+H      
Sbjct: 67  SFIVDSELYVVSPLMAYGS--CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KG 121

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGY----------IAPE 625
            IHR + +++ILL  + +  ++    +    +    +  R   + +          ++PE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSV--SMIKHGKRQRV-VHDFPKSSVKNLPWLSPE 178

Query: 626 LAYTIV--VTGKCDVYSFGVVALEVLMGTHP 654
           +    +     K D+YS G+ A E+  G  P
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 7e-09
 Identities = 72/256 (28%), Positives = 101/256 (39%), Gaps = 60/256 (23%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSET---EDSAFVKSFQNEAHVLST 505
           EDFH    IG G +G V   +    GK+ A+K L  SE    +  A VK+   E  VL+ 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKA---ERDVLAE 57

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
                +V LY      + ++LI E++  G L  +L   D   E     R  + + V  A+
Sbjct: 58  SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED--VTRFYMAECVL-AI 114

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV--DSSY------------ 611
             +H    L  IHRDI  +NIL+D      ++DFG +   H   DS+Y            
Sbjct: 115 EAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171

Query: 612 -----------------------------RTLRA----GTYGYIAPELAYTIVVTGKCDV 638
                                        R L A    GT  YIAPE+        +CD 
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231

Query: 639 YSFGVVALEVLMGTHP 654
           +S G +  E L+G  P
Sbjct: 232 WSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 57.9 bits (140), Expect = 7e-09
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 8/199 (4%)

Query: 458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLY 515
           +G G +G V  AEL    +V A+K L          V     E  +L+    H  +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
                K  +F + EY+  G L   +     + + +  +       V  AL +LH      
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRH---G 116

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK 635
           +I+RD+  +NILLD+     +ADFG  +   ++    T   GT  YIAPE+   +     
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPS 176

Query: 636 CDVYSFGVVALEVLMGTHP 654
            D ++ GV+  E++ G  P
Sbjct: 177 VDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 36/211 (17%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLSTVR 507
           IG+G  G V  A +   G  VA+KKL           + FQN+ H         +L  V 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKL----------SRPFQNQTHAKRAYRELVLLKCVN 78

Query: 508 HRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           H+NI+ L      +K +      +L+ E M+  +L  V+H     +EL+  +   ++  +
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQM 132

Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGY 621
              + +LH   +  IIHRD+  +NI++ S+    + DFG AR    +          Y Y
Sbjct: 133 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-Y 188

Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGT 652
            APE+   +      D++S G +  E++ G+
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGS 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 72/300 (24%), Positives = 121/300 (40%), Gaps = 49/300 (16%)

Query: 458 IGTGGYGSVY--------KAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +G G +G VY        K E  E +V A+K ++ S +        F NEA V+      
Sbjct: 14  LGQGSFGMVYEGNARDIIKGE-AETRV-AVKTVNESASLRERI--EFLNEASVMKGFTCH 69

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTKRVNIVKSVA 562
           ++V+L G     +   ++ E M  G L   L       E N         + + +   +A
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--G 620
             ++YL+       +HRD+++ N ++  +    + DFG  R ++    YR    G     
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS-----SGPKIMLIDVL 675
           ++APE     V T   D++SFGVV  E+          +SL+       S  +++   + 
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEI----------TSLAEQPYQGLSNEQVLKFVMD 236

Query: 676 NQRLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEIS 734
              L  P N  + V D++ +      C    PK RPT   I   L   K  +  +  E+S
Sbjct: 237 GGYLDQPDNCPERVTDLMRM------CWQFNPKMRPTFLEIVNLL---KDDLHPSFPEVS 287

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.9 bits (138), Expect = 9e-09
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 32/210 (15%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKL---HHSETEDSAFVKSFQNEAHVLSTVR-HRNIV 512
           IG G +  V KA     GK  A+K +     S  + +        E   L  +  H NI+
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-----REIQALRRLSPHPNIL 61

Query: 513 KLYGFCLHKK--CMFLIYEYMERGSLFCVLHDDDEAIE-----LNWTKRVNIVKSVAHAL 565
           +L      +K   + L++E M+  +L+       E I+     L   +  + +  +  +L
Sbjct: 62  RLIEVLFDRKTGRLALVFELMD-MNLY-------ELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
            ++H +    I HRDI   NIL+  ++   +ADFG+ R ++    Y T    T  Y APE
Sbjct: 114 DHMHRN---GIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPY-TEYISTRWYRAPE 168

Query: 626 LAYTIVVTG-KCDVYSFGVVALEVLMGTHP 654
              T    G K D+++ G V  E+L    P
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEIL-SLFP 197

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 16/199 (8%)

Query: 458 IGTGGYGSVYK--AELPEGKVVALK--KLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G G Y +V+K  ++L E  +VALK  +L H E      ++    E  +L  ++H NIV 
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVT 68

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+      K + L++EY+++  L   + D    + ++  K    +  +   L+Y H    
Sbjct: 69  LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKI--FLYQILRGLAYCHRR-- 123

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-LAYTIVV 632
             ++HRD+   N+L++   E  +ADFG AR   V +   +    T  Y  P+ L  +   
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 633 TGKCDVYSFGVVALEVLMG 651
           + + D++  G +  E+  G
Sbjct: 183 STQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 63/250 (25%), Positives = 99/250 (39%), Gaps = 68/250 (27%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSET---EDSAFVKSFQNEAHVLSTVRHRNIVK 513
           IG G +G V    ++    + A+K L  ++      +A VK+   E  +L+   +  +VK
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA---ERDILAEADNEWVVK 65

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVL-----HDDDEAIELNWTKRVNIVKSVAHALSYL 568
           LY     K  ++ + +Y+  G +  +L      ++D A       R  I + +  A+  +
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-------RFYIAE-LTCAIESV 117

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTA---RLLHVDSSY-------------- 611
           H    +  IHRDI  +NIL+D +    + DFG     R  H DS Y              
Sbjct: 118 HK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH-DSKYYQKGDHHRQDSMEP 173

Query: 612 -----------------RTLR----------AGTYGYIAPELAYTIVVTGKCDVYSFGVV 644
                            R  R           GT  YIAPE+      T  CD +S GV+
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233

Query: 645 ALEVLMGTHP 654
             E+L+G  P
Sbjct: 234 LYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 8/199 (4%)

Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG+G V   ++   GK+ A KKL     +         NE  +L  V  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 517 FCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
               K  + L+   M  G L F + +  +   +    + +     +   L  L  +    
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ--RAIFYAAELCCGLEDLQRE---R 122

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK 635
           I++RD+   NILLD      ++D G A  +    + R  R GT GY+APE+      T  
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG-RVGTVGYMAPEVINNEKYTFS 181

Query: 636 CDVYSFGVVALEVLMGTHP 654
            D +  G +  E++ G  P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 25/166 (15%)

Query: 494 KSFQNEAHVLSTVRHRNIVKLYGFCLHKK--CMFL------IYEYMERGSLFCVLHDDDE 545
           K+   E  +L T+ HR I+ L      K   CM +      ++ Y++R            
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDR----------SG 180

Query: 546 AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL 605
            + L   + + I + +  AL+YLH      IIHRD+ + NI LD    A + DFG A  L
Sbjct: 181 PLPLE--QAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235

Query: 606 --HVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
             H D+      +GT    +PEL        K D++S G+V  E+ 
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 40/172 (23%)

Query: 561 VAHALSYL-HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT- 618
           VA  + +L   +C    IHRD+++ N+LL     A + DFG AR +  DS+Y  +  G  
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--VVKGNA 274

Query: 619 ---YGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVL 675
                ++APE  +  V T + DV+S+G++  E+           SL  S  P I+    +
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----------SLGKSPYPGIL----V 320

Query: 676 NQRLSPPVNQKIVQDIILVSTIAFA----------CLSSQPKSRPTMQRISQ 717
           N +       K+V+    +S   FA          C + +P  RPT  +ISQ
Sbjct: 321 NSKF-----YKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 68/287 (23%), Positives = 125/287 (43%), Gaps = 58/287 (20%)

Query: 461 GGYGSVYKAELPEGKV-----VALKKL--HHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           G +G ++   L + K      V +K +  H SE + +  ++    E+ +L  + H+NI+ 
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ----ESCLLYGLSHQNILP 72

Query: 514 LYGFC--LHKKCMFLIYEYMERGSL-----FCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           +   C    +   F++Y YM  G+L      C L + +    L+  + V++   +A  +S
Sbjct: 73  ILHVCIEDGEP-PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL-----HV--DSSYRTLRAGTY 619
           YLH      +IH+DI++ N ++D  L+  + D   +R L     H   D+  R ++    
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---- 184

Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKI-------MLI 672
            ++A E       +   DV+SFGV+  E          L +L  +   +I        L 
Sbjct: 185 -WMALESLVNKEYSSASDVWSFGVLLWE----------LMTLGQTPYVEIDPFEMAAYLK 233

Query: 673 DVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           D    RL+ P+N     D +    +   C +  P+ RP+  ++ Q L
Sbjct: 234 D--GYRLAQPIN---CPDELF--AVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 55/200 (27%), Positives = 83/200 (41%), Gaps = 10/200 (5%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL-Y 515
           +G G +G V    E   G+  A+K L          V     E  VL   RH  +  L Y
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS-VAHALSYLHHDCTL 574
            F  H +  F++ EY   G LF  L  +    E     R     + +  AL YLH +   
Sbjct: 63  SFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHSE--K 115

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
           ++++RD+   N++LD +    + DFG  +    D +      GT  Y+APE+        
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 635 KCDVYSFGVVALEVLMGTHP 654
             D +  GVV  E++ G  P
Sbjct: 176 AVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 55.8 bits (135), Expect = 3e-08
 Identities = 55/218 (25%), Positives = 88/218 (40%), Gaps = 52/218 (23%)

Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAH---------VLSTVR 507
           +G+G YG V  A   +    VA+KKL           + FQ+  H         +L  + 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS----------RPFQSAIHAKRTYRELRLLKHMD 72

Query: 508 HRNIVKLYG-FC-----LHKKCMFLIYEYMERGSLFCVLHDD---DEAIELNWTKRVNIV 558
           H N++ L   F         + ++L+   M    L  ++      D+ I+        +V
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDHIQF-------LV 124

Query: 559 KSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT 618
             +   L Y+H   +  IIHRD+  +NI ++ + E  + DFG AR         T    T
Sbjct: 125 YQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGYVAT 178

Query: 619 YGYIAPE-----LAYTIVVTGKCDVYSFGVVALEVLMG 651
             Y APE     + Y   V    D++S G +  E+L G
Sbjct: 179 RWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 8/206 (3%)

Query: 451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF+    +G G +G V  AE     ++ A+K L          V+    E  VL+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 510 NIVKLYGFCLHK-KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             +     C      ++ + EY+  G L   ++   +  +    + V     ++  L +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFL 117

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H      II+RD+  +N++LDS     +ADFG  +   VD        GT  YIAPE+  
Sbjct: 118 HRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA 174

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +++GV+  E+L G  P
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 49.1 bits (118), Expect = 1e-07
 Identities = 31/61 (50%), Positives = 34/61 (55%), Gaps = 2/61 (3%)

Query: 102 NLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
           NLKSLDL NN L+  IP      L  LK L L GNNLT I P+    L +LR L L  N 
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 161 L 161
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 68/277 (24%), Positives = 108/277 (38%), Gaps = 70/277 (25%)

Query: 472 PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYM 531
           P+ KVVA K +  ++   +A+ +S   E H L+   H  IVK +        + LI EY 
Sbjct: 92  PKEKVVA-KFVMLNDERQAAYARS---ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147

Query: 532 ERGSLFCVLHDDDEAIELNWTKRVN--------IVKSVAHALSYLHHDCTLSIIHRDISS 583
             G L       ++ I+    + +         +   +  AL  +H      ++HRD+ S
Sbjct: 148 SGGDL-------NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKS 197

Query: 584 NNILLDSNLEASVADFGTARL------LHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCD 637
            NI L       + DFG ++       L V SS+     GT  Y+APEL      + K D
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF----CGTPYYLAPELWERKRYSKKAD 253

Query: 638 VYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTI 697
           ++S GV+  E+L                         L++    P  ++I+Q ++     
Sbjct: 254 MWSLGVILYELL------------------------TLHRPFKGPSQREIMQQVLYGKYD 289

Query: 698 AFAC-------------LSSQPKSRPTMQRISQ-ELL 720
            F C             LS  P  RPT Q++   E L
Sbjct: 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL 326

Length = 478

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 49/199 (24%), Positives = 81/199 (40%), Gaps = 8/199 (4%)

Query: 458 IGTGGYGSVYKAELPEG-KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G Y  V    L +  ++ A+K +      D   +   Q E HV         +    
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 517 FCLHKKC-MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
            C      +FL+ EY+  G L   +    +  E +   R      +  AL++LH      
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEH--ARF-YAAEICIALNFLHER---G 116

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK 635
           II+RD+  +N+LLD++    + D+G  +         +   GT  YIAPE+         
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176

Query: 636 CDVYSFGVVALEVLMGTHP 654
            D ++ GV+  E++ G  P
Sbjct: 177 VDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 38/229 (16%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKV-VALKK-----LHHSETEDSAFVKSFQNEAHVL 503
           EDF     I  G YG+VY     E +   A+KK     L         FV     E  +L
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-----ERDIL 55

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           +   +  +V ++     K+ + ++ EY+E G    +L +   A+ ++   R+   ++V  
Sbjct: 56  TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVD-MARMYFAETVL- 112

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG---------TARLL--HVDSSYR 612
           AL YLH      I+HRD+  +N+L+ S     + DFG         T  L   H++   R
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 613 TLR----AGTYGYIAPELAYTIVVTG---KCDVYSFGVVALEVLMGTHP 654
                   GT  YIAPE+   I+  G     D ++ G++  E L+G  P
Sbjct: 170 EFLDKQVCGTPEYIAPEV---ILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 19/204 (9%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL-Y 515
           +G G +G V    E   GK  A+K L          V     E+ VL   RH  +  L Y
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
            F  H +  F++ EY   G LF   H   E +      R    + V+ AL YLH   +  
Sbjct: 63  SFQTHDRLCFVM-EYANGGELF--FHLSRERVFSEDRARFYGAEIVS-ALGYLH---SCD 115

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA----YTIV 631
           +++RD+   N++LD +    + DFG  +    D +      GT  Y+APE+     Y   
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY--- 172

Query: 632 VTGKC-DVYSFGVVALEVLMGTHP 654
             G+  D +  GVV  E++ G  P
Sbjct: 173 --GRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 8/112 (7%)

Query: 477 VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL 536
           V LK L  S  + S    +F   A ++  V H++IV LYG C+      ++ E++E G L
Sbjct: 35  VILKVLDPSHRDISL---AFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL 91

Query: 537 FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL 588
              +H   + +   W  +  + K +A ALSYL       ++H ++ + NILL
Sbjct: 92  DLFMHRKSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILL 138

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 10/200 (5%)

Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG+G V   ++   GK+ A KKL     +         NE  +L  V  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 517 FCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWTKRVNIVKS-VAHALSYLHHDCTL 574
               K  + L+   M  G L F + +  +   +    +R     + +   L  LH +   
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAAEITCGLEDLHRE--- 121

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            I++RD+   NILLD      ++D G A  +    + R  R GT GY+APE+      T 
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG-RVGTVGYMAPEVVKNERYTF 180

Query: 635 KCDVYSFGVVALEVLMGTHP 654
             D +  G +  E++ G  P
Sbjct: 181 SPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 5/95 (5%)

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRTLRAGTY 619
           +A  L +LH   +  II+RD+  +N++LD+     +ADFG  +  +    + RT   GT 
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF-CGTP 165

Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            YIAPE+          D ++FGV+  E+L G  P
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 29/210 (13%)

Query: 458 IGTGGYGSVY---KAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           IG GG+G VY   KA+   GK+ A+K L      D   +K  Q E   L+     ++V  
Sbjct: 2   IGRGGFGEVYGCRKAD--TGKMYAMKCL------DKKRIKMKQGETLALNERIMLSLVST 53

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY------- 567
            G C    CM   +   ++      + D     +L++    + V S A    Y       
Sbjct: 54  -GDCPFIVCMSYAFHTPDK---LSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYGYIAPE 625
           L H     +++RD+   NILLD +    ++D G A     D S +   A  GT+GY+APE
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPE 165

Query: 626 -LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            L   +      D +S G +  ++L G  P
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 25/166 (15%)

Query: 496 FQNEAHVLSTVRHRNIVKL--------YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAI 547
            +NE   L  + H NI+K+          + + +K  F +Y +M   +      D  +  
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-----DWKDRP 264

Query: 548 ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
            L  T+   I+K +  A+ Y+H      +IHRDI   NI L+ + +  + DFGTA     
Sbjct: 265 LLKQTRA--IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319

Query: 608 DSSYRTLR-AGTYGYIAPELAYTIVVTGKC---DVYSFGVVALEVL 649
           +         GT    +PE+   +   G C   D++S G++ L++L
Sbjct: 320 EREAFDYGWVGTVATNSPEI---LAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 15/197 (7%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G +G V  A +   G+ VA+KK+           K    E  +L  +RH NI+ L  
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKHLRHENIISLSD 76

Query: 517 -FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
            F    + ++ + E +        LH    +  L        +  +   L Y+H   +  
Sbjct: 77  IFISPLEDIYFVTELLGTD-----LHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAG 128

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG- 634
           ++HRD+  +NIL++ N +  + DFG AR   +     T    T  Y APE+  T      
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYVSTRYYRAPEIMLTWQKYDV 185

Query: 635 KCDVYSFGVVALEVLMG 651
           + D++S G +  E+L G
Sbjct: 186 EVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 22/206 (10%)

Query: 458 IGTGGYGSVYKAELPEG-KVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLY 515
           IG G Y  V   EL +  ++ A+K +      D   +   Q E HV  T   H  +V L+
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN---WTKRVNIVKSVAHALSYLHHDC 572
                +  +F + E++  G L   +    +  E +   ++  +++      AL++LH   
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNFLHER- 115

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL----AY 628
              II+RD+  +N+LLD+     + D+G  +         +   GT  YIAPE+     Y
Sbjct: 116 --GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
              V    D ++ GV+  E++ G  P
Sbjct: 174 GFSV----DWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 64/253 (25%), Positives = 113/253 (44%), Gaps = 37/253 (14%)

Query: 477 VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL 536
           V LK L     +  AF ++    A ++S + H+++VKLYG C+  + + ++ EY++ G L
Sbjct: 33  VVLKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL 87

Query: 537 FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL-------D 589
              LH +   + L+W  ++++ K +A AL YL       ++H ++   NIL+        
Sbjct: 88  DVFLHREKNNVSLHW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEG 142

Query: 590 SNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV--TGKCDVYSFGVVALE 647
                 ++D G    + +    R  R     +IAPE         T   D +SFG   LE
Sbjct: 143 YVPFIKLSDPGIPITV-LSREERVERI---PWIAPECIRNGQASLTIAADKWSFGTTLLE 198

Query: 648 VLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQP 706
           +   G  P   LS+LSSS            +R     ++  + D   ++ +   C +  P
Sbjct: 199 ICSNGEEP---LSTLSSSE----------KERFYQDQHRLPMPDCAELANLINQCWTYDP 245

Query: 707 KSRPTMQRISQEL 719
             RP+ + I ++L
Sbjct: 246 TKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.5 bits (123), Expect = 5e-07
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)

Query: 458 IGTGGYGSVYKAELPEG---KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           IG G +G V   E+  G     V +K+L  S +        F  EA    +++H N+++ 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQ--MKFLEEAQPYRSLQHSNLLQC 60

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV--NIVKSVAHALSYLHHDC 572
            G C       L+ E+   G L   L    +A  +         +   +A  L +LH + 
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119

Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT-------LRAGTYGYIAPE 625
             + IH D++  N LL ++L   + D+G +   + +  Y T       LR     +IAPE
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR-----WIAPE 172

Query: 626 L-----AYTIVV--TGKCDVYSFGVVALEVL-MGTHP 654
           L        +VV  T + +V+S GV   E+  +G+ P
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 61/250 (24%), Positives = 108/250 (43%), Gaps = 30/250 (12%)

Query: 477 VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL 536
           V LK L  S   D A   +F   A ++S V H ++  ++G C+      ++ E++E G L
Sbjct: 47  VVLKVLDPSH-RDIAL--AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103

Query: 537 FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL-DSNLEAS 595
              L  +   + + W  ++ + + +A ALSYL      +++H ++ + NILL    L   
Sbjct: 104 DVCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158

Query: 596 VADFGTARLLHVDSSYRTL----RAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVLM 650
            + F   +L     S+  L    R     +IAPE       ++   D +SFG   LE+  
Sbjct: 159 TSPF--IKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF 216

Query: 651 -GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSR 709
            G  P      L   +  +         RL  P  +++       +T+   CL+ +P  R
Sbjct: 217 DGEVP------LKERTPSEKERFYEKKHRLPEPSCKEL-------ATLISQCLTYEPTQR 263

Query: 710 PTMQRISQEL 719
           P+ + I ++L
Sbjct: 264 PSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 22/157 (14%)

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFC----VLHDDDEAIELNWTKRVNIVKSVAHAL 565
           N+V L+ + + +  +FL+ ++ E G L+      L+  +E ++  W   + +      AL
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-RWAAEMVV------AL 98

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
             LH +    I+ RD++ NNILLD      +  F   R   V+ S     A    Y APE
Sbjct: 99  DALHRE---GIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDG-EAVENMYCAPE 152

Query: 626 LAYTIVVTGKCDVYSFGVVALEVLMGT-----HPGGL 657
           +      T  CD +S G +  E+L G      HP G+
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI 189

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.0 bits (124), Expect = 6e-07
 Identities = 59/214 (27%), Positives = 88/214 (41%), Gaps = 44/214 (20%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 83

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                +         E   ++ V H      +LN     NIVK               + 
Sbjct: 84  VFTPAR------SLEEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 130

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 184

Query: 623 APELA-----YTIVVTGKCDVYSFGVVALEVLMG 651
           APE+      Y   V    D++S G +  E+L G
Sbjct: 185 APEIMLNWMHYNQTV----DIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 8/206 (3%)

Query: 451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF+    +G G +G V  AE     ++ A+K L          V+    E  VL+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 510 NIVKLYGFCLHK-KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             +     C      ++ + EY+  G L   ++   +         V     +A  L +L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  II+RD+  +N++LDS     +ADFG  +    D        GT  YIAPE+  
Sbjct: 118 H---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA 174

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D ++FGV+  E+L G  P
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 51.6 bits (123), Expect = 8e-07
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 40/210 (19%)

Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKC 72

Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLY 126

Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 127 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 182

Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.6 bits (123), Expect = 9e-07
 Identities = 47/172 (27%), Positives = 86/172 (50%), Gaps = 23/172 (13%)

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY- 619
           VA  + +L    + + +HRD+++ N+LL       + DFG AR +  DS+Y + +  T+ 
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS-KGSTFL 301

Query: 620 --GYIAPELAYTIVVTGKCDVYSFGVVALEV--LMGT-HPGGLLSSLSSSSGPKIMLIDV 674
              ++APE  +  + T   DV+S+G++  E+  L GT +PG +   + S+   KI     
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI---VDSTFYNKIK---- 354

Query: 675 LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPM 726
              R++ P      Q+   V  I   C +S+P+ RP+   +S +++    P 
Sbjct: 355 SGYRMAKP--DHATQE---VYDIMVKCWNSEPEKRPSFLHLS-DIVESLLPS 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.6 bits (109), Expect = 1e-06
 Identities = 22/79 (27%), Positives = 32/79 (40%), Gaps = 19/79 (24%)

Query: 174 SLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIP 233
           +L  L ++NN L  +       L N                   L  LDLS N +  I P
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPN-------------------LKVLDLSGNNLTSISP 41

Query: 234 DELTKLSQLKNLNLSSNLL 252
           +  + L  L++L+LS N L
Sbjct: 42  EAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 56/257 (21%), Positives = 101/257 (39%), Gaps = 25/257 (9%)

Query: 465 SVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF----CLH 520
           S+YK      K V ++            +   +NE   L  +   NI+K+YGF       
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 521 KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRD 580
              + LI EY  RG L  VL   D+  +L++  ++++       L  L+     +  +++
Sbjct: 94  LPRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKN 148

Query: 581 ISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIV--VTGKCDV 638
           ++S + L+  N +  +   G  ++L               Y + ++   I    T K D+
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNV---NFMVYFSYKMLNDIFSEYTIKDDI 205

Query: 639 YSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIA 698
           YS GVV  E+  G  P   L++         ++I+  N    P      ++ I+      
Sbjct: 206 YSLGVVLWEIFTGKIPFENLTTKEIYD----LIINKNNSLKLPLDCPLEIKCIVE----- 256

Query: 699 FACLSSQPKSRPTMQRI 715
            AC S     RP ++ I
Sbjct: 257 -ACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.2 bits (108), Expect = 2e-06
 Identities = 23/60 (38%), Positives = 33/60 (55%)

Query: 241 QLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSL 300
            LK+L+LS+N L+     A   L NL  LDLS N L+   P       +L++L L+ N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 42/214 (19%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLSTVR 507
           IG+G  G V  A +   G+ VA+KKL           + FQN  H         ++  V 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLS----------RPFQNVTHAKRAYRELVLMKLVN 73

Query: 508 HRNIVKLYG-FCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           H+NI+ L   F   K       ++L+ E M+  +L  V+      ++L+  +   ++  +
Sbjct: 74  HKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ-----MDLDHERMSYLLYQM 127

Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD---SSYRTLRAGT 618
              + +LH   +  IIHRD+  +NI++ S+    + DFG AR        + Y   R   
Sbjct: 128 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR--- 181

Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGT 652
           Y Y APE+   +      D++S G +  E++ GT
Sbjct: 182 Y-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 28/149 (18%), Positives = 54/149 (36%), Gaps = 18/149 (12%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV--KLY 515
           +  G    VY     +   V LK     E          + E  +L  +  + +   K+ 
Sbjct: 6   LKGGLTNRVYLLGTKDEDYV-LKINPSREKG-----ADREREVAILQLLARKGLPVPKVL 59

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
                    +L+ E++E           +   E++  ++ +I + +A  L+ LH    L 
Sbjct: 60  ASGESDGWSYLLMEWIE----------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLV 109

Query: 576 IIHRDISSNNILLDSNLEASVADFGTARL 604
           + H D+   NIL+D      + D+  A  
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 25/208 (12%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG GG+G VY     + GK+ A+K L      D   +K  Q E   L+     ++V   G
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCL------DKKRIKMKQGETLALNERIMLSLVST-G 54

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY-------LH 569
            C    CM   +   ++    C + D     +L++    + V S      Y       L 
Sbjct: 55  DCPFIVCMTYAFHTPDK---LCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE 111

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYGYIAPE-L 626
           H     +++RD+   NILLD +    ++D G A     D S +   A  GT+GY+APE L
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVL 167

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                     D +S G +  ++L G  P
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 49/228 (21%)

Query: 452 FHIKYC-IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           F  + C +G G YG VYKA+  +GK    K+    + E +    S   E  +L  ++H N
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPN 59

Query: 511 IVKLYG-FCLHK-KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN---------IVK 559
           ++ L   F  H  + ++L+++Y E        HD    I+ +   + N         +VK
Sbjct: 60  VIALQKVFLSHSDRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPMQLPRSMVK 111

Query: 560 SVAH----ALSYLHHDCTLSIIHRDISSNNILL----DSNLEASVADFGTARLLHVDSSY 611
           S+ +     + YLH +    ++HRD+   NIL+           +AD G ARL   +S  
Sbjct: 112 SLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPL 166

Query: 612 RTLR-----AGTYGYIAPELA-----YTIVVTGKCDVYSFGVVALEVL 649
           + L        T+ Y APEL      YT  +    D+++ G +  E+L
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 40/212 (18%)

Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 79

Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLY 133

Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 189

Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            Y APE+   +      D++S G +  E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 55/231 (23%)

Query: 452 FHIKYC-IGTGGYGSVYKAELPEG---KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           F  + C +G G YG VYKA+  +G   +  ALK++     E +    S   E  +L  ++
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELK 56

Query: 508 HRNIVKLYG-FCLH-KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN--------- 556
           H N++ L   F  H  + ++L+++Y E        HD    I+ +   + N         
Sbjct: 57  HPNVISLQKVFLSHADRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPVQLPRG 108

Query: 557 IVKSVAH----ALSYLHHDCTLSIIHRDISSNNILL----DSNLEASVADFGTARLLHVD 608
           +VKS+ +     + YLH +    ++HRD+   NIL+           +AD G ARL   +
Sbjct: 109 MVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF--N 163

Query: 609 SSYRTLR-----AGTYGYIAPELA-----YTIVVTGKCDVYSFGVVALEVL 649
           S  + L        T+ Y APEL      YT  +    D+++ G +  E+L
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 50.1 bits (119), Expect = 3e-06
 Identities = 66/244 (27%), Positives = 101/244 (41%), Gaps = 53/244 (21%)

Query: 141 IPKEIGSLRNLRGLFLYSNKLSGVLPQEI-GNLKSLTELYVTNNALGGLIPSTLFRLTNI 199
           IP++I +L       L +N+L   LP+ + GN+K    LY  +N L   IP+TL      
Sbjct: 197 IPEQITTL------ILDNNELKS-LPENLQGNIK---TLYANSNQLTS-IPATLPDTIQE 245

Query: 200 SSNQFHSSIPLEIGNFSALDTLDLSDNKIHGI---IPDELTKLSQLKNLNLSSNLLSGQI 256
                +    L     SAL +LDL  NKI  +   +P+EL  LS   N ++ +  L   +
Sbjct: 246 MELSINRITELPERLPSALQSLDLFHNKISCLPENLPEELRYLSVYDN-SIRT--LPAHL 302

Query: 257 PYAIGKLF---------------NLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNS-- 299
           P  I  L                 L  L+  +N L+ S+P  +     L+ L ++ N   
Sbjct: 303 PSGITHLNVQSNSLTALPETLPPGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT 359

Query: 300 -LDGTIPLEMGKILLLQNLDLSHN---NLSGTIPKTLRPMYVDLSFNN---LEGEIPTYL 352
            L  T+P        +  LD+S N   NL   +P  L+   +  S NN   L   +P + 
Sbjct: 360 VLPETLPPT------ITTLDVSRNALTNLPENLPAALQ--IMQASRNNLVRLPESLPHFR 411

Query: 353 RGNP 356
              P
Sbjct: 412 GEGP 415

Length = 754

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.5 bits (106), Expect = 4e-06
 Identities = 22/60 (36%), Positives = 28/60 (46%)

Query: 126 KLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNAL 185
            LK L L  N LT I       L NL+ L L  N L+ + P+    L SL  L ++ N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 50.1 bits (119), Expect = 4e-06
 Identities = 70/309 (22%), Positives = 129/309 (41%), Gaps = 64/309 (20%)

Query: 442 YEDLINATEDFHIKYCIGTGGYGSVY------KAELPEGKVVALKKLHHSETEDSAFVKS 495
           Y+D  +   ++ +   IG G +G V+        E    K ++ + L   E E S  V  
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVI- 61

Query: 496 FQNEAHVLSTVRHRNIVKLYGFCLHK--KCMFLIYEYMERGSLFCVLHD--------DDE 545
              E +V+  ++H+NIV+     L+K  + ++++ E+ + G L   +          ++ 
Sbjct: 62  ---EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118

Query: 546 AIELNWTKRVNIVKSVAHALSYLHH----DCTLSIIHRDISSNNILLDSNLE-------- 593
           AI       V+I + + HAL+Y H+         ++HRD+   NI L + +         
Sbjct: 119 AI-------VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171

Query: 594 ---------ASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY--TIVVTGKCDVYSFG 642
                    A + DFG ++ + ++S   +   GT  Y +PEL    T     K D+++ G
Sbjct: 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSC-VGTPYYWSPELLLHETKSYDDKSDMWALG 230

Query: 643 VVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACL 702
            +  E+  G  P    ++ S        LI  L +    P+  K  +  IL+  +    L
Sbjct: 231 CIIYELCSGKTPFHKANNFSQ-------LISELKRGPDLPIKGKSKELNILIKNL----L 279

Query: 703 SSQPKSRPT 711
           +   K RP+
Sbjct: 280 NLSAKERPS 288

Length = 1021

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.9 bits (116), Expect = 5e-06
 Identities = 57/248 (22%), Positives = 94/248 (37%), Gaps = 60/248 (24%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G +G V  A ++    + A+K L   +  +   V   + E  +L+   +  +VKLY 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDD---EAIELNWTKRVNIVKSVAHALSYLHHDCT 573
               K  ++ + +Y+  G +  +L   +   E +   +   + +     H + +      
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF------ 122

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTA---RLLHVDSSY------------------- 611
              IHRDI  +NIL+D +    + DFG     R  H    Y                   
Sbjct: 123 ---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179

Query: 612 ----------RTL--RA-------------GTYGYIAPELAYTIVVTGKCDVYSFGVVAL 646
                     +TL  RA             GT  YIAPE+      T  CD +S GV+  
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239

Query: 647 EVLMGTHP 654
           E+L+G  P
Sbjct: 240 EMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.3 bits (103), Expect = 8e-06
 Identities = 25/59 (42%), Positives = 32/59 (54%)

Query: 218 LDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKL 276
           L +LDLS+N++  I       L  LK L+LS N L+   P A   L +L  LDLS N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 59/255 (23%), Positives = 94/255 (36%), Gaps = 74/255 (29%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G +G V  A ++    + A+K L   +      V   + E  +L+   +  +V+LY 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIV-KSVAH--------ALSY 567
               K  ++ + +Y+  G +  +L             R+ I  + +A         A+  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLL------------IRMGIFPEDLARFYIAELTCAVES 116

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA---RLLHVDSSY------------- 611
           +H    +  IHRDI  +NIL+D +    + DFG     R  H DS Y             
Sbjct: 117 VH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH-DSKYYQSGDHVRQDSMD 172

Query: 612 ----------------------RTLR----------AGTYGYIAPELAYTIVVTGKCDVY 639
                                 R  R           GT  YIAPE+      T  CD +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232

Query: 640 SFGVVALEVLMGTHP 654
           S GV+  E+L+G  P
Sbjct: 233 SVGVILYEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 61/234 (26%)

Query: 452 FHIKYCIGTGGYG---SVYKAELPEGKVVALKKLHHSETEDSAFVKSFQ-----NEAHVL 503
           + +   +G G YG   S   AE  E + VA+KK+       + F K         E  +L
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKI------TNVFSKKILAKRALRELKLL 55

Query: 504 STVR-HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV- 561
              R H+NI  LY        M +++       L+      +E +E +  +   I++S  
Sbjct: 56  RHFRGHKNITCLYD-------MDIVFPGNFNE-LYLY----EELMEADLHQ---IIRSGQ 100

Query: 562 ----AH----------ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
               AH           L Y+H   + +++HRD+   N+L++++ E  + DFG AR    
Sbjct: 101 PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157

Query: 608 D----SSYRTLRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMGT 652
           +    + + T    T  Y APE+     +YT  +    DV+S G +  E+L   
Sbjct: 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAI----DVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 45.0 bits (107), Expect = 7e-05
 Identities = 66/293 (22%), Positives = 99/293 (33%), Gaps = 74/293 (25%)

Query: 101 PNLKSLDLWNNSLSGS----IPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
             L+ L L  N+L       +   +     LK L L  N    I           RGL  
Sbjct: 23  LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRI----------PRGL-- 70

Query: 157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQF----HSSIPLEI 212
                   L Q +     L EL +++NALG      L  L   SS Q     ++ +    
Sbjct: 71  ------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRG 124

Query: 213 GNFSA---------LDTLDLSDNKIHGI----IPDELTKLSQLKNLNLSSNLLSGQIPYA 259
               A         L+ L L  N++ G     +   L     LK LNL++N +       
Sbjct: 125 LRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA---G 181

Query: 260 IGKLF-------NLMYLDLSKN--------KLSGSIPTEIGNCSALKNLTLNHNSLDGTI 304
           I  L        NL  LDL+ N         L+ ++ +      +L+ L L  N+L    
Sbjct: 182 IRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK----SLEVLNLGDNNLTDAG 237

Query: 305 PLEMGKILL-----LQNLDLSHNN--------LSGTIPKTLRPMYVDLSFNNL 344
              +   LL     L  L LS N+        L+  + +    + +DL  N  
Sbjct: 238 AAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 45.2 bits (107), Expect = 9e-05
 Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 45/223 (20%)

Query: 456 YCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
             +G G  G V+ A   +  K VA+KK+  +   D   VK    E  ++  + H NIVK+
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKV 67

Query: 515 Y--------------GFCLHKKCMFLIYEYMERGSLFCVLHDD---DEAIELNWTKRVNI 557
           Y              G       ++++ EYME   L  VL      +E   L        
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARL-------F 119

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-NLEASVADFGTARLLHVDSS---YRT 613
           +  +   L Y+H   + +++HRD+   N+ +++ +L   + DFG AR++    S   Y +
Sbjct: 120 MYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 614 LRAGTYGYIAPELA-----YTIVVTGKCDVYSFGVVALEVLMG 651
               T  Y +P L      YT  +    D+++ G +  E+L G
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 32/115 (27%), Positives = 62/115 (53%), Gaps = 8/115 (6%)

Query: 544 DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR 603
           +E+  L++   V     VA+ + +L    + + +HRD+++ N+L+       + DFG AR
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287

Query: 604 LLHVDSSYRTLRAGTY---GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            +  DS+Y + +  T+    ++APE  +  + T   DV+SFG++  E+  +G  P
Sbjct: 288 DIMRDSNYIS-KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 39.8 bits (94), Expect = 1e-04
 Identities = 16/40 (40%), Positives = 26/40 (65%), Gaps = 2/40 (5%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGI 140
            NL++LDL NN ++  +PP + +L  L+ L L GN +T +
Sbjct: 1   TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKITDL 38

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 48/240 (20%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL-- 514
           IG G +G VY+A  +   + VA+KK+     +D  +      E  ++  + H NI+ L  
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYK---NRELLIMKNLNHINIIFLKD 126

Query: 515 --YGFCLHK--KCMFL----------IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
             Y  C  K  K +FL          +++YM+  +       ++ A+ L   K  +    
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA------RNNHALPLFLVKLYSY--Q 178

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLL---HVDSSYRTLRA 616
           +  AL+Y+H   +  I HRD+   N+L+D N     + DFG+A+ L       SY   R 
Sbjct: 179 LCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235

Query: 617 GTYGYIAPELAY-TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVL 675
               Y APEL       T   D++S G +  E+++G +P   + S  SS    + +I VL
Sbjct: 236 ----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YP---IFSGQSSVDQLVRIIQVL 287

Length = 440

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 3e-04
 Identities = 38/113 (33%), Positives = 54/113 (47%), Gaps = 22/113 (19%)

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR----AGTY 619
           A+ Y+H +    IIHRDI + N+L++   +  + DFG A       S+ T      AGT 
Sbjct: 272 AIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA--CFARGSWSTPFHYGIAGTV 326

Query: 620 GYIAPE-LA---YTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPK 668
              APE LA   YT  V    D++S G+V  E  + T      S  S+S G +
Sbjct: 327 DTNAPEVLAGDPYTPSV----DIWSAGLVIFEAAVHT-----ASLFSASRGDE 370

Length = 461

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.7 bits (91), Expect = 4e-04
 Identities = 25/61 (40%), Positives = 32/61 (52%), Gaps = 2/61 (3%)

Query: 265 NLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNN 323
           NL  LDLS N+L+  IP         LK L L+ N+L    P     +  L++LDLS NN
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 324 L 324
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 37/154 (24%), Positives = 72/154 (46%), Gaps = 23/154 (14%)

Query: 458 IGTGGYGSVYKAELPEGKVVA---LKKLHHSET--EDSAFVKSFQNEAHVLSTVRHRNIV 512
           IG G +G V  +E+     VA   +K+L  + +  E + F++  Q + + +  ++H NI+
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQ--QGDPYRI--LQHPNIL 58

Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHD------DDEAIELNWTKRVNIVKSVAHALS 566
           +  G C+      L++EY E G L   L        + + + L       +   +A  ++
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVT 113

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFG 600
           ++H     + +H D++  N  L S+L   V D+G
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYG 144

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 42.3 bits (100), Expect = 5e-04
 Identities = 54/261 (20%), Positives = 92/261 (35%), Gaps = 52/261 (19%)

Query: 55  DRIPHNSSD-HCNWVGITCDYE-GRITDIDLLNSNIKGELGRL--NFSCFPNLKSLDLWN 110
             +    S             E GRI             L  L    +    L+ LDL +
Sbjct: 45  SALRPQPSLKELCL----SLNETGRIPRG----------LQSLLQGLTKGCGLQELDLSD 90

Query: 111 NSLSGSIPPQIGSLSK---LKCLYLHGNNL-TGIIPKEIGSLR----NLRGLFLYSNKLS 162
           N+L       + SL +   L+ L L+ N L    +      L+     L  L L  N+L 
Sbjct: 91  NALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLE 150

Query: 163 GVLPQEIGNL----KSLTELYVTNNALG---------GLIPSTLFRLTNISSNQFHS--S 207
           G   + +       + L EL + NN +G         GL  +    + ++++N      +
Sbjct: 151 GASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA 210

Query: 208 IPLEIG--NFSALDTLDLSDNKIHGIIPDEL-----TKLSQLKNLNLSSNLL----SGQI 256
             L     +  +L+ L+L DN +       L     +    L  L+LS N +    +  +
Sbjct: 211 SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDL 270

Query: 257 PYAIGKLFNLMYLDLSKNKLS 277
              + +  +L+ LDL  NK  
Sbjct: 271 AEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 24/204 (11%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +    + VA+KKL     +     +    E  +L  ++H N++ L  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 517 FCLHKKCM------FLIYEYM--ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
                  +      +L+   M  +  ++       DE ++        ++  +   L Y+
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLKYI 134

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  IIHRD+  +N+ ++ + E  + DFG AR    D    T    T  Y APE+  
Sbjct: 135 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEM-TGYVATRWYRAPEIML 188

Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
             +      D++S G +  E+L G
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 42.2 bits (99), Expect = 7e-04
 Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 20/195 (10%)

Query: 472 PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYM 531
           P G+ V +++++  E   +  V   Q E HV     H NIV      +    ++++  +M
Sbjct: 23  PTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81

Query: 532 ERGS---LFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL 588
             GS   L C  H  D   EL       I++ V  AL Y+HH   +  +HR + +++IL+
Sbjct: 82  AYGSAKDLICT-HFMDGMSELAIAY---ILQGVLKALDYIHH---MGYVHRSVKASHILI 134

Query: 589 D-------SNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIV--VTGKCDVY 639
                   S L ++++     + L V   +         +++PE+    +     K D+Y
Sbjct: 135 SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 194

Query: 640 SFGVVALEVLMGTHP 654
           S G+ A E+  G  P
Sbjct: 195 SVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.5 bits (92), Expect = 0.004
 Identities = 54/228 (23%), Positives = 85/228 (37%), Gaps = 52/228 (22%)

Query: 454 IKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST-------- 505
           I   IG GG+G VY+              H    +  A +++ +NE  V+ T        
Sbjct: 16  IDKLIGCGGFGCVYE--------TQCASDHCINNQAVAKIENLENETIVMETLVYNNIYD 67

Query: 506 ------------VRHRNIVKLYGFCLHKKCM----FLIYE--YMERGSLFC-VLHDDDEA 546
                       + H  I K YG    K+C     F++ E        +F  +   + + 
Sbjct: 68  IDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL 127

Query: 547 IELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL- 605
           I+       NI+K +   L Y+H      I H DI   NI++D N    + D+G A    
Sbjct: 128 IK-------NIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177

Query: 606 ----HVDSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALE 647
               H++ S   + L  GT  Y   +      VT + D+ S G   L+
Sbjct: 178 IHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	740
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.98
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.95
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.85
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.78
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.77
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.77
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.76
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.75
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.73
PRK10345	210	hypothetical protein; Provisional	99.73
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.73
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.72
smart00090	237	RIO RIO-like kinase.	99.72
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.72
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.72
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.55
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.53
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.52
PLN03150	623	hypothetical protein; Provisional	99.49
PLN03150	623	hypothetical protein; Provisional	99.47
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.45
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.4
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.4
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.33
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.28
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.26
KOG1243	690	consensus Protein kinase [General function predict	99.26
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.24
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.24
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.24
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.23
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.2
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.19
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.17
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.15
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.13
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.09
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.09
KOG3087	229	consensus Serine/threonine protein kinase [General	99.08
COG4248	637	Uncharacterized protein with protein kinase and he	99.08
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.08
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.07
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.03
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.96
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.89
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.89
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.82
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.81
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.8
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.75
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.71
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.67
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.62
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.58
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.56
PRK09902	216	hypothetical protein; Provisional	98.51
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.49
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.48
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.47

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.1e-77  Score=724.32  Aligned_cols=430  Identities=29%  Similarity=0.485  Sum_probs=277.2

Q ss_pred             cCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhcccccccceEEecCCcccCCCCCCCccc----cccCCCCCCCC
Q 004642          271 LSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEG  346 (740)
Q Consensus       271 l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~----~l~ls~N~l~~  346 (740)
                      |++|++++.+|..+.++++|+.|+|++|.++|.+|..+..+++|+.|+|++|+++|.+|..+..+    .+++++|++.|
T Consensus       506 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  585 (968)
T PLN00113        506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG  585 (968)
T ss_pred             CcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence            33333333344444444555555555555555555555555556666666666665555554332    36667777777


Q ss_pred             CcCc--cccCCCCCcccCCccCCCCCC--CCCCcccccCCCCcccceeeeehhhHHHHHHHHHHHHHHHHhhccCCcccc
Q 004642          347 EIPT--YLRGNPPKSFVGNKGLSGNVE--GFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNS  422 (740)
Q Consensus       347 ~~p~--~~~~~~~~~~~~n~~~~~~~~--~~~~~s~~~~~~~~~~~~~~i~~~~~~~l~~~i~~~~~~~~~~~~~~~~~~  422 (740)
                      .+|.  .+......++.+|+.+||...  +.++|..... .. .+ .++++.+++++++++++++++++++++++.+...
T Consensus       586 ~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~-~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  662 (968)
T PLN00113        586 SLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK-TP-SW-WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKR  662 (968)
T ss_pred             eCCCcchhcccChhhhcCCccccCCccccCCCCCccccc-cc-ee-eeehhHHHHHHHHHHHHHHHHHHHHhhhcccccc
Confidence            6665  244555667889999998643  3455533211 11 11 2222222332222222222223322222111111


Q ss_pred             ccccCCCce-eeec--CCCcccHHHHHHHhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHH
Q 004642          423 RAAKNGDVF-SVWN--YDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQN  498 (740)
Q Consensus       423 ~~~~~~~~~-~~~~--~~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~  498 (740)
                      .....+... ..+.  ....+.+++   ....|...+.||+|+||.||+|.. .+|+.||||++......       ..+
T Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~  732 (968)
T PLN00113        663 VENEDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSS  732 (968)
T ss_pred             cccccccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHH
Confidence            000111100 0000  011223333   345677888999999999999975 57899999998754322       124


Q ss_pred             HHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 004642          499 EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIH  578 (740)
Q Consensus       499 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  578 (740)
                      |++.+++++|||||+++|+|.+++..++||||+++|+|.++++      .++|.++.+++.|||+||+|||..+.++|+|
T Consensus       733 ~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  806 (968)
T PLN00113        733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVV  806 (968)
T ss_pred             HHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence            6888999999999999999999999999999999999999995      3789999999999999999999766669999


Q ss_pred             cCCCCCceEEcCCCcEEEeecccceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcc
Q 004642          579 RDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLL  658 (740)
Q Consensus       579 ~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~  658 (740)
                      |||||+||+++.++.+++. ||.+.....+    ....||+.|+|||++.+..++.++|||||||++|||+||+.||+..
T Consensus       807 ~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~  881 (968)
T PLN00113        807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE  881 (968)
T ss_pred             CCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence            9999999999999888875 6655433211    2236789999999999999999999999999999999999998542


Q ss_pred             ccccc-------CCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCC
Q 004642          659 SSLSS-------SSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP  725 (740)
Q Consensus       659 ~~~~~-------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  725 (740)
                      .....       ..........++++.+..... ...++..++.+++.+||+.||++||+|+|++++|+.....
T Consensus       882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        882 FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS-VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             cCCCCcHHHHHHHhcCccchhheeCccccCCCC-ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            21100       000111122333443322211 1224455688999999999999999999999999877543

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-50  Score=423.35  Aligned_cols=281  Identities=40%  Similarity=0.642  Sum_probs=237.5

Q ss_pred             CCcccHHHHHHHhcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeee
Q 004642          437 DGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG  516 (740)
Q Consensus       437 ~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  516 (740)
                      ...|+++++..+|++|.-.+.||+|+||.||+|..++|+.||||++.......   .++|.+|++++.+++|||+|+++|
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlG  138 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLG  138 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEE
Confidence            45689999999999999999999999999999999999999999887755432   256999999999999999999999


Q ss_pred             eeeecC-eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEE
Q 004642          517 FCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS  595 (740)
Q Consensus       517 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  595 (740)
                      ||.+.+ +.++|||||++|+|.++++..... .++|.+|++||.++|+||+|||+.+.+.|+||||||+|||+|+++++|
T Consensus       139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            999998 599999999999999999987655 789999999999999999999999888999999999999999999999


Q ss_pred             Eeecccceeccc-CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccc-----c---cCCC
Q 004642          596 VADFGTARLLHV-DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSL-----S---SSSG  666 (740)
Q Consensus       596 l~DfG~a~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-----~---~~~~  666 (740)
                      |+|||+|+.... .........||.+|+|||++..+..+.|+|||||||+++|++||+.|.+.....     .   ....
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            999999976543 222221117999999999999999999999999999999999999887643210     0   0111


Q ss_pred             CCchhhhhhcccCCC-cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          667 PKIMLIDVLNQRLSP-PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       667 ~~~~~~~~~~~~l~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      .+..+.+++|+.+.. ....  .++..++..++.+|++.+|++||+|.||+++|....
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~--~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPD--EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HCcchhheeCCCccCCCCCh--HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            223567888888763 2221  145666899999999999999999999999995543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-46  Score=393.03  Aligned_cols=256  Identities=35%  Similarity=0.553  Sum_probs=215.0

Q ss_pred             cccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC-eEEEEEEe
Q 004642          452 FHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK-CMFLIYEY  530 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  530 (740)
                      ..+.+.||+|+||+||+|.+.....||||++......... .++|.+|+.++.+++|||||+++|+|.++. ..++||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3344559999999999999965555999999887666555 789999999999999999999999999987 79999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCceEEcCCC-cEEEeecccceecccC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS-IIHRDISSNNILLDSNL-EASVADFGTARLLHVD  608 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~dlkp~NIll~~~~-~~kl~DfG~a~~~~~~  608 (740)
                      +++|+|.++++.. ....+++..+++++.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+++.....
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999885 334799999999999999999999999   7 99999999999999997 9999999999886543


Q ss_pred             CCcccccccCCCcccccccc--ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          609 SSYRTLRAGTYGYIAPELAY--TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      ....+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....       ......+.....++..+..
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~~~~Rp~~p~~  270 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVVGGLRPPIPKE  270 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCCCCCCcc
Confidence            23344468999999999999  56899999999999999999999999876432       2233344444444443332


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                         ....+..++.+||+.||+.||++.|++..|...
T Consensus       271 ---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  271 ---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             ---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence               223378899999999999999999999999854

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=373.66  Aligned_cols=259  Identities=27%  Similarity=0.392  Sum_probs=213.4

Q ss_pred             cccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC-eEEEEEE
Q 004642          452 FHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK-CMFLIYE  529 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  529 (740)
                      .+..+.||+|..|+||++.++ +++.+|+|++...  .++...+++.+|+++++..+||+||.+||.|..++ ...++||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            344677999999999999665 6889999999543  34456789999999999999999999999999998 5999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      ||++|+|++++...+   .+++...-+|+.+|++||.|||+.  .+|+||||||+|||++..|++||+|||.++.+... 
T Consensus       159 YMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            999999999997653   589999999999999999999963  29999999999999999999999999999877533 


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                       .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....  .........+..+++... +..+..  .
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll~~Iv~~pp-P~lP~~--~  306 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELLCAIVDEPP-PRLPEG--E  306 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHHHHHhcCCC-CCCCcc--c
Confidence             5566789999999999999999999999999999999999999976531  111112222334444322 222222  2


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      ...++..|+..|+++||.+||+++|+++|-.-.+.
T Consensus       307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  307 FSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            34459999999999999999999999999876644

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-47  Score=376.89  Aligned_cols=264  Identities=26%  Similarity=0.354  Sum_probs=216.8

Q ss_pred             HhcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchH----HHHHHHHHHHHHhccCCCccceeeeeeeecC
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSA----FVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK  522 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (740)
                      ..+.|.+.+.||+|+||.|-+| ..++|+.||||+++........    ......+|+++|++++|||||++++++..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            3467888999999999999999 5668999999999876544311    2234569999999999999999999999999


Q ss_pred             eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC---CcEEEeec
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN---LEASVADF  599 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Df  599 (740)
                      ..||||||++||+|.+.+-..+   .+.+..-..+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999987655   456666788999999999999999   99999999999999866   78999999


Q ss_pred             ccceecccCCCcccccccCCCccccccccccc--c-CCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhc
Q 004642          600 GTARLLHVDSSYRTLRAGTYGYIAPELAYTIV--V-TGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLN  676 (740)
Q Consensus       600 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  676 (740)
                      |+|+... ........+||+.|.|||++.+..  + ..++|+||+||++|-+++|..||....       .+..+.+.+.
T Consensus       324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~-------~~~sl~eQI~  395 (475)
T KOG0615|consen  324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY-------TDPSLKEQIL  395 (475)
T ss_pred             chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc-------CCccHHHHHh
Confidence            9999876 445566679999999999998654  3 347899999999999999999987532       2332333333


Q ss_pred             ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCC
Q 004642          677 QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP  725 (740)
Q Consensus       677 ~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  725 (740)
                      +.--...+..|.+-..+..++|.+||..||++||++.|+++|-+....|
T Consensus       396 ~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  396 KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            3333333444556666689999999999999999999999999877555

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-45  Score=381.77  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=221.1

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .+|...+.||+|||+.+|+++. ..|+.||+|++.+.........+...+|+++.++++|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999966 789999999999877666667789999999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      |+|++++|..++...+   ++++.++..+++||+.||.|||+.   +|+|||||-.|++++++.++||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999998887433   799999999999999999999999   9999999999999999999999999999999877


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      .......+|||-|.|||++....++..+||||+||++|-|++|++||+...-       .+....+.......+.  .. 
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-------kety~~Ik~~~Y~~P~--~l-  241 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-------KETYNKIKLNEYSMPS--HL-  241 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-------HHHHHHHHhcCccccc--cc-
Confidence            6666677999999999999999999999999999999999999999985321       1112222222222221  11 


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                        ..+..++|.++|+.+|.+|||+++|+.+-.....
T Consensus       242 --s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  242 --SAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             --CHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence              2237799999999999999999999998876433

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-46  Score=353.29  Aligned_cols=260  Identities=25%  Similarity=0.366  Sum_probs=212.8

Q ss_pred             cccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeee-eeeecCe-EEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG-FCLHKKC-MFL  526 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l  526 (740)
                      .+|++.++||.|.||+||++ +..+|..+|.|.+.-. ..+....+....|+.++++++|||||++++ .+.++.. .++
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            46888999999999999999 6779999999999843 344455788899999999999999999998 4545444 899


Q ss_pred             EEEeccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          527 IYEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTL-SIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ||||+++|+|...+...+ +...+++..+++++.|++.||.++|.+++. -|+||||||.||+++.+|.+|++|||++++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999999997654 345689999999999999999999995433 278999999999999999999999999999


Q ss_pred             cccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhccc-CCCcc
Q 004642          605 LHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQR-LSPPV  683 (740)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~  683 (740)
                      +..........+|||.||+||.+.+..|+.||||||+||++|||+.-+.||....-        ..+...+.+. .++-.
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------~~L~~KI~qgd~~~~p  249 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------LSLCKKIEQGDYPPLP  249 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--------HHHHHHHHcCCCCCCc
Confidence            98777777888999999999999999999999999999999999999999875321        1222333332 22222


Q ss_pred             hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      .......   +..+|..|+..||+.||+.-.+++.+..
T Consensus       250 ~~~YS~~---l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  250 DEHYSTD---LRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHhhhH---HHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            2333333   7889999999999999985555555544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-45  Score=378.02  Aligned_cols=253  Identities=28%  Similarity=0.505  Sum_probs=211.6

Q ss_pred             cccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +.+...+.||+|.||+||.|.+.....||+|.++.....    .+.|.+|+++|++++|++||+++|+|..++..+||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            345567889999999999999988889999999886544    2578899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      ||+.|+|.++|... ....+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+... ++
T Consensus       282 ~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~  356 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG-DD  356 (468)
T ss_pred             ecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC-CC
Confidence            99999999999873 334688999999999999999999999   99999999999999999999999999999543 33


Q ss_pred             Cccccc--ccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          610 SYRTLR--AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       610 ~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      .+....  --+..|.|||.+....++.|||||||||+||||+| |+.|+..+.        .....+.+.+..+.+.+..
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--------n~ev~~~le~GyRlp~P~~  428 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--------NEEVLELLERGYRLPRPEG  428 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--------HHHHHHHHhccCcCCCCCC
Confidence            322211  22678999999999999999999999999999999 888876543        2334455555555444443


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .+   ..+.++|..||+.+|++||||+.+...+...
T Consensus       429 CP---~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  429 CP---DEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CC---HHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            33   3488999999999999999999988887654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-45  Score=360.78  Aligned_cols=255  Identities=26%  Similarity=0.406  Sum_probs=215.6

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|+||+||.++. ++++.||+|++++....+....+....|..++.+++||+||+++..|++++..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            46899999999999999999954 46899999999987766665678889999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      +||+.||.|..+|++.+   .+++..+.-++.+|+.||.|||++   +|+||||||+|||+|++|+++|+|||+++..-.
T Consensus       104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999998765   588898999999999999999999   999999999999999999999999999996655


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      +.......+||+.|||||++.+..|+..+|.||+|+++|||++|..||....       ...+...+...++.. .+...
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-------~~~~~~~I~~~k~~~-~p~~l  249 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-------VKKMYDKILKGKLPL-PPGYL  249 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-------HHHHHHHHhcCcCCC-CCccC
Confidence            5555566799999999999999999999999999999999999999987532       233344444444221 11112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC----CHHHHHHHHH
Q 004642          688 VQDIILVSTIAFACLSSQPKSRP----TMQRISQELL  720 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RP----s~~ev~~~L~  720 (740)
                      ..+   ..+++.+.+..||++|-    ++.++.+|-.
T Consensus       250 s~~---ardll~~LL~rdp~~RLg~~~d~~~ik~Hpf  283 (357)
T KOG0598|consen  250 SEE---ARDLLKKLLKRDPRQRLGGPGDAEEIKRHPF  283 (357)
T ss_pred             CHH---HHHHHHHHhccCHHHhcCCCCChHHhhcCcc
Confidence            222   77899999999999995    5666555543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-44  Score=358.19  Aligned_cols=202  Identities=29%  Similarity=0.489  Sum_probs=181.3

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ..+|.+.+.||.|+||+||+|+++ ++..||||.+....-. ...++-+..|+++++.++|||||.+++++..++..|+|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            457888889999999999999665 5899999999876532 33457788999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC------CcEEEeeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN------LEASVADFGT  601 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~------~~~kl~DfG~  601 (740)
                      ||||.||+|.++++..+   .+++..+..++.|+|.||++||++   +||||||||+|||++..      -.+||+|||+
T Consensus        88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999999876   689999999999999999999999   99999999999999865      4589999999


Q ss_pred             ceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcc
Q 004642          602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLL  658 (740)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~  658 (740)
                      |+.+.. .......+|++.|||||++...+|+.|+|+||+|+|+|++++|+.||+..
T Consensus       162 AR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  162 ARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            999874 33445569999999999999999999999999999999999999999854

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.7e-44  Score=341.59  Aligned_cols=264  Identities=25%  Similarity=0.353  Sum_probs=207.8

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      +.|+...++|+|+||.||+++.+ +|+.||||++.... .++...+-..+|++++++++|+|+|.++++|......++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            46777888999999999999766 59999999997654 44566778899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||++.- +.+-+.....  .++...+.+++.|++.|+.|+|++   +++||||||+|||++.+|.+||||||+|+.+...
T Consensus        81 E~~dhT-vL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   81 EYCDHT-VLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             eecchH-HHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            999984 4444444433  478889999999999999999999   9999999999999999999999999999998866


Q ss_pred             CCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCcccccccC------CC-CCchhhhhhcc---
Q 004642          609 SSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS------SG-PKIMLIDVLNQ---  677 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~------~~-~~~~~~~~~~~---  677 (740)
                      ....+..+.|..|+|||.+.+ .+|...+|||++||++.||++|..-|...++...-      .+ -...-.+++..   
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            666677789999999999987 78999999999999999999999887655432100      00 00000001000   


Q ss_pred             ----cCC-----CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          678 ----RLS-----PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       678 ----~l~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                          .++     .+.....+.....+.++++.|++.||++|++-+|++.+-.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y  286 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY  286 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence                011     1111112222234789999999999999999999987653

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=355.99  Aligned_cols=259  Identities=26%  Similarity=0.391  Sum_probs=218.1

Q ss_pred             hcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (740)
                      ..+|.+.+.||+|+|++|++| +..+++.||||++.+...-++..++-...|-++|.++ .||.|++++..|.+...+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            467899999999999999999 4557999999999876655555566778899999999 89999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      |+||+++|+|.++|++.+   .+++.....++.+|+.||+|||+.   |||||||||+|||+|+|++++|+|||.|+.+.
T Consensus       152 vLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            999999999999999876   688888999999999999999999   99999999999999999999999999999875


Q ss_pred             cCCC-----------c--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhh
Q 004642          607 VDSS-----------Y--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLID  673 (740)
Q Consensus       607 ~~~~-----------~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  673 (740)
                      ....           .  ...++||..|.+||++.....++.+|+|+||||+|+|+.|+.||....+       ...+.+
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-------yliFqk  298 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-------YLIFQK  298 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-------HHHHHH
Confidence            3211           1  1347899999999999999999999999999999999999999986443       222333


Q ss_pred             hhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCC
Q 004642          674 VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP  725 (740)
Q Consensus       674 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  725 (740)
                      ++.-....+  ....+   .+.+++.+.|..||.+|++.+|+.+|.......
T Consensus       299 I~~l~y~fp--~~fp~---~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  299 IQALDYEFP--EGFPE---DARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             HHHhcccCC--CCCCH---HHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence            333222211  11122   277899999999999999999999998776543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.7e-42  Score=374.65  Aligned_cols=260  Identities=27%  Similarity=0.451  Sum_probs=212.0

Q ss_pred             hcccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (740)
                      ..+....+.||+|.||+||+|+..      +...||||.++.....  ...++|++|++++..++|||||+++|.|.+++
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            445566788999999999999643      3467999999876654  34689999999999999999999999999999


Q ss_pred             eEEEEEEeccCCCchhhhcCCC-------c----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC
Q 004642          523 CMFLIYEYMERGSLFCVLHDDD-------E----AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN  591 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  591 (740)
                      .+++|+|||..|+|.++|....       .    ..+++..+.+.||.|||.||+||-++   .+|||||..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence            9999999999999999985321       1    23489999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCccc--ccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCC
Q 004642          592 LEASVADFGTARLLHVDSSYRT--LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPK  668 (740)
Q Consensus       592 ~~~kl~DfG~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~  668 (740)
                      ..|||+|||+++..-..+.+..  ...-+.+|||||.+..++++++||||||||+|||+++ |+.|+...+       ..
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-------n~  712 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-------NQ  712 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-------hH
Confidence            9999999999987643333321  1234689999999999999999999999999999998 999966433       23


Q ss_pred             chhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          669 IMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       669 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      +.+..+-...+- +-+   ..+..+++.||..||+..|.+||+++||-..|+.-..
T Consensus       713 EVIe~i~~g~lL-~~P---e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  713 EVIECIRAGQLL-SCP---ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HHHHHHHcCCcc-cCC---CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            334333333331 111   2333448999999999999999999999999987644

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-41  Score=321.19  Aligned_cols=281  Identities=26%  Similarity=0.370  Sum_probs=222.8

Q ss_pred             cccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .+|...+.+|+|.||.||+| +..+|+.||||+++.....+. .-....+|++.++.++|+||+.++++|.+.+..-+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            46777889999999999999 566899999999988755433 2356789999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||++. +|+..+.+..  ..++..++..++.++++|++|||++   .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus        81 Efm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             Eeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            99986 8998887654  3688899999999999999999999   9999999999999999999999999999998876


Q ss_pred             CCcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc---------CCCCCc-----hh--
Q 004642          609 SSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS---------SSGPKI-----ML--  671 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~---------~~~~~~-----~~--  671 (740)
                      ....+..+-|..|+|||.+.|. .|+..+||||.|||+.||+-|.+-|...++++.         .+..+.     .+  
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            6666666789999999998865 588999999999999999999887765443210         000000     00  


Q ss_pred             hhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCChhhhhcccccc
Q 004642          672 IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISE  737 (740)
Q Consensus       672 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~~~~~~~  737 (740)
                      ...+.+...++.............+++..++..||.+|++++|++++--....|.+..-.++....
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~  300 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPS  300 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCc
Confidence            111111111211111222333368999999999999999999999998887777777666665543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=347.32  Aligned_cols=257  Identities=26%  Similarity=0.424  Sum_probs=205.9

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC--eEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK--CMFL  526 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l  526 (740)
                      .+|...+.||+|+||+||++... +|+..|||.+.......   .+.+.+|+.++.+++|||||+++|......  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            45667788999999999999654 49999999997763221   577899999999999999999999865554  6999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCcEEEeecccceec
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-NLEASVADFGTARLL  605 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfG~a~~~  605 (740)
                      .|||+++|+|.+++.+.+.  .+++..+..+.+||+.||+|||++   ||+||||||+|||++. ++.+||+|||.++..
T Consensus        94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            9999999999999988765  589999999999999999999999   9999999999999999 799999999999876


Q ss_pred             ccC---CCcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          606 HVD---SSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       606 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      ...   ........||+.|||||++..+ ....++||||+||++.||+||+.||...      .........+......+
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P  242 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLP  242 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCC
Confidence            531   1223346899999999999853 3345899999999999999999997642      11111122222222222


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      ..+....+   ...+++.+|+..||++||||++++++.....
T Consensus       243 ~ip~~ls~---~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  243 EIPDSLSD---EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             CCCcccCH---HHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            23332233   3789999999999999999999999997754

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-42  Score=356.90  Aligned_cols=266  Identities=27%  Similarity=0.441  Sum_probs=215.0

Q ss_pred             HHHHHHhcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC
Q 004642          443 EDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK  522 (740)
Q Consensus       443 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (740)
                      ++++...+++.+...||+|.||+||+|+|. | .||||++......++ ..+.|+.|+.++++-+|.||+-+.|||..+.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            555566677788899999999999999884 3 599999998776655 6799999999999999999999999999988


Q ss_pred             eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccc
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                      . .||+.||+|.+|+.++|-.+.  .++..+...|++|||+||.|||.+   +|||||||..||++.++++|||+|||++
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             e-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence            7 999999999999999997664  688899999999999999999999   9999999999999999999999999999


Q ss_pred             eecccC--CCcccccccCCCccccccccc---cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcc
Q 004642          603 RLLHVD--SSYRTLRAGTYGYIAPELAYT---IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ  677 (740)
Q Consensus       603 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  677 (740)
                      .....-  ........|...|||||++..   .+|++.+||||||+++|||+||..||....       .+..+..+-..
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-------~dqIifmVGrG  608 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-------RDQIIFMVGRG  608 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-------hhheEEEeccc
Confidence            764322  111222357889999999874   468899999999999999999999987321       12222222222


Q ss_pred             cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          678 RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       678 ~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      .+.+........+..++.+++..||..+|++||.+.+++..|+..-.
T Consensus       609 ~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  609 YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            22222222222333358899999999999999999999998766533

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-41  Score=338.11  Aligned_cols=263  Identities=25%  Similarity=0.399  Sum_probs=213.4

Q ss_pred             hcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|++...||.|..++||+| ..+.+..||||++..+.....  .+.+.+|++.|+.++||||++++..|..+...|+|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            468999999999999999999 567789999999988776644  68899999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |.||.+|++.+++...-.. .+++..+..|.+++++||.|||++   |.||||||+.|||++.+|.|||+|||.+..+..
T Consensus       103 mpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             ehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            9999999999999764332 388999999999999999999999   999999999999999999999999998877654


Q ss_pred             CCCcc----cccccCCCccccccccc--cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCC-
Q 004642          608 DSSYR----TLRAGTYGYIAPELAYT--IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS-  680 (740)
Q Consensus       608 ~~~~~----~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~-  680 (740)
                      .....    ...+||++|||||+++.  ..|+.|+||||||++..||.+|..||......       +++...+....+ 
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-------kvLl~tLqn~pp~  251 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-------KVLLLTLQNDPPT  251 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-------HHHHHHhcCCCCC
Confidence            32221    34589999999999653  35899999999999999999999998754321       122222222221 


Q ss_pred             ----CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          681 ----PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       681 ----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                          .............+.+++..|+..||++|||+++++++-.....
T Consensus       252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~  299 (516)
T KOG0582|consen  252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA  299 (516)
T ss_pred             cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence                00111111112248899999999999999999999998766543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=354.15  Aligned_cols=261  Identities=24%  Similarity=0.337  Sum_probs=217.3

Q ss_pred             hcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ...|....+||+|+.|.||.+ +..+++.||||++.......+   +-+.+|+.+|+..+|+|||.+++.|..++..|+|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            456777788999999999999 566789999999987665543   4568999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      ||||+||+|.+.+...    .+++.++..|++++++||+|||.+   ||+|||||.+|||++.+|.+||+|||++..+..
T Consensus       349 MEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            9999999999998765    489999999999999999999999   999999999999999999999999999998877


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      ........+||++|||||+.....|.+|+||||||++++||+-|..||-....       -..+.-+.+...+.  ....
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAlyLIa~ng~P~--lk~~  492 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGTPK--LKNP  492 (550)
T ss_pred             ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHHHHhhcCCCC--cCCc
Confidence            66666677999999999999999999999999999999999999999753221       11122222221111  1111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCChh
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQK  728 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~  728 (740)
                      ..-...+.+|+.+||..||++||++.|+++|-........+
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~s  533 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPES  533 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHH
Confidence            22233489999999999999999999999998775444433

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=349.68  Aligned_cols=266  Identities=23%  Similarity=0.325  Sum_probs=213.9

Q ss_pred             HhcccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeeeeecC-eE
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKK-CM  524 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~  524 (740)
                      ..++|.+.++||.|.||+||+|+ ..+|..||||+++.....-++.  .=.+|++.++++. |||||++.+.+.+.+ ..
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            45789999999999999999994 5578999999998877664432  2358999999998 999999999999988 99


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++|||||+. +|++++.+.  ...+++.++..|+.||++||+|+|++   |+.|||+||+|||+.....+||+|||+||.
T Consensus        86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence            999999986 999999876  34799999999999999999999999   999999999999999888999999999998


Q ss_pred             cccCCCcccccccCCCcccccccc-ccccCCcchhHhHHHHHHHHHhCCCCCCcccccc---------cCCC-----CCc
Q 004642          605 LHVDSSYRTLRAGTYGYIAPELAY-TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS---------SSSG-----PKI  669 (740)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~---------~~~~-----~~~  669 (740)
                      +...+.+ +..+.|..|+|||++. .+.|+.+.|||++|||++|+.+-+.-|...++.+         ....     ...
T Consensus       160 v~SkpPY-TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  160 VRSKPPY-TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             cccCCCc-chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            8654444 4557899999999875 6679999999999999999999998887654421         0111     112


Q ss_pred             hhhhhhcccCCCcc----hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          670 MLIDVLNQRLSPPV----NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       670 ~~~~~~~~~l~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .+...+.-..+...    ............+++.+|+++||++||||+|.+++....
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq  295 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ  295 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence            22333333332211    111223344588999999999999999999999987654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-41  Score=346.41  Aligned_cols=268  Identities=28%  Similarity=0.390  Sum_probs=209.2

Q ss_pred             cccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec--CeEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCMFL  526 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  526 (740)
                      +.|+..++||+|.||.||+| +..+|+.||+|++...... ++...-..+|+.++++++||||+++.+...+.  +..||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            45667788999999999999 5668999999999876543 34456778999999999999999999999876  78999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      |+|||++ +|.-++...+  ..++..++..+++|++.||+|+|.+   ||+|||||.+|||+|.+|.+||+|||+|+++.
T Consensus       196 VFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999998 7877776543  3689999999999999999999999   99999999999999999999999999999887


Q ss_pred             cCCCc-ccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccc---------cCCCCCchhhhhh
Q 004642          607 VDSSY-RTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS---------SSSGPKIMLIDVL  675 (740)
Q Consensus       607 ~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~  675 (740)
                      ..... .+.++-|..|+|||.+.|. .|+.++|+||.|||+.||++|+..|....+..         .....+.+....+
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            65433 5777889999999999865 69999999999999999999999987654321         0111111110000


Q ss_pred             c----ccCCCcchhhhHHH----HHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          676 N----QRLSPPVNQKIVQD----IILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       676 ~----~~l~~~~~~~~~~~----~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      .    .....++.....+.    .....+++..+|..||++|.||.++++.=.....
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence            0    00011111111111    1126689999999999999999999987665433

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=317.58  Aligned_cols=249  Identities=26%  Similarity=0.354  Sum_probs=211.5

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||.|+||.|.+++.+ +|..||+|++.....-+....+...+|..+++.+.||+++++++.+.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            57888999999999999999655 58899999999887777666778889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||++||.|.+++++.+   ++++..+..+|.||+.|++|||+.   +|++||+||+|||+|.+|.+||+|||+|+.....
T Consensus       124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999999998765   688999999999999999999999   9999999999999999999999999999987532


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                         ....+||+.|+|||++.+..+..++|.|||||++|||+.|..||.....       ......++...+..+..-  .
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~v~fP~~f--s  265 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGKVKFPSYF--S  265 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCcccCCccc--C
Confidence               3345999999999999999999999999999999999999999875332       334445555555433321  1


Q ss_pred             HHHHHHHHHHHHcccCCCCCC-----CCHHHHHHHH
Q 004642          689 QDIILVSTIAFACLSSQPKSR-----PTMQRISQEL  719 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~R-----Ps~~ev~~~L  719 (740)
                      .   .+.+++.+.++.|-.+|     +...+|..|-
T Consensus       266 ~---~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~  298 (355)
T KOG0616|consen  266 S---DAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHP  298 (355)
T ss_pred             H---HHHHHHHHHHhhhhHhhhcCcCCCccccccCc
Confidence            1   27789999999999998     2444554444

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=360.75  Aligned_cols=268  Identities=30%  Similarity=0.437  Sum_probs=222.3

Q ss_pred             CCcccHHHHHHHhc---------ccccceeeecccceEEEEEEeCC----CcEEEEEEccCCcccchHHHHHHHHHHHHH
Q 004642          437 DGKILYEDLINATE---------DFHIKYCIGTGGYGSVYKAELPE----GKVVALKKLHHSETEDSAFVKSFQNEAHVL  503 (740)
Q Consensus       437 ~~~~~~~~l~~~~~---------~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l  503 (740)
                      ..+++|+|-..+..         ...+.++||.|.||+||+|+++-    ...||||.++....++  ...+|..|+.+|
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek--qrrdFL~EAsIM  684 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK--QRRDFLSEASIM  684 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHH--HHhhhhhhhhhc
Confidence            34556665544433         34677899999999999997652    3569999999876553  358999999999


Q ss_pred             hccCCCccceeeeeeeecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 004642          504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISS  583 (740)
Q Consensus       504 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  583 (740)
                      .+++||||+++.|+.......+||.|||++|+|+.+|...++  ++++.+...+.++||.||+||-+.   ++|||||.+
T Consensus       685 GQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAA  759 (996)
T KOG0196|consen  685 GQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAA  759 (996)
T ss_pred             ccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhh
Confidence            999999999999999999999999999999999999988775  589999999999999999999988   999999999


Q ss_pred             CceEEcCCCcEEEeecccceecccCCCc-cccccc--CCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCccc
Q 004642          584 NNILLDSNLEASVADFGTARLLHVDSSY-RTLRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLS  659 (740)
Q Consensus       584 ~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~  659 (740)
                      +|||++.+..+||+|||+++.+..++.. .+...|  +.+|.|||.+...+++.+|||||||+++||.++ |..|+..++
T Consensus       760 RNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS  839 (996)
T KOG0196|consen  760 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS  839 (996)
T ss_pred             hheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence            9999999999999999999988766532 233233  579999999999999999999999999999997 999976543


Q ss_pred             ccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          660 SLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                              .....+.+.+..+-+.+.   .+...+.+++..||++|-.+||.|.|++.+|.+.
T Consensus       840 --------NQdVIkaIe~gyRLPpPm---DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  840 --------NQDVIKAIEQGYRLPPPM---DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             --------hHHHHHHHHhccCCCCCC---CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence                    233444455544433333   3444599999999999999999999999999764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=348.13  Aligned_cols=259  Identities=22%  Similarity=0.350  Sum_probs=211.2

Q ss_pred             HhcccccceeeecccceEEEEEE-eCCCcEEEEEEccCCccc-c-hHHHHHHHHHHHHHhccC-CCccceeeeeeeecCe
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETE-D-SAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKKC  523 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  523 (740)
                      ....|.+.+.||+|.||+|+.|. ..+|+.||+|++...... . ....+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            35689999999999999999994 457899999977664222 1 123456678999999998 9999999999999999


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CcEEEeecccc
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN-LEASVADFGTA  602 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfG~a  602 (740)
                      .++||||+.||+|.+++.+.+   ++.+.++..++.|++.|++|+|+.   ||+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999998733   678899999999999999999999   99999999999999999 99999999999


Q ss_pred             eecccCCCcccccccCCCccccccccccc-cC-CcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCC
Q 004642          603 RLLHVDSSYRTLRAGTYGYIAPELAYTIV-VT-GKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS  680 (740)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  680 (740)
                      .............+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+....       ......+......
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------~~l~~ki~~~~~~  241 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------PNLYRKIRKGEFK  241 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------HHHHHHHhcCCcc
Confidence            98743344455669999999999999877 76 679999999999999999999986221       1122222222222


Q ss_pred             CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       681 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      .+....    ...+..++.+|+..||.+|+++.|++++-+...
T Consensus       242 ~p~~~~----S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  242 IPSYLL----SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCCCcC----CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            221110    233789999999999999999999998877665

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5e-40  Score=351.39  Aligned_cols=260  Identities=27%  Similarity=0.402  Sum_probs=202.6

Q ss_pred             HhcccccceeeecccceEEEEEEe------CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeee
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLH  520 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  520 (740)
                      ..++|++.+.||+|+||.||+|..      .+++.||+|++......  ...+.+.+|++++.++ +||||+++++++..
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA--SEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--HHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            356899999999999999999953      23578999999754322  2346788999999999 89999999998876


Q ss_pred             c-CeEEEEEEeccCCCchhhhcCCCc------------------------------------------------------
Q 004642          521 K-KCMFLIYEYMERGSLFCVLHDDDE------------------------------------------------------  545 (740)
Q Consensus       521 ~-~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  545 (740)
                      . +..+++|||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 458999999999999998864321                                                      


Q ss_pred             -----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc--ccccccC
Q 004642          546 -----AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY--RTLRAGT  618 (740)
Q Consensus       546 -----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt  618 (740)
                           ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....+...  .....++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                 12478889999999999999999998   9999999999999999999999999999865433221  1223456


Q ss_pred             CCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHH
Q 004642          619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTI  697 (740)
Q Consensus       619 ~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~l  697 (740)
                      ..|+|||++.+..++.++|||||||++|||++ |+.||.....       .......+..........   .....+.++
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~---~~~~~l~~l  309 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------NEEFCQRLKDGTRMRAPE---NATPEIYRI  309 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-------cHHHHHHHhcCCCCCCCC---CCCHHHHHH
Confidence            88999999999899999999999999999997 9999864321       111111111111111111   112237899


Q ss_pred             HHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          698 AFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       698 i~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      +.+||+.||++||++.|+++.|+..
T Consensus       310 i~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         310 MLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=9.4e-41  Score=343.64  Aligned_cols=252  Identities=28%  Similarity=0.422  Sum_probs=214.4

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|.+.+.||+|.||.||||+. .+.+.||+|.+.+....+++ .+.+.+|+++++.++|||||.++++|+...+.++|.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~-l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE-LKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH-HHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            5788888999999999999954 46889999999877665544 678999999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+.| +|..++...+   .++++.+..++.|++.||.|||+.   +|+|||+||+|||++..+.+|++|||+|+.+...
T Consensus        81 e~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            99988 9999997655   689999999999999999999999   9999999999999999999999999999999877


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      ....+..-||+.|||||...+..|+..+|.||+||++||+++|++||-..+-.       .....++.....++.     
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-------~Lv~~I~~d~v~~p~-----  221 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-------QLVKSILKDPVKPPS-----  221 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-------HHHHHHhcCCCCCcc-----
Confidence            77777788999999999999999999999999999999999999998642210       011111111111111     


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      .....+..++...+.+||.+|.+-.+++.|-.-
T Consensus       222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~  254 (808)
T KOG0597|consen  222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW  254 (808)
T ss_pred             cccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence            223348899999999999999999999988643

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=339.07  Aligned_cols=255  Identities=30%  Similarity=0.449  Sum_probs=213.6

Q ss_pred             hcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ...|+..+.||+|.||.||+| +...++.||+|++......++  ...+.+|+.++.+++++||.++||.+..+..++++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchh--hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            345677788999999999999 556789999999988766543  57889999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+.||++.+.+....   .+++..+.-+++++..|+.|||.+   +.+|||||+.||++..+|.+|++|||.+..+..
T Consensus        90 Mey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             HHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence            99999999999997654   346677777899999999999999   999999999999999999999999999998876


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      ........+||+.|||||++....|+.|+||||||++.+||.+|.+|+......        ...-.+.+..+|....  
T Consensus       164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------rvlflIpk~~PP~L~~--  233 (467)
T KOG0201|consen  164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------RVLFLIPKSAPPRLDG--  233 (467)
T ss_pred             hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------eEEEeccCCCCCcccc--
Confidence            666667779999999999999889999999999999999999999997654321        1111122222222222  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                       .....+.+|+..|+..+|+.||+|.+++++=.-.
T Consensus       234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk  267 (467)
T KOG0201|consen  234 -DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIK  267 (467)
T ss_pred             -ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHH
Confidence             2233488999999999999999999999986543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-41  Score=345.08  Aligned_cols=242  Identities=30%  Similarity=0.476  Sum_probs=201.1

Q ss_pred             ceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCC
Q 004642          455 KYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERG  534 (740)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (740)
                      .+-||.|+.|.||+|++ .++.||||+++...          ..+++-+++++||||+.+.|+|.....++||||||+.|
T Consensus       129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhccCcccceeeeec-cCceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            56799999999999998 57889999996433          25788899999999999999999999999999999999


Q ss_pred             CchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccc
Q 004642          535 SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL  614 (740)
Q Consensus       535 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  614 (740)
                      -|+..|....   .+.......+.++||.||.|||.+   .|||||||.-|||++.+..|||+|||-++..... .....
T Consensus       198 qL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMS  270 (904)
T KOG4721|consen  198 QLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMS  270 (904)
T ss_pred             cHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhh
Confidence            9999998655   577788899999999999999999   9999999999999999999999999999876543 45566


Q ss_pred             cccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHH
Q 004642          615 RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILV  694 (740)
Q Consensus       615 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  694 (740)
                      ++||..|||||++...+.++|+||||||||||||+||..||..........+       +-...+.-+.+.   .+..-+
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG-------VGsNsL~LpvPs---tcP~Gf  340 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG-------VGSNSLHLPVPS---TCPDGF  340 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe-------ccCCcccccCcc---cCchHH
Confidence            7999999999999999999999999999999999999999876543111111       001111111111   122226


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          695 STIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       695 ~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      .-+++.||+..|..||+|++++.||...++
T Consensus       341 klL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  341 KLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             HHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            678999999999999999999999987754

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-39  Score=339.12  Aligned_cols=259  Identities=22%  Similarity=0.274  Sum_probs=204.5

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      .|+..+.||+|+||.||++.. .+|+.||+|.+.............+.+|++++.+++|++++++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377789999999999999954 5789999999876543333334567889999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++|+|.+++..... ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999999888764332 2588999999999999999999998   99999999999999999999999999998754322


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                       ......||..|+|||++.+..++.++||||+||++|||++|+.||.......    ........+.. .........  
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~-~~~~~~~~~--  228 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV----KREEVDRRVKE-DQEEYSEKF--  228 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch----hHHHHHHHhhc-ccccCCccC--
Confidence             2234478999999999999999999999999999999999999987532110    00011111111 011111111  


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHcC
Q 004642          690 DIILVSTIAFACLSSQPKSRPT-----MQRISQELLAG  722 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~L~~~  722 (740)
                       ...+.+++.+||+.||++||+     ++|++++-...
T Consensus       229 -s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~  265 (285)
T cd05631         229 -SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK  265 (285)
T ss_pred             -CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence             223788999999999999997     89999876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.7e-39  Score=336.18  Aligned_cols=248  Identities=23%  Similarity=0.312  Sum_probs=201.9

Q ss_pred             eeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee----cCeEEEEEEec
Q 004642          456 YCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH----KKCMFLIYEYM  531 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  531 (740)
                      ..||+|++|.||+|.. +|+.||||++...........+.+.+|++++.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999987 789999999987655555556788999999999999999999999877    34689999999


Q ss_pred             cCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc
Q 004642          532 ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY  611 (740)
Q Consensus       532 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  611 (740)
                      ++|+|.+++....   .+++.....++.|++.|++|||+.  .+++||||||+||++++++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            9999999997643   588999999999999999999973  178899999999999999999999999998653221  


Q ss_pred             ccccccCCCccccccccc--cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          612 RTLRAGTYGYIAPELAYT--IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       612 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                       ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.....       ......+.........+.   .
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~---~  246 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-------KEIYDLIINKNNSLKLPL---D  246 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCCCCCCC---c
Confidence             23468899999999876  6789999999999999999999999875321       111122222222222211   1


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ....+.+++.+||+.||++|||++|+++.|...
T Consensus       247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            223488999999999999999999999999765

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-40  Score=345.38  Aligned_cols=256  Identities=24%  Similarity=0.373  Sum_probs=213.0

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .-|...+.||+|+-|.|-.|++ .+|+.+|||++.......+.....+.+|+-+|+-+.|||++++|+.++++.++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4567788899999999999954 579999999998774444444567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|.|++++-..+   ++++.++.+++.||+.|+.|+|..   +|+|||+||+|+|+|..+++||+|||+|..-..+
T Consensus        92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999997765   688999999999999999999998   9999999999999999999999999999865443


Q ss_pred             CCcccccccCCCccccccccccccC-CcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVT-GKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                       ......||++.|.|||+++|.+|. .++||||.|||||.|+||+.||++...       ...+..+.......+.  .+
T Consensus       166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~LLlKV~~G~f~MPs--~I  235 (786)
T KOG0588|consen  166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RVLLLKVQRGVFEMPS--NI  235 (786)
T ss_pred             -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCcccCCC--cC
Confidence             344455999999999999999886 479999999999999999999985221       1222222222222221  12


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      .   .+..+++.+|+..||+.|.|++||++|..-.+-
T Consensus       236 s---~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  236 S---SEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             C---HHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence            2   237899999999999999999999999876543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.4e-40  Score=318.97  Aligned_cols=268  Identities=24%  Similarity=0.276  Sum_probs=212.9

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee--cCeEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH--KKCMF  525 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  525 (740)
                      .++|+..+.|++|.||.||+|+. ++++.||+|+++.....+ .+--...+|+.++.+.+|||||.+-.+...  -+..|
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            45788899999999999999954 468899999998766433 222345789999999999999999888764  45799


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      +||||+++ +|..+++...+  ++...++..++.|+++|++|||+.   .|+||||||+|+|+++.|.+||+|||+|+.+
T Consensus       154 ~VMe~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeHHHHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence            99999998 89999987764  688899999999999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccc------------------cCCC
Q 004642          606 HVDSSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS------------------SSSG  666 (740)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~------------------~~~~  666 (740)
                      .......+..+-|..|+|||.+.+. .|+++.|+||+|||+.||+++++-|...+++.                  ....
T Consensus       228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            8776667777889999999998875 58999999999999999999998876554311                  0000


Q ss_pred             CCch--------hhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCChhh
Q 004642          667 PKIM--------LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKA  729 (740)
Q Consensus       667 ~~~~--------~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~  729 (740)
                      ...+        ....+.+.....      .-...-.+++...+..||++|.||.|.+++=...+.|.+..
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~------~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~  372 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGAL------SLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPID  372 (419)
T ss_pred             cchhhccccCCCCchhhhhhcccc------ccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCC
Confidence            0000        001111111110      01123678999999999999999999999988887666554

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-40  Score=326.16  Aligned_cols=254  Identities=24%  Similarity=0.428  Sum_probs=217.9

Q ss_pred             hcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ..+|++.+.||+|.||.|-++ ....|+.||||.+++....++.-.-.+.+|+++|..++||||+.+|.+|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            357888899999999999999 5578999999999998888877677889999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||..+|.|++++.+.+   .+++.+...+++||..|+.|+|++   +++|||||-+|||+|+++++||+|||++..+. 
T Consensus       132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~-  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA-  204 (668)
T ss_pred             EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc-
Confidence            99999999999998765   689999999999999999999999   99999999999999999999999999998876 


Q ss_pred             CCCcccccccCCCccccccccccccC-CcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVT-GKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      +......++|++-|.+||++.+.+|. +.+|-||+||+||-++.|..||+....       ...+..+-......+... 
T Consensus       205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lvrQIs~GaYrEP~~P-  276 (668)
T KOG0611|consen  205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLVRQISRGAYREPETP-  276 (668)
T ss_pred             cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHHHHhhcccccCCCCC-
Confidence            45556677999999999999999885 579999999999999999999986432       222222222222221111 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                        ..   ..-+|++|+..+|++|.|..++..|++-.
T Consensus       277 --Sd---A~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  277 --SD---ASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             --ch---HHHHHHHHHhcCcccchhHHHHhhhheee
Confidence              11   45689999999999999999999999654

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=349.11  Aligned_cols=264  Identities=27%  Similarity=0.429  Sum_probs=211.5

Q ss_pred             HHhcccccceeeecccceEEEEEEeCC--C--cE-EEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAELPE--G--KV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK  521 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (740)
                      ...++....++||+|+||.||+|.+..  +  .. ||||..+..........++|++|+++|++++|||||++||++...
T Consensus       154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~  233 (474)
T KOG0194|consen  154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE  233 (474)
T ss_pred             EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence            334555666899999999999996543  3  23 899999875544456678999999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      ...++|||+|+||+|.++|.+.+.  .++..++..++.+.|.||+|||++   +++||||.++|+|++.++.+||+|||+
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccc
Confidence            999999999999999999998765  589999999999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCC
Q 004642          602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLS  680 (740)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  680 (740)
                      ++.-..-.......--+.+|+|||.+..+.+++++|||||||++||+++ |..||......       .....+.....+
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~kI~~~~~r  381 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKAKIVKNGYR  381 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHHHHHhcCcc
Confidence            8754210001111134689999999999999999999999999999999 88897754431       222223232333


Q ss_pred             CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCC
Q 004642          681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP  725 (740)
Q Consensus       681 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  725 (740)
                      .+.+...+.   .+..++.+||..+|++||+|.++.+.+......
T Consensus       382 ~~~~~~~p~---~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  382 MPIPSKTPK---ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             CCCCCCCHH---HHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence            222222223   377888999999999999999999999876543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2e-39  Score=343.95  Aligned_cols=248  Identities=23%  Similarity=0.291  Sum_probs=200.9

Q ss_pred             eeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCC
Q 004642          456 YCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERG  534 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (740)
                      +.||+|+||.||++.. .+|+.||+|++.............+.+|++++++++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999955 478999999997654333344567788999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccc
Q 004642          535 SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL  614 (740)
Q Consensus       535 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  614 (740)
                      +|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence            9998887543   578999999999999999999998   9999999999999999999999999999764333333344


Q ss_pred             cccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHH
Q 004642          615 RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILV  694 (740)
Q Consensus       615 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  694 (740)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+.......+  ...   ...+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~~~~p--~~~---~~~~  222 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEIRFP--RTL---SPEA  222 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCCCCC--CCC---CHHH
Confidence            5799999999999998999999999999999999999999864221       111111221211111  111   2237


Q ss_pred             HHHHHHcccCCCCCCC-----CHHHHHHHHHc
Q 004642          695 STIAFACLSSQPKSRP-----TMQRISQELLA  721 (740)
Q Consensus       695 ~~li~~cl~~dP~~RP-----s~~ev~~~L~~  721 (740)
                      .+++.+||+.||++||     ++.+++++-..
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f  254 (323)
T cd05571         223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF  254 (323)
T ss_pred             HHHHHHHccCCHHHcCCCCCCCHHHHHcCCCc
Confidence            8999999999999999     89999887543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.1e-39  Score=334.63  Aligned_cols=258  Identities=27%  Similarity=0.385  Sum_probs=212.3

Q ss_pred             HhcccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      ..++|++.+.||+|+||+||.|+ ..+|..+|+|++++........++-...|..+|....+|.||+++..|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            35799999999999999999994 45799999999998877777777888999999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      ||||++||++..+|.+.+   .+++..+..++.+++-|++.+|+.   |+|||||||+|+|+|..|++||+|||++.-+.
T Consensus       219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999998766   688899999999999999999999   99999999999999999999999999985321


Q ss_pred             c---------------------CCC-c-----c--------------------cccccCCCccccccccccccCCcchhH
Q 004642          607 V---------------------DSS-Y-----R--------------------TLRAGTYGYIAPELAYTIVVTGKCDVY  639 (740)
Q Consensus       607 ~---------------------~~~-~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~Dvw  639 (740)
                      .                     +.. .     .                    ...+|||-|||||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            0                     000 0     0                    013599999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhccc--CCCcchhhhHHHHHHHHHHHHHcccCCCCCCC---CHHH
Q 004642          640 SFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQR--LSPPVNQKIVQDIILVSTIAFACLSSQPKSRP---TMQR  714 (740)
Q Consensus       640 slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~e  714 (740)
                      |+|||+|||+.|.+||.....       ......++.-+  +..+......   .+..++|.+|+. ||++|-   .++|
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp-------~~T~rkI~nwr~~l~fP~~~~~s---~eA~DLI~rll~-d~~~RLG~~G~~E  441 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETP-------QETYRKIVNWRETLKFPEEVDLS---DEAKDLITRLLC-DPENRLGSKGAEE  441 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHhhhccCCCcCccc---HHHHHHHHHHhc-CHHHhcCcccHHH
Confidence            999999999999999875332       22222332222  2222222222   347899999999 999995   6899


Q ss_pred             HHHHHHcC
Q 004642          715 ISQELLAG  722 (740)
Q Consensus       715 v~~~L~~~  722 (740)
                      |.+|....
T Consensus       442 IK~HPfF~  449 (550)
T KOG0605|consen  442 IKKHPFFK  449 (550)
T ss_pred             HhcCCccc
Confidence            98887654

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=338.06  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=206.1

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|... +|+.||+|++......+....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46889999999999999999654 68999999997544333334567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999987643   578899999999999999999998   9999999999999999999999999999765422


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+.......+..  . 
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~--~-  221 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEKILAGKLEFPRH--L-  221 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCcCCCcc--C-
Confidence               2234689999999999988899999999999999999999999864321       11122222222221111  1 


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHcC
Q 004642          689 QDIILVSTIAFACLSSQPKSRPT-----MQRISQELLAG  722 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~L~~~  722 (740)
                        ...+.+++.+||+.||.+||+     ++|++++....
T Consensus       222 --~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         222 --DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             --CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence              223789999999999999995     99999887554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.3e-40  Score=339.35  Aligned_cols=254  Identities=21%  Similarity=0.360  Sum_probs=217.6

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe-EEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC-MFLI  527 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv  527 (740)
                      ++|...+++|+|+||.++.++++ +++.||+|++......+.+ .+...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            57889999999999999999554 5789999999887766554 3578899999999999999999999999998 9999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |+|++||++.+.+.+.. ...++++++..++.|++.|+.|||++   .|+|||||+.||+++.++.|+|+|||+|+.+..
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999998765 34689999999999999999999988   999999999999999999999999999999987


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      +.......+||+.||.||.+.+.+|..|+||||+||++|||++-+++|.....       ..-+.++.... ..+.+..+
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~ki~~~~-~~Plp~~y  230 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELILKINRGL-YSPLPSMY  230 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-------HHHHHHHhhcc-CCCCCccc
Confidence            77666777999999999999999999999999999999999999999875332       12222333222 22233223


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      .   ..+..++..|+..+|+.||++.+++.+.
T Consensus       231 s---~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  231 S---SELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             c---HHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            3   3388999999999999999999999873

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8e-39  Score=345.90  Aligned_cols=259  Identities=26%  Similarity=0.390  Sum_probs=204.3

Q ss_pred             HhcccccceeeecccceEEEEEEe------CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeee
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLH  520 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  520 (740)
                      ..++|++.+.||+|+||.||+|.+      .++..||||+++.....  ...+.+.+|++++..+ +||||+++++++.+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            346799999999999999999953      24668999999754432  2246788999999999 89999999999999


Q ss_pred             cCeEEEEEEeccCCCchhhhcCCCc-------------------------------------------------------
Q 004642          521 KKCMFLIYEYMERGSLFCVLHDDDE-------------------------------------------------------  545 (740)
Q Consensus       521 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  545 (740)
                      ++..++||||+++|+|.++++....                                                       
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            9999999999999999998864321                                                       


Q ss_pred             -----------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          546 -----------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       546 -----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                                       ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                             12478999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchh
Q 004642          609 SSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       609 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  685 (740)
                      ...  .....++..|+|||++.+..++.++|||||||++|||++ |..||.....       .......+........+.
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~  340 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------DSKFYKMIKEGYRMLSPE  340 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-------hHHHHHHHHhCccCCCCC
Confidence            221  112235678999999999999999999999999999998 8888764321       111222222222111111


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ..   ...+.+++.+||+.||++||++.|+++.|+.
T Consensus       341 ~~---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         341 CA---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            11   1237899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=335.25  Aligned_cols=264  Identities=26%  Similarity=0.364  Sum_probs=211.3

Q ss_pred             hcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .+...++++||+|.||+|..+....+..||||+++.....  ..+++|.+|+++|.+++|||||.++|+|..++..++++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            4566778999999999999999877899999999876654  33689999999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      |||++|+|..++..+... ........+|+.||+.||+||.+-   .+||||+.++|+|++.++++||+|||+++.+-..
T Consensus       615 EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence            999999999999876432 245566778999999999999988   9999999999999999999999999999865444


Q ss_pred             CCcc--cccccCCCccccccccccccCCcchhHhHHHHHHHHHh--CCCCCCcccccccCCCCCchhhhhhcccCCCcch
Q 004642          609 SSYR--TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM--GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN  684 (740)
Q Consensus       609 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  684 (740)
                      +.+.  ...+-+.+|||||.+.-+++++++|||+||+++||+++  ...||........    .+...+.++........
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v----ven~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV----VENAGEFFRDQGRQVVL  766 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH----HHhhhhhcCCCCcceec
Confidence            3332  22345789999999999999999999999999999987  6778775443111    01111222222222222


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ....-+...+.+++.+||..|-++||+++++...|++.
T Consensus       767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            22222333478999999999999999999999998764

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.6e-39  Score=342.06  Aligned_cols=252  Identities=23%  Similarity=0.295  Sum_probs=206.2

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|... +|+.||+|++...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57899999999999999999664 68999999997654333334567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999987643   578888999999999999999998   9999999999999999999999999999876432


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      .   ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+....+..+..  . 
T Consensus       172 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~~~~p~~--~-  238 (329)
T PTZ00263        172 T---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILAGRLKFPNW--F-  238 (329)
T ss_pred             c---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCCcCCCCC--C-
Confidence            1   234789999999999998899999999999999999999999864321       11112222222221111  1 


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHcC
Q 004642          689 QDIILVSTIAFACLSSQPKSRPT-----MQRISQELLAG  722 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~L~~~  722 (740)
                        ...+.+++.+||+.||++||+     ++++++|-...
T Consensus       239 --~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~  275 (329)
T PTZ00263        239 --DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH  275 (329)
T ss_pred             --CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence              123779999999999999986     78988886543

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9e-39  Score=336.44  Aligned_cols=263  Identities=24%  Similarity=0.354  Sum_probs=199.5

Q ss_pred             hcccccceeeecccceEEEEEEeCC-----------------CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCcc
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE-----------------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI  511 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  511 (740)
                      .++|.+.+.||+|+||.||+|.+++                 +..||+|.+.....  ....+.+.+|++++.+++||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCe
Confidence            3578899999999999999996532                 34699999876433  2335688999999999999999


Q ss_pred             ceeeeeeeecCeEEEEEEeccCCCchhhhcCCC----------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 004642          512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDD----------------EAIELNWTKRVNIVKSVAHALSYLHHDCTLS  575 (740)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  575 (740)
                      +++++++.+.+..++||||+++|+|.+++....                ....+++.++..++.||+.||+|||+.   +
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~  158 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N  158 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence            999999999999999999999999999885421                112478899999999999999999998   9


Q ss_pred             eEecCCCCCceEEcCCCcEEEeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh--C
Q 004642          576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM--G  651 (740)
Q Consensus       576 ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g  651 (740)
                      |+||||||+||+++.++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|||++  +
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            999999999999999999999999999865432221  122345789999999988889999999999999999997  4


Q ss_pred             CCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          652 THPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       652 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ..||.......    ...........................+.+++.+||+.||++||++.|+.+.|.
T Consensus       239 ~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         239 EQPYGELTDEQ----VIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCcCCHHH----HHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            56665322100    000000111110000000000111223789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=325.35  Aligned_cols=267  Identities=25%  Similarity=0.414  Sum_probs=210.8

Q ss_pred             cccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhc--cCCCccceeeeeeeecC----e
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST--VRHRNIVKLYGFCLHKK----C  523 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~  523 (740)
                      ...+..+.||+|+||.||+|.+ +++.||||++....      .+.|..|-++++.  ++|+||++++++-....    .
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            3445567799999999999988 46999999997543      4678888888876  48999999999887655    8


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCceEEcCCCcEEEe
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC------TLSIIHRDISSNNILLDSNLEASVA  597 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~dlkp~NIll~~~~~~kl~  597 (740)
                      ++||++|.+.|+|.++|..+    .++|....+|+..+++||+|||+..      +++|+|||||++|||+..|+...|+
T Consensus       283 ywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence            99999999999999999876    5899999999999999999999863      5689999999999999999999999


Q ss_pred             ecccceecccCCCcc--cccccCCCcccccccccccc------CCcchhHhHHHHHHHHHhCCCCCCc--ccc----c--
Q 004642          598 DFGTARLLHVDSSYR--TLRAGTYGYIAPELAYTIVV------TGKCDVYSFGVVALEVLMGTHPGGL--LSS----L--  661 (740)
Q Consensus       598 DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~------~~~~DvwslGvil~elltg~~p~~~--~~~----~--  661 (740)
                      |||+|..+.......  ...+||.+|||||++.+..-      -.+.||||+|.|+|||+++...+..  ...    +  
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            999999887543322  23589999999999876431      1268999999999999998755421  111    1  


Q ss_pred             --ccCCCCCchhhhhhcccCCCcchhhhHHH--HHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCCh
Q 004642          662 --SSSSGPKIMLIDVLNQRLSPPVNQKIVQD--IILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQ  727 (740)
Q Consensus       662 --~~~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~  727 (740)
                        ...+.-+.+..-++.++.+|..+..+...  ...+.+.+..||..||+.|-|+.-+.+++.......+
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence              11222344455566666666655544433  3448899999999999999999999999877654443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=321.12  Aligned_cols=265  Identities=26%  Similarity=0.402  Sum_probs=212.5

Q ss_pred             HHhcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc--CCCccceeeeeeeecC--
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV--RHRNIVKLYGFCLHKK--  522 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~--  522 (740)
                      ....+..+.+.||+|.||+||+|+| .|..||||++.....      +.+.+|.++++.+  +|+||+.+++.-..+.  
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            4567888899999999999999999 588999999976442      5677899999875  9999999998765433  


Q ss_pred             --eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceEEcCCCcEE
Q 004642          523 --CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD-----CTLSIIHRDISSNNILLDSNLEAS  595 (740)
Q Consensus       523 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~k  595 (740)
                        +++||.+|.+.|+|+|+|.+.    .++....++++..+|.||++||-+     ..|.|.|||||+.|||+..++...
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~  356 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  356 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence              589999999999999999875    589999999999999999999976     367899999999999999999999


Q ss_pred             EeecccceecccCCC----cccccccCCCccccccccccc------cCCcchhHhHHHHHHHHHhCC----------CCC
Q 004642          596 VADFGTARLLHVDSS----YRTLRAGTYGYIAPELAYTIV------VTGKCDVYSFGVVALEVLMGT----------HPG  655 (740)
Q Consensus       596 l~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~elltg~----------~p~  655 (740)
                      |+|+|+|.....+..    ..+.++||.+|||||++...-      .-..+||||||.|+||+..+.          .||
T Consensus       357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py  436 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY  436 (513)
T ss_pred             EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence            999999987765432    245678999999999987532      123589999999999999753          344


Q ss_pred             CcccccccCCCCCchhhhhhcccCCCcchhhhH--HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          656 GLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV--QDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       656 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      ....  +.++..+.+..-+..++++|..+..+.  +....+.++|+.||..+|..|-|+-.+.+.|.+...
T Consensus       437 yd~V--p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  437 YDVV--PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             ccCC--CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            3221  223334445555556666665554443  445558899999999999999999999999987653

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-39  Score=302.99  Aligned_cols=256  Identities=29%  Similarity=0.424  Sum_probs=216.1

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|.||.||.|+. +++-.||+|++.+.........+++.+|+++...++||||+++|+++.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            46899999999999999999954 46788999999877666555668999999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      +||.++|+++..+...... +++......+..|+|.|+.|+|.+   +|+||||||+|+|++.++..||+|||-+..-. 
T Consensus       101 lEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            9999999999999854432 578888899999999999999998   99999999999999999999999999986543 


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                       .......+||.-|.|||...+..++..+|+|++|++.||++.|..||....       .++...++..-.+..+  ...
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-------~~etYkrI~k~~~~~p--~~i  245 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-------HSETYKRIRKVDLKFP--STI  245 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-------hHHHHHHHHHccccCC--ccc
Confidence             444556699999999999999999999999999999999999999997532       2233333333333222  112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ...   ..++|.+|+..+|.+|.+..|++++..-.
T Consensus       246 s~~---a~dlI~~ll~~~p~~r~~l~~v~~hpwI~  277 (281)
T KOG0580|consen  246 SGG---AADLISRLLVKNPIERLALTEVMDHPWIV  277 (281)
T ss_pred             Chh---HHHHHHHHhccCccccccHHHHhhhHHHH
Confidence            222   78999999999999999999999987643

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-38  Score=344.54  Aligned_cols=262  Identities=27%  Similarity=0.410  Sum_probs=205.6

Q ss_pred             HHHhcccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeee
Q 004642          446 INATEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFC  518 (740)
Q Consensus       446 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (740)
                      ....++|++.+.||+|+||.||+|...      ++..||+|++......+  ....+.+|+++++.+ +|+||+++++++
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD--EREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH--HHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            344568999999999999999998532      34579999997654332  246788999999999 899999999999


Q ss_pred             eecCeEEEEEEeccCCCchhhhcCCCc-----------------------------------------------------
Q 004642          519 LHKKCMFLIYEYMERGSLFCVLHDDDE-----------------------------------------------------  545 (740)
Q Consensus       519 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  545 (740)
                      ...+..++||||+++|+|.++++....                                                     
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            999999999999999999988854210                                                     


Q ss_pred             --------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc
Q 004642          546 --------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY  611 (740)
Q Consensus       546 --------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  611 (740)
                                    ...+++.++.+++.||+.||+|||++   +|+||||||+||++++++.+||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                          12478899999999999999999998   9999999999999999999999999999865433221


Q ss_pred             --ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          612 --RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       612 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                        .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....       .....................
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~  341 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-------NSKFYKMVKRGYQMSRPDFAP  341 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-------cHHHHHHHHcccCccCCCCCC
Confidence              112235678999999998899999999999999999997 9999864321       111222222222211111111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                         ..+.+++.+||+.||++||++.++++.|...
T Consensus       342 ---~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         342 ---PEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               2378999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=303.06  Aligned_cols=261  Identities=23%  Similarity=0.337  Sum_probs=207.0

Q ss_pred             hcccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec-----C
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK-----K  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  522 (740)
                      .++|++.+.+|+|||+-||.++ ..+++.||+|++......   ..+..++|++..++++|||++++++++..+     .
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~---~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE---DIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH---HHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            4689999999999999999995 567899999999877633   247788999999999999999999988643     3


Q ss_pred             eEEEEEEeccCCCchhhhcCCCc-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDE-AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      ..|++++|...|+|.+.+..... ...+++.+.+.|+.+|++||++||+. .++++||||||.||++++++.+++.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            58999999999999999876543 33689999999999999999999998 33599999999999999999999999999


Q ss_pred             ceecccCCCc---------ccccccCCCcccccccc---ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCc
Q 004642          602 ARLLHVDSSY---------RTLRAGTYGYIAPELAY---TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKI  669 (740)
Q Consensus       602 a~~~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~  669 (740)
                      ++...-.-..         ......|..|+|||.+.   +...++++|||||||++|+|+.|..||+...+    .+. .
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----~Gg-S  250 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----QGG-S  250 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----cCC-e
Confidence            9765321111         11224689999999886   45678899999999999999999999986433    111 1


Q ss_pred             hhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          670 MLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       670 ~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ....+....+..+......+   .+.+++++|++.||.+||++.+++.++..
T Consensus       251 laLAv~n~q~s~P~~~~yse---~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSE---ALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             EEEeeeccccccCCCCCccH---HHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence            11122222222222222233   38899999999999999999999998864

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=364.22  Aligned_cols=256  Identities=31%  Similarity=0.500  Sum_probs=207.7

Q ss_pred             cccccceeeecccceEEEEEEeC--CCc----EEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP--EGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (740)
                      +..+..+.||+|.||.||+|...  +|.    .||+|.++.....  +...+|.+|..+|+.++|||||+++|+|.+.+.
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~--~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE--QEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            44556778999999999999654  343    4889988765443  446899999999999999999999999999999


Q ss_pred             EEEEEEeccCCCchhhhcCCC----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeec
Q 004642          524 MFLIYEYMERGSLFCVLHDDD----EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF  599 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  599 (740)
                      .++++|||++|+|..+|++..    +...++..+.+.++.|||+|+.||+++   ++|||||..+|+|+++...|||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence            999999999999999998752    234689999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecccCCCccc-cc-ccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhh-
Q 004642          600 GTARLLHVDSSYRT-LR-AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVL-  675 (740)
Q Consensus       600 G~a~~~~~~~~~~~-~~-~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-  675 (740)
                      |+|+.+.....+.. .. .-+..|||||.+..+.++.|+|||||||++||++| |..||...+.       ...+..++ 
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------~~v~~~~~~  919 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------FEVLLDVLE  919 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-------HHHHHHHHh
Confidence            99995543333321 11 22469999999999999999999999999999999 8889875432       12222222 


Q ss_pred             cccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          676 NQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       676 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ..++.++..     +...+.++|..||+.+|++||++..+++.+...
T Consensus       920 ggRL~~P~~-----CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  920 GGRLDPPSY-----CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             CCccCCCCC-----CChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            223443332     223378999999999999999999999987653

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.8e-39  Score=338.59  Aligned_cols=248  Identities=22%  Similarity=0.290  Sum_probs=200.3

Q ss_pred             eeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCC
Q 004642          456 YCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERG  534 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (740)
                      +.||+|+||.||++.. .+|+.||+|++.............+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999965 468999999997654333344567788999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccc
Q 004642          535 SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL  614 (740)
Q Consensus       535 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  614 (740)
                      +|..++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            9998886543   578999999999999999999998   9999999999999999999999999998764333333334


Q ss_pred             cccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHH
Q 004642          615 RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILV  694 (740)
Q Consensus       615 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  694 (740)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+.......+.  ...   ..+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~~~~~~~~~p~--~~~---~~~  222 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEIRFPR--TLS---PEA  222 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCCCCCC--CCC---HHH
Confidence            5799999999999988999999999999999999999999864221       1111222222211111  111   237


Q ss_pred             HHHHHHcccCCCCCCC-----CHHHHHHHHHc
Q 004642          695 STIAFACLSSQPKSRP-----TMQRISQELLA  721 (740)
Q Consensus       695 ~~li~~cl~~dP~~RP-----s~~ev~~~L~~  721 (740)
                      .+++.+||+.||++||     ++.+++++-..
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~  254 (323)
T cd05595         223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  254 (323)
T ss_pred             HHHHHHHccCCHHHhCCCCCCCHHHHHcCCCc
Confidence            8999999999999998     89999887543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-39  Score=342.95  Aligned_cols=257  Identities=23%  Similarity=0.303  Sum_probs=206.3

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|++++.+++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999765 58999999997654333334567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999997543   578899999999999999999998   999999999999999999999999999976532 


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhc--ccCC-Ccchh
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLN--QRLS-PPVNQ  685 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~-~~~~~  685 (740)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......       .....+..  ..+. +....
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~  224 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-------ETWENLKYWKETLQRPVYDD  224 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-------HHHHHHHhccccccCCCCCc
Confidence              223457999999999999989999999999999999999999998643210       00111110  0000 00000


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ........+.+++.+|+..+|++||+++|++++....
T Consensus       225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~  261 (333)
T cd05600         225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK  261 (333)
T ss_pred             cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence            0001123378899999999999999999999886544

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=338.50  Aligned_cols=254  Identities=25%  Similarity=0.377  Sum_probs=213.3

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (740)
                      .++|.+.++||+|.||+|+++..+ +++.||||++++...-..+.++..+.|.+++... +||.++.++++|.+++++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            468999999999999999999655 5789999999988776666678889999998887 59999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      ||||+.||++..+.+..    .+++..+.-++..|+.||+|||++   +||+||||-+|||+|.+|.+||+|||+++..-
T Consensus       447 vmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence            99999999966555543    589999999999999999999999   99999999999999999999999999998754


Q ss_pred             cCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          607 VDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      ......+..+||+.|||||++.+..|+..+|.|||||++|||+.|..||....       .++....++......+..  
T Consensus       520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-------Eee~FdsI~~d~~~yP~~--  590 (694)
T KOG0694|consen  520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD-------EEEVFDSIVNDEVRYPRF--  590 (694)
T ss_pred             CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHhcCCCCCCCc--
Confidence            33445566799999999999999999999999999999999999999987532       234445555444443322  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHc
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPT-----MQRISQELLA  721 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~L~~  721 (740)
                      ...   +...|+.+++.++|++|-.     +.+|.++-..
T Consensus       591 ls~---ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFF  627 (694)
T KOG0694|consen  591 LSK---EAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFF  627 (694)
T ss_pred             ccH---HHHHHHHHHhccCcccccCCCCCCchhhhhCCcc
Confidence            222   2678999999999999964     5666666543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-39  Score=337.45  Aligned_cols=246  Identities=26%  Similarity=0.330  Sum_probs=198.6

Q ss_pred             eecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCc
Q 004642          458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL  536 (740)
Q Consensus       458 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  536 (740)
                      ||+|+||.||+|... +++.||+|++.............+.+|++++.+++||||+++++++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999654 5889999998754333333456788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccccc
Q 004642          537 FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA  616 (740)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  616 (740)
                      .+++....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.............
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            99987643   588999999999999999999998   999999999999999999999999999986443333334457


Q ss_pred             cCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHH
Q 004642          617 GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVST  696 (740)
Q Consensus       617 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  696 (740)
                      ||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ..............+  ...   ...+.+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~~~~~~~~--~~~---~~~~~~  222 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKILQEPLRFP--DGF---DRDAKD  222 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCCCCCC--CcC---CHHHHH
Confidence            99999999999999999999999999999999999999864221       111222222222111  111   123789


Q ss_pred             HHHHcccCCCCCCC---CHHHHHHHHHc
Q 004642          697 IAFACLSSQPKSRP---TMQRISQELLA  721 (740)
Q Consensus       697 li~~cl~~dP~~RP---s~~ev~~~L~~  721 (740)
                      ++.+||+.||++||   ++.|++++...
T Consensus       223 li~~~L~~dp~~R~~~~~~~e~l~hp~~  250 (312)
T cd05585         223 LLIGLLSRDPTRRLGYNGAQEIKNHPFF  250 (312)
T ss_pred             HHHHHcCCCHHHcCCCCCHHHHHcCCCc
Confidence            99999999999997   57788776443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-38  Score=338.23  Aligned_cols=248  Identities=23%  Similarity=0.288  Sum_probs=200.3

Q ss_pred             eeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCC
Q 004642          456 YCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERG  534 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (740)
                      +.||+|+||.||++.. .+|+.||+|++.............+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999964 468999999997654433444567889999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccc
Q 004642          535 SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL  614 (740)
Q Consensus       535 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  614 (740)
                      +|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence            9998886543   588999999999999999999998   9999999999999999999999999998764333333344


Q ss_pred             cccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHH
Q 004642          615 RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILV  694 (740)
Q Consensus       615 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  694 (740)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+.......  +...   ...+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-------~~~~~~~~~~~~~~--p~~~---~~~~  222 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEDIKF--PRTL---SADA  222 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-------HHHHHHhccCCccC--CCCC---CHHH
Confidence            5799999999999988899999999999999999999999864221       11111111111111  1111   1237


Q ss_pred             HHHHHHcccCCCCCCC-----CHHHHHHHHHc
Q 004642          695 STIAFACLSSQPKSRP-----TMQRISQELLA  721 (740)
Q Consensus       695 ~~li~~cl~~dP~~RP-----s~~ev~~~L~~  721 (740)
                      .+++.+||+.||++||     ++.|++++...
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~  254 (328)
T cd05593         223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF  254 (328)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence            7899999999999997     89999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-39  Score=324.81  Aligned_cols=260  Identities=25%  Similarity=0.344  Sum_probs=204.9

Q ss_pred             HhcccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccch-----------HHHHHHHHHHHHHhccCCCccceee
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDS-----------AFVKSFQNEAHVLSTVRHRNIVKLY  515 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~  515 (740)
                      ..++|++.+.||+|.||.|-+|+ ..+++.||+|++.+......           ...+...+|+.+|++++|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            35789999999999999999995 44789999999976432211           1134788999999999999999999


Q ss_pred             eeeeec--CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc
Q 004642          516 GFCLHK--KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLE  593 (740)
Q Consensus       516 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  593 (740)
                      ++..++  +..|||+|||..|.+...-   .....++..++++++.++..||+|||.+   ||+||||||+|+|++++|+
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence            998875  5689999999998874222   2222389999999999999999999999   9999999999999999999


Q ss_pred             EEEeecccceecccC-----CCcccccccCCCccccccccccc----cCCcchhHhHHHHHHHHHhCCCCCCcccccccC
Q 004642          594 ASVADFGTARLLHVD-----SSYRTLRAGTYGYIAPELAYTIV----VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS  664 (740)
Q Consensus       594 ~kl~DfG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~  664 (740)
                      +||+|||.+......     .......+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||-....+   
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---  325 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---  325 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---
Confidence            999999999866221     11223358999999999987632    345789999999999999999998753321   


Q ss_pred             CCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          665 SGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       665 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                          .....++...+..+...   +....+.++|+++|.+||+.|.+..+|..|.+-..
T Consensus       326 ----~l~~KIvn~pL~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  326 ----ELFDKIVNDPLEFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             ----HHHHHHhcCcccCCCcc---cccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence                22334444444443332   23344889999999999999999999999987543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-38  Score=339.64  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=205.7

Q ss_pred             hcccccceeeecccceEEEEEEeCC--CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE--GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      .++|++.+.||+|+||.||+|....  +..||+|++...........+.+.+|+++++.++||||+++++++.+++..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3579999999999999999996443  36899999865443333345678899999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999997654   578899999999999999999998   99999999999999999999999999998754


Q ss_pred             cCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          607 VDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      ..   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+.......+.  .
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~i~~~~~~~p~--~  250 (340)
T PTZ00426        183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-------LLIYQKILEGIIYFPK--F  250 (340)
T ss_pred             CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-------HHHHHHHhcCCCCCCC--C
Confidence            22   2234799999999999988899999999999999999999999864322       1112222222221111  1


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHcC
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRP-----TMQRISQELLAG  722 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~L~~~  722 (740)
                      ..+   .+.+++.+|++.||++|+     +++|++++....
T Consensus       251 ~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~  288 (340)
T PTZ00426        251 LDN---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG  288 (340)
T ss_pred             CCH---HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence            112   267899999999999995     899999886544

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.2e-38  Score=330.60  Aligned_cols=261  Identities=21%  Similarity=0.275  Sum_probs=198.1

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|... +++.||+|++.......  ....+.+|++++++++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            57999999999999999999554 68999999987543222  1246778999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++ +|.+++.....  .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          83 EYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             eCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            99985 88888765432  478899999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCc---------h
Q 004642          609 SSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKI---------M  670 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~---------~  670 (740)
                      ........|++.|+|||++.+ ..++.++||||+||++|||++|+.||........        ......         .
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence            333344568999999998865 5688899999999999999999999864321000        000000         0


Q ss_pred             hhhhhcccCCC-cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          671 LIDVLNQRLSP-PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       671 ~~~~~~~~l~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ......+.... +.............+++.+|++.||.+|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00000000000 0000000111236799999999999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2e-38  Score=337.07  Aligned_cols=255  Identities=23%  Similarity=0.355  Sum_probs=201.7

Q ss_pred             eeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||++... +++.||+|+++..........+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999654 6889999999865544444456788999999988 799999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            99988886543   589999999999999999999998   999999999999999999999999999875332233334


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCC--CCchhhhhhcccCCCcchhhhHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG--PKIMLIDVLNQRLSPPVNQKIVQDI  691 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~  691 (740)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||+..........  .+.....+.......+.  ..   .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~---~  229 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SL---S  229 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CC---C
Confidence            45799999999999999999999999999999999999999975332111111  11111222222222111  11   1


Q ss_pred             HHHHHHHHHcccCCCCCCCC------HHHHHHHHHc
Q 004642          692 ILVSTIAFACLSSQPKSRPT------MQRISQELLA  721 (740)
Q Consensus       692 ~~l~~li~~cl~~dP~~RPs------~~ev~~~L~~  721 (740)
                      ..+.+++.+|++.||++||+      ++|++++-..
T Consensus       230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~  265 (329)
T cd05588         230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF  265 (329)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence            23788999999999999987      7888877544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.9e-38  Score=324.10  Aligned_cols=254  Identities=23%  Similarity=0.377  Sum_probs=202.2

Q ss_pred             cccccceeeecccceEEEEEEeC----CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (740)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.++.....  ...+.+.+|++++.+++||||+++++++..++..+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            56889999999999999999653    3578999999865432  23467889999999999999999999999999999


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      +||||+++|+|.+++....  ..+++.+++.++.|++.||+|||++   +++||||||+||+++.++.++++|||.+...
T Consensus        83 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999999987643  2588999999999999999999998   9999999999999999999999999987654


Q ss_pred             ccCCCcc-cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcc
Q 004642          606 HVDSSYR-TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV  683 (740)
Q Consensus       606 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  683 (740)
                      ....... ....++..|+|||++.+..++.++|||||||++||+++ |+.||......        ...+.+......+.
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  229 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDGFRLPA  229 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCCCCC
Confidence            3221111 12235678999999999999999999999999999775 99998653221        11111111111111


Q ss_pred             hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ...   ....+.+++.+||+.+|++||+++|+.+.|..
T Consensus       230 ~~~---~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         230 PRN---CPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             CCC---CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            111   12237889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.6e-38  Score=334.16  Aligned_cols=266  Identities=24%  Similarity=0.325  Sum_probs=207.2

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|+||.||++... +|..||+|.+.....  ....+.+.+|++++++++||||+++++++..++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            468999999999999999999654 688899999876432  23456789999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          82 MEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             eecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            99999999999987643   578899999999999999999975  1699999999999999999999999999976532


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccccc----------CCC-----------
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS----------SSG-----------  666 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~----------~~~-----------  666 (740)
                        .......|+..|+|||++.+..++.++|||||||++|||++|+.||........          ...           
T Consensus       157 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         157 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             --cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence              222344689999999999998999999999999999999999999864221000          000           


Q ss_pred             --------------CCch---hhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCC
Q 004642          667 --------------PKIM---LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP  725 (740)
Q Consensus       667 --------------~~~~---~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  725 (740)
                                    ....   ..+.+.....+....  ......+.+++.+||+.||++|||+.|++++.......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPN--GVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCC--ccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                          0000   000010000110000  01123488999999999999999999999998765443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.6e-38  Score=336.13  Aligned_cols=254  Identities=24%  Similarity=0.352  Sum_probs=199.6

Q ss_pred             eeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||++... +++.||+|++......+....+.+.+|..++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999654 6789999999875544444456788899888877 899999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|..++....   .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence            99988886543   588999999999999999999998   999999999999999999999999999976433333334


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCC-CCchhh-hhhcccCCCcchhhhHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG-PKIMLI-DVLNQRLSPPVNQKIVQDI  691 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-~~~~~~-~~~~~~l~~~~~~~~~~~~  691 (740)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||........... ...... .+.......+.     ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~-----~~~  229 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-----SLS  229 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC-----CCC
Confidence            45799999999999999999999999999999999999999864322111111 111111 12222222111     112


Q ss_pred             HHHHHHHHHcccCCCCCCCC------HHHHHHHHH
Q 004642          692 ILVSTIAFACLSSQPKSRPT------MQRISQELL  720 (740)
Q Consensus       692 ~~l~~li~~cl~~dP~~RPs------~~ev~~~L~  720 (740)
                      ..+.+++.+||+.||++||+      +++++++-.
T Consensus       230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~  264 (329)
T cd05618         230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  264 (329)
T ss_pred             HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCC
Confidence            23779999999999999998      578877743

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-38  Score=315.76  Aligned_cols=259  Identities=24%  Similarity=0.303  Sum_probs=221.4

Q ss_pred             cccccceeeecccceEEEEEEeCC-CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      +.|+..+.||+|.-|+||+++.++ +..+|+|++.+..........+...|.+|++.++||.++.+|+.++.++..++||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            467778899999999999997764 5899999998877666666778899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc-
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV-  607 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~-  607 (740)
                      |||+||+|..+++++... .+++..+..++.+|+-||+|||-.   |||.|||||+|||+.++|++.|+||.++..... 
T Consensus       157 eyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999999999886654 689999999999999999999988   999999999999999999999999998643211 


Q ss_pred             --------------------------------C-C----------------------CcccccccCCCcccccccccccc
Q 004642          608 --------------------------------D-S----------------------SYRTLRAGTYGYIAPELAYTIVV  632 (740)
Q Consensus       608 --------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~  632 (740)
                                                      . .                      ......+||-+|+|||++.+..+
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                      00122469999999999999999


Q ss_pred             CCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCC-
Q 004642          633 TGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPT-  711 (740)
Q Consensus       633 ~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-  711 (740)
                      +.++|.|+|||++|||+.|+.||..       ...+..+.+++.+.+..+...   .....+.++|++.|.+||.+|-. 
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG-------~~~~~Tl~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKG-------SNNKETLRNIVGQPLKFPEEP---EVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCC-------CCchhhHHHHhcCCCcCCCCC---cchhHHHHHHHHHhccChhhhhcc
Confidence            9999999999999999999999875       445677888888877655443   23334889999999999999987 


Q ss_pred             ---HHHHHHHHHcC
Q 004642          712 ---MQRISQELLAG  722 (740)
Q Consensus       712 ---~~ev~~~L~~~  722 (740)
                         |+||.+|-...
T Consensus       383 ~rGA~eIK~HpFF~  396 (459)
T KOG0610|consen  383 KRGAAEIKRHPFFE  396 (459)
T ss_pred             ccchHHhhcCcccc
Confidence               99999887654

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.4e-38  Score=338.05  Aligned_cols=255  Identities=25%  Similarity=0.383  Sum_probs=197.6

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|+..+.||+|+||.||+|.. .+|+.||+|++.....  ....+.+.+|+++++.++|+||+++++++...+..++||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            3466678899999999999965 4689999999865432  234567899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+..       ..++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus       152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            999999986432       345677888999999999999998   9999999999999999999999999999876533


Q ss_pred             CCcccccccCCCccccccccc-----cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcc
Q 004642          609 SSYRTLRAGTYGYIAPELAYT-----IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV  683 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  683 (740)
                      ........||..|+|||++..     ...+.++|||||||++|||++|+.||.....     ..................
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~  296 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAICMSQPPEA  296 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhccCCCCC
Confidence            333344579999999998743     2344689999999999999999999873211     000111111111111111


Q ss_pred             hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      ..   .....+.+++.+||+.||++||++.|++++-...+.
T Consensus       297 ~~---~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        297 PA---TASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             CC---ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            11   112238899999999999999999999999766654

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.9e-38  Score=334.39  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=198.0

Q ss_pred             cccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHH---hccCCCccceeeeeeeecCeEEEE
Q 004642          452 FHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVL---STVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      |++.+.||+|+||.||+|.. .+|+.||+|+++..........+.+.+|++++   +.++||||+++++++..++..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67789999999999999965 46899999999754332223345566666554   567899999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++++|...++..    .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999998887643    589999999999999999999998   999999999999999999999999999875433


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      .........|++.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+.......+.  ..
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~~~~p~--~~  224 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-------EEVFDSIVNDEVRYPR--FL  224 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCC--CC
Confidence            33333445799999999999998999999999999999999999999864321       1112222222221111  11


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHH
Q 004642          688 VQDIILVSTIAFACLSSQPKSRP-----TMQRISQELL  720 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~L~  720 (740)
                      .   ..+.+++.+||+.||++||     ++.+++++..
T Consensus       225 ~---~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~  259 (324)
T cd05589         225 S---REAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF  259 (324)
T ss_pred             C---HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence            1   2377899999999999999     6788877653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.6e-38  Score=322.16  Aligned_cols=262  Identities=21%  Similarity=0.273  Sum_probs=210.0

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+......+......+.+|+++++.++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5789999999999999999965 478999999887644444455577889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          529 EYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      ||+++++|.+++.... ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885432 223578899999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      .........|+..|+|||.+.+..++.++||||+|+++|||++|+.||.....      ........+.....++...  
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~--  230 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQKIEQCDYPPLPT--  230 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHHHhcCCCCCCCh--
Confidence            33333344688899999999888889999999999999999999999753211      1111222222211111111  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ......+.+++.+||+.+|++||++.++++.+...
T Consensus       231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11223488999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=343.01  Aligned_cols=256  Identities=26%  Similarity=0.381  Sum_probs=207.8

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++...........+.+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999654 68999999997654333334567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            9999999999997652   588999999999999999999998   9999999999999999999999999999876433


Q ss_pred             C-----------------------------CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccc
Q 004642          609 S-----------------------------SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLS  659 (740)
Q Consensus       609 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~  659 (740)
                      .                             .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                             12233468999999999999999999999999999999999999987532


Q ss_pred             ccccCCCCCchhhhhhc--ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHcC
Q 004642          660 SLSSSSGPKIMLIDVLN--QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPT-MQRISQELLAG  722 (740)
Q Consensus       660 ~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~~L~~~  722 (740)
                      .       ......+..  .....+.....   ...+.+++.+|+. ||++||+ ++|++++....
T Consensus       235 ~-------~~~~~~i~~~~~~~~~p~~~~~---~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~  289 (350)
T cd05573         235 L-------QETYNKIINWKESLRFPPDPPV---SPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK  289 (350)
T ss_pred             H-------HHHHHHHhccCCcccCCCCCCC---CHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence            1       111112222  11111111111   2237789999997 9999999 99999986554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.9e-38  Score=329.49  Aligned_cols=269  Identities=24%  Similarity=0.327  Sum_probs=202.5

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|+||.||+|... +++.||+|++........  ...+.+|+++++.++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            468999999999999999999664 689999999975443221  24567899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||++ ++|.+++....  ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          82 FEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             EECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            99996 57777775433  2478889999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc----------CCCCCch--hhh-
Q 004642          608 DSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS----------SSGPKIM--LID-  673 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~----------~~~~~~~--~~~-  673 (740)
                      .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||........          ......+  ... 
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence            3333344578999999998865 4578899999999999999999999975422100          0000000  000 


Q ss_pred             -hhcc-cC---CCcchhhhH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCC
Q 004642          674 -VLNQ-RL---SPPVNQKIV---QDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP  725 (740)
Q Consensus       674 -~~~~-~l---~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  725 (740)
                       ...+ ..   .+.......   .....+.+++.+|++.||++|||++|+++|-.....+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence             0000 00   000000000   0112367899999999999999999999988776543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-37  Score=319.67  Aligned_cols=250  Identities=25%  Similarity=0.416  Sum_probs=201.6

Q ss_pred             cccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      ++|++.+.||+|+||.||++.++++..+|+|.+......    .+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            468888999999999999999888889999998754332    2568889999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++|+|.++++....  .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          80 FMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            9999999999875432  588999999999999999999998   99999999999999999999999999998654322


Q ss_pred             Ccc-cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          610 SYR-TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       610 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      ... ....++..|+|||++.+..++.++||||||+++|||++ |+.||.....       ......+.... ....+.  
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~-~~~~~~--  224 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVEMISRGF-RLYRPK--  224 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCC-CCCCCC--
Confidence            211 12235668999999988889999999999999999999 8999864321       11111111111 111111  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                       .....+.+++.+||+.+|++||+++|+++.|
T Consensus       225 -~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         225 -LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence             1122478999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-38  Score=328.13  Aligned_cols=261  Identities=22%  Similarity=0.264  Sum_probs=206.5

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      .|++.+.||+|+||+||++.. .+++.||+|++.............+.+|++++++++||||+++++.+.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            478889999999999999965 4689999999976544333334567789999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++|+|.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            9999999988865332 3589999999999999999999998   99999999999999999999999999998764322


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                       ......|+..|+|||++.+..++.++||||+||++|||++|+.||......    .........+.... .....   .
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~-~~~~~---~  227 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK----VKREEVERRVKEDQ-EEYSE---K  227 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh----hHHHHHHHHhhhcc-cccCc---c
Confidence             223347899999999999888999999999999999999999998642210    00011111111111 11111   1


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHcCCC
Q 004642          690 DIILVSTIAFACLSSQPKSRP-----TMQRISQELLAGKT  724 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~L~~~~~  724 (740)
                      ....+.+++.+||+.||++||     ++++++++-...+.
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            122378999999999999999     89999888666543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.1e-38  Score=336.61  Aligned_cols=248  Identities=23%  Similarity=0.294  Sum_probs=199.6

Q ss_pred             eeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCC
Q 004642          456 YCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERG  534 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (740)
                      +.||+|+||.||++.. .+|+.||+|++.............+..|++++..++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999954 578999999997654333334567788999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          535 SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH-DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       535 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      +|..++....   .+++..+..++.||+.||+|||+ .   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence            9998886543   58899999999999999999997 6   999999999999999999999999999976433333334


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....       +.....+.......+  ...   ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-------~~~~~~i~~~~~~~p--~~~---~~~  222 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEIRFP--RTL---SPE  222 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-------HHHHHHHhcCCCCCC--CCC---CHH
Confidence            45799999999999988999999999999999999999999864221       111111111111111  111   123


Q ss_pred             HHHHHHHcccCCCCCCC-----CHHHHHHHHHc
Q 004642          694 VSTIAFACLSSQPKSRP-----TMQRISQELLA  721 (740)
Q Consensus       694 l~~li~~cl~~dP~~RP-----s~~ev~~~L~~  721 (740)
                      +.+++.+||+.||++|+     ++++++++...
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~  255 (325)
T cd05594         223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF  255 (325)
T ss_pred             HHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCc
Confidence            78899999999999996     99999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-38  Score=324.60  Aligned_cols=249  Identities=38%  Similarity=0.589  Sum_probs=192.3

Q ss_pred             cceeeecccceEEEEEEeC-----CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          454 IKYCIGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.....  ...+.+.+|++.+++++||||++++|++...+..++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE--EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH--HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc--ccceeeeecccccccccccccccccccccccccccccc
Confidence            4678999999999999776     3678999999653332  23578999999999999999999999999888899999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.++++... ...+++.++..|+.||+.||+|||+.   +++|+||+++||++++++.+||+|||++......
T Consensus        81 e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             E--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            9999999999998762 23689999999999999999999999   9999999999999999999999999999876322


Q ss_pred             CCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchh
Q 004642          609 SSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       609 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  685 (740)
                      ...  .....+...|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+.+.+.+....+...
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~  228 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQRLPIPD  228 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTEETTSBT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccceecc
Confidence            221  222346789999999999889999999999999999999 6788654221        11222222222221121


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ....   .+.+++.+||+.+|++||+++++++.|
T Consensus       229 ~~~~---~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  229 NCPK---DIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TSBH---HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             chhH---HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1222   378999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5e-38  Score=333.35  Aligned_cols=248  Identities=25%  Similarity=0.365  Sum_probs=199.3

Q ss_pred             eeeecccceEEEEEEe----CCCcEEEEEEccCCccc-chHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEe
Q 004642          456 YCIGTGGYGSVYKAEL----PEGKVVALKKLHHSETE-DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      +.||+|+||.||+++.    .+++.||+|++...... .......+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999964    35789999998754321 122245678899999999999999999999999999999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                      +++++|.+++....   .+.+..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999887543   467888889999999999999998   999999999999999999999999999976443333


Q ss_pred             cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHH
Q 004642          611 YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQD  690 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  690 (740)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+.......+.  ..   
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~~~~~~~~~--~~---  223 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKILKGKLNLPP--YL---  223 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCCCCC--CC---
Confidence            33445799999999999988899999999999999999999999864321       1122222222222111  11   


Q ss_pred             HHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHc
Q 004642          691 IILVSTIAFACLSSQPKSRP-----TMQRISQELLA  721 (740)
Q Consensus       691 ~~~l~~li~~cl~~dP~~RP-----s~~ev~~~L~~  721 (740)
                      ...+.+++.+||+.+|++||     ++++++++-..
T Consensus       224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~  259 (323)
T cd05584         224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF  259 (323)
T ss_pred             CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence            12378999999999999999     89999887543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-37  Score=324.50  Aligned_cols=256  Identities=26%  Similarity=0.452  Sum_probs=205.1

Q ss_pred             cccccceeeecccceEEEEEEeCC------CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPE------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (740)
                      ++|++.+.||+|+||.||+|....      +..||+|.+.....  ......+.+|++++.+++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            478889999999999999996532      25799999875432  2335678999999999999999999999999999


Q ss_pred             EEEEEEeccCCCchhhhcCCCc-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC
Q 004642          524 MFLIYEYMERGSLFCVLHDDDE-------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS  590 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~  590 (740)
                      .+++|||+++++|.+++.....             ...+++.++..++.|++.||+|||+.   +++|+||||+||++++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence            9999999999999999865321             13578999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCC--cccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCC
Q 004642          591 NLEASVADFGTARLLHVDSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGP  667 (740)
Q Consensus       591 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~  667 (740)
                      ++.++|+|||+++.......  ......++..|+|||++.+..++.++|||||||++|||++ |..||.....       
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-------  232 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-------  232 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence            99999999999976533221  1233456789999999988889999999999999999998 9999764221       


Q ss_pred             CchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          668 KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       668 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                       ......+..........   .....+.+++.+||+.||++||+++|++++|..
T Consensus       233 -~~~~~~i~~~~~~~~~~---~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         233 -QEVIEMIRSRQLLPCPE---DCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHHHHcCCcCCCcc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             12222222222222211   122348899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.8e-38  Score=333.08  Aligned_cols=251  Identities=23%  Similarity=0.338  Sum_probs=200.0

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCC-ccceeeeeeeecCeEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-NIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  528 (740)
                      +|++.+.||+|+||.||+|... +++.||+|++...........+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999654 5789999999765433333456778899999999764 6888999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999998886543   578899999999999999999998   9999999999999999999999999998754333


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      ........||+.|+|||++.+..++.++||||+||++|||+||+.||.....       ......+.......+  ....
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~~~~--~~~~  225 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHNVSYP--KSLS  225 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCC--CCCC
Confidence            3333445799999999999998999999999999999999999999864321       111222222222111  1112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCH-----HHHHHHH
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTM-----QRISQEL  719 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~~L  719 (740)
                         ..+.+++.+||+.||++|++.     +++.++.
T Consensus       226 ---~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp  258 (324)
T cd05587         226 ---KEAVSICKGLLTKHPAKRLGCGPTGERDIREHA  258 (324)
T ss_pred             ---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence               237789999999999999976     6776654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.6e-38  Score=325.63  Aligned_cols=253  Identities=25%  Similarity=0.294  Sum_probs=199.1

Q ss_pred             eecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCc
Q 004642          458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL  536 (740)
Q Consensus       458 lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  536 (740)
                      ||+|+||+||++.. .+|+.||+|++...........+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999954 46899999998765443333346778899999999999999999999999999999999999999


Q ss_pred             hhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccccc
Q 004642          537 FCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR  615 (740)
Q Consensus       537 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  615 (740)
                      .+++.... ....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||.+.............
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            88775432 234689999999999999999999998   99999999999999999999999999998765433333345


Q ss_pred             ccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHH
Q 004642          616 AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVS  695 (740)
Q Consensus       616 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  695 (740)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ...............  ...   .....+.
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~--~~~---~~~~~~~  229 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRILNDSVT--YPD---KFSPASK  229 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch---hHHHHHHhhcccCCC--Ccc---cCCHHHH
Confidence            78999999999999999999999999999999999999986432100   000111111111111  111   1122378


Q ss_pred             HHHHHcccCCCCCCC-----CHHHHHHHHHc
Q 004642          696 TIAFACLSSQPKSRP-----TMQRISQELLA  721 (740)
Q Consensus       696 ~li~~cl~~dP~~RP-----s~~ev~~~L~~  721 (740)
                      +++.+||+.||++||     ++++++++-..
T Consensus       230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~  260 (280)
T cd05608         230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLF  260 (280)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence            999999999999999     78888887544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.4e-38  Score=333.15  Aligned_cols=247  Identities=24%  Similarity=0.366  Sum_probs=197.5

Q ss_pred             eeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||+|..+ +++.||+|++...........+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999654 5889999998754332223346677888888876 699999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence            99998887543   588999999999999999999998   999999999999999999999999999876433333334


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+.......+  ....   ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~--~~~~---~~  222 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDEVVYP--TWLS---QD  222 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCCCCCC--CCCC---HH
Confidence            45799999999999988899999999999999999999999875321       111222222211111  1111   23


Q ss_pred             HHHHHHHcccCCCCCCCCH------HHHHHHHH
Q 004642          694 VSTIAFACLSSQPKSRPTM------QRISQELL  720 (740)
Q Consensus       694 l~~li~~cl~~dP~~RPs~------~ev~~~L~  720 (740)
                      +.+++.+|++.||++||++      ++++++-.
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~  255 (320)
T cd05590         223 AVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF  255 (320)
T ss_pred             HHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence            7889999999999999998      77777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=345.51  Aligned_cols=255  Identities=22%  Similarity=0.345  Sum_probs=205.5

Q ss_pred             hcccccceeeecccceEEEEEEeCCC-cEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeee-ee-----
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEG-KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFC-LH-----  520 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~-----  520 (740)
                      ..++++.+.|.+|||+.||.|....+ ..||+|++-..   ++...+...+|+++|++++ |||||.+++.. ..     
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            34677889999999999999976655 99999999765   4556788999999999996 99999999933 21     


Q ss_pred             -cCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeec
Q 004642          521 -KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF  599 (740)
Q Consensus       521 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  599 (740)
                       ..+++|.||||.||.|-+++...... .+++.++++|+.|+++|+++||.. .++|||||||-+|||++.++..|||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence             24689999999999999999865444 499999999999999999999986 678999999999999999999999999


Q ss_pred             ccceecccCCCcc---------cccccCCCcccccccc---ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCC
Q 004642          600 GTARLLHVDSSYR---------TLRAGTYGYIAPELAY---TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGP  667 (740)
Q Consensus       600 G~a~~~~~~~~~~---------~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~  667 (740)
                      |.|.-........         -...-|+.|+|||.+.   +..+++|+|||+|||+||-|+..++||+....       
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------  263 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------  263 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence            9987543222110         1134689999999764   67899999999999999999999999985322       


Q ss_pred             CchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          668 KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       668 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                          ..++......+....+   ...+.+||..||+.+|++||++.||++++...
T Consensus       264 ----laIlng~Y~~P~~p~y---s~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  264 ----LAILNGNYSFPPFPNY---SDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             ----eeEEeccccCCCCccH---HHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                1233333333332222   33488999999999999999999999998653

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.5e-38  Score=327.13  Aligned_cols=262  Identities=24%  Similarity=0.284  Sum_probs=199.8

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++......+ ...+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            46899999999999999999765 57899999997653322 23467789999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||++++.+..+....   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          80 EYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            999998776554332   2578899999999999999999998   9999999999999999999999999999876432


Q ss_pred             CC-cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCchhhhhh-c--
Q 004642          609 SS-YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIMLIDVL-N--  676 (740)
Q Consensus       609 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~-~--  676 (740)
                      .. ......|+..|+|||++.+..++.++||||+||++|||++|+.||........        ............ +  
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            22 22334689999999999988899999999999999999999999875322100        000000000000 0  


Q ss_pred             ---ccCCCcch-h-----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          677 ---QRLSPPVN-Q-----KIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       677 ---~~l~~~~~-~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                         ...+.... .     ........+.+++.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence               00000000 0     000112348899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.7e-38  Score=332.83  Aligned_cols=254  Identities=22%  Similarity=0.344  Sum_probs=200.5

Q ss_pred             eeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||+|.. .+++.||+|++......+....+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999965 46789999999876554444567788999999888 699999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|..++....   .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence            99988886543   589999999999999999999998   999999999999999999999999999975432233334


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||..........................+.  ...   ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~---~~  229 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLS---VK  229 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCC---HH
Confidence            4579999999999999999999999999999999999999996533211111111111222222222111  111   23


Q ss_pred             HHHHHHHcccCCCCCCCC------HHHHHHHHH
Q 004642          694 VSTIAFACLSSQPKSRPT------MQRISQELL  720 (740)
Q Consensus       694 l~~li~~cl~~dP~~RPs------~~ev~~~L~  720 (740)
                      +.+++.+||+.||++|++      ++++.++-.
T Consensus       230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~  262 (327)
T cd05617         230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF  262 (327)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCC
Confidence            678999999999999997      568877653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-37  Score=319.83  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=205.3

Q ss_pred             hcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .++|++.++||+|+||.||+|...++..||+|.+......    .+.+.+|+.++++++|+||+++++++..++..+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            4678999999999999999998888889999998654322    467889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.++++.... ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||.++.....
T Consensus        81 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          81 EYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             ecCCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            99999999999875432 3578899999999999999999998   9999999999999999999999999999876432


Q ss_pred             CCc-ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          609 SSY-RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      ... .....++..|+|||+..+..++.++|||||||++|+|++ |+.||.....        ......+......+....
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  228 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SDVMSALQRGYRMPRMEN  228 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HHHHHHHHcCCCCCCCCC
Confidence            211 122345678999999988889999999999999999998 9999864221        111111211111111111


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                         ....+.+++.+|++.+|++||+++++.+.|+.
T Consensus       229 ---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         229 ---CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               12237899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.5e-38  Score=332.57  Aligned_cols=250  Identities=23%  Similarity=0.339  Sum_probs=200.4

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      +|++.+.||+|+||.||+|... +++.||+|++...........+.+..|..++... +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999654 5789999999765433333345667788888777 5899999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+.+....   .+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999998886543   578899999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+.......+.  ...
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~p~--~~s  225 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHNVAYPK--SMS  225 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCC--cCC
Confidence            3334455799999999999999999999999999999999999999864321       1122223322222111  112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTM-----QRISQE  718 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~~  718 (740)
                         ..+.+++.+|++.||++|++.     .++.++
T Consensus       226 ---~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         226 ---KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             ---HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence               237889999999999999974     677655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.4e-38  Score=332.90  Aligned_cols=248  Identities=25%  Similarity=0.356  Sum_probs=199.5

Q ss_pred             eeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||+|... +++.||+|++...........+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            35899999999999654 5789999999765433333456677888888866 899999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|...+....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence            99998886543   578899999999999999999999   999999999999999999999999999976543333344


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+.......+.  ...   ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-------~~~~~~i~~~~~~~p~--~~~---~~  222 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-------DDLFESILHDDVLYPV--WLS---KE  222 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCCCCCC--CCC---HH
Confidence            45799999999999988999999999999999999999999875321       1122222222221111  011   23


Q ss_pred             HHHHHHHcccCCCCCCC-------CHHHHHHHHHc
Q 004642          694 VSTIAFACLSSQPKSRP-------TMQRISQELLA  721 (740)
Q Consensus       694 l~~li~~cl~~dP~~RP-------s~~ev~~~L~~  721 (740)
                      +.+++.+|++.||++||       ++++++++...
T Consensus       223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~  257 (321)
T cd05591         223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF  257 (321)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence            77899999999999999       88999887643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9.3e-38  Score=336.76  Aligned_cols=256  Identities=25%  Similarity=0.370  Sum_probs=198.3

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||+||++.. .+++.||+|++.............+.+|++++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4788999999999999999954 468999999997654333444567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++...+   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999997643   588999999999999999999998   9999999999999999999999999998754321


Q ss_pred             CC-----------------------------------cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCC
Q 004642          609 SS-----------------------------------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTH  653 (740)
Q Consensus       609 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~  653 (740)
                      ..                                   .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            00                                   0123479999999999999899999999999999999999999


Q ss_pred             CCCcccccccCCCCCchhhhhhc--ccCCCcchhhhHHHHHHHHHHHHHccc--CCCCCCCCHHHHHHHHHc
Q 004642          654 PGGLLSSLSSSSGPKIMLIDVLN--QRLSPPVNQKIVQDIILVSTIAFACLS--SQPKSRPTMQRISQELLA  721 (740)
Q Consensus       654 p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~ev~~~L~~  721 (740)
                      ||.....       ......+..  ..+..+......+   .+.+++.+++.  .++..||+++|++++-..
T Consensus       235 Pf~~~~~-------~~~~~~i~~~~~~~~~p~~~~~s~---~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f  296 (363)
T cd05628         235 PFCSETP-------QETYKKVMNWKETLIFPPEVPISE---KAKDLILRFCCEWEHRIGAPGVEEIKTNPFF  296 (363)
T ss_pred             CCCCCCH-------HHHHHHHHcCcCcccCCCcCCCCH---HHHHHHHHHcCChhhcCCCCCHHHHhCCCCC
Confidence            9864321       111122221  1111111111112   25566666433  333456999999998543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.7e-37  Score=336.45  Aligned_cols=260  Identities=23%  Similarity=0.379  Sum_probs=204.7

Q ss_pred             HhcccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeeeee
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLH  520 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  520 (740)
                      ..++|.+.+.||+|+||.||+|...      .+..||||++......  ...+.+.+|+++++++. ||||+++++++.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            3578899999999999999999642      2347999999754332  23467899999999996 9999999999999


Q ss_pred             cCeEEEEEEeccCCCchhhhcCCCc-------------------------------------------------------
Q 004642          521 KKCMFLIYEYMERGSLFCVLHDDDE-------------------------------------------------------  545 (740)
Q Consensus       521 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  545 (740)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999988864211                                                       


Q ss_pred             --------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 004642          546 --------------------------------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNIL  587 (740)
Q Consensus       546 --------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl  587 (740)
                                                            ...+++.++..++.||+.||+|||+.   +|+||||||+||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                                  12478888999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccC
Q 004642          588 LDSNLEASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSS  664 (740)
Q Consensus       588 l~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~  664 (740)
                      ++.++.+||+|||+++........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....    
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~----  345 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV----  345 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch----
Confidence            999999999999999876433221  122356788999999998889999999999999999997 9899764211    


Q ss_pred             CCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          665 SGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       665 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                         +......+............   ...+.+++.+||+.||++||++.++.+.|...
T Consensus       346 ---~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         346 ---DSTFYNKIKSGYRMAKPDHA---TQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             ---hHHHHHHHhcCCCCCCCccC---CHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence               11112222222211111111   22378999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.7e-38  Score=330.67  Aligned_cols=245  Identities=25%  Similarity=0.362  Sum_probs=193.4

Q ss_pred             eeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||+|... +++.||+|+++..........+.+..|..++... +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999654 5789999999765433333345556677777654 899999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence            99998887543   578899999999999999999998   999999999999999999999999999986543333344


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+......  .+....   ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~~~--~~~~~~---~~  222 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILNDRPH--FPRWIS---KE  222 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCC--CCCCCC---HH
Confidence            55799999999999988899999999999999999999999864321       1111122111111  111111   23


Q ss_pred             HHHHHHHcccCCCCCCCCHH-HHHHH
Q 004642          694 VSTIAFACLSSQPKSRPTMQ-RISQE  718 (740)
Q Consensus       694 l~~li~~cl~~dP~~RPs~~-ev~~~  718 (740)
                      +.+++.+||+.||++||++. +++++
T Consensus       223 ~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         223 AKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHHcC
Confidence            67899999999999999875 66554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.3e-38  Score=312.17  Aligned_cols=268  Identities=22%  Similarity=0.278  Sum_probs=205.3

Q ss_pred             cccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCc-cceeeeeeeecC-----
Q 004642          450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN-IVKLYGFCLHKK-----  522 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  522 (740)
                      ..|...++||+|.||+||+|+ ..+|+.||+|+++.....+ ..-....+|+.+++.++|+| ||.+++++....     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-CCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            456667789999999999994 4578999999998765532 12345678999999999999 999999998876     


Q ss_pred             -eEEEEEEeccCCCchhhhcCCCcc-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecc
Q 004642          523 -CMFLIYEYMERGSLFCVLHDDDEA-IELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG  600 (740)
Q Consensus       523 -~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  600 (740)
                       ..++|+||++. +|.+++...... ..++...+..++.||+.||+|||++   +|+||||||+|||++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             78999999976 888888765532 2466688999999999999999999   99999999999999999999999999


Q ss_pred             cceecccCCCcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccc---------cCCCCCch
Q 004642          601 TARLLHVDSSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS---------SSSGPKIM  670 (740)
Q Consensus       601 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~---------~~~~~~~~  670 (740)
                      +|+.+..+....+..++|..|+|||++.+. .|++..||||+|||++||++++.-|...++..         .-+..+.+
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            999877666656667899999999999876 68999999999999999999998887554310         00000000


Q ss_pred             --hhhhhccc------C-CCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          671 --LIDVLNQR------L-SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       671 --~~~~~~~~------l-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                        .....+..      . +...............+++.+|++.+|.+|.|++.+++|-...
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~  306 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFS  306 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhc
Confidence              00000000      0 0000000111112377899999999999999999999985444

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-37  Score=325.61  Aligned_cols=262  Identities=24%  Similarity=0.343  Sum_probs=194.1

Q ss_pred             cccccceeeecccceEEEEEEe-C-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc---CCCccceeeeeeee----
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-P-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV---RHRNIVKLYGFCLH----  520 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  520 (740)
                      ++|++.+.||+|+||.||+|.. . +|+.||+|++......+. ....+.+|+.+++.+   +||||+++++++..    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            3689999999999999999965 3 468899999875443321 123455677776665   69999999998852    


Q ss_pred             -cCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeec
Q 004642          521 -KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF  599 (740)
Q Consensus       521 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  599 (740)
                       ....++||||++ ++|.+++..... ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence             456899999997 588888865432 2578999999999999999999998   9999999999999999999999999


Q ss_pred             ccceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccccc---------CCCCCch
Q 004642          600 GTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS---------SSGPKIM  670 (740)
Q Consensus       600 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~---------~~~~~~~  670 (740)
                      |+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........         .......
T Consensus       155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             cceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            999876433 223345689999999999888899999999999999999999999875432100         0000000


Q ss_pred             h------hhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          671 L------IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       671 ~------~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      .      ......................+.+++.+|++.||++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0      00000000000000001112236789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.4e-38  Score=334.40  Aligned_cols=263  Identities=26%  Similarity=0.374  Sum_probs=197.6

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec-----CeE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK-----KCM  524 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  524 (740)
                      +|++.+.||+|+||.||+|.. .+|+.||+|++....... ....++.+|++++++++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV-SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc-hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            588899999999999999964 468999999987543222 2235688999999999999999999988643     247


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++||||++ ++|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          80 YVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            99999996 58888886543   588999999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCC---cccccccCCCccccccccc--cccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCch-
Q 004642          605 LHVDSS---YRTLRAGTYGYIAPELAYT--IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIM-  670 (740)
Q Consensus       605 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~-  670 (740)
                      ......   ......||..|+|||++.+  ..++.++|||||||++|||++|+.||........        ....... 
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            532221   1233468999999999865  5788999999999999999999999864321000        0000000 


Q ss_pred             ----------hhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          671 ----------LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       671 ----------~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                                ....+.+................+.+++.+||+.||++||+++|++++-..
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f  293 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF  293 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence                      000111111111111111112336799999999999999999999998754

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=313.41  Aligned_cols=265  Identities=24%  Similarity=0.315  Sum_probs=206.5

Q ss_pred             HhcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee-----c
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH-----K  521 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~  521 (740)
                      ....|...+.||+|+||.|+.+ +..+|+.||+|++....... -..++..+|+++++.++|+||+.+.+.+..     -
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~-~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ-IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch-HHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            4556666788999999999999 45578999999998544433 335778899999999999999999998865     3


Q ss_pred             CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      ...|+|+|+|+ .+|...++...   .++......++.||++||.|+|+.   +|+|||+||+|++++.++..||+|||+
T Consensus        99 ~DvYiV~elMe-tDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELME-TDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHHh-hHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence            46899999995 48888887654   478888999999999999999998   999999999999999999999999999


Q ss_pred             ceecccC--CCcccccccCCCcccccccc-ccccCCcchhHhHHHHHHHHHhCCCCCCcccccc--------cCCCCCch
Q 004642          602 ARLLHVD--SSYRTLRAGTYGYIAPELAY-TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS--------SSSGPKIM  670 (740)
Q Consensus       602 a~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~--------~~~~~~~~  670 (740)
                      |+.....  ....+..+.|..|+|||++. ...|+...||||.|||+.||++|+.-|.......        .+...+..
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            9987542  33445567899999999876 4578999999999999999999999887553210        00111111


Q ss_pred             --------hhhhh---cccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          671 --------LIDVL---NQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       671 --------~~~~~---~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                              ....+   .+..+.+.............+++.+||..||.+|+|++|.++|.-
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY  312 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY  312 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence                    11111   122222222222333445789999999999999999999999874

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.8e-37  Score=320.19  Aligned_cols=261  Identities=20%  Similarity=0.277  Sum_probs=208.9

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||++.. .+|+.+|||.+......+....+.+.+|+++++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999964 578999999887654444444578889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          529 EYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      ||+++++|.+++.... ....+++..+..++.||+.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 233689999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      .........|+..|+|||++.+..++.++||||||+++|+|++|..||.....     ........+.....++....  
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~--  231 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPSD--  231 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhhhcCCCCCCCcc--
Confidence            43333345688999999999888899999999999999999999999753211     00011111111111111111  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                       .....+.+++.+||+.+|++|||+.+|++.+.+
T Consensus       232 -~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         232 -HYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             -cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence             122348899999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-37  Score=331.72  Aligned_cols=260  Identities=26%  Similarity=0.393  Sum_probs=202.9

Q ss_pred             HhcccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeee
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLH  520 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  520 (740)
                      ..++|++.+.||+|+||.||+|...      +++.||+|++......  ...+.+.+|++++.++ +|+||+++++++..
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            3468999999999999999999432      3578999999754432  2246778899999999 89999999998875


Q ss_pred             c-CeEEEEEEeccCCCchhhhcCCCc------------------------------------------------------
Q 004642          521 K-KCMFLIYEYMERGSLFCVLHDDDE------------------------------------------------------  545 (740)
Q Consensus       521 ~-~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  545 (740)
                      . ...+++|||+++++|.+++.....                                                      
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            4 568899999999999988854211                                                      


Q ss_pred             ----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc--ccccccCC
Q 004642          546 ----AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY--RTLRAGTY  619 (740)
Q Consensus       546 ----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~  619 (740)
                          ...++|..+..++.||+.||+|||+.   +|+||||||+||++++++.++|+|||+++.+......  .....++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                12589999999999999999999998   9999999999999999999999999999876433221  12234577


Q ss_pred             CccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHH
Q 004642          620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIA  698 (740)
Q Consensus       620 ~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li  698 (740)
                      .|+|||++.+..++.++|||||||++|||++ |+.||.....       .......+..........   .....+.+++
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~---~~~~~~~~l~  309 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------DEEFCRRLKEGTRMRAPE---YATPEIYSIM  309 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc-------cHHHHHHHhccCCCCCCc---cCCHHHHHHH
Confidence            8999999999999999999999999999998 9999864211       111222222211111111   1123378999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHcC
Q 004642          699 FACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       699 ~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .+||+.+|++||++.|++++|...
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.2e-37  Score=317.31  Aligned_cols=251  Identities=25%  Similarity=0.426  Sum_probs=202.4

Q ss_pred             cccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      ++|.+.+.||+|+||.||+++..++..+|+|.+......    .+.+.+|+.++++++||||+++++++.+.+..+++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            468889999999999999998877778999998754332    2568899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++|+|.+++.....  .+++.+++.++.||+.||+|||+.   +++|+||||+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          80 YMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            9999999999876433  589999999999999999999998   99999999999999999999999999998654332


Q ss_pred             Ccc-cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          610 SYR-TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       610 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      ... ....++..|+|||+..+..++.++||||||+++|||++ |+.||.....        ....+.+........... 
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~-  225 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVSQGLRLYRPHL-  225 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHhcCCCCCCCCC-
Confidence            211 12235678999999988889999999999999999998 9999764321        111111111111111111 


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                        ....+.+++.+||+.+|++||++.++++.++
T Consensus       226 --~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         226 --ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              1234889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1e-37  Score=320.80  Aligned_cols=256  Identities=27%  Similarity=0.480  Sum_probs=208.8

Q ss_pred             HhcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ...+|++.+.||.|+||.||+|...+++.+|+|.+......   ....+.+|+++++.++|+||+++++++.+.+..++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            45678999999999999999998888999999998765432   245788999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++++|.+++..... ..+++.++..++.||+.|++|||+.   +++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          81 TELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             EeecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            999999999999976543 3589999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      .........++..|+|||...+..++.++||||||+++|+|++ |+.||.....       ...... +......+... 
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-------~~~~~~-~~~~~~~~~~~-  227 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-------HEVYDQ-ITAGYRMPCPA-  227 (261)
T ss_pred             ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHH-HHhCCcCCCCC-
Confidence            3322233346778999999988889999999999999999998 8999864321       111111 21222111111 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                        .....+.+++.+||+.||++|||++++++.|..
T Consensus       228 --~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         228 --KCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             --CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence              122337899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-37  Score=337.73  Aligned_cols=256  Identities=23%  Similarity=0.326  Sum_probs=200.7

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      .|.+.+.||+|+||+||+|.. .+++.||+|++...........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578899999999999999954 5689999999976544444445778999999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999987644   578888999999999999999998   99999999999999999999999999975431100


Q ss_pred             -----------------------------------------------CcccccccCCCccccccccccccCCcchhHhHH
Q 004642          610 -----------------------------------------------SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFG  642 (740)
Q Consensus       610 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  642 (740)
                                                                     .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence                                                           001124699999999999988899999999999


Q ss_pred             HHHHHHHhCCCCCCcccccccCCCCCchhhhhhc--ccCCCcchhhhHHHHHHHHHHHHH--cccCCCCCCCCHHHHHHH
Q 004642          643 VVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLN--QRLSPPVNQKIVQDIILVSTIAFA--CLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       643 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~ev~~~  718 (740)
                      |++|||++|+.||.....       ......+..  ..+..+......   ..+.+++.+  |+..+|..||+++|+++|
T Consensus       236 ~il~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s---~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         236 VILFEMLVGQPPFLAPTP-------TETQLKVINWENTLHIPPQVKLS---PEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             hHHHHHHhCCCCCcCCCH-------HHHHHHHHccccccCCCCCCCCC---HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            999999999999864321       111111211  111111111111   236677777  556677779999999998


Q ss_pred             HHcC
Q 004642          719 LLAG  722 (740)
Q Consensus       719 L~~~  722 (740)
                      -...
T Consensus       306 p~f~  309 (381)
T cd05626         306 PFFS  309 (381)
T ss_pred             cccC
Confidence            7544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.3e-37  Score=322.82  Aligned_cols=252  Identities=23%  Similarity=0.275  Sum_probs=195.6

Q ss_pred             eecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCc
Q 004642          458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL  536 (740)
Q Consensus       458 lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  536 (740)
                      ||+|+||.||+++. .+|+.||+|++...........+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999965 46899999999754333222234566799999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccccc
Q 004642          537 FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA  616 (740)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  616 (740)
                      .+++..... ..+++..+..++.||+.||+|||+.   +++||||||+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~  155 (277)
T cd05607          81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA  155 (277)
T ss_pred             HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence            988865432 2578999999999999999999998   99999999999999999999999999998764322 223346


Q ss_pred             cCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHH
Q 004642          617 GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVST  696 (740)
Q Consensus       617 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  696 (740)
                      |+..|+|||++.+..++.++||||+||++|||++|+.||......   ................... .   .....+.+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~  228 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK---VAKEELKRRTLEDEVKFEH-Q---NFTEESKD  228 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch---hhHHHHHHHhhcccccccc-c---cCCHHHHH
Confidence            899999999999888999999999999999999999998642210   0011111111111111110 1   11223789


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          697 IAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       697 li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ++.+||+.||++||+++|+++++..
T Consensus       229 li~~~L~~~P~~R~~~~~~~~~~~~  253 (277)
T cd05607         229 ICRLFLAKKPEDRLGSREKNDDPRK  253 (277)
T ss_pred             HHHHHhccCHhhCCCCccchhhhhc
Confidence            9999999999999999776655443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-37  Score=334.73  Aligned_cols=259  Identities=23%  Similarity=0.286  Sum_probs=198.2

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ..+|++.+.||+|+||.||++.. .+++.||+|+...         +.+.+|++++++++||||+++++++..+...++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            35799999999999999999954 5689999996532         3467899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      +|++. ++|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       162 ~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        162 LPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             EecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            99996 58887776543   578999999999999999999998   999999999999999999999999999975432


Q ss_pred             CC-CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCC------------------
Q 004642          608 DS-SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPK------------------  668 (740)
Q Consensus       608 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~------------------  668 (740)
                      .. .......||+.|+|||++.+..++.++||||+||++|||++|+.||-............                  
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            21 12233479999999999999899999999999999999999998753221110000000                  


Q ss_pred             ----chhhhhh---cccC--CC---cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          669 ----IMLIDVL---NQRL--SP---PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       669 ----~~~~~~~---~~~l--~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                          ....+..   .+..  .+   +...........+.+++.+||+.||++|||++|++++-....
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~  381 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD  381 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence                0000000   0000  00   000011112234789999999999999999999999877654

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.3e-37  Score=317.42  Aligned_cols=253  Identities=28%  Similarity=0.420  Sum_probs=203.2

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .+|.+.+.||+|+||.||+|... .++.||+|++.....    ..+.+.+|++++++++|+||+++++++...+..+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            46888899999999999999554 588999999875332    2467889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||.+......
T Consensus        82 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          82 EFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            99999999999865432 3588999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCcc-cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          609 SSYR-TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       609 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      .... ....++..|+|||++.+..++.++|||||||++|||++ |..||.....        ......+...........
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  229 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEKGYRMERPEG  229 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCCCCCCCC
Confidence            2211 11234568999999998899999999999999999998 8889754211        111222222222222221


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ..   ..+.+++.+||+.+|++||++.|+++.|+.
T Consensus       230 ~~---~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         230 CP---PKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CC---HHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            22   238899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-37  Score=316.14  Aligned_cols=254  Identities=26%  Similarity=0.434  Sum_probs=205.2

Q ss_pred             hcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .++|++.+.||+|+||.||+|...+++.||+|.++.....    .+.+.+|++++++++||||+++++++...+..+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            4678999999999999999998777889999998764432    356889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++.... ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            9999999999987643 23589999999999999999999998   9999999999999999999999999999876532


Q ss_pred             CCcc-cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          609 SSYR-TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       609 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      .... .....+..|+|||+..+..++.++||||||+++|||++ |+.||.....        ......+......+... 
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-  227 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVDQGYRMPCPP-  227 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCC-
Confidence            2111 11123457999999998889999999999999999999 9999864321        11112222221111111 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                        .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus       228 --~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         228 --GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             --cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence              112348899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.3e-37  Score=321.67  Aligned_cols=256  Identities=27%  Similarity=0.445  Sum_probs=204.6

Q ss_pred             hcccccceeeecccceEEEEEEeCC------CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (740)
                      .++|.+.+.||+|+||.||+|...+      ++.||+|.+......  +..+.+.+|+++++.++|+||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            3568888999999999999996533      478999999765432  23478899999999999999999999999999


Q ss_pred             eEEEEEEeccCCCchhhhcCCC-----------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC
Q 004642          523 CMFLIYEYMERGSLFCVLHDDD-----------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN  591 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  591 (740)
                      ..++||||+++++|.+++...+           ....+++.++..++.|++.|++|||++   +++||||||+||+++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence            9999999999999999987542           123578999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecccceecccCCC--cccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCC
Q 004642          592 LEASVADFGTARLLHVDSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPK  668 (740)
Q Consensus       592 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~  668 (740)
                      +.++|+|||.++.......  ......++..|+|||++.+..++.++|||||||++|||++ |+.||.....       .
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-------~  231 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-------E  231 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-------H
Confidence            9999999999976533221  1223345788999999999999999999999999999998 9999754221       1


Q ss_pred             chhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          669 IMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       669 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      .....+....... .....   ...+.+++.+||+.||++||++.|+++.|.
T Consensus       232 ~~~~~~~~~~~~~-~~~~~---~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         232 EVIECITQGRLLQ-RPRTC---PSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHHHHcCCcCC-CCCCC---CHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            1111111111111 11111   223789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-38  Score=338.65  Aligned_cols=255  Identities=25%  Similarity=0.362  Sum_probs=202.8

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|... +|+.||||++.............+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999654 68999999997644333344567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.++|+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999987643   588999999999999999999999   9999999999999999999999999998764321


Q ss_pred             CC--------------------------------------cccccccCCCccccccccccccCCcchhHhHHHHHHHHHh
Q 004642          609 SS--------------------------------------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM  650 (740)
Q Consensus       609 ~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt  650 (740)
                      ..                                      .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            10                                      0012358999999999999899999999999999999999


Q ss_pred             CCCCCCcccccccCCCCCchhhhhhcc--cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHHHc
Q 004642          651 GTHPGGLLSSLSSSSGPKIMLIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPT---MQRISQELLA  721 (740)
Q Consensus       651 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~~L~~  721 (740)
                      |+.||......       .....+...  .+..+......   ..+.+++.+|+. +|.+|++   ++|++++-..
T Consensus       235 G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s---~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~  299 (364)
T cd05599         235 GYPPFCSDNPQ-------ETYRKIINWKETLQFPDEVPLS---PEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF  299 (364)
T ss_pred             CCCCCCCCCHH-------HHHHHHHcCCCccCCCCCCCCC---HHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence            99998753221       111111111  11111111111   236788999996 9999997   9999887644

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-37  Score=330.04  Aligned_cols=247  Identities=24%  Similarity=0.348  Sum_probs=198.7

Q ss_pred             eeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||+|... +++.||+|++...........+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999654 5789999999765433333356677888888887 799999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|..++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence            99998887643   589999999999999999999998   999999999999999999999999999976433333334


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+.......+  ...   ...
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~~~~~~--~~~---~~~  222 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILEDEVRYP--RWL---SKE  222 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCCCC--CcC---CHH
Confidence            45789999999999999999999999999999999999999864321       111122222222111  111   123


Q ss_pred             HHHHHHHcccCCCCCCCCH-----HHHHHHHH
Q 004642          694 VSTIAFACLSSQPKSRPTM-----QRISQELL  720 (740)
Q Consensus       694 l~~li~~cl~~dP~~RPs~-----~ev~~~L~  720 (740)
                      +.+++.+||+.||++||++     .+++++-.
T Consensus       223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~  254 (318)
T cd05570         223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF  254 (318)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHhcCCC
Confidence            7899999999999999999     88887643

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-38  Score=300.41  Aligned_cols=257  Identities=25%  Similarity=0.340  Sum_probs=211.0

Q ss_pred             cccccceeeecccceEEEEEE-eCCCcEEEEEEccCCccc-----chHHHHHHHHHHHHHhcc-CCCccceeeeeeeecC
Q 004642          450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETE-----DSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKK  522 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  522 (740)
                      +.|.-.+.+|.|..++|-++. .++|.++|+|++......     ..+..+.-.+|+.+++++ .||+|+++.++|+.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            456777889999999999884 457899999998653322     234455667899999998 7999999999999999


Q ss_pred             eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccc
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                      ..++|+|.|+.|.|.+++...-   .+++++..+|++|+..|++|||..   .|+||||||+|||++++.++||+|||+|
T Consensus        97 F~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecccee
Confidence            9999999999999999997643   689999999999999999999999   9999999999999999999999999999


Q ss_pred             eecccCCCcccccccCCCcccccccc------ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhc
Q 004642          603 RLLHVDSSYRTLRAGTYGYIAPELAY------TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLN  676 (740)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  676 (740)
                      +.+..... .+..+||++|+|||.+.      ...|+..+|+|++|||+|.++.|..||.....       -.++..++.
T Consensus       171 ~~l~~Gek-LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~Ime  242 (411)
T KOG0599|consen  171 CQLEPGEK-LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMIME  242 (411)
T ss_pred             eccCCchh-HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHHHh
Confidence            98875444 34569999999999875      23578899999999999999999999875432       122333333


Q ss_pred             ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          677 QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       677 ~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ..... ....|........++|.+|++.||.+|.|++|+++|-..
T Consensus       243 GkyqF-~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  243 GKYQF-RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             ccccc-CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence            33322 223355555558899999999999999999999998754

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-37  Score=316.85  Aligned_cols=256  Identities=28%  Similarity=0.406  Sum_probs=204.5

Q ss_pred             hcccccceeeecccceEEEEEEeCC----CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE----GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCM  524 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (740)
                      .++|++.+.||+|+||.||+|.+..    ...||+|.+.....  ......+.+|+.++++++||||+++++++...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            3578899999999999999997642    45799999875443  23346788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      +++|||+++++|.+++.....  .+++.++..++.|++.|++|||+.   +|+|+||||+||++++++.++|+|||+++.
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            999999999999999976443  689999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCCcc--cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          605 LHVDSSYR--TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       605 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      ........  ....++..|+|||.+.+..++.++||||||+++|||++ |..||.....        ....+.+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~  227 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QDVIKAVEDGYRL  227 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence            75222211  12234678999999998889999999999999999998 9999753221        1111222111111


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      +...   .....+.+++.+||+.+|++||++.|++++|...
T Consensus       228 ~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 PPPM---DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111   1123378999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.8e-37  Score=316.26  Aligned_cols=262  Identities=22%  Similarity=0.290  Sum_probs=210.2

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++.....+....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999665 78999999987544444444578899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          529 EYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      ||+++++|.+++.... ....+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886432 234588999999999999999999998   999999999999999999999999999987644


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      .........++..|+|||.+.+..++.++|||||||++|+|++|+.||.....      ......+.+.....++.+.  
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~--  230 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEKCDYPPLPA--  230 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhcCCCCCCCh--
Confidence            33333345688999999999988899999999999999999999999753210      0001111111111111111  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ......+.+++.+||..+|++||++.++++.+...
T Consensus       231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            01222378999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.8e-37  Score=328.82  Aligned_cols=265  Identities=23%  Similarity=0.319  Sum_probs=205.1

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|+||.||++... +|..+|+|.+.....  ......+.+|++++++++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            468999999999999999999665 688899998876432  23346788999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||+.  .+++|+||||+||+++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999999987543   478889999999999999999974  1799999999999999999999999999976532


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccccc----------CCCC----------
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS----------SSGP----------  667 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~----------~~~~----------  667 (740)
                      .  ......|+..|+|||++.+..++.++|||||||++|||++|+.||........          ....          
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             h--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence            1  22334689999999999988899999999999999999999999864321000          0000          


Q ss_pred             -------------Cchh---hhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          668 -------------KIML---IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       668 -------------~~~~---~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                                   ....   .+.+.....+....  .....++.+++.+||+.||++||++.|++++-.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS--GVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCC--CCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                         0000   00000000000000  0012337899999999999999999999998876543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=302.47  Aligned_cols=259  Identities=21%  Similarity=0.310  Sum_probs=208.9

Q ss_pred             hcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ++.|++.+.||+|.|+.||++ ..++|+.+|+|.+........ ..+.+.+|+.+-+.++||||+++.+.+.+.+..|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            467888889999999999998 566899999998876554433 357889999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCcEEEeeccccee
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS---NLEASVADFGTARL  604 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DfG~a~~  604 (740)
                      +|+|+|++|..-+-..   ..+++..+-..++||+.+|+|+|.+   +|||||+||+|+++..   ...+|++|||+|..
T Consensus        89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            9999999986433221   3577788888999999999999999   9999999999999963   34589999999999


Q ss_pred             cccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcch
Q 004642          605 LHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN  684 (740)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  684 (740)
                      +. +......++|||+|||||++...+|+..+|||+.||+||-++.|..||...+.       ......++......+. 
T Consensus       163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-------~rlye~I~~g~yd~~~-  233 (355)
T KOG0033|consen  163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYEQIKAGAYDYPS-  233 (355)
T ss_pred             eC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-------HHHHHHHhccccCCCC-
Confidence            87 44555567899999999999999999999999999999999999999875321       1222222222222111 


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      ..+..-.+...+++.+|+..||.+|.|+.|.++|-+...
T Consensus       234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            123333344789999999999999999999999876553

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.6e-37  Score=352.13  Aligned_cols=260  Identities=27%  Similarity=0.396  Sum_probs=203.2

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.......+...+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999654 68999999998655444555678999999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCC--------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecc
Q 004642          529 EYMERGSLFCVLHDDD--------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG  600 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  600 (740)
                      ||++||+|.+++....        .....++..++.++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886421        123467788899999999999999998   99999999999999999999999999


Q ss_pred             cceecccCCC------------------cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccc
Q 004642          601 TARLLHVDSS------------------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS  662 (740)
Q Consensus       601 ~a~~~~~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~  662 (740)
                      +++.......                  ......||+.|+|||++.+..++.++||||+||++|||+||+.||...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            9987621110                  011246899999999999999999999999999999999999998642210 


Q ss_pred             cCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHc
Q 004642          663 SSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRP-TMQRISQELLA  721 (740)
Q Consensus       663 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev~~~L~~  721 (740)
                           .......+........   .......+.+++.+|++.||++|| +++++.+.|..
T Consensus       238 -----ki~~~~~i~~P~~~~p---~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        238 -----KISYRDVILSPIEVAP---YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             -----hhhhhhhccChhhccc---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 0000010100000000   011122378899999999999995 66777776654

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.1e-37  Score=321.42  Aligned_cols=257  Identities=24%  Similarity=0.365  Sum_probs=202.2

Q ss_pred             HhcccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK  521 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (740)
                      ..++|++.+.||+|+||.||+|...      ++..||+|++......  ....++.+|+.+++.++||||+++++++.++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4678999999999999999998643      3567999998653322  2246788999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCchhhhcCCCc-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcE
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDE-------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEA  594 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~  594 (740)
                      ...++||||+++++|.+++.....       ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence            999999999999999999865321       23467889999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCcc--cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchh
Q 004642          595 SVADFGTARLLHVDSSYR--TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIML  671 (740)
Q Consensus       595 kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  671 (740)
                      +|+|||+++.........  ....++..|+|||++.+..++.++|||||||++|||++ |..||.....       ....
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~~~  231 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVL  231 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHH
Confidence            999999987654322211  12245778999999998889999999999999999999 6888754221       1111


Q ss_pred             hhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          672 IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       672 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      .......... ...   .....+.+++.+||+.+|++||++.|++++|+
T Consensus       232 ~~~~~~~~~~-~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         232 RFVMEGGLLD-KPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHcCCcCC-CCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1111211111 111   11224889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=310.77  Aligned_cols=254  Identities=28%  Similarity=0.414  Sum_probs=214.8

Q ss_pred             cccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      +-|.++.+||+|+||+||++. ..+|+.+|+|++.....     .+++.+|+.+|++.+.|++|++||.|.....+|+||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            346678889999999999994 44699999999987654     578899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      |||.-|+..+.+....+  ++++.++..+++..++||+|||..   .-+|||||..|||++.+|.+|++|||.|-.+...
T Consensus       108 EYCGAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             hhcCCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            99999999999875443  689999999999999999999987   8899999999999999999999999999887654


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      -...+.+.||+.|||||++....|..++||||+|++..||.-|+.|+.....         +..-++-+.-+++......
T Consensus       183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---------MRAIFMIPT~PPPTF~KPE  253 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP---------MRAIFMIPTKPPPTFKKPE  253 (502)
T ss_pred             HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc---------cceeEeccCCCCCCCCChH
Confidence            4556677999999999999999999999999999999999999999875432         1111222222333333333


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      +-...+.++++.|+-..|++|.|+.++++|-.-.
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fik  287 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIK  287 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhc
Confidence            4445599999999999999999999999987644

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-37  Score=338.39  Aligned_cols=255  Identities=23%  Similarity=0.318  Sum_probs=199.1

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      .|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999954 4688999999976544334445778899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++|+|.+++.+..   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999987643   578888999999999999999998   99999999999999999999999999975321000


Q ss_pred             -----------------------------------------------CcccccccCCCccccccccccccCCcchhHhHH
Q 004642          610 -----------------------------------------------SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFG  642 (740)
Q Consensus       610 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  642 (740)
                                                                     ......+||+.|+|||++.+..++.++||||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                           001123689999999999998999999999999


Q ss_pred             HHHHHHHhCCCCCCcccccccCCCCCchhhhhhc--ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 004642          643 VVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLN--QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPT---MQRISQ  717 (740)
Q Consensus       643 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~  717 (740)
                      |++|||++|+.||.....       ......+..  .....+......   ..+.+++.+|+ .+|++|++   +.|+++
T Consensus       236 vil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~p~~~~~s---~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         236 VILYEMLVGQPPFLAQTP-------LETQMKVINWQTSLHIPPQAKLS---PEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHHHhCCCCCCCCCH-------HHHHHHHHccCCCcCCCCcccCC---HHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999999875322       111111111  111111111111   22567777765 49999987   999888


Q ss_pred             HHHcC
Q 004642          718 ELLAG  722 (740)
Q Consensus       718 ~L~~~  722 (740)
                      |-...
T Consensus       305 hp~f~  309 (382)
T cd05625         305 HPFFK  309 (382)
T ss_pred             CCCcC
Confidence            75443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.3e-37  Score=326.24  Aligned_cols=254  Identities=25%  Similarity=0.420  Sum_probs=201.4

Q ss_pred             cccccceeeecccceEEEEEEeC-CCc----EEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCM  524 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (740)
                      .+|++.+.||+|+||.||+|.+. +|+    .||+|++.....  ....+++.+|+.+++.++||||++++|++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            57899999999999999999653 343    389999875332  23346788999999999999999999999865 57


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++++||+++|+|.+++.....  .+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            799999999999999976442  578899999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCCcc--cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          605 LHVDSSYR--TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       605 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      ........  ....++..|+|||++.+..++.++|||||||++|||++ |+.||+....        ..+...+......
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~  230 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERL  230 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhCCCCC
Confidence            65433221  12234678999999999999999999999999999998 9999864321        1122222222221


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      +...   .....+.+++.+||+.+|++||++.++++++...
T Consensus       231 ~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         231 PQPP---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             CCCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1111   1122378899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.6e-37  Score=328.24  Aligned_cols=247  Identities=24%  Similarity=0.338  Sum_probs=193.9

Q ss_pred             eeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||+|... +|+.||+|+++..........+.+..|..++... +||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999654 6889999999764322222235566777777754 899999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++..........
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence            99998886543   578899999999999999999998   999999999999999999999999999875433333334


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+......  .+...   ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-------~~~~~~~~~~~~~--~~~~~---~~~  222 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFESIRVDTPH--YPRWI---TKE  222 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC--CCCCC---CHH
Confidence            45799999999999999999999999999999999999999864321       1111111111111  11111   123


Q ss_pred             HHHHHHHcccCCCCCCCCHH-HHHHHHH
Q 004642          694 VSTIAFACLSSQPKSRPTMQ-RISQELL  720 (740)
Q Consensus       694 l~~li~~cl~~dP~~RPs~~-ev~~~L~  720 (740)
                      +.+++.+||+.||++||++. ++.++..
T Consensus       223 ~~~li~~~l~~dP~~R~~~~~~~~~h~~  250 (316)
T cd05620         223 SKDILEKLFERDPTRRLGVVGNIRGHPF  250 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHHcCCC
Confidence            77899999999999999984 6665543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=338.16  Aligned_cols=256  Identities=25%  Similarity=0.362  Sum_probs=200.8

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|.+.+.||+|+||.||++.. .+|+.||+|++...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688999999999999999954 578999999987544333344577889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999987543   578889999999999999999998   9999999999999999999999999998643110


Q ss_pred             CC-----------------------------------------------cccccccCCCccccccccccccCCcchhHhH
Q 004642          609 SS-----------------------------------------------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSF  641 (740)
Q Consensus       609 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  641 (740)
                      ..                                               .....+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00                                               0012369999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCcccccccCCCCCchhhhhhc--ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCC---CCHHHHH
Q 004642          642 GVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLN--QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSR---PTMQRIS  716 (740)
Q Consensus       642 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ev~  716 (740)
                      ||++|||++|+.||.....       ......+..  ..+..+.....   ...+.+++.+|+. +|.+|   +++.|++
T Consensus       235 Gvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~p~~~~~---s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         235 GAIMFECLIGWPPFCSENS-------HETYRKIINWRETLYFPDDIHL---SVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             chhhhhhhcCCCCCCCCCH-------HHHHHHHHccCCccCCCCCCCC---CHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            9999999999999864321       111111111  11111111111   1237789999997 67765   6999999


Q ss_pred             HHHHcC
Q 004642          717 QELLAG  722 (740)
Q Consensus       717 ~~L~~~  722 (740)
                      ++....
T Consensus       304 ~hp~~~  309 (377)
T cd05629         304 SHPFFR  309 (377)
T ss_pred             cCCCcC
Confidence            986543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.9e-37  Score=319.80  Aligned_cols=256  Identities=23%  Similarity=0.402  Sum_probs=203.2

Q ss_pred             cccccceeeecccceEEEEEEe-----CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-----PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCM  524 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (740)
                      ++|++.+.||+|+||.||+|..     .+++.|++|.+.....  ....+.+.+|++++++++||||+++++++..+...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            4688889999999999999964     3567899999975433  23346788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhhhcCCC--------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC
Q 004642          525 FLIYEYMERGSLFCVLHDDD--------------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS  590 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~  590 (740)
                      ++||||+++++|.+++....              ....+++.++..++.|++.||+|||++   +++||||||+||+++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence            99999999999999885321              123578999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCC--cccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCC
Q 004642          591 NLEASVADFGTARLLHVDSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGP  667 (740)
Q Consensus       591 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~  667 (740)
                      ++.+||+|||+++.......  ......++..|+|||++.+..++.++|||||||++|||++ |..||.....       
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------  232 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------  232 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence            99999999999986543221  1223345778999999988889999999999999999998 8888754221       


Q ss_pred             CchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          668 KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       668 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                       ....+.+......+....   ....+.+++.+||+.||++||++.++.++|..
T Consensus       233 -~~~~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 -QEVIEMVRKRQLLPCSED---CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHHHHcCCcCCCCCC---CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence             122222222222211111   12337889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.6e-37  Score=318.96  Aligned_cols=255  Identities=28%  Similarity=0.430  Sum_probs=200.5

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.......   .+.+.+|+.++++++||||+++++++..++..++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~---~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD---FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch---HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            35799999999999999999965 578899999987543222   35678899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++++|.++++...   .+++..+..++.|++.|++|||+.   +|+|||+||+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          85 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            99999999999887543   578999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCcccccccCCCcccccccc---ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcch
Q 004642          608 DSSYRTLRAGTYGYIAPELAY---TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN  684 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  684 (740)
                      .........|+..|+|||.+.   ...++.++||||+||++|||++|+.||........       ..........++..
T Consensus       159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~  231 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFLMSKSNFQPPKL  231 (267)
T ss_pred             cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-------heeeecCCCCCCCC
Confidence            332233446889999999874   34477899999999999999999999753321100       00000011111110


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      .........+.+++.+||+.+|++||+++++++++
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00011123488999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-37  Score=330.38  Aligned_cols=246  Identities=26%  Similarity=0.338  Sum_probs=193.0

Q ss_pred             eeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHH-HHhccCCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAH-VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||+||+|... +|+.||+|++...........+.+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999654 68999999997543332222344555554 56778999999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence            99998887543   578899999999999999999998   999999999999999999999999999875433333334


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+.........  ..   ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~--~~---~~~  222 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILNKPLRLKP--NI---SVS  222 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCCCCCC--CC---CHH
Confidence            45799999999999998999999999999999999999999864321       1112222222221111  11   223


Q ss_pred             HHHHHHHcccCCCCCCCCHH----HHHHHH
Q 004642          694 VSTIAFACLSSQPKSRPTMQ----RISQEL  719 (740)
Q Consensus       694 l~~li~~cl~~dP~~RPs~~----ev~~~L  719 (740)
                      +.+++.+|++.||++||++.    |++++.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~il~~~  252 (323)
T cd05575         223 ARHLLEGLLQKDRTKRLGAKDDFLEIKNHV  252 (323)
T ss_pred             HHHHHHHHhhcCHHhCCCCCCCHHHHHcCC
Confidence            78899999999999999874    665543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.3e-37  Score=314.45  Aligned_cols=252  Identities=27%  Similarity=0.424  Sum_probs=205.7

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|++|.||+|... +|+.|++|.+...... ....+.+.+|++++++++|||++++++++.+++..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            4778899999999999999654 6899999998754333 2335678899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.++++... ...+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++......
T Consensus        80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999999997642 23688999999999999999999998   99999999999999999999999999998765444


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                      .......|++.|+|||+..+..++.++||||||+++|||++|+.||.....       ............. ......  
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~--  225 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-------GALILKIIRGVFP-PVSQMY--  225 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCC-CCcccc--
Confidence            434445688999999999988899999999999999999999999864321       1111122222111 111111  


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                       ...+.+++.+||+.+|++||++.+++++
T Consensus       226 -~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         226 -SQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             2237899999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.3e-37  Score=326.94  Aligned_cols=245  Identities=24%  Similarity=0.368  Sum_probs=192.5

Q ss_pred             eeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||+|... +++.||+|+++..........+.+..|..++... +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999654 5789999999764322222235566777787764 899999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence            99999887543   578899999999999999999998   999999999999999999999999999976433333334


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+......  .+...   ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~~~--~~~~~---~~~  222 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-------EELFQSIRMDNPC--YPRWL---TRE  222 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC--CCccC---CHH
Confidence            45789999999999988899999999999999999999999864321       1111111111111  11111   123


Q ss_pred             HHHHHHHcccCCCCCCCCHH-HHHHH
Q 004642          694 VSTIAFACLSSQPKSRPTMQ-RISQE  718 (740)
Q Consensus       694 l~~li~~cl~~dP~~RPs~~-ev~~~  718 (740)
                      +.+++.+||+.||++||++. ++.++
T Consensus       223 ~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         223 AKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             HHHHHHHHhccCHhhcCCChHHHHcC
Confidence            77899999999999999997 67654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-37  Score=334.88  Aligned_cols=259  Identities=24%  Similarity=0.312  Sum_probs=204.3

Q ss_pred             HhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      ..++|++.+.||+|+||.||++... +++.||+|++...........+.+.+|+++++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3568999999999999999999654 688999999965433222334567889999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      ||||+++|+|.+++...    .++...+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999988653    467788889999999999999998   99999999999999999999999999998764


Q ss_pred             cCCC-cccccccCCCcccccccccc----ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          607 VDSS-YRTLRAGTYGYIAPELAYTI----VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       607 ~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      .... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....       ......+.......
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~~~  266 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMDHKNSL  266 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCCCcC
Confidence            3322 22345799999999998653    478899999999999999999999875321       11222232221111


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHHc
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKS--RPTMQRISQELLA  721 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~L~~  721 (740)
                      ..+. .......+.+++.+|+..+|++  ||++.|++++...
T Consensus       267 ~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~  307 (370)
T cd05596         267 TFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF  307 (370)
T ss_pred             CCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence            1110 0011233788999999999998  9999999988654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.7e-37  Score=327.61  Aligned_cols=250  Identities=23%  Similarity=0.344  Sum_probs=198.7

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  528 (740)
                      +|+..+.||+|+||.||+|.. .+|+.||+|++...........+.+..|.+++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477889999999999999965 468999999997643333333466778888888885 577888999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999886543   588999999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+.......+.  ...
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~~~p~--~~~  225 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHNVSYPK--SLS  225 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCc--cCC
Confidence            3333445699999999999988899999999999999999999999875321       1122222222222111  111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTM-----QRISQE  718 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~-----~ev~~~  718 (740)
                         ..+.+++.+|++.+|++|++.     +++.++
T Consensus       226 ---~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         226 ---KEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             ---HHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence               237789999999999999974     555555

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.9e-37  Score=345.27  Aligned_cols=258  Identities=26%  Similarity=0.312  Sum_probs=204.2

Q ss_pred             HHhcccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC---
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK---  522 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  522 (740)
                      ...++|.+.+.||+|+||.||++. ..+|+.||||++....... .....+.+|+.++..++|+|++++++.+...+   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            345799999999999999999995 4579999999997654332 33567889999999999999999988765432   


Q ss_pred             -----eEEEEEEeccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEE
Q 004642          523 -----CMFLIYEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASV  596 (740)
Q Consensus       523 -----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  596 (740)
                           ..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence                 3689999999999999886532 234688999999999999999999998   9999999999999999999999


Q ss_pred             eecccceecccCC--CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhh
Q 004642          597 ADFGTARLLHVDS--SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDV  674 (740)
Q Consensus       597 ~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  674 (740)
                      +|||+++.+....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .......
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~  257 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKT  257 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHH
Confidence            9999998764321  122345799999999999999999999999999999999999999864221       1111122


Q ss_pred             hcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          675 LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       675 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ......+ .+...   ...+.+++.+||+.||++||++.+++++.
T Consensus       258 ~~~~~~~-~~~~~---~~~l~~li~~~L~~dP~~RPs~~ell~~p  298 (496)
T PTZ00283        258 LAGRYDP-LPPSI---SPEMQEIVTALLSSDPKRRPSSSKLLNMP  298 (496)
T ss_pred             hcCCCCC-CCCCC---CHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence            2111111 11111   22378999999999999999999998763

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-37  Score=343.62  Aligned_cols=252  Identities=23%  Similarity=0.269  Sum_probs=201.1

Q ss_pred             cccccceeeecccceEEEEEEeC-C-CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-E-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ..|.+.+.||+|+||.||+|... + ++.||+|.+.....   .....+.+|+++++.++||||+++++++..++..++|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE---RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            34889999999999999999543 4 67788887754332   2345678899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCC-CccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          528 YEYMERGSLFCVLHDD-DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      |||+++|+|.+++... .....+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            9999999999888642 2234688999999999999999999998   99999999999999999999999999998764


Q ss_pred             cCCC--cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcch
Q 004642          607 VDSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN  684 (740)
Q Consensus       607 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  684 (740)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....       .............+ .+
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~~-~~  292 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQVLYGKYDP-FP  292 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCC-CC
Confidence            3222  22344699999999999998999999999999999999999999864221       11122222222211 11


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ...   ...+.+++.+||+.||++||++++++++
T Consensus       293 ~~~---s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        293 CPV---SSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ccC---CHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            111   1237899999999999999999999764

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.5e-38  Score=312.42  Aligned_cols=261  Identities=23%  Similarity=0.287  Sum_probs=195.1

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC-----e
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK-----C  523 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  523 (740)
                      -.|...+.+|.|+||.||+|... +++.||||+........       .+|.++|+.++|||||++.-+|....     .
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            35666889999999999999654 46899999997655321       36999999999999999998887532     3


Q ss_pred             EEEEEEeccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CcEEEeeccc
Q 004642          524 MFLIYEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN-LEASVADFGT  601 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfG~  601 (740)
                      ..+|||||+. +|+..++... ....++...+.-+..||.+||+|||+.   +|+||||||+|+|+|.+ |.+||||||.
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence            4689999987 8888887531 223577788888999999999999998   99999999999999966 8999999999


Q ss_pred             ceecccCCCcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCchhh
Q 004642          602 ARLLHVDSSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIMLI  672 (740)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~  672 (740)
                      |+......... ....|..|+|||.+.+. .|+.+.||||.||++.||+-|+.-|...+....        +...+..+.
T Consensus       173 AK~L~~~epni-SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  173 AKVLVKGEPNI-SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             ceeeccCCCce-eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            99987655543 34679999999998875 689999999999999999999998876432100        000000000


Q ss_pred             -------hhhcccCCCcch-h-hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          673 -------DVLNQRLSPPVN-Q-KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       673 -------~~~~~~l~~~~~-~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                             +...+.+....- . ..........+++.+++..+|.+|.++.|++.+-...
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFd  310 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFD  310 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhH
Confidence                   111111111000 0 0011122377899999999999999999999886543

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.6e-37  Score=329.43  Aligned_cols=257  Identities=25%  Similarity=0.326  Sum_probs=200.2

Q ss_pred             ccccceeeecccceEEEEEEe----CCCcEEEEEEccCCccc-chHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL----PEGKVVALKKLHHSETE-DSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCM  524 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  524 (740)
                      +|++.+.||+|+||.||+++.    .+++.||+|++...... .....+.+.+|++++..+ +|++|+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999864    35889999998753322 222345678899999999 589999999999999999


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++||||+++|+|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999886543   578999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCC-cccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCc
Q 004642          605 LHVDSS-YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       605 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  682 (740)
                      ...... ......||..|+|||++.+. .++.++|||||||++|||++|+.||......   .........+.....  .
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~--~  229 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER---NTQSEVSRRILKCDP--P  229 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC---CCHHHHHHHHhcCCC--C
Confidence            543222 22335799999999998865 4788999999999999999999998642210   000111111111111  1


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHc
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRP-----TMQRISQELLA  721 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~L~~  721 (740)
                      .....   ...+.+++.+||+.||++||     ++++++++-..
T Consensus       230 ~~~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~  270 (332)
T cd05614         230 FPSFI---GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF  270 (332)
T ss_pred             CCCCC---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCc
Confidence            11111   12378899999999999999     78899887643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=325.40  Aligned_cols=259  Identities=23%  Similarity=0.316  Sum_probs=216.7

Q ss_pred             HhcccccceeeecccceEEEEEEeCC-CcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeeeeecCeEE
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  525 (740)
                      ..+.|++.+.||.|.||.||++..+. |+.+|+|.+.+...........+.+|+++|+++. |||||.+++.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            45678888999999999999996654 9999999998876654444568899999999998 999999999999999999


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC----CcEEEeeccc
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN----LEASVADFGT  601 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~DfG~  601 (740)
                      +|||++.||.|.+.+...    .+++.++..++.||+.+++|||+.   ||+|||+||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999998765    289999999999999999999998   99999999999999743    4799999999


Q ss_pred             ceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      +..... .......+||++|+|||++....|+.++||||+||++|.|++|..||.....       ......+.......
T Consensus       186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~-------~~~~~~i~~~~~~f  257 (382)
T KOG0032|consen  186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE-------FEIFLAILRGDFDF  257 (382)
T ss_pred             ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh-------hHHHHHHHcCCCCC
Confidence            998876 4455667999999999999999999999999999999999999999986543       12222333333322


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .. ..+......+.+++.+|+..||.+|+++.++++|.+-.
T Consensus       258 ~~-~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~  297 (382)
T KOG0032|consen  258 TS-EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK  297 (382)
T ss_pred             CC-CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence            11 11223334478999999999999999999999996543

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-37  Score=314.23  Aligned_cols=250  Identities=26%  Similarity=0.439  Sum_probs=200.9

Q ss_pred             cccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      .+|++.+.||+|+||.||++.++++..+|+|.+......    ...+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            457888999999999999998877888999998654332    2467889999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.+++.....  .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          80 YMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             cCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            9999999999875443  589999999999999999999998   99999999999999999999999999998654222


Q ss_pred             Ccc-cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          610 SYR-TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       610 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      ... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ....+.+........... 
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~-  225 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEVVESVSAGYRLYRPKL-  225 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHHHHHHHcCCcCCCCCC-
Confidence            111 11123457999999998889999999999999999999 8888864321        111112222211111111 


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                        ....+.+++.+||+.+|++||++.|+++.|
T Consensus       226 --~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         226 --APTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             --CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence              223488999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8e-38  Score=333.12  Aligned_cols=257  Identities=25%  Similarity=0.359  Sum_probs=205.0

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||++.. .+|+.||+|+++..........+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4688999999999999999955 468999999998655434444577889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++.....  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999976532  588999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCc-ccccccCCCcccccccc------ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhccc--C
Q 004642          609 SSY-RTLRAGTYGYIAPELAY------TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQR--L  679 (740)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--l  679 (740)
                      ... .....||+.|+|||++.      ...++.++|||||||++|||++|+.||.....       ......+....  +
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~  228 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-------AKTYNNIMNFQRFL  228 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-------HHHHHHHHcCCCcc
Confidence            322 23346899999999986      45677899999999999999999999864321       11112221111  1


Q ss_pred             CCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          680 SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       680 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ..+.....   ...+.+++.+|++ +|++||++++++++-...
T Consensus       229 ~~~~~~~~---~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~  267 (330)
T cd05601         229 KFPEDPKV---SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFS  267 (330)
T ss_pred             CCCCCCCC---CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcC
Confidence            11111111   1237789999998 999999999999876543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.8e-37  Score=317.09  Aligned_cols=256  Identities=23%  Similarity=0.322  Sum_probs=200.9

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+.....  ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            3678889999999999999954 5789999999865432  223467889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|..+.       .+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++......
T Consensus        79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            999999986442       467888899999999999999998   9999999999999999999999999999765322


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                        ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....................+.........   
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  223 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG---  223 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC---
Confidence              223347899999999999888999999999999999999999998653221111111111111111111110011   


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .....+.+++.+|++.+|++||+++|++++....
T Consensus       224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~  257 (279)
T cd06619         224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV  257 (279)
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence            1122378999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1e-36  Score=313.29  Aligned_cols=253  Identities=26%  Similarity=0.439  Sum_probs=203.8

Q ss_pred             hcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .++|++.+.||+|+||.||+|..++++.||+|.+......    ...+.+|++++++++|+|++++++++. .+..+++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            4678999999999999999998888999999998765433    357889999999999999999999864 55689999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++..... ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          80 EYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            99999999999865432 3689999999999999999999998   9999999999999999999999999999776422


Q ss_pred             CC-cccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          609 SS-YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       609 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      .. ......++..|+|||++.+..++.++||||||+++|||++ |+.||.....        ......+......+....
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  227 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQNLERGYRMPRPDN  227 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHHcCCCCCCCCC
Confidence            21 1122345678999999988889999999999999999999 9999864321        111122222222111111


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      .   ...+.+++.+|++.+|++||+++++.+.|..
T Consensus       228 ~---~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         228 C---PEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             C---CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1   1238899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.3e-37  Score=337.67  Aligned_cols=255  Identities=22%  Similarity=0.300  Sum_probs=199.4

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|+||.||+++. .+++.||+|++...........+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            688999999999999999964 4689999999875433333334678899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|..+....
T Consensus        82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999997643   578888899999999999999998   99999999999999999999999999975321000


Q ss_pred             -------------------------------------------CcccccccCCCccccccccccccCCcchhHhHHHHHH
Q 004642          610 -------------------------------------------SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVAL  646 (740)
Q Consensus       610 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~  646 (740)
                                                                 .......||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                       0011236999999999999999999999999999999


Q ss_pred             HHHhCCCCCCcccccccCCCCCchhhhhhc--ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHHHHc
Q 004642          647 EVLMGTHPGGLLSSLSSSSGPKIMLIDVLN--QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRP---TMQRISQELLA  721 (740)
Q Consensus       647 elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ev~~~L~~  721 (740)
                      ||++|+.||......       .....+..  .....+...   .....+.+++.+|+ .+|++|+   ++.|++++-..
T Consensus       236 ell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~---~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~  304 (376)
T cd05598         236 EMLVGQPPFLADTPA-------ETQLKVINWETTLHIPSQA---KLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF  304 (376)
T ss_pred             ehhhCCCCCCCCCHH-------HHHHHHhccCccccCCCCC---CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCc
Confidence            999999998753321       11111111  011111111   11122667777766 5999999   99999998654


Q ss_pred             C
Q 004642          722 G  722 (740)
Q Consensus       722 ~  722 (740)
                      .
T Consensus       305 ~  305 (376)
T cd05598         305 K  305 (376)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-36  Score=312.06  Aligned_cols=253  Identities=28%  Similarity=0.463  Sum_probs=202.9

Q ss_pred             hcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .++|++.+.||+|+||.||+|...++..+|+|.+......    .+.+.+|+.++++++|+|++++++++. ....+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT   79 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence            3578899999999999999998888889999999764433    256889999999999999999999875 45688999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.++++.... ..+++.++..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          80 EYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            99999999999876432 3579999999999999999999998   9999999999999999999999999999876432


Q ss_pred             CCc-ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          609 SSY-RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      ... .....++..|+|||+..+..++.++||||||+++|||++ |+.||.....        ....+.+......+... 
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-  226 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQVERGYRMPCPQ-  226 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCC-
Confidence            211 112235678999999988889999999999999999999 8888864221        11222222222222111 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                        .....+.+++.+|+..+|++|||++++.+.|+.
T Consensus       227 --~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         227 --DCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              122348899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.8e-37  Score=332.83  Aligned_cols=261  Identities=24%  Similarity=0.316  Sum_probs=203.6

Q ss_pred             HHhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEE
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (740)
                      ...++|++.+.||+|+||.||++... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999664 58899999986533332233456789999999999999999999999999999


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      +||||+++|+|.+++...    .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            999999999999998653    478888999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCC-cccccccCCCcccccccccc----ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCC
Q 004642          606 HVDSS-YRTLRAGTYGYIAPELAYTI----VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS  680 (740)
Q Consensus       606 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  680 (740)
                      ..... ......||+.|+|||++.+.    .++.++||||+||++|||++|+.||.....       ......+......
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~  265 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-------VGTYSKIMDHKNS  265 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCcc
Confidence            43222 22345799999999998754    377899999999999999999999864321       1122233322211


Q ss_pred             CcchhhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHHcC
Q 004642          681 PPVNQKIVQDIILVSTIAFACLSSQPKS--RPTMQRISQELLAG  722 (740)
Q Consensus       681 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~L~~~  722 (740)
                      ...+. .......+.+++.+|+..+|.+  |+++.|+++|-...
T Consensus       266 ~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~  308 (370)
T cd05621         266 LNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK  308 (370)
T ss_pred             cCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence            11111 0111223678888999855544  89999999997654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.1e-37  Score=327.68  Aligned_cols=244  Identities=25%  Similarity=0.295  Sum_probs=189.7

Q ss_pred             eeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHH-HHHhccCCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEA-HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||+|... +++.||+|++.............+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999654 5788999999754332222223444444 456788999999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence            99999887643   467888888999999999999998   999999999999999999999999999976433333344


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+........  ....   ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~~~~--~~~~---~~  222 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNKPLQLK--PNIT---NS  222 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCCcCCC--CCCC---HH
Confidence            45799999999999999999999999999999999999999864321       111122222211111  1111   23


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHH
Q 004642          694 VSTIAFACLSSQPKSRPTMQRISQ  717 (740)
Q Consensus       694 l~~li~~cl~~dP~~RPs~~ev~~  717 (740)
                      +.+++.+|++.||.+||++.+.++
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         223 ARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             HHHHHHHHcccCHHHCCCCCCCHH
Confidence            778999999999999998774333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-37  Score=329.63  Aligned_cols=244  Identities=26%  Similarity=0.336  Sum_probs=195.1

Q ss_pred             eeeecccceEEEEEEe----CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEec
Q 004642          456 YCIGTGGYGSVYKAEL----PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYM  531 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  531 (740)
                      +.||+|+||.||+++.    .+|+.||+|++....... .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            5799999999999854    368999999997643322 22356778999999999999999999999999999999999


Q ss_pred             cCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc
Q 004642          532 ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY  611 (740)
Q Consensus       532 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  611 (740)
                      ++|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence            9999999886543   589999999999999999999998   9999999999999999999999999999865443333


Q ss_pred             ccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHH
Q 004642          612 RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDI  691 (740)
Q Consensus       612 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  691 (740)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+.......+  ....   
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-------~~~~~~i~~~~~~~p--~~~~---  222 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-------KETMTMILKAKLGMP--QFLS---  222 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-------HHHHHHHHcCCCCCC--CCCC---
Confidence            3445789999999999988889999999999999999999999864321       111122222222111  1111   


Q ss_pred             HHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 004642          692 ILVSTIAFACLSSQPKSRPTM-----QRISQE  718 (740)
Q Consensus       692 ~~l~~li~~cl~~dP~~RPs~-----~ev~~~  718 (740)
                      ..+.+++.+||+.||++||++     .+++++
T Consensus       223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         223 PEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence            237789999999999999994     555544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.2e-36  Score=311.26  Aligned_cols=247  Identities=25%  Similarity=0.417  Sum_probs=196.4

Q ss_pred             eeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCC
Q 004642          456 YCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERG  534 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (740)
                      +.||+|+||.||+|.. .+++.||+|.+.....  ......+.+|++++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            3589999999999965 4789999998865432  233467899999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc--c
Q 004642          535 SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY--R  612 (740)
Q Consensus       535 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~  612 (740)
                      +|.+++....  ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+.........  .
T Consensus        79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            9999987543  2578999999999999999999998   9999999999999999999999999998764322111  1


Q ss_pred             cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHH
Q 004642          613 TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDI  691 (740)
Q Consensus       613 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  691 (740)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |..||.....        ......+...........   ..
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~---~~  222 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTREAIEQGVRLPCPEL---CP  222 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HHHHHHHHcCCCCCCccc---CC
Confidence            11223567999999998889999999999999999998 8888764321        111222222222221111   12


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          692 ILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       692 ~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ..+.+++.+|++.+|++||++.|+.+.|.
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            34789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-36  Score=316.13  Aligned_cols=257  Identities=27%  Similarity=0.373  Sum_probs=201.6

Q ss_pred             hcccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (740)
                      .++|.+.+.||+|+||.||+|.+.      .+..||+|.+......  .....+.+|+.++++++|+||+++++++.+.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            467899999999999999999664      3567899988654332  22357889999999999999999999999999


Q ss_pred             eEEEEEEeccCCCchhhhcCCCc----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---cEE
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDE----AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL---EAS  595 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~k  595 (740)
                      ..++||||+++++|.++++....    ...+++.++..++.||+.|++|||+.   +++|+||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence            99999999999999999875432    23589999999999999999999998   999999999999998755   589


Q ss_pred             EeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhh
Q 004642          596 VADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLI  672 (740)
Q Consensus       596 l~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  672 (740)
                      |+|||+++........  ......+..|+|||++.+..++.++|||||||++|||++ |+.||.....        ....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~  231 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVM  231 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence            9999999876322211  111233568999999998899999999999999999997 9999864221        1122


Q ss_pred             hhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          673 DVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       673 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      +.+........+...   ...+.+++.+|++.+|++||++.+|+++|..
T Consensus       232 ~~~~~~~~~~~~~~~---~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         232 EFVTGGGRLDPPKGC---PGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HHHHcCCcCCCCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            222222111111111   2237899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-36  Score=311.89  Aligned_cols=251  Identities=22%  Similarity=0.374  Sum_probs=202.5

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|+||.||++... +++.||+|.+......  ...+.+.+|+++++.++|+|++++++++.+++..+++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4788999999999999999654 6899999998654322  234678889999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++++|||.+.......
T Consensus        79 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          79 YCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            9999999988864322 2578899999999999999999998   99999999999999999999999999998765443


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                      .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....       ............. +.....  
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~--  224 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLILKVCQGSYK-PLPSHY--  224 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHHHHHhcCCCC-CCCccc--
Confidence            333445688999999999988899999999999999999999999864221       1111111111111 111111  


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                       ...+.+++.+||+.||++||++.|++..
T Consensus       225 -~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         225 -SYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             1237899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.4e-37  Score=328.57  Aligned_cols=241  Identities=25%  Similarity=0.322  Sum_probs=190.4

Q ss_pred             eeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHH-HHhccCCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAH-VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||+|.. .+|+.||+|++...........+.+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3599999999999954 468999999997643333233345555655 46778999999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|..++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence            99988886543   588999999999999999999998   999999999999999999999999999875433333334


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ...........+....     .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~~~~~~~~~~~-----~~~~~  222 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-------AEMYDNILHKPLVLRP-----GASLT  222 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-------HHHHHHHHcCCccCCC-----CCCHH
Confidence            45799999999999999999999999999999999999999864321       1122222222221111     11223


Q ss_pred             HHHHHHHcccCCCCCCCCHHH
Q 004642          694 VSTIAFACLSSQPKSRPTMQR  714 (740)
Q Consensus       694 l~~li~~cl~~dP~~RPs~~e  714 (740)
                      +.+++.+|++.+|++||++++
T Consensus       223 ~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         223 AWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             HHHHHHHHhccCHHhcCCCCC
Confidence            778999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.3e-37  Score=319.03  Aligned_cols=259  Identities=23%  Similarity=0.300  Sum_probs=204.1

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      .|+..+.||+|+||.||++.. .+++.||+|.+...........+.+.+|+.++++++|++++++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            367788999999999999954 4689999999876544433334567789999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.+++..... ..+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999988865332 2588999999999999999999998   99999999999999999999999999997654322


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                      . .....|+..|+|||++.+..++.++||||+||++|+|++|+.||......    ........... ..........  
T Consensus       157 ~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----~~~~~~~~~~~-~~~~~~~~~~--  228 (285)
T cd05630         157 T-IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEVERLVK-EVQEEYSEKF--  228 (285)
T ss_pred             c-ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc----chHHHHHhhhh-hhhhhcCccC--
Confidence            2 22347899999999999888999999999999999999999998743210    00011111111 0111111111  


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHcC
Q 004642          690 DIILVSTIAFACLSSQPKSRPT-----MQRISQELLAG  722 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~L~~~  722 (740)
                       ...+.+++.+||+.||++||+     ++|++++-...
T Consensus       229 -~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~  265 (285)
T cd05630         229 -SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK  265 (285)
T ss_pred             -CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence             123789999999999999999     89999877654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-36  Score=329.76  Aligned_cols=262  Identities=23%  Similarity=0.356  Sum_probs=206.0

Q ss_pred             HHHhcccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeee
Q 004642          446 INATEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFC  518 (740)
Q Consensus       446 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  518 (740)
                      ....++|.+.+.||+|+||.||+|.+.      .++.||+|+++.....  ...+.+.+|++++.++. ||||+++++++
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            334567888899999999999999753      3468999999765332  22457889999999997 99999999999


Q ss_pred             eecCeEEEEEEeccCCCchhhhcCCCc-----------------------------------------------------
Q 004642          519 LHKKCMFLIYEYMERGSLFCVLHDDDE-----------------------------------------------------  545 (740)
Q Consensus       519 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  545 (740)
                      ...+..++||||+++|+|.++++....                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            999999999999999999999865321                                                     


Q ss_pred             ------------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 004642          546 ------------------------------------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISS  583 (740)
Q Consensus       546 ------------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  583 (740)
                                                                ...+++.++..++.||+.||+|||+.   +++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence                                                      12367888999999999999999988   999999999


Q ss_pred             CceEEcCCCcEEEeecccceecccCCC--cccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccc
Q 004642          584 NNILLDSNLEASVADFGTARLLHVDSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSS  660 (740)
Q Consensus       584 ~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~  660 (740)
                      +||++++++.+||+|||+++.......  ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999986543221  1122356789999999998889999999999999999998 8889754221


Q ss_pred             cccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          661 LSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       661 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                             .....+.+........+...   ...+.+++.+||+.+|++||+++|+++.|...
T Consensus       348 -------~~~~~~~~~~~~~~~~p~~~---~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         348 -------NEQFYNAIKRGYRMAKPAHA---SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             -------hHHHHHHHHcCCCCCCCCCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                   11122222222222111111   23488999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.6e-37  Score=326.63  Aligned_cols=246  Identities=24%  Similarity=0.326  Sum_probs=191.9

Q ss_pred             eeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHH-HHhccCCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAH-VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||+|+.. +|+.||+|++.............+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999654 68899999997544333223344555554 57889999999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|...+....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence            99988886533   578888999999999999999998   999999999999999999999999999876433333334


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ......+.......+.     .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~-----~~~~~  222 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNILHKPLQLPG-----GKTVA  222 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHhcCCCCCCC-----CCCHH
Confidence            45789999999999988899999999999999999999999864221       1112222222222111     11223


Q ss_pred             HHHHHHHcccCCCCCCCCHH----HHHHHH
Q 004642          694 VSTIAFACLSSQPKSRPTMQ----RISQEL  719 (740)
Q Consensus       694 l~~li~~cl~~dP~~RPs~~----ev~~~L  719 (740)
                      +.+++.+|++.||++||++.    |++++.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~~  252 (321)
T cd05603         223 ACDLLVGLLHKDQRRRLGAKADFLEIKNHV  252 (321)
T ss_pred             HHHHHHHHccCCHhhcCCCCCCHHHHhCCC
Confidence            78899999999999998754    555443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.7e-37  Score=318.05  Aligned_cols=258  Identities=22%  Similarity=0.268  Sum_probs=202.4

Q ss_pred             cccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEe
Q 004642          452 FHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      |+..+.||+|+||+||++.. .+++.||+|.+.............+.+|++++++++|+|++++.+++..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778999999999999955 46899999998765443333345678899999999999999999999999999999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                      +++++|.+++..... ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            999999988865432 2589999999999999999999998   999999999999999999999999999976543222


Q ss_pred             cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHH
Q 004642          611 YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQD  690 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  690 (740)
                       .....|+..|+|||++.+..++.++|+||+||++|||++|+.||........   ............  .....   ..
T Consensus       158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~--~~~~~---~~  228 (285)
T cd05632         158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE--EVYSA---KF  228 (285)
T ss_pred             -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc--cccCc---cC
Confidence             2334789999999999988899999999999999999999999864321000   000001111110  01111   11


Q ss_pred             HHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHcC
Q 004642          691 IILVSTIAFACLSSQPKSRPT-----MQRISQELLAG  722 (740)
Q Consensus       691 ~~~l~~li~~cl~~dP~~RPs-----~~ev~~~L~~~  722 (740)
                      ...+.+++.+|++.||++||+     +.+++++-...
T Consensus       229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~  265 (285)
T cd05632         229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR  265 (285)
T ss_pred             CHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhh
Confidence            123778999999999999999     77888875443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.2e-36  Score=311.12  Aligned_cols=254  Identities=26%  Similarity=0.426  Sum_probs=201.8

Q ss_pred             hcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .++|++.++||+|+||.||+|...++..||+|++......    .+.+.+|++++++++||||+++++++.+ +..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   79 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence            3579999999999999999998777778999999754332    2568899999999999999999998754 5579999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          80 EYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EcCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            99999999999975432 2578999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCcc-cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          609 SSYR-TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       609 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      .... ....++..|+|||+..+..++.++||||||+++|||+| |+.||.....       . ...+........+... 
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~-  226 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------R-EVLDQVERGYRMPCPP-  226 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-------H-HHHHHHhcCCCCCCcc-
Confidence            2211 22346678999999988889999999999999999999 7888764221       1 1111111111111111 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                        .....+.+++.+|++.+|++||+++++.+.|+..
T Consensus       227 --~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         227 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              1223478999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-36  Score=318.17  Aligned_cols=259  Identities=28%  Similarity=0.436  Sum_probs=205.1

Q ss_pred             cccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (740)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+.....   ...+.+.+|++++++++|+||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            46788899999999999999642      356688998865443   224678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCchhhhcCCCc-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC
Q 004642          524 MFLIYEYMERGSLFCVLHDDDE-------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS  590 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~  590 (740)
                      .++||||+++++|.+++.....             ...+++..++.++.||+.|++|||++   +++||||||+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence            9999999999999999865321             23489999999999999999999999   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCC--cccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCC
Q 004642          591 NLEASVADFGTARLLHVDSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGP  667 (740)
Q Consensus       591 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~  667 (740)
                      ++.++|+|||+++.......  ......++..|+|||++.+..++.++|||||||++|||+| |+.||.....       
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------  231 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-------  231 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------
Confidence            99999999999976543221  1223356788999999998889999999999999999999 9999764321       


Q ss_pred             CchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCC
Q 004642          668 KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP  725 (740)
Q Consensus       668 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  725 (740)
                      .. ..+............   .....+.+++.+||+.+|++||++.++++.|....++
T Consensus       232 ~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         232 TE-VIECITQGRVLERPR---VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HH-HHHHHhCCCCCCCCc---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            11 111111111111111   1122378999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1e-36  Score=321.56  Aligned_cols=266  Identities=19%  Similarity=0.254  Sum_probs=200.9

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|++........  ...+.+|++++++++||||+++++++..++..++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            57899999999999999999654 678899999875443221  245778999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++ +|.+++.....  .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          84 EYLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             eCCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            99986 78777765432  478899999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCchhh------h
Q 004642          609 SSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIMLI------D  673 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~------~  673 (740)
                      ........++..|+|||++.+ ..++.++||||+||++|||+||+.||........        .........      +
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            333334468899999998865 4578899999999999999999999864321000        000000000      0


Q ss_pred             hhcccCCCc----chhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          674 VLNQRLSPP----VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       674 ~~~~~l~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      ..+...+..    ...........+.+++.+|++.||++|||++|++++-....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  291 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS  291 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence            000000000    00000011223679999999999999999999999876654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.5e-36  Score=316.97  Aligned_cols=257  Identities=26%  Similarity=0.451  Sum_probs=203.6

Q ss_pred             cccccceeeecccceEEEEEEe------CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (740)
                      ++|.+.+.||+|+||.||++..      .++..+|+|.+.....   ...+.+.+|++++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            5788899999999999999964      2346689998865432   235678999999999999999999999999999


Q ss_pred             EEEEEEeccCCCchhhhcCCC----------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc
Q 004642          524 MFLIYEYMERGSLFCVLHDDD----------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLE  593 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  593 (740)
                      .++||||+++++|.+++....          ....+++.++..++.|++.||+|||++   +++||||||+||++++++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            999999999999999986432          123489999999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCch
Q 004642          594 ASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIM  670 (740)
Q Consensus       594 ~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  670 (740)
                      ++|+|||+++........  .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....       ...
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-------~~~  231 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEV  231 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence            999999999765432211  122345778999999998889999999999999999998 8988764321       111


Q ss_pred             hhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          671 LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       671 ~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      ...+...... ......   ...+.+++.+||+.+|.+||++.|+.+.|+...
T Consensus       232 ~~~i~~~~~~-~~~~~~---~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         232 IECITQGRVL-QRPRTC---PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHHHHcCCcC-CCCCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            1112111111 111111   123889999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-36  Score=310.32  Aligned_cols=246  Identities=25%  Similarity=0.401  Sum_probs=196.1

Q ss_pred             eeecccceEEEEEEe---CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccC
Q 004642          457 CIGTGGYGSVYKAEL---PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      .||+|+||.||+|.+   .+++.+|+|++..... +....+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            589999999999954   3578899999875433 3344678899999999999999999999885 4567899999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc--
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY--  611 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--  611 (740)
                      |+|.+++....   .+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||+++........  
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999986543   578999999999999999999998   9999999999999999999999999999876433221  


Q ss_pred             -ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          612 -RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       612 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                       .....++..|+|||.+....++.++|||||||++|||++ |+.||.....        ....+.+.....++.+...  
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~~~--  223 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQMIESGERMECPQRC--  223 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHCCCCCCCCCCC--
Confidence             112234578999999988888899999999999999998 9999864321        1122223322222221112  


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                       ...+.+++.+||+.||++||++++|.++|..
T Consensus       224 -~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         224 -PPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             -CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence             2337899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=311.21  Aligned_cols=254  Identities=23%  Similarity=0.361  Sum_probs=203.1

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccc--hHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETED--SAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      +.|.+.+.||+|++|.||++.. .+++.||+|.+.......  ....+.+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5688999999999999999954 468999999987543221  2234678899999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      |+||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.++...
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999887543   578889999999999999999998   99999999999999999999999999997654


Q ss_pred             cCCCcc---cccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcc
Q 004642          607 VDSSYR---TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV  683 (740)
Q Consensus       607 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  683 (740)
                      ......   ....|+..|+|||++.+..++.++||||+|+++|||++|+.||......       ...............
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~  228 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPQL  228 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhccCCCCCC
Confidence            322111   2345788999999999988999999999999999999999998642211       111111111111111


Q ss_pred             hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ...   ....+.+++.+||..+|++||++.|++++.
T Consensus       229 ~~~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         229 PSH---VSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             Ccc---CCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence            111   122378899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-36  Score=317.83  Aligned_cols=256  Identities=29%  Similarity=0.422  Sum_probs=198.9

Q ss_pred             cccccceeeecccceEEEEEEeCC-Cc--EEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPE-GK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  525 (740)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++....  ....+.+.+|++++.++ +||||+++++++...+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS--ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC--HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            578899999999999999996643 33  478888764322  22346788999999999 7999999999999999999


Q ss_pred             EEEEeccCCCchhhhcCCC-------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 004642          526 LIYEYMERGSLFCVLHDDD-------------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL  592 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  592 (740)
                      +++||+++++|.++++...             ....+++..+..++.|++.|++|||+.   +++||||||+||++++++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence            9999999999999986532             112488999999999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchh
Q 004642          593 EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIML  671 (740)
Q Consensus       593 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  671 (740)
                      .+||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |..||.....       .. .
T Consensus       157 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-------~~-~  227 (297)
T cd05089         157 ASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-------AE-L  227 (297)
T ss_pred             eEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HH-H
Confidence            99999999986432111 1111233567999999988889999999999999999997 9999864321       11 1


Q ss_pred             hhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          672 IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       672 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .+.+.+..........   ...+.+++.+||+.+|.+||+++++++.|...
T Consensus       228 ~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         228 YEKLPQGYRMEKPRNC---DDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             HHHHhcCCCCCCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1222222222111111   12378999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.2e-36  Score=317.59  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=204.8

Q ss_pred             hcccccceeeecccceEEEEEEe------CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeec
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHK  521 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  521 (740)
                      .++|.+.+.||+|+||.||++..      ..+..||+|+++.....  ...+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--HHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            45799999999999999999953      23557999998754332  2346788999999999 799999999999999


Q ss_pred             CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      +..+++|||+++|+|.++++.... ..+++.++..++.|++.||+|||++   +++|+||||+||+++.++.++++|||+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999975432 2379999999999999999999998   999999999999999999999999999


Q ss_pred             ceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhccc
Q 004642          602 ARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQR  678 (740)
Q Consensus       602 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  678 (740)
                      ++........  .....++..|+|||.+.+..++.++||||+||++|||++ |..||.....       .....+.....
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-------~~~~~~~~~~~  260 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-------DSKFYKLIKEG  260 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-------hHHHHHHHHcC
Confidence            9865433221  122245778999999998889999999999999999998 9999764321       11122222222


Q ss_pred             CCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       679 l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      .........   ...+.+++.+|++.+|++||++.|+++.|.+
T Consensus       261 ~~~~~~~~~---~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         261 YRMAQPEHA---PAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             CcCCCCCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            222111111   2248899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.6e-37  Score=330.22  Aligned_cols=263  Identities=25%  Similarity=0.350  Sum_probs=204.9

Q ss_pred             HHHHHHhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec
Q 004642          443 EDLINATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK  521 (740)
Q Consensus       443 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (740)
                      .++....++|++.+.||+|+||.||++... +++.||+|++...........+.+.+|+.+++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344455689999999999999999999654 6789999998654333333345678899999999999999999999999


Q ss_pred             CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      +..++||||+++|+|.+++...    .++...+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            9999999999999999988653    477888899999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCC-cccccccCCCcccccccccc----ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhc
Q 004642          602 ARLLHVDSS-YRTLRAGTYGYIAPELAYTI----VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLN  676 (740)
Q Consensus       602 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  676 (740)
                      ++....... ......||+.|+|||++.+.    .++.++||||+||++|||++|+.||.....       ......+..
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~  261 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMN  261 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------HHHHHHHHc
Confidence            987643222 22345799999999998753    378899999999999999999999874321       111222222


Q ss_pred             cc--CCCcchhhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHHcC
Q 004642          677 QR--LSPPVNQKIVQDIILVSTIAFACLSSQPKS--RPTMQRISQELLAG  722 (740)
Q Consensus       677 ~~--l~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~L~~~  722 (740)
                      ..  +..+.....   ...+.+++.+|+..+|.+  ||+++|++++....
T Consensus       262 ~~~~~~~~~~~~~---s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~  308 (371)
T cd05622         262 HKNSLTFPDDNDI---SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  308 (371)
T ss_pred             CCCcccCCCcCCC---CHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccC
Confidence            11  111111111   223778999999844433  78999999987654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.5e-36  Score=327.01  Aligned_cols=263  Identities=23%  Similarity=0.285  Sum_probs=198.0

Q ss_pred             HhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC----
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK----  522 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  522 (740)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            457899999999999999999955 46899999999754332 223467789999999999999999999986543    


Q ss_pred             --eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecc
Q 004642          523 --CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG  600 (740)
Q Consensus       523 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  600 (740)
                        ..++||||+++ ++.+.++.     .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence              47999999976 55555532     478888999999999999999999   99999999999999999999999999


Q ss_pred             cceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccccc-------CCCCCc----
Q 004642          601 TARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-------SSGPKI----  669 (740)
Q Consensus       601 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~----  669 (740)
                      +++..... .......||..|+|||++.+..++.++||||+||++|+|++|+.||........       ......    
T Consensus       169 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         169 LARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             CccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            99764322 222334789999999999999999999999999999999999999974321100       000000    


Q ss_pred             ----hhhhhhcccCCCc---------------chhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          670 ----MLIDVLNQRLSPP---------------VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       670 ----~~~~~~~~~l~~~---------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                          .............               ...........+.+++.+||+.||++|||+.|++++...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  318 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI  318 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence                0000000000000               000000012337899999999999999999999998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-36  Score=314.17  Aligned_cols=256  Identities=24%  Similarity=0.370  Sum_probs=199.7

Q ss_pred             cccccceeeecccceEEEEEEeC-CCc----EEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCM  524 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (740)
                      ++|++.+.||+|+||.||+|.+. +|+    .+++|.+.....  .....++..|+.++++++||||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc--hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            57888899999999999999653 444    477788754322  2234677888889999999999999998764 457


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++++||+++|+|.+++.....  .+++..+..++.||+.||+|||+.   +++||||||+||++++++.+||+|||.++.
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            889999999999999975432  589999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCC--cccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          605 LHVDSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       605 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      ......  ......++..|+|||++.+..++.++|||||||++|||++ |+.||.....        ....+.+......
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~  230 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HEVPDLLEKGERL  230 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCcC
Confidence            643322  1223356788999999998889999999999999999998 9999864321        1112222222221


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      ......   ...+.+++.+||..+|++||++.|+++.|.....
T Consensus       231 ~~~~~~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 AQPQIC---TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            111111   1236789999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.5e-36  Score=315.65  Aligned_cols=256  Identities=25%  Similarity=0.434  Sum_probs=202.5

Q ss_pred             ccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCM  524 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (740)
                      +|++.+.||+|+||.||+|...      ....+++|.+......  ...+.+.+|+++++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            4778899999999999999642      2357888888754432  2346788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhhhcCCC---------------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 004642          525 FLIYEYMERGSLFCVLHDDD---------------------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISS  583 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  583 (740)
                      ++++||+++++|.+++....                     ....+++.+++.++.|++.||+|||+.   +++||||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence            99999999999999875421                     113588999999999999999999998   999999999


Q ss_pred             CceEEcCCCcEEEeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccc
Q 004642          584 NNILLDSNLEASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSS  660 (740)
Q Consensus       584 ~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~  660 (740)
                      +||++++++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|||++ |+.||.... 
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-  234 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-  234 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-
Confidence            9999999999999999999765432221  122345678999999988889999999999999999998 999976422 


Q ss_pred             cccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          661 LSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       661 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                             ...+.+.+............   ...+.+++.+||+.+|++||+++|+++.|+..
T Consensus       235 -------~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         235 -------PERLFNLLKTGYRMERPENC---SEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             -------HHHHHHHHhCCCCCCCCCCC---CHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence                   11222233222222211111   22378999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-36  Score=314.41  Aligned_cols=259  Identities=26%  Similarity=0.370  Sum_probs=199.9

Q ss_pred             cccceeeecccceEEEEEE-----eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec--CeE
Q 004642          452 FHIKYCIGTGGYGSVYKAE-----LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCM  524 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~-----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  524 (740)
                      |.+.+.||+|+||+||++.     ..+++.||+|.+......  .....+.+|++++++++||||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            3788999999999998763     235788999998764322  2346788999999999999999999988753  468


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      +++|||+++++|.+++...    .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||+++.
T Consensus        84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence            9999999999999998653    489999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCCc---ccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccc-c----cC--CCCCchhhhh
Q 004642          605 LHVDSSY---RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSL-S----SS--SGPKIMLIDV  674 (740)
Q Consensus       605 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-~----~~--~~~~~~~~~~  674 (740)
                      .......   .....++..|+|||...+..++.++||||||+++|||++|+.|+...... .    ..  ........+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            6432221   12224567799999998888999999999999999999999997542210 0    00  0011111222


Q ss_pred             hcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          675 LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       675 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ++.....+...   .....+.+++.+||+.+|++||+++++++.|...
T Consensus       237 ~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         237 LERGMRLPCPK---NCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhcCCCCCCCC---CCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            22222211111   1123488999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-36  Score=316.67  Aligned_cols=256  Identities=24%  Similarity=0.377  Sum_probs=201.1

Q ss_pred             cccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (740)
                      .+|.+.+.||+|+||.||+|...      +++.||+|++.....  ....+.+.+|+.++..++||||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            35777888999999999999653      257899999975443  2334678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCchhhhcCCC-------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC
Q 004642          524 MFLIYEYMERGSLFCVLHDDD-------------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS  590 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~  590 (740)
                      .++++||+++++|.+++....             ....+++..+..++.|++.||+|||+.   +++||||||+||++++
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence            999999999999998885211             123478899999999999999999998   9999999999999999


Q ss_pred             CCcEEEeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCC
Q 004642          591 NLEASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGP  667 (740)
Q Consensus       591 ~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~  667 (740)
                      ++.+||+|||+++........  .....+++.|+|||++.+..++.++|||||||++|||++ |..||.....       
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------  232 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------  232 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence            999999999998865432211  122345789999999988889999999999999999998 8888754221       


Q ss_pred             CchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          668 KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       668 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ......+...... +....   ....+.+++.+||+.+|++||+++|+++.|+.
T Consensus       233 ~~~~~~i~~~~~~-~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 QDVIEMIRNRQVL-PCPDD---CPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHHHcCCcC-CCCCC---CCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1112222222211 11111   22237899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.3e-36  Score=308.61  Aligned_cols=252  Identities=27%  Similarity=0.435  Sum_probs=200.9

Q ss_pred             cccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      ++|.+.+.||+|+||.||++...++..+|+|.+......    .+.+.+|++++++++|+|++++++++. .+..+++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence            568889999999999999998877778999988654332    356888999999999999999999875 456889999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.++++.... ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.++......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          81 FMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999999976432 3578999999999999999999998   99999999999999999999999999998764322


Q ss_pred             Cc-ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          610 SY-RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       610 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      .. .....++..|+|||+..+..++.++||||||+++|||++ |+.||.....        ....+.+......+...  
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~--  226 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQVERGYRMPCPQ--  226 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCc--
Confidence            11 122245678999999988889999999999999999999 8888764221        11111121221111111  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                       .....+.+++.+||+.+|++||+++++.+.|+.
T Consensus       227 -~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         227 -GCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             112348899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-36  Score=319.62  Aligned_cols=256  Identities=28%  Similarity=0.419  Sum_probs=199.1

Q ss_pred             cccccceeeecccceEEEEEEeC-CCc--EEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  525 (740)
                      ++|++.+.||+|+||.||+|.+. ++.  .+|+|.+.....  ....+.+.+|++++.++ +||||+++++++.+.+..+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC--HHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            57888999999999999999654 454  457777654322  23346788999999999 8999999999999999999


Q ss_pred             EEEEeccCCCchhhhcCCCc-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 004642          526 LIYEYMERGSLFCVLHDDDE-------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL  592 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  592 (740)
                      +||||+++++|.++++....             ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence            99999999999999875421             23578999999999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchh
Q 004642          593 EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIML  671 (740)
Q Consensus       593 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  671 (740)
                      .+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||.....        ...
T Consensus       162 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~  232 (303)
T cd05088         162 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL  232 (303)
T ss_pred             cEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HHH
Confidence            9999999998643211 11112234678999999988889999999999999999998 9999854321        111


Q ss_pred             hhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          672 IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       672 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .+.+..........   .....+.+++.+||+.+|++||+++++++++...
T Consensus       233 ~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         233 YEKLPQGYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHHHhcCCcCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11121111111111   1122378999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=324.23  Aligned_cols=260  Identities=25%  Similarity=0.339  Sum_probs=198.6

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||++... +++.||+|++...........+.+.+|..++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999654 68999999997533333334567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++.....  .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999965332  578899999999999999999999   9999999999999999999999999999765433


Q ss_pred             CCc-ccccccCCCccccccccc-----cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCc
Q 004642          609 SSY-RTLRAGTYGYIAPELAYT-----IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  682 (740)
                      ... .....||+.|+|||++..     ..++.++||||+||++|||++|+.||......       .....+........
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~  228 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKEHFQ  228 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCccc
Confidence            222 223469999999999863     45778999999999999999999998643210       11111111110000


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHHHHc
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPK--SRPTMQRISQELLA  721 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~ev~~~L~~  721 (740)
                      ...........+.+++.+|+..+++  .||++.+++++-..
T Consensus       229 ~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~  269 (331)
T cd05597         229 FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF  269 (331)
T ss_pred             CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence            0000001122367788887755443  37899999999654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.5e-36  Score=317.74  Aligned_cols=259  Identities=27%  Similarity=0.429  Sum_probs=204.3

Q ss_pred             HhcccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeee
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLH  520 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  520 (740)
                      ..++|++.+.||+|+||.||++...      ....+|+|.+......  .....+.+|++++.++ +|+||+++++++..
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            4567889999999999999999653      2367999998764332  2346788999999999 89999999999999


Q ss_pred             cCeEEEEEEeccCCCchhhhcCC-------------CccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceE
Q 004642          521 KKCMFLIYEYMERGSLFCVLHDD-------------DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNIL  587 (740)
Q Consensus       521 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIl  587 (740)
                      ++..+++|||+++|+|.++++..             .....+++..++.++.|++.||+|||+.   +|+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence            99999999999999999998642             1234689999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecccceecccCCCcc--cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccC
Q 004642          588 LDSNLEASVADFGTARLLHVDSSYR--TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSS  664 (740)
Q Consensus       588 l~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~  664 (740)
                      ++.++.+||+|||.++.+.......  ....++..|+|||+..+..++.++|||||||++|||++ |..||.....    
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  240 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----  240 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----
Confidence            9999999999999998764322111  11234678999999988889999999999999999998 8888754221    


Q ss_pred             CCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          665 SGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       665 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                          ....+.+..........   .....+.+++.+||+.+|++|||+.|++++|...
T Consensus       241 ----~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         241 ----EELFKLLKEGYRMEKPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             ----HHHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence                11112222221111111   1123478999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.6e-36  Score=308.50  Aligned_cols=246  Identities=22%  Similarity=0.375  Sum_probs=194.8

Q ss_pred             eecccceEEEEEEeC---CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCC
Q 004642          458 IGTGGYGSVYKAELP---EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERG  534 (740)
Q Consensus       458 lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (740)
                      ||+|+||.||+|.+.   .+..||+|++.....  ....+.+.+|++++++++||||+++++++.. ...++||||++++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            899999999999653   356799999876532  3345678999999999999999999998854 5689999999999


Q ss_pred             CchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc-
Q 004642          535 SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT-  613 (740)
Q Consensus       535 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-  613 (740)
                      +|.+++....  ..+++.++..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.....+..... 
T Consensus        80 ~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          80 PLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9999986533  2588999999999999999999998   999999999999999999999999999986543322211 


Q ss_pred             --ccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHH
Q 004642          614 --LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQD  690 (740)
Q Consensus       614 --~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  690 (740)
                        ...++..|+|||++....++.++|||||||++||+++ |+.||.....        ......+.+......+.   ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~---~~  223 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMSFIEQGKRLDCPA---EC  223 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHHCCCCCCCCC---CC
Confidence              1123578999999988889999999999999999996 9999864321        11222222222222211   11


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          691 IILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       691 ~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ...+.+++.+||+.+|++||++.++.+.|...
T Consensus       224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         224 PPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            23478999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=320.81  Aligned_cols=258  Identities=28%  Similarity=0.446  Sum_probs=216.6

Q ss_pred             HHHHHHhcccccceeeecccceEEEEEEeCC-CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec
Q 004642          443 EDLINATEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK  521 (740)
Q Consensus       443 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (740)
                      ++++-...+..+.++||-|.||.||.|.|+. .-.||||.++.....    +++|.+|+.+|+.++|||+|+++|+|...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            3344445567788999999999999998865 567999999876554    67899999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      ..+|||.|||.+|+|.++|.+.... .++....+.++.||+.||+||..+   .+|||||..+|+|+.++..|||.|||+
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence            9999999999999999999876643 577778889999999999999999   999999999999999999999999999


Q ss_pred             ceecccCCCccccccc---CCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcc
Q 004642          602 ARLLHVDSSYRTLRAG---TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ  677 (740)
Q Consensus       602 a~~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  677 (740)
                      ++++..+...  .+.|   +..|.|||.+....++.|+|||+|||+|||+.| |-.||....        .....+.+.+
T Consensus       412 sRlMtgDTYT--AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lSqVY~LLEk  481 (1157)
T KOG4278|consen  412 SRLMTGDTYT--AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYGLLEK  481 (1157)
T ss_pred             hhhhcCCcee--cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HHHHHHHHhc
Confidence            9998766543  2333   578999999998899999999999999999998 777765432        1234555666


Q ss_pred             cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          678 RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       678 ~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ..+...+....   ..++++|+.||++.|.+||+++|+-+.++.
T Consensus       482 gyRM~~PeGCP---pkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  482 GYRMDGPEGCP---PKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             cccccCCCCCC---HHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence            66555544333   348899999999999999999999988864

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.5e-37  Score=325.80  Aligned_cols=261  Identities=22%  Similarity=0.332  Sum_probs=204.7

Q ss_pred             ccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-C-----CccceeeeeeeecCe
Q 004642          451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-H-----RNIVKLYGFCLHKKC  523 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~  523 (740)
                      +|.+.+.||+|.||.|-+| +.++++.||||+++....    +..+...|+.++..++ |     -|+|++++++...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            8999999999999999999 666799999999987543    4567788999999996 4     389999999999999


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC--CcEEEeeccc
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN--LEASVADFGT  601 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~DfG~  601 (740)
                      .+||+|.++. +|++++....-. .++...+..|+.||+.||.+||+.   +|||+||||+|||+.+-  ..+||+|||.
T Consensus       263 lciVfELL~~-NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence            9999999976 999999876543 589999999999999999999998   99999999999999754  4699999999


Q ss_pred             ceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccc--------------------
Q 004642          602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSL--------------------  661 (740)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~--------------------  661 (740)
                      |++...  ... ..+.+..|+|||++.|.+|+.+.||||||||++||++|..-|....+.                    
T Consensus       338 Sc~~~q--~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  338 SCFESQ--RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             ccccCC--cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            987542  222 447889999999999999999999999999999999997766543220                    


Q ss_pred             -------ccC--CC-----C-C-----------chhhhhhcccCCCcc----hhhhH-HHHHHHHHHHHHcccCCCCCCC
Q 004642          662 -------SSS--SG-----P-K-----------IMLIDVLNQRLSPPV----NQKIV-QDIILVSTIAFACLSSQPKSRP  710 (740)
Q Consensus       662 -------~~~--~~-----~-~-----------~~~~~~~~~~l~~~~----~~~~~-~~~~~l~~li~~cl~~dP~~RP  710 (740)
                             ...  ..     . +           .......+....+..    ..... .+...+.+++++|+.+||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                   000  00     0 0           000001111111101    01111 2334489999999999999999


Q ss_pred             CHHHHHHHHHcCC
Q 004642          711 TMQRISQELLAGK  723 (740)
Q Consensus       711 s~~ev~~~L~~~~  723 (740)
                      |+.|.++|-+...
T Consensus       495 tp~qal~Hpfl~~  507 (586)
T KOG0667|consen  495 TPAQALNHPFLTG  507 (586)
T ss_pred             CHHHHhcCccccc
Confidence            9999999987763

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.1e-37  Score=313.78  Aligned_cols=256  Identities=29%  Similarity=0.451  Sum_probs=202.5

Q ss_pred             cccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEe
Q 004642          452 FHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      |++.+.||+|+||+||+++.. +++.||+|++......... .....+|+.++++++||||+++++++......++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            677899999999999999655 5678999999887654333 23445699999999999999999999999999999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                      +++++|.+++..   ...+++..+..++.|+++||++||+.   +++|+||||+||+++.++.++|+|||.+........
T Consensus        80 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   80 CPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             ETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred             cccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            999999999982   23689999999999999999999999   999999999999999999999999999986533344


Q ss_pred             cccccccCCCcccccccc-ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          611 YRTLRAGTYGYIAPELAY-TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                      ......++..|+|||++. +..++.++||||+|+++|+|++|..||......    .................. .....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~-~~~~~  228 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD----DQLEIIEKILKRPLPSSS-QQSRE  228 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH----HHHHHHHHHHHTHHHHHT-TSHTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccch----hhhhhhhhcccccccccc-cccch
Confidence            445567899999999998 788999999999999999999999998753100    000111111111110000 00001


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ....+.+++.+||+.||++||++.+++++-
T Consensus       229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~~~  258 (260)
T PF00069_consen  229 KSEELRDLIKKMLSKDPEQRPSAEELLKHP  258 (260)
T ss_dssp             SHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred             hHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence            124589999999999999999999998763

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.6e-36  Score=313.46  Aligned_cols=262  Identities=27%  Similarity=0.438  Sum_probs=200.8

Q ss_pred             cccccceeeecccceEEEEEEe-----CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee--cC
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-----PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH--KK  522 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  522 (740)
                      ++|++.+.||+|+||.||++..     .+++.||+|++.....   ...+.+.+|++++++++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            5788899999999999999964     3578999999875432   234678899999999999999999998754  34


Q ss_pred             eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccc
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                      ..++||||+++++|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence            68999999999999999975432  589999999999999999999998   9999999999999999999999999999


Q ss_pred             eecccCCCcc---cccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccC-CCC-------Cchh
Q 004642          603 RLLHVDSSYR---TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS-SGP-------KIML  671 (740)
Q Consensus       603 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~-------~~~~  671 (740)
                      +.........   ....++..|+|||+..+..++.++|||||||++|||++|..|+......... ...       ...+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence            8764332211   1122345699999998888999999999999999999998775432211000 000       0111


Q ss_pred             hhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          672 IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       672 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .+.+......+.....   ...+.+++.+||+.+|++|||+.|+++.|...
T Consensus       236 ~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         236 IELLKNNGRLPAPPGC---PAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHhcCCcCCCCCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1222222211111111   12388999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-36  Score=315.80  Aligned_cols=263  Identities=21%  Similarity=0.271  Sum_probs=198.7

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|++|.||+|... +++.||+|++....... ...+.+.+|+.++++++|||++++++++.+++..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            4788899999999999999654 68999999987543222 223677889999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |++ ++|.+++........+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            998 58888887654444689999999999999999999998   99999999999999999999999999997654333


Q ss_pred             CcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc---------CCC-----CCchhhh-
Q 004642          610 SYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS---------SSG-----PKIMLID-  673 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~---------~~~-----~~~~~~~-  673 (740)
                      .......+++.|+|||++.+. .++.++|||||||++|||+||+.||........         ...     ......+ 
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            333334678899999988654 468899999999999999999999864321100         000     0000000 


Q ss_pred             --hhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          674 --VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       674 --~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                        ...................++.+++.+||+.||++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence              000000000000000112236789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.9e-36  Score=313.51  Aligned_cols=259  Identities=21%  Similarity=0.328  Sum_probs=206.0

Q ss_pred             hcccccceeeecccceEEEEEEeCC-----CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee-cC
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE-----GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH-KK  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  522 (740)
                      .++|++.+.||+|+||.||+|...+     +..|++|++.....  ....+.+.+|+.++++++|+||+++++++.. +.
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS--EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            4688899999999999999997655     68899998875432  2335778899999999999999999998876 56


Q ss_pred             eEEEEEEeccCCCchhhhcCCCcc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEe
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEA-----IELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVA  597 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  597 (740)
                      ..++++||+++++|.+++......     ..+++.++..++.|++.||+|||+.   +++|+||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998654322     4689999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhh
Q 004642          598 DFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDV  674 (740)
Q Consensus       598 DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  674 (740)
                      |||+++.+......  .....++..|+|||++.+..++.++|||||||++||+++ |+.||......        .....
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~  231 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--------EMAAY  231 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--------HHHHH
Confidence            99999865433221  122345778999999988889999999999999999999 99998643221        11222


Q ss_pred             hcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          675 LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       675 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      +...........   ....+.+++.+||+.||++||++.|+++.|....
T Consensus       232 ~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         232 LKDGYRLAQPIN---CPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HHcCCCCCCCCc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            222211111111   1123789999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-36  Score=314.30  Aligned_cols=254  Identities=26%  Similarity=0.418  Sum_probs=198.3

Q ss_pred             HHhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeec---
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHK---  521 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---  521 (740)
                      .+++.|++.+.||+|+||.||+|.. .+++.||+|++......    ...+..|+.++.++ +|+|++++++++...   
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            3567888999999999999999965 46889999998654322    25677899999998 799999999998753   


Q ss_pred             ---CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEee
Q 004642          522 ---KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVAD  598 (740)
Q Consensus       522 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  598 (740)
                         ...+++|||+++++|.+++.... ...+++..+..++.|++.|++|||+.   +|+|+||||+||++++++.++|+|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence               46899999999999999987633 23588999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCcccccccCCCcccccccc-----ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhh
Q 004642          599 FGTARLLHVDSSYRTLRAGTYGYIAPELAY-----TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLID  673 (740)
Q Consensus       599 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  673 (740)
                      ||++..............|+..|+|||++.     +..++.++||||+||++|||++|+.||.......       ....
T Consensus       155 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~  227 (272)
T cd06637         155 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFL  227 (272)
T ss_pred             CCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHH
Confidence            999986543333334457899999999986     3457889999999999999999999986432110       0000


Q ss_pred             hhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          674 VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       674 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ..............   ...+.+++.+||..+|.+||++.|++++
T Consensus       228 ~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         228 IPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             HhcCCCCCCCCCCc---CHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            00000000000111   1237899999999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.2e-37  Score=330.70  Aligned_cols=256  Identities=24%  Similarity=0.361  Sum_probs=200.7

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||++... +++.||+|++...........+.+.+|++++.+++||+|+++++.+.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999654 68999999997544333344567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999987643   578899999999999999999998   9999999999999999999999999998754211


Q ss_pred             CC-----------------------------------cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCC
Q 004642          609 SS-----------------------------------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTH  653 (740)
Q Consensus       609 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~  653 (740)
                      ..                                   .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            00                                   0112469999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCchhhhhhcc--cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHHHHcC
Q 004642          654 PGGLLSSLSSSSGPKIMLIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRP---TMQRISQELLAG  722 (740)
Q Consensus       654 p~~~~~~~~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ev~~~L~~~  722 (740)
                      ||.....       ......+...  .+..+.....   ...+.+++.+|+. ||++|+   ++.|+++|-...
T Consensus       235 Pf~~~~~-------~~~~~~i~~~~~~~~~p~~~~~---s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~  297 (360)
T cd05627         235 PFCSETP-------QETYRKVMNWKETLVFPPEVPI---SEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFE  297 (360)
T ss_pred             CCCCCCH-------HHHHHHHHcCCCceecCCCCCC---CHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCC
Confidence            9864321       1111122211  1111111001   1236678887764 999998   478888886543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4e-36  Score=312.21  Aligned_cols=257  Identities=25%  Similarity=0.418  Sum_probs=202.0

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCc----EEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (740)
                      .++|++.+.||+|+||.||+|.+ .+|+    .||+|++......  ...+.+.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP--KANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH--HHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            45788899999999999999964 3454    4899998754332  2346788999999999999999999998764 4


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccce
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      .++++||+++|+|.++++....  .+++.++..++.||+.||+|||+.   +++||||||+||++++++.+||+|||+++
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence            7799999999999999876432  588999999999999999999998   99999999999999999999999999998


Q ss_pred             ecccCCCcc--cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCC
Q 004642          604 LLHVDSSYR--TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLS  680 (740)
Q Consensus       604 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  680 (740)
                      .........  ....++..|+|||...+..++.++|||||||++|||++ |..||+....        ......+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~  229 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------REIPDLLEKGER  229 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCc
Confidence            765332221  12234678999999998889999999999999999998 8888764221        112222222221


Q ss_pred             CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       681 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      .+...   .....+.+++.+||+.||++||++.|+++.|.....
T Consensus       230 ~~~~~---~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         230 LPQPP---ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             CCCCc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            11111   112237889999999999999999999999876643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.6e-36  Score=316.27  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=204.0

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+.......   .+.+.+|+.+++.++|+|++++++++..+...++|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            35788999999999999999964 568999999987644332   36688999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++++|.+++...    .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++.....
T Consensus        96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            9999999999988643    478899999999999999999998   999999999999999999999999999876544


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhh-cccCCCcchhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVL-NQRLSPPVNQK  686 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~  686 (740)
                      .........|++.|+|||.+.+..++.++|||||||++|+|++|+.||......       ....... .......... 
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~-  240 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPELQNPE-  240 (296)
T ss_pred             cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHHHHhcCCCCCCCCcc-
Confidence            333333457889999999998888899999999999999999999998643210       0111111 1111101111 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                        .....+.+++.+||..+|++||++.|++++-..
T Consensus       241 --~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~  273 (296)
T cd06654         241 --KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL  273 (296)
T ss_pred             --ccCHHHHHHHHHHCcCCcccCcCHHHHhhChhh
Confidence              112237889999999999999999999997544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.4e-36  Score=313.44  Aligned_cols=254  Identities=28%  Similarity=0.413  Sum_probs=199.5

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|.++.....   ....+.+|+.+++.++||||+++++++..++..++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            35788889999999999999954 46899999998754322   235678899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++++|.+++...+   .+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+.....
T Consensus        85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          85 MEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            99999999999886543   588999999999999999999998   999999999999999999999999999976643


Q ss_pred             CCCcccccccCCCcccccccc---ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcch
Q 004642          608 DSSYRTLRAGTYGYIAPELAY---TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN  684 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  684 (740)
                      .........|+..|+|||++.   ...++.++||||+||++|+|++|+.||......       ............++..
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~  231 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-------RALFLMTKSNFQPPKL  231 (267)
T ss_pred             cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-------hhHHhhhccCCCCCcc
Confidence            333334457899999999874   445788999999999999999999997532210       0000111111111110


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      .........+.+++.+|++.+|++||++++++++
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            0000111237889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-36  Score=310.45  Aligned_cols=255  Identities=24%  Similarity=0.416  Sum_probs=199.9

Q ss_pred             cccceeeecccceEEEEEEeCC----CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe----
Q 004642          452 FHIKYCIGTGGYGSVYKAELPE----GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC----  523 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  523 (740)
                      |.+.+.||+|+||.||+|....    +..||+|+++..... ......+.+|++.++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            5678899999999999996542    377999998764333 2335678999999999999999999998876554    


Q ss_pred             --EEEEEEeccCCCchhhhcCCC---ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEee
Q 004642          524 --MFLIYEYMERGSLFCVLHDDD---EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVAD  598 (740)
Q Consensus       524 --~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  598 (740)
                        .++++||+++|+|..++....   ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence              799999999999998885432   223689999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhh
Q 004642          599 FGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVL  675 (740)
Q Consensus       599 fG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  675 (740)
                      ||+++........  .....++..|+|||++.+..++.++|||||||++|||++ |..||.....       .. ..+.+
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-------~~-~~~~~  228 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-------HE-IYDYL  228 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHH
Confidence            9999876433222  122235678999999988889999999999999999999 8888764321       11 11222


Q ss_pred             cccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          676 NQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       676 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ........+.   .....+.+++.+||+.||++||++.|+++.|..
T Consensus       229 ~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         229 RHGNRLKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             HcCCCCCCCc---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            2111111111   122348899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.6e-36  Score=305.77  Aligned_cols=246  Identities=24%  Similarity=0.409  Sum_probs=197.0

Q ss_pred             eeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCc
Q 004642          457 CIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL  536 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  536 (740)
                      .||+|+||.||+|...+++.+|+|.+......  .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ--ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            58999999999998888999999998765432  2335688999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc-cccc
Q 004642          537 FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY-RTLR  615 (740)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~  615 (740)
                      .+++.....  .+++..+..++.|++.||.|+|+.   +++||||||+||+++.++.++|+|||++......... ....
T Consensus        80 ~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          80 LSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            998865432  578999999999999999999998   9999999999999999999999999999754322111 1122


Q ss_pred             ccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHH
Q 004642          616 AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILV  694 (740)
Q Consensus       616 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  694 (740)
                      .++..|+|||+..+..++.++||||||+++|++++ |..||......        .....+..........   .....+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~---~~~~~~  223 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKGYRMSCPQ---KCPDDV  223 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCCCCCCC---CCCHHH
Confidence            44678999999998889999999999999999998 99998643211        1111111111111111   112348


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          695 STIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       695 ~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      .+++.+|++.+|++||++.|++++|.
T Consensus       224 ~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         224 YKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHcccCcccCCCHHHHHHHhc
Confidence            89999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5e-36  Score=310.23  Aligned_cols=255  Identities=27%  Similarity=0.405  Sum_probs=196.2

Q ss_pred             cccceeeecccceEEEEEEeCC-Cc--EEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec------C
Q 004642          452 FHIKYCIGTGGYGSVYKAELPE-GK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK------K  522 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  522 (740)
                      |.+.+.||+|+||.||+|...+ +.  .||+|.++..... ....+.+.+|+++++.++|+||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3467889999999999997654 32  5899988764332 23357888999999999999999999987532      2


Q ss_pred             eEEEEEEeccCCCchhhhcCC---CccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeec
Q 004642          523 CMFLIYEYMERGSLFCVLHDD---DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF  599 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  599 (740)
                      ..+++|||+++|+|.+++...   .....+++..+..++.|++.||+|||++   +|+||||||+||++++++.++|+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence            468999999999998877422   1223588999999999999999999998   9999999999999999999999999


Q ss_pred             ccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhc
Q 004642          600 GTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLN  676 (740)
Q Consensus       600 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  676 (740)
                      |+++.+......  .....+++.|+|||+..+..++.++||||||+++|||++ |+.||.....        ....+.+.
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~  228 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDYLR  228 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHH
Confidence            999876433221  122346778999999999899999999999999999999 7888764221        11111111


Q ss_pred             ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          677 QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       677 ~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      .........   .....+.+++.+||+.+|++||++.|++++|..
T Consensus       229 ~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         229 QGNRLKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             cCCCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            111111111   112237899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.8e-36  Score=314.90  Aligned_cols=260  Identities=23%  Similarity=0.335  Sum_probs=203.7

Q ss_pred             HhcccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK  521 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  521 (740)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+......  .....+.+|+.++++++||||+++++++.++
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4578999999999999999998543      2457999988654322  2235678899999999999999999999999


Q ss_pred             CeEEEEEEeccCCCchhhhcCCCc-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcE
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDE-------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEA  594 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~  594 (740)
                      +..++||||+++|+|.+++.....       ....++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence            999999999999999999965321       23457788999999999999999998   99999999999999999999


Q ss_pred             EEeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchh
Q 004642          595 SVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIML  671 (740)
Q Consensus       595 kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  671 (740)
                      +|+|||+++........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....       ....
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~~~  231 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVL  231 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHH
Confidence            99999999865432221  122245678999999998889999999999999999999 7888754221       1111


Q ss_pred             hhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          672 IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       672 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      ....+..... ...   .....+.+++.+|++.+|++||++.|+++.+...-
T Consensus       232 ~~~~~~~~~~-~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         232 KFVMDGGYLD-QPD---NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHcCCCCC-CCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1222221111 111   11234889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-36  Score=333.20  Aligned_cols=261  Identities=20%  Similarity=0.274  Sum_probs=191.6

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec------
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK------  521 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  521 (740)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....       ....+|+.+++.++||||+++++++...      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            46799999999999999999965 468999999885432       2235799999999999999999887532      


Q ss_pred             --CeEEEEEEeccCCCchhhhcCC-CccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-cEEEe
Q 004642          522 --KCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVA  597 (740)
Q Consensus       522 --~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~  597 (740)
                        ...++||||+++ ++.+++... .....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence              246799999986 666665432 1233688999999999999999999998   999999999999999665 69999


Q ss_pred             ecccceecccCCCcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc-------CCCCCc
Q 004642          598 DFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-------SSGPKI  669 (740)
Q Consensus       598 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~  669 (740)
                      |||+|+.+..... .....||+.|+|||++.+. .++.++||||+||++|||++|..||........       ...+..
T Consensus       214 DFGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        214 DFGSAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccccchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9999987643322 2234689999999998764 689999999999999999999999875321100       000000


Q ss_pred             hhhhhhcc-----cCCCcchhhh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          670 MLIDVLNQ-----RLSPPVNQKI-----VQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       670 ~~~~~~~~-----~l~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      .......+     ..+.......     ......+.+++.+||+.||.+|||+.|+++|-..
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f  354 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF  354 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence            00000000     0000000000     0012347899999999999999999999988764

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.9e-36  Score=309.45  Aligned_cols=254  Identities=28%  Similarity=0.437  Sum_probs=201.7

Q ss_pred             cccccceeeecccceEEEEEEeC----CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (740)
                      ++|++.+.||+|+||.||+|...    .+..+|+|.+......  ...+.+.+|+.++.+++||||+++++++.+++..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            57888999999999999999653    2347999998754322  23568899999999999999999999999999999


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      +||||+++++|.+++.....  .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+...
T Consensus        82 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999999976542  578999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCCcc---cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          606 HVDSSYR---TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       606 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      .......   ....++..|+|||++.+..++.++||||||+++||+++ |+.||......       . ....+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-------~-~~~~~~~~~~~  228 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------D-VIKAIEEGYRL  228 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------H-HHHHHhCCCcC
Confidence            5332211   11123568999999998889999999999999999886 99997643210       1 11111111111


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      +....   ....+.+++.+|++.+|++||++.++++.|..
T Consensus       229 ~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         229 PAPMD---CPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             CCCCC---CCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            11111   12237899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=317.74  Aligned_cols=260  Identities=25%  Similarity=0.365  Sum_probs=199.0

Q ss_pred             hcccccceeeecccceEEEEEEeCC---------------CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccce
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE---------------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK  513 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  513 (740)
                      .++|++.+.||+|+||.||++...+               ...||+|++.....  ......+.+|++++++++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCe
Confidence            3579999999999999999986532               23589999976433  233467899999999999999999


Q ss_pred             eeeeeeecCeEEEEEEeccCCCchhhhcCCC---------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 004642          514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDD---------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSN  584 (740)
Q Consensus       514 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~  584 (740)
                      +++++...+..++||||+++++|.+++....         ....+++.+++.++.|++.||+|||+.   +++|+||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence            9999999999999999999999999886432         112478999999999999999999998   9999999999


Q ss_pred             ceEEcCCCcEEEeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh--CCCCCCcccc
Q 004642          585 NILLDSNLEASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM--GTHPGGLLSS  660 (740)
Q Consensus       585 NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~  660 (740)
                      ||+++.++.+||+|||++.........  .....++..|+|||+..+..++.++|||||||++|||++  |..||.....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999999999999999999765432211  122345778999999988889999999999999999998  5567654221


Q ss_pred             cccCCCCCchhhhhhc---ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          661 LSSSSGPKIMLIDVLN---QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       661 ~~~~~~~~~~~~~~~~---~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ...    .....+...   .........   .....+.+++.+||+.+|++||++.++++.|.
T Consensus       239 ~~~----~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQV----IENTGEFFRNQGRQIYLSQTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHH----HHHHHHhhhhccccccCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            000    000000000   000011011   11123889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-36  Score=324.08  Aligned_cols=260  Identities=23%  Similarity=0.324  Sum_probs=201.1

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.............+.+|..++..++|++|+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999654 67889999987543333333466888999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....+
T Consensus        81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999976432  578889999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCc-ccccccCCCccccccccc-----cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCc
Q 004642          609 SSY-RTLRAGTYGYIAPELAYT-----IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  682 (740)
                      ... .....||+.|+|||++.+     ..++.++||||+||++|||++|+.||.....       ......+.......+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~  228 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHEERFQ  228 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-------HHHHHHHHcCCCccc
Confidence            322 223469999999999875     4578899999999999999999999864321       111112222111111


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHHc
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKS--RPTMQRISQELLA  721 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~L~~  721 (740)
                      .+.........+.+++.+|+..++++  |+++++++++...
T Consensus       229 ~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f  269 (331)
T cd05624         229 FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF  269 (331)
T ss_pred             CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence            11111111234778999998876654  4689999887543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-36  Score=312.50  Aligned_cols=256  Identities=24%  Similarity=0.345  Sum_probs=202.8

Q ss_pred             hcccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (740)
                      .++|++.+.||+|+||.||+|...      .+..||+|.+......  .....+.+|+++++.++||||+++++++....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            467889999999999999999653      2468999998654322  22467889999999999999999999999999


Q ss_pred             eEEEEEEeccCCCchhhhcCCCc-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEE
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDE-------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS  595 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  595 (740)
                      ..++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence            99999999999999999865321       22478999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhh
Q 004642          596 VADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLI  672 (740)
Q Consensus       596 l~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  672 (740)
                      |+|||+++........  .....++..|+|||.+.+..++.++|||||||++||+++ |..||.....       .. ..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~-~~  231 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------EE-VL  231 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-------HH-HH
Confidence            9999999765433221  223356789999999988889999999999999999998 8888754221       11 11


Q ss_pred             hhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          673 DVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       673 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      +.+........+...   ...+.+++.+||+.+|++|||+.|+++.|.
T Consensus       232 ~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         232 KFVIDGGHLDLPENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHhcCCCCCCCCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111111111111111   234889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-36  Score=323.62  Aligned_cols=259  Identities=25%  Similarity=0.327  Sum_probs=199.5

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||++..+ +++.||+|++...........+.+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999665 57889999986543333333456888999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++.+...  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999976432  578899999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCc-ccccccCCCcccccccc-----ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCc
Q 004642          609 SSY-RTLRAGTYGYIAPELAY-----TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  682 (740)
                      ... .....||+.|+|||++.     ...++.++|||||||++|||++|+.||.....       ......+........
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~  228 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKERFQ  228 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCcccc
Confidence            222 23357999999999986     34578899999999999999999999864321       111112222111111


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHH
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKS--RPTMQRISQELL  720 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev~~~L~  720 (740)
                      .+.........+.+++.+|+..+|++  |++++|++++-.
T Consensus       229 ~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~  268 (332)
T cd05623         229 FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF  268 (332)
T ss_pred             CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence            11111111233778888888655544  689999998854

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-36  Score=306.52  Aligned_cols=250  Identities=26%  Similarity=0.447  Sum_probs=203.6

Q ss_pred             hcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .++|++.+.||+|+||.||+|.. .|+.||+|.+.....    ..+++.+|+.++++++|+||+++++++...+..++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            35788899999999999999986 488999999976543    3477889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++..... ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999876443 2589999999999999999999998   9999999999999999999999999999876322


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      ..   ...++..|+|||++.+..++.++||||||+++|||++ |+.||.....        ......+............
T Consensus       156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~  224 (256)
T cd05039         156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEKGYRMEAPEGC  224 (256)
T ss_pred             cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCCCCCccCC
Confidence            11   2235678999999988889999999999999999997 9999764321        1111222111111111111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                         ...+.+++.+||..+|++||++.|++++|..
T Consensus       225 ---~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         225 ---PPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence               2337899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.7e-36  Score=316.92  Aligned_cols=258  Identities=26%  Similarity=0.405  Sum_probs=202.9

Q ss_pred             hcccccceeeecccceEEEEEEeC--------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeee
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP--------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCL  519 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  519 (740)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+......  .....+.+|+++++.+ +||||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            467999999999999999999642        2357999999764322  2246788899999999 7999999999999


Q ss_pred             ecCeEEEEEEeccCCCchhhhcCCCc-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 004642          520 HKKCMFLIYEYMERGSLFCVLHDDDE-------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNI  586 (740)
Q Consensus       520 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI  586 (740)
                      ..+..++||||+++|+|.+++.....             ...+++.++..++.|++.||+|||+.   +++||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence            99999999999999999999975421             12488999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecccceecccCCCcc--cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCccccccc
Q 004642          587 LLDSNLEASVADFGTARLLHVDSSYR--TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSS  663 (740)
Q Consensus       587 ll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~  663 (740)
                      +++.++.++|+|||.++.........  ....++..|+|||++.+..++.++|||||||++|||++ |..||.....   
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---  248 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  248 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---
Confidence            99999999999999997654222111  11234568999999998889999999999999999998 8888753211   


Q ss_pred             CCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          664 SSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       664 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                           ....+.+......+....   ....+.+++.+||+.+|++||++.|+++.|...
T Consensus       249 -----~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         249 -----EELFKLLKEGHRMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             -----HHHHHHHHcCCCCCCCCc---CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence                 112222222222111111   123478899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.1e-36  Score=307.25  Aligned_cols=248  Identities=24%  Similarity=0.412  Sum_probs=198.3

Q ss_pred             cccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeee-ecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCL-HKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~  528 (740)
                      ++|.+.+.||+|+||.||++.. .|+.||+|.+.....     .+.+.+|+.++++++|+|++++++++. .++..+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            4788899999999999999976 478899999865332     357889999999999999999999765 456789999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++..... ..+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999876432 2478999999999999999999998   9999999999999999999999999998765322


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      .   ....++..|+|||++.+..++.++|||||||++|||++ |+.||.....        ......+.+..........
T Consensus       156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~  224 (256)
T cd05082         156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMDAPDGC  224 (256)
T ss_pred             C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCCCCCC
Confidence            1   22245678999999988889999999999999999998 9998764211        1111111111111111111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                         ...+.+++.+|++.+|++||++.+++++|..
T Consensus       225 ---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         225 ---PPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ---CHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence               2237899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.7e-36  Score=316.16  Aligned_cols=264  Identities=24%  Similarity=0.328  Sum_probs=204.2

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||++... +|..||+|.+.....  .....++.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            36889999999999999999654 678899998875432  233567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.  .+++|+||||+||+++.++.++|+|||++......
T Consensus        79 ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          79 EHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            9999999999997653   578899999999999999999973  18999999999999999999999999998765321


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccc------cCC--CCC------------
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS------SSS--GPK------------  668 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~------~~~--~~~------------  668 (740)
                        ......|+..|+|||...+..++.++||||||+++|||++|+.||.......      ...  ...            
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence              2234478999999999988889999999999999999999999985322100      000  000            


Q ss_pred             -----chhhhhhcc---cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          669 -----IMLIDVLNQ---RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       669 -----~~~~~~~~~---~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                           ....+..+.   ...+..+.  ......+.+++.+||+.+|++||+++|++++......
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                 000000000   00000000  0012237899999999999999999999999876544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-36  Score=308.24  Aligned_cols=255  Identities=30%  Similarity=0.452  Sum_probs=203.5

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|+||.||+|... +++.+++|.+......   ..+.+.+|++++++++||||+++++++...+..+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            367899999999999999999654 5788999999765432   347888999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          79 MEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            99999999999887542  2588999999999999999999998   999999999999999999999999999976543


Q ss_pred             CCCcccccccCCCcccccccccc---ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcch
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTI---VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN  684 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  684 (740)
                      .........++..|+|||.+.+.   .++.++||||||+++|||++|+.||......       ............+...
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~  226 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-------RALFLISKSNFPPPKL  226 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCCCccc
Confidence            32233344688899999998776   7888999999999999999999998643210       1111111111111111


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      .........+.+++.+||+.+|++||++++++++
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1111222348899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-36  Score=307.52  Aligned_cols=254  Identities=27%  Similarity=0.473  Sum_probs=205.1

Q ss_pred             hcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .++|.+.+.||+|+||.||+|..++++.||+|.+......    .+++.+|++++++++|+|++++++++......++||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            4689999999999999999998888889999998764432    357889999999999999999999999989999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++..... ..+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+.....+
T Consensus        81 e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          81 EYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             eccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            99999999999976432 3589999999999999999999998   9999999999999999999999999999876432


Q ss_pred             CCc-ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          609 SSY-RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      ... .....++..|+|||.+.+..++.++||||+|+++||+++ |+.||.....        ....+.+......+....
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  228 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERGYRMPRPPN  228 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCCC
Confidence            111 112234568999999998889999999999999999999 9999754221        111122222211111111


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      .   ...+.+++.+|++.+|++||+++++.+.|+.
T Consensus       229 ~---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         229 C---PEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             C---CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1   2237899999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.8e-36  Score=306.33  Aligned_cols=253  Identities=21%  Similarity=0.347  Sum_probs=206.0

Q ss_pred             ccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|+||.||.++ ..+++.+++|.+....... ...+.+.+|++++++++|+||+++++++.+.+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            47889999999999999985 4468899999986544332 234678899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.+++.... ...+++.++..++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999999997643 23588999999999999999999998   99999999999999999999999999998765444


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                      .......|++.|+|||+..+..++.++||||||+++|||++|..||.....       ......+......+.. .   .
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~~~-~---~  224 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKIVQGNYTPVV-S---V  224 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCCCc-c---c
Confidence            333445789999999999888889999999999999999999999864221       1122222222222111 1   1


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ....+.+++.+||+.+|++||++.|+++++
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         225 YSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            122378899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.7e-36  Score=321.67  Aligned_cols=259  Identities=25%  Similarity=0.374  Sum_probs=200.5

Q ss_pred             hcccccceeeecccceEEEEEEe------CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeec
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHK  521 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  521 (740)
                      .++|++.+.||+|+||.||+|..      .+++.||||+++.....  ...+.+.+|+.++.++ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            46899999999999999999953      35788999999764432  2246788999999999 689999999988654


Q ss_pred             -CeEEEEEEeccCCCchhhhcCCCc-------------------------------------------------------
Q 004642          522 -KCMFLIYEYMERGSLFCVLHDDDE-------------------------------------------------------  545 (740)
Q Consensus       522 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  545 (740)
                       ...+++|||+++|+|.++++....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             467899999999999998864210                                                       


Q ss_pred             ---------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc--ccc
Q 004642          546 ---------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY--RTL  614 (740)
Q Consensus       546 ---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~  614 (740)
                               ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++.........  ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     12368889999999999999999998   9999999999999999999999999999865432221  112


Q ss_pred             cccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          615 RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       615 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..||.....       .......+........+...   ...
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~---~~~  310 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEEFCRRLKEGTRMRAPDYT---TPE  310 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc-------cHHHHHHHhccCCCCCCCCC---CHH
Confidence            235678999999988889999999999999999997 8888754211       11112222221111111111   123


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          694 VSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       694 l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      +.+++.+||+.+|++||++.|++++|...
T Consensus       311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         311 MYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            78999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.3e-36  Score=315.35  Aligned_cols=258  Identities=26%  Similarity=0.410  Sum_probs=203.1

Q ss_pred             hcccccceeeecccceEEEEEEe--------CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeee
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCL  519 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  519 (740)
                      .++|.+.+.||+|+||.||++..        .++..||+|.+......  ...+.+.+|+.+++.+ +||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch--HHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            56788999999999999999953        13457999998754322  2346788999999999 8999999999999


Q ss_pred             ecCeEEEEEEeccCCCchhhhcCCCc-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 004642          520 HKKCMFLIYEYMERGSLFCVLHDDDE-------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNI  586 (740)
Q Consensus       520 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI  586 (740)
                      ..+..+++|||+++|+|.+++.....             ...+++.++..++.||+.||+|||+.   +++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            99999999999999999999875321             23578999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCccccccc
Q 004642          587 LLDSNLEASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSS  663 (740)
Q Consensus       587 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~  663 (740)
                      +++.++.+||+|||.++........  .....++..|+|||++.+..++.++||||||+++|||++ |..||.....   
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---  245 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---  245 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence            9999999999999999876433222  122345678999999988889999999999999999998 7788753221   


Q ss_pred             CCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          664 SSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       664 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                           ....+.+..........   .....+.+++.+||+.+|++||++.|+++.|...
T Consensus       246 -----~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         246 -----EELFKLLKEGHRMDKPA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             -----HHHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence                 11112222111111111   1123378899999999999999999999999654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-36  Score=315.82  Aligned_cols=261  Identities=26%  Similarity=0.327  Sum_probs=204.9

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||+||++... +|+.||+|++.....  ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            57888899999999999999654 688999998865432  234578899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++...+   .+++..+..++.+++.||.|||+.  .+++||||||+||+++.++.++|+|||++......
T Consensus        83 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          83 EFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             ecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999998887643   578999999999999999999973  18999999999999999999999999998654321


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCch----hhhhhcccCCCcch
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIM----LIDVLNQRLSPPVN  684 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~l~~~~~  684 (740)
                        ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...............    ..............
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS  235 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence              123346899999999998888999999999999999999999998753321111111111    11111111111100


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                         ......+.+++.+|++.||++||++.|++++....
T Consensus       236 ---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         236 ---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             ---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence               11123478999999999999999999999986544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.4e-36  Score=315.54  Aligned_cols=260  Identities=24%  Similarity=0.385  Sum_probs=199.9

Q ss_pred             hcccccceeeecccceEEEEEEeC-----------------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCcc
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-----------------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI  511 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  511 (740)
                      .++|++.+.||+|+||.||++...                 ++..||+|++.....  ....+.+.+|+++++.++|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence            357999999999999999998532                 234689999875432  2335688999999999999999


Q ss_pred             ceeeeeeeecCeEEEEEEeccCCCchhhhcCCCc--------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 004642          512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDE--------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISS  583 (740)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  583 (740)
                      +++++++..++..+++|||+++++|.+++.....        ...+++.++..++.|++.|++|||+.   +++|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp  158 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT  158 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence            9999999999999999999999999999875321        12478889999999999999999998   999999999


Q ss_pred             CceEEcCCCcEEEeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh--CCCCCCccc
Q 004642          584 NNILLDSNLEASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM--GTHPGGLLS  659 (740)
Q Consensus       584 ~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~  659 (740)
                      +||+++.++.++|+|||+++.+......  .....++..|+|||...+..++.++|||||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            9999999999999999999765432211  122234678999999888889999999999999999998  677875432


Q ss_pred             ccccCCCCCchhhhhhc---ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          660 SLSSSSGPKIMLIDVLN---QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       660 ~~~~~~~~~~~~~~~~~---~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      .....    ....+...   .....+...   .....+.+++.+||+.||++||++.|+.+.|.
T Consensus       239 ~~~~~----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         239 DEQVI----ENTGEFFRDQGRQVYLPKPA---LCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             hHHHH----HHHHHHHhhccccccCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11000    00001000   000001111   11234889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.5e-36  Score=311.96  Aligned_cols=254  Identities=27%  Similarity=0.464  Sum_probs=200.6

Q ss_pred             cccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (740)
                      .+|...+.||+|+||.||++...      ++..+|+|.+.....   ...+.+.+|++++++++|+||+++++++..++.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH---HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            46777889999999999999532      356789998865432   234678999999999999999999999999999


Q ss_pred             EEEEEEeccCCCchhhhcCCCc------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC
Q 004642          524 MFLIYEYMERGSLFCVLHDDDE------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN  591 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  591 (740)
                      .+++|||+++++|.+++.....            ...+++.++..++.|++.|++|||+.   +++||||||+||+++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence            9999999999999999875431            12478999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCC
Q 004642          592 LEASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPK  668 (740)
Q Consensus       592 ~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~  668 (740)
                      +.++|+|||+++........  .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.....        
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------  230 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------  230 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------
Confidence            99999999999765432211  122345678999999998899999999999999999998 8999754221        


Q ss_pred             chhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          669 IMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       669 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ....+..............   ...+.+++.+||+.||++||++.|+.+.|.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         231 TEAIECITQGRELERPRTC---PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHHHHcCccCCCCCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1111112121111111111   123789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7e-36  Score=306.36  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=201.7

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee-cCeEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH-KKCMFLIY  528 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  528 (740)
                      +|++.+.||+|++|.||++... +++.||+|++....... ...+.+.+|++++++++|+|++++++.+.. ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            4888999999999999999654 57889999987544332 234678899999999999999999998764 44689999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++..... ..+++.++..++.|++.|+++||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          80 GFCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             cccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999999875332 2589999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      ........+++.|+|||+..+..++.++||||+|+++|+|++|+.||.....       ...........+.. ...   
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~-~~~---  224 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRIIEGKLPP-MPK---  224 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcCCCC-Ccc---
Confidence            3333445688999999999998899999999999999999999999864211       11111222222211 111   


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      .....+.+++.+|++.+|++||++.+++++
T Consensus       225 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         225 DYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            122348899999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.9e-36  Score=308.02  Aligned_cols=251  Identities=29%  Similarity=0.443  Sum_probs=203.5

Q ss_pred             hcccccceeeecccceEEEEEEeCC-CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|+||.||+|...+ ++.|++|.+.....     .+.+.+|++++++++||||+++++++.++...+++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence            3678899999999999999997664 78999999865432     47889999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      +||+++++|.+++....  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          77 MEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            99999999999986533  2589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      .........|+..|+|||++.+..++.++||||||+++|+|++|+.||.......       ..... ........ ...
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~~~~~-~~~~~~~~-~~~  222 (256)
T cd06612         152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AIFMI-PNKPPPTL-SDP  222 (256)
T ss_pred             CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------hhhhh-ccCCCCCC-Cch
Confidence            3333344568899999999998889999999999999999999999987432210       00000 00000000 000


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ......+.+++.+||+.+|++||++.|++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             hhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            1111237899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-36  Score=310.33  Aligned_cols=256  Identities=31%  Similarity=0.457  Sum_probs=207.7

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||.|+||.||+|... +++.||+|.+......  .....+.+|+++++.++|+|++++++++.++...++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            36888899999999999999654 6899999998754322  22467889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++...    .+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||+++.....
T Consensus        79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999998754    688999999999999999999998   9999999999999999999999999999887644


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      ........|+..|+|||++.+..++.++||||||+++|+|+||+.||.....       .... ..+.....+.....  
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-------~~~~-~~~~~~~~~~~~~~--  221 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-------MRVL-FLIPKNNPPSLEGN--  221 (274)
T ss_pred             ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-------HHHH-HHhhhcCCCCCccc--
Confidence            3333445688899999999988899999999999999999999999864321       1111 11111111111111  


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      .....+.+++.+||+.+|++||++++++++-...+.
T Consensus       222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         222 KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            012237889999999999999999999998766543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-37  Score=317.18  Aligned_cols=259  Identities=22%  Similarity=0.381  Sum_probs=206.7

Q ss_pred             hcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ...|++.++||+||.+.||++...+.+.||+|++..... +......|..|+..+.++ .|.+||++++|-..++..|||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            457889999999999999999888888999998876543 445678999999999999 589999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||-+. +|..+|...... ...| .+..++.||+.|+.+.|++   ||||.||||.|+|+-. |.+||+|||+|..+..
T Consensus       439 mE~Gd~-DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  439 MECGDI-DLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             eecccc-cHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            998754 899999876543 3345 6788999999999999999   9999999999999854 6899999999998876


Q ss_pred             CCC--cccccccCCCccccccccccc-----------cCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhh
Q 004642          608 DSS--YRTLRAGTYGYIAPELAYTIV-----------VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDV  674 (740)
Q Consensus       608 ~~~--~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  674 (740)
                      +..  .....+||+.||+||.+....           ++.++||||+|||||+|+.|+.||+.....      ...+..+
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~aKl~aI  585 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IAKLHAI  585 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HHHHHhh
Confidence            644  245568999999999886432           557899999999999999999999854311      1123334


Q ss_pred             hcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          675 LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       675 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      .++.-..+++....  ..++.++++.||++||.+||+..|++++-.-.-
T Consensus       586 ~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  586 TDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             cCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            44433222222111  112789999999999999999999999876554

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.9e-36  Score=316.10  Aligned_cols=257  Identities=24%  Similarity=0.364  Sum_probs=201.7

Q ss_pred             hcccccceeeecccceEEEEEEeCC-----------------CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCcc
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE-----------------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI  511 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  511 (740)
                      .++|++.+.||+|+||.||++...+                 +..||+|++......  ...+.+.+|++++++++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence            4678999999999999999986542                 346899998765433  335788999999999999999


Q ss_pred             ceeeeeeeecCeEEEEEEeccCCCchhhhcCCCc--------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 004642          512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDE--------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISS  583 (740)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  583 (740)
                      +++++++..++..+++|||+++++|.+++.....        ...+++..+..++.|++.||+|||+.   +++|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence            9999999999999999999999999999876431        12589999999999999999999998   999999999


Q ss_pred             CceEEcCCCcEEEeecccceecccCCC--cccccccCCCccccccccccccCCcchhHhHHHHHHHHHh--CCCCCCccc
Q 004642          584 NNILLDSNLEASVADFGTARLLHVDSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM--GTHPGGLLS  659 (740)
Q Consensus       584 ~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~  659 (740)
                      +||+++.++.++|+|||+++.......  ......++..|+|||++.+..++.++|||||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            999999999999999999986543221  1223356788999999988889999999999999999998  667765422


Q ss_pred             ccccCCCCCchhhhhh------cccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          660 SLSSSSGPKIMLIDVL------NQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       660 ~~~~~~~~~~~~~~~~------~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ..       ..+....      ......+...   .....+.+++.+|++.||++||++.|+++.|.
T Consensus       239 ~~-------~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 DQ-------QVIENAGHFFRDDGRQIYLPRPP---NCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             hH-------HHHHHHHhccccccccccCCCcc---CCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            10       0011110      0000001111   11134889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-36  Score=306.64  Aligned_cols=249  Identities=29%  Similarity=0.482  Sum_probs=201.7

Q ss_pred             eeeecccceEEEEEEeCC----CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEec
Q 004642          456 YCIGTGGYGSVYKAELPE----GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYM  531 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  531 (740)
                      +.||+|+||.||+|....    +..|++|.+.......  ..+.+.+|+++++.++|+|++++++++......+++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            368999999999996653    7889999998765443  3578899999999999999999999999999999999999


Q ss_pred             cCCCchhhhcCCCc------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          532 ERGSLFCVLHDDDE------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       532 ~~g~L~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      ++++|.+++.....      ...+++.++..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||.+...
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999987521      24689999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCC--CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCc
Q 004642          606 HVDS--SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       606 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  682 (740)
                      ....  .......++..|+|||.+....++.++||||+|+++|||++ |..||.....        ....+.+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  227 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGYRLP  227 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            5432  12233457889999999988889999999999999999999 6999865321        11111111111111


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      .....   ...+.+++.+||+.+|++||++.|++++|.
T Consensus       228 ~~~~~---~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         228 KPEYC---PDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCccC---ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            11111   234889999999999999999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-37  Score=325.85  Aligned_cols=247  Identities=24%  Similarity=0.320  Sum_probs=191.2

Q ss_pred             eecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc---CCCccceeeeeeeecCeEEEEEEeccC
Q 004642          458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV---RHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       458 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      ||+|+||+||+|+.. +|+.||+|++.............+..|..++.+.   +||||+++++++.++...++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999654 6899999998654332222334455667776665   699999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.++|+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            99998887543   588999999999999999999998   999999999999999999999999999976433333334


Q ss_pred             ccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHH
Q 004642          614 LRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDII  692 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  692 (740)
                      ...||..|+|||++.+. .++.++||||+||++|||++|+.||.....       ......+.......+.. ..   ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~-~~---~~  223 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAFGKVRFPKN-VL---SD  223 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHcCCCCCCCc-cC---CH
Confidence            55799999999998754 478899999999999999999999864221       11112222111111111 01   12


Q ss_pred             HHHHHHHHcccCCCCCCC----CHHHHHHHHHc
Q 004642          693 LVSTIAFACLSSQPKSRP----TMQRISQELLA  721 (740)
Q Consensus       693 ~l~~li~~cl~~dP~~RP----s~~ev~~~L~~  721 (740)
                      .+.+++.+||+.||++||    ++.|++++-..
T Consensus       224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~  256 (330)
T cd05586         224 EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF  256 (330)
T ss_pred             HHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence            367899999999999998    67777776543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.9e-36  Score=307.35  Aligned_cols=255  Identities=30%  Similarity=0.447  Sum_probs=201.9

Q ss_pred             hcccccceeeecccceEEEEEEeC-CC---cEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EG---KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCM  524 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (740)
                      .++|+..+.||+|+||.||+|... ++   ..+|+|++......  ...+.+..|++++.+++|||++++.+++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE--KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            357888899999999999999764 23   37999998754322  2346788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++||||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          82 MIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence            99999999999999987543  2588999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCCcc---cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCC
Q 004642          605 LHVDSSYR---TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLS  680 (740)
Q Consensus       605 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  680 (740)
                      ........   .....+..|+|||++....++.++|||||||++|||++ |+.||.....       .. ....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~-~~~~i~~~~~  228 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HE-VMKAINDGFR  228 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HH-HHHHHhcCCC
Confidence            64322111   11123457999999988889999999999999999997 9999854321       11 1222222112


Q ss_pred             CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       681 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      .+...   .....+.+++.+||+.+|++||++.++++.|.+
T Consensus       229 ~~~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         229 LPAPM---DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             CCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            11111   112347899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7e-36  Score=308.45  Aligned_cols=257  Identities=23%  Similarity=0.378  Sum_probs=198.4

Q ss_pred             HHhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEE
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (740)
                      .+++.+.....||+|+||.||+|.. .+++.||+|.+......   ..+.+.+|++++++++|+||+++++++..++..+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH---HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            3455666677899999999999964 46788999988754432   2467889999999999999999999999999999


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCcEEEeeccccee
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-NLEASVADFGTARL  604 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfG~a~~  604 (740)
                      +++||+++++|.+++.........++..+..++.||+.|++|||+.   +|+||||||+||+++. ++.++|+|||.+..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999999997543322237888899999999999999998   9999999999999986 67899999999976


Q ss_pred             cccCCCcccccccCCCccccccccccc--cCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCc
Q 004642          605 LHVDSSYRTLRAGTYGYIAPELAYTIV--VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  682 (740)
                      ............|+..|+|||++.+..  ++.++||||+|+++|+|++|+.||......      .............+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~  232 (268)
T cd06624         159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP------QAAMFKVGMFKIHPE  232 (268)
T ss_pred             cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh------hhhHhhhhhhccCCC
Confidence            643333333346889999999986543  778999999999999999999998642210      000000000011111


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      .+..   ....+.+++.+||+.+|++||++.|++++
T Consensus       233 ~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         233 IPES---LSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CCcc---cCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            1111   12237889999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.4e-36  Score=307.75  Aligned_cols=252  Identities=22%  Similarity=0.364  Sum_probs=203.4

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|+||.||++.. .+|+.||+|.+....... ...+++.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            478899999999999999954 468999999987543322 234678899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.+++..... ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          80 YCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999998875332 2578899999999999999999998   99999999999999999999999999998764433


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                      .......|+..|+|||+..+..++.++|||||||++|+|++|+.||.....       ......++...... ...   .
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~-~~~---~  224 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKIIRGSYPP-VSS---H  224 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHhcCCCCC-Ccc---c
Confidence            333344688899999999988899999999999999999999999763211       11122222222111 111   1


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ....+.+++.+||+.+|++||++.|++++
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         225 YSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            12237899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.3e-36  Score=323.98  Aligned_cols=263  Identities=21%  Similarity=0.249  Sum_probs=198.1

Q ss_pred             HhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec-----
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK-----  521 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  521 (740)
                      ..++|++.+.||+|+||.||++.. ..++.||+|++....... ...+.+.+|+.+++.++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh-HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            457899999999999999999954 468899999997644332 2346778899999999999999999988643     


Q ss_pred             -CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecc
Q 004642          522 -KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG  600 (740)
Q Consensus       522 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  600 (740)
                       ...++||||+++ ++.+.+..     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence             357999999976 56555542     478889999999999999999998   99999999999999999999999999


Q ss_pred             cceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCC-----
Q 004642          601 TARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGP-----  667 (740)
Q Consensus       601 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~-----  667 (740)
                      +++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........        ....     
T Consensus       165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             ccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99865432 222345789999999999998999999999999999999999999864321100        0000     


Q ss_pred             --CchhhhhhcccCC---------------CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          668 --KIMLIDVLNQRLS---------------PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       668 --~~~~~~~~~~~l~---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                        .............               +............+.+++.+|++.||++|||+.|++++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~  314 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI  314 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence              0000011110000               00000000112347899999999999999999999998533

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7e-36  Score=307.93  Aligned_cols=252  Identities=24%  Similarity=0.423  Sum_probs=201.6

Q ss_pred             ccccceeeecccceEEEEEEeCCCcEEEEEEccCCccc---chHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETE---DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      +|.+.+.||+|+||+||+|...+|+.+|+|.+......   .....+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47888999999999999998788999999998754322   123346788999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++++|.+++.+..   .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999996543   578899999999999999999998   999999999999999999999999999876432


Q ss_pred             CC------CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcc-cCC
Q 004642          608 DS------SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-RLS  680 (740)
Q Consensus       608 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~  680 (740)
                      ..      .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......       ........ ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~  227 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-------AMFYIGAHRGLM  227 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-------HHHHhhhccCCC
Confidence            11      11223468899999999998889999999999999999999999986432210       01111111 111


Q ss_pred             CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       681 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      +......   ...+.+++.+||+.+|++||++.|++++
T Consensus       228 ~~~~~~~---~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         228 PRLPDSF---SAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             CCCCCCC---CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1111111   2237889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-35  Score=305.51  Aligned_cols=253  Identities=27%  Similarity=0.443  Sum_probs=203.4

Q ss_pred             hcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .++|++.+.||+|+||.||++...++..+|+|.+.....    ..+.+.+|++++++++|+|++++++++.+ ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            468899999999999999999887888899998875432    24678899999999999999999999887 7789999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++..... ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          80 EFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EeCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            99999999999976432 3578999999999999999999998   9999999999999999999999999999765432


Q ss_pred             CCc-ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          609 SSY-RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       609 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      ... .....++..|+|||++....++.++|+|||||++|++++ |+.||.....        ......+......+... 
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-  226 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALERGYRMPRPE-  226 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCCCCCCCcc-
Confidence            211 122345678999999988889999999999999999999 8999864321        11112222222111111 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                        .....+.+++.+|++.+|++||++.++.+.|..
T Consensus       227 --~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         227 --NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             --cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              112237899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-36  Score=315.41  Aligned_cols=256  Identities=25%  Similarity=0.324  Sum_probs=206.0

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++..++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999654 58999999998765544345678899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999987543 23688999999999999999999998   9999999999999999999999999998754321


Q ss_pred             CC-----------------------------cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccc
Q 004642          609 SS-----------------------------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLS  659 (740)
Q Consensus       609 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~  659 (740)
                      ..                             ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            11                             0112357889999999998889999999999999999999999986432


Q ss_pred             ccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCC----HHHHHHHH
Q 004642          660 SLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPT----MQRISQEL  719 (740)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ev~~~L  719 (740)
                      .       .....+........+....   ....+.+++.+|++.||++||+    ++|++++-
T Consensus       237 ~-------~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~  290 (316)
T cd05574         237 R-------DETFSNILKKEVTFPGSPP---VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP  290 (316)
T ss_pred             h-------HHHHHHHhcCCccCCCccc---cCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence            1       1222333333322221111   2234889999999999999999    77777653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1e-35  Score=304.99  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=200.7

Q ss_pred             cccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      .+|++.+.||+|+||.||++.+.+++.+|+|.+......    ...+.+|++++++++|||++++++++......++|||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            468888999999999999998777889999998754432    2568889999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.+++.....  .+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          80 FMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            9999999999875432  578999999999999999999998   99999999999999999999999999997654322


Q ss_pred             Cc-ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          610 SY-RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       610 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      .. .....++.+|+|||++.+..++.++||||||+++|||++ |+.||.....        ....+.+........... 
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~-  225 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETINAGFRLYKPRL-  225 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHhCCCCCCCCCC-
Confidence            11 112235678999999998889999999999999999998 9999864221        111111111111111111 


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                        ....+.+++.+||+.+|++||++.|++++|
T Consensus       226 --~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 --ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             --CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence              113388999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.8e-36  Score=323.19  Aligned_cols=263  Identities=21%  Similarity=0.247  Sum_probs=198.1

Q ss_pred             HhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec-----
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK-----  521 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  521 (740)
                      ..++|.+.+.||+|+||.||++.. ..++.||||++....... ...+.+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-hhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            457899999999999999999954 468899999997644322 2346778899999999999999999987643     


Q ss_pred             -CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecc
Q 004642          522 -KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG  600 (740)
Q Consensus       522 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  600 (740)
                       ...++||||+++ ++.+.+..     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence             357999999976 66666642     478889999999999999999998   99999999999999999999999999


Q ss_pred             cceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccccc-------CCCCC-----
Q 004642          601 TARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-------SSGPK-----  668 (740)
Q Consensus       601 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~-----  668 (740)
                      +++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........       .....     
T Consensus       172 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         172 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             CccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            99865432 222344789999999999999999999999999999999999999964321100       00000     


Q ss_pred             ---chhhhhhcccC---------------CCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          669 ---IMLIDVLNQRL---------------SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       669 ---~~~~~~~~~~l---------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                         ...........               .+............+.+++.+|++.||++|||+.|++++-..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~  321 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  321 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence               00000000000               000000000112347899999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.2e-36  Score=313.62  Aligned_cols=261  Identities=26%  Similarity=0.326  Sum_probs=192.1

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc---CCCccceeeeeeee-----c
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV---RHRNIVKLYGFCLH-----K  521 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~  521 (740)
                      +|++.+.||+|+||.||+|... +|+.||+|.+......+. ....+.+|+++++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            4888999999999999999654 689999999876432221 123455677766655   79999999998864     3


Q ss_pred             CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      ...+++|||+++ +|.+++..... ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            458999999985 88888765432 2589999999999999999999998   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccccc---------CCCCCchh-
Q 004642          602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS---------SSGPKIML-  671 (740)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~---------~~~~~~~~-  671 (740)
                      ++...... ......||..|+|||++.+..++.++||||+||++|||++|+.||........         ......+. 
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         155 ARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            98764322 22334689999999999988899999999999999999999999864321000         00000000 


Q ss_pred             -----hhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          672 -----IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       672 -----~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                           .....+................+.+++.+|++.||++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                 00000000000000011112337899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7e-36  Score=323.41  Aligned_cols=264  Identities=23%  Similarity=0.264  Sum_probs=198.8

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC-----eE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK-----CM  524 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  524 (740)
                      +|++.+.||+|+||.||++.. .+|+.||+|++...... ....+++.+|+++++.++||||+++++++..++     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            478889999999999999965 57899999998654322 223467889999999999999999999998776     78


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++||||+. ++|.+.+....   .+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            99999997 47777775433   588999999999999999999998   999999999999999999999999999986


Q ss_pred             cccCCC-cccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCc-----
Q 004642          605 LHVDSS-YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKI-----  669 (740)
Q Consensus       605 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~-----  669 (740)
                      ...... ......++..|+|||++.+. .++.++||||+||++|||++|+.||........        ......     
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            543222 22334678999999998874 478899999999999999999999875432100        000000     


Q ss_pred             --hhhhhh-cccCCCcchhh----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          670 --MLIDVL-NQRLSPPVNQK----IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       670 --~~~~~~-~~~l~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                        .....+ .....++....    .......+.+++.+|++.||++|||+.|++++-...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  292 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD  292 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhC
Confidence              000001 00011100000    001123478999999999999999999999986543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9e-36  Score=309.22  Aligned_cols=257  Identities=28%  Similarity=0.421  Sum_probs=207.6

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ..|+..+.||+|+||.||+|... +++.||+|.+......  ...+.+.+|++++++++||||+++++++.++...++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45777888999999999999654 5889999998754322  23468889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++...    .+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          82 EYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            999999999988643    478889999999999999999998   9999999999999999999999999999776543


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      ........++..|+|||++.+..++.++|||||||++|||++|+.||......       . ..........+....   
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~-~~~~~~~~~~~~~~~---  223 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-------R-VLFLIPKNNPPTLTG---  223 (277)
T ss_pred             ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-------h-HhhhhhcCCCCCCch---
Confidence            33334456888999999998888999999999999999999999998643221       0 011111111111111   


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCC
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPM  726 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  726 (740)
                      .....+.+++.+||+.+|++||++.+++++-.......
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         224 EFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             hhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence            12234789999999999999999999999977655444

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.8e-36  Score=310.58  Aligned_cols=256  Identities=24%  Similarity=0.332  Sum_probs=201.9

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      .|++.+.||+|+||.||+|... ++..+++|.+.....   ...+.+.+|+++++.++|||++++++++..++..++|||
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH---HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            4677888999999999999654 577889998865432   234678899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|..++....  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          83 FCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             ecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            999999988876533  2589999999999999999999998   99999999999999999999999999997654333


Q ss_pred             CcccccccCCCcccccccc-----ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccC-CCcc
Q 004642          610 SYRTLRAGTYGYIAPELAY-----TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRL-SPPV  683 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~  683 (740)
                      .......++..|+|||++.     +..++.++||||+||++|||++|+.||.....       ............ ....
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~  230 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLAQ  230 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-------HHHHHHHhhcCCCCCCC
Confidence            3334456899999999874     34577899999999999999999999864321       111111111110 0011


Q ss_pred             hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      +....   ..+.+++.+||+.+|++||++.+++++......
T Consensus       231 ~~~~~---~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         231 PSRWS---SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ccccC---HHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            11111   237899999999999999999999998876543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.2e-36  Score=313.03  Aligned_cols=254  Identities=25%  Similarity=0.354  Sum_probs=205.5

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ..+|++.+.||+|+||.||++.. .+++.||+|.+.......   .+.+.+|+.+++.++|+|++++++++..++..++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            46899999999999999999964 579999999987544332   35678899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++++|.+++.+.    .+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             ecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999999988643    478899999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhh-cccCCCcchhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVL-NQRLSPPVNQK  686 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~  686 (740)
                      .........+++.|+|||...+..++.++|||||||++|+|++|+.||.......       ...... .......... 
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~-  239 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTPELQNPE-  239 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-------heeeeccCCCCCCCCcc-
Confidence            4333344578899999999998889999999999999999999999986432110       000000 0100100111 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                        .....+.+++.+||+.+|++||++++++++-...
T Consensus       240 --~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (297)
T cd06656         240 --RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK  273 (297)
T ss_pred             --ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhc
Confidence              1122377899999999999999999999976654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.5e-36  Score=311.48  Aligned_cols=253  Identities=30%  Similarity=0.439  Sum_probs=202.8

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      +.|+..+.||+|+||.||+|.. .+++.||+|.+......  ...+.+.+|++++++++||||+++++++..+...++||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            3466678899999999999954 45788999988754322  23467889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++...    .+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||++......
T Consensus        82 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          82 EYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            999999999888642    578899999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      ........|+..|+|||++.+..++.++|||||||++|||++|+.||......       ... ..+.....+....   
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~-~~~~~~~~~~~~~---  223 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-------RVL-FLIPKNSPPTLEG---  223 (277)
T ss_pred             chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-------hHH-hhhhcCCCCCCCc---
Confidence            33333346889999999999888999999999999999999999997643211       001 1111111111111   


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .....+.+++.+||+.+|++||++.+++++....
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT  257 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence            1122378999999999999999999999986543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=319.43  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=205.4

Q ss_pred             ccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      .|.-.+.||.|+||.||-+ +..+...||||++.-......+....+.+|+..+++++|||++.+-|+|......|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3444566999999999999 455788999999987666666667889999999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      ||-| +-.|++.-..+  ++-+.++..|..+.++||+|||+.   +.||||||..|||+++.|.||++|||.|..+.+. 
T Consensus       107 YClG-SAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             HHhc-cHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence            9976 66666654333  577888999999999999999999   9999999999999999999999999999876543 


Q ss_pred             CcccccccCCCcccccccc---ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          610 SYRTLRAGTYGYIAPELAY---TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                         +.++|||+|||||++.   .+.|+.|+||||+|++..|+.-.++|.--+..       -..++.+.....+......
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSALYHIAQNesPtLqs~e  249 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPTLQSNE  249 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHHHHHHhcCCCCCCCch
Confidence               4568999999999875   57899999999999999999999998322111       1112233322222222333


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      |..   .+.+|+..|++.-|.+|||.+++++|-.-...
T Consensus       250 WS~---~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  250 WSD---YFRNFVDSCLQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             hHH---HHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence            443   48999999999999999999999998765543

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.2e-36  Score=316.26  Aligned_cols=260  Identities=25%  Similarity=0.410  Sum_probs=202.9

Q ss_pred             hcccccceeeecccceEEEEEEeC--------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeee
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP--------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCL  519 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  519 (740)
                      .++|.+.+.||+|+||.||++...        .+..+|+|.+......  .....+.+|+++++++ +||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD--KDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh--HHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            467889999999999999999642        2457899998754332  2346788999999999 6999999999999


Q ss_pred             ecCeEEEEEEeccCCCchhhhcCCCc-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 004642          520 HKKCMFLIYEYMERGSLFCVLHDDDE-------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNI  586 (740)
Q Consensus       520 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI  586 (740)
                      ..+..+++|||+++|+|.+++.....             ...+++.++..++.|++.||+|||++   +++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence            99999999999999999999865321             23588999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecccceecccCCCcc--cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCccccccc
Q 004642          587 LLDSNLEASVADFGTARLLHVDSSYR--TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSS  663 (740)
Q Consensus       587 ll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~  663 (740)
                      ++++++.+||+|||.++.........  ....++..|+|||++.+..++.++|||||||++|||++ |..||.....   
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---  242 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---  242 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence            99999999999999998654322211  11234567999999988889999999999999999999 8888754221   


Q ss_pred             CCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          664 SSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       664 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                           ....+.+..........   .....+.+++.+||+.+|++||++.|+++.|.....
T Consensus       243 -----~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         243 -----EELFKLLREGHRMDKPS---NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             -----HHHHHHHHcCCCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                 11112221111111111   112237789999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.2e-36  Score=311.02  Aligned_cols=257  Identities=28%  Similarity=0.460  Sum_probs=202.4

Q ss_pred             hcccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (740)
                      .++|++.+.||+|+||.||+|...      ++..||+|++.....  ....+.+.+|++++++++||||+++++++..++
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            467889999999999999999753      467899999875433  233467889999999999999999999999999


Q ss_pred             eEEEEEEeccCCCchhhhcCCC-------------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 004642          523 CMFLIYEYMERGSLFCVLHDDD-------------------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISS  583 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp  583 (740)
                      ..+++|||+++|+|.+++....                   ....+++.+++.++.|++.||+|||+.   +++||||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence            9999999999999999986421                   123478899999999999999999998   999999999


Q ss_pred             CceEEcCCCcEEEeecccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccc
Q 004642          584 NNILLDSNLEASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSS  660 (740)
Q Consensus       584 ~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~  660 (740)
                      +||+++.++.++|+|||.+.........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999998765332211  112234678999999988889999999999999999998 8888753221


Q ss_pred             cccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          661 LSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       661 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                             ........+..... ...   .....+.+++.+|++.+|++||++.|+++.|+.
T Consensus       239 -------~~~~~~~~~~~~~~-~~~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 -------EEVIYYVRDGNVLS-CPD---NCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -------HHHHHHHhcCCCCC-CCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                   11111111111111 011   112348899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-35  Score=306.35  Aligned_cols=251  Identities=27%  Similarity=0.436  Sum_probs=200.6

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccc------hHHHHHHHHHHHHHhccCCCccceeeeeeeecCe
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETED------SAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (740)
                      +|.+.+.||+|+||.||+|.. .+++.||+|.+.......      ....+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477888999999999999954 468899999887543322      2234678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccce
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      .+++|||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999997643   578889999999999999999998   99999999999999999999999999998


Q ss_pred             ecccCCC------cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcc
Q 004642          604 LLHVDSS------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ  677 (740)
Q Consensus       604 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  677 (740)
                      .......      ......|+..|+|||.+.+..++.++||||+||++|+|++|+.||......       ........ 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-  226 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIFKIGE-  226 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHHHHhc-
Confidence            7653211      112235788999999999888999999999999999999999998743211       11111111 


Q ss_pred             cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          678 RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       678 ~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ...+......   ...+.+++.+||+.||++||++.|++++
T Consensus       227 ~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         227 NASPEIPSNI---SSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             cCCCcCCccc---CHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            1111111111   2237889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=303.63  Aligned_cols=247  Identities=28%  Similarity=0.430  Sum_probs=195.9

Q ss_pred             eeeecccceEEEEEEeCC----CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEec
Q 004642          456 YCIGTGGYGSVYKAELPE----GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYM  531 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  531 (740)
                      +.||+|+||.||+|....    +..+|+|.+......  ...+++.+|++++++++|+|++++++++. .+..++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            369999999999995422    368999999865543  23467889999999999999999999876 45689999999


Q ss_pred             cCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc
Q 004642          532 ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY  611 (740)
Q Consensus       532 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  611 (740)
                      ++|+|.+++....   .+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||.++........
T Consensus        78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            9999999997654   578999999999999999999998   9999999999999999999999999999876443322


Q ss_pred             ccc---cccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          612 RTL---RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       612 ~~~---~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      ...   ..++..|+|||...+..++.++||||||+++|||++ |+.||.....        ......+......+...  
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~--  221 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVIAMLESGERLPRPE--  221 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcCCcCCCCC--
Confidence            111   123467999999998889999999999999999998 9999864321        11112221211111111  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                       .....+.+++.+||..+|++||++.++.+.|...
T Consensus       222 -~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         222 -ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence             1123478999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.5e-36  Score=312.63  Aligned_cols=254  Identities=24%  Similarity=0.368  Sum_probs=205.3

Q ss_pred             cccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .+|++.+.||.|+||.||+|. ..+|+.|++|.+......   ..+.+.+|+++++.++|||++++++++...+..++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            468999999999999999995 457899999998654332   2367789999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++...    .+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            999999999988643    478999999999999999999998   9999999999999999999999999998876544


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      ........|+..|+|||.+.+..++.++|||||||++|+|++|+.||......       ............. . ....
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-------~~~~~~~~~~~~~-~-~~~~  239 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIATNGTPE-L-QNPE  239 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCcc-c-CCcc
Confidence            33334456889999999999888999999999999999999999998653221       0111111111000 0 0001


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .....+.+++.+||..||++||++.+++++-...
T Consensus       240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence            1122377899999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-35  Score=309.79  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=201.3

Q ss_pred             cccccceeeecccceEEEEEEe-----CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec--C
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-----PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--K  522 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  522 (740)
                      ..|++.+.||+|+||.||.+..     .+++.||+|.++....  ....+.+.+|++++++++|||++++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            3578889999999999999963     3578899999875432  23346789999999999999999999998875  5


Q ss_pred             eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccc
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                      ..++||||+++++|.+++.....  .+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence            68999999999999999865432  579999999999999999999998   9999999999999999999999999999


Q ss_pred             eecccCCCc---ccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccc-cc---CCCCC---chhh
Q 004642          603 RLLHVDSSY---RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSL-SS---SSGPK---IMLI  672 (740)
Q Consensus       603 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-~~---~~~~~---~~~~  672 (740)
                      +........   .....++..|+|||+..+..++.++|||||||++|||++++.|+...... ..   .....   ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence            876433221   12335677899999998888999999999999999999988764321110 00   00000   1111


Q ss_pred             hhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          673 DVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       673 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      +.+......+...   .....+.+++.+||+.+|++||++.++++.+..
T Consensus       237 ~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         237 RVLEEGKRLPRPP---NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHHHcCccCCCCC---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            1111111111111   122348899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.9e-36  Score=343.70  Aligned_cols=261  Identities=21%  Similarity=0.332  Sum_probs=200.3

Q ss_pred             HHhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee--cCe
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH--KKC  523 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~  523 (740)
                      ...++|.+.+.||+|+||.||++... ++..||+|.+....... .....+..|+.++++++|||||++++++..  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            34578999999999999999999654 57789999887544332 335678899999999999999999998864  457


Q ss_pred             EEEEEEeccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCceEEcC--------
Q 004642          524 MFLIYEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCT----LSIIHRDISSNNILLDS--------  590 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~dlkp~NIll~~--------  590 (740)
                      +++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+...    .+|+||||||+|||++.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999987532 22368999999999999999999998521    25999999999999964        


Q ss_pred             ---------CCcEEEeecccceecccCCCcccccccCCCccccccccc--cccCCcchhHhHHHHHHHHHhCCCCCCccc
Q 004642          591 ---------NLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT--IVVTGKCDVYSFGVVALEVLMGTHPGGLLS  659 (740)
Q Consensus       591 ---------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~  659 (740)
                               .+.+||+|||++..+.... ......||+.|+|||++.+  ..++.++|||||||++|||+||+.||....
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                     2348999999998764332 2234479999999999864  457889999999999999999999986422


Q ss_pred             ccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          660 SLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       660 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ..       ..+...+......+..    .....+.+||..||+.+|++||++.|++++-.
T Consensus       248 ~~-------~qli~~lk~~p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~  297 (1021)
T PTZ00266        248 NF-------SQLISELKRGPDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLGYQI  297 (1021)
T ss_pred             cH-------HHHHHHHhcCCCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence            11       1111222221111111    11223789999999999999999999996543

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4e-36  Score=313.44  Aligned_cols=265  Identities=25%  Similarity=0.403  Sum_probs=203.3

Q ss_pred             ccHHHHHHHhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeee
Q 004642          440 ILYEDLINATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGF  517 (740)
Q Consensus       440 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  517 (740)
                      +.++.+..+.++|++.+.||+|+||.||++.. .+++.+|+|++......    ...+.+|+.+++++ +||||++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~   83 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGM   83 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeee
Confidence            34456666789999999999999999999955 46889999987653221    25677899999999 69999999998


Q ss_pred             ee-----ecCeEEEEEEeccCCCchhhhcCC-CccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC
Q 004642          518 CL-----HKKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN  591 (740)
Q Consensus       518 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  591 (740)
                      +.     .++..++||||+++++|.++++.. .....+++..+..++.|++.||.|||+.   +++||||||+||+++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~  160 (286)
T cd06638          84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE  160 (286)
T ss_pred             eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence            84     345789999999999999887632 1223578899999999999999999998   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCcccccccCCCccccccccc-----cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCC
Q 004642          592 LEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT-----IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG  666 (740)
Q Consensus       592 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~  666 (740)
                      +.++|+|||+++.............|+..|+|||++..     ..++.++||||+||++|||++|+.||.......    
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----  236 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----  236 (286)
T ss_pred             CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----
Confidence            99999999999876543333334468999999998753     447889999999999999999999986432110    


Q ss_pred             CCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          667 PKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       667 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                         ...... ....+.... .......+.+++.+||+.||++||++.|+++++.
T Consensus       237 ---~~~~~~-~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         237 ---ALFKIP-RNPPPTLHQ-PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             ---HHhhcc-ccCCCcccC-CCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence               011110 010000000 0001123789999999999999999999998763

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-35  Score=304.93  Aligned_cols=248  Identities=25%  Similarity=0.401  Sum_probs=197.7

Q ss_pred             eeeecccceEEEEEEeCC--C--cEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEec
Q 004642          456 YCIGTGGYGSVYKAELPE--G--KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYM  531 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  531 (740)
                      +.||+|++|.||+|.+.+  +  ..||+|.+......  ...+.+.+|++++++++||||+++++++.. ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            358999999999996543  3  36899999876553  446789999999999999999999999988 8899999999


Q ss_pred             cCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc
Q 004642          532 ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY  611 (740)
Q Consensus       532 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  611 (740)
                      ++++|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++........
T Consensus        78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99999999976543 3689999999999999999999998   9999999999999999999999999999876542221


Q ss_pred             ---ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          612 ---RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       612 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                         .....++..|+|||++.+..++.++|||||||++|||++ |+.||......       .................  
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~--  224 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------QILKKIDKEGERLERPE--  224 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhcCCcCCCCc--
Confidence               122356789999999998889999999999999999998 99998643211       11111111111111111  


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                       .....+.+++.+|++.+|++||++.|+++.|.
T Consensus       225 -~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         225 -ACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             11223889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.5e-35  Score=313.82  Aligned_cols=194  Identities=25%  Similarity=0.406  Sum_probs=159.0

Q ss_pred             ceeeecccceEEEEEEeC---CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEE
Q 004642          455 KYCIGTGGYGSVYKAELP---EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH--KKCMFLIYE  529 (740)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  529 (740)
                      .++||+|+||.||+|...   +++.||+|.+......     ..+.+|++++++++||||+++++++..  +...+++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            357999999999999754   4678999998754332     456789999999999999999998864  456899999


Q ss_pred             eccCCCchhhhcCCC------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----cCCCcEEEeec
Q 004642          530 YMERGSLFCVLHDDD------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL----DSNLEASVADF  599 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Df  599 (740)
                      |+.+ +|.+++....      ....+++..+..++.||+.||+|||++   +|+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            9865 7777664321      223588999999999999999999998   99999999999999    45678999999


Q ss_pred             ccceecccCCC---cccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCc
Q 004642          600 GTARLLHVDSS---YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGL  657 (740)
Q Consensus       600 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~  657 (740)
                      |+++.......   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            99987643221   12335789999999998764 578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.7e-36  Score=326.55  Aligned_cols=258  Identities=21%  Similarity=0.260  Sum_probs=195.0

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ...|.+.+.||+|+||.||++... .++.||||....         ..+.+|++++++++|+|||++++++..++..++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            457999999999999999999654 578899996432         3456899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      ||++. ++|.+++.....  .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       239 ~e~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            99995 688887764332  589999999999999999999998   999999999999999999999999999987543


Q ss_pred             CCC--cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccC------
Q 004642          608 DSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRL------  679 (740)
Q Consensus       608 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l------  679 (740)
                      ...  ......||..|+|||++.+..++.++|||||||++|||++|..|+-..............+..++.+..      
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            221  122346999999999999999999999999999999999988653211110000001111111111100      


Q ss_pred             --------------------CCcch-hhhH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          680 --------------------SPPVN-QKIV---QDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       680 --------------------~~~~~-~~~~---~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                                          .+... ..+.   .....+.+++.+||+.||++|||+.|++++-..
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f  458 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF  458 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence                                00000 0000   111237789999999999999999999998544

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.5e-35  Score=310.02  Aligned_cols=257  Identities=24%  Similarity=0.360  Sum_probs=203.1

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .+.|++.+.||+|+||.||+|... +++.|++|.+....   ....+.+.+|+++++.++|||++++++++..++..++|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            367889999999999999999664 58899999986543   23357788999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++++|..++.....  .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+.....
T Consensus        88 ~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          88 IEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EecCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            999999999887764332  588999999999999999999998   999999999999999999999999999876433


Q ss_pred             CCCcccccccCCCcccccccc-----ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC-
Q 004642          608 DSSYRTLRAGTYGYIAPELAY-----TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP-  681 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~-  681 (740)
                      .........++..|+|||++.     ...++.++|||||||++|||++|+.||.....       ............+. 
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~  235 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTL  235 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHhcCCCccC
Confidence            323333456889999999985     34467799999999999999999999864321       11111111111110 


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      ....   .....+.+++.+||+.+|++||+++|++++-....
T Consensus       236 ~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         236 SQPS---KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             CCCc---ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            0011   11223788999999999999999999998876554

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.3e-35  Score=306.63  Aligned_cols=255  Identities=28%  Similarity=0.445  Sum_probs=201.0

Q ss_pred             cccccceeeecccceEEEEEEeCC-C---cEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPE-G---KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (740)
                      .+|++.+.||+|+||.||+|.... +   ..||+|.+.....  ....++|..|++++++++||||+++++++..++..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            457889999999999999996543 3   3699999875432  333578999999999999999999999999999999


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      +||||+++++|.+++.....  .+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+...
T Consensus        82 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          82 IITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence            99999999999999876432  578999999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCCc---ccccc--cCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccC
Q 004642          606 HVDSSY---RTLRA--GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRL  679 (740)
Q Consensus       606 ~~~~~~---~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l  679 (740)
                      ......   .....  .+..|+|||++.+..++.++|||||||++|||++ |..||.....        ....+.+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------~~~~~~i~~~~  228 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVINAIEQDY  228 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------HHHHHHHHcCC
Confidence            432211   11111  2457999999998899999999999999999886 9999864321        11111221111


Q ss_pred             CCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          680 SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       680 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ..+....   ....+.+++.+||+.+|++||++.++++.|...
T Consensus       229 ~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 RLPPPMD---CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cCCCccc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111111   122378899999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2e-35  Score=304.78  Aligned_cols=253  Identities=24%  Similarity=0.377  Sum_probs=196.9

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCccc--chHHHHHHHHHHHHHhccCCCccceeeeeeee--cCeE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETE--DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH--KKCM  524 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  524 (740)
                      .+|++.+.||+|+||.||+|.. .+++.||+|++......  .....+.+.+|++++++++||||+++++++.+  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688899999999999999955 46899999988654322  22345678899999999999999999998875  4678


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++++||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            99999999999999987543   478899999999999999999998   999999999999999999999999999976


Q ss_pred             cccCCC---cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          605 LHVDSS---YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       605 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      ......   ......++..|+|||++.+..++.++||||+||++|||++|+.||.....       .............+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~  228 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFKIATQPTNP  228 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcCCCCC
Confidence            532111   11223588899999999988899999999999999999999999864321       11111111111111


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ......   ...+.+++ +||..+|++||+++|++++-
T Consensus       229 ~~~~~~---~~~~~~li-~~~~~~p~~Rp~~~eil~hp  262 (266)
T cd06651         229 QLPSHI---SEHARDFL-GCIFVEARHRPSAEELLRHP  262 (266)
T ss_pred             CCchhc---CHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence            111111   12255666 68889999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-35  Score=307.28  Aligned_cols=252  Identities=25%  Similarity=0.334  Sum_probs=189.3

Q ss_pred             eeecccceEEEEEEeCC---CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccC
Q 004642          457 CIGTGGYGSVYKAELPE---GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      .||+|+||.||+|...+   +..+|+|.+......  .....+.+|+.++++++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            58999999999996543   467999998765432  2235788899999999999999999999999999999999999


Q ss_pred             CCchhhhcCCC--ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc
Q 004642          534 GSLFCVLHDDD--EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY  611 (740)
Q Consensus       534 g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  611 (740)
                      |+|.++++...  .....++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.++........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            99999987533  223467788889999999999999998   9999999999999999999999999999754322211


Q ss_pred             --ccccccCCCcccccccccc-------ccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          612 --RTLRAGTYGYIAPELAYTI-------VVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       612 --~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                        .....++..|+|||++.+.       .++.++||||||+++|||++ |+.||.......      .............
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~  230 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ------VLTYTVREQQLKL  230 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH------HHHHHhhcccCCC
Confidence              1234578889999988642       35779999999999999996 999986432110      0000011111111


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ..+.........+.+++..|| .+|++||+++||.+.|.
T Consensus       231 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            110000011223778999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.4e-36  Score=313.36  Aligned_cols=265  Identities=20%  Similarity=0.255  Sum_probs=199.9

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+........  ...+.+|++++++++||||+++++++..++..++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            57899999999999999999654 688999999875433221  245678999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||++ ++|.+++.....  .+++..+..++.||+.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        84 e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          84 EYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             eccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            9997 488888765432  478899999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCchhhhhhcc--
Q 004642          609 SSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIMLIDVLNQ--  677 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~--  677 (740)
                      ........+++.|+|||.+.+. .++.++|||||||++|||++|+.||........        ..............  
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence            3333334678999999988653 477899999999999999999999864321000        00000000000000  


Q ss_pred             ----cCC---Ccch-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          678 ----RLS---PPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       678 ----~l~---~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                          ..+   .... .........+.+++.+|++.||++|||++|++++-...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence                000   0000 00001112377899999999999999999999987654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=305.56  Aligned_cols=248  Identities=29%  Similarity=0.430  Sum_probs=191.9

Q ss_pred             eeecccceEEEEEEeCC-Cc--EEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEecc
Q 004642          457 CIGTGGYGSVYKAELPE-GK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYME  532 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  532 (740)
                      .||+|+||.||+|...+ |.  .+++|.++.....  ...+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH--HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            58999999999997643 43  4688888743322  2346788999999999 89999999999999999999999999


Q ss_pred             CCCchhhhcCCC-------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeec
Q 004642          533 RGSLFCVLHDDD-------------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF  599 (740)
Q Consensus       533 ~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  599 (740)
                      +|+|.+++....             ....+++.++..++.|++.|++|||+.   +++||||||+||++++++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence            999999986532             122478999999999999999999998   9999999999999999999999999


Q ss_pred             ccceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhccc
Q 004642          600 GTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQR  678 (740)
Q Consensus       600 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  678 (740)
                      |++...... ........+..|+|||++....++.++|||||||++|||++ |..||.....        ....+.+...
T Consensus       157 gl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~~~~  227 (270)
T cd05047         157 GLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKLPQG  227 (270)
T ss_pred             CCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHHhCC
Confidence            998632211 11111234567999999988889999999999999999997 9999854221        0111111111


Q ss_pred             CCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       679 l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ...+...   .....+.+++.+||+.+|.+||++.|+++.|..
T Consensus       228 ~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         228 YRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             CCCCCCC---cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            1111111   111237899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.3e-36  Score=310.68  Aligned_cols=258  Identities=24%  Similarity=0.352  Sum_probs=202.0

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||++... +|+.||+|.+.....  ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            46888999999999999999665 789999998875432  223467889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|..++........+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.++|+|||.+..+...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            9999999998887643334689999999999999999999963  28999999999999999999999999999765322


Q ss_pred             CCcccccccCCCccccccccccc------cCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCc
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIV------VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  682 (740)
                        ......++..|+|||.+.+..      ++.++||||+||++|+|++|+.||.....    .............. .+.
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~-~~~  229 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANIFAQLSAIVDGD-PPT  229 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhHHHHHHHHhhcC-CCC
Confidence              223346788999999986543      47899999999999999999999864211    00001111122211 111


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ....   ....+.+++.+||+.+|++||++++++++-..
T Consensus       230 ~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~  265 (286)
T cd06622         230 LPSG---YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL  265 (286)
T ss_pred             CCcc---cCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence            1111   22337889999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-35  Score=301.10  Aligned_cols=247  Identities=27%  Similarity=0.418  Sum_probs=197.9

Q ss_pred             eeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCC
Q 004642          456 YCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGS  535 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  535 (740)
                      +.||+|+||.||++...+++.||+|++......  ...+.+.+|++++++++|+||+++++++......++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            368999999999998767999999998765443  234678999999999999999999999999999999999999999


Q ss_pred             chhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcc--c
Q 004642          536 LFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR--T  613 (740)
Q Consensus       536 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~  613 (740)
                      |.+++.....  .+++..+..++.+++.|++|||++   +++||||||+||+++.++.++|+|||.+..........  .
T Consensus        79 l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          79 LLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            9999865432  578899999999999999999998   99999999999999999999999999997654221111  1


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDII  692 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  692 (740)
                      ...++..|+|||.+.+..++.++|||||||++|||+| |..||.....        ....+.+...........   ...
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~---~~~  222 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRERIESGYRMPAPQL---CPE  222 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHHHHhcCCCCCCCcc---CCH
Confidence            2234667999999988889999999999999999999 7888754321        111122222111111111   122


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          693 LVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       693 ~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      .+.+++.+|+..+|++||++.|+++.|.
T Consensus       223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         223 EIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            4889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.7e-35  Score=302.95  Aligned_cols=247  Identities=26%  Similarity=0.453  Sum_probs=198.5

Q ss_pred             cccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      ++|++.+.||+|+||.||++.. +++.||+|.+.....     .+.+.+|+.++++++|||++++++++...+ .+++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e   78 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVME   78 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEE
Confidence            5688999999999999999975 688899999865432     357889999999999999999999987654 799999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.+++..... ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++...... 
T Consensus        79 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          79 LMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             CCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            9999999999876432 3578999999999999999999998   9999999999999999999999999999764321 


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                        ......+..|+|||++.+..++.++||||||+++|||++ |+.||.....        ....+.+.....+.....  
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~--  221 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEVKECVEKGYRMEPPEG--  221 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHHHhCCCCCCCCCc--
Confidence              112234678999999988889999999999999999998 9999864321        111222222222221111  


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                       ....+.+++.+||+.+|++||+++++++.|..
T Consensus       222 -~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         222 -CPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             12337899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2e-35  Score=304.69  Aligned_cols=257  Identities=26%  Similarity=0.428  Sum_probs=204.5

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|.. .++..+|+|++.......  ..+.+.+|+++++.++|+|++++++.+..++..++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            4788999999999999999965 467899999987544332  3578899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++........+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++..+...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            9999999999997643333689999999999999999999998   9999999999999999999999999998776543


Q ss_pred             CCc----ccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCc-
Q 004642          609 SSY----RTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP-  682 (740)
Q Consensus       609 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~-  682 (740)
                      ...    .....|+..|+|||++... .++.++|||||||++|||++|+.||......       ....+......... 
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~  228 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-------KVLMLTLQNDPPSLE  228 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-------hhHHHHhcCCCCCcC
Confidence            322    1334688999999998876 7888999999999999999999998643221       11111111111100 


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ...........+.+++.+||+.||++||+++|++++
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000000112337899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-35  Score=304.00  Aligned_cols=253  Identities=24%  Similarity=0.396  Sum_probs=202.8

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee--cCeEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH--KKCMFLI  527 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  527 (740)
                      +|++.+.||.|+||.||++.. .+|+.||+|.+...... ....+++..|++++++++|||++++++++..  +...+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            478889999999999999954 56889999998754432 3335678899999999999999999998764  4568999


Q ss_pred             EEeccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          528 YEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLH-----HDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      |||+++++|.+++.... ....+++..++.++.||+.||+|||     +.   +++|+||+|+||+++.++.+||+|||+
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence            99999999999986532 2346899999999999999999999     66   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      +..............|+..|+|||++.+..++.++||||||+++|+|++|+.||.....        ....+.+.....+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~  228 (265)
T cd08217         157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLASKIKEGKFR  228 (265)
T ss_pred             cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHHHHhcCCCC
Confidence            98775444333445789999999999988899999999999999999999999874321        1112222222211


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ....   .....+.+++.+|++.+|++||++.|++++
T Consensus       229 ~~~~---~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 RIPY---RYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCcc---ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            1111   112347899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-35  Score=315.46  Aligned_cols=259  Identities=26%  Similarity=0.405  Sum_probs=202.9

Q ss_pred             hcccccceeeecccceEEEEEEeC--------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeee
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP--------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCL  519 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  519 (740)
                      ..+|++.+.||+|+||.||++...        .+..||+|.+......  ...+.+.+|++++.++ +||||+++++++.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--KDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH--HHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            357899999999999999999542        1236899988754322  2356888999999999 8999999999999


Q ss_pred             ecCeEEEEEEeccCCCchhhhcCCC-------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 004642          520 HKKCMFLIYEYMERGSLFCVLHDDD-------------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNI  586 (740)
Q Consensus       520 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI  586 (740)
                      ..+..+++|||+++|+|.+++....             ....+++.++..++.|++.||+|||+.   +++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence            9999999999999999999986532             123588999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecccceecccCCCcc--cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCccccccc
Q 004642          587 LLDSNLEASVADFGTARLLHVDSSYR--TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSS  663 (740)
Q Consensus       587 ll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~  663 (740)
                      +++.++.+||+|||+++.........  ....++..|+|||++.+..++.++||||||+++|||++ |..||.....   
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---  242 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---  242 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---
Confidence            99999999999999998664322211  11234567999999999889999999999999999998 8888754221   


Q ss_pred             CCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          664 SSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       664 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                           ......+..........   .....+.+++.+||+.+|++||++.|++++|....
T Consensus       243 -----~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         243 -----EELFKLLKEGHRMDKPA---NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             -----HHHHHHHHcCCCCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence                 11112221111111111   11224789999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-35  Score=322.99  Aligned_cols=264  Identities=25%  Similarity=0.289  Sum_probs=201.2

Q ss_pred             hcccccceeeecccceEEEEEEeC---CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP---EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (740)
                      ..+|.+.+.||+|+||.||++...   .++.||+|.+...        +...+|++++++++||||+++++++......+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            457999999999999999999543   3578999988643        23457999999999999999999999999999


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      ++||++. ++|.+++...   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.++|+|||+++..
T Consensus       163 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            9999986 5788887433   3689999999999999999999998   9999999999999999999999999999766


Q ss_pred             ccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccc------------------cCC
Q 004642          606 HVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS------------------SSS  665 (740)
Q Consensus       606 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~------------------~~~  665 (740)
                      ......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......                  ...
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            433221  223469999999999999899999999999999999999999985432100                  000


Q ss_pred             CCCchhhhhh---cccCCCcch--hhh--HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCCh
Q 004642          666 GPKIMLIDVL---NQRLSPPVN--QKI--VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQ  727 (740)
Q Consensus       666 ~~~~~~~~~~---~~~l~~~~~--~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~  727 (740)
                      ..........   .....++..  ...  ......+.+++.+|+..||++||++.|++.+-...+.+..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence            0000000000   000000000  000  0011236789999999999999999999999888766544

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=308.91  Aligned_cols=258  Identities=24%  Similarity=0.388  Sum_probs=205.5

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|++++++++||||+++++++..+...++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            467899999999999999999664 68899999986542   23346788999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++++|.+++.....  .+++.++..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          81 IEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             eeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999999875432  588999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCcccccccCCCcccccccc-----ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC-
Q 004642          608 DSSYRTLRAGTYGYIAPELAY-----TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP-  681 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~-  681 (740)
                      .........|+..|+|||++.     ...++.++||||||+++|||++|+.||.....       ............+. 
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~  228 (280)
T cd06611         156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-------MRVLLKILKSEPPTL  228 (280)
T ss_pred             cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-------HHHHHHHhcCCCCCc
Confidence            333334456899999999875     34467799999999999999999999865321       11111211111100 


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      ......   ...+.+++.+||+.+|++||++.+++++-.....
T Consensus       229 ~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         229 DQPSKW---SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             CCcccC---CHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            001111   1237789999999999999999999998766544

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.3e-35  Score=308.92  Aligned_cols=260  Identities=24%  Similarity=0.370  Sum_probs=201.3

Q ss_pred             cHHHHHHHhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeee
Q 004642          441 LYEDLINATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFC  518 (740)
Q Consensus       441 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (740)
                      .+.++..+.+.|++.+.||+|+||.||+|.. .+++.+|+|.+.....    ....+..|+.++.++ +|+|++++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            4555666778999999999999999999965 4688999998865332    235678899999998 799999999998


Q ss_pred             ee------cCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 004642          519 LH------KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL  592 (740)
Q Consensus       519 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  592 (740)
                      ..      ....+++|||+++|+|.+++..... ..+++..+..++.||+.|++|||+.   +++|+||+|+||+++.++
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            53      4578999999999999998865332 2578888999999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCCCcccccccCCCcccccccc-----ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCC
Q 004642          593 EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY-----TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGP  667 (740)
Q Consensus       593 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~  667 (740)
                      .++|+|||++..............|+..|+|||.+.     ...++.++|||||||++|||++|+.||......      
T Consensus       159 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------  232 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------  232 (282)
T ss_pred             CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH------
Confidence            999999999876543222233456899999999875     345778999999999999999999998643211      


Q ss_pred             CchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          668 KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       668 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                       .................   .....+.+++.+||+.||++||++.|++++
T Consensus       233 -~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         233 -RALFLIPRNPPPKLKSK---KWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -hhhhhHhhCCCCCCccc---ccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence             00111111111110111   112238899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.1e-35  Score=307.97  Aligned_cols=263  Identities=25%  Similarity=0.329  Sum_probs=199.8

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|++....... ...+.+.+|++++++++|||++++++++..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            46888999999999999999665 58999999886543221 22356789999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||++++.+..++....   .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          80 EYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             eccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999988887765433   589999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCcccccccC--------CC-C--------Cch
Q 004642          609 SSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS--------SG-P--------KIM  670 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~-~--------~~~  670 (740)
                      ........++..|+|||++.+ ..++.++||||||+++|||++|+.||.........        .. .        ...
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence            323334467889999999876 45788999999999999999999998643321000        00 0        000


Q ss_pred             hhhhhcccCC--CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          671 LIDVLNQRLS--PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       671 ~~~~~~~~l~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ......+...  .+...........+.+++.+||+.+|++||++.|++++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~  284 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP  284 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence            0000000000  000000001123378999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2e-35  Score=308.73  Aligned_cols=251  Identities=26%  Similarity=0.352  Sum_probs=205.5

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||++... +++.||+|++...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999654 68999999987654444444577889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999987653   588999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                         .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||.....       ..............+  ... 
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~--~~~-  221 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGKVRFP--SFF-  221 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCccCC--ccC-
Confidence               2334688999999999888888999999999999999999999864321       111222222221111  111 


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHc
Q 004642          689 QDIILVSTIAFACLSSQPKSRP-----TMQRISQELLA  721 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~L~~  721 (740)
                        ...+.+++.+||..+|++|+     +++|++++-..
T Consensus       222 --~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~  257 (290)
T cd05580         222 --SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF  257 (290)
T ss_pred             --CHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence              22378999999999999998     88888877543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.8e-35  Score=302.87  Aligned_cols=249  Identities=25%  Similarity=0.364  Sum_probs=190.4

Q ss_pred             eeeecccceEEEEEEeC----CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeee-ecCeEEEEEEe
Q 004642          456 YCIGTGGYGSVYKAELP----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCL-HKKCMFLIYEY  530 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~  530 (740)
                      +.||+|+||.||+|...    ++..||+|++.....  ....+.+.+|+.+++.++|||++++++++. .++..+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCC--HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            35899999999999653    245799998864322  233567889999999999999999999876 45568999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                      +.+|+|.+++.....  ..++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.......
T Consensus        79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          79 MKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            999999999975432  367788899999999999999998   999999999999999999999999999976532211


Q ss_pred             ----cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhC-CCCCCcccccccCCCCCchhhhhhcccCCCcchh
Q 004642          611 ----YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMG-THPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       611 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  685 (740)
                          ......++..|+|||++.+..++.++|||||||++|||++| ..||.....        ......+..........
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~  225 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVYLLQGRRLLQPE  225 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhcCCCCCCCC
Confidence                11123457789999999888899999999999999999995 555543211        11111111111111111


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ...   ..+.+++.+||+.+|++||++.|++++|...
T Consensus       226 ~~~---~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         226 YCP---DPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             cCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111   2378999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-35  Score=309.95  Aligned_cols=273  Identities=25%  Similarity=0.309  Sum_probs=206.6

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCccc--chHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETE--DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      +|++.+.||+|+||.||+|.. .+|+.||+|++......  .......+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477888999999999999965 46899999999765443  122345677899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+ +++|.+++....  ..+++..+..++.||++||+|||++   +++|+||+|+||+++.++.++|+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889999997644  2589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCchh------h
Q 004642          608 DSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIML------I  672 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~------~  672 (740)
                      .........++..|+|||.+.+ ..++.++|||||||++|||++|..||........        ........      .
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            3333333456788999998865 4578899999999999999999877754322100        00000000      0


Q ss_pred             hhhcccC--CCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCChhh
Q 004642          673 DVLNQRL--SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKA  729 (740)
Q Consensus       673 ~~~~~~l--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~  729 (740)
                      .......  ..+...........+.+++.+||+.+|++||+++|++++-.....+.+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~  293 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP  293 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence            0000000  00000001112234789999999999999999999999877666555443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.8e-35  Score=305.19  Aligned_cols=256  Identities=23%  Similarity=0.373  Sum_probs=202.4

Q ss_pred             cccccceeeecccceEEEEEEeC------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (740)
                      ++|++.+.||+|+||.||+|+.+      +.+.|++|.+.....  ....+.+.+|++++++++|+||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            57888999999999999999754      346789998865432  2345788999999999999999999999999999


Q ss_pred             EEEEEEeccCCCchhhhcCCCcc------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEe
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEA------IELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVA  597 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  597 (740)
                      .++||||+++|+|.+++......      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence            99999999999999999765422      2589999999999999999999998   99999999999999999999999


Q ss_pred             ecccceecccCCC-cccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhh
Q 004642          598 DFGTARLLHVDSS-YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVL  675 (740)
Q Consensus       598 DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  675 (740)
                      |||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....       ........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~  232 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQ  232 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHH
Confidence            9999875432221 1223356788999999988888899999999999999999 7888754221       11111111


Q ss_pred             cccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          676 NQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       676 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ..........   .....+.+++.+||+.+|++||++.|++++|.
T Consensus       233 ~~~~~~~~~~---~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 AGKLELPVPE---GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cCCcCCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1111111111   11124889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-35  Score=309.61  Aligned_cols=264  Identities=26%  Similarity=0.375  Sum_probs=203.7

Q ss_pred             ccHHHHHHHhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeee
Q 004642          440 ILYEDLINATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGF  517 (740)
Q Consensus       440 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  517 (740)
                      +.++++..+.++|++.+.||+|+||.||++.. .+++.+|+|.+......    ...+.+|+.+++++ +|||+++++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~   87 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGM   87 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            34456666789999999999999999999965 46889999998654321    35677899999998 89999999999


Q ss_pred             eeec-----CeEEEEEEeccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC
Q 004642          518 CLHK-----KCMFLIYEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN  591 (740)
Q Consensus       518 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  591 (740)
                      +...     +..++||||+++++|.++++... ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.+
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~  164 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence            8754     35899999999999999886422 223588999999999999999999998   99999999999999999


Q ss_pred             CcEEEeecccceecccCCCcccccccCCCcccccccccc-----ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCC
Q 004642          592 LEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI-----VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG  666 (740)
Q Consensus       592 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~  666 (740)
                      +.++|+|||.+..............|+..|+|||++...     .++.++|||||||++|||++|+.||......     
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----  239 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----  239 (291)
T ss_pred             CCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----
Confidence            999999999998765433333344688999999987643     3678999999999999999999998643221     


Q ss_pred             CCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          667 PKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       667 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                        ....+...... +.. .........+.+++.+||+.+|++||++.|++++-
T Consensus       240 --~~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  288 (291)
T cd06639         240 --KTLFKIPRNPP-PTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP  288 (291)
T ss_pred             --HHHHHHhcCCC-CCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence              11111111100 000 00011122378999999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=317.86  Aligned_cols=255  Identities=24%  Similarity=0.423  Sum_probs=206.9

Q ss_pred             ccccceeeecccceEEEEEEeC--CCc--EEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP--EGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      +....+.||+|.||.|++|.|.  +|+  .||||.++......  ....|.+|+.+|.+++|+|++++||...+ ...++
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            3444577999999999999765  344  58999998766543  46899999999999999999999999988 56889


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      |+|.++.|+|.+.|++ .....+-......++.|||.||.||..+   ++|||||..+|+++.....+||+|||+.+.+.
T Consensus       188 V~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             HhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence            9999999999999998 3344678888999999999999999999   99999999999999999999999999999887


Q ss_pred             cCCCcccc---cccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCc
Q 004642          607 VDSSYRTL---RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       607 ~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  682 (740)
                      ........   +--.+.|+|||.+....++.++|||+|||++|||+| |..||-....        ..+.+.+|.+-.-+
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~~iD~~erLp  335 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILKNIDAGERLP  335 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHHhccccccCC
Confidence            65444322   234678999999999999999999999999999999 7778654332        22333444333222


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      .+....+   .++++++.||...|++||+|..+.+.+...+
T Consensus       336 RPk~cse---dIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  336 RPKYCSE---DIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             CCCCChH---HHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            2332333   4899999999999999999999987765543

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-35  Score=306.46  Aligned_cols=263  Identities=26%  Similarity=0.389  Sum_probs=205.6

Q ss_pred             cccccceeeecccceEEEEEEeC-----CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee--cC
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH--KK  522 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  522 (740)
                      +.|++.+.||+|+||.||++.+.     +++.||+|++......  ...+.+.+|+++++.++||||+++++++..  +.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            46778899999999999999753     3688999999765543  335789999999999999999999999887  56


Q ss_pred             eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccc
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                      ..+++|||+++++|.+++.....  .+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            78999999999999999976543  589999999999999999999998   9999999999999999999999999999


Q ss_pred             eecccCCCcc---cccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccC----C---CCCchhh
Q 004642          603 RLLHVDSSYR---TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS----S---GPKIMLI  672 (740)
Q Consensus       603 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~----~---~~~~~~~  672 (740)
                      ..........   ....++..|+|||...+..++.++||||||+++|||++|+.|+.........    .   .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            8765322211   1224566799999998888999999999999999999999997542211000    0   0111122


Q ss_pred             hhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          673 DVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       673 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      +.+......+...   .....+.+++.+||+.+|++||++.|++++|...
T Consensus       237 ~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPP---SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCc---cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            2222222221111   1123488999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.2e-35  Score=303.51  Aligned_cols=253  Identities=30%  Similarity=0.446  Sum_probs=204.0

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      +-|++.+.||+|+||.||+|.. .+++.||+|.+......  ...+.+.+|++++.+++||||+++++++..++..++||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            4577888999999999999954 46889999988654332  23467889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++...    .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06641          82 EYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  154 (277)
T ss_pred             EeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence            999999999988643    578999999999999999999998   9999999999999999999999999999776543


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      ........++..|+|||+..+..++.++|||||||++|+|++|..||.....        ......+.....+....   
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~---  223 (277)
T cd06641         155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFLIPKNNPPTLEG---  223 (277)
T ss_pred             hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHHHhcCCCCCCCc---
Confidence            3333345688899999999888888999999999999999999999864221        11111111111111111   


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .....+.+++.+||+.+|++||++.+++++-...
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~  257 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence            1122378899999999999999999999985544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=305.31  Aligned_cols=261  Identities=22%  Similarity=0.286  Sum_probs=214.0

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .+.|..-++||+||||.||-+.. .+|+.||.|++.+..............|.++++++..+.||.+--.|.+++.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            46788889999999999999954 47999999998776655555556778999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      +..|.||+|.-+|.+.+. ..+++..+..++.+|+.||++||+.   +||.||+||+|||+|++|+++|+|.|+|..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999988887665 4689999999999999999999999   999999999999999999999999999998865


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      .... ..++||.+|||||++....|+...|.||+||++|||+.|+.||.....        ....+-++++.........
T Consensus       340 g~~~-~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke--------Kvk~eEvdrr~~~~~~ey~  410 (591)
T KOG0986|consen  340 GKPI-RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE--------KVKREEVDRRTLEDPEEYS  410 (591)
T ss_pred             CCcc-ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh--------hhhHHHHHHHHhcchhhcc
Confidence            4444 444899999999999999999999999999999999999999875322        2222233333322111111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHcC
Q 004642          688 VQDIILVSTIAFACLSSQPKSRP-----TMQRISQELLAG  722 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~L~~~  722 (740)
                      ..-..+..++....++.||++|-     .+++|.+|....
T Consensus       411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk  450 (591)
T KOG0986|consen  411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFK  450 (591)
T ss_pred             cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccc
Confidence            22233367788889999999985     677888776554

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.3e-35  Score=301.67  Aligned_cols=255  Identities=28%  Similarity=0.406  Sum_probs=207.6

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|++|.||+|... +++.|++|++......  ...+.+.+|++++.+++|+|++++++++..++..++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            36888999999999999999665 5899999998765432  33578899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH-DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      ||+++++|.+++...   ..+++..+..++.|++.|++|||+ .   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999764   268899999999999999999999 8   999999999999999999999999999987654


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      .........++..|+|||.+.+..++.++||||||+++|+|++|+.||.....    .........+..... +..... 
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~-~~~~~~-  226 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAICDGPP-PSLPAE-  226 (264)
T ss_pred             CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHhcCCC-CCCCcc-
Confidence            44333345688999999999988899999999999999999999999865431    011111122221111 111111 


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                       .....+.+++.+|++.+|++||++.|++++-
T Consensus       227 -~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~  257 (264)
T cd06623         227 -EFSPEFRDFISACLQKDPKKRPSAAELLQHP  257 (264)
T ss_pred             -cCCHHHHHHHHHHccCChhhCCCHHHHHhCH
Confidence             0123488999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-36  Score=311.36  Aligned_cols=254  Identities=28%  Similarity=0.436  Sum_probs=206.0

Q ss_pred             hcccccceeeecccceEEEEEEeC---CCc--EEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP---EGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~---~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (740)
                      .+.....++||.|.||.||+|...   .|+  .||||..+.....+.  .+.|..|..+|++++|||||+++|.|.+. .
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~e~-P  464 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P  464 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence            344555678999999999999432   343  488898887665544  58899999999999999999999999876 4


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccce
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      .|+|||.++-|.|..+++..+.  .++......++.||+.||+|||+.   .+|||||..+|||+.....||++|||+++
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence            8999999999999999987665  578888999999999999999999   99999999999999999999999999999


Q ss_pred             ecccCCCccccc-ccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          604 LLHVDSSYRTLR-AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       604 ~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      .+..+..+...+ .-+..|||||.+.-.+++.+||||.|||.+||++. |..||.....-        +..-.+.+.-+.
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs--------DVI~~iEnGeRl  611 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS--------DVIGHIENGERL  611 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc--------ceEEEecCCCCC
Confidence            987666554332 23678999999999999999999999999999997 99998764321        111111222222


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      +.+   ..+...+..++.+||+.||.+||++.|+...|..
T Consensus       612 P~P---~nCPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  612 PCP---PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             CCC---CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence            222   2334458899999999999999999999988854

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.5e-36  Score=310.95  Aligned_cols=262  Identities=26%  Similarity=0.356  Sum_probs=199.9

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            46888999999999999999765 58999999987644332 33467889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||++++++..+.....   .+++.++..++.||+.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          80 EFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             ecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            9999999887765432   478999999999999999999998   9999999999999999999999999999876443


Q ss_pred             CCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc-------CCCCCchhhhhh-----
Q 004642          609 SSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-------SSGPKIMLIDVL-----  675 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~-----  675 (740)
                      ........++..|+|||+..+ ..++.++||||||+++|||++|+.||........       ............     
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence            333333467899999999875 3467899999999999999999998864321100       000000000000     


Q ss_pred             -cccCCCcc------hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          676 -NQRLSPPV------NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       676 -~~~l~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                       .....+..      ..........+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence             00000000      00001112348899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=317.78  Aligned_cols=263  Identities=21%  Similarity=0.255  Sum_probs=197.6

Q ss_pred             HHhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec----
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK----  521 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  521 (740)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++...    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            4568899999999999999999954 56889999998754322 22345677899999999999999999987543    


Q ss_pred             --CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeec
Q 004642          522 --KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF  599 (740)
Q Consensus       522 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  599 (740)
                        ...+++++++ +++|.+++...    .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence              3578999987 67888777532    588999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecccCCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCch
Q 004642          600 GTARLLHVDSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIM  670 (740)
Q Consensus       600 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~  670 (740)
                      |+++.....   .....||..|+|||++.+ ..++.++||||+||++|+|++|+.||........        .......
T Consensus       163 g~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         163 GLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             ccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999865432   233468999999999876 4688899999999999999999999864321000        0000000


Q ss_pred             h--------hhhhcccCCCcchh----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          671 L--------IDVLNQRLSPPVNQ----KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       671 ~--------~~~~~~~l~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .        ..... .++.....    ........+.+++.+|++.||++|||++|++++-...
T Consensus       240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~  302 (343)
T cd07878         240 LKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS  302 (343)
T ss_pred             HHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence            0        00000 00000000    0001112367899999999999999999999986443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=317.15  Aligned_cols=250  Identities=26%  Similarity=0.397  Sum_probs=201.9

Q ss_pred             eeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCC
Q 004642          457 CIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGS  535 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  535 (740)
                      +||+|.||+||.|+.. +..++|||-+.....   +..+-+.+|+.+.++++|+|||+++|.+.++++.-+.||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            5999999999999654 467799999876443   335778899999999999999999999999999999999999999


Q ss_pred             chhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCcEEEeecccceecccCCCcccc
Q 004642          536 LFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD-SNLEASVADFGTARLLHVDSSYRTL  614 (740)
Q Consensus       536 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~  614 (740)
                      |.+++...=+...=.+.++-.+.+||+.||.|||+.   .|||||||-.|||++ -.|.+||+|||-++.+..-......
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence            999997643322336778888999999999999999   999999999999997 6789999999999988665666666


Q ss_pred             cccCCCcccccccccc--ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHH
Q 004642          615 RAGTYGYIAPELAYTI--VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDII  692 (740)
Q Consensus       615 ~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  692 (740)
                      +.||..|||||++..+  .|..++|||||||++.||.||++||-....     ....++.--+.+. .++.+.   +-..
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs-----pqAAMFkVGmyKv-HP~iPe---elsa  806 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS-----PQAAMFKVGMYKV-HPPIPE---ELSA  806 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC-----hhHhhhhhcceec-CCCCcH---HHHH
Confidence            7899999999999865  478899999999999999999999864332     1122222222221 222222   2233


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          693 LVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       693 ~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      +...+|.+|+.+||..||+|+++++.-.-
T Consensus       807 eak~FilrcFepd~~~R~sA~~LL~DpFl  835 (1226)
T KOG4279|consen  807 EAKNFILRCFEPDPCDRPSAKDLLQDPFL  835 (1226)
T ss_pred             HHHHHHHHHcCCCcccCccHHHhccCccc
Confidence            47889999999999999999999987643

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.6e-35  Score=301.81  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=197.6

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcc--cchHHHHHHHHHHHHHhccCCCccceeeeeeeec--CeE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSET--EDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCM  524 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  524 (740)
                      ++|++.+.||+|+||.||++.. .+|+.||+|.+.....  ......+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4788999999999999999965 4589999998864321  2223456888999999999999999999988763  468


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      +++|||+++++|.+++....   .+++....+++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999886543   478888999999999999999998   999999999999999999999999999876


Q ss_pred             cccCC---CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          605 LHVDS---SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       605 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      .....   .......|+..|+|||++.+..++.++|||||||++|||++|+.||.....       .....+.......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~  228 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------MAAIFKIATQPTNP  228 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------HHHHHHHhcCCCCC
Confidence            53211   112234688999999999888889999999999999999999999864221       11111111111111


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ..+.   .....+.+++.+|+. +|++||+++|++++-
T Consensus       229 ~~~~---~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         229 VLPP---HVSDHCRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             CCch---hhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence            1111   122337788999984 999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=330.47  Aligned_cols=266  Identities=19%  Similarity=0.262  Sum_probs=194.3

Q ss_pred             HHHHHhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCC------Cccceeee
Q 004642          444 DLINATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH------RNIVKLYG  516 (740)
Q Consensus       444 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~  516 (740)
                      ++...+++|++.+.||+|+||+||+|.. ..++.||||+++....    ..+.+..|+++++.++|      .+++.+++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~  198 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQR  198 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence            3344568899999999999999999955 4678899999964321    12445567777776654      45888988


Q ss_pred             eeeec-CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCC--
Q 004642          517 FCLHK-KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH-DCTLSIIHRDISSNNILLDSNL--  592 (740)
Q Consensus       517 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~--  592 (740)
                      ++... +..++|||++ +++|.+++....   .+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++  
T Consensus       199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        199 YFQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTV  271 (467)
T ss_pred             EEEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcc
Confidence            88764 5788999988 668888886543   58899999999999999999997 5   999999999999998765  


Q ss_pred             --------------cEEEeecccceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcc
Q 004642          593 --------------EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLL  658 (740)
Q Consensus       593 --------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~  658 (740)
                                    .+||+|||.+....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus       272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        272 VDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             cccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                          49999999886432   2233457999999999999999999999999999999999999999753


Q ss_pred             ccccc--------CCCCCch--------hhhhhcc--cCCCcchh------------hhHHHHHHHHHHHHHcccCCCCC
Q 004642          659 SSLSS--------SSGPKIM--------LIDVLNQ--RLSPPVNQ------------KIVQDIILVSTIAFACLSSQPKS  708 (740)
Q Consensus       659 ~~~~~--------~~~~~~~--------~~~~~~~--~l~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~  708 (740)
                      .....        ...+..+        ..+..+.  .+.+....            ........+.+|+.+||+.||++
T Consensus       349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            32100        0000000        0000000  00000000            00011234779999999999999


Q ss_pred             CCCHHHHHHHHHcCC
Q 004642          709 RPTMQRISQELLAGK  723 (740)
Q Consensus       709 RPs~~ev~~~L~~~~  723 (740)
                      |||++|+++|-...+
T Consensus       429 R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        429 RLNARQMTTHPYVLK  443 (467)
T ss_pred             CCCHHHHhcCccccc
Confidence            999999999887654

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-36  Score=303.49  Aligned_cols=255  Identities=22%  Similarity=0.356  Sum_probs=213.5

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ..-|...+.||+|.|..|-++++ =+|..||||++.+....+ .....+.+|++.|+.++|||||++|++...+...|+|
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            35577788899999999999843 379999999998766543 3356788999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE-cCCCcEEEeecccceecc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL-DSNLEASVADFGTARLLH  606 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~DfG~a~~~~  606 (740)
                      .|.-++|+|+++|.+...  .+.+....+++.||+.|+.|+|+-   .+|||||||+||.+ .+-|-||++|||++..+.
T Consensus        96 LELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            999999999999987665  478888999999999999999998   99999999999866 567899999999998876


Q ss_pred             cCCCcccccccCCCccccccccccccC-CcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchh
Q 004642          607 VDSSYRTLRAGTYGYIAPELAYTIVVT-GKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  685 (740)
                      +.... +..+|+..|-|||++.+..|+ +++||||+|||||-+++|+.||+...       ..+.+..++|-....+.. 
T Consensus       171 PG~kL-~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN-------DSETLTmImDCKYtvPsh-  241 (864)
T KOG4717|consen  171 PGKKL-TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN-------DSETLTMIMDCKYTVPSH-  241 (864)
T ss_pred             Ccchh-hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc-------chhhhhhhhcccccCchh-
Confidence            54443 455999999999999999887 46899999999999999999997532       344555666655544322 


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                       ..   .+..++|..|+..||.+|.+.+|+..+-+-.
T Consensus       242 -vS---~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  242 -VS---KECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             -hh---HHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence             22   2378999999999999999999999876544

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4e-35  Score=303.01  Aligned_cols=256  Identities=23%  Similarity=0.388  Sum_probs=201.0

Q ss_pred             ccccceeeecccceEEEEEEeCC--CcEEEEEEccCCcc-------cchHHHHHHHHHHHHHhc-cCCCccceeeeeeee
Q 004642          451 DFHIKYCIGTGGYGSVYKAELPE--GKVVALKKLHHSET-------EDSAFVKSFQNEAHVLST-VRHRNIVKLYGFCLH  520 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  520 (740)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+.....       .......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999997654  68899998864321       122334567788888875 799999999999999


Q ss_pred             cCeEEEEEEeccCCCchhhhcCC-CccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCcEEEee
Q 004642          521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKRVNIVKSVAHALSYLHH-DCTLSIIHRDISSNNILLDSNLEASVAD  598 (740)
Q Consensus       521 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~D  598 (740)
                      ++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999887542 123368899999999999999999996 5   899999999999999999999999


Q ss_pred             cccceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhccc
Q 004642          599 FGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQR  678 (740)
Q Consensus       599 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  678 (740)
                      ||.+....... ......|+..|+|||...+..++.++||||||+++|||++|+.||.....       ...........
T Consensus       158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~~~~  229 (269)
T cd08528         158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLATKIVEAV  229 (269)
T ss_pred             ccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHHHHhhcc
Confidence            99998765433 33345689999999999988899999999999999999999999764221       11111222221


Q ss_pred             CCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       679 l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ..+.....   ....+.+++.+||+.||++||++.|+.+++.
T Consensus       230 ~~~~~~~~---~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 YEPLPEGM---YSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCcCCccc---CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11111111   1223789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.8e-35  Score=313.08  Aligned_cols=264  Identities=19%  Similarity=0.276  Sum_probs=195.3

Q ss_pred             cceeeecc--cceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEe
Q 004642          454 IKYCIGTG--GYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       454 ~~~~lg~G--~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      +.+.||+|  +|++||++.. .+|+.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            45679999  7899999954 578999999997654332 3346778899999999999999999999999999999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                      +++|+|.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||+.+........
T Consensus        81 ~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          81 MAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             cCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999999865322 2478999999999999999999998   999999999999999999999999986543321111


Q ss_pred             -------cccccccCCCccccccccc--cccCCcchhHhHHHHHHHHHhCCCCCCccccccc----CCC--C--------
Q 004642          611 -------YRTLRAGTYGYIAPELAYT--IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS----SSG--P--------  667 (740)
Q Consensus       611 -------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~----~~~--~--------  667 (740)
                             ......++..|+|||++.+  ..++.++|||||||++|||++|+.||........    ...  .        
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                   1122346778999999876  4588999999999999999999999974321000    000  0        


Q ss_pred             --------------Cchhhhhhc--ccCCC----cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          668 --------------KIMLIDVLN--QRLSP----PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       668 --------------~~~~~~~~~--~~l~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                                    +....+...  .....    ............+.+++.+||+.||++|||++|++++....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence                          000000000  00000    00000011123478999999999999999999999987654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.7e-35  Score=303.03  Aligned_cols=256  Identities=24%  Similarity=0.436  Sum_probs=201.5

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccc---hHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETED---SAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      +|+..+.||+|+||.||++.. .+++.||+|++.......   ....+.+.+|++++++++|+||+++++++.+++..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999954 578999999987543221   2345788999999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-cEEEeecccceec
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGTARLL  605 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfG~a~~~  605 (740)
                      ||||+++++|.+++.+..   .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999987543   578999999999999999999999   999999999999998776 5999999999776


Q ss_pred             ccCCC----cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          606 HVDSS----YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       606 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      .....    ......|+..|+|||.+.+..++.++||||+|+++|+|++|..||.....    ................+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~  230 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLALIFKIASATTAP  230 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHHHHHHhccCCCC
Confidence            53311    12234678899999999888889999999999999999999999863221    01111111111111111


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ..+.   .....+.+++.+|+..+|++||++.|++++-
T Consensus       231 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~  265 (268)
T cd06630         231 SIPE---HLSPGLRDVTLRCLELQPEDRPPSRELLKHP  265 (268)
T ss_pred             CCch---hhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence            1111   1123378899999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.9e-35  Score=299.25  Aligned_cols=251  Identities=23%  Similarity=0.390  Sum_probs=201.0

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|+||.||++.. .+++.+|+|.+....... ...+.+.+|++++++++|||++++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            478899999999999999955 468899999987654332 335788999999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CcEEEeecccceecccC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN-LEASVADFGTARLLHVD  608 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfG~a~~~~~~  608 (740)
                      |+++++|.+++.... ...+++..+..++.|++.|++|||++   +++|+||+|+||+++.+ +.++|+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999997643 22578999999999999999999998   99999999999999855 45799999999876533


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      .. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||+....       ............. +..... 
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~-  225 (256)
T cd08220         156 SK-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLKIMSGTFA-PISDRY-  225 (256)
T ss_pred             cc-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHHHHhcCCC-CCCCCc-
Confidence            22 2234688999999999988889999999999999999999999864221       1111122211111 111111 


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                        ...+.+++.+||+.+|++|||+.|++++
T Consensus       226 --~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         226 --SPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             --CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence              1237899999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3e-35  Score=303.94  Aligned_cols=251  Identities=25%  Similarity=0.330  Sum_probs=186.6

Q ss_pred             eeecccceEEEEEEeCC---CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccC
Q 004642          457 CIGTGGYGSVYKAELPE---GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      .||+|+||.||+|...+   ...+|+|.+.....  ......+.+|++.++.++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCC--hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            58999999999996543   35688888764432  23346788999999999999999999999999999999999999


Q ss_pred             CCchhhhcCCCc--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc
Q 004642          534 GSLFCVLHDDDE--AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY  611 (740)
Q Consensus       534 g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  611 (740)
                      |+|.+++.....  ....++.....++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            999999876432  22356788899999999999999998   9999999999999999999999999998754332211


Q ss_pred             --ccccccCCCccccccccc-------cccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcc-cCC
Q 004642          612 --RTLRAGTYGYIAPELAYT-------IVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ-RLS  680 (740)
Q Consensus       612 --~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~  680 (740)
                        .....++..|+|||+...       ..++.++|||||||++|||++ |..||......       ......+.. ...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~~  229 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQDIK  229 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhccCcc
Confidence              122345678999998643       356789999999999999999 77887643211       011111111 000


Q ss_pred             CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       681 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      .+.+.........+.+++..|| .||++||+++||++.|.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0000000111223667888898 59999999999998863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.7e-35  Score=307.37  Aligned_cols=257  Identities=26%  Similarity=0.358  Sum_probs=201.9

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .+.|.+.+.||+|+||.||+|... +|+.||+|++...........+++.+|+++++.++|||++++++++..++..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            456888999999999999999654 6899999998755444444456788999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++ ++.+.+.....  .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~g-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCLG-SASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhCC-CHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            999974 66666653322  589999999999999999999998   999999999999999999999999999976542


Q ss_pred             CCCcccccccCCCcccccccc---ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcch
Q 004642          608 DSSYRTLRAGTYGYIAPELAY---TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN  684 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  684 (740)
                      .    ....++..|+|||++.   ...++.++||||||+++|||++|+.||......       ...........+....
T Consensus       168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~  236 (307)
T cd06607         168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNDSPTLSS  236 (307)
T ss_pred             C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-------HHHHHHhcCCCCCCCc
Confidence            2    2346788999999874   456788999999999999999999997643211       0011111111111111


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCC
Q 004642          685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP  725 (740)
Q Consensus       685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  725 (740)
                      .   .....+.+++.+||+.+|++||++.+++++.......
T Consensus       237 ~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         237 N---DWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             h---hhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            1   1122378999999999999999999999987665443

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-35  Score=302.74  Aligned_cols=255  Identities=27%  Similarity=0.440  Sum_probs=202.0

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCc----EEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (740)
                      ..+|++.+.||+|+||.||+|..+ +|+    .+|+|.......  ......+.+|++++++++|||++++++++.. ..
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            357888999999999999999654 333    589998876543  2334678899999999999999999999987 78


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccce
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      .++||||+++|+|.+++.....  .+++..+..++.||+.|++|||+.   +++|+||||+||+++.++.+||+|||.++
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence            8999999999999999976543  488999999999999999999998   99999999999999999999999999998


Q ss_pred             ecccCCCccc--ccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCC
Q 004642          604 LLHVDSSYRT--LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLS  680 (740)
Q Consensus       604 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  680 (740)
                      ..........  ...++..|+|||......++.++|+||||+++||+++ |+.||.....        ......+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~  229 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEKGER  229 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhCCCC
Confidence            7653322211  1123568999999988889999999999999999998 9999864321        111222222111


Q ss_pred             CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       681 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .+.+..   ....+.+++.+||..+|.+||++.++++.|...
T Consensus       230 ~~~~~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         230 LPQPPI---CTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             CCCCCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111111   112377899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.4e-35  Score=309.16  Aligned_cols=193  Identities=26%  Similarity=0.415  Sum_probs=158.1

Q ss_pred             eeeecccceEEEEEEeC---CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee--cCeEEEEEEe
Q 004642          456 YCIGTGGYGSVYKAELP---EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH--KKCMFLIYEY  530 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~  530 (740)
                      .+||+|+||.||+|...   +++.||+|.+......     ..+.+|++++++++||||+++++++..  +...++||||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            57999999999999754   4578999998754322     457789999999999999999998854  5678999999


Q ss_pred             ccCCCchhhhcCC------CccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE----cCCCcEEEeecc
Q 004642          531 MERGSLFCVLHDD------DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL----DSNLEASVADFG  600 (740)
Q Consensus       531 ~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~DfG  600 (740)
                      +++ +|.+++...      .....+++..+..++.||+.||+|||+.   +|+||||||+||++    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            875 676666421      1223588999999999999999999998   99999999999999    566789999999


Q ss_pred             cceecccCCC---cccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCc
Q 004642          601 TARLLHVDSS---YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGL  657 (740)
Q Consensus       601 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~  657 (740)
                      +++.......   ......||+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            9987643221   12334689999999998764 578899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.5e-35  Score=300.45  Aligned_cols=253  Identities=30%  Similarity=0.445  Sum_probs=201.9

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|+||.||+|.. .+++.|++|.+...... ....+.+..|++++++++|+||+++++++...+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            578889999999999999965 47899999998765443 3456889999999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.+++....   .+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.+||+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          80 YCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             cCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999999987643   478899999999999999999998   99999999999999999999999999998765433


Q ss_pred             Cccc----ccccCCCccccccccccc---cCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCc
Q 004642          610 SYRT----LRAGTYGYIAPELAYTIV---VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       610 ~~~~----~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  682 (740)
                      ....    ...++..|+|||++.+..   ++.++||||||+++||+++|+.||.....      .......... ...+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~------~~~~~~~~~~-~~~~~  226 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN------EFQIMFHVGA-GHKPP  226 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc------hHHHHHHHhc-CCCCC
Confidence            2211    245788999999998766   78899999999999999999999864321      0011111111 11111


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      .+. .......+.+++.+||+.+|++||++.|++++
T Consensus       227 ~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         227 IPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            111 11112337789999999999999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.2e-35  Score=299.97  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=200.9

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCccc--chHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETE--DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      +|+..+.||+|+||.||+|... +++.|++|.+......  .++..+.+.+|++++++++|+||+++++++..+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999665 7899999988654321  233457889999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      +||+++++|.+++....   .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999987643   578999999999999999999998   999999999999999999999999999877543


Q ss_pred             CCCcccccccCCCccccccccccc-cCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      .. ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.....       .............+.....
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~  226 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPPIPDH  226 (258)
T ss_pred             cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccCCCcCCC
Confidence            32 223456889999999987766 88899999999999999999999864321       0111111110111111111


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                         ....+.+++.+||+.+|++||++.+++++
T Consensus       227 ---~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         227 ---LSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ---cCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence               12237789999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.9e-35  Score=301.38  Aligned_cols=254  Identities=25%  Similarity=0.395  Sum_probs=199.5

Q ss_pred             cccccceeeecccceEEEEEEeCC----CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPE----GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (740)
                      ++|.+.+.||+|+||.||+|...+    ...||+|........  ...+.+.+|++++++++||||+++++++.. +..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP--SVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            468888999999999999996543    246899988755432  334688999999999999999999998875 4578


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      +||||+++|+|.+++.....  .+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||+++..
T Consensus        83 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence            99999999999999976432  579999999999999999999998   9999999999999999999999999999876


Q ss_pred             ccCCCcc-cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcc
Q 004642          606 HVDSSYR-TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV  683 (740)
Q Consensus       606 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  683 (740)
                      ....... ....++..|+|||.+....++.++||||||+++||+++ |..||......       ..... +........
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~-~~~~~~~~~  229 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-------DVIGR-IENGERLPM  229 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHH-HHcCCcCCC
Confidence            4332211 22234568999999988889999999999999999996 99998643211       11111 111111111


Q ss_pred             hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ..   .....+.+++.+|+..+|++||++.++++.|...
T Consensus       230 ~~---~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         230 PP---NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             CC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11   1122488999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.5e-35  Score=300.54  Aligned_cols=240  Identities=23%  Similarity=0.322  Sum_probs=186.4

Q ss_pred             eeeecccceEEEEEEeCC-------------CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC
Q 004642          456 YCIGTGGYGSVYKAELPE-------------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK  522 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (740)
                      +.||+|+||.||+|.+..             ...|++|.+.....   .....+.+|+.++..++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR---DISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh---hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            358999999999996532             23588888765332   23467888999999999999999999999999


Q ss_pred             eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc-------EE
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLE-------AS  595 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~-------~k  595 (740)
                      ..++||||+++|+|..+++....  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.       ++
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence            99999999999999888865432  578999999999999999999998   9999999999999987664       89


Q ss_pred             EeecccceecccCCCcccccccCCCcccccccc-ccccCCcchhHhHHHHHHHHH-hCCCCCCcccccccCCCCCchhhh
Q 004642          596 VADFGTARLLHVDSSYRTLRAGTYGYIAPELAY-TIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLID  673 (740)
Q Consensus       596 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~  673 (740)
                      ++|||.+......    ....++..|+|||++. +..++.++|||||||++|||+ +|+.|+......        ....
T Consensus       153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~  220 (262)
T cd05077         153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--------EKER  220 (262)
T ss_pred             eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--------HHHH
Confidence            9999998654322    2235788999999886 466888999999999999998 588886532110        0111


Q ss_pred             hhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          674 VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       674 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ..........     .....+.+++.+||+.||++||++.+++++++
T Consensus       221 ~~~~~~~~~~-----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         221 FYEGQCMLVT-----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHhcCccCCC-----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1111111100     11123789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.1e-35  Score=302.80  Aligned_cols=238  Identities=24%  Similarity=0.352  Sum_probs=185.1

Q ss_pred             eeecccceEEEEEEeCC-------------------------CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCcc
Q 004642          457 CIGTGGYGSVYKAELPE-------------------------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI  511 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  511 (740)
                      .||+|+||.||+|.+..                         ...|++|++.....   .....+.+|++++++++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence            58999999999986421                         13588888865322   234678889999999999999


Q ss_pred             ceeeeeeeecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC
Q 004642          512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN  591 (740)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~  591 (740)
                      +++++++.++...++||||+++|+|..++.....  .+++..+..++.||+.||+|||++   +|+||||||+||+++..
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            9999999999999999999999999988865432  578899999999999999999998   99999999999999865


Q ss_pred             C-------cEEEeecccceecccCCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHH-hCCCCCCcccccc
Q 004642          592 L-------EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLS  662 (740)
Q Consensus       592 ~-------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell-tg~~p~~~~~~~~  662 (740)
                      +       .+|++|||.+......    ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.....  
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--  227 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP--  227 (274)
T ss_pred             CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh--
Confidence            4       3799999988643221    22357888999998865 56788999999999999995 68888764321  


Q ss_pred             cCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          663 SSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       663 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                            .............+..  .   ...+.+++.+||+.+|++||++.+++++|
T Consensus       228 ------~~~~~~~~~~~~~~~~--~---~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         228 ------SEKERFYEKKHRLPEP--S---CKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             ------HHHHHHHHhccCCCCC--C---ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence                  0111122222111111  1   12378899999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.1e-35  Score=307.59  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=198.9

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCc----EEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  523 (740)
                      .++|+..+.||+|+||.||+|.+. +|+    .||+|.+......  ....++.+|+.++++++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP--KANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            357788899999999999999653 444    4788888654332  2235788999999999999999999998764 4


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccce
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      .++++||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence            6799999999999999875432  478899999999999999999998   99999999999999999999999999998


Q ss_pred             ecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCC
Q 004642          604 LLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLS  680 (740)
Q Consensus       604 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  680 (740)
                      ........  .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....        ....+.+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~  229 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------REIPDLLEKGER  229 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHCCCC
Confidence            76432221  122345678999999998889999999999999999997 8899764221        111122222111


Q ss_pred             CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       681 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .+...   .....+.+++.+||..+|++||+++++++.+...
T Consensus       230 ~~~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         230 LPQPP---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             CCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111   1112378899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-35  Score=315.33  Aligned_cols=191  Identities=25%  Similarity=0.341  Sum_probs=163.3

Q ss_pred             HhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      ...+|.+.+.||+|+||.||+|... +++.||+|+....         ....|+.++++++||||+++++++..++..++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            3457999999999999999999654 5678999975432         23468999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      |+||+. ++|.+++....  ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       135 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            999996 58888776533  2589999999999999999999998   99999999999999999999999999997543


Q ss_pred             cCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCC
Q 004642          607 VDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP  654 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p  654 (740)
                      ... ......||..|+|||++.+..++.++|||||||++|||+++..|
T Consensus       209 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~  255 (357)
T PHA03209        209 VAP-AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST  255 (357)
T ss_pred             cCc-ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence            222 22334689999999999998999999999999999999986554

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.9e-35  Score=304.68  Aligned_cols=258  Identities=26%  Similarity=0.358  Sum_probs=204.8

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||++... +++.+|+|.+......  ...+++.+|++++++++||||+++++++..++..++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            36778889999999999999665 6899999998765432  33567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH-DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      ||+++++|.+++....  ..+++..+..++.|++.|++|||+ .   +++|+||||+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            9999999999987653  367889999999999999999998 7   999999999999999999999999999876532


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      ...  ....++..|+|||+..+..++.++||||+|+++|+|++|+.||......  ................ +..... 
T Consensus       154 ~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~-  227 (265)
T cd06605         154 SLA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEPP-PRLPSG-  227 (265)
T ss_pred             HHh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCCC-CCCChh-
Confidence            211  1257889999999999989999999999999999999999998643210  0001111112222211 111111 


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                       .....+.++|.+||..+|++||++.|++++-..
T Consensus       228 -~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  260 (265)
T cd06605         228 -KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI  260 (265)
T ss_pred             -hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence             022337899999999999999999999987544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-35  Score=305.96  Aligned_cols=262  Identities=23%  Similarity=0.322  Sum_probs=196.5

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|++|.||+|..+ +++.||+|.+........  ...+.+|++++++++|+||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC--chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            367899999999999999999654 689999999875432211  24567899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++ +|.+++.....  .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             EecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            999985 89888875443  578999999999999999999998   999999999999999999999999999876433


Q ss_pred             CCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc---------CCCCCchhhhh---
Q 004642          608 DSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS---------SSGPKIMLIDV---  674 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~---------~~~~~~~~~~~---  674 (740)
                      .........++..|+|||++.+ ..++.++||||+|+++|||++|+.||........         ...........   
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence            2222223356889999999875 4578899999999999999999999864321000         00000000000   


Q ss_pred             ---hccc---CC-Ccchhh--hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          675 ---LNQR---LS-PPVNQK--IVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       675 ---~~~~---l~-~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                         ....   .. ......  .......+.+++.+|++.+|++||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence               0000   00 000000  00011346789999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=316.10  Aligned_cols=263  Identities=24%  Similarity=0.364  Sum_probs=207.8

Q ss_pred             cccccceeeecccceEEEEEEeCCCcE-EEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      +.|.|+..||.|+||.||++..++... .|.|++...   .++....|.-|++++..++||+||++++.|+..+.++++.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            456667779999999999997665444 455666433   2344688999999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      |||.||..+..+-..+.  .++..++.-+++|++.||.|||++   .|||||||..|||++.+|.++|+|||.+......
T Consensus       109 EFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             eecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH
Confidence            99999999887765543  689999999999999999999999   9999999999999999999999999988654433


Q ss_pred             CCcccccccCCCcccccccc-----ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC-c
Q 004642          609 SSYRTLRAGTYGYIAPELAY-----TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP-P  682 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~-~  682 (740)
                      ......++||++|||||+.+     ..+|+.++||||||++|.||..+.+|-.....       -..+..+....++. .
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVllKiaKSePPTLl  256 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLL  256 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHHHHhhcCCCccc
Confidence            34456679999999999865     56799999999999999999999999443221       11222222222211 1


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCChhhh
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKAL  730 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~  730 (740)
                      .+.+|..   .+.+|+.+|+..+|+.||+++++++|-+....+..+..
T Consensus       257 qPS~Ws~---~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~i  301 (1187)
T KOG0579|consen  257 QPSHWSR---SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMI  301 (1187)
T ss_pred             Ccchhhh---HHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHH
Confidence            1233333   48999999999999999999999999877655444433

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.8e-35  Score=304.50  Aligned_cols=263  Identities=23%  Similarity=0.258  Sum_probs=196.2

Q ss_pred             HhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      ++++|.+.+.||+|+||.||+|.. .+|+.||+|++.......  ....+.+|+++++.++|+||+++++++..++..++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            457899999999999999999954 468999999987544322  12456789999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      ||||+. +++.+++....  ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||+++...
T Consensus        81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             EEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            999996 57766664432  2467888999999999999999998   99999999999999999999999999997654


Q ss_pred             cCCCcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc---------CCCCCc-------
Q 004642          607 VDSSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS---------SSGPKI-------  669 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~---------~~~~~~-------  669 (740)
                      ..........++..|+|||++.+. .++.++|||||||++|||++|+.||+.......         ......       
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            333333344678999999998754 478899999999999999999999874321000         000000       


Q ss_pred             ---hhhhhhcccCCCcchh--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          670 ---MLIDVLNQRLSPPVNQ--KIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       670 ---~~~~~~~~~l~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                         ................  ........+.+++.+|+..||++|||+.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence               0000000000000000  000112347789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.1e-35  Score=307.68  Aligned_cols=262  Identities=21%  Similarity=0.318  Sum_probs=195.3

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|+||.||+|... +|+.||+|++...... ......+.+|++++++++||||+++++++.+.+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            4788899999999999999654 6899999998754322 1223567789999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++ +|.+++.....  .+++..+..++.||++||+|||+.   +++||||||+||+++.++.++|+|||+++......
T Consensus        80 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          80 YCDQ-DLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             cCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            9975 77777654332  589999999999999999999998   99999999999999999999999999998664433


Q ss_pred             CcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccccC--------CCCCch----hhhhhc
Q 004642          610 SYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS--------SGPKIM----LIDVLN  676 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~----~~~~~~  676 (740)
                      .......++..|+|||++.+. .++.++|||||||++|||+||..|+.........        ......    .....+
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            333344678999999998764 4688999999999999999999985321110000        000000    000000


Q ss_pred             ccCCCcch------hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          677 QRLSPPVN------QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       677 ~~l~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ....+...      .........+.+++.+||+.||++|||++|++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            00000000      00001123477899999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.5e-35  Score=309.63  Aligned_cols=254  Identities=26%  Similarity=0.376  Sum_probs=200.6

Q ss_pred             cccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEe
Q 004642          452 FHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      |.....||+|+||.||++.. .+++.||+|++.....   ...+.+.+|+.+++.++|+|++++++.+..++..++||||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            33346699999999999965 4688999999865332   2346788999999999999999999999999999999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                      +++++|.+++...    .+++.++..++.||+.||+|||++   +++||||||+||+++.++.++|+|||++........
T Consensus       101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            9999999988543    478899999999999999999998   999999999999999999999999999876543333


Q ss_pred             cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHH
Q 004642          611 YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQD  690 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  690 (740)
                      ......|+..|+|||...+..++.++||||||+++|||++|+.||......       ... ..+.......... ....
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~-~~~~~~~~~~~~~-~~~~  244 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------QAM-RRIRDNLPPRVKD-SHKV  244 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHH-HHHHhcCCCcccc-cccc
Confidence            333456899999999998888999999999999999999999998643211       011 1111111111100 0011


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          691 IILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       691 ~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      ...+.+++.+|+..||++||+++|++++-.....
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence            2237789999999999999999999998655543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-35  Score=304.10  Aligned_cols=255  Identities=27%  Similarity=0.408  Sum_probs=200.1

Q ss_pred             HhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecC---
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKK---  522 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---  522 (740)
                      ++++|++.+.||+|+||.||+|..+ +++.+++|++.....    ..+.+.+|+++++++ +|+||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            5688999999999999999999764 678999999875443    236788999999999 7999999999997644   


Q ss_pred             ---eEEEEEEeccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEee
Q 004642          523 ---CMFLIYEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVAD  598 (740)
Q Consensus       523 ---~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  598 (740)
                         ..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence               4899999999999999886532 223688999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCcccccccCCCccccccccc-----cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhh
Q 004642          599 FGTARLLHVDSSYRTLRAGTYGYIAPELAYT-----IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLID  673 (740)
Q Consensus       599 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  673 (740)
                      ||.+..............|+..|+|||++..     ..++.++|||||||++|+|++|+.||.....       ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~  229 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-------MRALFK  229 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-------HHHHHH
Confidence            9999876433333344568999999998753     3467789999999999999999999864221       111111


Q ss_pred             hhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          674 VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       674 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ...... +.... .......+.+++.+||+.||++|||+.|++++
T Consensus       230 ~~~~~~-~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         230 IPRNPP-PTLKS-PENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             hhccCC-CCCCc-hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            111111 11000 11112347899999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.5e-35  Score=306.68  Aligned_cols=256  Identities=22%  Similarity=0.287  Sum_probs=198.7

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||++... .++.||+|.+...........+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999654 57899999987654433344567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++++|.+++....   .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999996543   578999999999999999999998   9999999999999999999999999998642111


Q ss_pred             CC---------------cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhh
Q 004642          609 SS---------------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLID  673 (740)
Q Consensus       609 ~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  673 (740)
                      ..               ......|+..|+|||++.+..++.++|+|||||++|||++|..||....       .......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-------~~~~~~~  227 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-------PEELFGQ  227 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHH
Confidence            00               0112357889999999988889999999999999999999999985321       1111222


Q ss_pred             hhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          674 VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       674 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ........+...  ......+.+++.+||+.+|++||++.++.+.+.
T Consensus       228 ~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         228 VISDDIEWPEGD--EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHhcccCCCCcc--ccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            222111111110  011223789999999999999998544444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.1e-35  Score=302.20  Aligned_cols=249  Identities=30%  Similarity=0.450  Sum_probs=194.7

Q ss_pred             eeeecccceEEEEEEeCC-------CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          456 YCIGTGGYGSVYKAELPE-------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      +.||+|+||.||+|...+       ++.+|+|.+......  .....+.+|+++++.++||||+++++++...+..++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            358999999999996542       357999988654322  22467889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCC----ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-----cEEEeec
Q 004642          529 EYMERGSLFCVLHDDD----EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-----EASVADF  599 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-----~~kl~Df  599 (740)
                      ||+++++|.+++....    ....+++.++..++.|++.|++|||+.   +++|+||||+||+++.++     .++++||
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence            9999999999987532    123478999999999999999999998   999999999999999887     8999999


Q ss_pred             ccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhc
Q 004642          600 GTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLN  676 (740)
Q Consensus       600 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  676 (740)
                      |+++........  .....++..|+|||++.+..++.++|||||||++|||++ |+.||......        .....+.
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~  227 (269)
T cd05044         156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------EVLQHVT  227 (269)
T ss_pred             ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------HHHHHHh
Confidence            999765322211  122345678999999999899999999999999999998 99998643211        1111111


Q ss_pred             ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          677 QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       677 ~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ............   ..+.+++.+||..+|++||++.++.+.|.
T Consensus       228 ~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         228 AGGRLQKPENCP---DKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cCCccCCcccch---HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            111111111112   23789999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-34  Score=297.27  Aligned_cols=251  Identities=29%  Similarity=0.501  Sum_probs=199.9

Q ss_pred             cccceeeecccceEEEEEEeCC-----CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          452 FHIKYCIGTGGYGSVYKAELPE-----GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      +++.+.||.|+||.||++...+     +..||+|++.......  ..+.+..|++++.+++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            4567889999999999996653     4889999997654321  35788999999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      +|||+++++|.+++...... .+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.+....
T Consensus        79 i~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence            99999999999998764421 289999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCCccc-ccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcch
Q 004642          607 VDSSYRT-LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN  684 (740)
Q Consensus       607 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  684 (740)
                      ....... ...++..|+|||.+.+..++.++||||+|+++|+|++ |+.||.....        ....+.+.........
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~  226 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRLPKP  226 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCCC
Confidence            4322221 2236789999999988889999999999999999998 7888764211        1111111111111111


Q ss_pred             hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ..   ....+.+++.+|+..+|++|||+.|+++.|
T Consensus       227 ~~---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      227 EN---CPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             Cc---CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            11   222388899999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.8e-35  Score=307.44  Aligned_cols=254  Identities=25%  Similarity=0.360  Sum_probs=200.9

Q ss_pred             cceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEecc
Q 004642          454 IKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYME  532 (740)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (740)
                      ....||+|+||.||++.. .+++.||+|.+......   ..+.+.+|+.++..++|||++++++++..++..++++||++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            345699999999999965 46899999998654322   23567889999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcc
Q 004642          533 RGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR  612 (740)
Q Consensus       533 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  612 (740)
                      +++|..++...    .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.....+....
T Consensus       102 ~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~  174 (297)
T cd06659         102 GGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR  174 (297)
T ss_pred             CCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence            99998877542    478999999999999999999998   99999999999999999999999999987654333333


Q ss_pred             cccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHH
Q 004642          613 TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDII  692 (740)
Q Consensus       613 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  692 (740)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||......       . ....+....... .........
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~-~~~~~~~~~~~~-~~~~~~~~~  245 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------Q-AMKRLRDSPPPK-LKNAHKISP  245 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHhccCCCC-ccccCCCCH
Confidence            4457899999999999888999999999999999999999998642211       0 011111111100 000011122


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCC
Q 004642          693 LVSTIAFACLSSQPKSRPTMQRISQELLAGKTPM  726 (740)
Q Consensus       693 ~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  726 (740)
                      .+.+++.+||+.+|++||+++|++++-...+...
T Consensus       246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         246 VLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            3788999999999999999999999876665533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.9e-35  Score=303.02  Aligned_cols=263  Identities=27%  Similarity=0.322  Sum_probs=202.4

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee--cCeEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH--KKCMFL  526 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  526 (740)
                      ++|...+.||.|++|.||++.. .+++.+|+|.+......  ....++.+|++++++++||||+++++++.+  ++..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            3688889999999999999966 46889999998754332  335778899999999999999999998865  447899


Q ss_pred             EEEeccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          527 IYEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      ||||+++++|.+++.... ....+++..+..++.||+.||+|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            999999999988775322 233578899999999999999999998   9999999999999999999999999998765


Q ss_pred             ccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchh
Q 004642          606 HVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  685 (740)
                      ....  .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||+.....  ................. ....
T Consensus       156 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~  230 (287)
T cd06621         156 VNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIVNMPNP-ELKD  230 (287)
T ss_pred             cccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHhcCCch-hhcc
Confidence            3221  12345788999999999888999999999999999999999998754220  00111111111111110 0000


Q ss_pred             hh---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          686 KI---VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       686 ~~---~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ..   ......+.+++.+||+.+|++|||+.|++++-...
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~  270 (287)
T cd06621         231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK  270 (287)
T ss_pred             CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence            00   01123478999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-35  Score=301.59  Aligned_cols=254  Identities=30%  Similarity=0.468  Sum_probs=202.2

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC---CCccceeeeeeeecCeEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR---HRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  526 (740)
                      .|++.+.||+|+||.||+|.. .+++.||+|.+......  ...+++.+|++++++++   |||++++++++..+...++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            467788899999999999965 57899999998754332  22467888999999986   9999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      ||||+++++|.+++...    .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            99999999999988653    588999999999999999999998   99999999999999999999999999998775


Q ss_pred             cCCCcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchh
Q 004642          607 VDSSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  685 (740)
                      ..........|+..|+|||.+.+. .++.++|||||||++|+|++|+.||........       . ........+....
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~-~~~~~~~~~~~~~  224 (277)
T cd06917         153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------M-MLIPKSKPPRLED  224 (277)
T ss_pred             CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------h-hccccCCCCCCCc
Confidence            544333445789999999988754 468899999999999999999999875322110       0 0000111111110


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      .  .....+.+++.+||+.||++||++.|++++-....
T Consensus       225 ~--~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~  260 (277)
T cd06917         225 N--GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA  260 (277)
T ss_pred             c--cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence            0  01233789999999999999999999998765543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.8e-35  Score=304.93  Aligned_cols=262  Identities=22%  Similarity=0.292  Sum_probs=196.8

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|++|.||+|... +|+.||+|++....... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            4788899999999999999654 68999999987544322 223578899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+. ++|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          80 FLH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             ccc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            996 588888865432 3689999999999999999999998   99999999999999999999999999987654333


Q ss_pred             CcccccccCCCccccccccccc-cCCcchhHhHHHHHHHHHhCCCCCCccccccc-------CCCCCchh----hh----
Q 004642          610 SYRTLRAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-------SSGPKIML----ID----  673 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~----~~----  673 (740)
                      .......++..|+|||++.+.. ++.++||||||+++|||+||+.||........       ........    ..    
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            3333345788999999887644 57889999999999999999999864321100       00000000    00    


Q ss_pred             --hhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          674 --VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       674 --~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                        ...+................+.+++.+|++.||++||+++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence              000000000000000111236789999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8e-35  Score=304.49  Aligned_cols=254  Identities=25%  Similarity=0.356  Sum_probs=204.1

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|.+.+.||+|+||.||++.. .+++.||+|.+......   ..+.+.+|+.++++++|||++++++++...+..++|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            36889999999999999999954 46889999998643322   236788899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      +||+++++|.+++.+.    .+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            9999999999988653    468899999999999999999998   999999999999999999999999999876654


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhh-cccCCCcchhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVL-NQRLSPPVNQK  686 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~  686 (740)
                      .........|++.|+|||.+.+..++.++|||||||++|++++|+.||........       ..... .........  
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~~~~~--  238 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIATNGTPELQNP--  238 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-------eeehhcCCCCCCCCc--
Confidence            43333445688999999999888889999999999999999999999875322110       00000 000000001  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                       ......+.+++.+||..+|++||++.+++++-...
T Consensus       239 -~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~  273 (293)
T cd06647         239 -EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (293)
T ss_pred             -cccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence             11122378899999999999999999999995443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2e-34  Score=305.03  Aligned_cols=254  Identities=26%  Similarity=0.361  Sum_probs=200.8

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      .|...+.||+|+||.||++.. .+|..||+|++...........+.+.+|++++++++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            466788899999999999965 4688999999876544444445678899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++ ++.+.+....  ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++.....  
T Consensus       106 ~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9975 7777665432  2589999999999999999999998   999999999999999999999999999875432  


Q ss_pred             CcccccccCCCcccccccc---ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          610 SYRTLRAGTYGYIAPELAY---TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                        .....|+..|+|||++.   ...++.++|||||||++|||++|+.||.....       ......+........... 
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~-  247 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPTLQSN-  247 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhccCCCCCCc-
Confidence              22346888999999974   45688899999999999999999999754211       111122222222111111 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                        .....+.+++.+||+.+|++||++.++++++.....
T Consensus       248 --~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         248 --EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             --cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence              112237899999999999999999999998876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.8e-35  Score=300.62  Aligned_cols=256  Identities=26%  Similarity=0.427  Sum_probs=198.3

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCccc-------chHHHHHHHHHHHHHhccCCCccceeeeeeeecC
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETE-------DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK  522 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (740)
                      +|.+.+.||+|+||.||+|.. .+|+.||+|.+......       .....+.+.+|++++++++|||++++++++..++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999954 46899999988643211       1123457888999999999999999999999999


Q ss_pred             eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccc
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                      ..++||||+++++|.+++....   .+++..+..++.||+.||.|||+.   +++||||+|+||+++.++.++++|||.+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999999987653   588899999999999999999998   9999999999999999999999999999


Q ss_pred             eecccCCC--cccccccCCCccccccccccc--cCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhccc
Q 004642          603 RLLHVDSS--YRTLRAGTYGYIAPELAYTIV--VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQR  678 (740)
Q Consensus       603 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  678 (740)
                      +.......  ......|+..|+|||.+....  ++.++||||+|+++||+++|..||......       ....+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-------AAMFKLGNKR  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------HHHHHhhccc
Confidence            76532211  122345788999999987654  788999999999999999999998532211       0111111111


Q ss_pred             CCCcchhhh-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          679 LSPPVNQKI-VQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       679 l~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ......... ......+.+++.+||+.+|++||++.|++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (272)
T cd06629         229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP  270 (272)
T ss_pred             cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence            111110000 11123478899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-34  Score=297.99  Aligned_cols=238  Identities=27%  Similarity=0.423  Sum_probs=187.5

Q ss_pred             eeeecccceEEEEEEeCCCc-----------EEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeE
Q 004642          456 YCIGTGGYGSVYKAELPEGK-----------VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCM  524 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  524 (740)
                      +.||+|+||.||+|...+..           .+++|.+......    ...+.+|+.++++++||||+++++++.. +..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            35899999999999765433           4777776544322    4678899999999999999999999988 778


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-------cEEEe
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-------EASVA  597 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-------~~kl~  597 (740)
                      ++||||+++|+|.+++.....  .+++..+..++.||+.||+|||++   +|+||||||+||+++.++       .+||+
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence            999999999999999876543  578999999999999999999998   999999999999999888       79999


Q ss_pred             ecccceecccCCCcccccccCCCcccccccccc--ccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhh
Q 004642          598 DFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI--VVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDV  674 (740)
Q Consensus       598 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  674 (740)
                      |||++.....    .....++..|+|||++.+.  .++.++|||||||++|||++ |..||.....       .......
T Consensus       151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-------~~~~~~~  219 (259)
T cd05037         151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-------SEKERFY  219 (259)
T ss_pred             CCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-------hhHHHHH
Confidence            9999986543    2233567789999998876  78899999999999999999 5677654321       0000011


Q ss_pred             hcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          675 LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       675 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ......+ ..     ....+.+++.+||..+|++||++.|+++.|.
T Consensus       220 ~~~~~~~-~~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 QDQHRLP-MP-----DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             hcCCCCC-CC-----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1111111 10     0134889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-34  Score=302.26  Aligned_cols=258  Identities=29%  Similarity=0.417  Sum_probs=207.8

Q ss_pred             HhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      .++.|++.+.||+|++|.||+|... +++.|++|++.....    ..+.+.+|++++++++|+|++++++++...+..++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            4567888899999999999999765 688999999976443    24678899999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      ++||+++++|.+++....  ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            999999999999998654  3689999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          607 VDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      ..........++..|+|||++.+..++.++|||||||++|+|++|+.||......       .....+........... 
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~-  239 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RALFLITTKGIPPLKNP-  239 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCCCcch-
Confidence            3322223345788999999998888999999999999999999999997643211       11111111111111100 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                       ......+.+++.+|++.+|.+||++.+++++....+
T Consensus       240 -~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         240 -EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             -hhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence             001123789999999999999999999998776554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9e-35  Score=299.11  Aligned_cols=250  Identities=26%  Similarity=0.373  Sum_probs=201.8

Q ss_pred             eecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCc
Q 004642          458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL  536 (740)
Q Consensus       458 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  536 (740)
                      ||.|+||.||++... +++.||+|++...........+.+.+|++++++++||||+++++++.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999664 4899999999765554444567899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccccc
Q 004642          537 FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA  616 (740)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  616 (740)
                      .+++.+..   .+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~  153 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC  153 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence            99997643   478899999999999999999998   99999999999999999999999999998765332 223346


Q ss_pred             cCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHH
Q 004642          617 GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVST  696 (740)
Q Consensus       617 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  696 (740)
                      |+..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....     ..................+...   ...+.+
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  225 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGKLEFPNYI---DKAAKD  225 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCCCCCCccc---CHHHHH
Confidence            88999999999888899999999999999999999999865321     1111122222111111111111   234889


Q ss_pred             HHHHcccCCCCCCCC-----HHHHHHHHHcC
Q 004642          697 IAFACLSSQPKSRPT-----MQRISQELLAG  722 (740)
Q Consensus       697 li~~cl~~dP~~RPs-----~~ev~~~L~~~  722 (740)
                      ++.+||+.+|++||+     ++|++++-...
T Consensus       226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  256 (262)
T cd05572         226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWFN  256 (262)
T ss_pred             HHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence            999999999999999     88888866543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.9e-35  Score=301.04  Aligned_cols=251  Identities=25%  Similarity=0.333  Sum_probs=203.4

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999665 589999999986554443456789999999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.+++...   ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999998764   2688999999999999999999998   99999999999999999999999999997664332


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                       ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||......     ........... .....+...  
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~--  225 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET-ADVLYPATW--  225 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc-ccccCcccC--
Confidence             223456888999999998888999999999999999999999998753320     01111111111 111111111  


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCH--HHHHH
Q 004642          690 DIILVSTIAFACLSSQPKSRPTM--QRISQ  717 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~--~ev~~  717 (740)
                       ...+.+++.+||+.||++||++  +|+++
T Consensus       226 -~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         226 -STEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -cHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence             1347899999999999999999  77654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.3e-34  Score=301.78  Aligned_cols=259  Identities=24%  Similarity=0.348  Sum_probs=204.0

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      .|...+.||+|++|.||++.. .+++.+++|++.....   ...+.+.+|+.+++.++|||++++++++..++..++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            344457899999999999964 4788999998864332   223568899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.+++...    .+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        97 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          97 FLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             ccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            99999999988762    578899999999999999999998   99999999999999999999999999887654333


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                      .......|+..|+|||...+..++.++|||||||++|||++|+.||.....       .... ..+.....+... ....
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~-~~~~~~~~~~~~-~~~~  240 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAM-KRIRDNLPPKLK-NLHK  240 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHH-HHHHhcCCCCCc-cccc
Confidence            333345689999999999888899999999999999999999999754221       1111 111111111110 0111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCChh
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQK  728 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~  728 (740)
                      ....+.+++.+||+.+|++||++.+++++-...+...++
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence            123488999999999999999999999876665444333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1e-34  Score=302.37  Aligned_cols=260  Identities=25%  Similarity=0.375  Sum_probs=196.0

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHH-HhccCCCccceeeeeeeecCeEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHV-LSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ++|++.+.||+|+||.||++... +|+.||+|++........  ..++..|... ++..+|||++++++++..++..+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            46889999999999999999654 699999999876543322  2345556554 5667899999999999999999999


Q ss_pred             EEeccCCCchhhhcCC-CccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          528 YEYMERGSLFCVLHDD-DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      |||++ |+|.+++... .....+++..+..++.||+.||+|||++  .+++||||||+||+++.++.+||+|||.++...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99997 5787776542 2234689999999999999999999974  289999999999999999999999999998654


Q ss_pred             cCCCcccccccCCCccccccccc----cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCc
Q 004642          607 VDSSYRTLRAGTYGYIAPELAYT----IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  682 (740)
                      .. .......|+..|+|||.+.+    ..++.++|+||+||++|||++|+.||.....      ................
T Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~  228 (283)
T cd06617         156 DS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------PFQQLKQVVEEPSPQL  228 (283)
T ss_pred             cc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------CHHHHHHHHhcCCCCC
Confidence            22 22233468899999998865    4467899999999999999999999863211      0011112221111110


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      ......   ..+.+++.+||+.+|++||++.+++++-...+.
T Consensus       229 ~~~~~~---~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         229 PAEKFS---PEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             CccccC---HHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            001111   237899999999999999999999987655543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8e-35  Score=298.49  Aligned_cols=252  Identities=22%  Similarity=0.364  Sum_probs=201.3

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|+||.||+|... +|..+|+|.+....... ...+.+.+|+++++.++|+|++++++.+..++..++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            4778899999999999999654 58899999987643222 224677899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-cEEEeecccceecccC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGTARLLHVD  608 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfG~a~~~~~~  608 (740)
                      |+++++|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++ .++|+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          80 YCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999999876432 2578999999999999999999998   999999999999999886 4699999999876543


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      ........|++.|+|||+..+..++.++||||||+++|||++|+.||.....       ................ .   
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~-~---  224 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQGYFAPIS-P---  224 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhcccCCCCC-C---
Confidence            3333334688999999999888899999999999999999999999864221       1112222222211111 1   


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      .....+.+++.+|+..+|++||++.|++++
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         225 NFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            111237899999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.3e-35  Score=300.72  Aligned_cols=239  Identities=23%  Similarity=0.407  Sum_probs=186.4

Q ss_pred             eeecccceEEEEEEeCC--------CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          457 CIGTGGYGSVYKAELPE--------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .||+|+||.||+|....        ...||+|.+....   ....+.+.+|+.+++.++|||++++++++..++..++||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            58999999999996532        2347888775432   233467888999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc--------EEEeecc
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLE--------ASVADFG  600 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--------~kl~DfG  600 (740)
                      ||+++|+|.++++....  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.        ++++|||
T Consensus        79 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          79 EYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             ecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence            99999999999976543  578999999999999999999998   9999999999999987765        6999999


Q ss_pred             cceecccCCCcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCC-CCCCcccccccCCCCCchhhhhhccc
Q 004642          601 TARLLHVDSSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGT-HPGGLLSSLSSSSGPKIMLIDVLNQR  678 (740)
Q Consensus       601 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  678 (740)
                      .+.....    .....++..|+|||++.+. .++.++|||||||++|||++|. .|+.....        ..........
T Consensus       154 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~  221 (258)
T cd05078         154 ISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQFYEDR  221 (258)
T ss_pred             cccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHHHHHHcc
Confidence            9865432    1234678899999998864 5788999999999999999995 55443211        0111111111


Q ss_pred             CCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       679 l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ...+.     .....+.+++.+||+.+|++||+++++++.|.
T Consensus       222 ~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 HQLPA-----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ccCCC-----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11111     11123789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-34  Score=302.36  Aligned_cols=262  Identities=24%  Similarity=0.334  Sum_probs=200.0

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|+||.||+|.. .+|+.||+|++....... ...+.+.+|++++++++|||++++++++..+...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            478889999999999999965 468999999987654322 234678899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+ +++|.+++....  ..+++.++..++.||+.||+|||+.   +++|+||||+||+++.++.++|+|||.+.......
T Consensus        80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            99 999999987544  3589999999999999999999998   99999999999999999999999999998765332


Q ss_pred             C-cccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCch---------
Q 004642          610 S-YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIM---------  670 (740)
Q Consensus       610 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~---------  670 (740)
                      . ......|+..|+|||.+.+. .++.++||||+|+++|||++|+.||........        .......         
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence            1 12334689999999998654 468899999999999999999887754321000        0000000         


Q ss_pred             hhhhhcccCCC-cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          671 LIDVLNQRLSP-PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       671 ~~~~~~~~l~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ........... ............+.+++.+|++.+|++||++++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            00000000000 00000011124488999999999999999999999874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=302.48  Aligned_cols=262  Identities=28%  Similarity=0.347  Sum_probs=199.8

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|..+ +++.||+|+++..... ....+.+.+|++++++++|+||+++++++..++..+++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            36889999999999999999665 5889999998754332 233467889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||++++.+..+.....   .+++.++..++.||+.|++|||+.   +++|+||+|+||++++++.+||+|||.+......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          80 EYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             ecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9999877766554432   478999999999999999999998   9999999999999999999999999999876544


Q ss_pred             CC-cccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCchh-----hh
Q 004642          609 SS-YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIML-----ID  673 (740)
Q Consensus       609 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~-----~~  673 (740)
                      .. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||........        ........     ..
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            32 22334678899999999887 788999999999999999999999864321000        00000000     00


Q ss_pred             hhcc-cCCCcc-hh----hhH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          674 VLNQ-RLSPPV-NQ----KIV-QDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       674 ~~~~-~l~~~~-~~----~~~-~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      .... ...... ..    ... .....+.+++.+||..+|++||++++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0000 000000 00    000 012348899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.7e-35  Score=304.46  Aligned_cols=260  Identities=22%  Similarity=0.267  Sum_probs=198.0

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec--CeEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCMFL  526 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  526 (740)
                      ++|++.+.||+|+||.||+|... +++.+|+|.++..... ......+.+|++++.+++||||+++++++...  +..++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            57888999999999999999765 5889999999755433 22334667899999999999999999999877  88999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      ||||+++ +|.+++.....  .+++.++..++.||+.||+|||+.   +++|+||||+||+++.++.++|+|||.+....
T Consensus        84 v~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             EehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            9999985 88888865432  589999999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCCcccccccCCCccccccccccc-cCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCchhh-----
Q 004642          607 VDSSYRTLRAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIMLI-----  672 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~-----  672 (740)
                      ..........++..|+|||.+.+.. ++.++|+||+|+++|||++|+.||........        .........     
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            4333333446788999999987644 68899999999999999999999864321100        000000000     


Q ss_pred             ---------hhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          673 ---------DVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       673 ---------~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                               ......+.......  .....+.+++.+||+.+|++||++.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPAL--SLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             chhcccccccccchhhhcccccc--CCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                     00000000000000  012337789999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.8e-34  Score=297.29  Aligned_cols=256  Identities=26%  Similarity=0.407  Sum_probs=196.7

Q ss_pred             cccceeeecccceEEEEEEeC----CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC-----
Q 004642          452 FHIKYCIGTGGYGSVYKAELP----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK-----  522 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  522 (740)
                      |.+.+.||+|+||.||+|.+.    +++.||+|++....... ...+++.+|++++++++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            567788999999999999643    46889999997654332 23567889999999999999999999886532     


Q ss_pred             -eEEEEEEeccCCCchhhhcCC---CccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEee
Q 004642          523 -CMFLIYEYMERGSLFCVLHDD---DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVAD  598 (740)
Q Consensus       523 -~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  598 (740)
                       ..++++||+++|+|.+++...   .....+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence             347899999999998877432   1223578999999999999999999998   999999999999999999999999


Q ss_pred             cccceecccCCCc--ccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhh
Q 004642          599 FGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVL  675 (740)
Q Consensus       599 fG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  675 (740)
                      ||.++........  .....++..|++||......++.++|||||||++|||++ |+.||.....        ......+
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~~  228 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNYL  228 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHHH
Confidence            9999865432221  122345678999999988888999999999999999999 8888754221        1111111


Q ss_pred             cccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          676 NQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       676 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ..........   .....+.+++.+||+.+|++||++.|+++.|...
T Consensus       229 ~~~~~~~~~~---~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IKGNRLKQPP---DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HcCCcCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1110000001   1123488999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=317.43  Aligned_cols=251  Identities=27%  Similarity=0.458  Sum_probs=204.4

Q ss_pred             cccceeeecccceEEEEE-EeCCCc----EEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          452 FHIKYCIGTGGYGSVYKA-ELPEGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~-~~~~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      ....++||+|+||+||+| ..++|+    +||+|++.......  ..+++..|+-.|.+++|||+++++|+|.... ..|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~--~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK--ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch--hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            344678999999999999 445554    58888887654443  2478999999999999999999999998776 889


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      |++|++.|+|.++++..+.  .+-....+.+..|||+||.|||++   +++||||..+|||+..-..+||.|||+++...
T Consensus       775 vtq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            9999999999999987654  467788999999999999999999   99999999999999999999999999999887


Q ss_pred             cCCCccccccc--CCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhccc--CCC
Q 004642          607 VDSSYRTLRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQR--LSP  681 (740)
Q Consensus       607 ~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~--l~~  681 (740)
                      .+........|  .+.|||=|.+....|+.++|||||||++||++| |..|++....        ..+.+.+...  ++.
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------~eI~dlle~geRLsq  921 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------EEIPDLLEKGERLSQ  921 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------HHhhHHHhccccCCC
Confidence            76655444333  578999999999999999999999999999998 9999775432        1122222222  332


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      +.     -+..-+..++.+||..|++.||+|+++...+.+-.
T Consensus       922 Pp-----iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  922 PP-----ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             CC-----CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            22     22233778999999999999999999999986643

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-34  Score=301.55  Aligned_cols=262  Identities=21%  Similarity=0.302  Sum_probs=198.7

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|++|.||+|... +|+.||+|++.......  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            4788999999999999999764 68999999997654322  23567789999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++ +|.+++........+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+|||.+.......
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            9985 8888876654444689999999999999999999998   99999999999999999999999999997654333


Q ss_pred             CcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCchhhhhh-----
Q 004642          610 SYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIMLIDVL-----  675 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~-----  675 (740)
                      .......++..|+|||++.+. .++.++|||||||++|+|++|+.||........        ............     
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            333334678899999988654 468899999999999999999999864321100        000000000000     


Q ss_pred             cccCCCcc----hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          676 NQRLSPPV----NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       676 ~~~l~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ....+...    ..........+.+++.+|++.||++||+++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00000000    00000112347799999999999999999999865

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.8e-35  Score=329.99  Aligned_cols=255  Identities=27%  Similarity=0.421  Sum_probs=194.6

Q ss_pred             HHhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec----
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK----  521 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  521 (740)
                      ....+|+..+.||+||||.||+++.+ ||+.||||++.... .+ .....+.+|+..+++++|||||+++..+.+.    
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~-~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SD-KLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HH-HHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            45678888999999999999999765 89999999998876 32 3356788999999999999999998655321    


Q ss_pred             --------------------------------------------------------------------------------
Q 004642          522 --------------------------------------------------------------------------------  521 (740)
Q Consensus       522 --------------------------------------------------------------------------------  521 (740)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHH
Q 004642          522 -----------------------------------KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS  566 (740)
Q Consensus       522 -----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~  566 (740)
                                                         -..||-||||+...+.+++++..-..  .....++++++|+.||+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence                                               01478889998878877777654211  35678899999999999


Q ss_pred             HHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc------------------cCCCcccccccCCCcccccccc
Q 004642          567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH------------------VDSSYRTLRAGTYGYIAPELAY  628 (740)
Q Consensus       567 ~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~  628 (740)
                      |+|++   |+|||||||.||++++++.|||+|||+|+...                  .+....+..+||.-|+|||++.
T Consensus       712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            99999   99999999999999999999999999998721                  0112345568999999999988


Q ss_pred             ccc---cCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCC
Q 004642          629 TIV---VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQ  705 (740)
Q Consensus       629 ~~~---~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~d  705 (740)
                      +..   |+.|+|+||+|+|++||+   +||+..-      .+...+...-+..++.+ .....+....-.++|.++++.|
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsM------ERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hd  858 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEML---YPFGTSM------ERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHD  858 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHh---ccCCchH------HHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCC
Confidence            654   999999999999999998   4555311      11122222222333322 1223333334568999999999


Q ss_pred             CCCCCCHHHHHHH
Q 004642          706 PKSRPTMQRISQE  718 (740)
Q Consensus       706 P~~RPs~~ev~~~  718 (740)
                      |.+||||.|+++.
T Consensus       859 P~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  859 PSKRPTATELLNS  871 (1351)
T ss_pred             CccCCCHHHHhhc
Confidence            9999999998753

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-34  Score=299.06  Aligned_cols=252  Identities=21%  Similarity=0.241  Sum_probs=191.2

Q ss_pred             eeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHh---ccCCCccceeeeeeeecCeEEEEEEecc
Q 004642          457 CIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS---TVRHRNIVKLYGFCLHKKCMFLIYEYME  532 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (740)
                      .||+|+||.||++.. .+|+.||+|.+.............+.+|..+++   ..+|||++.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999965 468999999887654332222233444444333   3479999999999999999999999999


Q ss_pred             CCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcc
Q 004642          533 RGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR  612 (740)
Q Consensus       533 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  612 (740)
                      +++|.+++...+   .+++.++..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++......  ..
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~  152 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP  152 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc--Cc
Confidence            999998886543   589999999999999999999998   9999999999999999999999999998755322  22


Q ss_pred             cccccCCCcccccccc-ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHH
Q 004642          613 TLRAGTYGYIAPELAY-TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDI  691 (740)
Q Consensus       613 ~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  691 (740)
                      ....|+..|+|||... +..++.++||||+||++|||++|+.||.....     .......... .......+.   ...
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~-~~~~~~~~~---~~~  223 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMT-LTVNVELPD---SFS  223 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC-----cCHHHHHHHh-hcCCcCCcc---ccC
Confidence            2346899999999886 45678899999999999999999999864321     0001111111 111111111   112


Q ss_pred             HHHHHHHHHcccCCCCCCC-----CHHHHHHHHHcCCCC
Q 004642          692 ILVSTIAFACLSSQPKSRP-----TMQRISQELLAGKTP  725 (740)
Q Consensus       692 ~~l~~li~~cl~~dP~~RP-----s~~ev~~~L~~~~~~  725 (740)
                      ..+.+++.+|++.||++||     +++|++++......+
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            3378999999999999999     699999997766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.4e-34  Score=298.61  Aligned_cols=248  Identities=21%  Similarity=0.333  Sum_probs=184.7

Q ss_pred             eeecccceEEEEEEeCCC---cEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccC
Q 004642          457 CIGTGGYGSVYKAELPEG---KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      .||+|+||.||++...++   ..+++|.+......  ...+.+.+|+.+++.++||||+++++.+......++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS--KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh--HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            589999999999965443   34566766543322  2347889999999999999999999999999999999999999


Q ss_pred             CCchhhhcCCCc-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC--
Q 004642          534 GSLFCVLHDDDE-AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS--  610 (740)
Q Consensus       534 g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--  610 (740)
                      |+|.++++.... ....++..+..++.||+.||+|||+.   +++||||||+||+++.++.++|+|||++........  
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            999999976432 23467777889999999999999998   999999999999999999999999999864322111  


Q ss_pred             cccccccCCCccccccccc-------cccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhccc----
Q 004642          611 YRTLRAGTYGYIAPELAYT-------IVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQR----  678 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  678 (740)
                      ......++..|+|||+...       ..++.++|||||||++|||++ |..||.....       .......+...    
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~~~~~~  229 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKDQQVKL  229 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhhccccc
Confidence            1233467889999998753       245778999999999999997 5667653221       01111111110    


Q ss_pred             CCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       679 l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      ..+.....   ....+.+++..|| .+|++||+++|+++.|.
T Consensus       230 ~~~~~~~~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLELP---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCCC---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            01111111   1223677889999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.4e-34  Score=300.24  Aligned_cols=252  Identities=25%  Similarity=0.285  Sum_probs=196.2

Q ss_pred             eecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCc
Q 004642          458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL  536 (740)
Q Consensus       458 lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  536 (740)
                      ||+|+||+||++.. .+|+.||+|.+.............+..|++++++++|||++++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999954 46899999998754433333345677899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccccc
Q 004642          537 FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA  616 (740)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  616 (740)
                      .+++..... ..+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+...... .......
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA  155 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence            999876443 3588999999999999999999998   9999999999999999999999999998765432 2223346


Q ss_pred             cCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHH
Q 004642          617 GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVST  696 (740)
Q Consensus       617 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  696 (740)
                      ++..|+|||+..+..++.++||||+||++|+|++|+.||......    .....+....... ........   ...+.+
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~---~~~~~~  227 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK----VEKEELKRRTLEM-AVEYPDKF---SPEAKD  227 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc----ccHHHHHhccccc-cccCCccC---CHHHHH
Confidence            788999999998888999999999999999999999998643210    0000111111100 11111111   223789


Q ss_pred             HHHHcccCCCCCCC-----CHHHHHHHHHcC
Q 004642          697 IAFACLSSQPKSRP-----TMQRISQELLAG  722 (740)
Q Consensus       697 li~~cl~~dP~~RP-----s~~ev~~~L~~~  722 (740)
                      ++.+||+.+|++||     ++.+++++-...
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~  258 (277)
T cd05577         228 LCEALLQKDPEKRLGCRGGSADEVREHPLFK  258 (277)
T ss_pred             HHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence            99999999999999     777787765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.3e-34  Score=293.06  Aligned_cols=252  Identities=28%  Similarity=0.424  Sum_probs=205.6

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec--CeEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCMFLI  527 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  527 (740)
                      +|...+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++++++++||||+++++.+...  ...+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            4777899999999999999665 6899999999765533 33457889999999999999999999999988  899999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      +||+++++|.+++....   .+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            99999999999987654   689999999999999999999998   999999999999999999999999999987754


Q ss_pred             CCC--cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchh
Q 004642          608 DSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       608 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  685 (740)
                      ...  ......++..|+|||...+...+.++||||||+++|+|++|..||.....      .................+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~  227 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYKIGSSGEPPEIPE  227 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHhccccCCCcCCCc
Confidence            432  13345688999999999888899999999999999999999999875331      0111111111111111111


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ..   ...+.+++.+|++.+|++||++.|++++
T Consensus       228 ~~---~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         228 HL---SEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cc---CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            11   2348899999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=300.59  Aligned_cols=261  Identities=23%  Similarity=0.289  Sum_probs=196.5

Q ss_pred             cccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEe
Q 004642          452 FHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      |++.+.||.|++|.||+|.. .+|+.||+|++....... ...+.+.+|++++++++|||++++++++.+++..+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            66788999999999999965 479999999987543222 2235678899999999999999999999999999999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                      ++ ++|.+++..... ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||.+........
T Consensus        80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            95 589888865442 3589999999999999999999998   999999999999999999999999999976543322


Q ss_pred             cccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc-------CCCCCch-------hhhh-
Q 004642          611 YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-------SSGPKIM-------LIDV-  674 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~-------~~~~-  674 (740)
                      ......++..|+|||++.+. .++.++||||||+++|+|++|+.||........       .......       ..+. 
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            22333568899999987664 468899999999999999999999864322100       0000000       0000 


Q ss_pred             --hcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          675 --LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       675 --~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                        ...................+.+++.+|++.+|++||+++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              00000000000001111347799999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.2e-34  Score=301.81  Aligned_cols=264  Identities=21%  Similarity=0.249  Sum_probs=195.5

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeeeeecCe----
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKKC----  523 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----  523 (740)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....... .....+.+|++++++++ ||||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            46888999999999999999654 68999999887643322 22356788999999995 6999999999887665    


Q ss_pred             -EEEEEEeccCCCchhhhcCCCc--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCcEEEeec
Q 004642          524 -MFLIYEYMERGSLFCVLHDDDE--AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-NLEASVADF  599 (740)
Q Consensus       524 -~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Df  599 (740)
                       .++||||+++ ++.+++.....  ...+++..+..++.||+.||+|||+.   +++||||||+||+++. ++.+||+||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence             8999999986 78887764332  23589999999999999999999998   9999999999999998 889999999


Q ss_pred             ccceecccCCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCcccccccC--------CCCCch
Q 004642          600 GTARLLHVDSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS--------SGPKIM  670 (740)
Q Consensus       600 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~  670 (740)
                      |.++.+...........+++.|+|||++.+ ..++.++||||||+++|+|++|..||.........        ......
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            999866433332333457889999998865 45788999999999999999999998643221100        000000


Q ss_pred             hhhh------h-cccCCCcc-hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          671 LIDV------L-NQRLSPPV-NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       671 ~~~~------~-~~~l~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ....      . .+...+.. ..........+.+++.+||+.+|++||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000      0 00000000 00001122347899999999999999999999876

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.2e-35  Score=305.44  Aligned_cols=253  Identities=25%  Similarity=0.374  Sum_probs=210.6

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ...|.+...||+|.|+.|..+.+ .+|..||+|.+.+........ +.+.+|+++|..+.|||||+++.+...+..+|+|
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            45688899999999999999954 479999999998876655443 4488999999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+.+|.+++++...+   .+....+..++.|+.+|++|||++   .|+|||||++|||++.+.++||+|||++.++..
T Consensus       134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence            99999999999998876   345578888999999999999999   999999999999999999999999999998874


Q ss_pred             CCCcccccccCCCccccccccccccC-CcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVT-GKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      . ......+|++.|.|||++.+..|. +++|+||+|+++|-|+.|..||+....       ......++....+.+....
T Consensus       208 ~-~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------k~Lr~rvl~gk~rIp~~ms  279 (596)
T KOG0586|consen  208 G-LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------KELRPRVLRGKYRIPFYMS  279 (596)
T ss_pred             c-ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------ccccchheeeeecccceee
Confidence            3 334456999999999999988765 689999999999999999999985332       1111233333344333321


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ..     ..+++.+++-.+|.+|++.+++.++-+.
T Consensus       280 ~d-----ce~lLrk~lvl~Pskr~~~dqim~~~W~  309 (596)
T KOG0586|consen  280 CD-----CEDLLRKFLVLNPSKRGPCDQIMKDRWR  309 (596)
T ss_pred             ch-----hHHHHHHhhccCccccCCHHHhhhhccc
Confidence            22     5689999999999999999999987654

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=278.67  Aligned_cols=253  Identities=23%  Similarity=0.322  Sum_probs=198.7

Q ss_pred             ccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEe
Q 004642          453 HIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       453 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      +....||.|..|.||+++.+ +|...|||.+......  +..+++...+.++..- .+|+||+.+|||..+..+++.||.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk--ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH--HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            34556999999999999665 5899999999876543  3357777777777666 489999999999999999999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                      |.. ..+.++....+  ++++.-+-++...+.+||.||.+++  +|+|||+||+|||+|+.|++|++|||++-++.. +.
T Consensus       173 Ms~-C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd-Sk  246 (391)
T KOG0983|consen  173 MST-CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD-SK  246 (391)
T ss_pred             HHH-HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec-cc
Confidence            864 56666655443  4777777889999999999998763  999999999999999999999999999988753 44


Q ss_pred             cccccccCCCccccccccc---cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          611 YRTLRAGTYGYIAPELAYT---IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      ..+...|-+.|||||.+.-   ..|+-++||||||+.++|+.||+.||....      ...+.+..+++... +..+.. 
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~------tdFe~ltkvln~eP-P~L~~~-  318 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK------TDFEVLTKVLNEEP-PLLPGH-  318 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC------ccHHHHHHHHhcCC-CCCCcc-
Confidence            4455589999999998864   357889999999999999999999986522      23344555555333 222111 


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ..-...+.+++..|+++|+.+||...++++|-..
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi  352 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFI  352 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcce
Confidence            1123348899999999999999999999988653

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.7e-34  Score=289.87  Aligned_cols=250  Identities=31%  Similarity=0.464  Sum_probs=202.8

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|++|.||++... +++.+++|++.....   ...+.+.+|++++++++|++++++++++......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            4778899999999999999765 688999999976554   234788899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.+++....  ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            999999999987653  3689999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                      . .....++..|+|||++.+..++.++||||||+++|+|++|+.||.....       ......... ...+.... ...
T Consensus       153 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~~~~-~~~  222 (253)
T cd05122         153 A-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-------MKALFKIAT-NGPPGLRN-PEK  222 (253)
T ss_pred             c-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-------HHHHHHHHh-cCCCCcCc-ccc
Confidence            2 3345688999999999888889999999999999999999999864321       011111111 11111100 000


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ....+.+++.+||+.||++||++.|++++
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            12338899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.6e-34  Score=302.12  Aligned_cols=272  Identities=27%  Similarity=0.331  Sum_probs=202.6

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec--CeEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCMF  525 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  525 (740)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++....... .....+.+|++++++++|+|++++++++...  +..+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            46899999999999999999965 468999999987543322 1123456799999999999999999998764  5689


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      +||||+++ +|.+++....  ..+++.++..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||.+...
T Consensus        85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            99999975 7877776543  3589999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc-------CCCCCchhhhhhc-
Q 004642          606 HVDSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-------SSGPKIMLIDVLN-  676 (740)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~-  676 (740)
                      ...........++..|+|||.+.+ ..++.++||||+||++|||++|+.||........       ............+ 
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            543333333356788999999875 4578899999999999999999999864332100       0000000000000 


Q ss_pred             ------ccCCCc---c-hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCCh
Q 004642          677 ------QRLSPP---V-NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQ  727 (740)
Q Consensus       677 ------~~l~~~---~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~  727 (740)
                            ......   . ..........+.+++.+|++.||++||++.|++++-...+.+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence                  000000   0 00000012336789999999999999999999999888766554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=302.60  Aligned_cols=264  Identities=24%  Similarity=0.332  Sum_probs=195.6

Q ss_pred             ccccceeeecccceEEEEEEeC---CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec--CeEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP---EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCMF  525 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  525 (740)
                      +|++.+.||+|+||.||+|...   +++.||+|.+...........+.+.+|++++.+++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999654   4789999999874422223346678899999999999999999999988  8899


Q ss_pred             EEEEeccCCCchhhhcCCC--ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC----CCcEEEeec
Q 004642          526 LIYEYMERGSLFCVLHDDD--EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS----NLEASVADF  599 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~Df  599 (740)
                      +||||+++ ++.+++....  ....++...+..++.||+.||+|||+.   +++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999986 5666654322  223688999999999999999999998   9999999999999999    999999999


Q ss_pred             ccceecccCCC---cccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCC--CCchhhh
Q 004642          600 GTARLLHVDSS---YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG--PKIMLID  673 (740)
Q Consensus       600 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~--~~~~~~~  673 (740)
                      |++........   ......++..|+|||++.+. .++.++|||||||++|+|++|+.||.....-.....  ......+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986543222   12234678899999988764 578899999999999999999999864332110000  0000000


Q ss_pred             h---h-----------------------cccCCCc--chhhhH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          674 V---L-----------------------NQRLSPP--VNQKIV----QDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       674 ~---~-----------------------~~~l~~~--~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      +   +                       .......  ......    .....+.+++.+|++.||++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0   0                       0000000  000000    122347899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-34  Score=292.37  Aligned_cols=253  Identities=24%  Similarity=0.341  Sum_probs=198.7

Q ss_pred             cccccceeeecccceEEEEEEe-CCCcEEEEEEccCCc--ccchHHHHHHHHHHHHHhccCCCccceeeeeeeec--CeE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSE--TEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCM  524 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  524 (740)
                      .+|++.+.||+|+||.||+|.. .+|+.||+|.+....  .......+.+.+|++++++++|+||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788999999999999999965 468999999875432  12233457889999999999999999999998764  568


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++++||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999887543   478889999999999999999998   999999999999999999999999999986


Q ss_pred             cccCC---CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          605 LHVDS---SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       605 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      .....   .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.....       .............+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~  228 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------MAAIFKIATQPTKP  228 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------HHHHHHHHcCCCCC
Confidence            53211   111234688999999999888889999999999999999999999864221       11122222222222


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ..+.   .....+.+++.+|+. +|.+||++.++++|.
T Consensus       229 ~~p~---~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         229 MLPD---GVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             CCCc---ccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence            1111   122338899999999 579999999988753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.8e-34  Score=298.40  Aligned_cols=266  Identities=22%  Similarity=0.303  Sum_probs=197.0

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|++|.||+|... +|+.||+|++....... ...+.+.+|++++++++||||+++++++..+...++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            47889999999999999999654 68999999986543322 23456788999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCcEEEeecccceeccc
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-NLEASVADFGTARLLHV  607 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfG~a~~~~~  607 (740)
                      ||+++ ++.+++..... ..+++..+..++.||+.||+|||++   +++|+||+|+||+++. ++.+||+|||++.....
T Consensus        81 e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         81 EYLDL-DLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ecccc-cHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            99964 77777654332 2467888889999999999999998   9999999999999985 55799999999976543


Q ss_pred             CCCcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc-------CCCC-C------chhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-------SSGP-K------IMLI  672 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~-~------~~~~  672 (740)
                      .........++..|+|||++.+. .++.++||||+||++|+|+||+.||........       .... .      ..+.
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence            33333334678899999988664 578899999999999999999999864321100       0000 0      0000


Q ss_pred             hhhc--ccCCC-cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          673 DVLN--QRLSP-PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       673 ~~~~--~~l~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      +...  ..... ............+.+++.+|++.+|++||++.+++++-..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~  287 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF  287 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchH
Confidence            0000  00000 0000001112337889999999999999999999987543

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.6e-34  Score=301.63  Aligned_cols=260  Identities=26%  Similarity=0.305  Sum_probs=195.1

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  528 (740)
                      +|...+.||+|+||.||++.. .+|+.||+|++......  .....+.+|+.++.++. |+||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            455667899999999999955 46899999998754433  23467889999999996 999999999999999999999


Q ss_pred             EeccCCCchhh---hcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          529 EYMERGSLFCV---LHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       529 e~~~~g~L~~~---l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      ||+.. ++.++   +... ....+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.++|+|||+++..
T Consensus        83 e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             ecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            99875 44433   2221 123689999999999999999999963  28999999999999999999999999999765


Q ss_pred             ccCCCcccccccCCCcccccccccc---ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCc
Q 004642          606 HVDSSYRTLRAGTYGYIAPELAYTI---VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~  682 (740)
                      .... ......|+..|+|||++.+.   .++.++||||+||++|||++|+.||......      .....+......+..
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~  231 (288)
T cd06616         159 VDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV------FDQLTQVVKGDPPIL  231 (288)
T ss_pred             ccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH------HHHHhhhcCCCCCcC
Confidence            4322 22333688999999998766   6888999999999999999999998643210      011111111110000


Q ss_pred             chhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      ...........+.+++.+||+.+|++||++.|++++-....
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            00000112234889999999999999999999999866543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9e-34  Score=290.53  Aligned_cols=253  Identities=26%  Similarity=0.407  Sum_probs=205.6

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|.+.+.||.|+||.||++... +++.||+|++...... ....+.+.+|++++++++|||++++++.+..++..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            4788899999999999999654 6899999999765432 2335678899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          530 YMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      |+++++|.+++.... ....+++.++..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999887642 124689999999999999999999998   9999999999999999999999999999876544


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                      ........|++.|+|||...+..++.++||||+|+++|+|++|+.||.....       .............+ ..... 
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~-  227 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKILKGQYPP-IPSQY-  227 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHHhcCCCCC-CCCCC-
Confidence            3333445788999999999888899999999999999999999999864321       11111222211111 11111 


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                        ...+.+++.+||..+|++||++.|++++
T Consensus       228 --~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         228 --SSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             --CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              2237899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.6e-34  Score=304.91  Aligned_cols=263  Identities=22%  Similarity=0.279  Sum_probs=198.2

Q ss_pred             HhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec-----
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK-----  521 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  521 (740)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.+|++++++++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            457899999999999999999954 47899999998654322 22345677899999999999999999988643     


Q ss_pred             -CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecc
Q 004642          522 -KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG  600 (740)
Q Consensus       522 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  600 (740)
                       ...++||||+.+ +|.+.+..     .++..++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence             357999999965 77777653     278889999999999999999998   99999999999999999999999999


Q ss_pred             cceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCC----
Q 004642          601 TARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPK----  668 (740)
Q Consensus       601 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~----  668 (740)
                      +++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........        .....    
T Consensus       164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         164 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             cceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            998764322 22334678999999999999999999999999999999999999864321000        00000    


Q ss_pred             ---chhhhhhcccC---------------CCcch-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          669 ---IMLIDVLNQRL---------------SPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       669 ---~~~~~~~~~~l---------------~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                         ...........               .+... .........+.+++.+||+.||++||++.|++++-..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~  314 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI  314 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence               00000011000               00000 0000122347899999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.6e-34  Score=299.37  Aligned_cols=257  Identities=25%  Similarity=0.359  Sum_probs=200.5

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      +.|+..+.||+|+||.||+|... +++.+|+|.+...........+++.+|+++++.++|+|++++++++..+...++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45777788999999999999654 67889999986543333334567889999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+. |++.+.+.....  .+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 577776654332  478999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCcccccccCCCcccccccc---ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchh
Q 004642          609 SSYRTLRAGTYGYIAPELAY---TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  685 (740)
                          ....|+..|+|||++.   ...++.++|||||||++|+|++|+.||.....       ............+.....
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~  237 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPALQSG  237 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------HHHHHHHhhcCCCCcCcc
Confidence                2336788999999875   34678899999999999999999999754221       111111111111111111


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCC
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPM  726 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~  726 (740)
                         .....+.+++.+||+.+|++||++.+++++....+...
T Consensus       238 ---~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         238 ---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             ---cccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence               12233789999999999999999999999987665433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.1e-34  Score=295.36  Aligned_cols=247  Identities=27%  Similarity=0.384  Sum_probs=197.3

Q ss_pred             eecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCc
Q 004642          458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL  536 (740)
Q Consensus       458 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  536 (740)
                      ||+|+||.||++... +|+.|++|.+...........+.+.+|++++++++|||++++++.+..+...+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999765 4899999999766554445567889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC------
Q 004642          537 FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS------  610 (740)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~------  610 (740)
                      .+++....   .+++..+..++.||+.||+|||+.   +++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99997644   589999999999999999999998   999999999999999999999999999876543311      


Q ss_pred             --cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          611 --YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       611 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                        ......++..|+|||.......+.++||||||+++|++++|+.||.....       ..............+....  
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~--  225 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQNILNGKIEWPEDVE--  225 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCcCCCcccc--
Confidence              22334678899999999888888999999999999999999999864321       1111122221222111110  


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                       ....+.+++.+||+.+|++||++.++.+.|.
T Consensus       226 -~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         226 -VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence             1233789999999999999999944444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=288.64  Aligned_cols=250  Identities=28%  Similarity=0.448  Sum_probs=203.8

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|++|.||++... +++.|++|.+...... ....+.+.+|++++++++|+|++++++++.+++..+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            4778899999999999999654 6789999999876543 2345789999999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          80 YAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             cCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            999999999987653   689999999999999999999998   99999999999999999999999999998776544


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                      .......++..|+|||...+..++.++||||+|+++|+|++|+.||......       ........ ...+......  
T Consensus       154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~~~~~~--  223 (254)
T cd06627         154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-------AALFRIVQ-DDHPPLPEGI--  223 (254)
T ss_pred             ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHhc-cCCCCCCCCC--
Confidence            4334456889999999998888889999999999999999999998643210       11111111 1111111111  


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                       ...+.+++.+|++.+|++||++.|++.+
T Consensus       224 -~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         224 -SPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             -CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence             2237899999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5e-34  Score=292.32  Aligned_cols=251  Identities=25%  Similarity=0.340  Sum_probs=203.3

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      +|++.+.||+|+||.||++.. .+++.+|+|++....... ....++.+|++++++++|+||+++++++.+....++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            478889999999999999954 478899999987644332 234677889999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          530 YMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      |+++++|.+++.+.. ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            999999999886532 123688999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhH
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  688 (740)
                        ......++..|+|||...+..++.++|+||+|+++|||++|+.||.....        ............+....   
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~---  223 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDLRYKVQRGKYPPIPP---  223 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCCCCCch---
Confidence              22334688999999999988899999999999999999999999864321        11111111111111111   


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      .....+.+++.+|++.+|++||++.|++++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         224 IYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            122338899999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=293.85  Aligned_cols=260  Identities=23%  Similarity=0.297  Sum_probs=195.5

Q ss_pred             cccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc---CCCccceeeeeeeecCe----
Q 004642          452 FHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV---RHRNIVKLYGFCLHKKC----  523 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----  523 (740)
                      |++.+.||+|+||.||+|..+ +++.||+|++......+ .....+.+|+.++.++   +|+|++++++++...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            567889999999999999776 48999999997654322 2234566777777666   59999999999988776    


Q ss_pred             -EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccc
Q 004642          524 -MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       524 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                       .+++|||+.+ +|.+++..... ..+++.++..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence             9999999975 78888865432 2589999999999999999999998   9999999999999999999999999999


Q ss_pred             eecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccccc---------CCCCCch---
Q 004642          603 RLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS---------SSGPKIM---  670 (740)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~---------~~~~~~~---  670 (740)
                      ......... ....++..|+|||++.+..++.++|||||||++|||++|+.||........         .......   
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         155 RIYSFEMAL-TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             eeccCCccc-ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            876433222 233578899999999988899999999999999999999999875332100         0000000   


Q ss_pred             ---hhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          671 ---LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       671 ---~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                         .......................+.+++.+||+.||++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence               000001111111111111222447799999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.3e-33  Score=296.24  Aligned_cols=258  Identities=25%  Similarity=0.349  Sum_probs=200.7

Q ss_pred             cccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEe
Q 004642          452 FHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      |...+.||+|+||.||+|.. .+|+.|++|++...........+.+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            56667899999999999965 46889999998765444444456788999999999999999999999999999999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                      +. |++.+.+....  ..+++.++..++.||+.|++|||+.   +++|+||+|+||+++.++.++|+|||++.....   
T Consensus       103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 47777765433  2588999999999999999999998   999999999999999999999999999864322   


Q ss_pred             cccccccCCCcccccccc---ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          611 YRTLRAGTYGYIAPELAY---TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                       .....|+..|+|||++.   ...++.++|||||||++|||++|..||......       ...........+......+
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~  245 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNDSPTLQSNEW  245 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCCcccc
Confidence             22346889999999974   456788999999999999999999997543210       1111111111111111111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCChhh
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKA  729 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~  729 (740)
                      .   ..+.+++.+||+.+|++||++.+++++-.....+..+.
T Consensus       246 ~---~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~  284 (313)
T cd06633         246 T---DSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARV  284 (313)
T ss_pred             C---HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchhHH
Confidence            1   23788999999999999999999999877665544443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-35  Score=307.75  Aligned_cols=252  Identities=24%  Similarity=0.370  Sum_probs=199.8

Q ss_pred             ceeeecccceEEEEE-EeCCCcEEEEEEccCC-cccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC--eEEEEEEe
Q 004642          455 KYCIGTGGYGSVYKA-ELPEGKVVALKKLHHS-ETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK--CMFLIYEY  530 (740)
Q Consensus       455 ~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~  530 (740)
                      ...||+|+|-+||+| +-.+|..||=-.++.. ....++..++|..|+.+++.++||||+++|.++.+..  ...+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            456999999999999 4446777773222111 1122344689999999999999999999999998754  47889999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCcEEEeecccceecccCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-NLEASVADFGTARLLHVDS  609 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfG~a~~~~~~~  609 (740)
                      +..|+|..++.+.+   .++.+.+.+|++||++||.|||++ .|+|+|||||-.||+++. .|.|||+|+|+|+.+..  
T Consensus       125 ~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~--  198 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK--  198 (632)
T ss_pred             ccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc--
Confidence            99999999998776   588899999999999999999998 679999999999999984 58999999999988753  


Q ss_pred             CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                      .+....+|||.|||||... ..|++.+||||||+.++||+|+..||..-       ....-++..+..+..|....... 
T Consensus       199 s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-------~n~AQIYKKV~SGiKP~sl~kV~-  269 (632)
T KOG0584|consen  199 SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-------TNPAQIYKKVTSGIKPAALSKVK-  269 (632)
T ss_pred             cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-------CCHHHHHHHHHcCCCHHHhhccC-
Confidence            3333478999999999876 67999999999999999999999997532       22233444444444432221111 


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                       .+++.+||.+|+.. .++|||+.|++++-+...
T Consensus       270 -dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  270 -DPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             -CHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence             23488999999999 999999999999876654

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=279.97  Aligned_cols=255  Identities=24%  Similarity=0.304  Sum_probs=208.9

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      .++|...+.||+|.||.|-.++- .+|+.||+|++++...-....+.--..|-++++..+||.+..+--.+..++..++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            36788899999999999999954 47999999999988776666666677899999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||..||.|+-++.+..   .+++.....+-..|+.||.|||++   +||.||+|.+|.|+|.||++||+|||+++.--.
T Consensus       247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999998887654   577888888899999999999998   999999999999999999999999999976433


Q ss_pred             CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhh
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  687 (740)
                      ........+||+.|+|||++....|...+|.|.+||++|||++|+.||-..       ..+..+.-++-..+..+..  .
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~-------dh~kLFeLIl~ed~kFPr~--l  391 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK-------DHEKLFELILMEDLKFPRT--L  391 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc-------chhHHHHHHHhhhccCCcc--C
Confidence            344456679999999999999999999999999999999999999997532       1222222222222322211  1


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHc
Q 004642          688 VQDIILVSTIAFACLSSQPKSRP-----TMQRISQELLA  721 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~L~~  721 (740)
                      .+   +...++...+..||.+|-     .+.|+.++-..
T Consensus       392 s~---eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF  427 (516)
T KOG0690|consen  392 SP---EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFF  427 (516)
T ss_pred             CH---HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhh
Confidence            12   256788889999999994     67787777644

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-34  Score=304.96  Aligned_cols=263  Identities=23%  Similarity=0.319  Sum_probs=195.8

Q ss_pred             HhcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec-----
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK-----  521 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  521 (740)
                      .+++|++.+.||+|+||.||+|.. .+|+.||+|++.....  ......+.+|+.++++++||||+++++++...     
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            357899999999999999999954 5789999999864322  22346678899999999999999999987654     


Q ss_pred             CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      ...++++||+++ ++.+.+...    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||+
T Consensus        81 ~~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          81 NDVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             ceEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence            357999999975 777766542    588999999999999999999998   999999999999999999999999999


Q ss_pred             ceecccCCCc---ccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCcccccc--------cCCCCCc
Q 004642          602 ARLLHVDSSY---RTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS--------SSSGPKI  669 (740)
Q Consensus       602 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~--------~~~~~~~  669 (740)
                      +.........   .....|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||.......        .......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            9765432221   123468899999998754 467889999999999999999999986432100        0000001


Q ss_pred             hhhhhhc-----------ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          670 MLIDVLN-----------QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       670 ~~~~~~~-----------~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      .......           .....+...........+.+++.+||+.+|++||++.|++++-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~  294 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY  294 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            0110000           00000000001112234789999999999999999999999843

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=277.01  Aligned_cols=267  Identities=21%  Similarity=0.328  Sum_probs=207.0

Q ss_pred             HHHHHHHhcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeee
Q 004642          442 YEDLINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCL  519 (740)
Q Consensus       442 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  519 (740)
                      ++|.-..++     +.||+|+|++|--+ .+.+|.+||||++.+...   ..+.+..+|++++.+. .|+||+.++++|+
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            445444443     45999999999988 677899999999987643   3457888999999998 5999999999999


Q ss_pred             ecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC---cEEE
Q 004642          520 HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL---EASV  596 (740)
Q Consensus       520 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl  596 (740)
                      ++..+|+|||.|.||.|..+|++..   .+++.++.++.++|+.||+|||.+   ||.|||+||+|||-.+..   -+||
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence            9999999999999999999998654   688999999999999999999999   999999999999997654   4799


Q ss_pred             eecccceecccCCC-------cccccccCCCcccccccc-----ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccC
Q 004642          597 ADFGTARLLHVDSS-------YRTLRAGTYGYIAPELAY-----TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS  664 (740)
Q Consensus       597 ~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~  664 (740)
                      +||.+..-+.....       .....+|+..|||||+..     ...|+.+.|.||+|||+|-|++|..||...-...=.
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG  300 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG  300 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence            99998765432211       112347899999999764     345888999999999999999999999765432111


Q ss_pred             CCC-------CchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          665 SGP-------KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       665 ~~~-------~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ..+       ...+.+-+...--.....+|..-..+..+++...+..||.+|-++.+++++....
T Consensus       301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~  365 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ  365 (463)
T ss_pred             ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence            111       1222232322222223344555555678899999999999999999999876544

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.6e-34  Score=304.29  Aligned_cols=264  Identities=21%  Similarity=0.254  Sum_probs=199.2

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec-----C
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK-----K  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  522 (740)
                      .++|.+.+.||+|+||.||++.. .+|+.||+|++....... .....+.+|+.+++.++|+||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            46799999999999999999954 468999999987643222 2245677899999999999999999988654     3


Q ss_pred             eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccc
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                      ..++|+||+. ++|.+++....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            5899999996 58888876543   588999999999999999999998   9999999999999999999999999999


Q ss_pred             eecccCCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCcccccc---------cC-------C
Q 004642          603 RLLHVDSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS---------SS-------S  665 (740)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~---------~~-------~  665 (740)
                      ..............++..|+|||.+.. ..++.++|||||||++|+|++|+.||.......         ..       .
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            876543333344468899999998764 468889999999999999999999986432100         00       0


Q ss_pred             CCCchhhhhhcccC---CCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          666 GPKIMLIDVLNQRL---SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       666 ~~~~~~~~~~~~~l---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      .......+.+....   ..............+.+++.+||+.+|++||+++|++++-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~  293 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY  293 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence            00001111111100   01001111122334789999999999999999999999943

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.1e-33  Score=294.38  Aligned_cols=257  Identities=22%  Similarity=0.273  Sum_probs=190.8

Q ss_pred             cccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeeeeec--CeEEEE
Q 004642          452 FHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHK--KCMFLI  527 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  527 (740)
                      |++.+.||+|+||.||+|.. .+++.||+|+++........  ....+|+.++.++. |+|++++++++.++  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~--~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh--hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            56788999999999999954 46899999998764332221  23457888888885 99999999999987  889999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++ ++.+.+....  ..+++.++..++.|++.||+|||+.   +++||||+|+||+++. +.+||+|||.++....
T Consensus        79 ~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          79 FELMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             EecCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            999975 7777776533  2589999999999999999999998   9999999999999999 9999999999987643


Q ss_pred             CCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc-------CCCCCchhhhhhcccC
Q 004642          608 DSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-------SSGPKIMLIDVLNQRL  679 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~l  679 (740)
                      .... ....++..|+|||++.. ..++.++||||+||++|||++|+.||........       ................
T Consensus       152 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         152 KPPY-TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             CCCc-CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            3222 23457889999997654 4578899999999999999999999865322100       0000000000000000


Q ss_pred             ------CCcc----hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          680 ------SPPV----NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       680 ------~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                            +...    ..........+.+++.+||+.+|++||++++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence                  0000    00001123448899999999999999999999876

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.8e-34  Score=303.89  Aligned_cols=268  Identities=24%  Similarity=0.307  Sum_probs=201.3

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee----cCe
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH----KKC  523 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~  523 (740)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++....... ...+.+.+|+.++++++||||+++++++..    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc-cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            47899999999999999999954 469999999987643322 234677789999999999999999998763    356


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccce
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      .++||||+. ++|.+++....   .+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            899999996 58888886543   489999999999999999999998   99999999999999999999999999997


Q ss_pred             ecccCCC----cccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCcccccc--------cCCC----
Q 004642          604 LLHVDSS----YRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS--------SSSG----  666 (740)
Q Consensus       604 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~--------~~~~----  666 (740)
                      .......    ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......        ....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            6543221    1123468899999998765 457889999999999999999999986432100        0000    


Q ss_pred             ----CCchhhhhhcc---cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          667 ----PKIMLIDVLNQ---RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       667 ----~~~~~~~~~~~---~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                          ......+....   ................+.+++.+||+.+|++||++++++++......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence                00001111110   00111000011123348899999999999999999999998866433

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-34  Score=317.03  Aligned_cols=273  Identities=19%  Similarity=0.225  Sum_probs=190.5

Q ss_pred             HhcccccceeeecccceEEEEEEeCC--CcEEEEEE--------------ccCCcccchHHHHHHHHHHHHHhccCCCcc
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELPE--GKVVALKK--------------LHHSETEDSAFVKSFQNEAHVLSTVRHRNI  511 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  511 (740)
                      ..++|++.+.||+|+||+||++..+.  +..++.|.              +.............+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999985432  22222221              111111112234578899999999999999


Q ss_pred             ceeeeeeeecCeEEEEEEeccCCCchhhhcCCCc--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 004642          512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDE--AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD  589 (740)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  589 (740)
                      +++++++...+..++|++++.+ ++.+++.....  .......++..++.||+.||+|||++   +|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            9999999999999999999864 66666643221  11234567788999999999999998   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCC-cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCC-CCcccccc-----
Q 004642          590 SNLEASVADFGTARLLHVDSS-YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP-GGLLSSLS-----  662 (740)
Q Consensus       590 ~~~~~kl~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p-~~~~~~~~-----  662 (740)
                      .++.+||+|||+++.+..... ......||..|+|||++.+..++.++|||||||++|||++|..+ +.......     
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999987653322 22235799999999999999999999999999999999998754 33211000     


Q ss_pred             ---------c--CCCCCchhhhhhcccCCCcchhhhH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          663 ---------S--SSGPKIMLIDVLNQRLSPPVNQKIV------QDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       663 ---------~--~~~~~~~~~~~~~~~l~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                               .  .........+.+.............      .....+.+++.+|++.||++||++.|++++-.....
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence                     0  0000000111111000000000000      001125678899999999999999999998776544

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.5e-34  Score=295.65  Aligned_cols=251  Identities=26%  Similarity=0.380  Sum_probs=203.2

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeeeeecCeEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  527 (740)
                      ++|.+.+.||+|+||.||++... +|+.||+|++...........+.+.+|.+++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999654 78999999987644433344567889999999998 99999999999999999999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999997654   689999999999999999999998   999999999999999999999999999886543


Q ss_pred             CCC--------------------cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCC
Q 004642          608 DSS--------------------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGP  667 (740)
Q Consensus       608 ~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~  667 (740)
                      ...                    ......++..|+|||...+..++.++||||+|++++++++|+.||.....       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------  227 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------  227 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-------
Confidence            221                    11223578899999999888889999999999999999999999875321       


Q ss_pred             CchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCH----HHHHHH
Q 004642          668 KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTM----QRISQE  718 (740)
Q Consensus       668 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~ev~~~  718 (740)
                      ..............  +...   ...+.+++.+||+.+|++||++    +|++++
T Consensus       228 ~~~~~~~~~~~~~~--~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         228 YLTFQKILKLEYSF--PPNF---PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHHHHHHhcCCCC--CCcc---CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            11111222111111  1111   1237899999999999999999    787765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-33  Score=295.43  Aligned_cols=254  Identities=25%  Similarity=0.377  Sum_probs=200.2

Q ss_pred             eeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCC
Q 004642          456 YCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERG  534 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  534 (740)
                      ..||+|+||.||++.. .+|+.||+|++.....   ...+.+.+|+.+++.++|+|++++++++..++..+++|||++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            5699999999999965 4789999998854332   23467889999999999999999999999999999999999999


Q ss_pred             CchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccc
Q 004642          535 SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL  614 (740)
Q Consensus       535 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  614 (740)
                      +|.+++...    .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++............
T Consensus       103 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657         103 ALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence            999887543    478899999999999999999998   9999999999999999999999999998766443333344


Q ss_pred             cccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHH
Q 004642          615 RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILV  694 (740)
Q Consensus       615 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  694 (740)
                      ..|+..|+|||+..+..++.++|+||+|+++|+|++|+.||......        .....+....+.... ........+
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~-~~~~~~~~l  246 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNLPPKLK-NLHKVSPSL  246 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhhCCcccC-CcccCCHHH
Confidence            56889999999998888899999999999999999999997642211        011111111111100 001112237


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHcCCCCChh
Q 004642          695 STIAFACLSSQPKSRPTMQRISQELLAGKTPMQK  728 (740)
Q Consensus       695 ~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~  728 (740)
                      .+++.+||+.+|.+||++.+++++-...+...+.
T Consensus       247 ~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         247 KGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             HHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence            7899999999999999999999986554443333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=290.50  Aligned_cols=246  Identities=25%  Similarity=0.313  Sum_probs=187.7

Q ss_pred             eeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHH-hccCCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVL-STVRHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.||+|+||.||+|.. .+|+.||+|.+.............+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999955 46899999998754332222233444555444 445899999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      ++|.+++....   .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++....    ..
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  151 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK  151 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence            99999987543   578899999999999999999998   999999999999999999999999999876432    22


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL  693 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  693 (740)
                      ...|+..|+|||...+..++.++||||+|+++|||++|..||.....       ..............+... .......
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~~  223 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-------DAVFDNILSRRINWPEEV-KEFCSPE  223 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcccCCCCcc-cccCCHH
Confidence            34688899999999888889999999999999999999999864221       111112111111111000 0011223


Q ss_pred             HHHHHHHcccCCCCCCCCH---HHHHHHH
Q 004642          694 VSTIAFACLSSQPKSRPTM---QRISQEL  719 (740)
Q Consensus       694 l~~li~~cl~~dP~~RPs~---~ev~~~L  719 (740)
                      +.+++.+||+.+|++||++   +|++++-
T Consensus       224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~~~  252 (260)
T cd05611         224 AVDLINRLLCMDPAKRLGANGYQEIKSHP  252 (260)
T ss_pred             HHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence            7899999999999999966   4555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.9e-33  Score=294.24  Aligned_cols=258  Identities=18%  Similarity=0.225  Sum_probs=181.5

Q ss_pred             hcccccceeeecccceEEEEEEeCC----CcEEEEEEccCCcccc--hHH------HHHHHHHHHHHhccCCCccceeee
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE----GKVVALKKLHHSETED--SAF------VKSFQNEAHVLSTVRHRNIVKLYG  516 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~--~~~------~~~~~~E~~~l~~l~h~niv~l~~  516 (740)
                      .++|.+.+.||+|+||.||+|...+    +..+|+|+........  +..      ......+...+..++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4689999999999999999997654    3456666543322110  000      011223344556678999999999


Q ss_pred             eeeecC----eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC
Q 004642          517 FCLHKK----CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL  592 (740)
Q Consensus       517 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~  592 (740)
                      ++....    ..++++|++.. ++.+.+....   ..++..+..++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            776543    34677777643 4555544322   356788899999999999999998   999999999999999999


Q ss_pred             cEEEeecccceecccCCC-------cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCC
Q 004642          593 EASVADFGTARLLHVDSS-------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSS  665 (740)
Q Consensus       593 ~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~  665 (740)
                      .++|+|||+|+.+.....       ......||+.|+|||+..+..++.++|||||||++|||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999999999987643221       1223469999999999999999999999999999999999999987542110000


Q ss_pred             C-C-CchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          666 G-P-KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       666 ~-~-~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      . . ..............+      .....+.+++..|++.+|++||+++++.+.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFIKRLHEGKIKIK------NANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHHHHhhhhhhccC------CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0 0 000111111111111      1123388999999999999999999999875

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.2e-33  Score=289.40  Aligned_cols=251  Identities=23%  Similarity=0.300  Sum_probs=192.6

Q ss_pred             HHHHHHhcccccceee--ecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeee
Q 004642          443 EDLINATEDFHIKYCI--GTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFC  518 (740)
Q Consensus       443 ~~l~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (740)
                      .+.....+.|.+.+.+  |+|+||.||++.. .+++.+|+|.+.......      .  |......+ +|||++++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~--e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------I--EPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------h--hHHHHHHhhcCCCEEEEEEEE
Confidence            4445556778887776  9999999999954 468889999986543221      1  22222222 799999999999


Q ss_pred             eecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-cEEEe
Q 004642          519 LHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVA  597 (740)
Q Consensus       519 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~  597 (740)
                      ..++..++||||+++++|.+++....   .+++.++..++.||++|++|||+.   +++||||||+||+++.++ .++|+
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~  152 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC  152 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence            99999999999999999999997653   689999999999999999999998   999999999999999998 99999


Q ss_pred             ecccceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcc
Q 004642          598 DFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ  677 (740)
Q Consensus       598 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  677 (740)
                      |||.++.....    ....|+..|+|||++.+..++.++||||+|+++|||++|+.||.......   ............
T Consensus       153 dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~  225 (267)
T PHA03390        153 DYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLKRQQK  225 (267)
T ss_pred             cCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHHHhhcc
Confidence            99999765422    22358899999999998889999999999999999999999987432110   000111111111


Q ss_pred             cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHH
Q 004642          678 RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPT-MQRISQEL  719 (740)
Q Consensus       678 ~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ev~~~L  719 (740)
                      ....  ..   .....+.+++.+||+.+|++||+ ++|++++-
T Consensus       226 ~~~~--~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~  263 (267)
T PHA03390        226 KLPF--IK---NVSKNANDFVQSMLKYNINYRLTNYNEIIKHP  263 (267)
T ss_pred             cCCc--cc---ccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence            1111  11   12233889999999999999996 69988763

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2e-33  Score=296.65  Aligned_cols=263  Identities=22%  Similarity=0.351  Sum_probs=192.5

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC-----
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK-----  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  522 (740)
                      .++|++.+.||+|+||.||+|... +++.||+|++....... .....+.+|++++++++||||+++++++...+     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            457999999999999999999654 68999999886543322 12245668999999999999999999987654     


Q ss_pred             ---eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeec
Q 004642          523 ---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF  599 (740)
Q Consensus       523 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  599 (740)
                         ..++||||+.+ ++.+.+....  ..+++.++..++.||+.||+|||++   +++|+||||+||+++.++.+||+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence               45999999975 7777775433  2578999999999999999999998   9999999999999999999999999


Q ss_pred             ccceecccCCC----cccccccCCCccccccccccc-cCCcchhHhHHHHHHHHHhCCCCCCcccccc------------
Q 004642          600 GTARLLHVDSS----YRTLRAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVLMGTHPGGLLSSLS------------  662 (740)
Q Consensus       600 G~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~------------  662 (740)
                      |++........    ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||.......            
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99976643221    112345788999999887643 6789999999999999999999986432100            


Q ss_pred             -cCCCCCchhhhhhcc-cCCCcchhhhH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          663 -SSSGPKIMLIDVLNQ-RLSPPVNQKIV------QDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       663 -~~~~~~~~~~~~~~~-~l~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                       ....+.....+..+. ..+........      .....+.+++.+||+.||++||+++|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence             000000000000000 00000000000      011236789999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-33  Score=296.05  Aligned_cols=257  Identities=24%  Similarity=0.339  Sum_probs=196.1

Q ss_pred             hcccccceeeecccceEEEEEEeCC-CcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (740)
                      .++|++.+.||+|+||.||+|...+ ++.||||.+.......  ...++.+|++++.+. .||||+++++++.+....++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            3678889999999999999997764 8999999997543322  235566677767666 49999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH-DCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      +|||+++ ++.+++.....  .+++..+..++.||+.||+|||+ .   +++||||+|+||++++++.+||+|||++..+
T Consensus        92 v~e~~~~-~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          92 CMELMST-CLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             EeeccCc-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            9999864 66666654332  68899999999999999999996 5   8999999999999999999999999999765


Q ss_pred             ccCCCcccccccCCCccccccccccc----cCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          606 HVDSSYRTLRAGTYGYIAPELAYTIV----VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      ..... .....++..|+|||++.+..    ++.++||||||+++|+|++|+.||.....      ........+......
T Consensus       166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~  238 (296)
T cd06618         166 VDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT------EFEVLTKILQEEPPS  238 (296)
T ss_pred             cCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh------HHHHHHHHhcCCCCC
Confidence            43222 22335788999999987553    78899999999999999999999864211      011122222221111


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ....  ......+.+++.+||+.||++||++.+++++....
T Consensus       239 ~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  277 (296)
T cd06618         239 LPPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR  277 (296)
T ss_pred             CCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence            0000  01123478999999999999999999999887543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=332.03  Aligned_cols=259  Identities=29%  Similarity=0.442  Sum_probs=205.8

Q ss_pred             HHhcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEE
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  525 (740)
                      ..+-+++-...||.|.||.||.+ ...+|...|+|-++..... ....+...+|+.++..++|||+|+++|+-.+.+..+
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34556777788999999999999 5667999999988765544 334577889999999999999999999999999999


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      |-||||++|+|.+.+....   ..++.....+..|++.|++|||++   |||||||||.||+++.+|.+|.+|||.|..+
T Consensus      1311 IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence            9999999999999998754   345566667889999999999999   9999999999999999999999999999887


Q ss_pred             ccCCCc----ccccccCCCccccccccccc---cCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhccc
Q 004642          606 HVDSSY----RTLRAGTYGYIAPELAYTIV---VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQR  678 (740)
Q Consensus       606 ~~~~~~----~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  678 (740)
                      ......    .....||+.|||||++.+..   ...+.||||+|||+.||+||+.||.....      .......+-..+
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMYHVAAGH 1458 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHhHHhccC
Confidence            654311    23347999999999998643   45689999999999999999999764321      111122222222


Q ss_pred             CCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       679 l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      . |+.+.....   +-.+++..|+..||++|.++.|++++=...
T Consensus      1459 ~-Pq~P~~ls~---~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1459 K-PQIPERLSS---EGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred             C-CCCchhhhH---hHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence            2 222222333   367899999999999999999999876544

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=293.01  Aligned_cols=260  Identities=27%  Similarity=0.373  Sum_probs=196.6

Q ss_pred             cccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec--CeEEEEE
Q 004642          452 FHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCMFLIY  528 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  528 (740)
                      |++.+.||+|+||.||+|... +|+.+|+|++.... ......+.+.+|++++++++|+|++++++++...  +..++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            667889999999999999665 58999999998764 2223346788999999999999999999999988  8999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++ +|.+++....  ..+++.++..++.||+.||+|||+.   +++|+||+|+||++++++.++|+|||.+......
T Consensus        80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            99985 8888876543  2689999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CC-cccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc---------CCCCC--ch-----
Q 004642          609 SS-YRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS---------SSGPK--IM-----  670 (740)
Q Consensus       609 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~---------~~~~~--~~-----  670 (740)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........         .....  ..     
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            21 1233457889999998765 4578899999999999999999999864332100         00000  00     


Q ss_pred             hhhhhcccCCC-cchhhhH-H-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          671 LIDVLNQRLSP-PVNQKIV-Q-DIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       671 ~~~~~~~~l~~-~~~~~~~-~-~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ........... ....... . ....+.+++.+||+.+|++||++++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00000000000 0000000 0 13347899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.2e-33  Score=290.12  Aligned_cols=251  Identities=21%  Similarity=0.237  Sum_probs=190.2

Q ss_pred             eeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHH---HHhccCCCccceeeeeeeecCeEEEEEEecc
Q 004642          457 CIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAH---VLSTVRHRNIVKLYGFCLHKKCMFLIYEYME  532 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (740)
                      .||+|+||.||++.. .+|+.||+|.+.............+..|..   .++...||+|+.+++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999965 468999999987643322221122333433   4444579999999999999999999999999


Q ss_pred             CCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcc
Q 004642          533 RGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR  612 (740)
Q Consensus       533 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  612 (740)
                      +++|.+++....   .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++......  ..
T Consensus        81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~  152 (278)
T cd05606          81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP  152 (278)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CC
Confidence            999998886543   589999999999999999999998   9999999999999999999999999998765322  22


Q ss_pred             cccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHH
Q 004642          613 TLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDI  691 (740)
Q Consensus       613 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  691 (740)
                      ....|+..|+|||++.+. .++.++||||+||++|||++|+.||......     ......... ...........   .
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~-~~~~~~~~~~~---s  223 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMT-LTMAVELPDSF---S  223 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-----chHHHHHHh-hccCCCCCCcC---C
Confidence            234789999999998754 5888999999999999999999998653210     001111111 11111111111   2


Q ss_pred             HHHHHHHHHcccCCCCCCC-----CHHHHHHHHHcCCC
Q 004642          692 ILVSTIAFACLSSQPKSRP-----TMQRISQELLAGKT  724 (740)
Q Consensus       692 ~~l~~li~~cl~~dP~~RP-----s~~ev~~~L~~~~~  724 (740)
                      ..+.+++.+|+..+|++||     ++.+++++-.....
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            2378999999999999999     99999987765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.2e-33  Score=298.57  Aligned_cols=259  Identities=22%  Similarity=0.302  Sum_probs=193.2

Q ss_pred             eeeecc--cceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEecc
Q 004642          456 YCIGTG--GYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYME  532 (740)
Q Consensus       456 ~~lg~G--~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (740)
                      ..||+|  +||+||++.. .+|+.||+|++......+ ...+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            346666  8999999965 479999999987654333 335788999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc-
Q 004642          533 RGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY-  611 (740)
Q Consensus       533 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  611 (740)
                      ++++.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+......... 
T Consensus        83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999998876432 2478999999999999999999998   9999999999999999999999999865433211111 


Q ss_pred             ------ccccccCCCcccccccccc--ccCCcchhHhHHHHHHHHHhCCCCCCcccccc-------cCCC-C-----C--
Q 004642          612 ------RTLRAGTYGYIAPELAYTI--VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS-------SSSG-P-----K--  668 (740)
Q Consensus       612 ------~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~-------~~~~-~-----~--  668 (740)
                            .....++..|+|||++.+.  .++.++||||+||++|||++|+.||.......       .... .     .  
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                  0112345679999998763  47889999999999999999999986432100       0000 0     0  


Q ss_pred             ---c-----------hhh---------hhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          669 ---I-----------MLI---------DVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       669 ---~-----------~~~---------~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                         .           ...         .........+.   .......+.+++.+||+.||++|||+.|++++-...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~  312 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS---SKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK  312 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchh---hhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence               0           000         00000001100   112234588999999999999999999999887643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-33  Score=300.28  Aligned_cols=263  Identities=25%  Similarity=0.311  Sum_probs=201.6

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC-----eE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK-----CM  524 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  524 (740)
                      +|++.+.||.|+||.||+|... +|+.||+|++..... +....+.+.+|++++++++|+||+++++++...+     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            4788999999999999999764 589999999976432 1233467889999999999999999999998775     78


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      +++|||+++ +|.+++....   .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+..
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            999999985 7888886543   689999999999999999999998   999999999999999999999999999987


Q ss_pred             cccCC---CcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccc---------cCCC-----
Q 004642          605 LHVDS---SYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS---------SSSG-----  666 (740)
Q Consensus       605 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~---------~~~~-----  666 (740)
                      .....   .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||.......         ....     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            65443   123334678899999999887 78899999999999999999999986433210         0000     


Q ss_pred             --CCchhhhhhcc---cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          667 --PKIMLIDVLNQ---RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       667 --~~~~~~~~~~~---~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                        ......+.+..   ................+.+++.+||+.+|++||++++++++...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  292 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL  292 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence              00000111110   00000000001112337899999999999999999999998543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=291.24  Aligned_cols=260  Identities=24%  Similarity=0.317  Sum_probs=199.4

Q ss_pred             cccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEe
Q 004642          452 FHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      |++.+.||+|++|.||++... +|+.+++|++....... .....+.+|++++++++|+||+++++++..++..++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            567789999999999999654 68899999987654332 3346788899999999999999999999999999999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                      +++ ++.+++....  ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+........
T Consensus        80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            976 8877776543  3689999999999999999999998   999999999999999999999999999987754432


Q ss_pred             cccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCchhhhhhc-----
Q 004642          611 YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIMLIDVLN-----  676 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~-----  676 (740)
                      ......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||........        .............     
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            23334678899999998776 788899999999999999999999864332100        0000000000000     


Q ss_pred             ----cc-CCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          677 ----QR-LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       677 ----~~-l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                          .. ...............+.+++.+||+.||.+||++++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                00 0000011111223448899999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-33  Score=301.46  Aligned_cols=263  Identities=28%  Similarity=0.356  Sum_probs=196.3

Q ss_pred             HhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeec--Ce
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHK--KC  523 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~  523 (740)
                      ..++|++.+.||+|+||.||+|... +|+.+|+|++....... .....+.+|+.+++++ +||||+++++++...  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            4578999999999999999999654 68899999886532222 2235677899999999 999999999998653  46


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccce
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      .++||||+++ +|..++...    .+++..+..++.||+.||+|||+.   +|+|+||||+||+++.++.+||+|||.+.
T Consensus        84 ~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          84 IYLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            8999999974 888887653    578899999999999999999998   99999999999999999999999999998


Q ss_pred             ecccCCC-----cccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCc
Q 004642          604 LLHVDSS-----YRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKI  669 (740)
Q Consensus       604 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~  669 (740)
                      .......     ......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||........        ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            6643321     1223468899999998765 4578899999999999999999999864321100        000000


Q ss_pred             hh--------hhhhc---ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          670 ML--------IDVLN---QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       670 ~~--------~~~~~---~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ..        ...+.   .................+.+++.+||+.+|++||++.+++++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~  296 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP  296 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence            00        00010   0000000000011123478999999999999999999999884

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=292.33  Aligned_cols=259  Identities=24%  Similarity=0.338  Sum_probs=194.8

Q ss_pred             cccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEE
Q 004642          452 FHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      |++.+.||+|++|+||+|... +++.|++|++........  .....+|+..+.+++ |+|++++++++..++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            567889999999999999765 578899999876443221  133456889999998 9999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+ +|+|.+.+.... ...+++.++..++.|++.+|.|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            99 789988887644 23579999999999999999999998   99999999999999999999999999998764322


Q ss_pred             CcccccccCCCcccccccc-ccccCCcchhHhHHHHHHHHHhCCCCCCccccccc---------CCCCCch-----hhhh
Q 004642          610 SYRTLRAGTYGYIAPELAY-TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS---------SSGPKIM-----LIDV  674 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~---------~~~~~~~-----~~~~  674 (740)
                      . .....++..|+|||++. ...++.++|+||||+++|||++|+.||........         ......+     ....
T Consensus       154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 P-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             C-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence            2 23346888999999875 44578899999999999999999999854321100         0000000     0000


Q ss_pred             hcccC----CCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          675 LNQRL----SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       675 ~~~~l----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      .....    ..............+.+++.+||+.+|++||+++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000    000000001112348899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.7e-33  Score=297.43  Aligned_cols=264  Identities=22%  Similarity=0.301  Sum_probs=197.6

Q ss_pred             HHHhcccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee-cCe
Q 004642          446 INATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH-KKC  523 (740)
Q Consensus       446 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  523 (740)
                      ..++++|++.+.||.|+||.||++. ..+|+.||+|++....... ...+.+.+|++++++++||||+++++++.. ...
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3467899999999999999999995 4478999999886543222 224677889999999999999999998876 557


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccce
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      .++++||+ +++|.+++...    .+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||.+.
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            89999998 45888777643    467788889999999999999998   99999999999999999999999999997


Q ss_pred             ecccCCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCchhh--
Q 004642          604 LLHVDSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIMLI--  672 (740)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~--  672 (740)
                      .....   .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||........        .........  
T Consensus       157 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         157 IQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             ccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            54321   122357889999998765 5688999999999999999999999864321000        000000000  


Q ss_pred             ------hhhc---ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          673 ------DVLN---QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       673 ------~~~~---~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                            +...   .....+...........+.+++.+|++.+|++||++++++.+-..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~  291 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL  291 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence                  0000   000001100011112348899999999999999999999988543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-34  Score=303.00  Aligned_cols=201  Identities=30%  Similarity=0.474  Sum_probs=176.1

Q ss_pred             cccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec------CeE
Q 004642          452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK------KCM  524 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  524 (740)
                      |...+.||+|+||.||+|+ ..+|+.||||.++.......  .+...+|++++++++|+|||++++.-.+.      ...
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~--~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP--RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccch--HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            3445679999999999997 45799999999988664443  47888999999999999999999987654      357


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc--CCCc--EEEeecc
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD--SNLE--ASVADFG  600 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~~--~kl~DfG  600 (740)
                      .+|||||.+|+|+..+.+......+++.+.+.+..+++.||.|||++   +|+||||||.||++-  ++|+  -||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            99999999999999999988888899999999999999999999999   999999999999884  4444  5999999


Q ss_pred             cceecccCCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCcc
Q 004642          601 TARLLHVDSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLL  658 (740)
Q Consensus       601 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~  658 (740)
                      .|+....++ .....+||..|.+||.... ..|+..+|.|||||++|+.+||..||...
T Consensus       170 ~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  170 AARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             ccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            999987555 5566799999999999984 78888999999999999999999998643

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.3e-33  Score=299.52  Aligned_cols=270  Identities=22%  Similarity=0.243  Sum_probs=198.3

Q ss_pred             hccccc-ceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchH-----------HHHHHHHHHHHHhccCCCccceee
Q 004642          449 TEDFHI-KYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSA-----------FVKSFQNEAHVLSTVRHRNIVKLY  515 (740)
Q Consensus       449 ~~~~~~-~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~  515 (740)
                      .++|.. .+.||+|+||.||+|.. .+++.||+|++.........           ....+.+|++++++++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            355654 46799999999999964 46899999998654332210           112577899999999999999999


Q ss_pred             eeeeecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEE
Q 004642          516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS  595 (740)
Q Consensus       516 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  595 (740)
                      +++..++..++||||++ |+|.+++....   .+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            99999999999999997 58888886433   578899999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccC--------------CCcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccc
Q 004642          596 VADFGTARLLHVD--------------SSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSS  660 (740)
Q Consensus       596 l~DfG~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~  660 (740)
                      |+|||.+......              ........++..|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999765411              1111223467899999998764 468899999999999999999999864332


Q ss_pred             ccc--------CCCCCchhhh--------hhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCC
Q 004642          661 LSS--------SSGPKIMLID--------VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       661 ~~~--------~~~~~~~~~~--------~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~  724 (740)
                      ...        ..........        ......+.............+.+++.+|++.+|++||+++|++.+......
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            100        0000000000        000000000000011112347899999999999999999999998876544


Q ss_pred             C
Q 004642          725 P  725 (740)
Q Consensus       725 ~  725 (740)
                      +
T Consensus       320 ~  320 (335)
T PTZ00024        320 P  320 (335)
T ss_pred             C
Confidence            3

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=318.36  Aligned_cols=259  Identities=27%  Similarity=0.432  Sum_probs=210.1

Q ss_pred             hcccccceeeecccceEEEEEEeC--------CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeee
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP--------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCL  519 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  519 (740)
                      .++..+.+.+|+|.||.|++|...        ....||||.++.....  ...+.+..|+++|+.+ +|+||+.++|+|.
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            344456668999999999999532        1457999999877665  3358899999999998 6999999999999


Q ss_pred             ecCeEEEEEEeccCCCchhhhcCCC-------c----c--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 004642          520 HKKCMFLIYEYMERGSLFCVLHDDD-------E----A--IELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNI  586 (740)
Q Consensus       520 ~~~~~~lv~e~~~~g~L~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NI  586 (740)
                      .++..++|+||++.|+|.+++....       .    .  ..++..+.+.++.|||.|++||++.   +++||||..+||
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV  449 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV  449 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence            9999999999999999999997654       0    0  1388999999999999999999999   999999999999


Q ss_pred             EEcCCCcEEEeecccceecccCCCcc-cccc--cCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccc
Q 004642          587 LLDSNLEASVADFGTARLLHVDSSYR-TLRA--GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLS  662 (740)
Q Consensus       587 ll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~  662 (740)
                      |++++..+||+|||+|+.......+. ....  -+..|||||.+....++.|+|||||||++||++| |..|+....   
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~---  526 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP---  526 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC---
Confidence            99999999999999999765444433 1112  2567999999999999999999999999999999 788865311   


Q ss_pred             cCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          663 SSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       663 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                          ....+.+.+.+..+.+.+....+   ++.++++.||+.+|++||++.|+.+.+...
T Consensus       527 ----~~~~l~~~l~~G~r~~~P~~c~~---eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 ----PTEELLEFLKEGNRMEQPEHCSD---EIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             ----cHHHHHHHHhcCCCCCCCCCCCH---HHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                12223445555554444443333   388999999999999999999999999873

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.1e-33  Score=294.07  Aligned_cols=265  Identities=27%  Similarity=0.377  Sum_probs=195.7

Q ss_pred             HHhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC---
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK---  522 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  522 (740)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|+++.....+ .....+.+|++++++++|||++++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            34678999999999999999999664 58999999987543222 12356778999999999999999999987654   


Q ss_pred             -------eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEE
Q 004642          523 -------CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS  595 (740)
Q Consensus       523 -------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  595 (740)
                             ..++|+||+++ ++.+.+....  ..+++..+..++.||+.||+|||+.   +|+|+||||+||++++++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                   78999999986 6666665432  2589999999999999999999998   999999999999999999999


Q ss_pred             EeecccceecccCCC-cccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CC
Q 004642          596 VADFGTARLLHVDSS-YRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SS  665 (740)
Q Consensus       596 l~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~  665 (740)
                      |+|||.+........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........        ..
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999999987654332 1222356788999998764 3578899999999999999999999864321100        00


Q ss_pred             CCCch---hhhh-----hcccC--CCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          666 GPKIM---LIDV-----LNQRL--SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       666 ~~~~~---~~~~-----~~~~l--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      .....   ..+.     .++..  ..............+.+++.+||+.+|++||++.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00000   0000     00000  000000000112347899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-33  Score=284.76  Aligned_cols=243  Identities=28%  Similarity=0.368  Sum_probs=198.1

Q ss_pred             eecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCc
Q 004642          458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL  536 (740)
Q Consensus       458 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  536 (740)
                      ||+|+||.||++... +++.+|+|.+...........+.+..|++++++++|||++++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999654 5899999998876555444567889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccccc
Q 004642          537 FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA  616 (740)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  616 (740)
                      .+++....   .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+..............
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            99987653   578999999999999999999998   999999999999999999999999999987654333334456


Q ss_pred             cCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHH
Q 004642          617 GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVST  696 (740)
Q Consensus       617 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  696 (740)
                      ++..|+|||...+...+.++|+||||+++|++++|+.||.....       ..............+..  .   ...+.+
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~--~---~~~l~~  222 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILKDPLRFPEF--L---SPEARD  222 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCCCCCCCC--C---CHHHHH
Confidence            88999999999888888999999999999999999999864321       11122222222211111  1   123789


Q ss_pred             HHHHcccCCCCCCCCH---HHHHHH
Q 004642          697 IAFACLSSQPKSRPTM---QRISQE  718 (740)
Q Consensus       697 li~~cl~~dP~~RPs~---~ev~~~  718 (740)
                      ++.+||..||++||++   +++.++
T Consensus       223 ~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         223 LISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             HHHHHhcCCHhhCCCcccHHHHHhC
Confidence            9999999999999999   565543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.4e-33  Score=288.15  Aligned_cols=253  Identities=23%  Similarity=0.342  Sum_probs=195.1

Q ss_pred             ccccceeeecccceEEEEEEeCC-CcEEEEEEccCCccc--chHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETE--DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      +|.+.+.||+|+||.||++.... +..+++|.++.....  ......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999996543 444555555432221  111234567789999999999999999999999999999


Q ss_pred             EEeccCCCchhhhcCCC-ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          528 YEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      |||+++++|.+++.... ....+++.++..++.|++.|++|||+.   +++|+||+|+||+++. +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999998886432 234689999999999999999999998   9999999999999975 569999999998765


Q ss_pred             cCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          607 VDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      ..........|+..|+|||...+..++.++|+||||+++|+|++|..||.....       ......... ...+.... 
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~~~~~-~~~~~~~~-  227 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVLRIVE-GPTPSLPE-  227 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHc-CCCCCCcc-
Confidence            443333445688899999999888888999999999999999999999863221       111111111 11111111 


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                        .....+.+++.+||+.+|++||++.|++++
T Consensus       228 --~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         228 --TYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             --hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence              112347889999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.5e-34  Score=276.56  Aligned_cols=274  Identities=23%  Similarity=0.293  Sum_probs=202.2

Q ss_pred             hcccccceeeecccceEEEEEEeCC-----CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee-cC
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE-----GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH-KK  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  522 (740)
                      ...|+....||+|.||.||+|.-++     .+.+|+|+++.+..... ......+|+.+++.++|||++.+..++.+ +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            4578889999999999999994332     23799999987654332 23567899999999999999999999887 78


Q ss_pred             eEEEEEEeccCCCchhhhcCC--CccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC----CcEEE
Q 004642          523 CMFLIYEYMERGSLFCVLHDD--DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN----LEASV  596 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl  596 (740)
                      ..++++||.+. +|+..++-.  .....++...+.+|+.||+.|+.|||++   =|+||||||.|||+..+    |.|||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence            89999999988 888887543  2334788999999999999999999998   79999999999999877    89999


Q ss_pred             eecccceecccCCC---cccccccCCCccccccccccc-cCCcchhHhHHHHHHHHHhCCCCCCcccc-cccC-------
Q 004642          597 ADFGTARLLHVDSS---YRTLRAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVLMGTHPGGLLSS-LSSS-------  664 (740)
Q Consensus       597 ~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~-~~~~-------  664 (740)
                      +|||+++.+...-.   ....++-|..|+|||.+.+.. ||.+.|||+.|||+.||+|-.+-|..... ....       
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            99999998764322   224456799999999998764 78889999999999999998766543211 0000       


Q ss_pred             ----------CC----------CC--chhhhhhcccCCCcchhhhHH----HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          665 ----------SG----------PK--IMLIDVLNQRLSPPVNQKIVQ----DIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       665 ----------~~----------~~--~~~~~~~~~~l~~~~~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                                +.          ++  ..+.++-...........+..    ......+++.+++..||.+|.|+++.+++
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence                      00          00  000000000000000000000    01115689999999999999999999999


Q ss_pred             HHcCCCCCh
Q 004642          719 LLAGKTPMQ  727 (740)
Q Consensus       719 L~~~~~~~~  727 (740)
                      .-..+.+.+
T Consensus       338 ~yF~~d~lp  346 (438)
T KOG0666|consen  338 PYFTEDPLP  346 (438)
T ss_pred             cccccCCCC
Confidence            988776544

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.1e-33  Score=290.59  Aligned_cols=260  Identities=26%  Similarity=0.345  Sum_probs=199.3

Q ss_pred             ccccceeeecccceEEEEEEe----CCCcEEEEEEccCCcccc-hHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL----PEGKVVALKKLHHSETED-SAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCM  524 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  524 (740)
                      .|++.+.||+|+||.||++..    .+|+.||+|++....... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999965    368999999987543221 22346678899999999 589999999999999999


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++||||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999987543   578889999999999999999998   999999999999999999999999999987


Q ss_pred             cccCCCc-ccccccCCCcccccccccc--ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          605 LHVDSSY-RTLRAGTYGYIAPELAYTI--VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       605 ~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      ....... .....|+..|+|||...+.  .++.++||||||+++|+|++|+.||.....    ........+.+..... 
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~-  229 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSEP-  229 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhccCC-
Confidence            5432221 2234688999999998753  467889999999999999999999863211    0111111111111111 


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHcCCC
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRP-----TMQRISQELLAGKT  724 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ev~~~L~~~~~  724 (740)
                      +.+.   .....+.+++.+|++.||++||     ++.+++++-...+.
T Consensus       230 ~~~~---~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         230 PYPQ---EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             CCCc---cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            1111   1122378999999999999997     78888877544433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=275.17  Aligned_cols=257  Identities=25%  Similarity=0.324  Sum_probs=203.9

Q ss_pred             Hhcccccc-eeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeee----
Q 004642          448 ATEDFHIK-YCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLH----  520 (740)
Q Consensus       448 ~~~~~~~~-~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----  520 (740)
                      ++++|.+. ++||-|-.|.|-.+. ..+|+.+|+|++...        ...++|++..-.. .|||||.++++|..    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            45667664 469999999999984 457899999999653        3456788876555 79999999998874    


Q ss_pred             cCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCcEEEe
Q 004642          521 KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS---NLEASVA  597 (740)
Q Consensus       521 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~  597 (740)
                      ...+.+|||.|+||.|.+.+++.+. ..+++.++-.|++||+.|+.|||+.   .|.||||||+|+|+..   +..+||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence            4678999999999999999987653 3689999999999999999999998   9999999999999974   5578999


Q ss_pred             ecccceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcc
Q 004642          598 DFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ  677 (740)
Q Consensus       598 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  677 (740)
                      |||+|+.-..... ....+-|++|.|||++-...|+...|+||+||++|-|++|..||-.........   .+...+...
T Consensus       207 DfGFAK~t~~~~~-L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp---gMk~rI~~g  282 (400)
T KOG0604|consen  207 DFGFAKETQEPGD-LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKRRIRTG  282 (400)
T ss_pred             ccccccccCCCcc-ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh---hHHhHhhcc
Confidence            9999987553332 333477999999999998899999999999999999999999986544322222   222233222


Q ss_pred             cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          678 RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       678 ~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ... .....|.+-.....++|+.+|..+|.+|-|..|++.+-.-
T Consensus       283 qy~-FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi  325 (400)
T KOG0604|consen  283 QYE-FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI  325 (400)
T ss_pred             Ccc-CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence            222 2233466666668899999999999999999999988753

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.3e-33  Score=294.01  Aligned_cols=263  Identities=19%  Similarity=0.213  Sum_probs=193.8

Q ss_pred             cceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccC
Q 004642          454 IKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      +.+.+|.|+++.||++.. +|+.||+|++...... ....+.+.+|++++++++|+||+++++++..++..+++|||+++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            344456666666666654 7999999999765322 23457899999999999999999999999999999999999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC---
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS---  610 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---  610 (740)
                      |+|.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||.+........   
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          84 GSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            999999875432 2578889999999999999999999   999999999999999999999999999876532211   


Q ss_pred             ----cccccccCCCcccccccccc--ccCCcchhHhHHHHHHHHHhCCCCCCccccccc----C--CCC-----Cc----
Q 004642          611 ----YRTLRAGTYGYIAPELAYTI--VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS----S--SGP-----KI----  669 (740)
Q Consensus       611 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~----~--~~~-----~~----  669 (740)
                          ......++..|+|||++...  .++.++|||||||++|||++|+.||........    .  ...     ..    
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence                11223567889999998753  578899999999999999999999874321000    0  000     00    


Q ss_pred             --hhhh----hhcccCCC-cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          670 --MLID----VLNQRLSP-PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       670 --~~~~----~~~~~l~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                        ....    ..+..... ............+.+++.+||+.||++||+++|++++....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~  299 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK  299 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence              0000    00000000 00000111123478899999999999999999999988765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-33  Score=297.23  Aligned_cols=270  Identities=21%  Similarity=0.263  Sum_probs=201.3

Q ss_pred             cHHHHHHHhcccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeee
Q 004642          441 LYEDLINATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCL  519 (740)
Q Consensus       441 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  519 (740)
                      ...++..++++|++.+.||+|+||.||+|. ..+|+.||+|++...... ....+.+.+|++++++++||||+++++++.
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            345667788999999999999999999995 457899999999764322 222456788999999999999999999886


Q ss_pred             ec------CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc
Q 004642          520 HK------KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLE  593 (740)
Q Consensus       520 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  593 (740)
                      ..      ...+++++++ +++|.+++...    .+++..+..++.|+++||+|||+.   +++||||||+||+++.++.
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence            43      3467888876 77888877543    478999999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------C
Q 004642          594 ASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------S  664 (740)
Q Consensus       594 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~  664 (740)
                      ++|+|||+++....   ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||........        .
T Consensus       159 ~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         159 LKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             EEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999999876432   1223467889999998866 4678899999999999999999999864321100        0


Q ss_pred             CCCCch--------hhhh---hcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          665 SGPKIM--------LIDV---LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       665 ~~~~~~--------~~~~---~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ......        ....   +..................+.+++.+|++.||++||++.+++++-...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~  304 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  304 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence            000000        0000   000000000000001123378999999999999999999999987654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-33  Score=297.50  Aligned_cols=258  Identities=23%  Similarity=0.292  Sum_probs=192.0

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec------
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK------  521 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  521 (740)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++......+ .....+.+|++++++++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            47899999999999999999965 468999999987543222 2245678999999999999999999998754      


Q ss_pred             CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      ...++|+||+.. ++..+..     ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            346999999864 6655542     1478899999999999999999998   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc-------CCCCCch---
Q 004642          602 ARLLHVDSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-------SSGPKIM---  670 (740)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~---  670 (740)
                      ++.....   .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........       .......   
T Consensus       164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         164 ARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9764321   223367889999999876 4578899999999999999999999875321100       0000000   


Q ss_pred             ------hhhhhcccC---CCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          671 ------LIDVLNQRL---SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       671 ------~~~~~~~~l---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                            .........   ..............+.+++.+||+.||++||+++|++++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~  298 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHP  298 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence                  000000000   0000000011123377999999999999999999999873

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.6e-33  Score=289.45  Aligned_cols=258  Identities=24%  Similarity=0.311  Sum_probs=197.7

Q ss_pred             ccccceeeecccceEEEEEEe----CCCcEEEEEEccCCccc-chHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL----PEGKVVALKKLHHSETE-DSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCM  524 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  524 (740)
                      +|++.+.||+|+||.||++..    .+++.||||.++..... .....+.+.+|++++.++ +||||+++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999854    35788999998754322 122346788999999999 599999999999999999


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++||||+++|+|.+++....   .+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999998886543   578899999999999999999998   999999999999999999999999999876


Q ss_pred             cccCCCc-ccccccCCCccccccccccc--cCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC
Q 004642          605 LHVDSSY-RTLRAGTYGYIAPELAYTIV--VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       605 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~  681 (740)
                      ....... .....|+..|+|||...+..  .+.++||||||+++|||++|+.||......   .................
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~  231 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ---NSQSEISRRILKSKPPF  231 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc---chHHHHHHHHHccCCCC
Confidence            5433221 22345889999999987655  678999999999999999999998632110   00001111111111111


Q ss_pred             cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                        ...   ....+.+++.+||+.+|++|||+.++.+.|.-.
T Consensus       232 --~~~---~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         232 --PKT---MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             --Ccc---cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence              111   112378899999999999999987776655443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-33  Score=302.10  Aligned_cols=272  Identities=25%  Similarity=0.411  Sum_probs=223.7

Q ss_pred             cHHHHHHHhcccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeee
Q 004642          441 LYEDLINATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFC  518 (740)
Q Consensus       441 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  518 (740)
                      .++.+...++.|++.+.||+|.+|.||+++ .++|+.+|+|+.......+    +++..|.++++.. .|||++.++|++
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEE
Confidence            345556678899999999999999999994 4578999999998776654    4566788888887 699999999998


Q ss_pred             ee-----cCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc
Q 004642          519 LH-----KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLE  593 (740)
Q Consensus       519 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~  593 (740)
                      ..     ++.+|+|||||.+|+..|++.... ...+.|..+.-|.+.++.|+.+||..   .++|||||-.|||++.++.
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence            74     578999999999999999998766 55799999999999999999999998   9999999999999999999


Q ss_pred             EEEeecccceecccCCCcccccccCCCccccccccc-----cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCC
Q 004642          594 ASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT-----IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPK  668 (740)
Q Consensus       594 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~  668 (740)
                      ||++|||.+..+..........+||+.|||||++..     ..|+.++|+||+|++..||.-|..|+.++..        
T Consensus       162 VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--------  233 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--------  233 (953)
T ss_pred             EEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--------
Confidence            999999999887655555667789999999999863     3477789999999999999999999765432        


Q ss_pred             chhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCChhh
Q 004642          669 IMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKA  729 (740)
Q Consensus       669 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~  729 (740)
                       +..-+.-++-+++....+..-..++.++|..|+..|.++||++.++++|-...+.+.++.
T Consensus       234 -mraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~~e~q  293 (953)
T KOG0587|consen  234 -MRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQPNERQ  293 (953)
T ss_pred             -hhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccccHHH
Confidence             222222333344444444444555999999999999999999999999887765554443

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-33  Score=290.34  Aligned_cols=260  Identities=23%  Similarity=0.298  Sum_probs=198.5

Q ss_pred             cccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEe
Q 004642          452 FHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      |+..+.||+|++|.||+|... +++.||+|++...... ....+.+..|++++++++|+|++++++++.+.+..++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            556788999999999999665 5899999999875422 22346778899999999999999999999999999999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                      +++ +|.+++....  ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||.++.......
T Consensus        80 ~~~-~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          80 CDM-DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             cCc-CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            984 8999987653  2589999999999999999999998   999999999999999999999999999987654333


Q ss_pred             cccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCchh---------h
Q 004642          611 YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIML---------I  672 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~---------~  672 (740)
                      ......++..|+|||.+.+. .++.++|||||||++|||++|+.||........        ........         .
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            33334567889999998766 788899999999999999999999865331100        00000000         0


Q ss_pred             hhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          673 DVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       673 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      .....................+.+++.+||..+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0000000000000001112348899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.4e-33  Score=294.20  Aligned_cols=263  Identities=25%  Similarity=0.319  Sum_probs=192.2

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec------
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK------  521 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  521 (740)
                      .++|++.+.||+|+||.||+|... +++.+|+|++......+. ....+.+|++++++++||||+++++++.+.      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            578999999999999999999654 689999998865433221 124567899999999999999999987543      


Q ss_pred             --CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeec
Q 004642          522 --KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF  599 (740)
Q Consensus       522 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  599 (740)
                        ...++|+||+++ ++...+....  ..+++.++..++.|+++||+|||+.   +++|+||||+||++++++.++|+||
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              346999999975 6666665432  2589999999999999999999998   9999999999999999999999999


Q ss_pred             ccceecccCCCc-----------ccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccccc----
Q 004642          600 GTARLLHVDSSY-----------RTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS----  663 (740)
Q Consensus       600 G~a~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~----  663 (740)
                      |+++........           .....++..|+|||.+.+. .++.++|||||||++|||++|+.||........    
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999765432211           1123567889999987654 578899999999999999999999864322100    


Q ss_pred             ----CC-CCC-----chhhh----hhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          664 ----SS-GPK-----IMLID----VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       664 ----~~-~~~-----~~~~~----~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                          .. ...     .....    .......+............+.+++.+|++.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence                00 000     00000    000001111000011112347899999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.3e-32  Score=316.74  Aligned_cols=148  Identities=29%  Similarity=0.466  Sum_probs=134.2

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ++|.+.+.||+|+||.||+|... +++.||+|+++............+.+|+.++..++||||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67999999999999999999655 68999999998655555555678899999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccce
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      ||+++++|.+++....   .+++..++.++.||+.||+|||.+   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999997643   478889999999999999999998   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-32  Score=294.76  Aligned_cols=263  Identities=22%  Similarity=0.294  Sum_probs=196.9

Q ss_pred             HHhcccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC---
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK---  522 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  522 (740)
                      ...++|++.+.||+|+||.||++. ..+|+.||||++..... .....+.+.+|++++++++||||+++++++....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            356789999999999999999995 45789999999865432 2233457889999999999999999999887543   


Q ss_pred             ---eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeec
Q 004642          523 ---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF  599 (740)
Q Consensus       523 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  599 (740)
                         ..++||||+ +++|.+++...    .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.++|+||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence               468999998 67888777542    588999999999999999999998   9999999999999999999999999


Q ss_pred             ccceecccCCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCch
Q 004642          600 GTARLLHVDSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIM  670 (740)
Q Consensus       600 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~  670 (740)
                      |++......   .....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||........        .......
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            999765322   223357889999998876 4578899999999999999999999874321100        0000000


Q ss_pred             --------hhhhhccc--CCC-cchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          671 --------LIDVLNQR--LSP-PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       671 --------~~~~~~~~--l~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                              ........  ..+ ............+.+++.+|++.||++||++.+++++-..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~  301 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF  301 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccH
Confidence                    00000000  000 0000001112237899999999999999999999976543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.5e-33  Score=295.47  Aligned_cols=262  Identities=21%  Similarity=0.282  Sum_probs=197.9

Q ss_pred             HhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCe---
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC---  523 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  523 (740)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++++++|||++++++++...+.   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            4678999999999999999999664 5789999998754322 2234667789999999999999999998876554   


Q ss_pred             ---EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecc
Q 004642          524 ---MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG  600 (740)
Q Consensus       524 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  600 (740)
                         .++|+||+ +++|.+++...    .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence               89999998 56898888652    589999999999999999999998   99999999999999999999999999


Q ss_pred             cceecccCCCcccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCch-
Q 004642          601 TARLLHVDSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIM-  670 (740)
Q Consensus       601 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~-  670 (740)
                      .+......   .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||........        ....+.. 
T Consensus       164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         164 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            99865432   223367889999998865 3578899999999999999999999864321100        0000000 


Q ss_pred             -------hhhhhcc---cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          671 -------LIDVLNQ---RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       671 -------~~~~~~~---~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                             ....+..   ................+.+++.+|++.+|++|||+.|++++-..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~  301 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL  301 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence                   0000000   00000000001113348899999999999999999999987644

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.4e-32  Score=291.11  Aligned_cols=263  Identities=22%  Similarity=0.308  Sum_probs=193.1

Q ss_pred             ccccceeeecccceEEEEEEeC-C--CcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeec----C
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-E--GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHK----K  522 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~  522 (740)
                      +|++.+.||+|+||.||++... .  ++.||+|++...... ....+.+.+|+++++++ +||||+++++.+...    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            4788899999999999999654 3  788999998753322 22346778899999999 599999999875432    4


Q ss_pred             eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccc
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                      ..++++||+. ++|.+++....   .+++..+..++.||+.||+|||+.   +++||||||+||+++.++.++|+|||.+
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            5788899886 58888886433   588999999999999999999998   9999999999999999999999999999


Q ss_pred             eecccCCC----cccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc--------CCCCCc
Q 004642          603 RLLHVDSS----YRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKI  669 (740)
Q Consensus       603 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~  669 (740)
                      +.......    ......|+..|+|||+..+ ..++.++||||+||++|+|++|+.||........        ......
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            86543221    1223468999999998765 4688899999999999999999999864321000        000000


Q ss_pred             hhhhh-----------hcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          670 MLIDV-----------LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       670 ~~~~~-----------~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      .....           ...................+.+++.+|++.||++||++.|++++-..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~  295 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL  295 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence            00000           00000000000001112348899999999999999999999987643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-32  Score=293.86  Aligned_cols=263  Identities=22%  Similarity=0.269  Sum_probs=193.1

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeec------
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK------  521 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  521 (740)
                      ..+|.+.+.||.|+||.||+|.. .+|+.||+|++......   ..+.+.+|++++++++||||+++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---hHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            46899999999999999999955 46899999998665432   246788899999999999999999876643      


Q ss_pred             --------CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CC
Q 004642          522 --------KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-NL  592 (740)
Q Consensus       522 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~  592 (740)
                              ...++||||++ ++|.+++...    .+++..+..++.||+.||+|||+.   +++||||||+||+++. ++
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~  152 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence                    35799999997 4888777542    478999999999999999999998   9999999999999984 55


Q ss_pred             cEEEeecccceecccCCC---cccccccCCCccccccccc-cccCCcchhHhHHHHHHHHHhCCCCCCccccccc-----
Q 004642          593 EASVADFGTARLLHVDSS---YRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-----  663 (740)
Q Consensus       593 ~~kl~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-----  663 (740)
                      .++++|||.++.......   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........     
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            789999999976532211   1123357889999998654 4577899999999999999999999964332100     


Q ss_pred             --CCC-CCchh-------hhhhc---ccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          664 --SSG-PKIML-------IDVLN---QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       664 --~~~-~~~~~-------~~~~~---~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                        ... .....       .....   .....+...........+.+++.+|++.||++||++.|++++-...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence              000 00000       00000   0000000000011123477899999999999999999999876543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=287.32  Aligned_cols=250  Identities=23%  Similarity=0.310  Sum_probs=203.1

Q ss_pred             ceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccC
Q 004642          455 KYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       455 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      .+.||+|.||+||-|. .++|+.||||++.+....... ..++++|+.++++++||.||.+-..|+.++..+.|||.+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            4679999999999994 457999999999886665543 37889999999999999999999999999999999999977


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC---CcEEEeecccceecccCCC
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN---LEASVADFGTARLLHVDSS  610 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~DfG~a~~~~~~~~  610 (740)
                      .-|+-.+....+  ++++.....++.||+.||.|||.+   +|+|+||||+|||+...   -++||+|||+|+.+.. ..
T Consensus       648 DMLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-ks  721 (888)
T KOG4236|consen  648 DMLEMILSSEKG--RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-KS  721 (888)
T ss_pred             hHHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch-hh
Confidence            555555544333  688888888999999999999999   99999999999999754   3699999999999864 55


Q ss_pred             cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHH
Q 004642          611 YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQD  690 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  690 (740)
                      +....+||+.|+|||++....|...-|+||.|||+|--++|.-||....          ++.+.+...-..-.+..|.+-
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----------dIndQIQNAaFMyPp~PW~ei  791 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----------DINDQIQNAAFMYPPNPWSEI  791 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----------chhHHhhccccccCCCchhhc
Confidence            6677799999999999999999999999999999999999999987422          222222222211112234455


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          691 IILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       691 ~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      .....++|...++..-++|-+..+-+.+.+-
T Consensus       792 s~~AidlIn~LLqVkm~kRysvdk~lsh~Wl  822 (888)
T KOG4236|consen  792 SPEAIDLINNLLQVKMRKRYSVDKSLSHPWL  822 (888)
T ss_pred             CHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence            5558899999999999999988887766543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-32  Score=270.74  Aligned_cols=263  Identities=21%  Similarity=0.325  Sum_probs=211.6

Q ss_pred             HHHHHHHhcccccceeeecccceEEEEEEeCC------CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceee
Q 004642          442 YEDLINATEDFHIKYCIGTGGYGSVYKAELPE------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY  515 (740)
Q Consensus       442 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  515 (740)
                      .+++.....+++....+-+|.||.||+|.|.+      .+.|-||.++....+-  ....+..|.-.+....|||+.++.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~i--Qv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQI--QVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHH--HHHHHHHHHHHHhcCcCCCcccee
Confidence            45666667788888889999999999995543      4557788887665443  356788888888889999999999


Q ss_pred             eeeee-cCeEEEEEEeccCCCchhhhc-----CCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 004642          516 GFCLH-KKCMFLIYEYMERGSLFCVLH-----DDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD  589 (740)
Q Consensus       516 ~~~~~-~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  589 (740)
                      +.+.+ ....+.+|.++.-|+|..++.     +......++..+...++.|++.|++|||++   +|+|.||..+|.++|
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence            99876 456799999999999999998     444556788899999999999999999999   999999999999999


Q ss_pred             CCCcEEEeecccceecccCCCcc--cccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCC
Q 004642          590 SNLEASVADFGTARLLHVDSSYR--TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSG  666 (740)
Q Consensus       590 ~~~~~kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~  666 (740)
                      +..++||+|=.+++.+.+.+.+.  .....+..||+||.+....|+.++|||||||++|||+| |+.|+.....++    
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE----  506 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE----  506 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH----
Confidence            99999999999999887655432  22234678999999999999999999999999999999 999977544321    


Q ss_pred             CCchhhhhhcc--cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          667 PKIMLIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       667 ~~~~~~~~~~~--~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                         + ...+.+  ++.++.     .+..++..++..||+.+|++||+++|++.-|.+-
T Consensus       507 ---m-~~ylkdGyRlaQP~-----NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  507 ---M-EHYLKDGYRLAQPF-----NCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ---H-HHHHhccceecCCC-----CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence               1 122222  222222     2334489999999999999999999999988653

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.98  E-value=2e-33  Score=278.79  Aligned_cols=275  Identities=20%  Similarity=0.291  Sum_probs=207.4

Q ss_pred             CCcccHHHHHHHhcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCC--C----
Q 004642          437 DGKILYEDLINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH--R----  509 (740)
Q Consensus       437 ~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----  509 (740)
                      +|...|+.-...+++|.+...+|+|.||.|-++ +...+..||+|+++....    ..+..+-|+++++++.+  |    
T Consensus        76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~  151 (415)
T KOG0671|consen   76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKF  151 (415)
T ss_pred             CceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCce
Confidence            444444444445889999999999999999999 444578999999976432    34566789999999932  2    


Q ss_pred             ccceeeeeeeecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 004642          510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD  589 (740)
Q Consensus       510 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  589 (740)
                      -+|.+.+++...++.++|+|.+ |-++++++..+.. .+++...+..|+.|+++++++||+.   +++|-||||+|||+.
T Consensus       152 rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfv  226 (415)
T KOG0671|consen  152 RCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFV  226 (415)
T ss_pred             EEEeeehhhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEe
Confidence            3788889999999999999987 5589999987554 4788999999999999999999998   999999999999984


Q ss_pred             C--------------------CCcEEEeecccceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHH
Q 004642          590 S--------------------NLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL  649 (740)
Q Consensus       590 ~--------------------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell  649 (740)
                      +                    ...++|+|||.|++-.   ...+..+.|..|+|||++.+..++.++||||+||||+|+.
T Consensus       227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely  303 (415)
T KOG0671|consen  227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY  303 (415)
T ss_pred             ccceEEEeccCCccceeccCCCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence            2                    2358999999998643   3335567899999999999999999999999999999999


Q ss_pred             hCCCCCCcccccc--------cCCCCCchh-----hhh-------------------hcccCCC--cchhhhHHHHHHHH
Q 004642          650 MGTHPGGLLSSLS--------SSSGPKIML-----IDV-------------------LNQRLSP--PVNQKIVQDIILVS  695 (740)
Q Consensus       650 tg~~p~~~~~~~~--------~~~~~~~~~-----~~~-------------------~~~~l~~--~~~~~~~~~~~~l~  695 (740)
                      ||..-|......+        -.+.+..++     .+.                   +.+...+  ..-.....+...+.
T Consensus       304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf  383 (415)
T KOG0671|consen  304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF  383 (415)
T ss_pred             ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence            9998876543110        000000000     000                   0000100  00111224445599


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          696 TIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       696 ~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      +++.+|+..||.+|+|+.|++.|-....
T Consensus       384 DLl~~mL~fDP~~RiTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  384 DLLRRMLEFDPARRITLREALSHPFFAR  411 (415)
T ss_pred             HHHHHHHccCccccccHHHHhcCHHhhc
Confidence            9999999999999999999999877653

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-33  Score=281.19  Aligned_cols=263  Identities=26%  Similarity=0.389  Sum_probs=203.5

Q ss_pred             HHhcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccch----HHHHHHHHHHHHHhccCCCccceeeeeee-e
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDS----AFVKSFQNEAHVLSTVRHRNIVKLYGFCL-H  520 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~  520 (740)
                      ...++|-..+.||+|||+.||++ ++.+.+.||||+-.......+    ...+-..+|..+.+.+.||.||++|+|+. +
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            34568888999999999999999 677788999998776544433    34556789999999999999999999997 5


Q ss_pred             cCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---CCcEEEe
Q 004642          521 KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS---NLEASVA  597 (740)
Q Consensus       521 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~  597 (740)
                      .+.++-|.|||+|.+|+-++....   .++++++..|+.||+.||.||.+. .++|||.||||.|||+..   -|.+||+
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence            677899999999999999987655   589999999999999999999987 679999999999999953   4679999


Q ss_pred             ecccceecccCCCc-------ccccccCCCcccccccccc----ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCC
Q 004642          598 DFGTARLLHVDSSY-------RTLRAGTYGYIAPELAYTI----VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG  666 (740)
Q Consensus       598 DfG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~  666 (740)
                      |||+++.+..++..       .+...||..|++||.+.-+    .++.|+||||.|||+|+.+.|+.||+....-..- .
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI-L  694 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI-L  694 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH-H
Confidence            99999998765442       2335799999999987633    4778999999999999999999999864321000 0


Q ss_pred             CCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          667 PKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       667 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ....+...-.-.. ++.+.    ...+...+|++|+++.-++|....++..+-
T Consensus       695 qeNTIlkAtEVqF-P~KPv----VsseAkaFIRRCLaYRKeDR~DV~qLA~dp  742 (775)
T KOG1151|consen  695 QENTILKATEVQF-PPKPV----VSSEAKAFIRRCLAYRKEDRIDVQQLACDP  742 (775)
T ss_pred             hhhchhcceeccC-CCCCc----cCHHHHHHHHHHHHhhhhhhhhHHHHccCc
Confidence            1111111111111 11111    122367899999999999999988887654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.6e-33  Score=274.74  Aligned_cols=244  Identities=25%  Similarity=0.358  Sum_probs=202.8

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (740)
                      ..+|.....||+|+||.|.++..+ +.+.||||++++...-...-++--+.|-+++... +-|.+++++.++..-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            357899999999999999999554 4678999999876543332233445677777766 67899999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      ||||+.||+|--+++..+   .+.+..+..+|..||-||-+||++   ||+.||||..|||++.+|++||+|||+++.--
T Consensus       428 VMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence            999999999988887765   467778888999999999999999   99999999999999999999999999998766


Q ss_pred             cCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhh
Q 004642          607 VDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  686 (740)
                      .+.......+||+.|+|||++...+|...+|.|||||+||||+.|+.||+..       ..++....+.+.....+..  
T Consensus       502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe-------DE~elF~aI~ehnvsyPKs--  572 (683)
T KOG0696|consen  502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-------DEDELFQAIMEHNVSYPKS--  572 (683)
T ss_pred             cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHHHHccCcCccc--
Confidence            6666667789999999999999999999999999999999999999999863       3355566777776655432  


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCC
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRP  710 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RP  710 (740)
                      ...+   ...+.+..+...|.+|.
T Consensus       573 lSkE---Av~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  573 LSKE---AVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ccHH---HHHHHHHHhhcCCcccc
Confidence            2222   56788888999999994

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=1.9e-34  Score=271.74  Aligned_cols=253  Identities=27%  Similarity=0.348  Sum_probs=192.2

Q ss_pred             eeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEeccC
Q 004642          456 YCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      ..||.|+||+|++.. .+.|+..|||+++......  ..+++..|.+...+- ++||||++||.+...+..|+.||.|+-
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k--eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~  147 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK--EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI  147 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH--HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence            459999999999984 4579999999998766533  247788888765554 799999999999999999999999964


Q ss_pred             CCch---hhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCC
Q 004642          534 GSLF---CVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       534 g~L~---~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                       ++.   .+++.-. ...+++.-.-.|..-.+.||+||.+.  ..|+|||+||+|||++..|.+|++|||++-.+. ++.
T Consensus       148 -SlDklYk~vy~vq-~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv-~Si  222 (361)
T KOG1006|consen  148 -SLDKLYKRVYSVQ-KSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV-DSI  222 (361)
T ss_pred             -hHHHHHHHHHHHH-hccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHH-HHH
Confidence             443   3333322 23577777778888899999999876  489999999999999999999999999997764 344


Q ss_pred             cccccccCCCccccccccc--cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcc-hhhh
Q 004642          611 YRTLRAGTYGYIAPELAYT--IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV-NQKI  687 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~  687 (740)
                      ..+...|-..|||||.+..  ..|+-+|||||+|+++||+.||+.|+.....      ..+.+..++....+.-. ....
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfeql~~Vv~gdpp~l~~~~~~  296 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFEQLCQVVIGDPPILLFDKEC  296 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHHHHHHHHcCCCCeecCcccc
Confidence            4455678899999998863  3488899999999999999999999764321      11112223322222211 1111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      ......+.+++..|+.+|-..||.+.++.++-..
T Consensus       297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy  330 (361)
T KOG1006|consen  297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY  330 (361)
T ss_pred             cccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence            2234458899999999999999999999877643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-32  Score=290.31  Aligned_cols=243  Identities=24%  Similarity=0.316  Sum_probs=194.8

Q ss_pred             hcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (740)
                      ++.|.+...+|.|+|+.|-.+ ...+++..+||++.....       .-.+|+.++... +|||++++.+.+.++.+.|+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence            567778888999999999888 455688999999987632       233567666665 79999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEE-cCCCcEEEeecccceec
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL-DSNLEASVADFGTARLL  605 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~DfG~a~~~  605 (740)
                      |||++.|+-+.+.+.....   .. .++..|+.+|+.|+.|||++   ||+|||+||+|||+ +..++++|+|||.++..
T Consensus       394 v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             eehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            9999999988877765432   22 67778999999999999999   99999999999999 69999999999999876


Q ss_pred             ccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchh
Q 004642          606 HVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  685 (740)
                      ..+   ....+-|..|.|||+.....|++++|+||||++||+|++|+.||.....      .    .++..+...+....
T Consensus       467 ~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~------~----~ei~~~i~~~~~s~  533 (612)
T KOG0603|consen  467 ERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA------G----IEIHTRIQMPKFSE  533 (612)
T ss_pred             chh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc------h----HHHHHhhcCCcccc
Confidence            543   2222457899999999999999999999999999999999999864211      1    22222222222222


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                         .-.....+++..||+.||.+||+|.++..+-..
T Consensus       534 ---~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  534 ---CVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ---ccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence               122237899999999999999999999998877

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.6e-33  Score=308.45  Aligned_cols=264  Identities=27%  Similarity=0.351  Sum_probs=211.1

Q ss_pred             HHHHHHHhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee
Q 004642          442 YEDLINATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH  520 (740)
Q Consensus       442 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  520 (740)
                      ..++.-..++|.+++.||+|+||.|..++++ +++.||.|++.+-..-......-|..|..+|..-..+=|+.++-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            3455566789999999999999999999765 588999999987433333335788999999999999999999999999


Q ss_pred             cCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecc
Q 004642          521 KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG  600 (740)
Q Consensus       521 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  600 (740)
                      ...+|+|||||+||+|..++.+.+   .+++..+..++..|+-||+-+|+-   |+|||||||.|||+|..|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence            999999999999999999998876   578888889999999999999988   99999999999999999999999999


Q ss_pred             cceecccCCCc-ccccccCCCcccccccc----c-cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhh
Q 004642          601 TARLLHVDSSY-RTLRAGTYGYIAPELAY----T-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDV  674 (740)
Q Consensus       601 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  674 (740)
                      .+-.+..+... ....+|||-|.+||++.    + +.|.+.+|.||+||++|||+.|..||-..+..       .....+
T Consensus       221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-------eTY~KI  293 (1317)
T KOG0612|consen  221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-------ETYGKI  293 (1317)
T ss_pred             hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH-------HHHHHH
Confidence            99877655443 44568999999999986    3 56889999999999999999999998643221       112233


Q ss_pred             hcc--cCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHHHcC
Q 004642          675 LNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPT---MQRISQELLAG  722 (740)
Q Consensus       675 ~~~--~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev~~~L~~~  722 (740)
                      ++.  .+..|......+   ...++|.+.+. +|+.|-.   ++++..|.+..
T Consensus       294 m~hk~~l~FP~~~~VSe---eakdLI~~ll~-~~e~RLgrngiedik~HpFF~  342 (1317)
T KOG0612|consen  294 MNHKESLSFPDETDVSE---EAKDLIEALLC-DREVRLGRNGIEDIKNHPFFE  342 (1317)
T ss_pred             hchhhhcCCCcccccCH---HHHHHHHHHhc-ChhhhcccccHHHHHhCcccc
Confidence            333  222221111222   36677766555 6888876   99999887654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.7e-33  Score=263.24  Aligned_cols=274  Identities=23%  Similarity=0.333  Sum_probs=202.5

Q ss_pred             cccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee--------
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH--------  520 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  520 (740)
                      ..|.-..+||+|.||+||+|+.+ +|+.||+|++..+.... .+-....+|+++++.++|+|++.+++.|..        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            44556678999999999999554 57888998775432221 222455789999999999999999998864        


Q ss_pred             cCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecc
Q 004642          521 KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG  600 (740)
Q Consensus       521 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  600 (740)
                      ....|+|+++|++ +|..++....  ..++..++.+++.++..||.|+|..   .|+|||+||.|+|++.+|.+||+|||
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            3458999999987 7888886543  3678899999999999999999998   99999999999999999999999999


Q ss_pred             cceecccCCC----cccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCccccc--------------
Q 004642          601 TARLLHVDSS----YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSL--------------  661 (740)
Q Consensus       601 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~--------------  661 (740)
                      +++.+.....    ..+.++-|..|++||.+.+. .|+++.|||+.|||+.||+||.+-+...+..              
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            9976643322    23445679999999998865 5889999999999999999999887644320              


Q ss_pred             --ccCCCCCchhhhhhccc-CCCcchhhhHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCCChhhh
Q 004642          662 --SSSSGPKIMLIDVLNQR-LSPPVNQKIVQD------IILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKAL  730 (740)
Q Consensus       662 --~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~  730 (740)
                        .+.......+.+.+.-. ++........+.      .....+++.+++..||.+|+.+.+++.+-..-+.|.+.+.
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqan  327 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQAN  327 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchhh
Confidence              01111111111211111 100000000000      1126789999999999999999999999998888887553

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.9e-31  Score=269.95  Aligned_cols=219  Identities=21%  Similarity=0.203  Sum_probs=173.0

Q ss_pred             ccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCchhh
Q 004642          461 GGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCV  539 (740)
Q Consensus       461 G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  539 (740)
                      |.+|.||++.. .+++.||+|++.....        +.+|...+....|||++++++++.+.+..+++|||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            88999999954 5789999999976432        23344455556799999999999999999999999999999998


Q ss_pred             hcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccccccCC
Q 004642          540 LHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY  619 (740)
Q Consensus       540 l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  619 (740)
                      +....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+......   .....++.
T Consensus        76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~  146 (237)
T cd05576          76 ISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVEN  146 (237)
T ss_pred             HHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCc
Confidence            86543   488999999999999999999998   9999999999999999999999999988655322   12234577


Q ss_pred             CccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHH
Q 004642          620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAF  699 (740)
Q Consensus       620 ~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~  699 (740)
                      .|+|||...+..++.++||||+|+++|||++|+.|+.......         .......++.    ..   ...+.+++.
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------~~~~~~~~~~----~~---~~~~~~li~  210 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------NTHTTLNIPE----WV---SEEARSLLQ  210 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------ccccccCCcc----cC---CHHHHHHHH
Confidence            8999999988888999999999999999999998865321100         0000001111    01   123778999


Q ss_pred             HcccCCCCCCCCH
Q 004642          700 ACLSSQPKSRPTM  712 (740)
Q Consensus       700 ~cl~~dP~~RPs~  712 (740)
                      +|++.||++||++
T Consensus       211 ~~l~~dp~~R~~~  223 (237)
T cd05576         211 QLLQFNPTERLGA  223 (237)
T ss_pred             HHccCCHHHhcCC
Confidence            9999999999986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=238.20  Aligned_cols=265  Identities=21%  Similarity=0.304  Sum_probs=197.5

Q ss_pred             ccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      .|.-.++||+|.||+||+++. .+++.||+|+++.....+. .-....+|+-+++.++|+|||++++....++..-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            345567899999999999965 4578899999987654433 33567899999999999999999999999999999999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      ||.. +|..+.....+  .++...+.+++.|+++|+.++|++   .+.|||+||+|.+++.+|+.|+.|||+++.+..+.
T Consensus        82 ~cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HhhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            9975 77766655443  578888999999999999999999   99999999999999999999999999999887665


Q ss_pred             CcccccccCCCccccccccccc-cCCcchhHhHHHHHHHHHh-CCCCCCcccc-------c--ccCCCCCc--hhhhhhc
Q 004642          610 SYRTLRAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVLM-GTHPGGLLSS-------L--SSSSGPKI--MLIDVLN  676 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~ellt-g~~p~~~~~~-------~--~~~~~~~~--~~~~~~~  676 (740)
                      ...+..+-|..|++|.++.+.. |++..|+||.|||+.|+.. |++-|....-       +  -.....+.  .+...-|
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            5555667899999999998765 7888999999999999997 4444432210       0  00000010  0111111


Q ss_pred             ccCCC--cchhhhHHHHHH----HHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          677 QRLSP--PVNQKIVQDIIL----VSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       677 ~~l~~--~~~~~~~~~~~~----l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      -..-+  +....+.+-.+.    =++++.+.+.-+|.+|.++++.+++--..
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~  287 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS  287 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence            11111  111112222222    34677888888999999999998875443

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=256.99  Aligned_cols=260  Identities=22%  Similarity=0.342  Sum_probs=215.4

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (740)
                      .++|...+.||.|+|..|..++++ +.+.||+|++++....+.+-.+....|-.+..+- +||.+|-++.++.....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            467899999999999999999765 5678999999988777777778888898888877 79999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      |.||++||+|--++++..   .++++.+..+...|+-||.|||+.   ||+.||+|..|+|+|..|++|++|+|+++.--
T Consensus       329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999976666544   688888888999999999999999   99999999999999999999999999998765


Q ss_pred             cCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCC-CCCchhhhhhcccCCCcchh
Q 004642          607 VDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSS-GPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~  685 (740)
                      .+....+..+||+.|.|||++.+..|...+|.|++||+++||+.|+.||+....-.... ..+..+.-++.+.++.+...
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl  482 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL  482 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence            55556677899999999999999999999999999999999999999999765322222 23344445556655554322


Q ss_pred             hhHHHHHHHHHHHHHcccCCCCCCC------CHHHHHHHH
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRP------TMQRISQEL  719 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RP------s~~ev~~~L  719 (740)
                           ..+...+++.-+.+||.+|.      .++++..+-
T Consensus       483 -----svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~  517 (593)
T KOG0695|consen  483 -----SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHA  517 (593)
T ss_pred             -----ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcch
Confidence                 12356788889999999984      455655543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=3e-30  Score=261.53  Aligned_cols=240  Identities=29%  Similarity=0.415  Sum_probs=193.0

Q ss_pred             cceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCchhhh
Q 004642          462 GYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL  540 (740)
Q Consensus       462 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l  540 (740)
                      +||.||+|... +|+.+|+|++........  .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            58999999776 489999999987554332  478899999999999999999999999999999999999999999998


Q ss_pred             cCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccccccCCC
Q 004642          541 HDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG  620 (740)
Q Consensus       541 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  620 (740)
                      ....   .+++..+..++.+++.++.|||+.   +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus        79 ~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~  151 (244)
T smart00220       79 KKRG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE  151 (244)
T ss_pred             Hhcc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence            7644   278999999999999999999998   99999999999999999999999999998765432 2334468889


Q ss_pred             ccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHH
Q 004642          621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFA  700 (740)
Q Consensus       621 y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~  700 (740)
                      |++||...+..++.++||||+|++++++++|..||....       ......+.+.......... .......+.+++.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~  223 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-------QLLELFKKIGKPKPPFPPP-EWKISPEAKDLIRK  223 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHhccCCCCccc-cccCCHHHHHHHHH
Confidence            999999988888999999999999999999999976421       1111222222111111100 00012237889999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 004642          701 CLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       701 cl~~dP~~RPs~~ev~~~  718 (740)
                      |+..+|++||++.+++++
T Consensus       224 ~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      224 LLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HccCCchhccCHHHHhhC
Confidence            999999999999999874

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.1e-30  Score=293.18  Aligned_cols=266  Identities=19%  Similarity=0.223  Sum_probs=172.9

Q ss_pred             HhcccccceeeecccceEEEEEEeC-C----CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeee-----
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP-E----GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF-----  517 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-----  517 (740)
                      ..++|.+.+.||+|+||.||+|... +    +..||+|++......     +....|  .+....+.++..+...     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            4678999999999999999999664 4    689999988643321     111111  1112222222222211     


Q ss_pred             -eeecCeEEEEEEeccCCCchhhhcCCCcc-----------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 004642          518 -CLHKKCMFLIYEYMERGSLFCVLHDDDEA-----------------IELNWTKRVNIVKSVAHALSYLHHDCTLSIIHR  579 (740)
Q Consensus       518 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~  579 (740)
                       ...+...++||||+++++|.++++.....                 .......+..++.||+.||+|||++   +|+||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR  279 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR  279 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence             24566799999999999999988754211                 0112344567999999999999998   99999


Q ss_pred             CCCCCceEEcC-CCcEEEeecccceecccCCC-cccccccCCCcccccccccc----------------------ccCCc
Q 004642          580 DISSNNILLDS-NLEASVADFGTARLLHVDSS-YRTLRAGTYGYIAPELAYTI----------------------VVTGK  635 (740)
Q Consensus       580 dlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------~~~~~  635 (740)
                      ||||+|||++. ++.+||+|||+|+.+..... ......+++.|+|||.+...                      .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999986 57899999999986543222 22345789999999965322                      23446


Q ss_pred             chhHhHHHHHHHHHhCCCCCCcccc-----cccCCCCCchhhhhhcccCCCcch---hhhHHHHHHHHHHHHHcccCCCC
Q 004642          636 CDVYSFGVVALEVLMGTHPGGLLSS-----LSSSSGPKIMLIDVLNQRLSPPVN---QKIVQDIILVSTIAFACLSSQPK  707 (740)
Q Consensus       636 ~DvwslGvil~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~dP~  707 (740)
                      +||||+||++|||+++..|++....     +.........+.........+...   ...........+++.+|++.||+
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            7999999999999998777542110     000000111111111111111000   00000111245899999999999


Q ss_pred             CCCCHHHHHHHHHcCC
Q 004642          708 SRPTMQRISQELLAGK  723 (740)
Q Consensus       708 ~RPs~~ev~~~L~~~~  723 (740)
                      +|||++|+++|-....
T Consensus       440 kR~ta~e~L~Hpff~~  455 (566)
T PLN03225        440 QRISAKAALAHPYFDR  455 (566)
T ss_pred             cCCCHHHHhCCcCcCC
Confidence            9999999999976543

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5e-32  Score=276.03  Aligned_cols=255  Identities=23%  Similarity=0.349  Sum_probs=207.5

Q ss_pred             cccccceeeecccceEEEEEEeCCCc-EEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .+++.+..||.|+||.|=++.....+ .+|+|.+++...-+....+-...|-.+|...+.|.||++|-.|.+.+..|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34556677999999999999775444 38889888766655555567788999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccC
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      |-|-||.++..+.+.+   .++......++..++.|++|||++   +||.|||||+|.+++.+|.+||.|||+|+.+...
T Consensus       500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999998765   577788888999999999999999   9999999999999999999999999999998755


Q ss_pred             CCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC-cchhhh
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP-PVNQKI  687 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~  687 (740)
                      .... .++||+.|.|||++....++..+|.||+|+++||+++|.+||......        .....+-+.+.. ..+..+
T Consensus       574 ~KTw-TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm--------ktYn~ILkGid~i~~Pr~I  644 (732)
T KOG0614|consen  574 RKTW-TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM--------KTYNLILKGIDKIEFPRRI  644 (732)
T ss_pred             Ccee-eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--------HHHHHHHhhhhhhhccccc
Confidence            5443 459999999999999999999999999999999999999999764331        122222222211 111112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHcC
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPT-----MQRISQELLAG  722 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs-----~~ev~~~L~~~  722 (740)
                      ...   ..+++++.+..+|.+|-.     ..++.+|-+..
T Consensus       645 ~k~---a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  645 TKT---ATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             chh---HHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence            222   568899999999999964     78888887543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=3.4e-30  Score=281.61  Aligned_cols=269  Identities=16%  Similarity=0.213  Sum_probs=184.9

Q ss_pred             HhcccccceeeecccceEEEEEEe-----------------CCCcEEEEEEccCCcccch-H----------HHHHHHHH
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAEL-----------------PEGKVVALKKLHHSETEDS-A----------FVKSFQNE  499 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~-~----------~~~~~~~E  499 (740)
                      ..++|.+.++||+|+||.||+|..                 ..++.||||++........ +          ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999953                 2457899999865432110 0          01223447


Q ss_pred             HHHHhccCCCcc-----ceeeeeeee--------cCeEEEEEEeccCCCchhhhcCCCc---------------------
Q 004642          500 AHVLSTVRHRNI-----VKLYGFCLH--------KKCMFLIYEYMERGSLFCVLHDDDE---------------------  545 (740)
Q Consensus       500 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  545 (740)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     677777753        3568999999999999999874311                     


Q ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcc-cccccCCCcccc
Q 004642          546 AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGTYGYIAP  624 (740)
Q Consensus       546 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~gt~~y~aP  624 (740)
                      ...++|..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......... ....+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            11356788999999999999999998   99999999999999999999999999997654322211 122347899999


Q ss_pred             cccccccc----------------------CCcchhHhHHHHHHHHHhCCC-CCCcccccccCCC-CCch---hhhhhcc
Q 004642          625 ELAYTIVV----------------------TGKCDVYSFGVVALEVLMGTH-PGGLLSSLSSSSG-PKIM---LIDVLNQ  677 (740)
Q Consensus       625 E~~~~~~~----------------------~~~~DvwslGvil~elltg~~-p~~~~~~~~~~~~-~~~~---~~~~~~~  677 (740)
                      |.+.....                      ..+.||||+||++|+|++|.. ||.....+..... .+..   +......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98753221                      124799999999999999985 6653322111000 0111   1111111


Q ss_pred             cCCCcchhhhHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHHHHcC
Q 004642          678 RLSPPVNQKIVQDIILVSTIAFACLSSQP---KSRPTMQRISQELLAG  722 (740)
Q Consensus       678 ~l~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~ev~~~L~~~  722 (740)
                      ......   .........+++.+++..+|   .+|+|++|+++|-...
T Consensus       460 ~~~~~~---~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        460 KYDFSL---LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             CCCccc---ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            111111   11222347789999999766   6899999999986543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=287.83  Aligned_cols=246  Identities=25%  Similarity=0.352  Sum_probs=188.9

Q ss_pred             ccceeeecccce-EEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEEEEe
Q 004642          453 HIKYCIGTGGYG-SVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       453 ~~~~~lg~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      .-.+.+|.|+.| .||+|.. +|+.||||++.....      +.+.+|++.++.- +|||||++++.-.++.+.|+..|.
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             ccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhH------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            334568999987 5699987 789999999976543      5677999999988 699999999999999999999999


Q ss_pred             ccCCCchhhhcCCCccc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC---C--CcEEEeeccccee
Q 004642          531 MERGSLFCVLHDDDEAI-ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS---N--LEASVADFGTARL  604 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~---~--~~~kl~DfG~a~~  604 (740)
                      |.. +|.+++....... ...-...+.+..|++.||++||+-   +||||||||+|||++.   +  ..++|+|||+++.
T Consensus       585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            976 9999998741111 111134567889999999999997   9999999999999986   3  4689999999999


Q ss_pred             cccCCCcc---cccccCCCccccccccccccCCcchhHhHHHHHHHHHhC-CCCCCcccccccCCCCCchhhhhhcccCC
Q 004642          605 LHVDSSYR---TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMG-THPGGLLSSLSSSSGPKIMLIDVLNQRLS  680 (740)
Q Consensus       605 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  680 (740)
                      +..+....   ....||-+|+|||++....-+.++||||+||++|+.++| .+||+....-.         .+++.....
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---------~NIl~~~~~  731 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---------ANILTGNYT  731 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---------hhhhcCccc
Confidence            87654432   334699999999999988888899999999999999996 89998643210         111111110


Q ss_pred             CcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004642          681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       681 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~  720 (740)
                      -........+  +..++|.+|++.+|..||+|.+|+.|..
T Consensus       732 L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPl  769 (903)
T KOG1027|consen  732 LVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPL  769 (903)
T ss_pred             eeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCc
Confidence            0000000111  4789999999999999999999998764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=237.67  Aligned_cols=203  Identities=27%  Similarity=0.386  Sum_probs=164.7

Q ss_pred             hcccccceeeecccceEEEEEEe-CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  526 (740)
                      .+.......||.|+||.|-+.++ .+|+..|+|++.......  ..++..+|+.+..+- .+|.+|.++|.+...+..++
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q--~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ--EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH--HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            34444456699999999988854 579999999998765432  246677788876654 79999999999999999999


Q ss_pred             EEEeccCCCchhhhcC-CCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          527 IYEYMERGSLFCVLHD-DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      .||.|+. +|..+-.+ .+....+++.-+-+|+..|.+||.|||++  ..++|||+||+|||++.+|++|+||||.+-.+
T Consensus       123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            9999975 66544321 12233678888999999999999999997  58999999999999999999999999999876


Q ss_pred             ccCCCcccccccCCCccccccccc----cccCCcchhHhHHHHHHHHHhCCCCCCc
Q 004642          606 HVDSSYRTLRAGTYGYIAPELAYT----IVVTGKCDVYSFGVVALEVLMGTHPGGL  657 (740)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~elltg~~p~~~  657 (740)
                      . ++-..+...|...|||||.+..    ..|+.|+||||+|+++.||.+++.|++.
T Consensus       200 ~-dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  200 V-DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             h-hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            5 3444455578889999998763    3688899999999999999999999764

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.1e-29  Score=264.74  Aligned_cols=204  Identities=25%  Similarity=0.361  Sum_probs=174.2

Q ss_pred             cccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      .-|..++.||-|+||+|.++ +.++...||.|.+.+...-....+.-.+.|..||..-..+=||++|-.|.+++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            45666788999999999999 45556789999998766655555667788999999999999999999999999999999


Q ss_pred             EeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc--
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH--  606 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~--  606 (740)
                      ||++||++-.+|-+.+   .+.+..+..++.++..|+++.|+.   |+|||||||.|||+|.||++||+|||+++-+.  
T Consensus       709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999887765   467777888899999999999988   99999999999999999999999999986321  


Q ss_pred             -------cCCCc---------------------------------ccccccCCCccccccccccccCCcchhHhHHHHHH
Q 004642          607 -------VDSSY---------------------------------RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVAL  646 (740)
Q Consensus       607 -------~~~~~---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~  646 (740)
                             ..+..                                 ....+||+.|+|||++....++.-+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                   10000                                 01124999999999999999999999999999999


Q ss_pred             HHHhCCCCCCccc
Q 004642          647 EVLMGTHPGGLLS  659 (740)
Q Consensus       647 elltg~~p~~~~~  659 (740)
                      ||+.|+.||-...
T Consensus       863 em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  863 EMLVGQPPFLADT  875 (1034)
T ss_pred             HHhhCCCCccCCC
Confidence            9999999997644

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=4.9e-30  Score=236.84  Aligned_cols=259  Identities=19%  Similarity=0.263  Sum_probs=196.6

Q ss_pred             HhcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeeeeecC--e
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKK--C  523 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  523 (740)
                      ..++|++.+++|.|.|++||.| ...+.+.++||+++...      .+.+.+|+++++.++ ||||+++++...++.  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            3578999999999999999999 45678889999998654      367899999999996 999999999998754  5


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CcEEEeecccc
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN-LEASVADFGTA  602 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfG~a  602 (740)
                      ..+++||+.+.+...+-.      .++...+...+.+++.||+|+|+.   ||.|||+||.|+++|.. -..+|+|+|+|
T Consensus       110 paLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             chhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence            789999999876654332      356667888999999999999999   99999999999999954 56999999999


Q ss_pred             eecccCCCcccccccCCCccccccccccc-cCCcchhHhHHHHHHHHHhCCCCCCcccccc-------------------
Q 004642          603 RLLHVDSSYRTLRAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVLMGTHPGGLLSSLS-------------------  662 (740)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~-------------------  662 (740)
                      .++.+... .+.++.+..|..||.+...+ |+..-|+|||||++..|+..+.||-...+-.                   
T Consensus       181 EFYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  181 EFYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hhcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            99875443 35557888999999987654 6677899999999999999999974322100                   


Q ss_pred             --cCCCCCchhhhhhcccCCCcchhhhH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          663 --SSSGPKIMLIDVLNQRLSPPVNQKIV-----QDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       663 --~~~~~~~~~~~~~~~~l~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                        ....-+....+++.+..+.+......     -...+..+++.+.+..|-.+|+|++|.+.|-...
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence              00001111222232222211111100     0123477899999999999999999999886543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=1.6e-29  Score=307.29  Aligned_cols=306  Identities=41%  Similarity=0.593  Sum_probs=192.3

Q ss_pred             HHHHHHhc-------CCCCcCCCCCCCCCCCccceeeeCCCCCEEEEEcCCCCcccc-----------------------
Q 004642           42 IERQALLN-------SGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGE-----------------------   91 (740)
Q Consensus        42 ~~~~~l~~-------~~~~~~~~~~~~~~~c~w~gv~c~~~~~v~~l~l~~~~l~~~-----------------------   91 (740)
                      .|++||+.       ...+...|. .+.|||.|.||+|+..++|+.|+|.++++.+.                       
T Consensus        29 ~~~~~l~~~~~~~~~~~~~~~~w~-~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~  107 (968)
T PLN00113         29 EELELLLSFKSSINDPLKYLSNWN-SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSG  107 (968)
T ss_pred             HHHHHHHHHHHhCCCCcccCCCCC-CCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCC
Confidence            57777764       112223332 35689999999999878899888887766543                       


Q ss_pred             -ccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccccccccccCCChhhhc
Q 004642           92 -LGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIG  170 (740)
Q Consensus        92 -~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~  170 (740)
                       ++...|..+++|++|+|++|++++.+|.  +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..++
T Consensus       108 ~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~  185 (968)
T PLN00113        108 PIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT  185 (968)
T ss_pred             cCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhh
Confidence             3333455777888888888887766653  4466666777766666666666666666666666666666666666666


Q ss_pred             cccccceeecccccccccCCCccccccc-----CCCccccCCCCccccccCCCCEEecCCCcCCCcCCccccccCCCCee
Q 004642          171 NLKSLTELYVTNNALGGLIPSTLFRLTN-----ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNL  245 (740)
Q Consensus       171 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~-----l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  245 (740)
                      ++++|++|+|++|++++.+|..+.++.+     ++.|++.+.+|..++++++|++|+|++|++++.+|..++++++|+.|
T Consensus       186 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  265 (968)
T PLN00113        186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL  265 (968)
T ss_pred             hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEE
Confidence            6666666666666666666665555442     35566666666666666666666666666666666666666666666


Q ss_pred             cccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhcccccccceEEecCCccc
Q 004642          246 NLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLS  325 (740)
Q Consensus       246 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  325 (740)
                      +|++|++++.+|..+.++++|+.|++++|.+++.+|..+.++++|+.|++++|.+++.+|..+..+++|+.|++++|+++
T Consensus       266 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~  345 (968)
T PLN00113        266 FLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS  345 (968)
T ss_pred             ECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCc
Confidence            66666666656666666666666666666666556655556666666666666665555555555555555555555555


Q ss_pred             CCCCCCCccc----cccCCCCCCCCCcCc
Q 004642          326 GTIPKTLRPM----YVDLSFNNLEGEIPT  350 (740)
Q Consensus       326 ~~~p~~~~~~----~l~ls~N~l~~~~p~  350 (740)
                      +.+|..+...    .+++++|++++.+|.
T Consensus       346 ~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~  374 (968)
T PLN00113        346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPE  374 (968)
T ss_pred             CcCChHHhCCCCCcEEECCCCeeEeeCCh
Confidence            5555443322    244455544444443

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-31  Score=248.48  Aligned_cols=263  Identities=25%  Similarity=0.301  Sum_probs=194.2

Q ss_pred             cccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC-----eEE
Q 004642          452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK-----CMF  525 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  525 (740)
                      .+-.+.||-|+||.||.+. -++|+.||.|++...... -...+++.+|.+++...+|.|++..++...-..     +.|
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~-L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN-LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH-HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3446779999999999994 457999999999764432 234578889999999999999999888765432     457


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceec
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      .++|.|.. +|.+.+-...   .++-..+.-+..||++||+|||+.   +|.||||||.|.|++.++..||+|||+|+..
T Consensus       134 V~TELmQS-DLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHh-hhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence            77887754 6766665433   577777888999999999999998   9999999999999999999999999999976


Q ss_pred             ccCC-CcccccccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccc---------cCCC-------C
Q 004642          606 HVDS-SYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS---------SSSG-------P  667 (740)
Q Consensus       606 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~---------~~~~-------~  667 (740)
                      ..+. ...+..+-|.+|+|||.+++. .|+.+.||||.|||+.|++-++.-|.......         ....       -
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            5443 334555678999999999976 58889999999999999998888776443211         0011       1


Q ss_pred             CchhhhhhcccCCCcchhh------hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          668 KIMLIDVLNQRLSPPVNQK------IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       668 ~~~~~~~~~~~l~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      +.....+++....++....      ......+...+...++..||++|.+.++.+.++...
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~  347 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE  347 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence            1222233333333222110      011122355677889999999999999998887544

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=245.34  Aligned_cols=261  Identities=25%  Similarity=0.317  Sum_probs=197.0

Q ss_pred             hcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecC-----
Q 004642          449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK-----  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  522 (740)
                      ..+|.-.+.+|.|.- .|..+ +.-.++.||+|+...+...... .++..+|..++..++|+|+++++.++.-..     
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~-akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH-AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc-chhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            356666777888888 55555 4446899999999876444332 467789999999999999999999987543     


Q ss_pred             -eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          523 -CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       523 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                       ..|+|||+|.. +|...++.     +++-.++..++.|++.|++|||+.   ||+||||||+||++..++..||.|||+
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence             57999999975 78777762     467788899999999999999998   999999999999999999999999999


Q ss_pred             ceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccccccc-------CCCCC------
Q 004642          602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-------SSGPK------  668 (740)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~-------~~~~~------  668 (740)
                      |+.-..+ -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|........       ...++      
T Consensus       165 ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  165 ARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             hcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            9875543 344556789999999999999999999999999999999999987764322100       00011      


Q ss_pred             -----------------chhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          669 -----------------IMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       669 -----------------~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                                       ..+.+.+.....+........+...+.+++.+||-.+|++|.+++++++|.-.
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~  313 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI  313 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence                             11111111111111111111222347899999999999999999999998743

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-28  Score=249.18  Aligned_cols=133  Identities=25%  Similarity=0.483  Sum_probs=113.7

Q ss_pred             hcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-----C---Cccceeeeeee
Q 004642          449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-----H---RNIVKLYGFCL  519 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~  519 (740)
                      ..+|.+.++||-|.|++||++ +....+.||+|+.+...    .+.+....|++++++++     |   ..||++++.|.
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            368999999999999999999 55677899999997644    44677889999999983     3   47999999998


Q ss_pred             e----cCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 004642          520 H----KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD  589 (740)
Q Consensus       520 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  589 (740)
                      .    +.+++||+|++ |.+|..+|...... .++...+.+|++||+.||.|||.+|  ||||.||||+|||+.
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            5    45899999998 56888888765543 5889999999999999999999997  999999999999994

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.3e-27  Score=236.42  Aligned_cols=212  Identities=35%  Similarity=0.599  Sum_probs=184.4

Q ss_pred             eecccceEEEEEEeCC-CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCc
Q 004642          458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL  536 (740)
Q Consensus       458 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  536 (740)
                      ||+|++|.||++...+ ++.+++|++.......  ..+.+.+|++.++.++|++++++++++......++++||+++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            6899999999997654 8999999998765432  246788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-CCcEEEeecccceecccCCCccccc
Q 004642          537 FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-NLEASVADFGTARLLHVDSSYRTLR  615 (740)
Q Consensus       537 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~  615 (740)
                      .+++....  ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+.............
T Consensus        79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            99987643  2578999999999999999999999   9999999999999999 8999999999998765433223334


Q ss_pred             ccCCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHH
Q 004642          616 AGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILV  694 (740)
Q Consensus       616 ~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  694 (740)
                      .+...|++||..... ..+.++|+|++|+++++|                                           ..+
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~  190 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PEL  190 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHH
Confidence            678899999998877 788899999999999999                                           237


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          695 STIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       695 ~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      .+++.+|++.+|++||++.++++++
T Consensus       191 ~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         191 KDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHhhCCcccCcCHHHHhhCC
Confidence            7899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=255.37  Aligned_cols=199  Identities=27%  Similarity=0.385  Sum_probs=169.9

Q ss_pred             hcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHH-----HHHHHHHHHHhccC---CCccceeeeeee
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFV-----KSFQNEAHVLSTVR---HRNIVKLYGFCL  519 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~---h~niv~l~~~~~  519 (740)
                      ..+|...+.+|.|+||.|+.+.++ +...|++|.+.+++.-...+.     -..-.|+++|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            456899999999999999999655 467799999987554322222     23456999999997   999999999999


Q ss_pred             ecCeEEEEEEec-cCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEee
Q 004642          520 HKKCMFLIYEYM-ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVAD  598 (740)
Q Consensus       520 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  598 (740)
                      +++.+|++||-. ++.+|.+++....   .+++.++.-|++||+.|+++||++   +|+|||||-+||.++.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            999999999975 5668999997654   689999999999999999999999   999999999999999999999999


Q ss_pred             cccceecccCCCcccccccCCCccccccccccccCC-cchhHhHHHHHHHHHhCCCCC
Q 004642          599 FGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG-KCDVYSFGVVALEVLMGTHPG  655 (740)
Q Consensus       599 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~elltg~~p~  655 (740)
                      ||.|....  +......+||..|.|||++.+..|-. .-|||++|+++|.++....||
T Consensus       714 fgsaa~~k--sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  714 FGSAAYTK--SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             ccchhhhc--CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99997653  33445668999999999999988754 479999999999999998886

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=5.3e-29  Score=262.18  Aligned_cols=255  Identities=28%  Similarity=0.423  Sum_probs=202.4

Q ss_pred             HhcccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      ..++|+....+|.|.||.|||++ ...++..|+|+++.....+.   +-..+|+-+++..+|||||.++|.+...+..++
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~---~~iqqei~~~~dc~h~nivay~gsylr~dklwi   89 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF---SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI   89 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc---cccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence            45688899999999999999994 45789999999987765543   556789999999999999999999999999999


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      .||||.+|+|.+.-|-.+   ++++.++..+.+..++|++|||+.   +-+|||||-.||++++.|.+|+.|||.+-.+.
T Consensus        90 cMEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             EEEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence            999999999988776544   688899999999999999999998   99999999999999999999999999998776


Q ss_pred             cCCCcccccccCCCcccccccc---ccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcc
Q 004642          607 VDSSYRTLRAGTYGYIAPELAY---TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV  683 (740)
Q Consensus       607 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  683 (740)
                      .--.....+.||++|||||+..   .+.|..++|||+.|+...|+---+.|--....     .+  .+.-.-.....++.
T Consensus       164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-----mr--~l~LmTkS~~qpp~  236 (829)
T KOG0576|consen  164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-----MR--ALFLMTKSGFQPPT  236 (829)
T ss_pred             hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-----HH--HHHHhhccCCCCCc
Confidence            5555566779999999999864   55788999999999999999877766211110     00  00000011111111


Q ss_pred             hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      ..+...-...+.++++.|+..+|++||+++.++++
T Consensus       237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             ccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            11122223348899999999999999999988774

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=1.5e-28  Score=251.38  Aligned_cols=274  Identities=19%  Similarity=0.211  Sum_probs=210.9

Q ss_pred             CCcccHHHHHHHhcccccceeeecccceEEEEEE-eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCC------C
Q 004642          437 DGKILYEDLINATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH------R  509 (740)
Q Consensus       437 ~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~  509 (740)
                      .|.+.+.--+....+|.+....|+|-|++|.+|. ...|..||||++......    .+.=..|+++|++++.      -
T Consensus       419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~  494 (752)
T KOG0670|consen  419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKF  494 (752)
T ss_pred             cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhh
Confidence            3445554445566899999999999999999994 445889999999876554    3555689999999952      4


Q ss_pred             ccceeeeeeeecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc
Q 004642          510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD  589 (740)
Q Consensus       510 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~  589 (740)
                      |+++++-.|....++|||+|-+.- +|.+++...+....+....+..++.|+.-||..|-..   +|+|.||||.|||++
T Consensus       495 Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVN  570 (752)
T KOG0670|consen  495 HCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVN  570 (752)
T ss_pred             HHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEec
Confidence            899999999999999999998854 8999999998888899999999999999999999988   999999999999999


Q ss_pred             CCC-cEEEeecccceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccc--------
Q 004642          590 SNL-EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSS--------  660 (740)
Q Consensus       590 ~~~-~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~--------  660 (740)
                      +.. .+||||||.|.+...+  ..+...-+..|.|||++.|.+|+...|+||.||+|||+.||+.-|...+.        
T Consensus       571 E~k~iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  571 ESKNILKLCDFGSASFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             cCcceeeeccCccccccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence            754 5799999999776432  22333556789999999999999999999999999999999987754321        


Q ss_pred             --------------------ccc----------CCC------------CCchhhhhhcccCCCcchhhhHHHHHHHHHHH
Q 004642          661 --------------------LSS----------SSG------------PKIMLIDVLNQRLSPPVNQKIVQDIILVSTIA  698 (740)
Q Consensus       661 --------------------~~~----------~~~------------~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li  698 (740)
                                          +..          ...            +-..+...+-..  +..+.........+.+++
T Consensus       649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~--q~~~deq~~~~~~~rdLL  726 (752)
T KOG0670|consen  649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV--QRLPDEQPKIVQQLRDLL  726 (752)
T ss_pred             HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc--CCCCchhHHHHHHHHHHH
Confidence                                000          000            000011111000  112222333444588999


Q ss_pred             HHcccCCCCCCCCHHHHHHHHHcC
Q 004642          699 FACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       699 ~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ..|+..||++|.|..|.++|.+..
T Consensus       727 dkml~LdP~KRit~nqAL~HpFi~  750 (752)
T KOG0670|consen  727 DKMLILDPEKRITVNQALKHPFIT  750 (752)
T ss_pred             HHHhccChhhcCCHHHHhcCCccc
Confidence            999999999999999999886654

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.95  E-value=8.1e-29  Score=256.71  Aligned_cols=282  Identities=24%  Similarity=0.261  Sum_probs=212.0

Q ss_pred             CCCEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhccccccccc
Q 004642           75 EGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGL  154 (740)
Q Consensus        75 ~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  154 (740)
                      .|+++.|+|.+|-|+. +....++.++.|++||||.|.|+.+.-+.|..-.++++|+|++|+|+.+..+.|.++.+|.+|
T Consensus       124 sghl~~L~L~~N~I~s-v~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl  202 (873)
T KOG4194|consen  124 SGHLEKLDLRHNLISS-VTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL  202 (873)
T ss_pred             ccceeEEeeecccccc-ccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence            4789999998887764 444467888889999999999987766778777889999999999988888888888899999


Q ss_pred             ccccccccCCChhhhccccccceeecccccccccCCCccccccc-----CCCccccCCCCccccccCCCCEEecCCCcCC
Q 004642          155 FLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN-----ISSNQFHSSIPLEIGNFSALDTLDLSDNKIH  229 (740)
Q Consensus       155 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-----l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~  229 (740)
                      .|++|+|+...+..|.+|++|+.|+|..|+|.-..-.+|.++.+     |..|.++..--..|-.+.++++|+|+.|+++
T Consensus       203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~  282 (873)
T KOG4194|consen  203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ  282 (873)
T ss_pred             ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence            99999999888888888999999999999887555556655543     4577777666667777778888888888887


Q ss_pred             CcCCccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhcc
Q 004642          230 GIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMG  309 (740)
Q Consensus       230 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~  309 (740)
                      ..-.+++.+|++|+.|+||+|.|..+-+..+.-+++|++|+|++|+|+...++.|..+..|++|+|++|.++..-...|.
T Consensus       283 ~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~  362 (873)
T KOG4194|consen  283 AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFV  362 (873)
T ss_pred             hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHH
Confidence            77777777788888888888888777777777777788888888888777777777777777777777777755556677


Q ss_pred             cccccceEEecCCcccCCCCCCC---ccc----cccCCCCCCCCCcCccccCCCC
Q 004642          310 KILLLQNLDLSHNNLSGTIPKTL---RPM----YVDLSFNNLEGEIPTYLRGNPP  357 (740)
Q Consensus       310 ~l~~L~~L~l~~N~l~~~~p~~~---~~~----~l~ls~N~l~~~~p~~~~~~~~  357 (740)
                      .+.+|+.|||++|.|+..+.+.-   ..+    .+++-+|+|....-..|.|++.
T Consensus       363 ~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~  417 (873)
T KOG4194|consen  363 GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEA  417 (873)
T ss_pred             HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcc
Confidence            77777777777777776554421   111    3667777775322224444443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-28  Score=255.64  Aligned_cols=258  Identities=28%  Similarity=0.328  Sum_probs=148.5

Q ss_pred             CEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhccccccccccc
Q 004642           77 RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL  156 (740)
Q Consensus        77 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (740)
                      .+..|||+.|.|. +++...|..-.++++|+|++|.|+....+.|.++.+|.+|.|+.|+|+.+.+..|.+|++|+.|+|
T Consensus       150 alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdL  228 (873)
T KOG4194|consen  150 ALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDL  228 (873)
T ss_pred             hhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhc
Confidence            4556777776664 555556666677777777777777777777777777777777777777777777777777777777


Q ss_pred             ccccccCCChhhhccccccceeecccccccccCCCcccccc-----cC------------------------CCccccCC
Q 004642          157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT-----NI------------------------SSNQFHSS  207 (740)
Q Consensus       157 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-----~l------------------------~~n~l~~~  207 (740)
                      ..|+|.-.---.|.+|++|+.|.|..|.+.......|..+.     +|                        +.|.|..+
T Consensus       229 nrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~ri  308 (873)
T KOG4194|consen  229 NRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRI  308 (873)
T ss_pred             cccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhhee
Confidence            77777644344566666666666666666555555544432     23                        44444444


Q ss_pred             CCccccccCCCCEEecCCCcCCCcCCccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCc---cc
Q 004642          208 IPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPT---EI  284 (740)
Q Consensus       208 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~---~l  284 (740)
                      -++...-+++|++|+|++|+|+...++.|..|..|+.|+|++|.++......|..+.+|+.|||++|.|++.|.+   .|
T Consensus       309 h~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f  388 (873)
T KOG4194|consen  309 HIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAF  388 (873)
T ss_pred             ecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhh
Confidence            444444444555555555555544444444455555555555555444444444555555555555555443332   24


Q ss_pred             ccCCCCCeEeccCCCCCCCCchhcccccccceEEecCCcccCCCCCCCccc
Q 004642          285 GNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM  335 (740)
Q Consensus       285 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~  335 (740)
                      .++++|+.|+|.+|+|....-..|..++.|+.|||.+|.|...-|..|.++
T Consensus       389 ~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m  439 (873)
T KOG4194|consen  389 NGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM  439 (873)
T ss_pred             ccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc
Confidence            445555555555555553333445555555555555555555555554443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=4.8e-26  Score=228.00  Aligned_cols=199  Identities=34%  Similarity=0.526  Sum_probs=172.2

Q ss_pred             cccceeeecccceEEEEEEeCC-CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEe
Q 004642          452 FHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      |.+.+.||+|++|.||++...+ ++.+|+|.+......  ...+.+.+|++.+++++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            5667889999999999997765 899999999865443  2357888999999999999999999999999999999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC-
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS-  609 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  609 (740)
                      +++++|.+++.....  .+++..+..++.+++.++.+||+.   +++|+|++|+||+++.++.++|+|||.+....... 
T Consensus        79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       79 CEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            999999999876542  178999999999999999999998   99999999999999999999999999998775432 


Q ss_pred             CcccccccCCCccccccc-cccccCCcchhHhHHHHHHHHHhCCCCCCc
Q 004642          610 SYRTLRAGTYGYIAPELA-YTIVVTGKCDVYSFGVVALEVLMGTHPGGL  657 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~elltg~~p~~~  657 (740)
                      .......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            122334678899999998 666778899999999999999999999854

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.1e-27  Score=222.95  Aligned_cols=254  Identities=21%  Similarity=0.319  Sum_probs=183.4

Q ss_pred             HhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeee-eeeecCeE
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYG-FCLHKKCM  524 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~  524 (740)
                      ..+.|.+.+.+|+|.||.+-+++++ +.+.+|+|.+..+...    .++|.+|...--.+ .|.||+.-|+ .|...+.+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            3568999999999999999999765 4678999999876654    46788887766566 5889998776 45677889


Q ss_pred             EEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc--CCCcEEEeecccc
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD--SNLEASVADFGTA  602 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~DfG~a  602 (740)
                      ++++||++.|+|.+-+...    .+-+....+++.|+++|+.|||++   .+||||||.+|||+-  +...+|++|||..
T Consensus        98 vF~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             EEeeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence            9999999999998777654    366778889999999999999999   999999999999994  3457999999998


Q ss_pred             eecccCCCcccccccCCCcccccccccc-----ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcc
Q 004642          603 RLLHVDSSYRTLRAGTYGYIAPELAYTI-----VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ  677 (740)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  677 (740)
                      +.......   ..--+..|.|||.....     ...+.+|||.||+++|..+||+.||.....  .  ....+-...-.+
T Consensus       171 ~k~g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~--~--d~~Y~~~~~w~~  243 (378)
T KOG1345|consen  171 RKVGTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI--M--DKPYWEWEQWLK  243 (378)
T ss_pred             cccCceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc--c--CchHHHHHHHhc
Confidence            75432211   12235578999976532     355678999999999999999999873211  1  111111111112


Q ss_pred             cCCCcchhhhHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHHH
Q 004642          678 RLSPPVNQKIVQDIILVSTIAFACLSSQPKSR---PTMQRISQEL  719 (740)
Q Consensus       678 ~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ev~~~L  719 (740)
                      +..+..+.....-...+.++.++-+.++|++|   -+++...+.+
T Consensus       244 rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~  288 (378)
T KOG1345|consen  244 RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL  288 (378)
T ss_pred             ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence            22222222122223346788889999999999   4444444444

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=3.4e-27  Score=237.98  Aligned_cols=268  Identities=25%  Similarity=0.350  Sum_probs=199.2

Q ss_pred             HHHHHHHhcccccceeeecccceEEEEEEeC----CCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeee
Q 004642          442 YEDLINATEDFHIKYCIGTGGYGSVYKAELP----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYG  516 (740)
Q Consensus       442 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  516 (740)
                      +++.....+.|..+++||+|.|++||++...    ..+.||+|.+......     .++..|++++..+ .+.||+++.+
T Consensus        28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchh
Confidence            3445566788999999999999999999443    4678999999876654     5688999999999 5899999999


Q ss_pred             eeeecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEc-CCCcEE
Q 004642          517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD-SNLEAS  595 (740)
Q Consensus       517 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~-~~~~~k  595 (740)
                      ++..++...+|+||+++....++...      ++..++..+++.+..||+++|..   |||||||||+|++++ ..+.-.
T Consensus       103 ~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~  173 (418)
T KOG1167|consen  103 CFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGV  173 (418)
T ss_pred             hhccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCce
Confidence            99999999999999999888777754      56788889999999999999999   999999999999998 456789


Q ss_pred             EeecccceecccCC----------------------------------C----------cccccccCCCcccccccccc-
Q 004642          596 VADFGTARLLHVDS----------------------------------S----------YRTLRAGTYGYIAPELAYTI-  630 (740)
Q Consensus       596 l~DfG~a~~~~~~~----------------------------------~----------~~~~~~gt~~y~aPE~~~~~-  630 (740)
                      |.|||+|.......                                  .          ....+.||++|.|||++... 
T Consensus       174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~  253 (418)
T KOG1167|consen  174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP  253 (418)
T ss_pred             EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence            99999997221000                                  0          00113599999999998765 


Q ss_pred             ccCCcchhHhHHHHHHHHHhCCCCCCcccc----------------------cccC------CCCCch---------h-h
Q 004642          631 VVTGKCDVYSFGVVALEVLMGTHPGGLLSS----------------------LSSS------SGPKIM---------L-I  672 (740)
Q Consensus       631 ~~~~~~DvwslGvil~elltg~~p~~~~~~----------------------~~~~------~~~~~~---------~-~  672 (740)
                      ..++++||||.|||+.-+++++.||-....                      +...      ......         + .
T Consensus       254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~  333 (418)
T KOG1167|consen  254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI  333 (418)
T ss_pred             CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence            467899999999999999999999743211                      0000      000000         0 0


Q ss_pred             hhhcccCCC-cchhhhHHHH-HHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          673 DVLNQRLSP-PVNQKIVQDI-ILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       673 ~~~~~~l~~-~~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      +.+.+.-.+ .......+.. ..+.+++.+|++.+|.+|.|++|.++|.....
T Consensus       334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence            111110000 0001111111 14789999999999999999999999987663

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=6.5e-26  Score=268.07  Aligned_cols=199  Identities=17%  Similarity=0.240  Sum_probs=142.4

Q ss_pred             ccCC-Cccceeeeeee-------ecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 004642          505 TVRH-RNIVKLYGFCL-------HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI  576 (740)
Q Consensus       505 ~l~h-~niv~l~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  576 (740)
                      .++| +||+++++++.       +.+..+.++||+ +++|.+++....  ..+++.++..++.||++||+|||++   +|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            3445 57888888772       334577888987 559999997543  3589999999999999999999998   99


Q ss_pred             EecCCCCCceEEcC-------------------CCcEEEeecccceecccCC----------------CcccccccCCCc
Q 004642          577 IHRDISSNNILLDS-------------------NLEASVADFGTARLLHVDS----------------SYRTLRAGTYGY  621 (740)
Q Consensus       577 vH~dlkp~NIll~~-------------------~~~~kl~DfG~a~~~~~~~----------------~~~~~~~gt~~y  621 (740)
                      +||||||+|||++.                   ++.+|++|||+++......                .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   4456666677665421100                000113578899


Q ss_pred             cccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHc
Q 004642          622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFAC  701 (740)
Q Consensus       622 ~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~c  701 (740)
                      ||||++.+..++.++|||||||++|||++|..|+.....         ..........++..    ........+++.+|
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  248 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSSLRHRVLPPQI----LLNWPKEASFCLWL  248 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHHHHHhhcChhh----hhcCHHHHHHHHHh
Confidence            999999999999999999999999999999888543111         11111111111111    11122356788899


Q ss_pred             ccCCCCCCCCHHHHHHHHHcC
Q 004642          702 LSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       702 l~~dP~~RPs~~ev~~~L~~~  722 (740)
                      |+.+|.+||++.|++++....
T Consensus       249 L~~~P~~Rps~~eil~h~~~~  269 (793)
T PLN00181        249 LHPEPSCRPSMSELLQSEFIN  269 (793)
T ss_pred             CCCChhhCcChHHHhhchhhh
Confidence            999999999999999887654

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.92  E-value=9.3e-27  Score=242.67  Aligned_cols=287  Identities=28%  Similarity=0.379  Sum_probs=184.2

Q ss_pred             CCEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccc
Q 004642           76 GRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF  155 (740)
Q Consensus        76 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  155 (740)
                      .++.++.+.+|++...--+..+-.+..|+.||||+|++. ..|..+..-+++-.|+||+|+|..+....|-+|+.|-.||
T Consensus        78 p~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLD  156 (1255)
T KOG0444|consen   78 PRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLD  156 (1255)
T ss_pred             hhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhc
Confidence            345555666666654433335667778888888888887 5677777777888888888888755445566788888888


Q ss_pred             cccccccCCChhhhccccccceeecccccccccCCCcccccccCCC------ccccCCCCccccccCCCCEEecCCCcCC
Q 004642          156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISS------NQFHSSIPLEIGNFSALDTLDLSDNKIH  229 (740)
Q Consensus       156 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~------n~l~~~~p~~l~~l~~L~~L~L~~N~l~  229 (740)
                      ||+|++. .+|+.+..|..|++|.|++|.+.-..-..+..++.|+-      +.-...+|.++..+.+|..+|||.|.+.
T Consensus       157 LS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp  235 (1255)
T KOG0444|consen  157 LSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP  235 (1255)
T ss_pred             cccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC
Confidence            8888887 56677788888888888888765332222222222221      1222356777777777777777777777


Q ss_pred             CcCCccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCC-CCchhc
Q 004642          230 GIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDG-TIPLEM  308 (740)
Q Consensus       230 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~p~~~  308 (740)
                       .+|+.+.++.+|+.|+||+|+|+ .+....+...+|++|+||.|+++ ..|.++..+++|+.|++.+|+++- -+|..+
T Consensus       236 -~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGI  312 (1255)
T KOG0444|consen  236 -IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGI  312 (1255)
T ss_pred             -cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccch
Confidence             67777777777777777777776 33344455567777777777776 667777777777777777776652 356666


Q ss_pred             ccccccceEEecCCcccCCCCCCCccc----cccCCCCCCCCCcCcc---ccCCCCCcccCCccCCCC
Q 004642          309 GKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPTY---LRGNPPKSFVGNKGLSGN  369 (740)
Q Consensus       309 ~~l~~L~~L~l~~N~l~~~~p~~~~~~----~l~ls~N~l~~~~p~~---~~~~~~~~~~~n~~~~~~  369 (740)
                      +++.+|+.+..++|.|. ..|+.+...    .+.|+.|+|. .+|+.   +.++....+..|+.+-.+
T Consensus       313 GKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMP  378 (1255)
T KOG0444|consen  313 GKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMP  378 (1255)
T ss_pred             hhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCC
Confidence            66666666666666665 555555332    3666666665 23432   233333444455544433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=1.3e-24  Score=209.09  Aligned_cols=165  Identities=23%  Similarity=0.181  Sum_probs=125.6

Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCccc
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT  613 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  613 (740)
                      |+|.++++..+.  .+++.++..++.||+.||+|||++   +      ||+||+++.++.+|+  ||.++......    
T Consensus         1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            688888875432  589999999999999999999988   5      999999999999999  99998764322    


Q ss_pred             ccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCC--c--chhhhHH
Q 004642          614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP--P--VNQKIVQ  689 (740)
Q Consensus       614 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~--~--~~~~~~~  689 (740)
                       ..||+.|+|||++.+..++.++|||||||++|||+||+.||......      ..............  .  .......
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL------SAILEILLNGMPADDPRDRSNLESVS  136 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh------cHHHHHHHHHhccCCccccccHHHHH
Confidence             26889999999999999999999999999999999999998643211      11111221111111  0  0000111


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ....+.+++.+||+.+|++||++.|+++++...
T Consensus       137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      137 AARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             hhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            112488999999999999999999999999765

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.90  E-value=8.5e-26  Score=235.56  Aligned_cols=244  Identities=27%  Similarity=0.395  Sum_probs=142.6

Q ss_pred             CEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhccccccccccc
Q 004642           77 RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL  156 (740)
Q Consensus        77 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (740)
                      -|..+|+++|.+.|.--+.....+++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-..++.|+.|+.+++
T Consensus         8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~   85 (1255)
T KOG0444|consen    8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV   85 (1255)
T ss_pred             eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence            45666777777775544445666667777777776665 56677777777777777777665 33455666667777777


Q ss_pred             ccccccC-CChhhhccccccceeecccccccccCCCccccc-----ccCCCccccCCCCccccccCCCCEEecCCCcCCC
Q 004642          157 YSNKLSG-VLPQEIGNLKSLTELYVTNNALGGLIPSTLFRL-----TNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHG  230 (740)
Q Consensus       157 ~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~  230 (740)
                      ..|++.. -+|+.+..|..|+.||||+|++. ..|..+...     .+|+.|+|..+....+.+++.|-.||||+|++. 
T Consensus        86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-  163 (1255)
T KOG0444|consen   86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-  163 (1255)
T ss_pred             hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-
Confidence            7776652 24556666667777777777765 334444332     246666666555555666667777777777776 


Q ss_pred             cCCccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCccc-CcCCcccccCCCCCeEeccCCCCCCCCchhcc
Q 004642          231 IIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLS-GSIPTEIGNCSALKNLTLNHNSLDGTIPLEMG  309 (740)
Q Consensus       231 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~  309 (740)
                      .+|..+..+.+|++|.|++|.+...--..+..+++|+.|.+++.+=+ ..+|.++.++.+|..+|||.|.+. .+|..+-
T Consensus       164 ~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly  242 (1255)
T KOG0444|consen  164 MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLY  242 (1255)
T ss_pred             hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHh
Confidence            45556666667777777776654332333334444444444444322 234444445555555555555554 4445444


Q ss_pred             cccccceEEecCCccc
Q 004642          310 KILLLQNLDLSHNNLS  325 (740)
Q Consensus       310 ~l~~L~~L~l~~N~l~  325 (740)
                      ++++|+.|+||+|+|+
T Consensus       243 ~l~~LrrLNLS~N~it  258 (1255)
T KOG0444|consen  243 KLRNLRRLNLSGNKIT  258 (1255)
T ss_pred             hhhhhheeccCcCcee
Confidence            5555555555555444

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4e-24  Score=202.48  Aligned_cols=250  Identities=21%  Similarity=0.366  Sum_probs=186.9

Q ss_pred             ccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEecc
Q 004642          453 HIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYME  532 (740)
Q Consensus       453 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (740)
                      ....+|.+...|+.|+|+|+ |..+++|++....... ...+.|.+|.-.++-..||||.+++|.|..+....++..||+
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhccCCCccccccccc-Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            33456889999999999995 5667778877654432 234688999999999999999999999999999999999999


Q ss_pred             CCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcc
Q 004642          533 RGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR  612 (740)
Q Consensus       533 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  612 (740)
                      .|+|+..+|+... ..++-.++.+++.+||+|++|||+-. +-|.---+.+..+++|++.+++|+ .+.+++...    .
T Consensus       271 ~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfsfq----e  343 (448)
T KOG0195|consen  271 FGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ----E  343 (448)
T ss_pred             chHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceeeee----c
Confidence            9999999998654 35788899999999999999999862 223344689999999999988874 222222111    1


Q ss_pred             cccccCCCccccccccccccC---CcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHH
Q 004642          613 TLRAGTYGYIAPELAYTIVVT---GKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ  689 (740)
Q Consensus       613 ~~~~gt~~y~aPE~~~~~~~~---~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  689 (740)
                      ..+.-.+.||+||.+...+-+   ..+|+|||++++||+.|...||......+-  +. +...+-+...+++.    ...
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec--gm-kialeglrv~ippg----is~  416 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC--GM-KIALEGLRVHIPPG----ISR  416 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh--hh-hhhhccccccCCCC----ccH
Confidence            112346789999998866533   468999999999999999999986543211  11 11122333333332    233


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          690 DIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       690 ~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      .   +.+++.-|+..||.+||.+..++-.|++
T Consensus       417 h---m~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  417 H---MNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             H---HHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            3   5678888999999999999999877764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=9.4e-23  Score=213.95  Aligned_cols=168  Identities=18%  Similarity=0.154  Sum_probs=129.8

Q ss_pred             HHhcccccceeeecccceEEEEEEeC--CCcEEEEEEccCCcc--cchHHHHHHHHHHHHHhccCCCccceeeeeeeecC
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAELP--EGKVVALKKLHHSET--EDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK  522 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (740)
                      ...++|.+.+.||+|+||+||+|...  +++.||||++.....  ......+.+.+|++++++++|+|+++.+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            34678999999999999999999654  577889998753321  122335678999999999999999853322   24


Q ss_pred             eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceEEcCCCcEEEeeccc
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDI-SSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~DfG~  601 (740)
                      ..++||||++|++|... ...      .   ...++.|+++||+|||+.   ||+|||| ||+|||++.++.+||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~~------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RPH------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Ccc------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            57999999999999632 111      1   135788999999999998   9999999 99999999999999999999


Q ss_pred             ceecccCCCcc--------cccccCCCcccccccccc
Q 004642          602 ARLLHVDSSYR--------TLRAGTYGYIAPELAYTI  630 (740)
Q Consensus       602 a~~~~~~~~~~--------~~~~gt~~y~aPE~~~~~  630 (740)
                      |+.+.......        +...+++.|+|||++...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99775432111        234578889999988643

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.9e-22  Score=188.28  Aligned_cols=257  Identities=18%  Similarity=0.233  Sum_probs=194.2

Q ss_pred             HhcccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCC-CccceeeeeeeecCeEE
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH-RNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~  525 (740)
                      ....|.++++||.|+||.+|.| ...+|..||+|.-......     .++..|.++...+++ ..|..+..+..+...-.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            3568999999999999999999 6678999999988765544     456789999999975 67888888888999999


Q ss_pred             EEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC---CcEEEeecccc
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN---LEASVADFGTA  602 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~DfG~a  602 (740)
                      +|||.. |-+|+++..-...  .++.++++-.+-|++.-++|+|.+   +++||||||+|+|+.-+   ..+.++|||+|
T Consensus        88 lVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence            999987 6689888765443  578899999999999999999999   99999999999999743   45889999999


Q ss_pred             eecccCCC-------cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhh
Q 004642          603 RLLHVDSS-------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVL  675 (740)
Q Consensus       603 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  675 (740)
                      +.+.....       ......||.+|.+-....+...+.+.|+-|+|.++.++-.|..||.......    .......+.
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t----k~QKyEkI~  237 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT----KKQKYEKIS  237 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh----HHHHHHHHH
Confidence            87753221       1223469999999888888888889999999999999999999998654311    112222333


Q ss_pred             cccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          676 NQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       676 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      .+....+..........++.-.+..|-..--++-|...-+.+.+
T Consensus       238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            33333332222222223366667778777777778765544443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=8.8e-22  Score=207.81  Aligned_cols=257  Identities=21%  Similarity=0.220  Sum_probs=189.8

Q ss_pred             ccccceeeecccceEEEEEEeCCC--cEEEEEEccCCcccchHHHHHHHHHHHHHhccCC----Cccceeeeee-eecCe
Q 004642          451 DFHIKYCIGTGGYGSVYKAELPEG--KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH----RNIVKLYGFC-LHKKC  523 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~  523 (740)
                      +|.+.+.||+|+||.||.+.....  ..+|+|..........   ..+..|..++..+..    +++..+++.. ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            799999999999999999965543  5788888766433321   156678888888862    6888999888 57888


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-----CcEEEee
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN-----LEASVAD  598 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-----~~~kl~D  598 (740)
                      .++||+.+ |.+|.++..... ...++..++..|+.|++.+|+++|+.   |++||||||.|+++...     ..+.|.|
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            99999977 679999886555 44789999999999999999999999   99999999999999865     4689999


Q ss_pred             cccce--ecccCCC-----c---ccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCC
Q 004642          599 FGTAR--LLHVDSS-----Y---RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPK  668 (740)
Q Consensus       599 fG~a~--~~~~~~~-----~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~  668 (740)
                      ||+++  .+.....     .   .....||..|++++...+...+.+.|+||++.++.|++.|..||........    .
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~  246 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----K  246 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----H
Confidence            99998  3322211     1   1234599999999999999999999999999999999999999854332111    1


Q ss_pred             chhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          669 IMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       669 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      .................   .....+.++...+-..+..++|....+.+.+...
T Consensus       247 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  247 SKFEKDPRKLLTDRFGD---LKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HHHHHHhhhhccccccC---CChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            11111111111110000   1112255666666678999999999998887544

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.87  E-value=9.3e-25  Score=217.57  Aligned_cols=245  Identities=30%  Similarity=0.454  Sum_probs=197.4

Q ss_pred             EEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccccc
Q 004642           78 ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLY  157 (740)
Q Consensus        78 v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  157 (740)
                      ...+.+++|++....+  .+.++..|++|++.+|++. ..|++++.+..++.|+.++|+++ .+|+.++.+.+|..|+++
T Consensus        47 l~~lils~N~l~~l~~--dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s  122 (565)
T KOG0472|consen   47 LQKLILSHNDLEVLRE--DLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS  122 (565)
T ss_pred             hhhhhhccCchhhccH--hhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence            4567778887765444  5788899999999999998 77889999999999999999998 778889999999999999


Q ss_pred             cccccCCChhhhccccccceeecccccccccCCCcccccc-----cCCCccccCCCCccccccCCCCEEecCCCcCCCcC
Q 004642          158 SNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT-----NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGII  232 (740)
Q Consensus       158 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-----~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  232 (740)
                      .|.+. ..|+.++.+..|+.|+..+|+++.. |..++.+.     .+.+|++....|..+. ++.|++||...|-++ .+
T Consensus       123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~sl-p~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tl  198 (565)
T KOG0472|consen  123 SNELK-ELPDSIGRLLDLEDLDATNNQISSL-PEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TL  198 (565)
T ss_pred             cccee-ecCchHHHHhhhhhhhccccccccC-chHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cC
Confidence            99998 6778889999999999999999855 44333332     3567887766666555 888888888888887 67


Q ss_pred             CccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccc-cCCCCCeEeccCCCCCCCCchhcccc
Q 004642          233 PDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIG-NCSALKNLTLNHNSLDGTIPLEMGKI  311 (740)
Q Consensus       233 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l  311 (740)
                      |..++.+.+|..|||.+|+|. ..| .|.++..|.+|+++.|+|. .+|.... ++++|..|||.+|+++ ..|+.++.+
T Consensus       199 P~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL  274 (565)
T KOG0472|consen  199 PPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL  274 (565)
T ss_pred             ChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence            788888888888888888887 556 7888888888888888887 5665554 8888888888888888 888888888


Q ss_pred             cccceEEecCCcccCCCCCCCccc
Q 004642          312 LLLQNLDLSHNNLSGTIPKTLRPM  335 (740)
Q Consensus       312 ~~L~~L~l~~N~l~~~~p~~~~~~  335 (740)
                      .+|+.||+|+|.++ .+|.+++.+
T Consensus       275 rsL~rLDlSNN~is-~Lp~sLgnl  297 (565)
T KOG0472|consen  275 RSLERLDLSNNDIS-SLPYSLGNL  297 (565)
T ss_pred             hhhhhhcccCCccc-cCCcccccc
Confidence            88888888888888 456555544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=8.4e-21  Score=201.75  Aligned_cols=258  Identities=31%  Similarity=0.443  Sum_probs=199.0

Q ss_pred             cccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCC-ccceeeeeeeecCeEEEEEEe
Q 004642          452 FHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-NIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  530 (740)
                      |.+.+.||.|+||.||++...  ..+++|.+.............+.+|..++..+.|+ +++++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667888999999999999765  78999999877665543467899999999999988 799999999878778999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-cEEEeecccceecccCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGTARLLHVDS  609 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  609 (740)
                      +.++++.+++........+.......++.|++.+++|+|+.   +++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999996665443112578889999999999999999999   999999999999999988 79999999998654433


Q ss_pred             C------cccccccCCCccccccccc---cccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCC
Q 004642          610 S------YRTLRAGTYGYIAPELAYT---IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS  680 (740)
Q Consensus       610 ~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~  680 (740)
                      .      ......|+..|+|||...+   ..+....|+||+|++++++++|..||......    .......+.+.....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCC
Confidence            2      2355689999999999987   57888999999999999999999996543210    001111111111111


Q ss_pred             C----cchhhh-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          681 P----PVNQKI-VQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       681 ~----~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                      +    ...... ......+.+++.+|+..+|..|.++.+....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1    000000 1112347789999999999999999887775

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=1.7e-22  Score=224.24  Aligned_cols=253  Identities=22%  Similarity=0.232  Sum_probs=187.8

Q ss_pred             ccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccch-HHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          451 DFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDS-AFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      ++..++.+|.+.|=+|.+++.++|. |+||++.+....-. ...++-.+|++ ...++|||.+++.-.-......|||.+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5677888999999999999998887 88999876553321 11222233444 556699999999888888888899999


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee--ccc
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL--LHV  607 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~--~~~  607 (740)
                      |..+ +|+|.+....   -+...+...|+.|++.|+..+|..   ||+|||||.+|||++.-..+.|+||..-+-  +..
T Consensus       102 yvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9976 8998887643   466677788999999999999999   999999999999999999999999987542  222


Q ss_pred             CCC-cccc----cccCCCcccccccccc----------c-cCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCch
Q 004642          608 DSS-YRTL----RAGTYGYIAPELAYTI----------V-VTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIM  670 (740)
Q Consensus       608 ~~~-~~~~----~~gt~~y~aPE~~~~~----------~-~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  670 (740)
                      |+. ..+.    ...-.+|.|||.+...          . .+++.||||+||+++|+++ |++||....-+....+....
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD  254 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence            221 1111    1223579999987541          1 5678899999999999998 78888865544444443333


Q ss_pred             hhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          671 LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       671 ~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      ....+.+....           .+++++..|++.||++|-++++.++.-....
T Consensus       255 ~e~~Le~Ied~-----------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  255 PEQLLEKIEDV-----------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             HHHHHHhCcCc-----------cHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence            33333222111           1788999999999999999999998855443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=2.2e-22  Score=225.16  Aligned_cols=258  Identities=21%  Similarity=0.284  Sum_probs=186.9

Q ss_pred             cceeeecccceEEEEEE-eCCCcEEEEEEccC---CcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEE
Q 004642          454 IKYCIGTGGYGSVYKAE-LPEGKVVALKKLHH---SETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  529 (740)
                      ..+.+|.|++|.|+.+. ....+.++.|.+..   ...........+..|+.+-..++|+|++..+..+.+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            45679999999888773 33444444444331   222222233346778888888999999988888877766666699


Q ss_pred             eccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCC
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++ +|+..+....   .+...++..+++|+..|++|+|+.   ||.|||+|++|++++.+|.+||+|||.+.....+-
T Consensus       402 ~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 9999887653   467788899999999999999999   99999999999999999999999999998765432


Q ss_pred             C----cccccccCCCccccccccccccCCc-chhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcc-cCCCcc
Q 004642          610 S----YRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-RLSPPV  683 (740)
Q Consensus       610 ~----~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~  683 (740)
                      .    .....+|+..|+|||++.+..|.+. .||||.|+++..|.+|+.||............    ....++ ......
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----~~~~~~~~~~~~~  550 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----NNYSDQRNIFEGP  550 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----hccccccccccCh
Confidence            2    2344579999999999999998875 79999999999999999998754321110000    000000 000111


Q ss_pred             hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcC
Q 004642          684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~  722 (740)
                      ..-.......-..++.+++++||.+|-|++++++.=+..
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~  589 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR  589 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence            111112222366799999999999999999998765544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=2.1e-21  Score=189.16  Aligned_cols=189  Identities=15%  Similarity=0.187  Sum_probs=144.2

Q ss_pred             eecCCCcccHHHHHH--HhcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHH------HHHHHHHHh
Q 004642          433 VWNYDGKILYEDLIN--ATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKS------FQNEAHVLS  504 (740)
Q Consensus       433 ~~~~~~~~~~~~l~~--~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~  504 (740)
                      ++..+....|.++..  ..++|.+.+.+|.|+||.||.++. +++.+|+|.+.......+.....      +.+|++.+.
T Consensus        12 ~~~~~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~   90 (232)
T PRK10359         12 VFYKDNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTD   90 (232)
T ss_pred             EEecCCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHH
Confidence            333444444555543  478999999999999999999866 57789999998766655554444      579999999


Q ss_pred             ccCCCccceeeeeeeec--------CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 004642          505 TVRHRNIVKLYGFCLHK--------KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI  576 (740)
Q Consensus       505 ~l~h~niv~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  576 (740)
                      +++|++|..+.+++...        +..+++|||++|.+|.++..       ++.    ....+++.++..+|+.   |+
T Consensus        91 rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi  156 (232)
T PRK10359         91 RVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GM  156 (232)
T ss_pred             HHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CC
Confidence            99999999999886643        35899999999999977631       222    2456999999999999   99


Q ss_pred             EecCCCCCceEEcCCCcEEEeecccceecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHH
Q 004642          577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL  649 (740)
Q Consensus       577 vH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell  649 (740)
                      +|||++|+||+++.++ ++|+|||..+....+....            .+.....+..++|+|+||+++..+.
T Consensus       157 ~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        157 VSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH------------HHHHHhHhcccccccceeEeehHHH
Confidence            9999999999999988 9999999887553221111            1333445667899999999876654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.6e-20  Score=183.44  Aligned_cols=199  Identities=20%  Similarity=0.279  Sum_probs=168.7

Q ss_pred             cccccceeeecccceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCeEEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  527 (740)
                      -.|.+.++||+|.||+++.| .+-+++.||||.-......     -++..|.+.++.+ ..+.|...|-+-.++.+-.+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            36889999999999999999 5568999999977654432     4667788888888 568999999888889899999


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCC-----cEEEeecccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-----EASVADFGTA  602 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~-----~~kl~DfG~a  602 (740)
                      +|.+ |-+|+|+..-.+.  .++.+++.-+|.|++.-++|+|++   .+|.|||||+|+|+...+     .+.|+|||+|
T Consensus       103 idLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            9987 6689888876654  588999999999999999999999   999999999999997433     5899999999


Q ss_pred             eecccCCCc-------ccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCccc
Q 004642          603 RLLHVDSSY-------RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLS  659 (740)
Q Consensus       603 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~  659 (740)
                      +.+......       .....||.+||+-....+.+-+.+.|+-|+|=++++++.|..||....
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            988644321       123469999999999999999999999999999999999999998654

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.85  E-value=2.2e-22  Score=200.60  Aligned_cols=293  Identities=25%  Similarity=0.297  Sum_probs=211.2

Q ss_pred             CCEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeeccc-ccccccCchhhccccccccc
Q 004642           76 GRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHG-NNLTGIIPKEIGSLRNLRGL  154 (740)
Q Consensus        76 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L  154 (740)
                      ...++|+|..|.|+ .+|+.+|+.+++|+.||||+|+|+.+-|++|..+.+|.+|-+-+ |+|+.+..+.|++|..|+-|
T Consensus        67 ~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrL  145 (498)
T KOG4237|consen   67 PETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRL  145 (498)
T ss_pred             CcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHH
Confidence            47889999998886 67777999999999999999999999999999999998886655 89998888899999999999


Q ss_pred             ccccccccCCChhhhccccccceeecccccccccCCCcccccccC-----CCccc------------cCCCCccccccCC
Q 004642          155 FLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNI-----SSNQF------------HSSIPLEIGNFSA  217 (740)
Q Consensus       155 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l-----~~n~l------------~~~~p~~l~~l~~  217 (740)
                      .+.-|++.-+..+.|..|++|..|.+.+|.+..+.-.+|..+..+     +.|.+            .-..|..++....
T Consensus       146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc  225 (498)
T KOG4237|consen  146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARC  225 (498)
T ss_pred             hcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccccee
Confidence            999999998889999999999999999999875544455544321     12220            0011111221111


Q ss_pred             ----------------------CCEE---ecCCCcCCCcCC-ccccccCCCCeecccCCccCCCchhhhcCccCCceecc
Q 004642          218 ----------------------LDTL---DLSDNKIHGIIP-DELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDL  271 (740)
Q Consensus       218 ----------------------L~~L---~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  271 (740)
                                            ++.+   ..+.....++-| ..|.+|++|+.|+|++|+|+++-+.+|.++..++.|.|
T Consensus       226 ~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L  305 (498)
T KOG4237|consen  226 VSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL  305 (498)
T ss_pred             cchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence                                  1111   112222333333 45788899999999999999888889999999999999


Q ss_pred             CCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhcccccccceEEecCCcccCCCCCCCcccccc---CCCCCCCCCc
Q 004642          272 SKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVD---LSFNNLEGEI  348 (740)
Q Consensus       272 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~---ls~N~l~~~~  348 (740)
                      ..|+|...-...|.++..|+.|+|.+|+|+...|..|..+.+|.+|+|-.|++.+.---.+-..++.   ..+|. -+.-
T Consensus       306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~-~Cq~  384 (498)
T KOG4237|consen  306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNP-RCQS  384 (498)
T ss_pred             CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCC-CCCC
Confidence            9999987777778889999999999999998888889999999999999999875322111011111   11111 1233


Q ss_pred             CccccCCCCCcccCCccCCCCC
Q 004642          349 PTYLRGNPPKSFVGNKGLSGNV  370 (740)
Q Consensus       349 p~~~~~~~~~~~~~n~~~~~~~  370 (740)
                      |..+++++......-..-|+.+
T Consensus       385 p~~~~~~~~~dv~~~~~~c~~~  406 (498)
T KOG4237|consen  385 PGFVRQIPISDVAFGDFRCGGP  406 (498)
T ss_pred             CchhccccchhccccccccCCc
Confidence            4556666666555555556543

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.83  E-value=3.9e-23  Score=206.08  Aligned_cols=238  Identities=32%  Similarity=0.470  Sum_probs=209.1

Q ss_pred             CCEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccc
Q 004642           76 GRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF  155 (740)
Q Consensus        76 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  155 (740)
                      .-.+.+++.+|++...++  ++..+..++.|+.++|+++ .+|++++.+..|..|+.++|.+. .+|+.++.+..|+.|+
T Consensus        68 ~~l~vl~~~~n~l~~lp~--aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~  143 (565)
T KOG0472|consen   68 ACLTVLNVHDNKLSQLPA--AIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLD  143 (565)
T ss_pred             cceeEEEeccchhhhCCH--HHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhh
Confidence            457889999998875554  5788889999999999998 88999999999999999999998 6677899999999999


Q ss_pred             cccccccCCChhhhccccccceeecccccccccCCCcccccccC-----CCccccCCCCccccccCCCCEEecCCCcCCC
Q 004642          156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNI-----SSNQFHSSIPLEIGNFSALDTLDLSDNKIHG  230 (740)
Q Consensus       156 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l-----~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~  230 (740)
                      ..+|+++ ..|+.+.++.+|..|++.+|++....|.... ++.|     .+|. -+.+|+.++.+.+|+-|+|..|+|. 
T Consensus       144 ~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~-L~tlP~~lg~l~~L~~LyL~~Nki~-  219 (565)
T KOG0472|consen  144 ATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNL-LETLPPELGGLESLELLYLRRNKIR-  219 (565)
T ss_pred             ccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhh-hhcCChhhcchhhhHHHHhhhcccc-
Confidence            9999998 6788899999999999999999977665443 4432     3344 4688999999999999999999999 


Q ss_pred             cCCccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhccc
Q 004642          231 IIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGK  310 (740)
Q Consensus       231 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  310 (740)
                      .+| .|.+++.|+.|+++.|+|.-...+...++++|..|||.+|+++ ..|+.+.-+.+|.+||+++|.|+ ..|.++++
T Consensus       220 ~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgn  296 (565)
T KOG0472|consen  220 FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGN  296 (565)
T ss_pred             cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCccccc
Confidence            567 7999999999999999998444444458999999999999999 78999999999999999999999 78889999


Q ss_pred             ccccceEEecCCccc
Q 004642          311 ILLLQNLDLSHNNLS  325 (740)
Q Consensus       311 l~~L~~L~l~~N~l~  325 (740)
                      + .|+.|-+.||++.
T Consensus       297 l-hL~~L~leGNPlr  310 (565)
T KOG0472|consen  297 L-HLKFLALEGNPLR  310 (565)
T ss_pred             c-eeeehhhcCCchH
Confidence            9 9999999999997

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.5e-20  Score=181.64  Aligned_cols=142  Identities=20%  Similarity=0.197  Sum_probs=109.1

Q ss_pred             ceeeecccceEEEEEEeCCCcEEEEEEccCCcccchH-----------------------HHHHHHHHHHHHhccCCCcc
Q 004642          455 KYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSA-----------------------FVKSFQNEAHVLSTVRHRNI  511 (740)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~ni  511 (740)
                      ...||+|+||.||+|..++|+.||||+++........                       .......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4579999999999998778999999999764321110                       01233459999999988776


Q ss_pred             ceeeeeeeecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCceEEcC
Q 004642          512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL-HHDCTLSIIHRDISSNNILLDS  590 (740)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~dlkp~NIll~~  590 (740)
                      .....+...  ..++||||++++++.......   ..+++.+...++.|++.+|+|+ |+.   +|+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            544333222  248999999998765443222   2578899999999999999999 677   999999999999998 


Q ss_pred             CCcEEEeecccceec
Q 004642          591 NLEASVADFGTARLL  605 (740)
Q Consensus       591 ~~~~kl~DfG~a~~~  605 (740)
                      ++.++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=9e-20  Score=183.06  Aligned_cols=236  Identities=19%  Similarity=0.245  Sum_probs=151.5

Q ss_pred             ccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCC----------Cccceeeeeee
Q 004642          451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH----------RNIVKLYGFCL  519 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~  519 (740)
                      .+...+.||.|+++.||.+... +|+.+|||++...........+++.+|.-....+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4455678999999999999654 589999999877665444456788877766655432          12222222221


Q ss_pred             e---------c---C-----eEEEEEEeccCCCchhhhcC---C-CccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 004642          520 H---------K---K-----CMFLIYEYMERGSLFCVLHD---D-DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIH  578 (740)
Q Consensus       520 ~---------~---~-----~~~lv~e~~~~g~L~~~l~~---~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  578 (740)
                      -         .   .     ..+++|+-+. ++|.+++..   . .....+....++.+..|+++.+++||+.   |++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence            1         1   1     2366777764 477766532   1 1123455667778889999999999999   9999


Q ss_pred             cCCCCCceEEcCCCcEEEeecccceecccCCCcccccccCCCccccccccc--------cccCCcchhHhHHHHHHHHHh
Q 004642          579 RDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT--------IVVTGKCDVYSFGVVALEVLM  650 (740)
Q Consensus       579 ~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~ellt  650 (740)
                      +||+|+|++++.+|.+.|+||+.......  .... ...+..|.+||....        ..++.+.|.|++|+++|.|++
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT--RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE--EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc--eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999999999999999998876432  1111 345678999997643        247788999999999999999


Q ss_pred             CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCC
Q 004642          651 GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSR  709 (740)
Q Consensus       651 g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  709 (740)
                      |+.||+..........   . .+    ...        .-...+..+|..+++++|++|
T Consensus       246 ~~lPf~~~~~~~~~~~---~-f~----~C~--------~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW---D-FS----RCR--------DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG---G-GT----TSS-----------HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc---c-ch----hcC--------CcCHHHHHHHHHHccCCcccC
Confidence            9999986543211110   0 00    011        111227889999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=2e-19  Score=174.69  Aligned_cols=142  Identities=22%  Similarity=0.266  Sum_probs=111.8

Q ss_pred             ceeeecccceEEEEEEeCCCcEEEEEEccCCcccc-----------------------hHHHHHHHHHHHHHhccCCCcc
Q 004642          455 KYCIGTGGYGSVYKAELPEGKVVALKKLHHSETED-----------------------SAFVKSFQNEAHVLSTVRHRNI  511 (740)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~h~ni  511 (740)
                      ...||+|++|.||+|...+|+.||||+++......                       ......+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999987789999999998653210                       0012234678999999999987


Q ss_pred             ceeeeeeeecCeEEEEEEeccCCCchhh-hcCCCccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEc
Q 004642          512 VKLYGFCLHKKCMFLIYEYMERGSLFCV-LHDDDEAIELNWTKRVNIVKSVAHALSYLHH-DCTLSIIHRDISSNNILLD  589 (740)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~  589 (740)
                      .....+....  .++||||++++++... +..    ..++..+...++.|++.++.++|+ .   ||+||||||+||+++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            5554443332  4899999998855433 322    246778899999999999999999 8   999999999999999


Q ss_pred             CCCcEEEeecccceecc
Q 004642          590 SNLEASVADFGTARLLH  606 (740)
Q Consensus       590 ~~~~~kl~DfG~a~~~~  606 (740)
                       ++.++|+|||+++...
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             7899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.9e-19  Score=169.19  Aligned_cols=186  Identities=12%  Similarity=0.064  Sum_probs=139.7

Q ss_pred             ccceeeecccceEEEEEEeCCCcEEEEEEccCCcccch-HHHHHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEe
Q 004642          453 HIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDS-AFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       453 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      .+...|+.|+||+||.+.. .+.+++.+.+........ -....+.+|++++++++ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998866 677788777765443211 11235789999999995 5789999886    346999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceEEcCCCcEEEeecccceecccCC
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDI-SSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      ++|.+|......          ....++.|++.+++++|++   ||+|||| ||+|||++.++.++|+|||+|.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999988644321          1134678999999999999   9999999 7999999999999999999998654333


Q ss_pred             Cc-------------ccccccCCCccccccccc--cccCCcchhHhHHHHHHHHHhCCCCCC
Q 004642          610 SY-------------RTLRAGTYGYIAPELAYT--IVVTGKCDVYSFGVVALEVLMGTHPGG  656 (740)
Q Consensus       610 ~~-------------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~  656 (740)
                      ..             ......++.|++|+...-  ..--...+.++-|+-+|.++||..++.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            21             111235778888875432  222246789999999999999998853

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.80  E-value=7.3e-21  Score=189.84  Aligned_cols=246  Identities=25%  Similarity=0.322  Sum_probs=197.5

Q ss_pred             CCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhccccccccccccc-ccccCCChhhhccccccceee
Q 004642          101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS-NKLSGVLPQEIGNLKSLTELY  179 (740)
Q Consensus       101 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~  179 (740)
                      +....++|..|+|+.+.|.+|+.+.+|++||||+|+|+.+-|++|.++++|..|-+.+ |+|+.+..+.|++|.+|+-|.
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            4578899999999999999999999999999999999999999999999999987766 999988889999999999999


Q ss_pred             cccccccccCCCcccccccC-----CCccccCCCCccccccCCCCEEecCCCcCC------------CcCCccccccCCC
Q 004642          180 VTNNALGGLIPSTLFRLTNI-----SSNQFHSSIPLEIGNFSALDTLDLSDNKIH------------GIIPDELTKLSQL  242 (740)
Q Consensus       180 L~~N~l~~~~~~~~~~l~~l-----~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~------------~~~~~~~~~l~~L  242 (740)
                      +.-|++.-....+|..+.++     .+|.+...-...|..+.+++.+++..|.+-            ...|-.++...-.
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~  226 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV  226 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence            99999998888888877665     678877666668889999999999988832            1222222222111


Q ss_pred             ----------------------Cee--ccc-CCccCCCc-hhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEecc
Q 004642          243 ----------------------KNL--NLS-SNLLSGQI-PYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLN  296 (740)
Q Consensus       243 ----------------------~~L--~l~-~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~  296 (740)
                                            +.+  .++ .....+.. ...|..+++|+.|+|++|+|+++-+.+|.++..++.|+|.
T Consensus       227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~  306 (498)
T KOG4237|consen  227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT  306 (498)
T ss_pred             chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence                                  111  111 12222233 3468899999999999999999999999999999999999


Q ss_pred             CCCCCCCCchhcccccccceEEecCCcccCCCCCCCccc----cccCCCCCCCC
Q 004642          297 HNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEG  346 (740)
Q Consensus       297 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~----~l~ls~N~l~~  346 (740)
                      .|+|...-...|..+..|+.|+|.+|+|+...|-.|...    .+++-.|++.+
T Consensus       307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C  360 (498)
T KOG4237|consen  307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC  360 (498)
T ss_pred             cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence            999986666788899999999999999998888877654    36666666654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=8.3e-21  Score=201.71  Aligned_cols=226  Identities=26%  Similarity=0.343  Sum_probs=178.7

Q ss_pred             eecccceEEEEEE----eCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeeeeecCeEEEEEEecc
Q 004642          458 IGTGGYGSVYKAE----LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKKCMFLIYEYME  532 (740)
Q Consensus       458 lg~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  532 (740)
                      +|+|.||.|+.++    ...|..||.|..+.......... ....|..++..++ ||.+|++.-.+..+...+++.+|..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            6899999999872    33577889988876544433222 4567888889886 9999999999999999999999999


Q ss_pred             CCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcc
Q 004642          533 RGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR  612 (740)
Q Consensus       533 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  612 (740)
                      +|.+...+....   .+++.........++-+++++|+.   +++|||+|++||+++.+|++++.|||+++........ 
T Consensus        81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999988776654   456667777788899999999998   9999999999999999999999999999876433222 


Q ss_pred             cccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHH
Q 004642          613 TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDII  692 (740)
Q Consensus       613 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  692 (740)
                         +||..|||||++.  .+...+|.||||++.+||+||..||..           .....++...+..+.     +-..
T Consensus       154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~~~~~p~-----~l~~  212 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKAELEMPR-----ELSA  212 (612)
T ss_pred             ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhhccCCch-----hhhH
Confidence               8999999999998  466789999999999999999999874           122233332333221     2223


Q ss_pred             HHHHHHHHcccCCCCCCCCH
Q 004642          693 LVSTIAFACLSSQPKSRPTM  712 (740)
Q Consensus       693 ~l~~li~~cl~~dP~~RPs~  712 (740)
                      .+.+++..++..+|..|-..
T Consensus       213 ~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  213 EARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHHHHHHhhCHHHHhcc
Confidence            36788888999999999644

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.80  E-value=1.6e-19  Score=204.61  Aligned_cols=238  Identities=31%  Similarity=0.399  Sum_probs=162.1

Q ss_pred             CEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhccccccccccc
Q 004642           77 RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL  156 (740)
Q Consensus        77 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (740)
                      +++.|++.+|+++. ++.    .+++|++|+|++|+|+. +|..   .++|++|+|++|.|+. +|..+   .+|+.|+|
T Consensus       223 ~L~~L~L~~N~Lt~-LP~----lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~~-Lp~lp---~~L~~L~L  289 (788)
T PRK15387        223 HITTLVIPDNNLTS-LPA----LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLTH-LPALP---SGLCKLWI  289 (788)
T ss_pred             CCCEEEccCCcCCC-CCC----CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCchhh-hhhch---hhcCEEEC
Confidence            56677777776664 332    24677777777777773 3432   3567777777777763 34322   56777888


Q ss_pred             ccccccCCChhhhccccccceeecccccccccCCCcccccc--cCCCccccCCCCccccccCCCCEEecCCCcCCCcCCc
Q 004642          157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPD  234 (740)
Q Consensus       157 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  234 (740)
                      ++|+|+. +|.   .+++|+.|+|++|+|++. |.....+.  .+++|++++ +|..   ..+|+.|+|++|+|++ +|.
T Consensus       290 s~N~Lt~-LP~---~p~~L~~LdLS~N~L~~L-p~lp~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~  359 (788)
T PRK15387        290 FGNQLTS-LPV---LPPGLQELSVSDNQLASL-PALPSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPT  359 (788)
T ss_pred             cCCcccc-ccc---cccccceeECCCCccccC-CCCcccccccccccCcccc-cccc---ccccceEecCCCccCC-CCC
Confidence            8888874 343   246788888888888864 33333333  356777764 4431   2478899999999985 454


Q ss_pred             cccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhccccccc
Q 004642          235 ELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLL  314 (740)
Q Consensus       235 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  314 (740)
                      .   ..+|+.|++++|+|++ +|..   ..+|+.|++++|+|++ +|..   .++|+.|++++|+|+ .+|...   .+|
T Consensus       360 l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L  424 (788)
T PRK15387        360 L---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGL  424 (788)
T ss_pred             C---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhh
Confidence            3   3567888899999884 4543   2578899999999884 5543   357888999999998 466533   467


Q ss_pred             ceEEecCCcccCCCCCCCccc----cccCCCCCCCCCcCcccc
Q 004642          315 QNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPTYLR  353 (740)
Q Consensus       315 ~~L~l~~N~l~~~~p~~~~~~----~l~ls~N~l~~~~p~~~~  353 (740)
                      +.|++++|+|+ .+|..+..+    .+++++|+|+|..|..+.
T Consensus       425 ~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~  466 (788)
T PRK15387        425 LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR  466 (788)
T ss_pred             hhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHH
Confidence            88999999998 678765443    488999999988777653

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.80  E-value=2.1e-21  Score=172.14  Aligned_cols=164  Identities=35%  Similarity=0.558  Sum_probs=109.4

Q ss_pred             cCCCCCceeecccccccccCchhhcccccccccccccccccCCChhhhccccccceeecccccccccCCCcccccccCCC
Q 004642          122 GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISS  201 (740)
Q Consensus       122 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~  201 (740)
                      .++++.+.|.||+|+++ .+|..+..+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++.               
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~---------------   92 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN---------------   92 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh---------------
Confidence            34556666667777766 44555666777777777777776 55666677777777777666664               


Q ss_pred             ccccCCCCccccccCCCCEEecCCCcCCC-cCCccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcC
Q 004642          202 NQFHSSIPLEIGNFSALDTLDLSDNKIHG-IIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSI  280 (740)
Q Consensus       202 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  280 (740)
                           ..|..|+.++.|+.|||.+|++.. .+|+.|..++.|+-|+|++|.+. .+|..++++++|+.|.+.+|.+- ..
T Consensus        93 -----~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~l  165 (264)
T KOG0617|consen   93 -----ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SL  165 (264)
T ss_pred             -----cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hC
Confidence                 556666666777777777766654 46666777777777777777776 56666777777777777777766 56


Q ss_pred             CcccccCCCCCeEeccCCCCCCCCchhccc
Q 004642          281 PTEIGNCSALKNLTLNHNSLDGTIPLEMGK  310 (740)
Q Consensus       281 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  310 (740)
                      |..++.+..|++|++.+|+++ .+|.+++.
T Consensus       166 pkeig~lt~lrelhiqgnrl~-vlppel~~  194 (264)
T KOG0617|consen  166 PKEIGDLTRLRELHIQGNRLT-VLPPELAN  194 (264)
T ss_pred             cHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence            666777777777777777776 55555443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=1.7e-19  Score=192.39  Aligned_cols=212  Identities=27%  Similarity=0.472  Sum_probs=161.0

Q ss_pred             HhccCCCccceeeeeeeecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCC
Q 004642          503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI-IHRDI  581 (740)
Q Consensus       503 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-vH~dl  581 (740)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+...  ...++|.-...+.++|+.||+|+|..   +| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            45789999999999999999999999999999999999873  34789999999999999999999987   55 89999


Q ss_pred             CCCceEEcCCCcEEEeecccceeccc--CCCcccccccCCCccccccccccc-------cCCcchhHhHHHHHHHHHhCC
Q 004642          582 SSNNILLDSNLEASVADFGTARLLHV--DSSYRTLRAGTYGYIAPELAYTIV-------VTGKCDVYSFGVVALEVLMGT  652 (740)
Q Consensus       582 kp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslGvil~elltg~  652 (740)
                      +++|.++|....+|++|||+......  +........-..-|.|||.+.+..       .+.+.||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999877642  111111222345799999987641       456799999999999999999


Q ss_pred             CCCCcccccccCCCCCchhhhhhc-cc--CCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          653 HPGGLLSSLSSSSGPKIMLIDVLN-QR--LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       653 ~p~~~~~~~~~~~~~~~~~~~~~~-~~--l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      .||+.......   +++.+..+.+ ..  .++...... +....+..++..||..+|++||+++++-..+....
T Consensus       156 ~~~~~~~~~~~---~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  156 GPFDLRNLVED---PDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             CccccccccCC---hHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            99885332111   1222222222 11  222221111 22234888999999999999999999988886543

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=6e-21  Score=169.21  Aligned_cols=167  Identities=34%  Similarity=0.523  Sum_probs=150.7

Q ss_pred             cCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccccccccccCCChhhhccccccc
Q 004642           97 FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLT  176 (740)
Q Consensus        97 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  176 (740)
                      +-++++++.|.||+|+++ .+|+.++.+.+|+.|++++|+|+ .+|..++.++.|+.|+++-|++. +.|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            345677889999999998 67888999999999999999998 67889999999999999999998 8899999999999


Q ss_pred             eeecccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCcCCccccccCCCCeecccCCccCCCc
Q 004642          177 ELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQI  256 (740)
Q Consensus       177 ~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  256 (740)
                      .|||..|++...                  .+|..|..++.|+.|+|++|.+. ++|..++++++|+.|.+..|.+- .+
T Consensus       106 vldltynnl~e~------------------~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~l  165 (264)
T KOG0617|consen  106 VLDLTYNNLNEN------------------SLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SL  165 (264)
T ss_pred             hhhccccccccc------------------cCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hC
Confidence            999999998743                  56667777889999999999998 88999999999999999999997 67


Q ss_pred             hhhhcCccCCceeccCCCcccCcCCcccccC
Q 004642          257 PYAIGKLFNLMYLDLSKNKLSGSIPTEIGNC  287 (740)
Q Consensus       257 ~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l  287 (740)
                      |..++.++.|+.|.+.+|+++ .+|+.++++
T Consensus       166 pkeig~lt~lrelhiqgnrl~-vlppel~~l  195 (264)
T KOG0617|consen  166 PKEIGDLTRLRELHIQGNRLT-VLPPELANL  195 (264)
T ss_pred             cHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence            999999999999999999999 777777765

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=6.2e-19  Score=200.73  Aligned_cols=248  Identities=21%  Similarity=0.236  Sum_probs=184.5

Q ss_pred             HHhcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC---CCccceeeeeeeecCe
Q 004642          447 NATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR---HRNIVKLYGFCLHKKC  523 (740)
Q Consensus       447 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~  523 (740)
                      ...+.|.|.+.||+|+||+||+|...+|+.||+|+-+.....+.....+      ++.+++   -+-|..+...+...+.
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q------~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQ------VMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHH------HHHhhchhhhcchHHHHHHHccCCc
Confidence            3457889999999999999999988789999999998887765433333      344444   2345666666677788


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-------CCcEEE
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-------NLEASV  596 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-------~~~~kl  596 (740)
                      -++|+||.+.|+|.+++...+   .++|.-++.+..|+++.+++||..   +||||||||+|.|+..       ..-++|
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             ceeeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence            899999999999999998443   689999999999999999999998   9999999999999953       234899


Q ss_pred             eecccceeccc--CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhh
Q 004642          597 ADFGTARLLHV--DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDV  674 (740)
Q Consensus       597 ~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  674 (740)
                      +|||.+..+..  +.......++|-.+-.+|...|..++..+|.|.++-+++-|+.|++-- .     .....     ..
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~-----~~g~~-----~~  911 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-V-----KNGSS-----WM  911 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-h-----cCCcc-----ee
Confidence            99999987643  333445668899999999999999999999999999999999998642 0     00000     00


Q ss_pred             hcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          675 LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       675 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                      +...++.    .+..+  ...+|+..+|..|-..=|...++...+....
T Consensus       912 ~~~~~~R----y~~~~--~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~  954 (974)
T KOG1166|consen  912 VKTNFPR----YWKRD--MWNKFFDLLLNPDCDTLPNLQELRTELEEVL  954 (974)
T ss_pred             ccccchh----hhhHH--HHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence            1111111    01111  1345666677744444477777777776553

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.77  E-value=2.3e-20  Score=204.56  Aligned_cols=239  Identities=31%  Similarity=0.384  Sum_probs=140.1

Q ss_pred             CEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhccccccccccc
Q 004642           77 RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL  156 (740)
Q Consensus        77 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (740)
                      +.+.|+..+|.++...   ....-.+|+++++++|+++ .+|+.++.+.+|+.|+.++|+|. .+|..+...++|+.|++
T Consensus       220 ~l~~L~a~~n~l~~~~---~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~  294 (1081)
T KOG0618|consen  220 SLTALYADHNPLTTLD---VHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSA  294 (1081)
T ss_pred             chheeeeccCcceeec---cccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHh
Confidence            4455555555555221   1223457999999999998 45699999999999999999996 77888888999999999


Q ss_pred             ccccccCCChhhhccccccceeecccccccccCCCcccccc-------cCCCccccCCCCccccccCCCCEEecCCCcCC
Q 004642          157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT-------NISSNQFHSSIPLEIGNFSALDTLDLSDNKIH  229 (740)
Q Consensus       157 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-------~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~  229 (740)
                      ..|.+. .+|+.+..+++|++|+|..|+|....+ .+....       +.+.|.+.......=..++.|+.|++.+|.++
T Consensus       295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~-~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Lt  372 (1081)
T KOG0618|consen  295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPD-NFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLT  372 (1081)
T ss_pred             hhhhhh-hCCCcccccceeeeeeehhccccccch-HHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccc
Confidence            999998 667788889999999999999975433 333222       11223332221111112333444444444444


Q ss_pred             CcCCccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhcc
Q 004642          230 GIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMG  309 (740)
Q Consensus       230 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~  309 (740)
                      +..-..+.++.+|+.|+|++|+|.......+.++..|+.|+||+|+++ .+|..+.+++.|++|...+|++. ..| .+.
T Consensus       373 d~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~  449 (1081)
T KOG0618|consen  373 DSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELA  449 (1081)
T ss_pred             ccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhh
Confidence            433333444444444444444444333334444444444444444444 34444444444444444444444 333 444


Q ss_pred             cccccceEEecCCccc
Q 004642          310 KILLLQNLDLSHNNLS  325 (740)
Q Consensus       310 ~l~~L~~L~l~~N~l~  325 (740)
                      .++.|+.+|+|.|+|+
T Consensus       450 ~l~qL~~lDlS~N~L~  465 (1081)
T KOG0618|consen  450 QLPQLKVLDLSCNNLS  465 (1081)
T ss_pred             hcCcceEEecccchhh
Confidence            4444444444444444

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.77  E-value=1.5e-18  Score=198.17  Aligned_cols=221  Identities=27%  Similarity=0.427  Sum_probs=121.8

Q ss_pred             CEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhccccccccccc
Q 004642           77 RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL  156 (740)
Q Consensus        77 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (740)
                      ..+.|++.+++++.....  +  .++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|+ .+|..+.  .+|+.|+|
T Consensus       179 ~~~~L~L~~~~LtsLP~~--I--p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L  248 (754)
T PRK15370        179 NKTELRLKILGLTTIPAC--I--PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL  248 (754)
T ss_pred             CceEEEeCCCCcCcCCcc--c--ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence            457788887777643221  1  256888888888888 4555443  57888888888887 4455443  46888888


Q ss_pred             ccccccCCChhhhccccccceeecccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCcCCccc
Q 004642          157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEL  236 (740)
Q Consensus       157 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~  236 (740)
                      ++|++. .+|..+.  .+|+.|+|++|+|+. +|..+.                     ++|+.|+|++|+|++ +|..+
T Consensus       249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~---------------------~sL~~L~Ls~N~Lt~-LP~~l  302 (754)
T PRK15370        249 SINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP---------------------EELRYLSVYDNSIRT-LPAHL  302 (754)
T ss_pred             cCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC---------------------CCCcEEECCCCcccc-Ccccc
Confidence            888887 4565553  478888888888873 333221                     245555555555553 33322


Q ss_pred             cccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhcccccccce
Q 004642          237 TKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQN  316 (740)
Q Consensus       237 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  316 (740)
                      .  ++|+.|++++|+++. +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.
T Consensus       303 p--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~  371 (754)
T PRK15370        303 P--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITT  371 (754)
T ss_pred             h--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCE
Confidence            2  245555555555542 222221  345555555555543 333332  34555555555554 3343332  34555


Q ss_pred             EEecCCcccCCCCCCCcc--ccccCCCCCCC
Q 004642          317 LDLSHNNLSGTIPKTLRP--MYVDLSFNNLE  345 (740)
Q Consensus       317 L~l~~N~l~~~~p~~~~~--~~l~ls~N~l~  345 (740)
                      |+|++|+|+ .+|..+..  ..+++++|+|+
T Consensus       372 LdLs~N~Lt-~LP~~l~~sL~~LdLs~N~L~  401 (754)
T PRK15370        372 LDVSRNALT-NLPENLPAALQIMQASRNNLV  401 (754)
T ss_pred             EECCCCcCC-CCCHhHHHHHHHHhhccCCcc
Confidence            555555555 23333221  13455555554

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.76  E-value=2.2e-18  Score=196.65  Aligned_cols=223  Identities=28%  Similarity=0.433  Sum_probs=143.2

Q ss_pred             CCEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccc
Q 004642           76 GRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF  155 (740)
Q Consensus        76 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  155 (740)
                      ..++.|+|.+|+++. ++...   +++|+.|+|++|+|+ .+|..+.  .+|+.|+|++|++. .+|..+.  .+|+.|+
T Consensus       199 ~~L~~L~Ls~N~Lts-LP~~l---~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~  268 (754)
T PRK15370        199 EQITTLILDNNELKS-LPENL---QGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLD  268 (754)
T ss_pred             cCCcEEEecCCCCCc-CChhh---ccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEE
Confidence            478899999999884 44322   368999999999998 4566553  47999999999998 5676664  5899999


Q ss_pred             cccccccCCChhhhccccccceeecccccccccCCCccc-ccc--cCCCccccCCCCccccccCCCCEEecCCCcCCCcC
Q 004642          156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLF-RLT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGII  232 (740)
Q Consensus       156 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~-~l~--~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  232 (740)
                      |++|+|+. +|..+.  ++|+.|+|++|+|++. |..+. .+.  ++++|+++. +|..+  .++|+.|++++|.+++ +
T Consensus       269 Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~lp~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-L  340 (754)
T PRK15370        269 LFHNKISC-LPENLP--EELRYLSVYDNSIRTL-PAHLPSGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALTS-L  340 (754)
T ss_pred             CcCCccCc-cccccC--CCCcEEECCCCccccC-cccchhhHHHHHhcCCcccc-CCccc--cccceeccccCCcccc-C
Confidence            99999994 676554  5899999999999854 33221 121  345566553 33322  2456666666666664 4


Q ss_pred             CccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhc----
Q 004642          233 PDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEM----  308 (740)
Q Consensus       233 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~----  308 (740)
                      |..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ..|+.|++++|+|+ .+|..+    
T Consensus       341 P~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~  411 (754)
T PRK15370        341 PASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFR  411 (754)
T ss_pred             Chhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHh
Confidence            44432  46666666666665 3444332  45666666666666 3444433  24666666666665 333332    


Q ss_pred             ccccccceEEecCCccc
Q 004642          309 GKILLLQNLDLSHNNLS  325 (740)
Q Consensus       309 ~~l~~L~~L~l~~N~l~  325 (740)
                      +.++.+..|++.+|+|+
T Consensus       412 ~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        412 GEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             hcCCCccEEEeeCCCcc
Confidence            23355566666666655

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.75  E-value=2.1e-18  Score=195.47  Aligned_cols=222  Identities=27%  Similarity=0.366  Sum_probs=175.0

Q ss_pred             CCEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccc
Q 004642           76 GRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF  155 (740)
Q Consensus        76 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  155 (740)
                      ..++.|+|.+|+++.. +.    ..++|+.|+|++|.|+. +|..   .++|+.|+|++|+|+. +|..   +++|+.|+
T Consensus       242 ~~Lk~LdLs~N~LtsL-P~----lp~sL~~L~Ls~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~Ld  308 (788)
T PRK15387        242 PELRTLEVSGNQLTSL-PV----LPPGLLELSIFSNPLTH-LPAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELS  308 (788)
T ss_pred             CCCcEEEecCCccCcc-cC----cccccceeeccCCchhh-hhhc---hhhcCEEECcCCcccc-cccc---ccccceeE
Confidence            4678899999998854 32    24789999999999984 4443   3678899999999985 4542   47899999


Q ss_pred             cccccccCCChhhhccccccceeecccccccccCCCcccccc--cCCCccccCCCCccccccCCCCEEecCCCcCCCcCC
Q 004642          156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIP  233 (740)
Q Consensus       156 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  233 (740)
                      |++|+|+++ |..   ..+|+.|++++|+|++ +|....++.  +|++|+|++ +|..   .++|+.|++++|+|++ +|
T Consensus       309 LS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP~lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP  378 (788)
T PRK15387        309 VSDNQLASL-PAL---PSELCKLWAYNNQLTS-LPTLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LP  378 (788)
T ss_pred             CCCCccccC-CCC---cccccccccccCcccc-ccccccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cc
Confidence            999999964 432   2468899999999986 444333443  578999986 4443   3578899999999995 66


Q ss_pred             ccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhcccccc
Q 004642          234 DELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILL  313 (740)
Q Consensus       234 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  313 (740)
                      ..   ..+|+.|+|++|+|++ +|..   .++|+.|++++|+|++ +|..+   .+|+.|+|++|+|+ .+|..+..+++
T Consensus       379 ~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~  446 (788)
T PRK15387        379 AL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSS  446 (788)
T ss_pred             cc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccC
Confidence            53   3579999999999995 4533   3679999999999985 66543   46889999999999 78999999999


Q ss_pred             cceEEecCCcccCCCCCCC
Q 004642          314 LQNLDLSHNNLSGTIPKTL  332 (740)
Q Consensus       314 L~~L~l~~N~l~~~~p~~~  332 (740)
                      |+.|+|++|+|++..|..+
T Consensus       447 L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        447 ETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             CCeEECCCCCCCchHHHHH
Confidence            9999999999999888765

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.73  E-value=2.1e-19  Score=197.03  Aligned_cols=243  Identities=30%  Similarity=0.368  Sum_probs=202.9

Q ss_pred             CCCCEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccc
Q 004642           74 YEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRG  153 (740)
Q Consensus        74 ~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  153 (740)
                      .....+.++++++++++..  .-+..+.+|+.|+..+|+|. .+|..+...++|+.|++.+|.++ -+|..+.+++.|++
T Consensus       239 ~p~nl~~~dis~n~l~~lp--~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~t  314 (1081)
T KOG0618|consen  239 VPLNLQYLDISHNNLSNLP--EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRT  314 (1081)
T ss_pred             ccccceeeecchhhhhcch--HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeee
Confidence            3467888999999988665  35788999999999999996 78889999999999999999998 56778888999999


Q ss_pred             cccccccccCCChhhhccccc-cceeecccccccccCC---Cccccc--ccCCCccccCCCCccccccCCCCEEecCCCc
Q 004642          154 LFLYSNKLSGVLPQEIGNLKS-LTELYVTNNALGGLIP---STLFRL--TNISSNQFHSSIPLEIGNFSALDTLDLSDNK  227 (740)
Q Consensus       154 L~L~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~~---~~~~~l--~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~  227 (740)
                      |+|..|+|....+..+.-+.. |+.|+.+.|++....-   ..+..+  ..+.+|.++...-+.+.++++|+.|+|++|+
T Consensus       315 LdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNr  394 (1081)
T KOG0618|consen  315 LDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNR  394 (1081)
T ss_pred             eeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccc
Confidence            999999998555545554444 8888888888874431   111112  2468999998888889999999999999999


Q ss_pred             CCCcCCccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCC-Cch
Q 004642          228 IHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGT-IPL  306 (740)
Q Consensus       228 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~  306 (740)
                      |.......+.++..|+.|+||+|+++ .+|..+.++..|++|....|+|. ..| .+..++.|+.+|++.|+|+.. +|.
T Consensus       395 L~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~  471 (1081)
T KOG0618|consen  395 LNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPE  471 (1081)
T ss_pred             cccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhh
Confidence            99665567899999999999999999 77899999999999999999998 667 799999999999999999854 344


Q ss_pred             hcccccccceEEecCCcc
Q 004642          307 EMGKILLLQNLDLSHNNL  324 (740)
Q Consensus       307 ~~~~l~~L~~L~l~~N~l  324 (740)
                      ... .++|++|||+||.-
T Consensus       472 ~~p-~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  472 ALP-SPNLKYLDLSGNTR  488 (1081)
T ss_pred             hCC-CcccceeeccCCcc
Confidence            333 38999999999984

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=3.8e-17  Score=159.16  Aligned_cols=136  Identities=19%  Similarity=0.243  Sum_probs=104.6

Q ss_pred             cceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-----CCCccceeeeeeeecC---e-E
Q 004642          454 IKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-----RHRNIVKLYGFCLHKK---C-M  524 (740)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~  524 (740)
                      -.+.||+|+||.||.  +++....+||++......   ..+.+.+|++++..+     .||||++++|++.++.   . +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            356799999999996  443333479988764332   236789999999999     5799999999999863   3 3


Q ss_pred             EEEEEe--ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCceEEcC----CCcEEEe
Q 004642          525 FLIYEY--MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL-SYLHHDCTLSIIHRDISSNNILLDS----NLEASVA  597 (740)
Q Consensus       525 ~lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~  597 (740)
                      .+|+||  +++++|.+++.+.    .+++.  ..++.+++.++ +|||++   +|+||||||+||+++.    ++.++|+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            478999  5679999999653    24444  35677888777 999999   9999999999999974    3479999


Q ss_pred             e-cccce
Q 004642          598 D-FGTAR  603 (740)
Q Consensus       598 D-fG~a~  603 (740)
                      | ||...
T Consensus       152 Dg~G~~~  158 (210)
T PRK10345        152 DNIGEST  158 (210)
T ss_pred             ECCCCcc
Confidence            9 55443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=1.2e-17  Score=166.97  Aligned_cols=195  Identities=22%  Similarity=0.307  Sum_probs=132.9

Q ss_pred             CCCccceeeeeeee---------------------------cCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHH
Q 004642          507 RHRNIVKLYGFCLH---------------------------KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK  559 (740)
Q Consensus       507 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~  559 (740)
                      +|||||++.++|.+                           +...|+||...+. +|..++....    .+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            59999999987753                           2357899987765 7877776543    45566677899


Q ss_pred             HHHHHHHHHHhcCCCCeEecCCCCCceEEc--CCC--cEEEeecccceecccC------CCcccccccCCCccccccccc
Q 004642          560 SVAHALSYLHHDCTLSIIHRDISSNNILLD--SNL--EASVADFGTARLLHVD------SSYRTLRAGTYGYIAPELAYT  629 (740)
Q Consensus       560 ~ia~~L~~LH~~~~~~ivH~dlkp~NIll~--~~~--~~kl~DfG~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~  629 (740)
                      |++.|+.|||++   ||.|||+|++|||+.  +|+  ...|+|||.+-.-...      ....-...|...-||||+...
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            999999999999   999999999999995  333  3678999987421110      011122357888999998764


Q ss_pred             cc------cCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHccc
Q 004642          630 IV------VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLS  703 (740)
Q Consensus       630 ~~------~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~  703 (740)
                      .+      -..|+|.|+.|-+.||+++...||-.....-      -.........+++ .+.   .....+.+++...++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~------L~~r~Yqe~qLPa-lp~---~vpp~~rqlV~~lL~  495 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML------LDTRTYQESQLPA-LPS---RVPPVARQLVFDLLK  495 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe------echhhhhhhhCCC-Ccc---cCChHHHHHHHHHhc
Confidence            32      2248999999999999999999986421100      0000111111111 111   112237889999999


Q ss_pred             CCCCCCCCHHHHHHHH
Q 004642          704 SQPKSRPTMQRISQEL  719 (740)
Q Consensus       704 ~dP~~RPs~~ev~~~L  719 (740)
                      .||.+|++..-....+
T Consensus       496 r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  496 RDPSKRVSPNIAANVL  511 (598)
T ss_pred             CCccccCCccHHHhHH
Confidence            9999999865444443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.72  E-value=1.5e-18  Score=181.12  Aligned_cols=175  Identities=23%  Similarity=0.370  Sum_probs=135.6

Q ss_pred             CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      ...|+.|+++...+|.+|+.+.......++.....++.|++.|++|   +   +.+|+|+||.||+...+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            3579999999999999999876666678899999999999999999   5   899999999999999999999999999


Q ss_pred             ceecccCC------CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhh
Q 004642          602 ARLLHVDS------SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDV  674 (740)
Q Consensus       602 a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  674 (740)
                      ........      ...+...||..||+||.+.+..|+.|+||||+|++++|+++ =..+++..          ....++
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDI  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhh
Confidence            98765443      12234579999999999999999999999999999999997 33333221          112222


Q ss_pred             hcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004642          675 LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRIS  716 (740)
Q Consensus       675 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~  716 (740)
                      -+..+++......++    -..++.++++..|.+||++.++.
T Consensus       473 r~g~ip~~~~~d~p~----e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  473 RDGIIPPEFLQDYPE----EYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             hcCCCChHHhhcCcH----HHHHHHHhcCCCcccCchHHHHh
Confidence            233333222222222    34688899999999999665544

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=5.9e-17  Score=162.04  Aligned_cols=146  Identities=21%  Similarity=0.211  Sum_probs=112.3

Q ss_pred             cccccceeeecccceEEEEEE--eCCCcEEEEEEccCCcccc---------------------hHHHHHHHHHHHHHhcc
Q 004642          450 EDFHIKYCIGTGGYGSVYKAE--LPEGKVVALKKLHHSETED---------------------SAFVKSFQNEAHVLSTV  506 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l  506 (740)
                      ..|.+.+.||+|+||.||+|.  ..+|+.||+|+++......                     ......+..|++.+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999997  5689999999987543210                     00123467899999999


Q ss_pred             CCCc--cceeeeeeeecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCC
Q 004642          507 RHRN--IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS-IIHRDISS  583 (740)
Q Consensus       507 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~dlkp  583 (740)
                      .+..  +.+++++    ...++||||++++++........   .....+...++.||+.++++||+.   + ++||||||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            7533  3444443    23589999999988866543222   345566788999999999999999   9 99999999


Q ss_pred             CceEEcCCCcEEEeecccceecc
Q 004642          584 NNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       584 ~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      +||+++ ++.++|+|||.+....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999987543

>PLN03210 Resistant to P

Probab=99.72  E-value=1.1e-16  Score=195.35  Aligned_cols=247  Identities=24%  Similarity=0.267  Sum_probs=140.8

Q ss_pred             CCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccccccccccCCChhhhccccccceee
Q 004642          100 FPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELY  179 (740)
Q Consensus       100 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  179 (740)
                      +.+|+.|+|++|.+. .++..+..+++|++|+|++|+.-..+|. ++.+++|+.|+|++|.....+|..+.++++|+.|+
T Consensus       610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~  687 (1153)
T PLN03210        610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD  687 (1153)
T ss_pred             ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence            456666777666665 4555566667777777766543334453 56666777777776655556666667777777777


Q ss_pred             cccccccccCCCccccccc-----CCCccccCCCCccccccCCCCEEecCCCcCCCcCCccccccCCCCeecccCCcc--
Q 004642          180 VTNNALGGLIPSTLFRLTN-----ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLL--  252 (740)
Q Consensus       180 L~~N~l~~~~~~~~~~l~~-----l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l--  252 (740)
                      +++|...+.+|..+ ++.+     +++|...+.+|..   .++|++|+|++|.++ .+|..+ .+++|+.|++.++..  
T Consensus       688 L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~  761 (1153)
T PLN03210        688 MSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK  761 (1153)
T ss_pred             CCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhh
Confidence            76654434444432 2222     2333333333322   245666777777665 344433 345555555544221  


Q ss_pred             -----CCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhcccccccceEEecCCcccCC
Q 004642          253 -----SGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGT  327 (740)
Q Consensus       253 -----~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  327 (740)
                           ....+..+...++|+.|+|++|...+.+|..++++++|+.|+|++|...+.+|... .+++|+.|++++|..-..
T Consensus       762 l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~  840 (1153)
T PLN03210        762 LWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRT  840 (1153)
T ss_pred             ccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccc
Confidence                 11111122233567777777777666777777777777777777765444666554 567777777777655555


Q ss_pred             CCCCCccc-cccCCCCCCCCCcCccccCCC
Q 004642          328 IPKTLRPM-YVDLSFNNLEGEIPTYLRGNP  356 (740)
Q Consensus       328 ~p~~~~~~-~l~ls~N~l~~~~p~~~~~~~  356 (740)
                      +|.....+ .+++++|.++ .+|.++..++
T Consensus       841 ~p~~~~nL~~L~Ls~n~i~-~iP~si~~l~  869 (1153)
T PLN03210        841 FPDISTNISDLNLSRTGIE-EVPWWIEKFS  869 (1153)
T ss_pred             ccccccccCEeECCCCCCc-cChHHHhcCC
Confidence            55543333 4667777766 4555444333

syringae 6; Provisional

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.72  E-value=6.9e-19  Score=186.51  Aligned_cols=112  Identities=23%  Similarity=0.308  Sum_probs=48.9

Q ss_pred             ccCCCCEEecCCCcCCCc----CCccccccCCCCeecccCCccCCCc----hhhhcCccCCceeccCCCcccCcCCcccc
Q 004642          214 NFSALDTLDLSDNKIHGI----IPDELTKLSQLKNLNLSSNLLSGQI----PYAIGKLFNLMYLDLSKNKLSGSIPTEIG  285 (740)
Q Consensus       214 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~l~  285 (740)
                      .+++|++|+|++|.+++.    ++..+..+++|+.|++++|.+++..    +..+..+++|++|++++|.+++.....+.
T Consensus       163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~  242 (319)
T cd00116         163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA  242 (319)
T ss_pred             hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence            344455555555555431    1122333345555555555554322    22233444555555555555432222221


Q ss_pred             c-----CCCCCeEeccCCCCCC----CCchhcccccccceEEecCCccc
Q 004642          286 N-----CSALKNLTLNHNSLDG----TIPLEMGKILLLQNLDLSHNNLS  325 (740)
Q Consensus       286 ~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~  325 (740)
                      .     .++|++|++++|.++.    .+...+..+++|+.+++++|+++
T Consensus       243 ~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~  291 (319)
T cd00116         243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG  291 (319)
T ss_pred             HHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence            1     2455555555555541    12233334445555555555554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PLN03210 Resistant to P

Probab=99.71  E-value=1.1e-16  Score=195.31  Aligned_cols=245  Identities=22%  Similarity=0.276  Sum_probs=149.7

Q ss_pred             CCEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccc
Q 004642           76 GRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF  155 (740)
Q Consensus        76 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  155 (740)
                      ..++.|+|.++.+.. +.. .+..+++|+.|+|++|...+.+| .++.+++|++|+|++|..-..+|..+.++++|+.|+
T Consensus       611 ~~L~~L~L~~s~l~~-L~~-~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~  687 (1153)
T PLN03210        611 ENLVKLQMQGSKLEK-LWD-GVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD  687 (1153)
T ss_pred             cCCcEEECcCccccc-ccc-ccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence            467778888877653 322 46788999999999876555666 488899999999999876668899999999999999


Q ss_pred             cccccccCCChhhhccccccceeecccccccccCCCcccccc--cCCCccccCCCCccccccCCCCEEecCCCcCC----
Q 004642          156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIH----  229 (740)
Q Consensus       156 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~----  229 (740)
                      +++|...+.+|..+ ++++|+.|+|++|...+..|....++.  +++.|.+. .+|..+ .+++|++|++.++...    
T Consensus       688 L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~  764 (1153)
T PLN03210        688 MSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWE  764 (1153)
T ss_pred             CCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCccc-cccccc-cccccccccccccchhhccc
Confidence            99876555667655 788999999998876666665544443  35566654 344433 3455555555442211    


Q ss_pred             ---CcCCccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCch
Q 004642          230 ---GIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPL  306 (740)
Q Consensus       230 ---~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~  306 (740)
                         ...+......++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|+|++|.....+|.
T Consensus       765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~  843 (1153)
T PLN03210        765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD  843 (1153)
T ss_pred             cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc
Confidence               1111112223455555555555544555555555555555555554333444433 455555555555443333333


Q ss_pred             hcccccccceEEecCCcccCCCCCC
Q 004642          307 EMGKILLLQNLDLSHNNLSGTIPKT  331 (740)
Q Consensus       307 ~~~~l~~L~~L~l~~N~l~~~~p~~  331 (740)
                      .   ..+|+.|+|++|.++ .+|.+
T Consensus       844 ~---~~nL~~L~Ls~n~i~-~iP~s  864 (1153)
T PLN03210        844 I---STNISDLNLSRTGIE-EVPWW  864 (1153)
T ss_pred             c---ccccCEeECCCCCCc-cChHH
Confidence            2   234555555555554 34443

syringae 6; Provisional

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1.1e-16  Score=158.60  Aligned_cols=137  Identities=18%  Similarity=0.325  Sum_probs=115.2

Q ss_pred             eeeecccceEEEEEEeCCCcEEEEEEccCCcccch-----HHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEe
Q 004642          456 YCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDS-----AFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  530 (740)
                      +.||+|++|.||+|.. .|..+++|+.........     .....+.+|++++..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5689999999999987 678899998765433221     1234678899999999999998888887777888999999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++|++|.+++....      + .+..++.+++.+|.++|+.   +++|+|++|.||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999998886432      2 7888999999999999998   999999999999999 78899999999864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=1.2e-16  Score=156.40  Aligned_cols=148  Identities=22%  Similarity=0.224  Sum_probs=113.0

Q ss_pred             HHHHHHhcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcccch-------------------HHHHHHHHHHHHH
Q 004642          443 EDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDS-------------------AFVKSFQNEAHVL  503 (740)
Q Consensus       443 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l  503 (740)
                      +++......|.+.+.||+|+||.||++..++|+.||||++........                   .....+..|..++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            344444445888899999999999999888899999998765321100                   0112366788889


Q ss_pred             hccCCC--ccceeeeeeeecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 004642          504 STVRHR--NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDI  581 (740)
Q Consensus       504 ~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dl  581 (740)
                      ..+.|+  .+...++.    ...++||||+++++|......         .....++.+++.++.++|+.   +++||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl  151 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDL  151 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence            888777  34444432    345899999999988755431         23456889999999999998   9999999


Q ss_pred             CCCceEEcCCCcEEEeecccceecc
Q 004642          582 SSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       582 kp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      ||+||++++++.++|+|||++....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.68  E-value=4.3e-18  Score=180.40  Aligned_cols=252  Identities=24%  Similarity=0.258  Sum_probs=180.0

Q ss_pred             EEcCCCCccccccCcccCCCCCccEEeCCCCCcccC----CCccccCCCCCceeecccccccc------cCchhhccccc
Q 004642           81 IDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGS----IPPQIGSLSKLKCLYLHGNNLTG------IIPKEIGSLRN  150 (740)
Q Consensus        81 l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~------~~p~~l~~l~~  150 (740)
                      |+|..+++.+.--...|..+++|+.|+|+++.++..    ++..+...+.|++|+++++.+.+      .++..+..+++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            566666666443334566777899999999988532    45567777889999999988762      23456777889


Q ss_pred             ccccccccccccCCChhhhccccc---cceeecccccccccCCCcccccccCCCccccCCCCcccccc-CCCCEEecCCC
Q 004642          151 LRGLFLYSNKLSGVLPQEIGNLKS---LTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNF-SALDTLDLSDN  226 (740)
Q Consensus       151 L~~L~L~~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l-~~L~~L~L~~N  226 (740)
                      |+.|+|++|.+.+..+..+..+.+   |++|++++|++++....               .+...+..+ ++|+.|+|++|
T Consensus        83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~---------------~l~~~l~~~~~~L~~L~L~~n  147 (319)
T cd00116          83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR---------------LLAKGLKDLPPALEKLVLGRN  147 (319)
T ss_pred             eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH---------------HHHHHHHhCCCCceEEEcCCC
Confidence            999999999998777777776666   99999999988742111               112234445 78999999999


Q ss_pred             cCCCc----CCccccccCCCCeecccCCccCCC----chhhhcCccCCceeccCCCcccCcC----CcccccCCCCCeEe
Q 004642          227 KIHGI----IPDELTKLSQLKNLNLSSNLLSGQ----IPYAIGKLFNLMYLDLSKNKLSGSI----PTEIGNCSALKNLT  294 (740)
Q Consensus       227 ~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~----~~~l~~l~~L~~L~  294 (740)
                      .+++.    ++..+..+++|+.|++++|.+++.    ++..+..+++|+.|++++|.+++..    ...+..+++|++|+
T Consensus       148 ~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~  227 (319)
T cd00116         148 RLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLN  227 (319)
T ss_pred             cCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEe
Confidence            99842    334566778899999999999853    3344556679999999999987543    34466788899999


Q ss_pred             ccCCCCCCCCchhccc-----ccccceEEecCCcccC--------CCCCCCccccccCCCCCCCCC
Q 004642          295 LNHNSLDGTIPLEMGK-----ILLLQNLDLSHNNLSG--------TIPKTLRPMYVDLSFNNLEGE  347 (740)
Q Consensus       295 L~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~--------~~p~~~~~~~l~ls~N~l~~~  347 (740)
                      +++|.+++.....+..     .+.|+.|++++|.+++        .+|..-....+|+++|.++..
T Consensus       228 ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~  293 (319)
T cd00116         228 LGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE  293 (319)
T ss_pred             cCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence            9999998644433332     3789999999999872        222221223589999998854

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.67  E-value=3.9e-16  Score=153.21  Aligned_cols=132  Identities=20%  Similarity=0.360  Sum_probs=108.1

Q ss_pred             eecccceEEEEEEeCCCcEEEEEEccCCcccc-----hHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEecc
Q 004642          458 IGTGGYGSVYKAELPEGKVVALKKLHHSETED-----SAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYME  532 (740)
Q Consensus       458 lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  532 (740)
                      ||+|+||.||+|.+ +|..+++|+........     .....++.+|++++..++|+++.....++...+..++||||++
T Consensus         2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            79999999999985 67889999865432211     1123567889999999998876666666666777899999999


Q ss_pred             CCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          533 RGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       533 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      |++|.+.+.....          .++.+++.+|.++|+.   +++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        81 GKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999887754321          6899999999999998   999999999999999 78999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=3.4e-16  Score=176.61  Aligned_cols=142  Identities=19%  Similarity=0.268  Sum_probs=113.4

Q ss_pred             HhcccccceeeecccceEEEEEEeCCCcEEEEEEccCCcc-----cchHHHHHHHHHHHHHhccCCCccceeeeeeeecC
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSET-----EDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK  522 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  522 (740)
                      ....|...+.||+|+||.||++.+.... +++|+......     .+....+++.+|++++..++|++++....++....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3455567889999999999999875443 44443222111     11122457889999999999999998888888877


Q ss_pred             eEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccc
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                      ..++||||+++++|.+++.           ....++.+++.+|.|||+.   +++|||+||+||++ .++.++|+|||++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            8899999999999988774           3467899999999999998   99999999999999 6778999999999


Q ss_pred             eec
Q 004642          603 RLL  605 (740)
Q Consensus       603 ~~~  605 (740)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=1.4e-16  Score=177.86  Aligned_cols=214  Identities=23%  Similarity=0.317  Sum_probs=142.6

Q ss_pred             hcccccceeeecccceEEEEEEeCC-CcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEE
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  527 (740)
                      ..+|+.++.|..|+||.||.+++++ .+++|. ++.+....       +++   ++.....|.+|               
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-------lRn---ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-------LRN---ILTFAGNPFVV---------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh-------hhc---cccccCCccee---------------
Confidence            4688999999999999999998764 456777 44432211       111   23333344443               


Q ss_pred             EEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceeccc
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                            |+=...+...+   .++.        +++.+++|+|+.   ||+|||+||+|.+++.-|++|++|||+++....
T Consensus       136 ------gDc~tllk~~g---~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 ------GDCATLLKNIG---PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             ------chhhhhcccCC---CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                  22223333322   2222        237889999998   999999999999999999999999999875321


Q ss_pred             CCC---------------cccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhh
Q 004642          608 DSS---------------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLI  672 (740)
Q Consensus       608 ~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  672 (740)
                      ...               .....+||+.|.|||++....|...+|.|++|+|+||++-|+.||.....       ++.+.
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-------eelfg  268 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFG  268 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-------HHHHh
Confidence            100               11234799999999999999999999999999999999999999875422       11122


Q ss_pred             hhhcccCC-CcchhhhHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 004642          673 DVLNQRLS-PPVNQKIVQDIILVSTIAFACLSSQPKSRP---TMQRISQE  718 (740)
Q Consensus       673 ~~~~~~l~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ev~~~  718 (740)
                      .++...+. ++.   ...-..+..+++.+.++.+|..|-   .+-+|.+|
T Consensus       269 ~visd~i~wpE~---dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h  315 (1205)
T KOG0606|consen  269 QVISDDIEWPEE---DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQH  315 (1205)
T ss_pred             hhhhhhcccccc---CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhc
Confidence            22211111 111   111122377899999999999993   44454444

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=3.6e-15  Score=144.80  Aligned_cols=139  Identities=22%  Similarity=0.230  Sum_probs=99.3

Q ss_pred             ceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHH---------------------HHHHHHHHhccCCC--cc
Q 004642          455 KYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKS---------------------FQNEAHVLSTVRHR--NI  511 (740)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--ni  511 (740)
                      .+.||+|+||.||+|...+|+.||||++.............                     ...|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999988789999999987643221111111                     13455666665433  24


Q ss_pred             ceeeeeeeecCeEEEEEEeccCCCchh-hhcCCCccccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceEEc
Q 004642          512 VKLYGFCLHKKCMFLIYEYMERGSLFC-VLHDDDEAIELNWTKRVNIVKSVAHALSYLHH-DCTLSIIHRDISSNNILLD  589 (740)
Q Consensus       512 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~dlkp~NIll~  589 (740)
                      .+.+++    ...++||||++++.+.. .+....    .. .+...++.+++.++.++|. .   +|+|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            444443    23589999999965432 121111    11 5677899999999999998 7   999999999999999


Q ss_pred             CCCcEEEeecccceecc
Q 004642          590 SNLEASVADFGTARLLH  606 (740)
Q Consensus       590 ~~~~~kl~DfG~a~~~~  606 (740)
                       ++.++++|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.59  E-value=1.6e-14  Score=134.66  Aligned_cols=135  Identities=21%  Similarity=0.208  Sum_probs=113.9

Q ss_pred             cceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCC--CccceeeeeeeecCeEEEEEEec
Q 004642          454 IKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH--RNIVKLYGFCLHKKCMFLIYEYM  531 (740)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~  531 (740)
                      +.+.||+|.++.||++...+ ..+++|.......     ...+.+|+.++..++|  ..+++++++...++..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            45779999999999998744 7899999876543     2568889999999976  58999999888888899999999


Q ss_pred             cCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          532 ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       532 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      +++.+...          +......++.+++.+++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus        76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            98777543          4566777899999999999986334799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=3.7e-14  Score=142.18  Aligned_cols=139  Identities=17%  Similarity=0.258  Sum_probs=106.3

Q ss_pred             ceeee-cccceEEEEEEeCCCcEEEEEEccCCcc----------cchHHHHHHHHHHHHHhccCCCcc--ceeeeeeeec
Q 004642          455 KYCIG-TGGYGSVYKAELPEGKVVALKKLHHSET----------EDSAFVKSFQNEAHVLSTVRHRNI--VKLYGFCLHK  521 (740)
Q Consensus       455 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  521 (740)
                      ...|| .|+.|+||.+... +..++||.+.....          .......++.+|++++.+++|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35688 8999999999874 77889998854211          011223567889999999998774  6677765432


Q ss_pred             C----eEEEEEEeccC-CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEE
Q 004642          522 K----CMFLIYEYMER-GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASV  596 (740)
Q Consensus       522 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  596 (740)
                      .    ..++||||++| .+|.+++...    .++..    .+.+|+.++.+||+.   ||+|+||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 6888887542    23432    367899999999999   9999999999999999899999


Q ss_pred             eecccceec
Q 004642          597 ADFGTARLL  605 (740)
Q Consensus       597 ~DfG~a~~~  605 (740)
                      +|||.++..
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999998753

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.55  E-value=5.3e-16  Score=162.14  Aligned_cols=175  Identities=30%  Similarity=0.495  Sum_probs=127.3

Q ss_pred             CCCCCceeecccccccccCchhhcccccccccccccccccCCChhhhccccccceeecccccccccCCCcccccccCCCc
Q 004642          123 SLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSN  202 (740)
Q Consensus       123 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n  202 (740)
                      .++.-...||+.|++. ++|..+..+..|+.|.|+.|.+. .+|..++++..|+.|||+.|+++                
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS----------------  134 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS----------------  134 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh----------------
Confidence            4455566777777777 66777777777777777777776 66777777777777777777776                


Q ss_pred             cccCCCCccccccCCCCEEecCCCcCCCcCCccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCc
Q 004642          203 QFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPT  282 (740)
Q Consensus       203 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  282 (740)
                          .+|..+..++ |+.|-+++|+++ .+|..++.+..|..|+.+.|.+. .+|..++++.+|+.|.+..|++. .+|+
T Consensus       135 ----~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~  206 (722)
T KOG0532|consen  135 ----HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPE  206 (722)
T ss_pred             ----cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCH
Confidence                4455555555 777777777777 56777777777777777777776 55667777777777777777777 4566


Q ss_pred             ccccCCCCCeEeccCCCCCCCCchhcccccccceEEecCCccc
Q 004642          283 EIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLS  325 (740)
Q Consensus       283 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  325 (740)
                      .+..| .|..||+++|+++ .+|..|.+|..|++|.|.+|+|+
T Consensus       207 El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  207 ELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             HHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence            66644 4777788888877 77777778888888888888877

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=1.4e-15  Score=170.61  Aligned_cols=257  Identities=22%  Similarity=0.281  Sum_probs=186.5

Q ss_pred             cccccceeeecccceEEEEEEeC--CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccC-CCccceeeeeeeecCeEEE
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP--EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  526 (740)
                      ..|.+.+.||+|.|+.|-.....  ....+|+|.+.... ...........|..+-..+. |+|++.+++...+.+..++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            46777888999999999887543  34456667665543 22233455666887777776 9999999999999999999


Q ss_pred             EEEeccCCCchhhh-cCCCccccCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCceEEcCCC-cEEEeecccce
Q 004642          527 IYEYMERGSLFCVL-HDDDEAIELNWTKRVNIVKSVAHALSYLH-HDCTLSIIHRDISSNNILLDSNL-EASVADFGTAR  603 (740)
Q Consensus       527 v~e~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfG~a~  603 (740)
                      ..+|.+++++.+.+ +....  ..+....-..+.|+..++.|+| +.   ++.|+|+||+|.+++..+ ..++.|||+|.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            99999999999888 43321  2344556678999999999999 77   999999999999999999 99999999998


Q ss_pred             eccc-CCC--ccccccc-CCCcccccccccc-ccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhccc
Q 004642          604 LLHV-DSS--YRTLRAG-TYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQR  678 (740)
Q Consensus       604 ~~~~-~~~--~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  678 (740)
                      .+.. ...  .....+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.......  ....+........
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~  251 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--RYSSWKSNKGRFT  251 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--cceeecccccccc
Confidence            7765 222  2234578 9999999998884 345678999999999999999999775432110  0011111100000


Q ss_pred             CCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004642          679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL  719 (740)
Q Consensus       679 l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L  719 (740)
                      ..+     +..-.....++..+++..+|..|.+.+++...-
T Consensus       252 ~~~-----~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~  287 (601)
T KOG0590|consen  252 QLP-----WNSISDQAHDLLHKILKENPSNRLSIEELKLDN  287 (601)
T ss_pred             cCc-----cccCChhhhhcccccccCCchhccccccccccc
Confidence            111     111112256788889999999999988876544

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.52  E-value=8.5e-16  Score=160.61  Aligned_cols=196  Identities=33%  Similarity=0.460  Sum_probs=171.5

Q ss_pred             CCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccccccccccCCChhhhcccccccee
Q 004642           99 CFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTEL  178 (740)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  178 (740)
                      .+..-...||+.|++. .+|..+..+-.|+.|.|.+|.|. .+|..++++..|++|||+.|+++ ..|..+..|+ |+.|
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl  148 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL  148 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence            4566788999999998 78999999999999999999998 78999999999999999999998 7788888877 9999


Q ss_pred             ecccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCcCCccccccCCCCeecccCCccCCCchh
Q 004642          179 YVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPY  258 (740)
Q Consensus       179 ~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  258 (740)
                      -+++|+++                    .+|+.++....|..|+.+.|.|. .+|..++++.+|+.|.+..|++. .+|.
T Consensus       149 i~sNNkl~--------------------~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~  206 (722)
T KOG0532|consen  149 IVSNNKLT--------------------SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPE  206 (722)
T ss_pred             EEecCccc--------------------cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCH
Confidence            99999997                    67888888899999999999999 67888999999999999999998 5566


Q ss_pred             hhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhcccccc---cceEEecCCc
Q 004642          259 AIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILL---LQNLDLSHNN  323 (740)
Q Consensus       259 ~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~l~~N~  323 (740)
                      .+..| .|..||++.|+++ .+|-.|.+|+.|++|-|.+|.|. ..|..++..-+   -++|+..-.+
T Consensus       207 El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q  271 (722)
T KOG0532|consen  207 ELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ  271 (722)
T ss_pred             HHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence            77744 6999999999999 89999999999999999999999 77776654333   3556655553

>PLN03150 hypothetical protein; Provisional

Probab=99.49  E-value=5.5e-14  Score=160.32  Aligned_cols=118  Identities=35%  Similarity=0.609  Sum_probs=85.9

Q ss_pred             ccceeeeCCC-----CCEEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeeccccccccc
Q 004642           66 NWVGITCDYE-----GRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGI  140 (740)
Q Consensus        66 ~w~gv~c~~~-----~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  140 (740)
                      .|.||.|+..     .+|+.|+|.++++.|.++. .+..+++|+.|+|++|.+.|.+|..++.+++|+.|+|++|++++.
T Consensus       403 ~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~-~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~  481 (623)
T PLN03150        403 PWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS  481 (623)
T ss_pred             ccccceeeccCCCCceEEEEEECCCCCccccCCH-HHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCC
Confidence            7999999631     2477777777777777665 467777777777777777777777777777777777777777777


Q ss_pred             CchhhcccccccccccccccccCCChhhhccc-cccceeeccccc
Q 004642          141 IPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNL-KSLTELYVTNNA  184 (740)
Q Consensus       141 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~L~~N~  184 (740)
                      +|+.++++++|+.|+|++|++++.+|..++.+ .++..+++.+|.
T Consensus       482 iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~  526 (623)
T PLN03150        482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA  526 (623)
T ss_pred             CchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCc
Confidence            77777777777777777777777777776653 355666666664

>PLN03150 hypothetical protein; Provisional

Probab=99.47  E-value=1.2e-13  Score=157.68  Aligned_cols=119  Identities=34%  Similarity=0.575  Sum_probs=83.2

Q ss_pred             CCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhcccccccceEEecC
Q 004642          242 LKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSH  321 (740)
Q Consensus       242 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~  321 (740)
                      ++.|+|++|.++|.+|..+..+++|+.|+|++|.++|.+|..++++++|+.|+|++|+++|.+|..++.+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            56677777777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             CcccCCCCCCCccccccCCCCCCCCCcCccccCCCCCcccCCccCCCCCCCCCCcc
Q 004642          322 NNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVEGFPSSS  377 (740)
Q Consensus       322 N~l~~~~p~~~~~~~l~ls~N~l~~~~p~~~~~~~~~~~~~n~~~~~~~~~~~~~s  377 (740)
                      |+++|.+|..+....+                ......+.+|+.+|+.+ ..+.|.
T Consensus       500 N~l~g~iP~~l~~~~~----------------~~~~l~~~~N~~lc~~p-~l~~C~  538 (623)
T PLN03150        500 NSLSGRVPAALGGRLL----------------HRASFNFTDNAGLCGIP-GLRACG  538 (623)
T ss_pred             CcccccCChHHhhccc----------------cCceEEecCCccccCCC-CCCCCc
Confidence            7777777765533211                11123466778888743 344553

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.45  E-value=8e-14  Score=152.15  Aligned_cols=201  Identities=40%  Similarity=0.561  Sum_probs=162.6

Q ss_pred             EEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccc-cccccccccccccCCChhhhccccccceeecccc
Q 004642          105 SLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLR-NLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNN  183 (740)
Q Consensus       105 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  183 (740)
                      .|+++.|.+... ...+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            688888888533 334566688999999999998 5566667774 9999999999998 55577889999999999999


Q ss_pred             cccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCcCCccccccCCCCeecccCCccCCCchhhhcCc
Q 004642          184 ALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKL  263 (740)
Q Consensus       184 ~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  263 (740)
                      +++                    .+|...+..++|+.|++++|+++ .+|.....+..|+.|.+++|.+. ..+..+.++
T Consensus       174 ~l~--------------------~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~  231 (394)
T COG4886         174 DLS--------------------DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNL  231 (394)
T ss_pred             hhh--------------------hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhc
Confidence            997                    34444457789999999999999 56766667778999999999654 445678888


Q ss_pred             cCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhcccccccceEEecCCcccCCCCCCCc
Q 004642          264 FNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLR  333 (740)
Q Consensus       264 ~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~  333 (740)
                      .++..+.+.+|++. ..+..++.++++++|++++|+++ .++. ++.+.+++.|++++|.+....|....
T Consensus       232 ~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~  298 (394)
T COG4886         232 KNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIAL  298 (394)
T ss_pred             ccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhhc
Confidence            99999999999997 34778889999999999999999 4444 88999999999999999877666543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.40  E-value=1.3e-12  Score=142.54  Aligned_cols=144  Identities=22%  Similarity=0.257  Sum_probs=100.7

Q ss_pred             ceeeecccceEEEEEEeCCCcEEEEEEccCCcccch-------------------------------HHHH------HHH
Q 004642          455 KYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDS-------------------------------AFVK------SFQ  497 (740)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------------------~~~~------~~~  497 (740)
                      .+.||.|++|.||+|++++|+.||||+.+......-                               +..+      .|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999875421110                               0000      244


Q ss_pred             HHHHHHhcc----CCCccceeeeee-eecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHH-HHHHHHhc
Q 004642          498 NEAHVLSTV----RHRNIVKLYGFC-LHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH-ALSYLHHD  571 (740)
Q Consensus       498 ~E~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~~  571 (740)
                      +|++.+.++    +|.+-+.+-..+ ......++||||++|++|.+.......  ..   .+..++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            566655555    232223322222 224457999999999999887643211  11   23456666666 46788988


Q ss_pred             CCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       572 ~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                         |++|+|++|.||+++.++.++++|||++..+.
T Consensus       277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               99999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.40  E-value=3e-13  Score=147.64  Aligned_cols=217  Identities=36%  Similarity=0.520  Sum_probs=169.8

Q ss_pred             CccceeeeCCCCCEE--EEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCC-CCceeecccccccccC
Q 004642           65 CNWVGITCDYEGRIT--DIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLS-KLKCLYLHGNNLTGII  141 (740)
Q Consensus        65 c~w~gv~c~~~~~v~--~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~  141 (740)
                      +.+.+..+.......  .+++..+.+...+.  .+..++.++.|++.+|.++ .+++..+.++ +|+.|++++|.+. .+
T Consensus        80 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l  155 (394)
T COG4886          80 ISSLDGSENLLNLLPLPSLDLNLNRLRSNIS--ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SL  155 (394)
T ss_pred             cccccccccccCCCCCceeeccccccccCch--hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hh
Confidence            455555554333222  46666666543333  3455688999999999999 5666777775 9999999999998 55


Q ss_pred             chhhcccccccccccccccccCCChhhhccccccceeecccccccccCCCcccccccCCCccccCCCCccccccCCCCEE
Q 004642          142 PKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTL  221 (740)
Q Consensus       142 p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L  221 (740)
                      |..+..+++|+.|++++|+++ .+|...+.+++|+.|++++|+++                    .+|........|++|
T Consensus       156 ~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~--------------------~l~~~~~~~~~L~~l  214 (394)
T COG4886         156 PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS--------------------DLPPEIELLSALEEL  214 (394)
T ss_pred             hhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc--------------------cCchhhhhhhhhhhh
Confidence            677899999999999999999 45555568899999999999998                    444444555679999


Q ss_pred             ecCCCcCCCcCCccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCC
Q 004642          222 DLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLD  301 (740)
Q Consensus       222 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  301 (740)
                      .+++|++. ..+..+.++.++..|.+.+|++.. .+..++.++++++|++++|+++. ++. ++.+.+|+.|++++|.+.
T Consensus       215 ~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~  290 (394)
T COG4886         215 DLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLS  290 (394)
T ss_pred             hhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccceeccccccccc-ccc-ccccCccCEEeccCcccc
Confidence            99999655 456778999999999999999974 36678889999999999999984 444 899999999999999999


Q ss_pred             CCCchhccc
Q 004642          302 GTIPLEMGK  310 (740)
Q Consensus       302 ~~~p~~~~~  310 (740)
                      ...|.....
T Consensus       291 ~~~~~~~~~  299 (394)
T COG4886         291 NALPLIALL  299 (394)
T ss_pred             ccchhhhcc
Confidence            766654443

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=8.7e-13  Score=129.65  Aligned_cols=210  Identities=25%  Similarity=0.313  Sum_probs=145.8

Q ss_pred             HHHHhccCCCccceeeeeeeecC-----eEEEEEEeccCCCchhhhcCCCc-cccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 004642          500 AHVLSTVRHRNIVKLYGFCLHKK-----CMFLIYEYMERGSLFCVLHDDDE-AIELNWTKRVNIVKSVAHALSYLHHDCT  573 (740)
Q Consensus       500 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~  573 (740)
                      +.-+-++.|.|||+++.|+.+.+     ...++.|||+.|++..+|.+... ...+....-.+++.||..||.|||+. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            34455667999999999987643     47889999999999999976543 23466677788999999999999985 7


Q ss_pred             CCeEecCCCCCceEEcCCCcEEEeecccceec-cc---CCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHH
Q 004642          574 LSIIHRDISSNNILLDSNLEASVADFGTARLL-HV---DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL  649 (740)
Q Consensus       574 ~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~-~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell  649 (740)
                      +.|+|+++.-+-|++..+|-+|++--.-...- ..   .........+-++|.+||+-.....+.++|||+||....||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            78999999999999999998887421111000 00   001112234678999999988777888999999999999998


Q ss_pred             hCCCC-CCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCCCC
Q 004642          650 MGTHP-GGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP  725 (740)
Q Consensus       650 tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~~~  725 (740)
                      -|..- ....+.    ...+..+...+.. +...          .-+.++.+|++..|..||+|.+++.|....+..
T Consensus       277 ilEiq~tnseS~----~~~ee~ia~~i~~-len~----------lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  277 ILEIQSTNSESK----VEVEENIANVIIG-LENG----------LQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             HheeccCCCcce----eehhhhhhhheee-ccCc----------cccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence            87643 111110    0111111111111 1110          023567789999999999999999887665443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=4.5e-12  Score=135.83  Aligned_cols=249  Identities=24%  Similarity=0.248  Sum_probs=178.3

Q ss_pred             cccccceeeec--ccceEEEEEEe---CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeecCe
Q 004642          450 EDFHIKYCIGT--GGYGSVYKAEL---PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       450 ~~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  523 (740)
                      ..|.+...+|.  |.+|.||.+..   .++..+|+|+-+........ ..+=.+|+.....+ .|++.++.+..+...+.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCCc
Confidence            45677888999  99999999955   46888999985443332111 12223566666666 59999999999999999


Q ss_pred             EEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCceEEcCC-CcEEEee
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH----ALSYLHHDCTLSIIHRDISSNNILLDSN-LEASVAD  598 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~D  598 (740)
                      .++-.|++. .++.++.+....  .++....+.+..+..+    |+.++|..   .++|-|+||.||+...+ ...+++|
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ceeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence            999999886 577777765443  2566777778888888    99999998   99999999999999999 8899999


Q ss_pred             cccceecccCCCccccc-----ccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhh
Q 004642          599 FGTARLLHVDSSYRTLR-----AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLID  673 (740)
Q Consensus       599 fG~a~~~~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  673 (740)
                      ||+...+....-.....     .|...|++||...+ .++...|+|++|.++.+..++..+.-...-..+..        
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--------  337 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--------  337 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--------
Confidence            99998876544222222     57889999998765 46778999999999999999887643210000000        


Q ss_pred             hhccc-CCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004642          674 VLNQR-LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       674 ~~~~~-l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~  718 (740)
                       +++. ++.+..   ..-..++...+..+++.+|..|++++.+..+
T Consensus       338 -~r~~~ip~e~~---~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  338 -LRQGYIPLEFC---EGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             -cccccCchhhh---cCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence             0110 111111   0111224557888999999999999877654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.28  E-value=2.8e-11  Score=133.37  Aligned_cols=146  Identities=21%  Similarity=0.230  Sum_probs=93.5

Q ss_pred             cccccceeeecccceEEEEEEeCC-CcEEEEEEccCCcccc---------------------------h----HHHH---
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETED---------------------------S----AFVK---  494 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~---------------------------~----~~~~---  494 (740)
                      ..|+. +.||+|++|.||+|++++ |+.||||+.+......                           .    +..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 789999999999999887 9999999997542110                           0    1112   


Q ss_pred             ---HHHHHHHHHhccC----CCccceeeeeeee-cCeEEEEEEeccCCCchhh--hcCCC-ccccCCHHHHHHHHHHHHH
Q 004642          495 ---SFQNEAHVLSTVR----HRNIVKLYGFCLH-KKCMFLIYEYMERGSLFCV--LHDDD-EAIELNWTKRVNIVKSVAH  563 (740)
Q Consensus       495 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~-~~~~l~~~~~~~i~~~ia~  563 (740)
                         .+.+|+..+.+++    +...+.+-..+.+ ....++||||++|+.+.+.  +...+ ....+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence               2334444444442    3333333333322 4457899999999999764  22211 11122222233333333  


Q ss_pred             HHHHHHhcCCCCeEecCCCCCceEEcCCC----cEEEeecccceecc
Q 004642          564 ALSYLHHDCTLSIIHRDISSNNILLDSNL----EASVADFGTARLLH  606 (740)
Q Consensus       564 ~L~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~DfG~a~~~~  606 (740)
                           ...   |++|+|++|.||+++.++    .+++.|||++..+.
T Consensus       277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 334   999999999999999888    99999999997654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.26  E-value=2.2e-11  Score=116.12  Aligned_cols=131  Identities=24%  Similarity=0.259  Sum_probs=95.8

Q ss_pred             ceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccc-eeeeeeeecCeEEEEEEeccC
Q 004642          455 KYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV-KLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~  533 (740)
                      .+.++.|.++.||+++.. |+.|++|........    ...+.+|+++++.+.+.+++ +++++.  ....++||||++|
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence            356899999999999864 788999998654321    13456788889888655544 444443  2335799999999


Q ss_pred             CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC--TLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      .++.+.    .    .   .....+.+++++++.||...  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        76 ~~l~~~----~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          76 SELLTE----D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             Cccccc----c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            887543    0    0   11235678999999999872  12369999999999999 66899999998853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.26  E-value=9.9e-11  Score=126.59  Aligned_cols=168  Identities=17%  Similarity=0.211  Sum_probs=124.4

Q ss_pred             EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEeccCCCchhhhcCCCccccC
Q 004642          470 ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL  549 (740)
Q Consensus       470 ~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l  549 (740)
                      +..++.+|.|...+....   +......+.++-++.+|||||+++++.+...+..|+|+|.+.  .|..++.+..     
T Consensus        33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----  102 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----  102 (690)
T ss_pred             eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----
Confidence            444678888887765543   234556778889999999999999999999999999999875  3444554332     


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCcccccccCCCccccccccc
Q 004642          550 NWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT  629 (740)
Q Consensus       550 ~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  629 (740)
                       ...+.-.+.||+.||.|||+.|  +++|++|.-.-|+++..|..||++|.++.....-........--..|..|+.+..
T Consensus       103 -~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  103 -KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             -HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence             3445557899999999999764  8999999999999999999999999988654322211111112234666765443


Q ss_pred             cccCCcchhHhHHHHHHHHHhCC
Q 004642          630 IVVTGKCDVYSFGVVALEVLMGT  652 (740)
Q Consensus       630 ~~~~~~~DvwslGvil~elltg~  652 (740)
                      ..+  ..|.|.|||+++|++.|.
T Consensus       180 s~~--s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  180 SEW--SIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccc--chhhhhHHHHHHHHhCcc
Confidence            332  359999999999999993

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.24  E-value=1.6e-10  Score=110.58  Aligned_cols=139  Identities=21%  Similarity=0.197  Sum_probs=99.3

Q ss_pred             eeeecccceEEEEEEeCC-------CcEEEEEEccCCccc----------c---------hHHHH----HHHHHHHHHhc
Q 004642          456 YCIGTGGYGSVYKAELPE-------GKVVALKKLHHSETE----------D---------SAFVK----SFQNEAHVLST  505 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~----------~---------~~~~~----~~~~E~~~l~~  505 (740)
                      ..||.|--+.||.|...+       +..+|||+.+.....          +         ....+    ...+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999996543       578999988642110          0         01122    33489999999


Q ss_pred             cCC--CccceeeeeeeecCeEEEEEEeccCCCchh-hhcCCCccccCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCC
Q 004642          506 VRH--RNIVKLYGFCLHKKCMFLIYEYMERGSLFC-VLHDDDEAIELNWTKRVNIVKSVAHALSYL-HHDCTLSIIHRDI  581 (740)
Q Consensus       506 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~dl  581 (740)
                      +..  -++..++++    ...++||||+.++.+.. .+.+.    .++..+...+..+++.+|..| |+.   +++|||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            853  456666654    45789999998754421 22221    244456677889999999999 777   9999999


Q ss_pred             CCCceEEcCCCcEEEeecccceecc
Q 004642          582 SSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       582 kp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      ++.||+++ ++.+.|+|||.+....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4679999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.24  E-value=5.6e-12  Score=118.08  Aligned_cols=101  Identities=33%  Similarity=0.340  Sum_probs=28.8

Q ss_pred             CCCCEEecCCCcCCCcCCccccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcC-CcccccCCCCCeEe
Q 004642          216 SALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSI-PTEIGNCSALKNLT  294 (740)
Q Consensus       216 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~l~~l~~L~~L~  294 (740)
                      .+|+.|+|++|+|+.+  +.+..++.|+.|++++|+|+...+.....+++|+.|++++|+|.... -..+..+++|+.|+
T Consensus        42 ~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~  119 (175)
T PF14580_consen   42 DKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLS  119 (175)
T ss_dssp             TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE
T ss_pred             cCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceee
Confidence            3444444444444432  23444555555555555554322211123455555555555554311 12344555555555


Q ss_pred             ccCCCCCCCC---chhcccccccceEE
Q 004642          295 LNHNSLDGTI---PLEMGKILLLQNLD  318 (740)
Q Consensus       295 L~~N~l~~~~---p~~~~~l~~L~~L~  318 (740)
                      |.+|.++...   ...+..+|+|+.||
T Consensus       120 L~~NPv~~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen  120 LEGNPVCEKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             -TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred             ccCCcccchhhHHHHHHHHcChhheeC
Confidence            5555555221   12244455555553

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.24  E-value=6.8e-12  Score=117.54  Aligned_cols=85  Identities=32%  Similarity=0.454  Sum_probs=21.7

Q ss_pred             CCCCCccEEeCCCCCcccCCCcccc-CCCCCceeecccccccccCchhhcccccccccccccccccCCChhhhccccccc
Q 004642           98 SCFPNLKSLDLWNNSLSGSIPPQIG-SLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLT  176 (740)
Q Consensus        98 ~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  176 (740)
                      .+...++.|+|++|.|+.+  +.++ .+.+|+.|+|++|.|+.+  +.+..+++|++|+|++|+|+.+.+.....+++|+
T Consensus        16 ~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~   91 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQ   91 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--
T ss_pred             ccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCC
Confidence            3444567777777777643  2344 466777777777777644  2466667777777777777654332223566777


Q ss_pred             eeeccccccc
Q 004642          177 ELYVTNNALG  186 (740)
Q Consensus       177 ~L~L~~N~l~  186 (740)
                      +|+|++|+|.
T Consensus        92 ~L~L~~N~I~  101 (175)
T PF14580_consen   92 ELYLSNNKIS  101 (175)
T ss_dssp             EEE-TTS---
T ss_pred             EEECcCCcCC
Confidence            7777777665

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.23  E-value=1.1e-12  Score=133.78  Aligned_cols=203  Identities=24%  Similarity=0.205  Sum_probs=107.0

Q ss_pred             EEeCCCCCcccCCCccc----cCCCCCceeecccccccccCc-hhhcccccccccccccccccCCCh--hhhccccccce
Q 004642          105 SLDLWNNSLSGSIPPQI----GSLSKLKCLYLHGNNLTGIIP-KEIGSLRNLRGLFLYSNKLSGVLP--QEIGNLKSLTE  177 (740)
Q Consensus       105 ~L~L~~n~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~  177 (740)
                      .+.+++-.+.++.-+.+    .++.+|+.+.|.+..+....- .....|++++.||||+|-|....+  .....|++|+.
T Consensus        97 ~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~  176 (505)
T KOG3207|consen   97 VLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLEN  176 (505)
T ss_pred             HhhhcCceeEEecHHHHHHHhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchh
Confidence            34445544543332222    246667777777666552211 355667777777777776664332  23446677777


Q ss_pred             eecccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCc-CCccccccCCCCeecccCCccCCCc
Q 004642          178 LYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGI-IPDELTKLSQLKNLNLSSNLLSGQI  256 (740)
Q Consensus       178 L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~  256 (740)
                      |+|+.|++......           +.+       ..++.|+.|.|+.|.|+.. +-..+..+++|+.|+|..|.....-
T Consensus       177 LNls~Nrl~~~~~s-----------~~~-------~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~  238 (505)
T KOG3207|consen  177 LNLSSNRLSNFISS-----------NTT-------LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIK  238 (505)
T ss_pred             cccccccccCCccc-----------cch-------hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccccccee
Confidence            77777776522110           000       1345566666666666531 1112234566666666666422222


Q ss_pred             hhhhcCccCCceeccCCCcccCcC-CcccccCCCCCeEeccCCCCCCC-Cchh-----cccccccceEEecCCccc
Q 004642          257 PYAIGKLFNLMYLDLSKNKLSGSI-PTEIGNCSALKNLTLNHNSLDGT-IPLE-----MGKILLLQNLDLSHNNLS  325 (740)
Q Consensus       257 ~~~~~~l~~L~~L~l~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~-~p~~-----~~~l~~L~~L~l~~N~l~  325 (740)
                      ......+..|+.|||++|++-... -...+.++.|+.|+++.+.+... .|+.     ...+++|++|+++.|++.
T Consensus       239 ~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  239 ATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             cchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            223334455666666666665321 13355666666666666666532 2222     244566666666666664

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.20  E-value=2e-12  Score=128.51  Aligned_cols=111  Identities=23%  Similarity=0.263  Sum_probs=46.8

Q ss_pred             ccCCCCEEecCCCcCCCc----CCccccccCCCCeecccCCccCCCc----hhhhcCccCCceeccCCCcccCcCCcccc
Q 004642          214 NFSALDTLDLSDNKIHGI----IPDELTKLSQLKNLNLSSNLLSGQI----PYAIGKLFNLMYLDLSKNKLSGSIPTEIG  285 (740)
Q Consensus       214 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~l~  285 (740)
                      ..+.|+.+.++.|.|...    +...+..+++|+.|||.+|.++...    ...+..+++|+.|++++|.++......|.
T Consensus       183 ~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~  262 (382)
T KOG1909|consen  183 SHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFV  262 (382)
T ss_pred             hccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHH
Confidence            334455555555544321    1122344455555555555544221    22333444455555555555432222221


Q ss_pred             -----cCCCCCeEeccCCCCCC----CCchhcccccccceEEecCCcc
Q 004642          286 -----NCSALKNLTLNHNSLDG----TIPLEMGKILLLQNLDLSHNNL  324 (740)
Q Consensus       286 -----~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l  324 (740)
                           ..++|+.|.|.+|.++.    .+...+...+.|..|+|++|.+
T Consensus       263 ~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  263 DALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             HHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence                 23445555555555442    1122233344444455544444

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.19  E-value=3.5e-12  Score=123.65  Aligned_cols=212  Identities=26%  Similarity=0.273  Sum_probs=110.1

Q ss_pred             CccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhccccccccccccc-ccccCCC
Q 004642           87 NIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS-NKLSGVL  165 (740)
Q Consensus        87 ~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~  165 (740)
                      ||....-+..++-+.+|+.+.+|++.-..+. +....-+.|+++...+..++.. | .+-....+..+.-+. .-.+|..
T Consensus       200 ni~~~~l~f~l~~f~~l~~~~~s~~~~~~i~-~~~~~kptl~t~~v~~s~~~~~-~-~l~pe~~~~D~~~~E~~t~~G~~  276 (490)
T KOG1259|consen  200 NIIPNRLSFNLNAFRNLKTLKFSALSTENIV-DIELLKPTLQTICVHNTTIQDV-P-SLLPETILADPSGSEPSTSNGSA  276 (490)
T ss_pred             cccccccccchHHhhhhheeeeeccchhhee-ceeecCchhheeeeeccccccc-c-cccchhhhcCccCCCCCccCCce
Confidence            3333333344555666667766666544221 1122235566666655444321 1 111111111111111 1112222


Q ss_pred             hhhhccccccceeecccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCcCCccccccCCCCee
Q 004642          166 PQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNL  245 (740)
Q Consensus       166 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  245 (740)
                      -..+.....|++|||++|.|+                    .+-++..-.|+++.|++|+|.|..+  +.+..+++|+.|
T Consensus       277 ~~~~dTWq~LtelDLS~N~I~--------------------~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~L  334 (490)
T KOG1259|consen  277 LVSADTWQELTELDLSGNLIT--------------------QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLL  334 (490)
T ss_pred             EEecchHhhhhhccccccchh--------------------hhhhhhhhccceeEEeccccceeee--hhhhhcccceEe
Confidence            222333456667777777665                    2233444456677777777777633  346667777777


Q ss_pred             cccCCccCCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCC-chhcccccccceEEecCCcc
Q 004642          246 NLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTI-PLEMGKILLLQNLDLSHNNL  324 (740)
Q Consensus       246 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l  324 (740)
                      |||+|.++.. ...-.++.|++.|.|+.|.|...  ..+..+-+|..||+++|+|.... -..++++|-|+.|.|-+|++
T Consensus       335 DLS~N~Ls~~-~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl  411 (490)
T KOG1259|consen  335 DLSGNLLAEC-VGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL  411 (490)
T ss_pred             ecccchhHhh-hhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence            7777777633 22333556677777777766521  33555666677777777776321 13466777777777777777


Q ss_pred             cC
Q 004642          325 SG  326 (740)
Q Consensus       325 ~~  326 (740)
                      .+
T Consensus       412 ~~  413 (490)
T KOG1259|consen  412 AG  413 (490)
T ss_pred             cc
Confidence            63

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=1.6e-11  Score=131.74  Aligned_cols=252  Identities=18%  Similarity=0.167  Sum_probs=176.8

Q ss_pred             HHHHhcccccceeeecccceEEEEEEe--CCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeeeeeec
Q 004642          445 LINATEDFHIKYCIGTGGYGSVYKAEL--PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHK  521 (740)
Q Consensus       445 l~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  521 (740)
                      ......+|..+..||.|.|+.|++...  .++..|++|............+. -..|+.+...+ .|.+++.++..+...
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccc
Confidence            344567889999999999999999843  46788999988776555433222 23456565555 588899888888887


Q ss_pred             CeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCC-CcEEEeecc
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN-LEASVADFG  600 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DfG  600 (740)
                      ...|+--||+++++....+   .....++...++++..|++.++.++|+.   .++|+|+||+||++..+ +.-+++|||
T Consensus       339 r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             ccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence            7788999999999887555   2223567788899999999999999988   99999999999999986 778999999


Q ss_pred             cceecccCCCcccccccCCCcc--ccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhccc
Q 004642          601 TARLLHVDSSYRTLRAGTYGYI--APELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQR  678 (740)
Q Consensus       601 ~a~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  678 (740)
                      .+..+..  .. ....+..+++  +|+......+..+.|++|||.-+.|..+|..--.-       ......+..-....
T Consensus       413 ~~t~~~~--~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~~~~~~i~~~~~p~  482 (524)
T KOG0601|consen  413 CWTRLAF--SS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------GVQSLTIRSGDTPN  482 (524)
T ss_pred             cccccce--ec-ccccccccccccchhhccccccccccccccccccccccccCcccCcc-------cccceeeecccccC
Confidence            9875321  11 1112333444  55556677788899999999999999998753111       00000011100111


Q ss_pred             CCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHc
Q 004642          679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       679 l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~  721 (740)
                      .+.        ....+..+.+.+...++..||.+.++..+...
T Consensus       483 ~~~--------~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  483 LPG--------LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             CCc--------hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            111        11225567778899999999999988766544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.15  E-value=3.9e-10  Score=103.67  Aligned_cols=133  Identities=20%  Similarity=0.335  Sum_probs=104.0

Q ss_pred             eeecccceEEEEEEeCCCcEEEEEEccCCcccchH-----HHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEEEec
Q 004642          457 CIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSA-----FVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYM  531 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  531 (740)
                      .+++|+-+.+|.+.+. |..+++|.-.......++     ...+-.+|+.++.+++--.|...+-+..+++...++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            4789999999999774 444666655443333322     2345678999999987667766677777888889999999


Q ss_pred             cCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccccee
Q 004642          532 ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       532 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      +|..|.+.+...          ...++..+=.-+.-||..   ||+|+|+.++||++..+. +.++|||++.+
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999888888654          234677778888899999   999999999999998775 99999999975

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.13  E-value=7.2e-12  Score=127.85  Aligned_cols=211  Identities=24%  Similarity=0.240  Sum_probs=143.6

Q ss_pred             CCCCCccEEeCCCCCcccCCC-ccccCCCCCceeeccccccccc--CchhhcccccccccccccccccCCChhh-hcccc
Q 004642           98 SCFPNLKSLDLWNNSLSGSIP-PQIGSLSKLKCLYLHGNNLTGI--IPKEIGSLRNLRGLFLYSNKLSGVLPQE-IGNLK  173 (740)
Q Consensus        98 ~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~p~~-l~~l~  173 (740)
                      +++..|+...|.+..+..... .....|++++.||||+|-|...  +-.....|++|+.|+|+.|++....... -..++
T Consensus       118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            457778888888887762221 3566788888888888877633  3345567888888999988886333222 22567


Q ss_pred             ccceeecccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCcCCccccccCCCCeecccCCccC
Q 004642          174 SLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLS  253 (740)
Q Consensus       174 ~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  253 (740)
                      .|+.|.|+.|.|+..                  .+...+..+|+|+.|+|..|..-.+-......+..|+.|+|++|++.
T Consensus       198 ~lK~L~l~~CGls~k------------------~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li  259 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWK------------------DVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI  259 (505)
T ss_pred             hhheEEeccCCCCHH------------------HHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc
Confidence            888888888887622                  11123345788888888888533344444556778888889888876


Q ss_pred             CCc-hhhhcCccCCceeccCCCcccCc-CCcc-----cccCCCCCeEeccCCCCCCC-CchhcccccccceEEecCCccc
Q 004642          254 GQI-PYAIGKLFNLMYLDLSKNKLSGS-IPTE-----IGNCSALKNLTLNHNSLDGT-IPLEMGKILLLQNLDLSHNNLS  325 (740)
Q Consensus       254 ~~~-~~~~~~l~~L~~L~l~~N~l~~~-~~~~-----l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~  325 (740)
                      ... -...+.++.|+.|+++.|.++.. +|+.     ...+++|++|+++.|++..- .-..+-.+++|+.|.+..|.|+
T Consensus       260 ~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  260 DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            432 13566788888888888888753 2222     34678899999999998621 1234556677888888888887


Q ss_pred             C
Q 004642          326 G  326 (740)
Q Consensus       326 ~  326 (740)
                      .
T Consensus       340 ~  340 (505)
T KOG3207|consen  340 K  340 (505)
T ss_pred             c
Confidence            4

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.09  E-value=1e-09  Score=109.52  Aligned_cols=143  Identities=20%  Similarity=0.236  Sum_probs=110.4

Q ss_pred             eeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCC--ccceeeeeeeec---CeEEEEEEe
Q 004642          456 YCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR--NIVKLYGFCLHK---KCMFLIYEY  530 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~  530 (740)
                      +.|+.|..+.||++...+|+.+++|........  .....+..|.++++.+++.  .+.+++.+....   +..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            568999999999998777789999998664432  1235678899999999753  456677777654   367899999


Q ss_pred             ccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC--------------------------------------  572 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------  572 (740)
                      ++|.++.+.+..    ..++..+...++.+++++|.+||+..                                      
T Consensus        82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            999988765532    13667778888889999998888531                                      


Q ss_pred             ---------------CCCeEecCCCCCceEEcC--CCcEEEeeccccee
Q 004642          573 ---------------TLSIIHRDISSNNILLDS--NLEASVADFGTARL  604 (740)
Q Consensus       573 ---------------~~~ivH~dlkp~NIll~~--~~~~kl~DfG~a~~  604 (740)
                                     ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           245799999999999998  66789999998854

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.09  E-value=1.2e-11  Score=135.32  Aligned_cols=197  Identities=29%  Similarity=0.389  Sum_probs=126.4

Q ss_pred             CCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccccccccccCCChhhhcccccccee
Q 004642           99 CFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTEL  178 (740)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  178 (740)
                      .+..++.++++.|.+.. +-..+..+++|+.|++.+|+|..+ ...+..+++|++|+|++|.|+.+  ..+..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence            45666677777777763 334467777888888888887744 22266777888888888888766  456667778888


Q ss_pred             ecccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCcCC-ccccccCCCCeecccCCccCCCch
Q 004642          179 YVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIP-DELTKLSQLKNLNLSSNLLSGQIP  257 (740)
Q Consensus       179 ~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~  257 (740)
                      ++++|.|+..                     ..+..+++|+.+++++|++..+-+ . ...+.+|+.+++.+|.+.... 
T Consensus       146 ~l~~N~i~~~---------------------~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~-  202 (414)
T KOG0531|consen  146 NLSGNLISDI---------------------SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIE-  202 (414)
T ss_pred             eeccCcchhc---------------------cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhccc-
Confidence            8888877632                     233346677777777777775433 1 466677777777777775332 


Q ss_pred             hhhcCccCCceeccCCCcccCcCCcccccCCC--CCeEeccCCCCCCCCchhcccccccceEEecCCcccC
Q 004642          258 YAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSA--LKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSG  326 (740)
Q Consensus       258 ~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~--L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  326 (740)
                       .+..+..+..+++..|.++..-  .+..+..  |+.+++++|++. .++..+..+..+..|++.+|++..
T Consensus       203 -~~~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~  269 (414)
T KOG0531|consen  203 -GLDLLKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISN  269 (414)
T ss_pred             -chHHHHHHHHhhcccccceecc--CcccchhHHHHHHhcccCccc-cccccccccccccccchhhccccc
Confidence             2333444555577777776321  1222233  677777777777 444556666777777777777764

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.08  E-value=1.1e-09  Score=100.09  Aligned_cols=146  Identities=18%  Similarity=0.253  Sum_probs=107.0

Q ss_pred             cceeeecccceEEEEEEeCCCcEEEEEEccCCcc-----cchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEEEE
Q 004642          454 IKYCIGTGGYGSVYKAELPEGKVVALKKLHHSET-----EDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  528 (740)
                      ....+.||+-+.|+++.+ .|+...||.-.....     ...-..++..+|++.+.+++--.|....-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            457799999999999988 577777765433322     22233467788999999987555555555666777778999


Q ss_pred             EeccC-CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc---EEEeeccccee
Q 004642          529 EYMER-GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLE---ASVADFGTARL  604 (740)
Q Consensus       529 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~DfG~a~~  604 (740)
                      ||++| .++.+++.........+ ......+.+|-..+.-||..   +|+|+||..+||++..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 46677765543322222 22367888999999999999   9999999999999976553   57999999854

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.08  E-value=5.7e-09  Score=106.64  Aligned_cols=257  Identities=16%  Similarity=0.222  Sum_probs=155.7

Q ss_pred             cceeeecccceEEEEEEeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhcc-CCCccceeeee----ee---ecCeEE
Q 004642          454 IKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGF----CL---HKKCMF  525 (740)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~~---~~~~~~  525 (740)
                      ..+.||+|+.+.+|-.-  +-..-+.|+++.....-.      .+.+..|... .||-+-.-+.+    -.   .+....
T Consensus        15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CCccccCCccceeeecc--hhhchhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            45679999999999752  112234477765543311      1223334444 56543221111    10   122356


Q ss_pred             EEEEeccCCCc-hhhh---cCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeeccc
Q 004642          526 LIYEYMERGSL-FCVL---HDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       526 lv~e~~~~g~L-~~~l---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      ++|..+++..- ..+.   ++...-...+|...++.++.+|.+.+.||..   |.+-+|+.++|+|+++++.+.+.|-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence            77777766421 1111   1122234578999999999999999999999   999999999999999999999987554


Q ss_pred             ceecccCCCcccccccCCCcccccccc-----ccccCCcchhHhHHHHHHHHHhC-CCCCCcccccccCCCCCc-hhh--
Q 004642          602 ARLLHVDSSYRTLRAGTYGYIAPELAY-----TIVVTGKCDVYSFGVVALEVLMG-THPGGLLSSLSSSSGPKI-MLI--  672 (740)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~-~~~--  672 (740)
                      -..- .+.......+|...|.+||.-.     +..-+...|-|.+||++++++.| ++||.............+ .+.  
T Consensus       164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            3322 2222233347899999999643     44556679999999999999997 999986543322222111 111  


Q ss_pred             ---hhhccc--C-CCcchhhhHHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHHHcC
Q 004642          673 ---DVLNQR--L-SPPVNQKIVQDIILVSTIAFACLSSQ--PKSRPTMQRISQELLAG  722 (740)
Q Consensus       673 ---~~~~~~--l-~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~ev~~~L~~~  722 (740)
                         ..-+++  . +++....+.---..+..+..+|+...  |.-||+++..+..|...
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence               111111  1 11111111111122556667787643  56899999999888654

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.08  E-value=1.3e-11  Score=119.76  Aligned_cols=177  Identities=24%  Similarity=0.322  Sum_probs=120.6

Q ss_pred             CCccEEeCCCCCcccCCCccccCCCCCceeecccc-cccccCchhhcccccccccccccccccCCChhhhccccccceee
Q 004642          101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGN-NLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELY  179 (740)
Q Consensus       101 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  179 (740)
                      |-|+++...+..++..  +.+-..+.+..+.-+.- ..+|..-......+.|++||||+|.|+ .+..+..-+|.++.|+
T Consensus       237 ptl~t~~v~~s~~~~~--~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~  313 (490)
T KOG1259|consen  237 PTLQTICVHNTTIQDV--PSLLPETILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLI  313 (490)
T ss_pred             chhheeeeeccccccc--ccccchhhhcCccCCCCCccCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEe
Confidence            5566776666555421  11222222322222211 122332233334467899999999988 4556777788999999


Q ss_pred             cccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCcCCccccccCCCCeecccCCccCCCchhh
Q 004642          180 VTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYA  259 (740)
Q Consensus       180 L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  259 (740)
                      +++|.|..+                     ..+..+++|+.||||+|.++. +.++-.++-+++.|.|+.|.|...  ..
T Consensus       314 lS~N~i~~v---------------------~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La~N~iE~L--SG  369 (490)
T KOG1259|consen  314 LSQNRIRTV---------------------QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLAQNKIETL--SG  369 (490)
T ss_pred             ccccceeee---------------------hhhhhcccceEeecccchhHh-hhhhHhhhcCEeeeehhhhhHhhh--hh
Confidence            999988733                     235567889999999999884 445556788899999999998643  45


Q ss_pred             hcCccCCceeccCCCcccCc-CCcccccCCCCCeEeccCCCCCCCC
Q 004642          260 IGKLFNLMYLDLSKNKLSGS-IPTEIGNCSALKNLTLNHNSLDGTI  304 (740)
Q Consensus       260 ~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~  304 (740)
                      ++++-+|.+||+++|+|... --..+++++.|+++.|.+|.+.+..
T Consensus       370 L~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  370 LRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            67778899999999998742 2245889999999999999999543

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.07  E-value=1.5e-11  Score=122.28  Aligned_cols=222  Identities=21%  Similarity=0.263  Sum_probs=160.0

Q ss_pred             cCCCCCccEEeCCCCCccc----CCCccccCCCCCceeecccc---cccccCchh-------hccccccccccccccccc
Q 004642           97 FSCFPNLKSLDLWNNSLSG----SIPPQIGSLSKLKCLYLHGN---NLTGIIPKE-------IGSLRNLRGLFLYSNKLS  162 (740)
Q Consensus        97 ~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N---~l~~~~p~~-------l~~l~~L~~L~L~~N~l~  162 (740)
                      ...+..++.|+||+|.+..    .+.+.+.+.++|+..++|+-   ++...+|+.       +..+++|++||||.|-|.
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G  105 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG  105 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence            4456778889999998862    34566778889999998873   334455543       345679999999999987


Q ss_pred             CCChhhh----ccccccceeecccccccccCCCcccc-cccCCCccccCCCCccccccCCCCEEecCCCcCCCcC----C
Q 004642          163 GVLPQEI----GNLKSLTELYVTNNALGGLIPSTLFR-LTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGII----P  233 (740)
Q Consensus       163 ~~~p~~l----~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~----~  233 (740)
                      ...+..|    ..+..|++|+|.||.+.-..-..+++ +..+..|       .....-++|+++...+|++....    .
T Consensus       106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~-------kk~~~~~~Lrv~i~~rNrlen~ga~~~A  178 (382)
T KOG1909|consen  106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVN-------KKAASKPKLRVFICGRNRLENGGATALA  178 (382)
T ss_pred             ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHH-------hccCCCcceEEEEeeccccccccHHHHH
Confidence            6666554    46788999999999886332222222 1112211       12344568999999999998532    2


Q ss_pred             ccccccCCCCeecccCCccCCC----chhhhcCccCCceeccCCCcccCc----CCcccccCCCCCeEeccCCCCCCCCc
Q 004642          234 DELTKLSQLKNLNLSSNLLSGQ----IPYAIGKLFNLMYLDLSKNKLSGS----IPTEIGNCSALKNLTLNHNSLDGTIP  305 (740)
Q Consensus       234 ~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~p  305 (740)
                      ..|...+.|+.+.++.|.|...    +...|..+++|+.|||.+|-++..    +...+..++.|+.|++++|.+...-.
T Consensus       179 ~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga  258 (382)
T KOG1909|consen  179 EAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGA  258 (382)
T ss_pred             HHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccH
Confidence            3466778999999999998532    345678899999999999999843    34556788999999999999986544


Q ss_pred             hhc-----ccccccceEEecCCccc
Q 004642          306 LEM-----GKILLLQNLDLSHNNLS  325 (740)
Q Consensus       306 ~~~-----~~l~~L~~L~l~~N~l~  325 (740)
                      ..+     ...++|+.|.+.+|.++
T Consensus       259 ~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  259 IAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             HHHHHHHhccCCCCceeccCcchhH
Confidence            333     33688999999999997

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.03  E-value=5.3e-11  Score=130.18  Aligned_cols=215  Identities=28%  Similarity=0.354  Sum_probs=140.2

Q ss_pred             EEEEEcCCCCccccccCcccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccccc
Q 004642           78 ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLY  157 (740)
Q Consensus        78 v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  157 (740)
                      +..+++..+.+....  ..+..+.+|+.|+|.+|+|..+. ..+..+++|++|+|++|.|+.+  ..+..++.|+.|+++
T Consensus        74 l~~l~l~~n~i~~~~--~~l~~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~  148 (414)
T KOG0531|consen   74 LKELNLRQNLIAKIL--NHLSKLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLS  148 (414)
T ss_pred             HHhhccchhhhhhhh--cccccccceeeeeccccchhhcc-cchhhhhcchheeccccccccc--cchhhccchhhheec
Confidence            333445555444311  13677899999999999998543 3378899999999999999866  357778889999999


Q ss_pred             cccccCCChhhhccccccceeecccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCcCCcccc
Q 004642          158 SNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELT  237 (740)
Q Consensus       158 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  237 (740)
                      +|.|+.+  ..+..+++|+.+++++|+++...+.                  . ...+.+|+.+++.+|.+..+  ..+.
T Consensus       149 ~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~------------------~-~~~~~~l~~l~l~~n~i~~i--~~~~  205 (414)
T KOG0531|consen  149 GNLISDI--SGLESLKSLKLLDLSYNRIVDIEND------------------E-LSELISLEELDLGGNSIREI--EGLD  205 (414)
T ss_pred             cCcchhc--cCCccchhhhcccCCcchhhhhhhh------------------h-hhhccchHHHhccCCchhcc--cchH
Confidence            9999865  5677789999999999998855331                  1 34556677777777776632  3344


Q ss_pred             ccCCCCeecccCCccCCCchhhhcCccC--CceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCCchhcccccccc
Q 004642          238 KLSQLKNLNLSSNLLSGQIPYAIGKLFN--LMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQ  315 (740)
Q Consensus       238 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~--L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  315 (740)
                      .+..+..+++..|.++..-+  +..+..  |+.+++++|++. .++..+..+.++..|++.+|++...-  .+.....+.
T Consensus       206 ~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~  280 (414)
T KOG0531|consen  206 LLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLS  280 (414)
T ss_pred             HHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--cccccchHH
Confidence            45555555666676653322  112222  667777777766 33345566666777777777666322  233444555


Q ss_pred             eEEecCCccc
Q 004642          316 NLDLSHNNLS  325 (740)
Q Consensus       316 ~L~l~~N~l~  325 (740)
                      .+.++.|.+.
T Consensus       281 ~~~~~~~~~~  290 (414)
T KOG0531|consen  281 ELWLNDNKLA  290 (414)
T ss_pred             HhccCcchhc
Confidence            5666666654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.96  E-value=1.3e-10  Score=130.83  Aligned_cols=251  Identities=20%  Similarity=0.253  Sum_probs=166.0

Q ss_pred             HhcccccceeeecccceEEEEEEeC-CCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeeecCeEEE
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  526 (740)
                      ..+.+.+.+-+-.|.++.++.+.-. .|...+.|.......-.....+....+-.+.-..++|.++...-.+.-....++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4567777888899999999877322 233333333322111100011222333333333456666665555455667899


Q ss_pred             EEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecc
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      +++|..+++|...+|..+   ..+..........+..+.+|||..   .+.|+|++|.|.+...++..+++|||......
T Consensus       882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence            999999999999998765   233344445566788899999986   68999999999999999999999998432211


Q ss_pred             cC-----C--------------------------CcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCC
Q 004642          607 VD-----S--------------------------SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPG  655 (740)
Q Consensus       607 ~~-----~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~  655 (740)
                      .-     .                          .......||+.|.+||...+......+|.|+.|++++|.++|..||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            00     0                          0112235899999999999999999999999999999999999998


Q ss_pred             CcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 004642          656 GLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ  713 (740)
Q Consensus       656 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  713 (740)
                      .....       ...+..++....+.+.  ...+......+++...+..+|.+|-.|.
T Consensus      1036 na~tp-------q~~f~ni~~~~~~~p~--g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETP-------QQIFENILNRDIPWPE--GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcch-------hhhhhccccCCCCCCC--CccccChhhhhhhhhhhccCchhccCcc
Confidence            76432       2222333333222111  1122233367788888999999997665

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=8.4e-09  Score=98.46  Aligned_cols=129  Identities=25%  Similarity=0.320  Sum_probs=84.3

Q ss_pred             EEEEEEeCCCcEEEEEEccCCcc-----------------------cchHHHHHHHHHHHHHhccCCC--ccceeeeeee
Q 004642          465 SVYKAELPEGKVVALKKLHHSET-----------------------EDSAFVKSFQNEAHVLSTVRHR--NIVKLYGFCL  519 (740)
Q Consensus       465 ~Vy~~~~~~g~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  519 (740)
                      .||.|...+|..+|+|..+....                       .......+..+|.+.|.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999888999999998864210                       1112234678899999999765  456665442 


Q ss_pred             ecCeEEEEEEecc--CCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCceEEcCCCcEEE
Q 004642          520 HKKCMFLIYEYME--RGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY-LHHDCTLSIIHRDISSNNILLDSNLEASV  596 (740)
Q Consensus       520 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~dlkp~NIll~~~~~~kl  596 (740)
                         ..++||||++  |..+..+....     ++......++.+++..+.. +|..   |++|+|+.+.||+++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence               3579999998  54554333221     1123445677788885555 4677   99999999999999988 8999


Q ss_pred             eecccceecc
Q 004642          597 ADFGTARLLH  606 (740)
Q Consensus       597 ~DfG~a~~~~  606 (740)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999997643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.89  E-value=7.7e-10  Score=85.23  Aligned_cols=59  Identities=46%  Similarity=0.556  Sum_probs=28.4

Q ss_pred             CccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhccccccccccccccc
Q 004642          102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK  160 (740)
Q Consensus       102 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~  160 (740)
                      +|++|+|++|+|+.+.+..|..+++|++|+|++|+|+...|..|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            44445555555544444444444455555555444444444444444444444444444

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.89  E-value=8.7e-10  Score=84.93  Aligned_cols=61  Identities=38%  Similarity=0.510  Sum_probs=56.7

Q ss_pred             CCCceeecccccccccCchhhcccccccccccccccccCCChhhhccccccceeecccccc
Q 004642          125 SKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNAL  185 (740)
Q Consensus       125 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  185 (740)
                      ++|++|+|++|+|+.+.+..|.++++|++|+|++|+|+.+.|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5789999999999988888999999999999999999988889999999999999999986

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.82  E-value=5.6e-08  Score=98.62  Aligned_cols=143  Identities=21%  Similarity=0.145  Sum_probs=99.9

Q ss_pred             eeecccceEEEEEEeCCCcEEEEEEccCCcccc--h------HHHHHHHHHHHHHhccCCCc--cceeeeeeee-----c
Q 004642          457 CIGTGGYGSVYKAELPEGKVVALKKLHHSETED--S------AFVKSFQNEAHVLSTVRHRN--IVKLYGFCLH-----K  521 (740)
Q Consensus       457 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--~------~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~  521 (740)
                      .+-......|+++.+ +|+.|.||+........  .      .....+.+|...+.++...+  .++++++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344444455777766 67889999775433210  0      00124778898888884333  3344555543     2


Q ss_pred             CeEEEEEEeccCC-CchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC-------CCc
Q 004642          522 KCMFLIYEYMERG-SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-------NLE  593 (740)
Q Consensus       522 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~-------~~~  593 (740)
                      ...++|+|++++- +|.+++..... .+.+...+..++.+++..+..||+.   ||+|+|++++|||++.       +..
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence            3578999999986 78888753211 1345567778999999999999999   9999999999999975       467


Q ss_pred             EEEeeccccee
Q 004642          594 ASVADFGTARL  604 (740)
Q Consensus       594 ~kl~DfG~a~~  604 (740)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            89999998854

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.81  E-value=1.1e-07  Score=100.00  Aligned_cols=221  Identities=15%  Similarity=0.218  Sum_probs=151.8

Q ss_pred             cceEEEEE-EeCCCcEEEEEEccCCcccchHHHHHHHHHHHHHhccCCCccceeeeeeee----cCeEEEEEEeccC-CC
Q 004642          462 GYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH----KKCMFLIYEYMER-GS  535 (740)
Q Consensus       462 ~~g~Vy~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~  535 (740)
                      ...+.|++ ...+|..|++|+++.......   ..-..-+++++++.|+|+|++.+++..    +...++||+|.++ ++
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            34578888 455899999999954433221   122345788999999999999988873    4578999999986 35


Q ss_pred             chhhhcCCC------------ccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccce
Q 004642          536 LFCVLHDDD------------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       536 L~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      |.++-....            .....++..+|.++.|+..||.++|+.   |+.-+-|.|++|+++.+.+++|+..|...
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence            655433211            123467889999999999999999999   99999999999999999999999999887


Q ss_pred             ecccCCCcccccccCCCccccccccccccCCcchhHhHHHHHHHHHhCCCCCCcccccccCCCCCchhhhhhcccCCCcc
Q 004642          604 LLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV  683 (740)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  683 (740)
                      ....++.              |-+.+   -.+-|.=.||.+++.|.||..--..         .+......+ ..+..  
T Consensus       442 vl~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~---------~d~~~~s~~-~~I~~--  492 (655)
T KOG3741|consen  442 VLQEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTENSNR---------TDSTQSSHL-TRITT--  492 (655)
T ss_pred             eecCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhccccccc---------ccchHHHHH-HHhhh--
Confidence            7665441              11111   1356899999999999999753110         000000000 00100  


Q ss_pred             hhhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHcCC
Q 004642          684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev~~~L~~~~  723 (740)
                           .....+++++.......+++ -+..+++.++....
T Consensus       493 -----~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~f  526 (655)
T KOG3741|consen  493 -----TYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRF  526 (655)
T ss_pred             -----hhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHH
Confidence                 11222667777777777777 67788877775543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.80  E-value=5.3e-08  Score=95.20  Aligned_cols=138  Identities=22%  Similarity=0.234  Sum_probs=99.3

Q ss_pred             cccceeeecccceEEEEEEeCCCcEEEEEEccCCccc-------------------chHHHHHHHHHHHHHhccCCC--c
Q 004642          452 FHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETE-------------------DSAFVKSFQNEAHVLSTVRHR--N  510 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-------------------~~~~~~~~~~E~~~l~~l~h~--n  510 (740)
                      ..+..+||.|--+.||.|..++|.++|||.-+.....                   -........+|.++|+++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            3456789999999999999999999999965432111                   011234667899999999655  6


Q ss_pred             cceeeeeeeecCeEEEEEEeccCCCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcC
Q 004642          511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS  590 (740)
Q Consensus       511 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~  590 (740)
                      +.+.+++    +...+||||++|-.|...--        +....-.++..|+.-+...-..   ||+|+|+++-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            6666554    45789999999976654331        1222333445555555544455   9999999999999999


Q ss_pred             CCcEEEeeccccee
Q 004642          591 NLEASVADFGTARL  604 (740)
Q Consensus       591 ~~~~kl~DfG~a~~  604 (740)
                      ||.+.++||-.+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999988754

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.75  E-value=2.9e-10  Score=122.65  Aligned_cols=125  Identities=29%  Similarity=0.312  Sum_probs=54.7

Q ss_pred             ccccccccccccCCChhhhccccccceeecccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCC
Q 004642          151 LRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHG  230 (740)
Q Consensus       151 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~  230 (740)
                      |.+.+.+.|.+. ....++.-++.|+.|+|++|+++..                     +.+..+++|++|||++|.+..
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v---------------------~~Lr~l~~LkhLDlsyN~L~~  223 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV---------------------DNLRRLPKLKHLDLSYNCLRH  223 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh---------------------HHHHhcccccccccccchhcc
Confidence            445555555554 3333444445555555555555422                     133444555555555555542


Q ss_pred             cCCc-cccccCCCCeecccCCccCCCchhhhcCccCCceeccCCCcccCcCC-cccccCCCCCeEeccCCCCC
Q 004642          231 IIPD-ELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIP-TEIGNCSALKNLTLNHNSLD  301 (740)
Q Consensus       231 ~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~  301 (740)
                       +|. ....+ +|+.|.|++|-++..  ..+.++.+|+.||+++|-|.+.-. ..++.+..|+.|+|.+|.+-
T Consensus       224 -vp~l~~~gc-~L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  224 -VPQLSMVGC-KLQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             -ccccchhhh-hheeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence             221 11122 255555555554422  233444555555555555443111 12333344444444444443

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.71  E-value=4e-10  Score=121.61  Aligned_cols=129  Identities=29%  Similarity=0.284  Sum_probs=102.9

Q ss_pred             cccceeecccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCcCCccccccCCCCeecccCCcc
Q 004642          173 KSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLL  252 (740)
Q Consensus       173 ~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  252 (740)
                      ..|...+.+.|.++                    .+-.++.-++.|+.|+|++|+++..  +.+..+++|++|||+.|.+
T Consensus       164 n~L~~a~fsyN~L~--------------------~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L  221 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV--------------------LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCL  221 (1096)
T ss_pred             hhHhhhhcchhhHH--------------------hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchh
Confidence            35777777888876                    3345667788999999999999965  4899999999999999999


Q ss_pred             CCCchhhhcCccCCceeccCCCcccCcCCcccccCCCCCeEeccCCCCCCCC-chhcccccccceEEecCCcccC
Q 004642          253 SGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTI-PLEMGKILLLQNLDLSHNNLSG  326 (740)
Q Consensus       253 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~  326 (740)
                      ....-.....+ .|+.|.+++|.++..  ..+.++++|+.||++.|-|.+.- -..+..+..|..|+|.||++.+
T Consensus       222 ~~vp~l~~~gc-~L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  222 RHVPQLSMVGC-KLQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             ccccccchhhh-hheeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            84322233344 499999999999843  45789999999999999998643 2457788899999999999975

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.67  E-value=6e-09  Score=113.47  Aligned_cols=154  Identities=20%  Similarity=0.245  Sum_probs=102.6

Q ss_pred             HHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCcEEEeecccceecccCCCc---------ccccccCCCcccccccc
Q 004642          558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY---------RTLRAGTYGYIAPELAY  628 (740)
Q Consensus       558 ~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~  628 (740)
                      +.+++.|+.|+|..  .++||++|.|++|.++..+..||+.|+++........+         .........|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            44566999999986  58999999999999999999999999998665432211         01112456899999999


Q ss_pred             ccccCCcchhHhHHHHHHHHHh-CCCCCCcccccccCCCCCchhhhhhcccCCCcchhhhHHHHHHHHHHHHHcccCCCC
Q 004642          629 TIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPK  707 (740)
Q Consensus       629 ~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~dP~  707 (740)
                      +...+.++|+||+||++|.+.. |+.-++.........     .....+............+   ++.+=+.+++..++.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-----~~~~~~~~~~~~~s~~~p~---el~~~l~k~l~~~~~  254 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-----FSRNLLNAGAFGYSNNLPS---ELRESLKKLLNGDSA  254 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-----hhhcccccccccccccCcH---HHHHHHHHHhcCCcc
Confidence            9888899999999999999994 544443322111000     0000000000001111122   266777889999999


Q ss_pred             CCCCHHHHHHHHHc
Q 004642          708 SRPTMQRISQELLA  721 (740)
Q Consensus       708 ~RPs~~ev~~~L~~  721 (740)
                      .||++.++......
T Consensus       255 ~rp~~~~l~~~~ff  268 (700)
T KOG2137|consen  255 VRPTLDLLLSIPFF  268 (700)
T ss_pred             cCcchhhhhccccc
Confidence            99988777655443

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.62  E-value=1.7e-08  Score=117.94  Aligned_cols=85  Identities=31%  Similarity=0.421  Sum_probs=45.6

Q ss_pred             ccCCCCCccEEeCCCCCcccCCCccccCCCCCceeecccccccccCchhhcccccccccccccccccCCChhhhcccccc
Q 004642           96 NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSL  175 (740)
Q Consensus        96 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  175 (740)
                      .|..+|.|+.|||++|.=-+.+|..++.|-+|++|+|++..++ .+|..+.+|..|.+|++..+.-...+|..+..|++|
T Consensus       566 ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~L  644 (889)
T KOG4658|consen  566 FFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSL  644 (889)
T ss_pred             HHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccc
Confidence            3555555555555554444455555555555555555555555 445555555555555555555444444444445555


Q ss_pred             ceeecc
Q 004642          176 TELYVT  181 (740)
Q Consensus       176 ~~L~L~  181 (740)
                      ++|.+.
T Consensus       645 r~L~l~  650 (889)
T KOG4658|consen  645 RVLRLP  650 (889)
T ss_pred             cEEEee
Confidence            555553

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.58  E-value=5.6e-09  Score=90.28  Aligned_cols=81  Identities=25%  Similarity=0.249  Sum_probs=35.6

Q ss_pred             ccEEeCCCCCcccCCCcc---ccCCCCCceeecccccccccCchhhcccccccccccccccccCCChhhhccccccceee
Q 004642          103 LKSLDLWNNSLSGSIPPQ---IGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELY  179 (740)
Q Consensus       103 L~~L~L~~n~l~~~~~~~---~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  179 (740)
                      +..++|+++.+- -+++.   +....+|+..+|++|.+....+..-...+.+++|+|++|+|+ .+|..++.++.|+.|+
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            444555555553 12222   223334444455555555322222223344555555555554 2344444444444444


Q ss_pred             cccccc
Q 004642          180 VTNNAL  185 (740)
Q Consensus       180 L~~N~l  185 (740)
                      +++|.+
T Consensus       107 l~~N~l  112 (177)
T KOG4579|consen  107 LRFNPL  112 (177)
T ss_pred             cccCcc
Confidence            444444

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.56  E-value=6.7e-09  Score=101.24  Aligned_cols=86  Identities=33%  Similarity=0.374  Sum_probs=40.7

Q ss_pred             CCCccEEeCCCCCccc--CCCccccCCCCCceeecccccccccCchhhcccccccccccccccccCCC-hhhhccccccc
Q 004642          100 FPNLKSLDLWNNSLSG--SIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVL-PQEIGNLKSLT  176 (740)
Q Consensus       100 l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~  176 (740)
                      .+.++.|||.+|.|+.  .+-..+.+++.|++|+|+.|.+...|-..-..+.+|++|-|.+..+.-.- ...+..+|.++
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt  149 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT  149 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence            3445555555555551  22233445555555555555555333222123445555555555544221 12334455555


Q ss_pred             eeecccccc
Q 004642          177 ELYVTNNAL  185 (740)
Q Consensus       177 ~L~L~~N~l  185 (740)
                      +|.++.|.+
T Consensus       150 elHmS~N~~  158 (418)
T KOG2982|consen  150 ELHMSDNSL  158 (418)
T ss_pred             hhhhccchh
Confidence            555555543

>PRK09902 hypothetical protein; Provisional

Probab=98.51  E-value=1.7e-06  Score=83.02  Aligned_cols=141  Identities=18%  Similarity=0.138  Sum_probs=101.4

Q ss_pred             eecccceEEEEEEeCCCcEEEEEEccCCcccc---hHHHHHHHHHHHHHhccCCC--ccceeeeeee-e----cCeEEEE
Q 004642          458 IGTGGYGSVYKAELPEGKVVALKKLHHSETED---SAFVKSFQNEAHVLSTVRHR--NIVKLYGFCL-H----KKCMFLI  527 (740)
Q Consensus       458 lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-~----~~~~~lv  527 (740)
                      -|.||.+.|++... +|+.+-+|+-.......   +-....|.+|+..+.++...  .+.++. ++. .    ....+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            36688899999877 45568888764211111   12346889999999998532  244444 332 1    1246899


Q ss_pred             EEeccC-CCchhhhcCCCccccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceEEcCCCc--EEEeeccccee
Q 004642          528 YEYMER-GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLE--ASVADFGTARL  604 (740)
Q Consensus       528 ~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~DfG~a~~  604 (740)
                      +|-+++ -+|.+++.+... .+.+...+..++.+++..+.-||+.   |+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 478888755332 2467777889999999999999999   9999999999999986667  99999987754

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.49  E-value=9.1e-08  Score=112.03  Aligned_cols=200  Identities=25%  Similarity=0.313  Sum_probs=98.7

Q ss_pred             CCccEEeCCCCCcccCCCccccCCCCCceeeccccc--ccccCchhhcccccccccccccccccCCChhhhcccccccee
Q 004642          101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN--LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTEL  178 (740)
Q Consensus       101 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~--l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  178 (740)
                      ...+...+-+|.+. .++... ..++|++|-+..|.  +....++.|..++.|++|||++|.=-+.+|..+++|-+|++|
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL  600 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL  600 (889)
T ss_pred             hheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence            34455555555554 222222 22356666666654  443444445556666666666655555566666666666666


Q ss_pred             ecccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCcCCccccccCCCCeecccCCcc--CCCc
Q 004642          179 YVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLL--SGQI  256 (740)
Q Consensus       179 ~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l--~~~~  256 (740)
                      +|++..+.                    .+|..++++..|.+|++..+.-...+|.....|++|++|.+..-..  +...
T Consensus       601 ~L~~t~I~--------------------~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~  660 (889)
T KOG4658|consen  601 DLSDTGIS--------------------HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLL  660 (889)
T ss_pred             cccCCCcc--------------------ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhh
Confidence            66666554                    4455556666666666665554444455555566666666554432  1222


Q ss_pred             hhhhcCccCCceeccCCCcccCcCCcccccCCCCC----eEeccCCCCCCCCchhcccccccceEEecCCccc
Q 004642          257 PYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALK----NLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLS  325 (740)
Q Consensus       257 ~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  325 (740)
                      -..+.++.+|+.+.......  .+-..+..+.+|.    .+.+.++... ..+..+..+.+|+.|.+.+....
T Consensus       661 l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~  730 (889)
T KOG4658|consen  661 LKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGIS  730 (889)
T ss_pred             HHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCc
Confidence            22333444444444322222  1112222233322    2222222222 44455666666777766666654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.48  E-value=9.4e-07  Score=86.74  Aligned_cols=106  Identities=21%  Similarity=0.301  Sum_probs=82.8

Q ss_pred             HHHHHHHHHHhccCCC--ccceeeeeeeec----CeEEEEEEeccCC-CchhhhcCCCccccCCHHHHHHHHHHHHHHHH
Q 004642          494 KSFQNEAHVLSTVRHR--NIVKLYGFCLHK----KCMFLIYEYMERG-SLFCVLHDDDEAIELNWTKRVNIVKSVAHALS  566 (740)
Q Consensus       494 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~  566 (740)
                      ..+.+|...+.++...  .+.+.+++....    ...++|+|++++. +|.+++.....   .+......++.+++..++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            4567788887777432  355566666542    2458999999984 78888875332   455667889999999999


Q ss_pred             HHHhcCCCCeEecCCCCCceEEcCCC---cEEEeecccceec
Q 004642          567 YLHHDCTLSIIHRDISSNNILLDSNL---EASVADFGTARLL  605 (740)
Q Consensus       567 ~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~DfG~a~~~  605 (740)
                      -||+.   ||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999   999999999999999887   8999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.47  E-value=2.7e-08  Score=97.06  Aligned_cols=207  Identities=21%  Similarity=0.158  Sum_probs=132.0

Q ss_pred             CccEEeCCCCCcccCCC-cccc-CCCCCceeecccccccc--cCchhhcccccccccccccccccCCChhhhccccccce
Q 004642          102 NLKSLDLWNNSLSGSIP-PQIG-SLSKLKCLYLHGNNLTG--IIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTE  177 (740)
Q Consensus       102 ~L~~L~L~~n~l~~~~~-~~~~-~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  177 (740)
                      .++.|.|.++.|..+.. ..|+ ..+.++.|||.+|.|+.  .+-..+.++|.|++|+|+.|.+...+...-..+.+|+.
T Consensus        46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~  125 (418)
T KOG2982|consen   46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRV  125 (418)
T ss_pred             chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEE
Confidence            34456666666653321 2233 45789999999999983  34456678999999999999998655433356678999


Q ss_pred             eecccccccccCCCcccccccCCCccccCCCCccccccCCCCEEecCCCcCCCc--CCccccccC-CCCeecccCCccCC
Q 004642          178 LYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGI--IPDELTKLS-QLKNLNLSSNLLSG  254 (740)
Q Consensus       178 L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~~~~~~~l~-~L~~L~l~~N~l~~  254 (740)
                      |-|.+..+.-.                  .....+.++|.++.|+||.|.+.-.  ......... .+++|.+..|...-
T Consensus       126 lVLNgT~L~w~------------------~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~  187 (418)
T KOG2982|consen  126 LVLNGTGLSWT------------------QSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQL  187 (418)
T ss_pred             EEEcCCCCChh------------------hhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHH
Confidence            99988777532                  1223456778888899988844321  111222221 34444444443211


Q ss_pred             C--chhhhcCccCCceeccCCCcccCc-CCcccccCCCCCeEeccCCCCCCC-CchhcccccccceEEecCCcccC
Q 004642          255 Q--IPYAIGKLFNLMYLDLSKNKLSGS-IPTEIGNCSALKNLTLNHNSLDGT-IPLEMGKILLLQNLDLSHNNLSG  326 (740)
Q Consensus       255 ~--~~~~~~~l~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~  326 (740)
                      .  ....-.-++++..+.+..|.+... -...+..++.+.-|+|+.|+|..- --+.+.+++.|..|.+++|+|..
T Consensus       188 w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  188 WLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             HHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence            0  011112356788888888887642 223455677777889999998742 23568889999999999999874

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	740
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-38
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-38
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-30
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-30
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-27
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-26
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-26
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-25
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-25
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-25
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-25
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-25
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-25
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-25
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-25
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-25
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-25
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-25
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-25
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-25
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-25
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-25
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-25
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-25
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-24
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-24
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-24
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-24
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-24
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-24
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-24
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-24
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-24
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-24
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-24
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-24
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-24
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-24
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-24
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-23
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-21
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-21
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-20
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-19
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-16
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-16
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-15
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-14
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-14
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-14
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-13
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-12
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-09
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-08
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		1e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-08
3soa_A	444	Full-Length Human Camkii Length = 444		3e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-08
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		7e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-08
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		7e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-07
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		8e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-07
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		8e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-07
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		9e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-06
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		1e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-05

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  157 bits (396), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 97/292 (33%), Positives = 144/292 (49%), Gaps = 25/292 (8%)
Query: 444 DLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           +L  A+++F  K  +G GG+G VYK  L +G +VA+K+L    T+       FQ E  ++
Sbjct: 24  ELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL--QFQTEVEMI 81
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE-LNWTKRVNIVKSVA 562
           S   HRN+++L GFC+      L+Y YM  GS+   L +  E+   L+W KR  I    A
Sbjct: 82  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL-----HVDSSYRTLRAG 617
             L+YLH  C   IIHRD+ + NILLD   EA V DFG A+L+     HV  + R    G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR----G 197
Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQ 677
             G+IAPE   T   + K DV+ +GV+ LE++ G                 +ML+D +  
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR---AFDLARLANDDDVMLLDWVKG 254
Query: 678 RLSPPVNQKIV----------QDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            L     + +V          +++  +  +A  C  S P  RP M  + + L
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  156 bits (395), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 97/292 (33%), Positives = 144/292 (49%), Gaps = 25/292 (8%)
Query: 444 DLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           +L  A+++F  K  +G GG+G VYK  L +G +VA+K+L     +       FQ E  ++
Sbjct: 32  ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL--QFQTEVEMI 89
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE-LNWTKRVNIVKSVA 562
           S   HRN+++L GFC+      L+Y YM  GS+   L +  E+   L+W KR  I    A
Sbjct: 90  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 149
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL-----HVDSSYRTLRAG 617
             L+YLH  C   IIHRD+ + NILLD   EA V DFG A+L+     HV  + R    G
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR----G 205
Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQ 677
           T G+IAPE   T   + K DV+ +GV+ LE++ G                 +ML+D +  
Sbjct: 206 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR---AFDLARLANDDDVMLLDWVKG 262
Query: 678 RLSPPVNQKIV----------QDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            L     + +V          +++  +  +A  C  S P  RP M  + + L
Sbjct: 263 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 88/209 (42%), Positives = 117/209 (55%), Gaps = 9/209 (4%)
Query: 444 DLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           DL  AT +F  K+ IG G +G VYK  L +G  VALK+      E S  ++ F+ E   L
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR---RTPESSQGIEEFETEIETL 89
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVA 562
           S  RH ++V L GFC  +  M LIY+YME G+L   L+  D   + ++W +R+ I    A
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSY-RTLRAGTYG 620
             L YLH   T +IIHRD+ S NILLD N    + DFG ++    +D ++   +  GT G
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLG 206
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
           YI PE      +T K DVYSFGVV  EVL
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  129 bits (324), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 87/209 (41%), Positives = 114/209 (54%), Gaps = 9/209 (4%)
Query: 444 DLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           DL  AT +F  K+ IG G +G VYK  L +G  VALK+      E S  ++ F+ E   L
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR---RTPESSQGIEEFETEIETL 89
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVA 562
           S  RH ++V L GFC  +  M LIY+YME G+L   L+  D   + ++W +R+ I    A
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV--DSSYRTLRAGTYG 620
             L YLH   T +IIHRD+ S NILLD N    + DFG ++       +    +  GT G
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLG 206
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
           YI PE      +T K DVYSFGVV  EVL
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 95/275 (34%), Positives = 133/275 (48%), Gaps = 9/275 (3%)
Query: 103 LKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLS 162
           L++L L  N L+G IP  + + + L  + L  N LTG IPK IG L NL  L L +N  S
Sbjct: 465 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 524
Query: 163 GVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN-ISSNQFHSSIPLEIGNFSALDTL 221
           G +P E+G+ +SL  L +  N   G IP+ +F+ +  I++N       + I N       
Sbjct: 525 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKEC 584
Query: 222 DLSDN--KIHGIIPDEXXXXXXXXXXXXXXXXXXGQIPYAIGKLFNLMYLDLSKNKLSGS 279
             + N  +  GI  ++                  G          ++M+LD+S N LSG 
Sbjct: 585 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 644
Query: 280 IPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMY--- 336
           IP EIG+   L  L L HN + G+IP E+G +  L  LDLS N L G IP+ +  +    
Sbjct: 645 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 704
Query: 337 -VDLSFNNLEGEIPTY--LRGNPPKSFVGNKGLSG 368
            +DLS NNL G IP        PP  F+ N GL G
Sbjct: 705 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 739

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 95/275 (34%), Positives = 133/275 (48%), Gaps = 9/275 (3%)
Query: 103 LKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLS 162
           L++L L  N L+G IP  + + + L  + L  N LTG IPK IG L NL  L L +N  S
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527
Query: 163 GVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN-ISSNQFHSSIPLEIGNFSALDTL 221
           G +P E+G+ +SL  L +  N   G IP+ +F+ +  I++N       + I N       
Sbjct: 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKEC 587
Query: 222 DLSDN--KIHGIIPDEXXXXXXXXXXXXXXXXXXGQIPYAIGKLFNLMYLDLSKNKLSGS 279
             + N  +  GI  ++                  G          ++M+LD+S N LSG 
Sbjct: 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647
Query: 280 IPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMY--- 336
           IP EIG+   L  L L HN + G+IP E+G +  L  LDLS N L G IP+ +  +    
Sbjct: 648 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707
Query: 337 -VDLSFNNLEGEIPTY--LRGNPPKSFVGNKGLSG 368
            +DLS NNL G IP        PP  F+ N GL G
Sbjct: 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 130/280 (46%), Gaps = 13/280 (4%)
Query: 436 YDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKS 495
           + G +  +D+     D +IK  IG G +G+V++AE   G  VA+K L   +   +  V  
Sbjct: 23  FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFH-AERVNE 80
Query: 496 FQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV 555
           F  E  ++  +RH NIV   G       + ++ EY+ RGSL+ +LH      +L+  +R+
Sbjct: 81  FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           ++   VA  ++YLH+     I+HRD+ S N+L+D      V DFG +RL           
Sbjct: 141 SMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA 199
Query: 616 AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVL 675
           AGT  ++APE+        K DVYSFGV+  E+     P              +  +   
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-----VAAVGFK 254
Query: 676 NQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
            +RL  P N         V+ I   C +++P  RP+   I
Sbjct: 255 CKRLEIPRNLN-----PQVAAIIEGCWTNEPWKRPSFATI 289

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY  RG ++  L    +  + +  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ---KLSKFDEQRTATYITELANALS 127
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY  RG ++  L    +  + +  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ---KLSKFDEQRTATYITELANALS 127
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS R    GT  Y+ PE+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPPEM 182
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 148
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 203
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 127/270 (47%), Gaps = 19/270 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHS-ETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG+G VYK  +     VA+KKL    +       + F  E  V++  +H N+V+L G
Sbjct: 39  MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
           F      + L+Y YM  GSL   L   D    L+W  R  I +  A+ +++LH +     
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HH 154
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLH--VDSSYRTLRAGTYGYIAPELAYTIVVTG 634
           IHRDI S NILLD    A ++DFG AR       +   +   GT  Y+APE A    +T 
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITP 213
Query: 635 KCDVYSFGVVALEVLMG-------THPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKI 687
           K D+YSFGVV LE++ G         P             +  + D +++++    N   
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM----NDAD 269
Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
              +  + ++A  CL  +   RP ++++ Q
Sbjct: 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  113 bits (283), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 139
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 140 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 194
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 177
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 13/280 (4%)
Query: 436 YDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKS 495
           + G +  +D+     D +IK  IG G +G+V++AE   G  VA+K L   +   +  V  
Sbjct: 23  FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFH-AERVNE 80
Query: 496 FQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV 555
           F  E  ++  +RH NIV   G       + ++ EY+ RGSL+ +LH      +L+  +R+
Sbjct: 81  FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           ++   VA  ++YLH+     I+HR++ S N+L+D      V DFG +RL           
Sbjct: 141 SMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199
Query: 616 AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVL 675
           AGT  ++APE+        K DVYSFGV+  E+     P              +  +   
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-----VAAVGFK 254
Query: 676 NQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
            +RL  P N         V+ I   C +++P  RP+   I
Sbjct: 255 CKRLEIPRNLN-----PQVAAIIEGCWTNEPWKRPSFATI 289

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 126/270 (46%), Gaps = 19/270 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHS-ETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG+G VYK  +     VA+KKL    +       + F  E  V++  +H N+V+L G
Sbjct: 39  MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
           F      + L+Y YM  GSL   L   D    L+W  R  I +  A+ +++LH +     
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HH 154
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLH--VDSSYRTLRAGTYGYIAPELAYTIVVTG 634
           IHRDI S NILLD    A ++DFG AR       +       GT  Y+APE A    +T 
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITP 213
Query: 635 KCDVYSFGVVALEVLMG-------THPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKI 687
           K D+YSFGVV LE++ G         P             +  + D +++++    N   
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM----NDAD 269
Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
              +  + ++A  CL  +   RP ++++ Q
Sbjct: 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 125
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 127
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 123
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +   H  SS RT  +GT  Y+ PE+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPPEM 178
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 110/206 (53%), Gaps = 9/206 (4%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NI++LYG+      ++LI EY   G+++  L    +    +  +    +  +A+ALSY 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSRFDEQRTATYITELANALSYC 128
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  +IHRDI   N+LL SN E  +ADFG +  +H  SS RT   GT  Y+ PE+  
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 183
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
             +   K D++S GV+  E L+G  P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEM 177
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 126
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 181
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 121
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 122 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 176
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEM 177
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 125
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 126/272 (46%), Gaps = 19/272 (6%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHS-ETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG+G VYK  +     VA+KKL    +       + F  E  V++  +H N+V+L G
Sbjct: 33  MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
           F      + L+Y YM  GSL   L   D    L+W  R  I +  A+ +++LH +     
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HH 148
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLH--VDSSYRTLRAGTYGYIAPELAYTIVVTG 634
           IHRDI S NILLD    A ++DFG AR               GT  Y+APE A    +T 
Sbjct: 149 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITP 207
Query: 635 KCDVYSFGVVALEVLMG-------THPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKI 687
           K D+YSFGVV LE++ G         P             +  + D +++++    N   
Sbjct: 208 KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM----NDAD 263
Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
              +  + ++A  CL  +   RP ++++ Q L
Sbjct: 264 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 123
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 178
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 127
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 182
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 119
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE+
Sbjct: 120 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 174
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 148
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS R    GT  Y+ PE+
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEM 203
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 125
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS R    GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 180
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 129/278 (46%), Gaps = 26/278 (9%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETED-SAFVKSFQNEAHVLSTVRHR 509
           +  ++  IG GG+G VY+A    G  VA+K   H   ED S  +++ + EA + + ++H 
Sbjct: 8   ELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI+ L G CL +  + L+ E+   G L  VL       ++     VN    +A  ++YLH
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI----LVNWAVQIARGMNYLH 122
Query: 570 HDCTLSIIHRDISSNNILLDSNLE--------ASVADFGTARLLHVDSSYRTLRAGTYGY 621
            +  + IIHRD+ S+NIL+   +E          + DFG AR  H   + +   AG Y +
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYAW 180
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
           +APE+    + +   DV+S+GV+  E+L G  P              +  + +      P
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
               K+++D          C +  P SRP+   I  +L
Sbjct: 241 EPFAKLMED----------CWNPDPHSRPSFTNILDQL 268

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 124
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS R    GT  Y+ PE+
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 179
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 124
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +A+FG +  +H  SS RT   GT  Y+ PE+
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEM 179
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS R    GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 177
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS R    GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 177
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  E    +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +A+FG +  +H  SS RT   GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 123
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS R    GT  Y+ PE+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEM 178
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 132/267 (49%), Gaps = 21/267 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++  ++  +G G +G V KA+    K VA+K++  SE+E  AF+   +     LS V H 
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQ----LSRVNHP 62
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKLYG CL+  C  L+ EY E GSL+ VLH  +          ++     +  ++YLH
Sbjct: 63  NIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
                ++IHRD+   N+LL +      + DFGTA  +    ++ T   G+  ++APE+  
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFE 177
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIV 688
               + KCDV+S+G++  EV+    P            P   ++  ++    PP+ + + 
Sbjct: 178 GSNYSEKCDVFSWGIILWEVITRRKP------FDEIGGPAFRIMWAVHNGTRPPLIKNLP 231
Query: 689 QDIILVSTIAFACLSSQPKSRPTMQRI 715
           + I    ++   C S  P  RP+M+ I
Sbjct: 232 KPI---ESLMTRCWSKDPSQRPSMEEI 255

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 132/267 (49%), Gaps = 21/267 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++  ++  +G G +G V KA+    K VA+K++  SE+E  AF+   +     LS V H 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQ----LSRVNHP 61
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKLYG CL+  C  L+ EY E GSL+ VLH  +          ++     +  ++YLH
Sbjct: 62  NIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
                ++IHRD+   N+LL +      + DFGTA  +    ++ T   G+  ++APE+  
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFE 176
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIV 688
               + KCDV+S+G++  EV+    P            P   ++  ++    PP+ + + 
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKP------FDEIGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 689 QDIILVSTIAFACLSSQPKSRPTMQRI 715
           + I    ++   C S  P  RP+M+ I
Sbjct: 231 KPI---ESLMTRCWSKDPSQRPSMEEI 254

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 125
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS R    GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 180
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 109/206 (52%), Gaps = 9/206 (4%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NI++LYG+      ++LI EY   G+++  L    +    +  +    +  +A+ALSY 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSRFDEQRTATYITELANALSYC 128
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  +IHRDI   N+LL SN E  +ADFG +  +H  SS R    GT  Y+ PE+  
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIE 183
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
             +   K D++S GV+  E L+G  P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 109/208 (52%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 127
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ PE 
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEX 182
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                   K D++S GV+  E L+G  P
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A   + K ++ALK L  ++ E +      + E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 125
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS R    GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEM 180
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 9/208 (4%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           A EDF I   +G G +G+VY A     K ++ALK L  ++ E +      + E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           RH NI++LYG+      ++LI EY   G+++  L    +  + +  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALS 122
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           Y H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS R    GT  Y+ PE+
Sbjct: 123 YCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 177
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               +   K D++S GV+  E L+G  P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (263), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 120/269 (44%), Gaps = 19/269 (7%)
Query: 459 GTGGYGSVYKAELPEGKVVALKKLHHS-ETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           G GG+G VYK  +     VA+KKL    +       + F  E  V +  +H N+V+L GF
Sbjct: 31  GEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
                 + L+Y Y   GSL   L   D    L+W  R  I +  A+ +++LH +     I
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHEN---HHI 146
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLH--VDSSYRTLRAGTYGYIAPELAYTIVVTGK 635
           HRDI S NILLD    A ++DFG AR           +   GT  Y APE A    +T K
Sbjct: 147 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPK 205
Query: 636 CDVYSFGVVALEVLMG-------THPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIV 688
            D+YSFGVV LE++ G         P             +  + D ++++     N    
Sbjct: 206 SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK----XNDADS 261
Query: 689 QDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             +    ++A  CL  +   RP ++++ Q
Sbjct: 262 TSVEAXYSVASQCLHEKKNKRPDIKKVQQ 290

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF I   +G G +G+VY A   + K ++ALK L  S+ E        + E  + S +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NI+++Y +   +K ++L+ E+  RG L+  L       E    +    ++ +A AL Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADALHYC 131
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H      +IHRDI   N+L+    E  +ADFG +  +H  S  R    GT  Y+ PE+  
Sbjct: 132 H---ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIE 186
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                 K D++  GV+  E L+G  P
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPP 212

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF I   +G G +G+VY A   + K ++ALK L  S+ E        + E  + S +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NI+++Y +   +K ++L+ E+  RG L+  L       E    +    ++ +A AL Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADALHYC 130
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H      +IHRDI   N+L+    E  +ADFG +  +H  S  R    GT  Y+ PE+  
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIE 185
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                 K D++  GV+  E L+G  P
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP 211

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 458 IGTGGYGSVYKAELP--EGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV 512
           IG G +G VYK  L    GK    VA+K L    TE       F  EA ++    H NI+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSHHNII 109
Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
           +L G     K M +I EYME G+L   L + D   E +  + V +++ +A  + YL    
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYL---A 164
Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG---TYGYIAPELAYT 629
            ++ +HRD+++ NIL++SNL   V+DFG +R+L  D       +G      + APE    
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 630 IVVTGKCDVYSFGVVALEVLM-GTHP 654
              T   DV+SFG+V  EV+  G  P
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 133/286 (46%), Gaps = 32/286 (11%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKL----HHSETEDSAFVKSFQNEAHV 502
           A  +   +  IG GG+G V+K  L + K VVA+K L       ETE     + FQ E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           +S + H NIVKLYG   +   M  + E++  G L+  L   D+A  + W+ ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIA 132
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLE-----ASVADFGTARL-LHVDSSYRTLRA 616
             + Y+ +     I+HRD+ S NI L S  E     A VADFGT++  +H  S       
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGL----L 187
Query: 617 GTYGYIAPEL--AYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV 674
           G + ++APE   A     T K D YSF ++   +L G  P             KI  I++
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIKFINM 241
Query: 675 LNQR-LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           + +  L P + +     +     +   C S  PK RP    I +EL
Sbjct: 242 IREEGLRPTIPEDCPPRL---RNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 9/206 (4%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF I   +G G +G+VY A   +   +VALK L  S+ E        + E  + + + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NI++LY +   ++ ++LI EY  RG L+  L    ++   +  +   I++ +A AL Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYC 139
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H      +IHRDI   N+LL    E  +ADFG +  +H  S  R    GT  Y+ PE+  
Sbjct: 140 HGK---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMIE 194
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
             +   K D++  GV+  E+L+G  P
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 130/273 (47%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 322
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 323 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 380
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 381 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 436
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 485
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C   +P+ RPT +
Sbjct: 486 PPECPESLHDLMC------QCWRKEPEERPTFE 512

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G +G   K    E G+V+ +K+L   + E     ++F  E  V+  + H N++K  G
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEHPNVLKFIG 74
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
                K +  I EY++ G+L  ++   D   +  W++RV+  K +A  ++YLH   +++I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLL--------------HVDSSYRTLRAGTYGYI 622
           IHRD++S+N L+  N    VADFG ARL+                D   R    G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL 649
           APE+        K DV+SFG+V  E++
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 130/273 (47%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 297
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 353
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 402
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C   +P+ RPT +
Sbjct: 403 PPECPESLHDLMC------QCWRKEPEERPTFE 429

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 130/273 (47%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 297
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 353
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 402
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C   +P+ RPT +
Sbjct: 403 PPECPESLHDLMC------QCWRKEPEERPTFE 429

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 130/273 (47%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 66
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 67  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 124
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 125 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 180
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 181 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 229
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C   +P+ RPT +
Sbjct: 230 PPECPESLHDLMC------QCWRKEPEERPTFE 256

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 132/286 (46%), Gaps = 32/286 (11%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKL----HHSETEDSAFVKSFQNEAHV 502
           A  +   +  IG GG+G V+K  L + K VVA+K L       ETE     + FQ E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           +S + H NIVKLYG   +   M  + E++  G L+  L   D+A  + W+ ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIA 132
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLE-----ASVADFG-TARLLHVDSSYRTLRA 616
             + Y+ +     I+HRD+ S NI L S  E     A VADFG + + +H  S       
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL----L 187
Query: 617 GTYGYIAPEL--AYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV 674
           G + ++APE   A     T K D YSF ++   +L G  P             KI  I++
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIKFINM 241
Query: 675 LNQR-LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           + +  L P + +     +     +   C S  PK RP    I +EL
Sbjct: 242 IREEGLRPTIPEDCPPRL---RNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 130/273 (47%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 297
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 353
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 402
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C   +P+ RPT +
Sbjct: 403 PPECPESLHDLMC------QCWRKEPEERPTFE 429

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 130/273 (47%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 70
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 71  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE 128
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 129 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 184
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 233
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C   +P+ RPT +
Sbjct: 234 PPECPESLHDLMC------QCWRKEPEERPTFE 260

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 110/232 (47%), Gaps = 26/232 (11%)
Query: 442 YEDLINATEDF---------HIKYCIGTGGYGSVYKAELP-EGK---VVALKKLHHSETE 488
           +ED   A  +F          I+  IG G +G V    L   GK    VA+K L    TE
Sbjct: 16  FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 75
Query: 489 DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE 548
                + F +EA ++    H N++ L G       + +I E+ME GSL   L  +D    
Sbjct: 76  KQR--RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           +   + V +++ +A  + YL     ++ +HRD+++ NIL++SNL   V+DFG +R L  D
Sbjct: 134 V--IQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188
Query: 609 SSYRTLRAGTYGYI-----APELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
           +S  T  +   G I     APE       T   DV+S+G+V  EV+  G  P
Sbjct: 189 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 129/293 (44%), Gaps = 39/293 (13%)
Query: 442 YEDLINATEDF---------HIKYCIGTGGYGSVYKAELP-EGK---VVALKKLHHSETE 488
           +ED   A  +F          I+  IG G +G V    L   GK    VA+K L    T+
Sbjct: 12  FEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTD 71
Query: 489 DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE 548
                + F +EA ++    H NI+ L G     K + +I EYME GSL   L  +D    
Sbjct: 72  KQR--RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           +   + V +++ +   + YL     +S +HRD+++ NIL++SNL   V+DFG +R+L  D
Sbjct: 130 V--IQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 609 -SSYRTLRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXX 664
             +  T R G     + APE       T   DV+S+G+V  EV+  G  P          
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-- 242
Query: 665 XXPKIMLIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
                 +I  + +  RL PP++  I      +  +   C   +   RP   +I
Sbjct: 243 ------VIKAIEEGYRLPPPMDCPIA-----LHQLMLDCWQKERSDRPKFGQI 284

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 454 IKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           I   +G G +G V   + +LP  K   VA+K L    TE     + F  EA ++    H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI++L G     K + ++ EYME GSL   L   D    +   + V +++ +A  + YL 
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL- 163
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-SSYRTLRAGT--YGYIAPEL 626
               +  +HRD+++ NIL++SNL   V+DFG AR+L  D  +  T R G     + +PE 
Sbjct: 164 --SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 627 AYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
                 T   DV+S+G+V  EV+  G  P
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 131/276 (47%), Gaps = 36/276 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+++ NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 132 R---MNYVHRDLAAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 187
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 236
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRIS 716
           PP   + + D++        C    P+ RPT + + 
Sbjct: 237 PPECPESLHDLMC------QCWRKDPEERPTFEYLQ 266

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 129/273 (47%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKIRHE 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 187
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 236
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C    P+ RPT +
Sbjct: 237 PPECPESLHDLMC------QCWRKDPEERPTFE 263

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 109/217 (50%), Gaps = 16/217 (7%)
Query: 446 INATEDFHIKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETEDSAFVKSFQNEAH 501
           ++AT +  I   +G G +G V   + +LP  K   VA+K L    TE     + F  EA 
Sbjct: 30  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 86
Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           ++    H NI++L G     K + ++ EYME GSL   L   D    +   + V +++ +
Sbjct: 87  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 144
Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-SSYRTLRAGT-- 618
           A  + YL     +  +HRD+++ NIL++SNL   V+DFG +R+L  D  +  T R G   
Sbjct: 145 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
             + +PE       T   DV+S+G+V  EV+  G  P
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 109/230 (47%), Gaps = 24/230 (10%)
Query: 442 YEDLINATEDF---------HIKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETE 488
           YED      +F          I   +G G +G V   + +LP  K   VA+K L    TE
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 489 DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE 548
                + F  EA ++    H NI++L G     K + ++ EYME GSL   L   D    
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           +   + V +++ +A  + YL     +  +HRD+++ NIL++SNL   V+DFG +R+L  D
Sbjct: 146 V--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 609 -SSYRTLRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
             +  T R G     + +PE       T   DV+S+G+V  EV+  G  P
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 109/230 (47%), Gaps = 24/230 (10%)
Query: 442 YEDLINATEDF---------HIKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETE 488
           YED      +F          I   +G G +G V   + +LP  K   VA+K L    TE
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 489 DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE 548
                + F  EA ++    H NI++L G     K + ++ EYME GSL   L   D    
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           +   + V +++ +A  + YL     +  +HRD+++ NIL++SNL   V+DFG +R+L  D
Sbjct: 146 V--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 609 -SSYRTLRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
             +  T R G     + +PE       T   DV+S+G+V  EV+  G  P
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 454 IKYCIGTGGYGSVYKAELP-EGK---VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           I+  IG G +G V    L   GK    VA+K L    T+     + F +EA ++    H 
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSEASIMGQFDHP 69
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI+ L G     K + +I EYME GSL   L  +D    +   + V +++ +   + YL 
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLS 127
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-SSYRTLRAGT--YGYIAPEL 626
               +S +HRD+++ NIL++SNL   V+DFG +R+L  D  +  T R G     + APE 
Sbjct: 128 D---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 627 AYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQ--RLSPPV 683
                 T   DV+S+G+V  EV+  G  P                +I  + +  RL PP+
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VIKAIEEGYRLPPPM 236
Query: 684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
           +  I      +  +   C   +   RP   +I
Sbjct: 237 DCPIA-----LHQLMLDCWQKERSDRPKFGQI 263

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 454 IKYCIGTGGYGSVYKAELP-EGK---VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           I+  IG G +G V    L   GK    VA+K L    T+     + F +EA ++    H 
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSEASIMGQFDHP 75
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI+ L G     K + +I EYME GSL   L  +D    +   + V +++ +   + YL 
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLS 133
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-SSYRTLRAGT--YGYIAPEL 626
               +S +HRD+++ NIL++SNL   V+DFG +R+L  D  +  T R G     + APE 
Sbjct: 134 D---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 627 AYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQ--RLSPPV 683
                 T   DV+S+G+V  EV+  G  P                +I  + +  RL PP+
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VIKAIEEGYRLPPPM 242
Query: 684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
           +  I      +  +   C   +   RP   +I
Sbjct: 243 DCPIA-----LHQLMLDCWQKERSDRPKFGQI 269

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 454 IKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           I   +G G +G V   + +LP  K   VA+K L    TE     + F  EA ++    H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI++L G     K + ++ EYME GSL   L   D    +   + V +++ +A  + YL 
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL- 163
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-SSYRTLRAGT--YGYIAPEL 626
               +  +HRD+++ NIL++SNL   V+DFG +R+L  D  +  T R G     + +PE 
Sbjct: 164 --SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 627 AYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
                 T   DV+S+G+V  EV+  G  P
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
            I+  IG G +G V +  L  P  K   VA+K L    TE     + F +EA ++    H
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEH 74
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NI++L G   +   + ++ E+ME G+L   L  +D    +   + V +++ +A  + YL
Sbjct: 75  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYL 132
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIA 623
                +S +HRD+++ NIL++SNL   V+DFG +R L  +SS  T  +   G     + A
Sbjct: 133 AE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTA 189
Query: 624 PELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
           PE       T   D +S+G+V  EV+  G  P
Sbjct: 190 PEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 139/308 (45%), Gaps = 71/308 (23%)
Query: 61  SSDHCN--WVGITCDYEG---RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSG 115
           ++D CN  W+G+ CD +    R+ ++DL   N+           +P              
Sbjct: 30  TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP--------YP-------------- 67
Query: 116 SIPPQIGSLSKLKCLYLHG-NNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKS 174
            IP  + +L  L  LY+ G NNL G IP  I  L  L  L++    +SG +P  +  +K+
Sbjct: 68  -IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 175 LTELYVTNNALGGLIPSTLFRLTNI-----SSNQFHSSIPLEIGNFSALDT-LDLSDNKI 228
           L  L  + NAL G +P ++  L N+       N+   +IP   G+FS L T + +S N++
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 229 HGIIPDEXXXXXXXXXXXXXXXXXXGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCS 288
            G IP                               NL ++DLS+N L G      G+  
Sbjct: 187 TGKIPPTFAN-------------------------LNLAFVDLSRNMLEGDASVLFGSDK 221
Query: 289 ALKNLTLNHNSLDGTIPLEMGKILLLQNL---DLSHNNLSGTIPKTLRPMY----VDLSF 341
             + + L  NSL      ++GK+ L +NL   DL +N + GT+P+ L  +     +++SF
Sbjct: 222 NTQKIHLAKNSLA----FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 342 NNLEGEIP 349
           NNL GEIP
Sbjct: 278 NNLCGEIP 285

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           HI+  IG+G  G V    L  P  +   VA+K L    TE     + F +EA ++    H
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDH 109
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NI++L G     +   ++ EYME GSL   L   D    +   + V +++ V   + YL
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL 167
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG---TYGYIAPE 625
                L  +HRD+++ N+L+DSNL   V+DFG +R+L  D        G      + APE
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPE 224
Query: 626 LAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
                  +   DV+SFGVV  EVL  G  P
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 130/273 (47%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 70
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 71  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE 128
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ +   +   +   + APE A
Sbjct: 129 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEWTARQGAKFPIKWTAPEAA 184
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 233
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C   +P+ RPT +
Sbjct: 234 PPECPESLHDLMC------QCWRKEPEERPTFE 260

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 109/217 (50%), Gaps = 16/217 (7%)
Query: 446 INATEDFHIKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETEDSAFVKSFQNEAH 501
           ++AT +  I   +G G +G V   + +LP  K   VA+K L    TE     + F  EA 
Sbjct: 13  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 69
Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           ++    H NI++L G     K + ++ EYME GSL   L   D    +   + V +++ +
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 127
Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-SSYRTLRAGT-- 618
           A  + YL     +  +HRD+++ NIL++SNL   V+DFG +R+L  D  +  T R G   
Sbjct: 128 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
             + +PE       T   DV+S+G+V  EV+  G  P
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 109/230 (47%), Gaps = 24/230 (10%)
Query: 442 YEDLINATEDF---------HIKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETE 488
           YED      +F          I   +G G +G V   + +LP  K   VA+K L    TE
Sbjct: 26  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 85
Query: 489 DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE 548
                + F  EA ++    H NI++L G     K + ++ EYME GSL   L   D    
Sbjct: 86  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 143
Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           +   + V +++ +A  + YL     +  +HRD+++ NIL++SNL   V+DFG +R+L  D
Sbjct: 144 V--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 198
Query: 609 -SSYRTLRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
             +  T R G     + +PE       T   DV+S+G+V  EV+  G  P
Sbjct: 199 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 129/273 (47%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 64
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 65  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 122
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 123 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 178
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 179 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 227
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C    P+ RPT +
Sbjct: 228 PPECPESLHDLMC------QCWRKDPEERPTFE 254

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 129/273 (47%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 187
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 236
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C    P+ RPT +
Sbjct: 237 PPECPESLHDLMC------QCWRKDPEERPTFE 263

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 129/273 (47%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 62
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 63  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 120
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 121 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 176
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 177 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 225
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C    P+ RPT +
Sbjct: 226 PPECPESLHDLMC------QCWRKDPEERPTFE 252

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 129/273 (47%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 187
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 236
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C    P+ RPT +
Sbjct: 237 PPECPESLHDLMC------QCWRKDPEERPTFE 263

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 110/234 (47%), Gaps = 32/234 (13%)
Query: 442 YEDLINATEDFH---------IKYCIGTGGYGSVY--------KAELPEGKVVALKKLHH 484
           YED   A  +F          I+  IG G +G V         K ELP    VA+K L  
Sbjct: 5   YEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELP----VAIKTLKV 60
Query: 485 SETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDD 544
             TE     + F  EA ++    H NI+ L G     K + ++ EYME GSL   L  +D
Sbjct: 61  GYTEKQR--RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKND 118
Query: 545 EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL 604
               +   + V +++ ++  + YL     +  +HRD+++ NIL++SNL   V+DFG +R+
Sbjct: 119 GQFTV--IQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 173
Query: 605 LHVD-SSYRTLRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
           L  D  +  T R G     + APE       T   DV+S+G+V  EV+  G  P
Sbjct: 174 LEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 454 IKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           I   +G G +G V   + +LP  K   VA+K L    TE     + F  EA ++    H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI++L G     K + ++ EYME GSL   L   D    +   + V +++ +A  + YL 
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL- 163
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-SSYRTLRAGT--YGYIAPEL 626
               +  +HRD+++ NIL++SNL   V+DFG +R+L  D  +  T R G     + +PE 
Sbjct: 164 --SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 627 AYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
                 T   DV+S+G+V  EV+  G  P
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 17/211 (8%)
Query: 454 IKYCIGTGGYGSVYKAEL--PEGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           I+  IG G +G V +  L  P  K   VA+K L    TE     + F +EA ++    H 
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHP 77
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI++L G   +   + ++ E+ME G+L   L  +D    +   + V +++ +A  + YL 
Sbjct: 78  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYL- 134
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI-----AP 624
               +S +HRD+++ NIL++SNL   V+DFG +R L  +SS  T  +   G I     AP
Sbjct: 135 --AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
           E       T   D +S+G+V  EV+  G  P
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 130/276 (47%), Gaps = 36/276 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 187
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 236
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRIS 716
           PP   + + D++        C    P+ RPT + + 
Sbjct: 237 PPECPESLHDLMC------QCWRKDPEERPTFEYLQ 266

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           HI+  IG+G  G V    L  P  +   VA+K L    TE     + F +EA ++    H
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDH 109
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NI++L G     +   ++ EYME GSL   L   D    +   + V +++ V   + YL
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL 167
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH--VDSSYRTLRAG-TYGYIAPE 625
                L  +HRD+++ N+L+DSNL   V+DFG +R+L    D++Y T        + APE
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 626 LAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
                  +   DV+SFGVV  EVL  G  P
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 454 IKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           I   +G G +G V   + +LP  K   VA+K L    TE     + F  EA ++    H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI++L G     K + ++ EYME GSL   L   D    +   + V +++ +A  + YL 
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL- 163
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-SSYRTLRAGT--YGYIAPEL 626
               +  +HRD+++ NIL++SNL   V+DFG +R+L  D  +  T R G     + +PE 
Sbjct: 164 --SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 627 AYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
                 T   DV+S+G+V  EV+  G  P
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 454 IKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           I   +G G +G V   + +LP  K   VA+K L    TE     + F  EA ++    H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI++L G     K + ++ EYME GSL   L   D    +   + V +++ +A  + YL 
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL- 163
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-SSYRTLRAGT--YGYIAPEL 626
               +  +HRD+++ NIL++SNL   V+DFG  R+L  D  +  T R G     + +PE 
Sbjct: 164 --SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 627 AYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
                 T   DV+S+G+V  EV+  G  P
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 134/271 (49%), Gaps = 26/271 (9%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+ A   +   VA+K +       S  V++F  EA+V+ T++H 
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHD 70
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +VKL+   + K+ +++I E+M +GSL   L  D E  +    K ++    +A  ++++ 
Sbjct: 71  KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPEL 626
                + IHRD+ + NIL+ ++L   +ADFG AR++  D+ Y T R G      + APE 
Sbjct: 129 QR---NYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEY-TAREGAKFPIKWTAPEA 183
Query: 627 AYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQ 685
                 T K DV+SFG++ +E++  G  P            P++  I  L +    P  +
Sbjct: 184 INFGSFTIKSDVWSFGILLMEIVTYGRIP------YPGMSNPEV--IRALERGYRMPRPE 235
Query: 686 KIVQDIILVSTIAFACLSSQPKSRPTMQRIS 716
              +++     I   C  ++P+ RPT + I 
Sbjct: 236 NCPEELY---NIMMRCWKNRPEERPTFEYIQ 263

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 140/288 (48%), Gaps = 26/288 (9%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+ A   +   VA+K +       S  V++F  EA+V+ T++H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHD 243
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +VKL+   + K+ +++I E+M +GSL   L  D E  +    K ++    +A  ++++ 
Sbjct: 244 KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPEL 626
                + IHRD+ + NIL+ ++L   +ADFG AR++  D+ Y T R G      + APE 
Sbjct: 302 QR---NYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEY-TAREGAKFPIKWTAPEA 356
Query: 627 AYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQ 685
                 T K DV+SFG++ +E++  G  P            P++  I  L +    P  +
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIP------YPGMSNPEV--IRALERGYRMPRPE 408
Query: 686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEI 733
              +++     I   C  ++P+ RPT + I   L    T  +   +EI
Sbjct: 409 NCPEELY---NIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQXEEI 453

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 36/273 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQ----EAQVMKKLRHE 240
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 241 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE 298
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG  RL+  D+ Y   +   +   + APE A
Sbjct: 299 R---MNYVHRDLRAANILVGENLVCKVADFGLGRLIE-DNEYTARQGAKFPIKWTAPEAA 354
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 355 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 403
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           PP   + + D++        C    P+ RPT +
Sbjct: 404 PPECPESLHDLMC------QCWRKDPEERPTFE 430

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 131/286 (45%), Gaps = 32/286 (11%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGK-VVALKKL----HHSETEDSAFVKSFQNEAHV 502
           A  +   +  IG GG+G V+K  L + K VVA+K L       ETE     + FQ E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           +S + H NIVKLYG   +   M  + E++  G L+  L   D+A  + W+ ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIA 132
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLE-----ASVADFG-TARLLHVDSSYRTLRA 616
             + Y+ +     I+HRD+ S NI L S  E     A VADF  + + +H  S       
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGL----L 187
Query: 617 GTYGYIAPEL--AYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV 674
           G + ++APE   A     T K D YSF ++   +L G  P             KI  I++
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIKFINM 241
Query: 675 LNQR-LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           + +  L P + +     +     +   C S  PK RP    I +EL
Sbjct: 242 IREEGLRPTIPEDCPPRL---RNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 38/274 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 63
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ + ++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 64  KLVQLYA-VVSEEPIXIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 121
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPEL 626
               ++ +HRD+ + NIL+  NL   VADFG ARL  ++ +  T R G      + APE 
Sbjct: 122 R---MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEXTARQGAKFPIKWTAPEA 176
Query: 627 AYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS 680
           A     T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+ 
Sbjct: 177 ALYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMP 225
Query: 681 -PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
            PP   + + D++        C   +P+ RPT +
Sbjct: 226 CPPECPESLHDLMC------QCWRKEPEERPTFE 253

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 38/274 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPEL 626
               ++ +HRD+ + NIL+  NL   VADFG ARL  ++ +  T R G      + APE 
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEXTARQGAKFPIKWTAPEA 186
Query: 627 AYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS 680
           A     T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+ 
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMP 235
Query: 681 -PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
            PP   + + D++        C    P+ RPT +
Sbjct: 236 CPPECPESLHDLMC------QCWRKDPEERPTFE 263

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 135/300 (45%), Gaps = 51/300 (17%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
            D  +K  +G G +G V+ AE        +  +VA+K L   +    A  K FQ EA +L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELL 71
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL--FCVLHDDDEAI-----------ELN 550
           + ++H +IVK YG C     + +++EYM+ G L  F   H  D  I           EL 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 551 WTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS 610
            ++ ++I   +A  + YL    +   +HRD+++ N L+ +NL   + DFG +R ++    
Sbjct: 132 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 611 YRTLRAGTYG-----YIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXX 664
           YR    G +      ++ PE       T + DV+SFGV+  E+   G  P          
Sbjct: 189 YRV---GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-- 243
Query: 665 XXPKIMLIDVLNQ-RL--SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA 721
                 +I+ + Q R+   P V  K V D++L       C   +P+ R  ++ I + L A
Sbjct: 244 ------VIECITQGRVLERPRVCPKEVYDVML------GCWQREPQQRLNIKEIYKILHA 291

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 70
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 71  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 129
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 130 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPES 184
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 185 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 232
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 233 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 265

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 36/276 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +G L   L  +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 187
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 236
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRIS 716
           PP   + + D++        C    P+ RPT + + 
Sbjct: 237 PPECPESLHDLMC------QCWRKDPEERPTFEYLQ 266

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 129/302 (42%), Gaps = 56/302 (18%)
Query: 450 EDFHIKYCIGTGGYGSVYKAE----LPEGK--VVALKKLHHSETEDSAFVKSFQNEAHVL 503
            D  +K+ +G G +G V+ AE    LPE    +VA+K L   E  +SA  + FQ EA +L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESA-RQDFQREAELL 97
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL--FCVLHDDDEAI----------ELNW 551
           + ++H++IV+ +G C   + + +++EYM  G L  F   H  D  +           L  
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 552 TKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY 611
            + + +   VA  + YL     L  +HRD+++ N L+   L   + DFG +R ++    Y
Sbjct: 158 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 612 RTLRAGT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXX 666
           R    G       ++ PE       T + DV+SFGVV  E+   G  P            
Sbjct: 215 RV--GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--- 269
Query: 667 PKIMLIDVLNQ-------RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                ID + Q       R  PP           V  I   C   +P+ R +++ +   L
Sbjct: 270 -----IDCITQGRELERPRACPPE----------VYAIMRGCWQREPQQRHSIKDVHARL 314
Query: 720 LA 721
            A
Sbjct: 315 QA 316

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 36/276 (13%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L        AF++    EA V+  +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY   + ++ ++++ EYM +G L   L  +     L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 131
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +   + APE A
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 187
Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLS- 680
                T K DV+SFG++  E+   G  P            P ++  +VL+Q     R+  
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVP-----------YPGMVNREVLDQVERGYRMPC 236
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRIS 716
           PP   + + D++        C    P+ RPT + + 
Sbjct: 237 PPECPESLHDLMC------QCWRKDPEERPTFEYLQ 266

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 137/303 (45%), Gaps = 33/303 (10%)
Query: 441 LYEDLINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNE 499
           LY   ++  E F     IG G +G V+K  +    KVVA+K +   E      ++  Q E
Sbjct: 18  LYFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQE 75
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
             VLS      + K YG  L    +++I EY+  GS   +L    E   L+ T+   I++
Sbjct: 76  ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILR 131
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   L YLH +     IHRDI + N+LL  + E  +ADFG A  L      R    GT 
Sbjct: 132 EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP 188
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRL 679
            ++APE+        K D++S G+ A+E+  G  P               M +  L  + 
Sbjct: 189 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---------MKVLFLIPKN 239
Query: 680 SPPVNQ----KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISI 735
           +PP  +    K +++ +       ACL+ +P  RPT    ++ELL  K  ++ A K   +
Sbjct: 240 NPPTLEGNYSKPLKEFVE------ACLNKEPSFRPT----AKELLKHKFILRNAKKTSYL 289
Query: 736 SEL 738
           +EL
Sbjct: 290 TEL 292

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 74
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 133
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPES 188
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 189 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 236
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 237 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 269

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 82
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 83  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 141
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 142 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 196
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 197 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 244
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 245 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 277

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 71
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 130
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 131 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 185
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 186 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 233
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 234 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 266

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 133
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 188
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 189 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 236
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 237 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 269

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 454 IKYCIGTGGYGSVYKAELP-EGK---VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           I+  IG G +G V    L   GK    VA+K L    TE     + F +EA ++    H 
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHP 68
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N++ L G       + +I E+ME GSL   L  +D    +   + V +++ +A  + YL 
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL- 125
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI-----AP 624
               ++ +HR +++ NIL++SNL   V+DFG +R L  D+S  T  +   G I     AP
Sbjct: 126 --ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
           E       T   DV+S+G+V  EV+  G  P
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 129/302 (42%), Gaps = 56/302 (18%)
Query: 450 EDFHIKYCIGTGGYGSVYKAE----LPEGK--VVALKKLHHSETEDSAFVKSFQNEAHVL 503
            D  +K+ +G G +G V+ AE    LPE    +VA+K L   E  +SA  + FQ EA +L
Sbjct: 12  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESA-RQDFQREAELL 68
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL--FCVLHDDDEAI----------ELNW 551
           + ++H++IV+ +G C   + + +++EYM  G L  F   H  D  +           L  
Sbjct: 69  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 128
Query: 552 TKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY 611
            + + +   VA  + YL     L  +HRD+++ N L+   L   + DFG +R ++    Y
Sbjct: 129 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 185
Query: 612 RTLRAGT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXX 666
           R    G       ++ PE       T + DV+SFGVV  E+   G  P            
Sbjct: 186 RV--GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--- 240
Query: 667 PKIMLIDVLNQ-------RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                ID + Q       R  PP           V  I   C   +P+ R +++ +   L
Sbjct: 241 -----IDCITQGRELERPRACPPE----------VYAIMRGCWQREPQQRHSIKDVHARL 285
Query: 720 LA 721
            A
Sbjct: 286 QA 287

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 74
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 75  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 133
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 188
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 189 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 236
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 237 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 269

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 129/302 (42%), Gaps = 56/302 (18%)
Query: 450 EDFHIKYCIGTGGYGSVYKAE----LPEGK--VVALKKLHHSETEDSAFVKSFQNEAHVL 503
            D  +K+ +G G +G V+ AE    LPE    +VA+K L   E  +SA  + FQ EA +L
Sbjct: 18  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESA-RQDFQREAELL 74
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL--FCVLHDDDEAI----------ELNW 551
           + ++H++IV+ +G C   + + +++EYM  G L  F   H  D  +           L  
Sbjct: 75  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 134
Query: 552 TKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY 611
            + + +   VA  + YL     L  +HRD+++ N L+   L   + DFG +R ++    Y
Sbjct: 135 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 191
Query: 612 RTLRAGT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXX 666
           R    G       ++ PE       T + DV+SFGVV  E+   G  P            
Sbjct: 192 RV--GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--- 246
Query: 667 PKIMLIDVLNQ-------RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                ID + Q       R  PP           V  I   C   +P+ R +++ +   L
Sbjct: 247 -----IDCITQGRELERPRACPPE----------VYAIMRGCWQREPQQRHSIKDVHARL 291
Query: 720 LA 721
            A
Sbjct: 292 QA 293

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 69
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 128
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 183
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 184 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 231
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 232 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 264

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 133
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 188
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 189 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 236
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 237 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 269

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 70
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 71  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 129
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 130 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAPAGAKFPIKWTAPES 184
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 185 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 232
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 233 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 265

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 132
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 133 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 187
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 188 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 235
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 236 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 268

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 69
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 128
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 183
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 184 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 231
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 232 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 71
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 130
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 131 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 185
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 186 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 233
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 234 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 266

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 24/230 (10%)
Query: 442 YEDLINATEDF---------HIKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETE 488
           YED      +F          I   +G G +G V   + +LP  K   VA+K L    TE
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 489 DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE 548
                + F  EA ++    H NI++L G     K + ++ E ME GSL   L   D    
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFT 145
Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           +   + V +++ +A  + YL     +  +HRD+++ NIL++SNL   V+DFG +R+L  D
Sbjct: 146 V--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 609 -SSYRTLRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
             +  T R G     + +PE       T   DV+S+G+V  EV+  G  P
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 108/217 (49%), Gaps = 16/217 (7%)
Query: 446 INATEDFHIKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETEDSAFVKSFQNEAH 501
           ++AT +  I   +G G +G V   + +LP  K   VA+K L    TE     + F  EA 
Sbjct: 13  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 69
Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           ++    H NI++L G     K + ++ E ME GSL   L   D    +   + V +++ +
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGI 127
Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-SSYRTLRAGT-- 618
           A  + YL     +  +HRD+++ NIL++SNL   V+DFG +R+L  D  +  T R G   
Sbjct: 128 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
             + +PE       T   DV+S+G+V  EV+  G  P
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 71
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 130
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 131 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAPAGAKFPIKWTAPES 185
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 186 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 233
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 234 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 266

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 454 IKYCIGTGGYGSVY--KAELPEGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           I   +G G +G V   + +LP  K   VA+K L    TE     + F  EA ++    H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI++L G     K + ++ E ME GSL   L   D    +   + V +++ +A  + YL 
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL- 163
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-SSYRTLRAGT--YGYIAPEL 626
               +  +HRD+++ NIL++SNL   V+DFG +R+L  D  +  T R G     + +PE 
Sbjct: 164 --SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 627 AYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
                 T   DV+S+G+V  EV+  G  P
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 127/282 (45%), Gaps = 25/282 (8%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+K  +    KVVA+K +   E      ++  Q E  VLS      + K YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    +++I EY+  GS   +L    E   L+ T+   I++ +   L YLH +     
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 125
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI + N+LL  + E  +ADFG A  L      R    GT  ++APE+        K 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 185
Query: 637 DVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVST 696
           D++S G+ A+E+  G  P               M +  L  + +PP  +      +    
Sbjct: 186 DIWSLGITAIELARGEPPHSELHP---------MKVLFLIPKNNPPTLEGNYSKPL--KE 234
Query: 697 IAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
              ACL+ +P  RPT    ++ELL  K  ++ A K   ++EL
Sbjct: 235 FVEACLNKEPSFRPT----AKELLKHKFILRNAKKTSYLTEL 272

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 127/282 (45%), Gaps = 25/282 (8%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+K  +    KVVA+K +   E      ++  Q E  VLS      + K YG
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    +++I EY+  GS   +L    E   L+ T+   I++ +   L YLH +     
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 140
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI + N+LL  + E  +ADFG A  L      R    GT  ++APE+        K 
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 200
Query: 637 DVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVST 696
           D++S G+ A+E+  G  P               M +  L  + +PP  +      +    
Sbjct: 201 DIWSLGITAIELARGEPPHSELHP---------MKVLFLIPKNNPPTLEGNYSKPL--KE 249
Query: 697 IAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
              ACL+ +P  RPT    ++ELL  K  ++ A K   ++EL
Sbjct: 250 FVEACLNKEPSFRPT----AKELLKHKFILRNAKKTSYLTEL 287

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 127/282 (45%), Gaps = 25/282 (8%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+K  +    KVVA+K +   E      ++  Q E  VLS      + K YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    +++I EY+  GS   +L    E   L+ T+   I++ +   L YLH +     
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 125
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI + N+LL  + E  +ADFG A  L      R    GT  ++APE+        K 
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKA 185
Query: 637 DVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVST 696
           D++S G+ A+E+  G  P               M +  L  + +PP  +      +    
Sbjct: 186 DIWSLGITAIELARGEPPHSELHP---------MKVLFLIPKNNPPTLEGNYSKPL--KE 234
Query: 697 IAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
              ACL+ +P  RPT    ++ELL  K  ++ A K   ++EL
Sbjct: 235 FVEACLNKEPSFRPT----AKELLKHKFILRNAKKTSYLTEL 272

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 38/266 (14%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        +F++    EA ++  ++H  +V+LY  
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLE----EAQIMKKLKHDKLVQLYA- 71
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ ++++ EYM +GSL   L D  E   L     V++   VA  ++Y+     ++ I
Sbjct: 72  VVSEEPIYIVTEYMNKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYI 127
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ S NIL+ + L   +ADFG ARL  ++ +  T R G      + APE A     T 
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARL--IEDNEXTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 635 KCDVYSFGVVALE-VLMGTHPXXXXXXXXXXXXPKIMLIDVLNQ-----RLSPPVNQKIV 688
           K DV+SFG++  E V  G  P            P +   +VL Q     R+  P      
Sbjct: 186 KSDVWSFGILLTELVTKGRVP-----------YPGMNNREVLEQVERGYRMPCP------ 228
Query: 689 QDI-ILVSTIAFACLSSQPKSRPTMQ 713
           QD  I +  +   C    P+ RPT +
Sbjct: 229 QDCPISLHELMIHCWKKDPEERPTFE 254

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 103/195 (52%), Gaps = 13/195 (6%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L       +  V++F  EA+++ T++H  +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              ++ +++I EYM +GSL   L   DE  ++   K ++    +A  ++Y+      + I
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 132
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + N+L+  +L   +ADFG AR++  D+ Y T R G      + APE       T 
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIE-DNEY-TAREGAKFPIKWTAPEAINFGCFTI 190
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 191 KSDVWSFGILLYEIV 205

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 31/223 (13%)
Query: 454 IKYCIGTGGYGSVYKAEL----PEGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           +K  +G G +G V+ AE     PE    +VA+K L   +  D+A  K F  EA +L+ ++
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNA-RKDFHREAELLTNLQ 73
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSL--FCVLHDDDEAI--------ELNWTKRVNI 557
           H +IVK YG C+    + +++EYM+ G L  F   H  D  +        EL  ++ ++I
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
            + +A  + YL    +   +HRD+++ N L+  NL   + DFG +R ++    YR    G
Sbjct: 134 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV---G 187
Query: 618 TYG-----YIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            +      ++ PE       T + DV+S GVV  E+   G  P
Sbjct: 188 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 129/268 (48%), Gaps = 22/268 (8%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 77  ST-KPQLAIVTQWCEGSSLYHHLHASETKFEMK--KLIDIARQTARGMDYLH---AKSII 130
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPE---LAYTIVV 632
           HRD+ SNNI L  +    + DFG A +    S        +G+  ++APE   +  +   
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 633 TGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQ-RLSPPVNQKIVQDI 691
           + + DVY+FG+V  E++ G  P             +  +I+++ +  LSP +++      
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIEMVGRGSLSPDLSKVRSNCP 243
Query: 692 ILVSTIAFACLSSQPKSRPTMQRISQEL 719
             +  +   CL  +   RP+  RI  E+
Sbjct: 244 KRMKRLMAECLKKKRDERPSFPRILAEI 271

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 130/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 315
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E+N    + +   ++ A+ YL 
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLE 374
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY---GYIAPE- 625
                + IHR++++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 375 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPES 429
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY      K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 430 LAYNKFSI-KSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 477
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 478 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 510

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 69
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E++    + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 128
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 183
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 184 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 231
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 232 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 264

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 69
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E++    + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 128
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 183
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 184 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 231
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 232 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 264

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E++    + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 128
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 183
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 184 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 231
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 232 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 264

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 73  ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 126
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPELAYTI---VV 632
           HRD+ SNNI L  +L   + DFG A +    S        +G+  ++APE+         
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
           + + DVY+FG+V  E++ G  P
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLP 208

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E++    + +   ++ A+ YL 
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 133
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 134 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 188
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 189 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 236
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 237 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 269

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E++    + +   ++ A+ YL 
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 128
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 183
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY    + K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 184 LAYN-KFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 231
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 232 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 264

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 75  ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 128
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPELAYTI---VV 632
           HRD+ SNNI L  +L   + DFG A +    S        +G+  ++APE+         
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
           + + DVY+FG+V  E++ G  P
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLP 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 78  ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 131
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPELAYTI---VV 632
           HRD+ SNNI L  +L   + DFG A +    S        +G+  ++APE+         
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 633 TGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDII 692
           + + DVY+FG+V  E++ G  P               ++  V    LSP +++       
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPDLSKVRSNCPK 245
Query: 693 LVSTIAFACLSSQPKSRPTMQRI--SQELLAGKTP 725
            +  +   CL  +   RP   +I  S ELLA   P
Sbjct: 246 AMKRLMAECLKKKRDERPLFPQILASIELLARSLP 280

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 78  ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 131
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPELAYTI---VV 632
           HRD+ SNNI L  +L   + DFG A +    S        +G+  ++APE+         
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
           + + DVY+FG+V  E++ G  P
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLP 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 128/268 (47%), Gaps = 22/268 (8%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 89  ST-KPQLAIVTQWCEGSSLYHHLHASETKFEMK--KLIDIARQTARGMDYLH---AKSII 142
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPE---LAYTIVV 632
           HRD+ SNNI L  +    + DFG A      S        +G+  ++APE   +  +   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 633 TGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQ-RLSPPVNQKIVQDI 691
           + + DVY+FG+V  E++ G  P             +  +I+++ +  LSP +++      
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 692 ILVSTIAFACLSSQPKSRPTMQRISQEL 719
             +  +   CL  +   RP+  RI  E+
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILAEI 283

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E + I   +G GG  +VY AE     + VA+K +     E    +K F+ E H  S + H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD-----DEAIELNWTKRVNIVKSVAH 563
           +NIV +        C +L+ EY+E  +L   +        D AI  N+T +  I+  + H
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI--NFTNQ--ILDGIKH 126
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GTYGYI 622
           A     HD  + I+HRDI   NIL+DSN    + DFG A+ L   S  +T    GT  Y 
Sbjct: 127 A-----HD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           +PE A         D+YS G+V  E+L+G  P
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 101 ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 154
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPELAYTI---VV 632
           HRD+ SNNI L  +L   + DFG A +    S        +G+  ++APE+         
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 633 TGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDII 692
           + + DVY+FG+V  E++ G  P               ++  V    LSP +++       
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPDLSKVRSNCPK 268
Query: 693 LVSTIAFACLSSQPKSRPTMQRI--SQELLAGKTP 725
            +  +   CL  +   RP   +I  S ELLA   P
Sbjct: 269 AMKRLMAECLKKKRDERPLFPQILASIELLARSLP 303

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 100 ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 153
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPELAYTI---VV 632
           HRD+ SNNI L  +L   + DFG A +    S        +G+  ++APE+         
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 633 TGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDII 692
           + + DVY+FG+V  E++ G  P               ++  V    LSP +++       
Sbjct: 214 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPDLSKVRSNCPK 267
Query: 693 LVSTIAFACLSSQPKSRPTMQRI--SQELLAGKTP 725
            +  +   CL  +   RP   +I  S ELLA   P
Sbjct: 268 AMKRLMAECLKKKRDERPLFPQILASIELLARSLP 302

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 64
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D  +  ++     
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 130/272 (47%), Gaps = 26/272 (9%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 67
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E++    + +   ++ A+ YL 
Sbjct: 68  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 126
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 127 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPES 181
Query: 626 LAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQ 685
           LAY    + K DV++FGV+  E+   T+              +++  D   +R  P    
Sbjct: 182 LAYN-KFSIKSDVWAFGVLLWEI--ATYGMSPYPGIDPSQVYELLEKDYRMER--PEGCP 236
Query: 686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
           + V +++       AC    P  RP+   I Q
Sbjct: 237 EKVYELMR------ACWQWNPSDRPSFAEIHQ 262

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 9   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 65
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 66  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 123
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHR++++ NIL+++     + DFG  ++L  D  Y  ++     
Sbjct: 124 ICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 180
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 181 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 21/225 (9%)
Query: 438 GKILYEDLINAT-EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETED 489
           G + +ED      E+ H+K+   +G G +GSV            G+VVA+KKL HS  E 
Sbjct: 1   GAMAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE- 59
Query: 490 SAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAI 547
              ++ F+ E  +L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I
Sbjct: 60  --HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 117
Query: 548 ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
             +  K +     +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  
Sbjct: 118 --DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 172
Query: 608 DSSYRTLRAGTYG---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
           D     ++        + APE       +   DV+SFGVV  E+ 
Sbjct: 173 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 217

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHH---SETEDSAFVKSFQNEAHVLST 505
           ED+ + Y IGTG YG   K     +GK++  K+L +   +E E    V    +E ++L  
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV----SEVNLLRE 61
Query: 506 VRHRNIVKLYGFCLHKK--CMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKS 560
           ++H NIV+ Y   + +    ++++ EY E G L  V+     + + ++  +  RV    +
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +A    +   D   +++HRD+   N+ LD      + DFG AR+L+ D+S+     GT  
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY 181
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEV 648
           Y++PE    +    K D++S G +  E+
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
               + + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 73  STAPQ-LAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 126
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPELAYTI---VV 632
           HRD+ SNNI L  +L   + DFG A +    S        +G+  ++APE+         
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
           + + DVY+FG+V  E++ G  P
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLP 208

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 26  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 82
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 140
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 141 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHH---SETEDSAFVKSFQNEAHVLS 504
            ED+ + Y IGTG YG   K     +GK++  K+L +   +E E    V    +E ++L 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV----SEVNLLR 60
Query: 505 TVRHRNIVKLYGFCLHKK--CMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVK 559
            ++H NIV+ Y   + +    ++++ EY E G L  V+     + + ++  +  RV    
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
           ++A    +   D   +++HRD+   N+ LD      + DFG AR+L+ D+S+     GT 
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP 180
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEV 648
            Y++PE    +    K D++S G +  E+
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF I   +GTG +G V+       G+  A+K L          V+   +E  +LS V H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             I++++G     + +F+I +Y+E G LF +L         N   +      V  AL YL
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKF-YAAEVCLALEYL 122
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  II+RD+   NILLD N    + DFG A+ +  D +Y     GT  YIAPE+  
Sbjct: 123 H---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYXL--CGTPDYIAPEVVS 176
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
           T       D +SFG++  E+L G  P
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 12  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 68
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 69  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 126
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 127 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 183
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 184 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 215

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 73  ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 126
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPELAYTI---VV 632
           HRD+ SNNI L  +L   + DFG A      S        +G+  ++APE+         
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
           + + DVY+FG+V  E++ G  P
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLP 208

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 15  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 71
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 72  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 129
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 130 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 186
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 187 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 13  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 69
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 70  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 127
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 128 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 184
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 185 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 39  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 95
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 153
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 154 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 210
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 242

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 42/280 (15%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 276
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E++    + +   ++ A+ YL 
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 335
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY---GYIAPE- 625
                + IHR++++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 336 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPES 390
Query: 626 LAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIMLIDVL-----NQRL 679
           LAY      K DV++FGV+  E+   G  P            P I L  V      + R+
Sbjct: 391 LAYNKFSI-KSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDYRM 438
Query: 680 SPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
             P    +K+ +       +  AC    P  RP+   I Q
Sbjct: 439 ERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQ 471

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 26  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 82
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 140
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 141 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 11  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 67
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 125
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 85
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 86  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 141
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL+  D+ Y T R G      + APE       T 
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIE-DNEY-TAREGAKFPIKWTAPEAINYGTFTI 199
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 200 KSDVWSFGILLTEIV 214

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E F +   +G G YGSVYKA   E G++VA+K++   E++    +K    E  ++     
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIK----EISIMQQCDS 83
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            ++VK YG       ++++ EY   GS+  ++   ++   L   +   I++S    L YL
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYL 141
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H    +  IHRDI + NILL++   A +ADFG A  L    + R    GT  ++APE+  
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQ 198
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
            I      D++S G+ A+E+  G  P
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 64
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 64
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 6   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 62
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 63  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 120
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 121 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 177
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 178 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 209

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 81
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 82  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 137
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL+  D+ Y T R G      + APE       T 
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIE-DNEY-TAREGAKFPIKWTAPEAINYGTFTI 195
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 196 KSDVWSFGILLTEIV 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 7   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 63
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 64  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 121
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 122 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 178
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 179 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 210

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 16/203 (7%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 67
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E++    + +   ++ A+ YL 
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 126
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 127 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF--TAHAGAKFPIKWTAPES 181
Query: 626 LAYTIVVTGKCDVYSFGVVALEV 648
           LAY    + K DV++FGV+  E+
Sbjct: 182 LAYN-KFSIKSDVWAFGVLLWEI 203

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 93  ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 146
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPELAYTI---VV 632
           HRD+ SNNI L  +L   + DFG A      S        +G+  ++APE+         
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 633 TGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDII 692
           + + DVY+FG+V  E++ G  P               ++  V    LSP +++       
Sbjct: 207 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPDLSKVRSNCPK 260
Query: 693 LVSTIAFACLSSQPKSRPTMQRI--SQELLAGKTP 725
            +  +   CL  +   RP   +I  S ELLA   P
Sbjct: 261 AMKRLMAECLKKKRDERPLFPQILASIELLARSLP 295

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 80
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 81  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 136
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL+  D+ Y T R G      + APE       T 
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIE-DNEY-TAREGAKFPIKWTAPEAINYGTFTI 194
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 195 KSDVWSFGILLTEIV 209

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              K  + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 101 ST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSII 154
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPELAYTI---VV 632
           HRD+ SNNI L  +L   + DFG A      S        +G+  ++APE+         
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 633 TGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDII 692
           + + DVY+FG+V  E++ G  P               ++  V    LSP +++       
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPDLSKVRSNCPK 268
Query: 693 LVSTIAFACLSSQPKSRPTMQRI--SQELLAGKTP 725
            +  +   CL  +   RP   +I  S ELLA   P
Sbjct: 269 AMKRLMAECLKKKRDERPLFPQILASIELLARSLP 303

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 75
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL+  D+ Y T R G      + APE       T 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIE-DNEY-TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 190 KSDVWSFGILLTEIV 204

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 22/268 (8%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH NI+   G+
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
               + + ++ ++ E  SL+  LH  +   E+   K ++I +  A  + YLH     SII
Sbjct: 89  STAPQ-LAIVTQWCEGSSLYHHLHASETKFEMK--KLIDIARQTARGMDYLH---AKSII 142
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPE---LAYTIVV 632
           HRD+ SNNI L  +    + DFG A      S        +G+  ++APE   +  +   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 633 TGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQ-RLSPPVNQKIVQDI 691
           + + DVY+FG+V  E++ G  P             +  +I+++ +  LSP +++      
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 692 ILVSTIAFACLSSQPKSRPTMQRISQEL 719
             +  +   CL  +   RP+  RI  E+
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILAEI 283

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 108/203 (53%), Gaps = 16/203 (7%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G +G VY+    +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 67
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   ++I E+M  G+L   L + +   E++    + +   ++ A+ YL 
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 126
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 127 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPES 181
Query: 626 LAYTIVVTGKCDVYSFGVVALEV 648
           LAY    + K DV++FGV+  E+
Sbjct: 182 LAYN-KFSIKSDVWAFGVLLWEI 203

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G+VYK +      VA+K L   +     F ++F+NE  VL   RH NI+   G+
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQF-QAFRNEVAVLRKTRHVNILLFMGY 100
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + K  + ++ ++ E  SL+  LH  +   ++   + ++I +  A  + YLH     +II
Sbjct: 101 -MTKDNLAIVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYLH---AKNII 154
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPELAYTI---VV 632
           HRD+ SNNI L   L   + DFG A +    S  + +    G+  ++APE+         
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
           + + DVYS+G+V  E++ G  P
Sbjct: 215 SFQSDVYSYGIVLYELMTGELP 236

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 70
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 71  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 126
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL+  D+ Y T R G      + APE       T 
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIE-DNEY-TAREGAKFPIKWTAPEAINYGTFTI 184
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 185 KSDVWSFGILLTEIV 199

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 84
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 85  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 140
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL  ++ +  T R G      + APE       T 
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTI 198
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 199 KSDVWSFGILLTEIV 213

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D  +K+ +G G YG VY     +  + VA+K L     ED+  V+ F  EA V+  ++H 
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 88
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V+L G C  +   +++ EYM  G+L   L + +   E+     + +   ++ A+ YL 
Sbjct: 89  NLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE-EVTAVVLLYMATQISSAMEYLE 147
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPE- 625
                + IHRD+++ N L+  N    VADFG +RL+  D+   T  AG      + APE 
Sbjct: 148 KK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPES 202
Query: 626 LAYTIVVTGKCDVYSFGVVALEV 648
           LAY    + K DV++FGV+  E+
Sbjct: 203 LAYN-TFSIKSDVWAFGVLLWEI 224

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 103/195 (52%), Gaps = 13/195 (6%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L       +  V++F  EA+++ T++H  +V+LY  
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
              ++ +++I E+M +GSL   L   DE  ++   K ++    +A  ++Y+      + I
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 131
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + N+L+  +L   +ADFG AR++  D+ Y T R G      + APE       T 
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIE-DNEY-TAREGAKFPIKWTAPEAINFGCFTI 189
Query: 635 KCDVYSFGVVALEVL 649
           K +V+SFG++  E++
Sbjct: 190 KSNVWSFGILLYEIV 204

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 81
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 82  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 137
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL  ++ +  T R G      + APE       T 
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTI 195
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 196 KSDVWSFGILLTEIV 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 83
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 84  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 139
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL  ++ +  T R G      + APE       T 
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTI 197
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 198 KSDVWSFGILLTEIV 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 75
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL  ++ +  T R G      + APE       T 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 190 KSDVWSFGILLTEIV 204

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 11  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 67
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI EY+  GSL   L    E I  +  K +     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI--DHIKLLQYTSQ 125
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 77
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 78  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 133
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL  ++ +  T R G      + APE       T 
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTI 191
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 192 KSDVWSFGILLTEIV 206

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G YG VYKA+  +G++VALK++   + ED     +   E  +L  + H NIV L   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIR-LDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTK--RVNIVKSVAHALSYLHHDCTLS 575
              ++C+ L++E+ME+  L  VL ++   ++ +  K     +++ VAH   +        
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-------R 139
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-LAYTIVVTG 634
           I+HRD+   N+L++S+    +ADFG AR   +     T    T  Y AP+ L  +   + 
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199
Query: 635 KCDVYSFGVVALEVLMG 651
             D++S G +  E++ G
Sbjct: 200 SVDIWSIGCIFAEMITG 216

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+K+   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +
Sbjct: 11  EERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEI 67
Query: 503 LSTVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L +++H NIVK  G C    ++ + LI E++  GSL   L    E I  +  K +     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI--DHIKLLQYTSQ 125
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    T   IHRD+++ NIL+++     + DFG  ++L  D     ++     
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE       +   DV+SFGVV  E+ 
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G YG VYKA+  +G++VALK++   + ED     +   E  +L  + H NIV L   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIR-LDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTK--RVNIVKSVAHALSYLHHDCTLS 575
              ++C+ L++E+ME+  L  VL ++   ++ +  K     +++ VAH   +        
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-------R 139
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-LAYTIVVTG 634
           I+HRD+   N+L++S+    +ADFG AR   +     T    T  Y AP+ L  +   + 
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199
Query: 635 KCDVYSFGVVALEVLMG 651
             D++S G +  E++ G
Sbjct: 200 SVDIWSIGCIFAEMITG 216

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 75
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL  ++ +  T R G      + APE       T 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 190 KSDVWSFGILLTEIV 204

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 76
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 77  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 132
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL  ++ +  T R G      + APE       T 
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEAINYGTFTI 190
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 191 KSDVWSFGILLTEIV 205

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 442 YEDLINATEDF---------HIKYCIGTGGYGSVYKAELP-EGK---VVALKKLHHSETE 488
           YED   A   F          I+  IG G +G V    L   GK    VA+K L    TE
Sbjct: 26  YEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTE 85
Query: 489 DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE 548
                + F  EA ++    H N+V L G     K + ++ E+ME G+L   L   D   +
Sbjct: 86  KQR--RDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG--Q 141
Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
               + V +++ +A  + YL     +  +HRD+++ NIL++SNL   V+DFG +R++  D
Sbjct: 142 FTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198
Query: 609 SSYRTLRAG---TYGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
                   G      + APE       T   DV+S+G+V  EV+  G  P
Sbjct: 199 PEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 6/206 (2%)
Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF +   +G G +  VY+AE +  G  VA+K +       +  V+  QNE  +   ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +I++LY +      ++L+ E    G +   L +  +    N  +  + +  +   + YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIITGMLYL 128
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  I+HRD++ +N+LL  N+   +ADFG A  L +         GT  YI+PE+A 
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                 + DV+S G +   +L+G  P
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPP 211

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G +G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 71
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 72  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 127
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HR++ + NIL+   L   +ADFG ARL+  D+ Y T R G      + APE       T 
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIE-DNEY-TAREGAKFPIKWTAPEAINYGTFTI 185
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 186 KSDVWSFGILLTEIV 200

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHH---SETEDSAFVKSFQNEAHVLS 504
            ED+ + Y IGTG YG   K     +GK++  K+L +   +E E    V    +E ++L 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV----SEVNLLR 60
Query: 505 TVRHRNIVKLYGFCLHKK--CMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVK 559
            ++H NIV+ Y   + +    ++++ EY E G L  V+     + + ++  +  RV    
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
           ++A    +   D   +++HRD+   N+ LD      + DFG AR+L+ D  +     GT 
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTP 180
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEV 648
            Y++PE    +    K D++S G +  E+
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G  G V+         VA+K L        AF+     EA+++  ++H+ +V+LY  
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 75
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
            + ++ +++I EYME GSL   L      I+L   K +++   +A  ++++      + I
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+ + NIL+   L   +ADFG ARL  ++ +  T R G      + APE       T 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL--IEDAEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFG++  E++
Sbjct: 190 KSDVWSFGILLTEIV 204

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 129/268 (48%), Gaps = 30/268 (11%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+ A   +   VA+K +       S  V++F  EA+V+ T++H 
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHD 237
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +VKL+   + K+ +++I E+M +GSL   L  D E  +    K ++    +A  ++++ 
Sbjct: 238 KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                + IHRD+ + NIL+ ++L   +ADFG AR   V + +         + APE    
Sbjct: 296 QR---NYIHRDLRAANILVSASLVCKIADFGLAR---VGAKF------PIKWTAPEAINF 343
Query: 630 IVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIV 688
              T K DV+SFG++ +E++  G  P            P++  I  L +    P  +   
Sbjct: 344 GSFTIKSDVWSFGILLMEIVTYGRIP------YPGMSNPEV--IRALERGYRMPRPENCP 395
Query: 689 QDIILVSTIAFACLSSQPKSRPTMQRIS 716
           +++     I   C  ++P+ RPT + I 
Sbjct: 396 EELY---NIMMRCWKNRPEERPTFEYIQ 420

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 28/261 (10%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 72
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           C  ++ +F+I EYM  G L   L +     +    + + + K V  A+ YL    +   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 127
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELAYTIVVTGK 635
           HRD+++ N L++      V+DFG +R + +D  Y + R   +   +  PE+      + K
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 636 CDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPP--VNQKIVQDII 692
            D+++FGV+  E+  +G  P                L      RL  P   ++K      
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK------ 234
Query: 693 LVSTIAFACLSSQPKSRPTMQ 713
            V TI ++C   +   RPT +
Sbjct: 235 -VYTIMYSCWHEKADERPTFK 254

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 35/287 (12%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+K  +    +VVA+K +   E      ++  Q E  VLS      + K YG
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    +++I EY+  GS   +L     A   +  +   ++K +   L YLH +     
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEKK--- 141
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI + N+LL    +  +ADFG A  L      R    GT  ++APE+        K 
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 201
Query: 637 DVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVST 696
           D++S G+ A+E+  G  P               M +  L  + +PP    +V D     T
Sbjct: 202 DIWSLGITAIELAKGEPPNSDMHP---------MRVLFLIPKNNPPT---LVGDF----T 245
Query: 697 IAF-----ACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
            +F     ACL+  P  RPT    ++ELL  K  ++ + K   ++EL
Sbjct: 246 KSFKEFIDACLNKDPSFRPT----AKELLKHKFIVKNSKKTSYLTEL 288

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 128/278 (46%), Gaps = 30/278 (10%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHH-SETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G +G V   +      VA+K +   S +ED  F      EA  +  + H  +VK YG
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFF-----QEAQTMMKLSHPKLVKFYG 70
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
            C  +  ++++ EY+  G L   L    + +E   ++ + +   V   +++L    +   
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP--SQLLEMCYDVCEGMAFLE---SHQF 125
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELAYTIVVTG 634
           IHRD+++ N L+D +L   V+DFG  R + +D  Y +     +   + APE+ +    + 
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 635 KCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIIL 693
           K DV++FG++  EV  +G  P             +++L      RL  P    +  D I 
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGHRLYRP---HLASDTIY 235
Query: 694 VSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALK 731
              I ++C    P+ RPT     Q+LL+   P+++  K
Sbjct: 236 --QIMYSCWHELPEKRPTF----QQLLSSIEPLREKDK 267

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 458 IGTGGYGSVYKAELPEG------KVVALKKLHHSETED-----SAFVKSFQNEAHVLSTV 506
           +G+G YG V   +   G      KV+   +       D       F +   NE  +L ++
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL---HDDDEAIELNWTKRVNIVKSVAH 563
            H NI+KL+     KK  +L+ E+ E G LF  +   H  DE          NI+K +  
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC------DAANIMKQILS 157
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSN---LEASVADFGTARLLHVDSSYRTLRAGTYG 620
            + YLH     +I+HRDI   NILL++    L   + DFG +     D   R  R GT  
Sbjct: 158 GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD-RLGTAY 213
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           YIAPE+        KCDV+S GV+   +L G  P
Sbjct: 214 YIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 134/302 (44%), Gaps = 33/302 (10%)
Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +D+ ++  IG+G    V  A   P+ + VA+K+++  + + S  +     E   +S   H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHH 72
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLF-----CVLHDDDEAIELNWTKRVNIVKSVAH 563
            NIV  Y   + K  ++L+ + +  GS+       V   + ++  L+ +    I++ V  
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-----SSYRTLRAGT 618
            L YLH +     IHRD+ + NILL  +    +ADFG +  L        +  R    GT
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 619 YGYIAPELAYTIV-VTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQ 677
             ++APE+   +     K D++SFG+ A+E+  G  P             K++++ + N 
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM------KVLMLTLQN- 242
Query: 678 RLSPPVNQKIVQDIILVSTIAFA-------CLSSQPKSRPTMQRISQELLAGKTPMQKAL 730
              PP  +  VQD  ++     +       CL   P+ RPT   + +     K   ++ L
Sbjct: 243 --DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFL 300
Query: 731 KE 732
           +E
Sbjct: 301 QE 302

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E +H    IG G YG VYKA+   G+  ALKK+   E ED     +   E  +L  ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHS 60
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERG--SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           NIVKLY     KK + L++E++++    L  V     E++        + +  + + ++Y
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAY 115
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-L 626
            H      ++HRD+   N+L++   E  +ADFG AR   +     T    T  Y AP+ L
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGT 652
             +   +   D++S G +  E++ GT
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E +H    IG G YG VYKA+   G+  ALKK+   E ED     +   E  +L  ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHS 60
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERG--SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           NIVKLY     KK + L++E++++    L  V     E++        + +  + + ++Y
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAY 115
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-L 626
            H      ++HRD+   N+L++   E  +ADFG AR   +     T    T  Y AP+ L
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGT 652
             +   +   D++S G +  E++ GT
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 458 IGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           IG G +G V++A  P         +VA+K L    + D      FQ EA +++   + NI
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDNPNI 112
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSL-----------FCVLHDDDEAIE----------LN 550
           VKL G C   K M L++EYM  G L            C L   D +            L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 551 WTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS 610
             +++ I + VA  ++YL        +HRD+++ N L+  N+   +ADFG +R ++    
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 611 YRTL--RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
           Y+     A    ++ PE  +    T + DV+++GVV  E+ 
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 126/281 (44%), Gaps = 33/281 (11%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +D+ ++  IG+G    V  A   P+ + VA+K+++  + + S  +     E   +S   H
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHH 67
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLF-----CVLHDDDEAIELNWTKRVNIVKSVAH 563
            NIV  Y   + K  ++L+ + +  GS+       V   + ++  L+ +    I++ V  
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD-----SSYRTLRAGT 618
            L YLH +     IHRD+ + NILL  +    +ADFG +  L        +  R    GT
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 619 YGYIAPELAYTIV-VTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQ 677
             ++APE+   +     K D++SFG+ A+E+  G  P             K++++ + N 
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM------KVLMLTLQN- 237
Query: 678 RLSPPVNQKIVQDIILVSTIAFA-------CLSSQPKSRPT 711
              PP  +  VQD  ++     +       CL   P+ RPT
Sbjct: 238 --DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 276

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSF-QNEAHVLSTVRHRNIVKLY 515
           +G G YG V K    + G++VA+KK    E++D   VK     E  +L  +RH N+V L 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKF--LESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE--LNWTKRVNIVKSVAHALSYLHHDCT 573
             C  KK  +L++E+++   L     DD E     L++      +  + + + + H   +
Sbjct: 91  EVCKKKKRWYLVFEFVDHTIL-----DDLELFPNGLDYQVVQKYLFQIINGIGFCH---S 142
Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVT 633
            +IIHRDI   NIL+  +    + DFG AR L            T  Y APEL    V  
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 634 GKC-DVYSFGVVALEVLMG 651
           GK  DV++ G +  E+ MG
Sbjct: 203 GKAVDVWAIGCLVTEMFMG 221

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 133/289 (46%), Gaps = 40/289 (13%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK---KLHHSETEDSAFVKSFQNEA 500
           ++  TE   +K  +G+G +G+VYK   +PEG+ V +    K+ +  T   A V+ F +EA
Sbjct: 34  ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEA 91
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRVN 556
            +++++ H ++V+L G CL    + L+ + M  G L   +H+  + I     LNW  ++ 
Sbjct: 92  LIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI- 149
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
                A  + YL       ++HRD+++ N+L+ S     + DFG ARLL  D        
Sbjct: 150 -----AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 201
Query: 617 GTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLID 673
           G     ++A E  +    T + DV+S+GV   E++  G  P            P   + D
Sbjct: 202 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP--------YDGIPTREIPD 253
Query: 674 VLN--QRL-SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +L   +RL  PP+        I V  +   C      SRP  + ++ E 
Sbjct: 254 LLEKGERLPQPPIC------TIDVYMVMVKCWMIDADSRPKFKELAAEF 296

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 123/265 (46%), Gaps = 24/265 (9%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G V  A E   GK VA+KK+   + +    +    NE  ++    H N+V +Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF---NEVVIMRDYHHDNVVDMYS 109
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    ++++ E++E G+L  ++        +N  +   +  SV  ALSYLH+     +
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ---GV 162
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI S++ILL S+    ++DFG    +  +   R    GT  ++APE+   +    + 
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 637 DVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVST 696
           D++S G++ +E++ G  P            P +  +  +   L P      V+D+  VS+
Sbjct: 223 DIWSLGIMVIEMIDGEPP--------YFNEPPLQAMRRIRDSLPPR-----VKDLHKVSS 269
Query: 697 IAFACLSSQPKSRPTMQRISQELLA 721
           +    L       P+ +  +QELL 
Sbjct: 270 VLRGFLDLMLVREPSQRATAQELLG 294

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+++++  +      +    NE  V+   ++ NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 84
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDD--DEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
             L    ++++ EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN--- 135
Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            +IHRDI S+NILL  +    + DFG    +  + S R+   GT  ++APE+        
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 195
Query: 635 KCDVYSFGVVALEVLMGTHP 654
           K D++S G++A+E++ G  P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+++++  +      +    NE  V+   ++ NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 84
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDD--DEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
             L    ++++ EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN--- 135
Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            +IHRDI S+NILL  +    + DFG    +  + S R+   GT  ++APE+        
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 635 KCDVYSFGVVALEVLMGTHP 654
           K D++S G++A+E++ G  P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G V+         VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 73
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           CL +  + L++E+ME G L   L              + +   V   ++YL   C   +I
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 128
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+++ N L+  N    V+DFG  R + +D  Y T   GT     + +PE+      + 
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQY-TSSTGTKFPVKWASPEVFSFSRYSS 186
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFGV+  EV 
Sbjct: 187 KSDVWSFGVLMWEVF 201

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+++++  +      +    NE  V+   ++ NIV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 85
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDD--DEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
             L    ++++ EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN--- 136
Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            +IHRDI S+NILL  +    + DFG    +  + S R+   GT  ++APE+        
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 196
Query: 635 KCDVYSFGVVALEVLMGTHP 654
           K D++S G++A+E++ G  P
Sbjct: 197 KVDIWSLGIMAIEMIEGEPP 216

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 133/289 (46%), Gaps = 40/289 (13%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK---KLHHSETEDSAFVKSFQNEA 500
           ++  TE   +K  +G+G +G+VYK   +PEG+ V +    K+ +  T   A V+ F +EA
Sbjct: 11  ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEA 68
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRVN 556
            +++++ H ++V+L G CL    + L+ + M  G L   +H+  + I     LNW  ++ 
Sbjct: 69  LIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI- 126
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
                A  + YL       ++HRD+++ N+L+ S     + DFG ARLL  D        
Sbjct: 127 -----AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 178
Query: 617 GTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLID 673
           G     ++A E  +    T + DV+S+GV   E++  G  P            P   + D
Sbjct: 179 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP--------YDGIPTREIPD 230
Query: 674 VLN--QRL-SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +L   +RL  PP+        I V  +   C      SRP  + ++ E 
Sbjct: 231 LLEKGERLPQPPIC------TIDVYMVMVKCWMIDADSRPKFKELAAEF 273

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G V+         VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIE----EAEVMMKLSHPKLVQLYGV 90
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           CL +  + L++E+ME G L   L              + +   V   ++YL   C   +I
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 145
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+++ N L+  N    V+DFG  R + +D  Y T   GT     + +PE+      + 
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQY-TSSTGTKFPVKWASPEVFSFSRYSS 203
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFGV+  EV 
Sbjct: 204 KSDVWSFGVLMWEVF 218

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G V+         VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 70
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           CL +  + L++E+ME G L   L              + +   V   ++YL   C   +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 125
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+++ N L+  N    V+DFG  R + +D  Y T   GT     + +PE+      + 
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQY-TSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFGV+  EV 
Sbjct: 184 KSDVWSFGVLMWEVF 198

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G V+         VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 68
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           CL +  + L++E+ME G L   L              + +   V   ++YL   C   +I
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 123
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+++ N L+  N    V+DFG  R + +D  Y T   GT     + +PE+      + 
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQY-TSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFGV+  EV 
Sbjct: 182 KSDVWSFGVLMWEVF 196

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 122/282 (43%), Gaps = 25/282 (8%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G VYK  +    +VVA+K +   E      ++  Q E  VLS      I + +G
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    +++I EY+  GS   +L    +   L  T    I++ +   L YLH +     
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 137
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI + N+LL    +  +ADFG A  L      R    GT  ++APE+        K 
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKA 197
Query: 637 DVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVST 696
           D++S G+ A+E+  G  P               M +  L  + SPP  +   Q       
Sbjct: 198 DIWSLGITAIELAKGEPPNSDLHP---------MRVLFLIPKNSPPTLEG--QHSKPFKE 246
Query: 697 IAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISEL 738
              ACL+  P+ RPT    ++ELL  K   +   K   ++EL
Sbjct: 247 FVEACLNKDPRFRPT----AKELLKHKFITRYTKKTSFLTEL 284

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+++++  +      +    NE  V+   ++ NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 84
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDD--DEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
             L    ++++ EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN--- 135
Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            +IHRDI S+NILL  +    + DFG    +  + S R+   GT  ++APE+        
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGP 195
Query: 635 KCDVYSFGVVALEVLMGTHP 654
           K D++S G++A+E++ G  P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E +H    IG G YG VYKA+   G+  ALKK+   E ED     +   E  +L  ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHS 60
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERG--SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           NIVKLY     KK + L++E++++    L  V     E++        + +  + + ++Y
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAY 115
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-L 626
            H      ++HRD+   N+L++   E  +ADFG AR   +     T    T  Y AP+ L
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGT 652
             +   +   D++S G +  E++ G 
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGA 198

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 457 CIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
            IG G +  V  A  +  GK VA+K +  ++   S+  K F+ E  ++  + H NIVKL+
Sbjct: 14  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 72
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI---VKSVAHALSYLHHDC 572
                +K ++L+ EY   G +F      D  +   W K        + +  A+ Y H   
Sbjct: 73  EVIETEKTLYLVMEYASGGEVF------DYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
              I+HRD+ + N+LLD+++   +ADFG +      +   T   G+  Y APEL      
Sbjct: 127 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQGKKY 182
Query: 633 TG-KCDVYSFGVVALEVLMGTHP 654
            G + DV+S GV+   ++ G+ P
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLP 205

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 118/281 (41%), Gaps = 52/281 (18%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G V+         VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 70
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           CL +  + L++E+ME G L   L              + +   V   ++YL      S+I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEE---ASVI 125
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+++ N L+  N    V+DFG  R + +D  Y T   GT     + +PE+      + 
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQY-TSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 635 KCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDII- 692
           K DV+SFGV+  EV   G  P                             N ++V+DI  
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRS------------------------NSEVVEDIST 219
Query: 693 --------LVSTIAFA----CLSSQPKSRPTMQRISQELLA 721
                   L ST  +     C   +P+ RP   R+ ++L A
Sbjct: 220 GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAA 260

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 28/261 (10%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           C  ++ +F+I EYM  G L   L +     +    + + + K V  A+ YL    +   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 142
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELAYTIVVTGK 635
           HRD+++ N L++      V+DFG +R + +D  Y +     +   +  PE+      + K
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 636 CDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPP--VNQKIVQDII 692
            D+++FGV+  E+  +G  P                L      RL  P   ++K      
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK------ 249
Query: 693 LVSTIAFACLSSQPKSRPTMQ 713
            V TI ++C   +   RPT +
Sbjct: 250 -VYTIMYSCWHEKADERPTFK 269

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 28/261 (10%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 72
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           C  ++ +F+I EYM  G L   L +     +    + + + K V  A+ YL    +   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 127
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELAYTIVVTGK 635
           HRD+++ N L++      V+DFG +R + +D  Y +     +   +  PE+      + K
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 636 CDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPP--VNQKIVQDII 692
            D+++FGV+  E+  +G  P                L      RL  P   ++K      
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK------ 234
Query: 693 LVSTIAFACLSSQPKSRPTMQ 713
            V TI ++C   +   RPT +
Sbjct: 235 -VYTIMYSCWHEKADERPTFK 254

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 112/275 (40%), Gaps = 24/275 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           ED  +   IG G +G V+   L  +  +VA+K     ET        F  EA +L    H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR--ETLPPDLKAKFLQEARILKQYSH 171
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIV+L G C  K+ ++++ E ++ G     L    E   L     + +V   A  + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT---LRAGTYGYIAPE 625
              C    IHRD+++ N L+       ++DFG +R    D  Y     LR     + APE
Sbjct: 230 ESKCC---IHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPE 285
Query: 626 LAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVN 684
                  + + DV+SFG++  E   +G  P             +         RL  P  
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK------GGRLPCP-- 337
Query: 685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            ++  D +    +   C + +P  RP+   I QEL
Sbjct: 338 -ELCPDAVF--RLMEQCWAYEPGQRPSFSTIYQEL 369

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 14/214 (6%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF I   IG G +  V   ++ + G+V A+K ++  +      V  F+ E  VL     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           R I +L+     +  ++L+ EY   G L  +L    E I     +    +  +  A+  +
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR--FYLAEIVMAIDSV 178
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GTYGYIAPELA 627
           H    L  +HRDI  +NILLD      +ADFG+   L  D + R+L A GT  Y++PE+ 
Sbjct: 179 HR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 628 YTIVVTG-------KCDVYSFGVVALEVLMGTHP 654
             +           +CD ++ GV A E+  G  P
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 28/261 (10%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 78
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           C  ++ +F+I EYM  G L   L +     +    + + + K V  A+ YL    +   +
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 133
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELAYTIVVTGK 635
           HRD+++ N L++      V+DFG +R + +D  Y +     +   +  PE+      + K
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192
Query: 636 CDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPP--VNQKIVQDII 692
            D+++FGV+  E+  +G  P                L      RL  P   ++K      
Sbjct: 193 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK------ 240
Query: 693 LVSTIAFACLSSQPKSRPTMQ 713
            V TI ++C   +   RPT +
Sbjct: 241 -VYTIMYSCWHEKADERPTFK 260

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 28/261 (10%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 71
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           C  ++ +F+I EYM  G L   L +     +    + + + K V  A+ YL    +   +
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 126
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELAYTIVVTGK 635
           HRD+++ N L++      V+DFG +R + +D  Y +     +   +  PE+      + K
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 636 CDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPP--VNQKIVQDII 692
            D+++FGV+  E+  +G  P                L      RL  P   ++K      
Sbjct: 186 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK------ 233
Query: 693 LVSTIAFACLSSQPKSRPTMQ 713
            V TI ++C   +   RPT +
Sbjct: 234 -VYTIMYSCWHEKADERPTFK 253

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           ++ + +   +G GG   V+ A +L + + VA+K L      D +F   F+ EA   + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 508 HRNIVKLYGFCLHKKCM----FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           H  IV +Y     +       +++ EY++  +L  ++H +     +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTY 619
           AL++ H +    IIHRD+   NIL+ +     V DFG AR +  DS     +     GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAI-ADSGNSVXQTAAVIGTA 183
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            Y++PE A    V  + DVYS G V  EVL G  P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELPE-----GKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+KY   +G G +GSV            G +VA+K+L HS  +     + FQ E  +
Sbjct: 9   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 65
Query: 503 LSTVRHRNIVKLYG--FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L  +    IVK  G  +   ++ + L+ EY+  G L   L        L+ ++ +     
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQ 123
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    +   +HRD+++ NIL++S     +ADFG A+LL +D  Y  +R     
Sbjct: 124 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 180
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE     + + + DV+SFGVV  E+ 
Sbjct: 181 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           ++ + +   +G GG   V+ A +L + + VA+K L      D +F   F+ EA   + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 508 HRNIVKLYGFCLHKKCM----FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           H  IV +Y     +       +++ EY++  +L  ++H +     +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA---GTYG 620
           AL++ H +    IIHRD+   NI++ +     V DFG AR +    +  T  A   GT  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y++PE A    V  + DVYS G V  EVL G  P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE+   +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEED--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I EY  +G+L   L           +D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR ++    Y+   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 270 KLLKEGHRMDKPAN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           ++ + +   +G GG   V+ A +L + + VA+K L      D +F   F+ EA   + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 508 HRNIVKLYGFCLHKKCM----FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           H  IV +Y     +       +++ EY++  +L  ++H +     +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA---GTYG 620
           AL++ H +    IIHRD+   NI++ +     V DFG AR +    +  T  A   GT  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y++PE A    V  + DVYS G V  EVL G  P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELPE-----GKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+KY   +G G +GSV            G +VA+K+L HS  +     + FQ E  +
Sbjct: 8   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 64
Query: 503 LSTVRHRNIVKLYG--FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L  +    IVK  G  +   ++ + L+ EY+  G L   L        L+ ++ +     
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQ 122
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    +   +HRD+++ NIL++S     +ADFG A+LL +D  Y  +R     
Sbjct: 123 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 179
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE     + + + DV+SFGVV  E+ 
Sbjct: 180 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 129/285 (45%), Gaps = 52/285 (18%)
Query: 458 IGTGGYGSVYKAEL----PEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRN 510
           +G G +G V +A       E  V  VA+K L  +   D    ++  +E  ++S + +H N
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 103
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-------DDDEAIELNWTKRVNIVKSVAH 563
           IV L G C H   + +I EY   G L   L        D ++   L     ++    VA 
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT--YGY 621
            +++L    + + IHRD+++ N+LL +   A + DFG AR +  DS+Y           +
Sbjct: 164 GMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLS 680
           +APE  +  V T + DV+S+G++  E+  +G +P            P I+    +N +  
Sbjct: 221 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-----------YPGIL----VNSKFY 265
Query: 681 PPVNQKIVQDIILVSTIAF----------ACLSSQPKSRPTMQRI 715
                K+V+D   ++  AF          AC + +P  RPT Q+I
Sbjct: 266 -----KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 120/293 (40%), Gaps = 24/293 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          +  F  E + + +
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           + HRN+++LYG  L    M ++ E    GSL   L        L    R  +   VA  +
Sbjct: 72  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 128
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---RAGTYGYI 622
            YL    +   IHRD+++ N+LL +     + DFG  R L  +  +  +   R   + + 
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
           APE   T   +   D + FGV   E+   G  P              +  ID   +RL  
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGERLPR 240
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEIS 734
           P  +   QDI     +   C + +P+ RPT   +   LL  +    +AL++  
Sbjct: 241 P--EDCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRALQDFE 288

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 54/297 (18%)
Query: 457 CIGTGGYGSVYKAELPEGK------VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
            +G G +G V KA     K       VA+K L   E    + ++   +E +VL  V H +
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNVLKQVNHPH 87
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------------------HDDDEAI 547
           ++KLYG C     + LI EY + GSL   L                       H D+ A+
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 548 ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
            +     ++    ++  + YL     + ++HRD+++ NIL+    +  ++DFG +R ++ 
Sbjct: 148 TMG--DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 608 DSSYRTLRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXX 664
           + SY     G     ++A E  +  + T + DV+SFGV+  E++ +G +P          
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--------YP 254
Query: 665 XXPKIMLIDVLN--QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             P   L ++L    R+  P N    +++     +   C   +P  RP    IS++L
Sbjct: 255 GIPPERLFNLLKTGHRMERPDN--CSEEMY---RLMLQCWKQEPDKRPVFADISKDL 306

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 113/274 (41%), Gaps = 22/274 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           ED  +   IG G +G V+   L  +  +VA+K     ET        F  EA +L    H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR--ETLPPDLKAKFLQEARILKQYSH 171
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIV+L G C  K+ ++++ E ++ G     L    E   L     + +V   A  + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH--VDSSYRTLRAGTYGYIAPEL 626
              C    IHRD+++ N L+       ++DFG +R     V ++   LR     + APE 
Sbjct: 230 ESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEA 286
Query: 627 AYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQ 685
                 + + DV+SFG++  E   +G  P             +         RL  P   
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK------GGRLPCP--- 337
Query: 686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           ++  D +    +   C + +P  RP+   I QEL
Sbjct: 338 ELCPDAVF--RLMEQCWAYEPGQRPSFSTIYQEL 369

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 28/261 (10%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 67
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           C  ++ +F+I EYM  G L   L +     +    + + + K V  A+ YL    +   +
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 122
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAPELAYTIVVTGK 635
           HRD+++ N L++      V+DFG +R + +D  Y +     +   +  PE+      + K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 636 CDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPP--VNQKIVQDII 692
            D+++FGV+  E+  +G  P                L      RL  P   ++K      
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK------ 229
Query: 693 LVSTIAFACLSSQPKSRPTMQ 713
            V TI ++C   +   RPT +
Sbjct: 230 -VYTIMYSCWHEKADERPTFK 249

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 14/195 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG+G +G V+         VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 71
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           CL +  + L+ E+ME G L   L              + +   V   ++YL   C   +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 126
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTG 634
           HRD+++ N L+  N    V+DFG  R + +D  Y T   GT     + +PE+      + 
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQY-TSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 635 KCDVYSFGVVALEVL 649
           K DV+SFGV+  EV 
Sbjct: 185 KSDVWSFGVLMWEVF 199

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G+VY A ++  G+ VA+++++  +      +    NE  V+   ++ NIV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 85
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDD--DEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
             L    ++++ EY+  GSL  V+ +   DE       +   + +    AL +LH +   
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLHSN--- 136
Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            +IHR+I S+NILL  +    + DFG    +  + S R+   GT  ++APE+        
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 196
Query: 635 KCDVYSFGVVALEVLMGTHP 654
           K D++S G++A+E++ G  P
Sbjct: 197 KVDIWSLGIMAIEMIEGEPP 216

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELPE-----GKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+KY   +G G +GSV            G +VA+K+L HS  +     + FQ E  +
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 77
Query: 503 LSTVRHRNIVKLYG--FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L  +    IVK  G  +   ++ + L+ EY+  G L   L        L+ ++ +     
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQ 135
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    +   +HRD+++ NIL++S     +ADFG A+LL +D  Y  +R     
Sbjct: 136 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE     + + + DV+SFGVV  E+ 
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 129/285 (45%), Gaps = 52/285 (18%)
Query: 458 IGTGGYGSVYKAEL----PEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRN 510
           +G G +G V +A       E  V  VA+K L  +   D    ++  +E  ++S + +H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 111
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-------DDDEAIELNWTKRVNIVKSVAH 563
           IV L G C H   + +I EY   G L   L        D ++   L     ++    VA 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT--YGY 621
            +++L    + + IHRD+++ N+LL +   A + DFG AR +  DS+Y           +
Sbjct: 172 GMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLS 680
           +APE  +  V T + DV+S+G++  E+  +G +P            P I+    +N +  
Sbjct: 229 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-----------YPGIL----VNSKFY 273
Query: 681 PPVNQKIVQDIILVSTIAF----------ACLSSQPKSRPTMQRI 715
                K+V+D   ++  AF          AC + +P  RPT Q+I
Sbjct: 274 -----KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQ-NEAHVLSTVRHRNIVKLY 515
           IG G YG V+K    + G++VA+KK    E+ED   +K     E  +L  ++H N+V L 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKF--LESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR---VNIVKSVA----HALSYL 568
                K+ + L++EY +      VLH      EL+  +R    ++VKS+      A+++ 
Sbjct: 69  EVFRRKRRLHLVFEYCDH----TVLH------ELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 569 H-HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           H H+C    IHRD+   NIL+  +    + DFG ARLL   S Y      T  Y +PEL 
Sbjct: 119 HKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL 174
Query: 628 YTIVVTG-KCDVYSFGVVALEVLMGT 652
                 G   DV++ G V  E+L G 
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 449 TEDFHIKYCIGTGGYGSV----YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
            ED+ +   IG G +G V    +KA      +  L K    +  DSAF   F  E  +++
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAF---FWEERDIMA 130
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
                 +V+L+      K ++++ EYM  G L  ++ + D  +   W K       V  A
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFY--TAEVVLA 186
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR------LLHVDSSYRTLRAGT 618
           L  +H   ++ +IHRD+  +N+LLD +    +ADFGT        ++H D++      GT
Sbjct: 187 LDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-----VGT 238
Query: 619 YGYIAPELAYTIVVTG----KCDVYSFGVVALEVLMGTHP 654
             YI+PE+  +    G    +CD +S GV   E+L+G  P
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I EY  +G+L   L           +D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR ++    Y+   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 270 KLLKEGHRMDKPAN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 9/198 (4%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +GT G   V K EL  G  VA+K L+  +      V   + E   L   RH +I+KLY  
Sbjct: 26  VGTFGKVKVGKHEL-TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
                 +F++ EY+  G LF  +  +     L+  +   + + +   + Y H      ++
Sbjct: 85  ISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHM---VV 138
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG-KC 636
           HRD+   N+LLD+++ A +ADFG + ++  D  +     G+  Y APE+    +  G + 
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXSCGSPNYAAPEVISGRLYAGPEV 197
Query: 637 DVYSFGVVALEVLMGTHP 654
           D++S GV+   +L GT P
Sbjct: 198 DIWSSGVILYALLCGTLP 215

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ +   IG G +  V  A  +  G+ VA+K +  ++   ++  K F+ E  ++  + H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 71
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKL+     +K ++LI EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---RQIVSAVQYCH 128
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+ + N+LLD+++   +ADFG +    V     T   G+  Y APEL   
Sbjct: 129 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTF-CGSPPYAAPELFQG 184
Query: 630 IVVTG-KCDVYSFGVVALEVLMGTHP 654
               G + DV+S GV+   ++ G+ P
Sbjct: 185 KKYDGPEVDVWSLGVILYTLVSGSLP 210

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G +G V   E    G  VA+K L+  +      V   + E   L   RH +I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
                   F++ EY+  G LF  +       E+   +   + + +  A+ Y H      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSAVDYCHRHM---V 132
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG-K 635
           +HRD+   N+LLD+++ A +ADFG + ++  D  +     G+  Y APE+    +  G +
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSCGSPNYAAPEVISGRLYAGPE 191
Query: 636 CDVYSFGVVALEVLMGTHP 654
            D++S GV+   +L GT P
Sbjct: 192 VDIWSCGVILYALLCGTLP 210

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 106/205 (51%), Gaps = 13/205 (6%)
Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           D ++K  IG G  G V  A E   G+ VA+K +   + +    +    NE  ++   +H 
Sbjct: 48  DSYVK--IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF---NEVVIMRDYQHF 102
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V++Y   L  + ++++ E+++ G+L  ++      + LN  +   + ++V  AL+YLH
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLH 158
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 +IHRDI S++ILL  +    ++DFG    +  D   R    GT  ++APE+   
Sbjct: 159 AQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISR 215
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
            +   + D++S G++ +E++ G  P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +    +  F NE  ++   +H N+V++Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--F-NEVVIMRDYQHENVVEMYN 215
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    ++++ E++E G+L  ++        +N  +   +  +V  ALS LH      +
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGV 268
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI S++ILL  +    ++DFG    +  +   R    GT  ++APEL   +    + 
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 637 DVYSFGVVALEVLMGTHP 654
           D++S G++ +E++ G  P
Sbjct: 329 DIWSLGIMVIEMVDGEPP 346

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 114/260 (43%), Gaps = 26/260 (10%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +GTG +G V   +      VA+K +      +  F++    EA V+  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 518 CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSII 577
           C  ++ +F+I EYM  G L   L +     +    + + + K V  A+ YL    +   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 142
Query: 578 HRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG-TYGYIAPELAYTIVVTGKC 636
           HRD+++ N L++      V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 637 DVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPP--VNQKIVQDIIL 693
           D+++FGV+  E+  +G  P                L      RL  P   ++K       
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK------- 249
Query: 694 VSTIAFACLSSQPKSRPTMQ 713
           V TI ++C   +   RPT +
Sbjct: 250 VYTIMYSCWHEKADERPTFK 269

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I EY  +G+L   L           +D +   E   T +  V
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR ++    Y+   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 270 KLLKEGHRMDKPAN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I EY  +G+L   L           +D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR ++    Y+   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 270 KLLKEGHRMDKPAN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ ++  IG G +  V  A  +  G+ VA+K +  ++   ++  K F+ E  ++  + H 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKL+     +K ++L+ EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 131
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+ + N+LLD ++   +ADFG +    V +   T   G+  Y APEL   
Sbjct: 132 QKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTF-CGSPPYAAPELFQG 187
Query: 630 IVVTG-KCDVYSFGVVALEVLMGTHP 654
               G + DV+S GV+   ++ G+ P
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +         NE  ++   +H N+V++Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 95
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    ++++ E++E G+L  ++        +N  +   +  +V  ALS LH      +
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GV 148
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI S++ILL  +    ++DFG    +  +   R    GT  ++APEL   +    + 
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 637 DVYSFGVVALEVLMGTHP 654
           D++S G++ +E++ G  P
Sbjct: 209 DIWSLGIMVIEMVDGEPP 226

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I EY  +G+L   L           +D +   E   T +  V
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR ++    Y+   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 270 KLLKEGHRMDKPAN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +    +    NE  ++   +H N+V++Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF---NEVVIMRDYQHENVVEMYN 93
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    ++++ E++E G+L  ++        +N  +   +  +V  ALS LH      +
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GV 146
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI S++ILL  +    ++DFG    +  +   R    GT  ++APEL   +    + 
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 637 DVYSFGVVALEVLMGTHP 654
           D++S G++ +E++ G  P
Sbjct: 207 DIWSLGIMVIEMVDGEPP 224

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ +   IG G +  V  A  +  GK VA+K +  ++   S+  K F+ E  ++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKL+     +K ++L+ EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 130
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+ + N+LLD+++   +ADFG +      +   T   G+  Y APEL   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQG 186
Query: 630 IVVTG-KCDVYSFGVVALEVLMGTHP 654
               G + DV+S GV+   ++ G+ P
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           ++ + +   +G GG   V+ A +L   + VA+K L      D +F   F+ EA   + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 508 HRNIVKLYGFCLHKKCM----FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           H  IV +Y     +       +++ EY++  +L  ++H +     +   + + ++     
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA---GTYG 620
           AL++ H +    IIHRD+   NI++ +     V DFG AR +    +  T  A   GT  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y++PE A    V  + DVYS G V  EVL G  P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 458 IGTGGYGSVY----KAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G YG V     K    E  +  ++K   S + +S  ++    E  VL  + H NI+K
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE----EVAVLKLLDHPNIMK 100
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFC-VLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
           LY F   K+  +L+ E  + G LF  ++H     ++ N      I+K V   ++YLH   
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH- 155
Query: 573 TLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
             +I+HRD+   N+LL+S  + +   + DFG + +       +  R GT  YIAPE+   
Sbjct: 156 --NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE-RLGTAYYIAPEVLRK 212
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
                KCDV+S GV+   +L G  P
Sbjct: 213 -KYDEKCDVWSIGVILFILLAGYPP 236

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +         NE  ++   +H N+V++Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 84
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    ++++ E++E G+L  ++        +N  +   +  +V  ALS LH      +
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GV 137
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI S++ILL  +    ++DFG    +  +   R    GT  ++APEL   +    + 
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 637 DVYSFGVVALEVLMGTHP 654
           D++S G++ +E++ G  P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ +   IG G +  V  A  +  GK VA+K +  ++   S+  K F+ E  ++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKL+     +K ++L+ EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 130
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+ + N+LLD+++   +ADFG +      +   T   G+  Y APEL   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQG 186
Query: 630 IVVTG-KCDVYSFGVVALEVLMGTHP 654
               G + DV+S GV+   ++ G+ P
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +    +    NE  ++   +H N+V++Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF---NEVVIMRDYQHENVVEMYN 138
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    ++++ E++E G+L  ++        +N  +   +  +V  ALS LH      +
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGV 191
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI S++ILL  +    ++DFG    +  +   R    GT  ++APEL   +    + 
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 637 DVYSFGVVALEVLMGTHP 654
           D++S G++ +E++ G  P
Sbjct: 252 DIWSLGIMVIEMVDGEPP 269

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 54/297 (18%)
Query: 457 CIGTGGYGSVYKAELPEGK------VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
            +G G +G V KA     K       VA+K L   E    + ++   +E +VL  V H +
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNVLKQVNHPH 87
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------------------HDDDEAI 547
           ++KLYG C     + LI EY + GSL   L                       H D+ A+
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 548 ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
            +     ++    ++  + YL     +S++HRD+++ NIL+    +  ++DFG +R ++ 
Sbjct: 148 TMG--DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 608 DSSYRTLRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXX 664
           + S      G     ++A E  +  + T + DV+SFGV+  E++ +G +P          
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--------YP 254
Query: 665 XXPKIMLIDVLN--QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             P   L ++L    R+  P N    +++     +   C   +P  RP    IS++L
Sbjct: 255 GIPPERLFNLLKTGHRMERPDN--CSEEMY---RLMLQCWKQEPDKRPVFADISKDL 306

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAE---LPEGKV-----VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE   L + K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 78
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCVLHDDDEAIELNWTKRV 555
           +NI+ L G C     +++I EY  +G+L             +C     +   +L+    V
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR +H    Y+   
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEELF 247
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 248 KLLKEGHRMDKPSN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 291

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I EY  +G+L   L           +D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL-HVDSSYRTL 614
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR + ++D   +T 
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 615 RAG-TYGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
                  ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 270 KLLKEGHRMDKPAN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 19/220 (8%)
Query: 444 DLINATEDFHIKYCIGTGGYGSVYKAELPEG-KVVALK---KLHHSETEDSAFVKSFQNE 499
           DL    ED+ +   IG G +G V         KV A+K   K    +  DSAF   F  E
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF---FWEE 119
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
             +++      +V+L+      + ++++ EYM  G L  ++ + D  +   W +      
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFY--TA 175
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GT 618
            V  AL  +H   ++  IHRD+  +N+LLD +    +ADFGT   ++ +   R   A GT
Sbjct: 176 EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
Query: 619 YGYIAPELAYTIVVTG----KCDVYSFGVVALEVLMGTHP 654
             YI+PE+  +    G    +CD +S GV   E+L+G  P
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 458 IGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G +G V   E    G  VA+K L+  +      V   + E   L   RH +I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
                   F++ EY+  G LF  +       E+   +   + + +  A+ Y H      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSAVDYCHRHM---V 132
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG-K 635
           +HRD+   N+LLD+++ A +ADFG + ++  D  +     G+  Y APE+    +  G +
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRDSCGSPNYAAPEVISGRLYAGPE 191
Query: 636 CDVYSFGVVALEVLMGTHP 654
            D++S GV+   +L GT P
Sbjct: 192 VDIWSCGVILYALLCGTLP 210

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I EY  +G+L   L           +D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL-HVDSSYRTL 614
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR + ++D   +T 
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 615 RAG-TYGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
                  ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 270 KLLKEGHRMDKPAN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G  G V  A +   GK+VA+KK+   + +         NE  ++   +H N+V++Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
             L    ++++ E++E G+L  ++        +N  +   +  +V  ALS LH      +
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLH---AQGV 141
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           IHRDI S++ILL  +    ++DFG    +  +   R    GT  ++APEL   +    + 
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 637 DVYSFGVVALEVLMGTHP 654
           D++S G++ +E++ G  P
Sbjct: 202 DIWSLGIMVIEMVDGEPP 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           ++ + +   +G GG   V+ A +L   + VA+K L      D +F   F+ EA   + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 508 HRNIVKLYGFCLHKKCM----FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           H  IV +Y     +       +++ EY++  +L  ++H +     +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA---GTYG 620
           AL++ H +    IIHRD+   NI++ +     V DFG AR +    +  T  A   GT  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y++PE A    V  + DVYS G V  EVL G  P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 19/220 (8%)
Query: 444 DLINATEDFHIKYCIGTGGYGSVYKAELPEG-KVVALK---KLHHSETEDSAFVKSFQNE 499
           DL    ED+ +   IG G +G V         KV A+K   K    +  DSAF   F  E
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF---FWEE 124
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
             +++      +V+L+      + ++++ EYM  G L  ++ + D  +   W +      
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFY--TA 180
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GT 618
            V  AL  +H   ++  IHRD+  +N+LLD +    +ADFGT   ++ +   R   A GT
Sbjct: 181 EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 237
Query: 619 YGYIAPELAYTIVVTG----KCDVYSFGVVALEVLMGTHP 654
             YI+PE+  +    G    +CD +S GV   E+L+G  P
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 87
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I EY  +G+L   L           +D +   E   T +  V
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR ++    Y+   
Sbjct: 148 SCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 256
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 257 KLLKEGHRMDKPAN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 300

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAE---LPEGKV-----VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE   L + K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 93
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCVLHDDDEAIELNWTKRV 555
           +NI+ L G C     +++I EY  +G+L             +C     +   +L+    V
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR +H    Y+   
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEELF 262
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 263 KLLKEGHRMDKPSN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 306

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 92
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I EY  +G+L   L           +D +   E   T +  V
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR ++    Y+   
Sbjct: 153 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 261
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 262 KLLKEGHRMDKPAN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 305

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 89
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I EY  +G+L   L           +D +   E   T +  V
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR ++    Y+   
Sbjct: 150 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 258
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 259 KLLKEGHRMDKPAN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 302

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 19/220 (8%)
Query: 444 DLINATEDFHIKYCIGTGGYGSVYKAELPEG-KVVALK---KLHHSETEDSAFVKSFQNE 499
           DL    ED+ +   IG G +G V         KV A+K   K    +  DSAF   F  E
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF---FWEE 124
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
             +++      +V+L+      + ++++ EYM  G L  ++ + D  +   W +      
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFY--TA 180
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GT 618
            V  AL  +H   ++  IHRD+  +N+LLD +    +ADFGT   ++ +   R   A GT
Sbjct: 181 EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 237
Query: 619 YGYIAPELAYTIVVTG----KCDVYSFGVVALEVLMGTHP 654
             YI+PE+  +    G    +CD +S GV   E+L+G  P
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 125/288 (43%), Gaps = 54/288 (18%)
Query: 458 IGTGGYGSVYKAEL----PEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRN 510
           +G G +G V +A       E  V  VA+K L  +   D    ++  +E  ++S + +H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 111
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           IV L G C H   + +I EY   G L   L      +E +      I  S A     LH 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD--PAFAIANSTASTRDLLHF 169
Query: 571 DCTLS----------IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-- 618
              ++           IHRD+++ N+LL +   A + DFG AR +  DS+Y         
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQ 677
             ++APE  +  V T + DV+S+G++  E+  +G +P            P I+    +N 
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-----------YPGIL----VNS 274
Query: 678 RLSPPVNQKIVQDIILVSTIAF----------ACLSSQPKSRPTMQRI 715
           +       K+V+D   ++  AF          AC + +P  RPT Q+I
Sbjct: 275 KFY-----KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ +   IG G +  V  A  +  GK VA++ +  ++   S+  K F+ E  ++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKL+     +K ++L+ EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 130
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+ + N+LLD+++   +ADFG +      +   T   G+  Y APEL   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF-CGSPPYAAPELFQG 186
Query: 630 IVVTG-KCDVYSFGVVALEVLMGTHP 654
               G + DV+S GV+   ++ G+ P
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 38/228 (16%)
Query: 451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF     +G G +G V KA    + +  A+KK+ H+E + S  +    +E  +L+++ H+
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL----SEVMLLASLNHQ 62
Query: 510 NIVKLYGFCLHKK-------------CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
            +V+ Y   L ++              +F+  EY E G+L+ ++H   E +     +   
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWR 120
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV--------- 607
           + + +  ALSY+H   +  IIHRD+   NI +D +    + DFG A+ +H          
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 608 -----DSSYRTLRAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVALEVL 649
                 S   T   GT  Y+A E L  T     K D+YS G++  E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 49/291 (16%)
Query: 458 IGTGGYGSVYKAE---LPEGKV-----VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE   L + K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 134
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL---------------HDDDEAIELNWTK 553
           +NI+ L G C     +++I EY  +G+L   L               H+ +E  +L+   
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 192
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            V+    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR +H    Y+ 
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 614 LRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIM 670
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P            P   
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEE 301
Query: 671 LIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           L  +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 302 LFKLLKEGHRMDKPSN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 347

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 89/165 (53%), Gaps = 14/165 (8%)
Query: 497 QNEAHVLSTVR-HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV 555
           + E H+L  V  H +I+ L         MFL+++ M +G LF  L    E + L+  +  
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETR 203
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +I++S+  A+S+LH +   +I+HRD+   NILLD N++  ++DFG +  L      R L 
Sbjct: 204 SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL- 259
Query: 616 AGTYGYIAPE-----LAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
            GT GY+APE     +  T    GK  D+++ GV+   +L G+ P
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 129/289 (44%), Gaps = 56/289 (19%)
Query: 458 IGTGGYGSVYKAEL----PEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRN 510
           +G G +G V +A       E  V  VA+K L  +   D    ++  +E  ++S + +H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 111
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE-----------LNWTKRVNIVK 559
           IV L G C H   + +I EY   G L   L      +E           L+    ++   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT- 618
            VA  +++L    + + IHRD+++ N+LL +   A + DFG AR +  DS+Y        
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 619 -YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLN 676
              ++APE  +  V T + DV+S+G++  E+  +G +P            P I+    +N
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-----------YPGIL----VN 273
Query: 677 QRLSPPVNQKIVQDIILVSTIAF----------ACLSSQPKSRPTMQRI 715
            +       K+V+D   ++  AF          AC + +P  RPT Q+I
Sbjct: 274 SKFY-----KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 113/278 (40%), Gaps = 32/278 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S + H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKLNHQNI 110
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 568 LHHDCTLSIIHRDISSNNILL---DSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++  S YR          ++
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 281
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           P N         V  I   C   QP+ RP    I + +
Sbjct: 282 PKNCPGP-----VYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 146
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I EY  +G+L   L           +D +   E   T +  V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR ++    Y+   
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 315
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ +   +   C  + P  RPT +++ ++L
Sbjct: 316 KLLKEGHRMDKPAN--CTNELYM---MMRDCWHAVPSQRPTFKQLVEDL 359

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 32/278 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDEL--DFLMEALIISKFNHQNI 110
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 568 LHHDCTLSIIHRDISSNNILL---DSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++  S YR          ++
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 281
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           P N         V  I   C   QP+ RP    I + +
Sbjct: 282 PKNCPGP-----VYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 110/269 (40%), Gaps = 32/269 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S + H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKLNHQNI 96
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 568 LHHDCTLSIIHRDISSNNILLD---SNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++  S YR          ++
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 267
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRP 710
           P N         V  I   C   QP+ RP
Sbjct: 268 PKNCPGP-----VYRIMTQCWQHQPEDRP 291

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 32/278 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 87
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 568 LHHDCTLSIIHRDISSNNILL---DSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++  S YR          ++
Sbjct: 148 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 204
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 258
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           P N         V  I   C   QP+ RP    I + +
Sbjct: 259 PKNCPGP-----VYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           ++ + +   +G GG   V+ A +L   + VA+K L      D +F   F+ EA   + + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 508 HRNIVKLYGFCLHKKCM----FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           H  IV +Y     +       +++ EY++  +L  ++H +     +   + + ++     
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 144
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA---GTYG 620
           AL++ H +    IIHRD+   NI++ +     V DFG AR +    +  T  A   GT  
Sbjct: 145 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y++PE A    V  + DVYS G V  EVL G  P
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 32/278 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 110
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 568 LHHDCTLSIIHRDISSNNILL---DSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++  S YR          ++
Sbjct: 171 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 281
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           P N         V  I   C   QP+ RP    I + +
Sbjct: 282 PKNCPGP-----VYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 117/288 (40%), Gaps = 24/288 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          +  F  E + + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           + HRN+++LYG  L    M ++ E    GSL   L        L    R  +   VA  +
Sbjct: 78  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 134
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---RAGTYGYI 622
            YL    +   IHRD+++ N+LL +     + DFG  R L  +  +  +   R   + + 
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
           APE   T   +   D + FGV   E+   G  P              +  ID   +RL  
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGERLPR 246
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKA 729
           P  +   QDI     +   C + +P+ RPT   +   LL  +    +A
Sbjct: 247 P--EDCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA 289

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 32/278 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 95
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 568 LHHDCTLSIIHRDISSNNILL---DSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++  S YR          ++
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 266
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           P N         V  I   C   QP+ RP    I + +
Sbjct: 267 PKNCPGP-----VYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 115/282 (40%), Gaps = 24/282 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          +  F  E + + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           + HRN+++LYG  L    M ++ E    GSL   L        L    R  +   VA  +
Sbjct: 68  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---RAGTYGYI 622
            YL    +   IHRD+++ N+LL +     + DFG  R L  +  +  +   R   + + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
           APE   T   +   D + FGV   E+   G  P              +  ID   +RL  
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGERLPR 236
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK 723
           P  +   QDI     +   C + +P+ RPT   +   LL  +
Sbjct: 237 P--EDCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 49/291 (16%)
Query: 458 IGTGGYGSVYKAE---LPEGKV-----VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE   L + K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 82
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL---------------HDDDEAIELNWTK 553
           +NI+ L G C     +++I EY  +G+L   L               H+ +E  +L+   
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 140
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            V+    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR +H    Y+ 
Sbjct: 141 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 614 LRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIM 670
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P            P   
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEE 249
Query: 671 LIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           L  +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 250 LFKLLKEGHRMDKPSN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 295

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 32/278 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 95
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 568 LHHDCTLSIIHRDISSNNILL---DSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++  S YR          ++
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 266
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           P N         V  I   C   QP+ RP    I + +
Sbjct: 267 PKNCPGP-----VYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 10/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ +   IG G +  V  A  +  G+ VA+K +  ++   ++  K F+ E  ++  + H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKL+     +K ++LI EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---RQIVSAVQYCH 131
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+ + N+LLD+++   +ADFG +    V         G   Y APEL   
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYAAPELFQG 187
Query: 630 IVVTG-KCDVYSFGVVALEVLMGTHP 654
               G + DV+S GV+   ++ G+ P
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 109/269 (40%), Gaps = 32/269 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 96
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 568 LHHDCTLSIIHRDISSNNILLD---SNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++  S YR          ++
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 267
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRP 710
           P N         V  I   C   QP+ RP
Sbjct: 268 PKNCPGP-----VYRIMTQCWQHQPEDRP 291

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 131/291 (45%), Gaps = 49/291 (16%)
Query: 458 IGTGGYGSVYKAE---LPEGKV-----VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE   L + K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 93
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSL---------------FCVLHDDDEAIELNWTK 553
           +NI+ L G C     +++I EY  +G+L               F   H+ +E  +L+   
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEE--QLSSKD 151
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR-LLHVDSSYR 612
            V+    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR + H+D   +
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 613 TLRAG-TYGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIM 670
           T        ++APE  +  + T + DV+SFGV+  E+  +G  P            P   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEE 260
Query: 671 LIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           L  +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 261 LFKLLKEGHRMDKPSN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 306

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 49/291 (16%)
Query: 458 IGTGGYGSVYKAE---LPEGK-----VVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE   L + K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 93
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL---------------HDDDEAIELNWTK 553
           +NI+ L G C     +++I EY  +G+L   L               H+ +E  +L+   
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEE--QLSSKD 151
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            V+    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR +H    Y+ 
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 614 LRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIM 670
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P            P   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEE 260
Query: 671 LIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           L  +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 261 LFKLLKEGHRMDKPSN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 306

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 49/291 (16%)
Query: 458 IGTGGYGSVYKAE---LPEGK-----VVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE   L + K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 85
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL---------------HDDDEAIELNWTK 553
           +NI+ L G C     +++I EY  +G+L   L               H+ +E  +L+   
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 143
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            V+    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR +H    Y+ 
Sbjct: 144 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 614 LRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIM 670
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P            P   
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEE 252
Query: 671 LIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           L  +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 253 LFKLLKEGHRMDKPSN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 298

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 128/297 (43%), Gaps = 54/297 (18%)
Query: 457 CIGTGGYGSVYKAELPEGK------VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
            +G G +G V KA     K       VA+K L   E    + ++   +E +VL  V H +
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNVLKQVNHPH 87
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------------------HDDDEAI 547
           ++KLYG C     + LI EY + GSL   L                       H D+ A+
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 548 ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
            +     ++    ++  + YL     + ++HRD+++ NIL+    +  ++DFG +R ++ 
Sbjct: 148 TMG--DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 608 DSSYRTLRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXX 664
           + S      G     ++A E  +  + T + DV+SFGV+  E++ +G +P          
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--------YP 254
Query: 665 XXPKIMLIDVLN--QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             P   L ++L    R+  P N    +++     +   C   +P  RP    IS++L
Sbjct: 255 GIPPERLFNLLKTGHRMERPDN--CSEEMY---RLMLQCWKQEPDKRPVFADISKDL 306

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 109/269 (40%), Gaps = 32/269 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 112
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 568 LHHDCTLSIIHRDISSNNILLD---SNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++  S YR          ++
Sbjct: 173 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 229
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 283
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRP 710
           P N         V  I   C   QP+ RP
Sbjct: 284 PKNCPGP-----VYRIMTQCWQHQPEDRP 307

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 126/289 (43%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I  Y  +G+L   L           +D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR ++    Y+   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 270 KLLKEGHRMDKPAN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 49/291 (16%)
Query: 458 IGTGGYGSVYKAE---LPEGK-----VVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE   L + K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 93
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL---------------HDDDEAIELNWTK 553
           +NI+ L G C     +++I EY  +G+L   L               H+ +E  +L+   
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 151
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            V+    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR +H    Y+ 
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 614 LRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIM 670
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P            P   
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEE 260
Query: 671 LIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           L  +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 261 LFKLLKEGHRMDKPSN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 306

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 109/269 (40%), Gaps = 32/269 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 102
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 568 LHHDCTLSIIHRDISSNNILLD---SNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++  S YR          ++
Sbjct: 163 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 219
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 273
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRP 710
           P N         V  I   C   QP+ RP
Sbjct: 274 PKNCPGP-----VYRIMTQCWQHQPEDRP 297

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 117/288 (40%), Gaps = 24/288 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          +  F  E + + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           + HRN+++LYG  L    M ++ E    GSL   L        L    R  +   VA  +
Sbjct: 78  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 134
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---RAGTYGYI 622
            YL    +   IHRD+++ N+LL +     + DFG  R L  +  +  +   R   + + 
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
           APE   T   +   D + FGV   E+   G  P              +  ID   +RL  
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGERLPR 246
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKA 729
           P  +   QDI     +   C + +P+ RPT   +   LL  +    +A
Sbjct: 247 P--EDCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA 289

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 49/291 (16%)
Query: 458 IGTGGYGSVYKAE---LPEGK-----VVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE   L + K      VA+K L    TE    +    +E  ++  + +H
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 86
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL---------------HDDDEAIELNWTK 553
           +NI+ L G C     +++I EY  +G+L   L               H+ +E  +L+   
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 144
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            V+    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR +H    Y+ 
Sbjct: 145 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 614 LRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIM 670
              G     ++APE  +  + T + DV+SFGV+  E+  +G  P            P   
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YPGVPVEE 253
Query: 671 LIDVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           L  +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 254 LFKLLKEGHRMDKPSN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 299

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 450 EDFHIKYC--IGTGGYGSVYKAELPE-----GKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           E+ H+KY   +G G +GSV            G +VA+K+L HS  +     + FQ E  +
Sbjct: 5   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 61
Query: 503 LSTVRHRNIVKLYG--FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           L  +    IVK  G  +   +  + L+ EY+  G L   L        L+ ++ +     
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQ 119
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   + YL    +   +HRD+++ NIL++S     +ADFG A+LL +D     +R     
Sbjct: 120 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 621 ---YIAPELAYTIVVTGKCDVYSFGVVALEVL 649
              + APE     + + + DV+SFGVV  E+ 
Sbjct: 177 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 115/282 (40%), Gaps = 24/282 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          +  F  E + + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           + HRN+++LYG  L    M ++ E    GSL   L        L    R  +   VA  +
Sbjct: 68  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---RAGTYGYI 622
            YL    +   IHRD+++ N+LL +     + DFG  R L  +  +  +   R   + + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
           APE   T   +   D + FGV   E+   G  P              +  ID   +RL  
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGERLPR 236
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK 723
           P  +   QDI     +   C + +P+ RPT   +   LL  +
Sbjct: 237 P--EDCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 109/269 (40%), Gaps = 32/269 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 122
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 568 LHHDCTLSIIHRDISSNNILLD---SNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++  S YR          ++
Sbjct: 183 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 239
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 293
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRP 710
           P N         V  I   C   QP+ RP
Sbjct: 294 PKNCPGP-----VYRIMTQCWQHQPEDRP 317

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 115/282 (40%), Gaps = 24/282 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          +  F  E + + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           + HRN+++LYG  L    M ++ E    GSL   L        L    R  +   VA  +
Sbjct: 68  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---RAGTYGYI 622
            YL    +   IHRD+++ N+LL +     + DFG  R L  +  +  +   R   + + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
           APE   T   +   D + FGV   E+   G  P              +  ID   +RL  
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGERLPR 236
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK 723
           P  +   QDI     +   C + +P+ RPT   +   LL  +
Sbjct: 237 P--EDCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 115/282 (40%), Gaps = 24/282 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +D  +   +G G +G V + E   P GK V  A+K L          +  F  E + + +
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           + HRN+++LYG  L    M ++ E    GSL   L        L    R  +   VA  +
Sbjct: 72  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 128
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---RAGTYGYI 622
            YL    +   IHRD+++ N+LL +     + DFG  R L  +  +  +   R   + + 
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
           APE   T   +   D + FGV   E+   G  P              +  ID   +RL  
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGERLPR 240
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK 723
           P  +   QDI     +   C + +P+ RPT   +   LL  +
Sbjct: 241 P--EDCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLLEAQ 277

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 10/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ +   IG G +  V  A  +  GK VA+K +  ++   S+  K F+ E  ++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKL+     +K ++L+ EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 130
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+ + N+LLD+++   +ADFG +      +       G   Y APEL   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAF-CGAPPYAAPELFQG 186
Query: 630 IVVTG-KCDVYSFGVVALEVLMGTHP 654
               G + DV+S GV+   ++ G+ P
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 126/289 (43%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V  AE          E   VA+K L    TE    +    +E  ++  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 100
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-----------HDDDEAIELNWTKR--V 555
           +NI+ L G C     +++I  Y  +G+L   L           +D +   E   T +  V
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR ++    Y+   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P            P   L 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--------YPGIPVEELF 269
Query: 673 DVLNQ--RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +L +  R+  P N     ++ ++      C  + P  RPT +++ ++L
Sbjct: 270 KLLKEGHRMDKPAN--CTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 26/240 (10%)
Query: 422 SRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALK 480
           S A +NG+  S W    K   ED+      F  K  +GTG +  V  AE    GK+ A+K
Sbjct: 1   SMARENGESSSSW----KKQAEDIKKI---FEFKETLGTGAFSEVVLAEEKATGKLFAVK 53
Query: 481 KLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL 540
            +     +      S +NE  VL  ++H NIV L         ++L+ + +  G LF   
Sbjct: 54  CIPKKALKGKE--SSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELF--- 108
Query: 541 HDDDEAIELNWTKRVN---IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS-- 595
              D  +E  +    +   +++ V  A+ YLH    + I+HRD+   N+L  S  E S  
Sbjct: 109 ---DRIVEKGFYTEKDASTLIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKI 162
Query: 596 -VADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            ++DFG +++        +   GT GY+APE+      +   D +S GV+A  +L G  P
Sbjct: 163 MISDFGLSKM-EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 65/298 (21%)
Query: 458 IGTGGYGSVYKAEL----PEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRN 510
           +G G +G V +A       E  V  VA+K L  +   D    ++  +E  ++S + +H N
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 96
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAI--------------------ELN 550
           IV L G C H   + +I EY   G L   L    EA+                     L 
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 551 WTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS 610
               ++    VA  +++L    + + IHRD+++ N+LL +   A + DFG AR +  DS+
Sbjct: 157 LRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 213
Query: 611 YRTLRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXP 667
           Y           ++APE  +  V T + DV+S+G++  E+  +G +P            P
Sbjct: 214 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-----------YP 262
Query: 668 KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAF----------ACLSSQPKSRPTMQRI 715
            I+    +N +       K+V+D   ++  AF          AC + +P  RPT Q+I
Sbjct: 263 GIL----VNSKFY-----KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 311

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 132/293 (45%), Gaps = 62/293 (21%)
Query: 458 IGTGGYGSVYKAEL----PEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRN 510
           +G G +G V +A       E  V  VA+K L  +   D    ++  +E  ++S + +H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIMSHLGQHEN 111
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVL---------------HDDDEAIELNWTKRV 555
           IV L G C H   + +I EY   G L   L               H+ +E  +L+    +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE--QLSSRDLL 169
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +    VA  +++L    + + IHRD+++ N+LL +   A + DFG AR +  DS+Y    
Sbjct: 170 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 616 AGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
                  ++APE  +  V T + DV+S+G++  E+  +G +P            P I+  
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-----------YPGIL-- 273
Query: 673 DVLNQRLSPPVNQKIVQDIILVSTIAF----------ACLSSQPKSRPTMQRI 715
             +N +       K+V+D   ++  AF          AC + +P  RPT Q+I
Sbjct: 274 --VNSKFY-----KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 458 IGTGGYGSVY--KAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G+G YG V   K +L  G   A+K +  S    ++   +  +E  VL  + H NI+KLY
Sbjct: 29  LGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN---IVKSVAHALSYLHHDC 572
            F   K+  +L+ E    G LF      DE I       V+   I+K V    +YLH   
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELF------DEIILRQKFSEVDAAVIMKQVLSGTTYLHKH- 140
Query: 573 TLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
             +I+HRD+   N+LL+S    +   + DFG +    V    +  R GT  YIAPE+   
Sbjct: 141 --NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE-RLGTAYYIAPEVLRK 197
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
                KCDV+S GV+   +L G  P
Sbjct: 198 -KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           D   +  IG G +G V KA + +  +    A+K++    ++D    + F  E  VL  + 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 83
Query: 508 HR-NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD-------------DDEAIELNWTK 553
           H  NI+ L G C H+  ++L  EY   G+L   L               +  A  L+  +
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            ++    VA  + YL        IHRD+++ NIL+  N  A +ADFG +R   V    +T
Sbjct: 144 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KT 199
Query: 614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
           +      ++A E     V T   DV+S+GV+  E++ +G  P                L 
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LY 251
Query: 673 DVLNQ--RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
           + L Q  RL  P+N    V D++        C   +P  RP+  +I
Sbjct: 252 EKLPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQI 291

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 108/269 (40%), Gaps = 32/269 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 113
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 568 LHHDCTLSIIHRDISSNNILL---DSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++    YR          ++
Sbjct: 174 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 230
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 284
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRP 710
           P N         V  I   C   QP+ RP
Sbjct: 285 PKNCPGP-----VYRIMTQCWQHQPEDRP 308

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 108/269 (40%), Gaps = 32/269 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 136
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 568 LHHDCTLSIIHRDISSNNILLD---SNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG AR ++    YR          ++
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 307
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRP 710
           P N         V  I   C   QP+ RP
Sbjct: 308 PKNCPGP-----VYRIMTQCWQHQPEDRP 331

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 458 IGTGGYGSVY--KAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G+G YG V   K +L  G   A+K +  S    ++   +  +E  VL  + H NI+KLY
Sbjct: 12  LGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN---IVKSVAHALSYLHHDC 572
            F   K+  +L+ E    G LF      DE I       V+   I+K V    +YLH   
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELF------DEIILRQKFSEVDAAVIMKQVLSGTTYLHKH- 123
Query: 573 TLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
             +I+HRD+   N+LL+S    +   + DFG +    V    +  R GT  YIAPE+   
Sbjct: 124 --NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE-RLGTAYYIAPEVLRK 180
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
                KCDV+S GV+   +L G  P
Sbjct: 181 -KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ +   IG G +  V  A  +  GK VA++ +  ++   S+  K F+ E  ++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKL+     +K ++L+ EY   G +F  L       E     +    + +  A+ Y H
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 130
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+ + N+LLD+++   +ADFG +      +       G+  Y APEL   
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEF-CGSPPYAAPELFQG 186
Query: 630 IVVTG-KCDVYSFGVVALEVLMGTHP 654
               G + DV+S GV+   ++ G+ P
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           D   +  IG G +G V KA + +  +    A+K++    ++D    + F  E  VL  + 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 73
Query: 508 HR-NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD-------------DDEAIELNWTK 553
           H  NI+ L G C H+  ++L  EY   G+L   L               +  A  L+  +
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            ++    VA  + YL        IHRD+++ NIL+  N  A +ADFG +R   V    +T
Sbjct: 134 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KT 189
Query: 614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
           +      ++A E     V T   DV+S+GV+  E++ +G  P                L 
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LY 241
Query: 673 DVLNQ--RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
           + L Q  RL  P+N    V D++        C   +P  RP+  +I
Sbjct: 242 EKLPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQI 281

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 129 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 12  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 68
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 128 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 15  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 71
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 131 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 181
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 127 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 131/295 (44%), Gaps = 44/295 (14%)
Query: 457 CIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV--RHRNIVKL 514
           C+G G YG V++  L  G+ VA+K +  S  E S F      E  + +TV  RH NI+  
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVK-IFSSRDEQSWF-----RETEIYNTVLLRHDNILGF 67
Query: 515 YGFCLHKK----CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
               +  +     ++LI  Y E GSL+  L    + +E +   R+ +  S A  L++LH 
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQR--QTLEPHLALRLAV--SAACGLAHLHV 123
Query: 571 DC-----TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL----RAGTYGY 621
           +        +I HRD  S N+L+ SNL+  +AD G A +    S Y  +    R GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRY 183
Query: 622 IAPELAYTIVVTG------KCDVYSFGVVALEVLMGT---------HPXXXXXXXXXXXX 666
           +APE+    + T         D+++FG+V  E+   T          P            
Sbjct: 184 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSF 243
Query: 667 PKIMLIDVLNQRLSPPVNQKIVQDIIL--VSTIAFACLSSQPKSRPTMQRISQEL 719
             +  +  ++Q+ +P +  ++  D +L  ++ +   C    P +R T  RI + L
Sbjct: 244 EDMKKVVCVDQQ-TPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTL 297

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 129 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 109/269 (40%), Gaps = 32/269 (11%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 96
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHD----DDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L +      +   L     +++ + +A    Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 568 LHHDCTLSIIHRDISSNNILLD---SNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           L  +     IHRDI++ N LL        A + DFG A+ ++  S YR          ++
Sbjct: 157 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWM 213
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSP 681
            PE     + T K D +SFGV+  E+  +G  P             +++       R+ P
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVTSGGRMDP 267
Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRP 710
           P N         V  I   C   QP+ RP
Sbjct: 268 PKNCPGP-----VYRIMTQCWQHQPEDRP 291

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGK----VVALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+     VA+K+L  + +  +   K   +E
Sbjct: 15  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 71
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 131 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 181
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 12  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 68
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 128 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 70
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 130 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 452 FHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH--VLSTVRHR 509
           F  K  +G+G +G V+   L E +   L+++  +  +D + V   Q EA   VL ++ H 
Sbjct: 24  FIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLF-CVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           NI+K++        M+++ E  E G L   ++        L+      ++K + +AL+Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
           H   +  ++H+D+   NIL       S   + DFG A L   D  + T  AGT  Y+APE
Sbjct: 141 H---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPE 196
Query: 626 LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           + +   VT KCD++S GVV   +L G  P
Sbjct: 197 V-FKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 129 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 127 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 177
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 18  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 74
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 134 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 184
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 127 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 129 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 127 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 108/221 (48%), Gaps = 34/221 (15%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV--R 507
            D  +  C+G G YG V++    +G+ VA+K +  S  E S F      E  + +TV  R
Sbjct: 8   RDITLLECVGKGRYGEVWRGSW-QGENVAVK-IFSSRDEKSWF-----RETELYNTVMLR 60
Query: 508 HRNIVKLYGFCLHKK----CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           H NI+      +  +     ++LI  Y E GSL+  L    +   L+    + IV S+A 
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIAS 116
Query: 564 ALSYLHHDC-----TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-----T 613
            L++LH +        +I HRD+ S NIL+  N +  +AD G A ++H  S+ +      
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNN 175
Query: 614 LRAGTYGYIAPE-LAYTIVVT-----GKCDVYSFGVVALEV 648
            R GT  Y+APE L  TI V       + D+++FG+V  EV
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 14/192 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG G +G V   +   G  VA+K + +  T      ++F  EA V++ +RH N+V+L G 
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 518 CLHKKC-MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
            + +K  ++++ EYM +GSL   L     ++ L     +     V  A+ YL  +   + 
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 129
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           +HRD+++ N+L+  +  A V+DFG   L    SS +        + APE       + K 
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALREAAFSTKS 186
Query: 637 DVYSFGVVALEV 648
           DV+SFG++  E+
Sbjct: 187 DVWSFGILLWEI 198

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 451 DFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF     +G G +G V KA    + +  A+KK+ H+E + S  +    +E  +L+++ H+
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL----SEVMLLASLNHQ 62
Query: 510 NIVKLYGFCLHKK-------------CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
            +V+ Y   L ++              +F+  EY E  +L+ ++H   E +     +   
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHS--ENLNQQRDEYWR 120
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV--------- 607
           + + +  ALSY+H   +  IIHRD+   NI +D +    + DFG A+ +H          
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 608 -----DSSYRTLRAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVALEVL 649
                 S   T   GT  Y+A E L  T     K D+YS G++  E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 127 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 18  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 74
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 134 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 70
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 130 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 21  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 77
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 78  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 136
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 137 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 187
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 188 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 70
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 130 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 129 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 70
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 130 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 36  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 92
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 93  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 151
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 152 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 202
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 203 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 8   ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 64
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 65  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 123
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 124 ------AEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 174
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 175 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 450 EDF-HIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF  I   +G G +G VYKA+  E  V+A  K+  +++E+   ++ +  E  +L++  H
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDH 93
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIV-KSVAHALSY 567
            NIVKL     ++  ++++ E+   G++  V+ + +  +      ++ +V K    AL+Y
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNY 150
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH +    IIHRD+ + NIL   + +  +ADFG +         R    GT  ++APE+ 
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVV 207
Query: 628 YTIVVTG-----KCDVYSFGVVALEV 648
                       K DV+S G+  +E+
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 112/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 17  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 73
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL    + LI + M  G L   + +  + I     LNW  ++
Sbjct: 74  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 132
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 133 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 183
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 184 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 34/214 (15%)
Query: 457 CIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV--RHRNIVKL 514
           C+G G YG V++    +G+ VA+K +  S  E S F      E  + +TV  RH NI+  
Sbjct: 44  CVGKGRYGEVWRGSW-QGENVAVK-IFSSRDEKSWF-----RETELYNTVMLRHENILGF 96
Query: 515 YGFCLHKK----CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
               +  +     ++LI  Y E GSL+  L    +   L+    + IV S+A  L++LH 
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 152
Query: 571 DC-----TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-----TLRAGTYG 620
           +        +I HRD+ S NIL+  N +  +AD G A ++H  S+ +       R GT  
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKR 211
Query: 621 YIAPE-LAYTIVVT-----GKCDVYSFGVVALEV 648
           Y+APE L  TI V       + D+++FG+V  EV
Sbjct: 212 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHR 509
           F +   +G G YG VYK   +  G++ A+K +  +  E+    +  + E ++L     HR
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 81
Query: 510 NIVKLYGFCLHK------KCMFLIYEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVA 562
           NI   YG  + K        ++L+ E+   GS+  ++ +     ++  W     I + + 
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 139
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             LS+LH      +IHRDI   N+LL  N E  + DFG +  L      R    GT  ++
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 623 APELAY-----TIVVTGKCDVYSFGVVALEVLMGTHP 654
           APE+             K D++S G+ A+E+  G  P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKL---HHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G G + +VYKA +    ++VA+KK+   H SE +D    ++   E  +L  + H NI+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD-GINRTALREIKLLQELSHPNIIG 76
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L     HK  + L++++ME   L  ++ D+   +  +  K   ++      L YLH    
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW- 132
Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVT 633
             I+HRD+  NN+LLD N    +ADFG A+     +     +  T  Y APEL +   + 
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMY 190
Query: 634 G-KCDVYSFGVVALEVLM 650
           G   D+++ G +  E+L+
Sbjct: 191 GVGVDMWAVGCILAELLL 208

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 121/286 (42%), Gaps = 20/286 (6%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
              VKLY      + ++    Y + G   C+L    +    + T        +  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNG---CLLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGYIAP 624
           H      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y++P
Sbjct: 149 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANSFVGTAQYVSP 203
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLSPPV 683
           EL      +   D+++ G +  +++ G  P             KI+ ++    ++  P  
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFFPKA 261
Query: 684 NQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
              + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 34/214 (15%)
Query: 457 CIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV--RHRNIVKL 514
           C+G G YG V++    +G+ VA+K +  S  E S F      E  + +TV  RH NI+  
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVK-IFSSRDEKSWF-----RETELYNTVMLRHENILGF 67
Query: 515 YGFCLHKK----CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
               +  +     ++LI  Y E GSL+  L    +   L+    + IV S+A  L++LH 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 571 DC-----TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-----TLRAGTYG 620
           +        +I HRD+ S NIL+  N +  +AD G A ++H  S+ +       R GT  
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKR 182
Query: 621 YIAPE-LAYTIVVT-----GKCDVYSFGVVALEV 648
           Y+APE L  TI V       + D+++FG+V  EV
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 122/290 (42%), Gaps = 28/290 (9%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 509 RNIVKLYGFCLHK-KCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHA 564
              VKLY FC    + ++    Y + G L   +      DE     +T        +  A
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSA 149
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYG 620
           L YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  
Sbjct: 150 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQ 204
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRL 679
           Y++PEL          D+++ G +  +++ G  P             KI+ ++    ++ 
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKF 262
Query: 680 SPPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
            P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 263 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 312

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 450 EDF-HIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF  I   +G G +G VYKA+  E  V+A  K+  +++E+   ++ +  E  +L++  H
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDH 93
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIV-KSVAHALSY 567
            NIVKL     ++  ++++ E+   G++  V+ + +  +      ++ +V K    AL+Y
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNY 150
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH +    IIHRD+ + NIL   + +  +ADFG +         R    GT  ++APE+ 
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVV 207
Query: 628 YTIVVTG-----KCDVYSFGVVALEV 648
                       K DV+S G+  +E+
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 450 EDF-HIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF  I   +G G +G VYKA+  E  V+A  K+  +++E+   ++ +  E  +L++  H
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDH 93
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIV-KSVAHALSY 567
            NIVKL     ++  ++++ E+   G++  V+ + +  +      ++ +V K    AL+Y
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNY 150
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH +    IIHRD+ + NIL   + +  +ADFG +         R    GT  ++APE+ 
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 207
Query: 628 YTIVVTG-----KCDVYSFGVVALEV 648
                       K DV+S G+  +E+
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  +G+G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 5   ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 61
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 121 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS-----TVRHRNIV 512
           +G GG+   ++    + K V   K+       S  +K  Q E   +      ++ H+++V
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
             +GF      +F++ E   R SL   LH   +A  L   +    ++ +     YLH + 
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKA--LTEPEARYYLRQIVLGCQYLHRN- 160
Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
              +IHRD+   N+ L+ +LE  + DFG A  +  D   + +  GT  YIAPE+      
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
           + + DV+S G +   +L+G  P
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPP 240

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 127/293 (43%), Gaps = 31/293 (10%)
Query: 443 EDLINATEDFHIKYCIGTGGYGSVYKAELPE--GKVVALK-KLHHSETEDSAFVKSFQNE 499
           ED++   + F +   +G G +GSV +A+L +  G  V +  K+  ++   S+ ++ F  E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVL---HDDDEAIELN 550
           A  +    H ++ KL G  L  +         +I  +M+ G L   L      +    L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 551 WTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS 610
               V  +  +A  + YL    + + IHRD+++ N +L  ++   VADFG +R ++    
Sbjct: 136 LQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 611 YRTLRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPXXXXXXXXXXXXP 667
           YR   A      ++A E     + T   DV++FGV   E++  G  P             
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------ 246
Query: 668 KIMLIDVLNQRL-SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +I    +   RL  PP   + V D++      + C S+ PK RP+   +  EL
Sbjct: 247 EIYNYLIGGNRLKQPPECMEEVYDLM------YQCWSADPKQRPSFTCLRMEL 293

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 12/212 (5%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEG-KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF I   IG G +G V   +L    KV A+K L+  E    A    F+ E  VL     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           + I  L+        ++L+ +Y   G L  +L   ++ +      R  + + V  A+  +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE-MARFYLAEMVI-AIDSV 191
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGTYGYIAPELA 627
           H    L  +HRDI  +NIL+D N    +ADFG+   L  D + + ++  GT  YI+PE+ 
Sbjct: 192 HQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 628 YTIV-----VTGKCDVYSFGVVALEVLMGTHP 654
             +         +CD +S GV   E+L G  P
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           D   +  IG G +G V KA + +  +    A+K++    ++D    + F  E  VL  + 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 80
Query: 508 HR-NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD-------------DDEAIELNWTK 553
           H  NI+ L G C H+  ++L  EY   G+L   L               +  A  L+  +
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            ++    VA  + YL        IHR++++ NIL+  N  A +ADFG +R   V    +T
Sbjct: 141 LLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVK-KT 196
Query: 614 LRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
           +      ++A E     V T   DV+S+GV+  E++ +G  P                L 
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LY 248
Query: 673 DVLNQ--RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
           + L Q  RL  P+N    V D++        C   +P  RP+  +I
Sbjct: 249 EKLPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQI 288

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEIXINKML 62
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 119
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 122/269 (45%), Gaps = 36/269 (13%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG G +G V   +   G  VA+K +     ++ A  ++F  EA V++ +RH N+V+L G 
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 518 CLHKKC-MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
            + +K  ++++ EYM +GSL   L     ++ L     +     V  A+ YL  +   + 
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           +HRD+++ N+L+  +  A V+DFG   L    SS +        + APE       + K 
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 637 DVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDI---- 691
           DV+SFG++  E+   G  P            P+I L DV+     P V +    D     
Sbjct: 368 DVWSFGILLWEIYSFGRVP-----------YPRIPLKDVV-----PRVEKGYKMDAPDGC 411
Query: 692 -ILVSTIAFACLSSQPKSRPTMQRISQEL 719
              V  +   C      +RPT  ++ ++L
Sbjct: 412 PPAVYDVMKNCWHLDAATRPTFLQLREQL 440

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS-----TVRHRNIV 512
           +G GG+   ++    + K V   K+       S  +K  Q E   +      ++ H+++V
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 102
Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
             +GF      +F++ E   R SL   LH   +A  L   +    ++ +     YLH + 
Sbjct: 103 GFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKA--LTEPEARYYLRQIVLGCQYLHRN- 158
Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
              +IHRD+   N+ L+ +LE  + DFG A  +  D   + +  GT  YIAPE+      
Sbjct: 159 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 216
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
           + + DV+S G +   +L+G  P
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPP 238

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 457 CIGTGGYGSVY--KAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
            +G G +G V   K ++  G+  A+K +   + +     +S   E  +L  + H NI+KL
Sbjct: 33  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN---IVKSVAHALSYLHHD 571
           Y F   K   +L+ E    G LF      DE I       V+   I++ V   ++Y+H +
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 572 CTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTL-RAGTYGYIAPELA 627
               I+HRD+   N+LL+S  + +   + DFG +   H ++S +   + GT  YIAPE+ 
Sbjct: 146 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKIGTAYYIAPEVL 200
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
           +      KCDV+S GV+   +L G  P
Sbjct: 201 HG-TYDEKCDVWSTGVILYILLSGCPP 226

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 457 CIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
            IG G +  V  A  +  GK VA+K +  ++   S+  K F+ E  +   + H NIVKL+
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLF 79
Query: 516 GFCLHKKCMFLIYEYMERGSLF--CVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
                +K ++L+ EY   G +F   V H   +  E     R      +  A+ Y H    
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-----QIVSAVQYCHQKF- 133
Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVT 633
             I+HRD+ + N+LLD++    +ADFG +      +       G   Y APEL       
Sbjct: 134 --IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAF-CGAPPYAAPELFQGKKYD 190
Query: 634 G-KCDVYSFGVVALEVLMGTHP 654
           G + DV+S GV+   ++ G+ P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKAE----LPEGKVVALKKLHHS----ETEDSAFVKSFQNEAH 501
           E F +   +G GGYG V++         GK+ A+K L  +      +D+A  K+ +N   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--- 73
Query: 502 VLSTVRHRNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           +L  V+H  IV L Y F    K ++LI EY+  G LF  L  + E I +  T    + + 
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQL--EREGIFMEDTACFYLAE- 129
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           ++ AL +LH      II+RD+   NI+L+      + DFG  +    D +      GT  
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y+APE+          D +S G +  ++L G  P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKAE----LPEGKVVALKKLHHS----ETEDSAFVKSFQNEAH 501
           E F +   +G GGYG V++         GK+ A+K L  +      +D+A  K+ +N   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--- 73
Query: 502 VLSTVRHRNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
           +L  V+H  IV L Y F    K ++LI EY+  G LF  L  + E I +  T    + + 
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQL--EREGIFMEDTACFYLAE- 129
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           ++ AL +LH      II+RD+   NI+L+      + DFG  +    D +      GT  
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y+APE+          D +S G +  ++L G  P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEIXINKML 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEIXINKML 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G+VY A ++   +VVA+KK+ +S  + +   +    E   L  +RH N ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 517 FCLHKKCMFLIYEY-MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
             L +   +L+ EY +   S    +H       L   +   +       L+YLH   + +
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH---SHN 174
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI---VV 632
           +IHRD+ + NILL       + DFG+A ++   + +     GT  ++APE+   +     
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF----VGTPYWMAPEVILAMDEGQY 230
Query: 633 TGKCDVYSFGVVALEV 648
            GK DV+S G+  +E+
Sbjct: 231 DGKVDVWSLGITCIEL 246

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 118/287 (41%), Gaps = 22/287 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 143
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYGYIA 623
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S      A  GT  Y++
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVS 200
Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLSPP 682
           PEL          D+++ G +  +++ G  P             KI+ ++    ++  P 
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFFPK 258
Query: 683 VNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
               + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 259 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 62
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 119
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 457 CIGTGGYGSVY--KAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
            +G G +G V   K ++  G+  A+K +   + +     +S   E  +L  + H NI+KL
Sbjct: 56  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN---IVKSVAHALSYLHHD 571
           Y F   K   +L+ E    G LF      DE I       V+   I++ V   ++Y+H +
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQVLSGITYMHKN 168
Query: 572 CTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTL-RAGTYGYIAPELA 627
               I+HRD+   N+LL+S  + +   + DFG +   H ++S +   + GT  YIAPE+ 
Sbjct: 169 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKIGTAYYIAPEVL 223
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
           +      KCDV+S GV+   +L G  P
Sbjct: 224 HG-TYDEKCDVWSTGVILYILLSGCPP 249

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 457 CIGTGGYGSVY--KAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
            +G G +G V   K ++  G+  A+K +   + +     +S   E  +L  + H NI+KL
Sbjct: 57  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN---IVKSVAHALSYLHHD 571
           Y F   K   +L+ E    G LF      DE I       V+   I++ V   ++Y+H +
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQVLSGITYMHKN 169
Query: 572 CTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTL-RAGTYGYIAPELA 627
               I+HRD+   N+LL+S  + +   + DFG +   H ++S +   + GT  YIAPE+ 
Sbjct: 170 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKIGTAYYIAPEVL 224
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
           +      KCDV+S GV+   +L G  P
Sbjct: 225 HG-TYDEKCDVWSTGVILYILLSGCPP 250

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  + + +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINAML 62
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 119
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 123
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 124 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 178
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 236
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 237 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 285

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 458 IGTGGYGSVY--KAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G G +G V   K ++  G+  A+K +   + +     +S   E  +L  + H NI+KLY
Sbjct: 40  LGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN---IVKSVAHALSYLHHDC 572
            F   K   +L+ E    G LF      DE I       V+   I++ V   ++Y+H + 
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQVLSGITYMHKN- 151
Query: 573 TLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTL-RAGTYGYIAPELAY 628
              I+HRD+   N+LL+S  + +   + DFG +   H ++S +   + GT  YIAPE+ +
Sbjct: 152 --KIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKIGTAYYIAPEVLH 207
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                 KCDV+S GV+   +L G  P
Sbjct: 208 G-TYDEKCDVWSTGVILYILLSGCPP 232

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 122
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 123 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 177
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 235
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 236 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 284

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 458 IGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++ +       K+  +E  D A       EA+V+  + +  IV++ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G C  +  M L+ E  E G L   L  +    + N    + +V  V+  + YL      +
Sbjct: 437 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 489
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPELAYTI 630
            +HRD+++ N+LL +   A ++DFG ++ L  D +Y   +A T+G     + APE     
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECINYY 547
Query: 631 VVTGKCDVYSFGVVALEVL 649
             + K DV+SFGV+  E  
Sbjct: 548 KFSSKSDVWSFGVLMWEAF 566

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 14/192 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG G +G V   +   G  VA+K + +  T      ++F  EA V++ +RH N+V+L G 
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 518 CLHKKC-MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
            + +K  ++++ EYM +GSL   L     ++ L     +     V  A+ YL  +   + 
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 123
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           +HRD+++ N+L+  +  A V+DFG   L    SS +        + APE       + K 
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 637 DVYSFGVVALEV 648
           DV+SFG++  E+
Sbjct: 181 DVWSFGILLWEI 192

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 145
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 200
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA--KIIKLEYDFPEKFF 258
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 259 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 19/219 (8%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGK----VVALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   +K  +G+G +G+VYK   +P+G+     VA+K L  + +  +   K   +E
Sbjct: 13  ILKETELRKVK-VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDE 69
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-HDDDEAIELNWTKRVNIV 558
           A+V++ V    + +L G CL      L+ + M  G   C+L H  +    L     +N  
Sbjct: 70  AYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYG---CLLDHVRENRGRLGSQDLLNWC 125
Query: 559 KSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT 618
             +A  +SYL     + ++HRD+++ N+L+ S     + DFG ARLL +D +      G 
Sbjct: 126 MQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 182
Query: 619 Y--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
               ++A E       T + DV+S+GV   E++  G  P
Sbjct: 183 VPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKP 221

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 120
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 121 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 175
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 233
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 234 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 282

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 143
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 198
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 256
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 257 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS-----TVRHRNIV 512
           +G GG+   ++    + K V   K+       S  +K  Q E   +      ++ H+++V
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 84
Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
             +GF      +F++ E   R SL   LH   +A  L   +    ++ +     YLH + 
Sbjct: 85  GFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKA--LTEPEARYYLRQIVLGCQYLHRN- 140
Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
              +IHRD+   N+ L+ +LE  + DFG A  +  D   +    GT  YIAPE+      
Sbjct: 141 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 198
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
           + + DV+S G +   +L+G  P
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPP 220

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 62
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 119
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 146
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 147 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANSFVGTAQY 201
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 259
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 260 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 308

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS-----TVRHRNIV 512
           +G GG+   ++    + K V   K+       S  +K  Q E   +      ++ H+++V
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
             +GF      +F++ E   R SL   LH   +A  L   +    ++ +     YLH + 
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKA--LTEPEARYYLRQIVLGCQYLHRN- 134
Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
              +IHRD+   N+ L+ +LE  + DFG A  +  D   + +  GT  YIAPE+      
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
           + + DV+S G +   +L+G  P
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPP 214

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 62
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 119
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 62
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 119
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 62
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 119
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 145
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 200
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 258
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 259 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 121
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 122 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 176
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 234
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 235 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 283

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 458 IGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++ +       K+  +E  D A       EA+V+  + +  IV++ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G C  +  M L+ E  E G L   L  +    + N    + +V  V+  + YL      +
Sbjct: 438 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 490
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPELAYTI 630
            +HRD+++ N+LL +   A ++DFG ++ L  D +Y   +A T+G     + APE     
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECINYY 548
Query: 631 VVTGKCDVYSFGVVALEVL 649
             + K DV+SFGV+  E  
Sbjct: 549 KFSSKSDVWSFGVLMWEAF 567

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 146
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 147 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 201
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 259
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 260 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 308

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 14/192 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG G +G V   +   G  VA+K + +  T      ++F  EA V++ +RH N+V+L G 
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 518 CLHKKC-MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
            + +K  ++++ EYM +GSL   L     ++ L     +     V  A+ YL  +   + 
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKC 636
           +HRD+++ N+L+  +  A V+DFG   L    SS +        + APE       + K 
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 637 DVYSFGVVALEV 648
           DV+SFG++  E+
Sbjct: 196 DVWSFGILLWEI 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    ++ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H N+VK YG        +L  EY   G LF  +  D   I +           +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 120
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPE 625
           LH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 626 LAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           L        +  DV+S G+V   +L G  P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 145
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 200
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 258
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 259 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 145
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 200
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA--KIIKLEYDFPEKFF 258
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 259 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 60
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 117
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 118 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 143
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 198
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 256
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 257 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 452 FHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           +  +  +GTG +  V  AE     K+VA+K +     E      S +NE  VL  ++H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-WTKR--VNIVKSVAHALSY 567
           IV L         ++LI + +  G LF      D  +E   +T+R    ++  V  A+ Y
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELF------DRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 568 LHHDCTLSIIHRDISSNNIL---LDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           LH    L I+HRD+   N+L   LD + +  ++DFG +++    S   T   GT GY+AP
Sbjct: 132 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAP 187
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+      +   D +S GV+A  +L G  P
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 110/222 (49%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  + +G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 18  ILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 74
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 134 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 145
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 200
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 258
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 259 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 307

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 452 FHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           +  +  +GTG +  V  AE     K+VA+K +     E      S +NE  VL  ++H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHPN 77
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-WTKR--VNIVKSVAHALSY 567
           IV L         ++LI + +  G LF      D  +E   +T+R    ++  V  A+ Y
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELF------DRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 568 LHHDCTLSIIHRDISSNNIL---LDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           LH    L I+HRD+   N+L   LD + +  ++DFG +++    S   T   GT GY+AP
Sbjct: 132 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAP 187
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+      +   D +S GV+A  +L G  P
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS-----TVRHRNIV 512
           +G GG+   ++    + K V   K+       S  +K  Q E   +      ++ H+++V
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 80
Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
             +GF      +F++ E   R SL   LH   +A  L   +    ++ +     YLH + 
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKA--LTEPEARYYLRQIVLGCQYLHRN- 136
Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
              +IHRD+   N+ L+ +LE  + DFG A  +  D   +    GT  YIAPE+      
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
           + + DV+S G +   +L+G  P
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPP 216

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS-----TVRHRNIV 512
           +G GG+   ++    + K V   K+       S  +K  Q E   +      ++ H+++V
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 80
Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
             +GF      +F++ E   R SL   LH   +A  L   +    ++ +     YLH + 
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKA--LTEPEARYYLRQIVLGCQYLHRN- 136
Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV 632
              +IHRD+   N+ L+ +LE  + DFG A  +  D   +    GT  YIAPE+      
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
           + + DV+S G +   +L+G  P
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPP 216

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 452 FHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           F I   IG G +G V   +  +  K+ A+K ++  +  +   V++   E  ++  + H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVL----HDDDEAIELNWTKRVNIVKSVAHALS 566
           +V L+     ++ MF++ + +  G L   L    H  +E ++L        +  +  AL 
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-------FICELVMALD 129
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           YL +     IIHRD+  +NILLD +    + DF  A +L  ++   T+ AGT  Y+APE+
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM-AGTKPYMAPEM 185
Query: 627 AYTIVVTG---KCDVYSFGVVALEVLMGTHP 654
             +    G     D +S GV A E+L G  P
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 142
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 143 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANSFVGTAQY 197
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 255
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 256 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 304

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 452 FHIKYCIGTGGYGSVYKAELPEG----KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           F +   +G G +G V+  +   G    ++ A+K L  +  +    V++ + E  +L  V 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 84
Query: 508 HRNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDD----DEAIELNWTKRVNIVKSVA 562
           H  IVKL Y F    K ++LI +++  G LF  L  +    +E ++         +  +A
Sbjct: 85  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELA 136
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR--LLHVDSSYRTLRAGTYG 620
            AL +LH   +L II+RD+   NILLD      + DFG ++  + H   +Y     GT  
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CGTVE 191
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y+APE+      T   D +SFGV+  E+L GT P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    ++ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H N+VK YG        +L  EY   G LF  +  D   I +           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPE 625
           LH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+APE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 626 LAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           L        +  DV+S G+V   +L G  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 16/196 (8%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G+VY A ++   +VVA+KK+ +S  + +   +    E   L  +RH N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 517 FCLHKKCMFLIYEY-MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
             L +   +L+ EY +   S    +H       L   +   +       L+YLH   + +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI---VV 632
           +IHRD+ + NILL       + DFG+A ++   + +     GT  ++APE+   +     
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF----VGTPYWMAPEVILAMDEGQY 191
Query: 633 TGKCDVYSFGVVALEV 648
            GK DV+S G+  +E+
Sbjct: 192 DGKVDVWSLGITCIEL 207

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           A E   +   +G G +G VY+        + PE +V A+K ++ + +        F NEA
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 72
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTK 553
            V+      ++V+L G     +   +I E M RG L   L      +E N        +K
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            + +   +A  ++YL+ +     +HRD+++ N ++  +    + DFG  R ++    YR 
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 614 LRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
              G     +++PE     V T   DV+SFGVV  E+
Sbjct: 190 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 8/207 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-R 507
           EDF +   +G G +G V+ AE  +  +  A+K L          V+    E  VLS    
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H  +  ++     K+ +F + EY+  G L   ++      + + ++       +   L +
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQF 134
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH   +  I++RD+  +NILLD +    +ADFG  +   +  +      GT  YIAPE+ 
Sbjct: 135 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEIL 191
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
                    D +SFGV+  E+L+G  P
Sbjct: 192 LGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 458 IGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++ +       K+  +E  D A       EA+V+  + +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G C  +  M L+ E  E G L   L  +    + N    + +V  V+  + YL      +
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 131
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPELAYTI 630
            +HRD+++ N+LL +   A ++DFG ++ L  D +Y   +A T+G     + APE     
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECINYY 189
Query: 631 VVTGKCDVYSFGVVALEVL-MGTHP 654
             + K DV+SFGV+  E    G  P
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 452 FHIKYCIGTGGYGSVYKAELPEG----KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           F +   +G G +G V+  +   G    ++ A+K L  +  +    V++ + E  +L  V 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 84
Query: 508 HRNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR--VNIVKSVAHA 564
           H  IVKL Y F    K ++LI +++  G LF  L     + E+ +T+      +  +A A
Sbjct: 85  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALA 138
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR--LLHVDSSYRTLRAGTYGYI 622
           L +LH   +L II+RD+   NILLD      + DFG ++  + H   +Y     GT  Y+
Sbjct: 139 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CGTVEYM 193
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           APE+      T   D +SFGV+  E+L GT P
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
            ED+ +   +G G YG V  A      + VA+K +      D    ++ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H N+VK YG        +L  EY   G LF  +  D   I +           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPE 625
           LH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+APE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 626 LAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           L        +  DV+S G+V   +L G  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 452 FHIKYCIGTGGYGSVYKAELPEG----KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           F +   +G G +G V+  +   G    ++ A+K L  +  +    V++ + E  +L  V 
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 85
Query: 508 HRNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDD----DEAIELNWTKRVNIVKSVA 562
           H  IVKL Y F    K ++LI +++  G LF  L  +    +E ++         +  +A
Sbjct: 86  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF-------YLAELA 137
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR--LLHVDSSYRTLRAGTYG 620
            AL +LH   +L II+RD+   NILLD      + DFG ++  + H   +Y     GT  
Sbjct: 138 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CGTVE 192
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y+APE+      T   D +SFGV+  E+L GT P
Sbjct: 193 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G YG V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 21/220 (9%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKK--LHHSETEDSAFVKSFQNEAH 501
           ++  TE   IK  +G+G +G+VYK   +PEG+ V +    +   E       K   +EA+
Sbjct: 45  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRVNI 557
           V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++  
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 160
Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
               A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +        G
Sbjct: 161 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 618 TY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
                ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 214 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           A E   +   +G G +G VY+        + PE +V A+K ++ + +        F NEA
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 66
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTK 553
            V+      ++V+L G     +   +I E M RG L   L      +E N        +K
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            + +   +A  ++YL+ +     +HRD+++ N ++  +    + DFG  R ++    YR 
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 614 LRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
              G     +++PE     V T   DV+SFGVV  E+
Sbjct: 184 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 127
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 128 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 182
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 240
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 241 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 289

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 142
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 143 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 197
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 255
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 256 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 304

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 458 IGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++ +       K+  +E  D A       EA+V+  + +  IV++ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G C  +  M L+ E  E G L   L  +    + N    + +V  V+  + YL      +
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 137
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPELAYTI 630
            +HRD+++ N+LL +   A ++DFG ++ L  D +Y   +A T+G     + APE     
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECINYY 195
Query: 631 VVTGKCDVYSFGVVALEVL-MGTHP 654
             + K DV+SFGV+  E    G  P
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 458 IGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++ +       K+  +E  D A       EA+V+  + +  IV++ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G C  +  M L+ E  E G L   L  +    + N    + +V  V+  + YL      +
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 145
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPELAYTI 630
            +HRD+++ N+LL +   A ++DFG ++ L  D +Y   +A T+G     + APE     
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECINYY 203
Query: 631 VVTGKCDVYSFGVVALEVL-MGTHP 654
             + K DV+SFGV+  E    G  P
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 110/222 (49%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  + +G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 18  ILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 74
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 134 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 108
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + Y
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 166
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  Y ++   T       ++
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWM 222
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           A E   +   +G G +G VY+        + PE +V A+K ++ + +        F NEA
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 70
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTK 553
            V+      ++V+L G     +   +I E M RG L   L      +E N        +K
Sbjct: 71  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 130
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            + +   +A  ++YL+ +     +HRD+++ N ++  +    + DFG  R ++    YR 
Sbjct: 131 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 187
Query: 614 LRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
              G     +++PE     V T   DV+SFGVV  E+
Sbjct: 188 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 452 FHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           +  +  +GTG +  V  AE     K+VA+K +     E      S +NE  VL  ++H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-WTKR--VNIVKSVAHALSY 567
           IV L         ++LI + +  G LF      D  +E   +T+R    ++  V  A+ Y
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELF------DRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 568 LHHDCTLSIIHRDISSNNIL---LDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           LH    L I+HRD+   N+L   LD + +  ++DFG +++    S   T   GT GY+AP
Sbjct: 132 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAP 187
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+      +   D +S GV+A  +L G  P
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF     +G G +G V KA    + +  A+KK+ H+E + S  +    +E  +L+++ H+
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL----SEVXLLASLNHQ 62
Query: 510 NIVKLYGFCLHKK-------------CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
            +V+ Y   L ++              +F+  EY E  +L+ ++H   E +     +   
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHS--ENLNQQRDEYWR 120
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV--------- 607
           + + +  ALSY+H   +  IIHR++   NI +D +    + DFG A+ +H          
Sbjct: 121 LFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 608 -----DSSYRTLRAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVALEVL 649
                 S   T   GT  Y+A E L  T     K D YS G++  E +
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 458 IGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++ +       K+  +E  D A       EA+V+  + +  IV++ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G C  +  M L+ E  E G L   L  +    + N    + +V  V+  + YL      +
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 125
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPELAYTI 630
            +HRD+++ N+LL +   A ++DFG ++ L  D +Y   +A T+G     + APE     
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECINYY 183
Query: 631 VVTGKCDVYSFGVVALEVL-MGTHP 654
             + K DV+SFGV+  E    G  P
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 110/222 (49%), Gaps = 25/222 (11%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVV----ALKKLHHSETEDSAFVKSFQNE 499
           ++  TE   IK  + +G +G+VYK   +PEG+ V    A+K+L  + +  +   K   +E
Sbjct: 11  ILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRV 555
           A+V+++V + ++ +L G CL      LI + M  G L   + +  + I     LNW  ++
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                 A  ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +       
Sbjct: 127 ------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 616 AGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
            G     ++A E     + T + DV+S+GV   E++  G+ P
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 452 FHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           +  +  +GTG +  V  AE     K+VA+K +     E      S +NE  VL  ++H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-WTKR--VNIVKSVAHALSY 567
           IV L         ++LI + +  G LF      D  +E   +T+R    ++  V  A+ Y
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELF------DRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 568 LHHDCTLSIIHRDISSNNIL---LDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           LH    L I+HRD+   N+L   LD + +  ++DFG +++    S   T   GT GY+AP
Sbjct: 132 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAP 187
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+      +   D +S GV+A  +L G  P
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 458 IGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++ +       K+  +E  D A       EA+V+  + +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G C  +  M L+ E  E G L   L  +    + N    + +V  V+  + YL      +
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 147
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPELAYTI 630
            +HRD+++ N+LL +   A ++DFG ++ L  D +Y   +A T+G     + APE     
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECINYY 205
Query: 631 VVTGKCDVYSFGVVALEVL-MGTHP 654
             + K DV+SFGV+  E    G  P
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 458 IGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++ +       K+  +E  D A       EA+V+  + +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G C  +  M L+ E  E G L   L  +    + N    + +V  V+  + YL      +
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 147
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPELAYTI 630
            +HRD+++ N+LL +   A ++DFG ++ L  D +Y   +A T+G     + APE     
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECINYY 205
Query: 631 VVTGKCDVYSFGVVALEVL-MGTHP 654
             + K DV+SFGV+  E    G  P
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           A E   +   +G G +G VY+        + PE +V A+K ++ + +        F NEA
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 79
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTK 553
            V+      ++V+L G     +   +I E M RG L   L      +E N        +K
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 139
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            + +   +A  ++YL+ +     +HRD+++ N ++  +    + DFG  R ++    YR 
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 614 LRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
              G     +++PE     V T   DV+SFGVV  E+
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 446 INATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           ++  E + I   +G G +G VYKA+  E   +A  K+  +++E+   ++ +  E  +L+T
Sbjct: 7   LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILAT 64
Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIV-KSVAHA 564
             H  IVKL G   H   ++++ E+   G++  ++ + D  +      ++ +V + +  A
Sbjct: 65  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEA 121
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           L++LH   +  IIHRD+ + N+L+    +  +ADFG +         R    GT  ++AP
Sbjct: 122 LNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 178
Query: 625 ELAYTIVVTG-----KCDVYSFGVVALEV 648
           E+     +       K D++S G+  +E+
Sbjct: 179 EVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 8/207 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-R 507
           EDF +   +G G +G V+ AE  +  +  A+K L          V+    E  VLS    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H  +  ++     K+ +F + EY+  G L   ++      + + ++       +   L +
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH   +  I++RD+  +NILLD +    +ADFG  +   +  +      GT  YIAPE+ 
Sbjct: 134 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEIL 190
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
                    D +SFGV+  E+L+G  P
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 458 IGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++ +       K+  +E  D A       EA+V+  + +  IV++ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G C  +  M L+ E  E G L   L  +    + N    + +V  V+  + YL      +
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 127
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPELAYTI 630
            +HRD+++ N+LL +   A ++DFG ++ L  D +Y   +A T+G     + APE     
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECINYY 185
Query: 631 VVTGKCDVYSFGVVALEVL-MGTHP 654
             + K DV+SFGV+  E    G  P
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           A E   +   +G G +G VY+        + PE +V A+K ++ + +        F NEA
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 72
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTK 553
            V+      ++V+L G     +   +I E M RG L   L      +E N        +K
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            + +   +A  ++YL+ +     +HRD+++ N ++  +    + DFG  R ++    YR 
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 614 LRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
              G     +++PE     V T   DV+SFGVV  E+
Sbjct: 190 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           A E   +   +G G +G VY+        + PE +V A+K ++ + +        F NEA
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 73
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTK 553
            V+      ++V+L G     +   +I E M RG L   L      +E N        +K
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            + +   +A  ++YL+ +     +HRD+++ N ++  +    + DFG  R ++    YR 
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 190
Query: 614 LRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
              G     +++PE     V T   DV+SFGVV  E+
Sbjct: 191 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 454 IKYCIGTGGYGSV-----YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           I+  +G G +G V     YK +    + VALK +     + S      + E   L  +RH
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +I+KLY        + ++ EY   G LF  + +     E    +     + +  A+ Y 
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRR---FFQQIICAIEYC 124
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H      I+HRD+   N+LLD NL   +ADFG + ++  D ++     G+  Y APE+  
Sbjct: 125 HRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVIN 180
Query: 629 TIVVTG-KCDVYSFGVVALEVLMGTHP 654
             +  G + DV+S G+V   +L+G  P
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           A E   +   +G G +G VY+        + PE +V A+K ++ + +        F NEA
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 101
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTK 553
            V+      ++V+L G     +   +I E M RG L   L      +E N        +K
Sbjct: 102 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 161
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            + +   +A  ++YL+ +     +HRD+++ N ++  +    + DFG  R ++    YR 
Sbjct: 162 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 218
Query: 614 LRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
              G     +++PE     V T   DV+SFGVV  E+
Sbjct: 219 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 109
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + Y
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 167
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  Y ++   T       ++
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWM 223
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ I   +G G +G V  A     G+ VALK ++      S      + E   L  +RH 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           +I+KLY     K  + ++ EY     LF  +   D+  E    +     + +  A+ Y H
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARR---FFQQIISAVEYCH 120
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+   N+LLD +L   +ADFG + ++  D ++     G+  Y APE+   
Sbjct: 121 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVISG 176
Query: 630 IVVTG-KCDVYSFGVV 644
            +  G + DV+S GV+
Sbjct: 177 KLYAGPEVDVWSCGVI 192

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 82
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + Y
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 140
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  Y ++   T       ++
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWM 196
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ I   +G G +G V  A     G+ VALK ++      S      + E   L  +RH 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           +I+KLY     K  + ++ EY     LF  +   D+  E    +     + +  A+ Y H
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARR---FFQQIISAVEYCH 124
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+   N+LLD +L   +ADFG + ++  D ++     G+  Y APE+   
Sbjct: 125 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVISG 180
Query: 630 IVVTG-KCDVYSFGVV 644
            +  G + DV+S GV+
Sbjct: 181 KLYAGPEVDVWSCGVI 196

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ I   +G G +G V  A     G+ VALK ++      S      + E   L  +RH 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           +I+KLY     K  + ++ EY     LF  +   D+  E    +     + +  A+ Y H
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARR---FFQQIISAVEYCH 130
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+   N+LLD +L   +ADFG + ++  D ++     G+  Y APE+   
Sbjct: 131 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVISG 186
Query: 630 IVVTG-KCDVYSFGVV 644
            +  G + DV+S GV+
Sbjct: 187 KLYAGPEVDVWSCGVI 202

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++ I   +G G +G V  A     G+ VALK ++      S      + E   L  +RH 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           +I+KLY     K  + ++ EY     LF  +   D+  E    +     + +  A+ Y H
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAG-NELFDYIVQRDKMSEQEARR---FFQQIISAVEYCH 129
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+   N+LLD +L   +ADFG + ++  D ++     G+  Y APE+   
Sbjct: 130 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVISG 185
Query: 630 IVVTG-KCDVYSFGVV 644
            +  G + DV+S GV+
Sbjct: 186 KLYAGPEVDVWSCGVI 201

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 26/289 (8%)
Query: 450 EDFHIKYCIGTGGYGS-VYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + + V   EL   +  A+K L          V     E  V+S + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 143
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 198
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDV-LNQRLS 680
           ++PEL          D+++ G +  +++ G  P             KI+ ++    ++  
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEYDFPEKFF 256
Query: 681 PPVNQKIVQDIILVSTIAFACLSSQP----KSRPTMQRISQELLAGKTP 725
           P     + + ++L +T    C   +     K+ P  + ++ E L  +TP
Sbjct: 257 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 90
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 148
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  Y ++   T       ++
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWM 204
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 125/305 (40%), Gaps = 37/305 (12%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           A E   +   +G G +G VY+        + PE +V A+K ++ + +        F NEA
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 66
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTK 553
            V+      ++V+L G     +   +I E M RG L   L      +E N        +K
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            + +   +A  ++YL+ +     +HRD+++ N  +  +    + DFG  R ++    YR 
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 614 LRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIM 670
              G     +++PE     V T   DV+SFGVV  E+  +   P             +++
Sbjct: 184 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVL 237
Query: 671 LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKAL 730
              +    L  P N     D++L   +   C    PK RP+   I   +   K  M+   
Sbjct: 238 RFVMEGGLLDKPDN---CPDMLL--ELMRMCWQYNPKMRPSFLEIISSI---KEEMEPGF 289
Query: 731 KEISI 735
           +E+S 
Sbjct: 290 REVSF 294

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           A E   +   +G G +G VY+        + PE +V A+K ++ + +        F NEA
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 79
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTK 553
            V+      ++V+L G     +   +I E M RG L   L     A+  N        +K
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            + +   +A  ++YL+ +     +HRD+++ N ++  +    + DFG  R ++    YR 
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 614 LRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
              G     +++PE     V T   DV+SFGVV  E+
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 87
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + Y
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 145
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  Y ++   T       ++
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWM 201
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 446 INATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           ++  E + I   +G G +G VYKA+  E   +A  K+  +++E+   ++ +  E  +L+T
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILAT 72
Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIV-KSVAHA 564
             H  IVKL G   H   ++++ E+   G++  ++ + D  +      ++ +V + +  A
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEA 129
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           L++LH   +  IIHRD+ + N+L+    +  +ADFG +         R    GT  ++AP
Sbjct: 130 LNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186
Query: 625 ELAYTIVVTG-----KCDVYSFGVVALEV 648
           E+     +       K D++S G+  +E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           A E   +   +G G +G VY+        + PE +V A+K ++ + +        F NEA
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 69
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTK 553
            V+      ++V+L G     +   +I E M RG L   L     A+  N        +K
Sbjct: 70  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 129
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            + +   +A  ++YL+ +     +HRD+++ N ++  +    + DFG  R ++    YR 
Sbjct: 130 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 614 LRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
              G     +++PE     V T   DV+SFGVV  E+
Sbjct: 187 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 461 GGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS--TVRHRNIVKLYGFC 518
           G +G V+KA+L   + VA+K     + +      S+QNE  V S   ++H NI++  G  
Sbjct: 35  GRFGCVWKAQLL-NEYVAVKIFPIQDKQ------SWQNEYEVYSLPGMKHENILQFIGAE 87
Query: 519 LHKKC----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC-- 572
                    ++LI  + E+GSL   L    +A  ++W +  +I +++A  L+YLH D   
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 573 -----TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL--RAGTYGYIAPE 625
                  +I HRDI S N+LL +NL A +ADFG A       S      + GT  Y+APE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 626 LAYTIV-----VTGKCDVYSFGVVALEV 648
           +    +        + D+Y+ G+V  E+
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 89
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 147
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  Y ++   T       ++
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWM 203
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 90
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 148
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  Y ++   T       ++
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWM 204
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 88
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + Y
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 146
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  Y ++   T       ++
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWM 202
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 85
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + Y
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 143
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  Y ++   T       ++
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWM 199
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 450 EDFHIKYCIGTGGYGSVYKAE----LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           E ++I   +G G +G V K +      E  V  + K      + S  ++    E  +L  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR----EVELLKK 77
Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE---LNWTKRVNIVKSVA 562
           + H NI+KL+         +++ E    G LF      DE I+    +      I+K V 
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQVF 131
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTY 619
             ++Y+H     +I+HRD+   NILL+S   + +  + DFG +     ++  +  R GT 
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTA 187
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            YIAPE+        KCDV+S GV+   +L GT P
Sbjct: 188 YYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 457 CIGTGGYGSVY--KAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
            +G G +G V   K ++  G+  A+K +   + +     +S   E  +L  + H NI KL
Sbjct: 33  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN---IVKSVAHALSYLHHD 571
           Y F   K   +L+ E    G LF      DE I       V+   I++ V   ++Y H +
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQVLSGITYXHKN 145
Query: 572 CTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTL-RAGTYGYIAPELA 627
               I+HRD+   N+LL+S  + +   + DFG +   H ++S +   + GT  YIAPE+ 
Sbjct: 146 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKXKDKIGTAYYIAPEVL 200
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
           +      KCDV+S GV+   +L G  P
Sbjct: 201 HG-TYDEKCDVWSTGVILYILLSGCPP 226

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 21/221 (9%)
Query: 447 NATEDFHIKY-------CIGTGGYGSVYKAEL--PEGKVVALK-KLHHSETEDSAFVKSF 496
           ++T D+ I+        CIG G +G V++     PE   +A+  K   + T DS   K F
Sbjct: 28  SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-F 86
Query: 497 QNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
             EA  +    H +IVKL G  + +  +++I E    G L   L     +++L     + 
Sbjct: 87  LQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLIL 143
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
               ++ AL+YL    +   +HRDI++ N+L+ SN    + DFG +R +  DS+Y     
Sbjct: 144 YAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASK 199
Query: 617 GTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
           G     ++APE       T   DV+ FGV   E+LM G  P
Sbjct: 200 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 240

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHAL 565
              VKLY      + ++    Y + G L   +      DE     +T        +  AL
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA------EIVSAL 148
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA----GTYGY 621
            YLH      IIHRD+   NILL+ ++   + DFGTA++L  +S  +  RA    GT  Y
Sbjct: 149 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANXFVGTAQY 203
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           ++PEL          D+++ G +  +++ G  P
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 12/212 (5%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEG-KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF I   IG G +G V   ++    ++ A+K L+  E    A    F+ E  VL     
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           + I  L+     +  ++L+ +Y   G L  +L   ++ +  +  +    +  +  A+  +
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY--IGEMVLAIDSI 207
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGTYGYIAPELA 627
           H    L  +HRDI  +N+LLD N    +ADFG+   ++ D + + ++  GT  YI+PE+ 
Sbjct: 208 HQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 264
Query: 628 YTIVV-TGK----CDVYSFGVVALEVLMGTHP 654
             +    GK    CD +S GV   E+L G  P
Sbjct: 265 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEA--HVLS 504
           AT  +     IG G YG+VYKA  P  G  VALK +     E+   + + +  A    L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 505 TVRHRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
              H N+V+L   C   +      + L++E++++  L   L D      L      ++++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG-- 617
                L +LH +C   I+HRD+   NIL+ S     +ADFG AR+     SY+   A   
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALAPVV 172
Query: 618 -TYGYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            T  Y APE+          D++S G +  E+ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 12/212 (5%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEG-KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF I   IG G +G V   ++    ++ A+K L+  E    A    F+ E  VL     
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           + I  L+     +  ++L+ +Y   G L  +L   ++ +  +  +    +  +  A+  +
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY--IGEMVLAIDSI 191
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGTYGYIAPELA 627
           H    L  +HRDI  +N+LLD N    +ADFG+   ++ D + + ++  GT  YI+PE+ 
Sbjct: 192 HQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 248
Query: 628 YTIVV-TGK----CDVYSFGVVALEVLMGTHP 654
             +    GK    CD +S GV   E+L G  P
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVVALK-KLHHSETEDSAFVKSFQNEAHVLSTV 506
           E   +  CIG G +G V++     PE   +A+  K   + T DS   K F  EA  +   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQF 68
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H +IVKL G  + +  +++I E    G L   L     +++L     +     ++ AL+
Sbjct: 69  DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALA 125
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAP 624
           YL    +   +HRDI++ N+L+ SN    + DFG +R +  DS+Y     G     ++AP
Sbjct: 126 YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAP 181
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
           E       T   DV+ FGV   E+LM G  P
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 100/220 (45%), Gaps = 27/220 (12%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL----PEGKVVALKKLHHSE-TEDSAFVKSFQNEAHVLS 504
           E+F +   +GTG YG V+          GK+ A+K L  +   + +   +  + E  VL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 505 TVRHRN-IVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI-VKSV 561
            +R    +V L Y F    K + LI +Y+  G LF  L   +   E      V I V  +
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEI 168
Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYG 620
             AL +LH    L II+RDI   NILLDSN    + DFG ++    D + R     GT  
Sbjct: 169 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 621 YIAPELAYTIVVTGK------CDVYSFGVVALEVLMGTHP 654
           Y+AP+    IV  G        D +S GV+  E+L G  P
Sbjct: 226 YMAPD----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVVALK-KLHHSETEDSAFVKSFQNEAHVLSTV 506
           E   +  CIG G +G V++     PE   +A+  K   + T DS   K F  EA  +   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQF 68
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H +IVKL G  + +  +++I E    G L   L     +++L     +     ++ AL+
Sbjct: 69  DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALA 125
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAP 624
           YL    +   +HRDI++ N+L+ SN    + DFG +R +  DS+Y     G     ++AP
Sbjct: 126 YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAP 181
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
           E       T   DV+ FGV   E+LM G  P
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 451 DFHIKYCIGTGGYGSV----YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           DFH    IG G +G V    +KAE     V  L+K    + ++   + S +N   +L  V
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV--LLKNV 96
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
           +H  +V L+        ++ + +Y+  G LF  L  +   +E    +       +A AL 
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE---PRARFYAAEIASALG 153
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           YLH   +L+I++RD+   NILLDS     + DFG  +     +S  +   GT  Y+APE+
Sbjct: 154 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            +        D +  G V  E+L G  P
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 21/221 (9%)
Query: 447 NATEDFHIKY-------CIGTGGYGSVYKAEL--PEGKVVALK-KLHHSETEDSAFVKSF 496
           ++T D+ I+        CIG G +G V++     PE   +A+  K   + T DS   K F
Sbjct: 5   SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-F 63
Query: 497 QNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
             EA  +    H +IVKL G  + +  +++I E    G L   L     +++L     + 
Sbjct: 64  LQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLIL 120
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
               ++ AL+YL    +   +HRDI++ N+L+ SN    + DFG +R +  DS+Y     
Sbjct: 121 YAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASK 176
Query: 617 GTY--GYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
           G     ++APE       T   DV+ FGV   E+LM G  P
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVVALK-KLHHSETEDSAFVKSFQNEAHVLSTV 506
           E   +  CIG G +G V++     PE   +A+  K   + T DS   K F  EA  +   
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQF 71
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H +IVKL G  + +  +++I E    G L   L     +++L     +     ++ AL+
Sbjct: 72  DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALA 128
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAP 624
           YL    +   +HRDI++ N+L+ SN    + DFG +R +  DS+Y     G     ++AP
Sbjct: 129 YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAP 184
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
           E       T   DV+ FGV   E+LM G  P
Sbjct: 185 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 215

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 458 IGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G+G +G+V K   ++ +       K+  +E  D A       EA+V+  + +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G C  +  M L+ E  E G L   L  +    + N    + +V  V+  + YL      +
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 131
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG-----YIAPELAYTI 630
            +HRD+++ N+LL +   A ++DFG ++ L  D +    +A T+G     + APE     
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--XYKAQTHGKWPVKWYAPECINYY 189
Query: 631 VVTGKCDVYSFGVVALEVL-MGTHP 654
             + K DV+SFGV+  E    G  P
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVVALK-KLHHSETEDSAFVKSFQNEAHVLSTV 506
           E   +  CIG G +G V++     PE   +A+  K   + T DS   K F  EA  +   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQF 65
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H +IVKL G  + +  +++I E    G L   L     +++L     +     ++ AL+
Sbjct: 66  DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALA 122
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAP 624
           YL    +   +HRDI++ N+L+ SN    + DFG +R +  DS+Y     G     ++AP
Sbjct: 123 YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAP 178
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
           E       T   DV+ FGV   E+LM G  P
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 209

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVVALK-KLHHSETEDSAFVKSFQNEAHVLSTV 506
           E   +  CIG G +G V++     PE   +A+  K   + T DS   K F  EA  +   
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQF 70
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H +IVKL G  + +  +++I E    G L   L     +++L     +     ++ AL+
Sbjct: 71  DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALA 127
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAP 624
           YL    +   +HRDI++ N+L+ SN    + DFG +R +  DS+Y     G     ++AP
Sbjct: 128 YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAP 183
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
           E       T   DV+ FGV   E+LM G  P
Sbjct: 184 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 214

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 38/231 (16%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSA-FVKS-------------F 496
           D+ I   +  G +  +   E  + K  ALKK   S  E    F KS             F
Sbjct: 32  DYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 497 QNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDE--AIELNWTKR 554
           +NE  +++ +++   +   G   +   +++IYEYME  S   +L  D+    ++ N+T  
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS---ILKFDEYFFVLDKNYTCF 147
Query: 555 VNI------VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           + I      +KSV ++ SY+H++   +I HRD+  +NIL+D N    ++DFG +  + VD
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM-VD 204
Query: 609 SSYRTLRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
              +  R GTY ++ PE      +Y      K D++S G+    +     P
Sbjct: 205 KKIKGSR-GTYEFMPPEFFSNESSYN---GAKVDIWSLGICLYVMFYNVVP 251

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 450 EDFHIKYCIGTGGYGSVYKAE----LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           E ++I   +G G +G V K +      E  V  + K      + S  ++    E  +L  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR----EVELLKK 77
Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE---LNWTKRVNIVKSVA 562
           + H NI+KL+         +++ E    G LF      DE I+    +      I+K V 
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQVF 131
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTY 619
             ++Y+H     +I+HRD+   NILL+S   + +  + DFG +     ++  +  R GT 
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTA 187
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            YIAPE+        KCDV+S GV+   +L GT P
Sbjct: 188 YYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 124/305 (40%), Gaps = 37/305 (12%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           A E   +   +G G +G VY+        + PE +V A+K ++ + +        F NEA
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 64
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTK 553
            V+      ++V+L G     +   +I E M RG L   L      +E N        +K
Sbjct: 65  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 124
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            + +   +A  ++YL+ +     +HRD+++ N ++  +    + DFG  R +      R 
Sbjct: 125 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 181
Query: 614 LRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEV-LMGTHPXXXXXXXXXXXXPKIM 670
              G     +++PE     V T   DV+SFGVV  E+  +   P             +++
Sbjct: 182 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVL 235
Query: 671 LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKAL 730
              +    L  P N     D++L   +   C    PK RP+   I   +   K  M+   
Sbjct: 236 RFVMEGGLLDKPDN---CPDMLL--ELMRMCWQYNPKMRPSFLEIISSI---KEEMEPGF 287
Query: 731 KEISI 735
           +E+S 
Sbjct: 288 REVSF 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEA--HVLS 504
           AT  +     IG G YG+VYKA  P  G  VALK +     E+   + + +  A    L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 505 TVRHRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
              H N+V+L   C   +      + L++E++++  L   L D      L      ++++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
                L +LH +C   I+HRD+   NIL+ S     +ADFG AR+     +   +   T 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPV-VVTL 175
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+          D++S G +  E+ 
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 450 EDFHIKYCIGTGGYGSVYKAE----LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           E ++I   +G G +G V K +      E  V  + K      + S  ++    E  +L  
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR----EVELLKK 77
Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE---LNWTKRVNIVKSVA 562
           + H NI+KL+         +++ E    G LF      DE I+    +      I+K V 
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQVF 131
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTY 619
             ++Y+H     +I+HRD+   NILL+S   + +  + DFG +     ++  +  R GT 
Sbjct: 132 SGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTA 187
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            YIAPE+        KCDV+S GV+   +L GT P
Sbjct: 188 YYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 14/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            ED+ +   +G G  G V  A   + E + VA+K +      D    ++ + E  +   +
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTE-EAVAVKIVDMKRAVDCP--ENIKKEICINKML 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H N+VK YG        +L  EY   G LF  +  D   I +           +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVV 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAP 624
           YLH    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 625 ELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           EL        +  DV+S G+V   +L G  P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 89
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKY 147
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D    ++   T       ++
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEXXSVHNKTGAKLPVKWM 203
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G +G V+K  E   G  +A K +     +D   VK   NE  V++ + H N+++LY 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYD 153
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
               K  + L+ EY++ G LF  +   DE+  L     +  +K +   + ++H    + I
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII--DESYNLTELDTILFMKQICEGIRHMHQ---MYI 208
Query: 577 IHRDISSNNILLDSNLEA---SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVT 633
           +H D+   NIL   N +A    + DFG AR        + +  GT  ++APE+     V+
Sbjct: 209 LHLDLKPENILC-VNRDAKQIKIIDFGLARRYKPREKLK-VNFGTPEFLAPEVVNYDFVS 266
Query: 634 GKCDVYSFGVVALEVLMGTHP 654
              D++S GV+A  +L G  P
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSP 287

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 458 IGTGGYG-SVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G ++      +G+   +K+++ S        +S + E  VL+ ++H NIV+   
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-RREVAVLANMKHPNIVQYRE 90
Query: 517 FCLHKKCMFLIYEYMERGSLF-------CVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
                  ++++ +Y E G LF        VL  +D+   L+W  ++ +      AL ++H
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI--LDWFVQICL------ALKHVH 142
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYGYIAPELA 627
                 I+HRDI S NI L  +    + DFG AR+L  +S+    RA  GT  Y++PE+ 
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEIC 197
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTH 653
                  K D+++ G V  E+    H
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH 223

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 452 FHIKYCIGTGGYGSVY---KAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           F +   +G G +G V+   K   P+ G + A+K L  +  +    V++ + E  +L+ V 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVN 88
Query: 508 HRNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR--VNIVKSVAHA 564
           H  +VKL Y F    K ++LI +++  G LF  L     + E+ +T+      +  +A  
Sbjct: 89  HPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALG 142
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR--LLHVDSSYRTLRAGTYGYI 622
           L +LH   +L II+RD+   NILLD      + DFG ++  + H   +Y     GT  Y+
Sbjct: 143 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSF--CGTVEYM 197
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           APE+      +   D +S+GV+  E+L G+ P
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEA--HVLS 504
           AT  +     IG G YG+VYKA  P  G  VALK +     E+   + + +  A    L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 505 TVRHRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
              H N+V+L   C   +      + L++E++++  L   L D      L      ++++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
                L +LH +C   I+HRD+   NIL+ S     +ADFG AR+     +   +   T 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPV-VVTL 175
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+          D++S G +  E+ 
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 22/217 (10%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKA-------ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           A E   +   +G G +G VY+        + PE +V A+K ++ + +        F NEA
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERI--EFLNEA 73
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTK 553
            V+      ++V+L G     +   +I E M RG L   L      +E N        +K
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            + +   +A  ++YL+ +     +HRD+++ N ++  +    + DFG  R +      R 
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 190
Query: 614 LRAG--TYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
              G     +++PE     V T   DV+SFGVV  E+
Sbjct: 191 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 90
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKF 148
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  + ++   T       ++
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWM 204
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G   +G VYK  L       + + VA+K L   +  +    + F++EA + + ++H N+
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSL--FCVLH---------DDDEAIE--LNWTKRVNIV 558
           V L G     + + +I+ Y   G L  F V+          DDD  ++  L     V++V
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 559 KSVAHALSYL--HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
             +A  + YL  HH     ++H+D+++ N+L+   L   ++D G  R ++    Y+ L  
Sbjct: 152 AQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 617 G--TYGYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
                 ++APE       +   D++S+GVV  EV 
Sbjct: 207 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 95
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + +
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKF 153
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  + ++   T       ++
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWM 209
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 121/254 (47%), Gaps = 33/254 (12%)
Query: 416 KNPRLNSRAAKNGD---VFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAE-L 471
           + P+ +S   ++ D     S+ N + ++  +DL    E       +G G YG V K   +
Sbjct: 21  EQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIME-------LGRGAYGVVEKMRHV 73
Query: 472 PEGKVVALKKLHHSETEDSAFVKSFQNEAHV-LSTVRHRNIVKLYGFCLHKKCMFLIYEY 530
           P G+++A+K++    T +S   K    +  + + TV     V  YG    +  +++  E 
Sbjct: 74  PSGQIMAVKRIR--ATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 131
Query: 531 MERG--SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL 588
           M+      +  + D  + I  +   ++ +  S+  AL +LH    LS+IHRD+  +N+L+
Sbjct: 132 MDTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHLH--SKLSVIHRDVKPSNVLI 187
Query: 589 DSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL--------AYTIVVTGKCDVYS 640
           ++  +  + DFG +  L VDS  +T+ AG   Y+APE          Y++    K D++S
Sbjct: 188 NALGQVKMCDFGISGYL-VDSVAKTIDAGCKPYMAPERINPELNQKGYSV----KSDIWS 242
Query: 641 FGVVALEVLMGTHP 654
            G+  +E+ +   P
Sbjct: 243 LGITMIELAILRFP 256

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 149
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKF 207
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  + ++   T       ++
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWM 263
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 42/288 (14%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G   +G VYK  L       + + VA+K L   +  +    + F++EA + + ++H N+
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSL--FCVLH---------DDDEAIE--LNWTKRVNIV 558
           V L G     + + +I+ Y   G L  F V+          DDD  ++  L     V++V
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 559 KSVAHALSYL--HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
             +A  + YL  HH     ++H+D+++ N+L+   L   ++D G  R ++    Y+ L  
Sbjct: 135 AQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 617 G--TYGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLID 673
                 ++APE       +   D++S+GVV  EV   G  P                +++
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--------VVE 241
Query: 674 VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA 721
           ++  R   P           V  +   C +  P  RP  + I   L A
Sbjct: 242 MIRNRQVLPCPDDCPA---WVYALMIECWNEFPSRRPRFKDIHSRLRA 286

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 88
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + +
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKF 146
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  + ++   T       ++
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWM 202
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 91
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + +
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKF 149
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR + +D  + ++   T       ++
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-LDKEFDSVHNKTGAKLPVKWM 205
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 91
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + +
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKF 149
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  + ++   T       ++
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWM 205
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 453 HIKYCIGTGGYGSVYKAEL--PEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L   +GK +  A+K L  +   D   V  F  E  ++    H
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 90
Query: 509 RNIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKF 148
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-----YGYI 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  + ++   T       ++
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWM 204
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A E   T   T K DV+SFGV+  E++    P
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 448 ATEDFHIKY-------CIGTGGYGSVYKAEL--PEGKVVALK-KLHHSETEDSAFVKSFQ 497
           +T D+ I+        CIG G +G V++     PE   +A+  K   + T DS   K F 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FL 439
Query: 498 NEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI 557
            EA  +    H +IVKL G  + +  +++I E    G L   L     +++L     +  
Sbjct: 440 QEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILY 496
Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
              ++ AL+YL    +   +HRDI++ N+L+ SN    + DFG +R +  DS+Y     G
Sbjct: 497 AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKG 552
Query: 618 TY--GYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
                ++APE       T   DV+ FGV   E+LM G  P
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 107/232 (46%), Gaps = 21/232 (9%)
Query: 458 IGTGGYGSVYKA--ELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G G +GSV +    + + ++ VA+K L   +  + A  +    EA ++  + +  IV+L
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
            G C   + + L+ E    G L   L    E I +  +    ++  V+  + YL      
Sbjct: 76  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEK--- 129
Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTY--GYIAPELAYTIV 631
           + +HRD+++ N+LL +   A ++DFG ++ L  D SY T R AG +   + APE      
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 632 VTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPP 682
            + + DV+S+GV   E L  G  P            P++M      +R+  P
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP------YKKMKGPEVMAFIEQGKRMECP 235

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E + I   +G G +G V++      K   + K    +  D   VK    E  +L+  RHR
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHR 61
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI+ L+      + + +I+E++    +F  +  +  A ELN  + V+ V  V  AL +LH
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVA--DFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
              + +I H DI   NI+  +   +++   +FG AR L    ++R L      Y APE+ 
Sbjct: 120 ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP-EYYAPEVH 175
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
              VV+   D++S G +   +L G +P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVVALK-KLHHSETEDSAFVKSFQNEAHVLSTV 506
           E   +  CIG G +G V++     PE   +A+  K   + T DS   K F  EA  +   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQF 68
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H +IVKL G  + +  +++I E    G L   L     +++L     +     ++ AL+
Sbjct: 69  DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALA 125
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAP 624
           YL    +   +HRDI++ N+L+ SN    + DFG +R +  DS+      G     ++AP
Sbjct: 126 YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAP 181
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
           E       T   DV+ FGV   E+LM G  P
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 119/284 (41%), Gaps = 41/284 (14%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   I   IG G +G VY      G+V    +L   E ++   +K+F+ E       RH 
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRW-HGEVAI--RLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V   G C+    + +I    +  +L+ V+ D    +++N T++  I + +   + YLH
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQ--IAQEIVKGMGYLH 147
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-----TLRAGTYGYIAP 624
                 I+H+D+ S N+  D N +  + DFG   +  V  + R      ++ G   ++AP
Sbjct: 148 ---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 625 ELAYTIV---------VTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVL 675
           E+   +           +   DV++ G +  E+     P            P   +I  +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--------FKTQPAEAIIWQM 255
Query: 676 NQRLSPPVNQ----KIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
              + P ++Q    K + DI+L       C + + + RPT  ++
Sbjct: 256 GTGMKPNLSQIGMGKEISDILLF------CWAFEQEERPTFTKL 293

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 458 IGTGGYGSVYK------AELPEGKVVA---LKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +G GG+   Y+       E+  GKVV    L K H  E            E  +  ++ +
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE--------KMSTEIAIHKSLDN 101
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            ++V  +GF      ++++ E   R SL   LH   +A+     +    ++     + YL
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYL 158
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H++    +IHRD+   N+ L+ +++  + DFG A  +  D   +    GT  YIAPE+  
Sbjct: 159 HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLC 215
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
               + + D++S G +   +L+G  P
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 21/233 (9%)
Query: 430 VFSVWNYDGKILYEDLINATED-----FHIKYCIGTGGYGSVYK-AELPEGKVVALKKLH 483
           VF +W    K  Y   +    D     + I   +GTG +G V++  E   G   A K + 
Sbjct: 136 VFDIW----KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 191
Query: 484 HSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD 543
                D   V+    E   +S +RH  +V L+        M +IYE+M  G LF  +   
Sbjct: 192 TPHESDKETVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA-- 246
Query: 544 DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL--EASVADFGT 601
           DE  +++  + V  ++ V   L ++H +   + +H D+   NI+  +    E  + DFG 
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
              L    S + +  GT  + APE+A    V    D++S GV++  +L G  P
Sbjct: 304 TAHLDPKQSVK-VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 458 IGTGGYGSVYKAELPEG-KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG+V+KA+  E  ++VALK++   + +D     S   E  +L  ++H+NIV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS----VAHALSYLHHDC 572
                K + L++E       FC           N      IVKS    +   L + H   
Sbjct: 69  VLHSDKKLTLVFE-------FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY-TIV 631
           + +++HRD+   N+L++ N E  +ADFG AR   +     +    T  Y  P++ +   +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 632 VTGKCDVYSFGVVALEVLMGTHP 654
            +   D++S G +  E+     P
Sbjct: 179 YSTSIDMWSAGCIFAELANAARP 201

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 458 IGTGGYGSVYK------AELPEGKVVA---LKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +G GG+   Y+       E+  GKVV    L K H  E            E  +  ++ +
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE--------KMSTEIAIHKSLDN 101
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            ++V  +GF      ++++ E   R SL   LH   +A+     +    ++     + YL
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYL 158
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H++    +IHRD+   N+ L+ +++  + DFG A  +  D   +    GT  YIAPE+  
Sbjct: 159 HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLC 215
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
               + + D++S G +   +L+G  P
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   LS+ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLSFC 119
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+  
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 177 GCKYYSTAV----DIWSLGCIFAEMV 198

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +DF     +G G  G V+K       +V  +KL H E +  A       E  VL      
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 126
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            IV  YG       + +  E+M+ GSL  VL       E     +V+I  +V   L+YL 
Sbjct: 127 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSI--AVIKGLTYLR 183
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+  +NIL++S  E  + DFG +  L +DS   +   GT  Y++PE    
Sbjct: 184 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQG 239
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
              + + D++S G+  +E+ +G +P
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 8/205 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +DF     +G G  G V K +     ++  +KL H E +  A       E  VL      
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 74
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            IV  YG       + +  E+M+ GSL  VL +     E     +V+I  +V   L+YL 
Sbjct: 75  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSI--AVLRGLAYLR 131
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+  +NIL++S  E  + DFG +  L +DS   +   GT  Y+APE    
Sbjct: 132 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMAPERLQG 187
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
              + + D++S G+  +E+ +G +P
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 112/255 (43%), Gaps = 42/255 (16%)
Query: 431 FSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAE---LPEGKV---VALKKLHH 484
           F  + YD K  +       E+      +G+G +G V  A    + +  V   VA+K L  
Sbjct: 31  FREYEYDLKWEF-----PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-- 83
Query: 485 SETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD 543
            E  DS+  ++  +E  +++ +  H NIV L G C     ++LI+EY   G L   L   
Sbjct: 84  KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK 143
Query: 544 DE-----AIELNWTKRVN---------------IVKSVAHALSYLHHDCTLSIIHRDISS 583
            E      IE    KR+                    VA  + +L      S +HRD+++
Sbjct: 144 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200
Query: 584 NNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIVVTGKCDVYS 640
            N+L+       + DFG AR +  DS+Y  +R        ++APE  +  + T K DV+S
Sbjct: 201 RNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWS 259
Query: 641 FGVVALEVL-MGTHP 654
           +G++  E+  +G +P
Sbjct: 260 YGILLWEIFSLGVNP 274

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 21/233 (9%)
Query: 430 VFSVWNYDGKILYEDLINATED-----FHIKYCIGTGGYGSVYK-AELPEGKVVALKKLH 483
           VF +W    K  Y   +    D     + I   +GTG +G V++  E   G   A K + 
Sbjct: 30  VFDIW----KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 85
Query: 484 HSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD 543
                D   V+    E   +S +RH  +V L+        M +IYE+M  G LF  +   
Sbjct: 86  TPHESDKETVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA-- 140
Query: 544 DEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL--EASVADFGT 601
           DE  +++  + V  ++ V   L ++H +   + +H D+   NI+  +    E  + DFG 
Sbjct: 141 DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 197
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
              L    S + +  GT  + APE+A    V    D++S GV++  +L G  P
Sbjct: 198 TAHLDPKQSVK-VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 458 IGTGGYGSVYK------AELPEGKVVA---LKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +G GG+   Y+       E+  GKVV    L K H  E            E  +  ++ +
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE--------KMSTEIAIHKSLDN 85
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            ++V  +GF      ++++ E   R SL   LH   +A+     +    ++     + YL
Sbjct: 86  PHVVGFHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYL 142
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H++    +IHRD+   N+ L+ +++  + DFG A  +  D   +    GT  YIAPE+  
Sbjct: 143 HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLC 199
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
               + + D++S G +   +L+G  P
Sbjct: 200 KKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKVVALK-KLHHSETEDSAFVKSFQNEAHVLSTV 506
           E   +  CIG G +G V++     PE   +A+  K   + T DS   K F  EA  +   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQF 68
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H +IVKL G  + +  +++I E    G L   L     +++L     +     ++ AL+
Sbjct: 69  DHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALA 125
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY--GYIAP 624
           YL    +   +HRDI++ N+L+ +     + DFG +R +  DS+Y     G     ++AP
Sbjct: 126 YLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAP 181
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
           E       T   DV+ FGV   E+LM G  P
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 68
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+  
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 184 GCKYYSTAV----DIWSLGCIFAEMV 205

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +DF     +G G  G V+K       +V  +KL H E +  A       E  VL      
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 64
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            IV  YG       + +  E+M+ GSL  VL       E     +V+I  +V   L+YL 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSI--AVIKGLTYLR 121
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+  +NIL++S  E  + DFG +  L +DS   +   GT  Y++PE    
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQG 177
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
              + + D++S G+  +E+ +G +P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 68
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 126
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+  
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 629 TI-VVTGKCDVYSFGVVALEVL 649
                +   D++S G +  E++
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMV 205

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +DF     +G G  G V+K       +V  +KL H E +  A       E  VL      
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 91
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            IV  YG       + +  E+M+ GSL  VL       E     +V+I  +V   L+YL 
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSI--AVIKGLTYLR 148
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+  +NIL++S  E  + DFG +  L +DS   +   GT  Y++PE    
Sbjct: 149 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQG 204
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
              + + D++S G+  +E+ +G +P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 33/231 (14%)
Query: 443 EDLINATEDFHIKY-------CIGTGGYGSVYKAELPEGKVVALK------KLHHSETED 489
           E+L N  ED  I          +G G +GSV +  L +    +LK      KL +S   +
Sbjct: 20  EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79
Query: 490 SAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCM-----FLIYEYMERGSL-----FCV 539
              ++ F +EA  +    H N+++L G C+           +I  +M+ G L     +  
Sbjct: 80  ---IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSR 136
Query: 540 LHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF 599
           L    + I L     +  +  +A  + YL +    + +HRD+++ N +L  ++   VADF
Sbjct: 137 LETGPKHIPLQ--TLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADF 191
Query: 600 GTARLLHVDSSYRTLRAGTY--GYIAPELAYTIVVTGKCDVYSFGVVALEV 648
           G ++ ++    YR  R       +IA E     V T K DV++FGV   E+
Sbjct: 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 175
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 176 LLGCKYYSTAV----DIWSLGCIFAEMV 199

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 458 IGTGGYGSVYK------AELPEGKVVA---LKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +G GG+   Y+       E+  GKVV    L K H  E            E  +  ++ +
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKE--------KMSTEIAIHKSLDN 101
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            ++V  +GF      ++++ E   R SL   LH   +A+     +    ++     + YL
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYL 158
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H++    +IHRD+   N+ L+ +++  + DFG A  +  D   +    GT  YIAPE+  
Sbjct: 159 HNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLC 215
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
               + + D++S G +   +L+G  P
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+  
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 629 TI-VVTGKCDVYSFGVVALEVL 649
                +   D++S G +  E++
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMV 198

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +DF     +G G  G V+K       +V  +KL H E +  A       E  VL      
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 64
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            IV  YG       + +  E+M+ GSL  VL       E     +V+I  +V   L+YL 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSI--AVIKGLTYLR 121
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+  +NIL++S  E  + DFG +  L +DS   +   GT  Y++PE    
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQG 177
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
              + + D++S G+  +E+ +G +P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +DF     +G G  G V+K       +V  +KL H E +  A       E  VL      
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 64
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            IV  YG       + +  E+M+ GSL  VL       E     +V+I  +V   L+YL 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSI--AVIKGLTYLR 121
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+  +NIL++S  E  + DFG +  L +DS   +   GT  Y++PE    
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQG 177
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
              + + D++S G+  +E+ +G +P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +DF     +G G  G V+K       +V  +KL H E +  A       E  VL      
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 64
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            IV  YG       + +  E+M+ GSL  VL       E     +V+I  +V   L+YL 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSI--AVIKGLTYLR 121
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+  +NIL++S  E  + DFG +  L +DS   +   GT  Y++PE    
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQG 177
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
              + + D++S G+  +E+ +G +P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +DF     +G G  G V+K       +V  +KL H E +  A       E  VL      
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 64
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            IV  YG       + +  E+M+ GSL  VL       E     +V+I  +V   L+YL 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSI--AVIKGLTYLR 121
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+  +NIL++S  E  + DFG +  L +DS   +   GT  Y++PE    
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQG 177
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
              + + D++S G+  +E+ +G +P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+  
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 177 GCKYYSTAV----DIWSLGCIFAEMV 198

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+  
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 177 GCKYYSTAV----DIWSLGCIFAEMV 198

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+  
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 176 GCKYYSTAV----DIWSLGCIFAEMV 197

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+  
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 176 GCKYYSTAV----DIWSLGCIFAEMV 197

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +DF     +G G  G V+K       +V  +KL H E +  A       E  VL      
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 83
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            IV  YG       + +  E+M+ GSL  VL       E     +V+I  +V   L+YL 
Sbjct: 84  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSI--AVIKGLTYLR 140
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+  +NIL++S  E  + DFG +  L +DS   +   GT  Y++PE    
Sbjct: 141 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSF-VGTRSYMSPERLQG 196
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
              + + D++S G+  +E+ +G +P
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 65
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 123
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+  
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 180
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 181 GCKYYSTAV----DIWSLGCIFAEMV 202

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 458 IGTGGYGSVYKA--ELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G G +GSV +    + + ++ VA+K L   +  + A  +    EA ++  + +  IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
            G C   + + L+ E    G L   L    E I +  +    ++  V+  + YL      
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEK--- 455
Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTY--GYIAPELAYTIV 631
           + +HR++++ N+LL +   A ++DFG ++ L  D SY T R AG +   + APE      
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 632 VTGKCDVYSFGVVALEVL 649
            + + DV+S+GV   E L
Sbjct: 516 FSSRSDVWSYGVTMWEAL 533

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 457 CIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
            IG G +G V++A+L E   VA+KK+           K F+N E  ++  V+H N+V L 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQD--------KRFKNRELQIMRIVKHPNVVDLK 98
Query: 516 GFCL----HKKCMF--LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK----SVAHAL 565
            F       K  +F  L+ EY+       V        +L  T  + ++K     +  +L
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           +Y+H   ++ I HRDI   N+LLD       + DFG+A++L       +     Y Y AP
Sbjct: 155 AYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-YRAP 210
Query: 625 ELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           EL +     T   D++S G V  E++ G
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 447 NATEDFHIKYCIGTGGYGSVY--KAELPEGKVVALKKLHHSET-EDSAFVKSFQNEAHVL 503
           N  + F     +G+G +  V+  K  L  GK+ ALK +  S    DS    S +NE  VL
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDS----SLENEIAVL 60
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-WTKRVN--IVKS 560
             ++H NIV L          +L+ + +  G LF      D  +E   +T++    +++ 
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF------DRILERGVYTEKDASLVIQQ 114
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILL---DSNLEASVADFGTARLLHVDSSYRTLRAG 617
           V  A+ YLH +    I+HRD+   N+L    + N +  + DFG +++    +   +   G
Sbjct: 115 VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTACG 169
Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           T GY+APE+      +   D +S GV+   +L G  P
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 446 INATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           + + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLK 60
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS---- 560
            + H NIVKL      +  ++L++E++        L D  +A  L     + ++KS    
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSMD-----LKDFMDASALTGIP-LPLIKSYLFQ 114
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   L++ H   +  ++HRD+   N+L+++     +ADFG AR   V          T  
Sbjct: 115 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 171
Query: 621 YIAPEL-----AYTIVVTGKCDVYSFGVVALEVL 649
           Y APE+      Y+  V    D++S G +  E++
Sbjct: 172 YRAPEILLGCKYYSTAV----DIWSLGCIFAEMV 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS----VA 562
            H NIVKL      +  ++L++E++ +      L D  +A  L     + ++KS    + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQD-----LKDFMDASALTGIP-LPLIKSYLFQLL 113
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L++ H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y 
Sbjct: 114 QGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 623 APEL-----AYTIVVTGKCDVYSFGVVALEVL 649
           APE+      Y+  V    D++S G +  E++
Sbjct: 171 APEILLGCKYYSTAV----DIWSLGCIFAEMV 198

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 446 INATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           + + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L 
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLK 59
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS---- 560
            + H NIVKL      +  ++L++E++        L D  +A  L     + ++KS    
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLSMD-----LKDFMDASALTGIP-LPLIKSYLFQ 113
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG 620
           +   L++ H   +  ++HRD+   N+L+++     +ADFG AR   V          T  
Sbjct: 114 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLW 170
Query: 621 YIAPEL-----AYTIVVTGKCDVYSFGVVALEVL 649
           Y APE+      Y+  V    D++S G +  E++
Sbjct: 171 YRAPEILLGCKYYSTAV----DIWSLGCIFAEMV 200

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 448 ATEDFHIKY-------CIGTGGYGSVYKAEL--PEGKVVALK-KLHHSETEDSAFVKSFQ 497
           +T D+ I+        CIG G +G V++     PE   +A+  K   + T DS   K F 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FL 439
Query: 498 NEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI 557
            EA  +    H +IVKL G  + +  +++I E    G L   L     +++L     +  
Sbjct: 440 QEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILY 496
Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
              ++ AL+YL    +   +HRDI++ N+L+ +     + DFG +R +  DS+Y     G
Sbjct: 497 AYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKG 552
Query: 618 TY--GYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
                ++APE       T   DV+ FGV   E+LM G  P
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 446 INATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           + + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L 
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLK 61
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
            + H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQG 119
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           L++ H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y AP
Sbjct: 120 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 176
Query: 625 EL-----AYTIVVTGKCDVYSFGVVALEVL 649
           E+      Y+  V    D++S G +  E++
Sbjct: 177 EILLGCKYYSTAV----DIWSLGCIFAEMV 202

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 52/302 (17%)
Query: 454 IKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV--RHRNI 511
           ++  IG G +G V++ +   G+ VA+K     E       +S+  EA +  TV  RH NI
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENI 98
Query: 512 VKLYGFCLHKK-------CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           +   GF             ++L+ +Y E GSLF  L+     +E      + +  S A  
Sbjct: 99  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 151
Query: 565 LSYLHHDCT-----LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL----- 614
           L++LH +        +I HRD+ S NIL+  N    +AD G A  +  DS+  T+     
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 209
Query: 615 -RAGTYGYIAPELAYTIV------VTGKCDVYSFGVVALEV-----LMGTHPXXXX-XXX 661
            R GT  Y+APE+    +         + D+Y+ G+V  E+     + G H         
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 662 XXXXXPKI--MLIDVLNQRLSP--PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
                P +  M   V  Q+L P  P   +  + + +++ I   C  +   +R T  RI +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 718 EL 719
            L
Sbjct: 330 TL 331

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 446 INATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           + + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLK 60
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
            + H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           L++ H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y AP
Sbjct: 119 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 625 EL-----AYTIVVTGKCDVYSFGVVALEVL 649
           E+      Y+  V    D++S G +  E++
Sbjct: 176 EILLGCKYYSTAV----DIWSLGCIFAEMV 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+  
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 176 GCKYYSTAV----DIWSLGCIFAEMV 197

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 114/258 (44%), Gaps = 51/258 (19%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETE--DSAFVKSFQNEAH 501
           L+   + +H+K  IG G YG V  A E     + A+K ++ ++    +   V+  + E  
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH---DD--------------- 543
           ++  + H NI +LY     ++ + L+ E    G L   L+   DD               
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 544 ------DEAI---------ELNWTKR----VNIVKSVAHALSYLHHDCTLSIIHRDISSN 584
                 +EAI          L++ +R     NI++ +  AL YLH+     I HRDI   
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPE 197
Query: 585 NILLDSN--LEASVADFGTARLLHV--DSSY--RTLRAGTYGYIAPELAYTIVVT--GKC 636
           N L  +N   E  + DFG ++  +   +  Y   T +AGT  ++APE+  T   +   KC
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 637 DVYSFGVVALEVLMGTHP 654
           D +S GV+   +LMG  P
Sbjct: 258 DAWSAGVLLHLLLMGAVP 275

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 178 LLGCKYYSTAV----DIWSLGCIFAEMV 201

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 130/302 (43%), Gaps = 52/302 (17%)
Query: 454 IKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV--RHRNI 511
           ++  IG G +G V++ +   G+ VA+K +  S  E S F      EA +  TV  RH NI
Sbjct: 33  LQESIGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWF-----REAEIYQTVMLRHENI 85
Query: 512 VKLYGFCLHKK-------CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           +   GF             ++L+ +Y E GSLF  L+     +E      + +  S A  
Sbjct: 86  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 138
Query: 565 LSYLHHDCT-----LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL----- 614
           L++LH +        +I HRD+ S NIL+  N    +AD G A  +  DS+  T+     
Sbjct: 139 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 196
Query: 615 -RAGTYGYIAPELAYTIV------VTGKCDVYSFGVVALEV-----LMGTHPXXXX-XXX 661
            R GT  Y+APE+    +         + D+Y+ G+V  E+     + G H         
Sbjct: 197 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 256
Query: 662 XXXXXPKI--MLIDVLNQRLSP--PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
                P +  M   V  Q+L P  P   +  + + +++ I   C  +   +R T  RI +
Sbjct: 257 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 316
Query: 718 EL 719
            L
Sbjct: 317 TL 318

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 52/298 (17%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV--RHRNIVKLY 515
           IG G +G V++ +   G+ VA+K +  S  E S F      EA +  TV  RH NI+   
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWF-----REAEIYQTVMLRHENIL--- 60
Query: 516 GFCLHKK-------CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           GF             ++L+ +Y E GSLF  L+     +E      + +  S A  L++L
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHL 116
Query: 569 HHDCT-----LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL------RAG 617
           H +        +I HRD+ S NIL+  N    +AD G A  +  DS+  T+      R G
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVG 174
Query: 618 TYGYIAPELAYTIV------VTGKCDVYSFGVVALEV-----LMGTHPXXXX-XXXXXXX 665
           T  Y+APE+    +         + D+Y+ G+V  E+     + G H             
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 666 XPKI--MLIDVLNQRLSP--PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            P +  M   V  Q+L P  P   +  + + +++ I   C  +   +R T  RI + L
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 178 LLGCKYYSTAV----DIWSLGCIFAEMV 201

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 458 IGTGGYGSVYKAELPEG-KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG+V+KA+  E  ++VALK++   + +D     S   E  +L  ++H+NIV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS----VAHALSYLHHDC 572
                K + L++E       FC           N      IVKS    +   L + H   
Sbjct: 69  VLHSDKKLTLVFE-------FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 573 TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY-TIV 631
           + +++HRD+   N+L++ N E  +A+FG AR   +     +    T  Y  P++ +   +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 632 VTGKCDVYSFGVVALEVLMGTHP 654
            +   D++S G +  E+     P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRP 201

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YGSV K    P G+++A+K++  S  ++    +   +   V+ +     IV+ YG
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 517 FCLHKK----CMFLIYEYMER--GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
               +     CM L+    ++    ++ VL   D+ I      ++ +  +   AL++L  
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVL---DDVIPEEILGKITL--ATVKALNHLKE 143
Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL---- 626
           +  L IIHRDI  +NILLD +    + DFG +  L VDS  +T  AG   Y+APE     
Sbjct: 144 N--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPERIDPS 200
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           A       + DV+S G+   E+  G  P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 8/207 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-R 507
           +DF +   IG G Y  V    L +  ++ A+K +      D   +   Q E HV      
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H  +V L+     +  +F + EY+  G L   +       +L           ++ AL+Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNY 125
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH      II+RD+  +N+LLDS     + D+G  +         +   GT  YIAPE+ 
Sbjct: 126 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL 182
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
                    D ++ GV+  E++ G  P
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSP 209

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 177 LLGCKYYSTAV----DIWSLGCIFAEMV 200

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 130/302 (43%), Gaps = 52/302 (17%)
Query: 454 IKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV--RHRNI 511
           ++  IG G +G V++ +   G+ VA+K +  S  E S F      EA +  TV  RH NI
Sbjct: 13  LQESIGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWF-----REAEIYQTVMLRHENI 65
Query: 512 VKLYGFCLHKK-------CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           +   GF             ++L+ +Y E GSLF  L+     +E      + +  S A  
Sbjct: 66  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 118
Query: 565 LSYLHHDCT-----LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL----- 614
           L++LH +        +I HRD+ S NIL+  N    +AD G A  +  DS+  T+     
Sbjct: 119 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 176
Query: 615 -RAGTYGYIAPELAYTIV------VTGKCDVYSFGVVALEV-----LMGTHPXXXX-XXX 661
            R GT  Y+APE+    +         + D+Y+ G+V  E+     + G H         
Sbjct: 177 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 236
Query: 662 XXXXXPKI--MLIDVLNQRLSP--PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
                P +  M   V  Q+L P  P   +  + + +++ I   C  +   +R T  RI +
Sbjct: 237 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 296
Query: 718 EL 719
            L
Sbjct: 297 TL 298

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 52/298 (17%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV--RHRNIVKLY 515
           IG G +G V++ +   G+ VA+K +  S  E S F      EA +  TV  RH NI+   
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWF-----REAEIYQTVMLRHENIL--- 63
Query: 516 GFCLHKK-------CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           GF             ++L+ +Y E GSLF  L+     +E      + +  S A  L++L
Sbjct: 64  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHL 119
Query: 569 HHDCT-----LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL------RAG 617
           H +        +I HRD+ S NIL+  N    +AD G A  +  DS+  T+      R G
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVG 177
Query: 618 TYGYIAPELAYTIV------VTGKCDVYSFGVVALEV-----LMGTHPXXXX-XXXXXXX 665
           T  Y+APE+    +         + D+Y+ G+V  E+     + G H             
Sbjct: 178 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 237
Query: 666 XPKI--MLIDVLNQRLSP--PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            P +  M   V  Q+L P  P   +  + + +++ I   C  +   +R T  RI + L
Sbjct: 238 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 295

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 8/207 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-R 507
           +DF +   IG G Y  V    L +  ++ A+K +      D   +   Q E HV      
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H  +V L+     +  +F + EY+  G L   +       +L           ++ AL+Y
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNY 121
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH      II+RD+  +N+LLDS     + D+G  +         +   GT  YIAPE+ 
Sbjct: 122 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL 178
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
                    D ++ GV+  E++ G  P
Sbjct: 179 RGEDYGFSVDWWALGVLMFEMMAGRSP 205

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 458 IGTGGYGSVYKAEL-PEG----KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV 512
           +G G +G V      PEG    + VA+K L          +   + E  +L  + H NIV
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 513 KLYGFCLHK--KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           K  G C       + LI E++  GSL   L  +   I  N  +++     +   + YL  
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI--NLKQQLKYAVQICKGMDYLG- 131
Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---RAGTYGYIAPELA 627
             +   +HRD+++ N+L++S  +  + DFG  + +  D    T+   R     + APE  
Sbjct: 132 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 628 YTIVVTGKCDVYSFGVVALEVL 649
                    DV+SFGV   E+L
Sbjct: 190 MQSKFYIASDVWSFGVTLHELL 211

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 177 LLGCKYYSTAV----DIWSLGCIFAEMV 200

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 18/196 (9%)
Query: 471 LPEGKVVALKKLHHSETEDSAFVK--SFQNEAHVLSTVR-------HRNIVKLYGFCLHK 521
           L EG     +K  H ++  +  VK  S + EA+    +        H NIVKL+     +
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78
Query: 522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDI 581
              FL+ E +  G LF  +       E   T+   I++ +  A+S++H    + ++HRD+
Sbjct: 79  LHTFLVMELLNGGELFERIKKKKHFSE---TEASYIMRKLVSAVSHMH---DVGVVHRDL 132
Query: 582 SSNNILL---DSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDV 638
              N+L    + NLE  + DFG ARL   D+        T  Y APEL         CD+
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDL 192
Query: 639 YSFGVVALEVLMGTHP 654
           +S GV+   +L G  P
Sbjct: 193 WSLGVILYTMLSGQVP 208

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 52/298 (17%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV--RHRNIVKLY 515
           IG G +G V++ +   G+ VA+K +  S  E S F      EA +  TV  RH NI+   
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWF-----REAEIYQTVMLRHENIL--- 61
Query: 516 GFCLHKK-------CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           GF             ++L+ +Y E GSLF  L+     +E      + +  S A  L++L
Sbjct: 62  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHL 117
Query: 569 HHDCT-----LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL------RAG 617
           H +        +I HRD+ S NIL+  N    +AD G A  +  DS+  T+      R G
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVG 175
Query: 618 TYGYIAPELAYTIV------VTGKCDVYSFGVVALEV-----LMGTHPXXXX-XXXXXXX 665
           T  Y+APE+    +         + D+Y+ G+V  E+     + G H             
Sbjct: 176 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 235
Query: 666 XPKI--MLIDVLNQRLSP--PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            P +  M   V  Q+L P  P   +  + + +++ I   C  +   +R T  RI + L
Sbjct: 236 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 293

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 458 IGTGGYGSVYKAEL-PEG----KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIV 512
           +G G +G V      PEG    + VA+K L          +   + E  +L  + H NIV
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 513 KLYGFCLHK--KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           K  G C       + LI E++  GSL   L  +   I  N  +++     +   + YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI--NLKQQLKYAVQICKGMDYLG- 143
Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---RAGTYGYIAPELA 627
             +   +HRD+++ N+L++S  +  + DFG  + +  D    T+   R     + APE  
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 628 YTIVVTGKCDVYSFGVVALEVL 649
                    DV+SFGV   E+L
Sbjct: 202 MQSKFYIASDVWSFGVTLHELL 223

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 175 LLGCKYYSTAV----DIWSLGCIFAEMV 198

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 175 LLGCKYYSTAV----DIWSLGCIFAEMV 198

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 176 LLGCKYYSTAV----DIWSLGCIFAEMV 199

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVA---LKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  +   GK  A   +KK   S +      +  + E ++L  +RH NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K +   + YLH   +
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ---FLKQILDGVHYLH---S 126
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
             I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI-FGTPEFVAPEIVNY 185
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 186 EPLGLEADMWSIGVITYILLSGASP 210

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++++     +       I L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 178 LLGCKYYSTAV----DIWSLGCIFAEMV 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 120 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 177 LLGCKYYSTAV----DIWSLGCIFAEMV 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 175 LLGCKYYSTAV----DIWSLGCIFAEMV 198

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 457 CIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQN-EAHVLS--TVRHRNIV 512
            +G+G +G+V+K   +PEG+ + +  +     ED +  +SFQ    H+L+  ++ H +IV
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIP-VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRVNIVKSVAHALSYL 568
           +L G C     + L+ +Y+  GSL   +     A+     LNW  ++      A  + YL
Sbjct: 97  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 149
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS---YRTLRAGTYGYIAPE 625
                  ++HR++++ N+LL S  +  VADFG A LL  D     Y   +     ++A E
Sbjct: 150 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT-PIKWMALE 205
Query: 626 LAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
             +    T + DV+S+GV   E++  G  P
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 8/207 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-R 507
           +DF +   IG G Y  V    L +  ++ A+K +      D   +   Q E HV      
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H  +V L+     +  +F + EY+  G L   +       +L           ++ AL+Y
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNY 136
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH      II+RD+  +N+LLDS     + D+G  +         +   GT  YIAPE+ 
Sbjct: 137 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL 193
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
                    D ++ GV+  E++ G  P
Sbjct: 194 RGEDYGFSVDWWALGVLMFEMMAGRSP 220

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+  
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 176 GCKYYSTAV----DIWSLGCIFAEMV 197

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVA---LKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  +   GK  A   +KK   S +      +  + E ++L  +RH NI+ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K +   + YLH   +
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ---FLKQILDGVHYLH---S 133
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
             I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI-FGTPEFVAPEIVNY 192
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 457 CIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEA-HVLS--TVRHRNIV 512
            +G+G +G+V+K   +PEG+ + +  +     ED +  +SFQ    H+L+  ++ H +IV
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIP-VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE----LNWTKRVNIVKSVAHALSYL 568
           +L G C     + L+ +Y+  GSL   +     A+     LNW  ++      A  + YL
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 131
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS---YRTLRAGTYGYIAPE 625
                  ++HR++++ N+LL S  +  VADFG A LL  D     Y   +     ++A E
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT-PIKWMALE 187
Query: 626 LAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
             +    T + DV+S+GV   E++  G  P
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+  
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 176 GCKYYSTAV----DIWSLGCIFAEMV 197

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 119 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 176 LLGCKYYSTAV----DIWSLGCIFAEMV 199

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 446 INATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           + + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLK 60
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
            + H NIVKL      +  ++L++E++       +       I L   K  + +  +   
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQG 118
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           L++ H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y AP
Sbjct: 119 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 625 EL-----AYTIVVTGKCDVYSFGVVALEVL 649
           E+      Y+  V    D++S G +  E++
Sbjct: 176 EILLGCKYYSTAV----DIWSLGCIFAEMV 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 175 LLGCKYYSTAV----DIWSLGCIFAEMV 198

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKAELPE--GKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           L  A + +     IG G YG V+KA   +  G+ VALK++     E+   + + +  A +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 503 --LSTVRHRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRV 555
             L T  H N+V+L+  C   +      + L++E++++     +    +  +     K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +++  +   L +LH   +  ++HRD+   NIL+ S+ +  +ADFG AR+     +  ++ 
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV- 179
Query: 616 AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
             T  Y APE+          D++S G +  E+ 
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 8/205 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +DF     +G G  G V+K       +V  +KL H E +  A       E  VL      
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 67
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            IV  YG       + +  E+M+ GSL  VL       E     +V+I  +V   L+YL 
Sbjct: 68  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSI--AVIKGLTYLR 124
Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
                 I+HRD+  +NIL++S  E  + DFG +  L +D        GT  Y++PE    
Sbjct: 125 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEMANEF-VGTRSYMSPERLQG 180
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
              + + D++S G+  +E+ +G +P
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVAL K+   +TE      +   E  +L  + H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIR-LDTETEGVPSTAIREISLLKELNH 61
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+  
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 177 GCKYYSTAV----DIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVAL K+   +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIR-LDTETEGVPSTAIREISLLKELNH 60
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE+  
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 176 GCKYYSTAV----DIWSLGCIFAEMV 197

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 17/213 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHV---- 502
           AT  +     IG G YG+VYKA  P  G  VALK +                   V    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 503 -LSTVRHRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
            L    H N+V+L   C   +      + L++E++++  L   L D      L      +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKD 124
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
           +++     L +LH +C   I+HRD+   NIL+ S     +ADFG AR+     +  T   
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVV 180
Query: 617 GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            T  Y APE+          D++S G +  E+ 
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF     IG+GG+G V+KA+   +GK   +K++ ++        +  + E   L+ + H 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHV 64
Query: 510 NIVKLYGFCL-----------------HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWT 552
           NIV  Y  C                    KC+F+  E+ ++G+L   + +     +L+  
Sbjct: 65  NIVH-YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKV 122
Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR 612
             + + + +   + Y+H   +  +I+RD+  +NI L    +  + DFG    L  D   R
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-R 178
Query: 613 TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
               GT  Y++PE   +     + D+Y+ G++  E+L
Sbjct: 179 XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 8/207 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR- 507
           ++F     +G G +G V  A + E G + A+K L          V+    E  +LS  R 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H  + +L+        +F + E++  G L   +    ++   +  +       +  AL +
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMF 139
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH      II+RD+  +N+LLD      +ADFG  +    +        GT  YIAPE+ 
Sbjct: 140 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
             ++     D ++ GV+  E+L G  P
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +     +       I L   K  + +  +   L++ 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 120
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+  
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 627 ---AYTIVVTGKCDVYSFGVVALEVL 649
               Y+  V    D++S G +  E++
Sbjct: 178 GCKYYSTAV----DIWSLGCIFAEMV 199

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 16/213 (7%)
Query: 452 FHIKYCIGTGGYGSVYK-AELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           + +K  +GTGG+G V +      G+ VA+K+     +  +   + +  E  ++  + H N
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKKLNHPN 73
Query: 511 IVKLYGF--CLHK----KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           +V        L K        L  EY E G L   L+  +    L       ++  ++ A
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 565 LSYLHHDCTLSIIHRDISSNNILLD---SNLEASVADFGTARLLHVDSSYRTLRAGTYGY 621
           L YLH +    IIHRD+   NI+L      L   + D G A+ L       T   GT  Y
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQY 189
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           +APEL      T   D +SFG +A E + G  P
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 16/213 (7%)
Query: 452 FHIKYCIGTGGYGSVYK-AELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           + +K  +GTGG+G V +      G+ VA+K+     +  +   + +  E  ++  + H N
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKKLNHPN 74
Query: 511 IVKLYGF--CLHK----KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           +V        L K        L  EY E G L   L+  +    L       ++  ++ A
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 565 LSYLHHDCTLSIIHRDISSNNILLD---SNLEASVADFGTARLLHVDSSYRTLRAGTYGY 621
           L YLH +    IIHRD+   NI+L      L   + D G A+ L       T   GT  Y
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQY 190
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           +APEL      T   D +SFG +A E + G  P
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G +G V++  E   G+V   K ++     D   VK   NE  +++ + H  ++ L+ 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHD 115
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
               K  M LI E++  G LF  +  +D   +++  + +N ++     L ++H     SI
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SI 170
Query: 577 IHRDISSNNILLDSNLEASVA--DFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
           +H DI   NI+ ++   +SV   DFG A  L+ D   +   A T  + APE+     V  
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-TAEFAAPEIVDREPVGF 229
Query: 635 KCDVYSFGVVALEVLMGTHP 654
             D+++ GV+   +L G  P
Sbjct: 230 YTDMWAIGVLGYVLLSGLSP 249

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 452 FHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           F ++  +G G    VY+ +     K  ALK L   +T D   V++   E  VL  + H N
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRT---EIGVLLRLSHPN 109
Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR---VNIVKSVAHALSY 567
           I+KL         + L+ E +  G LF      D  +E  +       + VK +  A++Y
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELF------DRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 568 LHHDCTLSIIHRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           LH +    I+HRD+   N+L  +   +    +ADFG ++++      +T+  GT GY AP
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV-CGTPGYCAP 219
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+        + D++S G++   +L G  P
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKAELPE--GKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           L  A + +     IG G YG V+KA   +  G+ VALK++     E+   + + +  A +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 503 --LSTVRHRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRV 555
             L T  H N+V+L+  C   +      + L++E++++     +    +  +     K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +++  +   L +LH   +  ++HRD+   NIL+ S+ +  +ADFG AR+     +  ++ 
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV- 179
Query: 616 AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
             T  Y APE+          D++S G +  E+ 
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 453 HIKYCIGTGGYGSVYKAEL---PEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY  E     + ++  A+K L  S   +   V++F  E  ++  + H
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNH 81
Query: 509 RNIVKLYGFCLHKKCM-FLIYEYMERGSLFCVLHDDDEAIELNWTKR--VNIVKSVAHAL 565
            N++ L G  L  + +  ++  YM  G L   +     + + N T +  ++    VA  +
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGM 137
Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYG----- 620
            YL        +HRD+++ N +LD +    VADFG AR + +D  Y +++   +      
Sbjct: 138 EYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPVK 193
Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           + A E   T   T K DV+SFGV+  E+L    P
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 132
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPAFVAPEIVNY 191
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHV-LSTVRHRNIVKLY 515
           +G G YG V K   +P G+++A+K++    T +S   K    +  + + TV     V  Y
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 516 GFCLHKKCMFLIYEYMERG--SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           G    +  +++  E M+      +  + D  + I  +   ++ +  S+  AL +LH    
Sbjct: 73  GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHLH--SK 128
Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL------- 626
           LS+IHRD+  +N+L+++  +  + DFG +  L VD   + + AG   Y+APE        
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 627 -AYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQ 685
             Y++    K D++S G+  +E+ +   P                    L Q +  P  Q
Sbjct: 188 KGYSV----KSDIWSLGITMIELAILRFPYDSWGTPFQQ----------LKQVVEEPSPQ 233
Query: 686 KIVQDIILVSTIAFA--CLSSQPKSRPTMQRISQ 717
            +  D      + F   CL    K RPT   + Q
Sbjct: 234 -LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 458 IGTGGYGSVYKA---ELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+    ++ +G+    VA+K ++ S +        F NEA V+      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCHHV 82
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTKRVNIVKSVAHA 564
           V+L G     +   ++ E M  G L   L       E N         + + +   +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           ++YL+       +HRD+++ N ++  +    + DFG  R ++  + YR    G     ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 623 APELAYTIVVTGKCDVYSFGVVALEV 648
           APE     V T   D++SFGVV  E+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 445 LINATEDFHIKYCIGTGGYGSVYKAELPE--GKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           L  A + +     IG G YG V+KA   +  G+ VALK++     E+   + + +  A +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 503 --LSTVRHRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRV 555
             L T  H N+V+L+  C   +      + L++E++++     +    +  +     K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
           +++  +   L +LH   +  ++HRD+   NIL+ S+ +  +ADFG AR+     +  ++ 
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV- 179
Query: 616 AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
             T  Y APE+          D++S G +  E+ 
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           + E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            H NIVKL      +  ++L++E++       +       I L   K  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           + H   +  ++HRD+   N+L+++     +ADFG AR   V          T  Y APE+
Sbjct: 119 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 627 -----AYTIVVTGKCDVYSFGVVALEVL 649
                 Y+  V    D++S G +  E++
Sbjct: 176 LLGCKYYSTAV----DIWSLGCIFAEMV 199

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 8/207 (3%)
Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-R 507
           +DF +   IG G Y  V    L +  ++ A++ +      D   +   Q E HV      
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H  +V L+     +  +F + EY+  G L   +       +L           ++ AL+Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNY 168
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH      II+RD+  +N+LLDS     + D+G  +         +   GT  YIAPE+ 
Sbjct: 169 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP 654
                    D ++ GV+  E++ G  P
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSP 252

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 14/164 (8%)
Query: 498 NEAHVLSTVR-HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
            E  +L  V  H NI++L          FL+++ M++G LF  L    E + L+  +   
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRK 128
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
           I++++   +  LH    L+I+HRD+   NILLD ++   + DFG +  L      R++  
Sbjct: 129 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSV-C 184
Query: 617 GTYGYIAPELAYTIV------VTGKCDVYSFGVVALEVLMGTHP 654
           GT  Y+APE+    +         + D++S GV+   +L G+ P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 458 IGTGGYGSVYKA---ELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+    ++ +G+    VA+K ++ S +        F NEA V+      ++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCHHV 81
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTKRVNIVKSVAHA 564
           V+L G     +   ++ E M  G L   L       E N         + + +   +A  
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           ++YL+       +HRD+++ N ++  +    + DFG  R ++    YR    G     ++
Sbjct: 142 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 623 APELAYTIVVTGKCDVYSFGVVALEV 648
           APE     V T   D++SFGVV  E+
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 14/164 (8%)
Query: 498 NEAHVLSTVR-HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
            E  +L  V  H NI++L          FL+++ M++G LF  L    E + L+  +   
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRK 115
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
           I++++   +  LH    L+I+HRD+   NILLD ++   + DFG +  L      R +  
Sbjct: 116 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-C 171
Query: 617 GTYGYIAPELAYTIV------VTGKCDVYSFGVVALEVLMGTHP 654
           GT  Y+APE+    +         + D++S GV+   +L G+ P
Sbjct: 172 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 86/206 (41%), Gaps = 9/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF     +G G +G V    E   G+  A+K L          V     E+ VL   RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +  L Y F  H +  F++ EY   G LF   H   E +      R    + V+ AL YL
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELF--FHLSRERVFTEERARFYGAEIVS-ALEYL 121
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  +++RDI   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +  GVV  E++ G  P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 86/206 (41%), Gaps = 9/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF     +G G +G V    E   G+  A+K L          V     E+ VL   RH 
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +  L Y F  H +  F++ EY   G LF   H   E +      R    + V+ AL YL
Sbjct: 71  FLTALKYAFQTHDRLCFVM-EYANGGELF--FHLSRERVFTEERARFYGAEIVS-ALEYL 126
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  +++RDI   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 127 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 183
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +  GVV  E++ G  P
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 86/206 (41%), Gaps = 9/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF     +G G +G V    E   G+  A+K L          V     E+ VL   RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +  L Y F  H +  F++ EY   G LF   H   E +      R    + V+ AL YL
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELF--FHLSRERVFTEERARFYGAEIVS-ALEYL 121
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  +++RDI   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +  GVV  E++ G  P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 452 FHIKYCIGTGGYGSVYKAELPEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           + ++  IG G +G V K  + +G  +  A KK+     ED   V  F+ E  ++ ++ H 
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHP 83
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLF------CVLHDDDEAIELNWTKRVNIVKSVAH 563
           NI++LY        ++L+ E    G LF       V  + D A          I+K V  
Sbjct: 84  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLS 134
Query: 564 ALSYLHHDCTLSIIHRDISSNNILL-----DSNLEASVADFGTARLLHVDSSYRTLRAGT 618
           A++Y H    L++ HRD+   N L      DS L+  + DFG A         RT + GT
Sbjct: 135 AVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRT-KVGT 188
Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
             Y++P++   +    +CD +S GV+   +L G  P
Sbjct: 189 PYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 223

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 452 FHIKYCIGTGGYGSVYKAELPEGKVV--ALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           + ++  IG G +G V K  + +G  +  A KK+     ED   V  F+ E  ++ ++ H 
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHP 66
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLF------CVLHDDDEAIELNWTKRVNIVKSVAH 563
           NI++LY        ++L+ E    G LF       V  + D A          I+K V  
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLS 117
Query: 564 ALSYLHHDCTLSIIHRDISSNNILL-----DSNLEASVADFGTARLLHVDSSYRTLRAGT 618
           A++Y H    L++ HRD+   N L      DS L+  + DFG A         RT + GT
Sbjct: 118 AVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRT-KVGT 171
Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
             Y++P++   +    +CD +S GV+   +L G  P
Sbjct: 172 PYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 206

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 86/206 (41%), Gaps = 9/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF     +G G +G V    E   G+  A+K L          V     E+ VL   RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +  L Y F  H +  F++ EY   G LF   H   E +      R    + V+ AL YL
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELF--FHLSRERVFTEERARFYGAEIVS-ALEYL 121
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  +++RDI   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +  GVV  E++ G  P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 455 KYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +  +G G YG VY       +V +A+K++      DS + +    E  +   ++H+NIV+
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
             G       + +  E +  GSL  +L      ++ N        K +   L YLH +  
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 141
Query: 574 LSIIHRDISSNNILLDSNLEA-SVADFGTA-RLLHVDSSYRTLRAGTYGYIAPELAYTIV 631
             I+HRDI  +N+L+++      ++DFGT+ RL  ++    T   GT  Y+APE    I+
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPE----II 195
Query: 632 VTG------KCDVYSFGVVALEVLMGTHP 654
             G        D++S G   +E+  G  P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 86/206 (41%), Gaps = 9/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF     +G G +G V    E   G+  A+K L          V     E+ VL   RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +  L Y F  H +  F++ EY   G LF   H   E +      R    + V+ AL YL
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELF--FHLSRERVFTEERARFYGAEIVS-ALEYL 121
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  +++RDI   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +  GVV  E++ G  P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           T+++ +   +G G +  V +  ++P G+  A K ++  +       K  + EA +   ++
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H NIV+L+     +   +L+++ +  G LF      ++ +   +    +    +   L  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILES 115
Query: 568 LHHDCTLS-IIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYIA 623
           ++H C L+ I+HRD+   N+LL S  + +   +ADFG A  +  D       AGT GY++
Sbjct: 116 VNH-CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+          D+++ GV+   +L+G  P
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 455 KYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +  +G G YG VY       +V +A+K++      DS + +    E  +   ++H+NIV+
Sbjct: 13  RVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLKHKNIVQ 69
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
             G       + +  E +  GSL  +L      ++ N        K +   L YLH +  
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 127
Query: 574 LSIIHRDISSNNILLDSNLEA-SVADFGTA-RLLHVDSSYRTLRAGTYGYIAPELAYTIV 631
             I+HRDI  +N+L+++      ++DFGT+ RL  ++    T   GT  Y+APE    I+
Sbjct: 128 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPE----II 181
Query: 632 VTG------KCDVYSFGVVALEVLMGTHP 654
             G        D++S G   +E+  G  P
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 458 IGTGGYGSVYKA---ELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+    ++ +G+    VA+K ++ S +        F NEA V+      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCHHV 82
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTKRVNIVKSVAHA 564
           V+L G     +   ++ E M  G L   L       E N         + + +   +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           ++YL+       +HRD+++ N ++  +    + DFG  R ++    YR    G     ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 623 APELAYTIVVTGKCDVYSFGVVALEV 648
           APE     V T   D++SFGVV  E+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 86/206 (41%), Gaps = 9/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF     +G G +G V    E   G+  A+K L          V     E+ VL   RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +  L Y F  H +  F++ EY   G LF   H   E +      R    + V+ AL YL
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELF--FHLSRERVFTEERARFYGAEIVS-ALEYL 121
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  +++RDI   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +  GVV  E++ G  P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 86/206 (41%), Gaps = 9/206 (4%)
Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF     +G G +G V    E   G+  A+K L          V     E+ VL   RH 
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +  L Y F  H +  F++ EY   G LF   H   E +      R    + V+ AL YL
Sbjct: 69  FLTALKYAFQTHDRLCFVM-EYANGGELF--FHLSRERVFTEERARFYGAEIVS-ALEYL 124
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H   +  +++RDI   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 125 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 181
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +  GVV  E++ G  P
Sbjct: 182 DNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 36/212 (16%)
Query: 461 GGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST--VRHRNIVKLYGFC 518
           G +G V+KA+L     VA+K     + +      S+Q+E  + ST  ++H N+++     
Sbjct: 26  GRFGCVWKAQL-MNDFVAVKIFPLQDKQ------SWQSEREIFSTPGMKHENLLQF--IA 76
Query: 519 LHKKC------MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
             K+       ++LI  + ++GSL   L  +     + W +  ++ ++++  LSYLH D 
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDV 132
Query: 573 TL--------SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL--RAGTYGYI 622
                     SI HRD  S N+LL S+L A +ADFG A              + GT  Y+
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 623 APELAYTIV-----VTGKCDVYSFGVVALEVL 649
           APE+    +        + D+Y+ G+V  E++
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 132
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 191
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           N + DF +K  +G G YG V  A   P G++VA+KK+     +   F      E  +L  
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKH 65
Query: 506 VRHRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
            +H NI+ ++             +++I E M+       LH       L+       +  
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQ 120
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS----------S 610
              A+  LH     ++IHRD+  +N+L++SN +  V DFG AR++   +          S
Sbjct: 121 TLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 611 YRTLRAGTYGYIAPELAYTIVVTGKC-DVYSFGVVALEVLM 650
             T    T  Y APE+  T     +  DV+S G +  E+ +
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           T+++ +   +G G +  V +  ++P G+  A K ++  +       K  + EA +   ++
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H NIV+L+     +   +L+++ +  G LF      ++ +   +    +    +   L  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILES 115
Query: 568 LHHDCTLS-IIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYIA 623
           ++H C L+ I+HRD+   N+LL S  + +   +ADFG A  +  D       AGT GY++
Sbjct: 116 VNH-CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+          D+++ GV+   +L+G  P
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVA---LKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  +   GK  A   +KK     +      +  + E ++L  +RH NI+ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K +   + YLH   +
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ---FLKQILDGVHYLH---S 147
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
             I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI-FGTPEFVAPEIVNY 206
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 207 EPLGLEADMWSIGVITYILLSGASP 231

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 101/236 (42%), Gaps = 56/236 (23%)
Query: 451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF     IG+GG+G V+KA+   +GK   ++++ ++        +  + E   L+ + H 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN-------EKAEREVKALAKLDHV 65
Query: 510 NIVKLYGFCL------------------------------HKKCMFLIYEYMERGSLFCV 539
           NIV  Y  C                                 KC+F+  E+ ++G+L   
Sbjct: 66  NIVH-YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL--- 121
Query: 540 LHDDDEAIELNWTKRVNIV------KSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLE 593
               ++ IE    ++++ V      + +   + Y+H   +  +IHRD+  +NI L    +
Sbjct: 122 ----EQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQ 174
Query: 594 ASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
             + DFG    L  D   RT   GT  Y++PE   +     + D+Y+ G++  E+L
Sbjct: 175 VKIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 132
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 191
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 114/285 (40%), Gaps = 41/285 (14%)
Query: 458 IGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 92
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSLFCVL---------HDDDEAIELNWTKRVNIVKS 560
           +V L G C      + +I E+ + G+L   L         + D     L     +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-- 618
           VA  + +L    +   IHRD+++ NILL       + DFG AR ++ D  Y  +R G   
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY--VRKGDAR 207
Query: 619 --YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVL 675
               ++APE  +  V T + DV+SFGV+  E+  +G  P            P + + +  
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEF 256
Query: 676 NQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +RL      +        +      C   +P  RPT   + + L
Sbjct: 257 XRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 14/164 (8%)
Query: 498 NEAHVLSTVR-HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
            E  +L  V  H NI++L          FL+++ M++G LF  L    E + L+  +   
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRK 128
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
           I++++   +  LH    L+I+HRD+   NILLD ++   + DFG +  L      R +  
Sbjct: 129 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-C 184
Query: 617 GTYGYIAPELAYTIV------VTGKCDVYSFGVVALEVLMGTHP 654
           GT  Y+APE+    +         + D++S GV+   +L G+ P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           N + DF +K  +G G YG V  A   P G++VA+KK+     +   F      E  +L  
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKH 65
Query: 506 VRHRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
            +H NI+ ++             +++I E M+       LH       L+       +  
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQ 120
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS----------S 610
              A+  LH     ++IHRD+  +N+L++SN +  V DFG AR++   +          S
Sbjct: 121 TLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 611 YRTLRAGTYGYIAPELAYTIVVTGKC-DVYSFGVVALEVLM 650
             T    T  Y APE+  T     +  DV+S G +  E+ +
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 446 INATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK--KLHHSETEDSAFVKSFQNEAHV 502
           ++++  F     +G G Y +VYK      G  VALK  KL   E   S  ++    E  +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISL 56
Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYME----RGSLFCVLHDDDEAIELNWTKRVNIV 558
           +  ++H NIV+LY     +  + L++E+M+    +      + +    +ELN  K     
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW- 115
Query: 559 KSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT 618
             +   L++ H +    I+HRD+   N+L++   +  + DFG AR   +  +  +    T
Sbjct: 116 -QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 619 YGYIAPE-LAYTIVVTGKCDVYSFGVVALEVLMG 651
             Y AP+ L  +   +   D++S G +  E++ G
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 132
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 191
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 132
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 191
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           N + DF +K  +G G YG V  A   P G++VA+KK+     +   F      E  +L  
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKH 65
Query: 506 VRHRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
            +H NI+ ++             +++I E M+       LH       L+       +  
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQ 120
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG--- 617
              A+  LH     ++IHRD+  +N+L++SN +  V DFG AR++   ++  +   G   
Sbjct: 121 TLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 618 -------TYGYIAPELAYTIVVTGKC-DVYSFGVVALEVLM 650
                  T  Y APE+  T     +  DV+S G +  E+ +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 132
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 191
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 132
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 191
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 132
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 191
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 131
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 190
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASP 215

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 132
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 191
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 131
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 190
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASP 215

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEG-----KVVALKKLHHSETEDSAFVKSFQNEAHV 502
           T+++ +   IG G +  V +  +L  G     K++  KKL   + +        + EA +
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ------KLEREARI 56
Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
              ++H NIV+L+     +   +L+++ +  G LF      ++ +   +    +    + 
Sbjct: 57  CRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQ 110
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTY 619
             L  + H   + ++HRD+   N+LL S  + +   +ADFG A  +  D       AGT 
Sbjct: 111 QILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTP 170
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           GY++PE+          D+++ GV+   +L+G  P
Sbjct: 171 GYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 132
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 191
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 117/287 (40%), Gaps = 44/287 (15%)
Query: 458 IGTGGYGSVYKA------ELPEGKVVALKKLHHSE--TEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V +A      +      VA+K L  S   TE  A +    +E  VLS +  H
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM----SELKVLSYLGNH 102
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTK--------------- 553
            NIV L G C       +I EY   G L   L    ++   + T                
Sbjct: 103 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 162
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            ++    VA  +++L    + + IHRD+++ NILL       + DFG AR +  DS+Y  
Sbjct: 163 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 219
Query: 614 LRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIM 670
                    ++APE  +  V T + DV+S+G+   E+  +G+ P                
Sbjct: 220 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK---- 275
Query: 671 LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
           +I    + LSP      + DI+        C  + P  RPT ++I Q
Sbjct: 276 MIKEGFRMLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQIVQ 316

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 117/287 (40%), Gaps = 44/287 (15%)
Query: 458 IGTGGYGSVYKA------ELPEGKVVALKKLHHSE--TEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V +A      +      VA+K L  S   TE  A +    +E  VLS +  H
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM----SELKVLSYLGNH 86
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTK--------------- 553
            NIV L G C       +I EY   G L   L    ++   + T                
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            ++    VA  +++L    + + IHRD+++ NILL       + DFG AR +  DS+Y  
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 614 LRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIM 670
                    ++APE  +  V T + DV+S+G+   E+  +G+ P                
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK---- 259
Query: 671 LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
           +I    + LSP      + DI+        C  + P  RPT ++I Q
Sbjct: 260 MIKEGFRMLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQIVQ 300

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKSVAHALSYLHHDCTLSII 577
           +KC+ ++ E ++ G LF  + D  D+A    +T+R    I+KS+  A+ YLH   +++I 
Sbjct: 101 RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH---SINIA 153
Query: 578 HRDISSNNILLDSNLEASV---ADFGTARLLHVDSSYRTLRAGTYG--YIAPELAYTIVV 632
           HRD+   N+L  S    ++    DFG A+     +S+ +L    Y   Y+APE+      
Sbjct: 154 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 210
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
              CD++S GV+   +L G  P
Sbjct: 211 DKSCDMWSLGVIMYILLCGYPP 232

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKSVAHALSYLHHDCTLSII 577
           +KC+ ++ E ++ G LF  + D  D+A    +T+R    I+KS+  A+ YLH   +++I 
Sbjct: 137 RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH---SINIA 189
Query: 578 HRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTYG--YIAPELAYTIVV 632
           HRD+   N+L  S   N    + DFG A+     +S+ +L    Y   Y+APE+      
Sbjct: 190 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 246
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
              CD++S GV+   +L G  P
Sbjct: 247 DKSCDMWSLGVIMYILLCGYPP 268

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSFQNEAHVL 503
           +++ +   +G+G  G V  A E    K VA+K     K       ++    + + E  +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI---VKS 560
             + H  I+K+  F    +  +++ E ME G LF      D+ +     K          
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQ 122
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLE---ASVADFGTARLLHVDSSYRTLRAG 617
           +  A+ YLH +    IIHRD+   N+LL S  E     + DFG +++L   S  RTL  G
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CG 178
Query: 618 TYGYIAPELAYTIVVTG---KCDVYSFGVVALEVLMGTHP 654
           T  Y+APE+  ++   G     D +S GV+    L G  P
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKSVAHALSYLHHDCTLSII 577
           +KC+ ++ E ++ G LF  + D  D+A    +T+R    I+KS+  A+ YLH   +++I 
Sbjct: 93  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH---SINIA 145
Query: 578 HRDISSNNILLDSNLEASV---ADFGTARLLHVDSSYRTLRAGTYG--YIAPELAYTIVV 632
           HRD+   N+L  S    ++    DFG A+     +S+ +L    Y   Y+APE+      
Sbjct: 146 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 202
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
              CD++S GV+   +L G  P
Sbjct: 203 DKSCDMWSLGVIMYILLCGYPP 224

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 132
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 191
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKSVAHALSYLHHDCTLSII 577
           +KC+ ++ E ++ G LF  + D  D+A    +T+R    I+KS+  A+ YLH   +++I 
Sbjct: 92  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH---SINIA 144
Query: 578 HRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTYG--YIAPELAYTIVV 632
           HRD+   N+L  S   N    + DFG A+     +S+ +L    Y   Y+APE+      
Sbjct: 145 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 201
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
              CD++S GV+   +L G  P
Sbjct: 202 DKSCDMWSLGVIMYILLCGYPP 223

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKSVAHALSYLHHDCTLSII 577
           +KC+ ++ E ++ G LF  + D  D+A    +T+R    I+KS+  A+ YLH   +++I 
Sbjct: 131 RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH---SINIA 183
Query: 578 HRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTYG--YIAPELAYTIVV 632
           HRD+   N+L  S   N    + DFG A+     +S+ +L    Y   Y+APE+      
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
              CD++S GV+   +L G  P
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPP 262

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYK-AELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVRHRNIVK 513
           +G+G +  V K  E   G   A K +    T+ S      +  + E  +L  ++H N++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           L+    +K  + LI E +  G LF  L + +   E   T+    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE---FLKQILNGVYYLH---S 132
Query: 574 LSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           L I H D+   NI LLD N+      + DFG A  +   + ++ +  GT  ++APE+   
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-FGTPEFVAPEIVNY 191
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
             +  + D++S GV+   +L G  P
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASP 216

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 4/212 (1%)
Query: 439 KILYEDL-INATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSF 496
           K L  D+  N   +F I+  IG G +  VY+A  L +G  VALKK+   +  D+      
Sbjct: 20  KALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADC 79
Query: 497 QNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
             E  +L  + H N++K Y   +    + ++ E  + G L  ++    +   L       
Sbjct: 80  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL--IPERT 137
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
           + K      S L H  +  ++HRDI   N+ + +     + D G  R     ++      
Sbjct: 138 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 197
Query: 617 GTYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
           GT  Y++PE  +      K D++S G +  E+
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKSVAHALSYLHHDCTLSII 577
           +KC+ ++ E ++ G LF  + D  D+A    +T+R    I+KS+  A+ YLH   +++I 
Sbjct: 91  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH---SINIA 143
Query: 578 HRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTYG--YIAPELAYTIVV 632
           HRD+   N+L  S   N    + DFG A+     +S+ +L    Y   Y+APE+      
Sbjct: 144 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 200
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
              CD++S GV+   +L G  P
Sbjct: 201 DKSCDMWSLGVIMYILLCGYPP 222

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 117/287 (40%), Gaps = 44/287 (15%)
Query: 458 IGTGGYGSVYKA------ELPEGKVVALKKLHHSE--TEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V +A      +      VA+K L  S   TE  A +    +E  VLS +  H
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM----SELKVLSYLGNH 109
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTK--------------- 553
            NIV L G C       +I EY   G L   L    ++   + T                
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            ++    VA  +++L    + + IHRD+++ NILL       + DFG AR +  DS+Y  
Sbjct: 170 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVV 226
Query: 614 LRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIM 670
                    ++APE  +  V T + DV+S+G+   E+  +G+ P                
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK---- 282
Query: 671 LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
           +I    + LSP      + DI+        C  + P  RPT ++I Q
Sbjct: 283 MIKEGFRMLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQIVQ 323

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSFQNEAHVL 503
           +++ +   +G+G  G V  A E    K VA+K     K       ++    + + E  +L
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI---VKS 560
             + H  I+K+  F    +  +++ E ME G LF      D+ +     K          
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQ 128
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLE---ASVADFGTARLLHVDSSYRTLRAG 617
           +  A+ YLH +    IIHRD+   N+LL S  E     + DFG +++L   S  RTL  G
Sbjct: 129 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CG 184
Query: 618 TYGYIAPELAYTIVVTG---KCDVYSFGVVALEVLMGTHP 654
           T  Y+APE+  ++   G     D +S GV+    L G  P
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSFQNEAHVL 503
           +++ +   +G+G  G V  A E    K VA+K     K       ++    + + E  +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI---VKS 560
             + H  I+K+  F    +  +++ E ME G LF      D+ +     K          
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQ 122
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLE---ASVADFGTARLLHVDSSYRTLRAG 617
           +  A+ YLH +    IIHRD+   N+LL S  E     + DFG +++L   S  RTL  G
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CG 178
Query: 618 TYGYIAPELAYTIVVTG---KCDVYSFGVVALEVLMGTHP 654
           T  Y+APE+  ++   G     D +S GV+    L G  P
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 117/287 (40%), Gaps = 44/287 (15%)
Query: 458 IGTGGYGSVYKA------ELPEGKVVALKKLHHSE--TEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V +A      +      VA+K L  S   TE  A +    +E  VLS +  H
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM----SELKVLSYLGNH 109
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTK--------------- 553
            NIV L G C       +I EY   G L   L    ++   + T                
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            ++    VA  +++L    + + IHRD+++ NILL       + DFG AR +  DS+Y  
Sbjct: 170 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 226
Query: 614 LRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIM 670
                    ++APE  +  V T + DV+S+G+   E+  +G+ P                
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK---- 282
Query: 671 LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
           +I    + LSP      + DI+        C  + P  RPT ++I Q
Sbjct: 283 MIKEGFRMLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQIVQ 323

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 6/208 (2%)
Query: 450 EDFHIKY-CIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           ED+ + +  +G GG+G V+  ++   GK+ A KKL+    +     +    E  +L+ V 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            R IV L      K  + L+   M  G + + + + D++       + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           +LH     +II+RD+   N+LLD +    ++D G A  L    +     AGT G++APEL
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                     D ++ GV   E++    P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 117/287 (40%), Gaps = 44/287 (15%)
Query: 458 IGTGGYGSVYKA------ELPEGKVVALKKLHHSE--TEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V +A      +      VA+K L  S   TE  A +    +E  VLS +  H
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM----SELKVLSYLGNH 104
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTK--------------- 553
            NIV L G C       +I EY   G L   L    ++   + T                
Sbjct: 105 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 164
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
            ++    VA  +++L    + + IHRD+++ NILL       + DFG AR +  DS+Y  
Sbjct: 165 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 221
Query: 614 LRAGT--YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIM 670
                    ++APE  +  V T + DV+S+G+   E+  +G+ P                
Sbjct: 222 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK---- 277
Query: 671 LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
           +I    + LSP      + DI+        C  + P  RPT ++I Q
Sbjct: 278 MIKEGFRMLSPEHAPAEMYDIMKT------CWDADPLKRPTFKQIVQ 318

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 6/208 (2%)
Query: 450 EDFHIKY-CIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           ED+ + +  +G GG+G V+  ++   GK+ A KKL+    +     +    E  +L+ V 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            R IV L      K  + L+   M  G + + + + D++       + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           +LH     +II+RD+   N+LLD +    ++D G A  L    +     AGT G++APEL
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                     D ++ GV   E++    P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKSVAHALSYLHHDCTLSII 577
           +KC+ ++ E ++ G LF  + D  D+A    +T+R    I+KS+  A+ YLH   +++I 
Sbjct: 86  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH---SINIA 138
Query: 578 HRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTYG--YIAPELAYTIVV 632
           HRD+   N+L  S   N    + DFG A+     +S+ +L    Y   Y+APE+      
Sbjct: 139 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 195
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
              CD++S GV+   +L G  P
Sbjct: 196 DKSCDMWSLGVIMYILLCGYPP 217

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKSVAHALSYLHHDCTLSII 577
           +KC+ ++ E ++ G LF  + D  D+A    +T+R    I+KS+  A+ YLH   +++I 
Sbjct: 87  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH---SINIA 139
Query: 578 HRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTYG--YIAPELAYTIVV 632
           HRD+   N+L  S   N    + DFG A+     +S+ +L    Y   Y+APE+      
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 196
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
              CD++S GV+   +L G  P
Sbjct: 197 DKSCDMWSLGVIMYILLCGYPP 218

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/294 (22%), Positives = 119/294 (40%), Gaps = 61/294 (20%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKV----VALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
           DF    C+G GG+G V++A+    KV     A+K++     E +   +    E   L+ +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAK---NKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKL 60
Query: 507 RHRNIVKLYGFCLHKKC------------MFLIYEYMERGSL------FCVLHDDDEAIE 548
            H  IV+ +   L K              +++  +   + +L       C + + + ++ 
Sbjct: 61  EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           L+      I   +A A+ +LH   +  ++HRD+  +NI    +    V DFG    +  D
Sbjct: 121 LH------IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171
Query: 609 SSYRTL------------RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPXX 656
              +T+            + GT  Y++PE  +    + K D++S G++  E+L   +P  
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFS 228
Query: 657 XXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRP 710
                         L DV N +  P   QK   + ++V  +    LS  P  RP
Sbjct: 229 TQMERVRT------LTDVRNLKFPPLFTQKYPCEYVMVQDM----LSPSPMERP 272

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 6/208 (2%)
Query: 450 EDFHIKY-CIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           ED+ + +  +G GG+G V+  ++   GK+ A KKL+    +     +    E  +L+ V 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            R IV L      K  + L+   M  G + + + + D++       + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           +LH     +II+RD+   N+LLD +    ++D G A  L    +     AGT G++APEL
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                     D ++ GV   E++    P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSFQNEAHVL 503
           +++ +   +G+G  G V  A E    K VA+K     K       ++    + + E  +L
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI---VKS 560
             + H  I+K+  F    +  +++ E ME G LF      D+ +     K          
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQ 121
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLE---ASVADFGTARLLHVDSSYRTLRAG 617
           +  A+ YLH +    IIHRD+   N+LL S  E     + DFG +++L   S  RTL  G
Sbjct: 122 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CG 177
Query: 618 TYGYIAPELAYTIVVTG---KCDVYSFGVVALEVLMGTHP 654
           T  Y+APE+  ++   G     D +S GV+    L G  P
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKSVAHALSYLHHDCTLSII 577
           +KC+ ++ E ++ G LF  + D  D+A    +T+R    I+KS+  A+ YLH   +++I 
Sbjct: 85  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH---SINIA 137
Query: 578 HRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTYG--YIAPELAYTIVV 632
           HRD+   N+L  S   N    + DFG A+     +S+ +L    Y   Y+APE+      
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 194
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
              CD++S GV+   +L G  P
Sbjct: 195 DKSCDMWSLGVIMYILLCGYPP 216

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSFQNEAHVL 503
           +++ +   +G+G  G V  A E    K VA+K     K       ++    + + E  +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI---VKS 560
             + H  I+K+  F    +  +++ E ME G LF      D+ +     K          
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQ 122
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLE---ASVADFGTARLLHVDSSYRTLRAG 617
           +  A+ YLH +    IIHRD+   N+LL S  E     + DFG +++L   S  RTL  G
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CG 178
Query: 618 TYGYIAPELAYTIVVTG---KCDVYSFGVVALEVLMGTHP 654
           T  Y+APE+  ++   G     D +S GV+    L G  P
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 6/208 (2%)
Query: 450 EDFHIKY-CIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           ED+ + +  +G GG+G V+  ++   GK+ A KKL+    +     +    E  +L+ V 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
            R IV L      K  + L+   M  G + + + + D++       + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           +LH     +II+RD+   N+LLD +    ++D G A  L    +     AGT G++APEL
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                     D ++ GV   E++    P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 29/229 (12%)
Query: 442 YEDLINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
           +ED+   T +      +G G Y  V  A  L  GK  A+K +        + V  F+   
Sbjct: 10  FEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV--FREVE 62
Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS 560
            +     ++NI++L  F       +L++E ++ GS+   +         N  +   +V+ 
Sbjct: 63  TLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH---FNEREASRVVRD 119
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYR----- 612
           VA AL +LH   T  I HRD+   NIL +S  + S   + DF     + +++S       
Sbjct: 120 VAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTP 176
Query: 613 --TLRAGTYGYIAPELA--YTIVVT---GKCDVYSFGVVALEVLMGTHP 654
             T   G+  Y+APE+   +T   T    +CD++S GVV   +L G  P
Sbjct: 177 ELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKSVAHALSYLHHDCTLSII 577
           +KC+ ++ E ++ G LF  + D  D+A    +T+R    I+KS+  A+ YLH   +++I 
Sbjct: 87  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH---SINIA 139
Query: 578 HRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTYG--YIAPELAYTIVV 632
           HRD+   N+L  S   N    + DFG A+     +S+ +L    Y   Y+APE+      
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 196
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
              CD++S GV+   +L G  P
Sbjct: 197 DKSCDMWSLGVIMYILLCGYPP 218

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKSVAHALSYLHHDCTLSII 577
           +KC+ ++ E ++ G LF  + D  D+A    +T+R    I+KS+  A+ YLH   +++I 
Sbjct: 85  RKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLH---SINIA 137
Query: 578 HRDISSNNILLDS---NLEASVADFGTARLLHVDSSYRTLRAGTYG--YIAPELAYTIVV 632
           HRD+   N+L  S   N    + DFG A+     +S+ +L    Y   Y+APE+      
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYYVAPEVLGPEKY 194
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
              CD++S GV+   +L G  P
Sbjct: 195 DKSCDMWSLGVIMYILLCGYPP 216

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 516 GFCL----HKKCMFL--IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F       K  ++L  + +Y+         H       L        +  +  +L+Y+H
Sbjct: 80  YFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 195
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 86/215 (40%), Gaps = 38/215 (17%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKS----FQNEAHVLSTVRHRNIVK 513
           IG G + +VYK    E  V    ++   E +D    KS    F+ EA  L  ++H NIV+
Sbjct: 34  IGRGSFKTVYKGLDTETTV----EVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVR 89
Query: 514 LY----GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK---------S 560
            Y         KKC+ L+ E    G+L   L            KR  + K          
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYL------------KRFKVXKIKVLRSWCRQ 137
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGTARLLHVDSSYRTLRAGTY 619
           +   L +LH   T  IIHRD+  +NI +        + D G A L    +S+     GT 
Sbjct: 138 ILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTP 194
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            + APE  Y        DVY+FG   LE     +P
Sbjct: 195 EFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K+F+N E  ++  + H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMRKLDHCNIVRLR 79
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 195
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/210 (21%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           ++++ +K  +G G +  V +       +    K+ +++   +   +  + EA +   ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NWTKRVNIVKSVAHALSY 567
            NIV+L+     +   +L+++ +  G LF    +D  A E  +     + ++ +  +++Y
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELF----EDIVAREFYSEADASHCIQQILESIAY 143
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYIAP 624
            H +    I+HR++   N+LL S  + +   +ADFG A  ++   ++    AGT GY++P
Sbjct: 144 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF-AGTPGYLSP 199
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+      +   D+++ GV+   +L+G  P
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 458 IGTGGYGSVYKA---ELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+    ++ +G+    VA+K ++ S +        F NEA V+      ++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCHHV 83
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTKRVNIVKSVAHA 564
           V+L G     +   ++ E M  G L   L       E N         + + +   +A  
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           ++YL+       +HR++++ N ++  +    + DFG  R ++    YR    G     ++
Sbjct: 144 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 623 APELAYTIVVTGKCDVYSFGVVALEV 648
           APE     V T   D++SFGVV  E+
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 458 IGTGGYGSVYKA---ELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+    ++ +G+    VA+K ++ S +        F NEA V+      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCHHV 82
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTKRVNIVKSVAHA 564
           V+L G     +   ++ E M  G L   L       E N         + + +   +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           ++YL+       +HR++++ N ++  +    + DFG  R ++    YR    G     ++
Sbjct: 143 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 623 APELAYTIVVTGKCDVYSFGVVALEV 648
           APE     V T   D++SFGVV  E+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K+F+N E  ++  + H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMRKLDHCNIVRLR 79
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 195
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 106/264 (40%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  IGTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EYM  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      VADFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 114/285 (40%), Gaps = 41/285 (14%)
Query: 458 IGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 92
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSLFCVL---------HDDDEAIELNWTKRVNIVKS 560
           +V L G C      + +I E+ + G+L   L         + D     L     +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT-- 618
           VA  + +L    +   IHRD+++ NILL       + DFG AR ++ D  Y  +R G   
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDAR 207
Query: 619 --YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVL 675
               ++APE  +  V T + DV+SFGV+  E+  +G  P            P + + +  
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEF 256
Query: 676 NQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +RL      +        +      C   +P  RPT   + + L
Sbjct: 257 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 94
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSLFCVLHDD-------DEAIE------LNWTKRVN 556
           +V L G C      + +I E+ + G+L   L           EA E      L     + 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
               VA  + +L    +   IHRD+++ NILL       + DFG AR ++ D  Y  +R 
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRK 209
Query: 617 GT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIML 671
           G       ++APE  +  V T + DV+SFGV+  E+  +G  P            P + +
Sbjct: 210 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKI 258
Query: 672 IDVLNQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +   +RL      +        +      C   +P  RPT   + + L
Sbjct: 259 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 474 GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCMFLIYEYM 531
           G++VA+K L   E         +Q E  +L T+ H +IVK  G C  +  K + L+ EY+
Sbjct: 37  GEMVAVKAL--KEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 94
Query: 532 ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN 591
             GSL     D      +   + +   + +   ++YLH       IHR +++ N+LLD++
Sbjct: 95  PLGSL----RDYLPRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDND 147
Query: 592 LEASVADFGTARLLHVDSSYRTLRA---GTYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
               + DFG A+ +     Y  +R        + APE           DV+SFGV   E+
Sbjct: 148 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 207
Query: 649 L 649
           L
Sbjct: 208 L 208

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 80
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 81  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 141 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 196
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 197 GATDYTSSIDVWSAGCVLAELLLG 220

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 474 GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCMFLIYEYM 531
           G++VA+K L   E         +Q E  +L T+ H +IVK  G C  +  K + L+ EY+
Sbjct: 38  GEMVAVKAL--KEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 95
Query: 532 ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN 591
             GSL     D      +   + +   + +   ++YLH       IHR +++ N+LLD++
Sbjct: 96  PLGSL----RDYLPRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDND 148
Query: 592 LEASVADFGTARLLHVDSSYRTLRA---GTYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
               + DFG A+ +     Y  +R        + APE           DV+SFGV   E+
Sbjct: 149 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 208
Query: 649 L 649
           L
Sbjct: 209 L 209

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 106/264 (40%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  IGTG +
Sbjct: 2   NAAAAKKGX-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EYM  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      VADFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 195
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 91
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 152 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 207
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLG 231

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 72/142 (50%), Gaps = 18/142 (12%)
Query: 521 KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKSVAHALSYLHHDCTLSII 577
           +KC+ ++ E ++ G LF  + D  D+A    +T+R    I KS+  A+ YLH   +++I 
Sbjct: 131 RKCLLIVXECLDGGELFSRIQDRGDQA----FTEREASEIXKSIGEAIQYLH---SINIA 183
Query: 578 HRDISSNNILLDSNLEASV---ADFGTARLLHVDSSYRTLRAGTYG--YIAPELAYTIVV 632
           HRD+   N+L  S    ++    DFG A+     +S+ +L    Y   Y+APE+      
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
Query: 633 TGKCDVYSFGVVALEVLMGTHP 654
              CD +S GV+   +L G  P
Sbjct: 241 DKSCDXWSLGVIXYILLCGYPP 262

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K+F+N E  ++  + H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMRKLDHCNIVRLR 79
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI-VKSVAHALSYL 568
            F      KK    + L+ +Y+   +++ V      A +      V + +  +  +L+Y+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           H   +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL 
Sbjct: 139 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELI 194
Query: 628 YTIV-VTGKCDVYSFGVVALEVLMG 651
           +     T   DV+S G V  E+L+G
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 83
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 84  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 144 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 199
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 200 GATDYTSSIDVWSAGCVLAELLLG 223

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 195
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 195
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 113
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 229
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLG 253

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 84
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 145 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 200
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 201 GATDYTSSIDVWSAGCVLAELLLG 224

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 92
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 93  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 153 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 208
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 209 GATDYTSSIDVWSAGCVLAELLLG 232

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 87
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 88  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 148 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 203
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 204 GATDYTSSIDVWSAGCVLAELLLG 227

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 98
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 99  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 159 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 214
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 215 GATDYTSSIDVWSAGCVLAELLLG 238

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 117
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 178 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 233
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 234 GATDYTSSIDVWSAGCVLAELLLG 257

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 115
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 176 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 231
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 232 GATDYTSSIDVWSAGCVLAELLLG 255

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 113
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 229
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLG 253

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 20/182 (10%)
Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+KA     G+ VALKK+   E E   F  +   E  +L  ++H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 517 FCLHK-----KC---MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            C  K     +C   ++L++++ E   L  +L +      L+  KRV  ++ + + L Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYI 141
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR----TLRAGTYGYIAP 624
           H +    I+HRD+ + N+L+  +    +ADFG AR   +  + +      R  T  Y  P
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 625 EL 626
           EL
Sbjct: 199 EL 200

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 20/182 (10%)
Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+KA     G+ VALKK+   E E   F  +   E  +L  ++H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 517 FCLHK-----KC---MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            C  K     +C   ++L++++ E   L  +L +      L+  KRV  ++ + + L Y+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYI 141
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR----TLRAGTYGYIAP 624
           H +    I+HRD+ + N+L+  +    +ADFG AR   +  + +      R  T  Y  P
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 625 EL 626
           EL
Sbjct: 199 EL 200

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 107
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 168 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 223
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 224 GATDYTSSIDVWSAGCVLAELLLG 247

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 158
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 219 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIF 274
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 275 GATDYTSSIDVWSAGCVLAELLLG 298

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+           K F+N E  ++  + H NIV+L 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 91
Query: 516 GFCL---HKK---CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            F      KK    + L+ +Y+         H       L        +  +  +L+Y+H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 570 HDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
              +  I HRDI   N+LLD +     + DFG+A+ L       +     Y Y APEL +
Sbjct: 152 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIF 207
Query: 629 TIV-VTGKCDVYSFGVVALEVLMG 651
                T   DV+S G V  E+L+G
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLG 231

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G YG VYKA +    + VA+K++   E E+     +   E  +L  ++HRNI++L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC-TLS 575
              H   + LI+EY E        +D  + ++ N    + ++KS  + L    + C +  
Sbjct: 101 VIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 576 IIHRDISSNNILLDSNLEAS------VADFGTARLLHVDSSYRTLRAGTYGYIAPE-LAY 628
            +HRD+   N+LL S  +AS      + DFG AR   +     T    T  Y  PE L  
Sbjct: 153 CLHRDLKPQNLLL-SVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 629 TIVVTGKCDVYSFGVVALEVLMGT 652
           +   +   D++S   +  E+LM T
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKT 235

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 20/182 (10%)
Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+KA     G+ VALKK+   E E   F  +   E  +L  ++H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 517 FCLHK-----KC---MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            C  K     +C   ++L++++ E   L  +L +      L+  KRV  ++ + + L Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYI 141
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR----TLRAGTYGYIAP 624
           H +    I+HRD+ + N+L+  +    +ADFG AR   +  + +      R  T  Y  P
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 625 EL 626
           EL
Sbjct: 199 EL 200

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSFQNEAHVL 503
           +++ +   +G+G  G V  A E    K VA++     K       ++    + + E  +L
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
             + H  I+K+  F    +  +++ E ME G LF  +  +    E   T ++   + +  
Sbjct: 209 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA--TCKLYFYQMLL- 264
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEA---SVADFGTARLLHVDSSYRTLRAGTYG 620
           A+ YLH +    IIHRD+   N+LL S  E     + DFG +++L   S  RTL  GT  
Sbjct: 265 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 320
Query: 621 YIAPELAYTIVVTG---KCDVYSFGVVALEVLMGTHP 654
           Y+APE+  ++   G     D +S GV+    L G  P
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSFQNEAHVL 503
           +++ +   +G+G  G V  A E    K VA++     K       ++    + + E  +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
             + H  I+K+  F    +  +++ E ME G LF  +  +    E   T ++   + +  
Sbjct: 195 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA--TCKLYFYQMLL- 250
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEA---SVADFGTARLLHVDSSYRTLRAGTYG 620
           A+ YLH +    IIHRD+   N+LL S  E     + DFG +++L   S  RTL  GT  
Sbjct: 251 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 306
Query: 621 YIAPELAYTIVVTG---KCDVYSFGVVALEVLMGTHP 654
           Y+APE+  ++   G     D +S GV+    L G  P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 20/182 (10%)
Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +G V+KA     G+ VALKK+   E E   F  +   E  +L  ++H N+V L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 517 FCLHK-----KC---MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            C  K     +C   ++L++++ E   L  +L +      L+  KRV  ++ + + L Y+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYI 140
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR----TLRAGTYGYIAP 624
           H +    I+HRD+ + N+L+  +    +ADFG AR   +  + +      R  T  Y  P
Sbjct: 141 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 625 EL 626
           EL
Sbjct: 198 EL 199

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLY 515
           +G G YG V+K+ +   G+VVA+KK+  +    +   ++F+ E  +L+ +  H NIV L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 516 GFCL--HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
                 + + ++L+++YME       LH    A  L    +  +V  +   + YLH   +
Sbjct: 76  NVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLH---S 127
Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARL---------------------LHVDSSYR 612
             ++HRD+  +NILL++     VADFG +R                         D    
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 613 TLRAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVALEVLMG 651
           T    T  Y APE L  +   T   D++S G +  E+L G
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/215 (22%), Positives = 96/215 (44%), Gaps = 21/215 (9%)
Query: 449 TEDFHIKYCIGTGGYGSVYK------AELPEGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           T+D+ +   +G G +  V +       +    K++  KKL   + +        + EA +
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ------KLEREARI 83
Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
              ++H NIV+L+     +   +L+++ +  G LF      ++ +   +    +    + 
Sbjct: 84  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIH 137
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTY 619
             L  ++H     I+HRD+   N+LL S  + +   +ADFG A  +  +       AGT 
Sbjct: 138 QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTP 197
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           GY++PE+          D+++ GV+   +L+G  P
Sbjct: 198 GYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG+  V   E L +G   ALK++   E +D    +  Q EA +     H NI++L  
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNHPNILRLVA 93
Query: 517 FCLHKKC----MFLIYEYMERGSLFCVLHD-DDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           +CL ++      +L+  + +RG+L+  +    D+   L   + + ++  +   L  +H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-- 151
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGT--ARLLHVDSSYRTL-------RAGTYGYI 622
                 HRD+   NILL    +  + D G+     +HV+ S + L       +  T  Y 
Sbjct: 152 -AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 623 APEL---AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           APEL       V+  + DV+S G V   ++ G  P
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 129
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSL-------------FCVLHDDDEAIELNWTKRVN 556
           +V L G C      + +I E+ + G+L             + V  +D     L     + 
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
               VA  + +L    +   IHRD+++ NILL       + DFG AR ++ D  Y  +R 
Sbjct: 190 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRK 244
Query: 617 GT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIML 671
           G       ++APE  +  V T + DV+SFGV+  E+  +G  P            P + +
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKI 293
Query: 672 IDVLNQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +   +RL      +        +      C   +P  RPT   + + L
Sbjct: 294 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 36/213 (16%)
Query: 471 LPEGKVVALKKLHHSETEDSAFVKSFQN------------EAHVLSTVRHRNIVKLYGF- 517
           L +G    + +  H +T D   +K F N            E  VL  + H+NIVKL+   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 518 ----CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
                 HK    LI E+   GSL+ VL +   A  L  ++ + +++ V   +++L  +  
Sbjct: 77  EETTTRHK---VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 574 LSIIHRDISSNNILL----DSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
             I+HR+I   NI+     D      + DFG AR L  D  +  L  GT  Y+ P++   
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXL-YGTEEYLHPDMYER 189
Query: 630 IVVT--------GKCDVYSFGVVALEVLMGTHP 654
            V+            D++S GV       G+ P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 458 IGTGGYGSVYKA---ELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+    ++ +G+    VA+K ++ S +        F NEA V+      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCHHV 82
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTKRVNIVKSVAHA 564
           V+L G     +   ++ E M  G L   L       E N         + + +   +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           ++YL+       +HRD+++ N ++  +    + DFG  R +      R    G     ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 623 APELAYTIVVTGKCDVYSFGVVALEV 648
           APE     V T   D++SFGVV  E+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/210 (21%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           ++++ +K  +G G +  V +       +    K+ +++   +   +  + EA +   ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NWTKRVNIVKSVAHALSY 567
            NIV+L+     +   +L+++ +  G LF    +D  A E  +     + ++ +  +++Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELF----EDIVAREFYSEADASHCIQQILESIAY 120
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYIAP 624
            H +    I+HR++   N+LL S  + +   +ADFG A  ++   ++    AGT GY++P
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF-AGTPGYLSP 176
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+      +   D+++ GV+   +L+G  P
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 458 IGTGGYGSVYKA---ELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+    ++ +G+    VA+K ++ S +        F NEA V+      ++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCHHV 79
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTKRVNIVKSVAHA 564
           V+L G     +   ++ E M  G L   L       E N         + + +   +A  
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           ++YL+       +HRD+++ N ++  +    + DFG  R +      R    G     ++
Sbjct: 140 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 623 APELAYTIVVTGKCDVYSFGVVALEV 648
           APE     V T   D++SFGVV  E+
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 449 TEDFHI-KYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEA--HVLS 504
           T+D+ + K  +G G  G V +      G+  ALK L+ S          +Q     H++ 
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVC 86
Query: 505 TVRHRNIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKS 560
                 I+ +Y    H K+C+ +I E ME G LF  + +  D+A    +T+R    I++ 
Sbjct: 87  ------ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----FTEREAAEIMRD 136
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASV---ADFGTARLLHVDSSYRTLRAG 617
           +  A+ +LH   + +I HRD+   N+L  S  + +V    DFG A+    +++   L+  
Sbjct: 137 IGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTP 189
Query: 618 TYG--YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            Y   Y+APE+         CD++S GV+   +L G  P
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 458 IGTGGYGSVYKA---ELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+    ++ +G+    VA+K ++ S +        F NEA V+      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCHHV 82
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELN-------WTKRVNIVKSVAHA 564
           V+L G     +   ++ E M  G L   L       E N         + + +   +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG--TYGYI 622
           ++YL+       +HRD+++ N ++  +    + DFG  R +      R    G     ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 623 APELAYTIVVTGKCDVYSFGVVALEV 648
           APE     V T   D++SFGVV  E+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 92
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSL-------------FCVLHDDDEAIELNWTKRVN 556
           +V L G C      + +I E+ + G+L             + V  +D     L     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
               VA  + +L    +   IHRD+++ NILL       + DFG AR ++ D  Y  +R 
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRK 207
Query: 617 GT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIML 671
           G       ++APE  +  V T + DV+SFGV+  E+  +G  P            P + +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKI 256
Query: 672 IDVLNQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +   +RL      +        +      C   +P  RPT   + + L
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 83
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSL-------------FCVLHDDDEAIELNWTKRVN 556
           +V L G C      + +I E+ + G+L             + V  +D     L     + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
               VA  + +L    +   IHRD+++ NILL       + DFG AR ++ D  Y  +R 
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRK 198
Query: 617 GT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIML 671
           G       ++APE  +  V T + DV+SFGV+  E+  +G  P            P + +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKI 247
Query: 672 IDVLNQRLSPPVNQKIVQDII-LVSTIAFACLSSQPKSRPTMQRISQEL 719
            +   +RL      +        +      C   +P  RPT   + + L
Sbjct: 248 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 16/225 (7%)
Query: 437 DGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFV-- 493
           D  +L+ED+    E       IG G +  V +    E G+  A+K +  ++   S  +  
Sbjct: 17  DDDVLFEDVYELCE------VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 494 KSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWT 552
           +  + EA +   ++H +IV+L         +++++E+M+   L F ++   D     +  
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDS 609
              + ++ +  AL Y H +   +IIHRD+   N+LL S   ++   + DFG A  L    
Sbjct: 131 VASHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG 187
Query: 610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                R GT  ++APE+          DV+  GV+   +L G  P
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 83
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSL-------------FCVLHDDDEAIELNWTKRVN 556
           +V L G C      + +I E+ + G+L             + V  +D     L     + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
               VA  + +L    +   IHRD+++ NILL       + DFG AR ++ D  Y  +R 
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRK 198
Query: 617 GT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIML 671
           G       ++APE  +  V T + DV+SFGV+  E+  +G  P            P + +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKI 247
Query: 672 IDVLNQRLSPPVNQKIVQDII-LVSTIAFACLSSQPKSRPTMQRISQEL 719
            +   +RL      +        +      C   +P  RPT   + + L
Sbjct: 248 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 78/164 (47%), Gaps = 9/164 (5%)
Query: 494 KSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTK 553
           +  + EA +   ++H NIV+L+     +   +LI++ +  G LF      ++ +   +  
Sbjct: 66  QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYS 119
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSS 610
             +    +   L  + H   + ++HRD+   N+LL S L+ +   +ADFG A  +  +  
Sbjct: 120 EADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 179
Query: 611 YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                AGT GY++PE+          D+++ GV+   +L+G  P
Sbjct: 180 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 449 TEDFHI-KYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEA--HVLS 504
           T+D+ + K  +G G  G V +      G+  ALK L+ S          +Q     H++ 
Sbjct: 8   TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVC 67
Query: 505 TVRHRNIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKR--VNIVKS 560
                 I+ +Y    H K+C+ +I E ME G LF  + +  D+A    +T+R    I++ 
Sbjct: 68  ------ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----FTEREAAEIMRD 117
Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASV---ADFGTARLLHVDSSYRTLRAG 617
           +  A+ +LH   + +I HRD+   N+L  S  + +V    DFG A+    +++   L+  
Sbjct: 118 IGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTP 170
Query: 618 TYG--YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            Y   Y+APE+         CD++S GV+   +L G  P
Sbjct: 171 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 209

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 119/291 (40%), Gaps = 43/291 (14%)
Query: 448 ATEDFHIK-------YCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNE 499
           A E+F +K         +G G YG V K   +P G++ A+K++    T +S   K    +
Sbjct: 25  AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIR--ATVNSQEQKRLLXD 82
Query: 500 AHV-LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERG--SLFCVLHDDDEAIELNWTKRVN 556
             +   TV     V  YG    +  +++  E  +      +  + D  + I  +   ++ 
Sbjct: 83  LDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIA 142
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
           +  S+  AL +LH    LS+IHRD+  +N+L+++  +    DFG +  L VD   + + A
Sbjct: 143 V--SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYL-VDDVAKDIDA 197
Query: 617 GTYGYIAPEL--------AYTIVVTGKCDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPK 668
           G   Y APE          Y++    K D++S G+  +E+ +   P              
Sbjct: 198 GCKPYXAPERINPELNQKGYSV----KSDIWSLGITXIELAILRFPYDSWGTP------- 246
Query: 669 IMLIDVLNQRLSPPVNQKIVQDIILVSTIAFA--CLSSQPKSRPTMQRISQ 717
                 L Q +  P  Q +  D      + F   CL    K RPT   + Q
Sbjct: 247 ---FQQLKQVVEEPSPQ-LPADKFSAEFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/210 (21%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           ++++ +K  +G G +  V +       +    K+ +++   +   +  + EA +   ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NWTKRVNIVKSVAHALSY 567
            NIV+L+     +   +L+++ +  G LF    +D  A E  +     + ++ +  +++Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELF----EDIVAREFYSEADASHCIQQILESIAY 120
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYIAP 624
            H +    I+HR++   N+LL S  + +   +ADFG A  ++   ++    AGT GY++P
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF-AGTPGYLSP 176
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+      +   D+++ GV+   +L+G  P
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/210 (21%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           ++++ +K  +G G +  V +       +    K+ +++   +   +  + EA +   ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NWTKRVNIVKSVAHALSY 567
            NIV+L+     +   +L+++ +  G LF    +D  A E  +     + ++ +  +++Y
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELF----EDIVAREFYSEADASHCIQQILESIAY 119
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYIAP 624
            H +    I+HR++   N+LL S  + +   +ADFG A  ++   ++    AGT GY++P
Sbjct: 120 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF-AGTPGYLSP 175
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+      +   D+++ GV+   +L+G  P
Sbjct: 176 EVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 36/213 (16%)
Query: 471 LPEGKVVALKKLHHSETEDSAFVKSFQN------------EAHVLSTVRHRNIVKLYGF- 517
           L +G    + +  H +T D   +K F N            E  VL  + H+NIVKL+   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 518 ----CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
                 HK    LI E+   GSL+ VL +   A  L  ++ + +++ V   +++L  +  
Sbjct: 77  EETTTRHK---VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 574 LSIIHRDISSNNILL----DSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
             I+HR+I   NI+     D      + DFG AR L  D  + +L  GT  Y+ P++   
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYLHPDMYER 189
Query: 630 IVVT--------GKCDVYSFGVVALEVLMGTHP 654
            V+            D++S GV       G+ P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 458 IGTGGYGSVYKAELP-EGKVVALK--KLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G G Y +VYK +      +VALK  +L H E      ++    E  +L  ++H NIV L
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 65
Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
           +     +K + L++EY+++  L   L D    I ++  K    +  +   L+Y H     
Sbjct: 66  HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKL--FLFQLLRGLAYCHRQ--- 119
Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-LAYTIVVT 633
            ++HRD+   N+L++   E  +ADFG AR   + +        T  Y  P+ L  +   +
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179
Query: 634 GKCDVYSFGVVALEVLMG 651
            + D++  G +  E+  G
Sbjct: 180 TQIDMWGVGCIFYEMATG 197

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGKV----VALKKLHHSETEDSAFVKSFQNEAHVL 503
           A ED  +   +G G +G VY+      K     VA+K      T D+   + F +EA ++
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIM 79
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
             + H +IVKL G  + ++  ++I E    G L   L  +  ++++     V     +  
Sbjct: 80  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICK 136
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGTYGYI 622
           A++YL    +++ +HRDI+  NIL+ S     + DFG +R +  +  Y+ ++      ++
Sbjct: 137 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 193
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
           +PE       T   DV+ F V   E+L  G  P
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGKV----VALKKLHHSETEDSAFVKSFQNEAHVL 503
           A ED  +   +G G +G VY+      K     VA+K      T D+   + F +EA ++
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIM 67
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
             + H +IVKL G  + ++  ++I E    G L   L  +  ++++     V     +  
Sbjct: 68  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICK 124
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGTYGYI 622
           A++YL    +++ +HRDI+  NIL+ S     + DFG +R +  +  Y+ ++      ++
Sbjct: 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
           +PE       T   DV+ F V   E+L  G  P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 83/181 (45%), Gaps = 14/181 (7%)
Query: 474 GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCMFLIYEYM 531
           G++VA+K L             ++ E  +L T+ H +I+K  G C  +  K + L+ EY+
Sbjct: 43  GEMVAVKAL--KADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 532 ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN 591
             GSL     D      +   + +   + +   ++YLH   +   IHR++++ N+LLD++
Sbjct: 101 PLGSL----RDYLPRHSIGLAQLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDND 153
Query: 592 LEASVADFGTARLLHVDSSYRTLRA---GTYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
               + DFG A+ +     Y  +R        + APE           DV+SFGV   E+
Sbjct: 154 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213
Query: 649 L 649
           L
Sbjct: 214 L 214

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 49/226 (21%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST--VRHRNIVKLY 515
           IG G YG+VYK  L E + VA+K    +  ++      F NE ++     + H NI +  
Sbjct: 21  IGRGRYGAVYKGSLDE-RPVAVKVFSFANRQN------FINEKNIYRVPLMEHDNIAR-- 71
Query: 516 GFCLHKKCM--------FLIYEYMERGSL--FCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
            F +  + +         L+ EY   GSL  +  LH  D      W     +  SV   L
Sbjct: 72  -FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD------WVSSCRLAHSVTRGL 124
Query: 566 SYLHHDCTL------SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR------- 612
           +YLH +         +I HRD++S N+L+ ++    ++DFG +  L  +   R       
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 613 -TLRAGTYGYIAPELAYTIV-------VTGKCDVYSFGVVALEVLM 650
                GT  Y+APE+    V          + D+Y+ G++  E+ M
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 106/264 (40%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  IGTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      VADFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 106/263 (40%), Gaps = 56/263 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 23  NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 75
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 76  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 124
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 125 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 179
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIV 631
            +L +I+RD+   N+L+D      V DFG A+   V  +  TL  GT  Y+APE+  +  
Sbjct: 180 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGATWTL-CGTPEYLAPEIILSKG 235
Query: 632 VTGKCDVYSFGVVALEVLMGTHP 654
                D ++ GV+  E+  G  P
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEGKV----VALKKLHHSETEDSAFVKSFQNEAHVL 503
           A ED  +   +G G +G VY+      K     VA+K      T D+   + F +EA ++
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIM 63
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
             + H +IVKL G  + ++  ++I E    G L   L  +  ++++     V     +  
Sbjct: 64  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICK 120
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGTYGYI 622
           A++YL    +++ +HRDI+  NIL+ S     + DFG +R +  +  Y+ ++      ++
Sbjct: 121 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 177
Query: 623 APELAYTIVVTGKCDVYSFGVVALEVL-MGTHP 654
           +PE       T   DV+ F V   E+L  G  P
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G+ VA+KKL     +   F K    E  +L  ++H N++ L  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQHENVIGLLD 108
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAI---ELNWTKRVNIVKSVAHALSYLHHDCT 573
                  +   Y++     +   +  D + I   E +  K   +V  +   L Y+H   +
Sbjct: 109 VFTPASSLRNFYDFY---LVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---S 162
Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIV-V 632
             ++HRD+   N+ ++ + E  + DFG AR  H D+   T    T  Y APE+  + +  
Sbjct: 163 AGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM-TGYVVTRWYRAPEVILSWMHY 219
Query: 633 TGKCDVYSFGVVALEVLMG 651
               D++S G +  E+L G
Sbjct: 220 NQTVDIWSVGCIMAEMLTG 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 106/264 (40%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT   AGT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLAGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 474 GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK--KCMFLIYEYM 531
           G++VA+K L             ++ E  +L T+ H +I+K  G C  +  K + L+ EY+
Sbjct: 43  GEMVAVKAL--KADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 532 ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN 591
             GSL     D      +   + +   + +   ++YLH       IHR++++ N+LLD++
Sbjct: 101 PLGSL----RDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDND 153
Query: 592 LEASVADFGTARLLHVDSSYRTLRA---GTYGYIAPELAYTIVVTGKCDVYSFGVVALEV 648
               + DFG A+ +     Y  +R        + APE           DV+SFGV   E+
Sbjct: 154 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213
Query: 649 L 649
           L
Sbjct: 214 L 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 447 NATEDFH-IKYCIGTGGYGSVYKAELP----EGKVVALKKLHHSETEDSAFVKSFQNEAH 501
              EDF+ I   +G+G +  V K        E     +KK     +      +  + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           +L  V H N++ L+    ++  + LI E +  G LF  L   +   E   T   + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQI 124
Query: 562 AHALSYLHHDCTLSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAG 617
              ++YLH   T  I H D+   NI LLD N+      + DFG A  +     ++ +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-FG 180
Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           T  ++APE+     +  + D++S GV+   +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 447 NATEDFH-IKYCIGTGGYGSVYK-AELPEGKVVA---LKKLHHSETEDSAFVKSFQNEAH 501
              EDF+ I   +G+G +  V K  E   G   A   +KK     +      +  + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           +L  V H N++ L+    ++  + LI E +  G LF  L   +    L+  +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 562 AHALSYLHHDCTLSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAG 617
              ++YLH   T  I H D+   NI LLD N+      + DFG A  +     ++ +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-FG 180
Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           T  ++APE+     +  + D++S GV+   +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 445 LINATEDFHIKYCIGTGGYG-SVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           +++ ++ + +   IG G +G +    +    ++VA+K +   E  D    +   N     
Sbjct: 14  IMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINH---- 69
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
            ++RH NIV+     L    + ++ EY   G LF  + +   A   +  +     + +  
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLIS 126
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEA--SVADFGTARLLHVDSSYRTLRAGTYGY 621
            +SY H    + + HRD+   N LLD +      +ADFG ++   + S  ++   GT  Y
Sbjct: 127 GVSYAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA-VGTPAY 182
Query: 622 IAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
           IAPE+       GK  DV+S GV    +L+G +P
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 447 NATEDFH-IKYCIGTGGYGSVYKAELP----EGKVVALKKLHHSETEDSAFVKSFQNEAH 501
              EDF+ I   +G+G +  V K        E     +KK     +      +  + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           +L  V H N++ L+    ++  + LI E +  G LF  L   +   E   T   + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQI 124
Query: 562 AHALSYLHHDCTLSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAG 617
              ++YLH   T  I H D+   NI LLD N+      + DFG A  +     ++ +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-FG 180
Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           T  ++APE+     +  + D++S GV+   +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 447 NATEDFH-IKYCIGTGGYGSVYKAELP----EGKVVALKKLHHSETEDSAFVKSFQNEAH 501
              EDF+ I   +G+G +  V K        E     +KK     +      +  + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           +L  V H N++ L+    ++  + LI E +  G LF  L   +   E   T   + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQI 124
Query: 562 AHALSYLHHDCTLSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAG 617
              ++YLH   T  I H D+   NI LLD N+      + DFG A  +     ++ +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-FG 180
Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           T  ++APE+     +  + D++S GV+   +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 105/263 (39%), Gaps = 56/263 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 3   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 55
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 56  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 104
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 159
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIV 631
            +L +I+RD+   N+L+D      V DFG A+   V     TL  GT  Y+APE+  +  
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTL-CGTPEYLAPEIILSKG 215
Query: 632 VTGKCDVYSFGVVALEVLMGTHP 654
                D ++ GV+  E+  G  P
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 38/215 (17%)
Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG G YG V+  +   G+ VA+K      TE++++ +  + E +    +RH NI+     
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFF--TTEEASWFR--ETEIYQTVLMRHENILGFIAA 99
Query: 518 CLHKKC----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC- 572
            +        ++LI +Y E GSL+  L    ++  L+    + +  S    L +LH +  
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 573 ----TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL----RAGTYGYIAP 624
                 +I HRD+ S NIL+  N    +AD G A     D++   +    R GT  Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 625 EL-----------AYTIVVTGKCDVYSFGVVALEV 648
           E+           +Y +      D+YSFG++  EV
Sbjct: 216 EVLDESLNRNHFQSYIMA-----DMYSFGLILWEV 245

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 51/236 (21%)
Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
           NL  ++  NN L+   P  + +L+KL  + ++ N +  I P  + +L NL GL L++N++
Sbjct: 64  NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 119
Query: 162 SGVLPQEIGNLKSLTELYVTNN------ALGGLIPSTLFRLTNISSNQFHSSIPLEIGNF 215
           + + P  + NL +L  L +++N      AL GL   T  +  N SSNQ     PL   N 
Sbjct: 120 TDIDP--LKNLTNLNRLELSSNTISDISALSGL---TSLQQLNFSSNQVTDLKPL--ANL 172
Query: 216 SALDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXXXXGQIPYAIGKLFNLMYLDLSKNK 275
           + L+ LD+S NK+  I                            + KL NL  L  + N+
Sbjct: 173 TTLERLDISSNKVSDI--------------------------SVLAKLTNLESLIATNNQ 206
Query: 276 LSGSIPTEIGNCSALKNLTLNHNSLD--GTIPLEMGKILLLQNLDLSHNNLSGTIP 329
           +S   P  +G  + L  L+LN N L   GT    +  +  L +LDL++N +S   P
Sbjct: 207 ISDITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP 256

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 447 NATEDFH-IKYCIGTGGYGSVYKAELP----EGKVVALKKLHHSETEDSAFVKSFQNEAH 501
              EDF+ I   +G+G +  V K        E     +KK     +      +  + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           +L  V H NI+ L+    ++  + LI E +  G LF  L   +   E   T   + +K +
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQI 124
Query: 562 AHALSYLHHDCTLSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAG 617
              ++YLH   T  I H D+   NI LLD N+      + DFG A  +     ++ +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-FG 180
Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           T  ++APE+     +  + D++S GV+   +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 16/217 (7%)
Query: 447 NATEDFH-IKYCIGTGGYGSVYKAELP----EGKVVALKKLHHSETEDSAFVKSFQNEAH 501
              EDF+ I   +G+G +  V K        E     +KK     +      +  + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           +L  V H N++ L+    ++  + LI E +  G LF  L   +   E   T   + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQI 124
Query: 562 AHALSYLHHDCTLSIIHRDISSNNI-LLDSNL---EASVADFGTARLLHVDSSYRTLRAG 617
              ++YLH   T  I H D+   NI LLD N+      + DFG A  +     ++ +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI-FG 180
Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           T  ++APE+     +  + D++S GV+   +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 14/181 (7%)
Query: 474 GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFC--LHKKCMFLIYEYM 531
           G++VA+K L             ++ E  +L T+ H +I+K  G C       + L+ EY+
Sbjct: 60  GEMVAVKAL--KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117
Query: 532 ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN 591
             GSL     D      +   + +   + +   ++YLH       IHRD+++ N+LLD++
Sbjct: 118 PLGSL----RDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDND 170
Query: 592 LEASVADFGTARLL-HVDSSYRTLRAGTYG--YIAPELAYTIVVTGKCDVYSFGVVALEV 648
               + DFG A+ +      YR    G     + APE           DV+SFGV   E+
Sbjct: 171 RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230
Query: 649 L 649
           L
Sbjct: 231 L 231

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 109/248 (43%), Gaps = 42/248 (16%)
Query: 422 SRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALK 480
           S AAKN  +    ++D         +  +++ I   IG G YG V  A     G+ VA+K
Sbjct: 33  SVAAKNLALLKARSFDVTF------DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIK 86
Query: 481 KLHHSETEDSAF-----VKSFQNEAHVLSTVRHRNIVKL---------YGFCLHKKCMFL 526
           K+       +AF      K    E  +L   +H NI+ +         YG     K +++
Sbjct: 87  KI------PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG---EFKSVYV 137
Query: 527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNI 586
           + + ME   L  ++H   + + L   +    +  +   L Y+H   +  +IHRD+  +N+
Sbjct: 138 VLDLME-SDLHQIIHSS-QPLTLEHVR--YFLYQLLRGLKYMH---SAQVIHRDLKPSNL 190
Query: 587 LLDSNLEASVADFGTARLLHVDSS----YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSF 641
           L++ N E  + DFG AR L    +    + T    T  Y APEL  ++   T   D++S 
Sbjct: 191 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 250
Query: 642 GVVALEVL 649
           G +  E+L
Sbjct: 251 GCIFGEML 258

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 22/166 (13%)
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT- 618
            VA  + +L    +   IHRD+++ NILL  N    + DFG AR ++ +  Y  +R G  
Sbjct: 207 QVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDY--VRKGDT 261
Query: 619 ---YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDV 674
                ++APE  +  + + K DV+S+GV+  E+  +G  P            P + + + 
Sbjct: 262 RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP-----------YPGVQMDED 310
Query: 675 LNQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
              RL   +  +  +     +  I   C    PK RP    + ++L
Sbjct: 311 FCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEA-HVLSTVRHRNIVKLY 515
           +G G +G V++ E  + G   A+KK+          ++ F+ E     + +    IV LY
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G       + +  E +E GSL  ++ +     E    + +  +      L YLH   +  
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPE---DRALYYLGQALEGLEYLH---SRR 205
Query: 576 IIHRDISSNNILLDSN-LEASVADFGTARLLHVDSSYRTLRAGTY-----GYIAPELAYT 629
           I+H D+ ++N+LL S+   A++ DFG A  L  D   ++L  G Y      ++APE+   
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
                K DV+S   + L +L G HP
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 144 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 203 NSKGYTKSIDIWSVGCILAEML 224

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 112/284 (39%), Gaps = 37/284 (13%)
Query: 458 IGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 94
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSLFCVLHDD-DEAIELNWTKRVNIVKSVAHALSY- 567
           +V L G C      + +I E+ + G+L   L    +E +            ++ H + Y 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 568 ------LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT--- 618
                 +    +   IHRD+++ NILL       + DFG AR +  D     +R G    
Sbjct: 155 FQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD--XVRKGDARL 212
Query: 619 -YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDVLN 676
              ++APE  +  V T + DV+SFGV+  E+  +G  P            P + + +   
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEEFC 261
Query: 677 QRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +RL      +        +      C   +P  RPT   + + L
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 23  NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 75
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 76  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 124
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 125 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH--ARFYAAQIVL-TFEYLH-- 179
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 180 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 234
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 12/201 (5%)
Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG+G V   ++   GK+ A KKL     +         NE  +L  V  R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 517 FCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
               K  + L+   M  G L F + H           + V     +   L  LH +    
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE--ARAVFYAAEICCGLEDLHRE---R 306
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL--RAGTYGYIAPELAYTIVVT 633
           I++RD+   NILLD +    ++D G A  +HV    +T+  R GT GY+APE+      T
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEG-QTIKGRVGTVGYMAPEVVKNERYT 363
Query: 634 GKCDVYSFGVVALEVLMGTHP 654
              D ++ G +  E++ G  P
Sbjct: 364 FSPDWWALGCLLYEMIAGQSP 384

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 3   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 55
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 56  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 104
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH--ARFYAAQIVL-TFEYLH-- 159
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 32/210 (15%)
Query: 457 CIGTGGYGSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
            +GTG +G V   +            L + KVV LK++ H+            NE  +L 
Sbjct: 34  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQ 82
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
            V    +VKL         ++++ EY+  G +F  L       E +   R    + V   
Sbjct: 83  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-T 139
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
             YLH   +L +I+RD+   N+L+D      V DFG A+   V     TL  GT  Y+AP
Sbjct: 140 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTL-CGTPEYLAP 193
Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+  +       D ++ GV+  E+  G  P
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 12/201 (5%)
Query: 458 IGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG+G V   ++   GK+ A KKL     +         NE  +L  V  R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 517 FCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
               K  + L+   M  G L F + H           + V     +   L  LH +    
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAG--FPEARAVFYAAEICCGLEDLHRE---R 306
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL--RAGTYGYIAPELAYTIVVT 633
           I++RD+   NILLD +    ++D G A  +HV    +T+  R GT GY+APE+      T
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEG-QTIKGRVGTVGYMAPEVVKNERYT 363
Query: 634 GKCDVYSFGVVALEVLMGTHP 654
              D ++ G +  E++ G  P
Sbjct: 364 FSPDWWALGCLLYEMIAGQSP 384

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 8/206 (3%)
Query: 451 DFHIKYCIGTGGYGSV-YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +F     +G G +G V    E   G+  A+K L          V     E  VL   RH 
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +  L Y F  H +  F++ EY   G LF   H   E +      R    + V+ AL YL
Sbjct: 209 FLTALKYSFQTHDRLCFVM-EYANGGELF--FHLSRERVFSEDRARFYGAEIVS-ALDYL 264
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H +   ++++RD+   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 265 HSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +  GVV  E++ G  P
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 8/206 (3%)
Query: 451 DFHIKYCIGTGGYGSV-YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +F     +G G +G V    E   G+  A+K L          V     E  VL   RH 
Sbjct: 152 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 211
Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +  L Y F  H +  F++ EY   G LF   H   E +      R    + V+ AL YL
Sbjct: 212 FLTALKYSFQTHDRLCFVM-EYANGGELF--FHLSRERVFSEDRARFYGAEIVS-ALDYL 267
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H +   ++++RD+   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 268 HSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 325
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +  GVV  E++ G  P
Sbjct: 326 DNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 97  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 149
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 150 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 209 NSKGYTKSIDIWSVGCILAEML 230

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 144 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 203 NSKGYTKSIDIWSVGCILAEML 224

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G+ VA+KKL     +   F K    E  +L  ++H N++ L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAI---ELNWTKRVNIVKSVAHALSYLHHDCT 573
                  +   Y++     +   +  D + I   + +  K   +V  +   L Y+H   +
Sbjct: 91  VFTPASSLRNFYDFY---LVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---S 144
Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIV-V 632
             ++HRD+   N+ ++ + E  + DFG AR  H D+   T    T  Y APE+  + +  
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM-TGYVVTRWYRAPEVILSWMHY 201
Query: 633 TGKCDVYSFGVVALEVLMG 651
               D++S G +  E+L G
Sbjct: 202 NQTVDIWSVGCIMAEMLTG 220

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 109 IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 161
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 162 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 221 NSKGYTKSIDIWSVGCILAEML 242

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLXGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 8/206 (3%)
Query: 451 DFHIKYCIGTGGYGSV-YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +F     +G G +G V    E   G+  A+K L          V     E  VL   RH 
Sbjct: 9   EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 68
Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +  L Y F  H +  F++ EY   G LF   H   E +      R    + V+ AL YL
Sbjct: 69  FLTALKYSFQTHDRLCFVM-EYANGGELF--FHLSRERVFSEDRARFYGAEIVS-ALDYL 124
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H +   ++++RD+   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 125 HSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 182
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +  GVV  E++ G  P
Sbjct: 183 DNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGX-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 109/248 (43%), Gaps = 42/248 (16%)
Query: 422 SRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALK 480
           S AAKN  +    ++D         +  +++ I   IG G YG V  A     G+ VA+K
Sbjct: 32  SVAAKNLALLKARSFDVTF------DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIK 85
Query: 481 KLHHSETEDSAF-----VKSFQNEAHVLSTVRHRNIVKL---------YGFCLHKKCMFL 526
           K+       +AF      K    E  +L   +H NI+ +         YG     K +++
Sbjct: 86  KI------PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG---EFKSVYV 136
Query: 527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNI 586
           + + ME   L  ++H   + + L   +    +  +   L Y+H   +  +IHRD+  +N+
Sbjct: 137 VLDLME-SDLHQIIHSS-QPLTLEHVR--YFLYQLLRGLKYMH---SAQVIHRDLKPSNL 189
Query: 587 LLDSNLEASVADFGTARLLHVDSS----YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSF 641
           L++ N E  + DFG AR L    +    + T    T  Y APEL  ++   T   D++S 
Sbjct: 190 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 249
Query: 642 GVVALEVL 649
           G +  E+L
Sbjct: 250 GCIFGEML 257

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 8/206 (3%)
Query: 451 DFHIKYCIGTGGYGSV-YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +F     +G G +G V    E   G+  A+K L          V     E  VL   RH 
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 70
Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +  L Y F  H +  F++ EY   G LF   H   E +      R    + V+ AL YL
Sbjct: 71  FLTALKYSFQTHDRLCFVM-EYANGGELF--FHLSRERVFSEDRARFYGAEIVS-ALDYL 126
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H +   ++++RD+   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 127 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 184
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +  GVV  E++ G  P
Sbjct: 185 DNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 87  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 139
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 140 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 199 NSKGYTKSIDIWSVGCILAEML 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 8/206 (3%)
Query: 451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF+    +G G +G V  A+     ++ A+K L          V+    E  VL+ +   
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 510 NIVKLYGFCLHK-KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             +     C      ++ + EY+  G L   ++   +  +    + V     ++  L +L
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H      II+RD+  +N++LDS     +ADFG  +   +D        GT  YIAPE+  
Sbjct: 137 H---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIA 193
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +++GV+  E+L G  P
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPP 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 78/164 (47%), Gaps = 9/164 (5%)
Query: 494 KSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTK 553
           +  + EA +   ++H NIV+L+     +   +LI++ +  G LF      ++ +   +  
Sbjct: 55  QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYS 108
Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSS 610
             +    +   L  + H   + ++HR++   N+LL S L+ +   +ADFG A  +  +  
Sbjct: 109 EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 611 YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                AGT GY++PE+          D+++ GV+   +L+G  P
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGX-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGX-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 92
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSL-------------FCVLHDDDEAIELNWTKRVN 556
           +V L G C      + +I E+ + G+L             + V  +D     L     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
               VA  + +L    +   IHRD+++ NILL       + DFG AR ++ D     +R 
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--XVRK 207
Query: 617 GT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIML 671
           G       ++APE  +  V T + DV+SFGV+  E+  +G  P            P + +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKI 256
Query: 672 IDVLNQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +   +RL      +        +      C   +P  RPT   + + L
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 8/206 (3%)
Query: 451 DFHIKYCIGTGGYGSV-YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +F     +G G +G V    E   G+  A+K L          V     E  VL   RH 
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 69
Query: 510 NIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            +  L Y F  H +  F++ EY   G LF   H   E +      R    + V+ AL YL
Sbjct: 70  FLTALKYSFQTHDRLCFVM-EYANGGELF--FHLSRERVFSEDRARFYGAEIVS-ALDYL 125
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H +   ++++RD+   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 126 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 183
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D +  GVV  E++ G  P
Sbjct: 184 DNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 94  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 146
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 206 NSKGYTKSIDIWSVGCILAEML 227

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 94
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 95  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 147
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 148 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 207 NSKGYTKSIDIWSVGCILAEML 228

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 85
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 86  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 138
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 139 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 198 NSKGYTKSIDIWSVGCILAEML 219

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 87  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 139
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 140 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 199 NSKGYTKSIDIWSVGCILAEML 220

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KCQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 144 -SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 203 NSKGYTKSIDIWSVGCILAEML 224

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 3   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 55
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 56  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 104
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 159
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 3   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 55
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 56  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 104
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 159
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 3   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSF 55
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 56  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 104
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 159
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 3   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSF 55
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 56  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 104
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 159
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 103/253 (40%), Gaps = 36/253 (14%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK 522
           G V   +  E G   A+K L   +      ++   NE  +L  V    +VKL        
Sbjct: 55  GRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNS 114
Query: 523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDIS 582
            ++++ EY+  G +F  L       E +   R    + V     YLH   +L +I+RD+ 
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH---SLDLIYRDLK 168
Query: 583 SNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTIVVTGKCDVYSF 641
             N+L+D      V DFG A+ +      RT    GT  Y+APE+  +       D ++ 
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 642 GVVALEVLMGTHP 654
           GV+  E+  G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 23  NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSF 75
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 76  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 124
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 125 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 179
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 180 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 234
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 445 LINATEDFHIKYCIGTGGYG-SVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           +++ ++ + +   IG+G +G +    +    ++VA+K +   E  D    +   N     
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH---- 68
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
            ++RH NIV+     L    + ++ EY   G LF  + +   A   +  +     + +  
Sbjct: 69  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLIS 125
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEA--SVADFGTAR--LLHVDSSYRTLRAGTY 619
            +SY H    + + HRD+   N LLD +      + DFG ++  +LH   S      GT 
Sbjct: 126 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTP 179
Query: 620 GYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
            YIAPE+       GK  DV+S GV    +L+G +P
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGX-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 22/166 (13%)
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT- 618
            VA  + +L    +   IHRD+++ NILL       + DFG AR ++ D  Y  +R G  
Sbjct: 199 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDA 253
Query: 619 ---YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDV 674
                ++APE  +  V T + DV+SFGV+  E+  +G  P            P + + + 
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEE 302
Query: 675 LNQRLSPPVNQKIVQDII-LVSTIAFACLSSQPKSRPTMQRISQEL 719
             +RL      +        +      C   +P  RPT   + + L
Sbjct: 303 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 22/166 (13%)
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT- 618
            VA  + +L    +   IHRD+++ NILL       + DFG AR ++ D  Y  +R G  
Sbjct: 206 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDA 260
Query: 619 ---YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDV 674
                ++APE  +  V T + DV+SFGV+  E+  +G  P            P + + + 
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEE 309
Query: 675 LNQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             +RL      +        +      C   +P  RPT   + + L
Sbjct: 310 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEA-HVLSTVRHRNIVKLY 515
           +G G +G V++ E  + G   A+KK+          ++ F+ E     + +    IV LY
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 132
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G       + +  E +E GSL  ++ +     E    + +  +      L YLH   +  
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPE---DRALYYLGQALEGLEYLH---SRR 186
Query: 576 IIHRDISSNNILLDSN-LEASVADFGTARLLHVDSSYRTLRAGTY-----GYIAPELAYT 629
           I+H D+ ++N+LL S+   A++ DFG A  L  D   + L  G Y      ++APE+   
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 630 IVVTGKCDVYSFGVVALEVLMGTHP 654
                K DV+S   + L +L G HP
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGX-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGX-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 22/166 (13%)
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT- 618
            VA  + +L    +   IHRD+++ NILL       + DFG AR ++ D  Y  +R G  
Sbjct: 208 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDA 262
Query: 619 ---YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDV 674
                ++APE  +  V T + DV+SFGV+  E+  +G  P            P + + + 
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEE 311
Query: 675 LNQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             +RL      +        +      C   +P  RPT   + + L
Sbjct: 312 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 22/166 (13%)
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT- 618
            VA  + +L    +   IHRD+++ NILL       + DFG AR ++ D  Y  +R G  
Sbjct: 201 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDA 255
Query: 619 ---YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLIDV 674
                ++APE  +  V T + DV+SFGV+  E+  +G  P            P + + + 
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKIDEE 304
Query: 675 LNQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             +RL      +        +      C   +P  RPT   + + L
Sbjct: 305 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 34/211 (16%)
Query: 457 CIGTGGYGSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
            +GTG +G V   +            L + KVV LK++ H+            NE  +L 
Sbjct: 43  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQ 91
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
            V    +VKL         ++++ EY+  G +F  L       E +   R    + V   
Sbjct: 92  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH--ARFYAAQIVL-T 148
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIA 623
             YLH   +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+A
Sbjct: 149 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 201
Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+  +       D ++ GV+  E+  G  P
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 3   NAAAAKKGX-------EQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSF 55
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 56  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 104
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 159
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YG+V  A +   G  VA+KKL+    +   F K    E  +L  +RH N++ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 517 FCLHKKCM------FLIYEYM--ERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
                + +      +L+  +M  + G L       ++ I+        +V  +   L Y+
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF-------LVYQMLKGLRYI 144
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H      IIHRD+   N+ ++ + E  + DFG AR    DS        T  Y APE+  
Sbjct: 145 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMXGX-VVTRWYRAPEVIL 198
Query: 629 T-IVVTGKCDVYSFGVVALEVLMG 651
             +  T   D++S G +  E++ G
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITG 222

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 34/211 (16%)
Query: 457 CIGTGGYGSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
            +GTG +G V   +            L + KVV LK++ H+            NE  +L 
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQ 89
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
            V    +VKL         ++++ EY+  G +F  L       E +   R    + V   
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH--ARFYAAQIVL-T 146
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIA 623
             YLH   +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+A
Sbjct: 147 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 199
Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+  +       D ++ GV+  E+  G  P
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA++K+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 51/236 (21%)
Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
           NL  ++  NN L+   P  + +L+KL  + ++ N +  I P  + +L NL GL L++N++
Sbjct: 64  NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 119
Query: 162 SGVLPQEIGNLKSLTELYVTNN------ALGGLIPSTLFRLTNISSNQFHSSIPLEIGNF 215
           + + P  + NL +L  L +++N      AL GL   T  +  + SSNQ     PL   N 
Sbjct: 120 TDIDP--LKNLTNLNRLELSSNTISDISALSGL---TSLQQLSFSSNQVTDLKPL--ANL 172
Query: 216 SALDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXXXXGQIPYAIGKLFNLMYLDLSKNK 275
           + L+ LD+S NK+  I                            + KL NL  L  + N+
Sbjct: 173 TTLERLDISSNKVSDI--------------------------SVLAKLTNLESLIATNNQ 206
Query: 276 LSGSIPTEIGNCSALKNLTLNHNSLD--GTIPLEMGKILLLQNLDLSHNNLSGTIP 329
           +S   P  +G  + L  L+LN N L   GT    +  +  L +LDL++N +S   P
Sbjct: 207 ISDITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP 256

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 34/211 (16%)
Query: 457 CIGTGGYGSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
            +GTG +G V   +            L + KVV LK++ H+            NE  +L 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQ 96
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
            V    +VKL         ++++ EY+  G +F  L       E +   R    + V   
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH--ARFYAAQIVL-T 153
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIA 623
             YLH   +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 206
Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+  +       D ++ GV+  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 51/236 (21%)
Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
           NL  ++  NN L+   P  + +L+KL  + ++ N +  I P  + +L NL GL L++N++
Sbjct: 64  NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 119
Query: 162 SGVLPQEIGNLKSLTELYVTNN------ALGGLIPSTLFRLTNISSNQFHSSIPLEIGNF 215
           + + P  + NL +L  L +++N      AL GL   T  +  + SSNQ     PL   N 
Sbjct: 120 TDIDP--LKNLTNLNRLELSSNTISDISALSGL---TSLQQLSFSSNQVTDLKPL--ANL 172
Query: 216 SALDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXXXXGQIPYAIGKLFNLMYLDLSKNK 275
           + L+ LD+S NK+  I                            + KL NL  L  + N+
Sbjct: 173 TTLERLDISSNKVSDI--------------------------SVLAKLTNLESLIATNNQ 206
Query: 276 LSGSIPTEIGNCSALKNLTLNHNSLD--GTIPLEMGKILLLQNLDLSHNNLSGTIP 329
           +S   P  +G  + L  L+LN N L   GT    +  +  L +LDL++N +S   P
Sbjct: 207 ISDITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP 256

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 113/289 (39%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 92
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSL-------------FCVLHDDDEAIELNWTKRVN 556
           +V L G C      + +I E+ + G+L             + V  +D     L     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
               VA  + +L    +   IHRD+++ NILL       + DFG AR +  D     +R 
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD--XVRK 207
Query: 617 GT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIML 671
           G       ++APE  +  V T + DV+SFGV+  E+  +G  P            P + +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKI 256
Query: 672 IDVLNQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +   +RL      +        +      C   +P  RPT   + + L
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 452 FHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETE--------DSAFVKSFQNEAHVL 503
           + ++  I +G YG+V      EG  VA+K++ ++ ++        DS   K    E  +L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 504 STVRHRNIVKLYGFCLHKK-----CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIV 558
           +   H NI+ L    +H +      ++L+ E M R  L  V+HD    I        +I 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ-----HIQ 137
Query: 559 KSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT 618
             + H L  LH      ++HRD+   NILL  N + ++ DF  AR    D++ +T     
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-KTHYVTH 196
Query: 619 YGYIAPELAYTIV-VTGKCDVYSFGVVALEVL 649
             Y APEL       T   D++S G V  E+ 
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 44/288 (15%)
Query: 458 IGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 93
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSLFCVLH------------DDDEAIELNWTKRVNI 557
           +V L G C      + +I E+ + G+L   L             +D     L     +  
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
              VA  + +L    +   IHRD+++ NILL       + DFG AR +  D     +R G
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD--XVRKG 208
Query: 618 T----YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIMLI 672
                  ++APE  +  V T + DV+SFGV+  E+  +G  P            P + + 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKID 257
Query: 673 DVLNQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +   +RL      +        +      C   +P  RPT   + + L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 452 FHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETE--------DSAFVKSFQNEAHVL 503
           + ++  I +G YG+V      EG  VA+K++ ++ ++        DS   K    E  +L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 504 STVRHRNIVKLYGFCLHKK-----CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIV 558
           +   H NI+ L    +H +      ++L+ E M R  L  V+HD    I        +I 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ-----HIQ 137
Query: 559 KSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT 618
             + H L  LH      ++HRD+   NILL  N + ++ DF  AR    D++ +T     
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-KTHYVTH 196
Query: 619 YGYIAPELAYTIV-VTGKCDVYSFGVVALEVL 649
             Y APEL       T   D++S G V  E+ 
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 104/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY   G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+++D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 34/211 (16%)
Query: 457 CIGTGGYGSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
            +GTG +G V   +            L + KVV LK++ H+            NE  +L 
Sbjct: 35  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQ 83
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
            V    +VKL         ++++ EY+  G +F  L       E +   R    + V   
Sbjct: 84  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-T 140
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIA 623
             YLH   +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+A
Sbjct: 141 FEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 193
Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+  +       D ++ GV+  E+  G  P
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 113/289 (39%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 83
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSL-------------FCVLHDDDEAIELNWTKRVN 556
           +V L G C      + +I E+ + G+L             + V  +D     L     + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
               VA  + +L    +   IHRD+++ NILL       + DFG AR +  D     +R 
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD--XVRK 198
Query: 617 GT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIML 671
           G       ++APE  +  V T + DV+SFGV+  E+  +G  P            P + +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKI 247
Query: 672 IDVLNQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +   +RL      +        +      C   +P  RPT   + + L
Sbjct: 248 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHV----LSTVRHRNIV 512
           +G G +G V++ +  + G   A+KK+          ++ F+ E  V    LS+ R   IV
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPR---IV 113
Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
            LYG       + +  E +E GSL  ++       E    + +  +      L YLH   
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLH--- 167
Query: 573 TLSIIHRDISSNNILLDSN-LEASVADFGTARLLHVDSSYRTLRAGTY-----GYIAPEL 626
           T  I+H D+ ++N+LL S+   A++ DFG A  L  D   ++L  G Y      ++APE+
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                   K D++S   + L +L G HP
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+++D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEIIISK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 113/289 (39%), Gaps = 45/289 (15%)
Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR-N 510
           +G G +G V +A+          + VA+K L    T      ++  +E  +L  + H  N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 83
Query: 511 IVKLYGFCLHKKC-MFLIYEYMERGSL-------------FCVLHDDDEAIELNWTKRVN 556
           +V L G C      + +I E+ + G+L             + V  +D     L     + 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
               VA  + +L    +   IHRD+++ NILL       + DFG AR +  D     +R 
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD--XVRK 198
Query: 617 GT----YGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPXXXXXXXXXXXXPKIML 671
           G       ++APE  +  V T + DV+SFGV+  E+  +G  P            P + +
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----------YPGVKI 247
Query: 672 IDVLNQRLSPPVNQKIVQ-DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +   +RL      +        +      C   +P  RPT   + + L
Sbjct: 248 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 34/211 (16%)
Query: 457 CIGTGGYGSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
            +GTG +G V   +            L + KVV LK++ H+            NE  +L 
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQ 89
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
            V    +VKL         ++++ EY+  G +F  L       E +   R    + V   
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-T 146
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIA 623
             YLH   +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+A
Sbjct: 147 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLA 199
Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+  +       D ++ GV+  E+  G  P
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  ++  G  P
Sbjct: 214 GYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 27/224 (12%)
Query: 441 LYEDLINATEDFHIKYCIGTGGYG----SVYKAELPEGKVVALKKLHHSETEDSAFVKSF 496
           L+ + I  T+ + +K  IG G Y      ++KA   E  V  + K     TE+   +   
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL--- 69
Query: 497 QNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR-- 554
                 L   +H NI+ L       K ++++ E M+ G L      D    +  +++R  
Sbjct: 70  ------LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL-----DKILRQKFFSEREA 118
Query: 555 VNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL---DSNLEA-SVADFGTARLLHVDSS 610
             ++ ++   + YLH      ++HRD+  +NIL      N E+  + DFG A+ L  ++ 
Sbjct: 119 SAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 611 YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                  T  ++APE+         CD++S GV+   +L G  P
Sbjct: 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 458 IGTGGYG--SVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           IG+G +G   + + +L + ++VA+K +       +A  ++ Q E     ++RH NIV+  
Sbjct: 28  IGSGNFGVARLMRDKLTK-ELVAVKYIERG----AAIDENVQREIINHRSLRHPNIVRFK 82
Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
              L    + +I EY   G L+  + +   A   +  +     + +   +SY H   ++ 
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCH---SMQ 136
Query: 576 IIHRDISSNNILLDSNLEA--SVADFGTAR--LLHVDSSYRTLRAGTYGYIAPELAYTIV 631
           I HRD+   N LLD +      + DFG ++  +LH   S      GT  YIAPE+     
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQE 193
Query: 632 VTGK-CDVYSFGVVALEVLMGTHP 654
             GK  DV+S GV    +L+G +P
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHV----LSTVRHRNIV 512
           +G G +G V++ +  + G   A+KK+          ++ F+ E  V    LS+ R   IV
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPR---IV 129
Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
            LYG       + +  E +E GSL  ++    +   L   + +  +      L YLH   
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLH--- 183
Query: 573 TLSIIHRDISSNNILLDSN-LEASVADFGTARLLHVDSSYRTLRAGTY-----GYIAPEL 626
           T  I+H D+ ++N+LL S+   A++ DFG A  L  D   ++L  G Y      ++APE+
Sbjct: 184 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 243
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                   K D++S   + L +L G HP
Sbjct: 244 VMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 104/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY   G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+++D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHV----LSTVRHRNIV 512
           +G G +G V++ +  + G   A+KK+          ++ F+ E  V    LS+ R   IV
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPR---IV 127
Query: 513 KLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
            LYG       + +  E +E GSL  ++       E    + +  +      L YLH   
Sbjct: 128 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLH--- 181
Query: 573 TLSIIHRDISSNNILLDSN-LEASVADFGTARLLHVDSSYRTLRAGTY-----GYIAPEL 626
           T  I+H D+ ++N+LL S+   A++ DFG A  L  D   ++L  G Y      ++APE+
Sbjct: 182 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 241
Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                   K D++S   + L +L G HP
Sbjct: 242 VMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + +      T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++++ + ME   L+ +L    +   L+       +  +   L Y+H  
Sbjct: 94  IIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 146
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + +      T  Y APE+  
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 206 NSKGYTKSIDIWSVGCILAEML 227

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 104/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 3   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSF 55
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 56  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 104
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY   G +F  L       E +   R    + V     YLH  
Sbjct: 105 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 159
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+++D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 160 -SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 104/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY   G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+++D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 104/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY   G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+++D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 104/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY   G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+++D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV----KGRTWXLCGTPEYLAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 104/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 3   NAAAAKKGX-------EQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIRTLGTGSF 55
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +   V    +
Sbjct: 56  GRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRIQQAVNFPFL 104
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY   G +F  L       E +   R    + V     YLH  
Sbjct: 105 VKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 159
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      VADFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     KV VA+KK+  S  E   + +    E  +L   RH NI+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 517 FCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     K ++L+   M    L+ +L    +   L+       +  +   L Y+H  
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMG-ADLYKLL----KTQHLSNDHICYFLYQILRGLKYIH-- 161
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+LL++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 162 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 221 NSKGYTKSIDIWSVGCILAEML 242

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLSTVR 507
           IG+G  G V  A +   G  VA+KKL           + FQN+ H         +L  V 
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLS----------RPFQNQTHAKRAYRELVLLKCVN 81
Query: 508 HRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           H+NI+ L      +K +      +L+ E M+  +L  V+H     +EL+  +   ++  +
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQM 135
Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGY 621
              + +LH   +  IIHRD+  +NI++ S+    + DFG AR    +          Y Y
Sbjct: 136 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-Y 191
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            APE+   +      D++S G +  E++ G
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 458 IGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V  A     K  VA+KK+  S  E   + +    E  +L   RH N++ +  
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKI--SPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 517 FCLHK-----KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                     + ++++ + ME   L+ +L    ++ +L+       +  +   L Y+H  
Sbjct: 109 ILRASTLEAMRDVYIVQDLME-TDLYKLL----KSQQLSNDHICYFLYQILRGLKYIH-- 161
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLL---HVDSSYRTLRAGTYGYIAPELAY 628
            + +++HRD+  +N+L+++  +  + DFG AR+    H  + + T    T  Y APE+  
Sbjct: 162 -SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 629 -TIVVTGKCDVYSFGVVALEVL 649
            +   T   D++S G +  E+L
Sbjct: 221 NSKGYTKSIDIWSVGCILAEML 242

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF +   IG GG+G VY     + GK+ A+K L      D   +K  Q E   L+     
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL------DKKRIKMKQGETLALNERIML 242
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY-- 567
           ++V   G C    CM   +   ++ S    L +     +L++    + V S A    Y  
Sbjct: 243 SLVST-GDCPFIVCMSYAFHTPDKLSFILDLMN---GGDLHYHLSQHGVFSEADMRFYAA 298
Query: 568 -----LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYG 620
                L H     +++RD+   NILLD +    ++D G A     D S +   A  GT+G
Sbjct: 299 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHG 354
Query: 621 YIAPE-LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y+APE L   +      D +S G +  ++L G  P
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF +   IG GG+G VY     + GK+ A+K L      D   +K  Q E   L+     
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL------DKKRIKMKQGETLALNERIML 243
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY-- 567
           ++V   G C    CM   +   ++ S    L +     +L++    + V S A    Y  
Sbjct: 244 SLVST-GDCPFIVCMSYAFHTPDKLSFILDLMN---GGDLHYHLSQHGVFSEADMRFYAA 299
Query: 568 -----LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYG 620
                L H     +++RD+   NILLD +    ++D G A     D S +   A  GT+G
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHG 355
Query: 621 YIAPE-LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y+APE L   +      D +S G +  ++L G  P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 36/211 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLSTVR 507
           IG+G  G V  A +   G  VA+KKL           + FQN+ H         +L  V 
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLS----------RPFQNQTHAKRAYRELVLLKCVN 79
Query: 508 HRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           H+NI+ L      +K +      +L+ E M+  +L  V+H     +EL+  +   ++  +
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQM 133
Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGY 621
              + +LH   +  IIHRD+  +NI++ S+    + DFG AR    +          Y Y
Sbjct: 134 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRY-Y 189
Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGT 652
            APE+   +      D++S G +  E++ G+
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKGS 220

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF +   IG GG+G VY     + GK+ A+K L      D   +K  Q E   L+     
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL------DKKRIKMKQGETLALNERIML 243
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY-- 567
           ++V   G C    CM   +   ++ S    L +     +L++    + V S A    Y  
Sbjct: 244 SLVST-GDCPFIVCMSYAFHTPDKLSFILDLMN---GGDLHYHLSQHGVFSEADMRFYAA 299
Query: 568 -----LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYG 620
                L H     +++RD+   NILLD +    ++D G A     D S +   A  GT+G
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHG 355
Query: 621 YIAPE-LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y+APE L   +      D +S G +  ++L G  P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 451 DFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF +   IG GG+G VY     + GK+ A+K L      D   +K  Q E   L+     
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL------DKKRIKMKQGETLALNERIML 243
Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY-- 567
           ++V   G C    CM   +   ++ S    L +     +L++    + V S A    Y  
Sbjct: 244 SLVST-GDCPFIVCMSYAFHTPDKLSFILDLMN---GGDLHYHLSQHGVFSEADMRFYAA 299
Query: 568 -----LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYG 620
                L H     +++RD+   NILLD +    ++D G A     D S +   A  GT+G
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHG 355
Query: 621 YIAPE-LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y+APE L   +      D +S G +  ++L G  P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 445 LINATEDFHIKYCIGTGGYG-SVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           +++ ++ + +   IG+G +G +    +    ++VA+K +   E   +   +   N     
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINH---- 69
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
            ++RH NIV+     L    + ++ EY   G LF  + +   A   +  +     + +  
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLIS 126
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEA--SVADFGTAR--LLHVDSSYRTLRAGTY 619
            +SY H    + + HRD+   N LLD +      + DFG ++  +LH   S      GT 
Sbjct: 127 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTP 180
Query: 620 GYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
            YIAPE+       GK  DV+S GV    +L+G +P
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 104/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT  Y+AP +  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPAIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 445 LINATEDFHIKYCIGTGGYG-SVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           +++ ++ + +   IG+G +G +    +    ++VA+K +   E  D    +   N     
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH---- 69
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
            ++RH NIV+     L    + ++ EY   G LF  + +   A   +  +     + +  
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLIS 126
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSN----LEASVADFGTARLLHVDSSYRTLRAGTY 619
            +SY H    + + HRD+   N LLD +    L+     +  + +LH   S      GT 
Sbjct: 127 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH---SQPKSTVGTP 180
Query: 620 GYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
            YIAPE+       GK  DV+S GV    +L+G +P
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 103/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 3   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 55
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 56  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 104
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
            KL         ++++ EY   G +F  L       E +   R    + V     YLH  
Sbjct: 105 TKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH--ARFYAAQIVL-TFEYLH-- 159
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+++D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 160 -SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 445 LINATEDFHIKYCIGTGGYG-SVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           +++ ++ + +   IG+G +G +    +    ++VA+K +   E  D    +   N     
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH---- 69
Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
            ++RH NIV+     L    + ++ EY   G LF  + +   A   +  +     + +  
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLIS 126
Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSN----LEASVADFGTARLLHVDSSYRTLRAGTY 619
            +SY H    + + HRD+   N LLD +    L+     +  + +LH   S      GT 
Sbjct: 127 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH---SQPKDTVGTP 180
Query: 620 GYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
            YIAPE+       GK  DV+S GV    +L+G +P
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 40/212 (18%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKV 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            Y APE+   +      D++S GV+  E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 40/212 (18%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKV 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            Y APE+   +      D++S GV+  E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G  G V+K    + G V+A+K++  S  ++    +   +   VL +     IV+ +G
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN-KRILMDLDVVLKSHDCPYIVQCFG 91
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV--NIVKSVAHALSYLHHDCTL 574
             +    +F+  E M  G+    L    + ++    +R+   +  ++  AL YL      
Sbjct: 92  TFITNTDVFIAMELM--GTCAEKLK---KRMQGPIPERILGKMTVAIVKALYYLKE--KH 144
Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            +IHRD+  +NILLD   +  + DFG +  L VD   +   AG   Y+APE       T 
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 635 -----KCDVYSFGVVALEVLMGTHP 654
                + DV+S G+  +E+  G  P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFP 228

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 94  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 140
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEM-TGYVATRWYR 194
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 16/225 (7%)
Query: 437 DGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFV-- 493
           D  +L+ED+    E       IG G +  V +    E G+  A+K +  ++   S  +  
Sbjct: 19  DDDVLFEDVYELCE------VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 72
Query: 494 KSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWT 552
           +  + EA +   ++H +IV+L         +++++E+M+   L F ++   D     +  
Sbjct: 73  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 132
Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDS 609
              + ++ +  AL Y H +   +IIHRD+  + +LL S   ++   +  FG A  L    
Sbjct: 133 VASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 189
Query: 610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                R GT  ++APE+          DV+  GV+   +L G  P
Sbjct: 190 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 103/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 3   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 55
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 56  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 104
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
            KL         ++++ EY   G +F  L       E +   R    + V     YLH  
Sbjct: 105 TKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 159
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+++D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 160 -SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 103/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 3   NAAAAKKGX-------EQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSF 55
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 56  GRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 104
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
            KL         ++++ EY   G +F  L       E +   R    + V     YLH  
Sbjct: 105 TKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 159
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+++D      V DFG A+ +      RT    GT  Y+APE+  + 
Sbjct: 160 -SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSK 214
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 215 GYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 85  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 131
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 185
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGXVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 108 VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 154
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 155 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 208
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 104/264 (39%), Gaps = 58/264 (21%)
Query: 421 NSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKY-----------------CIGTGGY 463
           N+ AAK G        + + + E L  A EDF  K+                  +GTG +
Sbjct: 2   NAAAAKKGS-------EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSF 54
Query: 464 GSVYKAE------------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           G V   +            L + KVV LK++ H+            NE  +L  V    +
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----------LNEKRILQAVNFPFL 103
Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
           VKL         ++++ EY+  G +F  L       E +   R    + V     YLH  
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVL-TFEYLH-- 158
Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAYTI 630
            +L +I+RD+   N+L+D      V DFG A+ +      RT    GT   +APE+  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEALAPEIILSK 213
Query: 631 VVTGKCDVYSFGVVALEVLMGTHP 654
                 D ++ GV+  E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 109 VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 156 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 209
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 80/170 (47%), Gaps = 23/170 (13%)
Query: 497 QNEAHVLSTVRHRNIVKLYG--FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR 554
           + E  +L  +RH+N+++L    +   K+ M+++ EY       C +    E ++    KR
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY-----CVCGMQ---EMLDSVPEKR 105
Query: 555 VNIVKSVAH------ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
             + ++  +       L YLH   +  I+H+DI   N+LL +     ++  G A  LH  
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 609 SSYRTLRA--GTYGYIAPELAYTI-VVTG-KCDVYSFGVVALEVLMGTHP 654
           ++  T R   G+  +  PE+A  +   +G K D++S GV    +  G +P
Sbjct: 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 98
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 99  VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 145
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 146 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 199
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 229

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKXQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 16/225 (7%)
Query: 437 DGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFV-- 493
           D  +L+ED+    E       IG G +  V +    E G+  A+K +  ++   S  +  
Sbjct: 17  DDDVLFEDVYELCE------VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 494 KSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL-FCVLHDDDEAIELNWT 552
           +  + EA +   ++H +IV+L         +++++E+M+   L F ++   D     +  
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDS 609
              + ++ +  AL Y H +   +IIHRD+  + +LL S   ++   +  FG A  L    
Sbjct: 131 VASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                R GT  ++APE+          DV+  GV+   +L G  P
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 83/206 (40%), Gaps = 8/206 (3%)
Query: 451 DFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           DF+    +G G +G V  +E     ++ A+K L          V+    E  VL+     
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 510 NIVKLYGFCLHK-KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             +     C      ++ + EY+  G L   ++   +         V     +A  L +L
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
               +  II+RD+  +N++LDS     +ADFG  +    D        GT  YIAPE+  
Sbjct: 138 Q---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA 194
Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP 654
                   D ++FGV+  E+L G  P
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 100 VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 146
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 147 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEM-TGYVATRWYR 200
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 517 FCLHKKCMFLIYE-YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
                + +    + Y+    +   L++  +  +L       ++  +   L Y+H   +  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH---SAD 141
Query: 576 IIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIV-VTG 634
           IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y APE+    +    
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYRAPEIMLNWMHYNQ 198
Query: 635 KCDVYSFGVVALEVLMG 651
             D++S G +  E+L G
Sbjct: 199 TVDIWSVGCIMAELLTG 215

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D       A T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D       A T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 85  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 131
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D       A T  Y 
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYR 185
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 94  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 140
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEM-TGYVATRWYR 194
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 441 LYEDLINATEDFHIKYCIGTGGYG----SVYKAELPEGKVVALKKLHHSETEDSAFVKSF 496
           L+ + I  T+ + +K  IG G Y      ++KA   E  V  + K     TE+   +   
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEIL--- 69
Query: 497 QNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR-- 554
                 L   +H NI+ L       K ++++ E  + G L      D    +  +++R  
Sbjct: 70  ------LRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELL-----DKILRQKFFSEREA 118
Query: 555 VNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL---DSNLEA-SVADFGTARLLHVDSS 610
             ++ ++   + YLH      ++HRD+  +NIL      N E+  + DFG A+ L  ++ 
Sbjct: 119 SAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 611 YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                  T  ++APE+         CD++S GV+    L G  P
Sbjct: 176 LLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 85  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 131
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 185
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 91  VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 191
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 86  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 132
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 133 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 186
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 101 VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 147
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 148 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 201
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 101 VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 147
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 148 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 201
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 86  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 132
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 133 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 186
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKS-----FQNEAHVLSTVRHRNI 511
           +G+G +G V+ A +  + K V +K +   +  +  +++         E  +LS V H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 512 VKLYGFCLHKKCMFLIYEYMERG-SLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           +K+     ++    L+ E    G  LF  +   D    L+      I + +  A+ YL  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI 630
                IIHRDI   NI++  +    + DFG+A  L     + T   GT  Y APE+    
Sbjct: 149 K---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF-CGTIEYCAPEVLMGN 204
Query: 631 VVTG-KCDVYSFGVVALEVLMGTHP 654
              G + +++S GV    ++   +P
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKXQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 100 VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 146
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 147 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 200
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 95  VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 195
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 96  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 142
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 196
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 108 VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 154
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 155 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 208
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKX 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 91  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 137
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 191
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 94  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 140
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 194
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 94  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 140
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 194
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 86
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 87  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 133
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 134 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 187
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 87
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 88  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 134
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 135 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 188
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 109 VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 155
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 156 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 209
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS-KPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 101 VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 147
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 148 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 201
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 112 VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 158
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 159 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 212
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 27/216 (12%)
Query: 449 TEDFHIKYCIGTGGYGS----VYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           ++ + +K  IG G Y      V+KA   E  V  + K     +E+   +         L 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL---------LR 76
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN--IVKSVA 562
             +H NI+ L       K ++L+ E M  G L      D    +  +++R    ++ ++ 
Sbjct: 77  YGQHPNIITLKDVYDDGKHVYLVTELMRGGELL-----DKILRQKFFSEREASFVLHTIG 131
Query: 563 HALSYLHHDCTLSIIHRDISSNNILL---DSNLEA-SVADFGTARLLHVDSSYRTLRAGT 618
             + YLH   +  ++HRD+  +NIL      N E   + DFG A+ L  ++        T
Sbjct: 132 KTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYT 188
Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
             ++APE+         CD++S G++   +L G  P
Sbjct: 189 ANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
           NL  ++  NN L+   P  + +L+KL  + ++ N +  I P  + +L NL GL L++N++
Sbjct: 64  NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 119
Query: 162 SGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISS----NQFHSSIPLEIGNFSA 217
           + + P  + NL +L  L +++N +  +  S L  LT++      NQ     PL   N + 
Sbjct: 120 TDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFGNQVTDLKPL--ANLTT 173
Query: 218 LDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXXXXGQIPYAIGKLFNLMYLDLSKNKLS 277
           L+ LD+S NK+  I                            + KL NL  L  + N++S
Sbjct: 174 LERLDISSNKVSDI--------------------------SVLAKLTNLESLIATNNQIS 207
Query: 278 GSIPTEIGNCSALKNLTLNHNSLD--GTIPLEMGKILLLQNLDLSHNNLSGTIP 329
              P  +G  + L  L+LN N L   GT    +  +  L +LDL++N +S   P
Sbjct: 208 DITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP 255

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 109 VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D       A T  Y 
Sbjct: 156 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGXVA-TRWYR 209
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 58/131 (44%), Gaps = 6/131 (4%)
Query: 524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISS 583
           ++ + EY+  G L   ++   +         V     +A  L +L    +  II+RD+  
Sbjct: 417 LYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKL 470
Query: 584 NNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGV 643
           +N++LDS     +ADFG  +    D        GT  YIAPE+          D ++FGV
Sbjct: 471 DNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 530
Query: 644 VALEVLMGTHP 654
           +  E+L G  P
Sbjct: 531 LLYEMLAGQAP 541

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 91  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 137
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 191
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
           NL  ++  NN L+   P  + +L+KL  + ++ N +  I P  + +L NL GL L++N++
Sbjct: 64  NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 119
Query: 162 SGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISS----NQFHSSIPLEIGNFSA 217
           + + P  + NL +L  L +++N +  +  S L  LT++      NQ     PL   N + 
Sbjct: 120 TDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFGNQVTDLKPL--ANLTT 173
Query: 218 LDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXXXXGQIPYAIGKLFNLMYLDLSKNKLS 277
           L+ LD+S NK+  I                            + KL NL  L  + N++S
Sbjct: 174 LERLDISSNKVSDI--------------------------SVLAKLTNLESLIATNNQIS 207
Query: 278 GSIPTEIGNCSALKNLTLNHNSLD--GTIPLEMGKILLLQNLDLSHNNLSGTIP 329
              P  +G  + L  L+LN N L   GT    +  +  L +LDL++N +S   P
Sbjct: 208 DITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP 255

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 95  VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 195
Query: 623 APELAYTIVVTGK-CDVYSFGVVALEVLMG 651
           APE+    +   +  D++S G +  E+L G
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 441 LYEDLINATEDFHIKYCIGTGGYGS----VYKAELPEGKVVALKKLHHSETEDSAFVKSF 496
           LY   +  ++ + +K  IG G Y      V+KA   E  V  + K     +E+   +   
Sbjct: 18  LYFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL--- 74
Query: 497 QNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
                 L   +H NI+ L       K ++L+ E M  G L      D    +  +++R  
Sbjct: 75  ------LRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELL-----DKILRQKFFSEREA 123
Query: 557 --IVKSVAHALSYLHHDCTLSIIHRDISSNNILL---DSNLEA-SVADFGTARLLHVDSS 610
             ++ ++   + YLH   +  ++HRD+  +NIL      N E   + DFG A+ L  ++ 
Sbjct: 124 SFVLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENG 180
Query: 611 YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                  T  ++APE+         CD++S G++   +L G  P
Sbjct: 181 LLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
           NL  ++  NN L+   P  + +L+KL  + ++ N +  I P  + +L NL GL L++N++
Sbjct: 69  NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 124
Query: 162 SGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISS----NQFHSSIPLEIGNFSA 217
           + + P  + NL +L  L +++N +  +  S L  LT++      NQ     PL   N + 
Sbjct: 125 TDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFGNQVTDLKPL--ANLTT 178
Query: 218 LDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXXXXGQIPYAIGKLFNLMYLDLSKNKLS 277
           L+ LD+S NK+  I                            + KL NL  L  + N++S
Sbjct: 179 LERLDISSNKVSDI--------------------------SVLAKLTNLESLIATNNQIS 212
Query: 278 GSIPTEIGNCSALKNLTLNHNSLD--GTIPLEMGKILLLQNLDLSHNNLSGTIP 329
              P  +G  + L  L+LN N L   GT    +  +  L +LDL++N +S   P
Sbjct: 213 DITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP 260

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKC 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPEVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            Y APE+   +      D++S G +  E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 91  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 137
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEM-TGYVATRWYR 191
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 72
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQ-----MELDHERMSYLLY 126
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 127 QMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTR 182
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 95  VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEM-TGYVATRWYR 195
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 21/162 (12%)
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           HRN+++L  F   +   +L++E M  GS+   +H      EL  +    +V+ VA AL +
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDF 126
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLR-------AG 617
           LH+     I HRD+   NIL +   + S   + DFG    + ++     +         G
Sbjct: 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCG 183
Query: 618 TYGYIAPELAYTI-----VVTGKCDVYSFGVVALEVLMGTHP 654
           +  Y+APE+         +   +CD++S GV+   +L G  P
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 48/234 (20%)
Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
           NL  ++  NN L+   P  + +L+KL  + ++ N +  I P  + +L NL GL L++N++
Sbjct: 68  NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 123
Query: 162 SGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISS----NQFHSSIPLEIGNFSA 217
           + + P  + NL +L  L +++N +  +  S L  LT++      NQ     PL   N + 
Sbjct: 124 TDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFGNQVTDLKPL--ANLTT 177
Query: 218 LDTLDLSDNKIHGIIPDEXXXXXXXXXXXXXXXXXXGQIPYAIGKLFNLMYLDLSKNKLS 277
           L+ LD+S NK+  I                            + KL NL  L  + N++S
Sbjct: 178 LERLDISSNKVSDI--------------------------SVLAKLTNLESLIATNNQIS 211
Query: 278 GSIPTEIGNCSALKNLTLNHNSLD--GTIPLEMGKILLLQNLDLSHNNLSGTIP 329
              P  +G  + L  L+LN N L   GT    +  +  L +LDL++N +S   P
Sbjct: 212 DITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAP 259

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 112 VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 158
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D       A T  Y 
Sbjct: 159 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGYVA-TRWYR 212
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/271 (21%), Positives = 110/271 (40%), Gaps = 31/271 (11%)
Query: 460 TGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCL 519
            G YG +++ E+    +  L K H + +E      SF   A ++S + H+++V  YG C 
Sbjct: 32  VGDYGQLHETEV---LLKVLDKAHRNYSE------SFFEAASMMSKLSHKHLVLNYGVCF 82
Query: 520 HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHR 579
                 L+ E+++ GSL   L  +   I + W  ++ + K +A A+ +L  +   ++IH 
Sbjct: 83  CGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEEN---TLIHG 137
Query: 580 DISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK---- 635
           ++ + NILL    +    +    +L     S   L         P +    +   K    
Sbjct: 138 NVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNL 197
Query: 636 -CDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILV 694
             D +SFG    E+  G                K+   +  +Q  +P   +        +
Sbjct: 198 ATDKWSFGTTLWEICSGGDKPLSALDSQR----KLQFYEDRHQLPAPKAAE--------L 245
Query: 695 STIAFACLSSQPKSRPTMQRISQELLAGKTP 725
           + +   C+  +P  RP+ + I ++L +  TP
Sbjct: 246 ANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 104/257 (40%), Gaps = 49/257 (19%)
Query: 420 LNSRAAKNGDVFSVWNYDGKILYEDLINAT-----EDFHIKYCIGTGGYGSVYKA-ELPE 473
           L  +A      F++ + +    Y   +N T     E +     +G+G YGSV  + ++  
Sbjct: 16  LYKKAGSAAAPFTMSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKS 75
Query: 474 GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMER 533
           G  +A+KKL     +     K    E  +L  ++H N++ L         +       E 
Sbjct: 76  GLKIAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSL------EEF 128
Query: 534 GSLFCVLHDDDEAIELNWTKRVNIVK--------------SVAHALSYLHHDCTLSIIHR 579
             ++ V H      +LN     NIVK               +   L Y+H   +  IIHR
Sbjct: 129 NDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHR 178
Query: 580 DISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-----LAYTIVVTG 634
           D+  +N+ ++ + E  + DFG AR  H D    T    T  Y APE     + Y + V  
Sbjct: 179 DLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYRAPEIMLNWMHYNMTV-- 233
Query: 635 KCDVYSFGVVALEVLMG 651
             D++S G +  E+L G
Sbjct: 234 --DIWSVGCIMAELLTG 248

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS--------------VA 562
                + +       E   ++ V H      +LN     NIVKS              + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKSQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG  R  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 95  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 141
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H D    T    T  Y 
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEM-TGYVATRWYR 195
Query: 623 APELAYTIVVTGK-CDVYSFGVVALEVLMG 651
           APE+    +   +  D++S G +  E+L G
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKV 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            Y APE+   +      D++S G +  E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/271 (21%), Positives = 111/271 (40%), Gaps = 31/271 (11%)
Query: 460 TGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCL 519
            G YG +++ E+    +  L K H + +E      SF   A ++S + H+++V  YG C+
Sbjct: 32  VGDYGQLHETEV---LLKVLDKAHRNYSE------SFFEAASMMSKLSHKHLVLNYGVCV 82
Query: 520 HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHR 579
                 L+ E+++ GSL   L  +   I + W  ++ + K +A A+ +L  +   ++IH 
Sbjct: 83  CGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEEN---TLIHG 137
Query: 580 DISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK---- 635
           ++ + NILL    +    +    +L     S   L         P +    +   K    
Sbjct: 138 NVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNL 197
Query: 636 -CDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILV 694
             D +SFG    E+  G                K+   +  +Q  +P   +        +
Sbjct: 198 ATDKWSFGTTLWEICSGGDKPLSALDSQR----KLQFYEDRHQLPAPKAAE--------L 245
Query: 695 STIAFACLSSQPKSRPTMQRISQELLAGKTP 725
           + +   C+  +P  RP+ + I ++L +  TP
Sbjct: 246 ANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKV 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            Y APE+   +      D++S G +  E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + D+G AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKC 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            Y APE+   +      D++S G +  E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKX 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 67/135 (49%), Gaps = 10/135 (7%)
Query: 524 MFLIYEYMERGSLFCV-LHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDIS 582
           + LI EY   G +F + L +  E +  N    + ++K +   + YLH +   +I+H D+ 
Sbjct: 104 IILILEYAAGGEIFSLCLPELAEMVSEN--DVIRLIKQILEGVYYLHQN---NIVHLDLK 158
Query: 583 SNNILLDSNL---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVY 639
             NILL S     +  + DFG +R +      R +  GT  Y+APE+     +T   D++
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI-MGTPEYLAPEILNYDPITTATDMW 217
Query: 640 SFGVVALEVLMGTHP 654
           + G++A  +L  T P
Sbjct: 218 NIGIIAYMLLTHTSP 232

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKC 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            Y APE+   +      D++S G +  E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKC 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            Y APE+   +      D++S G +  E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKC 80
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLY 134
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 135 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 190
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            Y APE+   +      D++S G +  E++ G
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKC 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            Y APE+   +      D++S G +  E++ G
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 117
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLY 171
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 172 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 227
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 78
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLY 132
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 133 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 188
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 189 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 80
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLY 134
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 135 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 190
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 80
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLY 134
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 135 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 190
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 72
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLY 126
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 127 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 182
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 73
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLY 127
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 128 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 183
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 184 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 73
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLY 127
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 128 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 183
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 184 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKC 117
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLY 171
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 172 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 227
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L   + VA+KKL           + FQN+ H         ++  
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS----------RPFQNQTHAKRAYRELVLMKX 79
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +L+ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLY 133
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTR 189
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 40/212 (18%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 34  IGSGAQGIVCAAYDAILERN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKC 81
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLY 135
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR               Y
Sbjct: 136 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRY 192
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
            Y APE+   +      D++S G +  E++ G
Sbjct: 193 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 21/162 (12%)
Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           HRN+++L  F   +   +L++E M  GS+   +H      EL  +    +V+ VA AL +
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDF 126
Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEAS---VADF--GTARLLHVDSSYRT-----LRAG 617
           LH+     I HRD+   NIL +   + S   + DF  G+   L+ D S  +        G
Sbjct: 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 618 TYGYIAPELAYTI-----VVTGKCDVYSFGVVALEVLMGTHP 654
           +  Y+APE+         +   +CD++S GV+   +L G  P
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 102/245 (41%), Gaps = 48/245 (19%)
Query: 446 INATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           +   +++ IK+ IG G YG VY A +    K VA+KK++    ED    K    E  +L+
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRM-FEDLIDCKRILREITILN 82
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI----VKS 560
            ++   I++L+   + +       + ++   L+ VL   D  ++  +   + +    VK+
Sbjct: 83  RLKSDYIIRLHDLIIPE-------DLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKT 135
Query: 561 VAHAL----SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR---- 612
           + + L     ++H      IIHRD+   N LL+ +    + DFG AR ++ D        
Sbjct: 136 ILYNLLLGEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVND 192
Query: 613 ---------------------TLRAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVL- 649
                                T    T  Y APEL       T   D++S G +  E+L 
Sbjct: 193 LEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252
Query: 650 -MGTH 653
            M +H
Sbjct: 253 MMKSH 257

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 23/198 (11%)
Query: 452 FHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           + +K CI  GG G +Y A      G+ V LK L HS   D+        E   L+ V H 
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHP 139
Query: 510 NIVKLYGFCLH-----KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           +IV+++ F  H         +++ EY+   SL        +  +L   + +  +  +  A
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILPA 194
Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           LSYLH   ++ +++ D+   NI+L +  +  + D G    ++   S+  L  GT G+ AP
Sbjct: 195 LSYLH---SIGLVYNDLKPENIML-TEEQLKLIDLGAVSRIN---SFGYL-YGTPGFQAP 246
Query: 625 ELAYTIVVTGKCDVYSFG 642
           E+  T   T   D+Y+ G
Sbjct: 247 EIVRT-GPTVATDIYTVG 263

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 96  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 142
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H  +   T    T  Y 
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HT-ADEMTGYVATRWYR 196
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 96  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 142
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H  +   T    T  Y 
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HT-ADEMTGYVATRWYR 196
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DF  AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 96  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 142
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR  H  +   T    T  Y 
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HT-ADEMTGYVATRWYR 196
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  +  FG AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + D G AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H      +LN     NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTHL--MGADLN-----NIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + D G AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 115/306 (37%), Gaps = 55/306 (17%)
Query: 452 FHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQN---EAHVLSTVR 507
           + +   +G+GG+GSVY    + +   VA+K +      D   + +      E  +L  V 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 508 --HRNIVKLYGFCLHKKCMFLIYEYME-----------RGSLFCVLHDDDEAIELNWTKR 554
                +++L  +        LI E ME           RG+L      ++ A    W   
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGAL-----QEELARSFFW--- 121
Query: 555 VNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGTARLLHVDSSYRT 613
             ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+  LL  D+ Y  
Sbjct: 122 -QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD 172
Query: 614 LRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXXXXXXXXPKIMLI 672
              GT  Y  PE        G+   V+S G++  +++ G  P                  
Sbjct: 173 F-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV------ 225
Query: 673 DVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKE 732
               QR+S      I             CL+ +P  RPT + I          + +   E
Sbjct: 226 -FFRQRVSSECQHLIR-----------WCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 273
Query: 733 ISISEL 738
           I +  L
Sbjct: 274 IHLHSL 279

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 34/185 (18%)
Query: 538 CVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVA 597
           C L D +  + L+      I   +A A+ +LH   +  ++HRD+  +NI    +    V 
Sbjct: 156 CSLEDREHGVCLH------IFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG 206
Query: 598 DFGTARLLHVDSSYRTL------------RAGTYGYIAPELAYTIVVTGKCDVYSFGVVA 645
           DFG    +  D   +T+            + GT  Y++PE  +    + K D++S G++ 
Sbjct: 207 DFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLIL 266
Query: 646 LEVLMGTHPXXXXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQ 705
            E+L                    ++ DV N +      QK  Q+ ++V  +    LS  
Sbjct: 267 FELLYSFSTQMERVR---------IITDVRNLKFPLLFTQKYPQEHMMVQDM----LSPS 313
Query: 706 PKSRP 710
           P  RP
Sbjct: 314 PTERP 318

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 85/210 (40%), Gaps = 36/210 (17%)
Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G+G YGSV  A +   G  VA+KKL     +     K    E  +L  ++H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK--------------SVA 562
                + +       E   ++ V H       L      NIVK               + 
Sbjct: 89  VFTPARSL------EEFNDVYLVTH-------LMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L Y+H   +  IIHRD+  +N+ ++ + E  + D G AR  H D    T    T  Y 
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEM-TGYVATRWYR 189
Query: 623 APELAYTIV-VTGKCDVYSFGVVALEVLMG 651
           APE+    +      D++S G +  E+L G
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 43/236 (18%)
Query: 446 INATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           ++  +++ IK+ IG G YG VY A +    K VA+KK++    ED    K    E  +L+
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILN 80
Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI----VKS 560
            ++   I++LY   +         + ++   L+ VL   D  ++  +   + +    +K+
Sbjct: 81  RLKSDYIIRLYDLIIPD-------DLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT 133
Query: 561 VAHAL----SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR---- 612
           + + L    +++H      IIHRD+   N LL+ +    V DFG AR ++ +        
Sbjct: 134 ILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 613 ------------------TLRAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVL 649
                             T    T  Y APEL       T   D++S G +  E+L
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 78/167 (46%), Gaps = 12/167 (7%)
Query: 493 VKSFQNEAHVLSTVRHRNIVKLYGFC--LHKKCMFLIYEYMERGSLFCVLHDDDEAIELN 550
           ++    E  +L  + H N+VKL       ++  +++++E + +G +  V         L+
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----PTLKPLS 135
Query: 551 WTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS 610
             +     + +   + YLH+     IIHRDI  +N+L+  +    +ADFG +       +
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 611 YRTLRAGTYGYIAPE-LAYT-IVVTGKC-DVYSFGVVALEVLMGTHP 654
             +   GT  ++APE L+ T  + +GK  DV++ GV     + G  P
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 81/179 (45%), Gaps = 36/179 (20%)
Query: 555 VNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD-----SNLEASVADFGTARLLHVDS 609
           + +++     L++LH   +L+I+HRD+  +NIL+        ++A ++DFG  + L V  
Sbjct: 121 ITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 610 ---SYRTLRAGTYGYIAPEL---------AYTIVVTGKCDVYSFGVVALEVL-MGTHPXX 656
              S R+   GT G+IAPE+          YT+      D++S G V   V+  G+HP  
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV------DIFSAGCVFYYVISEGSHPFG 231
Query: 657 XXXXXXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
                          +D L+    P  ++ ++   ++   IA       P+ RP+ + +
Sbjct: 232 KSLQRQANILLGACSLDCLH----PEKHEDVIARELIEKMIAM-----DPQKRPSAKHV 281

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 113
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 114 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 162
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 163 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 220
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 221 IIRGQV-------FFRQRVSSECQHLIR-----------WCLALRPSDRPTFEEIQNHPW 262
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 263 MQDVLLPQETAEIHLHSL 280

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 113
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 114 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 162
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 163 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 220
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 221 IIRGQV-------FFRQRVSSECQHLIR-----------WCLALRPSDRPTFEEIQNHPW 262
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 263 MQDVLLPQETAEIHLHSL 280

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 112
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 113 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 161
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 162 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 219
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 220 IIRGQV-------FFRQRVSSECQHLIR-----------WCLALRPSDRPTFEEIQNHPW 261
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 262 MQDVLLPQETAEIHLHSL 279

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 135
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 136 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 184
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 185 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 242
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 243 IIRGQV-------FFRQRVSXECQHLIR-----------WCLALRPSDRPTFEEIQNHPW 284
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 285 MQDVLLPQETAEIHLHSL 302

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 155
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 156 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 204
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 205 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 262
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 263 IIRGQV-------FFRQRVSSECQHLIRW-----------CLALRPSDRPTFEEIQNHPW 304
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 305 MQDVLLPQETAEIHLHSL 322

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 155
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 156 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 204
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 205 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 262
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 263 IIRGQV-------FFRQRVSXECQHLIRW-----------CLALRPSDRPTFEEIQNHPW 304
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 305 MQDVLLPQETAEIHLHSL 322

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 140
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 141 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 189
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 190 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 247
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 248 IIRGQV-------FFRQRVSSECQHLIRW-----------CLALRPSDRPTFEEIQNHPW 289
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 290 MQDVLLPQETAEIHLHSL 307

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 40/210 (19%)
Query: 458 IGTGGYGSV---YKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH---------VLST 505
           IG+G  G V   Y A L     VA+KKL           + FQN+ H         ++  
Sbjct: 37  IGSGAQGIVCAAYDAILERN--VAIKKLS----------RPFQNQTHAKRAYRELVLMKC 84
Query: 506 VRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK 559
           V H+NI+ L      +K +      +++ E M+  +L  V+      +EL+  +   ++ 
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLY 138
Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   T    T 
Sbjct: 139 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTR 194
Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVL 649
            Y APE+   +      D++S G +  E++
Sbjct: 195 YYRAPEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 110/296 (37%), Gaps = 79/296 (26%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 108
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 109 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 157
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 158 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRIS 716
                           QR+S      I             CL+ +P  RPT + I 
Sbjct: 216 IIRGQV-------FFRQRVSSECQHLIR-----------WCLALRPSDRPTFEEIQ 253

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 58  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 117
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 118 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 160
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 161 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 209
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 210 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 267
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 268 IIRGQV-------FFRQRVSXECQHLIRW-----------CLALRPSDRPTFEEIQNHPW 309
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 310 MQDVLLPQETAEIHLHSL 327

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 127
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 128 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 176
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 177 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 234
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 235 IIRGQV-------FFRQRVSSECQHLIRW-----------CLALRPSDRPTFEEIQNHPW 276
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 277 MQDVLLPQETAEIHLHSL 294

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 98  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 140
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 141 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 189
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 190 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 247
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 248 IIGGQV-------FFRQRVSSECQHLIRW-----------CLALRPSDRPTFEEIQNHPW 289
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 290 MQDVLLPQETAEIHLHSL 307

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 113
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 114 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 162
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 163 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 220
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 221 IIRGQV-------FFRQRVSSECQHLIRW-----------CLALRPSDRPTFEEIQNHPW 262
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 263 MQDVLLPQETAEIHLHSL 280

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 147
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 148 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 196
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 197 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 255 IIRGQV-------FFRQRVSSECQHLIRW-----------CLALRPSDRPTFEEIQNHPW 296
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 297 MQDVLLPQETAEIHLHSL 314

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 116/318 (36%), Gaps = 79/318 (24%)
Query: 452 FHIKYCIGTGGYGSVYKA-----------------------ELPEG-----KVVALKKLH 483
           + +   +G+GG+GSVY                         ELP G     +VV LKK+ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 484 HSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD 542
              +     +  F+  ++ VL   R   +  L+ F              ERG+L      
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------------TERGAL-----Q 128
Query: 543 DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGT 601
           ++ A    W     ++++V H      H+C   ++HRDI   NIL+D N  E  + DFG+
Sbjct: 129 EELARSFFW----QVLEAVRHC-----HNC--GVLHRDIKDENILIDLNRGELKLIDFGS 177
Query: 602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGK-CDVYSFGVVALEVLMGTHPXXXXXX 660
             LL  D+ Y     GT  Y  PE        G+   V+S G++  +++ G  P      
Sbjct: 178 GALLK-DTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 235
Query: 661 XXXXXXPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                           QR+S      I             CL+ +P  RPT + I     
Sbjct: 236 IIRGQV-------FFRQRVSSECQHLIRW-----------CLALRPSDRPTFEEIQNHPW 277
Query: 721 AGKTPMQKALKEISISEL 738
                + +   EI +  L
Sbjct: 278 MQDVLLPQETAEIHLHSL 295
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	740
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-89
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-86
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-82
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-80
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-69
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-76
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-74
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-70
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-68
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-67
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-64
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-64
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-58
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-57
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-57
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-52
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-37
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-33
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-56
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-55
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-54
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-52
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-45
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-43
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-55
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-54
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-49
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-49
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-47
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-47
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-44
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-40
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-29
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-49
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-30
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-46
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-43
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-41
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-38
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-30
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-26
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-46
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-45
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-44
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-34
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-31
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-22
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-45
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-43
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-27
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-44
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-41
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-39
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-38
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-36
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-35
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-24
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-38
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-40
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-30
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-42
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-40
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-40
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-37
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-37
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-35
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-31
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-27
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-39
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-37
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-37
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-37
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-37
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-37
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-36
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-37
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-36
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-36
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-33
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-24
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-18
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-11
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-35
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-35
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-33
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-24
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-35
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-35
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-23
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-15
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-35
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-34
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-34
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-34
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-34
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-28
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-16
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-28
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-34
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-33
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-33
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-33
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-30
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-29
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-26
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-33
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-33
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-30
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-30
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-30
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-23
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-33
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-33
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-33
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-32
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-30
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-29
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-32
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-31
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-31
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-30
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-29
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-27
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-30
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-29
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-28
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-30
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-28
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-30
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-30
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-04
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-29
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-29
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-29
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-28
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-28
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-28
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-27
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-27
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-27
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-27
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-24
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-04
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-26
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-26
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-25
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-25
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-24
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-24
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-23
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-18
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-24
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-24
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-24
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-24
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-24
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-13
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-23
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-23
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-22
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-22
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-21
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-20
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-11
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-17
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-17
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-17
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-09
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-15
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-15
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-11
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-11
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-11
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-11
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	8e-08
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	9e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	5e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	8e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	5e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	5e-04
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	7e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-04

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  282 bits (723), Expect = 2e-89
 Identities = 98/350 (28%), Positives = 155/350 (44%), Gaps = 66/350 (18%)

Query: 40  SEIERQALLNSGWWKDRIPH--------NSSDHCN--WVGITCDYEGRITDIDLLNSNIK 89
           +  ++QALL     K  + +         ++D CN  W+G+ CD + +            
Sbjct: 4   NPQDKQALLQ---IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTY---------- 50

Query: 90  GELGRLNFSCFPNLKSLDLWNNSLSGS--IPPQIGSLSKLKCLYLHG-NNLTGIIPKEIG 146
                        + +LDL   +L     IP  + +L  L  LY+ G NNL G IP  I 
Sbjct: 51  ------------RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 147 SLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHS 206
            L  L  L++    +SG +P  +  +K+L  L  + NAL G                   
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG------------------- 139

Query: 207 SIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQL-KNLNLSSNLLSGQIPYAIGKLFN 265
           ++P  I +   L  +    N+I G IPD     S+L  ++ +S N L+G+IP     L N
Sbjct: 140 TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-N 198

Query: 266 LMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLS 325
           L ++DLS+N L G      G+    + + L  NSL   +  ++G    L  LDL +N + 
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIY 257

Query: 326 GTIPKTLRPM----YVDLSFNNLEGEIPT--YLRGNPPKSFVGNKGLSGN 369
           GT+P+ L  +     +++SFNNL GEIP    L+     ++  NK L G+
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  274 bits (703), Expect = 3e-86
 Identities = 97/289 (33%), Positives = 143/289 (49%), Gaps = 23/289 (7%)

Query: 442 YEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH 501
             +L  A+++F  K  +G GG+G VYK  L +G +VA+K+L   E         FQ E  
Sbjct: 22  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL--KEERTQGGELQFQTEVE 79

Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEA-IELNWTKRVNIVKS 560
           ++S   HRN+++L GFC+      L+Y YM  GS+   L +  E+   L+W KR  I   
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTY 619
            A  L+YLH  C   IIHRD+ + NILLD   EA V DFG A+L+    ++ T    GT 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLID------ 673
           G+IAPE   T   + K DV+ +GV+ LE++ G            ++   +ML+D      
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA---FDLARLANDDDVMLLDWVKGLL 256

Query: 674 -------VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
                  +++  L      + V+ +I V   A  C  S P  RP M  +
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQV---ALLCTQSSPMERPKMSEV 302

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  276 bits (708), Expect = 4e-82
 Identities = 90/344 (26%), Positives = 143/344 (41%), Gaps = 36/344 (10%)

Query: 38  AASEIERQALLNSGWWKDRIPH--------NSSDHCNWVGITCDYEGRITDIDLLNSNIK 89
            +   E   L++   +KD +P         ++ + C + G+TC  + ++T IDL +  + 
Sbjct: 8   QSLYREIHQLIS---FKDVLPDKNLLPDWSSNKNPCTFDGVTCR-DDKVTSIDLSSKPLN 63

Query: 90  GELGRLN--FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIP--KEI 145
                ++        L+SL L N+ ++GS+       + L  L L  N+L+G +     +
Sbjct: 64  VGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSL 122

Query: 146 GSLRNLRGLFLYSNKLSGVLPQEIG-NLKSLTELYVTNNALGGLIPSTLFRLTN------ 198
           GS   L+ L + SN L        G  L SL  L ++ N++ G                 
Sbjct: 123 GSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 182

Query: 199 --ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQI 256
             IS N+    +   +     L+ LD+S N     IP  L   S L++L++S N LSG  
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDF 239

Query: 257 PYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKIL-LLQ 315
             AI     L  L++S N+  G IP       +L+ L+L  N   G IP  +      L 
Sbjct: 240 SRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297

Query: 316 NLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPTYLRGN 355
            LDLS N+  G +P           + LS NN  GE+P      
Sbjct: 298 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  272 bits (697), Expect = 2e-80
 Identities = 95/303 (31%), Positives = 141/303 (46%), Gaps = 14/303 (4%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQ-IGSLSKLKCLYLHGNNLTGIIP 142
               +    G         L+SL L +N+ SG +P   +  +  LK L L  N  +G +P
Sbjct: 306 FYGAVPPFFGSC-----SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360

Query: 143 KEIGSLR-NLRGLFLYSNKLSGVLPQEIGN--LKSLTELYVTNNALGGLIPSTLFRLTN- 198
           + + +L  +L  L L SN  SG +   +      +L ELY+ NN   G IP TL   +  
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSEL 420

Query: 199 ----ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSG 254
               +S N    +IP  +G+ S L  L L  N + G IP EL  +  L+ L L  N L+G
Sbjct: 421 VSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG 480

Query: 255 QIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLL 314
           +IP  +    NL ++ LS N+L+G IP  IG    L  L L++NS  G IP E+G    L
Sbjct: 481 EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL 540

Query: 315 QNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVEGFP 374
             LDL+ N  +GTIP  +      ++ N + G+   Y++ +  K      G     +G  
Sbjct: 541 IWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600

Query: 375 SSS 377
           S  
Sbjct: 601 SEQ 603

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  241 bits (617), Expect = 3e-69
 Identities = 82/272 (30%), Positives = 118/272 (43%), Gaps = 29/272 (10%)

Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
           NL  + L NN L+G IP  IG L  L  L L  N+ +G IP E+G  R+L  L L +N  
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550

Query: 162 SGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNI-------SSNQFHSSIPLEIGN 214
           +G +P  +             N + G     +             +  +F      ++  
Sbjct: 551 NGTIPAAMFKQSGKI----AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606

Query: 215 FSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKN 274
            S  +  +++     G           +  L++S N+LSG IP  IG +  L  L+L  N
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666

Query: 275 KLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRP 334
            +SGSIP E+G+   L  L L+ N LDG IP  M  + +L  +DLS+NNLSG IP+    
Sbjct: 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM--- 723

Query: 335 MYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGL 366
                 F              PP  F+ N GL
Sbjct: 724 ----GQFETF-----------PPAKFLNNPGL 740

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  247 bits (633), Expect = 4e-76
 Identities = 99/291 (34%), Positives = 139/291 (47%), Gaps = 24/291 (8%)

Query: 442 YEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH 501
             DL  AT +F  K+ IG G +G VYK  L +G  VALK+     ++    ++ F+ E  
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG---IEEFETEIE 87

Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE-LNWTKRVNIVKS 560
            LS  RH ++V L GFC  +  M LIY+YME G+L   L+  D     ++W +R+ I   
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRTLR-AGT 618
            A  L YLH      IIHRD+ S NILLD N    + DFG ++    +D ++ +    GT
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204

Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLID----- 673
            GYI PE      +T K DVYSFGVV  EVL           + S     + L +     
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA-----IVQSLPREMVNLAEWAVES 259

Query: 674 VLNQRLSPPVNQKIVQDIILVS-----TIAFACLSSQPKSRPTMQRISQEL 719
             N +L   V+  +   I   S       A  CL+   + RP+M  +  +L
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  242 bits (621), Expect = 1e-74
 Identities = 88/301 (29%), Positives = 136/301 (45%), Gaps = 39/301 (12%)

Query: 442 YEDLINATEDFHIKYC------IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAF-VK 494
           + +L N T +F  +        +G GG+G VYK  +     VA+KKL       +    +
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75

Query: 495 SFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR 554
            F  E  V++  +H N+V+L GF      + L+Y YM  GSL   L   D    L+W  R
Sbjct: 76  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135

Query: 555 VNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV-DSSYRT 613
             I +  A+ +++LH +     IHRDI S NILLD    A ++DFG AR       +  T
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192

Query: 614 LR-AGTYGYIAPELAYTIVVTG----KCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPK 668
            R  GT  Y+APE      + G    K D+YSFGVV LE++ G                 
Sbjct: 193 SRIVGTTAYMAPE--A---LRGEITPKSDIYSFGVVLLEIITGLPA-------VDEHREP 240

Query: 669 IMLID----VLNQR------LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE 718
            +L+D    + ++       +   +N      +  + ++A  CL  +   RP ++++ Q 
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300

Query: 719 L 719
           L
Sbjct: 301 L 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  231 bits (590), Expect = 5e-70
 Identities = 69/309 (22%), Positives = 126/309 (40%), Gaps = 42/309 (13%)

Query: 442 YEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH 501
            E+L   +    +      G +G V+KA+    + VA+K     +       +S+QNE  
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDK------QSWQNEYE 68

Query: 502 V--LSTVRHRNIVKLYGFCLH----KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV 555
           V  L  ++H NI++  G           ++LI  + E+GSL   L  +     ++W +  
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELC 124

Query: 556 NIVKSVAHALSYLHHD-------CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           +I +++A  L+YLH D          +I HRDI S N+LL +NL A +ADFG A      
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 609 SSYR--TLRAGTYGYIAPELA-----YTIVVTGKCDVYSFGVVALEVLMGTHPGG----- 656
            S      + GT  Y+APE+      +      + D+Y+ G+V  E+             
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

Query: 657 ----LLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL--VSTIAFACLSSQPKSRP 710
                   +      + M   V++++  P +     +   +  +      C     ++R 
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 711 TMQRISQEL 719
           +   + + +
Sbjct: 305 SAGCVGERI 313

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  224 bits (574), Expect = 8e-68
 Identities = 78/286 (27%), Positives = 135/286 (47%), Gaps = 23/286 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++  ++  +G G +G V KA+    K VA+K++           K+F  E   LS V H 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER-----KAFIVELRQLSRVNHP 61

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKLYG CL+  C+  + EY E GSL+ VLH  +          ++     +  ++YLH
Sbjct: 62  NIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 570 HDCTLSIIHRDISSNNILLDSNLEAS-VADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
                ++IHRD+   N+LL +      + DFGTA  +    ++ T   G+  ++APE+  
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFE 176

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP-GGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI 687
               + KCDV+S+G++  EV+    P   +        GP   ++  ++    PP+ + +
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEI-------GGPAFRIMWAVHNGTRPPLIKNL 229

Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEI 733
            + I    ++   C S  P  RP+M+ I + +         A + +
Sbjct: 230 PKPI---ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  224 bits (572), Expect = 2e-67
 Identities = 78/270 (28%), Positives = 128/270 (47%), Gaps = 13/270 (4%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
            D +IK  IG G +G+V++AE   G  VA+K L   +   +  V  F  E  ++  +RH 
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILM-EQDFHAERVNEFLREVAIMKRLRHP 94

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIV   G       + ++ EY+ RGSL+ +LH      +L+  +R+++   VA  ++YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
           +     I+HR++ S N+L+D      V DFG +RL           AGT  ++APE+   
Sbjct: 155 N-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213

Query: 630 IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQ 689
                K DVYSFGV+  E+     P G L+          ++  V  +     + + +  
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-------VVAAVGFKCKRLEIPRNLNP 266

Query: 690 DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +   + I   C +++P  RP+   I   L
Sbjct: 267 QV---AAIIEGCWTNEPWKRPSFATIMDLL 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  214 bits (546), Expect = 4e-64
 Identities = 77/283 (27%), Positives = 126/283 (44%), Gaps = 30/283 (10%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAF----VKSFQNEAHVLS 504
            +   +  IG GG+G V+K   + +  VVA+K L   ++E         + FQ E  ++S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
            + H NIVKLYG   +   M  + E++  G L+  L   D+A  + W+ ++ ++  +A  
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALG 134

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEAS-----VADFGTARLLHVDSSYRTLRAGTY 619
           + Y+ +     I+HRD+ S NI L S  E +     VADFG ++         +   G +
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGLLGNF 190

Query: 620 GYIAPEL--AYTIVVTGKCDVYSFGVVALEVLMGTHP-GGLLSSLSSSSGPKIMLIDVLN 676
            ++APE   A     T K D YSF ++   +L G  P          S G    +  +  
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY------SYGKIKFINMIRE 244

Query: 677 QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           + L P + +     +     +   C S  PK RP    I +EL
Sbjct: 245 EGLRPTIPEDCPPRL---RNVIELCWSGDPKKRPHFSYIVKEL 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  212 bits (543), Expect = 9e-64
 Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 26/279 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSA-FVKSFQNEAHVLSTVRH 508
            +  ++  IG GG+G VY+A    G  VA+K   H   ED +  +++ + EA + + ++H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NI+ L G CL +  + L+ E+   G L  VL        +     VN    +A  ++YL
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYL 121

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEAS--------VADFGTARLLHVDSSYRTLRAGTYG 620
           H +  + IIHRD+ S+NIL+   +E          + DFG AR  H   + +   AG Y 
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYA 179

Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS 680
           ++APE+    + +   DV+S+GV+  E+L G  P   +  L+       +   V   +L+
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-------VAYGVAMNKLA 232

Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            P+     +     + +   C +  P SRP+   I  +L
Sbjct: 233 LPIPSTCPEPF---AKLMEDCWNPDPHSRPSFTNILDQL 268

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  201 bits (512), Expect = 1e-58
 Identities = 66/320 (20%), Positives = 123/320 (38%), Gaps = 53/320 (16%)

Query: 442 YEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAH 501
             +     ++  +   IG G YG+VYK  L + + VA+K    +        ++F NE +
Sbjct: 5   ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKN 57

Query: 502 V--LSTVRHRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKR 554
           +  +  + H NI +                 L+ EY   GSL   L         +W   
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSS 113

Query: 555 VNIVKSVAHALSYLHHD------CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
             +  SV   L+YLH +         +I HRD++S N+L+ ++    ++DFG +  L  +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 609 SSYR--------TLRAGTYGYIAPELAYTIV-------VTGKCDVYSFGVVALEVLMGT- 652
              R            GT  Y+APE+    V          + D+Y+ G++  E+ M   
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 653 --HPGGLLSS--------LSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIA---F 699
              PG  +          + +    + M + V  ++  P   +   ++ + V ++     
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 700 ACLSSQPKSRPTMQRISQEL 719
            C     ++R T Q   + +
Sbjct: 294 DCWDQDAEARLTAQXAEERM 313

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  199 bits (507), Expect = 3e-58
 Identities = 78/312 (25%), Positives = 129/312 (41%), Gaps = 50/312 (16%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
            D      +G G +G   K      G+V+ +K+L   + E     ++F  E  V+  + H
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET---QRTFLKEVKVMRCLEH 66

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            N++K  G     K +  I EY++ G+L  ++   D   +  W++RV+  K +A  ++YL
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYL 124

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL--------------HVDSSYRTL 614
           H   +++IIHRD++S+N L+  N    VADFG ARL+                D   R  
Sbjct: 125 H---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 615 RAGTYGYIAPELA----YTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIM 670
             G   ++APE+     Y      K DV+SFG+V  E++   +        +        
Sbjct: 182 VVGNPYWMAPEMINGRSYDE----KVDVFSFGIVLCEIIGRVNADPDYLPRT----MDFG 233

Query: 671 LIDVLNQRLSPPVN--QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL------LAG 722
           L          P N              I   C    P+ RP+  ++   L      LAG
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFP-------ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286

Query: 723 KTPMQKALKEIS 734
             P+   L+++ 
Sbjct: 287 HLPLGPQLEQLD 298

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  197 bits (503), Expect = 4e-58
 Identities = 53/276 (19%), Positives = 105/276 (38%), Gaps = 26/276 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +  +    +     G ++K    +G  + +K L   +   +   + F  E   L    H 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHP 67

Query: 510 NIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           N++ + G C         LI  +M  GSL+ VLH+      ++ ++ V     +A  +++
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAF 126

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL- 626
           LH      I    ++S ++++D ++ A ++           S     R     ++APE  
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAPEAL 180

Query: 627 ---AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV 683
                        D++SF V+  E++    P   LS++        + + V  + L P +
Sbjct: 181 QKKPEDT-NRRSADMWSFAVLLWELVTREVPFADLSNME-------IGMKVALEGLRPTI 232

Query: 684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
              I   +   S +   C++  P  RP    I   L
Sbjct: 233 PPGISPHV---SKLMKICMNEDPAKRPKFDMIVPIL 265

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  197 bits (502), Expect = 1e-57
 Identities = 76/303 (25%), Positives = 123/303 (40%), Gaps = 44/303 (14%)

Query: 449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-- 506
             D  +  C+G G YG V++    +G+ VA+K     +       KS+  E  + +TV  
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVML 59

Query: 507 RHRNIVKLYGFCLHKKC----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           RH NI+      +  +     ++LI  Y E GSL+  L        L+    + IV S+A
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIA 115

Query: 563 HALSYLHHD-----CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS----YRT 613
             L++LH +        +I HRD+ S NIL+  N +  +AD G A +    ++       
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 614 LRAGTYGYIAPEL------AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS----- 662
            R GT  Y+APE+              + D+++FG+V  EV       G++         
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235

Query: 663 -SSSGPKI--MLIDVLNQRLSPPVNQKIVQDII---LVSTIAFACLSSQPKSRPTMQRIS 716
              + P    M   V   +  P +  +   D     L   +   C    P +R T  RI 
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK-ECWYQNPSARLTALRIK 294

Query: 717 QEL 719
           + L
Sbjct: 295 KTL 297

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  206 bits (526), Expect = 1e-57
 Identities = 47/287 (16%), Positives = 99/287 (34%), Gaps = 37/287 (12%)

Query: 96  NFSCFPNLKSLDLWNNSL-SGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGL 154
           +      ++ + +  N+L +  +   +  + KL  L    N L G +P   GS   L  L
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASL 358

Query: 155 FLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPST-LFRLTN-----ISSNQFHS-- 206
            L  N+++ +     G  + +  L   +N L  +        ++       S N+  S  
Sbjct: 359 NLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVD 418

Query: 207 -----SIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSG------- 254
                 +         + +++LS+N+I     +  +  S L ++NL  N+L+        
Sbjct: 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478

Query: 255 QIPYAIGKLFNLMYLDLSKNKLSGSIPTEI--GNCSALKNLTLNHNSLDGTIPLEMGK-- 310
                    + L  +DL  NKL+  +  +        L  + L++NS     P +     
Sbjct: 479 DENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSS 536

Query: 311 ----ILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIP 349
                 +    D   N      P+ +        + +  N++   + 
Sbjct: 537 TLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VN 582

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  198 bits (505), Expect = 1e-54
 Identities = 49/334 (14%), Positives = 107/334 (32%), Gaps = 48/334 (14%)

Query: 61  SSDHCNWV---GITCDYEGRITDIDLLNSNIKG----ELGRL------------------ 95
           + +   W    G++ +  GR+T + L      G     +G+L                  
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

Query: 96  -----NFSCFPNLKSLDLWNNSLSGSIPPQIG--SLSKLKCLYLHGNNLTGIIPKEIGSL 148
                  S   + +           +          S L    ++ +     I K     
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182

Query: 149 RNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSI 208
                +   SN ++  + + +  L  L + Y+ N+          +   N    Q + + 
Sbjct: 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE 241

Query: 209 PLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLL--------SGQIPYAI 260
            L+  N   L  +++ +      +P  L  L +++ +N++ N            Q     
Sbjct: 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA 301

Query: 261 GKLFNLMYLDLSKNKL-SGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDL 319
                +  + +  N L +  + T +     L  L   +N L+G +P   G  + L +L+L
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNL 360

Query: 320 SHNNLSGTIPKTLRPM----YVDLSFNNLEGEIP 349
           ++N ++               +  + N L+  IP
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLK-YIP 393

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  191 bits (486), Expect = 3e-52
 Identities = 52/302 (17%), Positives = 97/302 (32%), Gaps = 45/302 (14%)

Query: 79  TDIDLLNSNIKG---ELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHG 134
             ++ L + ++G     G         L SL+L  N ++  IP    G   +++ L    
Sbjct: 333 GMLECLYNQLEGKLPAFGSE-----IKLASLNLAYNQITE-IPANFCGFTEQVENLSFAH 386

Query: 135 NNLTGI-IPKEIGSLRNLRGLFLYSNKLSGV-------LPQEIGNLKSLTELYVTNNALG 186
           N L  I    +  S+  +  +    N++  V       L        +++ + ++NN + 
Sbjct: 387 NKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446

Query: 187 GLIPSTLFRLT-----NISSNQFHS-------SIPLEIGNFSALDTLDLSDNKIHGIIPD 234
                     +     N+  N                  N   L ++DL  NK+  +  D
Sbjct: 447 KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDD 506

Query: 235 -ELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYL------DLSKNKLSGSIPTEIGNC 287
              T L  L  ++LS N  S   P        L         D   N+     P  I  C
Sbjct: 507 FRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLC 565

Query: 288 SALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNN 343
            +L  L +  N +   +  ++     +  LD+  N         + P        L ++ 
Sbjct: 566 PSLTQLQIGSNDIR-KVNEKITP--NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622

Query: 344 LE 345
            +
Sbjct: 623 TQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  146 bits (371), Expect = 4e-37
 Identities = 39/225 (17%), Positives = 71/225 (31%), Gaps = 35/225 (15%)

Query: 86  SNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGI----- 140
             +     +       N+ S++L NN +S        + S L  + L GN LT I     
Sbjct: 423 DPLDPTPFKG-----INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477

Query: 141 --IPKEIGSLRNLRGLFLYSNKLSGVLPQEI--GNLKSLTELYVTNNALGGLIPSTLFRL 196
               +   +   L  + L  NKL+  L  +     L  L  + ++ N+     P+     
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535

Query: 197 TN-----------ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNL 245
           +               N+     P  I    +L  L +  N I  +  +++     +  L
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKV-NEKI--TPNISVL 592

Query: 246 NLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSAL 290
           ++  N         +          L  +K       +I  C AL
Sbjct: 593 DIKDNPNISIDLSYVCPYIEAGMYMLFYDK-----TQDIRGCDAL 632

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  135 bits (341), Expect = 3e-33
 Identities = 36/255 (14%), Positives = 74/255 (29%), Gaps = 31/255 (12%)

Query: 104 KSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSG 163
            +L+  N S  G       + +  K L + G    G+    + S   + GL L     SG
Sbjct: 40  DALNGKNWSQQGFGTQPGANWNFNKELDMWGA-QPGV---SLNSNGRVTGLSLEGFGASG 95

Query: 164 VLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDL 223
            +P  IG L  L  L + ++                         P  I    + +    
Sbjct: 96  RVPDAIGQLTELEVLALGSHGEKV---------------NERLFGPKGISANMSDEQKQK 140

Query: 224 SDNKIHGIIPDELTKL--SQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIP 281
                     D   +   S L    ++S+     I  +         +    N ++  + 
Sbjct: 141 MRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVS 199

Query: 282 TEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM----YV 337
             +   + L+   + ++        E       +N +  +     T       +     V
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENICE-----AWENENSEYAQQYKTEDLKWDNLKDLTDV 254

Query: 338 DLSFNNLEGEIPTYL 352
           ++       ++PT+L
Sbjct: 255 EVYNCPNLTKLPTFL 269

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 52.4 bits (126), Expect = 4e-07
 Identities = 20/147 (13%), Positives = 35/147 (23%), Gaps = 32/147 (21%)

Query: 244 NLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGT 303
           N N   ++   Q   ++     +  L L     SG +P  IG  + L             
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL------------- 107

Query: 304 IPLEMGKILLLQNLDLSHNNLSG----TIPKTLRPM----YVDLSFNNLEGEIPTYLRGN 355
                      + L L  +          PK +              + +     Y    
Sbjct: 108 -----------EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRE 156

Query: 356 PPKSFVGNKGLSGNVEGFPSSSQRQKL 382
                + +   S   +     S R  L
Sbjct: 157 DFSDLIKDCINSDPQQKSIKKSSRITL 183

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  204 bits (520), Expect = 1e-56
 Identities = 75/306 (24%), Positives = 128/306 (41%), Gaps = 18/306 (5%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
           IT ++L ++ ++  L   NF+ +  L SLD+  N++S   P     L  LK L L  N L
Sbjct: 27  ITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT 197
           + +  K      NL  L L SN +  +        K+L  L +++N L      T  +L 
Sbjct: 86  SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145

Query: 198 N-----ISSNQFHSSIPLEIGNF--SALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSN 250
           N     +S+N+  +    E+  F  S+L  L+LS N+I    P     + +L  L L++ 
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205

Query: 251 LLSGQIPYAIGKLFN---LMYLDLSKNKLSGSIPTEIGNC--SALKNLTLNHNSLDGTIP 305
            L   +   +        +  L LS ++LS +  T       + L  L L++N+L+    
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265

Query: 306 LEMGKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIP-TYLRGNPPKSF 360
                +  L+   L +NN+      +L  +    Y++L  +  +  I    L      SF
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325

Query: 361 VGNKGL 366
              K L
Sbjct: 326 QWLKCL 331

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  201 bits (514), Expect = 1e-55
 Identities = 69/271 (25%), Positives = 118/271 (43%), Gaps = 16/271 (5%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSN 159
             N+  L+L +N L           S+L  L +  N ++ + P+    L  L+ L L  N
Sbjct: 24  PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83

Query: 160 KLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNI-----SSNQFHSSIPLEIGN 214
           +LS +  +      +LTEL++ +N++  +  +   +  N+     S N   S+       
Sbjct: 84  ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143

Query: 215 FSALDTLDLSDNKIHGIIPDELT--KLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLS 272
              L  L LS+NKI  +  +EL     S LK L LSSN +    P     +  L  L L+
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203

Query: 273 KNKLSGSIPTEIG---NCSALKNLTLNHNSLDGTIPLEMG--KILLLQNLDLSHNNLSGT 327
             +L  S+  ++      ++++NL+L+++ L  T        K   L  LDLS+NNL+  
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263

Query: 328 IPKTLRPM----YVDLSFNNLEGEIPTYLRG 354
              +   +    Y  L +NN++      L G
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHG 294

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  196 bits (501), Expect = 6e-54
 Identities = 65/274 (23%), Positives = 102/274 (37%), Gaps = 19/274 (6%)

Query: 99  CFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
           C  + +  D  +  L+  +P  +   + +  L L  N L  +          L  L +  
Sbjct: 2   CTVSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58

Query: 159 NKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNI-----SSNQFHSSIPLEIG 213
           N +S + P+    L  L  L + +N L  L   T    TN+      SN           
Sbjct: 59  NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118

Query: 214 NFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFN--LMYLDL 271
               L TLDLS N +         +L  L+ L LS+N +       +    N  L  L+L
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178

Query: 272 SKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILL---LQNLDLSHNNLSGTI 328
           S N++    P        L  L LN+  L  ++  ++   L    ++NL LS++ LS T 
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238

Query: 329 PKTLRPM------YVDLSFNNLEGEIPTYLRGNP 356
             T   +       +DLS+NNL           P
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLP 272

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  191 bits (487), Expect = 5e-52
 Identities = 72/347 (20%), Positives = 128/347 (36%), Gaps = 29/347 (8%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIG----SLSKLKCLYL 132
            +  +++ +++I G +    F+   NLK L L N+  S            + S L  L L
Sbjct: 330 CLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388

Query: 133 HGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLP-QEIGNLKSLTELYVTNNALGGLIPS 191
             N ++ I       L +L  L L  N++   L  QE   L+++ E+Y++ N    L  +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448

Query: 192 TLFRLTN-----ISSNQFHS--SIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKN 244
           +   + +     +      +  S P        L  LDLS+N I  I  D L  L +L+ 
Sbjct: 449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI 508

Query: 245 LNLSSNLLS--------GQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLN 296
           L+L  N L+        G   Y +  L +L  L+L  N           +   LK + L 
Sbjct: 509 LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568

Query: 297 HNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRP-----MYVDLSFNNLEGEIPT- 350
            N+L+          + L++L+L  N ++    K   P       +D+ FN  +    + 
Sbjct: 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESI 628

Query: 351 -YLRGNPPKSFVGNKGLSGNVE-GFPSSSQRQKLTPSISLFAKIFLP 395
            +      ++      LS +     P       +    +   K    
Sbjct: 629 AWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSSCKDSAH 675

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  172 bits (438), Expect = 2e-45
 Identities = 61/309 (19%), Positives = 112/309 (36%), Gaps = 29/309 (9%)

Query: 77  RITDIDLLNSNIKG-ELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGN 135
            + ++ L N+ I+  +   L+     +LK L+L +N +    P    ++ +L  L+L+  
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205

Query: 136 NLTGIIPKEIG---SLRNLRGLFLYSNKLSGVLPQEIGNLK--SLTELYVTNNALGGLIP 190
            L   + +++    +  ++R L L +++LS         LK  +LT L ++ N L  +  
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265

Query: 191 STLFRLTN-----ISSNQFHSSIPLEIGNFSALDTLDLSDN---------KIHGIIPDEL 236
            +   L       +  N         +     +  L+L  +          +  I     
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325

Query: 237 TKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIG----NCSALKN 292
             L  L++LN+  N + G        L NL YL LS +  S    T         S L  
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385

Query: 293 LTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIP-KTLRPM----YVDLSFNNLEGE 347
           L L  N +          +  L+ LDL  N +   +  +  R +     + LS+N     
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445

Query: 348 IPTYLRGNP 356
                   P
Sbjct: 446 TRNSFALVP 454

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  165 bits (421), Expect = 3e-43
 Identities = 51/254 (20%), Positives = 87/254 (34%), Gaps = 17/254 (6%)

Query: 76  GRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGN 135
           G +  +DL  + I  EL    +    N+  + L  N            +  L+ L L   
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464

Query: 136 NLTGI--IPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTL 193
            L  +   P     LRNL  L L +N ++ +    +  L+ L  L + +N          
Sbjct: 465 ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN---------- 514

Query: 194 FRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLS 253
             L  +  +         +   S L  L+L  N    I  +    L +LK ++L  N L+
Sbjct: 515 -NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN 573

Query: 254 GQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIG-NCSALKNLTLNHNSLDGTIPLEMGKIL 312
                      +L  L+L KN ++       G     L  L +  N  D T         
Sbjct: 574 TLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW--- 630

Query: 313 LLQNLDLSHNNLSG 326
            +  ++ +H N+  
Sbjct: 631 FVNWINETHTNIPE 644

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  194 bits (496), Expect = 2e-56
 Identities = 77/301 (25%), Positives = 119/301 (39%), Gaps = 42/301 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV--R 507
           +   +   IG G YG V+  +   G+ VA+K    +E        S+  E  +  TV  R
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA------SWFRETEIYQTVLMR 89

Query: 508 HRNIVKLYGFCLHKKC----MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           H NI+      +        ++LI +Y E GSL+  L        L+    + +  S   
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVS 145

Query: 564 ALSYLH-----HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---- 614
            L +LH          +I HRD+ S NIL+  N    +AD G A     D++   +    
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 615 RAGTYGYIAPE-LAYTIVVTG-----KCDVYSFGVVALEVLMGTHPGGLLSSLS------ 662
           R GT  Y+ PE L  ++           D+YSFG++  EV      GG++          
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265

Query: 663 SSSGPKI--MLIDVLNQRLSPPVNQKIVQDIIL--VSTIAFACLSSQPKSRPTMQRISQE 718
             S P    M   V  ++L P    +   D  L  +  +   C +  P SR T  R+ + 
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325

Query: 719 L 719
           L
Sbjct: 326 L 326

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  191 bits (486), Expect = 6e-55
 Identities = 71/302 (23%), Positives = 120/302 (39%), Gaps = 44/302 (14%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHV--LSTVR 507
               ++  IG G +G V++ +   G+ VA+K     E       +S+  EA +     +R
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLR 94

Query: 508 HRNIVKLYGFCLHKK----CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           H NI+               ++L+ +Y E GSLF  L+       +     + +  S A 
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTAS 150

Query: 564 ALSYLHHD-----CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---- 614
            L++LH +        +I HRD+ S NIL+  N    +AD G A      +    +    
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 615 RAGTYGYIAPE-LAYTIVVTG-----KCDVYSFGVVALEVLMGTHPGGLLSS-------- 660
           R GT  Y+APE L  +I +       + D+Y+ G+V  E+      GG+           
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270

Query: 661 LSSSSGPKIMLIDVLNQRLSPPVNQKIVQDII---LVSTIAFACLSSQPKSRPTMQRISQ 717
           + S    + M   V  Q+L P +  +         +   +   C  +   +R T  RI +
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR-ECWYANGAARLTALRIKK 329

Query: 718 EL 719
            L
Sbjct: 330 TL 331

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  189 bits (483), Expect = 1e-54
 Identities = 66/289 (22%), Positives = 119/289 (41%), Gaps = 43/289 (14%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   I   IG G +G VY      G+V A++ +   E ++   +K+F+ E       RH 
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRW-HGEV-AIRLID-IERDNEDQLKAFKREVMAYRQTRHE 89

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+V   G C+    + +I    +  +L+ V+ D    I L+  K   I + +   + YLH
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH 147

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-----TLRAGTYGYIAP 624
                 I+H+D+ S N+  D N +  + DFG   +  V  + R      ++ G   ++AP
Sbjct: 148 ---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 625 EL---------AYTIVVTGKCDVYSFGVVALEVLMGTHP-GGLLSSLSSSSGPKIMLIDV 674
           E+            +  +   DV++ G +  E+     P             P   +I  
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ---------PAEAIIWQ 254

Query: 675 LNQRLSPPVNQ----KIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +   + P ++Q    K + DI+L       C + + + RPT  ++   L
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILL------FCWAFEQEERPTFTKLMDML 297

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  188 bits (480), Expect = 1e-54
 Identities = 73/281 (25%), Positives = 126/281 (44%), Gaps = 32/281 (11%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
               +   IG+G +G+VYK +   G V A+K L+         +++F+NE  VL   RH 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI+   G+      + ++ ++ E  SL+  LH  +   +    K ++I +  A  + YLH
Sbjct: 81  NILLFMGYST-APQLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLH 137

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH--VDSSYRTLRAGTYGYIAPELA 627
                SIIHRD+ SNNI L  +    + DFG A        S      +G+  ++APE+ 
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 628 -------YTIVVTGKCDVYSFGVVALEVLMGTHP-GGLLSSLSSSSGPKIMLIDVLNQRL 679
                  Y+     + DVY+FG+V  E++ G  P   +          +  +I+++ +  
Sbjct: 195 RMQDSNPYSF----QSDVYAFGIVLYELMTGQLPYSNI--------NNRDQIIEMVGRGS 242

Query: 680 SPPVNQKIVQDI-ILVSTIAFACLSSQPKSRPTMQRISQEL 719
             P   K+  +    +  +   CL  +   RP+  RI  E+
Sbjct: 243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  182 bits (464), Expect = 2e-49
 Identities = 60/303 (19%), Positives = 104/303 (34%), Gaps = 32/303 (10%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIP-----------------PQ 120
           I +  L   +   +     F+C  N+ S  L + ++                       Q
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ 318

Query: 121 IGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLS--GVLPQEIGNLKSLTEL 178
             +L       L   +  G        L +L  L L  N LS  G   Q      SL  L
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 179 YVTNNALGGLIPSTLFRLTNI-----SSNQFHSSIPLEI-GNFSALDTLDLSDNKIHGII 232
            ++ N +   + S    L  +       +         +  +   L  LD+S        
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 233 PDELTKLSQLKNLNLSSNLLSGQI-PYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALK 291
                 LS L+ L ++ N       P    +L NL +LDLS+ +L    PT   + S+L+
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497

Query: 292 NLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM-----YVDLSFNNLEG 346
            L ++HN+           +  LQ LD S N++  +  + L+       +++L+ N+   
Sbjct: 498 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

Query: 347 EIP 349
              
Sbjct: 558 TCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  181 bits (462), Expect = 4e-49
 Identities = 63/288 (21%), Positives = 107/288 (37%), Gaps = 23/288 (7%)

Query: 91  ELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLT--GIIPKEIGSL 148
           + G+       +LK L     S  G        L  L+ L L  N L+  G   +     
Sbjct: 315 KFGQFPTLKLKSLKRLTF--TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372

Query: 149 RNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFR-LTN-----ISSN 202
            +L+ L L  N +   +      L+ L  L   ++ L  +   ++F  L N     IS  
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 203 QFHSSIPLEIGNFSALDTLDLSDNKIHG-IIPDELTKLSQLKNLNLSSNLLSGQIPYAIG 261
               +        S+L+ L ++ N      +PD  T+L  L  L+LS   L    P A  
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 262 KLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKIL-LLQNLDLS 320
            L +L  L++S N             ++L+ L  + N +  +   E+      L  L+L+
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551

Query: 321 HNNLSGTIP--------KTLRPMYVDLSFNNLEGEIPTYLRGNPPKSF 360
            N+ + T          K  R + V++    +E   P+  +G P  S 
Sbjct: 552 QNDFACTCEHQSFLQWIKDQRQLLVEV--ERMECATPSDKQGMPVLSL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  175 bits (447), Expect = 4e-47
 Identities = 60/276 (21%), Positives = 99/276 (35%), Gaps = 17/276 (6%)

Query: 79  TDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLS--GSIPPQIGSLSKLKCLYLHGNN 136
             +   ++              P+L+ LDL  N LS  G         + LK L L  N 
Sbjct: 328 KRLTFTSNKGGNAFS---EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEI-GNLKSLTELYVTNNALGGLIPSTLFR 195
           +  +       L  L  L    + L  +    +  +L++L  L +++             
Sbjct: 385 VITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443

Query: 196 LT-----NISSNQFHSSIPLEI-GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSS 249
           L+      ++ N F  +   +I      L  LDLS  ++  + P     LS L+ LN+S 
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503

Query: 250 NLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNC-SALKNLTLNHNSLDGTIPLE- 307
           N       +    L +L  LD S N +  S   E+ +  S+L  L L  N    T   + 
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS 563

Query: 308 -MGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFN 342
            +  I   + L +    +    P   + M V LS N
Sbjct: 564 FLQWIKDQRQLLVEVERMECATPSDKQGMPV-LSLN 598

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  175 bits (446), Expect = 5e-47
 Identities = 64/274 (23%), Positives = 93/274 (33%), Gaps = 25/274 (9%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSN 159
             + K+LDL  N L         S  +L+ L L    +  I      SL +L  L L  N
Sbjct: 27  PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 160 KLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN-----ISSNQFHS-SIPLEIG 213
            +  +       L SL +L      L  L    +  L       ++ N   S  +P    
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 214 NFSALDTLDLSDNKIHGIIPDELTKLSQLKN----LNLSSNLLSGQIPYAIGKLFNLMYL 269
           N + L+ LDLS NKI  I   +L  L Q+      L+LS N ++   P A  K   L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKL 205

Query: 270 DLSKNKLSGSIPTE-IGNCSALKNLTLNHNSLDGTIPLEM---GKILLLQNLDLSHNNLS 325
            L  N  S ++    I   + L+   L          LE      +  L NL +    L+
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 326 ------GTIPKTLRPM----YVDLSFNNLEGEIP 349
                   I      +       L    +E    
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  166 bits (423), Expect = 7e-44
 Identities = 52/295 (17%), Positives = 88/295 (29%), Gaps = 20/295 (6%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSI---PPQIGSLSKLKCLYLH 133
           R+  + L N+     + +        L+   L                 +L  L  L + 
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 134 GNNLTGI------IPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGG 187
              L  +      I      L N+    L S  +  V             L + N   G 
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ 318

Query: 188 LIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIH--GIIPDELTKLSQLKNL 245
                L  L  ++             +  +L+ LDLS N +   G         + LK L
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 246 NLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTI 304
           +LS N +   +      L  L +LD   + L       +  +   L  L ++H       
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 305 PLEMGKILLLQNLDLSHNNLSGTI-PKTLRPM----YVDLSFNNLEGEIPTYLRG 354
                 +  L+ L ++ N+      P     +    ++DLS   LE   PT    
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  155 bits (394), Expect = 4e-40
 Identities = 51/294 (17%), Positives = 101/294 (34%), Gaps = 25/294 (8%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN 136
            +  +DL    I+  +    +    +L +L L  N +          LS L+ L     N
Sbjct: 53  ELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGV-LPQEIGNLKSLTELYVTNNALGGLIPSTLFR 195
           L  +    IG L+ L+ L +  N +    LP+   NL +L  L +++N +  +  + L  
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171

Query: 196 LT---------NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDE-LTKLSQLKNL 245
           L          ++S N  +   P        L  L L +N     +    +  L+ L+  
Sbjct: 172 LHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230

Query: 246 NLSSNLLSGQIPYA---IGKLFNLMYLDLSKNKLS------GSIPTEIGNCSALKNLTLN 296
            L       +          L  L  L + + +L+        I       + + + +L 
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290

Query: 297 HNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPT 350
             +++             Q+L+L +          L+ +   L+F + +G    
Sbjct: 291 SVTIERVKDFSYN--FGWQHLELVNCKFGQFPTLKLKSLK-RLTFTSNKGGNAF 341

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  123 bits (310), Expect = 2e-29
 Identities = 35/159 (22%), Positives = 63/159 (39%), Gaps = 7/159 (4%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
                  IP  +    +   LDLS N +  +         +L+ L+LS   +      A 
Sbjct: 15  MELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72

Query: 261 GKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLS 320
             L +L  L L+ N +           S+L+ L     +L       +G +  L+ L+++
Sbjct: 73  QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 321 HNNL-SGTIPKTLRPM----YVDLSFNNLEGEIPTYLRG 354
           HN + S  +P+    +    ++DLS N ++    T LR 
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  174 bits (443), Expect = 6e-49
 Identities = 51/265 (19%), Positives = 89/265 (33%), Gaps = 20/265 (7%)

Query: 82  DLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGII 141
                 +K     L  +  P   +L+L +  L    P Q   LS L+ + +    L   +
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119

Query: 142 PKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVT-NNALGGL--------IPST 192
           P  +     L  L L  N L   LP  I +L  L EL +     L  L            
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178

Query: 193 LFRLTN-----ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNL 247
              L N     +       S+P  I N   L +L + ++ +  +    +  L +L+ L+L
Sbjct: 179 HQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDL 236

Query: 248 SSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLE 307
                    P   G    L  L L       ++P +I   + L+ L L        +P  
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296

Query: 308 MGKILLLQNLDLSHNNLSGTIPKTL 332
           + ++     + +   +L   + +  
Sbjct: 297 IAQLPANCIILVP-PHLQAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  121 bits (305), Expect = 3e-30
 Identities = 41/255 (16%), Positives = 79/255 (30%), Gaps = 30/255 (11%)

Query: 115 GSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKS 174
           GS        S  + LY  G+         +   +                     N  +
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWH----SAWRQANSNN 57

Query: 175 LTELYVTNNALGGLIPSTLFRLT-------NISSNQFHSSIPLEIGNFSALDTLDLSDNK 227
                 T  AL       L   T        + S       P +    S L  + +    
Sbjct: 58  PQIETRTGRALKAT-ADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAG 115

Query: 228 IHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNC 287
           +   +PD + + + L+ L L+ N L   +P +I  L  L  L +        +P  + + 
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 288 SA---------LKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM--- 335
            A         L++L L    +  ++P  +  +  L++L + ++ LS  +   +  +   
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231

Query: 336 -YVDLSFNNLEGEIP 349
             +DL         P
Sbjct: 232 EELDLRGCTALRNYP 246

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 34/164 (20%), Positives = 53/164 (32%), Gaps = 28/164 (17%)

Query: 79  TDIDLLNSNIKG---ELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGN 135
             + L  + I+     +  L      NLKSL + N+ LS ++ P I  L KL+ L L G 
Sbjct: 186 QSLRLEWTGIRSLPASIANLQ-----NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGC 239

Query: 136 NLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFR 195
                 P   G    L+ L L        LP +I  L  L +L +               
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV----------N 289

Query: 196 LTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKL 239
           L+          +P  I    A   + +  +    +        
Sbjct: 290 LS---------RLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 24/107 (22%), Positives = 35/107 (32%), Gaps = 5/107 (4%)

Query: 91  ELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRN 150
            +  L       L+ LDL   +   + PP  G  + LK L L   +    +P +I  L  
Sbjct: 224 AIHHLP-----KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278

Query: 151 LRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT 197
           L  L L        LP  I  L +   + V  +    L         
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  174 bits (442), Expect = 2e-46
 Identities = 63/297 (21%), Positives = 109/297 (36%), Gaps = 18/297 (6%)

Query: 77  RITDIDLLNSNIKG-ELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGN 135
            +      + + +          C  +++S++L  +             S L+ L L   
Sbjct: 229 SLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTAT 288

Query: 136 NLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFR 195
           +L+ + P  +  L  L+ L L +NK   +      N  SLT L +  N     + +    
Sbjct: 289 HLSEL-PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347

Query: 196 -LTN-----ISSNQFHSS--IPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNL 247
            L N     +S +   +S    L++ N S L +L+LS N+   +  +   +  QL+ L+L
Sbjct: 348 NLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407

Query: 248 SSNLLSGQIPY-AIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPL 306
           +   L  +        L  L  L+LS + L  S         AL++L L  N        
Sbjct: 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQ 467

Query: 307 EMGKILL---LQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPTYLRGNP 356
           +   +     L+ L LS  +LS         +    +VDLS N L       L    
Sbjct: 468 KTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  163 bits (415), Expect = 7e-43
 Identities = 52/294 (17%), Positives = 94/294 (31%), Gaps = 18/294 (6%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
              ++   + +   +    FS   NL  LDL    +         S  +L  L L  N L
Sbjct: 35  TECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT 197
             +    +   + L+ LF     +S +    + N K+L  LY+ +N +  +     F   
Sbjct: 94  IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153

Query: 198 N-----ISSNQFHSSIPLEIGNFSALD--TLDLSDNKIHGIIPDELTKLSQLKNLNLSSN 250
                   +N  H     ++ +       +L+L+ N I G I       +  ++LN    
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGT 212

Query: 251 LLSGQIPYAIG--KLFNLMYLDLSKNKLSGSIPTEIGNCSA--LKNLTLNHNSLDGTIPL 306
                I   +    + +L              P          ++++ L  +        
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272

Query: 307 EMGKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPTYLRGNP 356
                  LQ LDL+  +LS  +P  L  +     + LS N  E          P
Sbjct: 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP 325

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  157 bits (399), Expect = 9e-41
 Identities = 55/240 (22%), Positives = 92/240 (38%), Gaps = 12/240 (5%)

Query: 79  TDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSL--SGSIPPQIGSLSKLKCLYLHGNN 136
           T + +  +  + ELG        NL+ LDL ++ +  S     Q+ +LS L+ L L  N 
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEI-GNLKSLTELYVTNNALGGLIPSTLFR 195
              +  +       L  L L   +L     Q    NL  L  L ++++ L          
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447

Query: 196 LTN-----ISSNQFHSSIPLEIGNFSALD---TLDLSDNKIHGIIPDELTKLSQLKNLNL 247
           L       +  N F      +  +   L     L LS   +  I     T L  + +++L
Sbjct: 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDL 507

Query: 248 SSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLE 307
           S N L+     A+  L  + YL+L+ N +S  +P+ +   S  + + L  N LD T    
Sbjct: 508 SHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI 566

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  148 bits (376), Expect = 7e-38
 Identities = 52/279 (18%), Positives = 103/279 (36%), Gaps = 21/279 (7%)

Query: 97  FSCFPNLK--SLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIG--SLRNLR 152
            S        SL+L  N ++  I P     +  + L   G     +I K +   ++++L 
Sbjct: 173 MSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW 231

Query: 153 GLFLYSNKLSGVLPQEIGNLK--SLTELYVTNNALGGLIPSTLFRLTNI-----SSNQFH 205
                      + P     L   S+  + +  +    +  +T    + +     ++    
Sbjct: 232 LGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL- 290

Query: 206 SSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQI-PYAIGKLF 264
           S +P  +   S L  L LS NK   +     +    L +L++  N    ++    +  L 
Sbjct: 291 SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350

Query: 265 NLMYLDLSKNKL--SGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHN 322
           NL  LDLS + +  S     ++ N S L++L L++N           +   L+ LDL+  
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410

Query: 323 NLSGTIPKT-LRPM----YVDLSFNNLEGEIPTYLRGNP 356
            L     ++  + +     ++LS + L+        G P
Sbjct: 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  126 bits (318), Expect = 2e-30
 Identities = 42/235 (17%), Positives = 73/235 (31%), Gaps = 27/235 (11%)

Query: 130 LYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLI 189
                  L  I P  +    +   L    N L  +       L +LT L +T   +  + 
Sbjct: 17  YNCENLGLNEI-PGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 190 PSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSS 249
             T                         LDTL L+ N +  +    L+    LK+L    
Sbjct: 74  EDTFQSQHR-------------------LDTLVLTANPLIFMAETALSGPKALKHLFFIQ 114

Query: 250 NLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMG 309
             +S      +     L  L L  N +S     +      LK L   +N++      +M 
Sbjct: 115 TGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMS 174

Query: 310 KILLLQN--LDLSHNNLSGTIPKTLRPM---YVDLSFNNLEGEIPTYLRGNPPKS 359
            +    N  L+L+ N+++G  P          ++         I   L+ +  +S
Sbjct: 175 SLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  111 bits (280), Expect = 8e-26
 Identities = 52/227 (22%), Positives = 87/227 (38%), Gaps = 27/227 (11%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN 136
           ++  +DL  + +K +  +  F     LK L+L ++ L  S       L  L+ L L GN+
Sbjct: 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNH 460

Query: 137 LTGIIPKEIGS---LRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTL 193
                 ++  S   L  L  L L    LS +      +LK +  + +++N L       L
Sbjct: 461 FPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520

Query: 194 FRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLS 253
             L  I                     L+L+ N I  I+P  L  LSQ + +NL  N L 
Sbjct: 521 SHLKGI--------------------YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560

Query: 254 GQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSL 300
                    ++ L +   +  KL  +  T   N   L+ + L+  +L
Sbjct: 561 C----TCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  176 bits (448), Expect = 2e-46
 Identities = 54/349 (15%), Positives = 104/349 (29%), Gaps = 51/349 (14%)

Query: 45  QALLNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLK 104
              ++S  W      +     +  G+  D  GR+T + L     KG +          LK
Sbjct: 294 NNTIHSLNWNFNKELDMW--GDQPGVDLDNNGRVTGLSLAGFGAKGRVPD-AIGQLTELK 350

Query: 105 SLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPK--------------------- 143
            L    +S + S                  + +     K                     
Sbjct: 351 VLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410

Query: 144 --EIGSLRNLRGLFLYSNKLSGV------LPQEIGNLKSLTELYVTNNALGGLIPSTLFR 195
             E+  ++    + L   ++  +      + + I  L  L  +Y  N+       +  + 
Sbjct: 411 NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470

Query: 196 LTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSG- 254
             N    + + +  L   N   L  ++L +      +PD L  L +L++LN++ N     
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530

Query: 255 --------QIPYAIGKLFNLMYLDLSKNKLSG-SIPTEIGNCSALKNLTLNHNSLDGTIP 305
                   ++         +    +  N L        +     L  L   HN +     
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHL 588

Query: 306 LEMGKILLLQNLDLSHNNLSGTIPKTLRPM-----YVDLSFNNLEGEIP 349
              G  + L +L L +N +   IP+           +  S N L+  IP
Sbjct: 589 EAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIP 635

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  174 bits (443), Expect = 1e-45
 Identities = 47/301 (15%), Positives = 103/301 (34%), Gaps = 47/301 (15%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQ-IGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
               P ++   +  N+L        +  + KL  L    N +  +  +  G+   L  L 
Sbjct: 544 EDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLK 601

Query: 156 LYSNKLSGVLPQEIG-NLKSLTELYVTNNALGGLIP----STLFRLT--NISSNQFHS-- 206
           L  N++   +P++       +  L  ++N L  +       +++ +   + S N+  S  
Sbjct: 602 LDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEG 660

Query: 207 ---SIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLS-------GQI 256
              S  ++        T+ LS N+I     +     S +  + LS+NL++          
Sbjct: 661 RNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPK 720

Query: 257 PYAIGKLFNLMYLDLSKNKLSGSIPTEI--GNCSALKNLTLNHNSLDGTIPLEMGK---- 310
                  + L  +DL  NKL+ S+  +        L N+ +++N    + P +       
Sbjct: 721 DGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQL 778

Query: 311 --ILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPT---------YLRGN 355
               +    D   N +    P  +        + +  N++  ++            +  N
Sbjct: 779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADN 837

Query: 356 P 356
           P
Sbjct: 838 P 838

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  171 bits (435), Expect = 1e-44
 Identities = 47/279 (16%), Positives = 89/279 (31%), Gaps = 35/279 (12%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGS-LSKLKCLYLHGNNLTGIIPK-EIGSLRNLRGL 154
           F     L  L L  N +   IP    +   +++ L    N L  I       S+  +  +
Sbjct: 591 FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSV 649

Query: 155 FLYSNKLSGVLPQ-----EIGNLKSLTELYVTNNALGGLIPSTLFRLT-----NISSNQF 204
               NK+           +     + + + ++ N +           +      +S+N  
Sbjct: 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM 709

Query: 205 -------HSSIPLEIGNFSALDTLDLSDNKIHGIIPD-ELTKLSQLKNLNLSSNLLSGQI 256
                           N   L T+DL  NK+  +  D   T L  L N+++S N  S   
Sbjct: 710 TSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-F 768

Query: 257 PYAIGKLFNLMYLDLSK------NKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGK 310
           P        L    +        N++    PT I  C +L  L +  N +   +  ++  
Sbjct: 769 PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTP 827

Query: 311 ILLLQNLDLSHNNLS----GTIPKTLRPMYVDLSFNNLE 345
              L  LD++ N        ++   +      L ++  +
Sbjct: 828 --QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  140 bits (355), Expect = 1e-34
 Identities = 44/250 (17%), Positives = 80/250 (32%), Gaps = 32/250 (12%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGS------LSKLKCLY 131
           +  +   ++ +K      N      + S+D   N +  S    I              + 
Sbjct: 621 VEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDYKGINASTVT 679

Query: 132 LHGNNLTGIIPKEIGSLRNLRGLFLYSNKLS-------GVLPQEIGNLKSLTELYVTNNA 184
           L  N +     +   +   +  + L +N ++               N   LT + +  N 
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNK 739

Query: 185 LGGLIPS----TLFRLT--NISSNQFHSSIPLEIGNFSALDTLDL------SDNKIHGII 232
           L  L       TL  L+  ++S N F SS P +  N S L    +        N+I    
Sbjct: 740 LTSLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798

Query: 233 PDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKL-SGSIPTEIGNCSA-L 290
           P  +T    L  L + SN +   +   +     L  LD++ N   S  + +      A +
Sbjct: 799 PTGITTCPSLIQLQIGSNDIRK-VDEKLTP--QLYILDIADNPNISIDVTSVCPYIEAGM 855

Query: 291 KNLTLNHNSL 300
             L  +    
Sbjct: 856 YVLLYDKTQD 865

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  129 bits (327), Expect = 3e-31
 Identities = 41/229 (17%), Positives = 75/229 (32%), Gaps = 32/229 (13%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGI--- 140
           + S  +     ++     N  ++ L  N +         + S +  + L  N +T I   
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715

Query: 141 ----IPKEIGSLRNLRGLFLYSNKLSGVLPQEI--GNLKSLTELYVTNNALGGLIPSTLF 194
                     +   L  + L  NKL+  L  +     L  L+ + V+ N      P+   
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773

Query: 195 RLTN-----------ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLK 243
             +               N+     P  I    +L  L +  N I  +  ++L    QL 
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKV-DEKL--TPQLY 830

Query: 244 NLNLSSN-LLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALK 291
            L+++ N  +S  +      +   MY  L  +K       +I  C AL 
Sbjct: 831 ILDIADNPNISIDVTSVCPYIEAGMY-VLLYDKTQ-----DIRGCDALG 873

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  102 bits (255), Expect = 1e-22
 Identities = 30/193 (15%), Positives = 58/193 (30%), Gaps = 24/193 (12%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLS-------GSIPPQIGSLSKLKC 129
             + + L  + I+       F+    + ++ L NN ++               +   L  
Sbjct: 674 NASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732

Query: 130 LYLHGNNLTGIIPK-EIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELY------VTN 182
           + L  N LT +       +L  L  + +  N  S   P +  N   L             
Sbjct: 733 IDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEG 791

Query: 183 NALGGLIPSTLFRLT-----NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELT 237
           N +    P+ +          I SN     +  ++     L  LD++DN    I    + 
Sbjct: 792 NRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTSVC 848

Query: 238 KLSQLKNLNLSSN 250
              +     L  +
Sbjct: 849 PYIEAGMYVLLYD 861

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 90.3 bits (224), Expect = 9e-19
 Identities = 25/251 (9%), Positives = 62/251 (24%), Gaps = 67/251 (26%)

Query: 104 KSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSG 163
           K LD+W +     +     +  ++  L L G    G +P  IG L  L+ L   ++  + 
Sbjct: 306 KELDMWGDQPGVDL----DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV 361

Query: 164 VLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDL 223
                     +        + +                        + +     L+  DL
Sbjct: 362 SGRLFGDEELTPDMSEERKHRIRMHYK------------------KMFLDYDQRLNLSDL 403

Query: 224 SDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTE 283
             + I+     E+  + +   ++L                     +    N+++  I   
Sbjct: 404 LQDAINRN--PEMKPIKKDSRISLKDT-----------------QIGNLTNRIT-FISKA 443

Query: 284 IGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNN 343
           I   + L                        Q +  +++  +      +     +  +  
Sbjct: 444 IQRLTKL------------------------QIIYFANSPFTY-DNIAVDWEDANSDYAK 478

Query: 344 LEGEIPTYLRG 354
                      
Sbjct: 479 QYENEELSWSN 489

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 31/290 (10%), Positives = 69/290 (23%), Gaps = 43/290 (14%)

Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKL 161
            LK + +     S        +  K   + +   +    +P     +        YS   
Sbjct: 172 ELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYT---TYSQSG 228

Query: 162 SGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTL 221
                 E  +++      V +N L      T      I   +    I       +  + L
Sbjct: 229 IKRSELETQSVRGE-SFTVIDNKL------TKDANVPIQLKETAEYIKDYKALKAIWEAL 281

Query: 222 DLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIP 281
           D  + + +    +         N N   ++   Q    +     +  L L+     G +P
Sbjct: 282 DGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340

Query: 282 TEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIP----KTLRPMYV 337
             IG  + L                        + L    ++ + +      + L P   
Sbjct: 341 DAIGQLTEL------------------------KVLSFGTHSETVSGRLFGDEELTPDMS 376

Query: 338 DLSFNNLEGEIPTYLRGNPPK----SFVGNKGLSGNVEGFPSSSQRQKLT 383
           +   + +             +      + +               R  L 
Sbjct: 377 EERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK 426

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 12/92 (13%), Positives = 30/92 (32%), Gaps = 4/92 (4%)

Query: 82  DLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGII 141
           D   + I  +      +  P+L  L + +N +   +  ++    +L  L +  N    I 
Sbjct: 788 DAEGNRILRQWPT-GITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISID 843

Query: 142 PKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLK 173
              +          L  +K   +   +   ++
Sbjct: 844 VTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  162 bits (412), Expect = 7e-45
 Identities = 54/262 (20%), Positives = 97/262 (37%), Gaps = 18/262 (6%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
              K   + ++SL  ++     S   +K L L GN L+ I   ++     L  L L SN 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 161 LSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT--NISSNQFHSSIPLEIGNFSAL 218
           L      ++ +L +L  L + NN +  L       +   + ++N   S +          
Sbjct: 70  LYET--LDLESLSTLRTLDLNNNYVQEL--LVGPSIETLHAANNNI-SRVSCSR--GQGK 122

Query: 219 DTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSG-QIPYAIGKLFNLMYLDLSKNKLS 277
             + L++NKI  +   +    S+++ L+L  N +              L +L+L  N + 
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182

Query: 278 GSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM-- 335
             +  ++   + LK L L+ N L   +  E      +  + L +N L   I K LR    
Sbjct: 183 -DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238

Query: 336 --YVDLSFNNLEGEIPTYLRGN 355
             + DL  N             
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSK 260

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  158 bits (401), Expect = 3e-43
 Identities = 65/285 (22%), Positives = 111/285 (38%), Gaps = 17/285 (5%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN 136
           R     + +S++K  L  L      N+K LDL  N LS      +   +KL+ L L  N 
Sbjct: 11  RYKIEKVTDSSLKQALASL-RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRL 196
           L   +   + SL  LR L L +N +      E+    S+  L+  NN +  +  S     
Sbjct: 70  LYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGK 122

Query: 197 T--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGI-IPDELTKLSQLKNLNLSSNLLS 253
               +++N+      L+ G  S +  LDL  N+I  +   +       L++LNL  N + 
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182

Query: 254 GQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILL 313
             +   +     L  LDLS NKL+  +  E  + + +  ++L +N L   I   +     
Sbjct: 183 -DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238

Query: 314 LQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPK 358
           L++ DL  N       +             +  +    L G   +
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKN--QRVQTVAKQTVKKLTGQNEE 281

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  138 bits (351), Expect = 2e-36
 Identities = 49/249 (19%), Positives = 104/249 (41%), Gaps = 20/249 (8%)

Query: 116 SIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSL 175
           +I     + ++ K   +  ++L   +     S  N++ L L  N LS +   ++     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 176 TELYVTNNALGGLIP-STLFRLT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGII 232
             L +++N L   +   +L  L   ++++N        E+    +++TL  ++N I  + 
Sbjct: 61  ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV- 114

Query: 233 PDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSG-SIPTEIGNCSALK 291
               ++    KN+ L++N ++       G    + YLDL  N++   +      +   L+
Sbjct: 115 --SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172

Query: 292 NLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGE 347
           +L L +N +   +  ++     L+ LDLS N L+  +    +      ++ L  N L   
Sbjct: 173 HLNLQYNFIY-DVKGQVVFA-KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228

Query: 348 IPTYLRGNP 356
           I   LR + 
Sbjct: 229 IEKALRFSQ 237

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  112 bits (283), Expect = 2e-27
 Identities = 35/239 (14%), Positives = 77/239 (32%), Gaps = 28/239 (11%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGI-IP 142
             +N    + R++ S     K++ L NN ++       G  S+++ L L  N +  +   
Sbjct: 106 AANN---NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162

Query: 143 KEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSN 202
           +   S   L  L L  N +   +  ++     L  L +++N L                 
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL----------------- 203

Query: 203 QFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGK 262
              + +  E  + + +  + L +NK+  +I   L     L++ +L  N            
Sbjct: 204 ---AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFF 258

Query: 263 LFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSH 321
             N     ++K  +          C+            +        +++ L +    H
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  168 bits (428), Expect = 1e-44
 Identities = 55/286 (19%), Positives = 94/286 (32%), Gaps = 21/286 (7%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPK 143
           L          + F C  N+ ++ L   S+       +    K + L +    L      
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQF--- 322

Query: 144 EIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT------ 197
               L  L+ L L  NK S  +  +   L SL+ L ++ NAL      +   L       
Sbjct: 323 PTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380

Query: 198 -NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIP-DELTKLSQLKNLNLSSNLLSGQ 255
            ++S N     +         L  LD   + +  +        L +L  L++S       
Sbjct: 381 LDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439

Query: 256 IPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKILLL 314
                  L +L  L ++ N    +  + +  N + L  L L+   L+         +  L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499

Query: 315 QNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPTYLRGNP 356
           Q L++SHNNL          +     +D SFN +E           
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  160 bits (406), Expect = 1e-41
 Identities = 57/269 (21%), Positives = 95/269 (35%), Gaps = 24/269 (8%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSN 159
             + K++DL  N L         + S+L+ L L    +  I  K    L +L  L L  N
Sbjct: 31  PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90

Query: 160 KLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN-----ISSNQFHS-SIPLEIG 213
            +    P     L SL  L      L  L    + +L       ++ N  HS  +P    
Sbjct: 91  PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150

Query: 214 NFSALDTLDLSDNKIHGIIPDELTKLSQLKN----LNLSSNLLSGQIPYAIGKLFNLMYL 269
           N + L  +DLS N I  I  ++L  L +       L++S N +   I     +   L  L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHEL 209

Query: 270 DLSKNKLSGSIP-TEIGNCSALKNLTLNHNSLDGTIPLEMGKI--------LLLQNLDLS 320
            L  N  S +I  T + N + L    L          LE+ +         + +    L+
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269

Query: 321 HNNLSGTIPKTLRPM----YVDLSFNNLE 345
           + N           +     + L+  +++
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIK 298

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  152 bits (385), Expect = 6e-39
 Identities = 54/260 (20%), Positives = 86/260 (33%), Gaps = 28/260 (10%)

Query: 92  LGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPK--EIGSLR 149
           L +      P LKSL L  N  S  I  +  +L  L  L L  N L+             
Sbjct: 319 LKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376

Query: 150 NLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIP 209
           +LR L L  N    ++      L+ L  L   ++ L  +   + F               
Sbjct: 377 SLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFL-------------- 421

Query: 210 LEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP-YAIGKLFNLMY 268
               +   L  LD+S              L+ L  L ++ N               NL +
Sbjct: 422 ----SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477

Query: 269 LDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTI 328
           LDLSK +L             L+ L ++HN+L         ++  L  LD S N +  + 
Sbjct: 478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSK 537

Query: 329 PKTLRPM----YVDLSFNNL 344
                      + +L+ N++
Sbjct: 538 GILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  150 bits (381), Expect = 2e-38
 Identities = 51/216 (23%), Positives = 80/216 (37%), Gaps = 10/216 (4%)

Query: 95  LNFSCFPNLKSLDLWNNSLS--GSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLR 152
                 P+L  LDL  N+LS  G         + L+ L L  N    I+      L  L+
Sbjct: 344 FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQ 402

Query: 153 GLFLYSNKLSGVLPQE-IGNLKSLTELYVTNNALGGLIPSTLFRLT-----NISSNQFHS 206
            L    + L  V       +L+ L  L ++              LT      ++ N F  
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462

Query: 207 SIPLEI-GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFN 265
           +    +  N + L  LDLS  ++  I       L +L+ LN+S N L         +L++
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYS 522

Query: 266 LMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLD 301
           L  LD S N++  S         +L    L +NS+ 
Sbjct: 523 LSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  144 bits (366), Expect = 2e-36
 Identities = 47/269 (17%), Positives = 86/269 (31%), Gaps = 23/269 (8%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
           +    +L +L L  N +    P     L+ L+ L      L  +    IG L  L+ L +
Sbjct: 76  WHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135

Query: 157 YSNKLSGV-LPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT---------NISSNQFHS 206
             N +    LP    NL +L  + ++ N +  +  + L  L          ++S N    
Sbjct: 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI-D 194

Query: 207 SIPLEIGNFSALDTLDLSDNKIHG-IIPDELTKLSQLKNLNLSSNLLSGQI------PYA 259
            I  +      L  L L  N     I+   L  L+ L    L       +       P  
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254

Query: 260 IGKLFNLMY--LDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNL 317
           +  L ++      L+          +    + +  ++L   S+      ++ K    Q+L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSL 312

Query: 318 DLSHNNLSGTIPKTLRP-MYVDLSFNNLE 345
            +    L       L     + L+ N   
Sbjct: 313 SIIRCQLKQFPTLDLPFLKSLTLTMNKGS 341

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  139 bits (352), Expect = 8e-35
 Identities = 42/294 (14%), Positives = 85/294 (28%), Gaps = 19/294 (6%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLS--------KLK 128
           ++ ++ L  +     + +        L    L           +I   S         + 
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264

Query: 129 CLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGL 188
              L   N       +   L N+  + L    +  +  +++        L +    L   
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQF 322

Query: 189 IPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPD--ELTKLSQLKNLN 246
               L  L +++      SI  +     +L  LDLS N +             + L++L+
Sbjct: 323 PTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382

Query: 247 LSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTE-IGNCSALKNLTLNHNSLDGTIP 305
           LS N     +      L  L +LD   + L          +   L  L +++ +      
Sbjct: 383 LSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441

Query: 306 LEMGKILLLQNLDLSHNNLSGTIPKTLRPM-----YVDLSFNNLEGEIPTYLRG 354
                +  L  L ++ N+        +        ++DLS   LE         
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDT 495

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  105 bits (265), Expect = 6e-24
 Identities = 36/162 (22%), Positives = 70/162 (43%), Gaps = 8/162 (4%)

Query: 198 NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP 257
                +  S +P +I   S+   +DLS N +  +     +  S+L+ L+LS   +     
Sbjct: 17  QCMDQKL-SKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIED 73

Query: 258 YAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNL 317
            A   L +L  L L+ N +    P      ++L+NL      L       +G+++ L+ L
Sbjct: 74  KAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKL 133

Query: 318 DLSHNNLSG-TIPKTLRPM----YVDLSFNNLEGEIPTYLRG 354
           +++HN +    +P     +    +VDLS+N ++      L+ 
Sbjct: 134 NVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  160 bits (407), Expect = 8e-44
 Identities = 58/279 (20%), Positives = 121/279 (43%), Gaps = 25/279 (8%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
           +  ++L  + I         S    L +L +  N ++      + +L+ L+ LYL+ +N+
Sbjct: 68  LEYLNLNGNQITDIS---PLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNI 122

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRL 196
           + I P  + +L  +  L L +N         + N+  L  L VT + +  + P + L  L
Sbjct: 123 SDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDL 179

Query: 197 T--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSG 254
              +++ NQ     PL   + ++L       N+I  I P  +  +++L +L + +N ++ 
Sbjct: 180 YSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235

Query: 255 QIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLL 314
             P  +  L  L +L++  N++S      + + + LK L +  N +     L    +  L
Sbjct: 236 LSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISVL--NNLSQL 289

Query: 315 QNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIP 349
            +L L++N L     + +  +     + LS N++    P
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  158 bits (402), Expect = 4e-43
 Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 16/233 (6%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
             +    + SL+L  N     + P + +++ L  L +  + +  + P  I +L +L  L 
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRLT--NISSNQFHSSIPLEI 212
           L  N++  + P  + +L SL       N +  + P + + RL    I +N+     PL  
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSPL-- 239

Query: 213 GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLS 272
            N S L  L++  N+I  I  + +  L++LK LN+ SN +S  I   +  L  L  L L+
Sbjct: 240 ANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLN 295

Query: 273 KNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLS 325
            N+L       IG  + L  L L+ N +    PL    +  + + D ++  + 
Sbjct: 296 NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPL--ASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  156 bits (398), Expect = 1e-42
 Identities = 58/276 (21%), Positives = 125/276 (45%), Gaps = 27/276 (9%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
                L  +++   +         ++  L +    ++ SI   I  L+ L+ L L+GN +
Sbjct: 24  GIRAVLQKASVTDVV---TQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQI 78

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRL 196
           T I P  + +L  L  L++ +NK++      + NL +L ELY+  + +  + P + L ++
Sbjct: 79  TDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISPLANLTKM 134

Query: 197 T--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSG 254
              N+ +N   S +   + N + L+ L ++++K+  + P  +  L+ L +L+L+ N +  
Sbjct: 135 YSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191

Query: 255 QIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLL 314
             P  +  L +L Y     N+++   P  + N + L +L + +N +    PL    +  L
Sbjct: 192 ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPL--ANLSQL 245

Query: 315 QNLDLSHNNLSGTIP----KTLRPMYVDLSFNNLEG 346
             L++  N +S          L+   +++  N +  
Sbjct: 246 TWLEIGTNQISDINAVKDLTKLK--MLNVGSNQISD 279

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  144 bits (365), Expect = 5e-38
 Identities = 52/275 (18%), Positives = 106/275 (38%), Gaps = 27/275 (9%)

Query: 79  TDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLT 138
             +  L + I         +         L   S++  +      L  +  L + G  + 
Sbjct: 3   ATLATLPAPINQIF---PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 139 GIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRLT 197
            I  + I  L NL  L L  N+++ + P  + NL  LT LY+  N +  +     L  L 
Sbjct: 58  SI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQNLTNLR 113

Query: 198 --NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQ 255
              ++ +      PL   N + + +L+L  N     +   L+ ++ L  L ++ + +   
Sbjct: 114 ELYLNEDNISDISPL--ANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDV 170

Query: 256 IPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQ 315
            P  I  L +L  L L+ N++    P  + + ++L   T   N +    P+    +  L 
Sbjct: 171 TP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPV--ANMTRLN 224

Query: 316 NLDLSHNNLSGTIP----KTLRPMYVDLSFNNLEG 346
           +L + +N ++   P      L   ++++  N +  
Sbjct: 225 SLKIGNNKITDLSPLANLSQLT--WLEIGTNQISD 257

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  110 bits (277), Expect = 2e-26
 Identities = 46/227 (20%), Positives = 87/227 (38%), Gaps = 38/227 (16%)

Query: 127 LKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALG 186
              L      +  I P     L       L    ++ V+      L+S+T+L V      
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE--- 54

Query: 187 GLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLN 246
                   ++ +I            I   + L+ L+L+ N+I  I P  L+ L +L NL 
Sbjct: 55  --------KVASIQ----------GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLY 94

Query: 247 LSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPL 306
           + +N ++     A+  L NL  L L+++ +S   P  + N + + +L L  N    +   
Sbjct: 95  IGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHN-LSDLS 149

Query: 307 EMGKILLLQNLDLSHNNLSGTIP----KTLRPMYVDLSFNNLEGEIP 349
            +  +  L  L ++ + +    P      L    + L++N +E   P
Sbjct: 150 PLSNMTGLNYLTVTESKVKDVTPIANLTDLY--SLSLNYNQIEDISP 194

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  160 bits (407), Expect = 1e-42
 Identities = 54/260 (20%), Positives = 96/260 (36%), Gaps = 14/260 (5%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
              K   + ++SL  ++     S   +K L L GN L+ I   ++     L  L L SN 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 161 LSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDT 220
           L   L   + +L +L  L + NN +  L+        + ++N       +          
Sbjct: 70  LYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISR---VSCSRGQGKKN 124

Query: 221 LDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSG-QIPYAIGKLFNLMYLDLSKNKLSGS 279
           + L++NKI  +   +    S+++ L+L  N +              L +L+L  N +   
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183

Query: 280 IPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM---- 335
           +  ++   + LK L L+ N L   +  E      +  + L +N L   I K LR      
Sbjct: 184 VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240

Query: 336 YVDLSFNNLEGEIPTYLRGN 355
           + DL  N             
Sbjct: 241 HFDLRGNGFHCGTLRDFFSK 260

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  153 bits (389), Expect = 3e-40
 Identities = 63/286 (22%), Positives = 110/286 (38%), Gaps = 17/286 (5%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN 136
           R     + +S++K +          N+K LDL  N LS      +   +KL+ L L  N 
Sbjct: 11  RYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRL 196
           L   +   + SL  LR L L +N +      E+    S+  L+  NN +  +  S     
Sbjct: 70  LYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGK 122

Query: 197 T--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGI-IPDELTKLSQLKNLNLSSNLLS 253
               +++N+      L+ G  S +  LDL  N+I  +   +       L++LNL  N + 
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182

Query: 254 GQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILL 313
             +   +     L  LDLS NKL+  +  E  + + +  ++L +N L   I   +     
Sbjct: 183 -DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238

Query: 314 LQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKS 359
           L++ DL  N       +             +  +    L G   + 
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKN--QRVQTVAKQTVKKLTGQNEEE 282

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  140 bits (354), Expect = 1e-35
 Identities = 49/249 (19%), Positives = 103/249 (41%), Gaps = 20/249 (8%)

Query: 116 SIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSL 175
           +I     + ++ K   +  ++L   +     S  N++ L L  N LS +   ++     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 176 TELYVTNNALGGLIP-STLFRLT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGII 232
             L +++N L   +   +L  L   ++++N        E+    +++TL  ++N I  + 
Sbjct: 61  ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVS 115

Query: 233 PDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSG-SIPTEIGNCSALK 291
                +    KN+ L++N ++       G    + YLDL  N++   +      +   L+
Sbjct: 116 CS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172

Query: 292 NLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGE 347
           +L L +N +   +  ++     L+ LDLS N L+  +    +      ++ L  N L   
Sbjct: 173 HLNLQYNFIY-DVKGQVVFA-KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228

Query: 348 IPTYLRGNP 356
           I   LR + 
Sbjct: 229 IEKALRFSQ 237

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  123 bits (311), Expect = 4e-30
 Identities = 46/368 (12%), Positives = 103/368 (27%), Gaps = 23/368 (6%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGI-IP 142
             +N    + R++ S     K++ L NN ++       G  S+++ L L  N +  +   
Sbjct: 106 AANN---NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162

Query: 143 KEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN---- 198
           +   S   L  L L  N +   +  ++     L  L +++N L   +             
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWI 219

Query: 199 -ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP 257
            + +N+    I   +     L+  DL  N  H     +       +   ++   +     
Sbjct: 220 SLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTG 277

Query: 258 YAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDG----TIPLEMGKILL 313
               +                          ALK       S  G     +  E      
Sbjct: 278 QNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337

Query: 314 LQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGN 369
            + +D         I +          ++     L+ E  +  R    +     +   G 
Sbjct: 338 QREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD-EQVSNGRRAHAELDGTLQQAVGQ 396

Query: 370 VEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGD 429
           +E   ++ ++  L    ++  +         +            Q+K  +L    A+   
Sbjct: 397 IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKK 456

Query: 430 VFSVWNYD 437
           +    +  
Sbjct: 457 LNGEADLA 464

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  157 bits (399), Expect = 2e-42
 Identities = 67/283 (23%), Positives = 106/283 (37%), Gaps = 40/283 (14%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           ED  +   IG G +G V+   L      VA+K    +   D      F  EA +L    H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARILKQYSH 171

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIV+L G C  K+ ++++ E ++ G     L  +     L     + +V   A  + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYL 229

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI-----A 623
               +   IHRD+++ N L+       ++DFG +R            +G    +     A
Sbjct: 230 E---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA---ASGGLRQVPVKWTA 283

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ----- 677
           PE       + + DV+SFG++  E    G  P            P +             
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASP-----------YPNLSNQQTREFVEKGG 332

Query: 678 RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           RL  P      V  ++        C + +P  RP+   I QEL
Sbjct: 333 RLPCPELCPDAVFRLME------QCWAYEPGQRPSFSTIYQEL 369

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  150 bits (380), Expect = 3e-40
 Identities = 64/300 (21%), Positives = 119/300 (39%), Gaps = 42/300 (14%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E +     IG G +G     +   +G+   +K+++ S        +  + E  VL+ ++H
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE-REESRREVAVLANMKH 82

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD-----DEAIELNWTKRVNIVKSVAH 563
            NIV+          ++++ +Y E G LF  ++        E   L+W  ++        
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CL 136

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
           AL ++H      I+HRDI S NI L  +    + DFG AR+L+          GT  Y++
Sbjct: 137 ALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP--GGLLSSLSSSSGPKIM--LIDVLNQRL 679
           PE+        K D+++ G V  E+    H    G + +L      KI+      ++   
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL----KIISGSFPPVSLHY 249

Query: 680 SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP-MQKALKEISISEL 738
           S  +   + Q                P+ RP+       +L  +   + K +++    +L
Sbjct: 250 SYDLRSLVSQ-----------LFKRNPRDRPS----VNSIL--EKGFIAKRIEKFLSPQL 292

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  148 bits (375), Expect = 5e-40
 Identities = 67/274 (24%), Positives = 111/274 (40%), Gaps = 35/274 (12%)

Query: 457 CIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
            IG G + +VYK  +      VA  +L   +   S   + F+ EA +L  ++H NIV+ Y
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEMLKGLQHPNIVRFY 91

Query: 516 GFCL----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                    KKC+ L+ E M  G+L   L        +      +  + +   L +LH  
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH-T 147

Query: 572 CTLSIIHRDISSNNILLDSNL-EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI 630
            T  IIHRD+  +NI +        + D G A L     + + +  GT  ++APE+ Y  
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA-KAVI-GTPEFMAPEM-YEE 204

Query: 631 VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI--- 687
                 DVY+FG+  LE+    +P     + +      I     +   + P    K+   
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRR--VTSGVKPASFDKVAIP 257

Query: 688 -VQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
            V++II        C+      R +     ++LL
Sbjct: 258 EVKEIIE------GCIRQNKDERYS----IKDLL 281

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  152 bits (385), Expect = 8e-40
 Identities = 65/268 (24%), Positives = 116/268 (43%), Gaps = 22/268 (8%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPK 143
             + +         +    L+ LD+ +N +S      +  L+ L+ L    N ++ I P 
Sbjct: 163 FGNQVTDLK---PLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP- 216

Query: 144 EIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRLT--NIS 200
            +G L NL  L L  N+L  +    + +L +LT+L + NN +  L P S L +LT   + 
Sbjct: 217 -LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLG 273

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
           +NQ  +  PL     +AL  L+L++N++  I P  ++ L  L  L L  N +S   P  +
Sbjct: 274 ANQISNISPL--AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--V 327

Query: 261 GKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLS 320
             L  L  L    NK+S    + + N + +  L+  HN +    PL    +  +  L L+
Sbjct: 328 SSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLN 383

Query: 321 HNNLSGTIPKTLRPMYVDLSFNNLEGEI 348
               +         + +  +  N+ G +
Sbjct: 384 DQAWTNAPVNYKANVSIPNTVKNVTGAL 411

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  143 bits (364), Expect = 5e-37
 Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 29/279 (10%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
                L  +N+   +   + +    + +L      +       +  L+ L  +    N L
Sbjct: 26  KMKTVLGKTNVTDTV---SQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQL 80

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRL 196
           T I P  + +L  L  + + +N+++ + P  + NL +LT L + NN +  + P   L  L
Sbjct: 81  TDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNL 136

Query: 197 T--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSG 254
               +SSN   S I   +   ++L  L    N++  + P  L  L+ L+ L++SSN +S 
Sbjct: 137 NRLELSSNTI-SDIS-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD 191

Query: 255 QIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLL 314
                + KL NL  L  + N++S   P  +G  + L  L+LN N L     L    +  L
Sbjct: 192 --ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL--ASLTNL 245

Query: 315 QNLDLSHNNLSGTIP----KTLRPMYVDLSFNNLEGEIP 349
            +LDL++N +S   P      L    + L  N +    P
Sbjct: 246 TDLDLANNQISNLAPLSGLTKLT--ELKLGANQISNISP 282

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  143 bits (363), Expect = 8e-37
 Identities = 69/260 (26%), Positives = 114/260 (43%), Gaps = 20/260 (7%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
             +   NL+SL   NN +S   P  +G L+ L  L L+GN L  I    + SL NL  L 
Sbjct: 194 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLD 249

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRLT--NISSNQFHSSIPLEI 212
           L +N++S + P  +  L  LTEL +  N +  + P + L  LT   ++ NQ     P  I
Sbjct: 250 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP--I 305

Query: 213 GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLS 272
            N   L  L L  N I  I P  ++ L++L+ L   +N +S     ++  L N+ +L   
Sbjct: 306 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAG 361

Query: 273 KNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTL 332
            N++S   P  + N + +  L LN  +     P+     + + N   +        P T+
Sbjct: 362 HNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATI 417

Query: 333 RPMYVDLSFNNLEGEIPTYL 352
                  +  ++   +P+Y 
Sbjct: 418 SDGGS-YTEPDITWNLPSYT 436

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  139 bits (352), Expect = 2e-35
 Identities = 60/261 (22%), Positives = 109/261 (41%), Gaps = 26/261 (9%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
             +         L   +++ ++      L ++  L      +  I    +  L NL  + 
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQIN 74

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRLT--NISSNQFHSSIPLEI 212
             +N+L+ + P  + NL  L ++ + NN +  + P + L  LT   + +NQ     PL  
Sbjct: 75  FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL-- 130

Query: 213 GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLS 272
            N + L+ L+LS N I  I    L+ L+ L+ L+  + +        +  L  L  LD+S
Sbjct: 131 KNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDIS 185

Query: 273 KNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTL 332
            NK+S    + +   + L++L   +N +    PL  G +  L  L L+ N L      TL
Sbjct: 186 SNKVSD--ISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTL 239

Query: 333 RPM----YVDLSFNNLEGEIP 349
             +     +DL+ N +    P
Sbjct: 240 ASLTNLTDLDLANNQISNLAP 260

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  125 bits (316), Expect = 8e-31
 Identities = 59/251 (23%), Positives = 106/251 (42%), Gaps = 25/251 (9%)

Query: 103 LKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLS 162
           L S  +  ++    I     +L++     L   N+T  +      L  +  L      + 
Sbjct: 3   LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59

Query: 163 GVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRLT--NISSNQFHSSIPLEIGNFSALD 219
                 +  L +LT++  +NN L  + P   L +L    +++NQ     PL   N + L 
Sbjct: 60  S--IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPL--ANLTNLT 115

Query: 220 TLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGS 279
            L L +N+I  I P  L  L+ L  L LSSN +S     A+  L +L  L    N+++  
Sbjct: 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDL 170

Query: 280 IPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIP----KTLRPM 335
            P  + N + L+ L ++ N +  +    + K+  L++L  ++N +S   P      L   
Sbjct: 171 KP--LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITPLGILTNLD-- 224

Query: 336 YVDLSFNNLEG 346
            + L+ N L+ 
Sbjct: 225 ELSLNGNQLKD 235

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  115 bits (289), Expect = 3e-27
 Identities = 54/231 (23%), Positives = 87/231 (37%), Gaps = 17/231 (7%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
           +TD+DL N+ I         S    L  L L  N +S   P  +  L+ L  L L+ N L
Sbjct: 245 LTDLDLANNQISNLA---PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL 299

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRL 196
             I P  I +L+NL  L LY N +S + P  + +L  L  L+  NN +  +   + L  +
Sbjct: 300 EDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNI 355

Query: 197 T--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSG 254
              +   NQ     P  + N + +  L L+D        +    +S    +   +  L  
Sbjct: 356 NWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI- 412

Query: 255 QIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIP 305
             P  I    +    D++ N  S          S    +     +  GT+ 
Sbjct: 413 -APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  105 bits (264), Expect = 4e-24
 Identities = 43/229 (18%), Positives = 83/229 (36%), Gaps = 42/229 (18%)

Query: 122 GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVT 181
           G L            +  I      +L       L    ++  + Q   +L  +T L   
Sbjct: 1   GPLGSA--TITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQAD 54

Query: 182 NNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQ 241
                         + +I            +   + L  ++ S+N++  I P  L  L++
Sbjct: 55  RL-----------GIKSID----------GVEYLNNLTQINFSNNQLTDITP--LKNLTK 91

Query: 242 LKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLD 301
           L ++ +++N ++   P  +  L NL  L L  N+++   P  + N + L  L L+ N++ 
Sbjct: 92  LVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS 147

Query: 302 GTIPLEMGKILLLQNLDLSHNNLSGTIP----KTLRPMYVDLSFNNLEG 346
               L    +  LQ L    N ++   P     TL    +D+S N +  
Sbjct: 148 DISAL--SGLTSLQQLSFG-NQVTDLKPLANLTTLE--RLDISSNKVSD 191

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  146 bits (370), Expect = 3e-39
 Identities = 63/290 (21%), Positives = 113/290 (38%), Gaps = 33/290 (11%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
                   +G G +G V            G+ VA+K L      +   +   + E  +L 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILR 78

Query: 505 TVRHRNIVKLYGFCLHKKC--MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
            + H NIVK  G C       + LI E++  GSL   L  +    ++N  +++     + 
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQIC 136

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             + YL    +   +HRD+++ N+L++S  +  + DFG  + +  D  Y T++      +
Sbjct: 137 KGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193

Query: 623 ---APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSG---PKIMLIDVL 675
              APE           DV+SFGV   E+L         ++      G    ++ +  ++
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253

Query: 676 NQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           N      RL  P N    V  ++        C   QP +R + Q + +  
Sbjct: 254 NTLKEGKRLPCPPNCPDEVYQLMR------KCWEFQPSNRTSFQNLIEGF 297

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  145 bits (369), Expect = 4e-39
 Identities = 56/280 (20%), Positives = 107/280 (38%), Gaps = 33/280 (11%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
            +F I+  IG G +  VY+A  L +G  VALKK+   +  D+        E  +L  + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD-------DEAIELNWTKRVNIVKSV 561
            N++K Y   +    + ++ E  + G L  ++           E     +  +      +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ------L 145

Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGY 621
             AL ++H   +  ++HRDI   N+ + +     + D G  R     ++      GT  Y
Sbjct: 146 CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 202

Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP 681
           ++PE  +      K D++S G +  E+     P                L   + Q   P
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNLYSLCKKIEQCDYP 256

Query: 682 PVNQKI----VQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
           P+        ++ ++        C++  P+ RP +  +  
Sbjct: 257 PLPSDHYSEELRQLVN------MCINPDPEKRPDVTYVYD 290

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  144 bits (366), Expect = 2e-38
 Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 43/286 (15%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL-PEGK----VVALKKLHHSETEDSAFVKSFQNEAHVLS 504
            +F     +G+G +G+VYK    PEG+     VA+K+L  + +  +   K   +EA+V++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMA 72

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           +V + ++ +L G CL    + LI + M  G L   + +  + I       +N    +A  
Sbjct: 73  SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKG 129

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG------T 618
           ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +        G       
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186

Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHP-GGLLSSLSSSSGPKIMLIDVLN 676
               A E     + T + DV+S+GV   E++  G+ P  G+          +I    +L 
Sbjct: 187 ----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-------PASEI--SSILE 233

Query: 677 Q--RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +  RL  P      V  I+        C      SRP  + +  E 
Sbjct: 234 KGERLPQPPICTIDVYMIMR------KCWMIDADSRPKFRELIIEF 273

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  143 bits (363), Expect = 2e-38
 Identities = 62/291 (21%), Positives = 111/291 (38%), Gaps = 43/291 (14%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
            DF    C+G GG+G V++A+   +    A+K++     E +   +    E   L+ + H
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEH 62

Query: 509 RNIVKLYGFCLHKKCM------------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
             IV+ +   L K               ++  +   + +L   ++      E   +  ++
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY----- 611
           I   +A A+ +LH   +  ++HRD+  +NI    +    V DFG    +  D        
Sbjct: 123 IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 612 -------RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS 664
                   T + GT  Y++PE  +    + K D++S G++  E         LL   S+ 
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE---------LLYPFSTQ 230

Query: 665 SGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
                 L DV N +  PP+  +          +    LS  P  RP    I
Sbjct: 231 MERVRTLTDVRNLKF-PPLFTQKYPC--EYVMVQ-DMLSPSPMERPEAINI 277

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  142 bits (361), Expect = 3e-38
 Identities = 65/306 (21%), Positives = 121/306 (39%), Gaps = 62/306 (20%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
            DF     IG+GG+G V+KA+   +GK   +K++ ++        +  + E   L+ + H
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDH 63

Query: 509 RNIVKLYGF----------------CLHKKCMFLIYEYMERGSLFCVLHDD-----DEAI 547
            NIV   G                     KC+F+  E+ ++G+L   +        D+ +
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 548 ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
            L         + +   + Y+H   +  +I+RD+  +NI L    +  + DFG    L  
Sbjct: 124 ALEL------FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174

Query: 608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGP 667
           D        GT  Y++PE   +     + D+Y+ G++  E+L         S        
Sbjct: 175 DGKRTRS-KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF------ 227

Query: 668 KIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP-M 726
                D+ +  +S   ++K  + ++         LS +P+ RP       E+L  +T  +
Sbjct: 228 ---FTDLRDGIISDIFDKKE-KTLLQ------KLLSKKPEDRPNT----SEIL--RTLTV 271

Query: 727 QKALKE 732
            K   E
Sbjct: 272 WKKSPE 277

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  142 bits (361), Expect = 4e-38
 Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 30/291 (10%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +D  +   +G G +G V + E   P GK   VA+K L          +  F  E + + +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           + HRN+++LYG  L    M ++ E    GSL   L        L           VA  +
Sbjct: 78  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGM 134

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYI 622
            YL    +   IHRD+++ N+LL +     + DFG  R L  +  +  ++      + + 
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLM-GTHP-GGLLSSLSSSSGPKIM-LIDVLNQRL 679
           APE   T   +   D + FGV   E+   G  P  GL       +G +I+  ID   +RL
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-------NGSQILHKIDKEGERL 244

Query: 680 SPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKA 729
             P +  + + ++++       C + +P+ RPT   +   LL  +    +A
Sbjct: 245 PRPEDCPQDIYNVMV------QCWAHKPEDRPTFVALRDFLLEAQPTDMRA 289

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  141 bits (358), Expect = 6e-38
 Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 22/274 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           ED+ + Y IGTG YG   K     +GK++  K+L +    ++   +   +E ++L  ++H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKH 64

Query: 509 RNIVKLYG-FCLHKKCMFLIY-EYMERGSLFCVLHDDDEAIELNWTKRV-NIVKSVAHAL 565
            NIV+ Y            I  EY E G L  V+    +  +    + V  ++  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 566 SYLH--HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
              H   D   +++HRD+   N+ LD      + DFG AR+L+ D+S+     GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP--GGLLSSLSSSSGPKIMLIDVLNQRLSP 681
           PE    +    K D++S G +  E+     P        L+     KI            
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG----KIREGKF------R 234

Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
            +  +   +  L   I    L+ +   RP+++ I
Sbjct: 235 RIPYRYSDE--LNEIIT-RMLNLKDYHRPSVEEI 265

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  140 bits (356), Expect = 9e-38
 Identities = 71/280 (25%), Positives = 113/280 (40%), Gaps = 38/280 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
            +      IG+G +G V+         VA+K +      +  F++    EA V+  + H 
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHP 63

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LYG CL +  + L+ E+ME G L   L              + +   V   ++YL 
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYL- 120

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI---APEL 626
                 +IHRD+++ N L+  N    V+DFG  R +  D  Y T   GT   +   +PE+
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQY-TSSTGTKFPVKWASPEV 176

Query: 627 AYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLS 680
                 + K DV+SFGV+  EV   G  P                  +V+       RL 
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIP-----------YENRSNSEVVEDISTGFRLY 225

Query: 681 PPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            P      V  I+        C   +P+ RP   R+ ++L
Sbjct: 226 KPRLASTHVYQIMN------HCWRERPEDRPAFSRLLRQL 259

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  141 bits (358), Expect = 1e-37
 Identities = 71/291 (24%), Positives = 121/291 (41%), Gaps = 35/291 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
                   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +L 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILK 66

Query: 505 TVRHRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           +++H NIVK  G C    ++ + LI EY+  GSL   L    E I+    K +     + 
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQIC 124

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             + YL    T   IHRD+++ NIL+++     + DFG  ++L  D  +  ++      I
Sbjct: 125 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181

Query: 623 ---APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSG----PKIMLIDV 674
              APE       +   DV+SFGVV  E+           +      G     ++++  +
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241

Query: 675 LNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +       RL  P      +  I+        C ++    RP+ + ++  +
Sbjct: 242 IELLKNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQRPSFRDLALRV 286

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  142 bits (359), Expect = 1e-37
 Identities = 87/302 (28%), Positives = 133/302 (44%), Gaps = 43/302 (14%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +  E F     IG G +G V+K  +    KVVA+K +   E ED   ++  Q E  VLS 
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQ 76

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVA 562
                + K YG  L    +++I EY+  GS   +L     D+  I         I++ + 
Sbjct: 77  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREIL 129

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L YLH +     IHRDI + N+LL  + E  +ADFG A  L      R    GT  ++
Sbjct: 130 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 186

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGT------HPGGLLSSLSSSSGPKIMLIDVLN 676
           APE+        K D++S G+ A+E+  G       HP  +L  +  ++ P       L 
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT------LE 240

Query: 677 QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISIS 736
              S P+ + +             CL+ +P  RPT    ++ELL  K  ++ A K   ++
Sbjct: 241 GNYSKPLKEFVEA-----------CLNKEPSFRPT----AKELLKHKFILRNAKKTSYLT 285

Query: 737 EL 738
           EL
Sbjct: 286 EL 287

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  142 bits (360), Expect = 1e-37
 Identities = 68/290 (23%), Positives = 113/290 (38%), Gaps = 34/290 (11%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
                   +G G +GSV            G +VA+K+L HS  +     + FQ E  +L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ---QRDFQREIQILK 79

Query: 505 TVRHRNIVKLYGFCLHKKC--MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
            +    IVK  G         + L+ EY+  G L   L      ++ +  + +     + 
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQIC 137

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             + YL    +   +HRD+++ NIL++S     +ADFG A+LL +D  Y  +R      I
Sbjct: 138 KGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194

Query: 623 ---APELAYTIVVTGKCDVYSFGVVALEVLM-GTHP---GGLLSSLSSSSGPKIMLIDVL 675
              APE     + + + DV+SFGVV  E+                +         L  +L
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254

Query: 676 NQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                  RL  P      V +++        C +  P+ RP+   +  +L
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMK------LCWAPSPQDRPSFSALGPQL 298

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  147 bits (372), Expect = 3e-37
 Identities = 64/254 (25%), Positives = 111/254 (43%), Gaps = 40/254 (15%)

Query: 98  SCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLY 157
           +  P L++L++  N L+ S+P     L +L        +L  +          L  L+++
Sbjct: 78  ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIF 129

Query: 158 SNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN--ISSNQFHSSIPLEIGNF 215
            N+L+  LP        L EL V++N L  L P+    L      +NQ  +S+P+     
Sbjct: 130 GNQLT-SLPVLPPG---LQELSVSDNQLASL-PALPSELCKLWAYNNQL-TSLPMLPSG- 182

Query: 216 SALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNK 275
             L  L +SDN++   +P      S+L  L   +N L+  +P        L  L +S N+
Sbjct: 183 --LQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPALPS---GLKELIVSGNR 232

Query: 276 LSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM 335
           L+ S+P        LK L ++ N L  ++P+       L +L +  N L+  +P++L  +
Sbjct: 233 LT-SLPVLPSE---LKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHL 283

Query: 336 ----YVDLSFNNLE 345
                V+L  N L 
Sbjct: 284 SSETTVNLEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  145 bits (366), Expect = 1e-36
 Identities = 66/306 (21%), Positives = 120/306 (39%), Gaps = 59/306 (19%)

Query: 75  EGRITDIDLLNSNIKGELGRLNFSC----------FPNLKSLDLWNNSLSGSIPPQIGSL 124
            GR   +  + + +      LN               ++ +L + +N+L+ S+P      
Sbjct: 25  RGRAAVVQKMRACLNNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLT-SLPALPP-- 81

Query: 125 SKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNA 184
            +L+ L + GN LT  +P     L  L         L  +          L +L++  N 
Sbjct: 82  -ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQ 132

Query: 185 LGGLIPSTLFRLT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQL 242
           L  L P     L   ++S NQ  +S+P        L  L   +N++   +P   +    L
Sbjct: 133 LTSL-PVLPPGLQELSVSDNQL-ASLPALPSE---LCKLWAYNNQLTS-LPMLPS---GL 183

Query: 243 KNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDG 302
           + L++S N L+  +P    +L+    L    N+L+ S+P        LK L ++ N L  
Sbjct: 184 QELSVSDNQLA-SLPTLPSELYK---LWAYNNRLT-SLPALPSG---LKELIVSGNRL-T 234

Query: 303 TIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM-YVDLSFNNLEGEIPT----------- 350
           ++P+   +   L+ L +S N L+ ++P     +  + +  N L   +P            
Sbjct: 235 SLPVLPSE---LKELMVSGNRLT-SLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTV 289

Query: 351 YLRGNP 356
            L GNP
Sbjct: 290 NLEGNP 295

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  136 bits (345), Expect = 7e-34
 Identities = 53/246 (21%), Positives = 91/246 (36%), Gaps = 28/246 (11%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
             L  L ++ N L+ S+P     L   + L +  N L  + P     L  L     Y+N+
Sbjct: 121 SGLCKLWIFGNQLT-SLPVLPPGL---QELSVSDNQLASL-PALPSELCKLW---AYNNQ 172

Query: 161 LSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN--ISSNQFHSSIPLEIGNFSAL 218
           L+  LP     L    EL V++N L  L P+    L      +N+  +S+P        L
Sbjct: 173 LT-SLPMLPSGL---QELSVSDNQLASL-PTLPSELYKLWAYNNRL-TSLPALPSG---L 223

Query: 219 DTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSG 278
             L +S N++  + P   +   +LK L +S N L+  +P        L+ L + +N+L+ 
Sbjct: 224 KELIVSGNRLTSL-PVLPS---ELKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT- 274

Query: 279 SIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVD 338
            +P  + + S+   + L  N L       + +I                     R     
Sbjct: 275 RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL 334

Query: 339 LSFNNL 344
                 
Sbjct: 335 HLAAAD 340

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  121 bits (305), Expect = 7e-29
 Identities = 55/271 (20%), Positives = 94/271 (34%), Gaps = 41/271 (15%)

Query: 77  RITDIDLLNSNIKG-ELGRLNFSCFP----NLKSLDLWNNSLSGSIPPQIGSLSKLKCLY 131
            +T +  L S +    +     +  P     L+ L + +N L+ S+P     L KL   +
Sbjct: 112 PLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA-SLPALPSELCKL---W 167

Query: 132 LHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLK-----------------S 174
            + N LT + P     L+ L    +  N+L+  LP     L                   
Sbjct: 168 AYNNQLTSL-PMLPSGLQELS---VSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSG 222

Query: 175 LTELYVTNNALGGLIPSTLFRLT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGII 232
           L EL V+ N L  L P     L    +S N+  +S+P+       L +L +  N++  + 
Sbjct: 223 LKELIVSGNRLTSL-PVLPSELKELMVSGNRL-TSLPMLPSG---LLSLSVYRNQLTRL- 276

Query: 233 PDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKN 292
           P+ L  LS    +NL  N LS +   A+ ++ +         +   +  +      AL  
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHL 336

Query: 293 LTLNHNSLDGTIPLEMGKILLLQNLDLSHNN 323
                + L      E              N 
Sbjct: 337 --AAADWLVPAREGEPAPADRWHMFGQEDNA 365

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  141 bits (357), Expect = 3e-37
 Identities = 72/291 (24%), Positives = 119/291 (40%), Gaps = 35/291 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELP-----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
                   +G G +GSV            G+VVA+KKL HS  E    ++ F+ E  +L 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILK 97

Query: 505 TVRHRNIVKLYGFCLHKKC--MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           +++H NIVK  G C       + LI EY+  GSL   L    E I+    K +     + 
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQIC 155

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             + YL    T   IHRD+++ NIL+++     + DFG  ++L  D  Y  ++      I
Sbjct: 156 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212

Query: 623 ---APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSG----PKIMLIDV 674
              APE       +   DV+SFGVV  E+           +      G     ++++  +
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272

Query: 675 LNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +       RL  P      +  I+        C ++    RP+ + ++  +
Sbjct: 273 IELLKNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQRPSFRDLALRV 317

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  140 bits (356), Expect = 3e-37
 Identities = 62/290 (21%), Positives = 109/290 (37%), Gaps = 35/290 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL-----PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
                   +G G +G V            G++VA+K L             ++ E  +L 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH--RSGWKQEIDILR 88

Query: 505 TVRHRNIVKLYGFCLHKKC--MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           T+ H +I+K  G C       + L+ EY+  GSL   L        +   + +   + + 
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQIC 144

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             ++YLH       IHRD+++ N+LLD++    + DFG A+ +     Y  +R      +
Sbjct: 145 EGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201

Query: 623 ---APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSG---PKIMLIDVL 675
              APE           DV+SFGV   E+L          +      G    ++ ++ + 
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261

Query: 676 N-----QRLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                 +RL  P      V  ++        C  ++   RPT + +   L
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMK------NCWETEASFRPTFENLIPIL 305

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  140 bits (354), Expect = 3e-37
 Identities = 65/280 (23%), Positives = 115/280 (41%), Gaps = 38/280 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +D      +GTG +G V   +      VA+K +      +  F++    EA V+  + H 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHE 79

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LYG C  ++ +F+I EYM  G L   L +          + + + K V  A+ YL 
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 137

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI---APEL 626
              +   +HRD+++ N L++      V+DFG +R +  D  Y T   G+   +    PE+
Sbjct: 138 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEY-TSSVGSKFPVRWSPPEV 192

Query: 627 AYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLS 680
                 + K D+++FGV+  E+   G  P             +    +         RL 
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMP-----------YERFTNSETAEHIAQGLRLY 241

Query: 681 PPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            P    + V  I+       +C   +   RPT + +   +
Sbjct: 242 RPHLASEKVYTIMY------SCWHEKADERPTFKILLSNI 275

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  144 bits (366), Expect = 3e-37
 Identities = 73/279 (26%), Positives = 122/279 (43%), Gaps = 34/279 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
            D  +K+ +G G YG VY+    +  + VA+K L     E   F+K    EA V+  ++H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKH 275

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            N+V+L G C  +   ++I E+M  G+L   L + +   E++    + +   ++ A+ YL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL 334

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGY--IAPEL 626
                 + IHR++++ N L+  N    VADFG +RL+    +Y       +     APE 
Sbjct: 335 EK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 390

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLSP 681
                 + K DV++FGV+  E+           +   S  P I L  V        R+  
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIA----------TYGMSPYPGIDLSQVYELLEKDYRMER 440

Query: 682 PVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           P    + V +++       AC    P  RP+   I Q  
Sbjct: 441 PEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF 473

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  138 bits (351), Expect = 5e-37
 Identities = 66/281 (23%), Positives = 117/281 (41%), Gaps = 40/281 (14%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E+  +   +G+G +G V   +      VA+K +      +  F +    EA  +  + H 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ----EAQTMMKLSHP 63

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +VK YG C  +  ++++ EY+  G L   L    +   L  ++ + +   V   +++L 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLE 121

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI---APE- 625
              +   IHRD+++ N L+D +L   V+DFG  R +  D  Y     GT   +   APE 
Sbjct: 122 ---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQY-VSSVGTKFPVKWSAPEV 176

Query: 626 LAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RL 679
             Y    + K DV++FG++  EV   G  P                  +V+ +     RL
Sbjct: 177 FHYF-KYSSKSDVWAFGILMWEVFSLGKMP-----------YDLYTNSEVVLKVSQGHRL 224

Query: 680 SPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             P      +  I+       +C    P+ RPT Q++   +
Sbjct: 225 YRPHLASDTIYQIMY------SCWHELPEKRPTFQQLLSSI 259

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  140 bits (355), Expect = 5e-37
 Identities = 82/286 (28%), Positives = 120/286 (41%), Gaps = 42/286 (14%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL---PEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLST 505
              HI+  IG+G  G V    L    +  V VA+K L    TE     + F +EA ++  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQ 106

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
             H NI++L G     +   ++ EYME GSL   L   D   +    + V +++ V   +
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGM 164

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI--- 622
            YL     L  +HRD+++ N+L+DSNL   V+DFG +R+L  D        G  G I   
Sbjct: 165 RYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG--GKIPIR 219

Query: 623 --APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ-- 677
             APE       +   DV+SFGVV  EVL  G  P              +   DV++   
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP-----------YWNMTNRDVISSVE 268

Query: 678 ---RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
              RL  P+     +  ++L       C       RP   +I   L
Sbjct: 269 EGYRLPAPMGCPHALHQLML------DCWHKDRAQRPRFSQIVSVL 308

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  138 bits (350), Expect = 1e-36
 Identities = 64/276 (23%), Positives = 117/276 (42%), Gaps = 32/276 (11%)

Query: 454 IKYCIGTGGYGSVYKAEL--PEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
               +G G +GSV +      + ++ VA+K L     +     +    EA ++  + +  
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPY 71

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           IV+L G C   + + L+ E    G L   L    E  E+  +    ++  V+  + YL  
Sbjct: 72  IVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYL-- 126

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI---APELA 627
               + +HRD+++ N+LL +   A ++DFG ++ L  D SY T R+     +   APE  
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185

Query: 628 YTIVVTGKCDVYSFGVVALEVLM-GTHP-GGLLSSLSSSSGPKIM-LIDVLNQRLSPPVN 684
                + + DV+S+GV   E L  G  P   +        GP++M  I+   +R+  P  
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-------KGPEVMAFIEQ-GKRMECPPE 237

Query: 685 -QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
               +  ++        C   + + RP    + Q +
Sbjct: 238 CPPELYALMS------DCWIYKWEDRPDFLTVEQRM 267

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  140 bits (356), Expect = 1e-36
 Identities = 77/284 (27%), Positives = 124/284 (43%), Gaps = 38/284 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL---PEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLST 505
            +  I   +G G +G V    L    + ++ VA+K L    TE     + F  EA ++  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQ 102

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
             H NI++L G     K + ++ EYME GSL   L   D   +    + V +++ +A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI--- 622
            YL     +  +HRD+++ NIL++SNL   V+DFG  R+L  D        G    I   
Sbjct: 161 KYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ---- 677
           +PE       T   DV+S+G+V  EV+  G  P   +S+            DV+      
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------DVIKAVDEG 266

Query: 678 -RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            RL PP++    +  ++L       C      +RP  ++I   L
Sbjct: 267 YRLPPPMDCPAALYQLML------DCWQKDRNNRPKFEQIVSIL 304

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  139 bits (351), Expect = 1e-36
 Identities = 71/323 (21%), Positives = 131/323 (40%), Gaps = 61/323 (18%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
             DF     +G G +G V KA    + +  A+KK+ H+E +    + +  +E  +L+++ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK----LSTILSEVMLLASLN 60

Query: 508 HRNIVKLYGF-------------CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR 554
           H+ +V+ Y                  K  +F+  EY E G+L+ ++H ++   + +   R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 555 VNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL 614
             + + +  ALSY+H   +  IIHRD+   NI +D +    + DFG A+ +H       L
Sbjct: 121 --LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 615 RA--------------GTYGYIAPE-LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLS 659
            +              GT  Y+A E L  T     K D+YS G++  E++     G    
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235

Query: 660 SLSSSSGPKIMLIDVLNQRLSPPVNQKI---VQDIILVSTIAFACLSSQPKSRPTMQRIS 716
           ++      K+  + +      P  +       + II         +   P  RP     +
Sbjct: 236 NILK----KLRSVSI---EFPPDFDDNKMKVEKKIIR------LLIDHDPNKRPG----A 278

Query: 717 QELLAGKTP-MQKALKEISISEL 738
           + LL   +  +    ++  I E 
Sbjct: 279 RTLL--NSGWLPVKHQDEVIKEA 299

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  138 bits (349), Expect = 2e-36
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 8/199 (4%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG G VY+AE     ++VALK +  + + D  F    Q EA     ++  ++V ++ 
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
           F      +++    +    L  +L        L   + V IV+ +  AL   H       
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---GA 155

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GTYGYIAPELAYTIVVTGK 635
            HRD+   NIL+ ++  A + DFG A     +   +     GT  Y+APE       T +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215

Query: 636 CDVYSFGVVALEVLMGTHP 654
            D+Y+   V  E L G+ P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  137 bits (347), Expect = 3e-36
 Identities = 76/283 (26%), Positives = 122/283 (43%), Gaps = 42/283 (14%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
            D  +K+ +G G YG VY+    +  + VA+K L     E   F+K    EA V+  ++H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKH 68

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            N+V+L G C  +   ++I E+M  G+L   L + +   E++    + +   ++ A+ YL
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL 127

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI-----A 623
                 + IHRD+++ N L+  N    VADFG +RL+    +Y    A           A
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY---TAHAGAKFPIKWTA 180

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ----- 677
           PE       + K DV++FGV+  E+   G  P            P I L  V        
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-----------YPGIDLSQVYELLEKDY 229

Query: 678 RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           R+  P    + V +++       AC    P  RP+   I Q  
Sbjct: 230 RMERPEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF 266

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  139 bits (353), Expect = 4e-36
 Identities = 67/248 (27%), Positives = 107/248 (43%), Gaps = 27/248 (10%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
           F   P L  L L  N LS S+P  I  +  KL  L +  NNL  I      +  +L+ L 
Sbjct: 113 FQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 171

Query: 156 LYSNKLS----GVLP------------QEIGNLKSLTELYVTNNALGGLIPSTLFRLT-- 197
           L SN+L+     ++P              +    ++ EL  ++N++  +       LT  
Sbjct: 172 LSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTIL 231

Query: 198 NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP 257
            +  N   +     + N+  L  +DLS N++  I+     K+ +L+ L +S+N L   + 
Sbjct: 232 KLQHNNL-TDTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALN 288

Query: 258 YAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNL 317
                +  L  LDLS N L   +         L+NL L+HNS+  T+ L       L+NL
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLKL--STHHTLKNL 344

Query: 318 DLSHNNLS 325
            LSHN+  
Sbjct: 345 TLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  131 bits (331), Expect = 3e-33
 Identities = 56/284 (19%), Positives = 107/284 (37%), Gaps = 27/284 (9%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIP 142
           ++   +            N K +   N+++   +P  +  S  +++ L L+   +  I  
Sbjct: 28  IDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDT 86

Query: 143 KEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT----- 197
                   ++ L++  N +  + P    N+  LT L +  N L  L              
Sbjct: 87  YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTL 146

Query: 198 NISSNQFHSSIPLEI-GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQI 256
           ++S+N     I  +     ++L  L LS N++  +   +L+ +  L + N+S NLLS   
Sbjct: 147 SMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS--- 199

Query: 257 PYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQN 316
              +     +  LD S N ++  +   +     L  L L HN+L       +     L  
Sbjct: 200 --TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVE 252

Query: 317 LDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPTYLRGNP 356
           +DLS+N L   +      M     + +S N L   +  Y +  P
Sbjct: 253 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  103 bits (259), Expect = 7e-24
 Identities = 39/230 (16%), Positives = 81/230 (35%), Gaps = 25/230 (10%)

Query: 116 SIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSL 175
            I   +        +++           E  +L N + +   ++ +  +    + + + +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 176 TELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDE 235
             L + +            ++  I +  F             +  L +  N I  + P  
Sbjct: 72  ELLNLNDL-----------QIEEIDTYAF--------AYAHTIQKLYMGFNAIRYLPPHV 112

Query: 236 LTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLT 294
              +  L  L L  N LS            L  L +S N L   I  +     ++L+NL 
Sbjct: 113 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQ 171

Query: 295 LNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNL 344
           L+ N L     +++  I  L + ++S+N LS T+   +    +D S N++
Sbjct: 172 LSSNRLTH---VDLSLIPSLFHANVSYNLLS-TLAIPIAVEELDASHNSI 217

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 85.9 bits (213), Expect = 5e-18
 Identities = 32/164 (19%), Positives = 56/164 (34%), Gaps = 8/164 (4%)

Query: 188 LIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNL 247
           L    +F   +I           E    +    +   ++ +  +    L    Q++ LNL
Sbjct: 17  LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 76

Query: 248 SSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPL 306
           +   +     YA      +  L +  N +   +P  +  N   L  L L  N L  ++P 
Sbjct: 77  NDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPR 134

Query: 307 EM-GKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLE 345
            +      L  L +S+NNL      T +       + LS N L 
Sbjct: 135 GIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 23/151 (15%), Positives = 50/151 (33%), Gaps = 8/151 (5%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
               +  I   +        + +           E   L+  K +   ++ +       +
Sbjct: 6   RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65

Query: 261 GKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKIL-LLQNLD 318
                +  L+L+  ++   I T        ++ L +  N++   +P  + + + LL  L 
Sbjct: 66  DSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLV 123

Query: 319 LSHNNLSGTIPKTLRPM----YVDLSFNNLE 345
           L  N+LS               + +S NNLE
Sbjct: 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 22/122 (18%), Positives = 45/122 (36%), Gaps = 10/122 (8%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
           F     L+ L + NN L  ++      +  LK L L  N+L   + +       L  L+L
Sbjct: 268 FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325

Query: 157 YSNKLSGVLPQEIGNLKSLTELYVTNNAL----GGLIPSTLFRLTNISSNQFHSSIPLEI 212
             N +  +   ++    +L  L +++N         +   + R   +     H  I  ++
Sbjct: 326 DHNSIVTL---KLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPA-VDDADQHCKIDYQL 381

Query: 213 GN 214
            +
Sbjct: 382 EH 383

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  136 bits (345), Expect = 4e-36
 Identities = 71/211 (33%), Positives = 107/211 (50%), Gaps = 19/211 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF I   +G G +G+VY A E     ++ALK L  ++ E +      + E  + S +RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-----DDDEAIELNWTKRVNIVKSVAH 563
            NI++LYG+      ++LI EY   G+++  L      D+              +  +A+
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITELAN 120

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
           ALSY H   +  +IHRDI   N+LL S  E  +ADFG +  +H  SS RT   GT  Y+ 
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLP 175

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+    +   K D++S GV+  E L+G  P
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  138 bits (349), Expect = 5e-36
 Identities = 83/288 (28%), Positives = 128/288 (44%), Gaps = 45/288 (15%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLS 504
                +  IG G +G VYK  L    GK    VA+K L    TE       F  EA ++ 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMG 101

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
              H NI++L G     K M +I EYME G+L   L + D   E +  + V +++ +A  
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAG 159

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI-- 622
           + YL     ++ +HRD+++ NIL++SNL   V+DFG +R+L  D       +G  G I  
Sbjct: 160 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG--GKIPI 214

Query: 623 ---APE-LAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ 677
              APE ++Y    T   DV+SFG+V  EV+  G  P             ++   +V+  
Sbjct: 215 RWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERP-----------YWELSNHEVMKA 262

Query: 678 -----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                RL  P++    +  +++       C   +   RP    I   L
Sbjct: 263 INDGFRLPTPMDCPSAIYQLMM------QCWQQERARRPKFADIVSIL 304

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  137 bits (347), Expect = 6e-36
 Identities = 68/286 (23%), Positives = 124/286 (43%), Gaps = 43/286 (15%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL-PEGK----VVALKKLHHSETEDSAFVKSFQNEAHVLS 504
            +F     +G+G +G+VYK    PEG+     VA+K+L  + +  +   K   +EA+V++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMA 72

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           +V + ++ +L G CL    + LI + M  G L   + +  +   +     +N    +A  
Sbjct: 73  SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKG 129

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG------T 618
           ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +        G       
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186

Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHP-GGLLSSLSSSSGPKIMLIDVLN 676
               A E     + T + DV+S+GV   E++  G+ P  G+          +I    +L 
Sbjct: 187 ----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-------PASEI--SSILE 233

Query: 677 Q--RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +  RL  P      V  I++       C      SRP  + +  E 
Sbjct: 234 KGERLPQPPICTIDVYMIMV------KCWMIDADSRPKFRELIIEF 273

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  136 bits (344), Expect = 7e-36
 Identities = 65/275 (23%), Positives = 113/275 (41%), Gaps = 38/275 (13%)

Query: 458 IGTGGYGSVYKAELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G+G +G+V K      KV   VA+K L  +E  D A       EA+V+  + +  IV++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
            G C   +   L+ E  E G L   L  +     +     + +V  V+  + YL      
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ES 136

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPELAYTIV 631
           + +HRD+++ N+LL +   A ++DFG ++ L  D +Y   +        + APE      
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196

Query: 632 VTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLSPPVN- 684
            + K DV+SFGV+  E    G  P              +   +V        R+  P   
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP-----------YRGMKGSEVTAMLEKGERMGCPAGC 245

Query: 685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            + + D++        C +   ++RP    +   L
Sbjct: 246 PREMYDLMN------LCWTYDVENRPGFAAVELRL 274

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  135 bits (343), Expect = 9e-36
 Identities = 73/280 (26%), Positives = 125/280 (44%), Gaps = 38/280 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   +   +G G +G V+         VA+K L        AF+     EA+++  ++H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQ 68

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY     ++ +++I EYME GSL   L       +L   K +++   +A  ++++ 
Sbjct: 69  RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIE 126

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT---YGYIAPEL 626
                + IHRD+ + NIL+   L   +ADFG ARL+  D+ Y T R G      + APE 
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEY-TAREGAKFPIKWTAPEA 181

Query: 627 AYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLS 680
                 T K DV+SFG++  E++  G  P            P +   +V+       R+ 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP-----------YPGMTNPEVIQNLERGYRMV 230

Query: 681 PPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            P N  + +  ++        C   +P+ RPT   +   L
Sbjct: 231 RPDNCPEELYQLMR------LCWKERPEDRPTFDYLRSVL 264

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  135 bits (343), Expect = 1e-35
 Identities = 66/286 (23%), Positives = 110/286 (38%), Gaps = 40/286 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGK----VVALKKLHHSETEDSAFVKSFQNEAHVLST 505
              H    IG G +G VY  E  +        A+K L          V++F  E  ++  
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ--VEAFLREGLLMRG 78

Query: 506 VRHRNIVKLYGFCLHKKCM-FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           + H N++ L G  L  + +  ++  YM  G L   +              ++    VA  
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARG 136

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI-- 622
           + YL        +HRD+++ N +LD +    VADFG AR +  D  Y +++   +  +  
Sbjct: 137 MEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRHARLPV 192

Query: 623 ---APELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-- 677
              A E   T   T K DV+SFGV+  E+L          +  +     I   D+ +   
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELL----------TRGAPPYRHIDPFDLTHFLA 242

Query: 678 ---RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
              RL  P      +  ++        C  + P  RPT + +  E+
Sbjct: 243 QGRRLPQPEYCPDSLYQVMQ------QCWEADPAVRPTFRVLVGEV 282

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  135 bits (342), Expect = 1e-35
 Identities = 66/302 (21%), Positives = 112/302 (37%), Gaps = 49/302 (16%)

Query: 443 EDLINATEDFHIKY---------CIGTGGYGSVYKAELPEGK----VVALKKLHHSETED 489
            +L+ A +   I            IG G +G VY   L +        A+K L+      
Sbjct: 9   PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68

Query: 490 SAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC-MFLIYEYMERGSLFCVLHDDDEAIE 548
              V  F  E  ++    H N++ L G CL  +    ++  YM+ G L   + ++     
Sbjct: 69  E--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--N 124

Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
                 +     VA  + YL    +   +HRD+++ N +LD      VADFG AR ++  
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181

Query: 609 SSYRTLRAGTYGYI-----APELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS 663
             Y      T   +     A E   T   T K DV+SFGV+  E++          +  +
Sbjct: 182 EYYSV-HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM----------TRGA 230

Query: 664 SSGPKIMLIDVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
              P +   D+        RL  P      + +++L       C   + + RP+   +  
Sbjct: 231 PPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML------KCWHPKAEMRPSFSELVS 284

Query: 718 EL 719
            +
Sbjct: 285 RI 286

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  136 bits (344), Expect = 2e-35
 Identities = 64/288 (22%), Positives = 114/288 (39%), Gaps = 47/288 (16%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL-PEGK----VVALKKLHHSETEDSAFVKSFQNEAHVLS 504
            +      +G+G +G+V+K    PEG+     V +K +       S   ++  +    + 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--FQAVTDHMLAIG 70

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           ++ H +IV+L G C     + L+ +Y+  GSL   +     A+       +N    +A  
Sbjct: 71  SLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQ--LLLNWGVQIAKG 127

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG------T 618
           + YL       ++HR++++ N+LL S  +  VADFG A LL  D                
Sbjct: 128 MYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184

Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ 677
               A E  +    T + DV+S+GV   E++  G  P              + L +V + 
Sbjct: 185 ----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP-----------YAGLRLAEVPDL 229

Query: 678 -----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                RL+ P      V  +++       C       RPT + ++ E 
Sbjct: 230 LEKGERLAQPQICTIDVYMVMV------KCWMIDENIRPTFKELANEF 271

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  135 bits (341), Expect = 2e-35
 Identities = 62/276 (22%), Positives = 112/276 (40%), Gaps = 39/276 (14%)

Query: 457 CIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
            +G G YG VY   +L     +A+K++      DS + +    E  +   ++H+NIV+  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 516 GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS 575
           G       + +  E +  GSL  +L      ++ N        K +   L YLH +    
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142

Query: 576 IIHRDISSNNILLDS-NLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVV-- 632
           I+HRDI  +N+L+++ +    ++DFGT++ L   +       GT  Y+APE     ++  
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE-----IIDK 197

Query: 633 -----TGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI 687
                    D++S G   +E+  G  P            P+  +  V   ++ P + + +
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP------FYELGEPQAAMFKVGMFKVHPEIPESM 251

Query: 688 ---VQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
               +  IL       C    P  R      + +LL
Sbjct: 252 SAEAKAFIL------KCFEPDPDKRAC----ANDLL 277

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  135 bits (341), Expect = 2e-35
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 8/199 (4%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G GG  +VY AE       VA+K +     E    +K F+ E H  S + H+NIV +  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
                 C +L+ EY+E  +L   +        L+    +N    +   + + H    + I
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD---MRI 132

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GTYGYIAPELAYTIVVTGK 635
           +HRDI   NIL+DSN    + DFG A+ L   S  +T    GT  Y +PE A        
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 636 CDVYSFGVVALEVLMGTHP 654
            D+YS G+V  E+L+G  P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  136 bits (345), Expect = 3e-35
 Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 42/284 (14%)

Query: 453 HIKYCIGTGGYGSVYKAELPEGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L +        A+K L+         V  F  E  ++    H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSH 149

Query: 509 RNIVKLYGFCLHKKC-MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +     +     VA  + +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 207

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI----- 622
           L    +   +HRD+++ N +LD      VADFG AR ++ D  + ++   T   +     
Sbjct: 208 LA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWM 263

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ---- 677
           A E   T   T K DV+SFGV+  E++  G  P            P +   D+       
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----------YPDVNTFDITVYLLQG 312

Query: 678 -RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            RL  P      + +++L       C   + + RP+   +   +
Sbjct: 313 RRLLQPEYCPDPLYEVML------KCWHPKAEMRPSFSELVSRI 350

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  135 bits (342), Expect = 4e-35
 Identities = 61/264 (23%), Positives = 106/264 (40%), Gaps = 23/264 (8%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGS-LSKLKCLYLHGNN 136
              +DL N+ I  E+   +F    NL +L L NN +S  I P   + L KL+ LYL  N 
Sbjct: 54  TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQ 111

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALG-GLIPSTLFR 195
           L  +        + L+ L ++ N+++ V       L  +  + +  N L    I +  F+
Sbjct: 112 LKEL---PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

Query: 196 -LTN-----ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSS 249
            +       I+     ++IP   G   +L  L L  NKI  +    L  L+ L  L LS 
Sbjct: 169 GMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225

Query: 250 NLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSL----DGTIP 305
           N +S     ++    +L  L L+ NKL   +P  + +   ++ + L++N++         
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284

Query: 306 LEMGKILL--LQNLDLSHNNLSGT 327
                        + L  N +   
Sbjct: 285 PPGYNTKKASYSGVSLFSNPVQYW 308

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  129 bits (327), Expect = 3e-33
 Identities = 72/266 (27%), Positives = 109/266 (40%), Gaps = 21/266 (7%)

Query: 100 FPNLKSLDLWNNSLSGSIPP-QIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
            P+   LDL NN ++  I      +L  L  L L  N ++ I P     L  L  L+L  
Sbjct: 51  PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109

Query: 159 NKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNI-----SSNQFHSSIPLEIG 213
           N+L   LP+++   K+L EL V  N +  +  S    L  +      +N   SS  +E G
Sbjct: 110 NQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS-GIENG 165

Query: 214 NFS---ALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLD 270
            F     L  + ++D  I  I P  L     L  L+L  N ++     ++  L NL  L 
Sbjct: 166 AFQGMKKLSYIRIADTNITTI-PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222

Query: 271 LSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPK 330
           LS N +S      + N   L+ L LN+N L   +P  +     +Q + L +NN+S     
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 281

Query: 331 TLRPMYVDLSFNNLEGEIPTYLRGNP 356
              P   +    +  G     L  NP
Sbjct: 282 DFCPPGYNTKKASYSG---VSLFSNP 304

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  112 bits (283), Expect = 2e-27
 Identities = 56/242 (23%), Positives = 102/242 (42%), Gaps = 23/242 (9%)

Query: 127 LKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALG 186
           L+ +      L  + PK++    +   L L +NK++ +   +  NLK+L  L + NN + 
Sbjct: 33  LRVVQCSDLGLEKV-PKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 187 GLIPSTLFRLTN-----ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQ 241
            + P     L       +S NQ    +P ++     L  L + +N+I  +       L+Q
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQL-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ 146

Query: 242 LKNLNLSSNLL-SGQIPY-AIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNS 299
           +  + L +N L S  I   A   +  L Y+ ++   ++ +IP   G   +L  L L+ N 
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNK 203

Query: 300 LDGTIPLEMGKILL-LQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPTYLRG 354
           +   +     K L  L  L LS N++S     +L        + L+ N L  ++P  L  
Sbjct: 204 IT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261

Query: 355 NP 356
           + 
Sbjct: 262 HK 263

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  102 bits (256), Expect = 8e-24
 Identities = 39/207 (18%), Positives = 82/207 (39%), Gaps = 19/207 (9%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSL-SGSIPPQI-GSLSKLKCLYLHGNNLTGII 141
           ++ N   ++ +  F+    +  ++L  N L S  I       + KL  + +   N+T I 
Sbjct: 128 VHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 187

Query: 142 PKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN--- 198
               G   +L  L L  NK++ V    +  L +L +L ++ N++  +   +L    +   
Sbjct: 188 Q---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 244

Query: 199 --ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGI------IPDELTKLSQLKNLNLSSN 250
             +++N+    +P  + +   +  + L +N I  I       P   TK +    ++L SN
Sbjct: 245 LHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303

Query: 251 LLSGQI--PYAIGKLFNLMYLDLSKNK 275
            +      P     ++    + L   K
Sbjct: 304 PVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  137 bits (348), Expect = 4e-35
 Identities = 76/280 (27%), Positives = 136/280 (48%), Gaps = 38/280 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+ A   +   VA+K +        AF+     EA+V+ T++H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHD 243

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +VKL+     K+ +++I E+M +GSL   L  D+ + +    K ++    +A  ++++ 
Sbjct: 244 KLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIE 301

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI---APEL 626
                + IHRD+ + NIL+ ++L   +ADFG AR++  D+ Y T R G    I   APE 
Sbjct: 302 Q---RNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEY-TAREGAKFPIKWTAPEA 356

Query: 627 AYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLS 680
                 T K DV+SFG++ +E++  G  P            P +   +V+       R+ 
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIP-----------YPGMSNPEVIRALERGYRMP 405

Query: 681 PPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            P N  + + +I++       C  ++P+ RPT + I   L
Sbjct: 406 RPENCPEELYNIMM------RCWKNRPEERPTFEYIQSVL 439

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  135 bits (341), Expect = 4e-35
 Identities = 65/262 (24%), Positives = 111/262 (42%), Gaps = 24/262 (9%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNN 136
            T +DL N++I  EL + +F    +L +L L NN +S  I  +    L KL+ LY+  N+
Sbjct: 56  TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNH 113

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGL-IPSTLF- 194
           L  I P       +L  L ++ N++  V       L+++  + +  N L         F 
Sbjct: 114 LVEIPP---NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 195 --RLT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSN 250
             +L    IS  +  + IP        L+ L L  NKI  I  ++L + S+L  L L  N
Sbjct: 171 GLKLNYLRISEAKL-TGIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN 227

Query: 251 LLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEM-- 308
            +      ++  L  L  L L  NKLS  +P  + +   L+ + L+ N++   + +    
Sbjct: 228 QIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFC 285

Query: 309 -----GKILLLQNLDLSHNNLS 325
                 K      + L +N + 
Sbjct: 286 PVGFGVKRAYYNGISLFNNPVP 307

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  100 bits (250), Expect = 4e-23
 Identities = 36/206 (17%), Positives = 75/206 (36%), Gaps = 18/206 (8%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSL-SGSIPPQIGSLSKLKCLYLHGNNLTGIIP 142
           ++ N   ++ +  FS   N+  +++  N L +    P      KL  L +    LTGI  
Sbjct: 130 IHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPK 189

Query: 143 KEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN---- 198
                   L  L L  NK+  +  +++     L  L + +N +  +   +L  L      
Sbjct: 190 ---DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLREL 246

Query: 199 -ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPD------ELTKLSQLKNLNLSSNL 251
            + +N+  S +P  + +   L  + L  N I  +  +         K +    ++L +N 
Sbjct: 247 HLDNNKL-SRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNP 305

Query: 252 LSGQI--PYAIGKLFNLMYLDLSKNK 275
           +      P     + + + +     K
Sbjct: 306 VPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 42/186 (22%), Positives = 70/186 (37%), Gaps = 27/186 (14%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
           S+    ++P EI        LDL +N I  +  D+   L  L  L L +N +S     A 
Sbjct: 41  SDLGLKAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAF 98

Query: 261 GKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEM-GKILLLQNLDL 319
             L  L  L +SKN L   IP  +   S+L  L ++ N +   +P  +   +  +  +++
Sbjct: 99  SPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRI-RKVPKGVFSGLRNMNCIEM 154

Query: 320 SHNNL-SGTIP----KTLRPMYVDLSFNNLEGEIPT---------YLRGN-----PPKSF 360
             N L +          L+  Y+ +S   L   IP          +L  N       +  
Sbjct: 155 GGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPETLNELHLDHNKIQAIELEDL 213

Query: 361 VGNKGL 366
           +    L
Sbjct: 214 LRYSKL 219

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  135 bits (342), Expect = 5e-35
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 30/216 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF     +G G  G V+K    P G V+A K +H       A       E  VL     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 90

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN------IVKSVA 562
             IV  YG       + +  E+M+ GSL  VL             R+       +  +V 
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---------AGRIPEQILGKVSIAVI 141

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             L+YL       I+HRD+  +NIL++S  E  + DFG +  L +DS   +   GT  Y+
Sbjct: 142 KGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANS-FVGTRSYM 197

Query: 623 APE----LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           +PE      Y++    + D++S G+  +E+ +G +P
Sbjct: 198 SPERLQGTHYSV----QSDIWSMGLSLVEMAVGRYP 229

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  137 bits (347), Expect = 6e-35
 Identities = 72/278 (25%), Positives = 128/278 (46%), Gaps = 34/278 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L       +   ++F  EA V+  +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHE 239

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY     ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 240 KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE 297

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT--YGYIAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +       + APE A
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 353

Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLSPP 682
                T K DV+SFG++  E+           +      P ++  +VL+Q     R+  P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELT----------TKGRVPYPGMVNREVLDQVERGYRMPCP 403

Query: 683 VN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
               + + D++        C   +P+ RPT + +   L
Sbjct: 404 PECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 435

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  133 bits (337), Expect = 7e-35
 Identities = 71/290 (24%), Positives = 120/290 (41%), Gaps = 50/290 (17%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHV-LSTVR 507
           +D      +G G YG V K   +P G+++A+K++    T +S   K    +  + + TV 
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVD 64

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN------IVKSV 561
               V  YG    +  +++  E M+  SL     D      ++  + +       I  S+
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMD-TSL-----DKFYKQVIDKGQTIPEDILGKIAVSI 118

Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGY 621
             AL +LH    LS+IHRD+  +N+L+++  +  + DFG +  L VD   + + AG   Y
Sbjct: 119 VKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPY 175

Query: 622 IAPE--------LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLID 673
           +APE          Y++    K D++S G+  +E+ +   P        S   P   L  
Sbjct: 176 MAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP------YDSWGTPFQQLKQ 225

Query: 674 VLNQ---RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
           V+ +   +L          D          CL    K RPT      EL+
Sbjct: 226 VVEEPSPQLPADKFSAEFVDFTS------QCLKKNSKERPT----YPELM 265

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  133 bits (337), Expect = 7e-35
 Identities = 79/316 (25%), Positives = 135/316 (42%), Gaps = 50/316 (15%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
              +D+ ++  IG+G    V  A   P+ + VA+K+++  + + S  +     E   +S 
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQ 69

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSL-----FCVLHDDDEAIELNWTKRVNIVKS 560
             H NIV  Y   + K  ++L+ + +  GS+       V   + ++  L+ +    I++ 
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG-----TARLLHVDSSYRTLR 615
           V   L YLH +     IHRD+ + NILL  +    +ADFG             +  R   
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186

Query: 616 AGTYGYIAPELAYTIVVT------GKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKI 669
            GT  ++APE     V+        K D++SFG+ A+E+  G  P             K+
Sbjct: 187 VGTPCWMAPE-----VMEQVRGYDFKADIWSFGITAIELATGAAP------YHKYPPMKV 235

Query: 670 MLIDVLNQRLSPPVNQKIVQDIILVS--TIAF-----ACLSSQPKSRPTMQRISQELLAG 722
           ++   L  +  PP  +  VQD  ++     +F      CL   P+ RPT    + ELL  
Sbjct: 236 LM---LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT----AAELL-- 286

Query: 723 KTP-MQKALKEISISE 737
           +    QKA  +  + E
Sbjct: 287 RHKFFQKAKNKEFLQE 302

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  139 bits (351), Expect = 1e-34
 Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 34/285 (11%)

Query: 446 INATEDFHIKYCIGTGGYGSVYKAELPEGKV---VALKKLHHSETEDSAFVKSFQNEAHV 502
           +           +G G +GSV +      K    VA+K L     +     +    EA +
Sbjct: 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQI 389

Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           +  + +  IV+L G C   + + L+ E    G L   L    E  E+  +    ++  V+
Sbjct: 390 MHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVS 446

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             + YL      + +HR++++ N+LL +   A ++DFG ++ L  D SY T R+     +
Sbjct: 447 MGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 503

Query: 623 ---APELAYTIVVTGKCDVYSFGVVALEVLM-GTHP-GGLLSSLSSSSGPKIMLIDVLNQ 677
              APE       + + DV+S+GV   E L  G  P   +        GP++  +  + Q
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-------KGPEV--MAFIEQ 554

Query: 678 --RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             R+  P      +  ++        C   + + RP    + Q +
Sbjct: 555 GKRMECPPECPPELYALMS------DCWIYKWEDRPDFLTVEQRM 593

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  135 bits (340), Expect = 1e-34
 Identities = 29/294 (9%), Positives = 68/294 (23%), Gaps = 49/294 (16%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +  G    V+   ++   +  ALK          + ++         + +   +  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 517 FCLHKKCM--------------------------FLIYEYMERGSLFCVLHDDDEAIE-- 548
                                              L+        L  +    D      
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 549 --LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH 606
                     +   +    + L       ++H   + +N+ +  +    + D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242

Query: 607 VDSSYRTLRAGTYGYIAPEL--AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS 664
              +     +    Y   E   A T   T   + +  G+    V     P GL++     
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302

Query: 665 SGPKIMLIDVLNQRLSPPVNQKI---VQDIILVSTIAFACLSSQPKSRPTMQRI 715
           S  +  L       L+      +   V+ +I         L+   + R      
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG------RFLNFDRRRRLLPLEA 350

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  133 bits (337), Expect = 1e-34
 Identities = 74/286 (25%), Positives = 116/286 (40%), Gaps = 38/286 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHV-LSTVR 507
           ED      IG G YGSV K    P G+++A+K++    T D    K    +  V + +  
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSD 79

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV--NIVKSVAHAL 565
              IV+ YG    +   ++  E M   S           ++    + +   I  +   AL
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
           ++L  +  L IIHRDI  +NILLD +    + DFG +  L VDS  +T  AG   Y+APE
Sbjct: 139 NHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPE 195

Query: 626 --------LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ 677
                     Y +    + DV+S G+   E+  G  P          +     L  V+  
Sbjct: 196 RIDPSASRQGYDV----RSDVWSLGITLYELATGRFP------YPKWNSVFDQLTQVVKG 245

Query: 678 ---RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
              +LS    ++       ++ +   CL+     RP      +ELL
Sbjct: 246 DPPQLSNSEEREFSPS--FINFVN-LCLTKDESKRPK----YKELL 284

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  132 bits (334), Expect = 1e-34
 Identities = 63/310 (20%), Positives = 118/310 (38%), Gaps = 70/310 (22%)

Query: 440 ILYEDLINATEDFHIKYCIGTGGYGSVYKAEL--------PEGKVVALKKLHHSETEDSA 491
           + ++  I   ED      +G G +  ++K                V LK L  +    S 
Sbjct: 1   VFHK--IRN-EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS- 56

Query: 492 FVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNW 551
             +SF   A ++S + H+++V  YG C+      L+ E+++ GSL   L  +   I + W
Sbjct: 57  --ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW 114

Query: 552 TKRVNIVKSVAHALSYL--HHDCTLSIIHRDISSNNILLDSNLEAS--------VADFGT 601
             ++ + K +A A+ +L  +      +IH ++ + NILL    +          ++D G 
Sbjct: 115 --KLEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167

Query: 602 ARLLHVDSSYR-----TLRAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVALEVLM-GTHP 654
           +  +      +                PE +     +    D +SFG    E+   G  P
Sbjct: 168 SITVLPKDILQERIPWV---------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

Query: 655 GGLLSSLSSSSGPKIMLIDVLNQ-----RLSPPVNQKIVQDIILVSTIAFACLSSQPKSR 709
              LS+L S           L       +L  P   ++  ++I        C+  +P  R
Sbjct: 219 ---LSALDSQ--------RKLQFYEDRHQLPAPKAAEL-ANLIN------NCMDYEPDHR 260

Query: 710 PTMQRISQEL 719
           P+ + I ++L
Sbjct: 261 PSFRAIIRDL 270

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  138 bits (349), Expect = 1e-34
 Identities = 55/260 (21%), Positives = 98/260 (37%), Gaps = 28/260 (10%)

Query: 82  DLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGII 141
            L   N    +  L          L L   +LS S+P  +    ++  L +  N L   +
Sbjct: 40  ALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SL 95

Query: 142 PKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT--NI 199
           P+   SL  L       N+LS  LP+   +LK    L V NN L  L P     L   N 
Sbjct: 96  PELPASLEYLD---ACDNRLS-TLPELPASLK---HLDVDNNQLTML-PELPALLEYINA 147

Query: 200 SSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYA 259
            +NQ  + +P    +   L+ L + +N++   +P+       L+ L++S+NLL   +P  
Sbjct: 148 DNNQL-TMLPELPTS---LEVLSVRNNQLTF-LPEL---PESLEALDVSTNLLE-SLPAV 198

Query: 260 IGKLFNL----MYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQ 315
             +  +     ++    +N+++  IP  I +      + L  N L   I   + +     
Sbjct: 199 PVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQP 257

Query: 316 NLDLSHNNLSGTIPKTLRPM 335
           +        S +  +     
Sbjct: 258 DYHGPRIYFSMSDGQQNTLH 277

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  118 bits (297), Expect = 5e-28
 Identities = 52/263 (19%), Positives = 101/263 (38%), Gaps = 39/263 (14%)

Query: 105 SLDLWNNSLSGSIPPQIGS----LSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
           S + + N++S        S      K      + N    ++ +    +     L L    
Sbjct: 14  SQNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLN 70

Query: 161 LSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT--NISSNQFHSSIPLEIGNFSAL 218
           LS  LP  +     +T L +T NAL  L P     L   +   N+  S++P    +   L
Sbjct: 71  LS-SLPDNLP--PQITVLEITQNALISL-PELPASLEYLDACDNRL-STLPELPAS---L 122

Query: 219 DTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSG 278
             LD+ +N++  ++P+       L+ +N  +N L+  +P       +L  L +  N+L+ 
Sbjct: 123 KHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPT---SLEVLSVRNNQLT- 173

Query: 279 SIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQN----LDLSHNNLSGTIPKTLRP 334
            +P    +   L+ L ++ N L+ ++P    +    +          N ++  IP+ +  
Sbjct: 174 FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILS 228

Query: 335 M----YVDLSFNNLEGEIPTYLR 353
           +     + L  N L   I   L 
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLS 251

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 80.4 bits (198), Expect = 7e-16
 Identities = 37/246 (15%), Positives = 77/246 (31%), Gaps = 19/246 (7%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLR----GLFL 156
            +L+ L + NN L+  +P    SL  L    +  N L  + P       +          
Sbjct: 160 TSLEVLSVRNNQLT-FLPELPESLEAL---DVSTNLLESL-PAVPVRNHHSEETEIFFRC 214

Query: 157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFS 216
             N+++  +P+ I +L     + + +N L   I  +L + T                   
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

Query: 217 ALDTLDLSDNKIHGIIPDELTKLSQLKN---LNLSSNLLSGQIPYAIGKLFNLMYLDLSK 273
                 L+D        ++ + +SQ+ +       +N  S      +    +       +
Sbjct: 274 NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFR 332

Query: 274 NKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLD---LSHNNLSGTIPK 330
            +++ +   ++   + L+       + D T   E    L   NL    L H    G    
Sbjct: 333 EQVA-AWLEKLSASAELRQ-QSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDN 390

Query: 331 TLRPMY 336
               + 
Sbjct: 391 DTGALL 396

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (348), Expect = 1e-34
 Identities = 72/278 (25%), Positives = 128/278 (46%), Gaps = 34/278 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L       +   ++F  EA V+  +RH 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHE 322

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY     ++ ++++ EYM +GSL   L  +     L   + V++   +A  ++Y+ 
Sbjct: 323 KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE 380

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGY--IAPELA 627
               ++ +HRD+ + NIL+  NL   VADFG ARL+  D+ Y   +   +     APE A
Sbjct: 381 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 436

Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLSPP 682
                T K DV+SFG++  E+           +      P ++  +VL+Q     R+  P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELT----------TKGRVPYPGMVNREVLDQVERGYRMPCP 486

Query: 683 VN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
               + + D++        C   +P+ RPT + +   L
Sbjct: 487 PECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 518

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  131 bits (332), Expect = 3e-34
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 19/211 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF I   +G G +G+VY A E     ++ALK L  S+ E        + E  + S +RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-----DDDEAIELNWTKRVNIVKSVAH 563
            NI+++Y +   +K ++L+ E+  RG L+  L      D+  +           ++ +A 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS--------ATFMEELAD 125

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
           AL Y H      +IHRDI   N+L+    E  +ADFG +  +H  S  R    GT  Y+ 
Sbjct: 126 ALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLP 180

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+        K D++  GV+  E L+G  P
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  137 bits (347), Expect = 3e-34
 Identities = 67/248 (27%), Positives = 107/248 (43%), Gaps = 27/248 (10%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
           F   P L  L L  N LS S+P  I  +  KL  L +  NNL  I      +  +L+ L 
Sbjct: 119 FQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177

Query: 156 LYSNKLS----GVLP------------QEIGNLKSLTELYVTNNALGGLIPSTLFRLT-- 197
           L SN+L+     ++P              +    ++ EL  ++N++  +       LT  
Sbjct: 178 LSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTIL 237

Query: 198 NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP 257
            +  N   +     + N+  L  +DLS N++  I+     K+ +L+ L +S+N L   + 
Sbjct: 238 KLQHNNL-TDTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALN 294

Query: 258 YAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNL 317
                +  L  LDLS N L   +         L+NL L+HNS+  T+ L       L+NL
Sbjct: 295 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLKL--STHHTLKNL 350

Query: 318 DLSHNNLS 325
            LSHN+  
Sbjct: 351 TLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  136 bits (344), Expect = 6e-34
 Identities = 61/277 (22%), Positives = 117/277 (42%), Gaps = 23/277 (8%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGN 135
           ++  ++L +  I+ E+    F+    ++ L +  N++   +PP +  ++  L  L L  N
Sbjct: 76  QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN 133

Query: 136 NLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFR 195
           +L+ +      +   L  L + +N L  +         SL  L +++N L  +  S +  
Sbjct: 134 DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS 193

Query: 196 LT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLS 253
           L   N+S N   +     +    A++ LD S N I+ ++   +    +L  L L  N L+
Sbjct: 194 LFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT 245

Query: 254 GQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKIL 312
                 +     L+ +DLS N+L   I          L+ L +++N L   + L    I 
Sbjct: 246 -DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIP 301

Query: 313 LLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLE 345
            L+ LDLSHN+L   + +          + L  N++ 
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  119 bits (300), Expect = 2e-28
 Identities = 59/277 (21%), Positives = 107/277 (38%), Gaps = 29/277 (10%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIP-----PQIGSLSKLKCLYLHGNNLT 138
              N+K                   ++  +           +  +L+  K +    + + 
Sbjct: 5   QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64

Query: 139 GIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT- 197
            +    + S R +  L L   ++  +         ++ +LY+  NA+  L P     +  
Sbjct: 65  KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 124

Query: 198 ----NISSNQFHSSIPLEI-GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLL 252
                +  N   SS+P  I  N   L TL +S+N +  I  D     + L+NL LSSN L
Sbjct: 125 LTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 183

Query: 253 SGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKIL 312
           +  +   +  + +L + ++S N L     + +    A++ L  +HNS++    +     +
Sbjct: 184 T-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINV---VRGPVNV 232

Query: 313 LLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLE 345
            L  L L HNNL+      L        VDLS+N LE
Sbjct: 233 ELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE 267

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 90.0 bits (223), Expect = 6e-19
 Identities = 44/192 (22%), Positives = 71/192 (36%), Gaps = 33/192 (17%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-----------------GSLSK 126
           L+SN    L  ++ S  P+L   ++  N LS ++   I                     +
Sbjct: 178 LSSN---RLTHVDLSLIPSLFHANVSYNLLS-TLAIPIAVEELDASHNSINVVRGPVNVE 233

Query: 127 LKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALG 186
           L  L L  NNLT      + +   L  + L  N+L  ++      ++ L  LY++NN L 
Sbjct: 234 LTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291

Query: 187 GLIPSTLFRLTN-----ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQ 241
             +      +       +S N     +      F  L+ L L  N I  +   +L+    
Sbjct: 292 A-LNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIVTL---KLSTHHT 346

Query: 242 LKNLNLSSNLLS 253
           LKNL LS N   
Sbjct: 347 LKNLTLSHNDWD 358

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  135 bits (342), Expect = 3e-34
 Identities = 69/278 (24%), Positives = 122/278 (43%), Gaps = 38/278 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++  +   IG G +G V   +   G  VA+K + +  T      ++F  EA V++ +RH 
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-----QAFLAEASVMTQLRHS 246

Query: 510 NIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           N+V+L G  + +K  ++++ EYM +GSL   L     +  L     +     V  A+ YL
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL 305

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
                 + +HRD+++ N+L+  +  A V+DFG  +          L      + APE   
Sbjct: 306 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALR 359

Query: 629 TIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLSPP 682
               + K DV+SFG++  E+   G  P            P+I L DV+ +     ++  P
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVP-----------YPRIPLKDVVPRVEKGYKMDAP 408

Query: 683 VN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                 V D++        C      +RPT  ++ ++L
Sbjct: 409 DGCPPAVYDVMK------NCWHLDAATRPTFLQLREQL 440

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  131 bits (332), Expect = 4e-34
 Identities = 75/298 (25%), Positives = 128/298 (42%), Gaps = 39/298 (13%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
            E F +   +G G YGSVYKA     G++VA+K++     E    ++    E  ++    
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESD--LQEIIKEISIMQQCD 82

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
             ++VK YG       ++++ EY   GS+  ++   ++ +  +      I++S    L Y
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEY 140

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH       IHRDI + NILL++   A +ADFG A  L    + R    GT  ++APE+ 
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197

Query: 628 YTIVVTGKCDVYSFGVVALEVLMG------THPGGLLSSLSSSSGPKIMLIDVLNQRLSP 681
             I      D++S G+ A+E+  G       HP   +  + ++  P         +  S 
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR----KPELWSD 253

Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP-MQKALKEISISEL 738
                + Q           CL   P+ R T    + +LL  + P ++ A     + +L
Sbjct: 254 NFTDFVKQ-----------CLVKSPEQRAT----ATQLL--QHPFVRSAKGVSILRDL 294

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  131 bits (331), Expect = 5e-34
 Identities = 70/301 (23%), Positives = 135/301 (44%), Gaps = 45/301 (14%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
            + +     IG G  G+VY A ++  G+ VA+++++  +       +   NE  V+   +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENK 75

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHA 564
           + NIV      L    ++++ EY+  GSL  V+ +   D+  I         + +    A
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQA 128

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           L +LH   +  +IHRDI S+NILL  +    + DFG    +  + S R+   GT  ++AP
Sbjct: 129 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMG------THPGGLLSSLSSSSGPKIMLIDVLNQR 678
           E+        K D++S G++A+E++ G       +P   L  ++++  P++   +    +
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE----K 241

Query: 679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP-MQKALKEISISE 737
           LS      + +           CL    + R +    ++ELL  +   ++ A    S++ 
Sbjct: 242 LSAIFRDFLNR-----------CLEMDVEKRGS----AKELL--QHQFLKIAKPLSSLTP 284

Query: 738 L 738
           L
Sbjct: 285 L 285

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  130 bits (330), Expect = 5e-34
 Identities = 67/288 (23%), Positives = 111/288 (38%), Gaps = 49/288 (17%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLST 505
           ED  +   +G G +G VY+      +G+   VA+K      T D+   + F +EA ++  
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN--KEKFMSEAVIMKN 69

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           + H +IVKL G    ++  ++I E    G L   L  +  ++++     V     +  A+
Sbjct: 70  LDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAM 126

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG------TY 619
           +YL    +++ +HRDI+  NIL+ S     + DFG +R +  D  Y              
Sbjct: 127 AYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWM- 181

Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHP-GGLLSSLSSSSGPKIMLIDVLNQ 677
              +PE       T   DV+ F V   E+L  G  P   L               DV+  
Sbjct: 182 ---SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL-------ENK-----DVIGV 226

Query: 678 -----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                RL  P     ++  ++        C    P  RP    +   L
Sbjct: 227 LEKGDRLPKPDLCPPVLYTLMT------RCWDYDPSDRPRFTELVCSL 268

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  130 bits (329), Expect = 6e-34
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 28/217 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF +   +G G +  VY+A  +  G  VA+K +       +  V+  QNE  +   ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH------DDDEAIELNWTKRVNIVKSVA 562
            +I++LY +      ++L+ E    G +   L        ++EA         + +  + 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--------HFMHQII 122

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             + YLH   +  I+HRD++ +N+LL  N+   +ADFG A  L +         GT  YI
Sbjct: 123 TGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179

Query: 623 APELAYTIVVTGK-----CDVYSFGVVALEVLMGTHP 654
           +PE     + T        DV+S G +   +L+G  P
Sbjct: 180 SPE-----IATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  131 bits (331), Expect = 7e-34
 Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 47/294 (15%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL----PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           + F +   +G G +GSV +A+L         VA+K L  ++   S+ ++ F  EA  +  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK-ADIIASSDIEEFLREAACMKE 81

Query: 506 VRHRNIVKLYGFCL------HKKCMFLIYEYMERGSLFCVL---HDDDEAIELNWTKRVN 556
             H ++ KL G  L            +I  +M+ G L   L      +    L     V 
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
            +  +A  + YL    + + IHRD+++ N +L  ++   VADFG +R ++    Y   R 
Sbjct: 142 FMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY---RQ 195

Query: 617 GTYGYI-----APELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIML 671
           G    +     A E     + T   DV++FGV   E++          +   +    I  
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM----------TRGQTPYAGIEN 245

Query: 672 IDVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            ++ N      RL  P    + V D++        C S+ PK RP+   +  EL
Sbjct: 246 AEIYNYLIGGNRLKQPPECMEEVYDLMY------QCWSADPKQRPSFTCLRMEL 293

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (330), Expect = 9e-34
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 22/209 (10%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY- 515
           +G GG   V+ A  L + + VA+K L      D +F   F+ EA   + + H  IV +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 516 -------GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
                     L     +++ EY++  +L  ++H +     +   + + ++     AL++ 
Sbjct: 80  TGEAETPAGPLP----YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFS 132

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA---GTYGYIAPE 625
           H      IIHRD+   NI++ +     V DFG AR +    +  T  A   GT  Y++PE
Sbjct: 133 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 626 LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            A    V  + DVYS G V  EVL G  P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  133 bits (337), Expect = 1e-33
 Identities = 60/278 (21%), Positives = 117/278 (42%), Gaps = 38/278 (13%)

Query: 451 DFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHR 509
            F  K  +G G  G++    + + + VA+K++                E  +L     H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI------LPECFSFADREVQLLRESDEHP 78

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           N+++ +     ++  ++  E     +L   +   D A      + + +++     L++LH
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLH 135

Query: 570 HDCTLSIIHRDISSNNILL-----DSNLEASVADFGTARLLHVDSSYRTLR---AGTYGY 621
               L+I+HRD+  +NIL+        ++A ++DFG  + L V     + R    GT G+
Sbjct: 136 S---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 622 IAPEL---AYTIVVTGKCDVYSFGVVALEVL-MGTHP-GGLLSSLSSSSGPKIMLIDVLN 676
           IAPE+         T   D++S G V   V+  G+HP G      S      I+L     
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK-----SLQRQANILLGACSL 247

Query: 677 QRLSPPVNQKIV-QDIILVSTIAFACLSSQPKSRPTMQ 713
             L P  ++ ++ +++I         ++  P+ RP+ +
Sbjct: 248 DCLHPEKHEDVIARELIE------KMIAMDPQKRPSAK 279

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  130 bits (330), Expect = 1e-33
 Identities = 70/301 (23%), Positives = 131/301 (43%), Gaps = 45/301 (14%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
                    IG G  G V  A E   G+ VA+K +   + +     +   NE  ++   +
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQ 100

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---DDEAIELNWTKRVNIVKSVAHA 564
           H N+V++Y   L  + ++++ E+++ G+L  ++     ++E I         + ++V  A
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT-------VCEAVLQA 153

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           L+YLH      +IHRDI S++ILL  +    ++DFG    +  D   R    GT  ++AP
Sbjct: 154 LAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210

Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLMG------THPGGLLSSLSSSSGPKIMLIDVLNQR 678
           E+    +   + D++S G++ +E++ G        P   +  L  S  PK+      + +
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK----NSHK 266

Query: 679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP-MQKALKEISISE 737
           +SP +   + +            L   P+ R T    +QELL    P + +      +  
Sbjct: 267 VSPVLRDFLER-----------MLVRDPQERAT----AQELL--DHPFLLQTGLPECLVP 309

Query: 738 L 738
           L
Sbjct: 310 L 310

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  130 bits (329), Expect = 1e-33
 Identities = 62/294 (21%), Positives = 114/294 (38%), Gaps = 48/294 (16%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL----PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
               +   +G G +GSV +  L         VA+K +    +     ++ F +EA  +  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE-IEEFLSEAACMKD 92

Query: 506 VRHRNIVKLYGFCL-----HKKCMFLIYEYMERGSLFCVL---HDDDEAIELNWTKRVNI 557
             H N+++L G C+           +I  +M+ G L   L     +     +     +  
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
           +  +A  + YL      + +HRD+++ N +L  ++   VADFG ++ ++    Y   R G
Sbjct: 153 MVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY---RQG 206

Query: 618 TYGYI-----APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIML 671
               +     A E     V T K DV++FGV   E+   G  P            P +  
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP-----------YPGVQN 255

Query: 672 IDVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            ++ +      RL  P +    + +I+       +C  + P  RPT   +  +L
Sbjct: 256 HEMYDYLLHGHRLKQPEDCLDELYEIMY------SCWRTDPLDRPTFSVLRLQL 303

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  129 bits (327), Expect = 1e-33
 Identities = 67/280 (23%), Positives = 122/280 (43%), Gaps = 42/280 (15%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++  +   IG G +G V   +   G  VA+K + +  T      ++F  EA V++ +RH 
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-----QAFLAEASVMTQLRHS 74

Query: 510 NIVKLYGFCLHKK-CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           N+V+L G  + +K  ++++ EYM +GSL   L     +  L     +     V  A+ YL
Sbjct: 75  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL 133

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL--RAGTYGYIAPEL 626
                 + +HRD+++ N+L+  +  A V+DFG  +          L  +     + APE 
Sbjct: 134 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-----WTAPEA 185

Query: 627 AYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ-----RLS 680
                 + K DV+SFG++  E+   G  P            P+I L DV+ +     ++ 
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVP-----------YPRIPLKDVVPRVEKGYKMD 234

Query: 681 PPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            P      V +++        C       RP+  ++ ++L
Sbjct: 235 APDGCPPAVYEVMK------NCWHLDAAMRPSFLQLREQL 268

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (329), Expect = 1e-33
 Identities = 62/299 (20%), Positives = 111/299 (37%), Gaps = 55/299 (18%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           + +     +G GG+  V   E L +G   ALK++   E +D    +    EA +     H
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ---READMHRLFNH 85

Query: 509 RNIVKLYGFCL----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV--------N 556
            NI++L  +CL     K   +L+  + +RG+L+         IE    K           
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW-------NEIERLKDKGNFLTEDQILW 138

Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
           ++  +   L  +H        HRD+   NILL    +  + D G+     +         
Sbjct: 139 LLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195

Query: 617 ---------GTYGYIAPEL----AYTIVVTGKCDVYSFGVVALEVLMGTHP--GGLLSSL 661
                     T  Y APEL    ++  V+  + DV+S G V   ++ G  P         
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

Query: 662 SSSSGPKIMLIDVLNQRLSPPVNQKIVQDII-LVSTIAFACLSSQPKSRPTMQRISQEL 719
           S        +   +  +LS P + +    +  L++    + ++  P  RP +  +  +L
Sbjct: 255 S--------VALAVQNQLSIPQSPRHSSALWQLLN----SMMTVDPHQRPHIPLLLSQL 301

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  130 bits (329), Expect = 1e-33
 Identities = 68/316 (21%), Positives = 118/316 (37%), Gaps = 53/316 (16%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           E   +   +G G +G VY+              VA+K ++ + +        F NEA V+
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVM 82

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL-------HDDDEAIELNWTKRVN 556
                 ++V+L G     +   +I E M RG L   L        ++      + +K + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142

Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
           +   +A  ++YL+       +HRD+++ N ++  +    + DFG  R ++    YR    
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---K 196

Query: 617 GTYGYI-----APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIM 670
           G  G +     +PE     V T   DV+SFGVV  E+      P              + 
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----------QGLS 245

Query: 671 LIDVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT 724
              VL        L  P N   ++ +++        C    PK RP+   I   +   K 
Sbjct: 246 NEQVLRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSI---KE 296

Query: 725 PMQKALKEISISELRN 740
            M+   +E+S      
Sbjct: 297 EMEPGFREVSFYYSEE 312

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  130 bits (330), Expect = 2e-33
 Identities = 69/301 (22%), Positives = 122/301 (40%), Gaps = 43/301 (14%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
            + F     IG G +G+VY A ++   +VVA+KK+ +S  + +   +    E   L  +R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H N ++  G  L +   +L+ EY   GS   +L    + ++        +       L+Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGLAY 169

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH     ++IHRD+ + NILL       + DFG+A ++    +      GT  ++APE+ 
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYWMAPEVI 222

Query: 628 YTIVVTG---KCDVYSFGVVALEVLMG------THPGGLLSSLSSSSGPKIMLIDVLNQR 678
             +       K DV+S G+  +E+          +    L  ++ +  P +      +  
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-----SGH 277

Query: 679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP-MQKALKEISISE 737
            S      +             CL   P+ RPT    S+ LL  K   + +      I +
Sbjct: 278 WSEYFRNFVDS-----------CLQKIPQDRPT----SEVLL--KHRFVLRERPPTVIMD 320

Query: 738 L 738
           L
Sbjct: 321 L 321

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  128 bits (325), Expect = 3e-33
 Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 27/216 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
             +     +G GG+   ++  +    +V A K +  S        +    E  +  ++ H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-----DDDEAIELNWTKRVNIVKSVAH 563
           +++V  +GF      +F++ E   R SL  +        + EA       R   ++ +  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 126

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
              YLH      +IHRD+   N+ L+ +LE  + DFG A  +  D   + +  GT  YIA
Sbjct: 127 GCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183

Query: 624 PELAYTIVVTGK-----CDVYSFGVVALEVLMGTHP 654
           PE     V++ K      DV+S G +   +L+G  P
Sbjct: 184 PE-----VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  129 bits (327), Expect = 3e-33
 Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 27/216 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
             +     +G GG+   ++  +    +V A K +  S        +    E  +  ++ H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-----DDDEAIELNWTKRVNIVKSVAH 563
           +++V  +GF      +F++ E   R SL  +        + EA       R   ++ +  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 152

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
              YLH +    +IHRD+   N+ L+ +LE  + DFG A  +  D   + +  GT  YIA
Sbjct: 153 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209

Query: 624 PELAYTIVVTGK-----CDVYSFGVVALEVLMGTHP 654
           PE     V++ K      DV+S G +   +L+G  P
Sbjct: 210 PE-----VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  134 bits (338), Expect = 4e-33
 Identities = 62/266 (23%), Positives = 94/266 (35%), Gaps = 20/266 (7%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSN 159
             + K+LDL  N L         S  +L+ L L    +  I      SL +L  L L  N
Sbjct: 27  PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 160 KLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN-----ISSNQFHS-SIPLEIG 213
            +  +       L SL +L      L  L    +  L       ++ N   S  +P    
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 214 NFSALDTLDLSDNKIHGIIPDELTKLSQLKN----LNLSSNLLSGQIPYAIGKLFNLMYL 269
           N + L+ LDLS NKI  I   +L  L Q+      L+LS N ++  I     K   L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKL 205

Query: 270 DLSKNKLSGSIP-TEIGNCSALKNLTLNHNSLDGTIPLEMGKI--------LLLQNLDLS 320
            L  N  S ++  T I   + L+   L          LE            L ++   L+
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 321 HNNLSGTIPKTLRPMYVDLSFNNLEG 346
           + +        L     ++S  +L  
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVS 291

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  124 bits (314), Expect = 4e-30
 Identities = 51/244 (20%), Positives = 90/244 (36%), Gaps = 28/244 (11%)

Query: 91  ELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLT--GIIPKEIGSL 148
           + G+       +LK L   +N    +   ++  L  L+ L L  N L+  G   +     
Sbjct: 315 KFGQFPTLKLKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGT 372

Query: 149 RNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSI 208
            +L+ L L  N +   +      L+ L  L   ++ L  +   ++F              
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL------------- 418

Query: 209 PLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQI-PYAIGKLFNLM 267
                +   L  LD+S              LS L+ L ++ N       P    +L NL 
Sbjct: 419 -----SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473

Query: 268 YLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKILL-LQNLDLSHNNLS 325
           +LDLS+ +L   +      + S+L+ L +  N L  ++P  +   L  LQ + L  N   
Sbjct: 474 FLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531

Query: 326 GTIP 329
            + P
Sbjct: 532 CSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  121 bits (306), Expect = 5e-29
 Identities = 46/227 (20%), Positives = 82/227 (36%), Gaps = 13/227 (5%)

Query: 64  HCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLS--GSIPPQI 121
           +C +          +  +   ++         +    P+L+ LDL  N LS  G      
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSNKGGNAF---SEVDLPSLEFLDLSRNGLSFKGCCSQSD 369

Query: 122 GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEI-GNLKSLTELYV 180
              + LK L L  N +   +      L  L  L    + L  +    +  +L++L  L +
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428

Query: 181 TNNALGGLIPSTLFRLTN-----ISSNQFHSSIPLEI-GNFSALDTLDLSDNKIHGIIPD 234
           ++             L++     ++ N F  +   +I      L  LDLS  ++  + P 
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488

Query: 235 ELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIP 281
               LS L+ LN++SN L         +L +L  + L  N    S P
Sbjct: 489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  115 bits (289), Expect = 6e-27
 Identities = 51/288 (17%), Positives = 89/288 (30%), Gaps = 24/288 (8%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGS---IPPQIGSLSKLKCLYLH 133
           R+  + L N+     + +        L+   L                 +L  L  L + 
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 134 GNNLTGI------IPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGG 187
              L  +      I      L N+    L S  +  V             L + N   G 
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQ 318

Query: 188 LIPSTLFRLT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIH--GIIPDELTKLSQLK 243
                L  L     +SN+  ++      +  +L+ LDLS N +   G         + LK
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376

Query: 244 NLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDG 302
            L+LS N +   +      L  L +LD   + L       +  +   L  L ++H     
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435

Query: 303 TIPLEMGKILLLQNLDLSHNNLSGTIPK-TLRPM----YVDLSFNNLE 345
                   +  L+ L ++ N+            +    ++DLS   LE
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  112 bits (283), Expect = 3e-26
 Identities = 45/269 (16%), Positives = 92/269 (34%), Gaps = 24/269 (8%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
           +    +L +L L  N +          LS L+ L     NL  +    IG L+ L+ L +
Sbjct: 72  YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131

Query: 157 YSNKLSGV-LPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT---------NISSNQFHS 206
             N +    LP+   NL +L  L +++N +  +  + L  L          ++S N   +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-N 190

Query: 207 SIPLEIGNFSALDTLDLSDNKIHG-IIPDELTKLSQLKNLNLSSNLLSGQ---IPYAIGK 262
            I         L  L L +N     ++   +  L+ L+   L       +     +    
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 263 LFNLMYLDLSKNKLSG------SIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKIL-LLQ 315
           L  L  L + + +L+        I       + + + +L   +++             L+
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310

Query: 316 NLDLSHNNLSGTIPKTLRPMYVDLSFNNL 344
            ++           K+L+   +  + N  
Sbjct: 311 LVNCKFGQFPTLKLKSLK--RLTFTSNKG 337

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 93.2 bits (232), Expect = 7e-20
 Identities = 38/175 (21%), Positives = 67/175 (38%), Gaps = 8/175 (4%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
                  IP  +    +   LDLS N +  +         +L+ L+LS   +      A 
Sbjct: 15  MELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72

Query: 261 GKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLS 320
             L +L  L L+ N +           S+L+ L     +L       +G +  L+ L+++
Sbjct: 73  QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 321 HNNL-SGTIPKTLRPM----YVDLSFNNLEGEIPTYLRGNPPKSFVGNK-GLSGN 369
           HN + S  +P+    +    ++DLS N ++    T LR       +     LS N
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (323), Expect = 4e-33
 Identities = 71/287 (24%), Positives = 117/287 (40%), Gaps = 47/287 (16%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLST 505
           E   +  CIG G +G V++     PE     VA+K   +  ++     + F  EA  +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQEALTMRQ 72

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
             H +IVKL G    +  +++I E    G L   L     +++L     +     ++ AL
Sbjct: 73  FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTAL 129

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI--- 622
           +YL    +   +HRDI++ N+L+ SN    + DFG +R +   + Y+  +    G +   
Sbjct: 130 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK----GKLPIK 182

Query: 623 --APELAYTIVVTGKCDVYSFGVVALEVLM-GTHP-GGLLSSLSSSSGPKIMLIDVLNQ- 677
             APE       T   DV+ FGV   E+LM G  P  G+               DV+ + 
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNN-----DVIGRI 230

Query: 678 ----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
               RL  P N    +  ++        C +  P  RP    +  +L
Sbjct: 231 ENGERLPMPPNCPPTLYSLMT------KCWAYDPSRRPRFTELKAQL 271

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (340), Expect = 4e-33
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 25/211 (11%)

Query: 452 FHIKYCIGTGGYGSVYKAE---LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           + +K CI  GG G +Y A    +  G+ V LK L HS   D+        E   L+ V H
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVH 138

Query: 509 RNIVKLYGFCLH-----KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
            +IV+++ F  H         +++ EY+   SL           +L   + +  +  +  
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILP 193

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
           ALSYLH    + +++ D+   NI+L    +  + D G    ++          GT G+ A
Sbjct: 194 ALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYL----YGTPGFQA 245

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+  T   T   D+Y+ G     + +    
Sbjct: 246 PEIVRT-GPTVATDIYTVGRTLAALTLDLPT 275

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  132 bits (333), Expect = 5e-33
 Identities = 55/265 (20%), Positives = 99/265 (37%), Gaps = 36/265 (13%)

Query: 95  LNFSCFPNLKSLDLWNNSLSGSIPPQIGSLS-------------KLKCLYLHGNNLTGII 141
           +      +        +    + PP  G                +   L L+   L+  +
Sbjct: 28  VEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SL 86

Query: 142 PKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISS 201
           P+    L +L       N L+  LP+   +LKSL        AL  L P  L  L  +S+
Sbjct: 87  PELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-LEYL-GVSN 140

Query: 202 NQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIG 261
           NQ    +P E+ N S L  +D+ +N +   +PD       L+ +   +N L  ++P  + 
Sbjct: 141 NQL-EKLP-ELQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLE-ELP-ELQ 192

Query: 262 KLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSH 321
            L  L  +    N L   +P    +   L+++   +N L      E+  +  L  +   +
Sbjct: 193 NLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNIL--EELPELQNLPFLTTIYADN 246

Query: 322 NNLSGTIPKTLRPM-YVDLSFNNLE 345
           N L  T+P     +  +++  N L 
Sbjct: 247 NLLK-TLPDLPPSLEALNVRDNYLT 270

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  124 bits (313), Expect = 2e-30
 Identities = 57/249 (22%), Positives = 101/249 (40%), Gaps = 32/249 (12%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
                +L+S+   NN L     P++ +L  L  +Y   N L   +P    SL     L +
Sbjct: 211 PDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA---LNV 264

Query: 157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFS 216
             N L+  LP+   +L  L       + L  L P+ L+ L N SSN+   S+     +  
Sbjct: 265 RDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPN-LYYL-NASSNEI-RSLCDLPPS-- 318

Query: 217 ALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKL 276
            L+ L++S+NK+   +P    +   L+ L  S N L+ ++P       NL  L +  N L
Sbjct: 319 -LEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQ---NLKQLHVEYNPL 369

Query: 277 SGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM- 335
               P    +   +++L +N +     +P        L+ L +  N L    P     + 
Sbjct: 370 R-EFPDIPES---VEDLRMNSHL--AEVPELPQN---LKQLHVETNPLR-EFPDIPESVE 419

Query: 336 YVDLSFNNL 344
            + ++   +
Sbjct: 420 DLRMNSERV 428

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  123 bits (312), Expect = 2e-30
 Identities = 53/267 (19%), Positives = 98/267 (36%), Gaps = 51/267 (19%)

Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLR------------ 149
            L+     +++L+  +P +  ++      Y   +      P   G  R            
Sbjct: 12  FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD 70

Query: 150 -NLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT-----NISSNQ 203
                L L +  LS  LP+   +   L  L  + N+L  L P     L      N +   
Sbjct: 71  RQAHELELNNLGLS-SLPELPPH---LESLVASCNSLTEL-PELPQSLKSLLVDNNNLKA 125

Query: 204 FHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKL 263
                PL       L+ L +S+N++  +   EL   S LK +++ +N L  ++P      
Sbjct: 126 LSDLPPL-------LEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK-KLPDLPP-- 173

Query: 264 FNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNN 323
            +L ++    N+L   +P E+ N   L  +  ++NSL   +P        L+++   +N 
Sbjct: 174 -SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNI 226

Query: 324 LSGTIP-----KTLRPMYVDLSFNNLE 345
           L   +P       L    +    N L+
Sbjct: 227 LE-ELPELQNLPFLT--TIYADNNLLK 250

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  123 bits (311), Expect = 3e-30
 Identities = 47/245 (19%), Positives = 92/245 (37%), Gaps = 35/245 (14%)

Query: 117 IPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNL---- 172
           I P+  S + L+    H +NLT  +P E  ++++    +   ++     P   G      
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 173 ---------KSLTELYVTNNALGGLIPSTLFRLT--NISSNQFHSSIPLEIGNFSALDTL 221
                    +   EL + N  L  L P     L     S N   + +P    +  +L   
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSSL-PELPPHLESLVASCNSL-TELPELPQSLKSLLVD 119

Query: 222 DLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIP 281
           + +   +  + P        L+ L +S+N L  ++P  +     L  +D+  N L   +P
Sbjct: 120 NNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLP 169

Query: 282 TEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM-YVDLS 340
               +   L+ +   +N L+  +P E+  +  L  +   +N+L   +P     +  +   
Sbjct: 170 DLPPS---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIVAG 223

Query: 341 FNNLE 345
            N LE
Sbjct: 224 NNILE 228

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  114 bits (288), Expect = 3e-27
 Identities = 48/227 (21%), Positives = 85/227 (37%), Gaps = 32/227 (14%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
           P+L++L++ +N L+  +P    SL+ L       + L+ + P       NL  L   SN+
Sbjct: 257 PSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNE 308

Query: 161 LSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT--NISSNQFHSSIPLEIGNFSAL 218
           +  +         SL EL V+NN L  L P+   RL     S N   + +P    N   L
Sbjct: 309 IRSL----CDLPPSLEELNVSNNKLIEL-PALPPRLERLIASFNHL-AEVPELPQN---L 359

Query: 219 DTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSG 278
             L +  N +    PD    +  L+  +  + +             NL  L +  N L  
Sbjct: 360 KQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPE--------LPQNLKQLHVETNPLR- 409

Query: 279 SIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLS 325
             P    +   +++L +N   +             L++    H++  
Sbjct: 410 EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  129 bits (325), Expect = 6e-33
 Identities = 63/290 (21%), Positives = 101/290 (34%), Gaps = 56/290 (19%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
                 +  +G G +G V++  +   G   A+KK+                E    + + 
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--------RLEVFRVEELVACAGLS 108

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD---DEAIELNWTKRVNIVKSVAHA 564
              IV LYG       + +  E +E GSL  ++       E   L +             
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYL------GQALEG 162

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSN-LEASVADFGTARLLHVDSSYRTLRA-----GT 618
           L YLH      I+H D+ ++N+LL S+   A++ DFG A  L  D   ++L       GT
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 619 YGYIAPELAYTIVVTG-----KCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLID 673
             ++APE     VV G     K D++S   + L +L G HP       +      + L  
Sbjct: 220 ETHMAPE-----VVMGKPCDAKVDIWSSCCMMLHMLNGCHP------WTQYFRGPLCLKI 268

Query: 674 VLNQRLSPPVNQKI---VQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
                    +           I         L  +P  R +    + EL 
Sbjct: 269 ASEPPPIREIPPSCAPLTAQAIQ------EGLRKEPVHRAS----AMELR 308

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  132 bits (333), Expect = 6e-33
 Identities = 57/279 (20%), Positives = 107/279 (38%), Gaps = 18/279 (6%)

Query: 79  TDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNL 137
            +++L  + +   +    F+   NL++L L +N L   IP  +   LS L  L +  N +
Sbjct: 59  EELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKI 116

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT 197
             ++      L NL+ L +  N L  +  +    L SL +L +    L  +    L  L 
Sbjct: 117 VILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLH 176

Query: 198 N-----ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLL 252
                 +     ++           L  L++S       +         L +L+++   L
Sbjct: 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236

Query: 253 SGQIPY-AIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGK 310
           +  +PY A+  L  L +L+LS N +S +I   +      L+ + L    L   +     +
Sbjct: 237 T-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFR 293

Query: 311 ILL-LQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNL 344
            L  L+ L++S N L+         +     + L  N L
Sbjct: 294 GLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  131 bits (332), Expect = 9e-33
 Identities = 62/281 (22%), Positives = 110/281 (39%), Gaps = 27/281 (9%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
               + LDL  N +  ++      S   L+ L L+ N ++ + P    +L NLR L L S
Sbjct: 31  PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89

Query: 159 NKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN-----ISSNQFHSSIPLEIG 213
           N+L  +       L +LT+L ++ N +  L+      L N     +  N       +   
Sbjct: 90  NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY---ISHR 146

Query: 214 NFSALD---TLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLD 270
            FS L+    L L    +  I  + L+ L  L  L L    ++    Y+  +L+ L  L+
Sbjct: 147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206

Query: 271 LSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEM-GKILLLQNLDLSHNNLSGTIP 329
           +S      ++         L +L++ H +L   +P      ++ L+ L+LS+N +S    
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEG 265

Query: 330 KTLRPM----YVDLSFNNLEGEIPTYLRGNPPKSFVGNKGL 366
             L  +     + L    L   +        P +F G   L
Sbjct: 266 SMLHELLRLQEIQLVGGQLA-VV-------EPYAFRGLNYL 298

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  103 bits (259), Expect = 2e-23
 Identities = 45/201 (22%), Positives = 74/201 (36%), Gaps = 9/201 (4%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIP 142
           +  N    +    FS   +L+ L L   +L+ SIP +    L  L  L L   N+  I  
Sbjct: 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRD 193

Query: 143 KEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN---- 198
                L  L+ L +        +        +LT L +T+  L  +    +  L      
Sbjct: 194 YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFL 253

Query: 199 -ISSNQFHSSIPLEI-GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQI 256
            +S N   S+I   +      L  + L   ++  + P     L+ L+ LN+S N L+   
Sbjct: 254 NLSYNPI-STIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLE 312

Query: 257 PYAIGKLFNLMYLDLSKNKLS 277
                 + NL  L L  N L+
Sbjct: 313 ESVFHSVGNLETLILDSNPLA 333

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  128 bits (324), Expect = 6e-33
 Identities = 55/281 (19%), Positives = 111/281 (39%), Gaps = 33/281 (11%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
             + I   IG+GG   V++    + ++ A+K ++  E ++   + S++NE   L+ ++  
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 86

Query: 510 N--IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           +  I++LY + +  + ++++ E      L   L    ++I+    K     K++  A+  
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKS--YWKNMLEAVHT 142

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD--SSYRTLRAGTYGYIAPE 625
           +H      I+H D+   N L+       + DFG A  +  D  S  +  + GT  Y+ PE
Sbjct: 143 IHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198

Query: 626 L-----------AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDV 674
                            ++ K DV+S G +   +  G  P                L  +
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------FQQIINQISKLHAI 252

Query: 675 LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
           ++            +D  L   +   CL   PK R ++  +
Sbjct: 253 IDPNHEIEFPDIPEKD--LQDVLK-CCLKRDPKQRISIPEL 290

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  128 bits (323), Expect = 6e-33
 Identities = 51/235 (21%), Positives = 87/235 (37%), Gaps = 14/235 (5%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLS-GSIPPQIGS-LSKLKCLYLHGN 135
            T ++L ++ ++  L    F     L  L L +N LS      Q     + LK L L  N
Sbjct: 30  ATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

Query: 136 NLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEI-GNLKSLTELYVTNNALGGLIPSTLF 194
            +   +      L  L  L    + L  +    +  +L++L  L +++            
Sbjct: 89  GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147

Query: 195 RLTN-----ISSNQFHSSIPLEI-GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLS 248
            L++     ++ N F  +   +I      L  LDLS  ++  + P     LS L+ LN+S
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207

Query: 249 SNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI--GNCSALKNLTLNHNSLD 301
            N       +    L +L  LD S N +  +   +      S+L  L L  N   
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  125 bits (315), Expect = 8e-32
 Identities = 62/270 (22%), Positives = 96/270 (35%), Gaps = 27/270 (10%)

Query: 99  CFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
           C  +   +   +  L+ S+P  I   S    L L  N L  +       L  L  L L S
Sbjct: 5   CSCSGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSS 61

Query: 159 NKLS--GVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN-----ISSNQFHSSIPLE 211
           N LS  G   Q      SL  L ++ N +   + S    L          +         
Sbjct: 62  NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS 120

Query: 212 I-GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSN-LLSGQIPYAIGKLFNLMYL 269
           +  +   L  LD+S              LS L+ L ++ N      +P    +L NL +L
Sbjct: 121 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180

Query: 270 DLSKNKLSGSIPTEIGNC-SALKNLTLNHNSLDGTIPLEMGKILL-LQNLDLSHNNLSGT 327
           DLS+ +L   +     N  S+L+ L ++HN+   ++     K L  LQ LD S N++  T
Sbjct: 181 DLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNF-FSLDTFPYKCLNSLQVLDYSLNHIM-T 237

Query: 328 IPKTLRPMYVDLSFNNLEGEIPT-YLRGNP 356
             K            +    +    L  N 
Sbjct: 238 SKKQE--------LQHFPSSLAFLNLTQND 259

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  128 bits (323), Expect = 7e-33
 Identities = 66/303 (21%), Positives = 127/303 (41%), Gaps = 42/303 (13%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
            E + I   +G G +G VYKA     G + A K +     E+   ++ +  E  +L+T  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCD 74

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H  IVKL G   H   ++++ E+   G++  ++ + D  +     +   + + +  AL++
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNF 132

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH      IIHRD+ + N+L+    +  +ADFG +         R    GT  ++APE+ 
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189

Query: 628 YTIVVT-----GKCDVYSFGVVALEVLMG------THPGGLLSSLSSSSGPKIMLIDVLN 676
               +       K D++S G+  +E+          +P  +L  ++ S  P ++      
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS--- 246

Query: 677 QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP-MQKALKEISI 735
            + S      +              L   P++RP+    + +LL  + P +       ++
Sbjct: 247 -KWSVEFRDFLKI-----------ALDKNPETRPS----AAQLL--EHPFVSSITSNKAL 288

Query: 736 SEL 738
            EL
Sbjct: 289 REL 291

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  128 bits (324), Expect = 7e-33
 Identities = 76/287 (26%), Positives = 111/287 (38%), Gaps = 50/287 (17%)

Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNHQNI 95

Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVL----HDDDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L        +   L     +++ + +A    Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 568 LHHDCTLSIIHRDISSNNILLD---SNLEASVADFGTARLLHVDSSYRTLRAGTYGYI-- 622
           L        IHRDI++ N LL        A + DFG AR ++  S Y   R G    +  
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY---RKGGCAMLPV 209

Query: 623 ---APE-LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ- 677
               PE      + T K D +SFGV+  E+           SL     P     +VL   
Sbjct: 210 KWMPPEAFMEG-IFTSKTDTWSFGVLLWEIF----------SLGYMPYPSKSNQEVLEFV 258

Query: 678 ----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
               R+ PP N    V  I+        C   QP+ RP    I + +
Sbjct: 259 TSGGRMDPPKNCPGPVYRIMT------QCWQHQPEDRPNFAIILERI 299

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  128 bits (323), Expect = 1e-32
 Identities = 62/288 (21%), Positives = 107/288 (37%), Gaps = 47/288 (16%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL-STVR 507
            D      +G+G  G V+K      G V+A+K++    + +    K    +  V+  +  
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR--SGNKEENKRILMDLDVVLKSHD 82

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN------IVKSV 561
              IV+ +G  +    +F+  E M   +           ++      +       +  ++
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAE---------KLKKRMQGPIPERILGKMTVAI 133

Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGY 621
             AL YL       +IHRD+  +NILLD   +  + DFG +  L VD   +   AG   Y
Sbjct: 134 VKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAY 190

Query: 622 IAPELAYTIVVTG-----KCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLN 676
           +APE       T      + DV+S G+  +E+  G  P        +      +L  VL 
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP------YKNCKTDFEVLTKVLQ 244

Query: 677 Q---RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
           +    L   +      Q  +        CL+   + RP       +LL
Sbjct: 245 EEPPLLPGHMGFSGDFQSFVK------DCLTKDHRKRPK----YNKLL 282

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  127 bits (322), Expect = 1e-32
 Identities = 59/278 (21%), Positives = 94/278 (33%), Gaps = 44/278 (15%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-R 507
           + F     +G G YG V+K     +G++ A+K+   S             E      V +
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSM-SPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD----DEAIELNWTKRVNIVKSVAH 563
           H   V+L         ++L  E     SL            EA    + +          
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLR------DTLL 168

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
           AL++LH   +  ++H D+   NI L       + DFG    L    +    + G   Y+A
Sbjct: 169 ALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMA 224

Query: 624 PEL---AYTIVVTGKCDVYSFGVVALEVLMGTHP---GGLLSSLSSSSGPKIMLIDVLNQ 677
           PEL   +Y        DV+S G+  LEV         G     L      +  L      
Sbjct: 225 PELLQGSYGT----AADVFSLGLTILEVACNMELPHGGEGWQQLR-----QGYLPPEFTA 275

Query: 678 RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
            LS       ++ +++        L   PK R T + +
Sbjct: 276 GLSSE-----LRSVLV------MMLEPDPKLRATAEAL 302

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  129 bits (325), Expect = 1e-32
 Identities = 75/287 (26%), Positives = 110/287 (38%), Gaps = 50/287 (17%)

Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G G +G VY+ ++      P    VA+K L    +E       F  EA ++S   H+NI
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNHQNI 136

Query: 512 VKLYGFCLHKKCMFLIYEYMERGSLFCVL----HDDDEAIELNWTKRVNIVKSVAHALSY 567
           V+  G  L     F++ E M  G L   L        +   L     +++ + +A    Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 568 LHHDCTLSIIHRDISSNNILLD---SNLEASVADFGTARLLHVDSSYRTLRAGTYGYI-- 622
           L        IHRDI++ N LL        A + DFG AR ++    Y   R G    +  
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY---RKGGCAMLPV 250

Query: 623 ---APE-LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ- 677
               PE      + T K D +SFGV+  E+           SL     P     +VL   
Sbjct: 251 KWMPPEAFMEG-IFTSKTDTWSFGVLLWEIF----------SLGYMPYPSKSNQEVLEFV 299

Query: 678 ----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
               R+ PP N    V  I+        C   QP+ RP    I + +
Sbjct: 300 TSGGRMDPPKNCPGPVYRIMT------QCWQHQPEDRPNFAIILERI 340

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  127 bits (320), Expect = 2e-32
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 21/223 (9%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
            +   + +   +G G   +V++      G + A+K  ++        V     E  VL  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKK 63

Query: 506 VRHRNIVKLYGF--CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           + H+NIVKL+        +   LI E+   GSL+ VL +   A  L  ++ + +++ V  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEAS----VADFGTARLLHVDSSYRTLRAGTY 619
            +++L       I+HR+I   NI+     +      + DFG AR L  D  + +L  GT 
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTE 179

Query: 620 GYIAPELAYTIVVTG--------KCDVYSFGVVALEVLMGTHP 654
            Y+ P++    V+            D++S GV       G+ P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  127 bits (321), Expect = 2e-32
 Identities = 68/293 (23%), Positives = 121/293 (41%), Gaps = 58/293 (19%)

Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLH-HSETEDSAFVKSFQNEAHVLSTVRHRN 510
           +G G +G V+ AE        +  +VA+K L   SE+      + FQ EA +L+ ++H++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA----RQDFQREAELLTMLQHQH 104

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVL------------HDDDEAIELNWTKRVNIV 558
           IV+ +G C   + + +++EYM  G L   L             +D     L   + + + 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 559 KSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT 618
             VA  + YL     L  +HRD+++ N L+   L   + DFG +R ++    Y   R G 
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY---RVGG 218

Query: 619 YGYI-----APE-LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLI 672
              +      PE + Y    T + DV+SFGVV  E+           +       ++   
Sbjct: 219 RTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIF----------TYGKQPWYQLSNT 267

Query: 673 DVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           + ++       L  P      V  I+        C   +P+ R +++ +   L
Sbjct: 268 EAIDCITQGRELERPRACPPEVYAIMR------GCWQREPQQRHSIKDVHARL 314

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  125 bits (317), Expect = 3e-32
 Identities = 61/301 (20%), Positives = 109/301 (36%), Gaps = 56/301 (18%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
                   +G   +G VYK  L       + + VA+K L           + F++EA + 
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL--REEFRHEAMLR 66

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCVLHDDDEAIELN 550
           + ++H N+V L G     + + +I+ Y   G L                  D      L 
Sbjct: 67  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 551 WTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS 610
               V++V  +A  + YL    +  ++H+D+++ N+L+   L   ++D G  R ++    
Sbjct: 127 PPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183

Query: 611 YRTLRAGTYGYI-----APE-LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSS 664
           Y   +      +     APE + Y    +   D++S+GVV  EV           S    
Sbjct: 184 Y---KLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVF----------SYGLQ 229

Query: 665 SGPKIMLIDVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE 718
                   DV+        L  P +    V  +++       C +  P  RP  + I   
Sbjct: 230 PYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMI------ECWNEFPSRRPRFKDIHSR 283

Query: 719 L 719
           L
Sbjct: 284 L 284

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  128 bits (323), Expect = 3e-32
 Identities = 47/226 (20%), Positives = 87/226 (38%), Gaps = 33/226 (14%)

Query: 449 TEDFHIKYCIGTG--GYGSVYKA-ELPEGKVVALKK--LHHSETEDSAFVKSFQNEAHVL 503
              + +   IG G     +V  A   P G+ V +++  L     E    V   Q E HV 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM---VTFLQGELHVS 80

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD------DDEAIELNWTKRVNI 557
               H NIV      +    ++++  +M  GS   ++        ++ AI         I
Sbjct: 81  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAI-------AYI 133

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG-TARLLHVDSSYRTLRA 616
           ++ V  AL Y+HH      +HR + +++IL+  + +  ++       ++      R +  
Sbjct: 134 LQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 617 GTYGYI------APELAYTIVV--TGKCDVYSFGVVALEVLMGTHP 654
                +      +PE+    +     K D+YS G+ A E+  G  P
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  127 bits (320), Expect = 3e-32
 Identities = 55/284 (19%), Positives = 111/284 (39%), Gaps = 39/284 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH- 508
             + I   IG+GG   V++    + ++ A+K ++  E ++   + S++NE   L+ ++  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 67

Query: 509 -RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
              I++LY + +  + ++++ E      L   L    ++I+    K     K++  A+  
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKS--YWKNMLEAVHT 123

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD--SSYRTLRAGTYGYIAPE 625
           +H      I+H D+   N L+       + DFG A  +  D  S  +  + GT  Y+ PE
Sbjct: 124 IHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 626 L-----------AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDV 674
                            ++ K DV+S G +   +  G  P                L  +
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------FQQIINQISKLHAI 233

Query: 675 LNQRLSPPVNQKI---VQDIILVSTIAFACLSSQPKSRPTMQRI 715
           ++              +QD++        CL   PK R ++  +
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIPEL 271

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  129 bits (325), Expect = 5e-32
 Identities = 52/249 (20%), Positives = 97/249 (38%), Gaps = 22/249 (8%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
                  L  L   +N+++ ++   +   + L  L    N LT +   ++  L  L  L 
Sbjct: 59  GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLN 112

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNF 215
             +NKL+ +   ++     LT L    N L  +  S   +LT +  +       L++   
Sbjct: 113 CDTNKLTKL---DVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLDVTPQ 169

Query: 216 SALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNK 275
           + L TLD S NKI  +   ++++   L  LN  +N ++ ++   + +   L +LD S NK
Sbjct: 170 TQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNK 223

Query: 276 LSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM 335
           L+  I   +   + L     + N L     L++  +  L  L     +L   I  T    
Sbjct: 224 LT-EID--VTPLTQLTYFDCSVNPL---TELDVSTLSKLTTLHCIQTDLL-EIDLTHNTQ 276

Query: 336 YVDLSFNNL 344
            +       
Sbjct: 277 LIYFQAEGC 285

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  124 bits (312), Expect = 2e-30
 Identities = 58/267 (21%), Positives = 104/267 (38%), Gaps = 27/267 (10%)

Query: 83  LLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIP 142
           +  +        ++      L SLD  N+S++  +   I  L+ L  L    NN+T +  
Sbjct: 24  VAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITTL-- 79

Query: 143 KEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT--NIS 200
            ++    NL  L   SNKL+ +   ++  L  LT L    N L  L  S    LT  N +
Sbjct: 80  -DLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCA 135

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
            N       +++ + + L  LD   NK   I   ++T  +QL  L+ S N ++ ++   +
Sbjct: 136 RNTLTE---IDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKIT-ELD--V 187

Query: 261 GKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLS 320
            +   L  L+   N ++  +   +     L  L  + N L   I +    +  L   D S
Sbjct: 188 SQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDV--TPLTQLTYFDCS 241

Query: 321 HNNLSGTIPKTLRPM--YVDLSFNNLE 345
            N L+  +  +       +     +L 
Sbjct: 242 VNPLT-ELDVSTLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  119 bits (300), Expect = 9e-29
 Identities = 44/237 (18%), Positives = 83/237 (35%), Gaps = 24/237 (10%)

Query: 95  LNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGL 154
           L+ S    L  L+   N+++  +   +    +L  L    N LT I   ++  L  L   
Sbjct: 185 LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYF 238

Query: 155 FLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGN 214
               N L+ +   ++  L  LT L+     L  +  +   +L    +        L++ +
Sbjct: 239 DCSVNPLTEL---DVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTH 295

Query: 215 FSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKN 274
            + L  LD     I  +   +L++  +L  L L++  L+ ++   +     L  L     
Sbjct: 296 NTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNA 349

Query: 275 KLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLL------QNLDLSHNNLS 325
            +       +G   AL N          T+P E      L        LD   N ++
Sbjct: 350 HIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMN 403

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  114 bits (286), Expect = 5e-27
 Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 28/251 (11%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
            N  S       +  +       L+ L  L  H +++T +    I  L  L  L   SN 
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75

Query: 161 LSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT--NISSNQFHSSIPLEIGNFSAL 218
           ++ +   ++    +LT L   +N L  L  + L +LT  N  +N+      L++     L
Sbjct: 76  ITTL---DLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLTK---LDVSQNPLL 129

Query: 219 DTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSG 278
             L+ + N +  I   +++  +QL  L+   N    ++   +     L  LD S NK++ 
Sbjct: 130 TYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT- 183

Query: 279 SIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIP----KTLRP 334
            +   +     L  L  + N++     L++ + + L  LD S N L+  I       L  
Sbjct: 184 ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EIDVTPLTQLT- 236

Query: 335 MYVDLSFNNLE 345
            Y D S N L 
Sbjct: 237 -YFDCSVNPLT 246

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 29/144 (20%), Positives = 61/144 (42%), Gaps = 11/144 (7%)

Query: 182 NNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQ 241
             +     P   F     ++ +  ++  +     + L +LD  ++ I  +    + KL+ 
Sbjct: 8   TQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTG 65

Query: 242 LKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLD 301
           L  L  +SN ++  +   + +  NL YL    NKL+ ++   +   + L  L  + N L 
Sbjct: 66  LTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL- 118

Query: 302 GTIPLEMGKILLLQNLDLSHNNLS 325
               L++ +  LL  L+ + N L+
Sbjct: 119 --TKLDVSQNPLLTYLNCARNTLT 140

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  128 bits (323), Expect = 8e-32
 Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 13/233 (5%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGN 135
               ++L+ +NI+  +    F    +L+ L L  NS+   I       L+ L  L L  N
Sbjct: 76  NTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDN 133

Query: 136 NLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVT-NNALGGLIPSTLF 194
            LT I       L  LR L+L +N +  +       + SL  L +     L  +      
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193

Query: 195 RLTN-----ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSS 249
            L N     +        +P  +     L+ L++S N    I P     LS LK L + +
Sbjct: 194 GLFNLKYLNLGMCNI-KDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251

Query: 250 NLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLD 301
           + +S     A   L +L+ L+L+ N LS S+P ++      L  L L+HN  +
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  128 bits (323), Expect = 9e-32
 Identities = 68/268 (25%), Positives = 100/268 (37%), Gaps = 26/268 (9%)

Query: 98  SCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLY 157
           SC      +      LS  +P  I   S  + L L  NN+  I       L +L  L L 
Sbjct: 51  SCSNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107

Query: 158 SNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN-----ISSNQFHSSIPLEI 212
            N +  +       L SL  L + +N L  +       L+      + +N    SIP   
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI-ESIPSYA 166

Query: 213 -GNFSALDTLDLSD-NKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLD 270
                +L  LDL +  K+  I       L  LK LNL    +   +P  +  L  L  L+
Sbjct: 167 FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELE 224

Query: 271 LSKNKLSGSIPTE-IGNCSALKNLTLNHNSLDGTIPLEMGKILL-LQNLDLSHNNLSGTI 328
           +S N     I        S+LK L + ++ +   I       L  L  L+L+HNNLS ++
Sbjct: 225 MSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SL 281

Query: 329 PKTLRPMYVDLSFNNLEGEIPTYLRGNP 356
           P  L        F  L   +  +L  NP
Sbjct: 282 PHDL--------FTPLRYLVELHLHHNP 301

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  125 bits (316), Expect = 1e-31
 Identities = 34/227 (14%), Positives = 71/227 (31%), Gaps = 27/227 (11%)

Query: 449 TEDFHIKYCIGTGGYGSVYKAE------LPEGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           ++  ++ + +G G +  VY+A           +   LK    +   +             
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMER 120

Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE--LNWTKRVNIVKS 560
           L        +K Y   L +    L+ E    G+L   ++      E  +     ++    
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS-----------VADFGTARLLHVDS 609
           + + +  +H      IIH DI  +N +L +                + D G +  + +  
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 610 SYRTLRA--GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                 A   T G+   E+        + D +        +L GT+ 
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  126 bits (317), Expect = 2e-31
 Identities = 58/283 (20%), Positives = 119/283 (42%), Gaps = 37/283 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH- 508
             + I   IG+GG   V++    + ++ A+K ++  E ++   + S++NE   L+ ++  
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 114

Query: 509 -RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
              I++LY + +  + ++++ E      L   L    ++I+    K     K++  A+  
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKS--YWKNMLEAVHT 170

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD--SSYRTLRAGTYGYIAPE 625
           +H      I+H D+   N L+       + DFG A  +  D  S  +  + G   Y+ PE
Sbjct: 171 IHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

Query: 626 L-----------AYTIVVTGKCDVYSFGVVALEVLMGTHP-GGLLSSLSSSSGPKIMLID 673
                            ++ K DV+S G +   +  G  P   +++ +      K+  I 
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAII 281

Query: 674 VLNQRLS-PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
             N  +  P + +K +QD++        CL   PK R ++  +
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIPEL 318

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  123 bits (311), Expect = 2e-31
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 59/294 (20%)

Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKLH-HSETEDSAFVKSFQNEAHVLSTVRHRN 510
           +G G +G V+ AE        +  +VA+K L   +        K FQ EA +L+ ++H +
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA----RKDFQREAELLTNLQHEH 78

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSL-------------FCVLHDDDEAIELNWTKRVNI 557
           IVK YG C     + +++EYM+ G L                        EL  ++ ++I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
              +A  + YL    +   +HRD+++ N L+ +NL   + DFG +R ++    Y   R G
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVG 192

Query: 618 TYGYI-----APE-LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIML 671
            +  +      PE + Y    T + DV+SFGV+  E+           +       ++  
Sbjct: 193 GHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIF----------TYGKQPWFQLSN 241

Query: 672 IDVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +V+        L  P    K V D++L       C   +P+ R  ++ I + L
Sbjct: 242 TEVIECITQGRVLERPRVCPKEVYDVML------GCWQREPQQRLNIKEIYKIL 289

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  125 bits (316), Expect = 3e-31
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 21/223 (9%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
            +   + +   +G G   +V++      G + A+K  ++        V     E  VL  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKK 63

Query: 506 VRHRNIVKLYGF--CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           + H+NIVKL+        +   LI E+   GSL+ VL +   A  L  ++ + +++ V  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEAS----VADFGTARLLHVDSSYRTLRAGTY 619
            +++L       I+HR+I   NI+     +      + DFG AR L  D  + +L  GT 
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTE 179

Query: 620 GYIAPELAYTIVVTG--------KCDVYSFGVVALEVLMGTHP 654
            Y+ P++    V+            D++S GV       G+ P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (324), Expect = 4e-31
 Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 45/286 (15%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKV--VALKKLHHSETEDSAFVKSFQNEAHVLST 505
           E   +  CIG G +G V++     PE     VA+K   +  ++     + F  EA  +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 447

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
             H +IVKL G    +  +++I E    G L   L     +++L     +     ++ AL
Sbjct: 448 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTAL 504

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI--- 622
           +YL    +   +HRDI++ N+L+ SN    + DFG +R +   + Y+     + G +   
Sbjct: 505 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKLPIK 557

Query: 623 --APELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQ-- 677
             APE       T   DV+ FGV   E+LM G  P              +   DV+ +  
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP-----------FQGVKNNDVIGRIE 606

Query: 678 ---RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
              RL  P N    +  ++        C +  P  RP    +  +L
Sbjct: 607 NGERLPMPPNCPPTLYSLMT------KCWAYDPSRRPRFTELKAQL 646

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  126 bits (317), Expect = 4e-31
 Identities = 67/269 (24%), Positives = 102/269 (37%), Gaps = 26/269 (9%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
            SC      +     +L   +P  I   +  + L LH N +  I       LR+L  L L
Sbjct: 39  CSCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95

Query: 157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN-----ISSNQFHSSIPLE 211
             N +  +       L +L  L + +N L  +       L+      + +N    SIP  
Sbjct: 96  SRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI-ESIPSY 154

Query: 212 I-GNFSALDTLDLSD-NKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYL 269
                 +L  LDL +  ++  I       LS L+ LNL+   L  +IP  +  L  L  L
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDEL 212

Query: 270 DLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKILL-LQNLDLSHNNLSGT 327
           DLS N LS +I          L+ L +  + +   I       L  L  ++L+HNNL+  
Sbjct: 213 DLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-L 269

Query: 328 IPKTLRPMYVDLSFNNLEGEIPTYLRGNP 356
           +P  L        F  L      +L  NP
Sbjct: 270 LPHDL--------FTPLHHLERIHLHHNP 290

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  126 bits (317), Expect = 4e-31
 Identities = 52/233 (22%), Positives = 93/233 (39%), Gaps = 13/233 (5%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGN 135
               ++L  + I+  +   +F    +L+ L L  N +  +I       L+ L  L L  N
Sbjct: 65  NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDN 122

Query: 136 NLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVT-NNALGGLIPSTLF 194
            LT I       L  L+ L+L +N +  +       + SL  L +     L  +      
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182

Query: 195 RLTN-----ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSS 249
            L+N     ++       IP  +     LD LDLS N +  I P     L  L+ L +  
Sbjct: 183 GLSNLRYLNLAMCNL-REIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240

Query: 250 NLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLD 301
           + +      A   L +L+ ++L+ N L+  +P ++      L+ + L+HN  +
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  123 bits (311), Expect = 5e-31
 Identities = 73/295 (24%), Positives = 121/295 (41%), Gaps = 60/295 (20%)

Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKL--HHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G G +G V +A             VA+K L       E  A +     E  ++S + +H
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS----ELKIMSHLGQH 109

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR-----------VNI 557
            NIV L G C H   + +I EY   G L   L      +E +               ++ 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
              VA  +++L    + + IHRD+++ N+LL +   A + DFG AR +  DS+Y      
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY---IVK 223

Query: 618 TYGYI-----APELAYTIVVTGKCDVYSFGVVALEVL-MGTHP-GGLLSSLSSSSGPKIM 670
               +     APE  +  V T + DV+S+G++  E+  +G +P  G+L +          
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--------- 274

Query: 671 LIDVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                       +++ P    K +  I+       AC + +P  RPT Q+I   L
Sbjct: 275 --KFYKLVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQICSFL 321

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  123 bits (310), Expect = 6e-31
 Identities = 72/306 (23%), Positives = 127/306 (41%), Gaps = 63/306 (20%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELP--------EGKVVALKKL--HHSETEDSAFVKSFQNE 499
           +   +   +G G +G V  AE          E   VA+K L    +E + S  V     E
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----E 90

Query: 500 AHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCVLHDDDE 545
             ++  + +H+NI+ L G C     +++I EY  +G+L             +    +   
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 546 AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL 605
             ++ +   V+    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207

Query: 606 HVDSSYRTLRAGTYGYI-----APE-LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLS 659
           +    Y   +  T G +     APE L    V T + DV+SFGV+  E+           
Sbjct: 208 NNIDYY---KKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIF---------- 253

Query: 660 SLSSSSGPKIMLIDVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           +L  S  P I + ++        R+  P N    +  ++        C  + P  RPT +
Sbjct: 254 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQRPTFK 307

Query: 714 RISQEL 719
           ++ ++L
Sbjct: 308 QLVEDL 313

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  125 bits (315), Expect = 7e-31
 Identities = 62/308 (20%), Positives = 117/308 (37%), Gaps = 53/308 (17%)

Query: 443 EDLINATEDFHIKYC----IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQN 498
            ++ N  +           +G G  G+V      +G+ VA+K++         F      
Sbjct: 4   ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM------LIDFCDIALM 57

Query: 499 EAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVL----HDDDEAIELNWTK 553
           E  +L+    H N+++ Y      + +++  E     +L  ++      D+         
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN 116

Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-------------NLEASVADFG 600
            +++++ +A  +++LH    L IIHRD+   NIL+ +             NL   ++DFG
Sbjct: 117 PISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173

Query: 601 TARLLHVDSSYRTLR----AGTYGYIAPEL-------AYTIVVTGKCDVYSFGVVALEVL 649
             + L    S         +GT G+ APEL            +T   D++S G V   +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

Query: 650 -MGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDII-LVSTIAFACLSSQPK 707
             G HP G       S    I+        +    ++ ++ +   L+S      +   P 
Sbjct: 234 SKGKHPFG----DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS----QMIDHDPL 285

Query: 708 SRPTMQRI 715
            RPT  ++
Sbjct: 286 KRPTAMKV 293

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  124 bits (312), Expect = 8e-31
 Identities = 70/306 (22%), Positives = 126/306 (41%), Gaps = 63/306 (20%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELP--------EGKVVALKKL--HHSETEDSAFVKSFQNE 499
           +   +   +G G +G V  AE              VA+K L    +E + S  +     E
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS----E 124

Query: 500 AHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCVLHDDDE 545
             ++  + +H+NI+ L G C     +++I EY  +G+L             +      + 
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 546 AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL 605
             +L+    V+    VA  + YL    +   IHRD+++ N+L+  +    +ADFG AR +
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241

Query: 606 HVDSSYRTLRAGTYGYI-----APE-LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLS 659
           H    Y   +  T G +     APE L    + T + DV+SFGV+  E+           
Sbjct: 242 HHIDYY---KKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIF---------- 287

Query: 660 SLSSSSGPKIMLIDVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           +L  S  P + + ++        R+  P N    +  ++        C  + P  RPT +
Sbjct: 288 TLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFK 341

Query: 714 RISQEL 719
           ++ ++L
Sbjct: 342 QLVEDL 347

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  127 bits (320), Expect = 1e-30
 Identities = 65/300 (21%), Positives = 105/300 (35%), Gaps = 27/300 (9%)

Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
            + +K  +GTGG+G V +      G+ VA+K+     +  +   + +  E  ++  + H 
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHP 72

Query: 510 NIVKLY------GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           N+V                   L  EY E G L   L+  +    L       ++  ++ 
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYG 620
           AL YLH      IIHRD+   NI+L    +     + D G A+ L           GT  
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF-VGTLQ 188

Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS 680
           Y+APEL      T   D +SFG +A E + G  P         +  P      V  +   
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP------FLPNWQPVQWHGKVREKSNE 242

Query: 681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISELRN 740
             V         L   + F+ +   P     +     E       M    +  +  +  N
Sbjct: 243 HIVVYD-----DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  123 bits (310), Expect = 1e-30
 Identities = 72/306 (23%), Positives = 127/306 (41%), Gaps = 63/306 (20%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL--------PEGKVVALKKL--HHSETEDSAFVKSFQNE 499
           +   +   +G G +G V  AE          E   VA+K L    +E + S  V     E
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----E 136

Query: 500 AHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCVLHDDDE 545
             ++  + +H+NI+ L G C     +++I EY  +G+L             +    +   
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 546 AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL 605
             ++ +   V+    +A  + YL    +   IHRD+++ N+L+  N    +ADFG AR +
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253

Query: 606 HVDSSYRTLRAGTYGYI-----APE-LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLS 659
           +    Y   +  T G +     APE L    V T + DV+SFGV+  E+           
Sbjct: 254 NNIDYY---KKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIF---------- 299

Query: 660 SLSSSSGPKIMLIDVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           +L  S  P I + ++        R+  P N    +  ++        C  + P  RPT +
Sbjct: 300 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQRPTFK 353

Query: 714 RISQEL 719
           ++ ++L
Sbjct: 354 QLVEDL 359

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  121 bits (306), Expect = 1e-30
 Identities = 74/311 (23%), Positives = 127/311 (40%), Gaps = 68/311 (21%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELP-----EGKV-VALKKL--HHSETEDSAFVKSFQNEAH 501
           ++  +   +G G +G V KA         G   VA+K L  + S +E    +     E +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS----EFN 78

Query: 502 VLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL---------------------FCVL 540
           VL  V H +++KLYG C     + LI EY + GSL                         
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 541 HDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG 600
            D  +   L     ++    ++  + YL     + ++HRD+++ NIL+    +  ++DFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFG 195

Query: 601 TARLLHVDSSYRTLRAGTYGYI-----APE-LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            +R ++ + SY      + G I     A E L    + T + DV+SFGV+  E++     
Sbjct: 196 LSRDVYEEDSY---VKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIV----- 246

Query: 655 GGLLSSLSSSSGPKIMLIDVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKS 708
                +L  +  P I    + N      R+  P N  + +  ++L       C   +P  
Sbjct: 247 -----TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLML------QCWKQEPDK 295

Query: 709 RPTMQRISQEL 719
           RP    IS++L
Sbjct: 296 RPVFADISKDL 306

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  122 bits (307), Expect = 2e-30
 Identities = 73/306 (23%), Positives = 116/306 (37%), Gaps = 58/306 (18%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELP-----EGKV-VALKKLHHSETEDSAFVKSFQNEAHVL 503
            +      IG G +G V++A  P     E    VA+K L    + D      FQ EA ++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 104

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSL--FCVLHDDDEAIELNWTKRVNIVKSV 561
           +   + NIVKL G C   K M L++EYM  G L  F           L+ +      +  
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164

Query: 562 AHALSYLHHDCTLSI----------------IHRDISSNNILLDSNLEASVADFGTARLL 605
           +     L     L I                +HRD+++ N L+  N+   +ADFG +R +
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224

Query: 606 HVDSSYRTLRAGTYGYI-----APE-LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLS 659
           +    Y   +A     I      PE + Y    T + DV+++GVV  E+           
Sbjct: 225 YSADYY---KADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIF---------- 270

Query: 660 SLSSSSGPKIMLIDVLN-----QRLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQ 713
           S        +   +V+        L+ P N    + +++        C S  P  RP+  
Sbjct: 271 SYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMR------LCWSKLPADRPSFC 324

Query: 714 RISQEL 719
            I + L
Sbjct: 325 SIHRIL 330

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  121 bits (305), Expect = 2e-30
 Identities = 75/299 (25%), Positives = 122/299 (40%), Gaps = 57/299 (19%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL--PEGKV-VALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            D   +  IG G +G V KA +     ++  A+K++    ++D    + F  E  VL  +
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 82

Query: 507 -RHRNIVKLYGFCLHKKCMFLIYEYMERGSL-------------FCVLHDDDEAIELNWT 552
             H NI+ L G C H+  ++L  EY   G+L                   +  A  L+  
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR 612
           + ++    VA  + YL        IHRD+++ NIL+  N  A +ADFG +R         
Sbjct: 143 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEV- 194

Query: 613 TLRAGTYGYI-----APE-LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG 666
                T G +     A E L Y+ V T   DV+S+GV+  E++          SL  +  
Sbjct: 195 -YVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIV----------SLGGTPY 242

Query: 667 PKIMLIDVLNQ-----RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             +   ++  +     RL  P+N    V D++        C   +P  RP+  +I   L
Sbjct: 243 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSL 295

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  126 bits (319), Expect = 3e-30
 Identities = 61/286 (21%), Positives = 105/286 (36%), Gaps = 28/286 (9%)

Query: 77  RITDIDLLNSNIKGELGRLNFS--CFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHG 134
            I        NIK +  +  F+     +++ LDL +  +         +L  LK L L  
Sbjct: 241 HIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY 299

Query: 135 NNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLF 194
           N +  I  +    L NL+ L L  N L  +       L  +  + +  N +  +   T  
Sbjct: 300 NKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK 359

Query: 195 RLTNI-----SSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSS 249
            L  +       N   +     I    ++  + LS NK+  +    L        ++LS 
Sbjct: 360 FLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSE 410

Query: 250 NLLSG-QIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLE 307
           N L    I Y + ++ +L  L L++N+ S     +      +L+ L L  N L      E
Sbjct: 411 NRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETE 470

Query: 308 MGKILL-----LQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNL 344
           +   +      LQ L L+HN L+   P     +     + L+ N L
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  123 bits (311), Expect = 3e-29
 Identities = 59/327 (18%), Positives = 117/327 (35%), Gaps = 47/327 (14%)

Query: 65  CNWVGITCDYEGR-----------ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSL 113
           C++ G    Y                 + L  + I+  +   +F     L+ L+L +   
Sbjct: 2   CSFDGRIAFYRFCNLTQVPQVLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYT 60

Query: 114 SGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQE--IG 170
             +I  +   +L  L+ L L  + +  + P     L +L  L LY   LS  + ++    
Sbjct: 61  PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120

Query: 171 NLKSLTELYVTNNALGGLIPSTLFR-LTN-----ISSNQFHSSIPLEIGNFSA--LDTLD 222
           NLK+LT L ++ N +  L     F  L +      SSNQ       E+       L    
Sbjct: 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFS 180

Query: 223 LSDNKIHGIIPDELTKLSQ------LKNLNLSSNLLSGQIPYAIGKLF------------ 264
           L+ N ++  +  +  K         L+ L++S N  +  I                    
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAH 240

Query: 265 NLMYLDLSKNKLSGSIPTEIGN--CSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHN 322
           ++M      + +             S++++L L+H  +          +  L+ L+L++N
Sbjct: 241 HIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYN 300

Query: 323 NLSGTIPKTLRPM----YVDLSFNNLE 345
            ++    +    +     ++LS+N L 
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLG 327

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  118 bits (297), Expect = 1e-27
 Identities = 67/298 (22%), Positives = 107/298 (35%), Gaps = 34/298 (11%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLS--KLKCLYLHG 134
            +T +DL  + I+      +F    +LKS+D  +N +      ++  L    L    L  
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183

Query: 135 NNLTGIIPKEIGSLRN------LRGLFLYSNKLSGVLPQEIGNLKSLTELY--------- 179
           N+L   +  + G   N      L  L +  N  +  +     N  S ++ +         
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243

Query: 180 -----------VTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKI 228
                         N   GL  S++  L ++S     S           L  L+L+ NKI
Sbjct: 244 GAGFGFHNIKDPDQNTFAGLARSSVRHL-DLSHGFVFSLNSRVFETLKDLKVLNLAYNKI 302

Query: 229 HGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCS 288
           + I  +    L  L+ LNLS NLL          L  + Y+DL KN ++           
Sbjct: 303 NKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362

Query: 289 ALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEG 346
            L+ L L  N+L       +  I  + ++ LS N L       L    + LS N LE 
Sbjct: 363 KLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLEN 415

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  103 bits (258), Expect = 7e-23
 Identities = 76/392 (19%), Positives = 131/392 (33%), Gaps = 68/392 (17%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPK 143
           L+ N+ GEL   NF   P +  +DL  N ++         L KL+ L L  N LT     
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT----- 375

Query: 144 EIGSLRNLRGLFLYSNKLSGVLPQEI---------------------GNLKSLTELYVTN 182
            I  + ++  +FL  NKL  +    +                       +  L  L +  
Sbjct: 376 TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQ 435

Query: 183 NALGGLIPSTLFRLT------NISSNQFHSSIPLEI-----GNFSALDTLDLSDNKIHGI 231
           N                     +  N    +   E+        S L  L L+ N ++ +
Sbjct: 436 NRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSL 495

Query: 232 IPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALK 291
            P   + L+ L+ L+L+SN L+  + +      NL  LD+S+N+L    P       +L 
Sbjct: 496 PPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNP---DVFVSLS 550

Query: 292 NLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTY 351
            L + HN       L       +  L+ ++  ++G                ++    P  
Sbjct: 551 VLDITHNKFICECELST----FINWLNHTNVTIAG-------------PPADIYCVYPDS 593

Query: 352 LRGNPPKSFVGNKGLSGNVEGFPSSSQRQKLTPSISLFAKIFLPLNLVLAFIIFGF-TLL 410
             G    S         + EG       + L  S+ +   + L L L+    +  F    
Sbjct: 594 FSGVSLFSL--------STEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFC 645

Query: 411 FKCQNKNPRLNSRAAKNGDVFSVWNYDGKILY 442
           F C     RL  +    G    ++ YD  + +
Sbjct: 646 FICYKTAQRLVFKDHPQGTEPDMYKYDAYLCF 677

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  119 bits (301), Expect = 4e-30
 Identities = 53/229 (23%), Positives = 78/229 (34%), Gaps = 26/229 (11%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
               + + L  N +S  +P     +   L  L+LH N L  I       L  L  L L  
Sbjct: 31  PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89

Query: 159 NKLSGVLPQEI-GNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSA 217
           N     +       L  L  L++               L  +    F           +A
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRC-----------GLQELGPGLFR--------GLAA 130

Query: 218 LDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLS 277
           L  L L DN +  +  D    L  L +L L  N +S     A   L +L  L L +N+++
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190

Query: 278 GSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKIL-LLQNLDLSHNNL 324
             +      +   L  L L  N+L   +P E    L  LQ L L+ N  
Sbjct: 191 -HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  116 bits (293), Expect = 4e-29
 Identities = 58/227 (25%), Positives = 81/227 (35%), Gaps = 25/227 (11%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNN 136
              I L  + I   +   +F    NL  L L +N L+  I       L+ L+ L L  N 
Sbjct: 34  SQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNA 91

Query: 137 LTGIIPKEI-GSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFR 195
               +       L  L  L L    L  + P     L +L  LY+ +N            
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN-----------A 140

Query: 196 LTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQ 255
           L  +  + F         +   L  L L  N+I  +       L  L  L L  N ++  
Sbjct: 141 LQALPDDTFR--------DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192

Query: 256 IPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLD 301
            P+A   L  LM L L  N LS ++PTE      AL+ L LN N   
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  115 bits (290), Expect = 1e-28
 Identities = 63/263 (23%), Positives = 101/263 (38%), Gaps = 37/263 (14%)

Query: 98  SCFPNLK-SLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
            C+   K +       L  ++P  I   +  + ++LHGN ++ +      + RNL  L+L
Sbjct: 7   VCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWL 63

Query: 157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFS 216
           +SN L+ +       L  L +L +++NA          +L ++    FH           
Sbjct: 64  HSNVLARIDAAAFTGLALLEQLDLSDNA----------QLRSVDPATFH--------GLG 105

Query: 217 ALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPY-AIGKLFNLMYLDLSKNK 275
            L TL L    +  + P     L+ L+ L L  N L   +P      L NL +L L  N+
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNR 164

Query: 276 LSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKIL-LLQNLDLSHNNLSGTIPKTLR 333
           +S S+P        +L  L L+ N +   +     + L  L  L L  NNLS  +P    
Sbjct: 165 IS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEA- 220

Query: 334 PMYVDLSFNNLEGEIPTYLRGNP 356
                     L       L  NP
Sbjct: 221 -------LAPLRALQYLRLNDNP 236

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  119 bits (301), Expect = 5e-30
 Identities = 56/254 (22%), Positives = 101/254 (39%), Gaps = 19/254 (7%)

Query: 98  SCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLY 157
               N   +    ++++ ++      L  +  L   G  +T I  + +  L NL GL L 
Sbjct: 16  PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71

Query: 158 SNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRLT--NISSNQFHSSIPLEIGN 214
            N+++ + P  + NL  +TEL ++ N L  +   + L  +   +++S Q     PL    
Sbjct: 72  DNQITDLAP--LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA--G 127

Query: 215 FSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKN 274
            S L  L L  N+I  I P  L  L+ L+ L++ +  +S   P  +  L  L  L    N
Sbjct: 128 LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDN 183

Query: 275 KLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRP 334
           K+S  I   + +   L  + L +N +    PL       L  + L++  ++         
Sbjct: 184 KIS-DIS-PLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNN 239

Query: 335 MYVDLSFNNLEGEI 348
           + V        G  
Sbjct: 240 LVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  115 bits (290), Expect = 2e-28
 Identities = 53/250 (21%), Positives = 100/250 (40%), Gaps = 20/250 (8%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
              I    SN+   +     +    + +L  +   ++ +I   +  L+ L  L L  N +
Sbjct: 21  AIKIAAGKSNVTDTV---TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQI 75

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRL 196
           T + P  + +L  +  L L  N L  V    I  L+S+  L +T+  +  + P + L  L
Sbjct: 76  TDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 197 T--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSG 254
               +  NQ  +  PL     + L  L + + ++  + P  L  LS+L  L    N +S 
Sbjct: 132 QVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS- 186

Query: 255 QIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLL 314
            I   +  L NL+ + L  N++S   P  + N S L  +TL + ++          +++ 
Sbjct: 187 DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVP 243

Query: 315 QNLDLSHNNL 324
             +       
Sbjct: 244 NVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 45/186 (24%), Positives = 80/186 (43%), Gaps = 15/186 (8%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
             +   ++K+LDL +  ++  + P +  LS L+ LYL  N +T I P  +  L NL+ L 
Sbjct: 102 AIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLS 157

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRLT--NISSNQFHSSIPLEI 212
           + + ++S +    + NL  LT L   +N +  + P ++L  L   ++ +NQ     PL  
Sbjct: 158 IGNAQVSDL--TPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSPLA- 214

Query: 213 GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNL-NLSSNLLSGQIPYAIGKLFNLMYLDL 271
            N S L  + L++  I          L     +   S   ++   P  I         +L
Sbjct: 215 -NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA---PATISDNGTYASPNL 270

Query: 272 SKNKLS 277
           + N  S
Sbjct: 271 TWNLTS 276

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  123 bits (310), Expect = 6e-30
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 30/225 (13%)

Query: 445 LINATEDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNE 499
           + ++T  F  +Y      G G +G V    +   G+  A+K +   + +     +S   E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNW---TKRVN 556
             +L  + H NI+KLY F   K   +L+ E    G LF      DE I            
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAAR 130

Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRT 613
           I++ V   ++Y+H      I+HRD+   N+LL+S  + +   + DFG +         + 
Sbjct: 131 IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187

Query: 614 LRAGTYGYIAPELAYTIVVTG----KCDVYSFGVVALEVLMGTHP 654
            + GT  YIAPE     V+ G    KCDV+S GV+   +L G  P
Sbjct: 188 -KIGTAYYIAPE-----VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  119 bits (301), Expect = 6e-30
 Identities = 74/302 (24%), Positives = 117/302 (38%), Gaps = 54/302 (17%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKL--HHSETEDSAFVKSFQNEAH 501
                   +G G +G V +A             VA+K L      TE  A +     E  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS----ELK 78

Query: 502 VLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMERGSL---------------FCVLHDDDE 545
           VLS +  H NIV L G C       +I EY   G L                     +D+
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 546 AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL 605
            + L+    ++    VA  +++L    + + IHRD+++ NILL       + DFG AR +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 606 HVDSSYRTLRAGTYGYI-----APELAYTIVVTGKCDVYSFGVVALEVL-MGTHP-GGLL 658
             DS+Y          +     APE  +  V T + DV+S+G+   E+  +G+ P  G+ 
Sbjct: 196 KNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM- 251

Query: 659 SSLSSSSGPKIMLIDVLNQRLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
                    K   +     R+  P +    + DI+        C  + P  RPT ++I Q
Sbjct: 252 -----PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQ 300

Query: 718 EL 719
            +
Sbjct: 301 LI 302

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  118 bits (299), Expect = 6e-30
 Identities = 51/298 (17%), Positives = 103/298 (34%), Gaps = 55/298 (18%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV- 506
           T +FH    IG+G +GSV+K  +  +G + A+K+        S   ++   E +  + + 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK-PLAGSVDEQNALREVYAHAVLG 68

Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE-LNWTKRVNIVKSVAHAL 565
           +H ++V+ +        M +  EY   GSL   + ++   +      +  +++  V   L
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSN-------------------LEASVADFGTARLLH 606
            Y+H     S++H DI  +NI +                      +   + D G    + 
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 607 VDSSYRTLRAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVALEVLMGTHP---GGLLSSLS 662
                     G   ++A E L        K D+++  +  +           G     + 
Sbjct: 186 SPQVEE----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR 241

Query: 663 SSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
               P+I       Q LS    + +              +   P+ RP+    +  L+
Sbjct: 242 QGRLPRI------PQVLSQEFTELLKV-----------MIHPDPERRPS----AMALV 278

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  120 bits (302), Expect = 8e-30
 Identities = 49/231 (21%), Positives = 94/231 (40%), Gaps = 36/231 (15%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLH--------------HSETEDSAFVKS 495
            D+ I   +  G +  +   E  + K  ALKK                + +    +    
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 496 FQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-----DDDEAIELN 550
           F+NE  +++ +++   +   G   +   +++IYEYME  S+          D +    + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 551 WTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS 610
                 I+KSV ++ SY+H+    +I HRD+  +NIL+D N    ++DFG +   ++   
Sbjct: 150 IQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDK 205

Query: 611 YRTLRAGTYGYIAPELAYTIVVTGK-------CDVYSFGVVALEVLMGTHP 654
                 GTY ++ PE       + +        D++S G+    +     P
Sbjct: 206 KIKGSRGTYEFMPPE-----FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  120 bits (302), Expect = 9e-30
 Identities = 54/268 (20%), Positives = 96/268 (35%), Gaps = 28/268 (10%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
              +KSLDL NN ++  I          L+ L L  N +  I      SL +L  L L  
Sbjct: 51  TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109

Query: 159 NKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN------ISSNQFHSSIPLEI 212
           N LS +       L SLT L +  N    L  ++LF          + +    + I  + 
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 213 -GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDL 271
               + L+ L++  + +    P  L  +  + +L L        +   +    ++  L+L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229

Query: 272 SKNKLSGSIPTEI--------GNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNN 323
               L     +E+              +N+ +   SL   +   + +I  L  L+ S N 
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL-FQVMKLLNQISGLLELEFSRNQ 288

Query: 324 LSGTIP-------KTLRPMYVDLSFNNL 344
           L  ++P        +L+   + L  N  
Sbjct: 289 LK-SVPDGIFDRLTSLQ--KIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  105 bits (263), Expect = 1e-24
 Identities = 49/222 (22%), Positives = 94/222 (42%), Gaps = 20/222 (9%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEI-GSLRNLRGL 154
           FS   +L+ LDL  N LS ++       LS L  L L GN    +    +   L  L+ L
Sbjct: 96  FSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154

Query: 155 FLYSN-KLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNI-----SSNQFHSSI 208
            + +    + +  ++   L  L EL +  + L    P +L  + N+        Q    +
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLL 214

Query: 209 PLEIGNFSALDTLDLSDNKIHG--------IIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
            + +   S+++ L+L D  +             + L K    +N+ ++   L  Q+   +
Sbjct: 215 EIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLL 273

Query: 261 GKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLD 301
            ++  L+ L+ S+N+L  S+P  I    ++L+ + L+ N  D
Sbjct: 274 NQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 80.2 bits (198), Expect = 3e-16
 Identities = 30/175 (17%), Positives = 65/175 (37%), Gaps = 14/175 (8%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGN 135
           ++  + + N +   ++ R +F+    L+ L++  + L  S  P+   S+  +  L LH  
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMK 208

Query: 136 NLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFR 195
               ++   +    ++  L L    L      E+           +      LI    FR
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL-----------STGETNSLIKKFTFR 257

Query: 196 LTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSN 250
              I+       +   +   S L  L+ S N++  +      +L+ L+ + L +N
Sbjct: 258 NVKITDESL-FQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 14/153 (9%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
           S+   +SIP  +    A+ +LDLS+N+I  I   +L +   L+ L L+SN ++     + 
Sbjct: 39  SSGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSF 96

Query: 261 GKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEM-GKILLLQNLD 318
             L +L +LDLS N LS ++ +      S+L  L L  N         +   +  LQ L 
Sbjct: 97  SSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155

Query: 319 LSHNNLSGTIPK-------TLRPMYVDLSFNNL 344
           + + +    I +        L    +++  ++L
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLE--ELEIDASDL 186

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 11/66 (16%), Positives = 27/66 (40%), Gaps = 1/66 (1%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
           +       +++ + + SL   +   +  +S L  L    N L  +       L +L+ ++
Sbjct: 249 SLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIW 307

Query: 156 LYSNKL 161
           L++N  
Sbjct: 308 LHTNPW 313

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  121 bits (305), Expect = 1e-29
 Identities = 66/261 (25%), Positives = 106/261 (40%), Gaps = 36/261 (13%)

Query: 419 RLNSRAAKNGDVFSVWNYDGKI-LYEDLI-----NATEDFHIKYCI----GTGGYGSVYK 468
           +   R   N    ++     K+ ++ DL         +    +Y +    G+G  G V  
Sbjct: 94  KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153

Query: 469 A-ELPEGKVVALK-----KLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK 522
           A E    K VA++     K       ++    + + E  +L  + H  I+K+  F    +
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAE 212

Query: 523 CMFLIYEYMERGSLFCVLHDDDEAIE---LNWTKRVNIVKSVAHALSYLHHDCTLSIIHR 579
             +++ E ME G LF      D+ +    L           +  A+ YLH      IIHR
Sbjct: 213 DYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHR 263

Query: 580 DISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG-- 634
           D+   N+LL S  E     + DFG +++L   S  RTL  GT  Y+APE+  ++   G  
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPTYLAPEVLVSVGTAGYN 322

Query: 635 -KCDVYSFGVVALEVLMGTHP 654
              D +S GV+    L G  P
Sbjct: 323 RAVDCWSLGVILFICLSGYPP 343

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  119 bits (300), Expect = 1e-29
 Identities = 68/301 (22%), Positives = 114/301 (37%), Gaps = 53/301 (17%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKL--HHSETEDSAFVKSFQNEAH 501
           +   +   +G G +G V +A+          + VA+K L    + +E  A +     E  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS----ELK 82

Query: 502 VLSTV-RHRNIVKLYGFCLHKKC-MFLIYEYMERGSL-------------FCVLHDDDEA 546
           +L  +  H N+V L G C      + +I E+ + G+L             + V  +D   
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 547 IELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH 606
             L     +     VA  + +L    +   IHRD+++ NILL       + DFG AR ++
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199

Query: 607 VDSSYRTLRAGTYGYI-----APELAYTIVVTGKCDVYSFGVVALEVL-MGTHP-GGLLS 659
            D  Y          +     APE  +  V T + DV+SFGV+  E+  +G  P  G+  
Sbjct: 200 KDPDY---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-- 254

Query: 660 SLSSSSGPKIMLIDVLNQRLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE 718
                   +         R+  P      +   +L       C   +P  RPT   + + 
Sbjct: 255 ----KIDEEFCRRLKEGTRMRAPDYTTPEMYQTML------DCWHGEPSQRPTFSELVEH 304

Query: 719 L 719
           L
Sbjct: 305 L 305

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  118 bits (297), Expect = 2e-29
 Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 33/231 (14%)

Query: 443 EDLINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAH 501
             L +    F +   +G G YG VYK   +  G++ A+K +  +  E+    +  + E +
Sbjct: 17  SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEIN 72

Query: 502 VLSTV-RHRNIVKLYGFCLHKKC------MFLIYEYMERGSLFCVLHDDDEAIELNWTKR 554
           +L     HRNI   YG  + K        ++L+ E+   GS+        + I+      
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-------TDLIKNTKGNT 125

Query: 555 VN------IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           +       I + +   LS+LH      +IHRDI   N+LL  N E  + DFG +  L   
Sbjct: 126 LKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182

Query: 609 SSYRTLRAGTYGYIAPELAYTIVVTG-----KCDVYSFGVVALEVLMGTHP 654
              R    GT  ++APE+             K D++S G+ A+E+  G  P
Sbjct: 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  121 bits (306), Expect = 4e-29
 Identities = 47/236 (19%), Positives = 86/236 (36%), Gaps = 9/236 (3%)

Query: 98  SCFPNLKSLDLWNNSLSGSIPPQ-IGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
                +KSLDL  N ++  I    + + + L+ L L  + +  I      SL +L  L L
Sbjct: 23  GLTAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81

Query: 157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFR-LTN-----ISSNQFHSSIPL 210
             N LS +     G L SL  L +  N    L  ++LF  LTN     I + +  S I  
Sbjct: 82  SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141

Query: 211 E-IGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYL 269
                 ++L+ L++    +       L  +  + +L L  +  +  +      L ++ YL
Sbjct: 142 IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYL 201

Query: 270 DLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLS 325
           +L    L+    + +        +                ++L L    L  + + 
Sbjct: 202 ELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  115 bits (290), Expect = 3e-27
 Identities = 45/301 (14%), Positives = 98/301 (32%), Gaps = 33/301 (10%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQ-IGSLSKLKCLYLHGNN 136
           +  ++L+ +  +       F    NL++L + N      I       L+ L  L +   +
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRL 196
           L     + + S+R++  L L+ ++ + +L      L S+  L + +  L     S L   
Sbjct: 160 LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVD 219

Query: 197 TNISS-----------------------NQFHSSIPLEIGNFSALDTLDLSDNKIHGIIP 233
              S                                +E  + +     D + ++   +  
Sbjct: 220 EVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSE 279

Query: 234 DELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNL 293
               +   ++ L++    L   +      L  +  + +  +K+     +   +  +L+ L
Sbjct: 280 LGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFL 339

Query: 294 TLNHN---SLDGTIPLEMGKILLLQNLDLSHNNLS--GTIPKTLRPM----YVDLSFNNL 344
            L+ N             G    LQ L LS N+L       + L  +     +D+S N  
Sbjct: 340 DLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399

Query: 345 E 345
            
Sbjct: 400 H 400

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  112 bits (282), Expect = 4e-26
 Identities = 51/275 (18%), Positives = 94/275 (34%), Gaps = 34/275 (12%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN 136
            +  +   N +    +  L       ++ L +    L   +      L K+K + +  + 
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQE---IGNLKSLTELYVTNNALGGLIPSTL 193
           +  +       L++L  L L  N +     +     G   SL  L ++ N          
Sbjct: 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN---------- 371

Query: 194 FRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLS 253
             L ++            +     L +LD+S N  H  +PD      +++ LNLSS  + 
Sbjct: 372 -HLRSM------QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423

Query: 254 GQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILL 313
             +   I     L  LD+S N L  S    +     L+ L ++ N L  T+P +     +
Sbjct: 424 -VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLP-DASLFPV 474

Query: 314 LQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNL 344
           L  + +S N L          +     + L  N  
Sbjct: 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  111 bits (279), Expect = 8e-26
 Identities = 48/273 (17%), Positives = 97/273 (35%), Gaps = 19/273 (6%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQ-IGSLSKLKCLYLHGNNLTGI-I 141
           L S+    +    F    +L+ LDL +N LS S+     G LS LK L L GN    + +
Sbjct: 57  LKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGV 115

Query: 142 PKEIGSLRNLRGLFLYS-NKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNI- 199
                +L NL+ L + +    S +   +   L SL EL +   +L      +L  + +I 
Sbjct: 116 TSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIH 175

Query: 200 ----SSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQ 255
                 ++    + +     S++  L+L D  +       L        +   +   S  
Sbjct: 176 HLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVL 235

Query: 256 IPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQ 315
              +  +L  L+   L  +++         +C+       N +  D    L   + + ++
Sbjct: 236 TDESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289

Query: 316 NLDLSHNNLSGTIPKTLRPM----YVDLSFNNL 344
            L +    L   +      +     + +  + +
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  108 bits (272), Expect = 7e-25
 Identities = 47/234 (20%), Positives = 89/234 (38%), Gaps = 22/234 (9%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGS-LSKLKCLYLHGNNLTGIIP 142
           +            +S    +K + + N+ +   +P      L  L+ L L  N +     
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYL 351

Query: 143 KE---IGSLRNLRGLFLYSNKLS--GVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT 197
           K     G+  +L+ L L  N L       + +  LK+LT L ++ N     +P +     
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPE 410

Query: 198 -----NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLL 252
                N+SS        ++      L+ LD+S+N +          L +L+ L +S N L
Sbjct: 411 KMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNNLDSFSLF----LPRLQELYISRNKL 463

Query: 253 SGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPL 306
              +P        L+ + +S+N+L           ++L+ + L+ N  D + P 
Sbjct: 464 K-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  120 bits (302), Expect = 8e-29
 Identities = 64/230 (27%), Positives = 94/230 (40%), Gaps = 41/230 (17%)

Query: 445 LINATEDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVK 494
           + +        Y      G+G YG V    +       A+K      +  S         
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK----- 82

Query: 495 SFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNW--- 551
               E  VL  + H NI+KLY F   K+  +L+ E  + G LF      DE I       
Sbjct: 83  -LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF------DEIIHRMKFNE 135

Query: 552 TKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVD 608
                I+K V   ++YLH     +I+HRD+   N+LL+S  + +   + DFG + +    
Sbjct: 136 VDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192

Query: 609 SSYRTLRAGTYGYIAPELAYTIVVTG----KCDVYSFGVVALEVLMGTHP 654
              +  R GT  YIAPE     V+      KCDV+S GV+   +L G  P
Sbjct: 193 KKMKE-RLGTAYYIAPE-----VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  117 bits (294), Expect = 1e-28
 Identities = 63/301 (20%), Positives = 117/301 (38%), Gaps = 63/301 (20%)

Query: 458 IGTGGYGSVYKAEL------PEGKVVALKKL--HHSETEDSAFVKSFQNEAHVLSTV-RH 508
           +G+G +G V  A             VA+K L      +E  A +     E  +++ +  H
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS----ELKMMTQLGSH 108

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSL--------------------FCVLHDDDEAIE 548
            NIV L G C     ++LI+EY   G L                       L ++++   
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           L +   +     VA  + +L      S +HRD+++ N+L+       + DFG AR +  D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 609 SSYRTLRAGTYGYI-----APELAYTIVVTGKCDVYSFGVVALEVL-MGTHP-GGLLSSL 661
           S+Y          +     APE  +  + T K DV+S+G++  E+  +G +P  G+    
Sbjct: 226 SNY---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI---- 278

Query: 662 SSSSGPKIMLIDVLNQ--RLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQE 718
                       ++    ++  P    + +  I+       +C +   + RP+   ++  
Sbjct: 279 ----PVDANFYKLIQNGFKMDQPFYATEEIYIIMQ------SCWAFDSRKRPSFPNLTSF 328

Query: 719 L 719
           L
Sbjct: 329 L 329

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  115 bits (291), Expect = 2e-28
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 26/211 (12%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSFQNEAHV 502
            +++ +   +G+G  G V  A E    K VA+K     K       ++    + + E  +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE---LNWTKRVNIVK 559
           L  + H  I+K+  F    +  +++ E ME G LF      D+ +    L          
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFY 121

Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRA 616
            +  A+ YLH      IIHRD+   N+LL S  E     + DFG +++L   S  RTL  
Sbjct: 122 QMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-C 177

Query: 617 GTYGYIAPELAYTIVVTG---KCDVYSFGVV 644
           GT  Y+APE+  ++   G     D +S GV+
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  114 bits (288), Expect = 2e-28
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)

Query: 449 TEDFHIKYCI----GTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
             D +  Y +    G G +G V  A         A KK+     ED   V  F+ E  ++
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIM 60

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NWTKR--VNIVKS 560
            ++ H NI++LY        ++L+ E    G LF      +  +    + +     I+K 
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELF------ERVVHKRVFRESDAARIMKD 114

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAG 617
           V  A++Y H    L++ HRD+   N L  ++   S   + DFG A         RT + G
Sbjct: 115 VLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT-KVG 170

Query: 618 TYGYIAPELAYTIVVTG----KCDVYSFGVV 644
           T  Y++P+     V+ G    +CD +S GV+
Sbjct: 171 TPYYVSPQ-----VLEGLYGPECDEWSAGVM 196

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  117 bits (294), Expect = 2e-28
 Identities = 54/232 (23%), Positives = 100/232 (43%), Gaps = 22/232 (9%)

Query: 433 VWNYDGKILYEDLINATEDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALKKLHHSET 487
             +   K + + +       +  Y I    G+G +G V++  E   G+V   K ++    
Sbjct: 30  YEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP 89

Query: 488 EDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLF--CVLHDDDE 545
            D     + +NE  +++ + H  ++ L+     K  M LI E++  G LF         E
Sbjct: 90  LD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA----AE 142

Query: 546 AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASV--ADFGTAR 603
             +++  + +N ++     L ++H     SI+H DI   NI+ ++   +SV   DFG A 
Sbjct: 143 DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199

Query: 604 LLHVDSSYRTLRAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            L+ D   +     T  + APE +     V    D+++ GV+   +L G  P
Sbjct: 200 KLNPDEIVKVT-TATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSP 249

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  114 bits (288), Expect = 2e-28
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 41/216 (18%)

Query: 449 TEDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSFQN 498
              F  +Y I    G G +G V K  +    +  A+K        + +T           
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST------ILR 70

Query: 499 EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NWTKR--V 555
           E  +L  + H NI+KL+         +++ E    G LF      DE I+   +++    
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAA 124

Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYR 612
            I+K V   ++Y+H     +I+HRD+   NILL+S  +     + DFG +     ++  +
Sbjct: 125 RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181

Query: 613 TLRAGTYGYIAPELAYTIVVTG----KCDVYSFGVV 644
             R GT  YIAPE     V+ G    KCDV+S GV+
Sbjct: 182 D-RIGTAYYIAPE-----VLRGTYDEKCDVWSAGVI 211

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  116 bits (293), Expect = 2e-28
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 18/201 (8%)

Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
                  +G G +G V+K  E   G  +A K +     +D    +  +NE  V++ + H 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHA 146

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLF--CVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           N+++LY     K  + L+ EY++ G LF   +    DE+  L     +  +K +   + +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRII----DESYNLTELDTILFMKQICEGIRH 202

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASV--ADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
           +H    + I+H D+   NIL  +     +   DFG AR        +    GT  ++APE
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN-FGTPEFLAPE 258

Query: 626 -LAYTIVVTGKCDVYSFGVVA 645
            + Y   V+   D++S GV+A
Sbjct: 259 VVNYD-FVSFPTDMWSVGVIA 278

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  117 bits (295), Expect = 3e-28
 Identities = 46/217 (21%), Positives = 96/217 (44%), Gaps = 41/217 (18%)

Query: 449 TEDFHIKYC----IGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSFQN 498
              F  +Y     +G G +  V +  ++  G+  A       KL   + +        + 
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK------LER 59

Query: 499 EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NWTKR--V 555
           EA +   ++H NIV+L+     +   +LI++ +  G LF      ++ +    +++    
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADAS 113

Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYR 612
           + ++ +  A+ + H    + ++HR++   N+LL S L+ +   +ADFG A  +  +    
Sbjct: 114 HCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170

Query: 613 TLRAGTYGYIAPELAYTIVVTGK-----CDVYSFGVV 644
              AGT GY++PE     V+         D+++ GV+
Sbjct: 171 FGFAGTPGYLSPE-----VLRKDPYGKPVDLWACGVI 202

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  115 bits (290), Expect = 4e-28
 Identities = 48/220 (21%), Positives = 88/220 (40%), Gaps = 38/220 (17%)

Query: 446 INATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSFQNE 499
           +   + + +   IG G +  V +      G+  A+K     K   S        +  + E
Sbjct: 20  VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS---TEDLKRE 76

Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV---- 555
           A +   ++H +IV+L         +++++E+M+   L        E ++      V    
Sbjct: 77  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLC------FEIVKRADAGFVYSEA 130

Query: 556 ---NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDS 609
              + ++ +  AL Y H     +IIHRD+  + +LL S   ++   +  FG A  L    
Sbjct: 131 VASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187

Query: 610 SYRTLRAGTYGYIAPELAYTIVVTGK-----CDVYSFGVV 644
                R GT  ++APE     VV  +      DV+  GV+
Sbjct: 188 LVAGGRVGTPHFMAPE-----VVKREPYGKPVDVWGCGVI 222

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  116 bits (292), Expect = 4e-28
 Identities = 36/298 (12%), Positives = 83/298 (27%), Gaps = 62/298 (20%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST----------- 505
           +G     +  +A     G+   +   + +E   S  +K  + E   L             
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 506 -----------VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAI------- 547
                      V+     K+    L ++ M+++  +     +   L    E +       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 548 -ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH 606
             L    R+ +   V   L+ LHH     ++H  +   +I+LD      +  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260

Query: 607 VDSSYRTLRAGTYG---YIAPELAY-----TIVVTGKCDVYSFGVVALEVLMGTHPGGLL 658
             +S  +     +      A  +         ++T   D ++ G+    +     P    
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316

Query: 659 SSLSSSSGPKIMLIDV-LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
              +  +            + +  P     V+ ++         L    + R    + 
Sbjct: 317 --NTDDAALGGSEWIFRSCKNIPQP-----VRALLE------GFLRYPKEDRLLPLQA 361

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  113 bits (285), Expect = 4e-28
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 36/215 (16%)

Query: 449 TEDFHIKYC----IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
                  +     +G+G +G V+  E    G    +K ++   ++    ++  + E  VL
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVL 74

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR-------VN 556
            ++ H NI+K++        M+++ E  E G L       +  +      +         
Sbjct: 75  KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELL------ERIVSAQARGKALSEGYVAE 128

Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRT 613
           ++K + +AL+Y H      ++H+D+   NIL       S   + DFG A L   D     
Sbjct: 129 LMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185

Query: 614 LRAGTYGYIAPELAYTIVVTG----KCDVYSFGVV 644
             AGT  Y+APE     V       KCD++S GVV
Sbjct: 186 -AAGTALYMAPE-----VFKRDVTFKCDIWSAGVV 214

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  117 bits (295), Expect = 5e-28
 Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 41/229 (17%)

Query: 446 INATEDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKS 495
           +     F  +Y I    G G +G V K  +    +  A+K        + +T        
Sbjct: 14  LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST------ 67

Query: 496 FQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNW---T 552
              E  +L  + H NI+KL+         +++ E    G LF      DE I+       
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEH 121

Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDS 609
               I+K V   ++Y+H     +I+HRD+   NILL+S  +     + DFG +     ++
Sbjct: 122 DAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178

Query: 610 SYRTLRAGTYGYIAPELAYTIVVTG----KCDVYSFGVVALEVLMGTHP 654
             +  R GT  YIAPE     V+ G    KCDV+S GV+   +L GT P
Sbjct: 179 KMKD-RIGTAYYIAPE-----VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  118 bits (297), Expect = 5e-28
 Identities = 60/248 (24%), Positives = 102/248 (41%), Gaps = 17/248 (6%)

Query: 414 QNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCI----GTGGYGSVYKA 469
           Q K  R     + N D +   +   +   + +    +     Y I    GTG +G V++ 
Sbjct: 118 QGKIVRGKGTVSSNYDNYVF-DIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176

Query: 470 -ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY 528
            E   G   A K +      D   V+    E   +S +RH  +V L+        M +IY
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233

Query: 529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL 588
           E+M  G LF  + D+    +++  + V  ++ V   L ++H     + +H D+   NI+ 
Sbjct: 234 EFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMF 288

Query: 589 DSNLEASV--ADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVAL 646
            +     +   DFG    L    S +    GT  + APE+A    V    D++S GV++ 
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSY 347

Query: 647 EVLMGTHP 654
            +L G  P
Sbjct: 348 ILLSGLSP 355

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  113 bits (284), Expect = 6e-28
 Identities = 46/217 (21%), Positives = 96/217 (44%), Gaps = 42/217 (19%)

Query: 449 TEDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSFQN 498
           +  F   Y +    G G +  V +      G   A K     KL   + +        + 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK------LER 54

Query: 499 EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NWTKRV-- 555
           EA +   ++H NIV+L+     +   +L+++ +  G LF      ++ +    +++    
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADAS 108

Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYR 612
           + ++ +  +++Y H   +  I+HR++   N+LL S  + +   +ADFG A  ++   ++ 
Sbjct: 109 HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165

Query: 613 TLRAGTYGYIAPELAYTIVVTGK-----CDVYSFGVV 644
              AGT GY++PE     V+         D+++ GV+
Sbjct: 166 GF-AGTPGYLSPE-----VLKKDPYSKPVDIWACGVI 196

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  114 bits (288), Expect = 8e-28
 Identities = 49/223 (21%), Positives = 101/223 (45%), Gaps = 42/223 (18%)

Query: 443 EDLINATEDFHIKY----CIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAF 492
           E ++NA+  F   Y     +G G +  V +      G   A K     KL   + +    
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK--- 74

Query: 493 VKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NW 551
               + EA +   ++H NIV+L+     +   +L+++ +  G LF      ++ +    +
Sbjct: 75  ---LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF------EDIVAREFY 125

Query: 552 TKRV--NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLH 606
           ++    + ++ +  +++Y H   +  I+HR++   N+LL S  + +   +ADFG A  ++
Sbjct: 126 SEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182

Query: 607 VDSSYRTLRAGTYGYIAPELAYTIVVTGK-----CDVYSFGVV 644
              ++    AGT GY++PE     V+         D+++ GV+
Sbjct: 183 DSEAWHG-FAGTPGYLSPE-----VLKKDPYSKPVDIWACGVI 219

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  116 bits (293), Expect = 1e-27
 Identities = 66/228 (28%), Positives = 94/228 (41%), Gaps = 34/228 (14%)

Query: 449 TEDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALKKLH----------HSETEDSAFV 493
                  Y      G+G YG V    E       A+K +                   F 
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 494 KSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTK 553
           +   NE  +L ++ H NI+KL+     KK  +L+ E+ E G LF  + +  +  E     
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE---CD 147

Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSS 610
             NI+K +   + YLH     +I+HRDI   NILL++        + DFG +     D  
Sbjct: 148 AANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204

Query: 611 YRTLRAGTYGYIAPELAYTIVVTG----KCDVYSFGVVALEVLMGTHP 654
            R  R GT  YIAPE     V+      KCDV+S GV+   +L G  P
Sbjct: 205 LRD-RLGTAYYIAPE-----VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  112 bits (283), Expect = 1e-27
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 35/212 (16%)

Query: 449 TEDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           T +    +      G+G +  V+   +   GK+ ALK +  S         S +NE  VL
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVL 60

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NWTKR--VNIVKS 560
             ++H NIV L          +L+ + +  G LF      D  +E   +T++    +++ 
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF------DRILERGVYTEKDASLVIQQ 114

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAG 617
           V  A+ YLH      I+HRD+   N+L  +  E S   + DFG +++   +    T   G
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTA-CG 169

Query: 618 TYGYIAPELAYTIVVTGK-----CDVYSFGVV 644
           T GY+APE     V+  K      D +S GV+
Sbjct: 170 TPGYVAPE-----VLAQKPYSKAVDCWSIGVI 196

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  113 bits (285), Expect = 2e-27
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 40/223 (17%)

Query: 447 NATEDFHIKY----CIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVKSF 496
            A ++F+ KY     IG G    V +      G   A+K         S  +     ++ 
Sbjct: 87  AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146

Query: 497 QNEAHVLSTVR-HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV 555
           + E H+L  V  H +I+ L         MFL+++ M +G LF       + +    T++V
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF-------DYL----TEKV 195

Query: 556 --------NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
                   +I++S+  A+S+LH     +I+HRD+   NILLD N++  ++DFG +  L  
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252

Query: 608 DSSYRTLRAGTYGYIAPE-LAYTIVVTGK-----CDVYSFGVV 644
               R L  GT GY+APE L  ++  T        D+++ GV+
Sbjct: 253 GEKLREL-CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score =  111 bits (280), Expect = 2e-27
 Identities = 55/227 (24%), Positives = 83/227 (36%), Gaps = 28/227 (12%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
            S   +   ++    +L+ ++PP +        L+L  N L       +     L  L L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFS 216
              +L+ +  Q  G L  L  L +++N L                     S+PL      
Sbjct: 63  DRAELTKL--QVDGTLPVLGTLDLSHNQL--------------------QSLPLLGQTLP 100

Query: 217 ALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKL 276
           AL  LD+S N++  +    L  L +L+ L L  N L    P  +     L  L L+ N L
Sbjct: 101 ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160

Query: 277 SGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHN 322
           +  +P  +      L  L L  NSL  TIP       LL    L  N
Sbjct: 161 T-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 45/191 (23%), Positives = 66/191 (34%), Gaps = 23/191 (12%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPK 143
           L+ N+           +  L  L+L    L+  +    G+L  L  L L  N L   +P 
Sbjct: 38  LSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQS-LPL 94

Query: 144 EIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQ 203
              +L  L  L +  N+L+ +    +  L  L ELY+  N L  L P  L          
Sbjct: 95  LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK----- 149

Query: 204 FHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKL 263
                         L+ L L++N +  +    L  L  L  L L  N L   IP      
Sbjct: 150 --------------LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGS 194

Query: 264 FNLMYLDLSKN 274
             L +  L  N
Sbjct: 195 HLLPFAFLHGN 205

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  111 bits (280), Expect = 6e-27
 Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 36/212 (16%)

Query: 449 TEDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
            +     + +    G G    VY+  +    K  ALK L  +  +        + E  VL
Sbjct: 48  RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-----VRTEIGVL 102

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NWTKR--VNIVKS 560
             + H NI+KL         + L+ E +  G LF      D  +E   +++R   + VK 
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELF------DRIVEKGYYSERDAADAVKQ 156

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAG 617
           +  A++YLH      I+HRD+   N+L  +    +   +ADFG ++++      +T+  G
Sbjct: 157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV-CG 212

Query: 618 TYGYIAPELAYTIVVTGK-----CDVYSFGVV 644
           T GY APE     ++ G       D++S G++
Sbjct: 213 TPGYCAPE-----ILRGCAYGPEVDMWSVGII 239

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  110 bits (277), Expect = 6e-27
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 41/224 (18%)

Query: 447 NATEDFHIKY----CIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFVK-S 495
           ++T  F+  Y     +G G    V +    P  K  A+K            E+   ++ +
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 496 FQNEAHVLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR 554
              E  +L  V  H NI++L          FL+++ M++G LF       + +    T++
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-------DYL----TEK 118

Query: 555 V--------NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH 606
           V         I++++   +  LH    L+I+HRD+   NILLD ++   + DFG +  L 
Sbjct: 119 VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

Query: 607 VDSSYRTLRAGTYGYIAPE-LAYTIVVTGK-----CDVYSFGVV 644
                R +  GT  Y+APE +  ++           D++S GV+
Sbjct: 176 PGEKLREV-CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  114 bits (287), Expect = 9e-27
 Identities = 56/255 (21%), Positives = 104/255 (40%), Gaps = 35/255 (13%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
               F      +L   S++ ++      L+ +  +  + +++  +  + I  L N+  LF
Sbjct: 16  PDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLF 71

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNF 215
           L  NKL+ + P  + NLK+L  L++  N           ++ ++SS          + + 
Sbjct: 72  LNGNKLTDIKP--LTNLKNLGWLFLDEN-----------KIKDLSS----------LKDL 108

Query: 216 SALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNK 275
             L +L L  N I  I    L  L QL++L L +N ++  I   + +L  L  L L  N+
Sbjct: 109 KKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQ 164

Query: 276 LSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM 335
           +S  I   +   + L+NL L+ N +     L    +  L  L+L               +
Sbjct: 165 IS-DIV-PLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNL 220

Query: 336 YVDLSFNNLEGEIPT 350
            V  +  N +G + T
Sbjct: 221 VVPNTVKNTDGSLVT 235

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  107 bits (267), Expect = 3e-24
 Identities = 64/270 (23%), Positives = 104/270 (38%), Gaps = 38/270 (14%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
           I  I   NS+IK  +        PN+  L L  N L+  I P + +L  L  L+L  N +
Sbjct: 45  IDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKI 99

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT 197
             +    +  L+ L+ L L  N +S +    + +L  L  LY+ NN           ++T
Sbjct: 100 KDLSS--LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNN-----------KIT 144

Query: 198 NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP 257
           +I+           +   + LDTL L DN+I  I    L  L++L+NL LS N +S  + 
Sbjct: 145 DITV----------LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS-DLR 191

Query: 258 YAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKIL----L 313
            A+  L NL  L+L   +          N      +     SL     +          +
Sbjct: 192 -ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNV 250

Query: 314 LQNLDLSHNNLSGTIPKTLRPMYVDLSFNN 343
             +L    N +S    + +        F+ 
Sbjct: 251 KWHLPEFTNEVSFIFYQPVTIGKAKARFHG 280

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.8 bits (222), Expect = 7e-19
 Identities = 38/199 (19%), Positives = 68/199 (34%), Gaps = 33/199 (16%)

Query: 127 LKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALG 186
           +         +  I P    +        L    ++  + Q    L S+ ++   N+   
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNS--- 53

Query: 187 GLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLN 246
                    + ++            I     +  L L+ NK+  I P  LT L  L  L 
Sbjct: 54  --------DIKSVQ----------GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93

Query: 247 LSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPL 306
           L  N +   +  ++  L  L  L L  N +S  I   + +   L++L L +N +     L
Sbjct: 94  LDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVL 149

Query: 307 EMGKILLLQNLDLSHNNLS 325
              ++  L  L L  N +S
Sbjct: 150 S--RLTKLDTLSLEDNQIS 166

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.6 bits (102), Expect = 2e-04
 Identities = 22/118 (18%), Positives = 38/118 (32%), Gaps = 17/118 (14%)

Query: 77  RITDIDLLNSNIKGELGRLN-----------FSCFPNLKSLDLWNNSLSGSIPPQIGSLS 125
           +ITDI +L+   K  L  L+            +    L++L L  N +S  +   +  L 
Sbjct: 142 KITDITVLSRLTK--LDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLRA-LAGLK 197

Query: 126 KLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNN 183
            L  L L              +L     +      L    P+ I +     +  V  +
Sbjct: 198 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH 253

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  110 bits (278), Expect = 1e-26
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 25/221 (11%)

Query: 449 TEDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALK---KLHHSETEDSAFVKSFQNEA 500
            +     Y I    G+G +  V K  E   G   A K   K     +      +  + E 
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR--VNIV 558
            +L  V H NI+ L+    ++  + LI E +  G LF     D  A + + ++    + +
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFI 121

Query: 559 KSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS----VADFGTARLLHVDSSYRTL 614
           K +   ++YLH   T  I H D+   NI+L           + DFG A  +     ++ +
Sbjct: 122 KQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178

Query: 615 RAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
             GT  ++APE + Y   +  + D++S GV+   +L G  P
Sbjct: 179 -FGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASP 217

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  108 bits (272), Expect = 2e-26
 Identities = 57/266 (21%), Positives = 94/266 (35%), Gaps = 41/266 (15%)

Query: 98  SCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLY 157
                  +      +    IP  +      K L L  N L  +      S   L+ L L 
Sbjct: 4   VEVVPNITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60

Query: 158 SNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSA 217
             ++  +      +L  L+ L +T N            + +++   F           S+
Sbjct: 61  RCEIQTIEDGAYQSLSHLSTLILTGN-----------PIQSLALGAFS--------GLSS 101

Query: 218 LDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSN-LLSGQIPYAIGKLFNLMYLDLSKNKL 276
           L  L   +  +  +    +  L  LK LN++ N + S ++P     L NL +LDLS NK+
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161

Query: 277 SGSIPTEIGNCSALKNLTLNHNSLD------GTIPLEMGKILLLQNLDLSHNNLSGTIPK 330
             SI     +   L  + L + SLD        I     K + L+ L L  N L  ++P 
Sbjct: 162 Q-SIYC--TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK-SVPD 217

Query: 331 TLRPMYVDLSFNNLEGEIPTYLRGNP 356
            +        F+ L      +L  NP
Sbjct: 218 GI--------FDRLTSLQKIWLHTNP 235

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  105 bits (265), Expect = 2e-25
 Identities = 67/225 (29%), Positives = 96/225 (42%), Gaps = 29/225 (12%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIP 142
           L+ N    LG  +F  FP L+ LDL    +  +I      SLS L  L L GN +  +  
Sbjct: 35  LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLAL 93

Query: 143 KEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLF-RLTNISS 201
                L +L+ L      L+ +    IG+LK+L EL V +N +        F  LTN   
Sbjct: 94  GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN--- 150

Query: 202 NQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLK----NLNLSSNLLSGQIP 257
                           L+ LDLS NKI  I   +L  L Q+     +L+LS N ++  I 
Sbjct: 151 ----------------LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193

Query: 258 YAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLD 301
               K   L  L L  N+L  S+P  I    ++L+ + L+ N  D
Sbjct: 194 PGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 237

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  108 bits (271), Expect = 4e-26
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 27/213 (12%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK---KLHHSETEDSAFVKSFQNEAHV 502
              + + +   +G+G +  V K  +   GK  A K   K   S +      +  + E ++
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDD-----EAIELNWTKRVNI 557
           L  +RH NI+ L+    +K  + LI E +  G LF  L + +     EA +         
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-------- 113

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS----VADFGTARLLHVDSSYRT 613
           +K +   + YLH   +  I H D+   NI+L      +    + DFG A  +   + ++ 
Sbjct: 114 LKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170

Query: 614 LRAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVA 645
           +  GT  ++APE + Y   +  + D++S GV+ 
Sbjct: 171 I-FGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 201

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  108 bits (273), Expect = 4e-26
 Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 27/213 (12%)

Query: 449 TEDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALK---KLHHSETEDSAFVKSFQNEA 500
            +     Y I    G+G +  V K  E   G   A K   K     +      +  + E 
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE---LNWTKRVNI 557
            +L  V H N++ L+    ++  + LI E +  G LF      D   +   L+  +  + 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELF------DFLAQKESLSEEEATSF 120

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS----VADFGTARLLHVDSSYRT 613
           +K +   ++YLH   T  I H D+   NI+L           + DFG A  +     ++ 
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177

Query: 614 LRAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVA 645
           +  GT  ++APE + Y   +  + D++S GV+ 
Sbjct: 178 I-FGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  108 bits (272), Expect = 5e-26
 Identities = 59/299 (19%), Positives = 107/299 (35%), Gaps = 56/299 (18%)

Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HR 509
             ++  +  GG+  VY+A+ +  G+  ALK+L  +E E +  +     E   +  +  H 
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII---QEVCFMKKLSGHP 86

Query: 510 NIVKLYGFCL-------HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           NIV+               +  FL+   + +G L   L   +    L+    + I     
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL-------- 614
            A+ ++H      IIHRD+   N+LL +     + DFG+A  +     Y           
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 615 ----RAGTYGYIAPELAYTIVVTGKC------DVYSFGVVALEVLMGTHP---GGLLSSL 661
               R  T  Y  PE+   I +          D+++ G +   +    HP   G  L   
Sbjct: 206 EEITRNTTPMYRTPEI---IDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260

Query: 662 SSSSGPKIMLIDVLNQRLSPPVNQKIVQDII-LVSTIAFACLSSQPKSRPTMQRISQEL 719
                       ++N + S P +         L+       L   P+ R ++  +  +L
Sbjct: 261 ------------IVNGKYSIPPHDTQYTVFHSLIRA----MLQVNPEERLSIAEVVHQL 303

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  108 bits (272), Expect = 6e-26
 Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 25/212 (11%)

Query: 449 TEDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALK---KLHHSETEDSAFVKSFQNEA 500
            E+    Y      G+G +  V K  E   G   A K   K     +      +  + E 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 501 HVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR--VNIV 558
            +L  ++H N++ L+    +K  + LI E +  G LF     D  A + + T+      +
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELF-----DFLAEKESLTEEEATEFL 120

Query: 559 KSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS----VADFGTARLLHVDSSYRTL 614
           K + + + YLH   +L I H D+   NI+L           + DFG A  +   + ++ +
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177

Query: 615 RAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVA 645
             GT  ++APE + Y   +  + D++S GV+ 
Sbjct: 178 -FGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 207

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  106 bits (267), Expect = 2e-25
 Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 26/216 (12%)

Query: 445 LINATEDFHIKYCI-----GTGGYGSVYKA-ELPEGKVVALK--KLHHSETEDSAFVKSF 496
              + E+F+  Y +     G G +  V +      G+  A K  K      +        
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC---RAEI 75

Query: 497 QNEAHVLSTVRHR-NIVKLYGFCLHKKCMFLIYEYMERGSLF--CVLHDDDEAIELNWTK 553
            +E  VL   +    ++ L+    +   + LI EY   G +F  C+    + A  ++   
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL---PELAEMVSEND 132

Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSS 610
            + ++K +   + YLH     +I+H D+   NILL S        + DFG +R +     
Sbjct: 133 VIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189

Query: 611 YRTLRAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVA 645
            R +  GT  Y+APE L Y   +T   D+++ G++A
Sbjct: 190 LREI-MGTPEYLAPEILNYD-PITTATDMWNIGIIA 223

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  106 bits (266), Expect = 3e-25
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 23/215 (10%)

Query: 450 EDFHIKYCI----GTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           ++ + KY I    G G +G V++  E    K    K +      D   VK    E  +L+
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVK---KEISILN 56

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLF--CVLHDDDEAIELNWTKRVNIVKSVA 562
             RHRNI+ L+      + + +I+E++    +F          A ELN  + V+ V  V 
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERIN----TSAFELNEREIVSYVHQVC 112

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASV--ADFGTARLLHVDSSYRTLRAGTYG 620
            AL +LH     +I H DI   NI+  +   +++   +FG AR L    ++R L      
Sbjct: 113 EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-FTAPE 168

Query: 621 YIAPE-LAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           Y APE   +  VV+   D++S G +   +L G +P
Sbjct: 169 YYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINP 202

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score =  105 bits (264), Expect = 3e-25
 Identities = 56/255 (21%), Positives = 105/255 (41%), Gaps = 35/255 (13%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
           +   F      +L   S++ ++      L+ +  +  + +++  +  + I  L N+  LF
Sbjct: 19  SDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLF 74

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNF 215
           L  NKL+ + P  + NLK+L  L++  N           ++ ++SS          + + 
Sbjct: 75  LNGNKLTDIKP--LANLKNLGWLFLDEN-----------KVKDLSS----------LKDL 111

Query: 216 SALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNK 275
             L +L L  N I  I    L  L QL++L L +N ++  I   + +L  L  L L  N+
Sbjct: 112 KKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQ 167

Query: 276 LSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM 335
           +S  I   +   + L+NL L+ N +     L    +  L  L+L               +
Sbjct: 168 IS-DIV-PLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNL 223

Query: 336 YVDLSFNNLEGEIPT 350
            V  +  N +G + T
Sbjct: 224 VVPNTVKNTDGSLVT 238

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 60/253 (23%), Positives = 106/253 (41%), Gaps = 20/253 (7%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
               +L   ++   +     +   ++  +   N+ +  S+   I  L  +  L+L+GN L
Sbjct: 26  TIKDNLKKKSVTDAV---TQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKL 80

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP-STLFRL 196
           T I P  + +L+NL  LFL  NK+  +   +  +LK L  L + +N +  +     L +L
Sbjct: 81  TDIKP--LANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGISDINGLVHLPQL 136

Query: 197 T--NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSG 254
               + +N+      L     + LDTL L DN+I  I+P  L  L++L+NL LS N +S 
Sbjct: 137 ESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS- 191

Query: 255 QIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLL 314
            +  A+  L NL  L+L   +          N      +     SL    P  +      
Sbjct: 192 DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDY 248

Query: 315 QNLDLSHNNLSGT 327
           +  ++  +    T
Sbjct: 249 EKPNVKWHLPEFT 261

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  106 bits (265), Expect = 5e-25
 Identities = 64/271 (23%), Positives = 102/271 (37%), Gaps = 67/271 (24%)

Query: 440 ILYEDLINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALK-----KLHHSETEDSAFV 493
                L+   + +H+K  IG G YG V  A E     + A+K     K+     +D   V
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD---V 72

Query: 494 KSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLF---------------- 537
           +  + E  ++  + H NI +LY     ++ + L+ E    G L                 
Sbjct: 73  ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132

Query: 538 ---------CVLHDDDEAIELNWTKRV------------NIVKSVAHALSYLHHDCTLSI 576
                    C   +++         R             NI++ +  AL YLH+     I
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGI 189

Query: 577 IHRDISSNNILLDSNLEASV--ADFGTARLLHV----DSSYRTLRAGTYGYIAPELAYTI 630
            HRDI   N L  +N    +   DFG ++  +     +    T +AGT  ++APE     
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE----- 244

Query: 631 VVTG-------KCDVYSFGVVALEVLMGTHP 654
           V+         KCD +S GV+   +LMG  P
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  106 bits (266), Expect = 5e-25
 Identities = 41/301 (13%), Positives = 90/301 (29%), Gaps = 67/301 (22%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR--------- 507
           +G     +  +A +   G+   +   + +E   S  +K  + E   L  +R         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 508 ----------------HRNIVKLYGFCLHKKCM--FLIYEYME--RGSLFCVLHDDDEAI 547
                            + ++++         +  F +Y  M+    +   VL       
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 548 E-LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH 606
           + L    R+ +   V   L+ LHH     ++H  +   +I+LD      +  F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-- 255

Query: 607 VDSSYRTLRAGTYGYIAPEL-----------AYTIVVTGKCDVYSFGVVALEVLMGTHPG 655
            D +       + G+  PEL               ++T   D ++ G+V   +     P 
Sbjct: 256 -DGARVVSS-VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312

Query: 656 GLLSSLSSSSGPKIM-LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQR 714
                ++  +       I    + +  P     V+ ++         L    + R    +
Sbjct: 313 -----ITKDAALGGSEWIFRSCKNIPQP-----VRALLE------GFLRYPKEDRLLPLQ 356

Query: 715 I 715
            
Sbjct: 357 A 357

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  104 bits (261), Expect = 7e-25
 Identities = 34/272 (12%), Positives = 75/272 (27%), Gaps = 49/272 (18%)

Query: 457 CIGTGGYGSVYKAE---LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVK 513
             G       ++A    L   + VAL  +          ++   +    LS +    + +
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 514 LYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCT 573
           +      +    ++ E++  GSL  V       +       +  ++S+A A    H    
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG-----AIRAMQSLAAAADAAHRA-- 148

Query: 574 LSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVT 633
             +       + + +  +        G   L                 +           
Sbjct: 149 -GVALSIDHPSRVRVSID--------GDVVL------------AYPATMPD-------AN 180

Query: 634 GKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDI-I 692
            + D+   G     +L+   P      L  +     +     +    P     I +DI  
Sbjct: 181 PQDDIRGIGASLYALLVNRWP------LPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 693 LVSTIAFACLSSQPKSRP--TMQRISQELLAG 722
            +S +A   +      R   T+  + Q+  A 
Sbjct: 235 QISAVAARSVQGDGGIRSASTLLNLMQQATAV 266

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  106 bits (266), Expect = 1e-24
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 16/215 (7%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF I   IG G +  V   ++ + G+V A+K ++  +      V  F+ E  VL     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 509 RNIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           R I +L+ F    +  ++L+ EY   G L  +L    E I      R  + + V  A+  
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVM-AIDS 177

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GTYGYIAPEL 626
           +H    L  +HRDI  +NILLD      +ADFG+   L  D + R+L A GT  Y++PE+
Sbjct: 178 VH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234

Query: 627 ------AYTIVVTGK-CDVYSFGVVALEVLMGTHP 654
                        G  CD ++ GV A E+  G  P
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  106 bits (267), Expect = 1e-24
 Identities = 63/294 (21%), Positives = 114/294 (38%), Gaps = 46/294 (15%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQI--GSLSKLKCLYLHGNNLTGIIPKEIGSL--RNLR 152
           F    +L+ L L +N++   I P     ++ +   L L  N +  I  +++ +   ++  
Sbjct: 125 FKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFT 183

Query: 153 GLFLYSNKLSGVLPQEIG--------NLKSLTELYVTNNALGGLIPSTLFRLTNIS---- 200
            L L S  L  +    +G           S+T L ++ N     +    F     +    
Sbjct: 184 LLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS 243

Query: 201 ---SNQFHSSIPLEIGNFSALD-------------TLDLSDNKIHGIIPDELTKLSQLKN 244
              SN ++        NF   D             T DLS +KI  ++    +  + L+ 
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQ 303

Query: 245 LNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGT 303
           L L+ N ++     A   L +L+ L+LS+N L  SI + +  N   L+ L L++N +   
Sbjct: 304 LTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RA 361

Query: 304 IPLEM-GKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNP 356
           +  +    +  L+ L L  N L  ++P        D  F+ L      +L  NP
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK-SVP--------DGIFDRLTSLQKIWLHTNP 406

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  103 bits (259), Expect = 1e-23
 Identities = 59/300 (19%), Positives = 103/300 (34%), Gaps = 51/300 (17%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNN 136
           +  +DL  ++I  EL   +FS   +L+ L +   +    I       LS L  L L  N 
Sbjct: 32  VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKL-SGVLPQEI-GNLKSLTELYVTNNALGGLIPSTLF 194
              +       L NL  L L    L   VL       L SL  L + +N +  + P++ F
Sbjct: 91  FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 195 RLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKL--SQLKNLNLSSNLL 252
                              N      LDL+ NK+  I  ++L          L LSS  L
Sbjct: 151 L------------------NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL 192

Query: 253 --------SGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI---GNCSALKNLTLNHNSLD 301
                     +      K  ++  LDLS N    S+          + +++L L+++   
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252

Query: 302 GT------------IPLEMGKILLLQNLDLSHNNLS---GTIPKTLRPM-YVDLSFNNLE 345
           G+               +  +   ++  DLS + +     ++      +  + L+ N + 
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN 312

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 88.3 bits (219), Expect = 1e-18
 Identities = 45/235 (19%), Positives = 77/235 (32%), Gaps = 38/235 (16%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLY------------ 131
           +N    G     N     ++ +LDL  N    S+  +         +             
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254

Query: 132 -LHGNNLTGIIPKEIGSLR--NLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGL 188
                N           L    ++   L  +K+  +L     +   L +L +  N     
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQN----- 309

Query: 189 IPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLS 248
                  +  I  N F           + L  L+LS N +  I       L +L+ L+LS
Sbjct: 310 ------EINKIDDNAFW--------GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLS 355

Query: 249 SNLLSGQIPY-AIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLD 301
            N +   +   +   L NL  L L  N+L  S+P  I    ++L+ + L+ N  D
Sbjct: 356 YNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 83.3 bits (206), Expect = 6e-17
 Identities = 41/232 (17%), Positives = 67/232 (28%), Gaps = 34/232 (14%)

Query: 133 HGNNLTGI--IPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIP 190
               L  +  +P       ++  + L  N ++ +       L+ L  L V     G +I 
Sbjct: 18  INRGLHQVPELP------AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR 71

Query: 191 STLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSN 250
           +  FR                    S+L  L L  N+   +       L+ L+ L L+  
Sbjct: 72  NNTFR------------------GLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQC 113

Query: 251 LL-SGQIPYAI-GKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIP-- 305
            L    +       L +L  L L  N +    P     N      L L  N +  +I   
Sbjct: 114 NLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEE 172

Query: 306 -LEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNP 356
            L   +      L LS   L   + +         +           L GN 
Sbjct: 173 DLLNFQGKHFTLLRLSSITLQ-DMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  104 bits (261), Expect = 1e-24
 Identities = 59/325 (18%), Positives = 116/325 (35%), Gaps = 30/325 (9%)

Query: 406 GFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYE-DLINATEDFHIKYCIGTGGYG 464
           GF ++F+ +NK     + A K   + +      K++ E   +   E   I          
Sbjct: 18  GFGVVFEAKNKVDD-CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLET 76

Query: 465 SVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCM 524
              K +    ++    +         + + +   +   +     +N V        K  +
Sbjct: 77  PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYL 136

Query: 525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSN 584
           ++  +   + +L   ++      +      ++I   +A A+ +LH      ++HRD+  +
Sbjct: 137 YIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPS 193

Query: 585 NILLDSNLEASVADFGTARLLHVDSSY------------RTLRAGTYGYIAPELAYTIVV 632
           NI    +    V DFG    +  D                T + GT  Y++PE  +    
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253

Query: 633 TGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDII 692
           + K D++S G++  E         LL S S+      ++ DV N +      QK  Q+ +
Sbjct: 254 SHKVDIFSLGLILFE---------LLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHM 304

Query: 693 LVSTIAFACLSSQPKSRPTMQRISQ 717
           +V       LS  P  RP    I +
Sbjct: 305 MVQ----DMLSPSPTERPEATDIIE 325

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  103 bits (258), Expect = 3e-24
 Identities = 57/261 (21%), Positives = 82/261 (31%), Gaps = 35/261 (13%)

Query: 102 NLKSLDLWNNSLSGSIPPQ---IGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
           +LK L +    +   I      +  +S L+ L L    +TG  P  +          L  
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 159 NKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSAL 218
             +S                      L   +   L  L +I+     +    ++  F AL
Sbjct: 129 RNVS------------WATRDAWLAELQQWLKPGLKVL-SIAQAHSLNFSCEQVRVFPAL 175

Query: 219 DTLDLSDNKIHGIIPDELT----KLSQLKNLNLSSNL---LSGQIPYAIGKLFNLMYLDL 271
            TLDLSDN   G           K   L+ L L +      SG           L  LDL
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235

Query: 272 SKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPK 330
           S N L  +         S L +L L+   L   +P  +     L  LDLS+N L    P 
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLD-RNPS 291

Query: 331 T-----LRPMYVDLSFNNLEG 346
                 +    + L  N    
Sbjct: 292 PDELPQVG--NLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 93.0 bits (231), Expect = 8e-21
 Identities = 44/221 (19%), Positives = 79/221 (35%), Gaps = 23/221 (10%)

Query: 77  RITDIDLLNSNIKGE-LGRLNFSCFPNLKSLDLWNNSLSG--SIPPQIGSLSK--LKCLY 131
            + ++ L N  + G     L  +  P+L  L+L N S +   +   ++    K  LK L 
Sbjct: 96  GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155

Query: 132 LHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEI----GNLKSLTELYVTNN---A 184
           +   +      +++     L  L L  N   G              +L  L + N     
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215

Query: 185 LGGLIPSTLFRLTN-----ISSNQFHSSIPLEIGNF-SALDTLDLSDNKIHGIIPDELTK 238
             G+  +            +S N    +      ++ S L++L+LS   +  + P  L  
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV-PKGL-- 272

Query: 239 LSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGS 279
            ++L  L+LS N L    P +  +L  +  L L  N    S
Sbjct: 273 PAKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 48/247 (19%), Positives = 75/247 (30%), Gaps = 45/247 (18%)

Query: 136 NLTGIIPKEI-GSLRNLRGLFLYSNKLSGVLP-QEIGNLKSLTELYVTNNALGGLIPSTL 193
           N  G    E+ G  R+L  L    +  + +    +I    SL  L V    +   I    
Sbjct: 29  NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88

Query: 194 FRLTNIS--------SNQFHSSIPLEIGNFS--ALDTLDLSDNKIHGIIPDELTKLSQ-- 241
            R+  IS        + +   + P  +   +   L+ L+L +          L +L Q  
Sbjct: 89  LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWL 147

Query: 242 ---LKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNC----SALKNLT 294
              LK L+++           +     L  LDLS N   G        C      L+ L 
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 295 LNHN---SLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTY 351
           L +    +  G         + LQ LDLSH                    N+L       
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSH--------------------NSLRDAAGAP 247

Query: 352 LRGNPPK 358
               P +
Sbjct: 248 SCDWPSQ 254

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  105 bits (264), Expect = 3e-24
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 12/212 (5%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF I   IG G +G V   +L    KV A+K L+  E    A    F+ E  VL     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           + I  L+        ++L+ +Y   G L  +L   ++ +     +    +  +  A+  +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--LAEMVIAIDSV 191

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA-GTYGYIAPE-L 626
           H    L  +HRDI  +NIL+D N    +ADFG+   L  D + ++  A GT  YI+PE L
Sbjct: 192 H---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 627 AYTIVVTGK----CDVYSFGVVALEVLMGTHP 654
                  G+    CD +S GV   E+L G  P
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 99.6 bits (249), Expect = 3e-24
 Identities = 33/177 (18%), Positives = 63/177 (35%), Gaps = 27/177 (15%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
           +T I L N N+    G        N+K L + N   +   P  I  LS L+ L + G ++
Sbjct: 46  LTYITLANINVTDLTG---IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDV 100

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT 197
           T      +  L +L  L +  +     +  +I  L  +  + ++ N            +T
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG----------AIT 150

Query: 198 NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSG 254
           +I            +     L +L++  + +H      +    +L  L   S  + G
Sbjct: 151 DIMP----------LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 99.3 bits (248), Expect = 5e-24
 Identities = 33/198 (16%), Positives = 64/198 (32%), Gaps = 26/198 (13%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
              K+        S +       ++ L  + L   N+T +    I    N++ L + +  
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIH 77

Query: 161 LSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDT 220
            +   P  I  L +L  L +    +       L  LT+                   L  
Sbjct: 78  ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTS-------------------LTL 116

Query: 221 LDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSI 280
           LD+S +     I  ++  L ++ +++LS N     I   +  L  L  L++  + +    
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYR 175

Query: 281 PTEIGNCSALKNLTLNHN 298
              I +   L  L     
Sbjct: 176 G--IEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 91.2 bits (227), Expect = 3e-21
 Identities = 24/157 (15%), Positives = 63/157 (40%), Gaps = 7/157 (4%)

Query: 171 NLKSLTELYVTNNALGGLIPSTLFRLT--NISSNQFHSSIPLEIGNFSALDTLDLSDNKI 228
             K+     +  ++   +  + +  LT   +++        +E      +  L +++   
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHA 78

Query: 229 HGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCS 288
               P  ++ LS L+ L +    ++      +  L +L  LD+S +    SI T+I    
Sbjct: 79  TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136

Query: 289 ALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLS 325
            + ++ L++N     I   +  +  L++L++  + + 
Sbjct: 137 KVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.2 bits (188), Expect = 5e-16
 Identities = 26/160 (16%), Positives = 69/160 (43%), Gaps = 9/160 (5%)

Query: 189 IPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLS 248
           IP + F+          S+  +     ++L  + L++  +  +    +     +K+L ++
Sbjct: 17  IPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTIN 74

Query: 249 SNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEM 308
           +   +   P  I  L NL  L +    ++      +   ++L  L ++H++ D +I  ++
Sbjct: 75  NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 309 GKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNL 344
             +  + ++DLS+N     I   L+ +     +++ F+ +
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 68.1 bits (167), Expect = 3e-13
 Identities = 22/110 (20%), Positives = 47/110 (42%), Gaps = 4/110 (3%)

Query: 79  TDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLT 138
             + ++  ++  +    N S   +L  LD+ +++   SI  +I +L K+  + L  N   
Sbjct: 91  ERLRIMGKDVTSDKIP-NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149

Query: 139 GIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGL 188
             I   + +L  L+ L +  + +       I +   L +LY  +  +GG 
Sbjct: 150 TDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  101 bits (255), Expect = 9e-24
 Identities = 48/216 (22%), Positives = 85/216 (39%), Gaps = 40/216 (18%)

Query: 449 TEDFHIKY-------CIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEA 500
              F+  Y        +G G +    K       +  A+K +      ++      Q E 
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT------QKEI 56

Query: 501 HVLSTVR-HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NWTKR--VN 556
             L     H NIVKL+     +   FL+ E +  G LF      +   +  ++++     
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF------ERIKKKKHFSETEASY 110

Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRT 613
           I++ +  A+S++H    + ++HRD+   N+L     +     + DFG ARL   D+    
Sbjct: 111 IMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167

Query: 614 LRAGTYGYIAPELAYTIVVTGK-----CDVYSFGVV 644
               T  Y APE     ++        CD++S GV+
Sbjct: 168 TPCFTLHYAAPE-----LLNQNGYDESCDLWSLGVI 198

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  102 bits (255), Expect = 9e-24
 Identities = 57/216 (26%), Positives = 88/216 (40%), Gaps = 37/216 (17%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALK-----KLHHSETEDSAFVKSFQNEAHVLSTVRHRNI 511
           +G+G +G V+ A    + K V +K     K+      +   +     E  +LS V H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 512 VKLYGFCLHKKCMFLIYEYMERGS-LF--CVLH---DDDEAIELNWTKRVNIVKSVAHAL 565
           +K+     ++    L+ E    G  LF     H   D+  A          I + +  A+
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS--------YIFRQLVSAV 143

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
            YL       IIHRDI   NI++  +    + DFG+A  L     + T   GT  Y APE
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF-CGTIEYCAPE 199

Query: 626 LAYTIVVTGK------CDVYSFGVVALEVLM-GTHP 654
                V+ G        +++S GV  L  L+   +P
Sbjct: 200 -----VLMGNPYRGPELEMWSLGVT-LYTLVFEENP 229

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  101 bits (254), Expect = 9e-24
 Identities = 51/226 (22%), Positives = 89/226 (39%), Gaps = 47/226 (20%)

Query: 449 TEDFHIKY-----CIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
           +  F   Y      +G G +  V     L   +  A+K +                E  +
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEM 63

Query: 503 LSTVR-HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN----- 556
           L   + HRN+++L  F   +   +L++E M  GS+          I     KR +     
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSIL-------SHI----HKRRHFNELE 112

Query: 557 ---IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSS 610
              +V+ VA AL +LH      I HRD+   NIL +   + S   + DF     + ++  
Sbjct: 113 ASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169

Query: 611 YRTL-------RAGTYGYIAPEL--AYTIVVTG---KCDVYSFGVV 644
              +         G+  Y+APE+  A++   +    +CD++S GV+
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  102 bits (256), Expect = 2e-23
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           + F I   IG G +G V   +  +  K+ A+K ++  +  +   V++   E  ++  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 509 RNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVK----SVAH 563
             +V L Y F   +  MF++ + +  G L   L  +    E         VK     +  
Sbjct: 75  PFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKE-------ETVKLFICELVM 126

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
           AL YL       IIHRD+  +NILLD +    + DF  A +L  ++   T+ AGT  Y+A
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM-AGTKPYMA 182

Query: 624 PEL-------AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+        Y+  V    D +S GV A E+L G  P
Sbjct: 183 PEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  102 bits (256), Expect = 2e-23
 Identities = 67/243 (27%), Positives = 104/243 (42%), Gaps = 23/243 (9%)

Query: 423 RAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKK 481
           R  KN D F     D      DL    ED+ +   IG G +G V         KV A+K 
Sbjct: 42  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101

Query: 482 LHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH 541
           L   E    +    F  E  +++      +V+L+      + ++++ EYM  G L  ++ 
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 161

Query: 542 DDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT 601
           + D  +   W +       V  AL  +H    +  IHRD+  +N+LLD +    +ADFGT
Sbjct: 162 NYD--VPEKWARFY--TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT 214

Query: 602 ARLLHVDSSYRTLRA-GTYGYIAPELAYTIVVTGK---------CDVYSFGVVALEVLMG 651
              ++ +   R   A GT  YI+PE     V+  +         CD +S GV   E+L+G
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPE-----VLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

Query: 652 THP 654
             P
Sbjct: 270 DTP 272

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 99.6 bits (249), Expect = 5e-23
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 34/209 (16%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           +G G YG VYKA+  +G++VALK++   + ED     +   E  +L  + H NIV L   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIR-LDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHD-----DDEAIELNWTKRVNIVKSVAH----ALSYL 568
              ++C+ L++E+ME         D     D+    L      + +K   +     +++ 
Sbjct: 88  IHSERCLTLVFEFME--------KDLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHC 135

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H      I+HRD+   N+L++S+    +ADFG AR   +     T    T  Y AP++  
Sbjct: 136 HQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM 192

Query: 627 ---AYTIVVTGKCDVYSFGVVALEVLMGT 652
               Y+  V    D++S G +  E++ G 
Sbjct: 193 GSKKYSTSV----DIWSIGCIFAEMITGK 217

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  100 bits (250), Expect = 6e-23
 Identities = 47/220 (21%), Positives = 91/220 (41%), Gaps = 33/220 (15%)

Query: 438 GKILYEDLINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSF 496
            + L+ + I  T+ + +K  IG G Y    +          A+K +  S+          
Sbjct: 10  VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPT 63

Query: 497 QNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIEL-NWTKR- 554
           +    +L   +H NI+ L       K ++++ E M+ G L       D+ +    +++R 
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL------DKILRQKFFSERE 117

Query: 555 -VNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS----VADFGTARLLHVDS 609
              ++ ++   + YLH      ++HRD+  +NIL            + DFG A+ L  ++
Sbjct: 118 ASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

Query: 610 SYRTLRAGTYGYIAPELAYTIVVTGK-----CDVYSFGVV 644
                   T  ++APE     V+  +     CD++S GV+
Sbjct: 175 GLLMTPCYTANFVAPE-----VLERQGYDAACDIWSLGVL 209

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 98.7 bits (247), Expect = 6e-23
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 34/209 (16%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGF 517
           IG G YG VYKA+   G+  ALKK+   E ED     +   E  +L  ++H NIVKLY  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 518 CLHKKCMFLIYEYMERGSLFCVLHD-----DDEAIELNWTKRVNIVKSVAH----ALSYL 568
              KK + L++E+++         D     D     L         KS        ++Y 
Sbjct: 69  IHTKKRLVLVFEHLD--------QDLKKLLDVCEGGLE----SVTAKSFLLQLLNGIAYC 116

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-- 626
           H      ++HRD+   N+L++   E  +ADFG AR   +     T    T  Y AP++  
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173

Query: 627 ---AYTIVVTGKCDVYSFGVVALEVLMGT 652
               Y+  +    D++S G +  E++ GT
Sbjct: 174 GSKKYSTTI----DIWSVGCIFAEMVNGT 198

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 99.6 bits (249), Expect = 6e-23
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 17/200 (8%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G YG V K      G++VA+KK      +D    K    E  +L  +RH N+V L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFL-ESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
            C  KK  +L++E+++  ++   L      ++    +    +  + + + + H     +I
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ--KYLFQIINGIGFCHSH---NI 145

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-----AYTIV 631
           IHRDI   NIL+  +    + DFG AR L            T  Y APEL      Y   
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKA 205

Query: 632 VTGKCDVYSFGVVALEVLMG 651
           V    DV++ G +  E+ MG
Sbjct: 206 V----DVWAIGCLVTEMFMG 221

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 97.7 bits (244), Expect = 8e-23
 Identities = 59/204 (28%), Positives = 85/204 (41%), Gaps = 23/204 (11%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
             + K LDL +N LS S+P +    L+KL+ LYL+ N L  +       L+NL  L++  
Sbjct: 36  PADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94

Query: 159 NKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSAL 218
           NKL  +       L +L EL +  N           +L ++    F S         + L
Sbjct: 95  NKLQALPIGVFDQLVNLAELRLDRN-----------QLKSLPPRVFDS--------LTKL 135

Query: 219 DTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSG 278
             L L  N++  +      KL+ LK L L +N L      A  KL  L  L L  N+L  
Sbjct: 136 TYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK- 194

Query: 279 SIPTEI-GNCSALKNLTLNHNSLD 301
            +P     +   LK L L  N  D
Sbjct: 195 RVPEGAFDSLEKLKMLQLQENPWD 218

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 54/193 (27%), Positives = 78/193 (40%), Gaps = 23/193 (11%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIP 142
           L SN    L    F     L+ L L +N L  ++P  I   L  L+ L++  N L  +  
Sbjct: 44  LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPI 102

Query: 143 KEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLF-RLTNISS 201
                L NL  L L  N+L  + P+   +L  LT L +  N L  L P  +F +LT+   
Sbjct: 103 GVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSL-PKGVFDKLTS--- 158

Query: 202 NQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIG 261
                           L  L L +N++  +      KL++LK L L +N L      A  
Sbjct: 159 ----------------LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202

Query: 262 KLFNLMYLDLSKN 274
            L  L  L L +N
Sbjct: 203 SLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 62/264 (23%), Positives = 86/264 (32%), Gaps = 81/264 (30%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
            SC  N  S+D  +  L+ +IP  I   +  K L L  N L+ +  K    L  LR L+L
Sbjct: 12  CSCNNNKNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYL 68

Query: 157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLF-RLTNISSNQFHSSIPLEIGNF 215
             NKL                           +P+ +F  L N                 
Sbjct: 69  NDNKLQT-------------------------LPAGIFKELKN----------------- 86

Query: 216 SALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNK 275
             L+TL ++DNK+  +      +L  L  L L  N L    P     L  L YL L  N+
Sbjct: 87  --LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144

Query: 276 LSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM 335
           L  S+P           LT                   L+ L L +N L   +P+     
Sbjct: 145 LQ-SLPK-----GVFDKLTS------------------LKELRLYNNQLK-RVPEGA--- 176

Query: 336 YVDLSFNNLEGEIPTYLRGNPPKS 359
                F+ L       L  N  K 
Sbjct: 177 -----FDKLTELKTLKLDNNQLKR 195

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 39/157 (24%), Positives = 63/157 (40%), Gaps = 17/157 (10%)

Query: 182 NNALGGLIP-----STLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEL 236
           N AL          +      + SS +  ++IP  I   +    LDL  NK+  +     
Sbjct: 1   NEALCKKDGGVCSCNNNKNSVDCSSKKL-TAIPSNI--PADTKKLDLQSNKLSSLPSKAF 57

Query: 237 TKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTL 295
            +L++L+ L L+ N L         +L NL  L ++ NKL  ++P  +      L  L L
Sbjct: 58  HRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116

Query: 296 NHNSLDGTIPLEMG---KILLLQNLDLSHNNLSGTIP 329
           + N L     L       +  L  L L +N L  ++P
Sbjct: 117 DRNQLKS---LPPRVFDSLTKLTYLSLGYNELQ-SLP 149

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 99.0 bits (247), Expect = 9e-23
 Identities = 53/217 (24%), Positives = 84/217 (38%), Gaps = 39/217 (17%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQN---EAHVLSTVRHR--NI 511
           +G+GG+GSVY    + +   VA+K +      D   + +      E  +L  V      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 512 VKLYGFCLHKKCMFLIYEYME-RGSLF--CVLH---DDDEAIELNWTKRVNIVKSVAHAL 565
           ++L  +        LI E  E    LF          ++ A         +    V  A+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--------SFFWQVLEAV 162

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSN-LEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
            + H      ++HRDI   NIL+D N  E  + DFG+  LL  D+ Y     GT  Y  P
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDF-DGTRVYSPP 217

Query: 625 ELAYTIVVTGKC------DVYSFGVVALEVLM-GTHP 654
           E      +           V+S G++ L  ++ G  P
Sbjct: 218 E-----WIRYHRYHGRSAAVWSLGIL-LYDMVCGDIP 248

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 50/219 (22%), Positives = 84/219 (38%), Gaps = 41/219 (18%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALK---KLHHSETEDSAFVKSFQNEAHVLSTVR----HR 509
           +G GG+G+V+    L +   VA+K   +         +   +   E  +L  V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGS-LF--CVLH---DDDEAIELNWTKRVNIVKSVAH 563
            +++L  +   ++   L+ E       LF          +  +       R      V  
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-------R-CFFGQVVA 150

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDS-NLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
           A+ + H   +  ++HRDI   NIL+D     A + DFG+  LLH D  Y     GT  Y 
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDF-DGTRVYS 205

Query: 623 APELAYTIVVTGK------CDVYSFGVVALEVLM-GTHP 654
            PE      ++          V+S G++ L  ++ G  P
Sbjct: 206 PPE-----WISRHQYHALPATVWSLGIL-LYDMVCGDIP 238

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 17/201 (8%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG V+K      G++VA+KK   SE +D    K    E  +L  ++H N+V L  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLE 69

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSI 576
               K+ + L++EY +  ++   L      +  +  K  +I      A+++ H     + 
Sbjct: 70  VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK--SITWQTLQAVNFCHKH---NC 123

Query: 577 IHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-----AYTIV 631
           IHRD+   NIL+  +    + DFG ARLL   S Y      T  Y +PEL      Y   
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183

Query: 632 VTGKCDVYSFGVVALEVLMGT 652
           V    DV++ G V  E+L G 
Sbjct: 184 V----DVWAIGCVFAELLSGV 200

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 97.6 bits (244), Expect = 2e-22
 Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 35/212 (16%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G YG+V+KA      ++VALK++   + +D     S   E  +L  ++H+NIV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHD-----DDEAIELNWTKRVNIVKSVAH----ALSY 567
                K + L++E+ +         D     D    +L+      IVKS        L +
Sbjct: 69  VLHSDKKLTLVFEFCD--------QDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGF 116

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL- 626
            H      ++HRD+   N+L++ N E  +A+FG AR   +     +    T  Y  P++ 
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 627 ----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                Y+  +    D++S G +  E+     P
Sbjct: 174 FGAKLYSTSI----DMWSAGCIFAELANAGRP 201

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 41/224 (18%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-----DDDEAI----ELNWTKRVNIVK 559
              VKLY      + ++    Y + G L   +      D+        E           
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----------- 138

Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--- 616
            +  AL YLH      IIHRD+   NILL+ ++   + DFGTA++  +    +  RA   
Sbjct: 139 -IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV--LSPESKQARANSF 192

Query: 617 -GTYGYIAPELAYTIVVTGK-----CDVYSFGVVALEVLMGTHP 654
            GT  Y++PE     ++T K      D+++ G +  +++ G  P
Sbjct: 193 VGTAQYVSPE-----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  100 bits (250), Expect = 3e-22
 Identities = 45/227 (19%), Positives = 86/227 (37%), Gaps = 13/227 (5%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPK 143
           +   I  E    + +   +L    + N     S        +++    L  ++   I   
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347

Query: 144 EIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNAL-----GGLIPSTLFRLT- 197
              S  +   L    N  +  + Q    LK L  L +  N L       L+   +  L  
Sbjct: 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407

Query: 198 -NISSNQFHSSI-PLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQ 255
            ++S N  +S           ++  L+LS N + G +   L    ++K L+L +N +   
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-S 464

Query: 256 IPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLD 301
           IP  +  L  L  L+++ N+L  S+P  +    ++L+ + L+ N  D
Sbjct: 465 IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWD 510

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 86.1 bits (213), Expect = 1e-17
 Identities = 51/247 (20%), Positives = 95/247 (38%), Gaps = 16/247 (6%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
           FS       +D  N +L+  +P  +    + K L L  N+++ +   +I  L  LR L L
Sbjct: 28  FSN-ELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRL 83

Query: 157 YSNKLSGVLPQEI-GNLKSLTELYVTNNALGGLIPSTLFRLT--NISSNQFHSSIPL--E 211
             N++   L   +    + L  L V++N L  +    +  L   ++S N F   +P+  E
Sbjct: 84  SHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHLDLSFNDF-DVLPVCKE 141

Query: 212 IGNFSALDTLDLSDNKIHGIIPDELTKLSQLKN-LNLSSNLLSGQIPYAIGKL-FNLMYL 269
            GN + L  L LS  K   +    +  L      L+L S  + G    ++      +++L
Sbjct: 142 FGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL 201

Query: 270 DLSKNKLSGSIPTEIGN---CSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSG 326
               N L         N      L N+ LN  +    +            L+++  ++  
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261

Query: 327 TIPKTLR 333
           T   +++
Sbjct: 262 TWKCSVK 268

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 81.5 bits (201), Expect = 3e-16
 Identities = 46/278 (16%), Positives = 95/278 (34%), Gaps = 22/278 (7%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIP 142
           L+ N   EL   + S    L+ L L +N +  S+   +      L+ L +  N L  I  
Sbjct: 59  LSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNI-- 115

Query: 143 KEIGSLRNLRGLFLYSNKLSGV-LPQEIGNLKSLTELYVTNNALGGLIPSTLFRL----- 196
                + +LR L L  N    + + +E GNL  LT L ++      L    +  L     
Sbjct: 116 -SCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCI 174

Query: 197 -TNISSNQFHSSIP--LEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLS 253
             ++ S          L+I N + L  +   ++     +   +  L  L+  N+  N  +
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN 234

Query: 254 GQ----IPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNC---SALKNLTLNHNSLDGTIPL 306
            Q        + +   L+ + L   + +     ++        ++ L + + ++   I  
Sbjct: 235 CQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDR 294

Query: 307 EMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNL 344
           E           L   ++   +    +   +   F  +
Sbjct: 295 EEFTYSETALKSLMIEHVKNQVFLFSKEA-LYSVFAEM 331

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 77.2 bits (190), Expect = 8e-15
 Identities = 49/312 (15%), Positives = 92/312 (29%), Gaps = 52/312 (16%)

Query: 83  LLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGI-- 140
           L   +   + G       PN   L L  +  S        S++ L  L L    L     
Sbjct: 176 LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC 235

Query: 141 -----IPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNL---KSLTELYVTNNALGGLIPST 192
                   E+     L  + L   + +     ++      + +  L + N  +   I   
Sbjct: 236 QRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDRE 295

Query: 193 LFRLT----------NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQL 242
            F  +          ++ +  F  S       F+ ++   LS +    I        S  
Sbjct: 296 EFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355

Query: 243 KNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDG 302
             LN + N+ +  +      L  L  L L +N L  +          + +L     SL+ 
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNS 414

Query: 303 TIPLEMG---------KILLLQN-----------------LDLSHNNLSGTIPKTLRPM- 335
                            +L L +                 LDL +N +  +IPK +  + 
Sbjct: 415 LNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQ 473

Query: 336 ---YVDLSFNNL 344
               ++++ N L
Sbjct: 474 ALQELNVASNQL 485

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 71.4 bits (175), Expect = 4e-13
 Identities = 49/264 (18%), Positives = 101/264 (38%), Gaps = 15/264 (5%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
           SN+  + +P ++        L LS N I  +   +++ LS+L+ L LS N +   + + +
Sbjct: 39  SNRNLTHVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHV 95

Query: 261 -GKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPL--EMGKILLLQNL 317
                +L YLD+S N+L  +I       ++L++L L+ N  D  +P+  E G +  L  L
Sbjct: 96  FLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFL 151

Query: 318 DLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVEGFPSSS 377
            LS           +  +++     +L      +++G   +S         ++   P+S 
Sbjct: 152 GLSAAKFRQLDLLPVAHLHLSCILLDLVS---YHIKGGETESLQIPNTTVLHLVFHPNSL 208

Query: 378 QRQKLTPSISLFAKIFLPLNLVLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVWNYD 437
              ++  S++    + L    +                + P L +   ++ +    W   
Sbjct: 209 FSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT--WKCS 266

Query: 438 GKILYEDLINATEDFHIKYCIGTG 461
            K+         E  +I     T 
Sbjct: 267 VKLFQFFWPRPVEYLNIYNLTITE 290

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 69.5 bits (170), Expect = 2e-12
 Identities = 51/338 (15%), Positives = 94/338 (27%), Gaps = 58/338 (17%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPP--QIGSLSKLKCLYLHGNNLTGII 141
           ++ N    L  ++     +L+ LDL  N     +P   + G+L+KL  L L       + 
Sbjct: 107 VSHN---RLQNISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLD 162

Query: 142 PKEIGSLR-NLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNN-------ALGGLIPSTL 193
              +  L  +   L L S  + G   + +    +     V +            +     
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGH 222

Query: 194 FRLTNISSNQFHSSIP-------------------------------LEIGNFSALDTLD 222
            +L+NI  N  +                                    +      ++ L+
Sbjct: 223 LQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLN 282

Query: 223 LSDNKIHGIIPDEL-----TKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLS 277
           + +  I   I  E      T L  L   ++ + +              +    LS +   
Sbjct: 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP 342

Query: 278 GSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNL------SGTIPKT 331
                   + S+   L    N    ++      +  LQ L L  N L      +      
Sbjct: 343 FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNM 402

Query: 332 LRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGN 369
                +D+S N+L                V N  LS N
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLN--LSSN 438

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 95.5 bits (238), Expect = 4e-22
 Identities = 45/238 (18%), Positives = 87/238 (36%), Gaps = 24/238 (10%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
                 N    +L   S++  +      LS ++      +N+  +    +    NL+ L 
Sbjct: 14  PDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELH 69

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT--NISSNQFHSSIPLEIG 213
           L  N++S + P  + +L  L EL V  N L  L       L+   + +N+   +  L   
Sbjct: 70  LSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDSLI-- 125

Query: 214 NFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSK 273
           +   L+ L + +NK+  I    L  LS+L+ L+L  N ++      + +L  + ++DL+ 
Sbjct: 126 HLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTG 181

Query: 274 NKLSGSIPTEIGNCSALKNLTLNHN--SLDGTI--PLEMGKILLLQNLDLSHNNLSGT 327
            K                 L + +     DG    P  +       +  +       T
Sbjct: 182 QKCVNE------PVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYT 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 40/239 (16%), Positives = 91/239 (38%), Gaps = 36/239 (15%)

Query: 110 NNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEI 169
              ++  + P    L+      L   ++T ++      L  ++     ++ +  +    +
Sbjct: 6   PTPIN-QVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSL--AGM 59

Query: 170 GNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIH 229
               +L EL++++N           +++++S           + + + L+ L ++ N++ 
Sbjct: 60  QFFTNLKELHLSHN-----------QISDLSP----------LKDLTKLEELSVNRNRLK 98

Query: 230 GIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSA 289
            +          L  L L +N L       +  L NL  L +  NKL  SI   +G  S 
Sbjct: 99  NLNGIPSAC---LSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK-SIV-MLGFLSK 151

Query: 290 LKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEI 348
           L+ L L+ N +  T  L   ++  +  +DL+         K    +Y+  +  + +G  
Sbjct: 152 LEVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 98.3 bits (245), Expect = 5e-22
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 44/207 (21%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLY 515
           +G G  G V +       +  ALK L     +D       + E  +     +  +IV++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKML-----QDC---PKARREVELHWRASQCPHIVRIV 121

Query: 516 GFC----LHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR------VNIVKSVAHAL 565
                    +KC+ ++ E ++ G LF         I+    +         I+KS+  A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELF-------SRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYI 622
            YLH   +++I HRD+   N+L  S    +   + DFG A+     +S  T    T  Y+
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYV 230

Query: 623 APELAYTIVVTGK-----CDVYSFGVV 644
           APE     V+  +     CD++S GV+
Sbjct: 231 APE-----VLGPEKYDKSCDMWSLGVI 252

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 96.5 bits (241), Expect = 6e-22
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 36/218 (16%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E +     +G G Y +VYK +      +VALK++   E E+ A   + + E  +L  ++H
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIR-EVSLLKDLKH 59

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD-----DDEAIELNWTKRVNIVKSVAH 563
            NIV L+     +K + L++EY++         D     DD    +N    ++ VK    
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLD--------KDLKQYLDDCGNIIN----MHNVKLFLF 107

Query: 564 ----ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
                L+Y H      ++HRD+   N+L++   E  +ADFG AR   + +        T 
Sbjct: 108 QLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL 164

Query: 620 GYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMGT 652
            Y  P++      Y+  +    D++  G +  E+  G 
Sbjct: 165 WYRPPDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 96.2 bits (240), Expect = 8e-22
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 32/210 (15%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G +  V  A  +  G+ VA+K +  ++   ++  K F+ E  ++  + H NIVKL+ 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81

Query: 517 FCLHKKCMFLIYEYMERGSLF--CVLH---DDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
               +K ++LI EY   G +F   V H    + EA         +  + +  A+ Y H  
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR--------SKFRQIVSAVQYCHQ- 132

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIV 631
               I+HRD+ + N+LLD+++   +ADFG +    V         G   Y APE     +
Sbjct: 133 --KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYAAPE-----L 184

Query: 632 VTGKC------DVYSFGVVALEVLM-GTHP 654
             GK       DV+S GV+ L  L+ G+ P
Sbjct: 185 FQGKKYDGPEVDVWSLGVI-LYTLVSGSLP 213

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 97.2 bits (242), Expect = 1e-21
 Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 50/228 (21%)

Query: 454 IKYCIGTGGYGSVYKA---ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
               +G G YG VYKA   +  + K  ALK++  +    SA       E  +L  ++H N
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-----CREIALLRELKHPN 79

Query: 511 IVKLYGFCLHK--KCMFLIYEYMERGSLFCVLHD-----DDEAIELNWTKRVNI----VK 559
           ++ L    L    + ++L+++Y E        HD               K V +    VK
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 560 SVAH----ALSYLHHDCTLSIIHRDISSNNILLDSNLEAS----VADFGTARLLHVDSSY 611
           S+ +     + YLH +    ++HRD+   NIL+           +AD G ARL +     
Sbjct: 132 SLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188

Query: 612 RTLRAG---TYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMG 651
                    T+ Y APEL      YT  +    D+++ G +  E+L  
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTS 232

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G YG VYKA +    + VA+K++   E E+     +   E  +L  ++HRNI++L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRL-EHEEEGVPGTAIREVSLLKELQHRNIIELKS 100

Query: 517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH----ALSYLHHDC 572
              H   + LI+EY E        +D  + ++ N    + ++KS  +     +++ H   
Sbjct: 101 VIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR- 151

Query: 573 TLSIIHRDISSNNILLDSNLEAS-----VADFGTARLLHVDSSYRTLRAGTYGYIAPEL- 626
               +HRD+   N+LL  +  +      + DFG AR   +     T    T  Y  PE+ 
Sbjct: 152 --RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209

Query: 627 ----AYTIVVTGKCDVYSFGVVALEVLMGT 652
                Y+  V    D++S   +  E+LM T
Sbjct: 210 LGSRHYSTSV----DIWSIACIWAEMLMKT 235

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 96.1 bits (240), Expect = 1e-21
 Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 47/229 (20%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
             +     IG G +G V+KA     G+ VALKK+   E E   F  +   E  +L  ++H
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLLKH 75

Query: 509 RNIVKLYG--------FCLHKKCMFLIYEYMERGSLFCVLHD-----DDEAIELNWTKRV 555
            N+V L          +   K  ++L++++ E        HD      +  ++      +
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFT----L 123

Query: 556 NIVKSVAH----ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY 611
           + +K V       L Y+H +    I+HRD+ + N+L+  +    +ADFG AR   +  + 
Sbjct: 124 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180

Query: 612 R----TLRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMG 651
           +    T R  T  Y  PEL      Y   +    D++  G +  E+   
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTR 225

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 95.7 bits (238), Expect = 2e-21
 Identities = 42/248 (16%), Positives = 90/248 (36%), Gaps = 26/248 (10%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYL-HGN 135
             ++  + + ++  + +  FS F +L+ +++  N +   I   +  +L KL  + +   N
Sbjct: 32  AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90

Query: 136 NLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFR 195
           NL  I P+   +L NL+ L + +  +  +      +      L + +N            
Sbjct: 91  NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI----------N 140

Query: 196 LTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQ 255
           +  I  N F        G       L L+ N I  I           +     +N L   
Sbjct: 141 IHTIERNSFV-------GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEEL 193

Query: 256 IPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKILLL 314
                      + LD+S+ ++  S+P+    N   L+  +  +      +P  + K++ L
Sbjct: 194 PNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVAL 248

Query: 315 QNLDLSHN 322
               L++ 
Sbjct: 249 MEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 42/225 (18%), Positives = 75/225 (33%), Gaps = 32/225 (14%)

Query: 130 LYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLI 189
                + +T I P ++   RN   L     KL  +          L ++ ++ N +  +I
Sbjct: 14  FLCQESKVTEI-PSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 190 PSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSD-NKIHGIIPDELTKLSQLKNLNLS 248
            + +F                   N   L  + +   N +  I P+    L  L+ L +S
Sbjct: 71  EADVFS------------------NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 112

Query: 249 SNLLSGQIP-YAIGKLFNLMYLDLSKNKLSGSIPTEI--GNCSALKNLTLNHNSLDGTIP 305
           +  +   +P          + LD+  N    +I      G       L LN N +   I 
Sbjct: 113 NTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIH 170

Query: 306 LEMGKILLLQNLDLSHNNLSGTIPKTL-----RPMYVDLSFNNLE 345
                   L  L+LS NN    +P  +      P+ +D+S   + 
Sbjct: 171 NSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 78.7 bits (194), Expect = 8e-16
 Identities = 34/227 (14%), Positives = 72/227 (31%), Gaps = 28/227 (12%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWN-NSLSGSIPPQI-GSLSKLKCLYLHG 134
            +  I++  +++   +    FS  P L  + +   N+L   I P+   +L  L+ L +  
Sbjct: 55  DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISN 113

Query: 135 NNLTGIIPKEIGSLRNLRGLFLYSN-KLSGVLPQEIGNLKS-LTELYVTNNALGGLIPST 192
             +  +             L +  N  +  +       L      L++  N         
Sbjct: 114 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN--------- 164

Query: 193 LFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLL 252
              +  I ++ F+ +           +     +N +  +  D     S    L++S   +
Sbjct: 165 --GIQEIHNSAFNGT--------QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 214

Query: 253 SGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNS 299
                Y +  L  L        K    +PT +    AL   +L + S
Sbjct: 215 HSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 30/159 (18%), Positives = 55/159 (34%), Gaps = 15/159 (9%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP-YA 259
                + IP ++        L     K+  I     +    L+ + +S N +   I    
Sbjct: 17  QESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74

Query: 260 IGKLFNLMYLDLSK-NKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKILL-LQN 316
              L  L  + + K N L   I  E   N   L+ L +++  +   +P       L    
Sbjct: 75  FSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIHSLQKVL 132

Query: 317 LDLSHNNLSGTIPK------TLRPMYVDLSFNNLEGEIP 349
           LD+  N    TI +      +   + + L+ N ++ EI 
Sbjct: 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIH 170

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 98.3 bits (244), Expect = 2e-21
 Identities = 41/222 (18%), Positives = 78/222 (35%), Gaps = 11/222 (4%)

Query: 108 LWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVL-- 165
           +              +  +L    L     T ++  E+ S + L+ L   +      +  
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL 390

Query: 166 -PQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLS 224
             + +  L    E     + L  + P     L ++ S        +    ++ +  L L+
Sbjct: 391 LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLE-NSVLKMEYADVRVLHLA 449

Query: 225 DNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI 284
              +  +    L +L  + +L+LS N L   +P A+  L  L  L  S N L  ++   +
Sbjct: 450 HKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GV 504

Query: 285 GNCSALKNLTLNHNSLDG-TIPLEMGKILLLQNLDLSHNNLS 325
            N   L+ L L +N L        +     L  L+L  N+L 
Sbjct: 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 94.1 bits (233), Expect = 3e-20
 Identities = 49/272 (18%), Positives = 99/272 (36%), Gaps = 11/272 (4%)

Query: 52  WWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNN 111
           W  D    + +D          + G  +  + +    + E    + +    L   +L   
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359

Query: 112 SLSGSIPPQIGSLSKLKCLYLHGNN--LTGII-PKEIGSLRNLRGLFLYSNKLSGVLPQE 168
             +  +  ++ S  +L+ L        LT I+  + +  L   +    Y + L  V P  
Sbjct: 360 KST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR 418

Query: 169 IGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKI 228
              L  L   ++  N++  +  + +  L +++     + +   +     +  LDLS N++
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVL-HLAHKD-LTVLC-HLEQLLLVTHLDLSHNRL 475

Query: 229 HGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSG-SIPTEIGNC 287
             + P  L  L  L+ L  S N L   +   +  L  L  L L  N+L   +    + +C
Sbjct: 476 RAL-PPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSC 532

Query: 288 SALKNLTLNHNSLDGTIPLEMGKILLLQNLDL 319
             L  L L  NSL     ++     +L ++  
Sbjct: 533 PRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 75.6 bits (185), Expect = 3e-14
 Identities = 30/171 (17%), Positives = 62/171 (36%), Gaps = 10/171 (5%)

Query: 17  WAALTLLIVHVASATKISIHVAASEIERQALLNSGWWKDRIPHNSSDHCNWVGITCDYEG 76
           W  LT++++  A    +              ++       +    S       +      
Sbjct: 383 WCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP-MRAAYLDDLRSKFLLENSVLKMEYA 441

Query: 77  RITDIDLLNSNIKGELGRL-NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGN 135
            +  + L + ++      L +      +  LDL +N L  ++PP + +L  L+ L    N
Sbjct: 442 DVRVLHLAHKDLT----VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDN 496

Query: 136 NLTGIIPKEIGSLRNLRGLFLYSNKLSGV-LPQEIGNLKSLTELYVTNNAL 185
            L  +    + +L  L+ L L +N+L      Q + +   L  L +  N+L
Sbjct: 497 ALENV--DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.4 bits (156), Expect = 6e-11
 Identities = 48/323 (14%), Positives = 93/323 (28%), Gaps = 55/323 (17%)

Query: 60  NSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPP 119
           +  + C  V  +           LL    +  L     +     +   +W   L  +   
Sbjct: 251 SREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLN 310

Query: 120 QIGSLSKLKCLYLHGNNLTGII---------PKEIGSLRNLRGLFLYSNKLSGVLPQEIG 170
                   + ++   ++    +          ++  +   L    L   K + VL  E+ 
Sbjct: 311 DQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELE 369

Query: 171 NLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHG 230
           + K L EL   N             LT I   +    +  E        TL   D     
Sbjct: 370 SCKELQELEPENK---------WCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPM--- 417

Query: 231 IIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSAL 290
                     +   L+   +    +      +  ++  L L+   L+  +   +     +
Sbjct: 418 ----------RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLV 465

Query: 291 KNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIP-----KTLRPMYVDLSFNNLE 345
            +L L+HN L   +P  +  +  L+ L  S N L   +        L+   + L  N L+
Sbjct: 466 THLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQ--ELLLCNNRLQ 521

Query: 346 --------GEIPT----YLRGNP 356
                      P      L+GN 
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNS 544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 51/223 (22%), Positives = 101/223 (45%), Gaps = 33/223 (14%)

Query: 446 INATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
           ++++  F     +G G Y +VYK      G  VALK++   ++E+     + + E  ++ 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIR-EISLMK 58

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD-----DDEAIELNWTK-RVNIV 558
            ++H NIV+LY     +  + L++E+M+        +D     D   +        +N+V
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMD--------NDLKKYMDSRTVGNTPRGLELNLV 110

Query: 559 KSVAH----ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL 614
           K         L++ H +    I+HRD+   N+L++   +  + DFG AR   +  +  + 
Sbjct: 111 KYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167

Query: 615 RAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMGT 652
              T  Y AP++      Y+  +    D++S G +  E++ G 
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 30/205 (14%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G +G V   E    G  VA+K L+  +      V   + E   L   RH +I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 517 FCLHKKCMFLIYEYMERGSLF--CVLH---DDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                   F++ EY+  G LF     H   ++ EA          + + +  A+ Y H  
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA--------RRLFQQILSAVDYCHR- 129

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIV 631
               ++HRD+   N+LLD+++ A +ADFG + ++      RT   G+  Y APE     V
Sbjct: 130 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPE-----V 181

Query: 632 VTGK------CDVYSFGVVALEVLM 650
           ++G+       D++S GV+ L  L+
Sbjct: 182 ISGRLYAGPEVDIWSCGVI-LYALL 205

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 36/212 (16%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKK--LHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G G + +VYKA +    ++VA+KK  L H         ++   E  +L  + H NI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHD-----DDEAIELNWTKRVNIVKSVAH----AL 565
                HK  + L++++ME         D      D ++ L      + +K+        L
Sbjct: 78  LDAFGHKSNISLVFDFME--------TDLEVIIKDNSLVLT----PSHIKAYMLMTLQGL 125

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
            YLH      I+HRD+  NN+LLD N    +ADFG A+     +   T +  T  Y APE
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 182

Query: 626 L-----AYTIVVTGKCDVYSFGVVALEVLMGT 652
           L      Y + V    D+++ G +  E+L+  
Sbjct: 183 LLFGARMYGVGV----DMWAVGCILAELLLRV 210

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 93.2 bits (232), Expect = 9e-21
 Identities = 51/221 (23%), Positives = 85/221 (38%), Gaps = 50/221 (22%)

Query: 449 TEDFHIKY-----CIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHV 502
                  Y      +G G  G V +      G+  ALK L+ S           + E   
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDH 74

Query: 503 LSTV-RHRNIVKLYGFC----LHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR--- 554
                   +IV +          K+C+ +I E ME G LF         I+    +    
Sbjct: 75  HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF-------SRIQERGDQAFTE 127

Query: 555 ---VNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVD 608
                I++ +  A+ +LH   + +I HRD+   N+L  S  + +   + DFG A+     
Sbjct: 128 REAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-Q 183

Query: 609 SSYRTLRAGTYGYIAPELAYTIVVTGK-----CDVYSFGVV 644
           ++ +T    T  Y+APE     V+  +     CD++S GV+
Sbjct: 184 NALQT-PCYTPYYVAPE-----VLGPEKYDKSCDMWSLGVI 218

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 95.6 bits (238), Expect = 1e-20
 Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 22/214 (10%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
             F     +G GG+G V   ++   GK+ A KKL     +         NE  +L  V  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 509 RNIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDDDEAI--ELNWTKRVNI-VKSVAHA 564
           R +V L  +    K  + L+   M  G L   ++   +A   E     R       +   
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE----ARAVFYAAEICCG 298

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAP 624
           L  LH      I++RD+   NILLD +    ++D G A  +    + +  R GT GY+AP
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAP 354

Query: 625 EL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+     YT       D ++ G +  E++ G  P
Sbjct: 355 EVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 54/219 (24%), Positives = 86/219 (39%), Gaps = 45/219 (20%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLH-HSETEDSAFV--------KSFQNEAHVLSTVR 507
           IG G YG+VYKA +   G  VALK +   +       +           +     L    
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR----LEAFE 72

Query: 508 HRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTKR--VNIVKS 560
           H N+V+L   C   +      + L++E+++         D    ++           +K 
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLDKAPPPGLPAETIKD 124

Query: 561 VAH----ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
           +       L +LH +C   I+HRD+   NIL+ S     +ADFG AR+     +  T   
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVV 180

Query: 617 GTYGYIAPEL----AYTIVVTGKCDVYSFGVVALEVLMG 651
            T  Y APE+     Y   V    D++S G +  E+   
Sbjct: 181 VTLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRR 215

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 93.7 bits (233), Expect = 4e-20
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 15/212 (7%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           + F     +G GG+G V+  ++   GK+ A KKL+    +     +    E  +L+ V  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 509 RNIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS-VAHALS 566
           R IV L  +    K  + L+   M  G +   +++ DE        R     + +   L 
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           +LH     +II+RD+   N+LLD +    ++D G A  L    +     AGT G++APEL
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

Query: 627 ----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                Y   V    D ++ GV   E++    P
Sbjct: 361 LLGEEYDFSV----DYFALGVTLYEMIAARGP 388

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.2 bits (229), Expect = 8e-20
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 31/210 (14%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G +G V   +    G  VA+K L+  +      V   + E   L   RH +I+KLY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 517 FCLHKKCMFLIYEYMERGSLF--CVLH---DDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                  +F++ EY+  G LF     +   D+ E+          + + +   + Y H  
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES--------RRLFQQILSGVDYCHR- 134

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIV 631
               ++HRD+   N+LLD+++ A +ADFG + ++      RT   G+  Y APE     V
Sbjct: 135 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPE-----V 186

Query: 632 VTGK------CDVYSFGVVALEVLM-GTHP 654
           ++G+       D++S GV+ L  L+ GT P
Sbjct: 187 ISGRLYAGPEVDIWSSGVI-LYALLCGTLP 215

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 45/218 (20%)

Query: 458 IGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAF-------VKSFQNEAHVLSTVRH 508
           IG G YG V+KA      G+ VALK++   +T +          V   ++    L T  H
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIREVAVLRH----LETFEH 73

Query: 509 RNIVKLY-----GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV--NIVKSV 561
            N+V+L+          +  + L++E+++         D    ++      V    +K +
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVD--------QDLTTYLDKVPEPGVPTETIKDM 125

Query: 562 AH----ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
                  L +LH      ++HRD+   NIL+ S+ +  +ADFG AR+     +  T    
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV 181

Query: 618 TYGYIAPEL----AYTIVVTGKCDVYSFGVVALEVLMG 651
           T  Y APE+    +Y   V    D++S G +  E+   
Sbjct: 182 TLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRR 215

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 36/219 (16%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           + F     +GTG +G V   +    G   A+K L   +      ++   NE  +L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD---DE------AIELNWTKRVNIVK 559
             +VKL         ++++ EY+  G +F  L       E      A +           
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ----------- 149

Query: 560 SVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTY 619
            +     YLH    L +I+RD+   N+L+D      V DFG A+   V     TL  GT 
Sbjct: 150 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTL-CGTP 202

Query: 620 GYIAPEL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
             +APE+     Y   V    D ++ GV+  E+  G  P
Sbjct: 203 EALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 90.6 bits (225), Expect = 2e-19
 Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 20/213 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
            +F     +G G +G V   +    G+  A+K L          V     E  VL   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 509 RNIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI-VKSVAHALS 566
             +  L  +       +  + EY   G LF  L  +    E     R       +  AL 
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALD 262

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRTLRAGTYGYIAPE 625
           YLH +   ++++RD+   N++LD +    + DFG  +  +   ++ +T   GT  Y+APE
Sbjct: 263 YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYLAPE 319

Query: 626 L----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           +     Y   V    D +  GVV  E++ G  P
Sbjct: 320 VLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 54/207 (26%), Positives = 84/207 (40%), Gaps = 33/207 (15%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G YG V  A      + VA+K +      D    ++ + E  +   + H N+VK YG
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG 72

Query: 517 FCLHKKCMFLIYEYMERGSLF--CVLH---DDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                   +L  EY   G LF          + +A              +   + YLH  
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA--------QRFFHQLMAGVVYLHG- 123

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYGYIAPELAYT 629
             + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+APE    
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE---- 177

Query: 630 IVVTGK------CDVYSFGVVALEVLM 650
            ++  +       DV+S G+V L  ++
Sbjct: 178 -LLKRREFHAEPVDVWSCGIV-LTAML 202

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 89.5 bits (222), Expect = 7e-19
 Identities = 51/295 (17%), Positives = 105/295 (35%), Gaps = 35/295 (11%)

Query: 81  IDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGI 140
           + L  +  + E    +     +  +  L     +      I  +S      L  +N+  +
Sbjct: 145 LVLGETYGEKE----DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200

Query: 141 -----------IPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNL---KSLTELYVTNNALG 186
                      I  ++ +   L  L L + + +      I  L    ++    ++N  L 
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260

Query: 187 GLIPSTLFRLT----------NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEL 236
           G +    F  +           + S+ F          FS ++  + + +    +     
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320

Query: 237 TKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLT-- 294
           +K+S   +L+ S+NLL+  +    G L  L  L L  N+L   +       + +K+L   
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQL 379

Query: 295 -LNHNSLDGTIPLEMGKILL-LQNLDLSHNNLSGTIPKTLRPM--YVDLSFNNLE 345
            ++ NS+              L +L++S N L+ TI + L P    +DL  N ++
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 88.4 bits (219), Expect = 2e-18
 Identities = 43/244 (17%), Positives = 71/244 (29%), Gaps = 27/244 (11%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
                L++  N +S      I SLSKL+ L +  N +  +        + L  L L  NK
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 161 LSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDT 220
           L   +        +L  L ++ NA   L     F                  GN S L  
Sbjct: 81  LVK-IS--CHPTVNLKHLDLSFNAFDALPICKEF------------------GNMSQLKF 119

Query: 221 LDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSI 280
           L LS   +       +  L+  K L +               L +     L     +   
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKE 177

Query: 281 PTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLS 340
              I + S      L  +++   +        L     L  N         L    ++ +
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKL----SNLTLNNIETT 233

Query: 341 FNNL 344
           +N+ 
Sbjct: 234 WNSF 237

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 88.0 bits (218), Expect = 2e-18
 Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 9/161 (5%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIG---SLRNLRG 153
            S       LD  NN L+ ++    G L++L+ L L  N L   + K       +++L+ 
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQ 378

Query: 154 LFLYSNKLSGVLPQEI-GNLKSLTELYVTNNALGGLIPSTLFRLT---NISSNQFHSSIP 209
           L +  N +S    +      KSL  L +++N L   I   L       ++ SN+   SIP
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKI-KSIP 437

Query: 210 LEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSN 250
            ++    AL  L+++ N++  +      +L+ L+ + L +N
Sbjct: 438 KQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 82.6 bits (204), Expect = 1e-16
 Identities = 44/281 (15%), Positives = 93/281 (33%), Gaps = 24/281 (8%)

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIP 142
           ++ N   EL   +      L+ L + +N +   +   +     +L+ L L  N L  I  
Sbjct: 28  ISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVKIS- 85

Query: 143 KEIGSLRNLRGLFLYSNKLSGV-LPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISS 201
                  NL+ L L  N    + + +E GN+  L  L ++   L       +  L     
Sbjct: 86  --CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKV 143

Query: 202 NQFHSS---IPLEIGNFSALDTLDL-----SDNKIHGIIPDELTKLSQLKNLNLSSNLLS 253
                       +       +T  L     ++ + H I+   +  ++ L+  N+   L  
Sbjct: 144 LLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203

Query: 254 GQIPYAIGKLFNLMY------LDLSKNKLSGSIPTEIGNC---SALKNLTLNHNSLDGTI 304
            +  Y +  L  L        L L+  + + +    I      + +   ++++  L G +
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263

Query: 305 PLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLE 345
                         LS + +   +       Y+   F+N+ 
Sbjct: 264 DFRDFDYSGTSLKALSIHQVVSDVFGFP-QSYIYEIFSNMN 303

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 78.4 bits (193), Expect = 3e-15
 Identities = 46/284 (16%), Positives = 88/284 (30%), Gaps = 34/284 (11%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRN-----L 151
           F     LK L L    L  S    I  L+  K L + G        ++   L++     L
Sbjct: 111 FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESL 168

Query: 152 RGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLE 211
             +F  + +   +L   +  + +L    +            L  L  + +N   S++ L 
Sbjct: 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLN 228

Query: 212 IGNFSALDT--------------LDLSDNKIHGIIPDEL-----TKLSQLKNLNLSSNLL 252
               +                    +S+ K+ G +         T L  L    + S++ 
Sbjct: 229 NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF 288

Query: 253 SGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKIL 312
                Y      N+   + + +             S   +L  ++N L  T+    G + 
Sbjct: 289 GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLT 348

Query: 313 LLQNLDLSHNNLSGTIPKTLRP-------MYVDLSFNNLEGEIP 349
            L+ L L  N L   + K             +D+S N++  +  
Sbjct: 349 ELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 74.1 bits (182), Expect = 6e-14
 Identities = 51/263 (19%), Positives = 88/263 (33%), Gaps = 14/263 (5%)

Query: 198 NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP 257
           + S N     +P ++        L++S N I  +   ++  LS+L+ L +S N +     
Sbjct: 6   DRSKNGL-IHVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDI 62

Query: 258 YAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPL--EMGKILLLQ 315
                   L YLDLS NKL   I         LK+L L+ N+ D  +P+  E G +  L+
Sbjct: 63  SVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLK 118

Query: 316 NLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGNVEGFPS 375
            L LS  +L  +    +  + +      L     TY     P+    +         FP+
Sbjct: 119 FLGLSTTHLEKSSVLPIAHLNISKVLLVLG---ETYGEKEDPEGLQ-DFNTESLHIVFPT 174

Query: 376 SSQRQKLTPSISLFAKIFLPLNL-VLAFIIFGFTLLFKCQNKNPRLNSRAAKNGDVFSVW 434
           + +   +              N+  +         L                  ++ + W
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234

Query: 435 NYDGKILYEDLINATEDFHIKYC 457
           N   +IL          F I   
Sbjct: 235 NSFIRILQLVWHTTVWYFSISNV 257

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 64.9 bits (158), Expect = 5e-11
 Identities = 27/105 (25%), Positives = 54/105 (51%), Gaps = 3/105 (2%)

Query: 79  TDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLT 138
             +D+  +++  +  + + S   +L SL++ +N L+ +I   +    ++K L LH N + 
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK 434

Query: 139 GIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNN 183
            I PK++  L  L+ L + SN+L  V       L SL ++++  N
Sbjct: 435 SI-PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 86.9 bits (216), Expect = 7e-19
 Identities = 47/226 (20%), Positives = 85/226 (37%), Gaps = 45/226 (19%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALK-----------------------KLHHSETEDSAFV 493
           IG G YG V  A    +    A+K                              +    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 494 KSFQNEAHVLSTVRHRNIVKLYG--FCLHKKCMFLIYEYMERGSLFCVLHDD----DEAI 547
           +    E  +L  + H N+VKL       ++  +++++E + +G +  V        D+A 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA- 139

Query: 548 ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
                      + +   + YLH+     IIHRDI  +N+L+  +    +ADFG +     
Sbjct: 140 -------RFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 608 DSSYRTLRAGTYGYIAPEL--AYTIVVTG-KCDVYSFGVVALEVLM 650
             +  +   GT  ++APE       + +G   DV++ GV  L   +
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT-LYCFV 234

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 87.3 bits (217), Expect = 1e-18
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 31/205 (15%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G +G V  A      + VALK +     + S      + E   L  +RH +I+KLY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 517 FCLHKKCMFLIYEYMERGSLF--CVLH---DDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                  + ++ EY   G LF   V      +DE             + +  A+ Y H  
Sbjct: 77  VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEG--------RRFFQQIICAIEYCHR- 126

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIV 631
               I+HRD+   N+LLD NL   +ADFG + ++   +  +T   G+  Y APE     V
Sbjct: 127 --HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-CGSPNYAAPE-----V 178

Query: 632 VTGK------CDVYSFGVVALEVLM 650
           + GK       DV+S G+V L V++
Sbjct: 179 INGKLYAGPEVDVWSCGIV-LYVML 202

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 43/241 (17%), Positives = 87/241 (36%), Gaps = 40/241 (16%)

Query: 125 SKLKCLYLHGNNLTGI--IPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTN 182
            + +   +   ++  I  +P       + + L L    L  +      NL +++ +YV+ 
Sbjct: 11  HQEEDFRVTCKDIQRIPSLP------PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSI 64

Query: 183 NALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNK-IHGIIPDELTKLSQ 241
           +            L  + S+ F+        N S +  +++ + + +  I PD L +L  
Sbjct: 65  DV----------TLQQLESHSFY--------NLSKVTHIEIRNTRNLTYIDPDALKELPL 106

Query: 242 LKNLNLSSNLLSGQIP--YAIGKLFNLMYLDLSKNKLSGSIPTEI--GNCSALKNLTLNH 297
           LK L + +  L    P    +        L+++ N    SIP     G C+    L L +
Sbjct: 107 LKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN 165

Query: 298 NSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTL------RPMYVDLSFNNLEGEIPTY 351
           N    ++         L  + L+ N     I K         P  +D+S  ++   +P+ 
Sbjct: 166 NGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK 223

Query: 352 L 352
            
Sbjct: 224 G 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 42/227 (18%), Positives = 89/227 (39%), Gaps = 29/227 (12%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNN 136
              + L+ ++++  +    FS  PN+  + +  +     +      +LSK+  + +    
Sbjct: 33  TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 137 -LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQE--IGNLKSLTELYVTNNALGGLIPSTL 193
            LT I P  +  L  L+ L +++  L  + P    + +      L +T+N          
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNP--------- 141

Query: 194 FRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLS 253
             +T+I  N F        G  +   TL L +N     +       ++L  + L+ N   
Sbjct: 142 -YMTSIPVNAFQ-------GLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYL 192

Query: 254 GQIP-YAIGKLFN-LMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHN 298
             I   A G +++    LD+S+  ++ ++P++      LK L   + 
Sbjct: 193 TVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 33/182 (18%), Positives = 58/182 (31%), Gaps = 12/182 (6%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGN 135
            I+ I +       +L   +F     +  +++ N      I P     L  LK L +   
Sbjct: 56  NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115

Query: 136 NLTGIIPKE-IGSLRNLRGLFLYSNKLSGVLPQEI--GNLKSLTELYVTNNALGGLIPST 192
            L        + S      L +  N     +P     G       L + NN     +   
Sbjct: 116 GLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGY 174

Query: 193 LFRLTNI-----SSNQFHSSIPLEI--GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNL 245
            F  T +     + N++ + I  +   G +S    LD+S   +  +    L  L +L   
Sbjct: 175 AFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIAR 234

Query: 246 NL 247
           N 
Sbjct: 235 NT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 24/145 (16%), Positives = 53/145 (36%), Gaps = 14/145 (9%)

Query: 216 SALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP-YAIGKLFNLMYLDLSKN 274
            +  TL L +  +  I     + L  +  + +S ++   Q+  ++   L  + ++++   
Sbjct: 31  PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90

Query: 275 KLSGSIPTEI-GNCSALKNLTLNHNSLDGTIP--LEMGKILLLQNLDLSHNNLSGTIPKT 331
           +    I  +       LK L + +  L    P   ++    +   L+++ N    +IP  
Sbjct: 91  RNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIP-- 147

Query: 332 LRPMYVDLSFNNLEGEIPT-YLRGN 355
                   +F  L  E  T  L  N
Sbjct: 148 ------VNAFQGLCNETLTLKLYNN 166

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 89.6 bits (222), Expect = 1e-18
 Identities = 55/216 (25%), Positives = 85/216 (39%), Gaps = 25/216 (11%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-- 506
            DF +   IG GG+G VY     + GK+ A+K L     +         NE  +LS V  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 507 -RHRNIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI-VKSVAH 563
                IV +  +  H    +  I + M  G L   L       E      +      +  
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIIL 303

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
            L ++H      +++RD+   NILLD +    ++D G A        +     GT+GY+A
Sbjct: 304 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMA 358

Query: 624 PEL-----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           PE+     AY        D +S G +  ++L G  P
Sbjct: 359 PEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 33/207 (15%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           +G G YG V  A      + VA+K +      D    ++ + E  +   + H N+VK YG
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG 72

Query: 517 FCLHKKCMFLIYEYMERGSLF--CVLH---DDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
                   +L  EY   G LF          + +A          ++      + YLH  
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH----QLM----AGVVYLHG- 123

Query: 572 CTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA--GTYGYIAPELAYT 629
             + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+APE    
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE---- 177

Query: 630 IVVTGK------CDVYSFGVVALEVLM 650
            ++  +       DV+S G+V L  ++
Sbjct: 178 -LLKRREFHAEPVDVWSCGIV-LTAML 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 85.7 bits (212), Expect = 4e-18
 Identities = 46/178 (25%), Positives = 70/178 (39%), Gaps = 25/178 (14%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQI--GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLY 157
                 LDL +N+LS  +  +     L+ L  L L  N+L  I  +    + NLR L L 
Sbjct: 38  PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96

Query: 158 SNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSA 217
           SN L  +      +L++L  L + NN            +  +  N F         + + 
Sbjct: 97  SNHLHTLDEFLFSDLQALEVLLLYNN-----------HIVVVDRNAFE--------DMAQ 137

Query: 218 LDTLDLSDNKIHGIIPD---ELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLS 272
           L  L LS N+I     +   +  KL +L  L+LSSN L       + KL   +   L 
Sbjct: 138 LQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 83.4 bits (206), Expect = 3e-17
 Identities = 41/176 (23%), Positives = 68/176 (38%), Gaps = 20/176 (11%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNN 136
              +DL ++N+         +   NL SL L +N L+  I  +    +  L+ L L  N+
Sbjct: 41  TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNH 99

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRL 196
           L  +       L+ L  L LY+N +  V      ++  L +LY++ N           ++
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN-----------QI 148

Query: 197 TNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLK--NLNLSSN 250
           +            L       L  LDLS NK+  +   +L KL       L L +N
Sbjct: 149 SRFPVELIKDGNKL-----PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 82.6 bits (204), Expect = 4e-17
 Identities = 46/203 (22%), Positives = 72/203 (35%), Gaps = 38/203 (18%)

Query: 133 HGNNLTGI---IPKEIGSLRNLRGLFLYSNKLSGVLPQEI-GNLKSLTELYVTNNALGGL 188
               L  +   +P           L L  N LS +  +     L +L  L +++N L  +
Sbjct: 26  SKQQLPNVPQSLP------SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFI 79

Query: 189 IPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLS 248
                  + N                   L  LDLS N +H +     + L  L+ L L 
Sbjct: 80  SSEAFVPVPN-------------------LRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120

Query: 249 SNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI----GNCSALKNLTLNHNSLDGTI 304
           +N +      A   +  L  L LS+N++S   P E+         L  L L+ N L   +
Sbjct: 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKL-KKL 178

Query: 305 PLEMGKIL---LLQNLDLSHNNL 324
           PL   + L   +   L L +N L
Sbjct: 179 PLTDLQKLPAWVKNGLYLHNNPL 201

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 86.3 bits (214), Expect = 5e-18
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 58/222 (26%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLY 515
           IG G +G VY+A+L + G++VA+KK+     +D    K F+N E  ++  + H NIV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVL----QD----KRFKNRELQIMRKLDHCNIVRLR 113

Query: 516 GF------CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI----VKSVAH-- 563
            F         +  + L+ +Y+        ++            +  +    VK   +  
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVP-----ETVY---RVARHYSRAKQTLPVIYVKLYMYQL 165

Query: 564 --ALSYLHHDCTLSIIHRDISSNNILLDSNLEA-SVADFGTARLLHVDSSYRTLRAGTYG 620
             +L+Y+H   +  I HRDI   N+LLD +     + DFG+A+ L       +       
Sbjct: 166 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS------- 215

Query: 621 YI------APEL-----AYTIVVTGKCDVYSFGVVALEVLMG 651
           YI      APEL      YT  +    DV+S G V  E+L+G
Sbjct: 216 YICSRYYRAPELIFGATDYTSSI----DVWSAGCVLAELLLG 253

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 49/217 (22%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQN-EAHVLSTVRHRNIVKLYG 516
           IG G +G V++A+L E   VA+KK+     +D    K F+N E  ++  V+H N+V L  
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVL----QD----KRFKNRELQIMRIVKHPNVVDLKA 99

Query: 517 F------CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH----ALS 566
           F         +  + L+ EY+   +++          +L  T  + ++K   +    +L+
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRAS---RHYAKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 567 YLHHDCTLSIIHRDISSNNILLDSN-LEASVADFGTARLLHVDSSYRTLRAGTYGYI--- 622
           Y+H   ++ I HRDI   N+LLD       + DFG+A++L               YI   
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV-------SYICSR 205

Query: 623 ---APEL-----AYTIVVTGKCDVYSFGVVALEVLMG 651
              APEL      YT  +    D++S G V  E++ G
Sbjct: 206 YYRAPELIFGATNYTTNI----DIWSTGCVMAELMQG 238

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 68/221 (30%), Positives = 100/221 (45%), Gaps = 40/221 (18%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF I   +GTG +G V+       G+  A+K L          V+   +E  +LS V H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-----DDDEA------IELNWTKRVNI 557
             I++++G     + +F+I +Y+E G LF +L       +  A      + L        
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------- 117

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
                 AL YLH      II+RD+   NILLD N    + DFG A+  +V     TL  G
Sbjct: 118 ------ALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYTL-CG 165

Query: 618 TYGYIAPEL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           T  YIAPE+     Y   +    D +SFG++  E+L G  P
Sbjct: 166 TPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 45/221 (20%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSE-TEDSAFVKSFQNEAHVLSTVRHRNIVKLY 515
           +G G YG V +          A+K L   +         + + E  +L  +RH+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 516 GFCLH--KKCMFLIYEYMERGS--LFCVLHDDDEAIELNWTKRVNIVKSVAH-------- 563
               +  K+ M+++ EY   G   +       D   E    KR  +    AH        
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEML------DSVPE----KRFPV--CQAHGYFCQLID 120

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGY 621
            L YLH      I+H+DI   N+LL +     ++  G A  LH  ++  T R   G+  +
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 622 IAPELAYTIVVTG-------KCDVYSFGVVALEVLM-GTHP 654
             PE     +  G       K D++S GV  L  +  G +P
Sbjct: 178 QPPE-----IANGLDTFSGFKVDIWSAGVT-LYNITTGLYP 212

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 53/243 (21%), Positives = 84/243 (34%), Gaps = 69/243 (28%)

Query: 450 EDFHI--KY----CIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           E   +   Y     I +G YG+V      EG  VA+K++  +   D   V    +     
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRV-FNTVSDGRTVNILSDSFLCK 74

Query: 504 STVR---------HRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIEL 549
             +R         H NI+ L    +H +      ++L+ E M        L         
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLA-------- 121

Query: 550 NWTKRVNIVKSVAHALS----------------YLHHDCTLSIIHRDISSNNILLDSNLE 593
                  ++      +S                 LH      ++HRD+   NILL  N +
Sbjct: 122 ------QVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNND 172

Query: 594 ASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEV 648
            ++ DF  AR    D++  T       Y APEL      +T +V    D++S G V  E+
Sbjct: 173 ITICDFNLAREDTADANK-THYVTHRWYRAPELVMQFKGFTKLV----DMWSAGCVMAEM 227

Query: 649 LMG 651
              
Sbjct: 228 FNR 230

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 59/207 (28%), Positives = 83/207 (40%), Gaps = 28/207 (13%)

Query: 98  SCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLY 157
           +C    K +D    SL  S+P  I + ++   L L    L  +       L  L  L L 
Sbjct: 11  TCNEGKKEVDCQGKSLD-SVPSGIPADTEK--LDLQSTGLATLSDATFRGLTKLTWLNLD 67

Query: 158 SNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLF-RLTNISSNQFHSSIPLEIGNFS 216
            N+L  +      +L  L  L + NN L  L P  +F  LT                   
Sbjct: 68  YNQLQTLSAGVFDDLTELGTLGLANNQLASL-PLGVFDHLTQ------------------ 108

Query: 217 ALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPY-AIGKLFNLMYLDLSKNK 275
            LD L L  N++  +      +L++LK L L++N L   IP  A  KL NL  L LS N+
Sbjct: 109 -LDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQ 166

Query: 276 LSGSIPTEI-GNCSALKNLTLNHNSLD 301
           L  S+P         L+ +TL  N  D
Sbjct: 167 LQ-SVPHGAFDRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 28/88 (31%), Positives = 37/88 (42%), Gaps = 2/88 (2%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
           F     L  L L  N L  S+P  +   L+KLK L L+ N L  I       L NL+ L 
Sbjct: 103 FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLS 161

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNN 183
           L +N+L  V       L  L  + +  N
Sbjct: 162 LSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 82.3 bits (204), Expect = 5e-17
 Identities = 55/234 (23%), Positives = 99/234 (42%), Gaps = 54/234 (23%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQN----EAH 501
              + F ++   G G +G+V    E   G  VA+KK+     +D      F+N       
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI----QD----PRFRNRELQIMQ 71

Query: 502 VLSTVRHRNIVKLYGFCLHKK-------CMFLIYEYMERGSLFCVLHDDDEAIELNWTKR 554
            L+ + H NIV+L  +             + ++ EY+        LH         + ++
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLH---RCCRNYYRRQ 123

Query: 555 VNI----VKS----VAHALSYLHHDCTLSIIHRDISSNNILLD-SNLEASVADFGTARLL 605
           V      +K     +  ++  LH   ++++ HRDI  +N+L++ ++    + DFG+A+ L
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 606 HVDS---SYRTLRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMG 651
                  +Y   R   Y Y APEL      YT  V    D++S G +  E+++G
Sbjct: 183 SPSEPNVAYICSR---Y-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLG 228

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 81.9 bits (203), Expect = 5e-17
 Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 27/216 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVA---LKKLHHSETEDSAFVKSFQNEAHVLST 505
            DF     +G G +G V        G+  A   L+K      ++   V     E+ VL  
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE---VAHTVTESRVLQN 61

Query: 506 VRHRNIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS-VAH 563
            RH  +  L  +       +  + EY   G LF  L  +    E    +R     + +  
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE----ERARFYGAEIVS 116

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRTLRAGTYGYI 622
           AL YLH   +  +++RDI   N++LD +    + DFG  +  +   ++ +T   GT  Y+
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYL 172

Query: 623 APEL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           APE+     Y   V    D +  GVV  E++ G  P
Sbjct: 173 APEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 82.4 bits (204), Expect = 5e-17
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 37/212 (17%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG+G +G           ++VA+K +      D    ++ Q E     ++RH NIV+   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKE 83

Query: 517 FCLHKKCMFLIYEYMERGSLF--CVLH---DDDEAIELNWTKRVNIVKSVAHALSYLHHD 571
             L    + +I EY   G L+          +DEA          ++      +SY H  
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ----QLL----SGVSYCHS- 134

Query: 572 CTLSIIHRDISSNNILLDSNLEAS--VADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT 629
             + I HRD+   N LLD +      + DFG ++   + S  ++   GT  YIAPE    
Sbjct: 135 --MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPE---- 187

Query: 630 IVVTGK------CDVYSFGVVALEVLM-GTHP 654
            V+  +       DV+S GV  L V++ G +P
Sbjct: 188 -VLLRQEYDGKIADVWSCGVT-LYVMLVGAYP 217

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 81.5 bits (201), Expect = 1e-16
 Identities = 63/345 (18%), Positives = 115/345 (33%), Gaps = 91/345 (26%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           +   +   +G G +G V +A+          + VA+K L   E    +  ++  +E  +L
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKIL 79

Query: 504 STV-RHRNIVKLYGFCLHKKC-MFLIYEYMERGSLFCVLH-------------------- 541
             +  H N+V L G C      + +I E+ + G+L   L                     
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGK 139

Query: 542 DDDEAIELNWTKRVNIVKSVAHA----------LSYLHHDCTLSIIHRDISSNNILL--- 588
           D   AI ++  +R++ + S   +          LS +  +     +++D  +   L+   
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS 199

Query: 589 ---------------------------DSNLEASVADFGTARLLHVDSSYRTLRAGTYGY 621
                                             + DFG AR ++ D  Y          
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDAR 256

Query: 622 I-----APELAYTIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVL 675
           +     APE  +  V T + DV+SFGV+  E+  +G  P      +         L +  
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEEFCRRLKE-- 311

Query: 676 NQRLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             R+  P      +   +L       C   +P  RPT   + + L
Sbjct: 312 GTRMRAPDYTTPEMYQTML------DCWHGEPSQRPTFSELVEHL 350

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.1 bits (196), Expect = 4e-16
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 29/219 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGK-------VVALKKLHHSETEDSAFVKSFQNEAHV 502
           E F +   +G GGYG V++     G        +  LKK               + E ++
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD--TAHTKAERNI 74

Query: 503 LSTVRHRNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI-VKS 560
           L  V+H  IV L Y F    K ++LI EY+  G LF  L  +   +E          +  
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME----DTACFYLAE 129

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRTLRAGTY 619
           ++ AL +LH      II+RD+   NI+L+      + DFG  +  +H  +   T   GT 
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF-CGTI 185

Query: 620 GYIAPEL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            Y+APE+     +   V    D +S G +  ++L G  P
Sbjct: 186 EYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 37/222 (16%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGK-------VVALKK---LHHSETEDSAFVKSFQNE 499
             F +   +G G +G V+  +   G        +  LKK                    E
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-------E 76

Query: 500 AHVLSTVRHRNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI- 557
             +L  V H  IVKL Y F    K ++LI +++  G LF  L  +    E    + V   
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE----EDVKFY 131

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRTLRA 616
           +  +A AL +LH   +L II+RD+   NILLD      + DFG ++  +  +    +   
Sbjct: 132 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-C 187

Query: 617 GTYGYIAPEL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           GT  Y+APE+     +T       D +SFGV+  E+L GT P
Sbjct: 188 GTVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP 225

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 44/201 (21%), Positives = 77/201 (38%), Gaps = 53/201 (26%)

Query: 458 IGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLY 515
           +G G  G V +       +  ALK L     +D       + E  +     +  +IV++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML-----QDC---PKARREVELHWRASQCPHIVRIV 77

Query: 516 GFC----LHKKCMFLIYEYMERGSLFCVLHDDDEAIE---LNWTKR--VNIVKSVAHALS 566
                    +KC+ ++ E ++ G LF          +     +T+R    I+KS+  A+ 
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELF------SRIQDRGDQAFTEREASEIMKSIGEAIQ 131

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTARLLHVDSSYRTLRAGTYGYIA 623
           YLH   +++I HRD+   N+L  S    +   + DFG A         +      Y    
Sbjct: 132 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------KETTGEKYDK-- 177

Query: 624 PELAYTIVVTGKCDVYSFGVV 644
                       CD++S GV+
Sbjct: 178 -----------SCDMWSLGVI 187

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.5 bits (193), Expect = 3e-15
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 22/214 (10%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-R 507
            DF+    +G G +G V  +E     ++ A+K L          V+    E  VL+   +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 508 HRNIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS-VAHAL 565
              + +L+  C      ++ + EY+  G L   +       E           + +A  L
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGL 455

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRTLRAGTYGYIAP 624
            +L    +  II+RD+  +N++LDS     +ADFG  +  +    + +T   GT  YIAP
Sbjct: 456 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-CGTPDYIAP 511

Query: 625 EL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           E+     Y   V    D ++FGV+  E+L G  P
Sbjct: 512 EIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 40/221 (18%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAH------ 501
            + +     IG+G  G V  A +    + VA+KKL           + FQN+ H      
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS----------RPFQNQTHAKRAYR 73

Query: 502 ---VLSTVRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHD--DDEAIELN 550
              ++  V H+NI+ L      +K +      +++ E M+  +L  V+    D E +   
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY- 131

Query: 551 WTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS 610
                 ++  +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S 
Sbjct: 132 ------LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSF 181

Query: 611 YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
             T    T  Y APE+   +      D++S G +  E++ G
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 35/207 (16%)

Query: 99  CFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
            F      +L   S++     Q   L+ +  +  + +++  +    I  L N+R L L  
Sbjct: 17  AFAETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGG 72

Query: 159 NKLSGVLPQEIG---NLKSLTELYVTNNALGGLIPSTLF-RLTNISSNQFHSSIPLEIGN 214
           NKL      +I     L +LT L +T N L  L P+ +F +LTN                
Sbjct: 73  NKL-----HDISALKELTNLTYLILTGNQLQSL-PNGVFDKLTN---------------- 110

Query: 215 FSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKN 274
              L  L L +N++  +      KL+ L  LNL+ N L         KL NL  LDLS N
Sbjct: 111 ---LKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYN 167

Query: 275 KLSGSIPTEI-GNCSALKNLTLNHNSL 300
           +L  S+P  +    + LK+L L  N L
Sbjct: 168 QLQ-SLPEGVFDKLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 51/180 (28%), Positives = 71/180 (39%), Gaps = 29/180 (16%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIG---SLSKLKCLYLH 133
            +  ID + +N             PN++ L L  N L       I     L+ L  L L 
Sbjct: 39  ELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILT 93

Query: 134 GNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTL 193
           GN L  +       L NL+ L L  N+L  +       L +LT L + +N L  L P  +
Sbjct: 94  GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSL-PKGV 152

Query: 194 F-RLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLL 252
           F +LTN                   L  LDLS N++  +      KL+QLK+L L  N L
Sbjct: 153 FDKLTN-------------------LTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 76.2 bits (188), Expect = 5e-15
 Identities = 66/228 (28%), Positives = 96/228 (42%), Gaps = 43/228 (18%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGK----VVALKKLHHSE-TEDSAFVKSFQNEAHVLS 504
           E+F +   +GTG YG V+      G     + A+K L  +   + +   +  + E  VL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 505 TVRHRN-IVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDD---DE------AIELNWTK 553
            +R    +V L Y F    K + LI +Y+  G LF  L       E        E+    
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI---- 168

Query: 554 RVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRT 613
                     AL +LH    L II+RDI   NILLDSN    + DFG ++    D + R 
Sbjct: 169 --------VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217

Query: 614 LR-AGTYGYIAPEL------AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
               GT  Y+AP++       +   V    D +S GV+  E+L G  P
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 75.7 bits (187), Expect = 7e-15
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 28/217 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVA---LKKLHHSETEDSAFVKSFQNEAHVLST 505
           EDF +   +G G +G V+ AE  +  +  A   LKK      +D   V+    E  VLS 
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMVEKRVLSL 73

Query: 506 V-RHRNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS-VA 562
              H  +  +   F   +  +F + EY+  G L   +    +        R     + + 
Sbjct: 74  AWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDL----SRATFYAAEII 128

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRTLRAGTYGY 621
             L +LH   +  I++RD+  +NILLD +    +ADFG  +  +  D+   T   GT  Y
Sbjct: 129 LGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDY 184

Query: 622 IAPEL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           IAPE+     Y   V    D +SFGV+  E+L+G  P
Sbjct: 185 IAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.8 bits (189), Expect = 7e-15
 Identities = 45/268 (16%), Positives = 92/268 (34%), Gaps = 64/268 (23%)

Query: 412 KCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKA-E 470
           + Q+ + +  +   +    + +                + + I++ IGTG YG V +A +
Sbjct: 30  RKQHHSSKPTASMPRPHSDWQI---------------PDRYEIRHLIGTGSYGHVCEAYD 74

Query: 471 LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY-----GFCLHKKCMF 525
             E +VVA+KK+     ED    K    E  +L+ + H ++VK+              ++
Sbjct: 75  KLEKRVVAIKKI-LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133

Query: 526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS-----VAH----------ALSYLHH 570
           ++ E  +                        + ++       H           + Y+H 
Sbjct: 134 VVLEIAD-----SDFK--------------KLFRTPVYLTELHIKTLLYNLLVGVKYVH- 173

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTI 630
             +  I+HRD+   N L++ +    V DFG AR +    +  +    +       L    
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231

Query: 631 VVTGKCDVYSFGVV-----ALEVLMGTH 653
                    +  VV     A E+++   
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQE 259

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 30/111 (27%), Positives = 50/111 (45%), Gaps = 2/111 (1%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
           FS +  L+ +DL NN +S  + P     L  L  L L+GN +T +       L +L+ L 
Sbjct: 52  FSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLL 110

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHS 206
           L +NK++ +      +L +L  L + +N L  +   T   L  I +     
Sbjct: 111 LNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 34/149 (22%), Positives = 54/149 (36%), Gaps = 21/149 (14%)

Query: 154 LFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIG 213
           + L  N +  + P      K L  + ++NN +  L P     L +               
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRS--------------- 81

Query: 214 NFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSK 273
               L++L L  NKI  +       L  L+ L L++N ++     A   L NL  L L  
Sbjct: 82  ----LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137

Query: 274 NKLSGSIPTEI-GNCSALKNLTLNHNSLD 301
           NKL  +I         A++ + L  N   
Sbjct: 138 NKLQ-TIAKGTFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 68.1 bits (167), Expect = 4e-13
 Identities = 34/145 (23%), Positives = 54/145 (37%), Gaps = 19/145 (13%)

Query: 130 LYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLI 189
           + L  N +  I P      + LR + L +N++S + P     L+SL  L +  N +  L 
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELP 96

Query: 190 PSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSS 249
            S    L +                   L  L L+ NKI+ +  D    L  L  L+L  
Sbjct: 97  KSLFEGLFS-------------------LQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137

Query: 250 NLLSGQIPYAIGKLFNLMYLDLSKN 274
           N L          L  +  + L++N
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.4 bits (165), Expect = 9e-13
 Identities = 39/158 (24%), Positives = 66/158 (41%), Gaps = 15/158 (9%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
             +  + IP  +     +  + L  N I  I P   +   +L+ ++LS+N +S   P A 
Sbjct: 19  RGKGLTEIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAF 76

Query: 261 GKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKILL-LQNLD 318
             L +L  L L  NK++  +P  +     +L+ L LN N +   + ++  + L  L  L 
Sbjct: 77  QGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLS 134

Query: 319 LSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNP 356
           L  N L  TI           +F+ L      +L  NP
Sbjct: 135 LYDNKLQ-TIA--------KGTFSPLRAIQTMHLAQNP 163

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 51/219 (23%), Positives = 94/219 (42%), Gaps = 36/219 (16%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAH------ 501
            + +     IG+G  G V  A +    + VA+KKL           + FQN+ H      
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS----------RPFQNQTHAKRAYR 110

Query: 502 ---VLSTVRHRNIVKLY------GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWT 552
              ++  V H+NI+ L             + ++L+ E M+  +L  V+  + +   +++ 
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY- 168

Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR 612
               ++  +   + +LH   +  IIHRD+  +NI++ S+    + DFG AR     S   
Sbjct: 169 ----LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMM 220

Query: 613 TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMG 651
           T    T  Y APE+   +      D++S G +  E++  
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 57/247 (23%), Positives = 97/247 (39%), Gaps = 81/247 (32%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           + DF +K  +G G YG V  A   P G++VA+KK           ++ F      L T+R
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK-----------IEPFDKPLFALRTLR 58

Query: 508 ---------HRNIVKLY-----GFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTK 553
                    H NI+ ++         +   +++I E M+       LH            
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-----TDLH------------ 101

Query: 554 RVNIVK----SVAH----------ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF 599
              ++     S  H          A+  LH     ++IHRD+  +N+L++SN +  V DF
Sbjct: 102 --RVISTQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDF 156

Query: 600 GTARLLHVDSSYRTLRAGTYG----------YIAPEL-----AYTIVVTGKCDVYSFGVV 644
           G AR++   ++  +   G             Y APE+      Y+  +    DV+S G +
Sbjct: 157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCI 212

Query: 645 ALEVLMG 651
             E+ + 
Sbjct: 213 LAELFLR 219

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 67/225 (29%), Positives = 98/225 (43%), Gaps = 44/225 (19%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVA---LKKLHHSETEDSAFVKSFQNEAHVLS- 504
            DFH    IG G +G V  A    E    A   L+K    + ++    K   +E +VL  
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE---EKHIMSERNVLLK 94

Query: 505 TVRHRNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDD---DE------AIELNWTKR 554
            V+H  +V L + F    K ++ + +Y+  G LF  L  +    E      A E      
Sbjct: 95  NVKHPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLEPRARFYAAE------ 147

Query: 555 VNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRT 613
                 +A AL YLH   +L+I++RD+   NILLDS     + DFG  +  +  +S+  T
Sbjct: 148 ------IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST 198

Query: 614 LRAGTYGYIAPEL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
              GT  Y+APE+     Y   V    D +  G V  E+L G  P
Sbjct: 199 F-CGTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 28/217 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVA---LKKLHHSETEDSAFVKSFQNEAHVLST 505
           +DF +   IG G Y  V    L +  ++ A   +KK   ++ ED   +   Q E HV   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED---IDWVQTEKHVFEQ 108

Query: 506 V-RHRNIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS-VA 562
              H  +V L+  C   +  +F + EY+  G L   +    +  E    +      + ++
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEIS 163

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRTLRAGTYGY 621
            AL+YLH      II+RD+  +N+LLDS     + D+G  +  L    +  T   GT  Y
Sbjct: 164 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-CGTPNY 219

Query: 622 IAPEL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           IAPE+     Y   V    D ++ GV+  E++ G  P
Sbjct: 220 IAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 252

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 28/217 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVA---LKKLHHSETEDSAFVKSFQNEAHVLST 505
           +DF +   IG G Y  V    L +  ++ A   +KK   ++ ED   +   Q E HV   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED---IDWVQTEKHVFEQ 65

Query: 506 V-RHRNIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI-VKSVA 562
              H  +V L+  C   +  +F + EY+  G L   +    +  E    +        ++
Sbjct: 66  ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEIS 120

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRTLRAGTYGY 621
            AL+YLH      II+RD+  +N+LLDS     + D+G  +  L    +  T   GT  Y
Sbjct: 121 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-CGTPNY 176

Query: 622 IAPEL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           IAPE+     Y   V    D ++ GV+  E++ G  P
Sbjct: 177 IAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 28/217 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVA---LKKLHHSETEDSAFVKSFQNEAHVLST 505
            DF+    +G G +G V  +E     ++ A   LKK    + +D   V+    E  VL+ 
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---VECTMVEKRVLAL 76

Query: 506 V-RHRNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS-VA 562
             +   + +L   F    + ++ + EY+  G L   +       E           + +A
Sbjct: 77  PGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIA 131

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRTLRAGTYGY 621
             L +L    +  II+RD+  +N++LDS     +ADFG  +  +    + +T   GT  Y
Sbjct: 132 IGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-CGTPDY 187

Query: 622 IAPEL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           IAPE+     Y   V    D ++FGV+  E+L G  P
Sbjct: 188 IAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 53/230 (23%), Positives = 92/230 (40%), Gaps = 59/230 (25%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAH------ 501
            + +     +G+G YGSV  A +   G+ VA+KKL           + FQ+E        
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS----------RPFQSEIFAKRAYR 72

Query: 502 ---VLSTVRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHD------DDEA 546
              +L  ++H N++ L         +      +L+  +M+       L         +E 
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIMGLKFSEEK 127

Query: 547 IELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH 606
           I+        +V  +   L Y+H   +  ++HRD+   N+ ++ + E  + DFG AR   
Sbjct: 128 IQY-------LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--- 174

Query: 607 VDSSYRTLRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMG 651
              +  T    T  Y APE+      Y   V    D++S G +  E+L G
Sbjct: 175 HADAEMTGYVVTRWYRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTG 220

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.5 bits (181), Expect = 4e-14
 Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 46/224 (20%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
              +     +G+G YG+V  A +   G  VA+KKL+          + FQ+E       R
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY----------RPFQSELFAKRAYR 73

Query: 508 ---------HRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWT 552
                    H N++ L       + +      +L+  +M        L    +  +L   
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-----TDLGKLMKHEKLGED 128

Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR 612
           +   +V  +   L Y+H      IIHRD+   N+ ++ + E  + DFG AR      S  
Sbjct: 129 RIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM 182

Query: 613 TLRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMG 651
           T    T  Y APE+      YT  V    D++S G +  E++ G
Sbjct: 183 TGYVVTRWYRAPEVILNWMRYTQTV----DIWSVGCIMAEMITG 222

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 71.2 bits (175), Expect = 4e-14
 Identities = 32/152 (21%), Positives = 54/152 (35%), Gaps = 22/152 (14%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIG--SLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
                L L NN  +  +        L +L+ +    N +T I          +  + L S
Sbjct: 32  QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90

Query: 159 NKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSAL 218
           N+L  V  +    L+SL  L + +N +  +   +   L++                   +
Sbjct: 91  NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSS-------------------V 131

Query: 219 DTLDLSDNKIHGIIPDELTKLSQLKNLNLSSN 250
             L L DN+I  + P     L  L  LNL +N
Sbjct: 132 RLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 2/90 (2%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
           F     +  + L +N L  ++  ++   L  LK L L  N +T +       L ++R L 
Sbjct: 77  FEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNAL 185
           LY N+++ V P     L SL+ L +  N  
Sbjct: 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 27/129 (20%), Positives = 52/129 (40%), Gaps = 2/129 (1%)

Query: 79  TDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNL 137
            ++ L N+          F   P L+ ++  NN ++  I        S +  + L  N L
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT 197
             +  K    L +L+ L L SN+++ V       L S+  L + +N +  + P     L 
Sbjct: 94  ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH 153

Query: 198 NISSNQFHS 206
           ++S+    +
Sbjct: 154 SLSTLNLLA 162

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 34/159 (21%), Positives = 64/159 (40%), Gaps = 16/159 (10%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPD-ELTKLSQLKNLNLSSNLLSGQIPYA 259
           SNQ  + IP  I        L L++N+   +       KL QL+ +N S+N ++     A
Sbjct: 19  SNQKLNKIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA 76

Query: 260 IGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEM-GKILLLQNL 317
                 +  + L+ N+L  ++  ++     +LK L L  N +   +  +    +  ++ L
Sbjct: 77  FEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLL 134

Query: 318 DLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNP 356
            L  N ++ T+           +F+ L       L  NP
Sbjct: 135 SLYDNQIT-TVA--------PGAFDTLHSLSTLNLLANP 164

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 32/151 (21%), Positives = 55/151 (36%), Gaps = 22/151 (14%)

Query: 174 SLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIP 233
              EL + NN    L  + +F+                      L  ++ S+NKI  I  
Sbjct: 33  YTAELRLNNNEFTVLEATGIFK------------------KLPQLRKINFSNNKITDIEE 74

Query: 234 DELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKN 292
                 S +  + L+SN L          L +L  L L  N+++  +  +     S+++ 
Sbjct: 75  GAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRL 133

Query: 293 LTLNHNSLDGTIPLEMGKILL-LQNLDLSHN 322
           L+L  N +  T+       L  L  L+L  N
Sbjct: 134 LSLYDNQI-TTVAPGAFDTLHSLSTLNLLAN 163

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 49/240 (20%), Positives = 89/240 (37%), Gaps = 74/240 (30%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
              +     IG G YG V  A +      VA+KK           +  F+++ +   T+R
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK-----------ISPFEHQTYCQRTLR 74

Query: 508 ---------HRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTK 553
                    H NI+ +              ++++ + ME       L+            
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-----TDLY------------ 117

Query: 554 RVNIVKS----VAH----------ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF 599
              ++K+      H           L Y+H   + +++HRD+  +N+LL++  +  + DF
Sbjct: 118 --KLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDF 172

Query: 600 GTARLLHVDSSYRTLRAG---TYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMG 651
           G AR+   D  +         T  Y APE+      YT  +    D++S G +  E+L  
Sbjct: 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSN 228

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 48/240 (20%), Positives = 98/240 (40%), Gaps = 51/240 (21%)

Query: 434 WNYD-GKILYEDLINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSA 491
           W+Y+   + + +     +D+ +   +G G Y  V++A  +   + V +K L   +     
Sbjct: 23  WDYESHVVEWGN----QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---- 74

Query: 492 FVKSFQNEAHVLSTVR-HRNIVKLYGFCLH---KKCMFLIYEYMERG---SLFCVLHDDD 544
             K  + E  +L  +R   NI+ L    +     +   L++E++       L+  L D D
Sbjct: 75  --KKIKREIKILENLRGGPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD 131

Query: 545 EAIELNWTKRVNIVKSVAH----ALSYLHHDCTLSIIHRDISSNNILLDS-NLEASVADF 599
                        ++   +    AL Y H   ++ I+HRD+  +N+++D  + +  + D+
Sbjct: 132 -------------IRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDW 175

Query: 600 GTARLLHVDSSYRTLRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           G A   H    Y  +R  +  +  PEL      Y   +    D++S G +   ++    P
Sbjct: 176 GLAEFYHPGQEY-NVRVASRYFKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 73.6 bits (181), Expect = 6e-14
 Identities = 59/336 (17%), Positives = 106/336 (31%), Gaps = 110/336 (32%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQN--------- 498
            +++ IK+ IG G YG VY A +    K VA+KK++          + F++         
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN----------RMFEDLIDCKRILR 74

Query: 499 EAHVLSTVRHRNIVKLYGFCLHKKC-----MFLIYEYMERGSLFCVLHDDDEAIELNWTK 553
           E  +L+ ++   I++LY   +         ++++ E  +       L             
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-----SDLK------------ 117

Query: 554 RVNIVKSVAH---------------ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVAD 598
              + K+                    +++H      IIHRD+   N LL+ +    V D
Sbjct: 118 --KLFKTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCD 172

Query: 599 FGTARLLHVDSSYRTLRAGTYG----------------------YIAPEL-----AYTIV 631
           FG AR ++ +     +                            Y APEL      YT  
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS 232

Query: 632 VTGKCDVYSFGVVALEVLMGTHPGGLLSSLS------SSSGPKIMLIDVLNQRLSPPVNQ 685
           +    D++S G +  E+L          +        SS  P     +          +Q
Sbjct: 233 I----DIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQ 288

Query: 686 --KIVQ--------DIILV-STIAFACLSSQPKSRP 710
              I          D+  +        +   P  +P
Sbjct: 289 LNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 28/217 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVA---LKKLHHSETEDSAFVKSFQNEAHVLST 505
           ++F     +G G +G V  A + E G + A   LKK    + +D   V+    E  +LS 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD---VECTMTEKRILSL 79

Query: 506 V-RHRNIVKL-YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKS-VA 562
              H  + +L   F    + +F + E++  G L   +       E     R     + + 
Sbjct: 80  ARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDE----ARARFYAAEII 134

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL-LHVDSSYRTLRAGTYGY 621
            AL +LH      II+RD+  +N+LLD      +ADFG  +  +    +  T   GT  Y
Sbjct: 135 SALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF-CGTPDY 190

Query: 622 IAPEL----AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           IAPE+     Y   V    D ++ GV+  E+L G  P
Sbjct: 191 IAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 72.8 bits (179), Expect = 9e-14
 Identities = 50/254 (19%), Positives = 95/254 (37%), Gaps = 68/254 (26%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQN-EAHVLS 504
            +++ + +   +GTG +G V +  ++  GK  ALKK+             ++N E  ++ 
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL--------QDPRYKNRELDIMK 55

Query: 505 TVRHRNIVKLYGF---CLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR----VNI 557
            + H NI+KL  +      ++                    ++    +         +N+
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 558 VK---------------------SVAH----------ALSYLHHDCTLSIIHRDISSNNI 586
           +                       +            A+ ++H   +L I HRDI   N+
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNL 172

Query: 587 LLDSNL-EASVADFGTARLLHVDS---SYRTLRAGTYGYIAPEL-----AYTIVVTGKCD 637
           L++S      + DFG+A+ L       +Y   R   + Y APEL      YT  +    D
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR---F-YRAPELMLGATEYTPSI----D 224

Query: 638 VYSFGVVALEVLMG 651
           ++S G V  E+++G
Sbjct: 225 LWSIGCVFGELILG 238

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 57/256 (22%), Positives = 94/256 (36%), Gaps = 89/256 (34%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
              + +   +G G YG V+K+ +   G+VVA+KK+            +FQN      T R
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF----------DAFQNSTDAQRTFR 57

Query: 508 ----------HRNIVKLYGFCL--HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV 555
                     H NIV L       + + ++L+++YME       LH              
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-----TDLH-------------- 98

Query: 556 NIVKS----VAH----------ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT 601
            ++++      H           + YLH   +  ++HRD+  +NILL++     VADFG 
Sbjct: 99  AVIRANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGL 155

Query: 602 ARLLHVDSSYRTLRAGTYG---------------------YIAPEL-----AYTIVVTGK 635
           +R              +                       Y APE+      YT  +   
Sbjct: 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI--- 212

Query: 636 CDVYSFGVVALEVLMG 651
            D++S G +  E+L G
Sbjct: 213 -DMWSLGCILGEILCG 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 51/236 (21%), Positives = 92/236 (38%), Gaps = 57/236 (24%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
              +     +G GG G V+ A +    K VA+KK+               +   V   +R
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI------------VLTDPQSVKHALR 57

Query: 508 ---------HRNIVKLY--------------GFCLHKKCMFLIYEYMERGSLFCVLHDDD 544
                    H NIVK++              G       ++++ EYME       L +  
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-----TDLANVL 112

Query: 545 EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-NLEASVADFGTAR 603
           E   L        +  +   L Y+H   + +++HRD+   N+ +++ +L   + DFG AR
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169

Query: 604 LLHVDSSYRTLRAG---TYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMG 651
           ++    S++   +    T  Y +P L      YT  +    D+++ G +  E+L G
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTG 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.2 bits (175), Expect = 3e-13
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 46/224 (20%)

Query: 449 TEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAH------ 501
            E +     +G+G YGSV  A +   G  VA+KKL           + FQ+  H      
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS----------RPFQSIIHAKRTYR 77

Query: 502 ---VLSTVRHRNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWT 552
              +L  ++H N++ L       + +      +L+   M        L++  +  +L   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDD 132

Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR 612
               ++  +   L Y+H   +  IIHRD+  +N+ ++ + E  + DFG AR     +   
Sbjct: 133 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEM 186

Query: 613 TLRAGTYGYIAPEL-----AYTIVVTGKCDVYSFGVVALEVLMG 651
           T    T  Y APE+      Y   V    D++S G +  E+L G
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTG 226

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 67.6 bits (164), Expect = 3e-12
 Identities = 34/247 (13%), Positives = 71/247 (28%), Gaps = 52/247 (21%)

Query: 448 ATEDFHIKYCIGTGGYGSVYKAELPEG----KVVALKKLHHSETEDSAFVKSFQNEAHVL 503
            TE       IG G +G V++          K++A++             +    E  + 
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 504 STV---------RHRNIVKLYGFCLHK----KCMFLIYEYM--ERGS------------L 536
             +         R    + L      +      +   +++    +GS            L
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 537 FCVLHDDDEAIEL--------NWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL 588
           F VL  +   I+L        +     +I+  +  +L+       L   HRD+   N+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLL 195

Query: 589 DSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYT--IVVTGKCDVYSFGVVAL 646
                  +      +   +          + G     + YT   +      V+    +  
Sbjct: 196 KKTSLKKLHYTLNGKSSTI---------PSCGLQVSIIDYTLSRLERDGIVVFCDVSMDE 246

Query: 647 EVLMGTH 653
           ++  G  
Sbjct: 247 DLFTGDG 253

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 68.1 bits (167), Expect = 4e-12
 Identities = 49/266 (18%), Positives = 95/266 (35%), Gaps = 42/266 (15%)

Query: 102 NLKSLDLWNNSLSGSIPPQIGS-LSKLKCLYLHGNNLT----GIIPKEIGSLRNLRGLFL 156
           +++SLD+    LS +   ++   L + + + L    LT      I   +     L  L L
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 157 YSNKLSGVLPQEIGN-LKS----LTELYVTNNALG----GLIPSTLFRLT-----NISSN 202
            SN+L  V    +   L++    + +L + N  L     G++ STL  L      ++S N
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123

Query: 203 QFHSSIPLEIG-----NFSALDTLDLSDNKIHGI----IPDELTKLSQLKNLNLSSNLLS 253
               +    +          L+ L L    +       +   L      K L +S+N ++
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

Query: 254 GQIPYAIGKLF-----NLMYLDLSKNKLS----GSIPTEIGNCSALKNLTLNHNSLDGTI 304
                 + +        L  L L    ++      +   + + ++L+ L L  N L    
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243

Query: 305 PLEMGKILL-----LQNLDLSHNNLS 325
             E+   LL     L+ L +    ++
Sbjct: 244 MAELCPGLLHPSSRLRTLWIWECGIT 269

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 65.4 bits (160), Expect = 3e-11
 Identities = 48/271 (17%), Positives = 90/271 (33%), Gaps = 46/271 (16%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSL-----SKLKCLYLHGNNLT----GIIPKEIGSLRNL 151
           P L  L+L +N L       +         K++ L L    LT    G++   + +L  L
Sbjct: 56  PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTL 115

Query: 152 RGLFLYSNKLSGVLPQEIG-----NLKSLTELYVTNNALGGLIPSTLF-------RLT-- 197
           + L L  N L     Q +          L +L +   +L       L             
Sbjct: 116 QELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKEL 175

Query: 198 NISSNQFHSSIPLEIG-----NFSALDTLDLSDNKIH----GIIPDELTKLSQLKNLNLS 248
            +S+N  + +    +      +   L+ L L    +       +   +   + L+ L L 
Sbjct: 176 TVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALG 235

Query: 249 SNLLSGQ-----IPYAIGKLFNLMYLDLSKNKLS----GSIPTEIGNCSALKNLTLNHNS 299
           SN L         P  +     L  L + +  ++    G +   +    +LK L+L  N 
Sbjct: 236 SNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295

Query: 300 LDGTIPLEMGKILL-----LQNLDLSHNNLS 325
           L       + + LL     L++L +   + +
Sbjct: 296 LGDEGARLLCETLLEPGCQLESLWVKSCSFT 326

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 44/275 (16%), Positives = 93/275 (33%), Gaps = 46/275 (16%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGSL-----SKLKCLYLHGNNLTGIIPKEIGSL--- 148
               P L+ L L +N L  +    +         +L+ L L   +L+    + + S+   
Sbjct: 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168

Query: 149 -RNLRGLFLYSNKLSGVLPQEIG-----NLKSLTELYVTNNALG---------GLIPSTL 193
             + + L + +N ++    + +      +   L  L + +  +           +     
Sbjct: 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKAS 228

Query: 194 FRLTNISSNQFHSS-----IPLEIGNFSALDTLDLSDNKIH----GIIPDELTKLSQLKN 244
            R   + SN+          P  +   S L TL + +  I     G +   L     LK 
Sbjct: 229 LRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKE 288

Query: 245 LNLSSNLLSGQIPYAIGKLF-----NLMYLDLSKNKLSG----SIPTEIGNCSALKNLTL 295
           L+L+ N L  +    + +        L  L +     +        + +     L  L +
Sbjct: 289 LSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 348

Query: 296 NHNSLDGTIPLEMGKILL-----LQNLDLSHNNLS 325
           ++N L+     E+ + L      L+ L L+  ++S
Sbjct: 349 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 51/257 (19%), Positives = 95/257 (36%), Gaps = 47/257 (18%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIG-----SLSKLKCLYLHGNNLT----GIIPKEIGSLRNL 151
           P+ K L + NN ++ +    +      S  +L+ L L    +T      +   + S  +L
Sbjct: 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL 229

Query: 152 RGLFLYSNKLSGVLPQEIGN-----LKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHS 206
           R L L SNKL  V   E+          L  L++    +                 +   
Sbjct: 230 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGIT---------------AKGCG 274

Query: 207 SIPLEIGNFSALDTLDLSDNKIHG----IIPDELTK-LSQLKNLNLSSNLLSGQ----IP 257
            +   +    +L  L L+ N++      ++ + L +   QL++L + S   +        
Sbjct: 275 DLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334

Query: 258 YAIGKLFNLMYLDLSKNKLSGSIPTEIG-----NCSALKNLTLNHNSLDGTIPLEMGKIL 312
             + +   L+ L +S N+L  +   E+        S L+ L L    +  +    +   L
Sbjct: 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL 394

Query: 313 L----LQNLDLSHNNLS 325
           L    L+ LDLS+N L 
Sbjct: 395 LANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 50.7 bits (122), Expect = 1e-06
 Identities = 31/181 (17%), Positives = 61/181 (33%), Gaps = 28/181 (15%)

Query: 173 KSLTELYVTNNALGG----LIPSTLFRLT--NISSNQFH----SSIPLEIGNFSALDTLD 222
             +  L +    L       +   L +     +            I   +    AL  L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 223 LSDNKIHG----IIPDELTKLS-QLKNLNLSSNLLSGQ----IPYAIGKLFNLMYLDLSK 273
           L  N++       +   L   S +++ L+L +  L+G     +   +  L  L  L LS 
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 274 NKLSGSIPTEIG-----NCSALKNLTLNHNSLDGTIPLEMGKILL----LQNLDLSHNNL 324
           N L  +    +          L+ L L + SL       +  +L      + L +S+N++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 325 S 325
           +
Sbjct: 183 N 183

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 41.9 bits (99), Expect = 6e-04
 Identities = 30/180 (16%), Positives = 61/180 (33%), Gaps = 36/180 (20%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSL-----SKLKCLYLHGNNLTGIIPKEIGSL----RNL 151
            +LK L L  N L       +         +L+ L++   + T        S+    R L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343

Query: 152 RGLFLYSNKL--SGVLPQEIG-----NLKSLTELYVTNNALG---------GLIPSTLFR 195
             L + +N+L  +GV  +E+          L  L++ +  +           L+ +   R
Sbjct: 344 LELQISNNRLEDAGV--RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401

Query: 196 LTNISSNQFHSSIPLEIG-----NFSALDTLDLSDNKI----HGIIPDELTKLSQLKNLN 246
             ++S+N    +  L++          L+ L L D          +         L+ ++
Sbjct: 402 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 30/88 (34%), Positives = 43/88 (48%), Gaps = 2/88 (2%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
           F   P+L  L+L  N L+  I P      S ++ L L  N +  I  K    L  L+ L 
Sbjct: 50  FGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNN 183
           LY N++S V+P    +L SLT L + +N
Sbjct: 109 LYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 29/102 (28%), Positives = 44/102 (43%), Gaps = 5/102 (4%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEL-TKLSQLKNLNLSSNLLSGQIPYA 259
           + +    IP +I        L L+DN++  I  D L  +L  L  L L  N L+G  P A
Sbjct: 16  TGRGLKEIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA 73

Query: 260 IGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSL 300
                ++  L L +NK+   I  ++      LK L L  N +
Sbjct: 74  FEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI 114

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 32/124 (25%), Positives = 48/124 (38%), Gaps = 24/124 (19%)

Query: 154 LFLYSNKLSGVLPQEI-GNLKSLTELYVTNNALGGLIPSTLF-RLTNISSNQFHSSIPLE 211
           L L  N+L  +    + G L  L +L +  N L G+     F   ++             
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI-EPNAFEGASH------------- 79

Query: 212 IGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPY-AIGKLFNLMYLD 270
                 +  L L +NKI  I       L QLK LNL  N +S  +   +   L +L  L+
Sbjct: 80  ------IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLN 132

Query: 271 LSKN 274
           L+ N
Sbjct: 133 LASN 136

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 53/252 (21%), Positives = 94/252 (37%), Gaps = 27/252 (10%)

Query: 411 FKCQNKNPRLNSRAAKNGDVFSVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAE 470
           F   N   R       N   +         +  D +     + +   IG G +G V KA 
Sbjct: 60  FLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVA--YRYEVLKVIGKGSFGQVVKAY 117

Query: 471 -LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR------NIVKLYGFCLHKKC 523
                + VALK + + +     F +    E  +L  +R +      N++ +      +  
Sbjct: 118 DHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173

Query: 524 MFLIYEYMERGSLFCVL-HDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDIS 582
           + + +E +   +L+ ++  +  +   L   ++     S+   L  LH      IIH D+ 
Sbjct: 174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALHK---NRIIHCDLK 227

Query: 583 SNNILLDSNLEAS--VADFGTARLLHVD-SSYRTLRAGTYGYIAPELAYTIVVTGKCDVY 639
             NILL     +   V DFG++   H    +Y   R     Y APE+          D++
Sbjct: 228 PENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF----YRAPEVILGARYGMPIDMW 283

Query: 640 SFGVVALEVLMG 651
           S G +  E+L G
Sbjct: 284 SLGCILAELLTG 295

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 62.8 bits (153), Expect = 1e-11
 Identities = 30/107 (28%), Positives = 44/107 (41%), Gaps = 3/107 (2%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
           + ++ L N            + F NL+ L L N  L  S+   +  L KLK L L  N +
Sbjct: 26  VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRI 83

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLP-QEIGNLKSLTELYVTNN 183
            G +      L NL  L L  NKL  +   + +  L+ L  L + N 
Sbjct: 84  FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 33/118 (27%), Positives = 49/118 (41%), Gaps = 3/118 (2%)

Query: 182 NNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQ 241
           +  L    P+ +  L   +       I      F  L+ L L +  +  +    L KL +
Sbjct: 15  HLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPK 72

Query: 242 LKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSG-SIPTEIGNCSALKNLTLNHN 298
           LK L LS N + G +     KL NL +L+LS NKL   S    +     LK+L L + 
Sbjct: 73  LKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.5 bits (134), Expect = 4e-09
 Identities = 29/111 (26%), Positives = 51/111 (45%), Gaps = 4/111 (3%)

Query: 214 NFSALDTLDLSDNKIHGI-IPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLS 272
             +A+  L L + K +   I     +   L+ L+L +  L   +   + KL  L  L+LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79

Query: 273 KNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLE-MGKILLLQNLDLSHN 322
           +N++ G +         L +L L+ N L     LE + K+  L++LDL + 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 6e-06
 Identities = 22/91 (24%), Positives = 36/91 (39%), Gaps = 9/91 (9%)

Query: 239 LSQLKNLNLS-SNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLT--- 294
            + ++ L L       G+I     +  NL +L L    L       + N   L  L    
Sbjct: 23  PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKKLE 77

Query: 295 LNHNSLDGTIPLEMGKILLLQNLDLSHNNLS 325
           L+ N + G + +   K+  L +L+LS N L 
Sbjct: 78  LSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.5 bits (108), Expect = 9e-06
 Identities = 25/87 (28%), Positives = 34/87 (39%), Gaps = 4/87 (4%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGI-IPKEIGSLRNLRGL 154
           N    P LK L+L  N + G +      L  L  L L GN L  I   + +  L  L+ L
Sbjct: 66  NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSL 125

Query: 155 FLYSN---KLSGVLPQEIGNLKSLTEL 178
            L++     L+         L  LT L
Sbjct: 126 DLFNCEVTNLNDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 31/131 (23%), Positives = 49/131 (37%), Gaps = 25/131 (19%)

Query: 147 SLRNLRGLFLYSNKLSGVLPQEIG-NLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFH 205
           +   +R L L + K +    + +     +L  L + N  L          ++N+      
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--------SVSNLP----- 68

Query: 206 SSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLS--GQIPYAIGKL 263
                       L  L+LS+N+I G +     KL  L +LNLS N L     +   + KL
Sbjct: 69  --------KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKL 119

Query: 264 FNLMYLDLSKN 274
             L  LDL   
Sbjct: 120 ECLKSLDLFNC 130

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 43/266 (16%), Positives = 80/266 (30%), Gaps = 51/266 (19%)

Query: 101 PNLKSLDLWNNSLSG----SIPPQIGSLSKLKCLYLHGN---NLTGIIPKEIGSL----- 148
            ++K + L  N++       +   I S   L+           +   IP+ +  L     
Sbjct: 32  DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALL 91

Query: 149 --RNLRGLFLYSNKLSGVLPQEIGNL----KSLTELYVTNNALG----GLIPSTLFRLTN 198
               L  + L  N       + + +       L  LY+ NN LG      I   L  L  
Sbjct: 92  KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV 151

Query: 199 ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGI----IPDELTKLSQLKNLNLSSNLLSG 254
               +              L ++    N++                 L  + +  N +  
Sbjct: 152 NKKAKNAPP----------LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201

Query: 255 Q-IPYAIGKLF----NLMYLDLSKNKLSG----SIPTEIGNCSALKNLTLNHNSL--DGT 303
           + I + + +       L  LDL  N  +     ++   + +   L+ L LN   L   G 
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 261

Query: 304 IP----LEMGKILLLQNLDLSHNNLS 325
                     + + LQ L L +N + 
Sbjct: 262 AAVVDAFSKLENIGLQTLRLQYNEIE 287

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 47/287 (16%), Positives = 82/287 (28%), Gaps = 62/287 (21%)

Query: 101 PNLKSLDLWNNS---LSGSIPPQIGSLSK-------LKCLYLHGNNLTGIIPKEIGSL-- 148
            +L+  +  +     +   IP  +  L +       L  + L  N       + +     
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 149 --RNLRGLFLYSNKLS-------------GVLPQEIGNLKSLTELYVTNNALG------- 186
               L  L+L++N L                + ++  N   L  +    N L        
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179

Query: 187 --GLIPSTLFRLTNISSNQFHSS-IPLEIGNF----SALDTLDLSDNKIHGI----IPDE 235
                   L     +  N      I   +         L  LDL DN    +    +   
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239

Query: 236 LTKLSQLKNLNLSSNLLSGQ----IPYAIGKLFN--LMYLDLSKNKLSGSIPTEIG---- 285
           L     L+ L L+  LLS +    +  A  KL N  L  L L  N++       +     
Sbjct: 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299

Query: 286 -NCSALKNLTLNHNSL--DGTIPLEMGKIL----LLQNLDLSHNNLS 325
                L  L LN N    +  +  E+ ++       +  +L      
Sbjct: 300 EKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEEL 346

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 48.2 bits (115), Expect = 7e-06
 Identities = 23/136 (16%), Positives = 45/136 (33%), Gaps = 23/136 (16%)

Query: 212 IGNFSALDTLDLSDNKI--HGI--IPDELTKLSQLKNLNLSSNLLSGQ----IPYAIGKL 263
           +  FS ++   L  + I       +   L +   +K + LS N +  +    +   I   
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 264 FNLMYLDLSKNKLS----------GSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILL 313
            +L   + S                 +   +  C  L  + L+ N+   T    +   L 
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 314 ----LQNLDLSHNNLS 325
               L++L L +N L 
Sbjct: 120 KHTPLEHLYLHNNGLG 135

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 48.2 bits (115), Expect = 7e-06
 Identities = 36/226 (15%), Positives = 72/226 (31%), Gaps = 49/226 (21%)

Query: 149 RNLRGLFLYSNKLSGV----LPQEIGNLKSLTELYVTNNALG---------GLIPSTLFR 195
            ++ G  L  + ++      +   +    S+ E+ ++ N +G          +       
Sbjct: 4   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63

Query: 196 ---LTNISSNQFHSSIPLEIGNFSA-------LDTLDLSDNKI--HGIIP--DELTKLSQ 241
               ++I + +    IP  +            L T+ LSDN        P  D L+K + 
Sbjct: 64  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123

Query: 242 LKNLNLSSN-------------LLSGQIPYAIGKLFNLMYLDLSKNKLSG----SIPTEI 284
           L++L L +N             L    +         L  +   +N+L            
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183

Query: 285 GNCSALKNLTLNHNSL-DGTIPLEMGKILL----LQNLDLSHNNLS 325
            +   L  + +  N +    I   + + L     L+ LDL  N  +
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 45/222 (20%)

Query: 458 IGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR--------- 507
           +G G + +V+ A+ +     VA+K +      D  + ++ ++E  +L  V          
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82

Query: 508 --HRNIVKLYGFCLHKKC----MFLIYEYMERGSLFCVLHD-DDEAIELNWTKRVNIVKS 560
               +I+KL     HK      + +++E +   +L  ++   +   I L + K+  I K 
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQ 139

Query: 561 VAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS------VADFGTARLLHVDSSYRTL 614
           +   L Y+H  C   IIH DI   N+L++            +AD G A        + T 
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTN 194

Query: 615 RAGTYGYIAPELAYTIVVTG-----KCDVYSFGVVALEVLMG 651
              T  Y +PE     V+ G       D++S   +  E++ G
Sbjct: 195 SIQTREYRSPE-----VLLGAPWGCGADIWSTACLIFELITG 231

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 61.9 bits (151), Expect = 4e-11
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 4/114 (3%)

Query: 189 IPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLS 248
           IP  +  L  +  NQF + +P E+ N+  L  +DLS+N+I  +     + ++QL  L LS
Sbjct: 29  IPRDVTEL-YLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86

Query: 249 SNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLD 301
            N L    P     L +L  L L  N +S  +P     + SAL +L +  N L 
Sbjct: 87  YNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 61.2 bits (149), Expect = 7e-11
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 4/89 (4%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
            S + +L  +DL NN +S ++  Q   ++++L  L L  N L  I P+    L++LR L 
Sbjct: 50  LSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLS 108

Query: 156 LYSNKLSGVLPQEI-GNLKSLTELYVTNN 183
           L+ N +S V P+    +L +L+ L +  N
Sbjct: 109 LHGNDISVV-PEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 33/123 (26%), Positives = 54/123 (43%), Gaps = 24/123 (19%)

Query: 130 LYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLI 189
           LYL GN  T ++PKE+ + ++L  + L +N++S +  Q   N+  L  L ++ N L  + 
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI- 93

Query: 190 PSTLF-RLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDEL-TKLSQLKNLNL 247
           P   F  L +                   L  L L  N I   +P+     LS L +L +
Sbjct: 94  PPRTFDGLKS-------------------LRLLSLHGNDISV-VPEGAFNDLSALSHLAI 133

Query: 248 SSN 250
            +N
Sbjct: 134 GAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 33/122 (27%), Positives = 54/122 (44%), Gaps = 22/122 (18%)

Query: 154 LFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIG 213
           L+L  N+ + ++P+E+ N K LT + ++NN +  L   +   +T                
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQ--------------- 79

Query: 214 NFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPY-AIGKLFNLMYLDLS 272
               L TL LS N++  I P     L  L+ L+L  N +S  +P  A   L  L +L + 
Sbjct: 80  ----LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIG 134

Query: 273 KN 274
            N
Sbjct: 135 AN 136

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 60.8 bits (148), Expect = 4e-11
 Identities = 28/107 (26%), Positives = 45/107 (42%), Gaps = 3/107 (2%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
           + ++ L NS             F  L+ L   N  L+ SI   +  L+KLK L L  N +
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRV 76

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVL-PQEIGNLKSLTELYVTNN 183
           +G +        NL  L L  NK+  +   + +  L++L  L + N 
Sbjct: 77  SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 56.6 bits (137), Expect = 1e-09
 Identities = 34/142 (23%), Positives = 56/142 (39%), Gaps = 24/142 (16%)

Query: 88  IKGELGRLNFSCFPNLKSLDLWNNSLS-GSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIG 146
           I  EL     S   ++K L L N+  + G +        +L+ L      LT I    + 
Sbjct: 7   IHLELRNRTPS---DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLP 61

Query: 147 SLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHS 206
            L  L+ L L  N++SG L        +LT L ++ N +  L  ST+  L  + +     
Sbjct: 62  KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL--STIEPLKKLEN----- 114

Query: 207 SIPLEIGNFSALDTLDLSDNKI 228
                      L +LDL + ++
Sbjct: 115 -----------LKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 55.5 bits (134), Expect = 2e-09
 Identities = 29/113 (25%), Positives = 53/113 (46%), Gaps = 8/113 (7%)

Query: 214 NFSALDTLDLSDNKIHGI-IPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLS 272
             S +  L L +++ +   +     +  +L+ L+  +  L+  I   + KL  L  L+LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72

Query: 273 KNKLSGSIPTEIGNCSALKNLTLNHN---SLDGTIPLEMGKILLLQNLDLSHN 322
            N++SG +      C  L +L L+ N    L    PL+  K+  L++LDL + 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLK--KLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 55.1 bits (133), Expect = 4e-09
 Identities = 33/118 (27%), Positives = 50/118 (42%), Gaps = 3/118 (2%)

Query: 182 NNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQ 241
           +  L    PS +  L   +S      +      F  L+ L   +  +  I    L KL++
Sbjct: 8   HLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNK 65

Query: 242 LKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSG-SIPTEIGNCSALKNLTLNHN 298
           LK L LS N +SG +     K  NL +L+LS NK+   S    +     LK+L L + 
Sbjct: 66  LKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 31/131 (23%), Positives = 50/131 (38%), Gaps = 25/131 (19%)

Query: 147 SLRNLRGLFLYSNKLS-GVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFH 205
           +  +++ L L +++ + G L       + L  L   N  L          + N+      
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--------SIANLP----- 61

Query: 206 SSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLS--GQIPYAIGKL 263
                     + L  L+LSDN++ G +     K   L +LNLS N +     I   + KL
Sbjct: 62  --------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKL 112

Query: 264 FNLMYLDLSKN 274
            NL  LDL   
Sbjct: 113 ENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.2 bits (110), Expect = 4e-06
 Identities = 23/87 (26%), Positives = 35/87 (40%), Gaps = 4/87 (4%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGI-IPKEIGSLRNLRGL 154
           N      LK L+L +N +SG +         L  L L GN +  +   + +  L NL+ L
Sbjct: 59  NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118

Query: 155 FLYSN---KLSGVLPQEIGNLKSLTEL 178
            L++     L+         L  LT L
Sbjct: 119 DLFNCEVTNLNDYRENVFKLLPQLTYL 145

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 61.6 bits (150), Expect = 9e-11
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 13/159 (8%)

Query: 98  SCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLY 157
           SC  +  ++D  +   + S+P  I + +++  LYLH N +T + P    SL NL+ L+L 
Sbjct: 18  SC--SGTTVDCRSKRHA-SVPAGIPTNAQI--LYLHDNQITKLEPGVFDSLINLKELYLG 72

Query: 158 SNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLF-RLTNI-----SSNQFHSSIPLE 211
           SN+L  +      +L  LT L +  N L  L PS +F RL ++       N+    +P  
Sbjct: 73  SNQLGALPVGVFDSLTQLTVLDLGTNQLTVL-PSAVFDRLVHLKELFMCCNKLT-ELPRG 130

Query: 212 IGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSN 250
           I   + L  L L  N++  I      +LS L +  L  N
Sbjct: 131 IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 29/88 (32%), Positives = 40/88 (45%), Gaps = 3/88 (3%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
           F     L  LDL  N L+  +P  +   L  LK L++  N LT + P+ I  L +L  L 
Sbjct: 84  FDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTEL-PRGIERLTHLTHLA 141

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNN 183
           L  N+L  +       L SLT  Y+  N
Sbjct: 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 5/130 (3%)

Query: 79  TDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNL 137
             I  L+ N   +L    F    NLK L L +N L  ++P  +  SL++L  L L  N L
Sbjct: 42  AQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL 100

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLF-RL 196
           T +       L +L+ LF+  NKL+  LP+ I  L  LT L +  N L   IP   F RL
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHGAFDRL 158

Query: 197 TNISSNQFHS 206
           ++++      
Sbjct: 159 SSLTHAYLFG 168

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 41/220 (18%)

Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR- 509
           + I   IG G +G V KA    E + VA+K + + +    AF+   Q E  +L  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHD 111

Query: 510 -----NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI--VKSVA 562
                 IV L    + +  + L++E +   +L+       + +     + V++   +  A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLY-------DLLRNTNFRGVSLNLTRKFA 163

Query: 563 H----ALSYLHHDCTLSIIHRDISSNNILLDSNLEAS--VADFGTARLLHVD-SSYRTLR 615
                AL +L     LSIIH D+   NILL +   ++  + DFG++  L      Y   R
Sbjct: 164 QQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR 222

Query: 616 AGTYGYIAPE----LAYTIVVTGKCDVYSFGVVALEVLMG 651
                Y +PE    + Y +      D++S G + +E+  G
Sbjct: 223 F----YRSPEVLLGMPYDL----AIDMWSLGCILVEMHTG 254

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 60.9 bits (147), Expect = 5e-10
 Identities = 21/91 (23%), Positives = 34/91 (37%), Gaps = 2/91 (2%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQ-IGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGL 154
           +     NL  L + N      +  + +  L +L+ L +  + L  + P        L  L
Sbjct: 26  HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85

Query: 155 FLYSNKLSGVLPQEIGNLKSLTELYVTNNAL 185
            L  N L   L  +     SL EL ++ N L
Sbjct: 86  NLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.0 bits (142), Expect = 2e-09
 Identities = 21/101 (20%), Positives = 34/101 (33%), Gaps = 5/101 (4%)

Query: 110 NNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKE-IGSLRNLRGLFLYSNKLSGVLPQE 168
               +      +     L  LY+        +    +  L  LR L +  + L  V P  
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 169 IGNLKSLTELYVTNNALGGLIPSTLFRLT----NISSNQFH 205
                 L+ L ++ NAL  L   T+  L+     +S N  H
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.4 bits (138), Expect = 6e-09
 Identities = 22/102 (21%), Positives = 40/102 (39%), Gaps = 2/102 (1%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNK-IHGIIPDELTKLSQLKNLNLSSNLLSGQIPYA 259
           +          +     L  L + + + +  +   +L  L +L+NL +  + L    P A
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 260 IGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLD 301
                 L  L+LS N L  S+  +     +L+ L L+ N L 
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 19/86 (22%), Positives = 34/86 (39%), Gaps = 3/86 (3%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGS-LSKLKCLYLHGN 135
            +T++ + N      L   +      L++L +  + L   + P       +L  L L  N
Sbjct: 32  NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFN 90

Query: 136 NLTGIIPKEIGSLRNLRGLFLYSNKL 161
            L  +  K +  L +L+ L L  N L
Sbjct: 91  ALESLSWKTVQGL-SLQELVLSGNPL 115

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 43/279 (15%), Positives = 89/279 (31%), Gaps = 53/279 (18%)

Query: 98  SCFPNLKSLDLWNNSLSGSIPPQIGSL-----SKLKCLYLHGNNLTGIIPKEIGSL---- 148
           +   N+ SL+L  N LS     ++          +  L L  N+ +     E        
Sbjct: 77  AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136

Query: 149 -RNLRGLFLYSNKLSGVLPQEIGNL-----KSLTELYVTNNALG-----------GLIPS 191
             ++  L L  N L      E+  +      ++  L +  N L              IP+
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196

Query: 192 TLFRLTNISSNQFHSSIPLEIG-----NFSALDTLDLSDNKIHG----IIPDELTKLSQL 242
           ++  L ++S+N        E+        + + +L+L  N +HG     +      L  L
Sbjct: 197 SVTSL-DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255

Query: 243 KNLNLSSNLLSGQ-------IPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTL 295
           + + L  +++          +  A   +  ++ +D +  ++  S    I N     +   
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKA 315

Query: 296 NHNSLDGTIPLEMGKILL----------LQNLDLSHNNL 324
           +  SL     +   K             L+    +   L
Sbjct: 316 DVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 49/279 (17%), Positives = 101/279 (36%), Gaps = 57/279 (20%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSL-----SKLKCLYLHGNNLTGIIPKEIGSL-----RN 150
             + SLDL  N+L      ++        + +  L L GN+L      E+  +      N
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81

Query: 151 LRGLFLYSNKLSGVLPQEIGNL-----KSLTELYVTNNALG-----------GLIPSTLF 194
           +  L L  N LS     E+         ++T L +  N                +P+++ 
Sbjct: 82  VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141

Query: 195 RLTNISSNQFHS------SIPLEIGNFSALDTLDLSDNKIH----GIIPDELTKL-SQLK 243
            L N+  N             L     + +++L+L  N +       +   L  + + + 
Sbjct: 142 SL-NLRGNDLGIKSSDELIQILAAIPAN-VNSLNLRGNNLASKNCAELAKFLASIPASVT 199

Query: 244 NLNLSSNLLSGQIPYAIGKLF-----NLMYLDLSKNKLSGSIPTEIG----NCSALKNLT 294
           +L+LS+NLL  +    +  +F     +++ L+L  N L G     +     +   L+ + 
Sbjct: 200 SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVY 259

Query: 295 LNHNSLDGTIPLEMGKILL--------LQNLDLSHNNLS 325
           L+++ +   +  E  K L         +  +D +   + 
Sbjct: 260 LDYDIV-KNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 63/336 (18%), Positives = 109/336 (32%), Gaps = 72/336 (21%)

Query: 78  ITDIDLLNSNIKGE----LGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSL-----SKLK 128
           +T +DL  +N+       L +   +   ++ SL+L  NSL      ++  +     + + 
Sbjct: 24  VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83

Query: 129 CLYLHGNNLTGIIPKEIGSL-----RNLRGLFLYSNKLSGVLPQEIGNL-----KSLTEL 178
            L L GN L+     E+          +  L L  N  S     E          S+T L
Sbjct: 84  SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSL 143

Query: 179 YVTNNALGG-----------LIPSTLFRLTNISSNQFHS------SIPLEIGNFSALDTL 221
            +  N LG             IP+ +  L N+  N   S      +  L     +++ +L
Sbjct: 144 NLRGNDLGIKSSDELIQILAAIPANVNSL-NLRGNNLASKNCAELAKFLASIP-ASVTSL 201

Query: 222 DLSDNKIHGIIPDELTKL-----SQLKNLNLSSNLLSGQIPYAIGKLF----NLMYLDLS 272
           DLS N +      EL  +     + + +LNL  N L G     +  L     +L  + L 
Sbjct: 202 DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261

Query: 273 KNKLSG-------SIPTEIGNCSALKNLTLNHNSL--DGTIPLEMGKILL---LQNLDLS 320
            + +         ++     N   +  +  N   +    +IP+      L        L 
Sbjct: 262 YDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLL 321

Query: 321 HNNLSGT-----------IPKTLRPMYVDLSFNNLE 345
           +  L              IP  LR      +   L 
Sbjct: 322 NQCLIFAQKHQTNIEDLNIPDELR--ESIQTCKPLL 355

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 47/225 (20%), Positives = 79/225 (35%), Gaps = 52/225 (23%)

Query: 171 NLKSLTELYVTNNALG-----------GLIPSTLFRLTNISSNQFHSSIPLEIG-----N 214
               +T L ++ N L               P+++  L N+S N        E+       
Sbjct: 20  IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSL-NLSGNSLGFKNSDELVQILAAI 78

Query: 215 FSALDTLDLSDNKIHGIIPDELTKL-----SQLKNLNLSSNLLSGQIPYAIGKLF----- 264
            + + +L+LS N +     DEL K        +  L+L  N  S +      + F     
Sbjct: 79  PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138

Query: 265 NLMYLDLSKNKLSGSIPTEIG------NCSALKNLTLNHNSLDGTIPLEMGKILL----- 313
           ++  L+L  N L      E+         + + +L L  N+L      E+ K L      
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPAN-VNSLNLRGNNLASKNCAELAKFLASIPAS 197

Query: 314 LQNLDLSHNNLS-----------GTIPKTLRPMYVDLSFNNLEGE 347
           + +LDLS N L             +IP  +    ++L  N L G 
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVV--SLNLCLNCLHGP 240

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 28/138 (20%), Positives = 52/138 (37%), Gaps = 28/138 (20%)

Query: 236 LTKLSQLKNLNLSSNLLSGQIPYAIGKLF-----NLMYLDLSKNKLSGSIPTEIG----- 285
            +    + +L+LS N L       + + F     ++  L+LS N L      E+      
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 286 NCSALKNLTLNHNSLDGTIPLEMGKILL-----LQNLDLSHNNLS-----------GTIP 329
             + + +L L+ N L      E+ K L      +  LDL  N+ S             +P
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 330 KTLRPMYVDLSFNNLEGE 347
            ++    ++L  N+L  +
Sbjct: 138 ASIT--SLNLRGNDLGIK 153

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 27/116 (23%), Positives = 53/116 (45%), Gaps = 6/116 (5%)

Query: 208 IPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLM 267
           +   +    A   L LS N I  I    L+ +  L+ L+L  NL+  +I         L 
Sbjct: 40  MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 268 YLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLE-MGKILLLQNLDLSHN 322
            L +S N+++ S+ + I     L+ L +++N +     ++ +  +  L++L L+ N
Sbjct: 97  ELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.8 bits (135), Expect = 4e-09
 Identities = 33/179 (18%), Positives = 62/179 (34%), Gaps = 33/179 (18%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
              ++L       E      S     K L L  N++   I   +  +  L+ L L  N +
Sbjct: 25  AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLI 82

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT 197
             I   +      L  L++  N+++ +    I  L +L  LY++NN           ++T
Sbjct: 83  KKIENLD-AVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNN-----------KIT 128

Query: 198 NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDE----------LTKLSQLKNLN 246
           N             +     L+ L L+ N ++    +           + +L  LK L+
Sbjct: 129 NWGEIDK-------LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 17/105 (16%), Positives = 39/105 (37%), Gaps = 6/105 (5%)

Query: 223 LSDNKIHGIIPDELTKLSQLKN--LNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSI 280
              + I      +    ++ +   L+     +   +   +  L    +L LS N +   I
Sbjct: 6   TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI 63

Query: 281 PTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLS 325
            + +     L+ L+L  N +     L+      L+ L +S+N ++
Sbjct: 64  -SSLSGMENLRILSLGRNLIKKIENLD-AVADTLEELWISYNQIA 106

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 33/185 (17%), Positives = 56/185 (30%), Gaps = 48/185 (25%)

Query: 94  RLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRG 153
              ++     + LDL    +   I     +L +   +    N +  +       LR L+ 
Sbjct: 12  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKT 68

Query: 154 LFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIG 213
           L + +N++  +       L  LTEL +TNN                            + 
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNN---------------------------SLV 101

Query: 214 NFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQI---PYAIGKLFNLMYLD 270
               L               D L  L  L  L +  N ++ +     Y I K+  +  LD
Sbjct: 102 ELGDL---------------DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146

Query: 271 LSKNK 275
             K K
Sbjct: 147 FQKVK 151

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 25/133 (18%), Positives = 45/133 (33%), Gaps = 23/133 (17%)

Query: 167 QEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDN 226
            +  N     EL +    +          + N+ +                 D +D SDN
Sbjct: 13  AQYTNAVRDRELDLRGYKIP--------VIENLGAT------------LDQFDAIDFSDN 52

Query: 227 KIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSG-SIPTEIG 285
           +I  +  D    L +LK L +++N +          L +L  L L+ N L        + 
Sbjct: 53  EIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLA 110

Query: 286 NCSALKNLTLNHN 298
           +  +L  L +  N
Sbjct: 111 SLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.1 bits (128), Expect = 3e-08
 Identities = 25/112 (22%), Positives = 39/112 (34%), Gaps = 8/112 (7%)

Query: 214 NFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSK 273
           N      LDL   KI  +I +    L Q   ++ S N +  ++      L  L  L ++ 
Sbjct: 17  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNN 73

Query: 274 NKLSGSIPTEIGNCSALKNLTLNHN---SLDGTIPLEMGKILLLQNLDLSHN 322
           N++             L  L L +N    L    PL    +  L  L +  N
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLA--SLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 20/105 (19%), Positives = 38/105 (36%), Gaps = 5/105 (4%)

Query: 221 LDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSI 280
           + L+   I      + T   + + L+L    +   I      L     +D S N++   +
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57

Query: 281 PTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLS 325
                    LK L +N+N +          +  L  L L++N+L 
Sbjct: 58  DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 55.3 bits (134), Expect = 5e-09
 Identities = 27/88 (30%), Positives = 39/88 (44%), Gaps = 2/88 (2%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
           F     L  L L  N +  S+P  +   L+KL  LYLH N L  +       L  L+ L 
Sbjct: 48  FDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA 106

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNN 183
           L +N+L  V       L SL ++++  N
Sbjct: 107 LDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 38/155 (24%), Positives = 60/155 (38%), Gaps = 28/155 (18%)

Query: 98  SCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLY 157
           SC  +   +   +  L+ S+P  I S +    L L  N L  +       L  L  L L 
Sbjct: 6   SC--SGTEIRCNSKGLT-SVPTGIPSSATR--LELESNKLQSLPHGVFDKLTQLTKLSLS 60

Query: 158 SNKLSGVLPQEI-GNLKSLTELYVTNNALGGLIPSTLF-RLTNISSNQFHSSIPLEIGNF 215
            N++   LP  +   L  LT LY+  N L  L P+ +F +LT                  
Sbjct: 61  QNQIQ-SLPDGVFDKLTKLTILYLHENKLQSL-PNGVFDKLTQ----------------- 101

Query: 216 SALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSN 250
             L  L L  N++  +      +L+ L+ + L +N
Sbjct: 102 --LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 32/97 (32%), Positives = 46/97 (47%), Gaps = 4/97 (4%)

Query: 205 HSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLF 264
            +S+P  I   S+   L+L  NK+  +      KL+QL  L+LS N +         KL 
Sbjct: 19  LTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLT 76

Query: 265 NLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSL 300
            L  L L +NKL  S+P  +    + LK L L+ N L
Sbjct: 77  KLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 2/88 (2%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
           F+   +L  L+L  N L  S+P  +   L++LK L L+ N L  +       L  L+ L 
Sbjct: 72  FNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNN 183
           LY N+L  V       L SL  +++ +N
Sbjct: 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 37/131 (28%), Positives = 53/131 (40%), Gaps = 6/131 (4%)

Query: 79  TDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNL 137
           T    L +N    L    F    +L  L L  N L  S+P  +   L+ L  L L  N L
Sbjct: 30  TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL 88

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEI-GNLKSLTELYVTNNALGGLIPSTLF-R 195
             +       L  L+ L L +N+L   LP  +   L  L +L +  N L   +P  +F R
Sbjct: 89  QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDR 146

Query: 196 LTNISSNQFHS 206
           LT++     H 
Sbjct: 147 LTSLQYIWLHD 157

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 34/113 (30%), Positives = 50/113 (44%), Gaps = 3/113 (2%)

Query: 189 IPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLS 248
           IP+    L ++ +N   S         ++L  L L  NK+  +      KL+ L  LNLS
Sbjct: 26  IPAQTTYL-DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS 84

Query: 249 SNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSL 300
           +N L         KL  L  L L+ N+L  S+P  +    + LK+L L  N L
Sbjct: 85  TNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 19/160 (11%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
            +Q  +S+P  I   +    LDL  N +  +      +L+ L  L L  N L        
Sbjct: 15  YSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72

Query: 261 GKLFNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMG---KILLLQN 316
            KL +L YL+LS N+L  S+P  +    + LK L LN N L  ++P   G   K+  L++
Sbjct: 73  NKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQL-QSLP--DGVFDKLTQLKD 128

Query: 317 LDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIPTYLRGNP 356
           L L  N L  ++P        D  F+ L      +L  NP
Sbjct: 129 LRLYQNQLK-SVP--------DGVFDRLTSLQYIWLHDNP 159

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 57/277 (20%), Positives = 95/277 (34%), Gaps = 89/277 (32%)

Query: 450 EDFHIKYCI----GTGGYGSVYKAE-LPEGKVVALK--KLHHSETEDSAFVKSFQNEAHV 502
           + F+ +Y +    G G + +V+ +  +   K VA+K  K     TE +       +E  +
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA------LDEIRL 86

Query: 503 LSTVR--------HRNIVKLYG-FCL------HKKCMFLIYEYMERGSLFCVLHD-DDEA 546
           L +VR           +V+L   F +      H  CM  ++E +    L   +   + + 
Sbjct: 87  LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI-CM--VFEVL-GHHLLKWIIKSNYQG 142

Query: 547 IELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILL------------------ 588
           + L   K+  I++ V   L YLH  C   IIH DI   NILL                  
Sbjct: 143 LPLPCVKK--IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198

Query: 589 -------------------------------DSNLEASVADFGTARLLHVDSSYRTLRAG 617
                                             L+  +AD G A  +H    + T    
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQ 255

Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           T  Y + E+          D++S   +A E+  G + 
Sbjct: 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 53.7 bits (129), Expect = 8e-08
 Identities = 50/254 (19%), Positives = 83/254 (32%), Gaps = 30/254 (11%)

Query: 47  LLNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSL 106
           LL+ G    R P +  D       +     R+  +DL NS I+        S    L++L
Sbjct: 67  LLSQGVIAFRCPRSFMDQPLAEHFSP---FRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123

Query: 107 DLWNNSLSGSIPPQIGSLSKLKCLYLHG-NNLTGIIPKEIGS-LRNLRGLFLYSNKLSGV 164
            L    LS  I   +   S L  L L G +  +    + + S    L  L L        
Sbjct: 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD--- 180

Query: 165 LPQEIGNLKSLTELYVTNNALGGLIPS-----TLFRLTNISSNQFHSSIPLEIGNFSALD 219
                           T   +   +       T   L+    N   S +   +     L 
Sbjct: 181 ---------------FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 225

Query: 220 TLDLSD-NKIHGIIPDELTKLSQLKNLNLSS-NLLSGQIPYAIGKLFNLMYLDLSKNKLS 277
            LDLSD   +      E  +L+ L++L+LS    +  +    +G++  L  L +      
Sbjct: 226 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 285

Query: 278 GSIPTEIGNCSALK 291
           G++         L+
Sbjct: 286 GTLQLLKEALPHLQ 299

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 50.3 bits (121), Expect = 2e-07
 Identities = 26/84 (30%), Positives = 42/84 (50%), Gaps = 4/84 (4%)

Query: 102 NLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
             + L L++N ++  + P +   L++L  L L  N LT +       L  L  L L  N+
Sbjct: 31  TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89

Query: 161 LSGVLPQEI-GNLKSLTELYVTNN 183
           L  + P+    NLKSLT +++ NN
Sbjct: 90  LKSI-PRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 45.7 bits (109), Expect = 9e-06
 Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 7/89 (7%)

Query: 98  SCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLY 157
           SC  +  ++D    SL+ S+P  I   +  + LYL+ N +T + P     L  L  L L 
Sbjct: 8   SC--SGTTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLD 62

Query: 158 SNKLSGVLPQEI-GNLKSLTELYVTNNAL 185
           +N+L+ VLP  +   L  LT+L + +N L
Sbjct: 63  NNQLT-VLPAGVFDKLTQLTQLSLNDNQL 90

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 42.2 bits (100), Expect = 1e-04
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 6/96 (6%)

Query: 205 HSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI-GKL 263
            +S+P  I   +    L L DN+I  + P    +L+QL  L+L +N L+  +P  +  KL
Sbjct: 21  LASVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKL 77

Query: 264 FNLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHN 298
             L  L L+ N+L  SIP     N  +L ++ L +N
Sbjct: 78  TQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 52/239 (21%), Positives = 86/239 (35%), Gaps = 59/239 (24%)

Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR- 509
           F +   +G G +G V   + +   K  A+K + + +     + +S + EA +L  +++  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDD 92

Query: 510 ----NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI--VKSVAH 563
               NIVK +G  ++   M LI+E +   SL+       E I  N     +I  +K    
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPLGP-SLY-------EIITRNNYNGFHIEDIKLYCI 144

Query: 564 ----ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGT- 618
               AL+YL     +S+ H D+   NILLD                         ++   
Sbjct: 145 EILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 619 ---------------YGYI------APELAYTIVVTG-----KCDVYSFGVVALEVLMG 651
                             I      APE     V+         D++SFG V  E+  G
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPE-----VILNLGWDVSSDMWSFGCVLAELYTG 255

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 49.6 bits (119), Expect = 5e-07
 Identities = 29/84 (34%), Positives = 41/84 (48%), Gaps = 4/84 (4%)

Query: 102 NLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
           + + L L NN ++  + P +   L  L+ LY + N LT I       L  L  L L  N 
Sbjct: 34  DKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92

Query: 161 LSGVLPQEI-GNLKSLTELYVTNN 183
           L  + P+    NLKSLT +Y+ NN
Sbjct: 93  LKSI-PRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 45.7 bits (109), Expect = 8e-06
 Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 7/89 (7%)

Query: 98  SCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLY 157
           SC  +   ++  N  L+ S+P  I   +  + L+L+ N +T + P     L NL+ L+  
Sbjct: 11  SC--DQTLVNCQNIRLA-SVPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFN 65

Query: 158 SNKLSGVLPQEI-GNLKSLTELYVTNNAL 185
           SNKL+  +P  +   L  LT+L + +N L
Sbjct: 66  SNKLT-AIPTGVFDKLTQLTQLDLNDNHL 93

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 4/95 (4%)

Query: 205 HSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLF 264
            +S+P  I   +    L L++N+I  + P     L  L+ L  +SN L+        KL 
Sbjct: 24  LASVPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLT 81

Query: 265 NLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHN 298
            L  LDL+ N L  SIP     N  +L ++ L +N
Sbjct: 82  QLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 51.8 bits (124), Expect = 6e-07
 Identities = 41/252 (16%), Positives = 80/252 (31%), Gaps = 21/252 (8%)

Query: 67  WVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWN-NSLSGSIPPQIGS-L 124
           W+         + +I L    +  +   L    F N K L L +    S      I +  
Sbjct: 96  WIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATC 155

Query: 125 SKLKCLYLHGNNLTGIIPKEIGSL----RNLRGLFL--YSNKLS-GVLPQEIGNLKSLTE 177
             LK L L  +++  +    +        +L  L +   ++++S   L + +    +L  
Sbjct: 156 RNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKS 215

Query: 178 LY----VTNNALGGLIPST-------LFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDN 226
           L     V    L  L+              T       +S + + +     L  L    +
Sbjct: 216 LKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWD 275

Query: 227 KIHGIIPDELTKLSQLKNLNLSS-NLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIG 285
            +   +P   +  S+L  LNLS   + S  +   + +   L  L +        +     
Sbjct: 276 AVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLAS 335

Query: 286 NCSALKNLTLNH 297
            C  L+ L +  
Sbjct: 336 TCKDLRELRVFP 347

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 50.3 bits (119), Expect = 1e-06
 Identities = 37/279 (13%), Positives = 81/279 (29%), Gaps = 50/279 (17%)

Query: 99  CFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCL--YLHGNNLTGIIPKEIGSLRNLRGLFL 156
                + ++L +  L     P +  ++           +++   I +      +  GLF 
Sbjct: 87  YDEAEEGVNLMDKILKDKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFW 146

Query: 157 Y---------SNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT--NISSNQFH 205
                     S      L   +  +  L  L +       +       L    I S    
Sbjct: 147 GDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLP 206

Query: 206 SSIPLEIG--NFSALDTLDL---SDNKIHGIIPDEL------TKLSQLKNLNLSSNLLSG 254
            S+  +I   +   L+ L L    ++       +         +   LK L +       
Sbjct: 207 DSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQN 266

Query: 255 QIPYAIGK---LFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKI 311
            +     +   L  L  +D+S   L+      +     +  +                  
Sbjct: 267 VVVEMFLESDILPQLETMDISAGVLTDEGARLL--LDHVDKIKH---------------- 308

Query: 312 LLLQNLDLSHNNLSGTIPKTLR---PMYVDLSFNNLEGE 347
             L+ +++ +N LS  + K L+   PM +D+S +    +
Sbjct: 309 --LKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQEYDD 345

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 50.0 bits (118), Expect = 1e-06
 Identities = 39/209 (18%), Positives = 73/209 (34%), Gaps = 36/209 (17%)

Query: 96  NFSCFPNLKSLDLWNNSLS---------GSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIG 146
           N   F + + L   +               + P + ++  L  L + G N   I  K   
Sbjct: 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKK--- 190

Query: 147 SLRNLRGLFLYSNKLSGVLPQEIG--NLKSLT--ELYVTNNALGG----------LIPST 192
              NL+ L + S  L   + ++I   +L +L    LYV     G                
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDR 250

Query: 193 LFRLT--NISSNQFHSSIPLEIGNF---SALDTLDLSDNKIHG----IIPDELTKLSQLK 243
              L    I   +  + +            L+T+D+S   +      ++ D + K+  LK
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310

Query: 244 NLNLSSNLLSGQIPYAIGKLFNLMYLDLS 272
            +N+  N LS ++   + K   +  +D+S
Sbjct: 311 FINMKYNYLSDEMKKELQKSLPMK-IDVS 338

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.9 bits (105), Expect = 5e-05
 Identities = 15/110 (13%), Positives = 41/110 (37%), Gaps = 11/110 (10%)

Query: 79  TDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGS---LSKLKCLYLHGN 135
            +    + ++       +   FPNLK L + +      +         L +L+ + +   
Sbjct: 230 VEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAG 289

Query: 136 NLTG----IIPKEIGSLRNLRGLFLYSNKLSGV----LPQEIGNLKSLTE 177
            LT     ++   +  +++L+ + +  N LS      L + +     +++
Sbjct: 290 VLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSD 339

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 48.5 bits (116), Expect = 5e-06
 Identities = 45/244 (18%), Positives = 87/244 (35%), Gaps = 73/244 (29%)

Query: 452 FHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           + I   +G G +G V +          VALK + +       + ++ + E +VL  ++ +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEK 76

Query: 510 ------NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI--VKSV 561
                   V +  +      M + +E + + + F       E ++ N  +   +  V+ +
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTF-------EFLKENNFQPYPLPHVRHM 128

Query: 562 AH----ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVA-------------------D 598
           A+    AL +LH      + H D+   NIL  ++   ++                    D
Sbjct: 129 AYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185

Query: 599 FGTA-----RLLHVDSS--YRTLRAGTYGYIAPE----LAYTIVVTGKCDVYSFGVVALE 647
           FG+A         + ++  YR           PE    L +       CDV+S G +  E
Sbjct: 186 FGSATFDHEHHTTIVATRHYR----------PPEVILELGWAQ----PCDVWSIGCILFE 231

Query: 648 VLMG 651
              G
Sbjct: 232 YYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 44/244 (18%), Positives = 91/244 (37%), Gaps = 73/244 (29%)

Query: 452 FHIKYCIGTGGYGSVYKA--ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           + I   +G G +G V +       G+ VA+K + + +     + ++ ++E  VL  +   
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTT 71

Query: 510 ------NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI--VKSV 561
                   V++  +  H   + +++E +   S +       + I+ N      +  ++ +
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELLGL-STY-------DFIKENGFLPFRLDHIRKM 123

Query: 562 AH----ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVA-------------------D 598
           A+    ++++LH      + H D+   NIL   +                         D
Sbjct: 124 AYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 599 FGTARLLH-----VDSS--YRTLRAGTYGYIAPE----LAYTIVVTGKCDVYSFGVVALE 647
           FG+A         + S+  YR          APE    L ++      CDV+S G + +E
Sbjct: 181 FGSATYDDEHHSTLVSTRHYR----------APEVILALGWSQ----PCDVWSIGCILIE 226

Query: 648 VLMG 651
             +G
Sbjct: 227 YYLG 230

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 43/268 (16%), Positives = 85/268 (31%), Gaps = 62/268 (23%)

Query: 102 NLKSLDLWNNSLSGSIPPQIGSLSK--------LKCLYLHGNNLTGIIPKEIGS-LRNLR 152
           +L+ L+L    ++   P +   ++         L  + L    L     + +       R
Sbjct: 73  SLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRAR 129

Query: 153 GLFLYSNKLSGVLPQEIG-----NLKSLTELYVTNNALG---------GLIP-STLFRLT 197
            L L  N L     +++      +   +T L ++NN L          GL   +++  L 
Sbjct: 130 KLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHL- 188

Query: 198 NISSNQFHSSIPLEIGNFSA------------LDTLDLSDNKIHG----IIPDELTKLSQ 241
           ++            +G+               L  L+++ N         +     +   
Sbjct: 189 SLLHTG--------LGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPS 240

Query: 242 LKNLNLSSNLLS----GQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNH 297
           L+ L+L  N LS      +    G       + +S     G+  +E      L  +  N 
Sbjct: 241 LELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVS--LTEGTAVSEYW-SVILSEVQRNL 297

Query: 298 NSLDGTIPLEMGKILLLQNLDLSHNNLS 325
           NS D      + + L L   DL  +  +
Sbjct: 298 NSWD---RARVQRHLELLLRDLEDSRGA 322

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 6e-05
 Identities = 86/505 (17%), Positives = 146/505 (28%), Gaps = 160/505 (31%)

Query: 166 PQEIGNLKS-LTEL----YVTNNALGGLIPSTLFRLTNISSNQFHSSIP-----LEIGN- 214
            Q    L+  L EL     V  + + G   + +       S +    +      L + N 
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV-CLSYKVQCKMDFKIFWLNLKNC 192

Query: 215 FSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQI-------PYA-------- 259
            S    L++    ++ I P+  ++     N+ L  + +  ++       PY         
Sbjct: 193 NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN 252

Query: 260 -----IGKLFNLM--YLDLSKNK-----LSGSIPTEIGNCSALKNLT-----------LN 296
                    FNL    L  ++ K     LS +  T I        LT           L+
Sbjct: 253 VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD 312

Query: 297 HNSLD------GTIPLEMGKI-LLLQN--------LDLSHNNLSGTI--------PKTLR 333
               D       T P  +  I   +++          ++ + L+  I        P   R
Sbjct: 313 CRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372

Query: 334 PMYVDLS-FNNLEGEIPT----YLRGNPPKSFVGNKGLSGNVEGFPSSS--QRQKLTPSI 386
            M+  LS F      IPT     +  +  KS V        V      S  ++Q    +I
Sbjct: 373 KMFDRLSVFPP-SAHIPTILLSLIWFDVIKSDVMVV-----VNKLHKYSLVEKQPKESTI 426

Query: 387 SLFAKIFLPLNLVLAFIIFGFTLLFKCQNKN-PRLNSRAAKNGDVFSVWNYDGKILY--E 443
           S                I    L  K + +N   L+           V +Y+    +  +
Sbjct: 427 S----------------IPSIYLELKVKLENEYALHRSI--------VDHYNIPKTFDSD 462

Query: 444 DLINATED----FHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNE 499
           DLI    D     HI       G+               LK + H E   + F   F + 
Sbjct: 463 DLIPPYLDQYFYSHI-------GH--------------HLKNIEHPE-RMTLFRMVFLD- 499

Query: 500 AHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDD---EAIELNWTKRVN 556
                          + F L +K       +   GS+   L         I  N  K   
Sbjct: 500 ---------------FRF-LEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYER 543

Query: 557 IVKSVAHALSYLHHDCTLSIIHRDI 581
           +V ++   L  +  +   S  + D+
Sbjct: 544 LVNAILDFLPKIEENLICS-KYTDL 567

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 36/167 (21%), Positives = 65/167 (38%), Gaps = 34/167 (20%)

Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH-R 509
           + +   IG G +G +++   L   + VA+K     E   S      ++E      +    
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSD-APQLRDEYRTYKLLAGCT 66

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA------- 562
            I  +Y F        L+ + +   SL        E + L+   R   VK+VA       
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGP-SL--------EDL-LDLCGRKFSVKTVAMAAKQML 116

Query: 563 HALSYLHHDCTLSIIHRDISSNNILL------DSNLEASVADFGTAR 603
             +  +H     S+++RDI  +N L+      ++N+   V DFG  +
Sbjct: 117 ARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVV-DFGMVK 159

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 41/174 (23%), Positives = 65/174 (37%), Gaps = 42/174 (24%)

Query: 458 IGTGGYGSVYKAELPEGKVVALK-----KLHHSE-----TEDSAFVKSFQNEAHVLSTVR 507
           IG GG+G +Y A++   + V        K+  S+     TE   F +       +   +R
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTE-LKFYQRAAKPEQIQKWIR 101

Query: 508 HRN-----IVKLYGFCLHKKCM----FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIV 558
            R      + K +G  LH K      F+I   M+R         D + I      +    
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMI---MDR------FGSDLQKI-YEANAKRFSR 151

Query: 559 KSVA-------HALSYLHHDCTLSIIHRDISSNNILLDSNLEASV--ADFGTAR 603
           K+V          L Y+H       +H DI ++N+LL+      V   D+G A 
Sbjct: 152 KTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 33/169 (19%), Positives = 62/169 (36%), Gaps = 40/169 (23%)

Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HR 509
           F +   IG+G +G +Y    +   + VA+K     E   +        E+ +   ++   
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTK-HPQLLYESKIYRILQGGT 63

Query: 510 NIVKLYGFCLHKKCMFLIYEYM------------ERGSLFCVLHDDDEAIELNWTKRVNI 557
            I  +  F +      L+ + +             + SL  VL   D+ I          
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN--------- 114

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTAR 603
                  + ++H   + S +HRDI  +N L+     A+   + DFG A+
Sbjct: 115 ------RVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 29/169 (17%), Positives = 59/169 (34%), Gaps = 40/169 (23%)

Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH-R 509
           + +   IG+G +G +Y    +  G+ VA+K     E   +        E+ +   ++   
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTK-HPQLHIESKIYKMMQGGV 65

Query: 510 NIVKLYGFCLHKKCMFLIYEYM------------ERGSLFCVLHDDDEAIELNWTKRVNI 557
            I  +           ++ E +             + SL  VL                +
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVL---------------LL 110

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEAS---VADFGTAR 603
              +   + Y+H     + IHRD+  +N L+    + +   + DFG A+
Sbjct: 111 ADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 27/178 (15%), Positives = 57/178 (32%), Gaps = 26/178 (14%)

Query: 436 YDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKS 495
                L+  L+ + +   I   +G G   +V+     +     +K      T      + 
Sbjct: 77  LSLYSLHR-LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEK 135

Query: 496 -------FQNEAHVLSTVRHRNIVKLYGFCLHKKCMF----LIYEYMERGSLFCVLHDDD 544
                  F   A   +    R + KL G  + K   +    ++ E ++   L+ V  ++ 
Sbjct: 136 RDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENP 195

Query: 545 EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA 602
           + +                 L  +       I+H D+S  N+L+       + DF  +
Sbjct: 196 DEVL-------------DMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 239

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 27/113 (23%), Positives = 46/113 (40%), Gaps = 11/113 (9%)

Query: 221 LDLSDNKIHGIIP--DELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSG 278
           LDL   +    +   +    L++   +  +  ++   IP        L+ L+LS N+L  
Sbjct: 132 LDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIP-------ELLSLNLSNNRLYR 184

Query: 279 --SIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIP 329
              + + +     LK L L+ N L     L+  K L L+ L L  N+L  T  
Sbjct: 185 LDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFR 237

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 41.2 bits (97), Expect = 7e-04
 Identities = 34/166 (20%), Positives = 61/166 (36%), Gaps = 32/166 (19%)

Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH-R 509
           F +   IG G +G +   + L   + VA+K L   ++           E      +    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAP----QLHLEYRFYKQLGSGD 65

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA------- 562
            I ++Y F    K   ++ E +   SL        E +  +   R   +K+V        
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGP-SL--------EDL-FDLCDRTFSLKTVLMIAIQLI 115

Query: 563 HALSYLHHDCTLSIIHRDISSNNILL--DSNLEASVA---DFGTAR 603
             + Y+H   + ++I+RD+   N L+    N    V    DF  A+
Sbjct: 116 SRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	740
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-64
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-60
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-55
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-54
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-53
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-52
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-52
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-52
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-49
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-49
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-48
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-44
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-44
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-39
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-31
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-26
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-08
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-25
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-23
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-20
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-13
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-11
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.001
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.003
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-09
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	7e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	4e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.004
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 2e-64
 Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 20/275 (7%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
               +   IG+G +G+VYK +      VA+K L+ +       +++F+NE  VL   RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHV 64

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NI+   G+      + ++ ++ E  SL+  LH  +   +    K ++I +  A  + YLH
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLH 121

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPELA 627
                 IIHRD+ SNNI L  +L   + DFG A +    S        +G+  ++APE+ 
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 628 YTI---VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN 684
                   + + DVY+FG+V  E++ G  P       S+ +    ++  V    LSP ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP------YSNINNRDQIIFMVGRGYLSPDLS 232

Query: 685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +        +  +   CL  +   RP   +I   +
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 3e-60
 Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 20/271 (7%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   +   +G G +G V+         VA+K L            +F  EA+++  ++H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY     +  +++I EYME GSL   L      I+L   K +++   +A  ++++ 
Sbjct: 69  RLVRLYAVVTQEP-IYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY-RTLRAGTYGYIAPELAY 628
                  IHRD+ + NIL+   L   +ADFG ARL+  +    R        + APE   
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV 688
               T K DV+SFG++  E++                     +I  L +           
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYRMVRPDNCP 236

Query: 689 QDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           +++     +   C   +P+ RPT   +   L
Sbjct: 237 EELY---QLMRLCWKERPEDRPTFDYLRSVL 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 1e-59
 Identities = 76/268 (28%), Positives = 124/268 (46%), Gaps = 23/268 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF I   +G G +G+VY A   +   ++ALK L  ++ E +      + E  + S +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NI++LYG+      ++LI EY   G+++  L       + +  +    +  +A+ALSY 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H      +IHRDI   N+LL S  E  +ADFG +   H  SS RT   GT  Y+ PE+  
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTTLCGTLDYLPPEMIE 177

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN-QKI 687
             +   K D++S GV+  E L+G  P         ++  +     +     + P    + 
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP-------FEANTYQETYKRISRVEFTFPDFVTEG 230

Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRI 715
            +D+I         L   P  RP ++ +
Sbjct: 231 ARDLIS------RLLKHNPSQRPMLREV 252

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 5e-59
 Identities = 65/274 (23%), Positives = 123/274 (44%), Gaps = 22/274 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           ED+ + Y IGTG YG   K      GK++  K+L +  +   A  +   +E ++L  ++H
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY-GSMTEAEKQMLVSEVNLLRELKH 62

Query: 509 RNIVKLYGFCLHK--KCMFLIYEYMERGSLFCVLHDDDEAIE-LNWTKRVNIVKSVAHAL 565
            NIV+ Y   + +    ++++ EY E G L  V+    +  + L+    + ++  +  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 566 SYLH--HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
              H   D   +++HRD+   N+ LD      + DFG AR+L+ D+S+     GT  Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV 683
           PE    +    K D++S G +  E+     P        ++   K +   +   +     
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP-------FTAFSQKELAGKIREGKFRRIP 235

Query: 684 NQ--KIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
            +    + +II         L+ +   RP+++ I
Sbjct: 236 YRYSDELNEIIT------RMLNLKDYHRPSVEEI 263

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 4e-58
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 10/208 (4%)

Query: 448 ATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
             +DF     +G G  G V+K    P G V+A K +H       A       E  VL   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC 61

Query: 507 RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALS 566
               IV  YG       + +  E+M+ GSL  VL        +       +  +V   L+
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLT 118

Query: 567 YLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           YL       I+HRD+  +NIL++S  E  + DFG +  L    S      GT  Y++PE 
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPER 174

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHP 654
                 + + D++S G+  +E+ +G +P
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-57
 Identities = 62/273 (22%), Positives = 114/273 (41%), Gaps = 22/273 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           +D      +GTG +G V   +      VA+K +      +      F  EA V+  + H 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHE 59

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LYG C  ++ +F+I EYM  G L   L +          + + + K V  A+ YL 
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 117

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAY 628
                  +HRD+++ N L++      V+DFG +R +  D    ++       +  PE+  
Sbjct: 118 SKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174

Query: 629 TIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI 687
               + K D+++FGV+  E+  +G  P    ++            + + Q L        
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIAQGLRLYRPHLA 226

Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
            + +    TI ++C   +   RPT + +   +L
Sbjct: 227 SEKVY---TIMYSCWHEKADERPTFKILLSNIL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 2e-57
 Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 20/271 (7%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E   ++  +G G +G V+         VA+K L           ++F  EA V+  +RH 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LY     +  ++++ EYM +GSL   L  +         + V++   +A  ++Y+ 
Sbjct: 73  KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE 130

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY-RTLRAGTYGYIAPELAY 628
                  +HRD+ + NIL+  NL   VADFG ARL+  +    R        + APE A 
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV 688
               T K DV+SFG++  E+                      ++D + +    P   +  
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMVNREVLDQVERGYRMPCPPECP 240

Query: 689 QDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           + +     +   C   +P+ RPT + +   L
Sbjct: 241 ESLH---DLMCQCWRKEPEERPTFEYLQAFL 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 9e-57
 Identities = 60/271 (22%), Positives = 110/271 (40%), Gaps = 20/271 (7%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
            +      IG+G +G V+         VA+K +      +    + F  EA V+  + H 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +V+LYG CL +  + L++E+ME G L    +   +         + +   V   ++YL 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAPELAY 628
             C   +IHRD+++ N L+  N    V+DFG  R +  D    +        + +PE+  
Sbjct: 119 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV 688
               + K DV+SFGV+  EV                +     +++ ++        +   
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKI-------PYENRSNSEVVEDISTGFRLYKPRLAS 228

Query: 689 QDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             +     I   C   +P+ RP   R+ ++L
Sbjct: 229 THVY---QIMNHCWKERPEDRPAFSRLLRQL 256

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (490), Expect = 1e-56
 Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 27/290 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
            D  +K+ +G G YG VY+    +    VA+K L     ED+  V+ F  EA V+  ++H
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKH 72

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            N+V+L G C  +   ++I E+M  G+L   L + +   E++    + +   ++ A+ YL
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYL 131

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR-TLRAGTYGYIAPELA 627
                 + IHRD+++ N L+  N    VADFG +RL+  D+            + APE  
Sbjct: 132 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI 687
                + K DV++FGV+  E+            LS        + ++L +       +  
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGC 241

Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISE 737
            + +     +  AC    P  RP+   I Q         +   +E SIS+
Sbjct: 242 PEKVY---ELMRACWQWNPSDRPSFAEIHQAF-------ETMFQESSISD 281

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-56
 Identities = 60/271 (22%), Positives = 113/271 (41%), Gaps = 24/271 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           ++  +   IG G +G V   +   G  VA+K +      + A  ++F  EA V++ +RH 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK-----NDATAQAFLAEASVMTQLRHS 60

Query: 510 NIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           N+V+L G  +  K  ++++ EYM +GSL   L     ++ L     +     V  A+ YL
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 119

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
             +     +HRD+++ N+L+  +  A V+DFG  +     SS +        + APE   
Sbjct: 120 EGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALR 173

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV 688
               + K DV+SFG++  E+                  P   ++  + +           
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRV-------PYPRIPLKDVVPRVEKGYKMDAPDGCP 226

Query: 689 QDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             +     +   C       RP+  ++ ++L
Sbjct: 227 PAVY---EVMKNCWHLDAAMRPSFLQLREQL 254

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  192 bits (488), Expect = 3e-56
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 37/297 (12%)

Query: 442 YEDLINATEDFH---------IKYCIGTGGYGSVYKAELP----EGKVVALKKLHHSETE 488
           +ED   A  +F          I+  IG G +G V    L         VA+K L    TE
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 489 DSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE 548
                + F +EA ++    H N++ L G       + +I E+ME GSL   L  +D    
Sbjct: 69  KQ--RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
               + V +++ +A  + YL        +HRD+++ NIL++SNL   V+DFG +R L  D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 609 SSYRTLRA-----GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS 663
           +S  T  +         + APE       T   DV+S+G+V  EV+              
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYWD 236

Query: 664 SSGPKIMLIDVLNQRLSPPVNQ-KIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +   ++     + RL PP++    +  ++L       C       RP   +I   L
Sbjct: 237 MTNQDVINAIEQDYRLPPPMDCPSALHQLML------DCWQKDRNHRPKFGQIVNTL 287

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (484), Expect = 2e-55
 Identities = 64/284 (22%), Positives = 121/284 (42%), Gaps = 26/284 (9%)

Query: 438 GKILYEDLINATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSF 496
            ++ ++D  +  + F     IG G +G+VY A  +   +VVA+KK+ +S  + +   +  
Sbjct: 5   AELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62

Query: 497 QNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVN 556
             E   L  +RH N ++  G  L +   +L+ EY    +   +         L   +   
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAA 119

Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA 616
           +       L+YLH     ++IHRD+ + NILL       + DFG+A ++   +S+     
Sbjct: 120 VTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF----V 172

Query: 617 GTYGYIAPELAYTI---VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLID 673
           GT  ++APE+   +      GK DV+S G+  +E+     P   ++++S        L  
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH 225

Query: 674 VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQ 717
           +         +    +          +CL   P+ RPT + + +
Sbjct: 226 IAQNESPALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLK 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 3e-55
 Identities = 66/286 (23%), Positives = 117/286 (40%), Gaps = 29/286 (10%)

Query: 443 EDLINATEDFHI-KYCIGTGGYGSVYKAEL---PEGKVVALKKLHHSETEDSAFVKSFQN 498
           + L    ++  I    +G G +GSV +       +   VA+K L      + A  +    
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMR 58

Query: 499 EAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIV 558
           EA ++  + +  IV+L G C   + + L+ E    G L   L    E  E+  +    ++
Sbjct: 59  EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELL 115

Query: 559 KSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--- 615
             V+  + YL      + +HRD+++ N+LL +   A ++DFG ++ L  D SY T R   
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 616 AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVL-MGTHPGGLLSSLSSSSGPKIMLIDV 674
                + APE       + + DV+S+GV   E L  G  P           GP++M    
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP------YKKMKGPEVMAFIE 226

Query: 675 LNQRLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
             +R+  P      +  ++        C   + + RP    + Q +
Sbjct: 227 QGKRMECPPECPPELYALMS------DCWIYKWEDRPDFLTVEQRM 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 9e-55
 Identities = 68/297 (22%), Positives = 130/297 (43%), Gaps = 33/297 (11%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +  + +     IG G  G+VY A ++  G+ VA+++++  +       +   NE  V+  
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRE 73

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
            ++ NIV      L    ++++ EY+  GSL  V+ +       +  +   + +    AL
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQAL 129

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
            +LH      +IHRDI S+NILL  +    + DFG    +  + S R+   GT  ++APE
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 626 LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ 685
           +        K D++S G++A+E++ G  P        + +  + + +   N        +
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP------YLNENPLRALYLIATNGTPELQNPE 240

Query: 686 KI---VQDIILVSTIAFACLSSQPKSRPTMQRISQ-------ELLAGKTPMQKALKE 732
           K+    +D +        CL    + R + + + Q       + L+  TP+  A KE
Sbjct: 241 KLSAIFRDFLN------RCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 9e-55
 Identities = 65/270 (24%), Positives = 114/270 (42%), Gaps = 28/270 (10%)

Query: 458 IGTGGYGSVYKAELPE---GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G+G +G+V K         K VA+K L  +E  D A       EA+V+  + +  IV++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
            G C  +  M L+ E  E G L   L  +     +     + +V  V+  + YL      
Sbjct: 74  IGICEAESWM-LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN-- 127

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR---AGTYGYIAPELAYTIV 631
             +HRD+++ N+LL +   A ++DFG ++ L  D +Y   +        + APE      
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 632 VTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN-QKIVQ 689
            + K DV+SFGV+  E    G  P           G ++  +    +R+  P    + + 
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKP------YRGMKGSEVTAMLEKGERMGCPAGCPREMY 240

Query: 690 DIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           D++        C +   ++RP    +   L
Sbjct: 241 DLMN------LCWTYDVENRPGFAAVELRL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-54
 Identities = 64/286 (22%), Positives = 122/286 (42%), Gaps = 32/286 (11%)

Query: 442 YEDL---INATEDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQ 497
           YE +   +N  + + I   +G G +G VYKA+  E   + A K +     E+   ++ + 
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYM 57

Query: 498 NEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI 557
            E  +L++  H NIVKL     ++  ++++ E+   G++  V+ + +    L  ++   +
Sbjct: 58  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVV 115

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
            K    AL+YLH      IIHRD+ + NIL   + +  +ADFG +         R    G
Sbjct: 116 CKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172

Query: 618 TYGYIAPELAYTIV-----VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLI 672
           T  ++APE+             K DV+S G+  +E+     P          +  +++L 
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP------HHELNPMRVLLK 226

Query: 673 DVLNQRLSPPVNQKI---VQDIILVSTIAFACLSSQPKSRPTMQRI 715
              ++  +     +     +D +        CL     +R T  ++
Sbjct: 227 IAKSEPPTLAQPSRWSSNFKDFLK------KCLEKNVDARWTTSQL 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (475), Expect = 2e-54
 Identities = 69/307 (22%), Positives = 119/307 (38%), Gaps = 44/307 (14%)

Query: 442 YEDLINATEDFHIKYCIGTGGYGSVYKAELPE------GKVVALKKLHHSETEDSAFVKS 495
              L     +      IG G +G V++A  P         +VA+K L    + D      
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQAD 62

Query: 496 FQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD------------- 542
           FQ EA +++   + NIVKL G C   K M L++EYM  G L   L               
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 543 --------DDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEA 594
                         L+  +++ I + VA  ++YL        +HRD+++ N L+  N+  
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVV 179

Query: 595 SVADFGTARLLHVDSSYR--TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGT 652
            +ADFG +R ++    Y+     A    ++ PE  +    T + DV+++GVV  E+    
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 653 HPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTM 712
                          + ++  V +  +     +    ++     +   C S  P  RP+ 
Sbjct: 240 LQ------PYYGMAHEEVIYYVRDGNI-LACPENCPLELY---NLMRLCWSKLPADRPSF 289

Query: 713 QRISQEL 719
             I + L
Sbjct: 290 CSIHRIL 296

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 5e-54
 Identities = 70/271 (25%), Positives = 105/271 (38%), Gaps = 23/271 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           ED+ +   +G G YG V  A      + VA+K +      D    ++ + E  +   + H
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 62

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            N+VK YG        +L  EY   G LF  +  D   I +           +   + YL
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYL 119

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL--RAGTYGYIAPEL 626
           H    + I HRDI   N+LLD      ++DFG A +   ++  R L    GT  Y+APEL
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 627 AYTIVVTG-KCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ 685
                      DV+S G+V   +L G  P          S       D   ++      +
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELP------WDQPSDSCQEYSDWKEKKTYLNPWK 230

Query: 686 KIVQDII-LVSTIAFACLSSQPKSRPTMQRI 715
           KI    + L+       L   P +R T+  I
Sbjct: 231 KIDSAPLALLH----KILVENPSARITIPDI 257

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 8e-54
 Identities = 64/278 (23%), Positives = 105/278 (37%), Gaps = 22/278 (7%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELP----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +D  +   +G G +G V + E      +   VA+K L          +  F  E + + +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           + HRN+++LYG       M ++ E    GSL   L        L    R      VA  +
Sbjct: 68  LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY---RTLRAGTYGYI 622
            YL        IHRD+++ N+LL +     + DFG  R L  +  +   +  R   + + 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP 682
           APE   T   +   D + FGV   E+                     +L  +  +    P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE------PWIGLNGSQILHKIDKEGERLP 235

Query: 683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
             +   QDI     +   C + +P+ RPT   +   LL
Sbjct: 236 RPEDCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLL 270

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-53
 Identities = 66/294 (22%), Positives = 109/294 (37%), Gaps = 38/294 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
                   +G G +G V +A             VA+K L  S        ++  +E  VL
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80

Query: 504 STV-RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHD---------------DDEAI 547
           S +  H NIV L G C       +I EY   G L   L                 +D+ +
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 548 ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
            L+    ++    VA  +++L        IHRD+++ NILL       + DFG AR +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 608 DSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSS 665
           DS+Y  +        ++APE  +  V T + DV+S+G+   E+                 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP------YPGM 251

Query: 666 GPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                   ++ +       +    ++     I   C  + P  RPT ++I Q +
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMY---DIMKTCWDADPLKRPTFKQIVQLI 302

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 4e-53
 Identities = 63/264 (23%), Positives = 106/264 (40%), Gaps = 23/264 (8%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYG 516
           IG G + +VYK    E    VA  +L   +   S   + F+ EA +L  ++H NIV+ Y 
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 517 FCL----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC 572
                   KKC+ L+ E M  G+L   L        +      +  + +   L +LH   
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 573 TLSIIHRDISSNNILLDS-NLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIV 631
              IIHRD+  +NI +        + D G A L    +S+     GT  ++APE+ Y   
Sbjct: 133 PP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEM-YEEK 188

Query: 632 VTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDI 691
                DVY+FG+  LE+    +P       S       +   V +       ++  + ++
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 692 ILVSTIAFACLSSQPKSRPTMQRI 715
                I   C+      R +++ +
Sbjct: 243 K---EIIEGCIRQNKDERYSIKDL 263

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 4e-53
 Identities = 63/299 (21%), Positives = 111/299 (37%), Gaps = 43/299 (14%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE------GKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           E+      +G+G +G V  A             VA+K L   E  DS+  ++  +E  ++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--EKADSSEREALMSELKMM 94

Query: 504 STV-RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIE-------------- 548
           + +  H NIV L G C     ++LI+EY   G L   L    E                 
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 549 ------LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA 602
                 L +   +     VA  + +L      S +HRD+++ N+L+       + DFG A
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 603 RLLHVDSSYRTLR--AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSS 660
           R +  DS+Y           ++APE  +  + T K DV+S+G++  E+            
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------ 265

Query: 661 LSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                        ++             ++I     I  +C +   + RP+   ++  L
Sbjct: 266 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIY---IIMQSCWAFDSRKRPSFPNLTSFL 321

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-52
 Identities = 62/295 (21%), Positives = 106/295 (35%), Gaps = 26/295 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           EDF     +G G + +V  A EL   +  A+K L          V     E  V+S + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
              VKLY      + ++    Y + G L   +         + T        +  AL YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYL 124

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYIAPEL 626
           H      IIHRD+   NILL+ ++   + DFGTA++L  +S         GT  Y++PEL
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN-Q 685
                     D+++ G +  +++ G  P         +    ++   ++      P    
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPP-------FRAGNEYLIFQKIIKLEYDFPEKFF 234

Query: 686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISELRN 740
              +D++         L      R   + +         P     + ++   L  
Sbjct: 235 PKARDLVE------KLLVLDATKRLGCEEMEGYGPLKAHPF---FESVTWENLHQ 280

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-52
 Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 38/299 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
               ++  IG G +G V++ +   G+ VA+K     E          + E +    +RH 
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHE 57

Query: 510 NIVKLYGFC----LHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           NI+               ++L+ +Y E GSLF  L+       +     + +  S A  L
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGL 113

Query: 566 SYLHHDC-----TLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY----RTLRA 616
           ++LH +        +I HRD+ S NIL+  N    +AD G A      +         R 
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 617 GTYGYIAPELAYTIV------VTGKCDVYSFGVVALEVLMGTHPGGLLSSLS-------- 662
           GT  Y+APE+    +         + D+Y+ G+V  E+      GG+             
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 663 SSSGPKIMLIDVLNQRLSPPVNQKIVQDIIL--VSTIAFACLSSQPKSRPTMQRISQEL 719
           S    + M   V  Q+L P +  +      L  ++ I   C  +   +R T  RI + L
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 5e-52
 Identities = 71/278 (25%), Positives = 109/278 (39%), Gaps = 25/278 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEG-----KVVALKKLHHSETEDSAFVKSFQNEAHVLS 504
                +  IG G +G VYK  L          VA+K L    TE       F  EA ++ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMG 64

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
              H NI++L G     K M +I EYME G+        ++  E +  + V +++ +A  
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRA---GTYGY 621
           + YL +      +HRD+++ NIL++SNL   V+DFG +R+L  D       +       +
Sbjct: 123 MKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 622 IAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP 681
            APE       T   DV+SFG+V  EV+                     ++  +N     
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGER-------PYWELSNHEVMKAINDGFRL 232

Query: 682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           P        I     +   C   +   RP    I   L
Sbjct: 233 PTPMDCPSAIY---QLMMQCWQQERARRPKFADIVSIL 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 3e-51
 Identities = 72/288 (25%), Positives = 116/288 (40%), Gaps = 35/288 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEG---KVVALKKLHHSETEDSAFVKSFQNEAHVLSTV 506
            D   +  IG G +G V KA + +       A+K++    ++D    + F  E  VL  +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 67

Query: 507 -RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-------------DDDEAIELNWT 552
             H NI+ L G C H+  ++L  EY   G+L   L               +  A  L+  
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 553 KRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR 612
           + ++    VA  + YL        IHRD+++ NIL+  N  A +ADFG +R   V     
Sbjct: 128 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 613 TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLI 672
             R     ++A E     V T   DV+S+GV+  E++               +  ++   
Sbjct: 185 MGR-LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEK 238

Query: 673 DVLNQRLSPPVN-QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                RL  P+N    V D++        C   +P  RP+  +I   L
Sbjct: 239 LPQGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSL 280

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  178 bits (453), Expect = 9e-51
 Identities = 66/294 (22%), Positives = 123/294 (41%), Gaps = 29/294 (9%)

Query: 430 VFSVWNYD----GKILYEDLINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHH 484
           VF +W        +I ++ +++    + I   +GTG +G V++  E   G   A K +  
Sbjct: 5   VFDIWKQYYPQPVEIKHDHVLD---HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 61

Query: 485 SETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDD 544
               D    ++ + E   +S +RH  +V L+        M +IYE+M  G LF  +   D
Sbjct: 62  PHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--D 116

Query: 545 EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS--NLEASVADFGTA 602
           E  +++  + V  ++ V   L ++H +     +H D+   NI+  +  + E  + DFG  
Sbjct: 117 EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173

Query: 603 RLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS 662
             L    S +    GT  + APE+A    V    D++S GV++  +L G  P G      
Sbjct: 174 AHLDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-----G 227

Query: 663 SSSGPKIMLIDVLNQRLSPPVNQKIVQDII-LVSTIAFACLSSQPKSRPTMQRI 715
            +    +  +   +  +       I +D    +       L + P +R T+ + 
Sbjct: 228 ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR----KLLLADPNTRMTIHQA 277

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 6e-50
 Identities = 62/276 (22%), Positives = 108/276 (39%), Gaps = 25/276 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELP----EGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           E   +  CIG G +G V++            VA+K   +  ++     + F  EA  +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQ 64

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
             H +IVKL G    +  +++I E    G L            L+    +     ++ AL
Sbjct: 65  FDHPHIVKLIGVI-TENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTAL 121

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR-AGTYGYIAP 624
           +YL        +HRDI++ N+L+ SN    + DFG +R +   + Y+  +      ++AP
Sbjct: 122 AYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 625 ELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV 683
           E       T   DV+ FGV   E+LM G  P   + +          +I  +      P+
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERLPM 230

Query: 684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                  +    ++   C +  P  RP    +  +L
Sbjct: 231 PPNCPPTLY---SLMTKCWAYDPSRRPRFTELKAQL 263

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-49
 Identities = 59/276 (21%), Positives = 105/276 (38%), Gaps = 26/276 (9%)

Query: 453 HIKYCIGTGGYGSVYKAELPEGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           H    IG G +G VY   L +        A+K L+     D   V  F  E  ++    H
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSH 87

Query: 509 RNIVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
            N++ L G CL  +    ++  YM+ G L   + ++     +       +  +       
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY----RTLRAGTYGYIA 623
           +    +   +HRD+++ N +LD      VADFG AR ++         +T       ++A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 624 PELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV 683
            E   T   T K DV+SFGV+  E++    P          +   I +  +  +RL  P 
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQP- 256

Query: 684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            +     +     +   C   + + RP+   +   +
Sbjct: 257 -EYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRI 288

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (440), Expect = 3e-49
 Identities = 72/303 (23%), Positives = 123/303 (40%), Gaps = 30/303 (9%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLST 505
           +  + +  +  +GTG +  V  AE     K+VA+K +     E      S +NE  VL  
Sbjct: 6   DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHK 63

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
           ++H NIV L         ++LI + +  G LF  + +              ++  V  A+
Sbjct: 64  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAV 120

Query: 566 SYLHHDCTLSIIHRDISSNNILL---DSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
            YLH      I+HRD+   N+L    D + +  ++DFG +++    S   T   GT GY+
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYV 176

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIM-LIDVLNQRLSP 681
           APE+      +   D +S GV+A  +L G  P          +  K+   I         
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPP------FYDENDAKLFEQILKAEYEFDS 230

Query: 682 PVNQKI---VQDIILVSTIAFACLSSQPKSRPTMQRISQ-ELLAGKTPMQKALKEISISE 737
           P    I    +D I         +   P+ R T ++  Q   +AG T + K + +    +
Sbjct: 231 PYWDDISDSAKDFIR------HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQ 284

Query: 738 LRN 740
           ++ 
Sbjct: 285 IKK 287

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-49
 Identities = 65/288 (22%), Positives = 120/288 (41%), Gaps = 25/288 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKV----VALKKLHHSETEDSAFVKSFQNEAHVLS 504
            +F     +G+G +G+VYK   +PEG+     VA+K+L  + +      K   +EA+V++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMA 66

Query: 505 TVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
           +V + ++ +L G CL    + LI + M  G L   + +  + I       +N    +A  
Sbjct: 67  SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKG 123

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR--AGTYGYI 622
           ++YL       ++HRD+++ N+L+ +     + DFG A+LL  +              ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP 682
           A E     + T + DV+S+GV   E++                 P   +  +L +    P
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------PYDGIPASEISSILEKGERLP 233

Query: 683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKAL 730
                  D+     I   C      SRP  + +  E        Q+ L
Sbjct: 234 QPPICTIDVY---MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 278

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-49
 Identities = 60/274 (21%), Positives = 111/274 (40%), Gaps = 23/274 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLS-TVR 507
           EDF +   +G G +G V+ AE  +  +  A+K L          V+    E  VLS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 508 HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSY 567
           H  +  ++     K+ +F + EY+  G L   +    +    + ++       +   L +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 568 LHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELA 627
           LH      I++RD+  +NILLD +    +ADFG  +   +  +      GT  YIAPE+ 
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI 687
                    D +SFGV+  E+L+G  P             ++     ++    P   +K 
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP------FHGQDEEELFHSIRMDNPFYPRWLEKE 229

Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLA 721
            +D+++           +P+ R  ++    ++  
Sbjct: 230 AKDLLV------KLFVREPEKRLGVR---GDIRQ 254

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  174 bits (442), Expect = 4e-49
 Identities = 56/271 (20%), Positives = 113/271 (41%), Gaps = 24/271 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           + + I   +G+G +G V++  E   G+V   K ++     D     + +NE  +++ + H
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 85

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             ++ L+     K  M LI E++  G LF  +  +D   +++  + +N ++     L ++
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHM 143

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASV--ADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           H     SI+H DI   NI+ ++   +SV   DFG A  L+ D   +     T  + APE+
Sbjct: 144 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPEI 199

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIM-LIDVLNQRLSPPVNQ 685
                V    D+++ GV+   +L G  P       +     + +  +   +         
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP------FAGEDDLETLQNVKRCDWEFDEDAFS 253

Query: 686 KIVQDII-LVSTIAFACLSSQPKSRPTMQRI 715
            +  +    +       L  +P+ R T+   
Sbjct: 254 SVSPEAKDFIK----NLLQKEPRKRLTVHDA 280

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-48
 Identities = 66/306 (21%), Positives = 121/306 (39%), Gaps = 37/306 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           E   +   +G G +G VY+              VA+K ++ + +        F NEA V+
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-------DDDEAIELNWTKRVN 556
                 ++V+L G     +   +I E M RG L   L        ++      + +K + 
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 557 IVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYR--TL 614
           +   +A  ++YL+ +     +HRD+++ N ++  +    + DFG  R ++    YR    
Sbjct: 138 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 615 RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDV 674
                 +++PE     V T   DV+SFGVV  E+                S  +++   +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSNEQVLRFVM 249

Query: 675 LNQRLSPPVNQ-KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEI 733
               L  P N   ++ +++        C    PK RP+   I   +   K  M+   +E+
Sbjct: 250 EGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSI---KEEMEPGFREV 300

Query: 734 S--ISE 737
           S   SE
Sbjct: 301 SFYYSE 306

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-48
 Identities = 69/300 (23%), Positives = 127/300 (42%), Gaps = 38/300 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E + I   +G G +G V++  E    K    K +    T+        + E  +L+  RH
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           RNI+ L+      + + +I+E++    +F  ++    A ELN  + V+ V  V  AL +L
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFL 118

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASV--ADFGTARLLHVDSSYRTLRAGTYGYIAPEL 626
           H     +I H DI   NI+  +   +++   +FG AR L    ++R L      Y APE+
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEYYAPEV 174

Query: 627 AYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ- 685
               VV+   D++S G +   +L G +P         +   + ++ +++N   +      
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPF-------LAETNQQIIENIMNAEYTFDEEAF 227

Query: 686 ----KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTP-MQKALKEISISELRN 740
                   D +         L  + KSR T      E L  + P +++ ++ +S   +R 
Sbjct: 228 KEISIEAMDFVD------RLLVKERKSRMTA----SEAL--QHPWLKQKIERVSTKVIRT 275

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  168 bits (426), Expect = 9e-48
 Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 31/285 (10%)

Query: 449 TEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR 507
           ++ + +   +G GG   V+ A  L   + VA+K L      D +F   F+ EA   + + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 508 HRNIVKLYGFCLHK----KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           H  IV +Y     +       +++ EY++  +L  ++H +     +   + + ++     
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR---AGTYG 620
           AL++ H +    IIHRD+   NI++ +     V DFG AR +    +  T      GT  
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 621 YIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS 680
           Y++PE A    V  + DVYS G V  EVL G  P       +  S   +    V    + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVAYQHVREDPIP 233

Query: 681 PPVNQKIV----QDIILVSTIAFACLSSQPKSRP-TMQRISQELL 720
           P    + +      ++L        L+  P++R  T   +  +L+
Sbjct: 234 PSARHEGLSADLDAVVL------KALAKNPENRYQTAAEMRADLV 272

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  168 bits (426), Expect = 2e-47
 Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 25/275 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           +DF I   +GTG +G V+       G+  A+K L          V+   +E  +LS V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             I++++G     + +F+I +Y+E G LF +L                 V         L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
            +  +  II+RD+   NILLD N    + DFG A+ +           GT  YIAPE+  
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVS 174

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN-QKI 687
           T       D +SFG++  E+L G  P          S        +LN  L  P    + 
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP-------FYDSNTMKTYEKILNAELRFPPFFNED 227

Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRIS-QELLA 721
           V+D++         ++     R    +   +++  
Sbjct: 228 VKDLLS------RLITRDLSQRLGNLQNGTEDVKN 256

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 3e-46
 Identities = 65/294 (22%), Positives = 116/294 (39%), Gaps = 39/294 (13%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE--------GKVVALKKLHHSETEDSAFVKSFQNEAH 501
           +   +   +G G +G V  AE              VA+K L    TE    +    +E  
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEME 70

Query: 502 VLSTV-RHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLH-------------DDDEAI 547
           ++  + +H+NI+ L G C     +++I EY  +G+L   L                +   
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 548 ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV 607
           +L+    V+    VA  + YL        IHRD+++ N+L+  +    +ADFG AR +H 
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 608 DSSYRTLRA--GTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSS 665
              Y+          ++APE  +  + T + DV+SFGV+  E+                 
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-------PYPG 240

Query: 666 GPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
            P   L  +L +            ++     +   C  + P  RPT +++ ++L
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELY---MMMRDCWHAVPSQRPTFKQLVEDL 291

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  160 bits (405), Expect = 6e-45
 Identities = 68/283 (24%), Positives = 117/283 (41%), Gaps = 35/283 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLH------HSETEDSAFVKSFQNEAHV 502
           E++  K  +G G    V +    P  K  A+K +        S  E     ++   E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 503 LSTVR-HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSV 561
           L  V  H NI++L          FL+++ M++G LF  L    E + L+  +   I++++
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 119

Query: 562 AHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGY 621
              +  LH    L+I+HRD+   NILLD ++   + DFG +  L      R +  GT  Y
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-GTPSY 175

Query: 622 IAPELAYTIVVTG------KCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVL 675
           +APE+    +         + D++S GV+   +L G+ P              + +I   
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIMSG 230

Query: 676 NQRLSPPVNQKI---VQDIILVSTIAFACLSSQPKSRPTMQRI 715
           N +   P        V+D++         L  QP+ R T +  
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVS------RFLVVQPQKRYTAEEA 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  162 bits (410), Expect = 1e-44
 Identities = 58/281 (20%), Positives = 99/281 (35%), Gaps = 29/281 (10%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNE---AHVLST 505
            DF +   IG GG+G VY     + GK+ A+K L     +         NE     ++ST
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 506 VRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHAL 565
                IV +         +  I + M  G L   L       E +          +   L
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM---RFYAAEIILGL 120

Query: 566 SYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE 625
            ++H+     +++RD+   NILLD +    ++D G A        + +   GT+GY+APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPE 175

Query: 626 -LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN 684
            L   +      D +S G +  ++L G  P                 ID +   ++  + 
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP------FRQHKTKDKHEIDRMTLTMAVELP 229

Query: 685 QKI---VQDIILVSTIAFACLSSQPKSRPTMQRIS-QELLA 721
                 ++ ++         L      R        QE+  
Sbjct: 230 DSFSPELRSLLE------GLLQRDVNRRLGCLGRGAQEVKE 264

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 4e-44
 Identities = 59/280 (21%), Positives = 107/280 (38%), Gaps = 29/280 (10%)

Query: 447 NATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDS---AFVKSFQNEAHV 502
           N  + +     +G+G +  V K  E   G   A K +    T+ S      +  + E  +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66

Query: 503 LSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           L  ++H N++ L+    +K  + LI E +  G LF  L + +   E          + + 
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE------EEATEFLK 120

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEAS----VADFGTARLLHVDSSYRTLRAGT 618
             L+ +++  +L I H D+   NI+L           + DFG A  +   + +     GT
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-KNIFGT 179

Query: 619 YGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQR 678
             ++APE+     +  + D++S GV+   +L G  P      L  +    +  +  +N  
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-----FLGDTKQETLANVSAVNYE 234

Query: 679 LSPPVNQKI---VQDIILVSTIAFACLSSQPKSRPTMQRI 715
                        +D I         L   PK R T+Q  
Sbjct: 235 FEDEYFSNTSALAKDFIR------RLLVKDPKKRMTIQDS 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-42
 Identities = 57/275 (20%), Positives = 95/275 (34%), Gaps = 22/275 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
            DF     +G G +G V        G+  A+K L          V     E+ VL   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             +  L         +  + EY   G LF  L  +    E             A  +S L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE------ERARFYGAEIVSAL 118

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
            +  +  +++RDI   N++LD +    + DFG  +    D +      GT  Y+APE+  
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN-QKI 687
                   D +  GVV  E++ G  P         +   + +   +L + +  P      
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP-------FYNQDHERLFELILMEEIRFPRTLSPE 231

Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRIS-QELLA 721
            + ++         L   PK R        +E++ 
Sbjct: 232 AKSLLA------GLLKKDPKQRLGGGPSDAKEVME 260

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-42
 Identities = 62/293 (21%), Positives = 104/293 (35%), Gaps = 37/293 (12%)

Query: 450 EDFHIKYCIGTGGYGSVYKA------ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           +   +   +G G +G V +A      +    + VA+K L    T      ++  +E  +L
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKIL 70

Query: 504 S-TVRHRNIVKLYGFCLHK-KCMFLIYEYMERGSLFCVLH-------------DDDEAIE 548
                H N+V L G C      + +I E+ + G+L   L              +D     
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 549 LNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD 608
           L     +     VA  + +L        IHRD+++ NILL       + DFG AR ++ D
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 609 SSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG 666
             Y  +        ++APE  +  V T + DV+SFGV+  E+                  
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPGVK 241

Query: 667 PKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
                   L +            ++         C   +P  RPT   + + L
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHL 291

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  153 bits (387), Expect = 2e-42
 Identities = 66/284 (23%), Positives = 117/284 (41%), Gaps = 25/284 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
           E +H    IG G YG VYKA+   G+  ALKK+   E ED     +   E  +L  ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHS 60

Query: 510 NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
           NIVKLY     KK + L++E++++     +   +     L      + +  + + ++Y H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH 117

Query: 570 HDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-LAY 628
                 ++HRD+   N+L++   E  +ADFG AR   +     T    T  Y AP+ L  
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHP-------------GGLLSSLSSSSGPKIMLIDVL 675
           +   +   D++S G +  E++ GT                 +L + +S + P +  +   
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 676 NQRLSPPVNQKIVQDIILVSTIAF----ACLSSQPKSRPTMQRI 715
           +   +          +  +           L   P  R T ++ 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 1e-41
 Identities = 62/278 (22%), Positives = 106/278 (38%), Gaps = 26/278 (9%)

Query: 458 IGTGGYGSVYKAELPE-GKVVALKKLH--HSETEDSAFVKSFQNEAHVLSTVRHRNIVKL 514
           +G G + +VYKA      ++VA+KK+   H         ++   E  +L  + H NI+ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 515 YGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTL 574
                HK  + L++++ME           D ++ L  +     +      L YLH     
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTG 634
            I+HRD+  NN+LLD N    +ADFG A+     +   T +  T  Y APEL +   + G
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 635 -KCDVYSFGVVALEVLMGTHP--------------GGLLSSLSSSSGPKIMLIDVLNQRL 679
              D+++ G +  E+L+                    L +           L D +  + 
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 680 SPPVNQKIVQDIILVSTIAF--ACLSSQPKSRPTMQRI 715
            P +    +        +          P +R T  + 
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-41
 Identities = 62/285 (21%), Positives = 105/285 (36%), Gaps = 25/285 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           E+F     IG G YG VYKA     G+VVALKK+   +TE      +   E  +L  + H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
            NIVKL      +  ++L++E++ +        D      +      + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPE-LA 627
           H      ++HRD+   N+L+++     +ADFG AR   V     T    T  Y APE L 
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 628 YTIVVTGKCDVYSFGVVALEVLMGTHP-------------GGLLSSLSSSSGPKIMLIDV 674
                +   D++S G +  E++                     L +      P +  +  
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 675 LNQRLSPPVNQKIVQDIILVSTIAF----ACLSSQPKSRPTMQRI 715
                     Q   + +  +           L   P  R + +  
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 3e-40
 Identities = 61/295 (20%), Positives = 110/295 (37%), Gaps = 29/295 (9%)

Query: 445 LINATEDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
           + +    +     IG G YG V  A +      VA+KK+  S  E   + +    E  +L
Sbjct: 3   VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKIL 60

Query: 504 STVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
              RH NI+ +           +   Y+    +   L+   +   L+       +  +  
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL---RAGTYG 620
            L Y+H     +++HRD+  +N+LL++  +  + DFG AR+   D  +         T  
Sbjct: 121 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 621 YIAPELAYTIVVTG-KCDVYSFGVVALEVLMGTHP-------------GGLLSSLSSSSG 666
           Y APE+           D++S G +  E+L                   G+L S S    
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 667 PKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFA------CLSSQPKSRPTMQRI 715
             I+ +   N  LS P   K+  + +  +  + A       L+  P  R  +++ 
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (369), Expect = 8e-40
 Identities = 41/280 (14%), Positives = 91/280 (32%), Gaps = 27/280 (9%)

Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           + +   IG+G +G +Y    +  G+ VA+K                  E+ +   ++   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 63

Query: 511 IVKLYGFCLH-KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            +    +C        ++ E +             +    +    + +   +   + Y+H
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIH 120

Query: 570 HDCTLSIIHRDISSNNIL---LDSNLEASVADFGTARLLHVDSSY-------RTLRAGTY 619
                + IHRD+  +N L           + DFG A+      ++            GT 
Sbjct: 121 S---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRL 679
            Y +      I  + + D+ S G V +   +G+ P         ++  +     +  +++
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP----WQGLKAATKRQKYERISEKKM 233

Query: 680 SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQEL 719
           S P+           +T    C S +   +P    + Q  
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-39
 Identities = 64/273 (23%), Positives = 103/273 (37%), Gaps = 33/273 (12%)

Query: 451 DFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKS---FQNEAHVLSTV 506
            + +   +G+GG+GSVY    + +   VA+K +      D   + +      E  +L  V
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 507 R--HRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHA 564
                 +++L  +        LI E  E          +  A  L      +    V  A
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 122

Query: 565 LSYLHHDCTLSIIHRDISSNNILLDSN-LEASVADFGTARLLHVDSSYRTLRAGTYGYIA 623
           + + H+     ++HRDI   NIL+D N  E  + DFG+  LL    +  T   GT  Y  
Sbjct: 123 VRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSP 177

Query: 624 PE-LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP 682
           PE + Y         V+S G++  +++ G  P              I       QR+S  
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-------FEHDEEIIRGQVFFRQRVSSE 230

Query: 683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRI 715
                 Q +I        CL+ +P  RPT + I
Sbjct: 231 -----CQHLIR------WCLALRPSDRPTFEEI 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (365), Expect = 2e-39
 Identities = 54/286 (18%), Positives = 111/286 (38%), Gaps = 27/286 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           + +     IG G YG+V+KA+     ++VALK++   + +D     S   E  +L  ++H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
           +NIV+L+      K + L++E+ ++         +             +   +   L  L
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGL 114

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
               + +++HRD+   N+L++ N E  +A+FG AR   +     +    T  Y  P++ +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 629 TI-VVTGKCDVYSFGVVALEVLMGTHP--------------GGLLSSLSSSSGPKIMLID 673
              + +   D++S G +  E+     P                LL + +    P +  + 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 674 VLNQRLSPPVNQKIVQDIILVSTIAF----ACLSSQPKSRPTMQRI 715
                   P    +V  +  ++          L   P  R + +  
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 3e-39
 Identities = 64/279 (22%), Positives = 111/279 (39%), Gaps = 33/279 (11%)

Query: 450 EDFHI-KYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV- 506
           +D+ +    +G G  G V +       +  ALK L              + E  +     
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRAS 62

Query: 507 RHRNIVKLYGFC----LHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           +  +IV++          +KC+ ++ E ++ G LF  + D  +       +   I+KS+ 
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIG 121

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASV---ADFGTARLLHVDSSYRTLRAGTY 619
            A+ YLH    ++I HRD+   N+L  S    ++    DFG A+     +S  T    T 
Sbjct: 122 EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTP 177

Query: 620 GYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRL 679
            Y+APE+         CD++S GV+   +L G  P      L+ S G K   I +     
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-TRIRMGQYEF 236

Query: 680 SPPVNQKI---VQDIILVSTIAFACLSSQPKSRPTMQRI 715
             P   ++   V+ +I         L ++P  R T+   
Sbjct: 237 PNPEWSEVSEEVKMLIR------NLLKTEPTQRMTITEF 269

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 5e-39
 Identities = 58/278 (20%), Positives = 106/278 (38%), Gaps = 26/278 (9%)

Query: 451 DFHIKYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHR 509
            +     IG G +G VY+A+L + G++VA+KK+   +       +    E  ++  + H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHC 73

Query: 510 NIVKLYGFCLH------KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
           NIV+L  F         +  + L+ +Y+         H       L        +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEAS-VADFGTARLLHVDSSYRTLRAGTYGYI 622
           +L+Y+H      I HRDI   N+LLD +     + DFG+A+ L       +     Y   
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP 682
              +      T   DV+S G V  E+L+G                 +  +  + + L  P
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPI--------FPGDSGVDQLVEIIKVLGTP 242

Query: 683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL 720
             ++I +     +   F  + + P ++    R   E +
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 280

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 2e-38
 Identities = 71/285 (24%), Positives = 110/285 (38%), Gaps = 30/285 (10%)

Query: 450 EDFHIKYCIGTGGYGSVYKAELPE----GKVVALKKLHHSE-TEDSAFVKSFQNEAHVLS 504
           E+F +   +GTG YG V+          GK+ A+K L  +   + +   +  + E  VL 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 505 TVRHR-NIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAH 563
            +R    +V L+     +  + LI +Y+  G LF  L   +   E      V        
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137

Query: 564 ALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA-RLLHVDSSYRTLRAGTYGYI 622
            +  L H   L II+RDI   NILLDSN    + DFG +   +  ++       GT  Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 623 APE--LAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS 680
           AP+             D +S GV+  E+L G  P  +    +S        I     +  
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-----QAEISRRILKSE 252

Query: 681 PPVNQKI---VQDIILVSTIAFACLSSQPKSRPTMQRIS-QELLA 721
           PP  Q++    +D+I         L   PK R         E+  
Sbjct: 253 PPYPQEMSALAKDLIQ------RLLMKDPKKRLGCGPRDADEIKE 291

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (360), Expect = 5e-38
 Identities = 53/275 (19%), Positives = 99/275 (36%), Gaps = 25/275 (9%)

Query: 450 EDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           + F     +GTG +G V   +    G   A+K L   +      ++   NE  +L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 509 RNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYL 568
             +VKL         ++++ EY+  G +F  L         +          +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157

Query: 569 HHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAY 628
           H    L +I+RD+   N+L+D      V DFG A+             GT   +APE+  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAPEIIL 211

Query: 629 TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN-QKI 687
           +       D ++ GV+  E+  G  P         +  P  +   +++ ++  P +    
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP-------FFADQPIQIYEKIVSGKVRFPSHFSSD 264

Query: 688 VQDIILVSTIAFACLSSQPKSRPTMQRIS-QELLA 721
           ++D++         L      R    +    ++  
Sbjct: 265 LKDLLR------NLLQVDLTKRFGNLKNGVNDIKN 293

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-37
 Identities = 60/293 (20%), Positives = 113/293 (38%), Gaps = 32/293 (10%)

Query: 448 ATEDFHIKYCIGTGGYGSVYKAE--LPEGKVVALKKLHHSETEDSAFVKSFQNEAHV--- 502
           A + +     IG G YG V+KA      G+ VALK++   +T +     S   E  V   
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRH 63

Query: 503 LSTVRHRNIVKLYGFCL-----HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNI 557
           L T  H N+V+L+  C       +  + L++E++++        D      +      ++
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDM 121

Query: 558 VKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAG 617
           +  +   L +LH      ++HRD+   NIL+ S+ +  +ADFG AR+     +  +    
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVV 177

Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP----------GGLLSSLSSSSGP 667
           T  Y APE+          D++S G +  E+                G +L  +      
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 668 KIMLIDVLNQRLSPPVNQKIVQDIIL-VSTIAF----ACLSSQPKSRPTMQRI 715
                  L ++     + + ++  +  +  +       CL+  P  R +    
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  138 bits (348), Expect = 6e-37
 Identities = 43/300 (14%), Positives = 95/300 (31%), Gaps = 36/300 (12%)

Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           + +   IG G +G +++   L   + VA+K                ++E      +    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCT 61

Query: 511 -IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLH 569
            I  +Y F        L+ + +           D    + +        K +   +  +H
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 570 HDCTLSIIHRDISSNNILLDSNLEAS-----VADFGTARLL-------HVDSSYRTLRAG 617
                S+++RDI  +N L+      +     V DFG  +         H+    +   +G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 618 TYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ 677
           T  Y++         + + D+ + G V +  L G+ P         ++  K     +  +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP----WQGLKAATNKQKYERIGEK 231

Query: 678 RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEISISE 737
           + S P+ +                 +    + P    +            K L+ ++ +E
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF-------SKVLERLNTTE 284

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-36
 Identities = 62/305 (20%), Positives = 111/305 (36%), Gaps = 41/305 (13%)

Query: 445 LINATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVL 503
             +    +     IG G +G V+KA     G+ VALKK+   E E   F  +   E  +L
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKIL 63

Query: 504 STVRHRNIVKLYGFCL--------HKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV 555
             ++H N+V L   C          K  ++L++++ E      + +   +   L+  KRV
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV 122

Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS----Y 611
                +   L+ L++     I+HRD+ + N+L+  +    +ADFG AR   +  +     
Sbjct: 123 -----MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 612 RTLRAGTYGYIAPE-LAYTIVVTGKCDVYSFGVVALEVLMGTHP-------------GGL 657
            T R  T  Y  PE L          D++  G +  E+   +                 L
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 658 LSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFA-------CLSSQPKSRP 710
             S++    P +   ++  +       ++ V+D +                L   P  R 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 711 TMQRI 715
                
Sbjct: 298 DSDDA 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-32
 Identities = 46/219 (21%), Positives = 85/219 (38%), Gaps = 12/219 (5%)

Query: 442 YEDLINATEDFHIKY----CIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSF 496
            +++     +    Y     +G+G YG+V  A +   G  VA+KKL+    +   F K  
Sbjct: 6   RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRA 64

Query: 497 QNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDD-DEAIELNWTKRV 555
             E  +L  +RH N++ L       + +    ++               +  +L   +  
Sbjct: 65  YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 124

Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
            +V  +   L Y+H      IIHRD+   N+ ++ + E  + DFG AR    DS      
Sbjct: 125 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYV 179

Query: 616 AGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
              +      +   +  T   D++S G +  E++ G   
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (316), Expect = 2e-32
 Identities = 43/229 (18%), Positives = 87/229 (37%), Gaps = 25/229 (10%)

Query: 432 SVWNYDGKILYEDLINATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDS 490
             W+Y+    +       +D+ +   +G G Y  V++A  +   + V +K L   +    
Sbjct: 20  EYWDYE---SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---- 72

Query: 491 AFVKSFQNEAHVLSTVR-HRNIVKLYGFCLH--KKCMFLIYEYMERGSLFCVLHDDDEAI 547
              K  + E  +L  +R   NI+ L         +   L++E++       +        
Sbjct: 73  --KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------ 124

Query: 548 ELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-NLEASVADFGTARLLH 606
            L        +  +  AL Y H      I+HRD+  +N+++D  + +  + D+G A   H
Sbjct: 125 TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181

Query: 607 VDSSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHP 654
                  +R  +  +  PEL     +     D++S G +   ++    P
Sbjct: 182 -PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 2e-32
 Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 18/212 (8%)

Query: 450 EDFHIKYCIGTGGYGSVYKA-ELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH 508
           + +     IG+G  G V  A +    + VA+KKL     ++    K    E  ++  V H
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75

Query: 509 RNIVKLYGFCLHKKCM------FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVA 562
           +NI+ L      +K +      +L+ E M+      +  + D        +   ++  + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE------RMSYLLYQML 129

Query: 563 HALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLRAGTYGYI 622
             + +LH      IIHRD+  +NI++ S+    + DFG AR     S   T    T  Y 
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 185

Query: 623 APELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           APE+   +      D++S G +  E++     
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 8e-31
 Identities = 48/220 (21%), Positives = 85/220 (38%), Gaps = 16/220 (7%)

Query: 441 LYEDLINATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNE 499
           L + +    E +     +G+G YGSV  A     G  VA+KKL     +     K    E
Sbjct: 9   LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRE 67

Query: 500 AHVLSTVRHRNIVKLYGFC-----LHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKR 554
             +L  ++H N++ L         L +     +  ++    L  ++       +L     
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHV 123

Query: 555 VNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTL 614
             ++  +   L Y+H      IIHRD+  +N+ ++ + E  + DFG AR  H D      
Sbjct: 124 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY 178

Query: 615 RAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
            A  +      +   +      D++S G +  E+L G   
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  108 bits (270), Expect = 1e-26
 Identities = 56/260 (21%), Positives = 94/260 (36%), Gaps = 11/260 (4%)

Query: 101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
           P+   LDL NN ++        +L  L  L L  N ++ I P     L  L  L+L  N+
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 161 LSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNIS----SNQFHSSIPLEIGNFS 216
           L  +  +    L+ L         +   + + L ++  +       +             
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150

Query: 217 ALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKL 276
            L  + ++D  I  I          L  L+L  N ++     ++  L NL  L LS N +
Sbjct: 151 KLSYIRIADTNITTIPQG---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207

Query: 277 SGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMY 336
           S      + N   L+ L LN+N L   +P  +     +Q + L +NN+S        P  
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266

Query: 337 VDLSFNNLEGEIPTYLRGNP 356
            +    +  G     L  NP
Sbjct: 267 YNTKKASYSG---VSLFSNP 283

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.0 bits (131), Expect = 1e-08
 Identities = 40/229 (17%), Positives = 80/229 (34%), Gaps = 32/229 (13%)

Query: 52  WWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLN-FSCFPNLKSLDLWN 110
                +  + ++         +   ++  ++L  + +K        F     L  + + +
Sbjct: 100 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 159

Query: 111 NSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIG 170
            +++ +IP   G    L  L+L GN +T +    +  L NL  L L  N +S V    + 
Sbjct: 160 TNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 216

Query: 171 NLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHG 230
           N   L EL++ NN L                      +P  + +   +  + L +N I  
Sbjct: 217 NTPHLRELHLNNNKL--------------------VKVPGGLADHKYIQVVYLHNNNISA 256

Query: 231 IIPD------ELTKLSQLKNLNLSSNLLSGQ--IPYAIGKLFNLMYLDL 271
           I  +        TK +    ++L SN +      P     ++    + L
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 54.3 bits (129), Expect = 2e-08
 Identities = 27/152 (17%), Positives = 47/152 (30%), Gaps = 3/152 (1%)

Query: 218 LDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLS 277
           L  +  SD  +  + P +L        L+L +N ++         L NL  L L  NK+S
Sbjct: 12  LRVVQCSDLGLEKV-PKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68

Query: 278 GSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYV 337
              P        L+ L L+ N L          +  L+  +     +  ++   L  M V
Sbjct: 69  KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128

Query: 338 DLSFNNLEGEIPTYLRGNPPKSFVGNKGLSGN 369
                N                 +    ++  
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  105 bits (261), Expect = 6e-25
 Identities = 42/225 (18%), Positives = 85/225 (37%), Gaps = 33/225 (14%)

Query: 452 FHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN 510
           + +   +G G + +V+ A+ +     VA+K +      D  + ++ ++E  +L  V   +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR----GDKVYTEAAEDEIKLLQRVNDAD 70

Query: 511 IVKLYGFCLH---------------KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRV 555
             K      +                  + +++E +    L  +   +   I L + K+ 
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ- 129

Query: 556 NIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN------LEASVADFGTARLLHVDS 609
            I K +   L Y+H  C   IIH DI   N+L++        ++  +AD G A       
Sbjct: 130 -ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186

Query: 610 SYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHP 654
           +       T  Y +PE+          D++S   +  E++ G   
Sbjct: 187 TNSI---QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.7 bits (244), Expect = 2e-23
 Identities = 59/254 (23%), Positives = 86/254 (33%), Gaps = 8/254 (3%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSN 159
               + + L  N +S        +   L  L+LH N L  I       L  L  L L  N
Sbjct: 31  PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 160 KLSGVL-PQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN-----ISSNQFHSSIPLEIG 213
                + P     L  L  L++    L  L P     L       +  N   +       
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 214 NFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSK 273
           +   L  L L  N+I  +       L  L  L L  N ++   P+A   L  LM L L  
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 274 NKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLR 333
           N LS      +    AL+ L LN N               LQ    S + +  ++P+ L 
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLA 269

Query: 334 PMYV-DLSFNNLEG 346
              +  L+ N+L+G
Sbjct: 270 GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.1 bits (206), Expect = 2e-18
 Identities = 60/271 (22%), Positives = 103/271 (38%), Gaps = 17/271 (6%)

Query: 98  SCFPNLK-SLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
            C+   K +       L  ++P  I +    + ++LHGN ++ +      + RNL  L+L
Sbjct: 7   VCYNEPKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWL 63

Query: 157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLF------RLTNISSNQFHSSIPL 210
           +SN L+ +       L  L +L +++NA    +    F         ++         P 
Sbjct: 64  HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG 123

Query: 211 EIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLD 270
                +AL  L L DN +  +  D    L  L +L L  N +S     A   L +L  L 
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183

Query: 271 LSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPK 330
           L +N+++   P    +   L  L L  N+L       +  +  LQ L L+ N        
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR- 242

Query: 331 TLRPMY-----VDLSFNNLEGEIPTYLRGNP 356
             RP++        S + +   +P  L G  
Sbjct: 243 -ARPLWAWLQKFRGSSSEVPCSLPQRLAGRD 272

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.7 bits (205), Expect = 3e-18
 Identities = 48/244 (19%), Positives = 78/244 (31%), Gaps = 10/244 (4%)

Query: 40  SEIERQALLNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSC 99
           S +   +            H++                       N+ +   +    F  
Sbjct: 45  SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL-RSVDPATFHG 103

Query: 100 FPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSN 159
              L +L L    L    P     L+ L+ LYL  N L  +       L NL  LFL+ N
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163

Query: 160 KLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRL-----TNISSNQFHSSIPLEIGN 214
           ++S V  +    L SL  L +  N +  + P     L       + +N   +     +  
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223

Query: 215 FSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKN 274
             AL  L L+DN             + L+    SS+ +   +P    +L       L+ N
Sbjct: 224 LRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAAN 279

Query: 275 KLSG 278
            L G
Sbjct: 280 DLQG 283

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  100 bits (248), Expect = 3e-23
 Identities = 62/276 (22%), Positives = 98/276 (35%), Gaps = 37/276 (13%)

Query: 48  LNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLD 107
           ++       +                    +T ++ L+ +          +   NL+SL 
Sbjct: 144 ISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLI 203

Query: 108 LWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQ 167
             NN +S   P  I +   L  L L+GN L  I    + SL NL  L L +N++S + P 
Sbjct: 204 ATNNQISDITPLGILT--NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP- 258

Query: 168 EIGNLKSLTELYVTNNALGGLIPST-LFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDN 226
            +  L  LTEL +  N +  + P   L  LTN+  N+        I N   L  L L  N
Sbjct: 259 -LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317

Query: 227 KIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGN 286
            I  I P                          +  L  L  L  + NK+S    + + N
Sbjct: 318 NISDISP--------------------------VSSLTKLQRLFFANNKVSD--VSSLAN 349

Query: 287 CSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHN 322
            + +  L+  HN +    PL    +  +  L L+  
Sbjct: 350 LTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 74.3 bits (181), Expect = 1e-14
 Identities = 63/300 (21%), Positives = 105/300 (35%), Gaps = 33/300 (11%)

Query: 70  ITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKC 129
           ++     ++T +      IK   G        NL  ++  NN L+   P  + +L+KL  
Sbjct: 38  VSQTDLDQVTTLQADRLGIKSIDG---VEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 92

Query: 130 LYLHGNNLTGIIPKEIGSLRNLR--------------------GLFLYSNKLSGVLPQEI 169
           + ++ N +  I P    +                          L L SN +S +     
Sbjct: 93  ILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSG 152

Query: 170 GNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIH 229
                          L  L   T     +ISSN+        +   + L++L  ++N+I 
Sbjct: 153 LTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQIS 210

Query: 230 GIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSA 289
            I P  +   + L  L+L+ N L       +  L NL  LDL+ N++S   P  +   + 
Sbjct: 211 DITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTK 264

Query: 290 LKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYVDLSFNNLEGEIP 349
           L  L L  N +    PL     L    L+ +       I       Y+ L FNN+    P
Sbjct: 265 LTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 324

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 72.0 bits (175), Expect = 6e-14
 Identities = 25/89 (28%), Positives = 45/89 (50%), Gaps = 6/89 (6%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
             S   NL  L L+ N++S   P  + SL+KL+ L+   N ++      + +L N+  L 
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNA 184
              N++S + P  + NL  +T+L + + A
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQA 384

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.4 bits (226), Expect = 1e-21
 Identities = 26/165 (15%), Positives = 52/165 (31%), Gaps = 17/165 (10%)

Query: 458 IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFV-------KSFQNEAHVLSTVRHRN 510
           +G G   +V+     +     +K      T               F   A   +    R 
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 511 IVKLYGFCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH 570
           + KL G  + K   +      E  ++   L D  E   +       ++  +   ++  +H
Sbjct: 68  LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSYRTLR 615
                I+H D+S  N+L+       + DF  +  +  +     L 
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILE 162

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 91.0 bits (224), Expect = 2e-20
 Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 37/316 (11%)

Query: 40  SEIERQALLN-----------SGWWKDRIPHNSSDHCN--WVGITCDYEG---RITDIDL 83
           +  ++QALL            S W        ++D CN  W+G+ CD +    R+ ++DL
Sbjct: 4   NPQDKQALLQIKKDLGNPTTLSSWL------PTTDCCNRTWLGVLCDTDTQTYRVNNLDL 57

Query: 84  LNSNIKGELGRLNFSCFPNLKSLDLW----NNSLSGSIPPQIGSLSKLKCLYLHGNNLTG 139
              N+         S   NL  L+       N+L G IPP I  L++L  LY+   N++G
Sbjct: 58  SGLNLPKPYP--IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115

Query: 140 IIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPST------L 193
            IP  +  ++ L  L    N LSG LP  I +L +L  +    N + G IP +      L
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175

Query: 194 FRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLS 253
           F    IS N+    IP    N +        +           +  +  K     ++L  
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235

Query: 254 GQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILL 313
                 + K  N +  DL  N++ G++P  +     L +L ++ N+L G IP + G +  
Sbjct: 236 DLGKVGLSKNLNGL--DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQR 292

Query: 314 LQNLDLSHNNLSGTIP 329
                 ++N      P
Sbjct: 293 FDVSAYANNKCLCGSP 308

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.7 bits (169), Expect = 1e-13
 Identities = 43/209 (20%), Positives = 74/209 (35%), Gaps = 10/209 (4%)

Query: 97  FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
            S   +   ++    +L+ ++PP +        L+L  N L       +     L  L L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 157 YSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSI----PLEI 212
              +      Q  G L  L  L +++N L  L             +   + +       +
Sbjct: 63  DRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 213 GNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLS 272
                L  L L  N++  + P  LT   +L+ L+L++N L+      +  L NL  L L 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180

Query: 273 KNKLSGSIPTEIGNCSALKNLTLNHNSLD 301
           +N L  +IP        L    L+ N   
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.3 bits (142), Expect = 3e-10
 Identities = 37/210 (17%), Positives = 59/210 (28%), Gaps = 11/210 (5%)

Query: 71  TCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCL 130
                    +++    N+      L      +   L L  N L       +   ++L  L
Sbjct: 5   EVSKVASHLEVNCDKRNLT----ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 131 YLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALG---- 186
            L    LT +       L  L  L L  N+L  +                 N        
Sbjct: 61  NLDRAELTKLQVDGT--LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 187 GLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLN 246
            L      +   +  N+  +  P  +     L+ L L++N +  +    L  L  L  L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 247 LSSNLLSGQIPYAIGKLFNLMYLDLSKNKL 276
           L  N L   IP        L +  L  N  
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.7 bits (104), Expect = 2e-05
 Identities = 43/229 (18%), Positives = 74/229 (32%), Gaps = 30/229 (13%)

Query: 120 QIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELY 179
           ++  ++    +     NLT + P ++   ++   L L  N L       +     LT+L 
Sbjct: 5   EVSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 180 VTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKL 239
           +               L  + +                        +     +P     L
Sbjct: 62  LDRA--ELTKLQVDGTLPVLGTLDLS--------------------HNQLQSLPLLGQTL 99

Query: 240 SQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNS 299
             L  L++S N L+     A+  L  L  L L  N+L    P  +     L+ L+L +N+
Sbjct: 100 PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159

Query: 300 LDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNL 344
           L       +  +  L  L L  N+L  TIPK         +  L  N  
Sbjct: 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 7e-05
 Identities = 27/134 (20%), Positives = 41/134 (30%), Gaps = 1/134 (0%)

Query: 52  WWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNN 111
                   + S +                +  ++ N    L          L+ L L  N
Sbjct: 75  TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134

Query: 112 SLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGN 171
            L    P  +    KL+ L L  NNLT +    +  L NL  L L  N L   +P+    
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193

Query: 172 LKSLTELYVTNNAL 185
              L   ++  N  
Sbjct: 194 SHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (97), Expect = 1e-04
 Identities = 36/194 (18%), Positives = 65/194 (33%), Gaps = 31/194 (15%)

Query: 201 SNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
             +  +++P ++        L LS+N ++      L   ++L  LNL    L+       
Sbjct: 18  DKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGT 75

Query: 261 GKLFNLMYLDLSKN---------------------KLSGSIPTEIGNCSALKNLTLNHNS 299
             +   + L  ++                      +L+      +     L+ L L  N 
Sbjct: 76  LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135

Query: 300 LDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM----YVDLSFNNLEGEIPTYLRGN 355
           L    P  +     L+ L L++NNL+      L  +     + L  N+L   IP    G+
Sbjct: 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGS 194

Query: 356 PPKSFVGNKGLSGN 369
               F     L GN
Sbjct: 195 HLLPFA---FLHGN 205

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.2 bits (152), Expect = 2e-11
 Identities = 40/271 (14%), Positives = 93/271 (34%), Gaps = 24/271 (8%)

Query: 79  TDIDLLNSNIKGE-LGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
             +DL   N+  +  GRL       + +     + +   +  +  S  +++ + L  + +
Sbjct: 3   QTLDLTGKNLHPDVTGRL---LSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVI 58

Query: 138 TGI-IPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNA------------ 184
               +   +     L+ L L   +LS  +   +    +L  L ++  +            
Sbjct: 59  EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118

Query: 185 -LGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLK 243
               L    L    + +      ++       + L+      N     +   + +   L 
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178

Query: 244 NLNLSSNLL-SGQIPYAIGKLFNLMYLDLSK-NKLSGSIPTEIGNCSALKNLTLNHNSLD 301
           +L+LS +++          +L  L +L LS+   +      E+G    LK L +     D
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238

Query: 302 GTIPLEMGKILLLQNLDLSHNNLSGTIPKTL 332
           GT+ L       L +L ++ ++ +     T+
Sbjct: 239 GTLQLLKEA---LPHLQINCSHFTTIARPTI 266

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.0 bits (123), Expect = 9e-08
 Identities = 43/226 (19%), Positives = 69/226 (30%), Gaps = 18/226 (7%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN 136
           R+  +DL NS I+        S    L++L L    LS  I   +   S L  L L G +
Sbjct: 47  RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 106

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPS----- 191
                  +       R   L  +       + +    +     +T   L G   +     
Sbjct: 107 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 166

Query: 192 ---------TLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSD-NKIHGIIPDELTKLSQ 241
                     L  L    S    +    E    + L  L LS    I      EL ++  
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226

Query: 242 LKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNC 287
           LK L +   +  G +      L +   L ++ +  +      IGN 
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNK 269

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.9 bits (89), Expect = 0.001
 Identities = 15/93 (16%), Positives = 33/93 (35%), Gaps = 7/93 (7%)

Query: 269 LDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTI 328
           LDL+   L   +   + +   +       + +D  +  E      +Q++DLS++ +  + 
Sbjct: 5   LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVST 62

Query: 329 PKTL-----RPMYVDLSFNNLEGEIPTYLRGNP 356
              +     +   + L    L   I   L  N 
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.003
 Identities = 16/101 (15%), Positives = 32/101 (31%), Gaps = 3/101 (2%)

Query: 52  WWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNN 111
                   +S    N           +  + L           L     P LK+L ++  
Sbjct: 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235

Query: 112 SLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLR 152
              G++     +L  L+   ++ ++ T I    IG+ +N  
Sbjct: 236 VPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQE 273

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 59.8 bits (143), Expect = 4e-10
 Identities = 24/124 (19%), Positives = 41/124 (33%), Gaps = 9/124 (7%)

Query: 52  WWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNN 111
           +  D      S     V             +L   N      R      P+L+ L++ NN
Sbjct: 235 YLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNN 294

Query: 112 SLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGN 171
            L   +P       +L+ L    N+L  +        +NL+ L +  N L    P    +
Sbjct: 295 KLI-ELPA---LPPRLERLIASFNHLAEVPE----LPQNLKQLHVEYNPLRE-FPDIPES 345

Query: 172 LKSL 175
           ++ L
Sbjct: 346 VEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 55.2 bits (131), Expect = 1e-08
 Identities = 24/100 (24%), Positives = 39/100 (39%), Gaps = 14/100 (14%)

Query: 246 NLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIP 305
               N  S +I        +L  L++S NKL   +P        L+ L  + N L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AEVP 320

Query: 306 LEMGKILLLQNLDLSHNNLSG--TIPKTLRPMYVDLSFNN 343
                   L+ L + +N L     IP+++     DL  N+
Sbjct: 321 ELPQN---LKQLHVEYNPLREFPDIPESVE----DLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.7 bits (122), Expect = 2e-07
 Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 12/95 (12%)

Query: 202 NQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIG 261
           N   + I        +L+ L++S+NK+   +P    +   L+ L  S N L+ ++P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPELPQ 324

Query: 262 KLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLN 296
              NL  L +  N L    P    +   +++L +N
Sbjct: 325 ---NLKQLHVEYNPLR-EFPDIPES---VEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.6 bits (119), Expect = 3e-07
 Identities = 28/158 (17%), Positives = 48/158 (30%), Gaps = 9/158 (5%)

Query: 45  QALLNSGWWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLK 104
             L       + +        +   +           +L  S    ++    FS    L 
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263

Query: 105 SLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGV 164
               + N+ S  I         L+ L +  N L   +P     L  L       N L+  
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLAE- 318

Query: 165 LPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSN 202
           +P+   NLK   +L+V  N L    P     + ++  N
Sbjct: 319 VPELPQNLK---QLHVEYNPLREF-PDIPESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 23/98 (23%), Positives = 37/98 (37%), Gaps = 12/98 (12%)

Query: 223 LSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPT 282
              N     I         L+ LN+S+N L  ++P        L  L  S N L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321

Query: 283 EIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLS 320
              N   LK L + +N L    P        +++L ++
Sbjct: 322 LPQN---LKQLHVEYNPLR-EFPDIPES---VEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 8/67 (11%)

Query: 240 SQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNS 299
            Q   L L++  LS  +P       +L  L  S N L+  +P    +   LK+L +++N+
Sbjct: 38  RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQS---LKSLLVDNNN 89

Query: 300 LDGTIPL 306
           L     L
Sbjct: 90  LKALSDL 96

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.4 bits (130), Expect = 3e-09
 Identities = 30/136 (22%), Positives = 51/136 (37%), Gaps = 6/136 (4%)

Query: 196 LTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQ 255
           L  +   Q    + L +          L    +      +L   +    LN  S++ +  
Sbjct: 1   LNELKPEQV-EQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-T 56

Query: 256 IPYAIGKLFNLMYLDLSKNKLSG--SIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILL 313
           +      +  L+ L+LS N+L     + + +     LK L L+ N L     L+  K L 
Sbjct: 57  LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116

Query: 314 LQNLDLSHNNLSGTIP 329
           L+ L L  N+LS T  
Sbjct: 117 LEELWLDGNSLSDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.2 bits (106), Expect = 4e-06
 Identities = 33/152 (21%), Positives = 60/152 (39%), Gaps = 7/152 (4%)

Query: 156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALG---GLIPSTLFRLTNISSNQFHSSIPLEI 212
           L   ++   L   +      ++  +    L     L+   +  + N  S+   + + +  
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAAT-LRIIE 61

Query: 213 GNFSALDTLDLSDNKIHGI--IPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLD 270
            N   L +L+LS+N+++ +  +   + K   LK LNLS N L  +      K   L  L 
Sbjct: 62  ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELW 121

Query: 271 LSKNKLSGSIPTEIGNCSALKNLTLNHNSLDG 302
           L  N LS +   +    SA++        LDG
Sbjct: 122 LDGNSLSDTFRDQSTYISAIRERFPKLLRLDG 153

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 3e-04
 Identities = 25/101 (24%), Positives = 37/101 (36%), Gaps = 2/101 (1%)

Query: 80  DIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSG--SIPPQIGSLSKLKCLYLHGNNL 137
           D+ L   +      R+     P L SL+L NN L     +   +     LK L L GN L
Sbjct: 44  DVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNEL 103

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTEL 178
                 +      L  L+L  N LS     +   + ++ E 
Sbjct: 104 KSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 53.2 bits (127), Expect = 4e-09
 Identities = 27/108 (25%), Positives = 44/108 (40%), Gaps = 6/108 (5%)

Query: 220 TLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGS 279
            L L+   +  +    L +L  + +L+LS N L    P A+  L  L  L  S N     
Sbjct: 2   VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LE 56

Query: 280 IPTEIGNCSALKNLTLNHNSLDGTIPLE-MGKILLLQNLDLSHNNLSG 326
               + N   L+ L L +N L  +  ++ +     L  L+L  N+L  
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.4 bits (112), Expect = 4e-07
 Identities = 26/143 (18%), Positives = 44/143 (30%), Gaps = 23/143 (16%)

Query: 104 KSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSG 163
           + L L +  L+  +   +  L  +  L L  N L  + P  + +LR L  L    N L  
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57

Query: 164 VLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDL 223
           V            EL + NN L                          + +   L  L+L
Sbjct: 58  VDGVANLPRL--QELLLCNNRLQQSAA------------------IQPLVSCPRLVLLNL 97

Query: 224 SDNKIHGIIPDELTKLSQLKNLN 246
             N +      +      L +++
Sbjct: 98  QGNSLCQEEGIQERLAEMLPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.9 bits (103), Expect = 7e-06
 Identities = 24/145 (16%), Positives = 45/145 (31%), Gaps = 27/145 (18%)

Query: 152 RGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPS--TLFRLTNISSNQFHSSIP 209
           R L L    L+      +  L  +T L +++N L  L P+   L  L  + ++       
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58

Query: 210 LEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYL 269
             + N   L  L L +N++                               +     L+ L
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAA-----------------------IQPLVSCPRLVLL 95

Query: 270 DLSKNKLSGSIPTEIGNCSALKNLT 294
           +L  N L      +      L +++
Sbjct: 96  NLQGNSLCQEEGIQERLAEMLPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 2e-05
 Identities = 25/110 (22%), Positives = 46/110 (41%), Gaps = 10/110 (9%)

Query: 243 KNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDG 302
           + L+L+   L+  +   + +L  + +LDLS N+L    P  +     L+ L  + N    
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--AL 55

Query: 303 TIPLEMGKILLLQNLDLSHNNLSGT-IPKTLRPM----YVDLSFNNLEGE 347
                +  +  LQ L L +N L  +   + L        ++L  N+L  E
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.5 bits (94), Expect = 9e-05
 Identities = 26/110 (23%), Positives = 44/110 (40%), Gaps = 7/110 (6%)

Query: 96  NFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF 155
           +      +  LDL +N L   +PP + +L  L+ L    N L  +          L+ L 
Sbjct: 15  HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVDGVANL--PRLQELL 71

Query: 156 LYSNKLSGV-LPQEIGNLKSLTELYVTNNAL---GGLIPSTLFRLTNISS 201
           L +N+L      Q + +   L  L +  N+L    G+       L ++SS
Sbjct: 72  LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 121

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.1 bits (133), Expect = 9e-09
 Identities = 16/90 (17%), Positives = 31/90 (34%), Gaps = 5/90 (5%)

Query: 218 LDTLDLSDNKI-HGIIPDELTKLSQLKNLNLSSNLLSGQ----IPYAIGKLFNLMYLDLS 272
           + +LD+   ++      + L  L Q + + L    L+      I  A+     L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 273 KNKLSGSIPTEIGNCSALKNLTLNHNSLDG 302
            N+L       +       +  +   SL  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.1 bits (120), Expect = 3e-07
 Identities = 19/76 (25%), Positives = 32/76 (42%), Gaps = 5/76 (6%)

Query: 102 NLKSLDLWNNSLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGS----LRNLRGLFL 156
           +++SLD+    LS +   ++   L + + + L    LT    K+I S       L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 157 YSNKLSGVLPQEIGNL 172
            SN+L  V    +   
Sbjct: 63  RSNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 4e-07
 Identities = 15/90 (16%), Positives = 31/90 (34%), Gaps = 5/90 (5%)

Query: 242 LKNLNLSSNLLS-GQIPYAIGKLFNLMYLDLSKNKLSG----SIPTEIGNCSALKNLTLN 296
           +++L++    LS  +    +  L     + L    L+      I + +    AL  L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 297 HNSLDGTIPLEMGKILLLQNLDLSHNNLSG 326
            N L       + + L   +  +   +L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 4e-07
 Identities = 19/95 (20%), Positives = 32/95 (33%), Gaps = 15/95 (15%)

Query: 240 SQLKNLNLSSNLLSGQ----IPYAIGKLFNLMYLDLSKNKLSGSIPTEIG-----NCSAL 290
           S L+ L L+   +S      +   +    +L  LDLS N L  +   ++          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 291 KNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLS 325
           + L L        +         LQ L+    +L 
Sbjct: 429 EQLVLYDIYWSEEME------DRLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 6e-07
 Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 9/78 (11%)

Query: 265 NLMYLDLSKNKLSG----SIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKIL-----LLQ 315
            L  L L+   +S     S+   +    +L+ L L++N L     L++ + +     LL+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 316 NLDLSHNNLSGTIPKTLR 333
            L L     S  +   L+
Sbjct: 430 QLVLYDIYWSEEMEDRLQ 447

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 8e-07
 Identities = 20/97 (20%), Positives = 31/97 (31%), Gaps = 15/97 (15%)

Query: 214 NFSALDTLDLSDNKIHGI----IPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLF----- 264
             S L  L L+D  +       +   L     L+ L+LS+N L       + +       
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 265 NLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLD 301
            L  L L     S  +         L+ L  +  SL 
Sbjct: 427 LLEQLVLYDIYWSEEME------DRLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 4e-06
 Identities = 20/131 (15%), Positives = 36/131 (27%), Gaps = 9/131 (6%)

Query: 52  WWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNN 111
                     S   + +             + L      EL +        L+ L L + 
Sbjct: 320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 379

Query: 112 SLSG----SIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGS-----LRNLRGLFLYSNKLS 162
            +S     S+   + +   L+ L L  N L      ++          L  L LY    S
Sbjct: 380 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439

Query: 163 GVLPQEIGNLK 173
             +   +  L+
Sbjct: 440 EEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 4e-06
 Identities = 13/73 (17%), Positives = 26/73 (35%), Gaps = 5/73 (6%)

Query: 265 NLMYLDLSKNKLSGSIPTEI-GNCSALKNLTLNHNSLDGTIPLEMGKILL----LQNLDL 319
           ++  LD+   +LS +   E+       + + L+   L      ++   L     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 320 SHNNLSGTIPKTL 332
             N L       +
Sbjct: 63  RSNELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 8e-06
 Identities = 11/90 (12%), Positives = 22/90 (24%), Gaps = 4/90 (4%)

Query: 78  ITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSG----SIPPQIGSLSKLKCLYLH 133
           I  +D+    +               + + L +  L+      I   +     L  L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 134 GNNLTGIIPKEIGSLRNLRGLFLYSNKLSG 163
            N L  +    +          +    L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 4e-05
 Identities = 12/110 (10%), Positives = 33/110 (30%), Gaps = 16/110 (14%)

Query: 150 NLRGLFLYSNKLSGV-LPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSI 208
           +++ L +   +LS     + +  L+    + + +  L       +               
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------ 50

Query: 209 PLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPY 258
              +    AL  L+L  N++  +    + +  Q  +  +    L      
Sbjct: 51  ---LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 6e-05
 Identities = 23/99 (23%), Positives = 31/99 (31%), Gaps = 18/99 (18%)

Query: 150 NLRGLFLYSNKLSGV----LPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFH 205
            LR L+L    +S      L   +    SL EL ++NN LG      L            
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR------- 422

Query: 206 SSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKN 244
                       L+ L L D      + D L  L + K 
Sbjct: 423 -------QPGCLLEQLVLYDIYWSEEMEDRLQALEKDKP 454

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 8e-04
 Identities = 14/75 (18%), Positives = 27/75 (36%), Gaps = 9/75 (12%)

Query: 198 NISSNQFH----SSIPLEIGNFSALDTLDLSDNKIHGIIPDELTK-----LSQLKNLNLS 248
            ++         SS+   +    +L  LDLS+N +      +L +        L+ L L 
Sbjct: 375 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLY 434

Query: 249 SNLLSGQIPYAIGKL 263
               S ++   +  L
Sbjct: 435 DIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.001
 Identities = 17/81 (20%), Positives = 26/81 (32%), Gaps = 13/81 (16%)

Query: 286 NCSALKNLTLNHNSLDGTIPLEMGKILL----LQNLDLSHNNLSGTIPKTLRPM------ 335
             S L+ L L    +  +    +   LL    L+ LDLS+N L       L         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 336 ---YVDLSFNNLEGEIPTYLR 353
               + L       E+   L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQ 447

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.5 bits (127), Expect = 1e-08
 Identities = 37/222 (16%), Positives = 71/222 (31%), Gaps = 13/222 (5%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSN 159
             N   +    ++++ ++      L  +  L   G  +T I  + +  L NL GL L  N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73

Query: 160 KLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALD 219
           ++      ++  LK+LT++     +   L   +             +S  +      A  
Sbjct: 74  QI-----TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128

Query: 220 TLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGS 279
           +           I +            LS           +  L  L  L    NK+S  
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188

Query: 280 IPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSH 321
            P  + +   L  + L +N +    PL       L  + L++
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 1e-06
 Identities = 39/220 (17%), Positives = 71/220 (32%), Gaps = 17/220 (7%)

Query: 84  LNSNIKGELGRLN------FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNL 137
           L + IK   G+ N       +    + +L  +   ++ +I   +  L+ L  L L  N +
Sbjct: 18  LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQI 75

Query: 138 TGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLT 197
           T + P +     NL  +       + +            +     +     +        
Sbjct: 76  TDLAPLK-----NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 198 NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP 257
                   + I          +   LS           L  LS+L  L    N +S   P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190

Query: 258 YAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNH 297
             +  L NL+ + L  N++S   P  + N S L  +TL +
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 1e-06
 Identities = 37/207 (17%), Positives = 64/207 (30%), Gaps = 11/207 (5%)

Query: 123 SLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTN 182
           +L+    +    +N+T  + +    L  +  L  +   ++ +  + +  L +L  L + +
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 183 NALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQL 242
           N +  L P              +                 L            L  LS L
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 243 KNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDG 302
           + L L  N    QI              LS      S  T + N S L  L  + N +  
Sbjct: 132 QVLYLDLN----QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 303 TIPLEMGKILLLQNLDLSHNNLSGTIP 329
             PL    +  L  + L +N +S   P
Sbjct: 188 ISPL--ASLPNLIEVHLKNNQISDVSP 212

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.6 bits (109), Expect = 3e-06
 Identities = 16/105 (15%), Positives = 33/105 (31%), Gaps = 4/105 (3%)

Query: 52  WWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNN 111
                                     +T++  L+            +    L +L   +N
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 112 SLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL 156
            +S   P  + SL  L  ++L  N ++ + P  + +  NL  + L
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.0 bits (118), Expect = 2e-07
 Identities = 36/173 (20%), Positives = 54/173 (31%), Gaps = 10/173 (5%)

Query: 77  RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN 136
            I  I   NS+IK   G       PN+  L L  N L+   P     L+ LK L     +
Sbjct: 47  SIDQIIANNSDIKSVQG---IQYLPNVTKLFLNGNKLTDIKP-----LANLKNLGWLFLD 98

Query: 137 LTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRL 196
              +                  +     +   +   +  +     N      + S L +L
Sbjct: 99  ENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKL 158

Query: 197 TNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSS 249
             +S      S  + +   + L  L LS N I  +    L  L  L  L L S
Sbjct: 159 DTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 3e-04
 Identities = 13/78 (16%), Positives = 30/78 (38%), Gaps = 10/78 (12%)

Query: 207 SIPLEIG------NFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI 260
           ++P  I        F+     +L    +   +     +L+ +  +  +++ +       I
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGI 64

Query: 261 GKLFNLMYLDLSKNKLSG 278
             L N+  L L+ NKL+ 
Sbjct: 65  QYLPNVTKLFLNGNKLTD 82

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 12/87 (13%), Positives = 35/87 (40%), Gaps = 12/87 (13%)

Query: 246 NLSSNLLSGQIPYAIGKLF------NLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNS 299
            L S  ++  +P  I ++F        +  +L K  ++ ++       +++  +  N++ 
Sbjct: 2   PLGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSD 57

Query: 300 LDGTIPLEMGKILLLQNLDLSHNNLSG 326
           +     ++      +  L L+ N L+ 
Sbjct: 58  IKSVQGIQYLP--NVTKLFLNGNKLTD 82

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 24/107 (22%), Positives = 44/107 (41%), Gaps = 4/107 (3%)

Query: 52  WWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNN 111
             KD     S    +      +    +  ++ L             S    L +L L +N
Sbjct: 107 SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDN 166

Query: 112 SLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
            +S  +P  +  L+KL+ LYL  N+++ +  + +  L+NL  L L+S
Sbjct: 167 QISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 45.6 bits (106), Expect = 5e-06
 Identities = 37/175 (21%), Positives = 62/175 (35%), Gaps = 5/175 (2%)

Query: 174 SLTELYVTNNALGGL---IPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHG 230
             T +  T   L  +   IP     L    +     S     G    L  L+L  N++ G
Sbjct: 9   EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68

Query: 231 IIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSAL 290
           I P+     S ++ L L  N +          L  L  L+L  N++S  +P    + ++L
Sbjct: 69  IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128

Query: 291 KNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPMYV-DLSFNNL 344
            +L L  N  +    L       L+   L+        P  +R + + DL  +  
Sbjct: 129 TSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.0 bits (89), Expect = 7e-04
 Identities = 20/103 (19%), Positives = 39/103 (37%), Gaps = 3/103 (2%)

Query: 109 WNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQE 168
             N +          L +LK L L+ N ++ ++P     L +L  L L SN  +      
Sbjct: 86  GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL- 144

Query: 169 IGNLKSLTELYVTNNALGGLIPSTL--FRLTNISSNQFHSSIP 209
               + L +  +   A     PS +   ++ ++  ++F  S  
Sbjct: 145 AWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSE 187

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.8 bits (109), Expect = 6e-06
 Identities = 17/110 (15%), Positives = 33/110 (30%), Gaps = 7/110 (6%)

Query: 52  WWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNN 111
                   +S+            E  + D  L        +   +      L++L L  N
Sbjct: 224 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 283

Query: 112 SLSGSIPPQIGS-----LSKLKCLYLHGNNLT--GIIPKEIGSLRNLRGL 154
            +       + +     +  L  L L+GN  +    +  EI  + + RG 
Sbjct: 284 EIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGR 333

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 15/69 (21%), Positives = 22/69 (31%), Gaps = 7/69 (10%)

Query: 209 PLEIGNFSALDTLDLSDNKIHGIIPDEL-----TKLSQLKNLNLSSNLLS--GQIPYAIG 261
                    L TL L  N+I       L      K+  L  L L+ N  S    +   I 
Sbjct: 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIR 325

Query: 262 KLFNLMYLD 270
           ++F+     
Sbjct: 326 EVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 13/86 (15%)

Query: 246 NLSSNLLSGQIPYAIGKLF------NLMYLDLSKNKLSGSIPTEI-----GNCSALKNLT 294
            L+  LLS +   A+   F       L  L L  N++       +          L  L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 295 LNHNSL--DGTIPLEMGKILLLQNLD 318
           LN N    +  +  E+ ++   +   
Sbjct: 309 LNGNRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 16/92 (17%), Positives = 33/92 (35%), Gaps = 17/92 (18%)

Query: 223 LSDNKIHGIIPDEL------TKLSQLKNLNLSSNLLSGQIPYAI-----GKLFNLMYLDL 271
           L+D  +       +       +   L+ L L  N +       +      K+ +L++L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 272 SKNKLSGSIPTEIGNCSALKNL--TLNHNSLD 301
           + N+ S     E      ++ +  T     LD
Sbjct: 310 NGNRFSE----EDDVVDEIREVFSTRGRGELD 337

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.003
 Identities = 13/81 (16%), Positives = 29/81 (35%), Gaps = 8/81 (9%)

Query: 195 RLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHG----IIPDELTKLSQLKNLNLSSN 250
           +L  I++     S+   +    ++  + LS N I       + + +     L+    S  
Sbjct: 11  KLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69

Query: 251 ---LLSGQIPYAIGKLFNLMY 268
               +  +IP A+  L   + 
Sbjct: 70  FTGRVKDEIPEALRLLLQALL 90

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (105), Expect = 1e-05
 Identities = 29/245 (11%), Positives = 60/245 (24%), Gaps = 24/245 (9%)

Query: 64  HCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGS 123
           HC+     C                   +  +      N   L      L          
Sbjct: 7   HCSNRVFLCQESK---------------VTEIPSDLPRNAIELRFVLTKLRVIQKGAFSG 51

Query: 124 LSKLKCLYLHGNNLTGIIPKEIG---------SLRNLRGLFLYSNKLSGVLPQEIGNLKS 174
              L+ + +  N++  +I  ++           +     L   + +    LP     L S
Sbjct: 52  FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 111

Query: 175 LTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPD 234
            T +    +         +      + N         +G       L L+ N I  I   
Sbjct: 112 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNC 171

Query: 235 ELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLT 294
                   +     +N L              + LD+S+ ++       + N   L+  +
Sbjct: 172 AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 231

Query: 295 LNHNS 299
             +  
Sbjct: 232 TYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (91), Expect = 5e-04
 Identities = 14/110 (12%), Positives = 34/110 (30%), Gaps = 1/110 (0%)

Query: 52  WWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNN 111
             K  +    + + + +            + L  +    +           L  L+L +N
Sbjct: 127 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDN 186

Query: 112 SLSGSIPPQI-GSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNK 160
           +    +P  +    S    L +    +  +    + +L+ LR    Y+ K
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 11/65 (16%), Positives = 20/65 (30%), Gaps = 3/65 (4%)

Query: 218 LDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLS 277
            +     +N +  +  D     S    L++S   +     Y +  L  L        K  
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK-- 236

Query: 278 GSIPT 282
             +PT
Sbjct: 237 -KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.003
 Identities = 26/240 (10%), Positives = 55/240 (22%), Gaps = 15/240 (6%)

Query: 99  CFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYS 158
           C  + +      + ++  IP  +        L      L  I         +L  + +  
Sbjct: 6   CHCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 62

Query: 159 NKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIG----- 213
           N +  V+  ++ +            A   L  +        +      S           
Sbjct: 63  NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH 122

Query: 214 ----NFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYL 269
                   L  +  + N         +    +   L L+ N +      A          
Sbjct: 123 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182

Query: 270 DLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIP 329
               N L           S    L ++   +       +  +  L+       NL   +P
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.9 bits (99), Expect = 2e-05
 Identities = 27/151 (17%), Positives = 48/151 (31%), Gaps = 7/151 (4%)

Query: 99  CFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNN-LTGIIPKEIGSLRNLRGLFLY 157
           C      L    +         +     L  LY+     L  +  +++  L  LR L + 
Sbjct: 6   CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 158 SNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTL----FRLTNISSNQFHSSIPLE-I 212
            + L  V P        L+ L ++ NAL  L   T+     +   +S N  H S  L  +
Sbjct: 65  KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124

Query: 213 GNFSALDTLDLSDNKIHGIIPDELTKLSQLK 243
             +       + + K+       L  +    
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 4e-05
 Identities = 35/194 (18%), Positives = 72/194 (37%), Gaps = 11/194 (5%)

Query: 100 FPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSN 159
                   L   +++ ++      L ++  L      +  I    +  L NL  +   +N
Sbjct: 17  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72

Query: 160 KLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALD 219
           +L+      + NL  L ++ + NN +  + P          +   +          +  +
Sbjct: 73  QLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD-IDPLKNLTN 129

Query: 220 TLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGS 279
              L  +         L+ L+ L+ LN SSN ++   P  +  L  L  LD+S NK+S  
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD- 186

Query: 280 IPTEIGNCSALKNL 293
             + +   + L++L
Sbjct: 187 -ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.0 bits (84), Expect = 0.004
 Identities = 18/103 (17%), Positives = 38/103 (36%), Gaps = 4/103 (3%)

Query: 52  WWKDRIPHNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNN 111
              +          N      D    +T+++ L  +          S   +L+ L+  +N
Sbjct: 101 PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSN 160

Query: 112 SLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGL 154
            ++   P  + +L+ L+ L +  N ++ I    +  L NL  L
Sbjct: 161 QVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (94), Expect = 1e-04
 Identities = 25/141 (17%), Positives = 44/141 (31%), Gaps = 12/141 (8%)

Query: 94  RLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRG 153
              ++     + LDL    +   I     +L +   +    N +  +       LR L+ 
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKT 67

Query: 154 LFLYSNKLSGVLPQEIGNLKSLTELYVTNNAL---------GGLIPSTLFRLTNISSNQF 204
           L + +N++  +       L  LTEL +TNN+L           L   T   +        
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127

Query: 205 HSSIPLEIGNFSALDTLDLSD 225
                  I     +  LD   
Sbjct: 128 KHYRLYVIYKVPQVRVLDFQK 148

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (92), Expect = 3e-04
 Identities = 25/155 (16%), Positives = 49/155 (31%), Gaps = 18/155 (11%)

Query: 119 PQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTEL 178
            Q  +  + + L L G  +  +I     +L     +    N++  +       L+ L  L
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 68

Query: 179 YVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTK 238
            V NN +  +       L +++     ++  +E+G+   L +L           P     
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV---- 124

Query: 239 LSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSK 273
                              Y I K+  +  LD  K
Sbjct: 125 -----------TNKKHYRLYVIYKVPQVRVLDFQK 148

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.002
 Identities = 22/121 (18%), Positives = 43/121 (35%), Gaps = 4/121 (3%)

Query: 198 NISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP 257
           ++   +    I          D +D SDN+I  +       L +LK L +++N +     
Sbjct: 24  DLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNNRICRIGE 80

Query: 258 YAIGKLFNLMYLDLSKNKLSG-SIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQN 316
                L +L  L L+ N L        + +  +L  L +  N +       +  I  +  
Sbjct: 81  GLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQ 140

Query: 317 L 317
           +
Sbjct: 141 V 141

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 37.0 bits (84), Expect = 0.004
 Identities = 16/72 (22%), Positives = 26/72 (36%), Gaps = 14/72 (19%)

Query: 232 IPDELTKLSQLKN---LNLSSNLLSGQIP------YAIGKLFNLMYLDLSKNKLSGSIPT 282
           I D +    + K+          L G IP        +  L    +L LS N +      
Sbjct: 7   IKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-----E 61

Query: 283 EIGNCSALKNLT 294
           +I + S ++NL 
Sbjct: 62  KISSLSGMENLR 73

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	740
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.95
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.92
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.92
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.9
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.9
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.9
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.9
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.89
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.89
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.89
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.89
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.88
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.83
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.82
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.81
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.8
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.76
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.74
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.72
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.68
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.67
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.65
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.65
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.61
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.58
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.19
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	99.02
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	99.02
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.93
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.59
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.44
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	98.44
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	98.3
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	98.29
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	98.04

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=371.03  Aligned_cols=255  Identities=28%  Similarity=0.440  Sum_probs=207.7

Q ss_pred             CCCCCCEEEECCCCEEEEEEEECC-C---CEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEE
Q ss_conf             156554056114515899999179-9---399999836876211598999999999972049996311643663067578
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPE-G---KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  525 (740)
                      ++|++.+.||+|+||+||+|..+. +   ..||||.+......  ...++|.+|++++++++|||||+++|++.+++..+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf             0427856980278829999999579978899999997844598--99999999999998579988861899996288779


Q ss_pred             EEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf             99982458870011028885334798999989999999999988269988386279999667769995799422453002
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      +||||+++|+|.+++.....  .+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       104 iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEECCCCCCEEEECCCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf             99972279853002104567--999999999999999988988527---9835761504489889991998884431575


Q ss_pred             CCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCHHHHHHCCCC
Q ss_conf             5698741-----01334777345211245666871016769999999983-99999964433358899831565520469
Q 004642          606 HVDSSYR-----TLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRL  679 (740)
Q Consensus       606 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  679 (740)
                      .......     ....||+.|+|||++.+..++.++|||||||++|||+| |+.||.....        ..+...+....
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------~~~~~~i~~~~  250 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVINAIEQDY  250 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTC
T ss_pred             CCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHCCC
T ss_conf             6777765365025666883003878883699786121445357899998679999999999--------99999997378


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             9962044588799999999972437999999999999999709
Q 004642          680 SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       680 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      .++.+...++   .+.+++.+||+.||++|||++|+++.|+..
T Consensus       251 ~~~~~~~~~~---~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         251 RLPPPMDCPS---ALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             CCCCCTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCHH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             8999742269---999999997587976892999999999998

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=370.61  Aligned_cols=253  Identities=24%  Similarity=0.360  Sum_probs=211.9

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             1565540561145158999991-799399999836876211598999999999972049996311643663067578999
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|++.......   .+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHH---HHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             05388789812858299999998999899999984301727---999999999998679998805857798899989999


Q ss_pred             EECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf             82458870011028885334798999989999999999988269988386279999667769995799422453002569
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++...    .+++.++..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+|+.....
T Consensus        97 Ey~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EECCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf             703798089886415----999999999999999999999987---9722677688868878996864251564132136


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCC-CCCCCCHHHH
Q ss_conf             874101334777345211245666871016769999999983999999644333588998315655204-6999620445
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQ-RLSPPVNQKI  687 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  687 (740)
                      ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.....       .......... ..........
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~  242 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGTPELQNPEKL  242 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHHCSCCCSSGGGS
T ss_pred             CCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHHCCCCCCCCCCCC
T ss_conf             6644444447773682664479988012031372999998048899899799-------999999985799988885537


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             88799999999972437999999999999999709
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      .   ..+.+++.+||+.||++|||++|+++|-+..
T Consensus       243 s---~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~  274 (293)
T d1yhwa1         243 S---AIFRDFLNRCLDMDVEKRGSAKELLQHQFLK  274 (293)
T ss_dssp             C---HHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred             C---HHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             9---9999999998669966890999996499657

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=369.61  Aligned_cols=257  Identities=26%  Similarity=0.351  Sum_probs=209.4

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEE
Q ss_conf             21565540561145158999991-79939999983687621159899999999997204999631164366306757899
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|++......+  ..+.+.+|++++++++||||+++++++.+++..|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCH--HHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf             746089989721748099999999999799999984566412--799999999999857998884696540467436798


Q ss_pred             EEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf             98245887001102888533479899998999999999998826998838627999966776999579942245300256
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++|+|.+++....   .+++.++..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+|+....
T Consensus        82 mEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECC
T ss_conf             86458980899975379---999999999999999999999975---983575468997887899879832314224046


Q ss_pred             CCC--CCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCH
Q ss_conf             987--4101334777345211245666-8710167699999999839999996443335889983156552046999620
Q 004642          608 DSS--YRTLRAGTYGYIAPELAYTIVV-TGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN  684 (740)
Q Consensus       608 ~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  684 (740)
                      ...  .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....      ...................
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~------~~~~~~~~~~~~~~~~~~~  229 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS------DSCQEYSDWKEKKTYLNPW  229 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS------TTSHHHHHHHTTCTTSTTG
T ss_pred             CCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHHCCCCCCCCC
T ss_conf             8865311132557474287286189999971016173799999982997888898------5999999986388878864


Q ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             44588799999999972437999999999999999709
Q 004642          685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      ...   ...+.+++.+||+.||++|||++|+++|.+..
T Consensus       230 ~~~---s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~  264 (271)
T d1nvra_         230 KKI---DSAPLALLHKILVENPSARITIPDIKKDRWYN  264 (271)
T ss_dssp             GGS---CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             CCC---CHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             469---99999999997679966890999996198458

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=371.87  Aligned_cols=260  Identities=27%  Similarity=0.430  Sum_probs=207.7

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             21565540561145158999991799399999836876211598999999999972049996311643663067578999
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  528 (740)
                      .++|.+.+.||+|+||+||+|+.+  ..||||+++....... ..+.|.+|++++.+++|||||+++|++.+ +..++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTT-HHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHH-HHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEE
T ss_conf             451899889830788589999999--9899999973469989-99999999999984799878645679715-5899999


Q ss_pred             EECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf             82458870011028885334798999989999999999988269988386279999667769995799422453002569
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.++++....  .+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        83 Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             ECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             ECCCCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCCC
T ss_conf             65899888999852357--899999999999999998887509---9951614789979818997887500221333556


Q ss_pred             CC--CCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCC-CCC
Q ss_conf             87--4101334777345211245---66687101676999999998399999964433358899831565520469-996
Q 004642          609 SS--YRTLRAGTYGYIAPELAYT---IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRL-SPP  682 (740)
Q Consensus       609 ~~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  682 (740)
                      ..  ......||+.|+|||++.+   ..++.++|||||||++|||+||+.||.....       .......+.... .+.
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~~p~  230 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIFMVGRGYLSPD  230 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHHHHTSCCCC
T ss_pred             CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHHCCCCCCC
T ss_conf             776312566557431799999505689999531516359999999978899899896-------9999999965888986


Q ss_pred             CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf             204458879999999997243799999999999999970999
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  724 (740)
                      ...........+.+++.+||+.||++|||++|++++|+....
T Consensus       231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             000365554999999999758897689299999999999997

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.90  Aligned_cols=258  Identities=24%  Similarity=0.403  Sum_probs=211.6

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEECC------CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEEEC
Q ss_conf             2156554056114515899999179------939999983687621159899999999997204-999631164366306
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHK  521 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  521 (740)
                      .++|++.+.||+|+||+||+|+...      ...||+|.+......  .....+.+|+.++.++ +|||||+++|++.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCH--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf             8993970198307881999999857885542049999996633587--89999999999999715899686877888629


Q ss_pred             CEEEEEEEECCCCCCHHHHCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC
Q ss_conf             757899982458870011028885--------------------334798999989999999999988269988386279
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDE--------------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDI  581 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl  581 (740)
                      +..++||||+++|+|.++++....                    ...+++..++.++.||++||+|||++   +|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCC
T ss_conf             9589999727999599999862577751022100001222001257789999999999999999999739---9050527


Q ss_pred             CCCCEEECCCCCEEEEECCCCEECCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCC
Q ss_conf             999667769995799422453002569874--101334777345211245666871016769999999983-99999964
Q 004642          582 SSNNILLDSNLEASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLL  658 (740)
Q Consensus       582 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~  658 (740)
                      ||+||+++.++.+||+|||+|+........  .....||+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCC
T ss_conf             03214434598289851422220457786156234357876578388727999963303000399999983899999998


Q ss_pred             CCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             433358899831565520469996204458879999999997243799999999999999970
Q 004642          659 SSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       659 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  721 (740)
                      .       ......+.+.....++.+...++   .+.+++.+||+.||++|||++||+++|..
T Consensus       271 ~-------~~~~~~~~~~~~~~~~~p~~~~~---~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         271 P-------VDANFYKLIQNGFKMDQPFYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             C-------CSHHHHHHHHTTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C-------HHHHHHHHHHCCCCCCCCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             9-------89999999856998998876789---99999999758896689399999999748

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.33  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=208.9

Q ss_pred             CCCCCCEEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf             15655405611451589999917993999998368762115989999999999720499963116436630675789998
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  529 (740)
                      ++|++.+.||+|+||+||+|.+.+++.||||++......    .+++.+|++++++++|||||+++|++.+++..++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEE
T ss_conf             995888898208882999999889999999998788676----8999999999996689975653524315993379998


Q ss_pred             ECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCC
Q ss_conf             24588700110288853347989999899999999999882699883862799996677699957994224530025698
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++|+|.+++.....  .+++..+..++.|+|.||+|||+.   +|+||||||+||+++.++.+||+|||+|+......
T Consensus        81 ~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             CCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             ECCCCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC
T ss_conf             3699918997520134--788999999999999987765316---43104431532666688776865532100236887


Q ss_pred             CC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHH
Q ss_conf             74-1013347773452112456668710167699999999839-999996443335889983156552046999620445
Q 004642          610 SY-RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMG-THPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       610 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  687 (740)
                      .. .....||+.|+|||++.+..++.++||||||+++|||+|+ .+|+....        .....+.+.....+..+...
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--------~~~~~~~i~~~~~~~~p~~~  227 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGFRLYKPRLA  227 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--------HHHHHHHHHHTCCCCCCTTS
T ss_pred             CEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCC--------HHHHHHHHHHCCCCCCCCCC
T ss_conf             3350430017666785786079998403321059999999878988877899--------99999999806888995436


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             88799999999972437999999999999999709
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      .+   .+.+++.+||+.||++|||++|++++|+..
T Consensus       228 ~~---~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         228 ST---HVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             79---999999997657976891999999999999

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=370.03  Aligned_cols=252  Identities=28%  Similarity=0.450  Sum_probs=210.4

Q ss_pred             CCCCCCEEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             15655405611451589999917-99399999836876211598999999999972049996311643663067578999
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||+||+|..+ +++.||+|++......+....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf             37699889851778589999998999499999981688567689999999999998568888885999999899989998


Q ss_pred             EECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf             82458870011028885334798999989999999999988269988386279999667769995799422453002569
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.... 
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred             EECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCC-
T ss_conf             5047985898875048---999999999999999999999988---946522023441466899871155563354488-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHH
Q ss_conf             87410133477734521124566687101676999999998399999964433358899831565520469996204458
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  688 (740)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+.......  +....
T Consensus       159 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~--p~~~s  228 (263)
T d2j4za1         159 -SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVEFTF--PDFVT  228 (263)
T ss_dssp             -CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCCC--CTTSC
T ss_pred             -CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHCCCCCC--CCCCC
T ss_conf             -852355788763499997589989314404675999998329999888999-------99999997189999--86689


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             879999999997243799999999999999970
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  721 (740)
                      +   .+.+++.+||+.||++|||++|+++|.+.
T Consensus       229 ~---~~~~li~~~L~~dp~~R~t~~eil~hp~~  258 (263)
T d2j4za1         229 E---GARDLISRLLKHNPSQRPMLREVLEHPWI  258 (263)
T ss_dssp             H---HHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred             H---HHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf             9---99999999764797689099999719070

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=368.53  Aligned_cols=254  Identities=24%  Similarity=0.352  Sum_probs=208.4

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEE
Q ss_conf             21565540561145158999991-79939999983687621159899999999997204999631164366306757899
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  527 (740)
                      .+.|+..+.||+|+||+||+|.. .+++.||||++......+....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf             78567627970188809999999899939999998444435889999999999999977899982389999989988999


Q ss_pred             EEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf             98245887001102888533479899998999999999998826998838627999966776999579942245300256
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++|++..++....   .+++.++..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+|.....
T Consensus        94 ~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             EECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EEECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf             98069994578997379---999999999999999999999868---976667884217987999789844365334677


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCH
Q ss_conf             9874101334777345211245---6668710167699999999839999996443335889983156552046999620
Q 004642          608 DSSYRTLRAGTYGYIAPELAYT---IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN  684 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  684 (740)
                          .....||+.|+|||++.+   ..|+.++||||+||++|||++|+.||.....       .................
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~  236 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPALQS  236 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCSC
T ss_pred             ----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHHCCCCCCCC
T ss_conf             ----8731347663688998346788867214545589999999878899999799-------99999998289998887


Q ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             44588799999999972437999999999999999709
Q 004642          685 QKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       685 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      ....+   .+.+++.+||+.||++|||++|+++|.+..
T Consensus       237 ~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~  271 (309)
T d1u5ra_         237 GHWSE---YFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (309)
T ss_dssp             TTSCH---HHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             CCCCH---HHHHHHHHHCCCCHHHCCCHHHHHHCHHHC
T ss_conf             88899---999999997737965791899997199753

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.70  Aligned_cols=254  Identities=25%  Similarity=0.397  Sum_probs=207.0

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             21565540561145158999991799399999836876211598999999999972049996311643663067578999
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  528 (740)
                      .++|++.+.||+|+||.||+|.+++++.||||+++.....    .+.|.+|++++.+++|||||+++|++.+ +..++||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEE
T ss_conf             8993886798107982899999999999999998647688----8999999999986799988578731045-9769999


Q ss_pred             EECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf             82458870011028885334798999989999999999988269988386279999667769995799422453002569
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++.... ...+++..++.++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        87 Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EECCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCC
T ss_conf             9578982888875147-89887889999999999999999748---9546756422515620244042341014773588


Q ss_pred             CC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHH
Q ss_conf             87-41013347773452112456668710167699999999839999996443335889983156552046999620445
Q 004642          609 SS-YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       609 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  687 (740)
                      .. ......|++.|+|||++.+..++.++|||||||++|||+||..|+...       .........+.....+..+...
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~-------~~~~~~~~~i~~~~~~~~p~~~  235 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------MTNPEVIQNLERGYRMVRPDNC  235 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTCCCCCCTTC
T ss_pred             CCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-------CCHHHHHHHHHHCCCCCCCCCC
T ss_conf             644203567744445828983799982456452579999999689888888-------8999999999706888896557


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             8879999999997243799999999999999970
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  721 (740)
                      ++   .+.+++.+||+.||++|||++++++.|+.
T Consensus       236 ~~---~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         236 PE---ELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf             19---99999999758897689399999998611

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=367.84  Aligned_cols=259  Identities=26%  Similarity=0.382  Sum_probs=213.7

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEE
Q ss_conf             7215655405611451589999917-993999998368762115989999999999720499963116436630675789
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  526 (740)
                      ..++|++.+.||+|+||+||+|.+. +++.||||+++.....    .+++.+|++++++++|||||+++|++.+++..++
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCH----HHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEE
T ss_conf             579939865982088808999999999969999997776103----9999999999986799988267752745785478


Q ss_pred             EEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECC
Q ss_conf             99824588700110288853347989999899999999999882699883862799996677699957994224530025
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLH  606 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~  606 (740)
                      ||||+++|+|.+++.... ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EEECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf             763146760677753035-54157999999999999978889878---93057604576899899928983244546537


Q ss_pred             CCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHH
Q ss_conf             69874-10133477734521124566687101676999999998399999964433358899831565520469996204
Q 004642          607 VDSSY-RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       607 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  685 (740)
                      .+... .....|++.|+|||++.+..++.++|||||||++|||++|..|+..       ........+.+.....++.+.
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~-------~~~~~~~~~~i~~~~~~~~~~  239 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMERPE  239 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST-------TCCHHHHHHHHHTTCCCCCCT
T ss_pred             CCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-------CCHHHHHHHHHHCCCCCCCCC
T ss_conf             8872210355665466692787279998104302178999999867998877-------425999999985588888874


Q ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf             458879999999997243799999999999999970999
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  724 (740)
                      ..++   .+.+++.+||+.||++|||++|+++.|+....
T Consensus       240 ~~~~---~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         240 GCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCHH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             3309---99999999757797689399999999999987

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=370.59  Aligned_cols=260  Identities=25%  Similarity=0.431  Sum_probs=210.5

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE--CCEEE
Q ss_conf             21565540561145158999991-7993999998368762115989999999999720499963116436630--67578
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH--KKCMF  525 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~  525 (740)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|.+......+ ...+.+.+|++++++++|||||++++++.+  .+..|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCH-HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf             333799679830889199999999999799999987465797-9999999999999977899982489999917899899


Q ss_pred             EEEEECCCCCCHHHHCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf             9998245887001102888-5334798999989999999999988269--988386279999667769995799422453
Q 004642          526 LIYEYMERGSLFCVLHDDD-EAIELNWTKRVNIVKSVAHALSYLHHDC--TLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                      +||||+++|+|.+++.... ....+++..++.++.|++.||+|||++.  ..+|+||||||+|||++.++.+||+|||+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCE
T ss_conf             99956899938999985154578999999999999999999999971677887885867654257478885798001000


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCC
Q ss_conf             00256987410133477734521124566687101676999999998399999964433358899831565520469996
Q 004642          603 RLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  682 (740)
                      +....+........||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+...... .
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~~~i~~~~~~-~  233 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFR-R  233 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCC-C
T ss_pred             EECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCC-C
T ss_conf             3224577755667788232799998399999389887527899998018899899899-------9999999718998-8


Q ss_pred             CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf             20445887999999999724379999999999999997
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELL  720 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  720 (740)
                      .+....+   .+.+++.+||+.||++|||++|+++|.+
T Consensus       234 ~~~~~s~---~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         234 IPYRYSD---ELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             CCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             CCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHHCCC
T ss_conf             9743599---9999999976799557918999972981

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.97  Aligned_cols=263  Identities=25%  Similarity=0.349  Sum_probs=208.3

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEE
Q ss_conf             721565540561145158999991-7993999998368762115989999999999720499963116436630675789
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  526 (740)
                      ..++|++.+.||+|+||+||+|.. .+|+.||+|+++.....  ...+.+.+|+.++++++|||||++++++.+++..++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf             756888978971277809999999899969999998754097--899999999999986799999949999998999999


Q ss_pred             EEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf             99824588700110288853347989999899999999999882-69988386279999667769995799422453002
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH-DCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      ||||+++|+|.+++.+.+   .+++..+..++.|++.||.|||+ .   ||+||||||+|||++.++.+||+|||+|+..
T Consensus        82 VmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEECCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEEEECCCCCCC
T ss_conf             997679986899874249---9999999999999999999999859---9971445779946878998999548776256


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC---------CC-----------
Q ss_conf             5698741013347773452112456668710167699999999839999996443335---------88-----------
Q 004642          606 HVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS---------SS-----------  665 (740)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~---------~~-----------  665 (740)
                      ..  ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||........         ..           
T Consensus       156 ~~--~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         156 ID--SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             HH--HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             CC--CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf             78--8621113771411946875899894888998999999999888998998878999999887517754577421233


Q ss_pred             -----------CCCCH---HHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             -----------99831---5655204699962044588799999999972437999999999999999709
Q 004642          666 -----------GPKIM---LIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       666 -----------~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                                 .....   ..........+.....  .....+.+++.+||+.||++|||++|+++|.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~  302 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG--VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  302 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBT--TBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHC
T ss_conf             32211112223541347788766502687667644--4899999999998689946790899996098647

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=363.87  Aligned_cols=258  Identities=22%  Similarity=0.310  Sum_probs=210.3

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEE
Q ss_conf             21565540561145158999991-79939999983687621159899999999997204999631164366306757899
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++......   ..+.+.+|++++.+++|||||++++++.+++..++|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf             65758988984076819999998899989999998452431---699999999999867997999299999989999999


Q ss_pred             EEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCEEC
Q ss_conf             982458870011028885334798999989999999999988269988386279999667769--995799422453002
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS--NLEASVADFGTARLL  605 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~DfG~a~~~  605 (740)
                      |||+++|+|.+++.....  .+++..+..++.||+.||+|||++   ||+||||||+|||++.  ++.+||+|||+|+..
T Consensus       102 mE~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EECCCCCCHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEEC
T ss_conf             985799889999976237--899999999999999999999756---976000154673641688986999545210442


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHH
Q ss_conf             56987410133477734521124566687101676999999998399999964433358899831565520469996204
Q 004642          606 HVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  685 (740)
                      .... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+.......+.. 
T Consensus       177 ~~~~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~-  247 (350)
T d1koaa2         177 DPKQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWNMDDS-  247 (350)
T ss_dssp             CTTS-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCSCCG-
T ss_pred             CCCC-CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHHCCCCCCCC-
T ss_conf             5654-32000686242188997589987267655465999999859899899799-------99999998478898942-


Q ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             45887999999999724379999999999999997099
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  723 (740)
                      ........+.+++.+||+.||++|||++|+++|-+...
T Consensus       248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~  285 (350)
T d1koaa2         248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  285 (350)
T ss_dssp             GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             23589999999999975689667908999862913288

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.55  Aligned_cols=257  Identities=24%  Similarity=0.342  Sum_probs=209.3

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEE
Q ss_conf             21565540561145158999991-79939999983687621159899999999997204999631164366306757899
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  527 (740)
                      .+.|++.+.||+|+||+||+|.. .+++.||+|++.......   .+.+.+|++++++++|||||++++++.+++..++|
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   87 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHH---HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf             037598479930778199999999999399999987289999---99999999999867999988498898009958999


Q ss_pred             EEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf             98245887001102888533479899998999999999998826998838627999966776999579942245300256
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++|+|.+++.....  .+++.++..++.|++.||.|||++   ||+||||||+|||++.++.+||+|||+|+....
T Consensus        88 mEy~~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             EECCCCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCC
T ss_conf             962799818899986289--999999999999999999999988---988714070031487899989971612303577


Q ss_pred             CCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCC-C
Q ss_conf             987410133477734521124-----5666871016769999999983999999644333588998315655204699-9
Q 004642          608 DSSYRTLRAGTYGYIAPELAY-----TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS-P  681 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~  681 (740)
                      .........||+.|+|||++.     +..|+.++||||+||++|||++|+.||.....       ............. .
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-------~~~~~~i~~~~~~~~  235 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-------MRVLLKIAKSEPPTL  235 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-------GGHHHHHHHSCCCCC
T ss_pred             CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCCCC
T ss_conf             8641001025626479999832025788888066578789999998208899999899-------999999970799877


Q ss_pred             CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             620445887999999999724379999999999999997099
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  723 (740)
                      .......   ..+.+++.+||+.||++|||++|+++|.+...
T Consensus       236 ~~~~~~s---~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         236 AQPSRWS---SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             SSGGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             CCCCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             7656699---99999999976699668919999962923188

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=363.52  Aligned_cols=255  Identities=21%  Similarity=0.295  Sum_probs=209.0

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEE
Q ss_conf             21565540561145158999991-79939999983687621159899999999997204999631164366306757899
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++......   ..+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf             40359989993177829999999899979999998872646---799999999999867997989199999989999999


Q ss_pred             EEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCEEC
Q ss_conf             98245887001102888533479899998999999999998826998838627999966776--9995799422453002
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD--SNLEASVADFGTARLL  605 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~DfG~a~~~  605 (740)
                      |||+++|+|.+++....  ..+++.++..++.||+.||+|||+.   ||+||||||+|||++  .++.+||+|||+|+..
T Consensus       105 mE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         105 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EECCCCCHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEEC
T ss_conf             98289980888898638--9989999999999999999999977---926513144553113467884899525630343


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCC--CCC
Q ss_conf             569874101334777345211245666871016769999999983999999644333588998315655204699--962
Q 004642          606 HVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS--PPV  683 (740)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  683 (740)
                      ..+. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+......  ...
T Consensus       180 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~  251 (352)
T d1koba_         180 NPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDWEFDEDA  251 (352)
T ss_dssp             CTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCCCCCSST
T ss_pred             CCCC-CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHHCCCCCCCCC
T ss_conf             7887-20100476453489997479989763338989999999968899899799-------999999984788989300


Q ss_pred             HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             044588799999999972437999999999999999709
Q 004642          684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      .....   ..+.+++.+||+.||.+|||++|+++|-+..
T Consensus       252 ~~~~s---~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~  287 (352)
T d1koba_         252 FSSVS---PEAKDFIKNLLQKEPRKRLTVHDALEHPWLK  287 (352)
T ss_dssp             TTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             24799---9999999997569966891899996097348

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=366.51  Aligned_cols=258  Identities=24%  Similarity=0.313  Sum_probs=210.2

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEE
Q ss_conf             7215655405611451589999917-993999998368762115989999999999720499963116436630675789
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  526 (740)
                      ..+.|++.+.||+|+||+||+|..+ +++.||+|++........  .+.+.+|++++++++||||+++++++.+++..|+
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHH--HHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf             76666998899406583999999999998999999815773128--9999999999986799899919899998998889


Q ss_pred             EEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCE
Q ss_conf             998245887001102888533479899998999999999998826998838627999966776---99957994224530
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLD---SNLEASVADFGTAR  603 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~DfG~a~  603 (740)
                      ||||++||+|.+++...+   .+++.++..++.|++.||+|||+.   +|+||||||+||++.   .++.+||+|||+|+
T Consensus        85 vmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEE
T ss_conf             885268984888653036---788789999999999998752413---05568704630011046888249983154358


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCC
Q ss_conf             02569874101334777345211245666871016769999999983999999644333588998315655204699962
Q 004642          604 LLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPV  683 (740)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  683 (740)
                      ...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+.......+.
T Consensus       159 ~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~  230 (307)
T d1a06a_         159 MEDPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-------AKLFEQILKAEYEFDS  230 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHTTCCCCCT
T ss_pred             ECCCCC-EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCCCCC
T ss_conf             725897-04400328422591887379998078734515999999859799999899-------9999998616877787


Q ss_pred             HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             044588799999999972437999999999999999709
Q 004642          684 NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       684 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      . ........+.+++.+||+.||++|||++|+++|.+..
T Consensus       231 ~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  268 (307)
T d1a06a_         231 P-YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA  268 (307)
T ss_dssp             T-TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred             C-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             6-6667899999999997608975791899986298447

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.71  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=205.9

Q ss_pred             CCCCCCE-EEECCCCEEEEEEEEC---CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEE
Q ss_conf             1565540-5611451589999917---99399999836876211598999999999972049996311643663067578
Q 004642          450 EDFHIKY-CIGTGGYGSVYKAELP---EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       450 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  525 (740)
                      ++|.+.. +||+|+||+||+|.++   ++..||||+++....  ....++|.+|++++.+++|||||+++|++.. +..+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEE
T ss_conf             471887848730608099999996089768999999882039--7899999999999986799888068656036-8079


Q ss_pred             EEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf             99982458870011028885334798999989999999999988269988386279999667769995799422453002
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      +||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        85 lvmE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEECCCCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf             99980789968997521256--999999999999999987899868---8105767646604546885420331342115


Q ss_pred             CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCHHHHHHCCCCCC
Q ss_conf             569874---101334777345211245666871016769999999983-9999996443335889983156552046999
Q 004642          606 HVDSSY---RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       606 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (740)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.....        ......+.....+
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~~~i~~~~~~  231 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKRM  231 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHHHTTCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHCCCCC
T ss_conf             54343211356211374335868872799995412322017899999389999999799--------9999999818999


Q ss_pred             CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             62044588799999999972437999999999999999709
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      +.+...++   .+.+++.+||+.+|++|||+.++.+.|+..
T Consensus       232 ~~p~~~~~---~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         232 ECPPECPP---ELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CCCTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             99976789---999999997577976890999999999999

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.32  Aligned_cols=256  Identities=22%  Similarity=0.294  Sum_probs=213.5

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEE
Q ss_conf             21565540561145158999991-79939999983687621159899999999997204999631164366306757899
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  527 (740)
                      .++|.+.+.||+|+||.||+|+. .+|+.||+|++.+.........+.+.+|++++++++||||+++++++.+++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             47428988983176849999999899989999998156544979999999999999867999887787640356421110


Q ss_pred             EEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf             98245887001102888533479899998999999999998826998838627999966776999579942245300256
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf             00357986055553256---775999999999996521134315---962246477784765899888820565200356


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHH
Q ss_conf             98741013347773452112456668710167699999999839999996443335889983156552046999620445
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  687 (740)
                      ........+||+.|+|||++.+..|+.++||||+||++|||++|+.||.....       ...........+..+  ...
T Consensus       158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~~i~~~~~~~p--~~~  228 (337)
T d1o6la_         158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEIRFP--RTL  228 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCC--TTS
T ss_pred             CCCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCCCC--CCC
T ss_conf             78620551008899666650489888333102230678899878999999699-------999999852899898--668


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHHHHCC
Q ss_conf             887999999999724379999999-----99999999709
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPT-----MQRISQELLAG  722 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~~~  722 (740)
                      .+   .+.+++.+||++||.+||+     ++|+++|.+..
T Consensus       229 s~---~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~  265 (337)
T d1o6la_         229 SP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             CH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             CH---HHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCC
T ss_conf             99---99999986663893442256523499997291503

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.74  Aligned_cols=252  Identities=25%  Similarity=0.422  Sum_probs=211.1

Q ss_pred             CCCCCCEEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf             15655405611451589999917993999998368762115989999999999720499963116436630675789998
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  529 (740)
                      ++|++.+.||+|+||+||+|++++++.||||+++.....    .+++.+|++++.+++||||++++|++.+++..++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
T ss_conf             997996898207883999999889989999998747577----8999999999996689860158899850781699997


Q ss_pred             ECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCC
Q ss_conf             24588700110288853347989999899999999999882699883862799996677699957994224530025698
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++|++..++.....  .+++..+.+++.|+++||+|||+.   ||+||||||+||+++.++.+||+|||+++......
T Consensus        80 y~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          80 YMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             CCTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             CCCCCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCC
T ss_conf             0489938886410246--776899999999999999987546---84346654135887699847988614420235787


Q ss_pred             CC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHH
Q ss_conf             74-101334777345211245666871016769999999983-9999996443335889983156552046999620445
Q 004642          610 SY-RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       610 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  687 (740)
                      .. .....||+.|+|||++.+..++.++||||||+++|||+| |+.||.....       . .....+........+...
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------~-~~~~~i~~~~~~~~p~~~  226 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------S-ETAEHIAQGLRLYRPHLA  226 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------H-HHHHHHHTTCCCCCCTTC
T ss_pred             CEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH-------H-HHHHHHHHCCCCCCCCCC
T ss_conf             22524657887757807863799885210336432467397559999889999-------9-999999807978996546


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             8879999999997243799999999999999970
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  721 (740)
                      .   ..+.+++.+||+.||++|||+++++++|..
T Consensus       227 ~---~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         227 S---EKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             C---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             C---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             5---999999999766897689399999987418

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.24  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=207.5

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             1565540561145158999991-799399999836876211598999999999972049996311643663067578999
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||+||+|.. .+++.||||++......+....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             87789889850879099999998999799999986577557778999999999998768888617999999899889999


Q ss_pred             EECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf             82458870011028885334798999989999999999988269988386279999667769995799422453002569
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|+|.+++...+   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|+.....
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf             7048987777653159---999999999999999999762165---0884767741236688853886032102422567


Q ss_pred             CC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHH
Q ss_conf             87--4101334777345211245666871016769999999983999999644333588998315655204699962044
Q 004642          609 SS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       609 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  686 (740)
                      ..  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+.......  +..
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~~--p~~  232 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKLEYDF--PEK  232 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCCCC--CTT
T ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCCC--CCC
T ss_conf             764333555677552584400268989666230456999998038899899599-------99999997189999--854


Q ss_pred             HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             58879999999997243799999999999999
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQE  718 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  718 (740)
                      ..+   .+.+++.+||+.||++|||++|++++
T Consensus       233 ~s~---~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         233 FFP---KARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CCH---HHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CCH---HHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf             799---99999999855797689197897377

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.89  Aligned_cols=266  Identities=22%  Similarity=0.288  Sum_probs=213.6

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
Q ss_conf             721565540561145158999991-799399999836876211---5989999999999720499963116436630675
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETED---SAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  523 (740)
                      ..++|++.+.||+|+||+||+|.. .+|+.||+|++.......   ....+.+.+|++++++++|||||++++++.+++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf             55677982798117895999999999998999999875663213406899999999999986799899938899997998


Q ss_pred             EEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEEC
Q ss_conf             789998245887001102888533479899998999999999998826998838627999966776999----5799422
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL----EASVADF  599 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Df  599 (740)
                      .++||||+++|+|.+++...+   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+|++||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEECCCCCCCCCHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECCH
T ss_conf             999998677864310010356---421557899999999998766625---42211333012798258986664696433


Q ss_pred             CCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCC
Q ss_conf             45300256987410133477734521124566687101676999999998399999964433358899831565520469
Q 004642          600 GTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRL  679 (740)
Q Consensus       600 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  679 (740)
                      |+|....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+.....
T Consensus       162 G~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~  233 (293)
T d1jksa_         162 GLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVNY  233 (293)
T ss_dssp             TTCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCC
T ss_pred             HHHHHCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHHCCC
T ss_conf             4421057776-31224777743099998189999766522140999999708899889999-------999999981688


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCHH
Q ss_conf             9962044588799999999972437999999999999999709998813
Q 004642          680 SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQK  728 (740)
Q Consensus       680 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  728 (740)
                      ..+ ..........+.+++.+||+.||++|||++|+++|.+....+.++
T Consensus       234 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         234 EFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             CCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             CCC-CHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCHHH
T ss_conf             887-010478899999999998638966891999996190418887057

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.81  Aligned_cols=258  Identities=28%  Similarity=0.398  Sum_probs=209.2

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEECCC-----CEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
Q ss_conf             21565540561145158999991799-----3999998368762115989999999999720499963116436630675
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEG-----KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKC  523 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  523 (740)
                      .++|+..+.||+|+||+||+|.++..     ..||||++......  ....+|.+|++++.+++|||||+++|++.+.+.
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf             899686159811779099999996899878799999998844596--899999999999985689878323677833880


Q ss_pred             EEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf             78999824588700110288853347989999899999999999882699883862799996677699957994224530
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      .++||||++++++.+.+.....  .+++.++..++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+|+
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEEEECCCCCCHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHH
T ss_conf             3899972135740222102345--420899999999999854121212---34257656442788899849984551030


Q ss_pred             ECCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCC
Q ss_conf             02569874---101334777345211245666871016769999999983999999644333588998315655204699
Q 004642          604 LLHVDSSY---RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS  680 (740)
Q Consensus       604 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  680 (740)
                      ........   .....||+.|+|||++.+..++.++||||||+++|||+++..|+..       ........+.+.....
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~-------~~~~~~~~~~i~~~~~  231 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-------ELSNHEVMKAINDGFR  231 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT-------TCCHHHHHHHHHTTCC
T ss_pred             CCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC-------CCCHHHHHHHHHCCCC
T ss_conf             035787652674267777343488887049999735563448989999967988655-------6899999999863578


Q ss_pred             CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             9620445887999999999724379999999999999997099
Q 004642          681 PPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       681 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  723 (740)
                      ++.+...+.   .+.+++.+||+.+|++||++.|+++.|+...
T Consensus       232 ~~~~~~~~~---~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         232 LPTPMDCPS---AIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             CCCCTTCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCHHHHH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             998504579---9999999977679768939999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=356.50  Aligned_cols=248  Identities=24%  Similarity=0.386  Sum_probs=202.4

Q ss_pred             EEEECCCCEEEEEEEEC---CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEEEECC
Q ss_conf             05611451589999917---993999998368762115989999999999720499963116436630675789998245
Q 004642          456 YCIGTGGYGSVYKAELP---EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEYME  532 (740)
Q Consensus       456 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  532 (740)
                      ++||+|+||+||+|.++   .++.||||+++..... ....+++.+|++++++++|||||+++|+|.. +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCC
T ss_conf             783458782999999816973859999998801089-8999999999999986799898527777505-97799997478


Q ss_pred             CCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCC-
Q ss_conf             8870011028885334798999989999999999988269988386279999667769995799422453002569874-
Q 004642          533 RGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY-  611 (740)
Q Consensus       533 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  611 (740)
                      +|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|+........ 
T Consensus        91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf             896899975225---789999999999999997668747---95567776113102356751234134533134323443


Q ss_pred             --CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHH
Q ss_conf             --101334777345211245666871016769999999983-99999964433358899831565520469996204458
Q 004642          612 --RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       612 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  688 (740)
                        .....||+.|+|||++.+..++.++||||||+++|||++ |+.||.....        ..+...+.....++.+...+
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~~~~~~~p~~~~  236 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGCPAGCP  236 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCTTCC
T ss_pred             CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHCCCCCCCCCCCC
T ss_conf             2244567784203916653799984344303403132896589999999899--------99999998289999986567


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             8799999999972437999999999999999709
Q 004642          689 QDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      +   .+.+++.+||+.||++|||++++.+.|+..
T Consensus       237 ~---~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         237 R---EMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             H---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf             9---999999997588976890989999985288

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=356.56  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=200.3

Q ss_pred             CCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE----CCEEEE
Q ss_conf             65540561145158999991-7993999998368762115989999999999720499963116436630----675789
Q 004642          452 FHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH----KKCMFL  526 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l  526 (740)
                      |.+.+.||+|+||+||+|.. .+++.||+|++....... ...+.+.+|++++++++|||||++++++..    +...++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCH-HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEE
T ss_conf             885169700828499999999999599999985122798-9999999999999857999850699998403345888999


Q ss_pred             EEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCEEEEECCCCE
Q ss_conf             9982458870011028885334798999989999999999988269988--38627999966776-99957994224530
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLS--IIHRDISSNNILLD-SNLEASVADFGTAR  603 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~DfG~a~  603 (740)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||++   +  |+||||||+|||++ .++.+||+|||+|+
T Consensus        90 vmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCCCE
T ss_conf             995789894899975135---546999999999999999999978---99799687674351166799988980057654


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCC-
Q ss_conf             0256987410133477734521124566687101676999999998399999964433358899831565520469996-
Q 004642          604 LLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP-  682 (740)
Q Consensus       604 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  682 (740)
                      ...  ........||+.|+|||++.+ .++.++||||+||++|||++|+.||....       ....+.+.+.....+. 
T Consensus       164 ~~~--~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------~~~~~~~~i~~~~~~~~  233 (270)
T d1t4ha_         164 LKR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVKPAS  233 (270)
T ss_dssp             GCC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCCCGG
T ss_pred             ECC--CCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHCCCCCCC
T ss_conf             236--876677553813008988478-99986711007999999987889998765-------59999999973899865


Q ss_pred             CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             204458879999999997243799999999999999970
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  721 (740)
                      .....   ...+.+++.+||++||++|||++|+++|.+.
T Consensus       234 ~~~~~---~~~~~~li~~~l~~dp~~R~s~~ell~Hp~f  269 (270)
T d1t4ha_         234 FDKVA---IPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  269 (270)
T ss_dssp             GGGCC---CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             CCCCC---CHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf             67557---8999999999763797589299999677540

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=357.61  Aligned_cols=266  Identities=26%  Similarity=0.383  Sum_probs=214.6

Q ss_pred             HHHHHHHHCCCCCCEEEECCCCEEEEEEEEC------CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEE
Q ss_conf             8999997215655405611451589999917------9939999983687621159899999999997204999631164
Q 004642          442 YEDLINATEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLY  515 (740)
Q Consensus       442 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~  515 (740)
                      +.+++...++|++.+.||+|+||+||+|+++      +++.||||+++....  ....+++.+|++++++++||||++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~   82 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLL   82 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCC--HHHHHHHHHHHHHHHHCCCCCCCCCE
T ss_conf             3311389889388679820788399999988876577882999999882108--57999999999999966899765524


Q ss_pred             EEEEECCEEEEEEEECCCCCCHHHHCCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf             36630675789998245887001102888---------------------533479899998999999999998826998
Q 004642          516 GFCLHKKCMFLIYEYMERGSLFCVLHDDD---------------------EAIELNWTKRVNIVKSVAHALSYLHHDCTL  574 (740)
Q Consensus       516 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  574 (740)
                      +++...+..+++|||+++|+|.++++...                     ....+++..++.++.|++.||+|||++   
T Consensus        83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---  159 (301)
T d1lufa_          83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---  159 (301)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             EEECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---
T ss_conf             66605980389998158992999998527554210000111001210346788989999999999999985541357---


Q ss_pred             CEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf             8386279999667769995799422453002569874--10133477734521124566687101676999999998399
Q 004642          575 SIIHRDISSNNILLDSNLEASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGT  652 (740)
Q Consensus       575 ~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~  652 (740)
                      +++||||||+|||++.++.+||+|||+|+........  .+...|++.|+|||.+.+..++.++|||||||++|||++|.
T Consensus       160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CEEEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCC
T ss_conf             86854884011689899928983314421136776411157777676767989972688980563025236299998068


Q ss_pred             -CCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             -99996443335889983156552046999620445887999999999724379999999999999997099
Q 004642          653 -HPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       653 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  723 (740)
                       +||.....       ...... +.....++.+...++   .+.+++.+||+.+|++||||.||++.|+...
T Consensus       240 ~~p~~~~~~-------~e~~~~-v~~~~~~~~p~~~~~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         240 LQPYYGMAH-------EEVIYY-VRDGNILACPENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CCTTTTSCH-------HHHHHH-HHTTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCCH-------HHHHHH-HHCCCCCCCCCCCHH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf             999999899-------999999-973997888732529---9999999974889657939999999999842

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=354.11  Aligned_cols=256  Identities=20%  Similarity=0.251  Sum_probs=201.6

Q ss_pred             CCCCCCEEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHH---HHHHHHHCCCCCCCCEEEEEEEECCEEE
Q ss_conf             15655405611451589999917-9939999983687621159899999---9999972049996311643663067578
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQ---NEAHVLSTVRHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~  525 (740)
                      ++|.+.+.||+|+||.||+|+.. +|+.||+|++.............+.   .++++++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf             76851018842889099999999999799999984587542667999999999999985089985889999999899889


Q ss_pred             EEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf             99982458870011028885334798999989999999999988269988386279999667769995799422453002
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      +||||+++|+|.+++....   .+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+|+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf             9999148983899987325---532789999999999999999977---9622044422167858896798220102333


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCH
Q ss_conf             56987410133477734521124-56668710167699999999839999996443335889983156552046999620
Q 004642          606 HVDSSYRTLRAGTYGYIAPELAY-TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVN  684 (740)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  684 (740)
                      ...  ......||+.|+|||++. +..|+.++||||+||++|||++|+.||.....     .....+..... ......+
T Consensus       158 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~-~~~~~~~  229 (364)
T d1omwa3         158 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTL-TMAVELP  229 (364)
T ss_dssp             SSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-----SCHHHHHHHSS-SCCCCCC
T ss_pred             CCC--CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHCC-CCCCCCC
T ss_conf             788--643311345542168760389998441046778999999859998888998-----99999998604-6888788


Q ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHHHHCC
Q ss_conf             445887999999999724379999999-----99999999709
Q 004642          685 QKIVQDIILVSTIAFACLSSQPKSRPT-----MQRISQELLAG  722 (740)
Q Consensus       685 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~~~  722 (740)
                      ....+   .+.+++.+||+.||++||+     ++|+++|.+..
T Consensus       230 ~~~s~---~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~  269 (364)
T d1omwa3         230 DSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  269 (364)
T ss_dssp             SSSCH---HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred             CCCCH---HHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCC
T ss_conf             77899---99999999856698880887435799997491023

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.98  Aligned_cols=260  Identities=26%  Similarity=0.405  Sum_probs=211.0

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             21565540561145158999991799399999836876211598999999999972049996311643663067578999
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  528 (740)
                      .++|++.+.||+|+||.||+|..++++.||||+++.....    .+.|.+|+.++.+++|||||+++|++.+ +..++||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEE
T ss_conf             7997984699307980999999999999999998804488----8999999999986666788689999823-9759999


Q ss_pred             EECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf             82458870011028885334798999989999999999988269988386279999667769995799422453002569
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+++|++..++.... ...++|.+++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        91 Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          91 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             CCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EECCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCC
T ss_conf             9447994354200003-55305999999999999999987541---1433531230799989992998442555425688


Q ss_pred             CC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHH
Q ss_conf             87-41013347773452112456668710167699999999839999996443335889983156552046999620445
Q 004642          609 SS-YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       609 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  687 (740)
                      .. ......||+.|+|||++....++.++||||||+++|||++|..|+..       ..........+.....++.....
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~-------~~~~~~~~~~i~~~~~~~~~~~~  239 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP-------GMVNREVLDQVERGYRMPCPPEC  239 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST-------TCCHHHHHHHHHTTCCCCCCTTS
T ss_pred             CCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCC-------CCCHHHHHHHHHHCCCCCCCCCC
T ss_conf             73352454556654580898379989177413235899999868999998-------88899999999826899998323


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCH
Q ss_conf             8879999999997243799999999999999970999881
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQ  727 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~  727 (740)
                      .+   .+.+++.+||+.||++||++++|++.|+......+
T Consensus       240 ~~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         240 PE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCC
T ss_conf             79---99999999756697589199999998766623899

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=354.80  Aligned_cols=252  Identities=21%  Similarity=0.275  Sum_probs=210.0

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             1565540561145158999991-799399999836876211598999999999972049996311643663067578999
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||.||+|.. .+|+.||+|++......+....+.+.+|+++++.++||||+++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             37089889611768089999998999899999982677458899999999999999748772740344443222223222


Q ss_pred             EECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf             82458870011028885334798999989999999999988269988386279999667769995799422453002569
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+.+|+|..++...+   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf             2334662266675158---989999999999999989999859---9861767999936077897886101033322566


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHH
Q ss_conf             87410133477734521124566687101676999999998399999964433358899831565520469996204458
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  688 (740)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||....       .......+.......+.  ...
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~--~~s  262 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-------PIQIYEKIVSGKVRFPS--HFS  262 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCT--TCC
T ss_pred             ---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHCCCCCCCC--CCC
T ss_conf             ---643367635678899717998853311450078999975889989959-------99999998617988976--689


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHHHHCC
Q ss_conf             8799999999972437999999-----999999999709
Q 004642          689 QDIILVSTIAFACLSSQPKSRP-----TMQRISQELLAG  722 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~~~  722 (740)
                      +   .+.+++.+||+.||.+|+     +++++++|-+..
T Consensus       263 ~---~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~  298 (350)
T d1rdqe_         263 S---DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             H---HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             H---HHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCC
T ss_conf             9---99999999834099860655345499997190515

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=353.57  Aligned_cols=252  Identities=28%  Similarity=0.379  Sum_probs=209.1

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             1565540561145158999991-799399999836876211598999999999972049996311643663067578999
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|+++..........+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf             47088889720768089999998999799999984577548899999999999998636967533035685288005676


Q ss_pred             EECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf             82458870011028885334798999989999999999988269988386279999667769995799422453002569
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||++||++..++....   .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EECCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf             5037863223432222---111007999999998765541247---6770556810503868998898317521671245


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHH
Q ss_conf             87410133477734521124566687101676999999998399999964433358899831565520469996204458
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKIV  688 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  688 (740)
                         ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.....       ......+.......+  ....
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~~~~p--~~~s  225 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAELRFP--PFFN  225 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCCCCCC--TTSC
T ss_pred             ---CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCCCC--CCCC
T ss_conf             ---6434576343599998389998043046533368999759899999699-------999999970898899--7789


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHHHHCC
Q ss_conf             8799999999972437999999-----999999999709
Q 004642          689 QDIILVSTIAFACLSSQPKSRP-----TMQRISQELLAG  722 (740)
Q Consensus       689 ~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~~~  722 (740)
                      +   .+.+++.+|+..||.+|+     +++++++|.+..
T Consensus       226 ~---~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~  261 (316)
T d1fota_         226 E---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK  261 (316)
T ss_dssp             H---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred             H---HHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCC
T ss_conf             9---99999999954499766643102199998193514

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.98  Aligned_cols=254  Identities=24%  Similarity=0.415  Sum_probs=205.7

Q ss_pred             CCCCCCEEEECCCCEEEEEEEEC-CCC----EEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEE
Q ss_conf             15655405611451589999917-993----9999983687621159899999999997204999631164366306757
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGK----VVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCM  524 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  524 (740)
                      ++|++.+.||+|+||+||+|.+. +|+    .||+|+++......  ..+++.+|++++++++|||||+++|+|.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C--THHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CE
T ss_conf             999783198208992999999958998898999999965134979--999999999999867998881589999619-83


Q ss_pred             EEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf             89998245887001102888533479899998999999999998826998838627999966776999579942245300
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      +++++|+.+|+|.+++.....  .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+.
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             EEEEEECCCCCCCCCCCCCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEE
T ss_conf             699984268740101113345--799999999999999999999876---950476212031167998758602552223


Q ss_pred             CCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCHHHHHHCCCCCC
Q ss_conf             2569874--101334777345211245666871016769999999983-9999996443335889983156552046999
Q 004642          605 LHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       605 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (740)
                      .......  .....||+.|+|||++.+..++.++|||||||++|||+| |..||.....        ..+...+.....+
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------~~~~~~i~~~~~~  232 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERL  232 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------GGHHHHHHHTCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHCCCCC
T ss_conf             35444532236510586446708874699983565440799999999779999999998--------9999999759989


Q ss_pred             CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             62044588799999999972437999999999999999709
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      +.+...++   .+.+++.+||+.||++|||+.|++++|...
T Consensus       233 ~~p~~~~~---~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         233 PQPPICTI---DVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             CCCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             99855689---999999984789934691999999999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=347.92  Aligned_cols=256  Identities=24%  Similarity=0.326  Sum_probs=200.1

Q ss_pred             HCCCCCCE-EEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEEE----C
Q ss_conf             21565540-561145158999991-79939999983687621159899999999997204-99963116436630----6
Q 004642          449 TEDFHIKY-CIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLH----K  521 (740)
Q Consensus       449 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~  521 (740)
                      .++|.+.. .||+|+||.||+|.. .+++.||+|+++..        ..+.+|++++.++ +|||||++++++.+    .
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC--------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCC
T ss_conf             148798107965454869999998899989999998974--------779999999998669999782989995034689


Q ss_pred             CEEEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEE
Q ss_conf             757899982458870011028885334798999989999999999988269988386279999667769---99579942
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS---NLEASVAD  598 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~D  598 (740)
                      ...|+||||++||+|.+++...+. ..+++.++..++.|++.||+|||+.   ||+||||||+||+++.   .+.+||+|
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             CEEEEEEECCCCCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             789999977899849999986278-7757999999999999999999976---986444100220113555566311354


Q ss_pred             CCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCC
Q ss_conf             24530025698741013347773452112456668710167699999999839999996443335889983156552046
Q 004642          599 FGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQR  678 (740)
Q Consensus       599 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  678 (740)
                      ||+|+...... ......||+.|+|||++.+..|+.++||||+||++|+|++|+.||.........   ...........
T Consensus       158 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~  233 (335)
T d2ozaa1         158 FGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQ  233 (335)
T ss_dssp             CTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS
T ss_pred             CCEEEECCCCC-CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHH---HHHHHHHHCCC
T ss_conf             55123336888-643226775637927774898888888876451677886588998898877889---99999985388


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             9996204458879999999997243799999999999999970
Q 004642          679 LSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       679 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  721 (740)
                      ...+. .........+.+++.+|++.||++|||+.|+++|-+.
T Consensus       234 ~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  275 (335)
T d2ozaa1         234 YEFPN-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  275 (335)
T ss_dssp             SSCCT-THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred             CCCCC-CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf             88898-5434699999999999756996579099999709876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.14  Aligned_cols=255  Identities=24%  Similarity=0.302  Sum_probs=208.9

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEE
Q ss_conf             215655405611451589999917-9939999983687621159899999999997204999631164366306757899
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  527 (740)
                      .++|++.+.||+|+||+||+|... +++.||+|+++.....    ...+.+|++++..++||||+++++++.+++..|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf             01058878983177839999999899969999997578665----99999999999857997989098999889988999


Q ss_pred             EEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCEEEEECCCCEEC
Q ss_conf             9824588700110288853347989999899999999999882699883862799996677699--95799422453002
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSN--LEASVADFGTARLL  605 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~DfG~a~~~  605 (740)
                      |||++||+|.+++...+  ..+++.++..++.||+.||+|||+.   ||+||||||+|||++.+  ..+||+|||+++..
T Consensus        80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EECCCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCC
T ss_conf             95389980889987538--9999999999999999999999876---997513554443443788518997644111003


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHH
Q ss_conf             56987410133477734521124566687101676999999998399999964433358899831565520469996204
Q 004642          606 HVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       606 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  685 (740)
                      ... .......+++.|+|||...+..++.++||||+||++|+|++|+.||.....       ......+.......+.. 
T Consensus       155 ~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~-  225 (321)
T d1tkia_         155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEYTFDEE-  225 (321)
T ss_dssp             CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCCCCHH-
T ss_pred             CCC-CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHHCCCCCCHH-
T ss_conf             467-753212233222340210487778401130279999999828999999899-------99999998389998802-


Q ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             458879999999997243799999999999999970
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  721 (740)
                      ........+.+++.+|+..||++|||++|+++|.+.
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  261 (321)
T d1tkia_         226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf             236789999999999866996689099999639965

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.75  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=207.3

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCEEEEEEEECCEEEEE
Q ss_conf             1565540561145158999991-799399999836876211598999999999972-04999631164366306757899
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLS-TVRHRNIVKLYGFCLHKKCMFLI  527 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv  527 (740)
                      ++|.+.+.||+|+||+||+|.. .+++.||||+++..........+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf             97188658940878289999999999899999980555338489999999999999847999687898897049831677


Q ss_pred             EEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf             98245887001102888533479899998999999999998826998838627999966776999579942245300256
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++|+|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEECCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf             75037980899864047---899999999999999999999868---934034765404444899630155530232356


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHH
Q ss_conf             98741013347773452112456668710167699999999839999996443335889983156552046999620445
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQKI  687 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  687 (740)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ......+....+.  .+...
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~~--~p~~~  226 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDNPF--YPRWL  226 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTTS
T ss_pred             CCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCCCC--CCCCC
T ss_conf             65334545787776899998279988323201122789898738899999899-------9999999718998--97567


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHH-HHHHHHHC
Q ss_conf             88799999999972437999999999-99999970
Q 004642          688 VQDIILVSTIAFACLSSQPKSRPTMQ-RISQELLA  721 (740)
Q Consensus       688 ~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~L~~  721 (740)
                      .+   .+.+++.+||..||++||++. ++++|.+.
T Consensus       227 s~---~~~dli~~~L~~dP~~R~s~~~~l~~hpff  258 (320)
T d1xjda_         227 EK---EAKDLLVKLFVREPEKRLGVRGDIRQHPLF  258 (320)
T ss_dssp             CH---HHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred             CH---HHHHHHHHHCCCCCCCCCCHHHHHHHCCHH
T ss_conf             99---999999996544898783889999809013

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.81  Aligned_cols=257  Identities=28%  Similarity=0.415  Sum_probs=206.9

Q ss_pred             CCCCCCEEEECCCCEEEEEEEEC-CCC--EEEEEECCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEEECCEEE
Q ss_conf             15655405611451589999917-993--9999983687621159899999999997204-9996311643663067578
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELP-EGK--VVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  525 (740)
                      ++|++.+.||+|+||+||+|.++ ++.  .||||++......+  ..+.+.+|++++.++ +|||||+++|++.+++..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHH--HHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
T ss_conf             9968877982078828999999899969999999978233857--99999999999986228998836788884187369


Q ss_pred             EEEEECCCCCCHHHHCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC
Q ss_conf             9998245887001102888-------------533479899998999999999998826998838627999966776999
Q 004642          526 LIYEYMERGSLFCVLHDDD-------------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL  592 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~  592 (740)
                      +||||+++|+|.++++...             ....+++..+..++.||+.||.|+|+.   +|+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCC
T ss_conf             99980289869999864035555512310123457899999999999999998766308---954555052048986887


Q ss_pred             CEEEEECCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCCCCCCCCCCCCCHH
Q ss_conf             5799422453002569874101334777345211245666871016769999999983999-999644333588998315
Q 004642          593 EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTH-PGGLLSSLSSSSGPKIML  671 (740)
Q Consensus       593 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-p~~~~~~~~~~~~~~~~~  671 (740)
                      .+||+|||+|+..... .......||..|+|||.+.+..++.++||||||+++|||++|.. ||....        ...+
T Consensus       165 ~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~~~  235 (309)
T d1fvra_         165 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAEL  235 (309)
T ss_dssp             CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHH
T ss_pred             CEEECCCCCCCCCCCC-CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCC--------HHHH
T ss_conf             6387434432244422-345530137755553875269999622153138899999836899999999--------9999


Q ss_pred             HHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             6552046999620445887999999999724379999999999999997099
Q 004642          672 IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  723 (740)
                      .+.+.....++.+...++   .+.+++.+||+.||++|||++|++++|....
T Consensus       236 ~~~i~~~~~~~~~~~~~~---~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         236 YEKLPQGYRLEKPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             HHHGGGTCCCCCCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHCCCCCCCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             999982688888766789---9999999976789668949999999999998

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.52  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=210.4

Q ss_pred             CCCCCCEEEECCCCEEEEEEEECC--C--CEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEE
Q ss_conf             156554056114515899999179--9--399999836876211598999999999972049996311643663067578
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPE--G--KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  525 (740)
                      ++|++.+.||+|+||.||+|+...  +  ..||||++......+....++|.+|++++++++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CHH
T ss_conf             8919978980388839999999889990799999999835557989999999999999868999987898777401-001


Q ss_pred             EEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf             99982458870011028885334798999989999999999988269988386279999667769995799422453002
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLL  605 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~  605 (740)
                      +||||+++|++.+++....  ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEECCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf             1465423861254442126--8999999999999999999875217---8752056688815655654332561155530


Q ss_pred             CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCHHHHHHCCCCCC
Q ss_conf             569874---101334777345211245666871016769999999983-9999996443335889983156552046999
Q 004642          606 HVDSSY---RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSP  681 (740)
Q Consensus       606 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  681 (740)
                      ......   .....|+..|+|||++.+..++.++||||||+++|||+| |+.||.....       ......+......+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-------~~~~~~i~~~~~~~  234 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEGERL  234 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSCCCC
T ss_pred             CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHHCCCCC
T ss_conf             35887526547632573107999983799994215661489999999689999999699-------99999998479999


Q ss_pred             CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             62044588799999999972437999999999999999709
Q 004642          682 PVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       682 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      +.....++   .+.+++.+||+.||++||||++|.+.|.+.
T Consensus       235 ~~~~~~~~---~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         235 PRPEDCPQ---DIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf             98544539---999999997688966792999999999964

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.80  Aligned_cols=260  Identities=23%  Similarity=0.337  Sum_probs=206.8

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEEC------CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEEE
Q ss_conf             7215655405611451589999917------9939999983687621159899999999997204-99963116436630
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLH  520 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  520 (740)
                      ..++|++.+.||+|+||.||+|...      +++.||||+++......  ..+.+.+|.+.+.++ +|+||+.+++++.+
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCH--HHHHHHHHHHHHHHHCCCCEEEEEEEEECC
T ss_conf             679979844984167839999998677755578399999986001717--899999999998861499849974115404


Q ss_pred             C-CEEEEEEEECCCCCCHHHHCCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCE
Q ss_conf             6-757899982458870011028885-------------33479899998999999999998826998838627999966
Q 004642          521 K-KCMFLIYEYMERGSLFCVLHDDDE-------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNI  586 (740)
Q Consensus       521 ~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NI  586 (740)
                      . ...++||||+++|+|.++++....             ...+++.++..++.||+.||+|||++   +|+||||||+||
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI  165 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  165 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             CCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCE
T ss_conf             79757999984589929999985366666532220233214689999999999999999988737---971786773106


Q ss_pred             EECCCCCEEEEECCCCEECCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCC
Q ss_conf             776999579942245300256987--410133477734521124566687101676999999998399-99996443335
Q 004642          587 LLDSNLEASVADFGTARLLHVDSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGT-HPGGLLSSLSS  663 (740)
Q Consensus       587 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~  663 (740)
                      |++.++.+||+|||+|+.......  ......||+.|+|||++.+..++.++|||||||++|||++|. .||....    
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~----  241 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK----  241 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred             EECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCC----
T ss_conf             5779982898457520011356652224751667210203686468899663221367899999868899998999----


Q ss_pred             CCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             88998315655204699962044588799999999972437999999999999999709
Q 004642          664 SSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                         ........+.....+..+....+   .+.+++.+||+.||++|||++|++++|+..
T Consensus       242 ---~~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         242 ---IDEEFCRRLKEGTRMRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             ---CSHHHHHHHHHTCCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHHCCCCCCCCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             ---89999999963898888865789---999999997677966791999999999799

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=346.15  Aligned_cols=260  Identities=25%  Similarity=0.379  Sum_probs=213.1

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEE------CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEEE
Q ss_conf             721565540561145158999991------79939999983687621159899999999997204-99963116436630
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAEL------PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCLH  520 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  520 (740)
                      ..++|++.+.||+|+||.||+|.+      .+++.||||+++.....  .....+.+|+.++..+ +|||||+++|++.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCH--HHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
T ss_conf             78996985498206882999999806644778869999998742487--7999999999998762699988789989831


Q ss_pred             CCEEEEEEEECCCCCCHHHHCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC
Q ss_conf             675789998245887001102888---------------53347989999899999999999882699883862799996
Q 004642          521 KKCMFLIYEYMERGSLFCVLHDDD---------------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNN  585 (740)
Q Consensus       521 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~N  585 (740)
                      ++..+++|||+++|+|.++++...               ....+++..+..++.||++||+|||++   +++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCC
T ss_conf             997899997379987999998535665444445332223345889999999999999999988757---92666241021


Q ss_pred             EEECCCCCEEEEECCCCEECCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCC
Q ss_conf             67769995799422453002569874--1013347773452112456668710167699999999839-99999644333
Q 004642          586 ILLDSNLEASVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMG-THPGGLLSSLS  662 (740)
Q Consensus       586 Ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~p~~~~~~~~  662 (740)
                      |+++.++.+|++|||.++........  .....||+.|+|||++.+..++.++||||||+++|||+|+ .+|+..     
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~-----  250 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-----  250 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-----
T ss_pred             CCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC-----
T ss_conf             000025752102340102336788615862013596876778861799997400102589999998589988778-----


Q ss_pred             CCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             588998315655204699962044588799999999972437999999999999999709
Q 004642          663 SSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                        ......+.+.+.....+..+...++.   +.+++.+||+.||++||||+|+++.|+..
T Consensus       251 --~~~~~~~~~~i~~~~~~~~~~~~~~~---l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         251 --MPVDSKFYKMIKEGFRMLSPEHAPAE---MYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             --CCSSHHHHHHHHHTCCCCCCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCHHHHHHHHHHCCCCCCCCCCCCHH---HHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             --99899999998668988985436599---99999997577965792999999999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=346.14  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=211.6

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC----E
Q ss_conf             21565540561145158999991-799399999836876211598999999999972049996311643663067----5
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK----C  523 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~  523 (740)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+++.....+....+.+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf             62069868996089929999999999989999998556646989999999999999856999887311435432688766


Q ss_pred             EEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf             78999824588700110288853347989999899999999999882699883862799996677699957994224530
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      .|+||||++|++|.+++...+   .+++.++..++.|++.||+|||+.   ||+||||||+||+++.++..+++|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEEHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf             999997788987101120358---999999999999999999999857---95276346755665754320100344432


Q ss_pred             ECCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCC
Q ss_conf             0256987---4101334777345211245666871016769999999983999999644333588998315655204699
Q 004642          604 LLHVDSS---YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLS  680 (740)
Q Consensus       604 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  680 (740)
                      .......   ......||+.|+|||++.+..++.++||||+||++|||+||+.||.....       .......+.....
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~~~~~~~~  232 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVREDPI  232 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCCC
T ss_pred             HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCH-------HHHHHHHHHCCCC
T ss_conf             212354433334642576243699998399999663202652899999769799899699-------9999999846999


Q ss_pred             CCCHHHHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHC
Q ss_conf             962044588799999999972437999999-99999999970
Q 004642          681 PPVNQKIVQDIILVSTIAFACLSSQPKSRP-TMQRISQELLA  721 (740)
Q Consensus       681 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~  721 (740)
                      ++.. ........+.+++.+|+++||++|| |++++++.|..
T Consensus       233 ~~~~-~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         233 PPSA-RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CGGG-TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCH-HCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf             9710-0347899999999998667976777399999999999

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=346.45  Aligned_cols=255  Identities=24%  Similarity=0.380  Sum_probs=206.2

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEECC----CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEE
Q ss_conf             2156554056114515899999179----939999983687621159899999999997204999631164366306757
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE----GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCM  524 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  524 (740)
                      .++|++.+.||+|+||.||+|.+..    +..||+|.++....  ....+.+.+|++++++++||||++++|++.+ +..
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEE
T ss_conf             8996987799307882999999936996449999999365668--7999999999999986899998569889953-747


Q ss_pred             EEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf             89998245887001102888533479899998999999999998826998838627999966776999579942245300
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ++||||+++|++.+++.....  .+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||+|+.
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEEECCCCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf             999984069807765422478--999999999999998775230226---744141026553206789678765034213


Q ss_pred             CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCC
Q ss_conf             2569874-101334777345211245666871016769999999983-99999964433358899831565520469996
Q 004642          605 LHVDSSY-RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPP  682 (740)
Q Consensus       605 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  682 (740)
                      ....... .....||+.|+|||++.+..++.++|||||||++|||++ |..||.....       ......+. ....++
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-------~~~~~~i~-~~~~~~  229 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIE-NGERLP  229 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-------GGHHHHHH-TTCCCC
T ss_pred             CCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH-------HHHHHHHH-CCCCCC
T ss_conf             3677623305400583103266751699887452444247899998269999888999-------99999998-189998


Q ss_pred             CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             2044588799999999972437999999999999999709
Q 004642          683 VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       683 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      .+...++   .+.+++.+||+.||++|||++|++++|...
T Consensus       230 ~~~~~~~---~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         230 MPPNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             9877799---999999997687976892999999999999

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=344.42  Aligned_cols=259  Identities=24%  Similarity=0.315  Sum_probs=209.6

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCC------HHHHHHHHHHHHHHHCCC-CCCCCEEEEEEEE
Q ss_conf             21565540561145158999991-799399999836876211------598999999999972049-9963116436630
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETED------SAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLH  520 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  520 (740)
                      .++|++.+.||+|+||+||+|+. .+++.||||++.......      ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf             66388852884176849999999999989999999624464114788899999999999999985079974799762146


Q ss_pred             CCEEEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf             67578999824588700110288853347989999899999999999882699883862799996677699957994224
Q 004642          521 KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFG  600 (740)
Q Consensus       521 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG  600 (740)
                      ++..|+||||+++|+|.+++...+   .+++.++..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCEEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCH
T ss_conf             760599997689866899998659---999999999999999999999875---99432346254898689983871240


Q ss_pred             CCEECCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf             53002569874101334777345211245------666871016769999999983999999644333588998315655
Q 004642          601 TARLLHVDSSYRTLRAGTYGYIAPELAYT------IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDV  674 (740)
Q Consensus       601 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  674 (740)
                      +++...... ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||.....       ......+
T Consensus       156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-------~~~~~~i  227 (277)
T d1phka_         156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMI  227 (277)
T ss_dssp             TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHH
T ss_pred             HEEECCCCC-CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCH-------HHHHHHH
T ss_conf             316726887-21345246788898886053445678899233185656023103228889889999-------9999999


Q ss_pred             HCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             204699962044588799999999972437999999999999999709
Q 004642          675 LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      .......... ........+.+++.+||++||++|||++|+++|-+..
T Consensus       228 ~~~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~  274 (277)
T d1phka_         228 MSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  274 (277)
T ss_dssp             HHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHH
T ss_conf             8189888985-4346899999999997658966891999997397879

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=347.04  Aligned_cols=270  Identities=23%  Similarity=0.268  Sum_probs=205.4

Q ss_pred             CCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCC--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEEEE
Q ss_conf             540561145158999991-799399999836876211--59899999999997204999631164366306757899982
Q 004642          454 IKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETED--SAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYEY  530 (740)
Q Consensus       454 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  530 (740)
                      ..+.||+|+||+||+|.. .+|+.||||+++......  ....+.+.+|++++++++|||||++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf             56385127282999999999996999999842021245679999999999999867999986898542258740220455


Q ss_pred             CCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCC
Q ss_conf             45887001102888533479899998999999999998826998838627999966776999579942245300256987
Q 004642          531 MERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDSS  610 (740)
Q Consensus       531 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  610 (740)
                      ++++.+........   .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||.|+.......
T Consensus        82 ~~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             HCCHHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC
T ss_conf             34507765541266---778999999999999999886316---355035776258853778411465761000578755


Q ss_pred             CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC----------CCCC---C-CHHHH--
Q ss_conf             4101334777345211245-6668710167699999999839999996443335----------8899---8-31565--
Q 004642          611 YRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS----------SSGP---K-IMLID--  673 (740)
Q Consensus       611 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~----------~~~~---~-~~~~~--  673 (740)
                      .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||........          ....   . .....  
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHH
T ss_conf             43302047333639997267788805643630428999985969999999999999999851899725452100021344


Q ss_pred             HHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCHHH
Q ss_conf             52046999620445887999999999724379999999999999997099988132
Q 004642          674 VLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKA  729 (740)
Q Consensus       674 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~  729 (740)
                      ........+...........+.+++.+|++.||++|||++|+++|-+....|.+..
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~  291 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP  291 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred             HHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCC
T ss_conf             30347898867856568999999999976389456908999967996578999989

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.69  Aligned_cols=253  Identities=24%  Similarity=0.343  Sum_probs=201.8

Q ss_pred             CEEEECCCCEEEEEEEECCC----CEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE-CCEEEEEEE
Q ss_conf             40561145158999991799----3999998368762115989999999999720499963116436630-675789998
Q 004642          455 KYCIGTGGYGSVYKAELPEG----KVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH-KKCMFLIYE  529 (740)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  529 (740)
                      .++||+|+||+||+|.+..+    ..||||+++...  .....++|.+|++++.+++||||++++|++.. ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf             669813688099999997799879999999988436--978999999999999867899986786789806994389998


Q ss_pred             ECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCC
Q ss_conf             24588700110288853347989999899999999999882699883862799996677699957994224530025698
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      |+++|+|.+++.....  ..++..++.++.|++.||.|+|+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       110 ~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEECCCHHHHHCCCCC--CCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf             7406741442101345--404899999999988765200336---76257766875767799988991065232255665


Q ss_pred             CC----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHH
Q ss_conf             74----10133477734521124566687101676999999998399999964433358899831565520469996204
Q 004642          610 SY----RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQ  685 (740)
Q Consensus       610 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  685 (740)
                      ..    .....||+.|+|||.+....++.++||||||+++|||++|..||....      .... ....+.....+..+.
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~------~~~~-~~~~i~~g~~~~~p~  257 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFD-ITVYLLQGRRLLQPE  257 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCCCCCT
T ss_pred             CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC------CHHH-HHHHHHCCCCCCCCC
T ss_conf             553100256555645567688743799974574661999999997899998889------9999-999998089889964


Q ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf             458879999999997243799999999999999970999
Q 004642          686 KIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKT  724 (740)
Q Consensus       686 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~  724 (740)
                      ...+   .+.+++.+||+.||++||++.||+++|+....
T Consensus       258 ~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         258 YCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             4759---99999999768897689399999999999997

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=346.19  Aligned_cols=250  Identities=24%  Similarity=0.397  Sum_probs=206.6

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE-CCEEEEE
Q ss_conf             215655405611451589999917993999998368762115989999999999720499963116436630-6757899
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH-KKCMFLI  527 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv  527 (740)
                      .++|++.+.||+|+||.||+|+. .|+.||||+++....     .+.+.+|++++++++||||++++|++.+ ++..++|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             HHHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCHHH-----HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf             89948857982079808999999-990999999885777-----999999999998678989854987887238928999


Q ss_pred             EEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf             98245887001102888533479899998999999999998826998838627999966776999579942245300256
Q 004642          528 YEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHV  607 (740)
Q Consensus       528 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~  607 (740)
                      |||+++|+|.+++.... ...+++..+++++.||+.||.|||+.   +++||||||+||+++.++.+|++|||+++....
T Consensus        80 ~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EECCCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCC
T ss_conf             96369998999987457-88889999999999998523211337---655366656760146899776324560034478


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHH
Q ss_conf             9874101334777345211245666871016769999999983-999999644333588998315655204699962044
Q 004642          608 DSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSSSSGPKIMLIDVLNQRLSPPVNQK  686 (740)
Q Consensus       608 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  686 (740)
                      .   .....++..|+|||++.+..++.++||||||+++|||+| |+.||....        ...+...+.....++.+..
T Consensus       156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--------~~~~~~~i~~~~~~~~~~~  224 (262)
T d1byga_         156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKGYKMDAPDG  224 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--------GGGHHHHHTTTCCCCCCTT
T ss_pred             C---CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC--------HHHHHHHHHCCCCCCCCCC
T ss_conf             7---7655666467781787279888588777579999999978999999999--------9999999980899999765


Q ss_pred             HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             588799999999972437999999999999999709
Q 004642          687 IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       687 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      ..+   .+.+++.+||+.||++|||+.+++++|+..
T Consensus       225 ~~~---~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         225 CPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             799---999999997566976893999999999999

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.29  Aligned_cols=265  Identities=26%  Similarity=0.361  Sum_probs=202.0

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC----EE
Q ss_conf             21565540561145158999991799399999836876211598999999999972049996311643663067----57
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK----CM  524 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~  524 (740)
                      .++|.+.++||+|+||.||+|+. +|+.||||+++.....    ......|+..+.+++||||++++|++.+.+    ..
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCCHH----HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEE
T ss_conf             86899988982078819999999-9989999998720046----799999999996279986832688998379860489


Q ss_pred             EEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf             89998245887001102888533479899998999999999998826-----9988386279999667769995799422
Q 004642          525 FLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHD-----CTLSIIHRDISSNNILLDSNLEASVADF  599 (740)
Q Consensus       525 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~Df  599 (740)
                      ++||||+++|+|.+++++.    .++|..++.++.|+|.||+|+|+.     ...+|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEECCCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEEC
T ss_conf             9999646698989998658----999899999999999999998876652046898661531731357868877688763


Q ss_pred             CCCEECCCCCC----CCCCCCCCCCCCCCCCCCCC------CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC---
Q ss_conf             45300256987----41013347773452112456------668710167699999999839999996443335889---
Q 004642          600 GTARLLHVDSS----YRTLRAGTYGYIAPELAYTI------VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG---  666 (740)
Q Consensus       600 G~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~---  666 (740)
                      |+++.......    ......||+.|+|||++.+.      .++.++|||||||++|||+||..|++..........   
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCC
T ss_conf             86623467776200135525035476782210565454677767501220159999999628998876631124101225


Q ss_pred             ---C--CCHHHHHHCCCCCCCCHHH--HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             ---9--8315655204699962044--588799999999972437999999999999999709
Q 004642          667 ---P--KIMLIDVLNQRLSPPVNQK--IVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       667 ---~--~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                         .  .........+...+..+..  ..+....+.+++.+||+.||++|||+.|++++|...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             564309999998750246888776557768999999999997606985895999999999988

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.67  Aligned_cols=265  Identities=23%  Similarity=0.336  Sum_probs=212.2

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEEC------CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
Q ss_conf             7215655405611451589999917------9939999983687621159899999999997204999631164366306
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAELP------EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK  521 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  521 (740)
                      ..++|++.+.||+|+||+||+|.+.      +++.||||+++.....  .....+.+|++++++++||||++++|++...
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf             68991883598207881899999878644778968999998701286--8999999999999976999884125478428


Q ss_pred             CEEEEEEEECCCCCCHHHHCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf             75789998245887001102888-------53347989999899999999999882699883862799996677699957
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDD-------EAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEA  594 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~  594 (740)
                      +..++||||+++|+|.+++....       ....+++..+..++.|+++||.|||++   +|+||||||+|||++.++.+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred             CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEE
T ss_conf             810677760489988999875033211344468879999999999999999987647---96543286775403599649


Q ss_pred             EEEECCCCEECCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCCCCCCCCHH
Q ss_conf             99422453002569874--10133477734521124566687101676999999998399-9999644333588998315
Q 004642          595 SVADFGTARLLHVDSSY--RTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGT-HPGGLLSSLSSSSGPKIML  671 (740)
Q Consensus       595 kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~  671 (740)
                      ||+|||+|+........  .....|++.|+|||.+.+..++.++||||||+++|||+||. .||.....       ....
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-------~~~~  245 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQVL  245 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HHHH
T ss_pred             EEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH-------HHHH
T ss_conf             994245420235776303134023163237888873699883334443789999999689999999899-------9999


Q ss_pred             HHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCHH
Q ss_conf             655204699962044588799999999972437999999999999999709998813
Q 004642          672 IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQK  728 (740)
Q Consensus       672 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~  728 (740)
                      ..+.+. ..++.+...+   ..+.+++.+||+.+|++|||+++++++|+....|.-+
T Consensus       246 ~~i~~~-~~~~~p~~~~---~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~  298 (308)
T d1p4oa_         246 RFVMEG-GLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  298 (308)
T ss_dssp             HHHHTT-CCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             HHHHHC-CCCCCCCCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCCCC
T ss_conf             999808-8888863353---9999999997577965893999999997876177875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.74  Aligned_cols=268  Identities=21%  Similarity=0.255  Sum_probs=206.0

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             1565540561145158999991-799399999836876211598999999999972049996311643663067578999
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||+||+|.. .+++.||+|+++..... +...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf             9977651772376809999999999979999998022257-589999999999998679983887445332243203788


Q ss_pred             EECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf             82458870011028885334798999989999999999988269988386279999667769995799422453002569
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      ||+.++.+........  ..+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||.|+.....
T Consensus        81 e~~~~~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          81 EFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             ECCSEEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             EECCCCHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCC
T ss_conf             6237744555442025--6888899999999999999986528---8992135711401134676210357861343688


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC----------CCCC-CCCHHHHHHC
Q ss_conf             87410133477734521124566-6871016769999999983999999644333----------5889-9831565520
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVLMGTHPGGLLSSLS----------SSSG-PKIMLIDVLN  676 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~----------~~~~-~~~~~~~~~~  676 (740)
                      ........||+.|+|||...... ++.++||||+||++|+|++|+.||.......          .... ..........
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCC
T ss_conf             64100103652154112213665777422103333134279668799898899999999998328983331444222421


Q ss_pred             ------CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             ------46999620445887999999999724379999999999999997099
Q 004642          677 ------QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       677 ------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  723 (740)
                            .................+.+++.+|++.||++|||++|+++|-+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~  288 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD  288 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             24345432222044416678999999999976399557918999967870146

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.16  Aligned_cols=258  Identities=26%  Similarity=0.389  Sum_probs=211.3

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEECC--------CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEE
Q ss_conf             2156554056114515899999179--------939999983687621159899999999997204-9996311643663
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELPE--------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV-RHRNIVKLYGFCL  519 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  519 (740)
                      .++|++.+.||+|+||.||+|+...        +..||||+++.....  ....++.+|...+.++ +|||||++++++.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCH--HHHHHHHHHHHHHHHHCCCCEEEECCCCCC
T ss_conf             899697009851678289999985787555667549999998811286--889999999999998139996973465220


Q ss_pred             ECCEEEEEEEECCCCCCHHHHCCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCE
Q ss_conf             06757899982458870011028885-------------33479899998999999999998826998838627999966
Q 004642          520 HKKCMFLIYEYMERGSLFCVLHDDDE-------------AIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNI  586 (740)
Q Consensus       520 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NI  586 (740)
                      +++..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+.   +|+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCE
T ss_conf             18868999973699909999986067764322233457434679999999999999999876637---978630221022


Q ss_pred             EECCCCCEEEEECCCCEECCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCC
Q ss_conf             776999579942245300256987--4101334777345211245666871016769999999983-9999996443335
Q 004642          587 LLDSNLEASVADFGTARLLHVDSS--YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLM-GTHPGGLLSSLSS  663 (740)
Q Consensus       587 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~p~~~~~~~~~  663 (740)
                      |++.++.+||+|||+++.......  ......+++.|+|||.+.+..|+.++||||||+++|||++ |..||.....   
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---  243 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  243 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             EECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH---
T ss_conf             45478976762211101135555543146678884663266751798882555477588888740179898999999---


Q ss_pred             CCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             88998315655204699962044588799999999972437999999999999999709
Q 004642          664 SSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       664 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                           ....+.+.....++.+....+   .+.+++.+||+.||.+|||+.|+++.|+..
T Consensus       244 -----~~~~~~i~~~~~~~~p~~~~~---~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         244 -----EELFKLLKEGHRMDKPSNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             -----HHHHHHHHTTCCCCCCSSCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHHHHHHCCCCCCCCCCCHH---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -----999999972888898743529---999999997667976793999999999888

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=336.83  Aligned_cols=265  Identities=23%  Similarity=0.302  Sum_probs=207.4

Q ss_pred             CCCCCCEEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf             15655405611451589999917993999998368762115989999999999720499963116436630675789998
Q 004642          450 EDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIYE  529 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  529 (740)
                      ++|++.+.||+|+||+||+|+.++|+.||||++......+ ...+.+.+|+.++++++||||+++++++...+..++++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCH-HHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEE
T ss_conf             9963431872277818999996899999999981232685-899999999999986799868766012046773158997


Q ss_pred             ECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCC
Q ss_conf             24588700110288853347989999899999999999882699883862799996677699957994224530025698
Q 004642          530 YMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVDS  609 (740)
Q Consensus       530 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~~  609 (740)
                      ++.++.+..+.....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||.|.......
T Consensus        81 ~~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CCSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             EEHHHHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf             400456789986047---751445689999999999986057---48826787750568689978732366430114676


Q ss_pred             CCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC----------CCCCCC-CHHHHH---
Q ss_conf             741013347773452112456-66871016769999999983999999644333----------588998-315655---
Q 004642          610 SYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS----------SSSGPK-IMLIDV---  674 (740)
Q Consensus       610 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~----------~~~~~~-~~~~~~---  674 (740)
                      .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.......          ...... ......   
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf             54101024311013788717888884100211175899997797998988989999999986389971104212333221


Q ss_pred             ---HCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             ---20469996204458879999999997243799999999999999970
Q 004642          675 ---LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       675 ---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  721 (740)
                         .......+...........+.+++.+|++.||++|||++|+++|.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f  284 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf             43333356764666512589999999999866896689099998569220

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.25  Aligned_cols=260  Identities=23%  Similarity=0.334  Sum_probs=206.4

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCH---HHHHHHHHHHHHHHCCC--CCCCCEEEEEEEECC
Q ss_conf             21565540561145158999991-7993999998368762115---98999999999972049--996311643663067
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDS---AFVKSFQNEAHVLSTVR--HRNIVKLYGFCLHKK  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~  522 (740)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++......+.   ....++.+|+.++++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf             88379967984087839999999999979999998568844334556799999999999974358988127999983099


Q ss_pred             EEEEEEEECCC-CCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEEECC
Q ss_conf             57899982458-870011028885334798999989999999999988269988386279999667769-9957994224
Q 004642          523 CMFLIYEYMER-GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-NLEASVADFG  600 (740)
Q Consensus       523 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DfG  600 (740)
                      ..++||||+.+ +++.+++....   .+++.++..++.|++.||+|||++   +|+||||||+||+++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEEECCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf             68999983368622899986158---999999999999999999999877---975566761114774478848977546


Q ss_pred             CCEECCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHCCCC
Q ss_conf             53002569874101334777345211245666-87101676999999998399999964433358899831565520469
Q 004642          601 TARLLHVDSSYRTLRAGTYGYIAPELAYTIVV-TGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLNQRL  679 (740)
Q Consensus       601 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  679 (740)
                      +|+....  ...+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....             ......
T Consensus       157 ~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~~~  221 (273)
T d1xwsa_         157 SGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQV  221 (273)
T ss_dssp             TCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCCC
T ss_pred             CCEECCC--CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH-------------HHHCCC
T ss_conf             5353244--4556656587747999984899788653325540345367568899887367-------------761544


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCHHHHHCCC
Q ss_conf             9962044588799999999972437999999999999999709998813220034
Q 004642          680 SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKALKEIS  734 (740)
Q Consensus       680 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~~~~  734 (740)
                      ..+  ....+   .+.+++.+||+.||++|||++|+++|.+......+++..|+.
T Consensus       222 ~~~--~~~s~---~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p~e~~~~~  271 (273)
T d1xwsa_         222 FFR--QRVSS---ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH  271 (273)
T ss_dssp             CCS--SCCCH---HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHHHHHHH
T ss_pred             CCC--CCCCH---HHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCCCCCCC
T ss_conf             778--77999---999999997608975893999985398667887888744467

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=333.65  Aligned_cols=267  Identities=22%  Similarity=0.311  Sum_probs=198.6

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCC---CCCCCCEEEEEEEE---
Q ss_conf             21565540561145158999991-79-939999983687621159899999999997204---99963116436630---
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PE-GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTV---RHRNIVKLYGFCLH---  520 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---  520 (740)
                      .++|++.+.||+|+||+||+|.. ++ ++.||+|+++.....+.. ...+.+|+.+++.+   +||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHH-HHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf             589798889921558699999998889989999998023245167-9999999999998742589880236632214666


Q ss_pred             --CCEEEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf             --675789998245887001102888533479899998999999999998826998838627999966776999579942
Q 004642          521 --KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVAD  598 (740)
Q Consensus       521 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  598 (740)
                        ....+++|||++++.+........  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCCEEEEEEEECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEECC
T ss_conf             66746999997405871444443037--8999899999999999999999758---898357986278985899754210


Q ss_pred             CCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC----------------
Q ss_conf             2453002569874101334777345211245666871016769999999983999999644333----------------
Q 004642          599 FGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS----------------  662 (740)
Q Consensus       599 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~----------------  662 (740)
                      ||.+...... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.......                
T Consensus       160 fg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         160 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             HHHHHHHCCC-CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHC
T ss_conf             0010110023-457776548511483100179888111000328999999878799899898999999998407996110


Q ss_pred             CCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             5889983156552046999620445887999999999724379999999999999997099
Q 004642          663 SSSGPKIMLIDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  723 (740)
                      +...... ...........+...........+.+++.+||+.||++|||++|+++|.+...
T Consensus       239 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~  298 (305)
T d1blxa_         239 WPRDVAL-PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  298 (305)
T ss_dssp             SCTTCSS-CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             CCCCCCC-HHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             5321111-03330223456454404458999999999987489667918999966963407

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=326.95  Aligned_cols=274  Identities=20%  Similarity=0.266  Sum_probs=206.8

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE-------
Q ss_conf             21565540561145158999991-7993999998368762115989999999999720499963116436630-------
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH-------  520 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------  520 (740)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++......+ ...+++.+|+++++.++|||++++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCH-HHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCC
T ss_conf             279889999722748299999998999799999984222463-7899999999999983599966067654024654444


Q ss_pred             -CCEEEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf             -6757899982458870011028885334798999989999999999988269988386279999667769995799422
Q 004642          521 -KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADF  599 (740)
Q Consensus       521 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df  599 (740)
                       .+..++||||++++.+........   .++...+..++.|++.||.|||+.   ||+||||||+|||++.++.+|++||
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CCCEEEEEEECCCCCCCCHHHHCCC---CCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEEC
T ss_conf             5763899985357874101222034---433089999999999999885229---9885676722203668996876313


Q ss_pred             CCCEECCCCCC----CCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC-----------
Q ss_conf             45300256987----41013347773452112456-668710167699999999839999996443335-----------
Q 004642          600 GTARLLHVDSS----YRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS-----------  663 (740)
Q Consensus       600 G~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~-----------  663 (740)
                      |+++.......    ......||+.|+|||++.+. .++.++||||+||++|||++|+.||........           
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             CEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf             50022355444321135660249787428997079998917870067864661744879989989999999999841899


Q ss_pred             -----CCCCCCHHHHHHCCCCCCCC-HHHH---HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCHHH
Q ss_conf             -----88998315655204699962-0445---887999999999724379999999999999997099988132
Q 004642          664 -----SSGPKIMLIDVLNQRLSPPV-NQKI---VQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGKTPMQKA  729 (740)
Q Consensus       664 -----~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~  729 (740)
                           .................... ....   ......+.+++.+||+.||++|||++|+++|-+....|.+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~  316 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD  316 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred             CHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCC
T ss_conf             825534432034443320133445550334044459989999999987389658909999974950156999978

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=327.85  Aligned_cols=266  Identities=21%  Similarity=0.270  Sum_probs=200.6

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEE-ECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC----
Q ss_conf             72156554056114515899999-1799399999836876211598999999999972049996311643663067----
Q 004642          448 ATEDFHIKYCIGTGGYGSVYKAE-LPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK----  522 (740)
Q Consensus       448 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  522 (740)
                      ..++|++.+.||+|+||+||+|. ..+|+.||||++.....  ....+.+.+|++++++++|||++++++++....    
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCC
T ss_conf             38985997899406480999999999994999999803109--5899999999999997689898858889950564554


Q ss_pred             EEEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf             57899982458870011028885334798999989999999999988269988386279999667769995799422453
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                      ..+++++++.+|+|.+++...    .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+|
T Consensus        84 ~~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          84 KDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             CCEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEEECCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCE
T ss_conf             149999962598656644058----999999999999999999999978---9867778764378879997787545705


Q ss_pred             EECCCCCC---CCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC--------CCCC---
Q ss_conf             00256987---410133477734521124-56668710167699999999839999996443335--------8899---
Q 004642          603 RLLHVDSS---YRTLRAGTYGYIAPELAY-TIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGP---  667 (740)
Q Consensus       603 ~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~---  667 (740)
                      ........   ......|++.|+|||++. +..++.++||||+||++|||++|+.||........        ....   
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             EECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf             65047776410101102652000387860478887410100467013377669799788888999998765206997566


Q ss_pred             -----CCHHHHH---HCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             -----8315655---204699962044588799999999972437999999999999999709
Q 004642          668 -----KIMLIDV---LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       668 -----~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                           .......   .......+...........+.+++.+|++.||++|||++|+++|.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~  299 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  299 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             HHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             423433222202446775577877783789999999999997648956790899986198655

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=328.09  Aligned_cols=260  Identities=23%  Similarity=0.299  Sum_probs=193.0

Q ss_pred             CCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC------CE
Q ss_conf             565540561145158999991-79939999983687621159899999999997204999631164366306------75
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK------KC  523 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  523 (740)
                      +|+..++||+|+||+||+|+. .+|+.||||++.....       ...+|++++++++|+||+++++++...      ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf             76751698217683999999999997999999881606-------89999999986689898738789974476577318


Q ss_pred             EEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCC
Q ss_conf             789998245887001102888533479899998999999999998826998838627999966776999-5799422453
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGTA  602 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfG~a  602 (740)
                      .++||||++++.+....+.......+++.++..++.|++.||+|||++   ||+||||||+|||++.++ .+||+|||++
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCH
T ss_conf             999984168860788886310368999999999999999999999866---87645788603787358971167336605


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC--------CCCCCCHHHH
Q ss_conf             002569874101334777345211245-6668710167699999999839999996443335--------8899831565
Q 004642          603 RLLHVDSSYRTLRAGTYGYIAPELAYT-IVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGPKIMLID  673 (740)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~  673 (740)
                      +....... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||........        .......+..
T Consensus       171 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         171 KQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             EECCTTSC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             HHCCCCCC-CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHH
T ss_conf             44047765-32002555556827764046888210002465277855028799898799999999999748981776543


Q ss_pred             HHCC-------CCCC-C-CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             5204-------6999-6-204458879999999997243799999999999999970
Q 004642          674 VLNQ-------RLSP-P-VNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       674 ~~~~-------~~~~-~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  721 (740)
                      ....       .... + ...........+.+++.+|+..||++|||++|+++|-+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  306 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  306 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf             062101103554456744443156899999999999765895579299999669845

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=326.15  Aligned_cols=262  Identities=23%  Similarity=0.275  Sum_probs=200.8

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC-----
Q ss_conf             21565540561145158999991-799399999836876211598999999999972049996311643663067-----
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKK-----  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  522 (740)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|+++.... .+...+.+.+|++++++++|||||++++++...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             7718998898017781999999999998999999852225-969999999999999866898754799986357655554


Q ss_pred             -EEEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf             -5789998245887001102888533479899998999999999998826998838627999966776999579942245
Q 004642          523 -CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       523 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                       ..++||||+ +.++.......    .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+|++|||.
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEECC-CCCHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf             1599998405-52189998740----226999999999999999998737---876456685111121001221134310


Q ss_pred             CEECCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC--------CCCC-----
Q ss_conf             30025698741013347773452112456-668710167699999999839999996443335--------8899-----
Q 004642          602 ARLLHVDSSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------SSGP-----  667 (740)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------~~~~-----  667 (740)
                      |+....   ..+...||+.|+|||++.+. .++.++||||+||++|||++|+.||........        ....     
T Consensus       168 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         168 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             EECCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHH
T ss_conf             220687---63102455333588998178789965010300389999997869988897689999998503788488886


Q ss_pred             --CCH-H---HHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             --831-5---655204699962044588799999999972437999999999999999709
Q 004642          668 --KIM-L---IDVLNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       668 --~~~-~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                        ... .   ......................+.+|+.+|+..||++|||++|+++|.+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~  305 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  305 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             HHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             5300034433115786665566775568999999999997729955792999996396237

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=318.69  Aligned_cols=264  Identities=21%  Similarity=0.226  Sum_probs=204.7

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE------C
Q ss_conf             215655405611451589999917-993999998368762115989999999999720499963116436630------6
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAELP-EGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLH------K  521 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~  521 (740)
                      .++|++.+.||+|+||+||+|... +|+.||||++...... ....+++.+|+.++++++||||+++++++..      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf             37759988962175859999999999989999998823369-79999999999999864898764899897025643457


Q ss_pred             CEEEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf             75789998245887001102888533479899998999999999998826998838627999966776999579942245
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGT  601 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~  601 (740)
                      ...|+||||+.++.+. .+..     .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.++++|||+
T Consensus        95 ~~~~iv~Ey~~~~l~~-~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQ-VIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             CEEEEEEECCSEEHHH-HHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             CEEEEEEECCCHHHHH-HHHC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHH
T ss_conf             6269998414467787-6503-----899999999999999999886522---112456776321136544313201023


Q ss_pred             CEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC---------------CCCC
Q ss_conf             3002569874101334777345211245666871016769999999983999999644333---------------5889
Q 004642          602 ARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS---------------SSSG  666 (740)
Q Consensus       602 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~---------------~~~~  666 (740)
                      ++.... ....+...+|+.|+|||++.+..++.++||||+||++|||++|+.||.......               ....
T Consensus       166 ~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         166 ARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             HHCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf             211466-6553322146555581331477778774333566257898659899888977889999997205898799987


Q ss_pred             CCCHHHHHHCC---------------CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             98315655204---------------6999620445887999999999724379999999999999997099
Q 004642          667 PKIMLIDVLNQ---------------RLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       667 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  723 (740)
                      ......+....               ...+............+.+++.+|++.||++||||+|+++|.+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             656677776417543566642126433354321013337999999999987699457908999966942087

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=315.61  Aligned_cols=258  Identities=18%  Similarity=0.226  Sum_probs=197.3

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCEEEEEEEE--CCEEE
Q ss_conf             1565540561145158999991-799399999836876211598999999999972049-9963116436630--67578
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLH--KKCMF  525 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~  525 (740)
                      ++|++.+.||+|+||+||+|+. .+++.||+|+++...      .+++.+|++++..++ ||||+++++++..  ....+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEE
T ss_conf             67189789831748199999988999799999988899------999999999998515799876799999816877126


Q ss_pred             EEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCEE
Q ss_conf             9998245887001102888533479899998999999999998826998838627999966776999-579942245300
Q 004642          526 LIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNL-EASVADFGTARL  604 (740)
Q Consensus       526 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DfG~a~~  604 (740)
                      +||||+++++|.....      .+++..+..++.||+.||+|||++   ||+||||||+|||++.++ .+||+|||+|+.
T Consensus       109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EEEEECCCCCHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEE
T ss_conf             8886317985899746------899999999999999999887643---3443456441237748998366415654266


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC--------------------
Q ss_conf             25698741013347773452112456-668710167699999999839999996443335--------------------
Q 004642          605 LHVDSSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSS--------------------  663 (740)
Q Consensus       605 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~~--------------------  663 (740)
                      ..... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........                    
T Consensus       180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf             46887-44432248642476102688888845232335455587604889998876018999999998788415555542


Q ss_pred             -CCCCCCHHHHHHCCCCCCCC-----HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             -88998315655204699962-----0445887999999999724379999999999999997099
Q 004642          664 -SSGPKIMLIDVLNQRLSPPV-----NQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       664 -~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  723 (740)
                       ....................     ..........+.+++.+|++.||++|||++|+++|.+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf             254447430000033343311211552112448999999999986699568908999964935588

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=319.25  Aligned_cols=258  Identities=17%  Similarity=0.213  Sum_probs=193.0

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCC-CEEEEEEEECCEEEE
Q ss_conf             21565540561145158999991-7993999998368762115989999999999720499963-116436630675789
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNI-VKLYGFCLHKKCMFL  526 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~l  526 (740)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......     .++..|+++++.++|+++ +.+.++..+++..++
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC-----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEE
T ss_conf             88899968985078809999999889989999997210058-----8899999999970389960179999951987789


Q ss_pred             EEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEECCCCE
Q ss_conf             9982458870011028885334798999989999999999988269988386279999667769---9957994224530
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS---NLEASVADFGTAR  603 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DfG~a~  603 (740)
                      ||||+++ ++...+.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++.   +..++++|||+|+
T Consensus        81 vme~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          81 VMELLGP-SLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EEECCCC-BHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEECCC-CHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCE
T ss_conf             9987387-13332443068--876899999999999999999979---94426678766064335777615650467513


Q ss_pred             ECCCCCC-------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHC
Q ss_conf             0256987-------410133477734521124566687101676999999998399999964433358899831565520
Q 004642          604 LLHVDSS-------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDVLN  676 (740)
Q Consensus       604 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  676 (740)
                      .......       ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    ...........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~----~~~~~~~~~~~  230 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA----TKRQKYERISE  230 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------HHHHHH
T ss_pred             ECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHH----HHHHHHHHHHC
T ss_conf             42554455410001357767873532999991899898321886177899998498766553057----79999998523


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             469996204458879999999997243799999999999999970
Q 004642          677 QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLA  721 (740)
Q Consensus       677 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  721 (740)
                      .....+...........+.+++..||+.+|++||+++++.+.|+.
T Consensus       231 ~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             CCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf             567898357534788999999999843995579199999999999

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=323.38  Aligned_cols=259  Identities=27%  Similarity=0.381  Sum_probs=204.5

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE----CCCCEEEEEECCCCCCC-CHHHHHHHHHHHHHHHCCCC-CCCCEEEEEEEECCE
Q ss_conf             1565540561145158999991----79939999983687621-15989999999999720499-963116436630675
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL----PEGKVVALKKLHHSETE-DSAFVKSFQNEAHVLSTVRH-RNIVKLYGFCLHKKC  523 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~  523 (740)
                      ++|++.+.||+|+||+||+|..    .+|+.||+|+++..... +....+.+.+|++++.+++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf             02599989832878399999987658879489999983677210168999999999999864679839996200024873


Q ss_pred             EEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf             78999824588700110288853347989999899999999999882699883862799996677699957994224530
Q 004642          524 MFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTAR  603 (740)
Q Consensus       524 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~  603 (740)
                      .+++|||+.+|+|.+++....   .++...+..++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf             001231234117999987304---543788888899999999885149---98965477320124699988874132022


Q ss_pred             ECCCCCC-CCCCCCCCCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHH-HHHHCCCC
Q ss_conf             0256987-41013347773452112456--66871016769999999983999999644333588998315-65520469
Q 004642          604 LLHVDSS-YRTLRAGTYGYIAPELAYTI--VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIML-IDVLNQRL  679 (740)
Q Consensus       604 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~  679 (740)
                      .+..... ......|++.|++||.+.+.  .++.++||||+||++|||++|+.||......    .....+ ........
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~----~~~~~i~~~~~~~~~  253 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSEP  253 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHCCC
T ss_pred             HHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHCCCCCC
T ss_conf             2034444322122233333106876057768871325177779999997689998888777----799999983356899


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHHHHCCC
Q ss_conf             9962044588799999999972437999999-----9999999997099
Q 004642          680 SPPVNQKIVQDIILVSTIAFACLSSQPKSRP-----TMQRISQELLAGK  723 (740)
Q Consensus       680 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~~~~  723 (740)
                        +.+....   ..+.+++.+||++||++||     +++|+++|.+...
T Consensus       254 --~~~~~~s---~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         254 --PYPQEMS---ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             --CCCTTSC---HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             --CCCCCCC---HHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCC
T ss_conf             --8865479---9999999997445898819997450999974972348

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=316.26  Aligned_cols=266  Identities=19%  Similarity=0.272  Sum_probs=207.0

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf             1565540561145158999991-799399999836876211598999999999972049996311643663067578999
Q 004642          450 EDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHKKCMFLIY  528 (740)
Q Consensus       450 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  528 (740)
                      ++|++.+.||+|+||+||+|+. .+++.||||+++..... +....++.+|+.+++.++||||+++++++......++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf             9978626971286819999999999969999998032178-689999999999998567578882135444443115886


Q ss_pred             EECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf             82458870011028885334798999989999999999988269988386279999667769995799422453002569
Q 004642          529 EYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTARLLHVD  608 (740)
Q Consensus       529 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~~~~~  608 (740)
                      +++.++++..++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.|+.....
T Consensus        81 ~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          81 EFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             EECCCCCCCCCCCCCC---CCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC
T ss_conf             3023322211212356---540367899999999998774339---9860014676121133782665204601104688


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC-----------CCCC-CCCHHHHHH
Q ss_conf             87410133477734521124566-6871016769999999983999999644333-----------5889-983156552
Q 004642          609 SSYRTLRAGTYGYIAPELAYTIV-VTGKCDVYSFGVVALEVLMGTHPGGLLSSLS-----------SSSG-PKIMLIDVL  675 (740)
Q Consensus       609 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~p~~~~~~~~-----------~~~~-~~~~~~~~~  675 (740)
                      ........++..|+|||++.+.. ++.++||||+||++|||++|+.||.......           .... .........
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             CCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCC
T ss_conf             75100103443101466750698888044402654188998518999988999999999998611899735513443222


Q ss_pred             CCCC------CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             0469------9962044588799999999972437999999999999999709
Q 004642          676 NQRL------SPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       676 ~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      ....      ..............+.+++.+|++.||.+|||++|+++|-+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~  287 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred             CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC
T ss_conf             11334445443104330656899999999998649966890999996495340

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=319.06  Aligned_cols=264  Identities=20%  Similarity=0.217  Sum_probs=201.6

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC-----C
Q ss_conf             21565540561145158999991-79939999983687621159899999999997204999631164366306-----7
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRNIVKLYGFCLHK-----K  522 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~  522 (740)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++....... ...+.+.+|++++++++|||+|++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCH-HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf             987188889831788399999999999799999988200286-8999999999999866898742599999634645668


Q ss_pred             EEEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf             57899982458870011028885334798999989999999999988269988386279999667769995799422453
Q 004642          523 CMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASVADFGTA  602 (740)
Q Consensus       523 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a  602 (740)
                      ..+++++|+.+|+|.+++...    .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+|++|||.+
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             CEEEEEEEECCCCHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf             649999962588623200224----530999999999999999999738---8765166776334554322001321000


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC----------------CCC
Q ss_conf             0025698741013347773452112456-66871016769999999983999999644333----------------588
Q 004642          603 RLLHVDSSYRTLRAGTYGYIAPELAYTI-VVTGKCDVYSFGVVALEVLMGTHPGGLLSSLS----------------SSS  665 (740)
Q Consensus       603 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~p~~~~~~~~----------------~~~  665 (740)
                      ....   .......|+..|+|||...+. .++.++||||+||++|+|++|+.||.......                ...
T Consensus       169 ~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         169 RHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             -CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             CCCC---CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf             1257---5444434543555835533775678551243205899999768899788988999999997307997577320


Q ss_pred             CCCCHHHHHHC---CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             99831565520---46999620445887999999999724379999999999999997099
Q 004642          666 GPKIMLIDVLN---QRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAGK  723 (740)
Q Consensus       666 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~  723 (740)
                      ...........   .................+.+++.+|++.||.+|||++|+++|-+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             0102445444303557875556626789999999999977588345938999855995487

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=312.68  Aligned_cols=259  Identities=16%  Similarity=0.168  Sum_probs=199.3

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCC-CCCCEEEEEEEECCEEEE
Q ss_conf             21565540561145158999991-7993999998368762115989999999999720499-963116436630675789
Q 004642          449 TEDFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRH-RNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       449 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~l  526 (740)
                      .++|++.+.||+|+||+||+|+. .+++.||+|++......     ..+.+|++.+..++| ++++.+++++.++...++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEE
T ss_conf             98069979984178829999999889979999997502582-----9999999999996489998779999601881179


Q ss_pred             EEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEECCC
Q ss_conf             9982458870011028885334798999989999999999988269988386279999667769-----99579942245
Q 004642          527 IYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDS-----NLEASVADFGT  601 (740)
Q Consensus       527 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~DfG~  601 (740)
                      ||||+ +++|.+++.....  .+++.++..++.|++.||+|||++   ||+||||||+||+++.     ++.+||+|||+
T Consensus        79 vme~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEEC-CCCHHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCE
T ss_conf             99964-8887999975203--110689999999999999999977---96626677131523475434479568723660


Q ss_pred             CEECCCCCC-------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf             300256987-------4101334777345211245666871016769999999983999999644333588998315655
Q 004642          602 ARLLHVDSS-------YRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSGPKIMLIDV  674 (740)
Q Consensus       602 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  674 (740)
                      |+.+.....       ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......    .........
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~----~~~~~~~~i  228 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----TNKQKYERI  228 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC----CHHHHHHHH
T ss_pred             EEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHHHHHHHH
T ss_conf             5771467665411102467627751026798964888886999898319999998698767885302----199999999


Q ss_pred             HCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             204699962044588799999999972437999999999999999709
Q 004642          675 LNQRLSPPVNQKIVQDIILVSTIAFACLSSQPKSRPTMQRISQELLAG  722 (740)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~  722 (740)
                      .......+...........+.+++..|++.+|++||+++.+.+.+...
T Consensus       229 ~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf             705679995896579989999999998439930085999999999999

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=0  Score=287.69  Aligned_cols=270  Identities=31%  Similarity=0.535  Sum_probs=223.5

Q ss_pred             CCCHHHHHHHHCCC------CCCCCCCCCCCCCC--CCCEEEECCC---CCEEEEECCCCCCCCC--CCCCCCCCCCCCC
Q ss_conf             58699999986399------97678999999999--6451453899---9978997499975444--5675457999864
Q 004642           38 AASEIERQALLNSG------WWKDRIPHNSSDHC--NWVGITCDYE---GRITDIDLLNSNIKGE--LGRLNFSCFPNLK  104 (740)
Q Consensus        38 ~~~~~~~~~ll~~~------~~~~~~~~~~~~~c--~w~gv~c~~~---~~v~~l~l~~~~l~~~--~~~~~~~~l~~L~  104 (740)
                      .|.+.|++||++..      ...+.|. .+.|||  .|.||+|+..   +||+.|+|.++++.+.  ++. .+..+++|+
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~-~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~   79 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPTTLSSWL-PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCC-TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCC-CCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCH-HHHCCCCCC
T ss_conf             989899999999999779998677889-999998894889697489994798899898998888887984-784675335


Q ss_pred             EEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCC
Q ss_conf             875789-9744678822259887766642354443458600006655343221042046877454236666561422154
Q 004642          105 SLDLWN-NSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNN  183 (740)
Q Consensus       105 ~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  183 (740)
                      +|+|++ |.++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.++++.|.+.+..|..+.++++|+.+++++|
T Consensus        80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n  159 (313)
T d1ogqa_          80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCC
T ss_conf             20202654333002431145420011020356434433222220111001111224555568512206740000002355


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHHHCC
Q ss_conf             2346677754334457775123899822335577-888755788688768931004477882113477367970232138
Q 004642          184 ALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSA-LDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGK  262 (740)
Q Consensus       184 ~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  262 (740)
                      .+.+.+|..+.                   .+.. ++.++++.|++++..+..+..+..+ .++++.+...+.+|..+..
T Consensus       160 ~l~~~ip~~~~-------------------~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~  219 (313)
T d1ogqa_         160 RISGAIPDSYG-------------------SFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGS  219 (313)
T ss_dssp             CCEEECCGGGG-------------------CCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCT
T ss_pred             CCCCCCCCCCC-------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCC
T ss_conf             33562031214-------------------431123231022464353324332222222-3333334332222222222


Q ss_pred             CCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCCC
Q ss_conf             56776303588734576770101488887474368878898820002433455687058735687799
Q 004642          263 LFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPK  330 (740)
Q Consensus       263 l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~  330 (740)
                      +++++.+++++|.+.+.++ .+..+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|.
T Consensus       220 ~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~  286 (313)
T d1ogqa_         220 DKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ  286 (313)
T ss_dssp             TSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred             CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC
T ss_conf             2221112222222222222-222455444444765706660876884799999897958835166898

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=285.59  Aligned_cols=264  Identities=20%  Similarity=0.257  Sum_probs=191.6

Q ss_pred             CCCCCEEEECCCCEEEEEEEE-CCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCC-----------CCCCCEEEEEE
Q ss_conf             565540561145158999991-799399999836876211598999999999972049-----------99631164366
Q 004642          451 DFHIKYCIGTGGYGSVYKAEL-PEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-----------HRNIVKLYGFC  518 (740)
Q Consensus       451 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~  518 (740)
                      +|++.+.||+|+||+||+|+. .+|+.||||+++....    ..+.+.+|+++++.++           |+||+++++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC----CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEE
T ss_conf             57998997507781899999999997999999834313----36899999999998401455555422767647899876


Q ss_pred             EE--CCEEEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCC---
Q ss_conf             30--67578999824588700110288853347989999899999999999882-6998838627999966776999---
Q 004642          519 LH--KKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHH-DCTLSIIHRDISSNNILLDSNL---  592 (740)
Q Consensus       519 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlkp~NIll~~~~---  592 (740)
                      ..  ....+.+++++..+..............+++..+..++.|++.|++|||+ .   ||+||||||+|||++.++   
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred             EECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCCC
T ss_conf             31256520234320003542000001223467868999999999999988876405---864656770570563057656


Q ss_pred             ---CEEEEECCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC---
Q ss_conf             ---57994224530025698741013347773452112456668710167699999999839999996443335889---
Q 004642          593 ---EASVADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVALEVLMGTHPGGLLSSLSSSSG---  666 (740)
Q Consensus       593 ---~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p~~~~~~~~~~~~---  666 (740)
                         .++++|||.+.....   ......|++.|+|||++....++.++||||+||++++|++|+.||...........   
T Consensus       167 ~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             CCCEEEEEECCCCCCCCC---CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf             443056753144212344---54223665210571321466777643201237899999878899898755432102689


Q ss_pred             -----------CCCHH------HHHHC-----CCCCC----C-------CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf             -----------98315------65520-----46999----6-------2044588799999999972437999999999
Q 004642          667 -----------PKIML------IDVLN-----QRLSP----P-------VNQKIVQDIILVSTIAFACLSSQPKSRPTMQ  713 (740)
Q Consensus       667 -----------~~~~~------~~~~~-----~~~~~----~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  713 (740)
                                 +....      .....     .....    .       ...........+.+++.+|+..||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf             99999983799878862453220001320122024323577644421000156743589999999998779945790899


Q ss_pred             HHHHHHHCCCC
Q ss_conf             99999970999
Q 004642          714 RISQELLAGKT  724 (740)
Q Consensus       714 eil~~L~~~~~  724 (740)
                      |+++|-+....
T Consensus       324 e~L~Hp~f~~~  334 (362)
T d1q8ya_         324 GLVNHPWLKDT  334 (362)
T ss_dssp             HHHTCGGGTTC
T ss_pred             HHHCCCCCCCC
T ss_conf             99669340789

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=7.8e-40  Score=230.91  Aligned_cols=254  Identities=34%  Similarity=0.561  Sum_probs=225.4

Q ss_pred             CCCCEEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCE
Q ss_conf             986487578997446--7882225988776664235-4443458600006655343221042046877454236666561
Q 004642          101 PNLKSLDLWNNSLSG--SIPPQIGSLSKLKCLYLHG-NNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTE  177 (740)
Q Consensus       101 ~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  177 (740)
                      .+++.|+|++|.+.+  .+|..++++++|++|+|++ |++.+.+|..++++++|++|+|++|++.+..+..+..+.+|+.
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCC
T ss_conf             79889989899888888798478467533520202654333002431145420011020356434433222220111001


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CEECCCCCCCCCCC
Q ss_conf             42215423466777543344577751238998223355778887557886887689310044778-82113477367970
Q 004642          178 LYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQL-KNLNLSSNLLSGQI  256 (740)
Q Consensus       178 L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~  256 (740)
                      ++++.|.+.+.                   +|..+.+++.++.+++++|.+++.+|..+..+..+ +.+++++|++++..
T Consensus       130 l~l~~N~~~~~-------------------~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~  190 (313)
T d1ogqa_         130 LDFSYNALSGT-------------------LPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI  190 (313)
T ss_dssp             EECCSSEEESC-------------------CCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEEC
T ss_pred             CCCCCCCCCCC-------------------CCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             11122455556-------------------85122067400000023553356203121443112323102246435332


Q ss_pred             HHHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCCCCCCCC-
Q ss_conf             2321385677630358873457677010148888747436887889882000243345568705873568779987544-
Q 004642          257 PYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM-  335 (740)
Q Consensus       257 ~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~-  335 (740)
                      +..+..+. ...++++.|...+.++..+..+++++.+++++|.+.+.++ .+..+++|+.|++++|+++|.+|..+..+ 
T Consensus       191 ~~~~~~l~-~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~  268 (313)
T d1ogqa_         191 PPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLK  268 (313)
T ss_dssp             CGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCT
T ss_pred             CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCC
T ss_conf             43322222-2233333343322222222222221112222222222222-222455444444765706660876884799


Q ss_pred             ---CCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             ---3347789887885754--56999986568866888988998765
Q 004642          336 ---YVDLSFNNLEGEIPTY--LRGNPPKSFVGNKGLSGNVEGFPSSS  377 (740)
Q Consensus       336 ---~l~l~~n~l~~~~p~~--~~~~~~~~~~~n~~~~~~~~~~~~~~  377 (740)
                         .+++++|+++|.+|..  +..+....+.+|+.+||.|  +|+|+
T Consensus       269 ~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p--lp~c~  313 (313)
T d1ogqa_         269 FLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP--LPACT  313 (313)
T ss_dssp             TCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT--SSCCC
T ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC--CCCCC
T ss_conf             9998979588351668986667998978868895001989--88989

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-35  Score=204.68  Aligned_cols=243  Identities=24%  Similarity=0.230  Sum_probs=207.2

Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCC-CCCCCCCCCHHHHCCCCCCCEEE
Q ss_conf             98648757899744678822259887766642354443458600006655343221-04204687745423666656142
Q 004642          101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFL-YSNKLSGVLPQEIGNLKSLTELY  179 (740)
Q Consensus       101 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L-s~N~l~~~~~~~~~~l~~L~~L~  179 (740)
                      +.+++|+|++|.|+.+.+..|.++++|++|++++|++....+..+.+++.+..++. ..|.++.+.+..|.++++|+.|+
T Consensus        32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf             99888977488179879778641421300001344543321112122222222222210223544620101010277875


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHH
Q ss_conf             21542346677754334457775123899822335577888755788688768931004477882113477367970232
Q 004642          180 VTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYA  259 (740)
Q Consensus       180 L~~N~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  259 (740)
                      +++|.+....                   +..+....+|+.+++++|.++++.+..|..+++|+.|++++|.+++..+..
T Consensus       112 l~~n~~~~~~-------------------~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~  172 (284)
T d1ozna_         112 LDRCGLQELG-------------------PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA  172 (284)
T ss_dssp             CTTSCCCCCC-------------------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred             CCCCCCCCCC-------------------CCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHH
T ss_conf             6885443201-------------------353320001211020014314458057404340502231417656625666


Q ss_pred             HCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCCCCC-CCC--C
Q ss_conf             1385677630358873457677010148888747436887889882000243345568705873568779987-544--3
Q 004642          260 IGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTL-RPM--Y  336 (740)
Q Consensus       260 ~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~~--~  336 (740)
                      |.++++|+.+++++|++++..|..|.++++|+.|++++|.+.+..+..+..+++|+.|++++|++.|..+... ...  .
T Consensus       173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~  252 (284)
T d1ozna_         173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQK  252 (284)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHH
T ss_pred             HCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCHHHHHHHHH
T ss_conf             54656341314211434662816766532000233333522100000235546568898119988787564699999986


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             34778988788575456999986568
Q 004642          337 VDLSFNNLEGEIPTYLRGNPPKSFVG  362 (740)
Q Consensus       337 l~l~~n~l~~~~p~~~~~~~~~~~~~  362 (740)
                      .....+.+.+..|..+.+.+...+..
T Consensus       253 ~~~~~~~~~C~~p~~l~g~~l~~l~~  278 (284)
T d1ozna_         253 FRGSSSEVPCSLPQRLAGRDLKRLAA  278 (284)
T ss_dssp             CCSEECCCBEEESGGGTTCBGGGSCG
T ss_pred             CCCCCCCEEECCCHHHCCCCCCCCCH
T ss_conf             73888866747966984985341898

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.4e-33  Score=193.27  Aligned_cols=265  Identities=25%  Similarity=0.317  Sum_probs=194.1

Q ss_pred             CCCCCCCCCCEEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             99999996451453899997899749997544456754579998648757899744678822259887766642354443
Q 004642           59 HNSSDHCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLT  138 (740)
Q Consensus        59 ~~~~~~c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  138 (740)
                      ++..+.|.|++|.|+..+ ++           .+|. .+  .+++++|+|++|.|+.+.+..|.++++|++|++++|.+.
T Consensus         4 ~p~~c~c~~~~~~C~~~~-L~-----------~lP~-~l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~   68 (305)
T d1xkua_           4 CPFRCQCHLRVVQCSDLG-LE-----------KVPK-DL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS   68 (305)
T ss_dssp             CCTTCEEETTEEECTTSC-CC-----------SCCC-SC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCCEECCCEEEECCCC-CC-----------CCCC-CC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC
T ss_conf             999889559999855999-88-----------5198-88--999798978499189869657604656523112344344


Q ss_pred             CCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCC-----CCCC--CCCCCCCCC
Q ss_conf             458600006655343221042046877454236666561422154234667775433445-----7775--123899822
Q 004642          139 GIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN-----ISSN--QFHSSIPLE  211 (740)
Q Consensus       139 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-----l~~n--~l~~~~~~~  211 (740)
                      ...|..|.++++|+.|++++|+++.+.. .  ....+..|.+.+|.+....+..+.....     ...|  ......+..
T Consensus        69 ~i~~~~f~~l~~L~~L~l~~n~l~~l~~-~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~  145 (305)
T d1xkua_          69 KISPGAFAPLVKLERLYLSKNQLKELPE-K--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA  145 (305)
T ss_dssp             CBCTTTTTTCTTCCEEECCSSCCSBCCS-S--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTG
T ss_pred             CCCHHHHHCCCCCCEECCCCCCCCCCCC-C--HHHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             5235665279855783156875676764-0--011132321024610234444540133110000123333346777642


Q ss_pred             CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             33557788875578868876893100447788211347736797023213856776303588734576770101488887
Q 004642          212 IGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALK  291 (740)
Q Consensus       212 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~  291 (740)
                      +..+++|+.+++++|.++. ++..+  +++|+.|++++|.+++..+..|.+++.++.|++++|.+.+..+..+.++++|+
T Consensus       146 ~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~  222 (305)
T d1xkua_         146 FQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR  222 (305)
T ss_dssp             GGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCC
T ss_pred             CCCCCCCCCCCCCCCCCCC-CCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf             2345656712034677451-67101--77667898978867788826764134133015445533222345433443322


Q ss_pred             EEECCCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCCCCCCCC----------CCCCCCCCCC
Q ss_conf             47436887889882000243345568705873568779987544----------3347789887
Q 004642          292 NLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM----------YVDLSFNNLE  345 (740)
Q Consensus       292 ~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~----------~l~l~~n~l~  345 (740)
                      .|+|++|.++ .+|..+..+++|+.|++++|+++......+...          .+++++|++.
T Consensus       223 ~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         223 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             EEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             EEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCHHCCCCCCCEEECCCCCCC
T ss_conf             4302554002-46311033467898989898657638100267210021588897889899576

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-33  Score=197.05  Aligned_cols=250  Identities=26%  Similarity=0.257  Sum_probs=213.8

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC-CCCCCCCCCHHHCCCCCCCCC
Q ss_conf             9978997499975444567545799986487578997446788222598877666423-544434586000066553432
Q 004642           76 GRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLH-GNNLTGIIPKEIGSLRNLRGL  154 (740)
Q Consensus        76 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~n~l~~~~p~~l~~l~~L~~L  154 (740)
                      ..++.|++++++++ .++...|..+++|++|++++|.+..+.+..+..+..+..+... .|.+....+..|.++++|++|
T Consensus        32 ~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L  110 (284)
T d1ozna_          32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL  110 (284)
T ss_dssp             TTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCEEECCCCCCC-CCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEE
T ss_conf             99888977488179-87977864142130000134454332111212222222222221022354462010101027787


Q ss_pred             CCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf             21042046877454236666561422154234667775433445777512389982233557788875578868876893
Q 004642          155 FLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPD  234 (740)
Q Consensus       155 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  234 (740)
                      ++++|.+....+..+....+|+.+++++|+++++.+                   ..|..+++|+.|++++|+++.+.+.
T Consensus       111 ~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~-------------------~~f~~~~~L~~L~l~~N~l~~l~~~  171 (284)
T d1ozna_         111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD-------------------DTFRDLGNLTHLFLHGNRISSVPER  171 (284)
T ss_dssp             ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT-------------------TTTTTCTTCCEEECCSSCCCEECTT
T ss_pred             ECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCH-------------------HHHCCCCCHHHCCCCCCCCCCCCHH
T ss_conf             568854432013533200012110200143144580-------------------5740434050223141765662566


Q ss_pred             CCCCCCCCCEECCCCCCCCCCCHHHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCC
Q ss_conf             10044778821134773679702321385677630358873457677010148888747436887889882000243345
Q 004642          235 ELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLL  314 (740)
Q Consensus       235 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  314 (740)
                      .|.++++|+.+++++|++++..|..|.++++|++|++++|.+.+..+..|.++++|++|++++|.+...-+ ...-..++
T Consensus       172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l  250 (284)
T d1ozna_         172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWL  250 (284)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHH
T ss_pred             HHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC-CHHHHHHH
T ss_conf             65465634131421143466281676653200023333352210000023554656889811998878756-46999999


Q ss_pred             CEEEECCCCCCCCCCCCCCCC-CCCCCCCCCCC
Q ss_conf             568705873568779987544-33477898878
Q 004642          315 QNLDLSHNNLSGTIPKTLRPM-YVDLSFNNLEG  346 (740)
Q Consensus       315 ~~L~ls~N~l~~~~p~~~~~~-~l~l~~n~l~~  346 (740)
                      +.+....+.++|..|..+... ..+++.+.|+|
T Consensus       251 ~~~~~~~~~~~C~~p~~l~g~~l~~l~~~~l~g  283 (284)
T d1ozna_         251 QKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG  283 (284)
T ss_dssp             HHCCSEECCCBEEESGGGTTCBGGGSCGGGSCC
T ss_pred             HHCCCCCCCEEECCCHHHCCCCCCCCCHHHCCC
T ss_conf             867388886674796698498534189888789

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-32  Score=187.46  Aligned_cols=202  Identities=25%  Similarity=0.235  Sum_probs=144.4

Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEEEC
Q ss_conf             98648757899744678822259887766642354443458600006655343221042046877454236666561422
Q 004642          101 PNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYV  180 (740)
Q Consensus       101 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  180 (740)
                      ..+.+++.++++++ .+|..+.  +++++|+|++|+|++..+..|.++++|++|+|++|+|+.+.  .++.+++|+.|+|
T Consensus        10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~L   84 (266)
T d1p9ag_          10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDL   84 (266)
T ss_dssp             TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEEC
T ss_pred             CCCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCC
T ss_conf             89869980699988-6196757--68898988499289859778634565522135665444431--1111223211111


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHHH
Q ss_conf             15423466777543344577751238998223355778887557886887689310044778821134773679702321
Q 004642          181 TNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAI  260 (740)
Q Consensus       181 ~~N~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  260 (740)
                      ++|+++.                    .+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+
T Consensus        85 s~N~l~~--------------------~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~  144 (266)
T d1p9ag_          85 SHNQLQS--------------------LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL  144 (266)
T ss_dssp             CSSCCSS--------------------CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred             CCCCCCC--------------------CCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCC
T ss_conf             2222211--------------------11121222222222222231101100112222111122124342102212333


Q ss_pred             CCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCC
Q ss_conf             38567763035887345767701014888874743688788988200024334556870587356877
Q 004642          261 GKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTI  328 (740)
Q Consensus       261 ~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~  328 (740)
                      ..+++++.+++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.|..
T Consensus       145 ~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCCCC
T ss_conf             22111000000015652237200134212423430139785-56866777888999983699987886

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.4e-28  Score=169.59  Aligned_cols=255  Identities=25%  Similarity=0.422  Sum_probs=134.0

Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCC
Q ss_conf             99997899749997544456754579998648757899744678822259887766642354443458600006655343
Q 004642           74 YEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRG  153 (740)
Q Consensus        74 ~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  153 (740)
                      ....++.|++.++++.. +.  .+..+++|++|+|++|.|++..  .++++++|++|++++|++.+..  .+.++++|+.
T Consensus        42 ~l~~l~~L~l~~~~I~~-l~--gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~  114 (384)
T d2omza2          42 DLDQVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTG  114 (384)
T ss_dssp             HHTTCCEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCE
T ss_pred             HHCCCCEEECCCCCCCC-CC--CCCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf             95787899899989877-62--4245899998968188179886--3347711010301343332222--1112334333


Q ss_pred             CCCCCCCCCCCCHH---------------------------------------------------------------HHC
Q ss_conf             22104204687745---------------------------------------------------------------423
Q 004642          154 LFLYSNKLSGVLPQ---------------------------------------------------------------EIG  170 (740)
Q Consensus       154 L~Ls~N~l~~~~~~---------------------------------------------------------------~~~  170 (740)
                      |++++|.+++..+.                                                               .+.
T Consensus       115 L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (384)
T d2omza2         115 LTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA  194 (384)
T ss_dssp             EECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGG
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             44332222222222222222112134663131002322221122222123220111124542110112224333211002


Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCC-CC--CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf             666656142215423466777543-34--457775123899822335577888755788688768931004477882113
Q 004642          171 NLKSLTELYVTNNALGGLIPSTLF-RL--TNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNL  247 (740)
Q Consensus       171 ~l~~L~~L~L~~N~l~~~~~~~~~-~l--~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  247 (740)
                      .+++++.+++++|.+++..+.... ++  .+++.|.++..  ..+..+++|+.|++++|.+++..  .+..+++|+.|++
T Consensus       195 ~l~~~~~l~l~~n~i~~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l  270 (384)
T d2omza2         195 KLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKL  270 (384)
T ss_dssp             GCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEEC
T ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCC--CCCCCCCCCEEEC
T ss_conf             2353233303577447878644457787888877777896--13432565341004467447877--5355466877545


Q ss_pred             CCCCCCCCCHHHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECCCCCCCC
Q ss_conf             47736797023213856776303588734576770101488887474368878898820002433455687058735687
Q 004642          248 SSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGT  327 (740)
Q Consensus       248 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  327 (740)
                      ++|++++..  .+..++.++.++++.|.+.+  ...+..+++++.|++++|++++..  .+..+++|+.|++++|++++ 
T Consensus       271 ~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-  343 (384)
T d2omza2         271 GANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-  343 (384)
T ss_dssp             CSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-
T ss_pred             CCCCCCCCC--CCCCCCCCCCCCCCCCCCCC--CCCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-
T ss_conf             674457877--32356522223323233333--221000024676777788778984--53668988989898998999-


Q ss_pred             CCCCCCCC----CCCCCCCCCCCC
Q ss_conf             79987544----334778988788
Q 004642          328 IPKTLRPM----YVDLSFNNLEGE  347 (740)
Q Consensus       328 ~p~~~~~~----~l~l~~n~l~~~  347 (740)
                      ++ .+..+    .+++++|++++.
T Consensus       344 l~-~l~~l~~L~~L~l~~N~l~~l  366 (384)
T d2omza2         344 VS-SLANLTNINWLSAGHNQISDL  366 (384)
T ss_dssp             CG-GGGGCTTCCEEECCSSCCCBC
T ss_pred             CH-HHCCCCCCCEEECCCCCCCCC
T ss_conf             74-670899999898979958998

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-29  Score=175.08  Aligned_cols=204  Identities=25%  Similarity=0.195  Sum_probs=169.7

Q ss_pred             ECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCC
Q ss_conf             38999978997499975444567545799986487578997446788222598877666423544434586000066553
Q 004642           72 CDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNL  151 (740)
Q Consensus        72 c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L  151 (740)
                      |.......+++..+++++ .+|.. +  .++++.|+|++|.|+++.+..|.++++|++|+|++|+|+.. + .++.+++|
T Consensus         6 ~~~~~~~~~v~C~~~~L~-~iP~~-l--p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L   79 (266)
T d1p9ag_           6 VSKVASHLEVNCDKRNLT-ALPPD-L--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVL   79 (266)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSC-C--CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTC
T ss_pred             ECCCCCCEEEECCCCCCC-EECCC-C--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC-C-CCCCCCCC
T ss_conf             742689869980699988-61967-5--76889898849928985977863456552213566544443-1-11112232


Q ss_pred             CCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf             43221042046877454236666561422154234667775433445777512389982233557788875578868876
Q 004642          152 RGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGI  231 (740)
Q Consensus       152 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  231 (740)
                      ++|+|++|+++.. +..+.++++|+.|++++|.+....+                   ..+..+.+++.|++++|.++.+
T Consensus        80 ~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~~~~~~~~~-------------------~~~~~l~~l~~L~l~~n~l~~l  139 (266)
T d1p9ag_          80 GTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPL-------------------GALRGLGELQELYLKGNELKTL  139 (266)
T ss_dssp             CEEECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCS-------------------STTTTCTTCCEEECTTSCCCCC
T ss_pred             CCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCEEEC-------------------CCCCCCCCCCCCCCCCCCCCEE
T ss_conf             1111122222111-1121222222222222231101100-------------------1122221111221243421022


Q ss_pred             CCCCCCCCCCCCEECCCCCCCCCCCHHHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             89310044778821134773679702321385677630358873457677010148888747436887889
Q 004642          232 IPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDG  302 (740)
Q Consensus       232 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  302 (740)
                      .+..+..++.|+.|++++|++++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+.-
T Consensus       140 ~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             CCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCC
T ss_conf             1233322111000000015652237200134212423430139785-568667778889999836999878

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=7.4e-29  Score=171.10  Aligned_cols=243  Identities=24%  Similarity=0.306  Sum_probs=201.6

Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCC
Q ss_conf             99978997499975444567545799986487578997446788222598877666423544434586000066553432
Q 004642           75 EGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGL  154 (740)
Q Consensus        75 ~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  154 (740)
                      ...++.|++.+++++ .++...|.++++|+.|++++|.+..+.|..|.++++|++|++++|+++. +|..+  ...+..|
T Consensus        30 ~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L  105 (305)
T d1xkua_          30 PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQEL  105 (305)
T ss_dssp             CTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEE
T ss_pred             CCCCCEEECCCCCCC-CCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCCC-CCCCH--HHHHHHH
T ss_conf             999798978499189-8696576046565231123443445235665279855783156875676-76400--1113232


Q ss_pred             CCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCC--CCCCCCCCCCC-----CCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf             210420468774542366665614221542346--67775433445-----77751238998223355778887557886
Q 004642          155 FLYSNKLSGVLPQEIGNLKSLTELYVTNNALGG--LIPSTLFRLTN-----ISSNQFHSSIPLEIGNFSALDTLDLSDNK  227 (740)
Q Consensus       155 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~-----l~~n~l~~~~~~~~~~l~~L~~L~l~~N~  227 (740)
                      ++..|.+.++.+..+.....+..++...|....  ..+..+..+..     ++.|.+... +..  .+++|+.|++++|.
T Consensus       106 ~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l-~~~--~~~~L~~L~l~~n~  182 (305)
T d1xkua_         106 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI-PQG--LPPSLTELHLDGNK  182 (305)
T ss_dssp             ECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC-CSS--CCTTCSEEECTTSC
T ss_pred             HCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCC--CCCCCCEEECCCCC
T ss_conf             102461023444454013311000012333334677764223456567120346774516-710--17766789897886


Q ss_pred             CCCCCCCCCCCCCCCCEECCCCCCCCCCCHHHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHH
Q ss_conf             88768931004477882113477367970232138567763035887345767701014888874743688788988200
Q 004642          228 IHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLE  307 (740)
Q Consensus       228 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~  307 (740)
                      ++...+..|..++.++.|++++|.+++..+..+.++++|+.|++++|+++ .+|..+.++++|+.|+|++|+|+......
T Consensus       183 ~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~  261 (305)
T d1xkua_         183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND  261 (305)
T ss_dssp             CCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTS
T ss_pred             CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCHHH
T ss_conf             77888267641341330154455332223454334433224302554002-46311033467898989898657638100


Q ss_pred             ------CCCCCCCCEEEECCCCCC
Q ss_conf             ------024334556870587356
Q 004642          308 ------MGKILLLQNLDLSHNNLS  325 (740)
Q Consensus       308 ------~~~l~~L~~L~ls~N~l~  325 (740)
                            ...+.+|+.|++++|+++
T Consensus       262 f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         262 FCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             SSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             CCCCCHHCCCCCCCEEECCCCCCC
T ss_conf             267210021588897889899576

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=1.8e-27  Score=163.61  Aligned_cols=84  Identities=20%  Similarity=0.327  Sum_probs=44.8

Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEE
Q ss_conf             99986487578997446788222598877666423544434586000066553432210420468774542366665614
Q 004642           99 CFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTEL  178 (740)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  178 (740)
                      .+.+|++|+++++.|+..  +.+..+++|++|+|++|+|++..  .++++++|++|++++|++.++.  .++++++|+.|
T Consensus        42 ~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L  115 (384)
T d2omza2          42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGL  115 (384)
T ss_dssp             HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred             HHCCCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCC
T ss_conf             957878998999898776--24245899998968188179886--3347711010301343332222--11123343334


Q ss_pred             ECCCCCCCCC
Q ss_conf             2215423466
Q 004642          179 YVTNNALGGL  188 (740)
Q Consensus       179 ~L~~N~l~~~  188 (740)
                      ++++|.+++.
T Consensus       116 ~~~~~~~~~~  125 (384)
T d2omza2         116 TLFNNQITDI  125 (384)
T ss_dssp             ECCSSCCCCC
T ss_pred             CCCCCCCCCC
T ss_conf             4332222222

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.95  E-value=8.2e-28  Score=165.42  Aligned_cols=174  Identities=15%  Similarity=0.160  Sum_probs=121.9

Q ss_pred             CCCCEEEECCCCEEEEEEEECCCCEEEEEECCCCCCC---------------CHHHHHHHHHHHHHHHCCCCCCCCEEEE
Q ss_conf             6554056114515899999179939999983687621---------------1598999999999972049996311643
Q 004642          452 FHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETE---------------DSAFVKSFQNEAHVLSTVRHRNIVKLYG  516 (740)
Q Consensus       452 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~niv~~~~  516 (740)
                      +.+.++||+|+||+||+|...+|+.||||+++.....               .........+|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf             02277802485659999997999999999986044346665565630008889999997789999999816999144998


Q ss_pred             EEEECCEEEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf             66306757899982458870011028885334798999989999999999988269988386279999667769995799
Q 004642          517 FCLHKKCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDCTLSIIHRDISSNNILLDSNLEASV  596 (740)
Q Consensus       517 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  596 (740)
                      +..    .+++|||+++..+..          ++......++.|++.++.|||+.   ||+||||||+|||++++ .++|
T Consensus        82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             ECC----CEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEE
T ss_conf             628----889999504565420----------01578999999999999998268---88983689036114289-8999


Q ss_pred             EECCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             42245300256987410133477734521124566687101676999999
Q 004642          597 ADFGTARLLHVDSSYRTLRAGTYGYIAPELAYTIVVTGKCDVYSFGVVAL  646 (740)
Q Consensus       597 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  646 (740)
                      +|||.|......... ......... -.+. ....|..++|+||..--+.
T Consensus       144 iDFG~a~~~~~~~~~-~~l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         144 IDFPQSVEVGEEGWR-EILERDVRN-IITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCCTTCEETTSTTHH-HHHHHHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             EECCCCCCCCCCCCH-HHHHHHHHH-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf             877884308998709-999877999-9999-7578998446899999874

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.8e-24  Score=147.18  Aligned_cols=224  Identities=16%  Similarity=0.124  Sum_probs=162.0

Q ss_pred             CCCCCEEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CC
Q ss_conf             99645145389999789974999754445675457999864875789974467882225988776664235444345-86
Q 004642           64 HCNWVGITCDYEGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGI-IP  142 (740)
Q Consensus        64 ~c~w~gv~c~~~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~p  142 (740)
                      .|..+.|.|...           +++ .+|...   .+++++|+|++|.|+.+.+..|.++++|++|++++|.+... .+
T Consensus         7 ~C~~~~i~c~~~-----------~l~-~iP~~l---~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~   71 (242)
T d1xwdc1           7 HCSNRVFLCQES-----------KVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA   71 (242)
T ss_dssp             EECSSEEEEESC-----------SCS-SCCSCS---CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS
T ss_pred             CCCCCEEEEECC-----------CCC-CCCCCC---CCCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEEC
T ss_conf             873999998189-----------988-768888---99889998769918964966861464323211022112420100


Q ss_pred             HHHCCCCCCCCCCCCC-CCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             0000665534322104-204687745423666656142215423466777543344577751238998223355778887
Q 004642          143 KEIGSLRNLRGLFLYS-NKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTL  221 (740)
Q Consensus       143 ~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L  221 (740)
                      ..|.++++++++.+.. |.+....+..|.++++|+.|++++|++....+..                  .+..+..+..+
T Consensus        72 ~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~------------------~~~~l~~l~~~  133 (242)
T d1xwdc1          72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH------------------KIHSLQKVLLD  133 (242)
T ss_dssp             SSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCT------------------TTCBSSCEEEE
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC------------------CCCCCCCCCCC
T ss_conf             112222222221111123432222221222222222234211112554333------------------22211112222


Q ss_pred             ECCCCCCCCCCCCCCCCCC-CCCEECCCCCCCCCCCHHHHCCCCCCC-EECCCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf             5578868876893100447-788211347736797023213856776-30358873457677010148888747436887
Q 004642          222 DLSDNKIHGIIPDELTKLS-QLKNLNLSSNLLSGQIPYAIGKLFNLM-YLDLSKNKLSGSIPTEIGNCSALKNLTLNHNS  299 (740)
Q Consensus       222 ~l~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~  299 (740)
                      ...++.+..+.+..|.+++ .++.|++++|+++...+..+.. .++. .+++++|+++...+..|.++++|+.|++++|+
T Consensus       134 ~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~-~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~  212 (242)
T d1xwdc1         134 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNG-TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTR  212 (242)
T ss_dssp             EESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTT-CCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCC-HHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCC
T ss_conf             222121112222222222331001220012333322222220-1110121235432464247886689999989897992


Q ss_pred             CCCCCCHHCCCCCCCCEEEECC
Q ss_conf             8898820002433455687058
Q 004642          300 LDGTIPLEMGKILLLQNLDLSH  321 (740)
Q Consensus       300 l~~~~~~~~~~l~~L~~L~ls~  321 (740)
                      ++...+..|..+++|+.+++.+
T Consensus       213 l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         213 IHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CCCCCSSSCTTCCEEESSSEES
T ss_pred             CCCCCHHHHCCCCCCCCCCCCC
T ss_conf             8945977973771341476788

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.92  E-value=3.9e-24  Score=145.37  Aligned_cols=190  Identities=22%  Similarity=0.312  Sum_probs=145.4

Q ss_pred             CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf             57999864875789974467882225988776664235444345860000665534322104204687745423666656
Q 004642           97 FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLT  176 (740)
Q Consensus        97 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  176 (740)
                      +..+.+|+.|++.+|+++.. + .+..+++|++|++++|++.+..  .+..+++|+.+++++|.++.+  ..+.++++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~  110 (227)
T d1h6ua2          37 QADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLKNV--SAIAGLQSIK  110 (227)
T ss_dssp             HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred             HHHCCCCCEEECCCCCCCCC-H-HHHCCCCCCEEECCCCEEECCC--CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf             87848868997779999766-4-5744888837635785320254--311233432012111222222--2222222221


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCC
Q ss_conf             14221542346677754334457775123899822335577888755788688768931004477882113477367970
Q 004642          177 ELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQI  256 (740)
Q Consensus       177 ~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  256 (740)
                      .+++++|.....                     ..+...+.+..+.++.+.+...  ..+..+++|+.|++++|.+.+..
T Consensus       111 ~l~l~~~~~~~~---------------------~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~  167 (227)
T d1h6ua2         111 TLDLTSTQITDV---------------------TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT  167 (227)
T ss_dssp             EEECTTSCCCCC---------------------GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG
T ss_pred             CCCCCCCCCCCC---------------------CHHCCCCCHHHHHCHHHHHCHH--HHHCCCCCCCCCCCCCCCCCCCH
T ss_conf             221222443311---------------------0000023012220000000000--00010211100233333333100


Q ss_pred             HHHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECC
Q ss_conf             23213856776303588734576770101488887474368878898820002433455687058
Q 004642          257 PYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSH  321 (740)
Q Consensus       257 ~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  321 (740)
                        .+.++++|+.|++++|++++. + .+.++++|++|+|++|++++. + .+..+++|+.|++++
T Consensus       168 --~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         168 --PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLTN  226 (227)
T ss_dssp             --GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEEE
T ss_pred             --HHCCCCCCEECCCCCCCCCCC-H-HHCCCCCCCEEECCCCCCCCC-C-CCCCCCCCCEEEEEC
T ss_conf             --105646335644588841778-5-344799999897959968998-0-203699989897129

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.90  E-value=2e-21  Score=130.66  Aligned_cols=245  Identities=25%  Similarity=0.280  Sum_probs=138.9

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCC
Q ss_conf             99789974999754445675457999864875789974467882225988776664235444345860000665534322
Q 004642           76 GRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLF  155 (740)
Q Consensus        76 ~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  155 (740)
                      .+++.|++++++++ .+|.    .+++|++|+|++|.|+ .+|..   +.+|+.|++++|+++. ++..   .+.|++|+
T Consensus        38 ~~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~-l~~l---p~~L~~L~  104 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLG  104 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEE
T ss_pred             CCCCEEEECCCCCC-CCCC----CCCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCCH-HHHH---CCCCCCCC
T ss_conf             69989993799988-7889----8789888989999796-33620---3320332665514320-3210---22111113


Q ss_pred             CCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC---
Q ss_conf             10420468774542366665614221542346677754334457775123899822335577888755788688768---
Q 004642          156 LYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGII---  232 (740)
Q Consensus       156 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~---  232 (740)
                      +++|.+... | .+..+++|+.|++++|.+.... .....+..+............+..++.++.|.+..|.+....   
T Consensus       105 L~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~~~-~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~  181 (353)
T d1jl5a_         105 VSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKLP-DLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLP  181 (353)
T ss_dssp             CCSSCCSSC-C-CCTTCTTCCEEECCSSCCSCCC-CCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCC
T ss_pred             CCCCCCCCC-C-CHHHHCCCEEECCCCCCCCCCC-CCCCCCCCHHHCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCC
T ss_conf             345543222-1-0011013123113565100132-233332100001222223332000122200111233443222212


Q ss_pred             ---------------CCCCCCCCCCCEECCCCCCCCCCCHHHHCCCCCCCEECCCCCCCCCC------------------
Q ss_conf             ---------------93100447788211347736797023213856776303588734576------------------
Q 004642          233 ---------------PDELTKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLSGS------------------  279 (740)
Q Consensus       233 ---------------~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~------------------  279 (740)
                                     ...+..++.|+.+++++|..... +..   ..++..+.+.+|.+...                  
T Consensus       182 ~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~-~~~---~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  257 (353)
T d1jl5a_         182 LSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTL-PDL---PPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFS  257 (353)
T ss_dssp             TTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSC-CSC---CTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCS
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             22222334443222212234555333122254222345-532---33433322233333444333443222222223332


Q ss_pred             ------------------CCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCCCCCCCC-CCCCC
Q ss_conf             ------------------77010148888747436887889882000243345568705873568779987544-33477
Q 004642          280 ------------------IPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM-YVDLS  340 (740)
Q Consensus       280 ------------------~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~-~l~l~  340 (740)
                                        +......+++|++|++++|+++ .+|.   .+++|+.|++++|+++ .+|.....+ .++++
T Consensus       258 ~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~~~~L~~L~L~  332 (353)
T d1jl5a_         258 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPELPQNLKQLHVE  332 (353)
T ss_dssp             EESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCCCTTCCEEECC
T ss_pred             CCCCCCCHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCC---CCCCCCEEECCCCCCC-CCCCCCCCCCEEECC
T ss_conf             2234530001233335753234566898898979799168-3566---5487998989999687-545322888989876


Q ss_pred             CCCCC
Q ss_conf             89887
Q 004642          341 FNNLE  345 (740)
Q Consensus       341 ~n~l~  345 (740)
                      +|+++
T Consensus       333 ~N~L~  337 (353)
T d1jl5a_         333 YNPLR  337 (353)
T ss_dssp             SSCCS
T ss_pred             CCCCC
T ss_conf             99189

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.90  E-value=6.8e-24  Score=144.08  Aligned_cols=85  Identities=28%  Similarity=0.324  Sum_probs=33.1

Q ss_pred             CCCEEECCCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEEEC
Q ss_conf             86487578997446-78822259887766642354443458600006655343221042046877454236666561422
Q 004642          102 NLKSLDLWNNSLSG-SIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYV  180 (740)
Q Consensus       102 ~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  180 (740)
                      ++++|+|++|.|+. +.+..|.++++|++|+|++|++....+..+..+++|++|+|++|+|+.+.+..|.++++|++|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCC
T ss_conf             87889848987755302002578762721301363221212122211222210100355344349799807974655245


Q ss_pred             CCCCCC
Q ss_conf             154234
Q 004642          181 TNNALG  186 (740)
Q Consensus       181 ~~N~l~  186 (740)
                      ++|+|+
T Consensus       110 ~~N~l~  115 (192)
T d1w8aa_         110 YDNQIS  115 (192)
T ss_dssp             CSSCCC
T ss_pred             CCCCCC
T ss_conf             774535

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.90  E-value=3.7e-23  Score=140.10  Aligned_cols=182  Identities=25%  Similarity=0.404  Sum_probs=113.2

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCC
Q ss_conf             87578997446788222598877666423544434586000066553432210420468774542366665614221542
Q 004642          105 SLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNA  184 (740)
Q Consensus       105 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  184 (740)
                      ..++..+.+++.++.  ..+.+|++|++++|.++.. + .+..+++|++|+|++|+|++..  .++.+++|+.|++++|+
T Consensus        28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~  101 (210)
T d1h6ta2          28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENK  101 (210)
T ss_dssp             HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             HHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCC-H-HHHHCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCC
T ss_conf             998575765775188--7954845897827988874-4-4764899898769896025860--11358621201433333


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHHHCCCC
Q ss_conf             34667775433445777512389982233557788875578868876893100447788211347736797023213856
Q 004642          185 LGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLF  264 (740)
Q Consensus       185 l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  264 (740)
                      ++..                     ..+.++++|+.|++++|.+...  ..+..++.|+.++++.|.+++..  .+..++
T Consensus       102 i~~l---------------------~~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~~--~~~~l~  156 (210)
T d1h6ta2         102 VKDL---------------------SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDIT--VLSRLT  156 (210)
T ss_dssp             CCCG---------------------GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGGGCT
T ss_pred             CCCC---------------------CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCC--CCCCCC
T ss_conf             2122---------------------2121222111223456532211--22011111222112223334543--100013


Q ss_pred             CCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECC
Q ss_conf             776303588734576770101488887474368878898820002433455687058
Q 004642          265 NLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSH  321 (740)
Q Consensus       265 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  321 (740)
                      +|+.+++++|++++. + .+.++++|+.|++++|+++. ++ .+..+++|+.|+|++
T Consensus       157 ~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         157 KLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             TCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             CCCCCCCCCCCCCCC-C-CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCC
T ss_conf             321001346430256-4-53678989999897998998-72-116999989997118

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2.1e-23  Score=141.46  Aligned_cols=209  Identities=16%  Similarity=0.093  Sum_probs=143.4

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCC-HHHHCCCCCCCEEECCC
Q ss_conf             48757899744678822259887766642354443458600006655343221042046877-45423666656142215
Q 004642          104 KSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVL-PQEIGNLKSLTELYVTN  182 (740)
Q Consensus       104 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~  182 (740)
                      +.++.+++.++ .+|..+.  +++++|+|++|+|+...+..|.++++|++|++++|.+...+ +..|.++++++.+.+..
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCC
T ss_conf             99998189988-7688889--98899987699189649668614643232110221124201001122222222211111


Q ss_pred             -CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEECCCCCCCCCCCHHHH
Q ss_conf             -4234667775433445777512389982233557788875578868876893-10044778821134773679702321
Q 004642          183 -NALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPD-ELTKLSQLKNLNLSSNLLSGQIPYAI  260 (740)
Q Consensus       183 -N~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~  260 (740)
                       |.+..                   ..+..|.++++|+.|++++|++....+. .+..+..+..+...++.+....+..|
T Consensus        88 ~n~l~~-------------------~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~  148 (242)
T d1xwdc1          88 ANNLLY-------------------INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF  148 (242)
T ss_dssp             CTTCCE-------------------ECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSS
T ss_pred             CCCCCC-------------------CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             234322-------------------2222122222222223421111255433322211112222222121112222222


Q ss_pred             CCCC-CCCEECCCCCCCCCCCCCCCCCCCCCCE-EECCCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf             3856-7763035887345767701014888874-7436887889882000243345568705873568779987544
Q 004642          261 GKLF-NLMYLDLSKNKLSGSIPTEIGNCSALKN-LTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPKTLRPM  335 (740)
Q Consensus       261 ~~l~-~L~~L~l~~N~l~~~~~~~l~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~  335 (740)
                      .+++ .++.|+++.|+++...+. .....++.. +.+++|+++...+..|.++++|+.|++++|+++...+..+..+
T Consensus       149 ~~~~~~l~~L~l~~n~l~~i~~~-~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l  224 (242)
T d1xwdc1         149 VGLSFESVILWLNKNGIQEIHNC-AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL  224 (242)
T ss_dssp             TTSBSSCEEEECCSSCCCEECTT-TTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred             CCCCCCCEEEECCCCCCCCCCCC-CCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCHHHHCCC
T ss_conf             22233100122001233332222-22201110121235432464247886689999989897992894597797377

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.89  E-value=5.2e-22  Score=133.82  Aligned_cols=186  Identities=26%  Similarity=0.419  Sum_probs=90.1

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCC
Q ss_conf             87578997446788222598877666423544434586000066553432210420468774542366665614221542
Q 004642          105 SLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNA  184 (740)
Q Consensus       105 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  184 (740)
                      .++++.+.+++..  .+..+.+|+.|++.+|.++..  ..+..+++|++|++++|++.+..+  +..+++|+.+++++|.
T Consensus        23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~   96 (227)
T d1h6ua2          23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP   96 (227)
T ss_dssp             HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred             HHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCCC--HHHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCC
T ss_conf             9984888767757--987848868997779999766--457448888376357853202543--1123343201211122


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHHHCCCC
Q ss_conf             34667775433445777512389982233557788875578868876893100447788211347736797023213856
Q 004642          185 LGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLF  264 (740)
Q Consensus       185 l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  264 (740)
                      ++..                     ..+..+++|+.+.++++...+.  ..+...+.+..+.++.+.+....  .+.+.+
T Consensus        97 ~~~i---------------------~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~  151 (227)
T d1h6ua2          97 LKNV---------------------SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLT  151 (227)
T ss_dssp             CSCC---------------------GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCT
T ss_pred             CCCC---------------------CCCCCCCCCCCCCCCCCCCCCC--CHHCCCCCHHHHHCHHHHHCHHH--HHCCCC
T ss_conf             2222---------------------2222222221221222443311--00000230122200000000000--001021


Q ss_pred             CCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECCCCCC
Q ss_conf             7763035887345767701014888874743688788988200024334556870587356
Q 004642          265 NLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLS  325 (740)
Q Consensus       265 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  325 (740)
                      +|+.|++++|.+.+.  ..+.++++|+.|+|++|++++. + .+..+++|+.|++++|+++
T Consensus       152 ~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt  208 (227)
T d1h6ua2         152 NLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQIS  208 (227)
T ss_dssp             TCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCC
T ss_pred             CCCCCCCCCCCCCCC--HHHCCCCCCEECCCCCCCCCCC-H-HHCCCCCCCEEECCCCCCC
T ss_conf             110023333333310--0105646335644588841778-5-3447999998979599689

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.89  E-value=2.1e-22  Score=135.92  Aligned_cols=166  Identities=29%  Similarity=0.428  Sum_probs=132.8

Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEE
Q ss_conf             99986487578997446788222598877666423544434586000066553432210420468774542366665614
Q 004642           99 CFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTEL  178 (740)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  178 (740)
                      .+..|+.|++++|.++...  .+..+++|++|+|++|.+++..  .++.+++|++|++++|+|+++ + .+.++++|+.|
T Consensus        44 ~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L  117 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSL  117 (210)
T ss_dssp             HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEE
T ss_pred             HHCCCCEEECCCCCCCCCH--HHHHCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCC
T ss_conf             9548458978279888744--4764899898769896025860--113586212014333332122-2-12122211122


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHH
Q ss_conf             22154234667775433445777512389982233557788875578868876893100447788211347736797023
Q 004642          179 YVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPY  258 (740)
Q Consensus       179 ~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  258 (740)
                      ++++|.+...                     ..+..++.++.++++.|.+++.  ..+..+++|+.+++++|++++..  
T Consensus       118 ~l~~~~~~~~---------------------~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--  172 (210)
T d1h6ta2         118 SLEHNGISDI---------------------NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--  172 (210)
T ss_dssp             ECTTSCCCCC---------------------GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--
T ss_pred             CCCCCCCCCC---------------------CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCC--
T ss_conf             3456532211---------------------2201111122211222333454--31000133210013464302564--


Q ss_pred             HHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             213856776303588734576770101488887474368
Q 004642          259 AIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNH  297 (740)
Q Consensus       259 ~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~  297 (740)
                      .+.++++|+.|++++|++++ ++ .+.++++|+.|+|++
T Consensus       173 ~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         173 PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCC
T ss_conf             53678989999897998998-72-116999989997118

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.89  E-value=1.9e-22  Score=136.16  Aligned_cols=178  Identities=26%  Similarity=0.419  Sum_probs=95.8

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCC
Q ss_conf             87578997446788222598877666423544434586000066553432210420468774542366665614221542
Q 004642          105 SLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNA  184 (740)
Q Consensus       105 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  184 (740)
                      .+.++.+.+++...  ...+.++++|++++|.+...  +.+..+++|++|++++|++++..+  +.++++|+.|++++|.
T Consensus        22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~   95 (199)
T d2omxa2          22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   95 (199)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHHCCCCCCCCCC--HHHHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCC
T ss_conf             99967787788559--87946878998999999775--202137886757545655667640--1677522311112222


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHHHCCCC
Q ss_conf             34667775433445777512389982233557788875578868876893100447788211347736797023213856
Q 004642          185 LGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIPYAIGKLF  264 (740)
Q Consensus       185 l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  264 (740)
                      +...                     ..+.+++.|+.|++++|.+...  ..+..+++|+.|++++|.+...  ..+..++
T Consensus        96 ~~~~---------------------~~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~  150 (199)
T d2omxa2          96 IADI---------------------TPLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLT  150 (199)
T ss_dssp             CCCC---------------------GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCT
T ss_pred             CCCC---------------------CCCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHCCC--CCCCCCC
T ss_conf             2222---------------------1111122322211122222232--1000122367764311110023--4333211


Q ss_pred             CCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEE
Q ss_conf             77630358873457677010148888747436887889882000243345568
Q 004642          265 NLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNL  317 (740)
Q Consensus       265 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  317 (740)
                      +++.|++.+|++++.  ..+.++++|+.|++++|++++ ++ .+..+++|+.|
T Consensus       151 ~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         151 SLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             TCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             CCCCCCCCCCCCCCC--CCCCCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCC
T ss_conf             111122345555677--011679989999787997998-81-01278998949

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.89  E-value=7.8e-23  Score=138.31  Aligned_cols=110  Identities=28%  Similarity=0.382  Sum_probs=64.6

Q ss_pred             CCCCEEECCCCCCCC-CCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             877666423544434-5860000665534322104204687745423666656142215423466777543344577751
Q 004642          125 SKLKCLYLHGNNLTG-IIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQ  203 (740)
Q Consensus       125 ~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~  203 (740)
                      +++++|+|++|+|+. ..+..|.++++|+.|+|++|.+....+..|..+++|+.|+|++|+++.+.+.            
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~------------   96 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNK------------   96 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSS------------
T ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHH------------
T ss_conf             78788984898775530200257876272130136322121212221122221010035534434979------------


Q ss_pred             CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf             23899822335577888755788688768931004477882113477367
Q 004642          204 FHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLS  253 (740)
Q Consensus       204 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  253 (740)
                             .|.++++|+.|+|++|+|+.+.++.|..+++|++|++++|.+.
T Consensus        97 -------~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~  139 (192)
T d1w8aa_          97 -------MFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             -------SSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             -------HHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf             -------9807974655245774535359778568753342000364434

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.88  E-value=8.7e-22  Score=132.60  Aligned_cols=163  Identities=28%  Similarity=0.429  Sum_probs=114.1

Q ss_pred             CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCE
Q ss_conf             79998648757899744678822259887766642354443458600006655343221042046877454236666561
Q 004642           98 SCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTE  177 (740)
Q Consensus        98 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  177 (740)
                      ..+++++.|++++|.++..  +.+..+++|++|++++|++++..+  +.++++|++|++++|.+....  .+.++++|+.
T Consensus        37 ~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~  110 (199)
T d2omxa2          37 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTG  110 (199)
T ss_dssp             HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSE
T ss_pred             HHHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf             7946878998999999775--202137886757545655667640--167752231111222222221--1111223222


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCH
Q ss_conf             42215423466777543344577751238998223355778887557886887689310044778821134773679702
Q 004642          178 LYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP  257 (740)
Q Consensus       178 L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  257 (740)
                      |++++|.+...                     ..+..+++|+.|++++|++.. + +.+..+++|+.|++.+|++++.. 
T Consensus       111 L~l~~~~~~~~---------------------~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~-  166 (199)
T d2omxa2         111 LTLFNNQITDI---------------------DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK-  166 (199)
T ss_dssp             EECCSSCCCCC---------------------GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG-
T ss_pred             CCCCCCCCCCC---------------------CCCCHHHHHHHHHHHHHHHCC-C-CCCCCCCCCCCCCCCCCCCCCCC-
T ss_conf             11122222232---------------------100012236776431111002-3-43332111111223455556770-


Q ss_pred             HHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             321385677630358873457677010148888747
Q 004642          258 YAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNL  293 (740)
Q Consensus       258 ~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L  293 (740)
                       .+.++++|+.|++++|++++ + +.+.++++|+.|
T Consensus       167 -~l~~l~~L~~L~ls~N~i~~-i-~~l~~L~~L~~L  199 (199)
T d2omxa2         167 -PLANLTTLERLDISSNKVSD-I-SVLAKLTNLESL  199 (199)
T ss_dssp             -GGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEE
T ss_pred             -CCCCCCCCCEEECCCCCCCC-C-CCCCCCCCCCCC
T ss_conf             -11679989999787997998-8-101278998949

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=7.3e-19  Score=116.69  Aligned_cols=233  Identities=26%  Similarity=0.279  Sum_probs=139.0

Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCC
Q ss_conf             99978997499975444567545799986487578997446788222598877666423544434586000066553432
Q 004642           75 EGRITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGL  154 (740)
Q Consensus        75 ~~~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  154 (740)
                      ..+++.|++++++++ .++.    .+.+|+.|++++|.++.. +. +  .+.|++|++++|.+. .+|. ++.+++|+.|
T Consensus        57 ~~~L~~L~Ls~N~l~-~lp~----~~~~L~~L~l~~n~l~~l-~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L  125 (353)
T d1jl5a_          57 PPHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKAL-SD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKII  125 (353)
T ss_dssp             CTTCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSCC-CS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEE
T ss_pred             CCCCCEEECCCCCCC-CCCC----CHHHHHHHHHHHCCCCHH-HH-H--CCCCCCCCCCCCCCC-CCCC-HHHHCCCEEE
T ss_conf             789888989999796-3362----033203326655143203-21-0--221111133455432-2210-0110131231


Q ss_pred             CCCCCCCCCCCH------------------HHHCCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCC
Q ss_conf             210420468774------------------542366665614221542346677754334-4577751238998223355
Q 004642          155 FLYSNKLSGVLP------------------QEIGNLKSLTELYVTNNALGGLIPSTLFRL-TNISSNQFHSSIPLEIGNF  215 (740)
Q Consensus       155 ~Ls~N~l~~~~~------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~l~~n~l~~~~~~~~~~l  215 (740)
                      ++++|.+.....                  ..+..++.++.+.+++|............. .....+.+. .. ..+..+
T Consensus       126 ~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~-~~-~~~~~l  203 (353)
T d1jl5a_         126 DVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILE-EL-PELQNL  203 (353)
T ss_dssp             ECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCS-SC-CCCTTC
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCC
T ss_conf             1356510013223333210000122222333200012220011123344322221222222334443222-21-223455


Q ss_pred             CCCCEEECCCCCCCCCCCCCCCC-----------------CCCCCEECCCCCCCCC---C-------------CHHHHCC
Q ss_conf             77888755788688768931004-----------------4778821134773679---7-------------0232138
Q 004642          216 SALDTLDLSDNKIHGIIPDELTK-----------------LSQLKNLNLSSNLLSG---Q-------------IPYAIGK  262 (740)
Q Consensus       216 ~~L~~L~l~~N~l~~~~~~~~~~-----------------l~~L~~L~l~~N~l~~---~-------------~~~~~~~  262 (740)
                      +.|+.+++++|.... .+.....                 ...+....+..+.+.+   .             +......
T Consensus       204 ~~L~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~  282 (353)
T d1jl5a_         204 PFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDL  282 (353)
T ss_dssp             TTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCC
T ss_pred             CCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCC
T ss_conf             533312225422234-5532334333222333334443334432222222233322234530001233335753234566


Q ss_pred             CCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEEECCCCCCCCCCC
Q ss_conf             56776303588734576770101488887474368878898820002433455687058735687799
Q 004642          263 LFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNHNSLDGTIPLEMGKILLLQNLDLSHNNLSGTIPK  330 (740)
Q Consensus       263 l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~  330 (740)
                      +++|++|++++|+++ .+|.   .+++|+.|+|++|+++ .+|..   +++|+.|++++|+++ .+|.
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~  341 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD  341 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred             CCCCCEEECCCCCCC-CCCC---CCCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCC
T ss_conf             898898979799168-3566---5487998989999687-54532---288898987699189-7776

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=1.9e-21  Score=130.70  Aligned_cols=200  Identities=19%  Similarity=0.174  Sum_probs=93.3

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEEECCC
Q ss_conf             4875789974467882225988776664235444345-860000665534322104204687745423666656142215
Q 004642          104 KSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGI-IPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTN  182 (740)
Q Consensus       104 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  182 (740)
                      ..+.++...+...... .....+|++|++++|.+... +...+.++++|++|+|++|.+.+..+..++.+++|+.|++++
T Consensus        26 ~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~  104 (284)
T d2astb2          26 IAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG  104 (284)
T ss_dssp             SEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred             EEEECCCCCCCCCHHH-HCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCC
T ss_conf             2746523334552244-256787887889898457779999997487765145234679867899985189975715100


Q ss_pred             C-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCC-CCCCCCC-CCCCCEECCCCC--CCCCCC
Q ss_conf             4-2346677754334457775123899822335577888755788-68876-8931004-477882113477--367970
Q 004642          183 N-ALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDTLDLSDN-KIHGI-IPDELTK-LSQLKNLNLSSN--LLSGQI  256 (740)
Q Consensus       183 N-~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~-l~~L~~L~l~~N--~l~~~~  256 (740)
                      + .++...                  +...+.++++|++|+++++ .+++. ....+.. .+.|+.|+++++  .+++..
T Consensus       105 c~~itd~~------------------l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~  166 (284)
T d2astb2         105 CSGFSEFA------------------LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD  166 (284)
T ss_dssp             CBSCCHHH------------------HHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHH
T ss_pred             CCCCCCCC------------------CCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf             13412355------------------403657887435652245332333220001000111110122135542444443


Q ss_pred             -HHHHCCCCCCCEECCCCCC-CCCCCCCCCCCCCCCCEEECCCC-CCCCCCCHHCCCCCCCCEEEECCC
Q ss_conf             -2321385677630358873-45767701014888874743688-788988200024334556870587
Q 004642          257 -PYAIGKLFNLMYLDLSKNK-LSGSIPTEIGNCSALKNLTLNHN-SLDGTIPLEMGKILLLQNLDLSHN  322 (740)
Q Consensus       257 -~~~~~~l~~L~~L~l~~N~-l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~ls~N  322 (740)
                       .....++++|+.|++++|. +++.....+.++++|++|++++| .+++.....++.+++|+.|+++++
T Consensus       167 l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             HHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf             434232322212355322347783033332135768779899999787378999726999898964488

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.82  E-value=1.8e-21  Score=130.89  Aligned_cols=230  Identities=20%  Similarity=0.194  Sum_probs=105.7

Q ss_pred             CCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCC---C-------CCHHHCCCCCCCCCCCCCCCC
Q ss_conf             457999864875789974467----88222598877666423544434---5-------860000665534322104204
Q 004642           96 NFSCFPNLKSLDLWNNSLSGS----IPPQIGSLSKLKCLYLHGNNLTG---I-------IPKEIGSLRNLRGLFLYSNKL  161 (740)
Q Consensus        96 ~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~---~-------~p~~l~~l~~L~~L~Ls~N~l  161 (740)
                      .+.....|+.|+|++|.+...    +...+...++|+.|+++++....   .       +...+..+++|+.|+|++|.+
T Consensus        26 ~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i  105 (344)
T d2ca6a1          26 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF  105 (344)
T ss_dssp             HHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCC
T ss_pred             HHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf             99638997889784983778999999999985899888888777543345421067879998875477756330000134


Q ss_pred             CCCCHH----HHCCCCCCCEEECCCCCCCCCCCCCCCCC------------------CCCCCCCCCCC----CCCCCCCC
Q ss_conf             687745----42366665614221542346677754334------------------45777512389----98223355
Q 004642          162 SGVLPQ----EIGNLKSLTELYVTNNALGGLIPSTLFRL------------------TNISSNQFHSS----IPLEIGNF  215 (740)
Q Consensus       162 ~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------------------~~l~~n~l~~~----~~~~~~~l  215 (740)
                      ......    .+...++|+.|++++|.++......++..                  ..++.|.+...    +...+...
T Consensus       106 ~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~  185 (344)
T d2ca6a1         106 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH  185 (344)
T ss_dssp             CTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred             CCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCHHHHH
T ss_conf             55433310111002343210000024666654311112122221100014676421110136501355433221111233


Q ss_pred             CCCCEEECCCCCCCCC-----CCCCCCCCCCCCEECCCCCCCCCC----CHHHHCCCCCCCEECCCCCCCCCCCCCCC--
Q ss_conf             7788875578868876-----893100447788211347736797----02321385677630358873457677010--
Q 004642          216 SALDTLDLSDNKIHGI-----IPDELTKLSQLKNLNLSSNLLSGQ----IPYAIGKLFNLMYLDLSKNKLSGSIPTEI--  284 (740)
Q Consensus       216 ~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~l--  284 (740)
                      +.|+.|++++|+|+..     +...+..+++|+.|++++|.++..    +...+...++|+.|++++|.+++.....+  
T Consensus       186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~  265 (344)
T d2ca6a1         186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD  265 (344)
T ss_dssp             TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred             HHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHH
T ss_conf             32133543332222222320024332110121122233332222222234443323221111030047567156678887


Q ss_pred             --CC--CCCCCEEECCCCCCCCCC----CHHCC-CCCCCCEEEECCCCCC
Q ss_conf             --14--888874743688788988----20002-4334556870587356
Q 004642          285 --GN--CSALKNLTLNHNSLDGTI----PLEMG-KILLLQNLDLSHNNLS  325 (740)
Q Consensus       285 --~~--l~~L~~L~L~~N~l~~~~----~~~~~-~l~~L~~L~ls~N~l~  325 (740)
                        ..  .+.|+.|++++|.++...    ...+. +.++|+.|++++|++.
T Consensus       266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             HHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCC
T ss_conf             76315688889898989869808999999999703899998978798089

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=3.4e-23  Score=140.26  Aligned_cols=111  Identities=19%  Similarity=0.218  Sum_probs=76.0

Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCCC----CHHHC-C
Q ss_conf             978997499975444567545799986487578997446----78822259887766642354443458----60000-6
Q 004642           77 RITDIDLLNSNIKGELGRLNFSCFPNLKSLDLWNNSLSG----SIPPQIGSLSKLKCLYLHGNNLTGII----PKEIG-S  147 (740)
Q Consensus        77 ~v~~l~l~~~~l~~~~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~----p~~l~-~  147 (740)
                      .+..|++..+++.+..-...+..++++++|+|++|.++.    .+...+..+++|++|+|++|.|+...    ...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf             87779820895886899999976779999982899998899999999985399988897959859728999999998437


Q ss_pred             CCCCCCCCCCCCCCCCCC----HHHHCCCCCCCEEECCCCCCCC
Q ss_conf             655343221042046877----4542366665614221542346
Q 004642          148 LRNLRGLFLYSNKLSGVL----PQEIGNLKSLTELYVTNNALGG  187 (740)
Q Consensus       148 l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~  187 (740)
                      ..+|+.|+|++|++++..    +..+..+++|++|++++|.++.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHH
T ss_conf             88778877888775432210121100003432002444332023

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=1.7e-20  Score=125.57  Aligned_cols=213  Identities=20%  Similarity=0.206  Sum_probs=149.4

Q ss_pred             CCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCC-CCCCCCHHH-HCCCCC
Q ss_conf             7999864875789974467-8822259887766642354443458600006655343221042-046877454-236666
Q 004642           98 SCFPNLKSLDLWNNSLSGS-IPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSN-KLSGVLPQE-IGNLKS  174 (740)
Q Consensus        98 ~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~-~~~l~~  174 (740)
                      .....|++|+|+++.++.. +...+..+++|++|+|++|.+++..+..+..+++|+.|+++++ .+++..... +.++++
T Consensus        43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~  122 (284)
T d2astb2          43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR  122 (284)
T ss_dssp             CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred             CCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
T ss_conf             56787887889898457779999997487765145234679867899985189975715100134123554036578874


Q ss_pred             CCEEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCEEECCCC--CCCCC-CCCCCCCCCCCCEECCCC
Q ss_conf             5614221542-3466777543344577751238998223-35577888755788--68876-893100447788211347
Q 004642          175 LTELYVTNNA-LGGLIPSTLFRLTNISSNQFHSSIPLEI-GNFSALDTLDLSDN--KIHGI-IPDELTKLSQLKNLNLSS  249 (740)
Q Consensus       175 L~~L~L~~N~-l~~~~~~~~~~l~~l~~n~l~~~~~~~~-~~l~~L~~L~l~~N--~l~~~-~~~~~~~l~~L~~L~l~~  249 (740)
                      |++|+++++. ++...                  ....+ ...++|+.|+++++  .+++. +...+.++++|+.|++++
T Consensus       123 L~~L~ls~c~~~~~~~------------------~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~  184 (284)
T d2astb2         123 LDELNLSWCFDFTEKH------------------VQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD  184 (284)
T ss_dssp             CCEEECCCCTTCCHHH------------------HHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTT
T ss_pred             CCCCCCCCCCCCCCCC------------------CHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             3565224533233322------------------0001000111110122135542444443434232322212355322


Q ss_pred             C-CCCCCCHHHHCCCCCCCEECCCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCHHCCCCCCCCEEEECCCCCCC
Q ss_conf             7-367970232138567763035887-34576770101488887474368878898-82000243345568705873568
Q 004642          250 N-LLSGQIPYAIGKLFNLMYLDLSKN-KLSGSIPTEIGNCSALKNLTLNHNSLDGT-IPLEMGKILLLQNLDLSHNNLSG  326 (740)
Q Consensus       250 N-~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~~  326 (740)
                      | .+++.....+..+++|++|++++| .+++.....+.++++|+.|++.++ ++.. .......+   ..|.++.+++++
T Consensus       185 ~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~l---p~L~i~~~~ls~  260 (284)
T d2astb2         185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEAL---PHLQINCSHFTT  260 (284)
T ss_dssp             CTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHS---TTSEESCCCSCC
T ss_pred             CCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC-CCHHHHHHHHHHC---CCCCCCCCCCCC
T ss_conf             347783033332135768779899999787378999726999898964488-8989999999768---436616865877


Q ss_pred             CCCCCC
Q ss_conf             779987
Q 004642          327 TIPKTL  332 (740)
Q Consensus       327 ~~p~~~  332 (740)
                      ..++.+
T Consensus       261 ~~~~~~  266 (284)
T d2astb2         261 IARPTI  266 (284)
T ss_dssp             TTCSSC
T ss_pred             CCCCCC
T ss_conf             778854

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.78  E-value=4.1e-21  Score=128.93  Aligned_cols=89  Identities=29%  Similarity=0.334  Sum_probs=33.3

Q ss_pred             CCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEECCCCCCCCCCCHHHH----CC--CCCCCEECCCCCCCCCCC--
Q ss_conf             3557788875578868876----89310044778821134773679702321----38--567763035887345767--
Q 004642          213 GNFSALDTLDLSDNKIHGI----IPDELTKLSQLKNLNLSSNLLSGQIPYAI----GK--LFNLMYLDLSKNKLSGSI--  280 (740)
Q Consensus       213 ~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~----~~--l~~L~~L~l~~N~l~~~~--  280 (740)
                      ..+++|+.|++++|.++..    +...+..+++|+.|++++|.|++.....+    ..  ...|+.|++++|+++...  
T Consensus       212 ~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~  291 (344)
T d2ca6a1         212 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR  291 (344)
T ss_dssp             GGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHH
T ss_pred             CCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCHHHHH
T ss_conf             11012112223333222222223444332322111103004756715667888776315688889898989869808999


Q ss_pred             --CCCCC-CCCCCCEEECCCCCCC
Q ss_conf             --70101-4888874743688788
Q 004642          281 --PTEIG-NCSALKNLTLNHNSLD  301 (740)
Q Consensus       281 --~~~l~-~l~~L~~L~L~~N~l~  301 (740)
                        ...+. ++++|++|+|++|.+.
T Consensus       292 ~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         292 TLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             HHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             HHHHHHHCCCCCCCEEECCCCCCC
T ss_conf             999999703899998978798089

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=3.9e-21  Score=129.04  Aligned_cols=249  Identities=20%  Similarity=0.205  Sum_probs=110.3

Q ss_pred             CEEEEECCCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCCC----CCCCC-CCCCCCEEECCCCCCCCC----CCH
Q ss_conf             978997499975444----56754579998648757899744678----82225-988776664235444345----860
Q 004642           77 RITDIDLLNSNIKGE----LGRLNFSCFPNLKSLDLWNNSLSGSI----PPQIG-SLSKLKCLYLHGNNLTGI----IPK  143 (740)
Q Consensus        77 ~v~~l~l~~~~l~~~----~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~-~l~~L~~L~L~~n~l~~~----~p~  143 (740)
                      ..+.++|.+++++..    +.. .+..+++|+.|+|++|.|+...    ...+. ...+|++|+|++|.++..    ++.
T Consensus        28 ~l~~L~L~~~~i~~~~~~~l~~-~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~  106 (460)
T d1z7xw1          28 QCQVVRLDDCGLTEARCKDISS-ALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS  106 (460)
T ss_dssp             TCSEEEEESSCCCHHHHHHHHH-HHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred             CCCEEEECCCCCCHHHHHHHHH-HHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf             9999982899998899999999-985399988897959859728999999998437887788778887754322101211


Q ss_pred             HHCCCCCCCCCCCCCCCCCCCCHHHH---------------------------------CCCCCCCEEECCCCCCCCCCC
Q ss_conf             00066553432210420468774542---------------------------------366665614221542346677
Q 004642          144 EIGSLRNLRGLFLYSNKLSGVLPQEI---------------------------------GNLKSLTELYVTNNALGGLIP  190 (740)
Q Consensus       144 ~l~~l~~L~~L~Ls~N~l~~~~~~~~---------------------------------~~l~~L~~L~L~~N~l~~~~~  190 (740)
                      .+..+++|++|+|++|.+.+.....+                                 .....++.++++++.+.....
T Consensus       107 ~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~  186 (460)
T d1z7xw1         107 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV  186 (460)
T ss_dssp             HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred             HHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             00003432002444332023455554430135543332222223222001100112223333222223322221245555


Q ss_pred             CCCC----------CCCCCCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCC-----CCCCCCCCCCCCEECCCCCC
Q ss_conf             7543----------3445777512389----982233557788875578868876-----89310044778821134773
Q 004642          191 STLF----------RLTNISSNQFHSS----IPLEIGNFSALDTLDLSDNKIHGI-----IPDELTKLSQLKNLNLSSNL  251 (740)
Q Consensus       191 ~~~~----------~l~~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~L~l~~N~  251 (740)
                      ..+.          ....+..+.+...    ....+...+.++.+++..|.+...     ..........++.+++++|.
T Consensus       187 ~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~  266 (460)
T d1z7xw1         187 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG  266 (460)
T ss_dssp             HHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCC
T ss_conf             43234332112210012411245421011012233222222100100211223344201100011111110000134543


Q ss_pred             CCCCC----HHHHCCCCCCCEECCCCCCCCCCCCCCC-----CCCCCCCEEECCCCCCCCCCCHHC----CCCCCCCEEE
Q ss_conf             67970----2321385677630358873457677010-----148888747436887889882000----2433455687
Q 004642          252 LSGQI----PYAIGKLFNLMYLDLSKNKLSGSIPTEI-----GNCSALKNLTLNHNSLDGTIPLEM----GKILLLQNLD  318 (740)
Q Consensus       252 l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~  318 (740)
                      +....    ...+...+.++.+++++|.+++.....+     .....|+.+++++|.++......+    ...++|+.|+
T Consensus       267 i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~  346 (460)
T d1z7xw1         267 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQ  346 (460)
T ss_dssp             CCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEE
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf             32123343322111234333444443332245642111012333444333323334102334432133221101111320


Q ss_pred             ECCCCCCC
Q ss_conf             05873568
Q 004642          319 LSHNNLSG  326 (740)
Q Consensus       319 ls~N~l~~  326 (740)
                      |++|++++
T Consensus       347 Ls~N~i~~  354 (460)
T d1z7xw1         347 ISNNRLED  354 (460)
T ss_dssp             CCSSBCHH
T ss_pred             EEEECCCC
T ss_conf             12101357

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=1.9e-18  Score=114.42  Aligned_cols=87  Identities=22%  Similarity=0.271  Sum_probs=40.3

Q ss_pred             CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf             57999864875789974467882225988776664235444345860000665534322104204687745423666656
Q 004642           97 FSCFPNLKSLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLT  176 (740)
Q Consensus        97 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  176 (740)
                      |.+...++.|+|++|+|+.+ +..+..+++|+.|+|++|.|+..  +.+..+++|++|++++|+++.+.+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             CCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCC
T ss_conf             16857484897889978865-76200414599898979978764--7744576130643102134577763223345344


Q ss_pred             EEECCCCCCC
Q ss_conf             1422154234
Q 004642          177 ELYVTNNALG  186 (740)
Q Consensus       177 ~L~L~~N~l~  186 (740)
                      .|++++|+++
T Consensus        91 ~L~L~~N~i~  100 (162)
T d1a9na_          91 ELILTNNSLV  100 (162)
T ss_dssp             EEECCSCCCC
T ss_pred             CCEECCCCCC
T ss_conf             3420300016

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=5.3e-18  Score=111.99  Aligned_cols=64  Identities=27%  Similarity=0.260  Sum_probs=25.8

Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCH-HHHCCCCCCCEECCCCCCCC
Q ss_conf             55778887557886887689310044778821134773679702-32138567763035887345
Q 004642          214 NFSALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP-YAIGKLFNLMYLDLSKNKLS  277 (740)
Q Consensus       214 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~  277 (740)
                      .+++|+.|++++|+++.+.+..+..+++|+.|++++|.++.... ..+..+++|++|++++|+++
T Consensus        61 ~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          61 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf             57613064310213457776322334534434203000166542110013653206640799634

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.68  E-value=1.3e-18  Score=115.34  Aligned_cols=59  Identities=29%  Similarity=0.281  Sum_probs=22.2

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCH-HHHCCCCCCCEECCCCCCCC
Q ss_conf             78887557886887689310044778821134773679702-32138567763035887345
Q 004642          217 ALDTLDLSDNKIHGIIPDELTKLSQLKNLNLSSNLLSGQIP-YAIGKLFNLMYLDLSKNKLS  277 (740)
Q Consensus       217 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~  277 (740)
                      +|+.|++++|+++.+  ..+..+++|+.|++++|+++.... ..+..+++|+.|++++|++.
T Consensus        94 ~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_          94 TLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             HCCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             CCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCC
T ss_conf             233333333222222--222222234111234102125542212367776302342798434

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.67  E-value=1.7e-16  Score=103.76  Aligned_cols=77  Identities=31%  Similarity=0.357  Sum_probs=33.5

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCC
Q ss_conf             87578997446788222598877666423544434586000066553432210420468774542366665614221542
Q 004642          105 SLDLWNNSLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNA  184 (740)
Q Consensus       105 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  184 (740)
                      .|+|++|+++.. + .+..+++|++|++++|+|+ .+|..+..+++|+.|++++|+|++. + .+..+++|+.|++++|+
T Consensus         2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred             EEECCCCCCCCC-C-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCC-C-CCCCCCCCCEEECCCCC
T ss_conf             898689989887-1-0105898898979787168-6521565543135453243211235-7-41233555768888986


Q ss_pred             CC
Q ss_conf             34
Q 004642          185 LG  186 (740)
Q Consensus       185 l~  186 (740)
                      ++
T Consensus        77 i~   78 (124)
T d1dcea3          77 LQ   78 (124)
T ss_dssp             CC
T ss_pred             CC
T ss_conf             58

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.65  E-value=1.2e-18  Score=115.40  Aligned_cols=111  Identities=30%  Similarity=0.375  Sum_probs=44.7

Q ss_pred             CCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf             22259887766642354443458600006655343221042046877454236666561422154234667775433445
Q 004642          119 PQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLSGVLPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTN  198 (740)
Q Consensus       119 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  198 (740)
                      ..+..+++|++|+|++|+|+.. + .+.++++|+.|+|++|+|+.+ +..+..+++|+.|++++|+++..          
T Consensus        42 ~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i-~~~~~~~~~L~~L~l~~N~i~~l----------  108 (198)
T d1m9la_          42 ATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKI-ENLDAVADTLEELWISYNQIASL----------  108 (198)
T ss_dssp             HHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSC-SSHHHHHHHCCEEECSEEECCCH----------
T ss_pred             HHHHCCCCCCEEECCCCCCCCC-C-CCCCCCCCCCHHHCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCC----------
T ss_conf             6776260461519944689986-4-424782535734135343210-00033221233333333222222----------


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCCEECCCCCCCC
Q ss_conf             77751238998223355778887557886887689-31004477882113477367
Q 004642          199 ISSNQFHSSIPLEIGNFSALDTLDLSDNKIHGIIP-DELTKLSQLKNLNLSSNLLS  253 (740)
Q Consensus       199 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~  253 (740)
                                 ..+..+++|+.|++++|+|++... ..+..+++|+.|++++|.+.
T Consensus       109 -----------~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         109 -----------SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             -----------HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             -----------CCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCC
T ss_conf             -----------222222234111234102125542212367776302342798434

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.65  E-value=3.8e-16  Score=101.88  Aligned_cols=16  Identities=31%  Similarity=0.216  Sum_probs=5.3

Q ss_pred             CCCCCCCCCCCCCCCC
Q ss_conf             0665534322104204
Q 004642          146 GSLRNLRGLFLYSNKL  161 (740)
Q Consensus       146 ~~l~~L~~L~Ls~N~l  161 (740)
                      ..+++|++|++++|+|
T Consensus        17 ~~l~~L~~L~ls~N~l   32 (124)
T d1dcea3          17 EQLLLVTHLDLSHNRL   32 (124)
T ss_dssp             GGGTTCCEEECCSSCC
T ss_pred             CCCCCCCEEECCCCCC
T ss_conf             0589889897978716

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=2.9e-15  Score=97.10  Aligned_cols=63  Identities=24%  Similarity=0.189  Sum_probs=21.6

Q ss_pred             CCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCCCCCCCCCCC
Q ss_conf             998648757899-744678822259887766642354443458600006655343221042046
Q 004642          100 FPNLKSLDLWNN-SLSGSIPPQIGSLSKLKCLYLHGNNLTGIIPKEIGSLRNLRGLFLYSNKLS  162 (740)
Q Consensus       100 l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~  162 (740)
                      +++|+.|++++| .++.+.+..|.++++|+.|+|++|+|+.+.+..|..+++|++|+|++|+|+
T Consensus        30 l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~   93 (156)
T d2ifga3          30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE   93 (156)
T ss_dssp             CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred             CCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC
T ss_conf             6565743168986644369212256666672162021247742011124554333322678785

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=3.9e-15  Score=96.38  Aligned_cols=106  Identities=23%  Similarity=0.138  Sum_probs=48.5

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEECCCCC-CCCCCCHHHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             88755788688768931004477882113477-36797023213856776303588734576770101488887474368
Q 004642          219 DTLDLSDNKIHGIIPDELTKLSQLKNLNLSSN-LLSGQIPYAIGKLFNLMYLDLSKNKLSGSIPTEIGNCSALKNLTLNH  297 (740)
Q Consensus       219 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~  297 (740)
                      +.++.+++.+. ..|..+..+++|+.|++++| .|+...+..|.++++|+.|++++|+|+...+.+|.++++|+.|+|++
T Consensus        11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             CEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCC
T ss_conf             96985289976-58600257656574316898664436921225666667216202124774201112455433332267


Q ss_pred             CCCCCCCCHHCCCCCCCCEEEECCCCCCC
Q ss_conf             87889882000243345568705873568
Q 004642          298 NSLDGTIPLEMGKILLLQNLDLSHNNLSG  326 (740)
Q Consensus       298 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  326 (740)
                      |+++...+..+. ...|+.|+|++|++.+
T Consensus        90 N~l~~l~~~~~~-~~~l~~L~L~~Np~~C  117 (156)
T d2ifga3          90 NALESLSWKTVQ-GLSLQELVLSGNPLHC  117 (156)
T ss_dssp             SCCSCCCSTTTC-SCCCCEEECCSSCCCC
T ss_pred             CCCCCCCHHHHC-CCCCCCCCCCCCCCCC
T ss_conf             878515745633-5321243357986338

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.19  E-value=3e-10  Score=69.73  Aligned_cols=150  Identities=16%  Similarity=0.147  Sum_probs=101.5

Q ss_pred             HHHHHHHCCCCCCEEEECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCEEEEEEEEC
Q ss_conf             99999721565540561145158999991799399999836876211598999999999972049-99631164366306
Q 004642          443 EDLINATEDFHIKYCIGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHK  521 (740)
Q Consensus       443 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  521 (740)
                      .++....+.|+.++..+.++.+.||+... +++.+++|+.........   ..+.+|...+..+. +--+.+++.+...+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~---~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCH---HHHHHHHHHHHHHHCCCCCCCEEEEEECC
T ss_conf             99997513527997678998771899990-898699998488765325---56999999999876069987289997508


Q ss_pred             CEEEEEEEECCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------
Q ss_conf             757899982458870011028885334798999989999999999988269-----------------------------
Q 004642          522 KCMFLIYEYMERGSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC-----------------------------  572 (740)
Q Consensus       522 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----------------------------  572 (740)
                      +..++||++++|.++.+......     .   ...++.++++.+..||+..                             
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             CCEEEEEEECCCCCCCCCCCCCC-----C---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf             96499998604334354334402-----6---999999899999998556842143576446565557789987765555


Q ss_pred             ---------------------------CCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf             ---------------------------98838627999966776999579942245300
Q 004642          573 ---------------------------TLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       573 ---------------------------~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                                                 ...++|+|+.|.||+++++..+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf             43033232005799999999844986781789860047642364996599960231441

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.02  E-value=5.5e-11  Score=73.74  Aligned_cols=41  Identities=39%  Similarity=0.266  Sum_probs=14.4

Q ss_pred             CCCCCCCEECCCCCCCCCCCHHHHCCCCCCCEECCCCCCCC
Q ss_conf             04477882113477367970232138567763035887345
Q 004642          237 TKLSQLKNLNLSSNLLSGQIPYAIGKLFNLMYLDLSKNKLS  277 (740)
Q Consensus       237 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  277 (740)
                      ..+++|+.|++++|.|+...+..+....+|+.|++++|++.
T Consensus        88 ~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          88 QKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             HHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCC
T ss_conf             65885610004357213423442220331042664899767

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.02  E-value=4.1e-11  Score=74.43  Aligned_cols=16  Identities=31%  Similarity=0.384  Sum_probs=5.9

Q ss_pred             CCCCCCCCCCCCCCCC
Q ss_conf             6655343221042046
Q 004642          147 SLRNLRGLFLYSNKLS  162 (740)
Q Consensus       147 ~l~~L~~L~Ls~N~l~  162 (740)
                      .+++|++|+|++|+|+
T Consensus        63 ~~~~L~~L~Ls~N~i~   78 (162)
T d1koha1          63 NIPELLSLNLSNNRLY   78 (162)
T ss_dssp             HCTTCCCCCCCSSCCC
T ss_pred             HCCCCCEEECCCCCCC
T ss_conf             4878788637776666

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.93  E-value=3.3e-09  Score=64.07  Aligned_cols=131  Identities=18%  Similarity=0.158  Sum_probs=86.9

Q ss_pred             EEECCCC-EEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCC--CCCCCEEEEEEEECCEEEEEEEECCC
Q ss_conf             5611451-58999991799399999836876211598999999999972049--99631164366306757899982458
Q 004642          457 CIGTGGY-GSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR--HRNIVKLYGFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       457 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~  533 (740)
                      .+..|.. +.||+....++..+++|.......      ..+..|...++.+.  .-.+.+++++...++..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH------HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEEC
T ss_conf             76786547758999938987899995896677------689999999999986599988613222456615999874413


Q ss_pred             CCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------------
Q ss_conf             870011028885334798999989999999999988269-----------------------------------------
Q 004642          534 GSLFCVLHDDDEAIELNWTKRVNIVKSVAHALSYLHHDC-----------------------------------------  572 (740)
Q Consensus       534 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----------------------------------------  572 (740)
                      .++.+..        ....   ..+.+++..+..||+..                                         
T Consensus        91 ~~~~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (255)
T d1nd4a_          91 QDLLSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  159 (255)
T ss_dssp             EETTTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCCCCCC--------CCHH---HHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHH
T ss_conf             5543221--------2689---9999999999987368854488755412468899999987541101134011213799


Q ss_pred             --------------CCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf             --------------98838627999966776999579942245300
Q 004642          573 --------------TLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       573 --------------~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                                    ...++|+|+.|.||+++.+..+.|+||+.+..
T Consensus       160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             9999998718765795678678887635773796589998533265

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.59  E-value=1.9e-07  Score=54.54  Aligned_cols=80  Identities=13%  Similarity=0.145  Sum_probs=48.5

Q ss_pred             CEEEECCCCEEEEEEEECC-CCEEEEEECCCCCCC--C--HHHHHHHHHHHHHHHCC-CC--CCCCEEEEEEEECCEEEE
Q ss_conf             4056114515899999179-939999983687621--1--59899999999997204-99--963116436630675789
Q 004642          455 KYCIGTGGYGSVYKAELPE-GKVVALKKLHHSETE--D--SAFVKSFQNEAHVLSTV-RH--RNIVKLYGFCLHKKCMFL  526 (740)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~--~~~~~~~~~E~~~l~~l-~h--~niv~~~~~~~~~~~~~l  526 (740)
                      .+.||.|....||++...+ ++.+++|.-......  +  .....+...|.+.+..+ .+  ..+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf             99807985276899995799848999617713034677788877899999999998650579885528998--5988779


Q ss_pred             EEEECCCCCC
Q ss_conf             9982458870
Q 004642          527 IYEYMERGSL  536 (740)
Q Consensus       527 v~e~~~~g~L  536 (740)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEECCCCCCC
T ss_conf             8713577653

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.44  E-value=2.9e-08  Score=58.96  Aligned_cols=115  Identities=16%  Similarity=0.151  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCCC-CCCCCC----CHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
Q ss_conf             0665534322104-204687----74542366665614221542346677754334457775123899822335577888
Q 004642          146 GSLRNLRGLFLYS-NKLSGV----LPQEIGNLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSSIPLEIGNFSALDT  220 (740)
Q Consensus       146 ~~l~~L~~L~Ls~-N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~~~~~~~~l~~L~~  220 (740)
                      .+.++|++|+|++ +.++..    +...+...++|+.|+|++|.++......+...               +...+.|+.
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~---------------L~~n~~L~~   76 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIEL---------------IETSPSLRV   76 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHH---------------HHHCSSCCE
T ss_pred             HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHH---------------HHHCCCCCC
T ss_conf             28999819782799998989999999997637764540120156215679887531---------------000234330


Q ss_pred             EECCCCCCCC----CCCCCCCCCCCCCEECCCCCCCCCC-------CHHHHCCCCCCCEECCCCCC
Q ss_conf             7557886887----6893100447788211347736797-------02321385677630358873
Q 004642          221 LDLSDNKIHG----IIPDELTKLSQLKNLNLSSNLLSGQ-------IPYAIGKLFNLMYLDLSKNK  275 (740)
Q Consensus       221 L~l~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~-------~~~~~~~l~~L~~L~l~~N~  275 (740)
                      |+|++|.|+.    .+...+...+.|+.|++++|.+...       +...+...+.|+.|+++.+.
T Consensus        77 L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          77 LNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             EECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             EEEEHHHCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             033010214599999999998489389877887768886579999999999729985386486888

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=98.44  E-value=2e-06  Score=48.93  Aligned_cols=138  Identities=13%  Similarity=0.146  Sum_probs=77.2

Q ss_pred             CCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCC--CCEEE-----EEEEECCEEEEEEEECCC
Q ss_conf             45158999991799399999836876211598999999999972049996--31164-----366306757899982458
Q 004642          461 GGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVRHRN--IVKLY-----GFCLHKKCMFLIYEYMER  533 (740)
Q Consensus       461 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~-----~~~~~~~~~~lv~e~~~~  533 (740)
                      +..-.||++...+|+.|++|+.+.....    .+++..|...+..+....  ++...     ......+..+.++++++|
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             CCCCEEEEEECCCCCEEEEEEECCCCCC----HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCC
T ss_conf             6120269998389997999984787788----999999999999998559987875206898056653479999865277


Q ss_pred             CCCHHH--------------HC----CCC--CCCCCCHH----------------------HHHHHHHHHHHHHHHH-HH
Q ss_conf             870011--------------02----888--53347989----------------------9998999999999998-82
Q 004642          534 GSLFCV--------------LH----DDD--EAIELNWT----------------------KRVNIVKSVAHALSYL-HH  570 (740)
Q Consensus       534 g~L~~~--------------l~----~~~--~~~~l~~~----------------------~~~~i~~~ia~~l~~L-H~  570 (740)
                      ..+...              +|    ...  .....++.                      .....+..+...+... ..
T Consensus       109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~  188 (325)
T d1zyla1         109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  188 (325)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf             68899999999998999999886303578655677897887665689998747699889899999999999999984545


Q ss_pred             CCCCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf             6998838627999966776999579942245300
Q 004642          571 DCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       571 ~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      ..+.+++|+|+.+.||+++++  ..++||+.+..
T Consensus       189 ~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         189 DFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CCCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             687120247888042878389--35886520146

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=98.30  E-value=5.1e-06  Score=46.71  Aligned_cols=74  Identities=22%  Similarity=0.210  Sum_probs=48.9

Q ss_pred             CEEEECCCCEEEEEEEECC--------CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCEEEEEEEECCEEE
Q ss_conf             4056114515899999179--------9399999836876211598999999999972049-996311643663067578
Q 004642          455 KYCIGTGGYGSVYKAELPE--------GKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-HRNIVKLYGFCLHKKCMF  525 (740)
Q Consensus       455 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  525 (740)
                      .+.|+.|-.-.+|++..++        .+.|.+++......     .....+|.++++.+. +.-..++++++..    +
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-----~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCCH-----HHHHHHHHHHHHHHHHCCCCCEEEEECCC----C
T ss_conf             99917853343489996887754457898179996599611-----65899999999999757999808998189----5


Q ss_pred             EEEEECCCCCCH
Q ss_conf             999824588700
Q 004642          526 LIYEYMERGSLF  537 (740)
Q Consensus       526 lv~e~~~~g~L~  537 (740)
                      .|+||++|..+.
T Consensus       118 ~I~efi~g~~l~  129 (395)
T d1nw1a_         118 RLEEYIPSRPLS  129 (395)
T ss_dssp             EEECCCCEEECC
T ss_pred             EEEEEECCCCCC
T ss_conf             699973455488

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=98.29  E-value=3.6e-06  Score=47.49  Aligned_cols=159  Identities=13%  Similarity=0.038  Sum_probs=84.6

Q ss_pred             CCHHHHHHHHCCCCCCEE-----EECCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCC-----CC
Q ss_conf             018999997215655405-----61145158999991799399999836876211598999999999972049-----99
Q 004642          440 ILYEDLINATEDFHIKYC-----IGTGGYGSVYKAELPEGKVVALKKLHHSETEDSAFVKSFQNEAHVLSTVR-----HR  509 (740)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~  509 (740)
                      .+.+++.....+|.+.+.     |..|---+.|.....+| .+++|++......     +++..|.+.+..+.     .|
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~-----~~l~~~~~~l~~L~~~g~pvp   76 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCP   76 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCCCH-----HHHHHHHHHHHHHHHCCCCCC
T ss_conf             8999999999867999856852378885267389997897-2899980789998-----899999999875430255545


Q ss_pred             CCCEEE-E--EEEECCEEEEEEEECCCCCCHHHH--------------C----CC--CCCCC------------------
Q ss_conf             631164-3--663067578999824588700110--------------2----88--85334------------------
Q 004642          510 NIVKLY-G--FCLHKKCMFLIYEYMERGSLFCVL--------------H----DD--DEAIE------------------  548 (740)
Q Consensus       510 niv~~~-~--~~~~~~~~~lv~e~~~~g~L~~~l--------------~----~~--~~~~~------------------  548 (740)
                      ..+... |  .....+..+.++.+..+.......              +    ..  .....                  
T Consensus        77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (316)
T d2ppqa1          77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  156 (316)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             CCCEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHH
T ss_conf             56410489762134125502453114655333204678888899876454443202453101110120024567777653


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf             7989999899999999999882-6998838627999966776999579942245300
Q 004642          549 LNWTKRVNIVKSVAHALSYLHH-DCTLSIIHRDISSNNILLDSNLEASVADFGTARL  604 (740)
Q Consensus       549 l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DfG~a~~  604 (740)
                      .........+......+..... ..+.|++|+|+.+.|++++.+...-|+||+.+..
T Consensus       157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf             114127999999987642048554545033378636564020454126742221236

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.04  E-value=1.9e-07  Score=54.45  Aligned_cols=128  Identities=12%  Similarity=0.151  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCHHHCCCCCCCCCCCCC-CCCCCCCHHHHC----CCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             35444345860000665534322104-204687745423----6666561422154234667775433445777512389
Q 004642          133 HGNNLTGIIPKEIGSLRNLRGLFLYS-NKLSGVLPQEIG----NLKSLTELYVTNNALGGLIPSTLFRLTNISSNQFHSS  207 (740)
Q Consensus       133 ~~n~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~n~l~~~  207 (740)
                      ....+...+.....+.++|++|+|++ +.++......+.    ..++|++|++++|.++......+...           
T Consensus         1 ~~~~i~~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~-----------   69 (166)
T d1io0a_           1 NSTDVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEM-----------   69 (166)
T ss_dssp             CCCCHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHH-----------
T ss_pred             CCCCHHHHHHHHHHCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHH-----------
T ss_conf             976399999999955999868876899998989999999888419825743015896117789999987-----------


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCE--ECCCCCCCCC----CCHHHHCCCCCCCEECCCCCC
Q ss_conf             98223355778887557886887----68931004477882--1134773679----702321385677630358873
Q 004642          208 IPLEIGNFSALDTLDLSDNKIHG----IIPDELTKLSQLKN--LNLSSNLLSG----QIPYAIGKLFNLMYLDLSKNK  275 (740)
Q Consensus       208 ~~~~~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~--L~l~~N~l~~----~~~~~~~~l~~L~~L~l~~N~  275 (740)
                          +...+.++.+++++|.++.    .+...+...+.|+.  |+++.|.+..    .+...+...++|+.|+++.+.
T Consensus        70 ----l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          70 ----LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             ----HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             ----HHHCCCCHHHHHCCCCCCCHHHHHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             ----75212210121025432201478899999848652477321677867679999999999849984788581898